Citrus Sinensis ID: 036624

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890---
Protein Sequence
MKNLNKQFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGNSKQKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDVDCKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR
Secondary Structure (PSIPRED)
cccccHHHHHHHHHHHHHHHHHHHcccccccccccEEEEcccccccccccccEEEcccccccccccccccccccccccccccccccEEEEEEccccEEEEEEccccEEEEEEEcccccccccccccEEEEEEccEEEcccccccHHccccccccEEEEEEEEEccccEEEEEEEccccccEEEEEEEEEEEccccccccccccEEccccccccccccccccEEEEEcccccccccccccccEEEcccccccccccccccEEEcccccEEEcccccccccccHHHHHHHHHccccccccccccEEEEEEcccccEEEEEEEEEcccccccccccEEEEEEEcccccccccccccccccccccEEEEEEEEcccccccccEEEEEEEcccccccccccccccEEEEEEccccccccccccccccccccccccccccccccccccccEEEEcHHHHHHHHHHHHHHHEEEccEEEccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHcccccccccEEccccEEEEEEEccccEEEEEEEccccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEccccccHHHHccccccccccHHHHHHHHHHHccccccccccccccEEEccccccccccccccccccccccccccccccccccEEEEEEcccccccHHHHHHcccccccccccHHHHHHHHHcccccccccccccccHHHHccHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHHHHHHHHHHHHccccccccccEEEEcccccccccccccEEEEcccccccccccccEEEccccccccccccccEEEEEEccccEEEEEcccccEEEEEEEEEcccccccccccEEEEEEccEEEEccccccccccccccccEEEEEEEEccccEEEEEEEcccccccEEEEEEEEEEccccHccccccccccccccccccccccccEEEEEEEEcccccccccccccccEEccccccHcccccccEEcccccccEEEcccccccccccHHHHHHHHHHccccccccccEEEEEEEcccccEEEEEEEEEEEcccccccccEEEEEEEcccEccccccHHHHccccccEEEEEEEEEEccccccEEEEEEccccccccccccccEEEEEEEEEEccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHcccccccEEEccccccEEEEEEccccEEEEEEEcccccHccHHHHHHHHHHHHHHHHHHHHHEEccccccccEEEEEHHHccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccHccEEcccccHHHEEEcccccEEEccccccccccccccccEEEEEEcccccccHHHHHHHHccccccHHHHHHEEHHHHcccccccccccHHHHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHccccc
Coil and Loop (DISEMBL)
MKNLNKQFLSTLFIFLSLASAIHVTLAadyipseqillncgessilsdddkrswtpdigskfllstkdsttskaatqdpstptipymtarvfrseftysfpvvagrkfvrlyfypnsynrlnatdalfsvstgpytllkNFSVAQTAEALNYAYVIKEyaipvdgetlnitfspmnvsnaYAFVNGievmsmpdiykntdgdlmivgqsspisidnttaLENVYrlnvggkdispsgdtdlfrswyddqpyifgaalgvpvtigpnmtvrypsnipsyvapvdvyatarqmgpnpqinlnyeLSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNnqtafpafdvagltkgngiplyqdfavfvpgngpqkdlwlglhpnvaskTQYYDAILNGVEIfklsdpnsnlagpnpipapkqdvvdpslalpssssgnskqkaiiggGVGGGIALALVVGFCVFAasrcrrqgkdpsssdaqsgwlplslygnshsagsaktnttgsyasslpsnlcrhfSFAEIKAATNNFDEALLLGVGgfgkvyrgeidgATTKVAIKrgnplseqgvHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHlyktqkpplpwkqRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSdfglsktgptldhthvstvvkgsfgyldpeyfrrqqlteksdvySFGVVLFEILCarpalnptlpkeQVSLAEWAAHCHKKGILEqimdpylkgkiapECFKKFAETAMKCVsdqgierpsmgDVLWNLEFALQLQESAEESgkvlgggmdieegafdvdckgkkdpnacsgfngnitdsrstgmsmsiggrslasedsdgltpsavfsqimnpkgr
Flexible Loop (DISEMBL)
MKNLNKQFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKfllstkdsttskaatqdpstptipYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLnvggkdispsgDTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGNSKQKAIIGGGVGGGIALALVVGFCVFAASRCrrqgkdpsssdaqsgWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYktqkpplpwKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGlsktgptldhthvstVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDVDCKGkkdpnacsgfngnitdsrstgMSMSIGGRSLasedsdgltpsavfsqimnpkgr
Low Complexity Region (SEG)
MKNLNKQFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGskfllstkdsttskaatQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDpslalpssssGNSKQKaiigggvgggialalvvgFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDVDCKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR
Disordered region (IsUnstruct)
******QFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSIL*************************************IPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKL**************************************AIIGGGVGGGIALALVVGFCVFAASRC********************************************SNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQ***************I**GAFDV**********************************************************
Disordered Region (DISOPRED)
******Q*LSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSK***********************PYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMG***QINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNVAS*TQYYDAILNGVEIFKLSDPNSNLAG********************************GGGVGGGIALALVVGFCVFAASRCRRQ*********************************************RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL**QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA******************************************************************************IMNP***
Disordered Region (DISEMBL)
MKNLNKQFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTK*************TPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSL***********QKAIIGGGVGGGIALALVVGFCVFAASRC*************SGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDVDCKGKKDPNACSGFNGNITDSRSTGMSMSIGGR*********LTPSAVFSQIMNPKGR
Disordered Region (DISPRO)
*KNLNKQFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNL*G**************************KQKAIIGGGVGGGIALALVVGFCVFAASRCRRQ*****************************************SNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAE*****************************************************************************
Transmembrane Helix (TMHMM)
iiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKNLNKQFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGNSKQKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDVDCKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	893	2.2.26 [Sep-21-2011]
Q9SCZ4	895	Receptor-like protein kin	yes	no	0.997	0.995	0.738	0.0
Q9SR05	850	Receptor-like protein kin	no	no	0.903	0.949	0.524	0.0
Q3E8W4	858	Receptor-like protein kin	no	no	0.935	0.973	0.511	0.0
Q9FID8	873	Putative receptor-like pr	no	no	0.951	0.973	0.488	0.0
Q9FID9	880	Probable receptor-like pr	no	no	0.952	0.967	0.472	0.0
Q9LK35	855	Receptor-like protein kin	no	no	0.942	0.984	0.447	0.0
Q9SA72	849	Probable receptor-like pr	no	no	0.873	0.918	0.445	0.0
Q9FLJ8	842	Probable receptor-like pr	no	no	0.849	0.901	0.455	1e-179
Q9LX66	830	Receptor-like protein kin	no	no	0.914	0.984	0.418	1e-177
Q9T020	878	Probable receptor-like pr	no	no	0.910	0.925	0.422	1e-177

>sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1

 Score = 1343 bits (3475), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 662/897 (73%), Positives = 749/897 (83%), Gaps = 6/897 (0%)

Query: 1   MKNLNKQFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGE-SSILSDDDKRSWTPDIG 59
           MK    +F  +L + L L SA  +  AADY P+E+ILLNCG  +S L+D D R W  D+ 
Sbjct: 1   MKITEGRFRLSLLLLLLLISAATLISAADYSPTEKILLNCGGGASNLTDTDNRIWISDVK 60

Query: 60  SKFLLSTKDSTTSKAA-TQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSY 118
           SKFL S+ + + +  A TQDPS P +PYMTARVFRS FTY+FPV +GRKFVRLYFYPNSY
Sbjct: 61  SKFLSSSSEDSKTSPALTQDPSVPEVPYMTARVFRSPFTYTFPVASGRKFVRLYFYPNSY 120

Query: 119 NRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNV- 177
           + LNAT++LFSVS GPYTLLKNFS +QTAEAL YA++IKE+ + V+G TLN+TF+P +  
Sbjct: 121 DGLNATNSLFSVSFGPYTLLKNFSASQTAEALTYAFIIKEFVVNVEGGTLNMTFTPESAP 180

Query: 178 SNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSG 237
           SNAYAFVNGIEV SMPD+Y +TDG L +VG S  ++IDN+TALENVYRLNVGG DISPS 
Sbjct: 181 SNAYAFVNGIEVTSMPDMYSSTDGTLTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSA 240

Query: 238 DTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQI 297
           DT L+RSWYDDQPYIFGA LG+P T  PNMT++YP+  P+YVAPVDVY+TAR MGP  QI
Sbjct: 241 DTGLYRSWYDDQPYIFGAGLGIPETADPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQI 300

Query: 298 NLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKG 357
           NLNY L+W+FS+DSGF+YLVRLHFCEV   ITKINQRVF I LNNQTA P  DV   T  
Sbjct: 301 NLNYNLTWIFSIDSGFTYLVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSS 360

Query: 358 NGIPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPN 417
           NG+P ++D+ V  P    Q+DLWL LHPN  +K +YYD++LNGVEIFK++  + NLAG N
Sbjct: 361 NGVPFHKDYVVNPPEGNGQQDLWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTN 420

Query: 418 PIPAPKQDVVDPSLALPSSSSGNSKQKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKD 477
           PIP P Q   DPS  L  ++  +    AII G   G + LAL++GFCVF A R R++G  
Sbjct: 421 PIPGP-QVTADPSKVLRPTTRKSKSNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDY 479

Query: 478 PSSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEA 537
             +SDA SGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAAT NFDE+
Sbjct: 480 QPASDATSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDES 539

Query: 538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
            +LGVGGFGKVYRGEIDG TTKVAIKRGNP+SEQGVHEFQTEIEMLSKLRHRHLVSLIGY
Sbjct: 540 RVLGVGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 599

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           CEENCEMILVYDYMA+GT+REHLYKTQ P LPWKQRLEICIGAARGLHYLHTGAKHTIIH
Sbjct: 600 CEENCEMILVYDYMAHGTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIH 659

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS
Sbjct: 660 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 719

Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECF 777
           DVYSFGVVLFE LCARPALNPTL KEQVSLAEWA +C+KKG+L+QI+DPYLKGKI PECF
Sbjct: 720 DVYSFGVVLFEALCARPALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECF 779

Query: 778 KKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDV-D 836
           KKFAETAMKCV DQGIERPSMGDVLWNLEFALQLQESAEE+GK + G MD++E  +D  +
Sbjct: 780 KKFAETAMKCVLDQGIERPSMGDVLWNLEFALQLQESAEENGKGVCGDMDMDEIKYDDGN 839

Query: 837 CKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
           CKGK D  +   + GN+TDSRS+G+ MSIGGRSLASEDSDGLTPSAVFSQIMNPKGR
Sbjct: 840 CKGKND-KSSDVYEGNVTDSRSSGIDMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 895

Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1

 Score =  868 bits (2243), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 460/877 (52%), Positives = 600/877 (68%), Gaps = 70/877 (7%)

Query: 34  EQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDPST-PTIPYMTARVF 92
           + + L+CG S   +D DK+ W PD  +KFL  T +S  + A  QDPS   T+PYMTAR+F
Sbjct: 27  QDLALSCGTSEASADQDKKKWEPD--TKFL-KTGNSIHATATYQDPSLLSTVPYMTARIF 83

Query: 93  RSEFTYSFPVVAG-RKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALN 151
            +  TY  P+    R  +RLYFYP++Y  LN +++ F+V     TLL NFS A T +AL 
Sbjct: 84  TAPATYEIPIKGDKRHLLRLYFYPSTYTGLNISNSYFTVEANDVTLLSNFSAAITCQALT 143

Query: 152 YAYVIKEYAI-PVDGETLNITFSPMN-VSNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQS 209
            AY++KEY++ P D + L+I F+P +   +A+AF+NGIEV+ MP+++        +VG +
Sbjct: 144 QAYLVKEYSLAPTDKDVLSIKFTPSDKYRDAFAFINGIEVIQMPELFDTA----ALVGFT 199

Query: 210 SPISIDNTTALENVYRLNVGGKDISPSGDTD-LFRSWYDDQPYIFGAALGVPVTIGPNMT 268
                  T  L++++RLNVGG+DI  S D+  L R+WY+D PYIF A LGV +    N  
Sbjct: 200 DQTMDAKTANLQSMFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFR 259

Query: 269 VRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEI 328
           + Y  N+P  +AP D+Y TAR  GPN  INL   L+W+F +D  F+Y++RLHFCE   ++
Sbjct: 260 INY-QNMPVSIAPADIYKTARSQGPNGDINLKSNLTWMFQIDKNFTYILRLHFCEF--QL 316

Query: 329 TKINQRVFDILLNNQTA----FPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLH 384
           +KINQ+VF+I +NN+TA     PA D+ G T   GIP+Y+D+A++V  N   +++ L + 
Sbjct: 317 SKINQKVFNIYINNRTAQADTTPA-DIIGWTGEKGIPMYKDYAIYVDANNGGEEITLQMT 375

Query: 385 PNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGNSKQK 444
           P+   + +YYD+ LNG+EIFK+ D   NLAGPNP P+P Q   +           N K+ 
Sbjct: 376 PSTFGQPEYYDSSLNGLEIFKM-DTMKNLAGPNPEPSPMQAEEEVKKEFK-----NEKRH 429

Query: 445 AIIGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKT 504
           A I G  GG   LA+++G   F A + ++QG     S   S WLP+  YGNS ++G+  T
Sbjct: 430 AFIIGSAGG--VLAVLIGALCFTAYK-KKQGYQGGDSHTSS-WLPI--YGNSTTSGTKST 483

Query: 505 ----NTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKV 560
               +  GS+ S+L + LCR FS  EIK  T NFD++ ++GVGGFGKVY+G IDG TTKV
Sbjct: 484 ISGKSNNGSHLSNLAAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDG-TTKV 542

Query: 561 AIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL 620
           A+K+ NP SEQG++EF+TEIE+LS+LRH+HLVSLIGYC+E  EM LVYDYMA+GTLREHL
Sbjct: 543 AVKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHL 602

Query: 621 YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL 680
           Y T+KP L WK+RLEI IGAARGLHYLHTGAK+TIIHRDVKTTNIL+DE WVAKVSDFGL
Sbjct: 603 YNTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDFGL 662

Query: 681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTL 740
           SKTGP ++  HV+TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNP+L
Sbjct: 663 SKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPSL 722

Query: 741 PKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGD 800
           PKEQVSL +WA +C +KG LE I+DP LKGKI  EC KKFA+TA KC++D G+ERP+MGD
Sbjct: 723 PKEQVSLGDWAMNCKRKGNLEDIIDPNLKGKINAECLKKFADTAEKCLNDSGLERPTMGD 782

Query: 801 VLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDVDCKGKKDPNACSGFNGNITDSRSTG 860
           VLWNLEFALQLQE+A                    D    + PN      G+  D    G
Sbjct: 783 VLWNLEFALQLQETA--------------------DGTRHRTPNN----GGSSEDLGRGG 818

Query: 861 MSMSIGGR----SLASEDSDGLTPSAVFSQIMNPKGR 893
           M++++ GR     L+SED+     + +FSQI+NPKGR
Sbjct: 819 MAVNVAGRDDVSDLSSEDN-----TEIFSQIVNPKGR 850

Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1

 Score =  852 bits (2200), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 462/904 (51%), Positives = 599/904 (66%), Gaps = 69/904 (7%)

Query: 9   LSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKD 68
           L  LF FL     + V+ +      + I L+CG S    D DK+ W PD  +KFL  T +
Sbjct: 5   LRILFSFLCFFYVLLVSPSQS--NGQDISLSCGASEPAVDQDKKKWEPD--TKFL-KTPN 59

Query: 69  STTSKAATQDPST-PTIPYMTARVFRSEFTYSFPVVAG-RKFVRLYFYPNSYNRLNATDA 126
           +  + A  QDPS   T+PYMT+R+F +  TY  PV    R  +RL+FYP++Y  LN  D+
Sbjct: 60  TVHAPATYQDPSLLSTVPYMTSRIFTAPATYEIPVKGDKRHMLRLHFYPSTYTGLNILDS 119

Query: 127 LFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAI-PVDGETLNITFSPMNVS-NAYAFV 184
            FSV+    TLL NFS A T +AL  AY+++EY++ P + + L+I F+P +    A+AF+
Sbjct: 120 YFSVAANDLTLLSNFSAAITCQALTQAYLVREYSLAPSEKDVLSIIFTPSDKHPKAFAFI 179

Query: 185 NGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTD-LFR 243
           NGIEV+ MP+++        +VG S   S   T  L+ ++RLNVGG+DI  S D+  L R
Sbjct: 180 NGIEVIPMPELFDTAS----LVGFSDQTSDTKTANLQTMFRLNVGGQDIPGSQDSGGLTR 235

Query: 244 SWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYEL 303
           +WY+D PYIF A LGV +    N  + Y   +P   AP DVY TAR  GPN  IN+   L
Sbjct: 236 TWYNDAPYIFSAGLGVTLQASNNFRIDY-QKMPVSTAPADVYKTARSQGPNGDINMKSNL 294

Query: 304 SWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTA----FPAFDVAGLTKGNG 359
           +W+F VD+ F+Y++RLHFCE   ++ KINQ+VF+I +NN+TA     PA D+ G T G G
Sbjct: 295 TWMFQVDTNFTYIMRLHFCEF--QLAKINQKVFNIFINNRTAQGDTNPA-DILGWTGGKG 351

Query: 360 IPLYQDFAVFVPGN--GPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPN 417
           IP Y+D+A++V  N  G  +++ L + P+   + +YYD+ LNG+EIFK+ D   NLAGPN
Sbjct: 352 IPTYKDYAIYVDANTGGGGEEISLQMTPSTFGQPEYYDSQLNGLEIFKI-DTMKNLAGPN 410

Query: 418 PIPAPKQDVVDPSLALPSSSSGNSKQKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKD 477
           P P+P Q   D    +     G+ +  A + G  GG  A    V FC    +  +R+ K 
Sbjct: 411 PKPSPMQANED----VKKDFQGDKRITAFVIGSAGGVAA----VLFCALCFTMYQRKRKF 462

Query: 478 PSSSDAQSGWLPLSLYGNSHSAGSAKT----NTTGSYASSLPSNLCRHFSFAEIKAATNN 533
             S    S WLP+  YGNSH++ +  T    +  GS+ S+L + LCR FS +EIK  T+N
Sbjct: 463 SGSDSHTSSWLPI--YGNSHTSATKSTISGKSNNGSHLSNLAAGLCRRFSLSEIKHGTHN 520

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           FDE+ ++GVGGFGKVY+G IDG T KVAIK+ NP SEQG++EF+TEIE+LS+LRH+HLVS
Sbjct: 521 FDESNVIGVGGFGKVYKGVIDGGT-KVAIKKSNPNSEQGLNEFETEIELLSRLRHKHLVS 579

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           LIGYC+E  EM L+YDYM+ GTLREHLY T++P L WK+RLEI IGAARGLHYLHTGAK+
Sbjct: 580 LIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYLHTGAKY 639

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
           TIIHRDVKTTNILLDE WVAKVSDFGLSKTGP ++  HV+TVVKGSFGYLDPEYFRRQQL
Sbjct: 640 TIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQL 699

Query: 714 TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA 773
           TEKSDVYSFGVVLFE+LCARPALNP+L KEQVSL +WA +C +KG LE I+DP LKGKI 
Sbjct: 700 TEKSDVYSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLEDIIDPNLKGKIN 759

Query: 774 PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAF 833
           PEC KKFA+TA KC+SD G++RP+MGDVLWNLEFALQLQE+A                  
Sbjct: 760 PECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEFALQLQETA------------------ 801

Query: 834 DVDCKGKKDPNACSGFNGNITDSRSTGMSMSIG----GRSLASEDSDGLTPSAVFSQIMN 889
             D    + P+   G            +++S G    G  L+SE++ G     +FSQI+N
Sbjct: 802 --DGSRHRTPSNGGGSVDLGGGGGGVTVNISAGESDLGDDLSSEENSG-----IFSQIVN 854

Query: 890 PKGR 893
           PKGR
Sbjct: 855 PKGR 858

Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1

 Score =  779 bits (2012), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 440/900 (48%), Positives = 569/900 (63%), Gaps = 50/900 (5%)

Query: 12  LFIFLSLASAIHVTLAAD--YIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLS--TK 67
           L IF  L S   V   A   Y P++  L NCG++S   D   R+WT +   K L S    
Sbjct: 6   LLIFSILVSTPIVGEGATSTYEPTDVFLFNCGDTSNNVDVSGRNWTAE-NQKILSSNLVN 64

Query: 68  DSTTSKAATQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSY-NRLNATDA 126
            S T++A+ Q+     IPYMTAR+FRSEFTYSFPV  G  F+RLYFYP  Y ++ NA  +
Sbjct: 65  ASFTAQASYQESGVSQIPYMTARIFRSEFTYSFPVTPGSNFLRLYFYPTRYGSQFNAVKS 124

Query: 127 LFSVSTGPYTLLKNFSVAQTAEAL--NYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFV 184
            FSV    +TLL NFS   T +A      ++IKE+ IPV  +TLN+TF+P    ++ AFV
Sbjct: 125 FFSVKVNGFTLLNNFSADLTVKASKPQTEFIIKEFIIPV-YQTLNLTFTPS--LDSLAFV 181

Query: 185 NGIEVMSMPDIYKNTDG--DLMI-VGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDL 241
           NGIE++S+P+ + +  G  D++  VG S    I+N+TA E VYRLNVGGK +   GD+ +
Sbjct: 182 NGIEIVSIPNRFYSKGGFDDVITNVGSSVDFHIENSTAFETVYRLNVGGKTV---GDSGM 238

Query: 242 FRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMG--PNPQINL 299
           FR W  D   I   + G+   I P++ + Y    PSYVAP DVYAT+R MG   +P+ NL
Sbjct: 239 FRRWVSDDEIILSESSGIS-PIVPDIKINYTEKTPSYVAPDDVYATSRSMGNADHPEQNL 297

Query: 300 NYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNG 359
           N+ L+W+F+VD+GFSYLVRLHFCE L E+ K  QRVF I + NQTA    DV  ++ G+ 
Sbjct: 298 NFNLTWLFTVDAGFSYLVRLHFCETLSEVNKEGQRVFSIFIENQTATLEMDVFRMSGGSW 357

Query: 360 IPLYQDFAVFV-PGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNP 418
           IP+Y D+ V    G+G + DL L LHP V+   +YYDAILNGVEI K++DP+ NLAGPNP
Sbjct: 358 IPMYLDYTVIAGSGSGRRHDLRLDLHPLVSINPKYYDAILNGVEILKMNDPDGNLAGPNP 417

Query: 419 IPAPKQDVVDPSLALPSSSSGNSKQKAIIGGGVGGGIALAL-VVGFCVFAASRCRRQGKD 477
            P    D++ P+ A P      S    I    VG  + LA+ VVG  V    + +     
Sbjct: 418 DPLVSPDLI-PNRATPRIRKNKSHILPITLAVVGSLVVLAMFVVGVLVIMKKKKK----- 471

Query: 478 PSSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEA 537
            S     S W PL         G+  TNT    A SLP++LCR FS  EIK+ATN+F++ 
Sbjct: 472 -SKPSTNSSWCPLP-------HGTDSTNTKP--AKSLPADLCRRFSIFEIKSATNDFEDK 521

Query: 538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           L++GVGGFG VY+G+IDG  T VA+KR    S QG  EF+TE+EMLSKLRH HLVSLIGY
Sbjct: 522 LIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFETELEMLSKLRHVHLVSLIGY 581

Query: 598 CEENCEMILVYDYMAYGTLREHLY---KTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
           C+E+ EM+LVY+YM +GTL++HL+   KT  PPL WK+RLEICIGAARGL YLHTGAK+T
Sbjct: 582 CDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLEICIGAARGLQYLHTGAKYT 641

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQQL 713
           IIHRD+KTTNILLDE +V KVSDFGLS+ GPT    THVSTVVKG+FGYLDPEY+RRQ L
Sbjct: 642 IIHRDIKTTNILLDENFVTKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQVL 701

Query: 714 TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA 773
           TEKSDVYSFGVVL E+LC RP    ++P EQ  L  W    +++G ++QI+D  L   I 
Sbjct: 702 TEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVKSNYRRGTVDQIIDSDLSADIT 761

Query: 774 PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAF 833
               +KF E A++CV D+G+ERP M DV+W LEFALQL E+A++    +     +  G  
Sbjct: 762 STSLEKFCEIAVRCVQDRGMERPPMNDVVWALEFALQLHETAKKKNDNVESLDLMPSGEV 821

Query: 834 DVDCKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
                G+ D    S   G++  S +T  S+ + G      D    +   VFS+I  PK R
Sbjct: 822 GTTTDGEDD--LFSRTTGHVGKSTTTDDSVLVVG------DERSGSSWGVFSEINEPKAR 873

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1

 Score =  733 bits (1893), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 428/906 (47%), Positives = 551/906 (60%), Gaps = 55/906 (6%)

Query: 12  LFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLST---KD 68
           L IF  L SA+ V   A Y P++  L+NCG++S   D   R+WT +   KF+ S      
Sbjct: 6   LVIFTILVSAV-VDATASYEPTDVFLINCGDTSNNMDYSGRNWTTE-NPKFMSSNAVDDA 63

Query: 69  STTSKAATQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSY-NRLNATDAL 127
           S TS A+ Q+   P +PY+ AR+FR +FTYSFPV  G KF+RLYFYP  Y +  +A  + 
Sbjct: 64  SFTSSASYQESGIPQVPYLKARIFRYDFTYSFPVSPGWKFLRLYFYPTRYGSDFDAVKSF 123

Query: 128 FSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGI 187
           FSV+   +TLL NFSV   A     + +IKE+ +PV+ +TL++TF+P    N+ AFVNGI
Sbjct: 124 FSVNVNRFTLLHNFSVK--ASIPESSSLIKEFIVPVN-QTLDLTFTPS--PNSLAFVNGI 178

Query: 188 EVMSMPDIYKNTDG-DLMI--VGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRS 244
           E++SMPD + +  G D ++  VG+     IDN+TA E VYR+NVGGK +   GD+ +FR 
Sbjct: 179 EIISMPDRFYSKGGFDDVVRNVGRDVDFEIDNSTAFETVYRVNVGGKVVGDVGDSGMFRR 238

Query: 245 WYDDQPYIFGAALGVPVTIGPNMT---VRYPSNIPSYVAPVDVYATARQMG--PNPQINL 299
           W  D+ ++ G   G      PN+T   + Y    P+YVAP DVY T R MG   +P++NL
Sbjct: 239 WLSDEGFLLGINSGAI----PNITGVKINYTDKTPAYVAPEDVYTTCRLMGNKDSPELNL 294

Query: 300 NYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNG 359
           N+ L+W+F VD+GF+Y+VRLHFCE  PE+ K   RVF I    Q A    DV  L+ G  
Sbjct: 295 NFNLTWLFEVDAGFAYIVRLHFCETQPEVNKTGDRVFSIFFGYQLAMREMDVFRLSGGFR 354

Query: 360 IPLYQDFAVFVPGNGPQK--DLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPN 417
           +P+Y DF V V  +G  +   L + L P       YYDAIL+GVEI KLS+ + NLAG N
Sbjct: 355 LPMYLDFKVLVDADGTSQRPSLRVDLTPYKEDYPTYYDAILSGVEILKLSNSDGNLAGLN 414

Query: 418 PIPAPKQDVVDPSLALPSSSSGNSKQKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKD 477
           PIP   Q    P    P    G S     I   V G           V      R++  +
Sbjct: 415 PIP---QLSPPPQSITPLKGKGKSSHVLPIIIAVVGSAVALAFFVLVVVLVVMKRKKKSN 471

Query: 478 PSSSD------AQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAAT 531
            SS D        S W PL      H  GS  T +    ASSLPS+LCR FS  EIK+AT
Sbjct: 472 ESSVDTTNKPSTNSSWGPL-----LHGTGSTNTKS----ASSLPSDLCRRFSIYEIKSAT 522

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           N+F+E L++GVGGFG VY+G IDG  T VA+KR    S QG  EF TE+EMLSKLRH HL
Sbjct: 523 NDFEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTELEMLSKLRHVHL 582

Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK---PPLPWKQRLEICIGAARGLHYLH 648
           VSLIGYC+++ EM+LVY+YM +GTL++HL++  K   PPL WK+RLEICIGAARGL YLH
Sbjct: 583 VSLIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLEICIGAARGLQYLH 642

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEY 707
           TGAK+TIIHRD+KTTNILLDE +VAKVSDFGLS+ GPT    THVSTVVKG+FGYLDPEY
Sbjct: 643 TGAKYTIIHRDIKTTNILLDENFVAKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEY 702

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY 767
           +RRQ LTEKSDVYSFGVVL E+LC RP    ++P EQ  L  W      K  ++QI+D  
Sbjct: 703 YRRQILTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVKSNFNKRTVDQIIDSD 762

Query: 768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMD 827
           L   I     +KF E A++CV D+G+ERP M DV+W LEFALQL E+A++    +     
Sbjct: 763 LTADITSTSMEKFCEIAIRCVQDRGMERPPMNDVVWALEFALQLHETAKKKNDNVESLDL 822

Query: 828 IEEGAFDVDCKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQI 887
           +  G       G+ D    S   G++  S +T  S+ + G      D    +   VFS+I
Sbjct: 823 MPSGEVGTTTDGEDD--LFSRTTGHVGKSTTTDDSVLVVG------DERSGSSWGVFSEI 874

Query: 888 MNPKGR 893
             PK R
Sbjct: 875 NEPKAR 880

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1

 Score =  674 bits (1740), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 401/897 (44%), Positives = 551/897 (61%), Gaps = 55/897 (6%)

Query: 8   FLSTLFIFLSLASAIHVTLA-ADYIPSEQILLNCGESSILSDDDKRSWTPD-IGSKFLLS 65
           F  +L + L   S    T + A + P +  L++CG S  ++  + R + PD + S  +L 
Sbjct: 3   FTKSLLVLLWFLSCYTTTTSSALFNPPDNYLISCGSSQNITFQN-RIFVPDSLHSSLVLK 61

Query: 66  TKDSTTSKAATQDPSTPTIPYMTARVFRSEFTYSFPVVA-GRKFVRLYFYPNSYNRLNAT 124
             +S+ + + T + ST +I Y TARVF S  +Y F + + GR ++RL+F P + +  N T
Sbjct: 62  IGNSSVATSTTSNNSTNSI-YQTARVFSSLASYRFKITSLGRHWIRLHFSPINNSTWNLT 120

Query: 125 DALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFV 184
            A  +V T  + LL NFS      +    Y+ KEY + V  E L ++F P N  N+  FV
Sbjct: 121 SASITVVTEDFVLLNNFSFNNFNGS----YIFKEYTVNVTSEFLTLSFIPSN--NSVVFV 174

Query: 185 NGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRS 244
           N IEV+S+PD         + +  S+P S  +  A E VYRLN+GG  ++   DT L R 
Sbjct: 175 NAIEVVSVPD--NLIPDQALALNPSTPFSGLSLLAFETVYRLNMGGPLLTSQNDT-LGRQ 231

Query: 245 WYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELS 304
           W +D  Y+   +  + VT  P+ +++Y  ++    AP  VYATA  MG     + ++ ++
Sbjct: 232 WDNDAEYLHVNSSVLVVTANPS-SIKYSPSVTQETAPNMVYATADTMGDANVASPSFNVT 290

Query: 305 WVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQ 364
           WV  VD  F Y VR+HFC+++ +   +N  VF++ +N+  A  + D++ LT G  +P ++
Sbjct: 291 WVLPVDPDFRYFVRVHFCDIVSQ--ALNTLVFNLYVNDDLALGSLDLSTLTNGLKVPYFK 348

Query: 365 DFAVFVPGNGPQKD---LWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPA 421
           DF      NG  +    L + + P+  S+    +A +NG+E+ K+S+   +L+G + + +
Sbjct: 349 DFI----SNGSVESSGVLTVSVGPD--SQADITNATMNGLEVLKISNEAKSLSGVSSVKS 402

Query: 422 PKQDVVDPSLALPSSSSGNSKQKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSS 481
                      LP  S   SK+KA+I G + G + L L++  C +      R+ +  S  
Sbjct: 403 ----------LLPGGSGSKSKKKAVIIGSLVGAVTLILLIAVCCYCCLVASRKQRSTSPQ 452

Query: 482 DAQSG--WLPLSLYGNSHS---AGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDE 536
           +  +G  WLPL LYG S +   + ++  + T S  S   ++L R F F EI  ATN FDE
Sbjct: 453 EGGNGHPWLPLPLYGLSQTLTKSTASHKSATASCISLASTHLGRCFMFQEIMDATNKFDE 512

Query: 537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           + LLGVGGFG+VY+G ++  T KVA+KRGNP SEQG+ EF+TEIEMLSKLRHRHLVSLIG
Sbjct: 513 SSLLGVGGFGRVYKGTLEDGT-KVAVKRGNPRSEQGMAEFRTEIEMLSKLRHRHLVSLIG 571

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
           YC+E  EMILVY+YMA G LR HLY    PPL WKQRLEICIGAARGLHYLHTGA  +II
Sbjct: 572 YCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGAARGLHYLHTGASQSII 631

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRDVKTTNILLDE  VAKV+DFGLSKTGP+LD THVST VKGSFGYLDPEYFRRQQLTEK
Sbjct: 632 HRDVKTTNILLDENLVAKVADFGLSKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 691

Query: 717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC 776
           SDVYSFGVVL E+LC RPALNP LP+EQV++AEWA    KKG+L+QIMD  L GK+ P  
Sbjct: 692 SDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPAS 751

Query: 777 FKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDVD 836
            KKF ETA KC+++ G++RPSMGDVLWNLE+ALQL    EE+   L    D         
Sbjct: 752 LKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQL----EETSSALMEPDDNSTNHIPGI 807

Query: 837 CKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
                +P     F+ +++     G++   G      +D++  T SAVFSQ+++P+GR
Sbjct: 808 PMAPMEP-----FDNSMSIIDRGGVNSGTG----TDDDAEDATTSAVFSQLVHPRGR 855

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  644 bits (1662), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/833 (44%), Positives = 494/833 (59%), Gaps = 53/833 (6%)

Query: 1   MKNLNKQFLSTLFIFLSLASAIHVTLAADY--IPSEQILLNCGESSILSDDDKRSWTPDI 58
           M  L K++L  L   L     I  T    Y    S+  L++CG S+  ++ D R+W  D+
Sbjct: 1   MSKLRKKYLEHLLCVL-----IFFTYVIGYGEAQSKSFLVDCG-SNATTEVDGRTWVGDL 54

Query: 59  --GSKFLLSTKDSTTSKAATQDPSTPTIPYMTARVFRSEFTYSFP-VVAGRKFVRLYFYP 115
                  L   D+ T+ + ++  S     Y TARVF +   Y+F  +  G  FVRL+F P
Sbjct: 55  SPNKSVTLQGFDAITA-STSKGSSVYAEIYKTARVFDAVLNYTFEGITQGNYFVRLHFSP 113

Query: 116 NSYNRLNATDALFSVSTGPYTLL-----------KNFSVAQTAEALNYAYVIKEYAIPVD 164
            +    N  ++ FSV      L+           KN  +  T      + ++KE+ +P  
Sbjct: 114 FAIENHNVNESSFSVFADGLRLMLDINIAGEIAHKNLILESTGHNATASSLVKEFLLPTG 173

Query: 165 GETLNITFSPMNVSNAYAFVNGIEVMSMPD-IYKNTDGDLMIVGQSSPISIDNTTALENV 223
              L ++F P   S  + FVN IE++S+ D ++K +   +  VG S          +E +
Sbjct: 174 PGKLVLSFIPEKGS--FGFVNAIEIVSVDDKLFKES---VTKVGGSEVELGLGGRGIETM 228

Query: 224 YRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVD 283
           YRLNVGG  + PS D  L+R+W  D  Y+     GV V    N+T     + P  VAP+ 
Sbjct: 229 YRLNVGGPKLGPSKDLKLYRTWETDLSYMVIENAGVEVKNSSNITYALADDSP--VAPLL 286

Query: 284 VYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQ 343
           VY TAR M     +   + +SW F VD  F YLVRLHFCE+L  + K NQR+F I +NNQ
Sbjct: 287 VYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVRLHFCELL--VDKQNQRIFRIYINNQ 344

Query: 344 TAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEI 403
           TA   FD+     G    +YQD+    P +     LW+ L P+ +S     DA+L+G+EI
Sbjct: 345 TAAGNFDIFAHAGGKNKGIYQDY--LDPVSSKNDVLWIQLGPD-SSVGASGDALLSGLEI 401

Query: 404 FKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGNSKQKAIIGGGVGGGIALALVVGF 463
           FKLS  N NLA      +    V D  +              II   VG GIA+ +   F
Sbjct: 402 FKLS-KNGNLAHLIRFDSTGHSVSDSKMR-------------IIWISVGAGIAIIIFFVF 447

Query: 464 C-VFAASRCR-RQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRH 521
             +     C+ R+ K   S +   GW PL L+ N+ +A +  T  +    +   S + R 
Sbjct: 448 LGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATGGSLRLNTLAASTMGRK 507

Query: 522 FSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIE 581
           F+ AEI+AAT NFD+ L +GVGGFGKVYRGE++  T  +AIKR  P S+QG+ EF+TEI 
Sbjct: 508 FTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTL-IAIKRATPHSQQGLAEFETEIV 566

Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
           MLS+LRHRHLVSLIG+C+E+ EMILVY+YMA GTLR HL+ +  PPL WKQRLE CIG+A
Sbjct: 567 MLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGSA 626

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
           RGLHYLHTG++  IIHRDVKTTNILLDE +VAK+SDFGLSK GP++DHTHVST VKGSFG
Sbjct: 627 RGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHTHVSTAVKGSFG 686

Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE 761
           YLDPEYFRRQQLTEKSDVYSFGVVLFE +CAR  +NPTLPK+Q++LAEWA    K+  LE
Sbjct: 687 YLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQKQRNLE 746

Query: 762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
            I+D  L+G  +PE  +K+ E A KC++D+G  RP MG+VLW+LE+ LQ+ E+
Sbjct: 747 SIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQIHEA 799

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1

 Score =  629 bits (1621), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 376/826 (45%), Positives = 509/826 (61%), Gaps = 67/826 (8%)

Query: 24  VTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGS-KFLLSTKDSTTS--KAATQDPS 80
           V  ++ + P++  L++CG S      D R++  D  S  FL + +D  TS       D +
Sbjct: 22  VKSSSSFTPADNYLIDCGSSDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSN 81

Query: 81  TPTIP-YMTARVFRSEFTYSFPVVA-GRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLL 138
             T+P Y+TAR+F  + TYSF +   GR ++RL+FYP ++   N T+++FSV+T    LL
Sbjct: 82  ASTLPLYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTTVLL 141

Query: 139 KNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKN 198
            +FS   T+     + V KEY I    E L++ F P   S A  F+N +E++S+PD  + 
Sbjct: 142 HDFSAGDTS-----SIVFKEYLI-YAAEKLSLYFKPHKGSTA--FINAVEIVSVPD--EL 191

Query: 199 TDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALG 258
                  V Q+      ++ +LE ++R+N+GG  ISP  D  L R+W  D+PY       
Sbjct: 192 VPDSASSVPQAPDFKGLSSFSLEILHRINIGGDLISPKIDP-LSRTWLSDKPYNTFPEGS 250

Query: 259 VPVTIGPNMTVRYPSN-IPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLV 317
             VT+ P+ T+ YP     + +AP  VYATA +M        N+ LSW  SVD G  Y +
Sbjct: 251 RNVTVDPS-TITYPDGGATALIAPNPVYATAEEMADAQTSQPNFNLSWRMSVDFGHDYFI 309

Query: 318 RLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPG--NGP 375
           RLHFC+++ +   +N  +F++ +N  +A  A D++ LT   G   Y DF +      NG 
Sbjct: 310 RLHFCDIVSK--SLNDLIFNVFINKLSAISALDLSSLTSALGTAYYADFVLNASTITNGS 367

Query: 376 QKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPS 435
              + +G  PN+ S     +AILNG+EI KL++   +L G   +    +  +        
Sbjct: 368 IL-VQVGPTPNLQSGKP--NAILNGLEIMKLNNAAGSLDGLFGVDGKYKGPI-------- 416

Query: 436 SSSGNSKQKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGN 495
              G    K +   G+G  +AL   +G  V    R +R+ KD    ++ S WL L L+  
Sbjct: 417 ---GGMSSKKLAIAGIGFVMALTAFLGVVVLLV-RWQRRPKDWQKQNSFSSWL-LPLHA- 470

Query: 496 SHSA----------------GSAKTNTTGSYASSLPSN--LCRHFSFAEIKAATNNFDEA 537
           SHS+                GS K+ + G   SS  SN  L R+F F E++ AT NFDE 
Sbjct: 471 SHSSYISSKGGSTSRRMSIFGSKKSKSNG--FSSFFSNQGLGRYFPFTELQTATQNFDEN 528

Query: 538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
            + GVGGFGKVY GEIDG T +VAIKRG+  SEQG++EFQTEI+MLSKLRHRHLVSLIG+
Sbjct: 529 AVCGVGGFGKVYIGEIDGGT-QVAIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGF 587

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQK------PPLPWKQRLEICIGAARGLHYLHTGA 651
           C+EN EMILVY+YM+ G LR+HLY +++      P L WKQRLEICIG+ARGLHYLHTGA
Sbjct: 588 CDENKEMILVYEYMSNGPLRDHLYGSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGA 647

Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRDVKTTNILLDE  VAKVSDFGLSK  P +D  HVST VKGSFGYLDPEYFRRQ
Sbjct: 648 AQGIIHRDVKTTNILLDENLVAKVSDFGLSKDAP-MDEGHVSTAVKGSFGYLDPEYFRRQ 706

Query: 712 QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK 771
           QLT+KSDVYSFGVVLFE+LCARP +NP LP+EQV+LAE+A + H+KG+LE+I+DP + G 
Sbjct: 707 QLTDKSDVYSFGVVLFEVLCARPVINPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGT 766

Query: 772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEE 817
           I+    +KF E A KC+++ G++RP MGDVLWNLE+ALQLQE++ +
Sbjct: 767 ISKGSLRKFVEAAEKCLAEYGVDRPGMGDVLWNLEYALQLQEASAQ 812

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1

 Score =  623 bits (1607), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 371/886 (41%), Positives = 514/886 (58%), Gaps = 69/886 (7%)

Query: 13  FIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKDSTTS 72
           FI +S  S I + +   + P +  L+NCG  +  +   +   +  + SK L S+K+   S
Sbjct: 9   FILISTIS-ILLCICHGFTPVDNYLINCGSPTNGTLMGRIFLSDKLSSKLLTSSKEILAS 67

Query: 73  KAATQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVST 132
                        Y TARVF    +Y F V  GR +VRLYF P  Y       A F+VS+
Sbjct: 68  VGGNSGSDI----YHTARVFTEVSSYKFSVTRGRHWVRLYFNPFDYQNFKMGSAKFAVSS 123

Query: 133 GPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSM 192
             + LL +F+V  +        V+KEY++ V    L +TF+P   S ++AFVN IEV+S+
Sbjct: 124 QSHVLLSDFTVTSSK-------VVKEYSLNVTTNDLVLTFTPS--SGSFAFVNAIEVISI 174

Query: 193 PDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYI 252
           PD      G    VG  +     +   LE ++R+N+GG  ++ + DT L R+W  D  ++
Sbjct: 175 PDTL--ITGSPRFVGNPAQFPDMSMQGLETIHRVNMGGPLVASNNDT-LTRTWVPDSEFL 231

Query: 253 FGAALGVPVTIGPNMTVRYPSNIPSYV----APVDVYATARQMGPNPQINLNYELSWVFS 308
               L    ++    TV +   +P Y     AP  VY +  +M      N  + ++W F 
Sbjct: 232 LEKNLAK--SMSKFSTVNF---VPGYATEDSAPRTVYGSCTEMNSADNPNSIFNVTWEFD 286

Query: 309 VDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLY-QDFA 367
           VD GF Y  R HFC+++     +NQ  F++ +++  A    D++ L        Y  DF 
Sbjct: 287 VDPGFQYYFRFHFCDIVS--LSLNQLYFNLYVDSMVAATDIDLSTLVDNTLAGAYSMDFV 344

Query: 368 VFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVV 427
              P    +  + +G  P+    T Y +AI+NG+EI K+++    L+    +P       
Sbjct: 345 TQTPKGSNKVRVSIG--PSTV-HTDYPNAIVNGLEIMKMNNSKGQLSTGTFVPGSSSSSK 401

Query: 428 DPSLALPSSSSGNSKQKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGW 487
             +L L            I+G  +G  +A+  + G C F   + R++G+D  S      W
Sbjct: 402 S-NLGL------------IVGSAIGSLLAVVFL-GSC-FVLYKKRKRGQDGHSKT----W 442

Query: 488 LPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGK 547
           +P S+  N  S GS  +N  G+  +S+ +N      FA +K ATNNFDE+  +GVGGFGK
Sbjct: 443 MPFSI--NGTSMGSKYSN--GTTLTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGK 498

Query: 548 VYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV 607
           VY+GE++  T KVA+KRGNP S+QG+ EF+TEIEMLS+ RHRHLVSLIGYC+EN EMIL+
Sbjct: 499 VYKGELNDGT-KVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILI 557

Query: 608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL 667
           Y+YM  GT++ HLY +  P L WKQRLEICIGAARGLHYLHTG    +IHRDVK+ NILL
Sbjct: 558 YEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILL 617

Query: 668 DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLF 727
           DE ++AKV+DFGLSKTGP LD THVST VKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLF
Sbjct: 618 DENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLF 677

Query: 728 EILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKC 787
           E+LCARP ++PTLP+E V+LAEWA    KKG L+QI+D  L+G I P+  +KFAET  KC
Sbjct: 678 EVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKC 737

Query: 788 VSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDVDCKGKKDPNACS 847
           ++D G++RPSMGDVLWNLE+ALQLQE+           +D E      +  G+  P   +
Sbjct: 738 LADYGVDRPSMGDVLWNLEYALQLQEAV----------IDGEPEDNSTNMIGELPPQ-IN 786

Query: 848 GFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
            F+   T     G +      S+  +D  G++ S VFSQ++  +GR
Sbjct: 787 NFSQGDTSVNVPGTAGRFEESSI--DDLSGVSMSKVFSQLVKSEGR 830

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1

 Score =  622 bits (1605), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 371/878 (42%), Positives = 509/878 (57%), Gaps = 65/878 (7%)

Query: 30  YIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDPSTPTIPYMTA 89
           + P++ IL++CG  S     D R +  D  +   +  K+     A   D     I Y+TA
Sbjct: 52  FKPADDILIDCGSKSSSKTPDGRVFKSDQETIQYIEAKEDIQVSAPPSDKVASPI-YLTA 110

Query: 90  RVFRSEFTYSFPVVA-GRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAE 148
           R+FR E TY F +   G  +VRL+F     ++ +   A FSV T  Y LL NF ++    
Sbjct: 111 RIFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLHNFKISNNNN 170

Query: 149 ALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNTDGDLM--IV 206
             + A V KEY + +      + F PM  S A  F+N IEV+S PD   +  G  +  ++
Sbjct: 171 D-SQAAVQKEYLVNMTDAQFALRFRPMKSSAA--FINAIEVVSAPDELISDSGTALFPVI 227

Query: 207 GQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPN 266
           G S      +  A ++VYR+NVGG  I P  DT L R+W  D+ ++    L   V   P+
Sbjct: 228 GFSGL----SDYAYQSVYRVNVGGPLIMPQNDT-LGRTWIPDKEFLKDENLAKDVKTTPS 282

Query: 267 MTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLP 326
             ++YP  +   +AP  VYATA +M  +  I+ N+ +SW F  +  F+YL+RLHFC+++ 
Sbjct: 283 -AIKYPPEVTPLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVS 341

Query: 327 EITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPN 386
           +   +N   F++ +N +TA    D++ +      P Y+D  V     GP+  + +G    
Sbjct: 342 K--SLNDLYFNVYINGKTAISGLDLSTVAGNLAAPYYKDIVVNATLMGPELQVQIG---P 396

Query: 387 VASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGNSKQKAI 446
           +   T   +AILNGVE+ K+S+  ++L G                 +   ++G  K   +
Sbjct: 397 MGEDTGTKNAILNGVEVLKMSNSVNSLDG--------------EFGVDGRTTGMGKHGMV 442

Query: 447 IGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNS----HSAGSA 502
              G        + +G  V+   + +++ +D    ++ S WL     G+S       GS 
Sbjct: 443 ATAGFVMMFGAFIGLGAMVY---KWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKGGSQ 499

Query: 503 KTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAI 562
           K+N    Y S+L   L R+FS +E++ AT NF+ + ++GVGGFG VY G +D  T KVA+
Sbjct: 500 KSNF---YNSTL--GLGRYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGT-KVAV 553

Query: 563 KRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYK 622
           KRGNP SEQG+ EFQTEI+MLSKLRHRHLVSLIGYC+EN EMILVY++M+ G  R+HLY 
Sbjct: 554 KRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYG 613

Query: 623 TQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK 682
               PL WKQRLEICIG+ARGLHYLHTG    IIHRDVK+TNILLDE  VAKV+DFGLSK
Sbjct: 614 KNLAPLTWKQRLEICIGSARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSK 673

Query: 683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPK 742
                   HVST VKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL E LCARPA+NP LP+
Sbjct: 674 D-VAFGQNHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPR 732

Query: 743 EQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
           EQV+LAEWA    +KG+LE+I+DP+L G I PE  KKFAE A KC+ D G++RP+MGDVL
Sbjct: 733 EQVNLAEWAMQWKRKGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVL 792

Query: 803 WNLEFALQLQESAEESGKVLGGGMDIEEGAFDVDCKGK---KDPNACSGFNGNITDSRST 859
           WNLE+ALQLQE+  +     G   + E    DV   G     DP+        IT S +T
Sbjct: 793 WNLEYALQLQEAFTQ-----GKAEETENAKPDVVTPGSVPVSDPSP-------ITPSVTT 840

Query: 860 GMSMSIGGRSLASEDS----DGLTPSAVFSQIMNPKGR 893
             + ++   +   E+S    D  + +A+F+Q  N  GR
Sbjct: 841 NEAATVPVPAKVEENSGTAVDEHSGTAMFTQFANLNGR 878

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	893
255575610	891	kinase, putative [Ricinus communis] gi|2	0.992	0.994	0.769	0.0
224087891	893	predicted protein [Populus trichocarpa]	0.992	0.992	0.772	0.0
449449849	897	PREDICTED: receptor-like protein kinase	0.988	0.984	0.738	0.0
297819852	891	hypothetical protein ARALYDRAFT_485507 [	0.968	0.970	0.756	0.0
155242084	895	FERONIA receptor-like kinase [Brassica o	0.967	0.965	0.746	0.0
155242159	891	FERONIA receptor-like kinase [Cardamine	0.966	0.968	0.747	0.0
15230520	895	receptor-like protein kinase FERONIA [Ar	0.997	0.995	0.738	0.0
155242172	892	FERONIA receptor-like kinase [Cardamine	0.973	0.974	0.740	0.0
155242106	891	FERONIA receptor-like kinase [Cardamine	0.966	0.968	0.746	0.0
155242200	893	FERONIA receptor-like kinase [Arabidopsi	0.968	0.968	0.750	0.0

>gi|255575610|ref|XP_002528705.1| kinase, putative [Ricinus communis] gi|223531877|gb|EEF33694.1| kinase, putative [Ricinus communis]

 Score = 1420 bits (3677), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 689/895 (76%), Positives = 772/895 (86%), Gaps = 9/895 (1%)

Query: 4   LNKQFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFL 63
           + K F +++   L L+SA+ +  A +Y+P+++ILL+CG +S  +DDD + WT D  SKFL
Sbjct: 1   MGKSFPASVLFLLCLSSAVILVFAQNYVPTDKILLDCGATSDNADDDGQKWTADKNSKFL 60

Query: 64  LSTKDSTTSKAATQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNA 123
           LS+ +ST S AATQDP+   IP+MTARVF S FTYSFP+ AGRKFVRLYFYP SY+ LNA
Sbjct: 61  LSSDNSTISSAATQDPAVSQIPFMTARVFHSNFTYSFPLAAGRKFVRLYFYPASYSGLNA 120

Query: 124 TDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSP-MNVSNAYA 182
           +DALFSV+ G YT+LKNFSVAQT +ALNYAY++KEY+I VDG +LNITFSP  N S +YA
Sbjct: 121 SDALFSVTAGSYTILKNFSVAQTTQALNYAYIVKEYSINVDGGSLNITFSPSTNPSKSYA 180

Query: 183 FVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLF 242
           FVNGIE++SMPDIY +TDG LM++G  SPI IDN+TALENVYR+NVGG  ISPS DT + 
Sbjct: 181 FVNGIEIVSMPDIYGSTDGTLMLLGNDSPIYIDNSTALENVYRINVGGNVISPSRDTGML 240

Query: 243 RSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYE 302
           RSW DDQPYI+GAA+GVP T  PNMT++ P  +P Y+AP DVY+TAR MGP   +NLNY 
Sbjct: 241 RSWVDDQPYIYGAAIGVPETADPNMTIKDP--VPPYIAPKDVYSTARSMGPTVYVNLNYN 298

Query: 303 LSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDV-AGLTKGNGIP 361
           L+W+FSVDSGF+YLVRLHFCEV   ITKINQR F I LNNQTA    DV A   + NG+P
Sbjct: 299 LTWIFSVDSGFNYLVRLHFCEVASNITKINQRAFTIFLNNQTAEDQADVVAWANEHNGVP 358

Query: 362 LYQDFAVFVPGNGPQKDLWLGLHPNVAS--KTQYYDAILNGVEIFKLSDPNSNLAGPNPI 419
           +++D+AV V    PQ+DLWL +HPN  +  K+QYYDA+LNGVEIFKLS  ++NLAGPNP+
Sbjct: 359 VHRDYAVLVSSKNPQEDLWLAIHPNTDAVLKSQYYDALLNGVEIFKLSTADNNLAGPNPV 418

Query: 420 PAPKQDVVDPSLALPSSSSGNSK-QKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKDP 478
           P PK D  DP +  PSS SG+SK QKAII GGV GGI LALV+GFC+ AA+R RR GK+ 
Sbjct: 419 PLPKPDRTDPYVR-PSSGSGHSKNQKAIIAGGVSGGIVLALVIGFCIVAATRRRRHGKEA 477

Query: 479 SSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEAL 538
           S+SD  SGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIK+ATNNFDEAL
Sbjct: 478 SASDGPSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKSATNNFDEAL 537

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           LLGVGGFGKVY+GEIDG TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC
Sbjct: 538 LLGVGGFGKVYKGEIDGGTTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 597

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
           EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR
Sbjct: 598 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 657

Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD
Sbjct: 658 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 717

Query: 719 VYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFK 778
           VYSFGVVLFEI+CARPALNP LPKEQVSLAEWAAHCHKKGIL+QI+DPYLKGKIAPECFK
Sbjct: 718 VYSFGVVLFEIICARPALNPALPKEQVSLAEWAAHCHKKGILDQIVDPYLKGKIAPECFK 777

Query: 779 KFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDVDCK 838
           KFAETAMKCVSD GI+RPSMGDVLWNLEFALQLQESAEESGK + G +D EE  F+   K
Sbjct: 778 KFAETAMKCVSDVGIDRPSMGDVLWNLEFALQLQESAEESGKGI-GRLDEEEMPFNTASK 836

Query: 839 GKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
           GKKD +A  GF+GNITDSRS+GMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR
Sbjct: 837 GKKDLDASPGFDGNITDSRSSGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 891

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224087891|ref|XP_002308259.1| predicted protein [Populus trichocarpa] gi|222854235|gb|EEE91782.1| predicted protein [Populus trichocarpa]

 Score = 1399 bits (3620), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 693/897 (77%), Positives = 777/897 (86%), Gaps = 11/897 (1%)

Query: 4   LNKQFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFL 63
           ++K F  ++++ L L S+I V  AA+Y+P+E+ILL+CG +S  SD D R WT D GS FL
Sbjct: 1   MDKCFYVSVYVSLCLLSSIQVIFAANYVPTEKILLDCGANSDQSDSDGRDWTSDRGSSFL 60

Query: 64  LSTKDSTTSKAATQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNA 123
            S+ +S+T+ A+TQDPS P +PY+TAR+FRS FTYSFPVV+GRKF+RLYFYP+SY+ LNA
Sbjct: 61  SSSTNSSTATASTQDPSVPQVPYLTARIFRSSFTYSFPVVSGRKFIRLYFYPSSYSGLNA 120

Query: 124 TDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPM-NVSNAYA 182
           ++ALFSV+ G YTLL NFSVAQTAEALNY  ++KEY + VDG+TL ITFSP  N S+AYA
Sbjct: 121 SNALFSVTAGSYTLLSNFSVAQTAEALNYVSIMKEYLVNVDGDTLKITFSPSSNPSSAYA 180

Query: 183 FVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLF 242
           FVNGIE++SMPDIY N DG +MIVGQ +P +I NTTALENVYRLNVGG  I+PS DT LF
Sbjct: 181 FVNGIEIVSMPDIYSNVDG-VMIVGQDAPFTIYNTTALENVYRLNVGGNSITPSADTGLF 239

Query: 243 RSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYE 302
           RSW DDQ Y++GAA G+  +  PNMT+RYP+ + SYVAP DVYATAR MG +P+IN+NY 
Sbjct: 240 RSWSDDQIYLYGAAYGLTQSADPNMTIRYPAGMSSYVAPSDVYATARSMGTDPRINMNYN 299

Query: 303 LSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDV---AGLTKGNG 359
           L+WVFSVDS F+YLVRLHFCEV   ITK+NQ+VFDI LNNQTA    DV   AG    NG
Sbjct: 300 LTWVFSVDSNFNYLVRLHFCEV-SNITKVNQQVFDIFLNNQTAEDGADVIAWAGGNGNNG 358

Query: 360 IPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNS-NLAGPNP 418
           +P+Y+D+ V VPG  PQ+D+WLGLHPN  SK QYYDAILNGVEIFKLS+PN  NLAGPNP
Sbjct: 359 VPVYKDYVVLVPGGPPQQDMWLGLHPNPKSKPQYYDAILNGVEIFKLSNPNDGNLAGPNP 418

Query: 419 IPAPKQDVVDPSLALPSSSSGNSK-QKAIIGGGVGGGIALALVVGFCVFAASRCR-RQGK 476
           IPAPKQ+ +DP  A P S SG SK Q AII GGV GG+ LA+V+GFCV AASR R R GK
Sbjct: 419 IPAPKQEEIDPIKARPGSGSGQSKSQTAIIAGGVSGGVVLAIVIGFCVLAASRRRHRHGK 478

Query: 477 DPSSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDE 536
           +PSSSD  SGWLPLSLYGNSHSA SAKTNTTGSY SSLPSNLCRHFSFAEIKAAT NFDE
Sbjct: 479 EPSSSDGPSGWLPLSLYGNSHSASSAKTNTTGSYVSSLPSNLCRHFSFAEIKAATKNFDE 538

Query: 537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           AL+LGVGGFGKVY+GEIDG TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG
Sbjct: 539 ALILGVGGFGKVYKGEIDGGTTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 598

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
           YCEEN EMILVYD+MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK+TII
Sbjct: 599 YCEENTEMILVYDHMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKYTII 658

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK
Sbjct: 659 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 718

Query: 717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC 776
           SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL+QI+DPYLKGKIAPEC
Sbjct: 719 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILDQILDPYLKGKIAPEC 778

Query: 777 FKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDVD 836
           FKKFAETAMKCVSD+ I+RPSMGDVLWNLEFALQLQESAE+  K +  G+D EE  F+V 
Sbjct: 779 FKKFAETAMKCVSDESIDRPSMGDVLWNLEFALQLQESAEDGAKGI-VGVD-EEVPFNVA 836

Query: 837 CKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
            KGKKDP+A  G++GN+TDSRS+G+SMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR
Sbjct: 837 YKGKKDPDASPGYDGNVTDSRSSGISMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449449849|ref|XP_004142677.1| PREDICTED: receptor-like protein kinase FERONIA-like [Cucumis sativus] gi|449502659|ref|XP_004161706.1| PREDICTED: receptor-like protein kinase FERONIA-like [Cucumis sativus]

 Score = 1364 bits (3530), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 655/887 (73%), Positives = 745/887 (83%), Gaps = 4/887 (0%)

Query: 9   LSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKD 68
            +++ +F+SL   +HV LA +YIP + ILL+CG  S  +D D R W  D  SKF+ +T D
Sbjct: 13  FASISVFVSLFFDVHVVLAQNYIPRDVILLDCGGPSTANDIDNRKWNTDDKSKFVPATGD 72

Query: 69  STTSKAATQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALF 128
           S+ SKAATQDPS P IP+MTARVF S FTYSFPV   R FVRLYFYP+SY  L+A+DALF
Sbjct: 73  SSVSKAATQDPSVPDIPFMTARVFSSSFTYSFPVAPSRLFVRLYFYPSSYGGLDASDALF 132

Query: 129 SVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVS-NAYAFVNGI 187
           SVST  YTLLKNFS +QTA ALNYAY+IKEY+I VD + LN+TF+P +    AYAFVNGI
Sbjct: 133 SVSTQSYTLLKNFSASQTAAALNYAYIIKEYSIHVDDDRLNLTFTPSSTHPKAYAFVNGI 192

Query: 188 EVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYD 247
           E++SM DIY +T G  +IVG S+P  +DN+TALENV+RLNVGG DISPS DT ++RSW+D
Sbjct: 193 EIVSMADIYSDTSGSTLIVGPSTPFIVDNSTALENVFRLNVGGNDISPSDDTGMYRSWFD 252

Query: 248 DQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVF 307
           D P+++GAA GV ++   N T+ YP   PSYVAP +VY+TAR MGP+  +NLNY L+W+F
Sbjct: 253 DTPFLYGAAQGVTMSTDQNTTLNYPPGFPSYVAPENVYSTARAMGPDNNVNLNYNLTWIF 312

Query: 308 SVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFA 367
            VDSGF YLVRLHFCE+   ITK+NQRVFDI L N+TA  + DV   +K N  P Y+D+ 
Sbjct: 313 PVDSGFFYLVRLHFCEIAANITKVNQRVFDIFLYNKTAMDSADVIAWSKSNDTPFYKDYV 372

Query: 368 VFVPGNG-PQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDV 426
           VFVP NG PQ+DLWL LHP+   +  YYDAILNGVEIFK++D ++NLAG NPIPAPKQD+
Sbjct: 373 VFVPANGNPQQDLWLELHPDKTMRPNYYDAILNGVEIFKINDSSANLAGLNPIPAPKQDI 432

Query: 427 VDPSLALPSSSSGNSKQKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSG 486
           +DPSLA P+S   +     +I G V G + LAL++GF VFA  R R +GKD S+ +  SG
Sbjct: 433 IDPSLAKPASHGKSKNNSGVIAGVVCGAVVLALIIGFFVFAKRR-RGRGKDSSTVEGPSG 491

Query: 487 WLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFG 546
           WLPLSLYGNSHSAGSAKTNTTGSY SSLPSNLCRHFSF+EIK+AT +FDE+LLLGVGGFG
Sbjct: 492 WLPLSLYGNSHSAGSAKTNTTGSYTSSLPSNLCRHFSFSEIKSATRDFDESLLLGVGGFG 551

Query: 547 KVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL 606
           KVY+GEIDG TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL
Sbjct: 552 KVYKGEIDGGTTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL 611

Query: 607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNIL 666
           VYDYMA+GTLREHLYKT KPPL W+QRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNIL
Sbjct: 612 VYDYMAHGTLREHLYKTHKPPLSWRQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNIL 671

Query: 667 LDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           LDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL
Sbjct: 672 LDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVL 731

Query: 727 FEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMK 786
           FE+LCARPALNPTLPKEQVSLAEWAAHC+ KGIL+QI+D +LKGKIA EC KKFAETAMK
Sbjct: 732 FEVLCARPALNPTLPKEQVSLAEWAAHCYNKGILDQIIDTFLKGKIASECLKKFAETAMK 791

Query: 787 CVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDVDCKGKKDPNAC 846
           CVSDQGI+RPSMGDVLWNLEFALQLQESAEESGKV G GMD+EEG  DV  KGKKDP+A 
Sbjct: 792 CVSDQGIDRPSMGDVLWNLEFALQLQESAEESGKV-GSGMDVEEGQLDVVYKGKKDPDAS 850

Query: 847 SGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
            G +GNITDSRSTG+SMSIG RSLASEDSDGLTPSAVFSQIMNPKGR
Sbjct: 851 PGIDGNITDSRSTGISMSIGSRSLASEDSDGLTPSAVFSQIMNPKGR 897

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297819852|ref|XP_002877809.1| hypothetical protein ARALYDRAFT_485507 [Arabidopsis lyrata subsp. lyrata] gi|155242124|gb|ABT18096.1| FERONIA receptor-like kinase [Arabidopsis lyrata] gi|297323647|gb|EFH54068.1| hypothetical protein ARALYDRAFT_485507 [Arabidopsis lyrata subsp. lyrata]

 Score = 1360 bits (3519), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 658/870 (75%), Positives = 738/870 (84%), Gaps = 5/870 (0%)

Query: 27  AADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAA-TQDPSTPTIP 85
           AADY P+E+ILLNCG +S L D D R+W  D+ SKFL S+   + +  A TQDPS P +P
Sbjct: 24  AADYSPTEKILLNCGGASDLVDTDNRTWISDVKSKFLSSSSSDSKTSPALTQDPSVPEVP 83

Query: 86  YMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQ 145
           YMTARVFRS FTY+FPV +GRKFVRLYFYPNSY+ LNAT++LFSVS GPYTLLKNFS AQ
Sbjct: 84  YMTARVFRSPFTYTFPVASGRKFVRLYFYPNSYDGLNATNSLFSVSFGPYTLLKNFSAAQ 143

Query: 146 TAEALNYAYVIKEYAIPVDGETLNITFSPMNV-SNAYAFVNGIEVMSMPDIYKNTDGDLM 204
           TAEAL YA++IKE+ + V+G TLN+TF+P +  SNAYAFVNGIEV SMPDIY +TDG L 
Sbjct: 144 TAEALTYAFIIKEFVVNVEGGTLNMTFTPESTPSNAYAFVNGIEVTSMPDIYSSTDGTLT 203

Query: 205 IVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIG 264
           +VG S+ I+IDN+TALENVYRLNVGG DISPS DT L+RSWYDDQPYIFGA LG+P T  
Sbjct: 204 MVGSSTSITIDNSTALENVYRLNVGGNDISPSADTGLYRSWYDDQPYIFGAGLGIPETAD 263

Query: 265 PNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEV 324
           PNMT++YP+  P+YVAPVDVY+TAR MGP  QINLNY L+W+FS+DSGF+YLVRLHFCEV
Sbjct: 264 PNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSGFTYLVRLHFCEV 323

Query: 325 LPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLH 384
              ITKINQRVF I LNNQTA P  D+   T  NG+P ++D+ V  P    Q+D+WL LH
Sbjct: 324 SSNITKINQRVFTIYLNNQTAEPEADIIAWTSSNGVPFHKDYVVNPPEGNGQQDMWLALH 383

Query: 385 PNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGNSKQK 444
           PN  +K +YYD+ILNGVEIFK++  + NLAGPNPIP P Q   DPS  L  +S  +    
Sbjct: 384 PNPINKPEYYDSILNGVEIFKMNTSDGNLAGPNPIPGP-QVTADPSKVLSPTSGKSKSNT 442

Query: 445 AIIGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKT 504
           AI+ G   G + LAL++GFCVF A R R++G    +SDA SGWLPLSLYGNSHSAGSAKT
Sbjct: 443 AIVAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLYGNSHSAGSAKT 502

Query: 505 NTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR 564
           NTTGSYASSLPSNLCRHFSFAEIKAAT NFDE+ +LGVGGFGKVYRGEIDG TTKVAIKR
Sbjct: 503 NTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIKR 562

Query: 565 GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQ 624
           GNP+SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA+GT+REHLYKTQ
Sbjct: 563 GNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHLYKTQ 622

Query: 625 KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG 684
            P LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG
Sbjct: 623 NPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG 682

Query: 685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ 744
           PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE LCARPALNPTL KEQ
Sbjct: 683 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNPTLAKEQ 742

Query: 745 VSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN 804
           VSLAEWA +C+KKG+L+QI+DPYLKGKI PECFKKFAETAMKCV DQGIERPSMGDVLWN
Sbjct: 743 VSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMGDVLWN 802

Query: 805 LEFALQLQESAEESGKVLGGGMDIEEGAFDV-DCKGKKDPNACSGFNGNITDSRSTGMSM 863
           LEFALQLQESAEESGK + G MD++E  +D  +CKGK D  +   + GN+TDSRS+G+ M
Sbjct: 803 LEFALQLQESAEESGKGVCGDMDMDEIKYDDGNCKGKND-KSSDVYEGNVTDSRSSGIDM 861

Query: 864 SIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
           SIGGRSLASEDSDGLTPSAVFSQIMNPKGR
Sbjct: 862 SIGGRSLASEDSDGLTPSAVFSQIMNPKGR 891

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|155242084|gb|ABT18094.1| FERONIA receptor-like kinase [Brassica oleracea]

 Score = 1345 bits (3482), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 648/868 (74%), Positives = 730/868 (84%), Gaps = 4/868 (0%)

Query: 29  DYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDPSTPTIPYMT 88
           DY P++   LNCG SS L D D R+W PD+ SKFL S+ DS TS AATQDPS P +PYMT
Sbjct: 29  DYSPTDNFFLNCGGSSDLPDTDNRTWIPDVKSKFLSSSADSKTSPAATQDPSVPDVPYMT 88

Query: 89  ARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAE 148
           AR+FRS FTYSFPV AGRKFVRL+FYPNSY+ LNAT++LFSVS G YTLLKNFS AQTA+
Sbjct: 89  ARIFRSPFTYSFPVAAGRKFVRLHFYPNSYDGLNATNSLFSVSLGSYTLLKNFSAAQTAQ 148

Query: 149 ALNYAYVIKEYAIPVDGETLNITFSPMNV-SNAYAFVNGIEVMSMPDIYKNTDGDLMIVG 207
           AL +++++KE+ + V+G  LN+TF+P +  SNAYA+VNGIEV SMPD+Y +TDG L +VG
Sbjct: 149 ALTFSFIVKEFIVNVEGGALNVTFTPESAPSNAYAYVNGIEVTSMPDLYSSTDGSLTVVG 208

Query: 208 QSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPNM 267
            S  ++IDN+TALENVYRLNVGG DISPS DT L+RSWYDDQPYIFGA LG+  T  PNM
Sbjct: 209 SSGGVTIDNSTALENVYRLNVGGNDISPSDDTGLYRSWYDDQPYIFGAGLGITETADPNM 268

Query: 268 TVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPE 327
           T+ YPS  P+YVAPVDVY+TAR MGP PQINLNY L+W+FS+DSGFSYLVRLHFCEV P 
Sbjct: 269 TIEYPSGTPTYVAPVDVYSTARSMGPTPQINLNYNLTWIFSIDSGFSYLVRLHFCEVAPN 328

Query: 328 ITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNV 387
           +TKINQRVF + LNNQTA P  DVAG T G+GIPL++D+ V  P    Q+DLWL LHPN 
Sbjct: 329 MTKINQRVFTVYLNNQTAEPEADVAGWTGGHGIPLHKDYVVNPPDGKGQQDLWLALHPNT 388

Query: 388 ASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGNSKQKAII 447
            +  +YYDAILNGVEIFK+++ + NLAGPNPIP P Q   DPS  L   +S +    A++
Sbjct: 389 KNNPEYYDAILNGVEIFKMNNSDGNLAGPNPIPGP-QVTADPSKVLRPRTSQSKNHTAVV 447

Query: 448 GGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKTNTT 507
            G   G + L L+VG C   A R R +G++  +SDA SGWLPLSLYGNSHS GS KTNTT
Sbjct: 448 AGAASGAVVLGLIVGLCAMIAYRRRNRGENQPASDATSGWLPLSLYGNSHSGGSGKTNTT 507

Query: 508 GSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP 567
           GSYASSLPSNLCRHFSFAEIKAAT NFDE+ +LGVGGFGKVYRGEIDG TTKVAIKRGNP
Sbjct: 508 GSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIKRGNP 567

Query: 568 LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP 627
           +SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA+GT+REHLYKTQ  P
Sbjct: 568 MSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHLYKTQNSP 627

Query: 628 LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL 687
           LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP L
Sbjct: 628 LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPAL 687

Query: 688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           DHTHVSTVVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFE LCARPALNPTL KEQVSL
Sbjct: 688 DHTHVSTVVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEALCARPALNPTLAKEQVSL 747

Query: 748 AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF 807
           AEWA +C+KKG+L+QI+DP+LKGKI PECFKKFAETAMKCV DQGIERPSMGDVLWNLEF
Sbjct: 748 AEWAPYCYKKGMLDQIVDPHLKGKITPECFKKFAETAMKCVLDQGIERPSMGDVLWNLEF 807

Query: 808 ALQLQESAEESGKVLGGGMDIEEGAFDVD-CKGKKD-PNACSGFNGNITDSRSTGMSMSI 865
           ALQLQESAEESGK +   MD++E  +D D CKGK +    C  + GN+TDSRS+G+ MSI
Sbjct: 808 ALQLQESAEESGKGICSEMDMDEIKYDDDNCKGKNNSEKGCDVYEGNVTDSRSSGIDMSI 867

Query: 866 GGRSLASEDSDGLTPSAVFSQIMNPKGR 893
           GGRSLASEDSDGLTPS VFSQIMNPKGR
Sbjct: 868 GGRSLASEDSDGLTPSGVFSQIMNPKGR 895

Source: Brassica oleracea

Species: Brassica oleracea

Genus: Brassica

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|155242159|gb|ABT18097.1| FERONIA receptor-like kinase [Cardamine flexuosa]

 Score = 1343 bits (3477), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 649/868 (74%), Positives = 727/868 (83%), Gaps = 5/868 (0%)

Query: 27  AADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDPSTPTIPY 86
           AADY P+++ILLNCG  S L D D R+W  D+ SKFL S+ DS TS AATQDPS   +PY
Sbjct: 28  AADYSPTDKILLNCGGVSDLVDTDNRTWISDVKSKFLSSSGDSKTSPAATQDPSVSQVPY 87

Query: 87  MTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQT 146
           MTARVFRS FTYSFPV AGRKFVRLYFYPN+Y+ LNAT+ALFSVS GPYTLLKNFS AQT
Sbjct: 88  MTARVFRSPFTYSFPVAAGRKFVRLYFYPNTYDGLNATNALFSVSFGPYTLLKNFSAAQT 147

Query: 147 AEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNTDGDLMIV 206
           AEAL YA ++KE+ + V+G +LN+TF+P   SNAYAF+NGIEV SMPDIY +TDG L++V
Sbjct: 148 AEALTYAVIVKEFIVNVEGGSLNMTFTPE--SNAYAFMNGIEVTSMPDIYSSTDGSLIMV 205

Query: 207 GQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPN 266
           G SS  +IDN+TALENV+RLNVGG DISPS DT L+RSWYDDQPYIF A LG+P T  PN
Sbjct: 206 GASSDFTIDNSTALENVFRLNVGGNDISPSADTGLYRSWYDDQPYIFAAGLGIPETADPN 265

Query: 267 MTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLP 326
           MT++YP+  P+YVAPVDVY+TAR MGP   IN+NY L+WVFS+DSGFSYLVRLHFCEV P
Sbjct: 266 MTIQYPTGTPTYVAPVDVYSTARSMGPTASININYNLTWVFSIDSGFSYLVRLHFCEVSP 325

Query: 327 EITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPN 386
            ITKINQRVF I LNNQTA    DV    +GNGIP ++D+ V  P    Q+DLWL LHPN
Sbjct: 326 RITKINQRVFTIYLNNQTAEEEADVIAWAQGNGIPFHKDYVVNPPEGKGQQDLWLALHPN 385

Query: 387 VASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGNSKQKAI 446
             +K +YYD+IL+GVEIFK++  + NLAG NPIP PK    DP   L   +S +     I
Sbjct: 386 TRNKPEYYDSILSGVEIFKVNTSDGNLAGSNPIPGPKV-TADPFKVLRPRTSQSRNHTTI 444

Query: 447 IGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKTNT 506
           I G   G + LAL++G CV  A   R +G    +SDA SGWLPLSLYGNSHSAGS KTNT
Sbjct: 445 IVGAAIGAVVLALIIGLCVMVAYCRRNRGDYQPASDATSGWLPLSLYGNSHSAGSTKTNT 504

Query: 507 TGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN 566
           TGSYASSLPSNLCRHFSFAEIKAAT NFDE+ +LGVGGFGKVYRGEIDG TTKVAIKRGN
Sbjct: 505 TGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIKRGN 564

Query: 567 PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP 626
           P+SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA+GT+REHLYKTQ  
Sbjct: 565 PMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHLYKTQNS 624

Query: 627 PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT 686
           PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT
Sbjct: 625 PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT 684

Query: 687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS 746
           LDHTHVSTVVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFE LCARPALNPTL KEQVS
Sbjct: 685 LDHTHVSTVVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEALCARPALNPTLAKEQVS 744

Query: 747 LAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
           LAEWA +C+KKG+L+QI+DPYLKGKI PECFKKFAETAMKCV DQGIERPSMGDVLWNLE
Sbjct: 745 LAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMGDVLWNLE 804

Query: 807 FALQLQESAEESGKVLGGGMDIEEGAFDVDCKGK-KDPNACSGFNGNITDSRSTGMSMSI 865
           FALQLQESAEE+GK + G MD++E  ++ D  GK K+  +   + GN+TDSRS+G+ MSI
Sbjct: 805 FALQLQESAEENGKGMSGDMDMDEIKYN-DGNGKGKNEMSSDVYEGNVTDSRSSGIDMSI 863

Query: 866 GGRSLASEDSDGLTPSAVFSQIMNPKGR 893
           GGRSLASEDS+GLTPSAVFSQIMNPKGR
Sbjct: 864 GGRSLASEDSEGLTPSAVFSQIMNPKGR 891

Source: Cardamine flexuosa

Species: Cardamine flexuosa

Genus: Cardamine

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15230520|ref|NP_190723.1| receptor-like protein kinase FERONIA [Arabidopsis thaliana] gi|75337066|sp|Q9SCZ4.1|FER_ARATH RecName: Full=Receptor-like protein kinase FERONIA; AltName: Full=Protein SIRENE; Flags: Precursor gi|6572076|emb|CAB63019.1| receptor-protein kinase-like protein [Arabidopsis thaliana] gi|332645284|gb|AEE78805.1| receptor-like protein kinase FERONIA [Arabidopsis thaliana]

 Score = 1343 bits (3475), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 662/897 (73%), Positives = 749/897 (83%), Gaps = 6/897 (0%)

Query: 1   MKNLNKQFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGE-SSILSDDDKRSWTPDIG 59
           MK    +F  +L + L L SA  +  AADY P+E+ILLNCG  +S L+D D R W  D+ 
Sbjct: 1   MKITEGRFRLSLLLLLLLISAATLISAADYSPTEKILLNCGGGASNLTDTDNRIWISDVK 60

Query: 60  SKFLLSTKDSTTSKAA-TQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSY 118
           SKFL S+ + + +  A TQDPS P +PYMTARVFRS FTY+FPV +GRKFVRLYFYPNSY
Sbjct: 61  SKFLSSSSEDSKTSPALTQDPSVPEVPYMTARVFRSPFTYTFPVASGRKFVRLYFYPNSY 120

Query: 119 NRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNV- 177
           + LNAT++LFSVS GPYTLLKNFS +QTAEAL YA++IKE+ + V+G TLN+TF+P +  
Sbjct: 121 DGLNATNSLFSVSFGPYTLLKNFSASQTAEALTYAFIIKEFVVNVEGGTLNMTFTPESAP 180

Query: 178 SNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSG 237
           SNAYAFVNGIEV SMPD+Y +TDG L +VG S  ++IDN+TALENVYRLNVGG DISPS 
Sbjct: 181 SNAYAFVNGIEVTSMPDMYSSTDGTLTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSA 240

Query: 238 DTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQI 297
           DT L+RSWYDDQPYIFGA LG+P T  PNMT++YP+  P+YVAPVDVY+TAR MGP  QI
Sbjct: 241 DTGLYRSWYDDQPYIFGAGLGIPETADPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQI 300

Query: 298 NLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKG 357
           NLNY L+W+FS+DSGF+YLVRLHFCEV   ITKINQRVF I LNNQTA P  DV   T  
Sbjct: 301 NLNYNLTWIFSIDSGFTYLVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSS 360

Query: 358 NGIPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPN 417
           NG+P ++D+ V  P    Q+DLWL LHPN  +K +YYD++LNGVEIFK++  + NLAG N
Sbjct: 361 NGVPFHKDYVVNPPEGNGQQDLWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTN 420

Query: 418 PIPAPKQDVVDPSLALPSSSSGNSKQKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKD 477
           PIP P Q   DPS  L  ++  +    AII G   G + LAL++GFCVF A R R++G  
Sbjct: 421 PIPGP-QVTADPSKVLRPTTRKSKSNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDY 479

Query: 478 PSSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEA 537
             +SDA SGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAAT NFDE+
Sbjct: 480 QPASDATSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDES 539

Query: 538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
            +LGVGGFGKVYRGEIDG TTKVAIKRGNP+SEQGVHEFQTEIEMLSKLRHRHLVSLIGY
Sbjct: 540 RVLGVGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 599

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           CEENCEMILVYDYMA+GT+REHLYKTQ P LPWKQRLEICIGAARGLHYLHTGAKHTIIH
Sbjct: 600 CEENCEMILVYDYMAHGTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIH 659

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS
Sbjct: 660 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 719

Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECF 777
           DVYSFGVVLFE LCARPALNPTL KEQVSLAEWA +C+KKG+L+QI+DPYLKGKI PECF
Sbjct: 720 DVYSFGVVLFEALCARPALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECF 779

Query: 778 KKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDV-D 836
           KKFAETAMKCV DQGIERPSMGDVLWNLEFALQLQESAEE+GK + G MD++E  +D  +
Sbjct: 780 KKFAETAMKCVLDQGIERPSMGDVLWNLEFALQLQESAEENGKGVCGDMDMDEIKYDDGN 839

Query: 837 CKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
           CKGK D  +   + GN+TDSRS+G+ MSIGGRSLASEDSDGLTPSAVFSQIMNPKGR
Sbjct: 840 CKGKND-KSSDVYEGNVTDSRSSGIDMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 895

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|155242172|gb|ABT18098.1| FERONIA receptor-like kinase [Cardamine flexuosa]

 Score = 1342 bits (3472), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 648/875 (74%), Positives = 731/875 (83%), Gaps = 6/875 (0%)

Query: 20  SAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDP 79
           SA H+  AADYIP+++ILLNCG SS  SD DKR+W+ D  +KFL S+ DS TS AATQDP
Sbjct: 23  SASHLISAADYIPTDKILLNCGASSNSSDADKRAWSADNINKFL-SSGDSKTSPAATQDP 81

Query: 80  STPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLK 139
           S   IPYMTARV RS FTYSFPV  GRKFVRLYFYPN+Y+ LNATDALFSVS GPYTLLK
Sbjct: 82  SVSEIPYMTARVSRSPFTYSFPVATGRKFVRLYFYPNTYDGLNATDALFSVSFGPYTLLK 141

Query: 140 NFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNT 199
           NFS AQTAEAL YA ++KE+ + V+G +LN+TF+P   SNAYAFVNGIEV SMPDIY +T
Sbjct: 142 NFSAAQTAEALTYAVIVKEFIVNVEGGSLNMTFTPE--SNAYAFVNGIEVTSMPDIYSST 199

Query: 200 DGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGV 259
           DG L +VG S   +IDN+TALENV+RLNVGG DISPS DT L+RSWYDD+PY+FGAA+G+
Sbjct: 200 DGTLTMVGSSGAFTIDNSTALENVFRLNVGGNDISPSADTGLYRSWYDDEPYVFGAAIGI 259

Query: 260 PVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRL 319
           P T   NMT++YP++ P+YVAP DVY+TAR MGPN  IN+NY L+WVFS+DSGFSYLVRL
Sbjct: 260 PYTADANMTIKYPADTPTYVAPEDVYSTARTMGPNATININYNLTWVFSIDSGFSYLVRL 319

Query: 320 HFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDL 379
           HFCEV    TKINQRVF I LNNQTA P  DV G   GNGI  ++D+ V  P    Q+DL
Sbjct: 320 HFCEVASNNTKINQRVFTIYLNNQTAEPEADVIGWVGGNGIAFHKDYVVNPPDGKGQQDL 379

Query: 380 WLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSG 439
           WL L PN  +K Q YD+ILNGVEIFK++    NLAGPNPIP PK    DPS  +P+ +  
Sbjct: 380 WLALTPNPRNKPQLYDSILNGVEIFKMNTSEGNLAGPNPIPGPKV-TADPSKVVPARTGK 438

Query: 440 NSKQKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSA 499
           +    AI+ G   G + LAL++G CV    R R +     +SDA SGWLPLSLYGN+HSA
Sbjct: 439 SGNHTAIVAGAASGAVVLALIIGLCVLVTYRRRNRVNYQPASDATSGWLPLSLYGNTHSA 498

Query: 500 GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK 559
           GS KTNTTGSYASSLP+NLCRHFSFAEIK AT NFDE+ +LGVGGFGKVYRGEIDG TTK
Sbjct: 499 GSGKTNTTGSYASSLPANLCRHFSFAEIKVATKNFDESRVLGVGGFGKVYRGEIDGGTTK 558

Query: 560 VAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREH 619
           VAIKRGNP+SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGT+REH
Sbjct: 559 VAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTMREH 618

Query: 620 LYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG 679
           LYKTQ  PL WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD+KWVAKVSDFG
Sbjct: 619 LYKTQNSPLAWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDDKWVAKVSDFG 678

Query: 680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPT 739
           LSKTGPT+DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE LCARPALNPT
Sbjct: 679 LSKTGPTVDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNPT 738

Query: 740 LPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMG 799
           L KEQVSLAEWA +C+KKG+L+QI+DPYLKGKI PECFKKF+ETAMKCV DQGIERPSMG
Sbjct: 739 LAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFSETAMKCVLDQGIERPSMG 798

Query: 800 DVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDV-DCKGKKDPNACSGFNGNITDSRS 858
           DVLWNLEFALQLQESAEE+GK +GG +D++E  +D  +CKGK D ++   + GN+TDSRS
Sbjct: 799 DVLWNLEFALQLQESAEENGKGVGGDVDMDEIKYDDGNCKGKNDMSS-DVYEGNVTDSRS 857

Query: 859 TGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
           +G+ MSIGGRSLASEDS+GLTPSAVFSQIMNPKGR
Sbjct: 858 SGIDMSIGGRSLASEDSEGLTPSAVFSQIMNPKGR 892

Source: Cardamine flexuosa

Species: Cardamine flexuosa

Genus: Cardamine

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|155242106|gb|ABT18095.1| FERONIA receptor-like kinase [Cardamine flexuosa]

 Score = 1341 bits (3471), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 648/868 (74%), Positives = 727/868 (83%), Gaps = 5/868 (0%)

Query: 27  AADYIPSEQILLNCGESSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDPSTPTIPY 86
           AADY P+++ILLNCG +S L D D R+W  D+ SKFL S+ DS TS AATQDPS   +PY
Sbjct: 28  AADYSPTDKILLNCGGASDLVDTDNRTWISDVKSKFLSSSGDSKTSPAATQDPSVSQVPY 87

Query: 87  MTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQT 146
           MTARVFRS FTY FPV AGRKFVRLYFYPN+Y+ LNAT+ALFSVS GPYTLLKNFS AQT
Sbjct: 88  MTARVFRSPFTYPFPVAAGRKFVRLYFYPNTYDGLNATNALFSVSFGPYTLLKNFSAAQT 147

Query: 147 AEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNTDGDLMIV 206
           AEAL YA ++KE+ + V+G +LN+TF+P   SNAYAF+NGIEV SMPDIY +TDG L++V
Sbjct: 148 AEALTYAVIVKEFIVNVEGGSLNMTFTPE--SNAYAFMNGIEVTSMPDIYSSTDGSLIMV 205

Query: 207 GQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPN 266
           G SS  +IDN+TALENV+RLNVGG DISPS DT L+RSWYDDQPYIF A LG+P T  PN
Sbjct: 206 GASSDFTIDNSTALENVFRLNVGGNDISPSADTGLYRSWYDDQPYIFAAGLGIPETADPN 265

Query: 267 MTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLP 326
           MT++YP+  P+YVAPVDVY+TAR MGP   IN+NY L+WVFS+DSGFSYLVRLHFCEV P
Sbjct: 266 MTIQYPTGTPTYVAPVDVYSTARSMGPTASININYNLTWVFSIDSGFSYLVRLHFCEVSP 325

Query: 327 EITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPN 386
            ITKINQRVF I LNNQTA    DV    +GNGIP ++D+ V  P    Q+DLWL LHPN
Sbjct: 326 RITKINQRVFTIYLNNQTAEEEADVIAWAQGNGIPFHKDYVVNPPEGKGQQDLWLALHPN 385

Query: 387 VASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGNSKQKAI 446
             +K +YYD+IL+GVEIFK++  + NLAG NPIP PK    DP   L   +S +     I
Sbjct: 386 TRNKPEYYDSILSGVEIFKVNTSDGNLAGSNPIPGPKV-TADPFKVLRPRTSQSRNHTTI 444

Query: 447 IGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKTNT 506
           I G   G + LAL++G CV  A   R +G    +SDA SGWLPLSLYGNSHSAGS KTNT
Sbjct: 445 IVGAAIGAVVLALIIGLCVMVAYCRRNRGDYQPASDATSGWLPLSLYGNSHSAGSTKTNT 504

Query: 507 TGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN 566
           TGSYASSLPSNLCRHFSFAEIKAAT NFDE+ +LGVGGFGKVYRGEIDG TTKVAIKRGN
Sbjct: 505 TGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIKRGN 564

Query: 567 PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP 626
           P+SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA+GT+REHLYKTQ  
Sbjct: 565 PMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHLYKTQNS 624

Query: 627 PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT 686
           PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT
Sbjct: 625 PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT 684

Query: 687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS 746
           LDHTHVSTVVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFE LCARPALNPTL KEQVS
Sbjct: 685 LDHTHVSTVVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEALCARPALNPTLAKEQVS 744

Query: 747 LAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
           LAEWA +C+KKG+L+QI+DPYLKGKI PECFKKFAETAMKCV DQGIERPSMGDVLWNLE
Sbjct: 745 LAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMGDVLWNLE 804

Query: 807 FALQLQESAEESGKVLGGGMDIEEGAFDVDCKGK-KDPNACSGFNGNITDSRSTGMSMSI 865
           FALQLQESAEE+GK + G MD++E  ++ D  GK K+  +   + GN+TDSRS+G+ MSI
Sbjct: 805 FALQLQESAEENGKGMSGDMDMDEIKYN-DGNGKGKNEMSSDVYEGNVTDSRSSGIDMSI 863

Query: 866 GGRSLASEDSDGLTPSAVFSQIMNPKGR 893
           GGRSLASEDS+GLTPSAVFSQIMNPKGR
Sbjct: 864 GGRSLASEDSEGLTPSAVFSQIMNPKGR 891

Source: Cardamine flexuosa

Species: Cardamine flexuosa

Genus: Cardamine

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|155242200|gb|ABT18100.1| FERONIA receptor-like kinase [Arabidopsis thaliana]

 Score = 1340 bits (3469), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 654/871 (75%), Positives = 737/871 (84%), Gaps = 6/871 (0%)

Query: 27  AADYIPSEQILLNCGE-SSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAA-TQDPSTPTI 84
           AADY P+E+ILLNCG  +S L+D D R W  D+ SKFL S+ + + +  A TQDPS P +
Sbjct: 25  AADYSPTEKILLNCGGGASNLTDTDNRIWISDVKSKFLSSSSEDSKTSPALTQDPSVPEV 84

Query: 85  PYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVA 144
           PYMTARVFRS FTY+FPV +GRKFVRLYFYPNSY+ LNAT++LFSVS GPYTLLKNFS +
Sbjct: 85  PYMTARVFRSPFTYTFPVASGRKFVRLYFYPNSYDGLNATNSLFSVSFGPYTLLKNFSAS 144

Query: 145 QTAEALNYAYVIKEYAIPVDGETLNITFSPMNV-SNAYAFVNGIEVMSMPDIYKNTDGDL 203
           QTAEAL YA++IKE+ + V+G TLN+TF+P +  SNAYAFVNGIEV SMPD+Y +TDG L
Sbjct: 145 QTAEALTYAFIIKEFVVNVEGGTLNMTFTPESSPSNAYAFVNGIEVTSMPDMYSSTDGTL 204

Query: 204 MIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTI 263
            +VG S  ++IDN+TALENVYRLNVGG DISPS DT L+RSWYDDQPYIFGA LG+P T 
Sbjct: 205 TMVGSSGSVTIDNSTALENVYRLNVGGNDISPSADTGLYRSWYDDQPYIFGAGLGIPETA 264

Query: 264 GPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCE 323
            PNMT++YP+  P+YVAPVDVY+TAR MGP  QINLNY L+W+FS+DSGF+YLVRLHFCE
Sbjct: 265 DPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSGFTYLVRLHFCE 324

Query: 324 VLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGL 383
           V   ITKINQRVF I LNNQTA P  DV   T  NG+P ++D+ V  P    Q+DLWL L
Sbjct: 325 VSSNITKINQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYVVNPPEGNGQQDLWLAL 384

Query: 384 HPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGNSKQ 443
           HPN  +K +YYD++LNGVEIFK++  + NLAG NPIP P Q   DPS  L  ++  +   
Sbjct: 385 HPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGP-QVTADPSKVLRPTTRKSKSN 443

Query: 444 KAIIGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAK 503
            AII G   G + LAL++GFCVF A R R++G    +SDA SGWLPLSLYGNSHSAGSAK
Sbjct: 444 TAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLYGNSHSAGSAK 503

Query: 504 TNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK 563
           TNTTGSYASSLPSNLCRHFSFAEIKAAT NFDE+ +LGVGGFGKVYRGEIDG TTKVAIK
Sbjct: 504 TNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIK 563

Query: 564 RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKT 623
           RGNP+SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA+GT+REHLYKT
Sbjct: 564 RGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHLYKT 623

Query: 624 QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT 683
           Q P LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT
Sbjct: 624 QNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT 683

Query: 684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE LCARPALNPTL KE
Sbjct: 684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNPTLAKE 743

Query: 744 QVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLW 803
           QVSLAEWA +C+KKG+L+QI+DPYLKGKI PECFKKFAETAMKCV DQGIERPSMGDVLW
Sbjct: 744 QVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMGDVLW 803

Query: 804 NLEFALQLQESAEESGKVLGGGMDIEEGAFDV-DCKGKKDPNACSGFNGNITDSRSTGMS 862
           NLEFALQLQESAEE+GK + G MD++E  +D  +CKGK D  +   + GN+TDSRS+G+ 
Sbjct: 804 NLEFALQLQESAEENGKGVCGDMDMDEIKYDDGNCKGKND-KSSDVYEGNVTDSRSSGID 862

Query: 863 MSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
           MSIGGRSLASEDSDGLTPSAVFSQIMNPKGR
Sbjct: 863 MSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	893
TAIR|locus:2081895	895	FER "FERONIA" [Arabidopsis tha	0.996	0.994	0.719	0.0
TAIR|locus:2084953	850	ANX1 "ANXUR1" [Arabidopsis tha	0.879	0.923	0.521	3.1e-225
TAIR|locus:2148830	858	ANX2 "ANXUR2" [Arabidopsis tha	0.898	0.934	0.515	9.2e-224
TAIR|locus:2177202	873	AT5G39000 [Arabidopsis thalian	0.952	0.974	0.473	4.5e-201
TAIR|locus:2152312	880	AT5G38990 [Arabidopsis thalian	0.957	0.971	0.462	1.9e-193
TAIR|locus:2204564	849	HERK2 "hercules receptor kinas	0.574	0.604	0.490	7.4e-176
TAIR|locus:2136338	878	AT4G39110 [Arabidopsis thalian	0.462	0.470	0.543	8.3e-164
TAIR|locus:2178707	824	AT5G24010 [Arabidopsis thalian	0.376	0.407	0.625	3.2e-163
TAIR|locus:2163158	842	AT5G61350 [Arabidopsis thalian	0.358	0.380	0.658	5.8e-163
TAIR|locus:2050080	871	AT2G21480 [Arabidopsis thalian	0.382	0.392	0.627	2.6e-160

TAIR|locus:2081895 FER "FERONIA" [Arabidopsis thaliana (taxid:3702)]

 Score = 3357 (1186.8 bits), Expect = 0., P = 0.
 Identities = 646/898 (71%), Positives = 725/898 (80%)

Query:     1 MKNLNKQFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGE-SSILSDDDKRSWTPDIG 59
             MK    +F  +L + L L SA  +  AADY P+E+ILLNCG  +S L+D D R W  D+ 
Sbjct:     1 MKITEGRFRLSLLLLLLLISAATLISAADYSPTEKILLNCGGGASNLTDTDNRIWISDVK 60

Query:    60 XXXXXXXXXXXXXX-XXXQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSY 118
                               QDPS P +PYMTARVFRS FTY+FPV +GRKFVRLYFYPNSY
Sbjct:    61 SKFLSSSSEDSKTSPALTQDPSVPEVPYMTARVFRSPFTYTFPVASGRKFVRLYFYPNSY 120

Query:   119 NRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNV- 177
             + LNAT++LFSVS GPYTLLKNFS +QTAEAL YA++IKE+ + V+G TLN+TF+P +  
Sbjct:   121 DGLNATNSLFSVSFGPYTLLKNFSASQTAEALTYAFIIKEFVVNVEGGTLNMTFTPESAP 180

Query:   178 SNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSG 237
             SNAYAFVNGIEV SMPD+Y +TDG L +VG S  ++IDN+TALENVYRLNVGG DISPS 
Sbjct:   181 SNAYAFVNGIEVTSMPDMYSSTDGTLTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSA 240

Query:   238 DTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQI 297
             DT L+RSWYDDQPYIFGA LG+P T  PNMT++YP+  P+YVAPVDVY+TAR MGP  QI
Sbjct:   241 DTGLYRSWYDDQPYIFGAGLGIPETADPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQI 300

Query:   298 NLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKG 357
             NLNY L+W+FS+DSGF+YLVRLHFCEV   ITKINQRVF I LNNQTA P  DV   T  
Sbjct:   301 NLNYNLTWIFSIDSGFTYLVRLHFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSS 360

Query:   358 NGIPLYQDFAVFVP-GNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGP 416
             NG+P ++D+ V  P GNG Q+DLWL LHPN  +K +YYD++LNGVEIFK++  + NLAG 
Sbjct:   361 NGVPFHKDYVVNPPEGNG-QQDLWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGT 419

Query:   417 NPIPAPKQDVVDXXXXXXXXXXGNSKQKXXXXXXXXXXXXXXXXXXFCVFAASRCRRQGK 476
             NPIP P Q   D           +                      FCVF A R R++G 
Sbjct:   420 NPIPGP-QVTADPSKVLRPTTRKSKSNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGD 478

Query:   477 DPSSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDE 536
                +SDA SGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAAT NFDE
Sbjct:   479 YQPASDATSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDE 538

Query:   537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
             + +LGVGGFGKVYRGEIDG TTKVAIKRGNP+SEQGVHEFQTEIEMLSKLRHRHLVSLIG
Sbjct:   539 SRVLGVGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIG 598

Query:   597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
             YCEENCEMILVYDYMA+GT+REHLYKTQ P LPWKQRLEICIGAARGLHYLHTGAKHTII
Sbjct:   599 YCEENCEMILVYDYMAHGTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTII 658

Query:   657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
             HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK
Sbjct:   659 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 718

Query:   717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC 776
             SDVYSFGVVLFE LCARPALNPTL KEQVSLAEWA +C+KKG+L+QI+DPYLKGKI PEC
Sbjct:   719 SDVYSFGVVLFEALCARPALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPEC 778

Query:   777 FKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEEGAFDV- 835
             FKKFAETAMKCV DQGIERPSMGDVLWNLEFALQLQESAEE+GK + G MD++E  +D  
Sbjct:   779 FKKFAETAMKCVLDQGIERPSMGDVLWNLEFALQLQESAEENGKGVCGDMDMDEIKYDDG 838

Query:   836 DCKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
             +CKGK D ++   + GN+TDSRS+G+ MSIGGRSLASEDSDGLTPSAVFSQIMNPKGR
Sbjct:   839 NCKGKNDKSS-DVYEGNVTDSRSSGIDMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 895

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0016020 "membrane" evidence=IDA

GO:0010483 "pollen tube reception" evidence=IMP

GO:0043680 "filiform apparatus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009791 "post-embryonic development" evidence=IMP

GO:0050832 "defense response to fungus" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0000902 "cell morphogenesis" evidence=RCA

GO:0006007 "glucose catabolic process" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0010193 "response to ozone" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0030244 "cellulose biosynthetic process" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048193 "Golgi vesicle transport" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2084953 ANX1 "ANXUR1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2125 (753.1 bits), Expect = 3.1e-225, Sum P(2) = 3.1e-225
 Identities = 431/826 (52%), Positives = 561/826 (67%)

Query:    34 EQILLNCGESSILSDDDKRSWTPDIGXXXXXXXXXXXXXXXXXQDPST-PTIPYMTARVF 92
             + + L+CG S   +D DK+ W PD                   QDPS   T+PYMTAR+F
Sbjct:    27 QDLALSCGTSEASADQDKKKWEPD---TKFLKTGNSIHATATYQDPSLLSTVPYMTARIF 83

Query:    93 RSEFTYSFPVVAGRK-FVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALN 151
              +  TY  P+   ++  +RLYFYP++Y  LN +++ F+V     TLL NFS A T +AL 
Sbjct:    84 TAPATYEIPIKGDKRHLLRLYFYPSTYTGLNISNSYFTVEANDVTLLSNFSAAITCQALT 143

Query:   152 YAYVIKEYAI-PVDGETLNITFSPMN-VSNAYAFVNGIEVMSMPDIYKNTDGDLMIVGQS 209
              AY++KEY++ P D + L+I F+P +   +A+AF+NGIEV+ MP+++        +VG +
Sbjct:   144 QAYLVKEYSLAPTDKDVLSIKFTPSDKYRDAFAFINGIEVIQMPELFDTA----ALVGFT 199

Query:   210 SPISIDNTTALENVYRLNVGGKDISPSGDTD-LFRSWYDDQPYIFGAALGVPVTIGPNMT 268
                    T  L++++RLNVGG+DI  S D+  L R+WY+D PYIF A LGV +    N  
Sbjct:   200 DQTMDAKTANLQSMFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQASNNFR 259

Query:   269 VRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEI 328
             + Y  N+P  +AP D+Y TAR  GPN  INL   L+W+F +D  F+Y++RLHFCE   ++
Sbjct:   260 INY-QNMPVSIAPADIYKTARSQGPNGDINLKSNLTWMFQIDKNFTYILRLHFCEF--QL 316

Query:   329 TKINQRVFDILLNNQTA----FPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLH 384
             +KINQ+VF+I +NN+TA     PA D+ G T   GIP+Y+D+A++V  N   +++ L + 
Sbjct:   317 SKINQKVFNIYINNRTAQADTTPA-DIIGWTGEKGIPMYKDYAIYVDANNGGEEITLQMT 375

Query:   385 PNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDXXXXXXXXXXGNSKQK 444
             P+   + +YYD+ LNG+EIFK+ D   NLAGPNP P+P Q   +           N K +
Sbjct:   376 PSTFGQPEYYDSSLNGLEIFKM-DTMKNLAGPNPEPSPMQAEEEVKKEFK-----NEK-R 428

Query:   445 XXXXXXXXXXXXXXXXXXFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKT 504
                                C F A + ++QG     S   S WLP+  YGNS ++G+  T
Sbjct:   429 HAFIIGSAGGVLAVLIGALC-FTAYK-KKQGYQGGDSHTSS-WLPI--YGNSTTSGTKST 483

Query:   505 ----NTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKV 560
                 +  GS+ S+L + LCR FS  EIK  T NFD++ ++GVGGFGKVY+G IDG TTKV
Sbjct:   484 ISGKSNNGSHLSNLAAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDG-TTKV 542

Query:   561 AIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL 620
             A+K+ NP SEQG++EF+TEIE+LS+LRH+HLVSLIGYC+E  EM LVYDYMA+GTLREHL
Sbjct:   543 AVKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHL 602

Query:   621 YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL 680
             Y T+KP L WK+RLEI IGAARGLHYLHTGAK+TIIHRDVKTTNIL+DE WVAKVSDFGL
Sbjct:   603 YNTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDFGL 662

Query:   681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTL 740
             SKTGP ++  HV+TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNP+L
Sbjct:   663 SKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPSL 722

Query:   741 PKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGD 800
             PKEQVSL +WA +C +KG LE I+DP LKGKI  EC KKFA+TA KC++D G+ERP+MGD
Sbjct:   723 PKEQVSLGDWAMNCKRKGNLEDIIDPNLKGKINAECLKKFADTAEKCLNDSGLERPTMGD 782

Query:   801 VLWNLEFALQLQESAEESGKVL---GGGM-DIEEGAFDVDCKGKKD 842
             VLWNLEFALQLQE+A+ +       GG   D+  G   V+  G+ D
Sbjct:   783 VLWNLEFALQLQETADGTRHRTPNNGGSSEDLGRGGMAVNVAGRDD 828

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009860 "pollen tube growth" evidence=IGI;RCA

GO:0016324 "apical plasma membrane" evidence=IDA

GO:0090404 "pollen tube tip" evidence=IDA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2148830 ANX2 "ANXUR2" [Arabidopsis thaliana (taxid:3702)]

 Score = 2112 (748.5 bits), Expect = 9.2e-224, Sum P(2) = 9.2e-224
 Identities = 437/847 (51%), Positives = 566/847 (66%)

Query:     4 LNKQFLSTLFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGXXXX 63
             +N++ L  LF FL     + V+ +      + I L+CG S    D DK+ W PD      
Sbjct:     1 MNEK-LRILFSFLCFFYVLLVSPSQSN--GQDISLSCGASEPAVDQDKKKWEPD---TKF 54

Query:    64 XXXXXXXXXXXXXQDPST-PTIPYMTARVFRSEFTYSFPVVAGRK-FVRLYFYPNSYNRL 121
                          QDPS   T+PYMT+R+F +  TY  PV   ++  +RL+FYP++Y  L
Sbjct:    55 LKTPNTVHAPATYQDPSLLSTVPYMTSRIFTAPATYEIPVKGDKRHMLRLHFYPSTYTGL 114

Query:   122 NATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAI-PVDGETLNITFSPMNVS-N 179
             N  D+ FSV+    TLL NFS A T +AL  AY+++EY++ P + + L+I F+P +    
Sbjct:   115 NILDSYFSVAANDLTLLSNFSAAITCQALTQAYLVREYSLAPSEKDVLSIIFTPSDKHPK 174

Query:   180 AYAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDT 239
             A+AF+NGIEV+ MP+++        +VG S   S   T  L+ ++RLNVGG+DI  S D+
Sbjct:   175 AFAFINGIEVIPMPELFDTAS----LVGFSDQTSDTKTANLQTMFRLNVGGQDIPGSQDS 230

Query:   240 D-LFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQIN 298
               L R+WY+D PYIF A LGV +    N  + Y   +P   AP DVY TAR  GPN  IN
Sbjct:   231 GGLTRTWYNDAPYIFSAGLGVTLQASNNFRIDY-QKMPVSTAPADVYKTARSQGPNGDIN 289

Query:   299 LNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAF----PAFDVAGL 354
             +   L+W+F VD+ F+Y++RLHFCE   ++ KINQ+VF+I +NN+TA     PA D+ G 
Sbjct:   290 MKSNLTWMFQVDTNFTYIMRLHFCEF--QLAKINQKVFNIFINNRTAQGDTNPA-DILGW 346

Query:   355 TKGNGIPLYQDFAVFVPGN--GPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSN 412
             T G GIP Y+D+A++V  N  G  +++ L + P+   + +YYD+ LNG+EIFK+ D   N
Sbjct:   347 TGGKGIPTYKDYAIYVDANTGGGGEEISLQMTPSTFGQPEYYDSQLNGLEIFKI-DTMKN 405

Query:   413 LAGPNPIPAPKQDVVDXXXXXXXXXXGNSKQKXXXXXXXXXXXXXXXXXXFCVFAASRCR 472
             LAGPNP P+P Q   D          G+ +                    FC    +  +
Sbjct:   406 LAGPNPKPSPMQANEDVKKDFQ----GDKR----ITAFVIGSAGGVAAVLFCALCFTMYQ 457

Query:   473 RQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKT----NTTGSYASSLPSNLCRHFSFAEIK 528
             R+ K   S    S WLP+  YGNSH++ +  T    +  GS+ S+L + LCR FS +EIK
Sbjct:   458 RKRKFSGSDSHTSSWLPI--YGNSHTSATKSTISGKSNNGSHLSNLAAGLCRRFSLSEIK 515

Query:   529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH 588
               T+NFDE+ ++GVGGFGKVY+G IDG T KVAIK+ NP SEQG++EF+TEIE+LS+LRH
Sbjct:   516 HGTHNFDESNVIGVGGFGKVYKGVIDGGT-KVAIKKSNPNSEQGLNEFETEIELLSRLRH 574

Query:   589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
             +HLVSLIGYC+E  EM L+YDYM+ GTLREHLY T++P L WK+RLEI IGAARGLHYLH
Sbjct:   575 KHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYLH 634

Query:   649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
             TGAK+TIIHRDVKTTNILLDE WVAKVSDFGLSKTGP ++  HV+TVVKGSFGYLDPEYF
Sbjct:   635 TGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYF 694

Query:   709 RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL 768
             RRQQLTEKSDVYSFGVVLFE+LCARPALNP+L KEQVSL +WA +C +KG LE I+DP L
Sbjct:   695 RRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLEDIIDPNL 754

Query:   769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVL----GG 824
             KGKI PEC KKFA+TA KC+SD G++RP+MGDVLWNLEFALQLQE+A+ S        GG
Sbjct:   755 KGKINPECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEFALQLQETADGSRHRTPSNGGG 814

Query:   825 GMDIEEG 831
              +D+  G
Sbjct:   815 SVDLGGG 821

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009860 "pollen tube growth" evidence=IGI

GO:0016324 "apical plasma membrane" evidence=IDA

GO:0090404 "pollen tube tip" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2177202 AT5G39000 [Arabidopsis thaliana (taxid:3702)]

 Score = 1946 (690.1 bits), Expect = 4.5e-201, P = 4.5e-201
 Identities = 426/899 (47%), Positives = 557/899 (61%)

Query:    12 LFIFLSLASAIHVTLAAD--YIPSEQILLNCGESSILSDDDKRSWTPDIGXXXXXXXXXX 69
             L IF  L S   V   A   Y P++  L NCG++S   D   R+WT +            
Sbjct:     6 LLIFSILVSTPIVGEGATSTYEPTDVFLFNCGDTSNNVDVSGRNWTAENQKILSSNLVNA 65

Query:    70 XXXXXXX-QDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSY-NRLNATDAL 127
                     Q+     IPYMTAR+FRSEFTYSFPV  G  F+RLYFYP  Y ++ NA  + 
Sbjct:    66 SFTAQASYQESGVSQIPYMTARIFRSEFTYSFPVTPGSNFLRLYFYPTRYGSQFNAVKSF 125

Query:   128 FSVSTGPYTLLKNFSVAQTAEALN--YAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVN 185
             FSV    +TLL NFS   T +A      ++IKE+ IPV  +TLN+TF+P    ++ AFVN
Sbjct:   126 FSVKVNGFTLLNNFSADLTVKASKPQTEFIIKEFIIPVY-QTLNLTFTPS--LDSLAFVN 182

Query:   186 GIEVMSMPDIYKNTDG--DLMI-VGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLF 242
             GIE++S+P+ + +  G  D++  VG S    I+N+TA E VYRLNVGGK +   GD+ +F
Sbjct:   183 GIEIVSIPNRFYSKGGFDDVITNVGSSVDFHIENSTAFETVYRLNVGGKTV---GDSGMF 239

Query:   243 RSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMG--PNPQINLN 300
             R W  D   I   + G+   + P++ + Y    PSYVAP DVYAT+R MG   +P+ NLN
Sbjct:   240 RRWVSDDEIILSESSGISPIV-PDIKINYTEKTPSYVAPDDVYATSRSMGNADHPEQNLN 298

Query:   301 YELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGI 360
             + L+W+F+VD+GFSYLVRLHFCE L E+ K  QRVF I + NQTA    DV  ++ G+ I
Sbjct:   299 FNLTWLFTVDAGFSYLVRLHFCETLSEVNKEGQRVFSIFIENQTATLEMDVFRMSGGSWI 358

Query:   361 PLYQDFAVFV-PGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPI 419
             P+Y D+ V    G+G + DL L LHP V+   +YYDAILNGVEI K++DP+ NLAGPNP 
Sbjct:   359 PMYLDYTVIAGSGSGRRHDLRLDLHPLVSINPKYYDAILNGVEILKMNDPDGNLAGPNPD 418

Query:   420 PAPKQDVVDXXXXXXXXXXGNSKQKXXXXXXXXXXXXXXXXXXFCVFAASRCRRQGKDPS 479
             P    D++            N                        V    + +++ K PS
Sbjct:   419 PLVSPDLIPNRATPRIRK--NKSHILPITLAVVGSLVVLAMFVVGVLVIMKKKKKSK-PS 475

Query:   480 SSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALL 539
             ++   S W PL      H  G+  TNT    A SLP++LCR FS  EIK+ATN+F++ L+
Sbjct:   476 TN---SSWCPLP-----H--GTDSTNTKP--AKSLPADLCRRFSIFEIKSATNDFEDKLI 523

Query:   540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
             +GVGGFG VY+G+IDG  T VA+KR    S QG  EF+TE+EMLSKLRH HLVSLIGYC+
Sbjct:   524 IGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFETELEMLSKLRHVHLVSLIGYCD 583

Query:   600 ENCEMILVYDYMAYGTLREHLY---KTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
             E+ EM+LVY+YM +GTL++HL+   KT  PPL WK+RLEICIGAARGL YLHTGAK+TII
Sbjct:   584 EDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLEICIGAARGLQYLHTGAKYTII 643

Query:   657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQQLTE 715
             HRD+KTTNILLDE +V KVSDFGLS+ GPT    THVSTVVKG+FGYLDPEY+RRQ LTE
Sbjct:   644 HRDIKTTNILLDENFVTKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQVLTE 703

Query:   716 KSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPE 775
             KSDVYSFGVVL E+LC RP    ++P EQ  L  W    +++G ++QI+D  L   I   
Sbjct:   704 KSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVKSNYRRGTVDQIIDSDLSADITST 763

Query:   776 CFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDI-EEGAFD 834
               +KF E A++CV D+G+ERP M DV+W LEFALQL E+A++    +   +D+   G   
Sbjct:   764 SLEKFCEIAVRCVQDRGMERPPMNDVVWALEFALQLHETAKKKNDNVES-LDLMPSGEVG 822

Query:   835 VDCKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 893
                 G+ D    S   G++  S +T  S+ + G     ++  G +   VFS+I  PK R
Sbjct:   823 TTTDGEDD--LFSRTTGHVGKSTTTDDSVLVVG-----DERSG-SSWGVFSEINEPKAR 873

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2152312 AT5G38990 [Arabidopsis thaliana (taxid:3702)]

 Score = 1874 (664.7 bits), Expect = 1.9e-193, P = 1.9e-193
 Identities = 417/902 (46%), Positives = 543/902 (60%)

Query:    12 LFIFLSLASAIHVTLAADYIPSEQILLNCGESSILSDDDKRSWTPDIGXXXXXXXX--XX 69
             L IF  L SA+ V   A Y P++  L+NCG++S   D   R+WT +              
Sbjct:     6 LVIFTILVSAV-VDATASYEPTDVFLINCGDTSNNMDYSGRNWTTENPKFMSSNAVDDAS 64

Query:    70 XXXXXXXQDPSTPTIPYMTARVFRSEFTYSFPVVAGRKFVRLYFYPNSYNR-LNATDALF 128
                    Q+   P +PY+ AR+FR +FTYSFPV  G KF+RLYFYP  Y    +A  + F
Sbjct:    65 FTSSASYQESGIPQVPYLKARIFRYDFTYSFPVSPGWKFLRLYFYPTRYGSDFDAVKSFF 124

Query:   129 SVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIE 188
             SV+   +TLL NFSV   A     + +IKE+ +PV+ +TL++TF+P    N+ AFVNGIE
Sbjct:   125 SVNVNRFTLLHNFSVK--ASIPESSSLIKEFIVPVN-QTLDLTFTPS--PNSLAFVNGIE 179

Query:   189 VMSMPDIYKNTDG-DLMI--VGQSSPISIDNTTALENVYRLNVGGKDISPSGDTDLFRSW 245
             ++SMPD + +  G D ++  VG+     IDN+TA E VYR+NVGGK +   GD+ +FR W
Sbjct:   180 IISMPDRFYSKGGFDDVVRNVGRDVDFEIDNSTAFETVYRVNVGGKVVGDVGDSGMFRRW 239

Query:   246 YDDQPYIFGAALG-VPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMG--PNPQINLNYE 302
               D+ ++ G   G +P   G  + + Y    P+YVAP DVY T R MG   +P++NLN+ 
Sbjct:   240 LSDEGFLLGINSGAIPNITG--VKINYTDKTPAYVAPEDVYTTCRLMGNKDSPELNLNFN 297

Query:   303 LSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPL 362
             L+W+F VD+GF+Y+VRLHFCE  PE+ K   RVF I    Q A    DV  L+ G  +P+
Sbjct:   298 LTWLFEVDAGFAYIVRLHFCETQPEVNKTGDRVFSIFFGYQLAMREMDVFRLSGGFRLPM 357

Query:   363 YQDFAVFVPGNGPQK--DLWLGLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIP 420
             Y DF V V  +G  +   L + L P       YYDAIL+GVEI KLS+ + NLAG NPIP
Sbjct:   358 YLDFKVLVDADGTSQRPSLRVDLTPYKEDYPTYYDAILSGVEILKLSNSDGNLAGLNPIP 417

Query:   421 A---PKQDVVDXXXXXXXXXXGNSKQKXXXXXXXXXXXXXXXXXXFCVFAASRCRRQGKD 477
                 P Q +            G S                       V      R++  +
Sbjct:   418 QLSPPPQSITPLKGK------GKSSHVLPIIIAVVGSAVALAFFVLVVVLVVMKRKKKSN 471

Query:   478 PSSSDAQSGWLPLSLYGNS-HSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDE 536
              SS D  +     S +G   H  GS  TNT    ASSLPS+LCR FS  EIK+ATN+F+E
Sbjct:   472 ESSVDTTNKPSTNSSWGPLLHGTGS--TNTKS--ASSLPSDLCRRFSIYEIKSATNDFEE 527

Query:   537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
              L++GVGGFG VY+G IDG  T VA+KR    S QG  EF TE+EMLSKLRH HLVSLIG
Sbjct:   528 KLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTELEMLSKLRHVHLVSLIG 587

Query:   597 YCEENCEMILVYDYMAYGTLREHLYKTQK---PPLPWKQRLEICIGAARGLHYLHTGAKH 653
             YC+++ EM+LVY+YM +GTL++HL++  K   PPL WK+RLEICIGAARGL YLHTGAK+
Sbjct:   588 YCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLEICIGAARGLQYLHTGAKY 647

Query:   654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             TIIHRD+KTTNILLDE +VAKVSDFGLS+ GPT    THVSTVVKG+FGYLDPEY+RRQ 
Sbjct:   648 TIIHRDIKTTNILLDENFVAKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQI 707

Query:   713 LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI 772
             LTEKSDVYSFGVVL E+LC RP    ++P EQ  L  W      K  ++QI+D  L   I
Sbjct:   708 LTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVKSNFNKRTVDQIIDSDLTADI 767

Query:   773 APECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDI-EEG 831
                  +KF E A++CV D+G+ERP M DV+W LEFALQL E+A++    +   +D+   G
Sbjct:   768 TSTSMEKFCEIAIRCVQDRGMERPPMNDVVWALEFALQLHETAKKKNDNVES-LDLMPSG 826

Query:   832 AFDVDCKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNPK 891
                    G+ D    S   G++  S +T  S+ + G     ++  G +   VFS+I  PK
Sbjct:   827 EVGTTTDGEDD--LFSRTTGHVGKSTTTDDSVLVVG-----DERSG-SSWGVFSEINEPK 878

Query:   892 GR 893
              R
Sbjct:   879 AR 880

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1234 (439.4 bits), Expect = 7.4e-176, Sum P(2) = 7.4e-176
 Identities = 265/540 (49%), Positives = 344/540 (63%)

Query:   328 ITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNV 387
             + K NQR+F I +NNQTA   FD+     G    +YQD+    P +     LW+ L P+ 
Sbjct:   329 VDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQDY--LDPVSSKNDVLWIQLGPD- 385

Query:   388 ASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDXXXXXXXXXXGNSKQKXXX 447
             +S     DA+L+G+EIFKLS  N NLA      +    V D            SK +   
Sbjct:   386 SSVGASGDALLSGLEIFKLSK-NGNLAHLIRFDSTGHSVSD------------SKMRIIW 432

Query:   448 XXXXXXXXXXXXXXXFCVFAASRCR-RQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKTNT 506
                              +     C+ R+ K   S +   GW PL L+ N+ +A +  T  
Sbjct:   433 ISVGAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATGG 492

Query:   507 TGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN 566
             +    +   S + R F+ AEI+AAT NFD+ L +GVGGFGKVYRGE++  T  +AIKR  
Sbjct:   493 SLRLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTL-IAIKRAT 551

Query:   567 PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP 626
             P S+QG+ EF+TEI MLS+LRHRHLVSLIG+C+E+ EMILVY+YMA GTLR HL+ +  P
Sbjct:   552 PHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLP 611

Query:   627 PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT 686
             PL WKQRLE CIG+ARGLHYLHTG++  IIHRDVKTTNILLDE +VAK+SDFGLSK GP+
Sbjct:   612 PLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPS 671

Query:   687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS 746
             +DHTHVST VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE +CAR  +NPTLPK+Q++
Sbjct:   672 MDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQIN 731

Query:   747 LAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
             LAEWA    K+  LE I+D  L+G  +PE  +K+ E A KC++D+G  RP MG+VLW+LE
Sbjct:   732 LAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLE 791

Query:   807 FALQLQES--AEESGK-VLGGGMDIEEGAFDVDCKGKKDPNACSGFNGNITDSRSTGMSM 863
             + LQ+ E+   +++G+        +EE            P ACS  + + T+   TG ++
Sbjct:   792 YVLQIHEAWLRKQNGENSFSSSQAVEEAPESFTL-----P-ACSNQDSSETEQSQTGSAL 845

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1120 (399.3 bits), Expect = 8.3e-164, Sum P(2) = 8.3e-164
 Identities = 230/423 (54%), Positives = 291/423 (68%)

Query:   472 RRQGKDPSSSDAQSGWL-PLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAA 530
             +++ +D    ++ S WL P+    ++       +  +  Y S+L   L R+FS +E++ A
Sbjct:   465 KKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKGGSQKSNFYNSTL--GLGRYFSLSELQEA 522

Query:   531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH 590
             T NF+ + ++GVGGFG VY G +D  T KVA+KRGNP SEQG+ EFQTEI+MLSKLRHRH
Sbjct:   523 TKNFEASQIIGVGGFGNVYIGTLDDGT-KVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH 581

Query:   591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
             LVSLIGYC+EN EMILVY++M+ G  R+HLY     PL WKQRLEICIG+ARGLHYLHTG
Sbjct:   582 LVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHYLHTG 641

Query:   651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
                 IIHRDVK+TNILLDE  VAKV+DFGLSK        HVST VKGSFGYLDPEYFRR
Sbjct:   642 TAQGIIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRR 700

Query:   711 QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG 770
             QQLT+KSDVYSFGVVL E LCARPA+NP LP+EQV+LAEWA    +KG+LE+I+DP+L G
Sbjct:   701 QQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLAG 760

Query:   771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLGGGMDIEE 830
              I PE  KKFAE A KC+ D G++RP+MGDVLWNLE+ALQLQE+  + GK      + E 
Sbjct:   761 TINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQ-GKA----EETEN 815

Query:   831 GAFDVDCKGKKDPNACSGFNGNITDSRSTGMSMSIGGRSLASEDSDGLTPSAVFSQIMNP 890
                DV   G    +  S    ++T + +  + +       +    D  + +A+F+Q  N 
Sbjct:   816 AKPDVVTPGSVPVSDPSPITPSVTTNEAATVPVPAKVEENSGTAVDEHSGTAMFTQFANL 875

Query:   891 KGR 893
              GR
Sbjct:   876 NGR 878

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

GO:0030048 "actin filament-based movement" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2178707 AT5G24010 [Arabidopsis thaliana (taxid:3702)]

 Score = 1120 (399.3 bits), Expect = 3.2e-163, Sum P(3) = 3.2e-163
 Identities = 215/344 (62%), Positives = 267/344 (77%)

Query:   471 CRRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAA 530
             CRR+     SS++ +GW PL  +      GS+ + TT    SS   +  R  SFAE+++ 
Sbjct:   433 CRRKNNKTRSSES-TGWTPLRRF-----RGSSNSRTTERTVSSSGYHTLR-ISFAELQSG 485

Query:   531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH 590
             TNNFD +L++GVGGFG V+RG +    TKVA+KRG+P S QG+ EF +EI +LSK+RHRH
Sbjct:   486 TNNFDRSLVIGVGGFGMVFRGSLKD-NTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRH 544

Query:   591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
             LVSL+GYCEE  EMILVY+YM  G L+ HLY +  PPL WKQRLE+CIGAARGLHYLHTG
Sbjct:   545 LVSLVGYCEEQSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGLHYLHTG 604

Query:   651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
             +   IIHRD+K+TNILLD  +VAKV+DFGLS++GP +D THVST VKGSFGYLDPEYFRR
Sbjct:   605 SSQGIIHRDIKSTNILLDNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRR 664

Query:   711 QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG 770
             QQLT+KSDVYSFGVVLFE+LCARPA++P L +EQV+LAEWA    +KG+L+QI+DP +  
Sbjct:   665 QQLTDKSDVYSFGVVLFEVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNIAD 724

Query:   771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
             +I P   KKFAETA KC +D G++RP++GDVLWNLE  LQLQES
Sbjct:   725 EIKPCSLKKFAETAEKCCADYGVDRPTIGDVLWNLEHVLQLQES 768

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2163158 AT5G61350 [Arabidopsis thaliana (taxid:3702)]

 Score = 1113 (396.9 bits), Expect = 5.8e-163, Sum P(2) = 5.8e-163
 Identities = 220/334 (65%), Positives = 267/334 (79%)

Query:   490 LSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVY 549
             +S++G+  S    K+N   S+ S+    L R+F F E++ AT NFDE  + GVGGFGKVY
Sbjct:   487 MSIFGSKKS----KSNGFSSFFSN--QGLGRYFPFTELQTATQNFDENAVCGVGGFGKVY 540

Query:   550 RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD 609
              GEIDG T +VAIKRG+  SEQG++EFQTEI+MLSKLRHRHLVSLIG+C+EN EMILVY+
Sbjct:   541 IGEIDGGT-QVAIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYE 599

Query:   610 YMAYGTLREHLY--KTQKP-PLP---WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTT 663
             YM+ G LR+HLY  K   P P+P   WKQRLEICIG+ARGLHYLHTGA   IIHRDVKTT
Sbjct:   600 YMSNGPLRDHLYGSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTT 659

Query:   664 NILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFG 723
             NILLDE  VAKVSDFGLSK  P +D  HVST VKGSFGYLDPEYFRRQQLT+KSDVYSFG
Sbjct:   660 NILLDENLVAKVSDFGLSKDAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFG 718

Query:   724 VVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAET 783
             VVLFE+LCARP +NP LP+EQV+LAE+A + H+KG+LE+I+DP + G I+    +KF E 
Sbjct:   719 VVLFEVLCARPVINPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEA 778

Query:   784 AMKCVSDQGIERPSMGDVLWNLEFALQLQESAEE 817
             A KC+++ G++RP MGDVLWNLE+ALQLQE++ +
Sbjct:   779 AEKCLAEYGVDRPGMGDVLWNLEYALQLQEASAQ 812

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2050080 AT2G21480 [Arabidopsis thaliana (taxid:3702)]

 Score = 1110 (395.8 bits), Expect = 2.6e-160, Sum P(2) = 2.6e-160
 Identities = 221/352 (62%), Positives = 269/352 (76%)

Query:   472 RRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSN---LCRHFSFAEIK 528
             +++ +D    ++ S WL L ++       +  T+ TGS+ S+L ++   L R+FS +E++
Sbjct:   464 KKRPQDWQKRNSFSSWL-LPIHAGD---STFMTSKTGSHKSNLYNSALGLGRYFSLSELQ 519

Query:   529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH 588
               T NFD + ++GVGGFG VY G ID  T +VAIKRGNP SEQG+ EF TEI+MLSKLRH
Sbjct:   520 EVTKNFDASEIIGVGGFGNVYIGTIDDGT-QVAIKRGNPQSEQGITEFHTEIQMLSKLRH 578

Query:   589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
             RHLVSLIGYC+EN EMILVY+YM+ G  R+HLY     PL WKQRLEICIGAARGLHYLH
Sbjct:   579 RHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAARGLHYLH 638

Query:   649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
             TG    IIHRDVK+TNILLDE  VAKV+DFGLSK        HVST VKGSFGYLDPEYF
Sbjct:   639 TGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYF 697

Query:   709 RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL 768
             RRQQLT+KSDVYSFGVVL E LCARPA+NP LP+EQV+LAEWA    +KG+LE+I+DP+L
Sbjct:   698 RRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLEKIIDPHL 757

Query:   769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGK 820
              G + PE  KKFAE A KC++D G++RP+MGDVLWNLE+ALQLQE+  + GK
Sbjct:   758 VGAVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQ-GK 808

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SCZ4	FERON_ARATH	2, ., 7, ., 1, 1, ., 1	0.7380	0.9977	0.9955	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	893
pfam12819	335	pfam12819, Malectin_like, Carbohydrate-binding pro	2e-58
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-52
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-45
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-38
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-35
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-30
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-30
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-29
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-29
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-28
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-27
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-26
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-25
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-25
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-24
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-24
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-23
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-23
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-23
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-22
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-22
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-22
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-22
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-21
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-21
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-20
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-18
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-15
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-11
pfam11721	164	pfam11721, Malectin, Di-glucose binding within end	2e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-11
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-08
pfam11721	164	pfam11721, Malectin, Di-glucose binding within end	2e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.004

>gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER

 Score =  202 bits (517), Expect = 2e-58
 Identities = 100/386 (25%), Positives = 146/386 (37%), Gaps = 68/386 (17%)

Query: 38  LNCG---ESSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDPSTPTI--PYMTARVF 92
           ++CG     S        +W  D G        D+  S   +++ S+  +  PY T R F
Sbjct: 1   IDCGLPSNESYTDPSTGITWVSDAG------FIDTGKSGNISKENSSSFLSKPYKTLRSF 54

Query: 93  --RSEFTYSFPVVAGRK---FVRLYFYPNSYNRLNATDALFSVSTGPYTLLK---NFSVA 144
                  Y+ PV  G+     +R  F   +Y+ LN      SVS+ P   L    N    
Sbjct: 55  PDGKRNCYTLPVTPGKGTKYLIRATFLYGNYDGLN------SVSSPPSFDLYLGVNLWTT 108

Query: 145 QTAEALNYAYVIKEYAIPV-DGETLNITFSPMNVSNAYAFVNGIEVMSMPD-IYKNTDGD 202
                 +   V+KEY I V   +TL++    +N      F++ +E+  +PD +Y ++ G 
Sbjct: 109 VNLSNDSGDSVVKEYIIHVTKSDTLSVCL--VNTGTGTPFISALELRPLPDSLYPSSGGS 166

Query: 203 LMIVGQSSPISIDNTTALENVYRLNVG--GKDISPSGDTDLFRSWYDDQPYIFGAALGVP 260
                           AL+ V RLN G     I    D    R W    P+         
Sbjct: 167 ---------------QALKLVARLNFGGSEGTIRYPDDV-YDRIWE---PFFSSPGWSQI 207

Query: 261 VTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLH 320
            T   +++V   SN   Y+ P  V  TA         +     +W   VD  F Y V LH
Sbjct: 208 ST---SLSVDISSNNAPYIPPSAVLQTAVTPTNA---SAPLNFTWDL-VDPNFEYYVYLH 260

Query: 321 FCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLW 380
           F E    I  +  R FDI +N +T +           +   LY DF V V G G    L 
Sbjct: 261 FAE----IQSLETREFDIYINGKTVYGDVSPK-YLGTDTGALYLDFPVNVSGGG---LLN 312

Query: 381 LGLHPNVASKTQYYDAILNGVEIFKL 406
           + L P   S       +LN +EIFK+
Sbjct: 313 ISLVPTSGST---LPPLLNALEIFKV 335

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  187 bits (478), Expect = 7e-54
 Identities = 92/278 (33%), Positives = 132/278 (47%), Gaps = 37/278 (13%)

Query: 540 LGVGGFGKVYRGE---IDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG+VY+G+    DG TT+VA+K      SE+   +F  E  ++ KL H ++V L+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 596 GYCEENCEMILVYDYMAYGTLREHL-------YKTQKPPLPWKQRLEICIGAARGLHYLH 648
           G C E   + LV +YM  G L ++L          +K  L  K  L   I  A+G+ YL 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
                  +HRD+   N L+ E  V K+SDFGLS+     D+    T  K    ++ PE  
Sbjct: 123 ---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179

Query: 709 RRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP 766
           +    T KSDV+SFGV+L+EI  L A P   P L  E+V              LE +   
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEV--------------LEYLRKG 223

Query: 767 Y-LKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVL 802
           Y L     PE C  +  E  + C      +RP+  +++
Sbjct: 224 YRLP---KPEYCPDELYELMLSCWQLDPEDRPTFSELV 258

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  182 bits (464), Expect = 1e-52
 Identities = 71/193 (36%), Positives = 100/193 (51%), Gaps = 9/193 (4%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           LG GGFG VY         KVAIK      S   + E   EIE+L KL H ++V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
           E+   + LV +Y   G+L++ L +  +  L   + L I +    GL YLH    + IIHR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116

Query: 659 DVKTTNILLDEK-WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ-LTEK 716
           D+K  NILLD      K++DFGLSK         +   + G+  Y+ PE    +   +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 717 SDVYSFGVVLFEI 729
           SD++S GV+L+E+
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  178 bits (454), Expect = 1e-50
 Identities = 69/197 (35%), Positives = 104/197 (52%), Gaps = 9/197 (4%)

Query: 540 LGVGGFGKVYRG----EIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FG+VY+G    + +G  TKVA+K      SE+   EF  E  ++ KL H ++V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
           +G C +   + +V +YM  G L + L +     L  K  L++ +  A+G+ YL       
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE---SKN 122

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
            +HRD+   N L+ E  V K+SDFGLS+     D+       K    ++ PE  +  + T
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182

Query: 715 EKSDVYSFGVVLFEILC 731
            KSDV+SFGV+L+EI  
Sbjct: 183 SKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  177 bits (452), Expect = 3e-50
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 28/270 (10%)

Query: 540 LGVGGFGKVYRGEIDG----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FG+VY+G + G       +VA+K      SEQ + EF  E  ++ KL H ++V L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
           +G C E   +++V +YM  G L ++L K +   L     L   +  ARG+ YL       
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
            IHRD+   N L+ E  V K+SDFGLS+     D  +     K    ++ PE  +  + T
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYKVKGGKLPIRWMAPESLKEGKFT 182

Query: 715 EKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI 772
            KSDV+SFGV+L+EI  L   P   P +   +V              LE +   Y   K 
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEP--YPGMSNAEV--------------LEYLKKGYRLPKP 226

Query: 773 APECFKKFAETAMKCVSDQGIERPSMGDVL 802
            P C  +  +  ++C ++   +RP+  +++
Sbjct: 227 -PNCPPELYKLMLQCWAEDPEDRPTFSELV 255

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  176 bits (449), Expect = 5e-50
 Identities = 85/270 (31%), Positives = 133/270 (49%), Gaps = 29/270 (10%)

Query: 540 LGVGGFGKVYRGEIDGATTK----VAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FG+VY+G++ G   K    VA+K      SEQ + EF  E  ++ KL H ++V L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
           +G C E   + +V +YM  G L  +L +  +P L     L   +  ARG+ YL       
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE---SKN 122

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
            IHRD+   N L+ E  V K+SDFGLS+     D  +     K    ++ PE  +  + T
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPESLKEGKFT 181

Query: 715 EKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI 772
            KSDV+SFGV+L+EI  L  +P   P +  E+V              LE + + Y   + 
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQP--YPGMSNEEV--------------LEYLKNGYRLPQP 225

Query: 773 APECFKKFAETAMKCVSDQGIERPSMGDVL 802
            P C  +  +  ++C ++   +RP+  +++
Sbjct: 226 -PNCPPELYDLMLQCWAEDPEDRPTFSELV 254

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  161 bits (410), Expect = 9e-45
 Identities = 69/235 (29%), Positives = 104/235 (44%), Gaps = 29/235 (12%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
            LG G FGKVY    D  T   VAIK       ++       EI++L KL+H ++V L  
Sbjct: 6   KLGEGSFGKVYLA-RDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL--EICIGAARGLHYLHTGAKHT 654
             E+  ++ LV +Y   G L + L K  +      +    +I       L YLH      
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL----SALEYLH---SKG 117

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           I+HRD+K  NILLDE    K++DFGL++    LD     T   G+  Y+ PE    +   
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK 769
           +  D++S GV+L+E+L  +P   P           +        + ++I  P   
Sbjct: 175 KAVDIWSLGVILYELLTGKP---P-----------FPGDDQLLELFKKIGKPKPP 215

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  146 bits (370), Expect = 3e-39
 Identities = 71/198 (35%), Positives = 103/198 (52%), Gaps = 10/198 (5%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSE--QGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G FG VY+ +  G    VA+K     SE  +     + EI +L +L H ++V LI  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            E+   + LV +Y   G L ++L  ++  PL   +  +I +   RGL YLH    + IIH
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLH---SNGIIH 121

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE-YFRRQQLTEK 716
           RD+K  NILLDE  V K++DFGL+K       +   T   G+  Y+ PE          K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 717 SDVYSFGVVLFEILCARP 734
            DV+S GV+L+E+L  +P
Sbjct: 180 VDVWSLGVILYELLTGKP 197

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (364), Expect = 2e-38
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 9/200 (4%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           LLG G FG VY          +A+K    +  SE+ +   + EI +LS L+H ++V   G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 597 YCEEN-CEMILVY-DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
              +     + ++ +Y++ G+L   L K  K P P  ++    I    GL YLH    + 
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI--LEGLAYLH---SNG 121

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           I+HRD+K  NIL+D   V K++DFG +K    ++    +  V+G+  ++ PE  R ++  
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181

Query: 715 EKSDVYSFGVVLFEILCARP 734
             +D++S G  + E+   +P
Sbjct: 182 RAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  133 bits (338), Expect = 5e-35
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 13/203 (6%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
            +G G FGKVY            +K  +   +SE+   +   E+++L KL H +++    
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 597 YCEENCEMILVYDYMAYGTLREHL--YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
             EE  ++ +V +Y   G L + +   K +  P P +Q L+  +     L YLH      
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRK 123

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT--HVSTVVKGSFGYLDPEYFRRQQ 712
           I+HRD+K  NI L    + K+ DFG+SK    L  T     TVV G+  YL PE  + + 
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISK---VLSSTVDLAKTVV-GTPYYLSPELCQNKP 179

Query: 713 LTEKSDVYSFGVVLFEILCARPA 735
              KSD++S G VL+E+   +  
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  123 bits (311), Expect = 3e-31
 Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 15/209 (7%)

Query: 540 LGVGGFGKVYRG----EIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV         D    +VA+K  N    EQ   +F+ EIE+L  L H ++V  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 595 IGYCEENCEMI--LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            G CE+       L+ +Y+  G+LR++L +  +  +  K+ L       +G+ YL +  +
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGS--Q 128

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS--FGYLDPEYFRR 710
              IHRD+   NIL++ + + K+SDFGL+K  P     +       S  F Y  PE  R 
Sbjct: 129 R-YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186

Query: 711 QQLTEKSDVYSFGVVLFEILC-ARPALNP 738
            + +  SDV+SFGV L+E+     P+ +P
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSP 215

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  122 bits (308), Expect = 5e-31
 Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 7/195 (3%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           F+    +G GGFG+VY+        +VAIK     S++   +   EI++L K +H ++V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
             G   +  E+ +V ++ + G+L++ L K+    L   Q   +C    +GL YLH    +
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLH---SN 117

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            IIHRD+K  NILL      K+ DFGLS     L  T     + G+  ++ PE    +  
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPY 174

Query: 714 TEKSDVYSFGVVLFE 728
             K+D++S G+   E
Sbjct: 175 DYKADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  121 bits (305), Expect = 2e-30
 Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 21/208 (10%)

Query: 540 LGVGGFGKVYRGEI-----DGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVS 593
           LG G FGKV+ GE      +     VA+K     +     + F+ E E+L+  +H ++V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHL---------YKTQKPP---LPWKQRLEICIGAA 641
             G C E    I+V++YM +G L + L          K+   P   L   Q L+I +  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
            G+ YL   A    +HRD+ T N L+    V K+ DFG+S+   T D+  V         
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEI 729
           ++ PE    ++ T +SDV+SFGVVL+EI
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  119 bits (301), Expect = 6e-30
 Identities = 72/284 (25%), Positives = 128/284 (45%), Gaps = 33/284 (11%)

Query: 533 NFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKL 586
           N  E   LG G FG+V+       E +G  T V +K      ++ +  EF+ E++M  KL
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK-------PPLPWKQRLEICIG 639
            H+++V L+G C E     ++ +Y   G L++ L  T+        PPL  KQ++ +C  
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD-HTHVSTVVKG 698
            A G+ +L   +    +HRD+   N L+  +   KVS   LSK     + +   + ++  
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-- 180

Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG 758
              +L PE  +    + KSDV+SFGV+++E+          L  E+V             
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV------------- 227

Query: 759 ILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
            L ++    L+  +   C  +  +   +C +    +RPS  +++
Sbjct: 228 -LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  119 bits (300), Expect = 1e-29
 Identities = 74/213 (34%), Positives = 110/213 (51%), Gaps = 29/213 (13%)

Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIK----RGNPLSEQGVHEFQTEIEMLSKLRHRH 590
           LG G FGKVY+GE+ G     + T VAIK       P  +Q   EF+ E E++S L+H +
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDLQHPN 69

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYK--------------TQKPPLPWKQRLEI 636
           +V L+G C +     ++++Y+A+G L E L +              T K  L     L I
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
            I  A G+ YL   + H  +HRD+   N L+ E    K+SDFGLS+   + D+  V +  
Sbjct: 130 AIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEI 729
                ++ PE     + T +SD++SFGVVL+EI
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  116 bits (292), Expect = 5e-29
 Identities = 68/193 (35%), Positives = 104/193 (53%), Gaps = 13/193 (6%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG V+ G       KVAIK  R   +SE+   +F  E +++ KL H  LV L G 
Sbjct: 12  IGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGV 67

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C E   + LV+++M +G L ++L + Q+     +  L +C+    G+ YL       +IH
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIH 123

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV-STVVKGSFGYLDPEYFRRQQLTEK 716
           RD+   N L+ E  V KVSDFG+++    LD  +  ST  K    +  PE F   + + K
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181

Query: 717 SDVYSFGVVLFEI 729
           SDV+SFGV+++E+
Sbjct: 182 SDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 5e-29
 Identities = 78/272 (28%), Positives = 123/272 (45%), Gaps = 34/272 (12%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG--VHEFQTEIEMLSKLRHRHLVSLIG 596
            +G G FG V  G+  G   KVA+K    L +       F  E  +++ LRH +LV L+G
Sbjct: 13  TIGKGEFGDVMLGDYRG--QKVAVKC---LKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
              +   + +V +YMA G+L ++L    +  +   Q+L   +    G+ YL        +
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFV 124

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+   N+L+ E  VAKVSDFGL+K   +         VK    +  PE  R ++ + K
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEA-SQGQDSGKLPVK----WTAPEALREKKFSTK 179

Query: 717 SDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPE 775
           SDV+SFG++L+EI    R      +P  ++ L +   H  K   +E           APE
Sbjct: 180 SDVWSFGILLWEIYSFGR------VPYPRIPLKDVVPHVEKGYRME-----------APE 222

Query: 776 -CFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
            C  +  +    C      +RP+   +   L 
Sbjct: 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 1e-28
 Identities = 81/269 (30%), Positives = 125/269 (46%), Gaps = 28/269 (10%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G FG V+ G+  G    VAIK  R   +SE    +F  E +++ KL H +LV L G 
Sbjct: 12  LGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGV 67

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C +   + +V +YMA G L  +L + +K  L  +  L++C      + YL     +  IH
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIH 123

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-VKGSFGYLDPEYFRRQQLTEK 716
           RD+   N L+ E  V KVSDFGL++    LD  + S+   K    +  PE F   + + K
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181

Query: 717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC 776
           SDV+SFGV+++E+          +P E+ S +E          L +   P L        
Sbjct: 182 SDVWSFGVLMWEVFSE-----GKMPYERFSNSEVVESVSAGYRLYR---PKL-------A 226

Query: 777 FKKFAETAMKCVSDQGIERPSMGDVLWNL 805
             +       C  ++  +RP+   +L  L
Sbjct: 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (295), Expect = 2e-28
 Identities = 78/277 (28%), Positives = 116/277 (41%), Gaps = 23/277 (8%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRH-RHLVSL 594
            LG G FG+VY          VA+K          + V  F  EI++L+ L H  ++V L
Sbjct: 7   KLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKT-QKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
             + ++   + LV +Y+  G+L + L K  +K PL   + L I       L YLH     
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SK 120

Query: 654 TIIHRDVKTTNILLDEK-WVAKVSDFGLSK----TGPTLDHTHVSTVVKGSFGYLDPEYF 708
            IIHRD+K  NILLD    V K+ DFGL+K     G T     + +   G+ GY+ PE  
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 709 RRQQL---TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
               L   +  SD++S G+ L+E+L   P        E+ S A          +    + 
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPP----FEGEKNSSATSQTLKIILELPTPSLA 236

Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
             L         K  ++   K ++     R S    L
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  114 bits (286), Expect = 5e-28
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 23/210 (10%)

Query: 540 LGVGGFGKVYRGEI-----DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV+  E      +     VA+K     SE    +FQ E E+L+ L+H+H+V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKP--------------PLPWKQRLEICIGA 640
            G C E   +++V++YM +G L   L ++  P               L   Q L I    
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFL-RSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           A G+ YL   A    +HRD+ T N L+ +  V K+ DFG+S+   + D+  V        
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            ++ PE    ++ T +SD++SFGVVL+EI 
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  112 bits (282), Expect = 1e-27
 Identities = 61/190 (32%), Positives = 98/190 (51%), Gaps = 6/190 (3%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G       +VAIK           +FQ E++ L +LRH+HL+SL   C 
Sbjct: 14  LGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
               + ++ + M  G+L   L   +   LP    +++    A G+ YL    +   IHRD
Sbjct: 73  VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRD 129

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   NIL+ E  V KV+DFGL++     +  ++S+  K  + +  PE       + KSDV
Sbjct: 130 LAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDV 187

Query: 720 YSFGVVLFEI 729
           +SFG++L+E+
Sbjct: 188 WSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  111 bits (279), Expect = 4e-27
 Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 28/248 (11%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           LG G  G VY+          A+K+ +    E+   +   E++ L      ++V   G  
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
            +  E+ +V +YM  G+L + L K     +P      I     +GL YLHT  K  IIHR
Sbjct: 69  YKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT--KRHIIHR 124

Query: 659 DVKTTNILLDEKWVAKVSDFGLSKT-GPTLD--HTHVSTVVKGSFGYLDPEYFRRQQLTE 715
           D+K +N+L++ K   K++DFG+SK    TLD  +T V TV      Y+ PE  + +  + 
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT-----YMSPERIQGESYSY 179

Query: 716 KSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD---PYLKGKI 772
            +D++S G+ L E    +    P LP  Q S  E         +++ I D   P L  + 
Sbjct: 180 AADIWSLGLTLLECALGK---FPFLPPGQPSFFE---------LMQAICDGPPPSLPAEE 227

Query: 773 APECFKKF 780
               F+ F
Sbjct: 228 FSPEFRDF 235

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 5e-27
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 539 LLGVGGFGKVYRGEIDGATTK-VAIKR--GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           L+G G FG VY+G ++  T   VAIK+     + E+ +     EI++L  L+H ++V  I
Sbjct: 7   LIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKP--PLPWKQRLEICIGAA---RGLHYLHTG 650
           G  E +  + ++ +Y   G+LR    +  K   P P      + +      +GL YLH  
Sbjct: 66  GSIETSDSLYIILEYAENGSLR----QIIKKFGPFP---ESLVAVYVYQVLQGLAYLH-- 116

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
            +  +IHRD+K  NIL  +  V K++DFG++     +        V G+  ++ PE    
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEM 173

Query: 711 QQLTEKSDVYSFGVVLFEILCARPA---LNPT 739
              +  SD++S G  + E+L   P    LNP 
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPM 205

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  108 bits (270), Expect = 4e-26
 Identities = 70/193 (36%), Positives = 102/193 (52%), Gaps = 13/193 (6%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G FG V  G+  G    VAIK  +   +SE    EF  E +++ KL H  LV L G 
Sbjct: 12  LGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGV 67

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C +   + +V +YM+ G L  +L +  K   P  Q LE+C     G+ YL +      IH
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP-SQLLEMCKDVCEGMAYLES---KQFIH 123

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-VKGSFGYLDPEYFRRQQLTEK 716
           RD+   N L+D++   KVSDFGLS+    LD  + S+V  K    +  PE     + + K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181

Query: 717 SDVYSFGVVLFEI 729
           SDV++FGV+++E+
Sbjct: 182 SDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 8e-26
 Identities = 75/267 (28%), Positives = 121/267 (45%), Gaps = 21/267 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +  TT VA+K   P +     +F  E +++ KLRH  L+ L   C 
Sbjct: 14  LGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
               + +V + M YG+L E+L       L   Q +++    A G+ YL        IHRD
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N+L+ E  + KV+DFGL++      +       K    +  PE     + + KSDV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L EI+       P +   +V              L+Q+   Y +    P C K+
Sbjct: 188 WSFGILLTEIVTYGRMPYPGMTNAEV--------------LQQVDQGY-RMPCPPGCPKE 232

Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLE 806
             +  + C  +   +RP+   + W LE
Sbjct: 233 LYDIMLDCWKEDPDDRPTFETLQWKLE 259

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  106 bits (266), Expect = 2e-25
 Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 540 LGVGGFGKVYRGEI-----DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV+  E      +     VA+K     S+    +F  E E+L+ L+H H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 595 IGYCEENCEMILVYDYMAYGTL----REH-----LYKTQKPP--LPWKQRLEICIGAARG 643
            G C E   +I+V++YM +G L    R H     L      P  L   Q L I    A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           + YL   A    +HRD+ T N L+ E  + K+ DFG+S+   + D+  V         ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            PE    ++ T +SDV+S GVVL+EI 
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  105 bits (263), Expect = 5e-25
 Identities = 68/272 (25%), Positives = 108/272 (39%), Gaps = 31/272 (11%)

Query: 539 LLGVGGFGKVYRGEID---GATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
            LG G FG V RGE     G    VA+K              +F  E  ++  L H +L+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM--DDFLKEAAIMHSLDHENLI 59

Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            L G    +  +++V +    G+L + L K            +  +  A G+ YL +  K
Sbjct: 60  RLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES--K 116

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-VKGSFGYLDPEYFRRQ 711
              IHRD+   NILL      K+ DFGL +  P  +  +V    +K  F +  PE  R +
Sbjct: 117 R-FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 712 QLTEKSDVYSFGVVLFEIL--CARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK 769
             +  SDV+ FGV L+E+      P               W A      IL++I     +
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP---------------W-AGLSGSQILKKIDKEGER 219

Query: 770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDV 801
            +    C +      ++C +    +RP+   +
Sbjct: 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 7e-25
 Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 20/217 (9%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
            +G G FG VY+G + G  T+VA+K  R     +    +F  E E+L +  H ++V LIG
Sbjct: 2   KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIG 59

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
            C +   + +V + +  G+L   L + +K  L  K+ L++ + AA G+ YL +      I
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCI 115

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG----SFGYLDPEYFRRQQ 712
           HRD+   N L+ E  V K+SDFG+S+     +   + TV  G       +  PE     +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 713 LTEKSDVYSFGVVLFEIL----CARPALNPTLPKEQV 745
            T +SDV+S+G++L+E         P ++    +E++
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  104 bits (262), Expect = 7e-25
 Identities = 79/279 (28%), Positives = 122/279 (43%), Gaps = 39/279 (13%)

Query: 538 LLLGVGGFGKVYRG---EIDGATT---KVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
             LG G FG+VY G   +I G  +   +VA+K   +G    E+   EF  E  ++S   H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLY-----KTQKPPLPWKQRLEICIGAARG 643
            ++V L+G C  N    ++ + M  G L  +L      +   P L  K+ L+IC+  A+G
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKW-----VAKVSDFGLSKTGPTLDHTHVSTVVKG 698
             YL    +   IHRD+   N L+ EK      V K+ DFGL++     D+         
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG 758
              ++ PE     + T +SDV+SFGV+++EIL       P L  ++V       H    G
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV-----LQHVTAGG 230

Query: 759 ILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS 797
            L++             C  K  +    C +    ERP+
Sbjct: 231 RLQK----------PENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  103 bits (259), Expect = 1e-24
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 11/210 (5%)

Query: 540 LGVGGFGK--VYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG+  +YR   D   + V  K  N   LSE+   +   EI +LS L+H ++++  
Sbjct: 8   LGKGAFGEATLYRRTEDD--SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
            +  ++  +++  +Y   GTL + + + +      +  L         + Y+H   K  I
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE 715
           +HRD+KT NI L +  + K+ DFG+SK   + +++   TVV G+  Y+ PE  +  +   
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETVV-GTPYYMSPELCQGVKYNF 180

Query: 716 KSDVYSFGVVLFEILCARPALNPTLPKEQV 745
           KSD+++ G VL+E+L  +   + T P   V
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  103 bits (258), Expect = 2e-24
 Identities = 69/208 (33%), Positives = 106/208 (50%), Gaps = 15/208 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK-RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY- 597
           +G G FG V  G+  G   KVA+K   N  + Q    F  E  ++++LRH +LV L+G  
Sbjct: 14  IGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            EE   + +V +YMA G+L ++L    +  L     L+  +     + YL     +  +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVH 125

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+   N+L+ E  VAKVSDFGL+K   +   T      K    +  PE  R ++ + KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKS 180

Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQV 745
           DV+SFG++L+EI        P +P + V
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDV 208

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  102 bits (256), Expect = 3e-24
 Identities = 68/208 (32%), Positives = 111/208 (53%), Gaps = 15/208 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG V +GE  G   KVA+K  N   +     F  E  +++KL H++LV L+G   
Sbjct: 14  IGEGEFGAVLQGEYTG--QKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
            N  + +V + M+ G L   L    +  +   Q L+  +  A G+ YL +     ++HRD
Sbjct: 70  HN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRD 125

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           +   NIL+ E  VAKVSDFGL++ G   +D++ +   VK    +  PE  + ++ + KSD
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP--VK----WTAPEALKHKKFSSKSD 179

Query: 719 VYSFGVVLFEILCARPALNPTLPKEQVS 746
           V+S+GV+L+E+     A  P +  ++V 
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVK 207

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  102 bits (256), Expect = 3e-24
 Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 21/204 (10%)

Query: 539 LLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVSL 594
           ++G G FG VY G +   DG     A+K  N +++ + V +F  E  ++    H +++SL
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 595 IGYC--EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
           +G C   E   ++ V  YM +G LR  +      P   K  +   +  A+G+ YL   A 
Sbjct: 62  LGICLPSEGSPLV-VLPYMKHGDLRNFIRSETHNPTV-KDLIGFGLQVAKGMEYL---AS 116

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKT------GPTLDHTHVSTVVKGSFGYLDPE 706
              +HRD+   N +LDE +  KV+DFGL++           +HT     VK    ++  E
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMALE 172

Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
             + Q+ T KSDV+SFGV+L+E++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 7e-24
 Identities = 66/204 (32%), Positives = 98/204 (48%), Gaps = 22/204 (10%)

Query: 540 LGVGGFGKVY--RGEIDGAT--TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FGKV   R +  G     KV +K+   +  + V    TE  +LS++ H  +V L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKV-LKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 596 GYC---EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL--EICIGAARGLHYLHTG 650
            Y    EE   ++L  +Y   G L  HL K  +      +    EI +     L YLH  
Sbjct: 60  -YAFQTEEKLYLVL--EYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLH-- 110

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
               II+RD+K  NILLD     K++DFGL+K   + + +  +T   G+  YL PE    
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLG 167

Query: 711 QQLTEKSDVYSFGVVLFEILCARP 734
           +   +  D +S GV+L+E+L  +P
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  102 bits (255), Expect = 1e-23
 Identities = 67/229 (29%), Positives = 121/229 (52%), Gaps = 28/229 (12%)

Query: 539 LLGVGGFGKVYRGEIDG-----ATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKL-RHRH 590
            LG G FG+V + E  G      T+ VA+K  + +  +E+ + +  +E+EM+  + +H++
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKN 77

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C +   + +V +Y A+G LR+ L + ++PP               L  K  + 
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ +L   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193

Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ 744
            +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E+
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  102 bits (255), Expect = 1e-23
 Identities = 75/290 (25%), Positives = 123/290 (42%), Gaps = 40/290 (13%)

Query: 540 LGVGGFGKVYRGEIDG----------------ATTKVAIKRGNP-LSEQGVHEFQTEIEM 582
           LG G FG+V+  E DG                A   VA+K   P  S+    +F  E+++
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQ---------KPPLPWKQR 633
           LS+L   ++  L+G C  +  + ++ +YM  G L + L K              L +   
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 634 LEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS 693
           L +    A G+ YL        +HRD+ T N L+ + +  K++DFG+S+   + D+  V 
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189

Query: 694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWA 751
                   ++  E     + T KSDV++FGV L+EI  LC        L  +QV   E A
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE-HLTDQQV--IENA 246

Query: 752 AHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDV 801
            H  +    +  +         P C K   E  ++C      +RP+  ++
Sbjct: 247 GHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  102 bits (255), Expect = 1e-23
 Identities = 68/230 (29%), Positives = 122/230 (53%), Gaps = 28/230 (12%)

Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G         TKVA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               L +K  + 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E++
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 3e-23
 Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 12/202 (5%)

Query: 540 LGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FG VY+G    E +     VAIK      S +   E   E  +++ + H H+V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
           +G C  + ++ L+   M  G L +++ +  K  +  +  L  C+  A+G+ YL    +  
Sbjct: 75  LGICLSS-QVQLITQLMPLGCLLDYV-RNHKDNIGSQYLLNWCVQIAKGMSYLE---EKR 129

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E    +  T
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189

Query: 715 EKSDVYSFGVVLFEILC--ARP 734
            KSDV+S+GV ++E++   A+P
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 99.3 bits (247), Expect = 9e-23
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 22/210 (10%)

Query: 540 LGVGGFGKVYRGEI-DGATTK----VAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV+  E  + + TK    VA+K     +     +FQ E E+L+ L+H H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLY--------------KTQKPPLPWKQRLEICIGA 640
            G C +   +I+V++YM +G L + L               +  K  L   Q L I    
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           A G+ YL   A    +HRD+ T N L+    + K+ DFG+S+   + D+  V        
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            ++ PE    ++ T +SDV+SFGV+L+EI 
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIF 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 99.7 bits (248), Expect = 9e-23
 Identities = 65/229 (28%), Positives = 119/229 (51%), Gaps = 26/229 (11%)

Query: 540 LGVGGFGKVYRGE---IDGATTK----VAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E   ID    K    VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP--------------PLPWKQRLEI 636
           +++L+G C ++  + ++ +Y + G LRE+L   + P               + +K  +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T  
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
           +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 98.8 bits (246), Expect = 1e-22
 Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 26/205 (12%)

Query: 540 LGVGGFGKV----YRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           LG G FGKV    Y    DG    VA+K   R     +Q    ++ EI +L  L H ++V
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIV 69

Query: 593 SLIGYCEENCEMI--LVYDYMAYGTLREHLYKTQKPPLPWKQRL----EICIGAARGLHY 646
              G C E       L+ +Y+  G+LR++L K +   L   Q L    +IC     G+ Y
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQIC----EGMAY 122

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDP 705
           LH  ++H  IHRD+   N+LLD   + K+ DFGL+K  P   ++  V         +   
Sbjct: 123 LH--SQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179

Query: 706 EYFRRQQLTEKSDVYSFGVVLFEIL 730
           E  +  + +  SDV+SFGV L+E+L
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 99.7 bits (248), Expect = 1e-22
 Identities = 65/230 (28%), Positives = 120/230 (52%), Gaps = 28/230 (12%)

Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +++ + +  +E+EM+  + +H++
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               L +K  + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E++
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 67/200 (33%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 541 GVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           G G FGKV   +        A+K   +   + +  V     E  +L +L H  LV+L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ-RLEIC-IGAARGLHYLHTGAKHTI 655
            ++   M LV D +  G LR HL  +QK     +Q +  IC I  A  L YLH+     I
Sbjct: 69  FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLA--LEYLHS---KGI 121

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLS--KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
           IHRD+K  NILLDE+    ++DF ++   T  TL     +T   G+ GY+ PE   RQ  
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-----TTSTSGTPGYMAPEVLCRQGY 176

Query: 714 TEKSDVYSFGVVLFEILCAR 733
           +   D +S GV  +E L  +
Sbjct: 177 SVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 98.9 bits (246), Expect = 1e-22
 Identities = 85/299 (28%), Positives = 141/299 (47%), Gaps = 49/299 (16%)

Query: 539 LLGVGGFGKVYRGEI--DGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKL-RHRHLVSL 594
           ++G G FG+V +  I  DG     AIKR    + +  H +F  E+E+L KL  H ++++L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGA 640
           +G CE    + L  +Y  +G L + L K++                 L  +Q L      
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           ARG+ YL   ++   IHRD+   NIL+ E +VAK++DFGLS+             VK + 
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 182

Query: 701 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH 755
           G L   +   + L     T  SDV+S+GV+L+EI+    +L  T P   ++ AE      
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SLGGT-PYCGMTCAELYEKLP 237

Query: 756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
           +   LE+ ++          C  +  +   +C  ++  ERPS   +L +L   L+ +++
Sbjct: 238 QGYRLEKPLN----------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 98.5 bits (245), Expect = 2e-22
 Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 34/215 (15%)

Query: 539 LLGVGGFGKVYRGEI--DGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKL-RHRHLVSL 594
           ++G G FG+V R  I  DG     AIK     + +  H +F  E+E+L KL  H ++++L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGA 640
           +G CE    + +  +Y  YG L + L K++                 L  +Q L+     
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           A G+ YL   ++   IHRD+   N+L+ E   +K++DFGLS+             VK + 
Sbjct: 129 ATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGE--------EVYVKKTM 177

Query: 701 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEIL 730
           G L   +   + L     T KSDV+SFGV+L+EI+
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 62/196 (31%), Positives = 96/196 (48%), Gaps = 11/196 (5%)

Query: 540 LGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V +G      G   +VA+K         G  EF  E  ++++L H  +V LI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G C+    ++LV +    G L    Y  ++  +P     E+    A G+ YL +  KH  
Sbjct: 63  GVCKGE-PLMLVMELAPLGPL--LKYLKKRREIPVSDLKELAHQVAMGMAYLES--KH-F 116

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSK-TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           +HRD+   N+LL  +  AK+SDFG+S+  G   D+   +T  +    +  PE     + +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176

Query: 715 EKSDVYSFGVVLFEIL 730
            KSDV+S+GV L+E  
Sbjct: 177 SKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 96.8 bits (241), Expect = 4e-22
 Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 15/195 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG--VHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G +G+VY G     +  VA+K    L E    V EF  E  ++ +++H +LV L+G 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C       ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IH
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSK--TGPTLD-HTHVSTVVKGSFGYLDPEYFRRQQLT 714
           RD+   N L+ E  + KV+DFGLS+  TG T   H      +K    +  PE     + +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----WTAPESLAYNKFS 183

Query: 715 EKSDVYSFGVVLFEI 729
            KSDV++FGV+L+EI
Sbjct: 184 IKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 97.2 bits (242), Expect = 4e-22
 Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 29/216 (13%)

Query: 540 LGVGGFGKVYRGEIDGAT-----TKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           +G G FG+V++    G       T VA+K      S     +FQ E  ++++  H ++V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHL--------------------YKTQKPPLPWKQR 633
           L+G C     M L+++YMAYG L E L                          PL   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 634 LEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS 693
           L I    A G+ YL   ++   +HRD+ T N L+ E  V K++DFGLS+   + D+   S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEI 729
                   ++ PE     + T +SDV+++GVVL+EI
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 96.7 bits (240), Expect = 4e-22
 Identities = 76/258 (29%), Positives = 120/258 (46%), Gaps = 22/258 (8%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 14  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 72  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 231

Query: 780 FAETAMKCVSDQGIERPS 797
             +   +C   +  ERP+
Sbjct: 232 LHDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.9 bits (242), Expect = 5e-22
 Identities = 57/192 (29%), Positives = 101/192 (52%), Gaps = 9/192 (4%)

Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G  G+VY+   D AT K VAIK+   L +Q       EI ++   +H ++V      
Sbjct: 27  IGEGASGEVYKA-TDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
               E+ +V +YM  G+L + + +     +   Q   +C    +GL YLH  +++ +IHR
Sbjct: 85  LVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLEYLH--SQN-VIHR 140

Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           D+K+ NILL +    K++DFG +    T + +  ++VV G+  ++ PE  +R+    K D
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQL-TKEKSKRNSVV-GTPYWMAPEVIKRKDYGPKVD 198

Query: 719 VYSFGVVLFEIL 730
           ++S G++  E+ 
Sbjct: 199 IWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 96.2 bits (240), Expect = 5e-22
 Identities = 67/190 (35%), Positives = 97/190 (51%), Gaps = 6/190 (3%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TTKVA+K   P +      F  E +++ KLRH  LV L   C 
Sbjct: 14  LGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L   +   L   Q +++    A G+ YL        IHRD
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRD 128

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   NIL+ E  V K++DFGL++     D        K    +  PE     + T KSDV
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIED-DEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187

Query: 720 YSFGVVLFEI 729
           +SFG++L EI
Sbjct: 188 WSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 95.7 bits (238), Expect = 7e-22
 Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 13/193 (6%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G FG V+ G+   A  KVAIK      +SE+   +F  E +++ KL H  LV L G 
Sbjct: 12  LGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGV 67

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C +   + +V ++M  G L  +L + ++  L     L +C     G+ YL    +++ IH
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIH 123

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-VKGSFGYLDPEYFRRQQLTEK 716
           RD+   N L+    V KVSDFG+++    LD  + S+   K    +  PE F   + + K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 717 SDVYSFGVVLFEI 729
           SDV+SFGV+++E+
Sbjct: 182 SDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 95.7 bits (238), Expect = 7e-22
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 15/204 (7%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRH 590
            +++  ++G G FG V+          V IK+     +++      Q E ++L  L H  
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP- 59

Query: 591 LVSLIGYCE---ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
             ++I Y E   E+  +++V +Y   GTL E++ K     L     L   +     LH++
Sbjct: 60  --NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 648 HTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           HT     I+HRD+KT NILLD+ K V K+ DFG+SK   +   +   TVV G+  Y+ PE
Sbjct: 118 HT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS--KSKAYTVV-GTPCYISPE 171

Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +   +KSD+++ G VL+E+ 
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.8 bits (239), Expect = 7e-22
 Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 41/238 (17%)

Query: 534 FDEALLLGVGGFGKVY--RGEIDGATTKVAIKR---GNPLSEQGVHEFQTEIEMLSKLRH 588
           ++    +G G FG V   R + DG    +  K    GN ++E+   +  +E+ +L +L+H
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKI--LVWKEIDYGN-MTEKEKQQLVSEVNILRELKH 58

Query: 589 RHLVSLIGYCEE--NCEMILVYDYMAY------GTLREHLYKTQKPPLP----WKQRLEI 636
            ++V    Y +   +     +Y  M Y        L +   K +K  +     W+   ++
Sbjct: 59  PNIV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQL 114

Query: 637 CIGAARGLHYLHTG--AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK---TGPTLDHTH 691
            +     L+  H      +T++HRD+K  NI LD     K+ DFGL+K      +   T+
Sbjct: 115 LLA----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170

Query: 692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAE 749
           V T       Y+ PE        EKSD++S G +++E+    P   P   + Q+ LA 
Sbjct: 171 VGTPY-----YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP---PFTARNQLQLAS 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 10/202 (4%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           FD    LG G +G VY+         VAIK      E+ + E   EI +L +    ++V 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
             G   +N ++ +V +Y   G++ + +  T K  L  ++   I     +GL YLH    +
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT-LTEEEIAAILYQTLKGLEYLH---SN 118

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST-VVKGSFGYLDPEYFRRQQ 712
             IHRD+K  NILL+E+  AK++DFG+S     L  T      V G+  ++ PE  +   
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSG---QLTDTMAKRNTVIGTPFWMAPEVIQEIG 175

Query: 713 LTEKSDVYSFGVVLFEILCARP 734
              K+D++S G+   E+   +P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 95.4 bits (237), Expect = 3e-21
 Identities = 62/231 (26%), Positives = 118/231 (51%), Gaps = 30/231 (12%)

Query: 540 LGVGGFGKVYRGEIDG---------ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHR 589
           LG G FG+V R E  G          T  V + + N  +++ + +  +E+E++  + +H+
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHK 78

Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP---------------WKQRL 634
           ++++L+G C +   + ++ +Y A G LRE L + ++PP P               +K  +
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST 694
                 ARG+ YL        IHRD+   N+L+ E  V K++DFGL++    +D+   ++
Sbjct: 138 SCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
             +    ++ PE    +  T +SDV+SFG++++EI     +  P +P E++
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 73/209 (34%), Positives = 102/209 (48%), Gaps = 27/209 (12%)

Query: 540 LGVGGFGKVYRGE---IDGATTK--VAIK-RGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G     DG   +  VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 594 LIGYCEENCEMILVYDYMAYGT----LREHLYKTQKP-PLPWKQRLEICIGAARGLHYLH 648
           LIG   E     ++ + MA G     LRE+  + ++P  L  K  L      A+G  YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 649 TGAKHTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGS-----F 700
               H  IHRD+   N LL  K    VAK++DFG+++     D    S   KG       
Sbjct: 134 E--NH-FIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAMLPI 185

Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEI 729
            ++ PE F     T K+DV+SFGV+L+EI
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 94.0 bits (233), Expect = 3e-21
 Identities = 84/301 (27%), Positives = 136/301 (45%), Gaps = 55/301 (18%)

Query: 539 LLGVGGFGKVYRGEI--DGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKL-RHRHLVSL 594
           ++G G FG+V +  I  DG     AIKR    + +  H +F  E+E+L KL  H ++++L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGA 640
           +G CE    + L  +Y  +G L + L K++                 L  +Q L      
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           ARG+ YL   ++   IHRD+   NIL+ E +VAK++DFGLS+             VK + 
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 170

Query: 701 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH 755
           G L   +   + L     T  SDV+S+GV+L+EI+    +L  T P   ++ AE      
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SLGGT-PYCGMTCAELYEKLP 225

Query: 756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESA 815
           +   LE+ ++          C  +  +   +C  ++  ERPS   +       + L    
Sbjct: 226 QGYRLEKPLN----------CDDEVYDLMRQCWREKPYERPSFAQI------LVSLNRML 269

Query: 816 E 816
           E
Sbjct: 270 E 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 15/211 (7%)

Query: 532 NNFDEALLLGVGGFGKVYRG-EIDG----ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL 586
            N+    LLG G FG+VY   ++D     A  +V     +P +++ V+  + EI++L  L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL--YKTQKPPLPWKQRLEICIGAARGL 644
           +H  +V   G   ++  + +  +YM  G++++ L  Y      +  K   +I      G+
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGV 117

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL-DHTHVSTVVKGSFGYL 703
            YLH+   + I+HRD+K  NIL D     K+ DFG SK   T+         V G+  ++
Sbjct: 118 EYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174

Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE    +    K+DV+S G  + E+L  +P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 16/199 (8%)

Query: 540 LGVGGFGKVYRGEI---DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +G G FG+V RG +         VAIK      S++   +F TE  ++ +  H +++ L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 596 GYCEENCEMILVYDYMAYGTL----REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G   ++  ++++ +YM  G+L    RE+  K         Q + +  G A G+ YL   +
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDGK-----FTVGQLVGMLRGIASGMKYL---S 123

Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
           +   +HRD+   NIL++   V KVSDFGLS+     + T+ +   K    +  PE    +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 712 QLTEKSDVYSFGVVLFEIL 730
           + T  SDV+SFG+V++E++
Sbjct: 184 KFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 93.7 bits (233), Expect = 6e-21
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 35/210 (16%)

Query: 539 LLGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
            LG G FG V    Y    D     VA+K+    + + + +F+ EIE+L  L+H ++V  
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 595 IGYCEE--NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE----------ICIGAAR 642
            G C       + LV +Y+ YG+LR++L K        ++RL+          IC    +
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-------RERLDHRKLLLYASQIC----K 119

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS--- 699
           G+ YL  G+K   +HRD+ T NIL++ +   K+ DFGL+K  P  D  +      G    
Sbjct: 120 GMEYL--GSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPI 175

Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEI 729
           F Y  PE     + +  SDV+SFGVVL+E+
Sbjct: 176 FWYA-PESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 75/249 (30%), Positives = 116/249 (46%), Gaps = 25/249 (10%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G  TKVA+K   P        F  E +++ KLRH  LV L     
Sbjct: 14  LGNGQFGEVWMGTWNG-NTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L   +   L     +++    A G+ Y+    +   IHRD
Sbjct: 72  EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +++ NIL+ +  V K++DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 720 YSFGVVLFEILCA----RPALNPTLPKEQV--------------SLAEWAAHCHKKGILE 761
           +SFG++L E++       P +N     EQV              SL E    C KK   E
Sbjct: 187 WSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEE 246

Query: 762 QIMDPYLKG 770
           +    YL+ 
Sbjct: 247 RPTFEYLQS 255

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 69/284 (24%), Positives = 113/284 (39%), Gaps = 43/284 (15%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G VY+         VAIK+     E          EI++L +L H +++ L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
                ++ LV+++M   T    L K ++  LP            +GL + H    H I+H
Sbjct: 67  FRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTH-VSTVVKGSFGYLDPE-YFRRQQL 713
           RD+K  N+L++ + V K++DFGL+++   P   +TH V T       Y  PE     +  
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGY 176

Query: 714 TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA 773
           +   D++S G +  E+L  RP        +Q+             I   +  P       
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK-----------IFRTLGTP------D 219

Query: 774 PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF------ALQL 811
           PE + KF   A     +     P    +     F      AL L
Sbjct: 220 PEVWPKFTSLA----RNYKFSFPKKAGMPLPKLFPNASPQALDL 259

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 25/210 (11%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
            LG G +G VY+ +        A+K  +   +S++   +   EI +L+ + H ++   I 
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI---IS 63

Query: 597 YCE---ENCEMILVYDYMAYGTLREHLYKTQKP--PLP----WKQRLEICIGAARGLHYL 647
           Y E   +  ++ +V +Y  +G L + + K +K    +P    W+  +++     RGL  L
Sbjct: 64  YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQAL 119

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H      I+HRD+K+ NILL    + K+ D G+SK    L      T + G+  Y+ PE 
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKTQI-GTPHYMAPEV 172

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARPALN 737
           ++ +  + KSD++S G +L+E+    P   
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 91.4 bits (227), Expect = 2e-20
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 14/197 (7%)

Query: 540 LGVGGFGKVYRG--EIDG---ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           +G G FG V++   + D    A  ++ + + N    +   E   E  +L+KL   +++  
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE---EAIDEARVLAKLDSSYIIRY 64

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
                +  ++ +V +Y   G L + L   +  PLP  Q     I    GL +LH      
Sbjct: 65  YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKK 121

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           I+HRD+K+ N+ LD     K+ D G++K     D+T+ +  + G+  YL PE    +   
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYN 179

Query: 715 EKSDVYSFGVVLFEILC 731
           EKSDV++ GVVL+E  C
Sbjct: 180 EKSDVWALGVVLYE-CC 195

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 91.4 bits (227), Expect = 3e-20
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 18/207 (8%)

Query: 539 LLGVGGFGKVYRGEI---DGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           +LG G FG V  G++   DG+  KVA+K  + +  +   + EF +E   +    H +++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 594 LIGYCEENCEM------ILVYDYMAYGTLREHLYK----TQKPPLPWKQRLEICIGAARG 643
           LIG C E   +      +++  +M +G L   L           LP +  L+  +  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           + YL        IHRD+   N +L E     V+DFGLSK   + D+     + K    ++
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             E    +  T KSDV++FGV ++EI 
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 4e-20
 Identities = 77/289 (26%), Positives = 118/289 (40%), Gaps = 48/289 (16%)

Query: 540 LGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G           T+VAIK  N  +      EF  E  ++ +    H+V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQK--------PPLPWKQRLEICIGAARGLH 645
           L+G        ++V + MA G L+ +L   +          P   ++ +++    A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL-- 703
           YL   AK   +HRD+   N ++ E    K+ DFG+     T D        KG  G L  
Sbjct: 134 YLA--AKK-FVHRDLAARNCMVAEDLTVKIGDFGM-----TRDIYETDYYRKGGKGLLPV 185

Query: 704 ---DPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWAAHCHKKG 758
               PE  +    T KSDV+SFGVVL+E+  L  +P     L  E+V             
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--QGLSNEEV------------- 230

Query: 759 ILEQIMDPYLKGKIAPECFKKFAETAMK-CVSDQGIERPSMGDVLWNLE 806
            L+ ++D        PE         M+ C       RP+  +++ +L+
Sbjct: 231 -LKFVIDGGHLDL--PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 90.1 bits (223), Expect = 5e-20
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 13/213 (6%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LLG G FG+V++G +   T  VA+K     L ++   +F +E  +L +  H ++V LIG 
Sbjct: 2   LLGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C +   + +V + +  G     L K +K  L  KQ ++  + AA G+ YL +      IH
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRK-KKDELKTKQLVKFALDAAAGMAYLES---KNCIH 116

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG-SFGYLDPEYFRRQQLTEK 716
           RD+   N L+ E  V K+SDFG+S+     D  + S+ +K     +  PE     + + +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174

Query: 717 SDVYSFGVVLFEI----LCARPALNPTLPKEQV 745
           SDV+S+G++L+E     +C  P +     +EQV
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 90.8 bits (225), Expect = 5e-20
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 10/197 (5%)

Query: 539 LLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LLG G FG V++G    E D     VAIK   +    Q   E    +  +  L H ++V 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L+G C     + LV      G+L +H+ +  +  L  ++ L  C+  A+G++YL    +H
Sbjct: 74  LLGICP-GASLQLVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIAKGMYYLE---EH 128

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            ++HR++   NILL    + +++DFG++      D  +  +  K    ++  E     + 
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 714 TEKSDVYSFGVVLFEIL 730
           T +SDV+S+GV ++E++
Sbjct: 189 THQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.2 bits (224), Expect = 7e-20
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 20/201 (9%)

Query: 539 LLGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSL 594
            +G G FG VY+G     +     VA+K     +   V E F  E  ++ +  H H+V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
           IG   EN  + +V +    G LR +L +  K  L     +      +  L YL +     
Sbjct: 73  IGVITEN-PVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLES---KR 127

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-----YLDPEYFR 709
            +HRD+   N+L+      K+ DFGLS+      +    +  K S G     ++ PE   
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSR------YLEDESYYKASKGKLPIKWMAPESIN 181

Query: 710 RQQLTEKSDVYSFGVVLFEIL 730
            ++ T  SDV+ FGV ++EIL
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 90.4 bits (224), Expect = 8e-20
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 25/212 (11%)

Query: 540 LGVGGFGKVYRGEI-----DGATTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVS 593
           LG   FGK+Y+G +     D A   VAIK    ++  Q   EFQ E  ++++L H ++V 
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQL-VAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYK---------------TQKPPLPWKQRLEICI 638
           L+G   +   + ++++Y+  G L E L                 T K  L     L I I
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
             A G+ YL   + H  +H+D+   NIL+ E+   K+SD GLS+   + D+  V      
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
              ++ PE     + +  SD++SFGVVL+EI 
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 89.5 bits (222), Expect = 2e-19
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 20/210 (9%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQTEIEMLSK 585
           NN      LG G FGKV      G     A  KVA+K   P +     E   +E++++S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 586 L-RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
           L  H ++V+L+G C     ++++ +Y  YG L   L + ++  L  +  L      A+G+
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST-VVKGS---- 699
            +L   A    IHRD+   N+LL    + K+ DFGL++     D  + S  VVKG+    
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLP 206

Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEI 729
             ++ PE       T +SDV+S+G++L+EI
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.0 bits (231), Expect = 3e-19
 Identities = 70/242 (28%), Positives = 115/242 (47%), Gaps = 21/242 (8%)

Query: 578 TEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEIC 637
           +EI  + KL+H ++V LIG C       L+++Y+    L E L       L W++R +I 
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIA 786

Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
           IG A+ L +LH      ++  ++    I++D K         L  + P L  T     + 
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH-----LRLSLPGLLCTDTKCFI- 840

Query: 698 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV--SLAEWAAHCH 755
            S  Y+ PE    + +TEKSD+Y FG++L E+L  +   +P   +  V  S+ EWA +C+
Sbjct: 841 -SSAYVAPETRETKDITEKSDIYGFGLILIELLTGK---SPADAEFGVHGSIVEWARYCY 896

Query: 756 KKGILEQIMDPYLKGKIAPECFKKFAET---AMKCVSDQGIERPSMGDVLWNLEFALQLQ 812
               L+  +DP ++G ++     +  E    A+ C +     RP   DVL  LE A +  
Sbjct: 897 SDCHLDMWIDPSIRGDVSVNQ-NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955

Query: 813 ES 814
            S
Sbjct: 956 SS 957

Length = 968

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 6/191 (3%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +  +TKVA+K   P     V  F  E  ++  L+H  LV L     
Sbjct: 14  LGAGQFGEVWMGYYNN-STKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YMA G+L + L   +   +   + ++     A G+ Y+    +   IHRD
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  N+L+ E  + K++DFGL++     ++T      K    +  PE       T KSDV
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 720 YSFGVVLFEIL 730
           +SFG++L+EI+
Sbjct: 188 WSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 75/258 (29%), Positives = 117/258 (45%), Gaps = 22/258 (8%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TTKVAIK   P        F  E +++ KLRH  LV L     
Sbjct: 14  LGQGCFGEVWMGTWNG-TTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V ++M  G+L + L +     L   Q +++    A G+ Y+    +   IHRD
Sbjct: 72  EE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ +  V K++DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E++       P +   +V              LEQ+   Y +      C + 
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREV--------------LEQVERGY-RMPCPQGCPES 231

Query: 780 FAETAMKCVSDQGIERPS 797
             E    C      ERP+
Sbjct: 232 LHELMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 88.5 bits (219), Expect = 4e-19
 Identities = 67/241 (27%), Positives = 110/241 (45%), Gaps = 45/241 (18%)

Query: 540 LGVGGFGKVYRG---EIDG--ATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           LG G FGKV +     + G    T VA+K        SE  + +  +E  +L ++ H H+
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLKQVNHPHV 65

Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK----------------------PPLP 629
           + L G C ++  ++L+ +Y  YG+LR  L +++K                        L 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 630 WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH 689
               +      +RG+ YL   A+  ++HRD+   N+L+ E    K+SDFGLS+     D 
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-----DV 177

Query: 690 THVSTVVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ 744
               + VK S G     ++  E       T +SDV+SFGV+L+EI+       P +  E+
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237

Query: 745 V 745
           +
Sbjct: 238 L 238

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 87.7 bits (217), Expect = 8e-19
 Identities = 63/199 (31%), Positives = 106/199 (53%), Gaps = 12/199 (6%)

Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV    Y  E D    +VA+K   P S    + + + EIE+L  L H ++V  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 595 IGYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            G C E+    + L+ +++  G+L+E+L +  K  +  KQ+L+  +   +G+ YL  G++
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYL--GSR 128

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQ 711
              +HRD+   N+L++ +   K+ DFGL+K   T  ++  V   +     +  PE   + 
Sbjct: 129 Q-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 712 QLTEKSDVYSFGVVLFEIL 730
           +    SDV+SFGV L+E+L
Sbjct: 188 KFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 30/211 (14%)

Query: 540 LGVGGFGKVYRG-EIDG----ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           +G G FGKVY    +D     A  ++ I+  +P + + + +   E+++L  L+H +LV  
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD---EMKVLELLKHPNLVKY 64

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-----ARGLHYLHT 649
            G      ++ +  +Y + GTL E L   +          E  I         GL YLH+
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILD-------EHVIRVYTLQLLEGLAYLHS 117

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKGSFGYLDPE 706
              H I+HRD+K  NI LD   V K+ DFG +       T     V ++  G+  Y+ PE
Sbjct: 118 ---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA-GTPAYMAPE 173

Query: 707 YFRRQQLTEK---SDVYSFGVVLFEILCARP 734
                +       +D++S G V+ E+   + 
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 13/199 (6%)

Query: 539 LLGVGGFGKVYRGEIDGATTK---VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           ++G G FG+V+RG +     K   VAIK   P  +E+   +F +E  ++ +  H +++ L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
            G   +    +++ +YM  G L ++L +         Q + +  G A G+ YL   +   
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKT---GPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
            +HRD+   NIL++     KVSDFGLS+     P  + T+ ++  K    +  PE    +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP--EGTYTTSGGKIPIRWTAPEAIAYR 185

Query: 712 QLTEKSDVYSFGVVLFEIL 730
           + T  SDV+SFG+V++E++
Sbjct: 186 KFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 11/200 (5%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
            +G G FG+VY+         VAIK  + L  +E  + + Q EI+ LS+ R  ++    G
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVID-LEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
              +  ++ ++ +Y   G+    L K     L       I      GL YLH   K   I
Sbjct: 67  SFLKGSKLWIIMEYCGGGSCL-DLLKPG--KLDETYIAFILREVLLGLEYLHEEGK---I 120

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+K  NILL E+   K++DFG+S    T   +  +T V   F ++ PE  ++    EK
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVS-GQLTSTMSKRNTFVGTPF-WMAPEVIKQSGYDEK 178

Query: 717 SDVYSFGVVLFEILCARPAL 736
           +D++S G+   E+    P L
Sbjct: 179 ADIWSLGITAIELAKGEPPL 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 539 LLGVGGFGKVYRG--EIDG---ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LLG G FG VY G    DG   A  +V++       ++ V + + EI +LSKL+H ++V 
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW-----KQRLEICIGAARGLHYLH 648
            +G   E   + +  + +  G+L + L K    P P      +Q L        GL YLH
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------GLEYLH 119

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
              ++T+ HRD+K  NIL+D   V K++DFG++K              KGS  ++ PE  
Sbjct: 120 --DRNTV-HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWMAPEVI 173

Query: 709 RRQQL-TEKSDVYSFGVVLFEILCARP 734
            +Q      +D++S G  + E+   +P
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKP 200

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 5/206 (2%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G FG+V+ G +    T VA+K     L      +F  E  +L +  H ++V LIG C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
            +   + +V + +  G     L +T+ P L  K+ +++   AA G+ YL +  KH I HR
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLES--KHCI-HR 118

Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           D+   N L+ EK V K+SDFG+S+      +     + +    +  PE     + + +SD
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178

Query: 719 VYSFGVVLFEILCARPALNPTLPKEQ 744
           V+SFG++L+E           L  +Q
Sbjct: 179 VWSFGILLWEAFSLGAVPYANLSNQQ 204

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 18/210 (8%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG--Y 597
           LG G FGKVY+ +        A K     SE+ + +F  EI++LS+ +H ++V L    +
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            E    +++  ++   G L   + + ++  L   Q   +C      L++LH    H +IH
Sbjct: 73  YENKLWILI--EFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLH---SHKVIH 126

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY-----FRRQQ 712
           RD+K  NILL      K++DFG+S    +      + +  G+  ++ PE      F+   
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFKDNP 184

Query: 713 LTEKSDVYSFGVVLFEILCARP---ALNPT 739
              K+D++S G+ L E+    P    LNP 
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPM 214

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 22/214 (10%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR----GNPLSEQG--VHEFQTEIEMLSKLRHRHLV 592
            LG G F   Y+       T +A+K+     N  SEQ   V   + EI ++++L H H++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI--CIGAARGLHYLHTG 650
            ++G   E+    L  ++MA G++   L K       +K+ + I       RGL YLH  
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLH-- 120

Query: 651 AKHTIIHRDVKTTNILLDEK-WVAKVSDFG----LSKTGPTLDHTHVSTVVKGSFGYLDP 705
            ++ IIHRDVK  N+L+D      +++DFG    L+  G          +  G+  ++ P
Sbjct: 121 -ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL--GTIAFMAP 177

Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPT 739
           E  R +Q     DV+S G V+ E+  A+P  N  
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 31/227 (13%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKL-R 587
           ++F    ++G G F  V   +      + AIK  +    + E+ V   + E E+L++L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGAARGLH 645
           H  ++ L    ++   +  V +Y   G L +++ K         +    EI +     L 
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA----LE 116

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV--------- 696
           YLH      IIHRD+K  NILLD+    K++DFG +K          +            
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 697 -----KGSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
                  SF G   Y+ PE    +   + SD+++ G +++++L  +P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 86.0 bits (214), Expect = 2e-18
 Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 20/203 (9%)

Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKR-GNPLSEQGVHEFQT---EIEMLSKLRHRHLVSL 594
           LG G +G VY+   D  T + VA+K+      E+G+    T   EI +L +L+H ++V L
Sbjct: 7   LGEGTYGVVYKA-RDKKTGEIVALKKIRLDNEEEGI--PSTALREISLLKELKHPNIVKL 63

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
           +       ++ LV++Y     L+++L   +  PL       I     RGL Y H+   H 
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHS---HR 118

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
           I+HRD+K  NIL++   V K++DFGL++    P   +TH   VV  +  Y  PE     +
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE--VV--TLWYRAPEILLGSK 174

Query: 713 LTEKS-DVYSFGVVLFEILCARP 734
               + D++S G +  E++  +P
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKP 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 58/201 (28%), Positives = 107/201 (53%), Gaps = 15/201 (7%)

Query: 539 LLGVGGFGKVYRGEIDGATTK---VAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           ++G G FG+V RG +     +   VAIK   +  +E+   +F +E  ++ +  H +++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            G   ++  ++++ ++M  G L   L +   Q   +   Q + +  G A G+ YL   ++
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL---SE 124

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTV-VKGSFGYLDPEYFR 709
              +HRD+   NIL++   V KVSDFGLS+     T D T+ S++  K    +  PE   
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 710 RQQLTEKSDVYSFGVVLFEIL 730
            ++ T  SDV+S+G+V++E++
Sbjct: 185 YRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.3 bits (211), Expect = 3e-18
 Identities = 55/212 (25%), Positives = 104/212 (49%), Gaps = 24/212 (11%)

Query: 539 LLGVGGFGKVYRGEIDG----ATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVS 593
           +LG G +G VY G  +     A  +V +   N L+ E+   + Q E+++L  L+H ++V 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP-----WKQRLEICIGAARGLHYLH 648
            +G C ++  + +  +++  G++   L +    P P      KQ L+       G+ YLH
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-------GVAYLH 119

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK----TGPTLDHTHVSTVVKGSFGYLD 704
               + ++HRD+K  N++L    + K+ DFG ++     G    H+++   + G+  ++ 
Sbjct: 120 ---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARPAL 736
           PE         KSD++S G  +FE+   +P L
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 85.5 bits (211), Expect = 4e-18
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 25/225 (11%)

Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGA-----TTKVAIKRGNPLSEQGV-HEFQTE 579
           EI  +T  F E L  G   FGKVY+G + G      T  VAIK     +E  +  EF+ E
Sbjct: 1   EINLSTVRFMEEL--GEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLY--------------KTQK 625
             M S+L+H ++V L+G   +   + +++ Y ++  L E L               KT K
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 626 PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP 685
             L     + I    A G+ +L   + H ++H+D+ T N+L+ +K   K+SD GL +   
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             D+  +         ++ PE     + +  SD++S+GVVL+E+ 
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 54/237 (22%), Positives = 109/237 (45%), Gaps = 30/237 (12%)

Query: 576 FQTEIEMLSKLRHRHLVSLIGY----CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWK 631
            + EI+ L ++   +++ + G+     ++   + L+ +Y   G LRE L K +   L +K
Sbjct: 65  TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--LSFK 122

Query: 632 QRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH 691
            +L++ I   +GL+ L+        ++++ + + L+ E +  K+   GL K   +    +
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN 180

Query: 692 VSTVVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAE 749
           V+ +V     Y   +       + T K D+YS GVVL+EI   +      +P E ++   
Sbjct: 181 VNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK------IPFENLTT-- 227

Query: 750 WAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
                  K I + I++     K+  +C  +       C S   I+RP++ ++L+NL 
Sbjct: 228 -------KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.9 bits (207), Expect = 8e-18
 Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 11/204 (5%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHE---FQTEIEMLSKLRHR 589
            ++    +G G FGK+Y  +    +    IK  + L++  V E    + E+ +L+K++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEID-LTKMPVKEKEASKKEVILLAKMKHP 59

Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V+     +EN  + +V +Y   G L + + + +       Q L   +  + GL ++H 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH- 118

Query: 650 GAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
                I+HRD+K+ NI L +   VAK+ DFG+++     D   ++    G+  YL PE  
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEIC 174

Query: 709 RRQQLTEKSDVYSFGVVLFEILCA 732
           + +    K+D++S G VL+E LC 
Sbjct: 175 QNRPYNNKTDIWSLGCVLYE-LCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 84.3 bits (208), Expect = 9e-18
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 29/226 (12%)

Query: 540 LGVGGFGKVYRGEIDGAT-----TKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G   G       T+VAIK  N   S +   EF  E  ++ +    H+V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYK---------TQKPPLPWKQRLEICIGAARGL 644
           L+G   +    +++ + M  G L+ +L            Q PP   K+ +++    A G+
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP-SLKKMIQMAGEIADGM 132

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG--- 701
            YL+    +  +HRD+   N ++ E +  K+ DFG+++     D+       KG  G   
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLP 184

Query: 702 --YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
             ++ PE  +    T  SDV+SFGVVL+EI          +  EQV
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV 230

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 1e-17
 Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 23/155 (14%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEF-QT---EIEMLSKLRHRHLVSLI 595
           +G G +G+VY+         VA+K+     E     F  T   EI++L KLRH ++V L 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 596 GYCEENC--EMILVYDYMAY---GTLREHLYKTQKPPLP--WKQRLEICIGAARGLHYLH 648
                     + +V++YM +   G L     K  +  +    KQ LE       GL YLH
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE-------GLQYLH 117

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT 683
           +   + I+HRD+K +NIL++   V K++DFGL++ 
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARP 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 13/154 (8%)

Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L K    ++V   G    N ++ +  +YM  G+L + + K  +  +P +   +I +
Sbjct: 49  ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAV 107

Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              +GL YLH   KH IIHRDVK +NIL++ +   K+ DFG+S          V+++ K 
Sbjct: 108 AVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG-------QLVNSLAKT 158

Query: 699 SFG---YLDPEYFRRQQLTEKSDVYSFGVVLFEI 729
             G   Y+ PE  +    + KSD++S G+ L E+
Sbjct: 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIEL 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 35/281 (12%)

Query: 533 NFDEALLLGVGGFGKVYRG-EIDG----ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR 587
           N+    LLG G FG+VY   ++D     A  +V     +P + + V   + EI++L  L+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 588 HRHLVSLIGYCEENCE--MILVYDYMAYGTLREHL--YKTQKPPLPWKQRLEICIGAARG 643
           H  +V   G   +  E  + +  +YM  G++++ L  Y      +  K   +I      G
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EG 118

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT--LDHTHVSTVVKGSFG 701
           + YLH+   + I+HRD+K  NIL D     K+ DFG SK   T  +  T + +V  G+  
Sbjct: 119 MSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPY 174

Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE 761
           ++ PE    +    K+DV+S G  + E+L  +P             AE+ A      I  
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP-----------PWAEYEAMAAIFKIAT 223

Query: 762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
           Q  +P L     P    + A   + C+  +   RPS  ++L
Sbjct: 224 QPTNPQL-----PSHISEHARDFLGCIFVEARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 11/200 (5%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSL 594
           +LG G FGKV   E+ G     A+K   +   L +  V    TE  +L+   +H  L  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
               +    +  V +Y+  G L  H+ ++ +   P  +     I    GL +LH   +  
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQFLH---ERG 116

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           II+RD+K  N+LLD +   K++DFG+ K G     T  ++   G+  Y+ PE    Q   
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYG 174

Query: 715 EKSDVYSFGVVLFEILCARP 734
              D ++ GV+L+E+L  + 
Sbjct: 175 PAVDWWALGVLLYEMLAGQS 194

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.8 bits (202), Expect = 4e-17
 Identities = 58/191 (30%), Positives = 95/191 (49%), Gaps = 7/191 (3%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G  TKVAIK     S      F  E  ++ +L+H  LV L     
Sbjct: 14  LGAGQFGEVWMGYYNG-HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L   +   L   + +++    A G+ ++    +   IHRD
Sbjct: 72  QE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E    K++DFGL++     ++T      K    +  PE       T KSDV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 720 YSFGVVLFEIL 730
           +SFG++L EI+
Sbjct: 187 WSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 17/201 (8%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           LG GGFG+V   ++       A K+ +       +G      E ++L K+  R +VSL  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL----EICIGAARGLHYLHTGAK 652
             E   ++ LV   M  G L+ H+Y   +P  P  + +    +I  G    L +LH   +
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLH---Q 113

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             I++RD+K  N+LLD+    ++SD GL+                G+ GY+ PE  + + 
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEV 170

Query: 713 LTEKSDVYSFGVVLFEILCAR 733
                D ++ G  L+E++  R
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 81.9 bits (202), Expect = 5e-17
 Identities = 77/284 (27%), Positives = 123/284 (43%), Gaps = 35/284 (12%)

Query: 539 LLGVGGFGKVYRGEI---DGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           +LG G FG V   ++   DG+  KVA+K  + +  S   + EF  E   + +  H +++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 594 LIGYCEEN-------CEMILVYDYMAYGTLREHLYKT---QKP-PLPWKQRLEICIGAAR 642
           LIG    +         M+++  +M +G L   L  +   ++P  LP +  +   I  A 
Sbjct: 66  LIGVSLRSRAKGRLPIPMVIL-PFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ YL   +    IHRD+   N +L+E     V+DFGLSK   + D+       K    +
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ 762
           L  E       T  SDV++FGV ++EI+        T P   V  +E   +  K   L+Q
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIM----TRGQT-PYAGVENSEIYNYLIKGNRLKQ 236

Query: 763 IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
                      P+C +   E   +C S +   RPS   +   LE
Sbjct: 237 ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.4 bits (201), Expect = 6e-17
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 31/214 (14%)

Query: 539 LLGVGGFGKVYRGEIDGATT------------KVAIKRGNPLSEQGVHEFQTEIEMLSKL 586
           L+G G +G+VY       TT                 R +   +  V   ++EIE L  L
Sbjct: 8   LIGKGTYGRVYLAL--NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK--PPLP---WKQRLEICIGAA 641
            H ++V  +G+      + +  +Y+  G++   L    +    L     +Q LE      
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE------ 119

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
            GL YLH      I+HRD+K  N+L+D   + K+SDFG+SK    +     +  ++GS  
Sbjct: 120 -GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175

Query: 702 YLDPE--YFRRQQLTEKSDVYSFGVVLFEILCAR 733
           ++ PE  +   Q  + K D++S G V+ E+   R
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.1 bits (201), Expect = 7e-17
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 42/218 (19%)

Query: 543 GGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC- 598
           G +G+V+  +        AIK   + + + +  V +  TE ++LS+ +  ++V L  Y  
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62

Query: 599 --EENCEMILVYDYM----------AYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
             ++N  + LV +Y+            G+L E + +             I I      L 
Sbjct: 63  QGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVAR-------------IYIAEIVLALE 107

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK------GS 699
           YLH    + IIHRD+K  NIL+D     K++DFGLSK G      +++   K      G+
Sbjct: 108 YLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
             Y+ PE    Q  ++  D +S G +L+E L   P  +
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 74/284 (26%), Positives = 120/284 (42%), Gaps = 32/284 (11%)

Query: 540 LGVGGFGKVYRGEI--DGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V  G++  D +  KVA+K  +    +   + +F +E   + +  H +++ LI
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 596 GYCEENCEM------ILVYDYMAYGTLREHLYKT----QKPPLPWKQRLEICIGAARGLH 645
           G C +  E       +++  +M +G L   L  +        LP +  ++     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YL +    + IHRD+   N +L+E     V+DFGLSK     D+     + K    ++  
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E    +  T KSDV+SFGV ++EI     A     P   V  +E   +  +   L+Q   
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI-----ATRGQTPYPGVENSEIYDYLRQGNRLKQ--- 235

Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL 809
                   P+C          C      +RPS   +   LE AL
Sbjct: 236 -------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 81.3 bits (200), Expect = 1e-16
 Identities = 58/197 (29%), Positives = 104/197 (52%), Gaps = 10/197 (5%)

Query: 539 LLGVGGFGKVYRG--EIDGATTK--VAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVS 593
           +LG G FG VY+G    +G T K  VAIK  N  +    + EF  E  +++ + H HLV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L+G C     + LV   M +G L +++++  K  +  +  L  C+  A+G+ YL    + 
Sbjct: 74  LLGVCLSP-TIQLVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---ER 128

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            ++HRD+   N+L+      K++DFGL++     +  + +   K    ++  E    ++ 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 714 TEKSDVYSFGVVLFEIL 730
           T +SDV+S+GV ++E++
Sbjct: 189 THQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 69/287 (24%), Positives = 128/287 (44%), Gaps = 43/287 (14%)

Query: 540 LGVGGFGKVYRGEIDGAT--------------TKVAIKRGNP-LSEQGVHEFQTEIEMLS 584
           LG G FG+V+  E +G                  VA+K     +++   ++F  EI+++S
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK----------PPLPWKQRL 634
           +L++ +++ L+G C  +  + ++ +YM  G L + L + +           P +     L
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST 694
            + +  A G+ YL   A    +HRD+ T N L+   +  K++DFG+S+   + D+  +  
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQV--SLAEW 750
                  ++  E     + T  SDV++FGV L+E+  LC     +  L  EQV  +  E+
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS-LLSDEQVIENTGEF 248

Query: 751 AAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS 797
             +  ++  L Q           P C     +  M+C S    +RP+
Sbjct: 249 FRNQGRQIYLSQ----------TPLCPSPVFKLMMRCWSRDIKDRPT 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 80/274 (29%), Positives = 121/274 (44%), Gaps = 42/274 (15%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ---TEIEMLSKLRHRHLVSLIG 596
           +G G FG VY          VAIK+ +   +Q   ++Q    E+  L +LRH + +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 597 -YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI---CIGAARGLHYLHTGAK 652
            Y  E+    LV +Y   G+  + + +  K PL   Q +EI   C GA +GL YLH+   
Sbjct: 83  CYLREHTAW-LVMEY-CLGSASD-ILEVHKKPL---QEVEIAAICHGALQGLAYLHS--- 133

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFG-LSKTGPTLDHTHVSTVVKGSFGYLDPEY---F 708
           H  IHRD+K  NILL E    K++DFG  S   P   ++ V T       ++ PE     
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFVGTPY-----WMAPEVILAM 186

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL 768
              Q   K DV+S G+   E+   +P L         ++   +A  H    + Q   P L
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL--------FNMNAMSALYH----IAQNDSPTL 234

Query: 769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
                 + F+ F +    C+     +RPS  ++L
Sbjct: 235 SSNDWSDYFRNFVD---SCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 9/195 (4%)

Query: 540 LGVGGFGKVYRG--EIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIG 596
           LG G FG V +G  ++      VAIK     +E+ V  E   E E++ +L + ++V +IG
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
            CE    M LV +  + G L + L   +K  +     +E+    + G+ YL        +
Sbjct: 63  VCEAEALM-LVMEMASGGPLNKFL-SGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE 715
           HRD+   N+LL  +  AK+SDFGLSK  G    +    +  K    +  PE    ++ + 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 716 KSDVYSFGVVLFEIL 730
           +SDV+S+G+ ++E  
Sbjct: 178 RSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 48/162 (29%), Positives = 85/162 (52%), Gaps = 6/162 (3%)

Query: 577 QTEIEMLSKLRHRHLVSLIGYCE-ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE 635
           + E ++LS+L+H ++V+     E E+  + +V  +   G L   L + +   LP  Q +E
Sbjct: 47  EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106

Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
             +  A  L YLH   KH I+HRD+KT N+ L    + KV D G+++     +   +++ 
Sbjct: 107 WFVQIAMALQYLHE--KH-ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMAST 161

Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
           + G+  Y+ PE F  +    KSDV++ G  ++E+   + A N
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 10/199 (5%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           LG GGFG+V   ++       A K+ N       +G      E  +L+K+  R +VSL  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
             +   ++ LV   M  G LR H+Y    + P  P  +          GL +LH   +  
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           II+RD+K  N+LLD     ++SD GL+      D    +    G+ G++ PE  + ++  
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVE--LKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 715 EKSDVYSFGVVLFEILCAR 733
              D ++ GV L+E++ AR
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 79.3 bits (195), Expect = 4e-16
 Identities = 67/254 (26%), Positives = 113/254 (44%), Gaps = 33/254 (12%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR-----GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LLG G FG+VY         ++A+K+      +P + + V+  + EI++L  L H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 594 LIGYCEENCEMIL--VYDYMAYGTLREHL--YKTQKPPLPWKQRLEICIGAARGLHYLHT 649
             G   +  E  L    ++M  G++++ L  Y      +  K   +I      G+ YLH+
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT--LDHTHVSTVVKGSFGYLDPEY 707
              + I+HRD+K  NIL D     K+ DFG SK   T  L  T + +V  G+  ++ PE 
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSPEV 180

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP--------------ALNPTLPKEQVSLAEWAAH 753
              +    K+D++S G  + E+L  +P              A  PT P     +++    
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240

Query: 754 CHKKGILEQIMDPY 767
             K+  +E  + P 
Sbjct: 241 FLKRIFVEAKLRPS 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 47/293 (16%)

Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
           E +   +   E ++LG G +G VY         ++AIK       + V     EI + S 
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW---------KQRLEI 636
           L+HR++V  +G   EN    +  + +  G+L   L +++  PL           KQ LE 
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTKQILE- 119

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPTLDHTHVSTV 695
                 GL YLH    + I+HRD+K  N+L++    V K+SDFG SK    ++    +  
Sbjct: 120 ------GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTET 168

Query: 696 VKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH 753
             G+  Y+ PE   +        +D++S G  + E+   +P          + L E  A 
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF--------IELGEPQAA 220

Query: 754 CHKKGILEQIMDPYLKGKIAPECFKKFAETA----MKCVSDQGIERPSMGDVL 802
             K G+           KI PE  +  +  A    ++C      +R S  D+L
Sbjct: 221 MFKVGMF----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 44/225 (19%)

Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ-----------TE 579
             NF     +G G F  VY+         VA+K+        V  F+            E
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKK--------VQIFEMMDAKARQDCLKE 52

Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL--YKTQKPPLP----WKQR 633
           I++L +L H +++  +    EN E+ +V +    G L   +  +K QK  +P    WK  
Sbjct: 53  IDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF 112

Query: 634 LEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL-----SKTGPTLD 688
           +++C      L ++H+     I+HRD+K  N+ +    V K+ D GL     SKT  T  
Sbjct: 113 VQLC----SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAA 163

Query: 689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           H+ V T       Y+ PE         KSD++S G +L+E+   +
Sbjct: 164 HSLVGTPY-----YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 26/210 (12%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRH 590
               E   LG G  G V +  +       A+K         +  +   E+E+    +  +
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 591 LVSLIGYC--EENCEMILVYDYMAYGTLREHLYK--------TQKPPLPWKQRLEICIGA 640
           +V   G    E +  + +  +Y   G+L + +YK          +  L      +I    
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL-----GKIAESV 114

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS-KTGPTLDHTHVSTVVKGS 699
            +GL YLH+     IIHRD+K +NILL  K   K+ DFG+S +   +L  T   T    S
Sbjct: 115 LKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGT----S 167

Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEI 729
           F Y+ PE  + +  +  SDV+S G+ L E+
Sbjct: 168 F-YMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 79.7 bits (197), Expect = 6e-16
 Identities = 60/197 (30%), Positives = 88/197 (44%), Gaps = 14/197 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTE---IEMLSKLRHRHLVS 593
           LG G FGKV   E        AIK   +G+ ++   V     E    E  +  RH  LV+
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L    +    +  V +Y A G L  H++       P       C+    GL YLH   ++
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYAACV--VLGLQYLH---EN 120

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            I++RD+K  N+LLD +   K++DFGL K G        ST   G+  +L PE       
Sbjct: 121 KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TSTFC-GTPEFLAPEVLTETSY 178

Query: 714 TEKSDVYSFGVVLFEIL 730
           T   D +  GV+++E+L
Sbjct: 179 TRAVDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 78.5 bits (193), Expect = 7e-16
 Identities = 73/292 (25%), Positives = 126/292 (43%), Gaps = 40/292 (13%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ---TEIEMLSKLRHR 589
           NF     +G G F +VYR         VA+K+            Q    EI++L +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHL--YKTQKPPLP----WKQRLEICIGAARG 643
           +++  +    E+ E+ +V +    G L + +  +K QK  +P    WK  +++C      
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SA 118

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKGSF 700
           + ++H+     ++HRD+K  N+ +    V K+ D GL +   +  T  H+ V T      
Sbjct: 119 VEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY---- 171

Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL 760
            Y+ PE         KSD++S G +L+E+     AL      ++++L    + C K   +
Sbjct: 172 -YMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNL---FSLCQK---I 220

Query: 761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQ 812
           EQ   P L  +   E   K  E    C+     +RP +G V    + A Q+ 
Sbjct: 221 EQCDYPPLPTEHYSE---KLRELVSMCIYPDPDQRPDIGYV---HQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 57/191 (29%), Positives = 94/191 (49%), Gaps = 7/191 (3%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+    +   TKVA+K   P S   V  F  E  ++  L+H  LV L     
Sbjct: 14  LGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ ++MA G+L + L   +    P  + ++     A G+ ++    +   IHRD
Sbjct: 72  KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 127

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+    V K++DFGL++     ++T      K    +  PE       T KSDV
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDV 186

Query: 720 YSFGVVLFEIL 730
           +SFG++L EI+
Sbjct: 187 WSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 78.3 bits (193), Expect = 8e-16
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 44/218 (20%)

Query: 539 LLGVGGFGKVYRG--EIDGATTKVAIKRGNPLSEQG-------VHEFQTEIEMLSKLRHR 589
           L+G G FG VY G     G    V       +S          +     EI +L +L+H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 590 HLVSLIGYCEENCEMILVYDYMA----------YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++V  +G   +   + +  +Y+           YG   E L +        +Q L     
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFV-----RQIL----- 116

Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV---- 695
             +GL+YLH      IIHRD+K  NIL+D K   K+SDFG+SK    L+   +ST     
Sbjct: 117 --KGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTKTNGA 168

Query: 696 ---VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
              ++GS  ++ PE  ++   T K+D++S G ++ E+L
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 15/203 (7%)

Query: 540 LGVGGFGK--VYRGEIDG---ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           +G G FGK  + + + DG      ++ I + +P   +   E + E+ +LS ++H ++V  
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQY 64

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
               EEN  + +V DY   G L + +   +    P  Q L+  +     L ++H      
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRK 121

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT-HVSTVVKGSFGYLDPEYFRRQQL 713
           I+HRD+K+ NI L +    K+ DFG+++    L+ T  ++    G+  YL PE    +  
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIAR---VLNSTVELARTCIGTPYYLSPEICENRPY 178

Query: 714 TEKSDVYSFGVVLFEILCARPAL 736
             KSD+++ G VL+E+   + A 
Sbjct: 179 NNKSDIWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.9 bits (195), Expect = 9e-16
 Identities = 67/239 (28%), Positives = 102/239 (42%), Gaps = 50/239 (20%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--------GNPLSEQGVHEFQTEIEMLS 584
            F++   +G G +G VYR     +   VA+K+        G P+S         EI +L 
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL------REITLLL 61

Query: 585 KLRHRHLVSL---------------IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP 629
            LRH ++V L               + YCE++   +L  D M               P  
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNM-------------PTPFS 106

Query: 630 WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH 689
             Q   + +   RGL YLH   ++ IIHRD+K +N+LL +K   K++DFGL++T      
Sbjct: 107 ESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163

Query: 690 THVSTVVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
                VV  +  Y  PE        T   D+++ G +L E+L  +P L      EQ+ L
Sbjct: 164 PMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 49/143 (34%), Positives = 72/143 (50%), Gaps = 6/143 (4%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G VY+         VAIK    L         Q EI ML + RH ++V+  G  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKV-IKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
               ++ +V +Y   G+L++ +Y+  + PL   Q   +C    +GL YLH   K   IHR
Sbjct: 70  LRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHETGK---IHR 125

Query: 659 DVKTTNILLDEKWVAKVSDFGLS 681
           D+K  NILL E    K++DFG+S
Sbjct: 126 DIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 78.4 bits (193), Expect = 1e-15
 Identities = 74/297 (24%), Positives = 126/297 (42%), Gaps = 46/297 (15%)

Query: 540 LGVGGFGKVYRGEIDGATTKVA------IKRGNPL-----------SEQGVHEFQTEIEM 582
           LG G FG+V+  E+              +++G PL           ++   ++F  E+++
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL--------------YKTQKPPL 628
           LS+L+  +++ L+G C +   + ++ +YM  G L + L                     L
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 629 P---WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP 685
           P   +   L + +  A G+ YL   +    +HRD+ T N L+ E    K++DFG+S+   
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL-CARPALNPTLPKEQ 744
             D+  +         ++  E     + T  SDV++FGV L+EIL   +      L  EQ
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249

Query: 745 VSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDV 801
           V   E A    +    +Q    YL     P C +   E  ++C S    ERPS  D+
Sbjct: 250 V--IENAGEFFR----DQGRQVYLFR--PPPCPQGLYELMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 25/212 (11%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ------TEIEMLSK 585
           ++F+    LG G FG+V      G+    A+K    LS+  + + +       E  +L  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI---LSKAKIVKLKQVEHVLNEKRILQS 57

Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR--- 642
           +RH  LV+L G  +++  + LV +Y+  G L  HL K+ + P P          AA+   
Sbjct: 58  IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-----ARFYAAQVVL 112

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+     I++RD+K  N+LLD     K++DFG +K       T+  T+  G+  Y
Sbjct: 113 ALEYLHS--LD-IVYRDLKPENLLLDSDGYIKITDFGFAKRVK--GRTY--TLC-GTPEY 164

Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           L PE    +   +  D ++ G++++E+L   P
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 31/227 (13%)

Query: 540 LGVGGFGKVYRGE----IDG-ATTKVAIKRGN---PLSEQGVHEFQTEIEMLSKLRHRHL 591
           LG G FG VY G     I G A T+VA+K  N    L E+   EF  E  ++      H+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER--IEFLNEASVMKGFTCHHV 71

Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHLY--------KTQKPPLPWKQRLEICIGAARG 643
           V L+G   +    ++V + MA+G L+ +L            +PP   ++ +++    A G
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-- 701
           + YL+  AK   +HRD+   N ++   +  K+ DFG+++     D+       KG  G  
Sbjct: 132 MAYLN--AK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGLL 183

Query: 702 ---YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
              ++ PE  +    T  SD++SFGVVL+EI          L  EQV
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 79.5 bits (196), Expect = 2e-15
 Identities = 70/236 (29%), Positives = 110/236 (46%), Gaps = 22/236 (9%)

Query: 518 LCRHFS--FAEIKAATNNFDE----ALLLGVGGFGKVY--RGEIDGATTKVAIKRGNPLS 569
           +CR F   FA+ +A      +    + +LG G  G V   +   DG    V +     +S
Sbjct: 12  VCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS 71

Query: 570 EQGVHEFQTEIEML------SKLR-HRHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLY 621
           E   +  Q E+  L      S ++ H           EN  MI LV DY   G LR+ + 
Sbjct: 72  EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIK 131

Query: 622 KTQKPPLPWKQRLE--ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG 679
              K    +++     + I     +H++H+  KH +IHRD+K+ NILL    + K+ DFG
Sbjct: 132 SRAKTNRTFREHEAGLLFIQVLLAVHHVHS--KH-MIHRDIKSANILLCSNGLVKLGDFG 188

Query: 680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARP 734
            SK         V     G+  Y+ PE +RR+  ++K+D++S GV+L+E+L   RP
Sbjct: 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 11/197 (5%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG+V++G ID  T KV   +   L  +E  + + Q EI +LS+    ++    G 
Sbjct: 12  IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             ++ ++ ++ +Y+  G+  + L   +  PL   Q   I     +GL YLH+  K   IH
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK---IH 124

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+LL E    K++DFG++  G   D         G+  ++ PE  ++     K+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182

Query: 718 DVYSFGVVLFEILCARP 734
           D++S G+   E+    P
Sbjct: 183 DIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 11/194 (5%)

Query: 540 LGVGGFGKVYRG--EIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V +G  ++  +   VA+K  + +        E   E  ++ +L + ++V +I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G CE    M LV +    G L + L K +   +  K   E+    + G+ YL    +   
Sbjct: 63  GICEAESWM-LVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLE---ETNF 116

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           +HRD+   N+LL  +  AK+SDFGLSK  G   ++    T  K    +  PE     + +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 715 EKSDVYSFGVVLFE 728
            KSDV+SFGV+++E
Sbjct: 177 SKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 76/285 (26%), Positives = 121/285 (42%), Gaps = 48/285 (16%)

Query: 540 LGVGGFGKVYRG--------EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRH 590
           LG G F  +Y+G        +I G   +V++      S+      F     ++S+L H+H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYK-TQKPPLPWKQRLEICIGAARGLHYLHT 649
           LV L G C  + E I+V +Y+ +G L   L++      L WK  L++    A  LHYL  
Sbjct: 63  LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLE- 118

Query: 650 GAKHTIIHRDVKTTNILL-----DEKWV--AKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
                ++H +V   NIL+     +E +V   K+SD G+  T  + +   V  +      +
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER-VERI-----PW 170

Query: 703 LDPEYFRRQQ--LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL 760
           + PE  R  Q  LT  +D +SFG  L EI       N   P   +S +E       +  L
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICS-----NGEEPLSTLSSSEKERFYQDQHRL 225

Query: 761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
                        P+C  + A    +C +    +RPS   +L +L
Sbjct: 226 P-----------MPDC-AELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 76.1 bits (188), Expect = 6e-15
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)

Query: 534 FDEALLLGVGGFGKVYRG--EIDGATTKVAIKRGN-PLSEQGVHEFQT-EIEMLSKLR-- 587
           ++E   +G G +G VY+      G    VA+K+   PLSE+G+      EI +L +L   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRF--VALKKVRVPLSEEGIPLSTLREIALLKQLESF 58

Query: 588 -HRHLVSLIGYC-----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
            H ++V L+  C     +   ++ LV++++    L  +L K  KP LP +   ++     
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL 117

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
           RG+ +LH+   H I+HRD+K  NIL+      K++DFGL++           T V  +  
Sbjct: 118 RGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLW 171

Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           Y  PE   +       D++S G +  E+   RP
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 19/202 (9%)

Query: 540 LGVGGFGKVY--------RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           LG G FG VY          E      ++ +   NP   + V   Q E ++LSKL H  +
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP--NETVQANQ-EAQLLSKLDHPAI 64

Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHL--YKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           V       E     ++ +Y     L   L   K     L   Q  E  I    G+HY+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH- 123

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             +  I+HRD+K  NI L +  + K+ DFG+S+    +    ++T   G+  Y+ PE  +
Sbjct: 124 --QRRILHRDLKAKNIFL-KNNLLKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEALK 178

Query: 710 RQQLTEKSDVYSFGVVLFEILC 731
            Q    KSD++S G +L+E+ C
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 76.1 bits (188), Expect = 7e-15
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 25/210 (11%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIK--RGNPLSEQ--GVHEFQT---EIEMLSKLRHRH 590
            LG G +  VY+   D  T   VAIK  +     E   G++   T   EI++L +L+H +
Sbjct: 7   KLGEGTYAVVYKAR-DKETGRIVAIKKIKLGERKEAKDGIN--FTALREIKLLQELKHPN 63

Query: 591 LVSLIG-YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++ L+  +  ++  + LV+++M   T  E + K +   L         +   RGL YLH 
Sbjct: 64  IIGLLDVFGHKSN-INLVFEFME--TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH- 119

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTHVSTVVKGSFGYLDPE- 706
              + I+HRD+K  N+L+    V K++DFGL+++   P    TH   VV  +  Y  PE 
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--QVV--TRWYRAPEL 173

Query: 707 YFRRQQLTEKSDVYSFGVVLFEILCARPAL 736
            F  +      D++S G +  E+L   P L
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRVPFL 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 15/199 (7%)

Query: 543 GGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           G FG+++ G    E  G   +V +K   +  SE  V     E  +L  L H++++ ++  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 598 CEENCEMILV-YDYMAYGTLREHLYKTQKPP------LPWKQRLEICIGAARGLHYLHTG 650
           C E+ E   V Y YM +G L+  L + +         L  +Q + + I  A G+ YLH  
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
            K  +IH+D+   N ++DE+   K++D  LS+    +D+  +         ++  E    
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193

Query: 711 QQLTEKSDVYSFGVVLFEI 729
           ++ +  SDV+SFGV+L+E+
Sbjct: 194 KEYSSASDVWSFGVLLWEL 212

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 52/169 (30%), Positives = 88/169 (52%), Gaps = 8/169 (4%)

Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L +    ++V   G    + E+ +  ++M  G+L + L K  + P     ++ I +
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108

Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              RGL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D    S V  G
Sbjct: 109 --LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV--G 160

Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           +  Y+ PE  +    T +SD++S G+ L E+   R  + P   KE  ++
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 79/276 (28%), Positives = 123/276 (44%), Gaps = 37/276 (13%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ---TEIEMLSKLRHRHLVSLIG 596
           +G G FG VY       +  VAIK+ +   +Q   ++Q    E+  L KLRH + +   G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 597 -YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
            Y  E+    LV +Y   G+  + L +  K PL   +   +  GA +GL YLH+   H +
Sbjct: 83  CYLREHTAW-LVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNM 136

Query: 656 IHRDVKTTNILLDEKWVAKVSDFG-LSKTGPTLDHTHVSTVVKGSFGYLDPEY---FRRQ 711
           IHRDVK  NILL E  + K+ DFG  S   P       +    G+  ++ PE        
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILAMDEG 189

Query: 712 QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK 771
           Q   K DV+S G+   E+   +P L         ++   +A  H    + Q   P L+  
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPL--------FNMNAMSALYH----IAQNESPALQSG 237

Query: 772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF 807
              E F+ F ++ ++ +     +RP+  +VL    F
Sbjct: 238 HWSEYFRNFVDSCLQKIPQ---DRPT-SEVLLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 19/203 (9%)

Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKR--GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           +G G  G V++   D  T + VA+K+     L     ++   EI+ L   +H ++V L+ 
Sbjct: 8   IGEGAHGIVFKA-KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                   +LV +YM    L E L   ++P LP  Q         +G+ Y+H    + I+
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH---ANGIM 121

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTH-VSTVVKGSFGYLDPE-YFRRQ 711
           HRD+K  N+L+    V K++DFGL+          ++H V+T       Y  PE  +  +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-----WYRAPELLYGAR 176

Query: 712 QLTEKSDVYSFGVVLFEILCARP 734
           +     D+++ G +  E+L   P
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 29/208 (13%)

Query: 540 LGVGGFGKVY--RGEIDGA------TTKVAIKRGNP----LSEQGVHEFQTEIEMLSKLR 587
           +G G FGKV   + + DG         K AI +       ++E+ V        +L  ++
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV--------LLKNVK 54

Query: 588 HRHLVSLIGYCEENCE-MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
           H  LV L  Y  +  + +  V DY+  G L  HL + +  P P  +     I +A G  Y
Sbjct: 55  HPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--Y 111

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           LH+     II+RD+K  NILLD +    ++DFGL K G  ++H+  ++   G+  YL PE
Sbjct: 112 LHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG--IEHSKTTSTFCGTPEYLAPE 166

Query: 707 YFRRQQLTEKSDVYSFGVVLFEILCARP 734
             R+Q      D +  G VL+E+L   P
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 78.0 bits (192), Expect = 1e-14
 Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 19/191 (9%)

Query: 559 KVAIKRGNPLSEQGVHE---FQTEIEMLSKLRHRHLVSLI--GYCEENCEMILVYDYMAY 613
           +VAIK     + +  H+   F+ E  + ++L H ++V+L+  G       +  V++Y+  
Sbjct: 5   EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPG 63

Query: 614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEK 670
            TLRE L       LP  +   + +     L   H      I+HRD+K  NI++     +
Sbjct: 64  RTLREVL--AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVR 118

Query: 671 WVAKVSDFGLSKTGPTLDHTHVSTV-----VKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 725
             AKV DFG+    P +    V+T+     V G+  Y  PE  R + +T  SD+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 726 LFEILCARPAL 736
             E L  +  +
Sbjct: 179 FLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 20/201 (9%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG--VHEFQTEIEMLSKLRHRHLVSLIGY 597
           +GVG    VY         KVAIKR + L +    V E + E++ +S+  H ++V     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA-----RGLHYLHTGAK 652
                E+ LV  Y++ G+L        K   P     E  I        +GL YLH    
Sbjct: 68  FVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---S 120

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKGSFGYLDPEYFR 709
           +  IHRD+K  NILL E    K++DFG+S     G         T V G+  ++ PE   
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEVME 179

Query: 710 RQQ-LTEKSDVYSFGVVLFEI 729
           +      K+D++SFG+   E+
Sbjct: 180 QVHGYDFKADIWSFGITAIEL 200

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 10/202 (4%)

Query: 534 FDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRH 588
           F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
            H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++YL 
Sbjct: 69  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 126

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
              +  ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E  
Sbjct: 127 ---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Query: 709 RRQQLTEKSDVYSFGVVLFEIL 730
             +  T +SDV+S+GV ++E++
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 69/265 (26%), Positives = 123/265 (46%), Gaps = 27/265 (10%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G FG+VY+G  +     VAIK  +   +E  + + Q EI +LS+    ++    G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKP-PLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            +  ++ ++ +Y+  G+  + L    KP PL       I     +GL YLH+  K   IH
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK---IH 124

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+LL E+   K++DFG++  G   D         G+  ++ PE  ++     K+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECF 777
           D++S G+   E+    P  +   P   + L            + +   P L+G+ + + F
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLFL------------IPKNSPPTLEGQYS-KPF 229

Query: 778 KKFAETAMKCVSDQGIERPSMGDVL 802
           K+F E    C++     RP+  ++L
Sbjct: 230 KEFVEA---CLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 21/206 (10%)

Query: 534 FDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH 588
           F +  +LG GGFG+V   ++       A  K+  KR      +G      E ++L K+  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMALNEKQILEKVNS 59

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL----EICIGAARGL 644
           R +VSL    E    + LV   M  G L+ H+Y   +      + +    EIC G    L
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----L 115

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
             LH   +  I++RD+K  NILLD+    ++SD GL+   P    T    V  G+ GY+ 
Sbjct: 116 EDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQTIKGRV--GTVGYMA 169

Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
           PE  + ++ T   D ++ G +L+E++
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.9 bits (181), Expect = 4e-14
 Identities = 76/271 (28%), Positives = 123/271 (45%), Gaps = 36/271 (13%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ---TEIEMLSKLRHRHLVSLIG 596
           +G G FG VY          VA+K+ +   +Q   ++Q    E++ L +L+H + +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 597 -YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
            Y +E+    LV +Y   G+  + L +  K PL   +   I  GA +GL YLH+   H +
Sbjct: 89  CYLKEHTAW-LVMEY-CLGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNM 142

Query: 656 IHRDVKTTNILLDEKWVAKVSDFG-LSKTGPTLDHTHVSTVVKGSFGYLDPEY---FRRQ 711
           IHRD+K  NILL E    K++DFG  SK+ P       +    G+  ++ PE        
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEG 195

Query: 712 QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK 771
           Q   K DV+S G+   E+   +P L         ++   +A  H    + Q   P L+  
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPL--------FNMNAMSALYH----IAQNDSPTLQSN 243

Query: 772 IAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
              + F+ F +    C+     ERP+  ++L
Sbjct: 244 EWTDSFRGFVDY---CLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 16/208 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI-GYC 598
           LG G FGKVY+ +        A K  +  SE+ + ++  EI++L+   H ++V L+  + 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
            EN   IL+ ++ A G +   + + ++ PL   Q   +C      L+YLH   ++ IIHR
Sbjct: 73  YENNLWILI-EFCAGGAVDAVMLELER-PLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127

Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF-----RRQQL 713
           D+K  NIL       K++DFG+S           S +  G+  ++ PE       + +  
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 185

Query: 714 TEKSDVYSFGVVLFEILCARPA---LNP 738
             K+DV+S G+ L E+    P    LNP
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELNP 213

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 19/213 (8%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKR-----GNPLSEQGVHEFQTEIEMLSKLR 587
           N+    LLG G FG+VY         ++A+K+      +  + + V+  + EI++L  LR
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 588 HRHLVSLIGYCEENCE--MILVYDYMAYGTLREHL--YKTQKPPLPWKQRLEICIGAARG 643
           H  +V   G   +  E  + +  +YM  G++++ L  Y      +  +   +I     +G
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QG 118

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT--LDHTHVSTVVKGSFG 701
           + YLH+   + I+HRD+K  NIL D     K+ DFG SK   T  +  T + +V  G+  
Sbjct: 119 VSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-GTPY 174

Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           ++ PE    +    K+DV+S    + E+L  +P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 72.7 bits (178), Expect = 7e-14
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 17/204 (8%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKR---GNPLSEQGVHEFQTEIEMLSKLRHRH 590
           F +  +LG GGFG+V   ++       A KR         +G      E ++L K+  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL----EICIGAARGLHY 646
           +V+L    E    + LV   M  G L+ H+Y    P    ++ L    EI  G    L  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LED 117

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           LH   +   ++RD+K  NILLD+    ++SD GL+   P  +         G+ GY+ PE
Sbjct: 118 LH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPE 171

Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               Q+ T   D +  G +++E++
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 72.2 bits (177), Expect = 7e-14
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 13/199 (6%)

Query: 539 LLGVGGFGKVYRGEIDGATTK---VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           ++G G FG+V  G +     +   VAIK      +E+   +F +E  ++ +  H +++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
            G   ++  +++V +YM  G+L   L K         Q + +  G A G+ YL   +   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYL---SDMG 126

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKT---GPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
            +HRD+   NIL++   V KVSDFGLS+     P  +  + +   K    +  PE    +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTAPEAIAYR 184

Query: 712 QLTEKSDVYSFGVVLFEIL 730
           + T  SDV+S+G+V++E++
Sbjct: 185 KFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 29/215 (13%)

Query: 539 LLGVGGFGKVYR-GEIDGATTKVAIK----------RGNPLSEQGVHEFQTEIEMLSK-L 586
            LG G FG VY+  + +     +A+K          +     ++ + +  +E+ ++ + L
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL--YKTQKPPLP----WKQRLEICIGA 640
           RH ++V       EN  + +V D +    L EH    K +K        W   +++ +  
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK-TGPTLDHTHVSTVVKGS 699
              L YLH   +  I+HRD+   NI+L E     ++DFGL+K   P    + +++VV G+
Sbjct: 126 ---LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP---ESKLTSVV-GT 176

Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             Y  PE  + +   EK+DV++FG +L+++   +P
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 71.7 bits (175), Expect = 1e-13
 Identities = 75/278 (26%), Positives = 127/278 (45%), Gaps = 37/278 (13%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLV 592
           F+   L+G G +G+VY+G         AIK  +   ++   E + EI ML K   HR++ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 593 SLIG-YCEENC-----EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
           +  G + ++N      ++ LV ++   G++ + +  T+   L  +    IC    RGL +
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT--HVSTVVKGSFGYLD 704
           LH   +H +IHRD+K  N+LL E    K+ DFG+S     LD T    +T + G+  ++ 
Sbjct: 127 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFI-GTPYWMA 179

Query: 705 PEYFRRQQLTE-----KSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI 759
           PE     +  +     KSD++S G+   E+    P L    P   + L            
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------------ 227

Query: 760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS 797
           + +   P LK K   + F+ F E+   C+     +RP+
Sbjct: 228 IPRNPAPRLKSKKWSKKFQSFIES---CLVKNHSQRPT 262

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 50/165 (30%), Positives = 88/165 (53%), Gaps = 8/165 (4%)

Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L +    ++V   G    + E+ +  ++M  G+L + L + ++  +P +   ++ I
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSI 110

Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              RGL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D    S V  G
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV--G 164

Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           +  Y+ PE  +    + +SD++S G+ L E+   R  + P   KE
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 11/197 (5%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG+V++G ID  T +V   +   L  +E  + + Q EI +LS+    ++    G 
Sbjct: 12  IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +  ++ ++ +Y+  G+  + L   +  P    Q   +     +GL YLH+  K   IH
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLHSEKK---IH 124

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+LL E+   K++DFG++  G   D         G+  ++ PE  ++     K+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182

Query: 718 DVYSFGVVLFEILCARP 734
           D++S G+   E+    P
Sbjct: 183 DIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 28/232 (12%)

Query: 533 NFDEALLLGVGGFGKVY----RGEIDGAT---TKVAIKRGNPLSEQGVHEF-QTEIEMLS 584
           NF+   +LG G +GKV+     G  D       KV +K+   + +    E  +TE ++L 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKV-LKKATIVQKAKTAEHTRTERQVLE 59

Query: 585 KLRHR-HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-AR 642
            +R    LV+L    + + ++ L+ DY+  G L  HLY+ +         + + I     
Sbjct: 60  AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE---SEVRVYIAEIVL 116

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSF 700
            L +LH   +  II+RD+K  NILLD +    ++DFGLSK       +  +      G+ 
Sbjct: 117 ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTI 170

Query: 701 GYLDPEYFRRQQLTEKS--DVYSFGVVLFEILC-ARPALNPTLPKEQVSLAE 749
            Y+ PE  R          D +S GV+ FE+L  A P    T+  EQ S +E
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF---TVDGEQNSQSE 219

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 12/197 (6%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQ-TEIEMLSKLRHRHLVSLIGY 597
           +G G  G VY   ID AT  +VAIK+ N L +Q   E    EI ++ + +H ++V+ +  
Sbjct: 27  IGQGASGTVYTA-IDVATGQEVAIKQMN-LQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
                E+ +V +Y+A G+L + + +T    +   Q   +C    + L +LH+   + +IH
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHS---NQVIH 138

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K+ NILL      K++DFG      T + +  ST+V G+  ++ PE   R+    K 
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 718 DVYSFGVVLFEILCARP 734
           D++S G++  E++   P
Sbjct: 197 DIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 71.6 bits (175), Expect = 3e-13
 Identities = 50/165 (30%), Positives = 87/165 (52%), Gaps = 8/165 (4%)

Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L +    ++V   G    + E+ +  ++M  G+L + L K  +  +P +   ++ I
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 110

Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              +GL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D    S V  G
Sbjct: 111 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV--G 164

Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           +  Y+ PE  +    + +SD++S G+ L E+   R  + P   KE
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.4 bits (175), Expect = 3e-13
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 21/201 (10%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS-KLRHRHLVSL 594
           +LG G FGKV   E+ G     AIK   +   L +  V     E  +L+    H  L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 595 IGYC--EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL---EICIGAARGLHYLHT 649
             +C  +    +  V +Y+  G L  H+  + +     + R    EI  G    L +LH 
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE-ARARFYAAEIICG----LQFLH- 113

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             K  II+RD+K  N+LLD+    K++DFG+ K     +    ++   G+  Y+ PE  +
Sbjct: 114 --KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILK 169

Query: 710 RQQLTEKSDVYSFGVVLFEIL 730
            Q+  E  D +SFGV+L+E+L
Sbjct: 170 GQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 71.2 bits (174), Expect = 4e-13
 Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 11/200 (5%)

Query: 539 LLGVGGFGKVY--RGEIDGA--TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           ++G G FGKV   + ++DG     KV  K+     ++  H       +L  ++H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
               +   ++  V D++  G L  HL + +  P P  +     I +A G  YLH+     
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS---IN 116

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           I++RD+K  NILLD +    ++DFGL K G     T  +T   G+  YL PE  R+Q   
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPYD 174

Query: 715 EKSDVYSFGVVLFEILCARP 734
              D +  G VL+E+L   P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 70.3 bits (172), Expect = 4e-13
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 30/226 (13%)

Query: 540 LGVGGFGKVYRGEIDGAT--TKVAIKR----GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           +G G FGKV  GE        +V +K       P  EQ    F  E++   +L H +++ 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATP-DEQ--LLFLQEVQPYRELNHPNVLQ 59

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYK-----TQKPPLPWKQRLEICIGAARGLHYLH 648
            +G C E+   +LV ++   G L+ +L        Q       QR+   +  A GL +LH
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV--ASGLLWLH 117

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
              +   IH D+   N  L      K+ D+GL+      D+            +L PE  
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174

Query: 709 --RRQQL-----TEKSDVYSFGVVLFEI--LCARPALNPTLPKEQV 745
             R Q L     T+KS+++S GV ++E+     +P   P L  EQV
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQV 218

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 71.3 bits (174), Expect = 4e-13
 Identities = 63/200 (31%), Positives = 94/200 (47%), Gaps = 14/200 (7%)

Query: 539 LLGVGGFGKV--YRGEIDGATTKVAI-KRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LLG G FGKV   R +  G    + I K+   +++  V    TE  +L   RH  L SL 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--ARGLHYLHTGAKH 653
              +    +  V +Y+  G L  HL + +     + +      GA     L YLH+G   
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSG--- 114

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            I++RD+K  N++LD+    K++DFGL K G T D   + T   G+  YL PE       
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKTFC-GTPEYLAPEVLEDNDY 172

Query: 714 TEKSDVYSFGVVLFEILCAR 733
               D +  GVV++E++C R
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 12/198 (6%)

Query: 539 LLGVGGFGKVYRG--EIDGATTK--VAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           +LG G FG VY+G    DG   K  VAIK  R N  S +   E   E  +++ +   ++ 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72

Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            L+G C  +  + LV   M YG L +++ +  K  +  +  L  C+  A+G+ YL    +
Sbjct: 73  RLLGICLTS-TVQLVTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYLE---E 127

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             ++HRD+   N+L+      K++DFGL++     +  + +   K    ++  E    ++
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187

Query: 713 LTEKSDVYSFGVVLFEIL 730
            T +SDV+S+GV ++E++
Sbjct: 188 FTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 70.8 bits (173), Expect = 4e-13
 Identities = 67/202 (33%), Positives = 93/202 (46%), Gaps = 23/202 (11%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS-KLRHRHLVSL 594
           +LG G FGKV+  E+ G     AIK   +   L +  V     E  +LS    H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 595 IGYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGAARGLHYLH 648
             YC    +EN  +  V +Y+  G L  H+    K  LP       EI  G    L +LH
Sbjct: 62  --YCTFQTKEN--LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLH 113

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
           +     I++RD+K  NILLD     K++DFG+ K    L      T   G+  Y+ PE  
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN-MLGDAKTCTFC-GTPDYIAPEIL 168

Query: 709 RRQQLTEKSDVYSFGVVLFEIL 730
             Q+     D +SFGV+L+E+L
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 16/159 (10%)

Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEIC- 637
           E++++ + R  ++VS  G       + +  ++M  G+L + +YK   P       +EI  
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGP-----IPVEILG 106

Query: 638 ---IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST 694
              +    GL YL+    H I+HRD+K +NIL++ +   K+ DFG+S     L ++   T
Sbjct: 107 KIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADT 161

Query: 695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
            V G+  Y+ PE  +  + T KSDV+S G+ + E+   +
Sbjct: 162 FV-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FGKVY+ +        A K     SE+ + ++  EIE+L+   H ++V L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
            + ++ ++ ++   G +   + +  +  L   Q   IC      L YLH+     IIHRD
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHS---MKIIHRD 135

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE---- 715
           +K  N+LL      K++DFG+S           S +  G+  ++ PE    + + +    
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETMKDTPYD 193

Query: 716 -KSDVYSFGVVLFEILCARPA---LNP 738
            K+D++S G+ L E+    P    LNP
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHELNP 220

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 70.6 bits (173), Expect = 5e-13
 Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 20/201 (9%)

Query: 539 LLGVGGFGKVY-----RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           +LG G FGKV+      G   G    + + +   L  +     + E ++L+++ H  +V 
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYK----TQKPPLPWKQRLEICIGAARGLHYLHT 649
           L    +   ++ L+ D++  G L   L K    T++    +   L      A  L +LH+
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL------ALALDHLHS 116

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
                II+RD+K  NILLDE+   K++DFGLSK   ++DH   +    G+  Y+ PE   
Sbjct: 117 LG---IIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVN 171

Query: 710 RQQLTEKSDVYSFGVVLFEIL 730
           R+  T+ +D +SFGV++FE+L
Sbjct: 172 RRGHTQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 69.9 bits (172), Expect = 7e-13
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 30/208 (14%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--------EIEMLSKL-RHRH 590
           LG G FG VY          VAIK+          +F +        E++ L KL  H +
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP-PLPWKQRLEICIGAARGLHYLHT 649
           +V L     EN E+  V++YM  G L   L K +K  P        I     +GL ++H 
Sbjct: 60  IVKLKEVFRENDELYFVFEYME-GNLY-QLMKDRKGKPFSESVIRSIIYQILQGLAHIH- 116

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK-TGPTLDHT-HVSTVVKGSFGYLDPEY 707
             KH   HRD+K  N+L+    V K++DFGL++       +T +VST       Y  PE 
Sbjct: 117 --KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEI 169

Query: 708 FRRQQL-TEKSDVYSFGVVLFEILCARP 734
             R    +   D+++ G ++ E+   RP
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRP 197

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 69.9 bits (172), Expect = 7e-13
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 44/216 (20%)

Query: 543 GGFGKVYRGEIDGATTK-VAIKR--------GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           G +G VYR   D  T + VA+K+        G P++         EI +L KL+H ++V+
Sbjct: 16  GTYGVVYRAR-DKKTGEIVALKKLKMEKEKEGFPITSL------REINILLKLQHPNIVT 68

Query: 594 L----IGYCEENCEMI-LVYDYMAYGTLREH----LYKTQKPPLPWKQRLEICIGAARGL 644
           +    +G    N + I +V +Y+      EH    L +T K P    +   + +    G+
Sbjct: 69  VKEVVVG---SNLDKIYMVMEYV------EHDLKSLMETMKQPFLQSEVKCLMLQLLSGV 119

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTHVSTVVKGSFGY 702
            +LH    + I+HRD+KT+N+LL+ + + K+ DFGL++    P   +T +  VV  +  Y
Sbjct: 120 AHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL--VV--TLWY 172

Query: 703 LDPE-YFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
             PE     ++ +   D++S G +  E+L  +P   
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 70.1 bits (171), Expect = 7e-13
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 21/211 (9%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ---TEIEMLSKLRHRH 590
           F +   +G G FG VY          VAIK+ +   +Q   ++Q    E++ L +++H +
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 591 LVSLIG-YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
            +   G Y  E+    LV +Y   G+  + L +  K PL   +   I  GA +GL YLH+
Sbjct: 87  SIEYKGCYLREHTAW-LVMEY-CLGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFG-LSKTGPTLDHTHVSTVVKGSFGYLDPEY- 707
              H +IHRD+K  NILL E    K++DFG  S   P       +    G+  ++ PE  
Sbjct: 144 ---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------ANSFVGTPYWMAPEVI 193

Query: 708 --FRRQQLTEKSDVYSFGVVLFEILCARPAL 736
                 Q   K DV+S G+   E+   +P L
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 28/209 (13%)

Query: 540 LGVGGFGKVYRG----EIDGA---TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           LG G F K+++G      D      T+V +K  +         F     M+S+L H+HLV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQ-KPPLPWKQRLEICIGAARGLHYLHTGA 651
              G C    E I+V +Y+ +G+L  +L K +    + WK  LE+    A  LH+L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLE--- 117

Query: 652 KHTIIHRDVKTTNILL----DEKW----VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
              + H +V   N+LL    D K       K+SD G+S T    +      ++     ++
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE------ILLERIPWV 171

Query: 704 DPEYFRR-QQLTEKSDVYSFGVVLFEILC 731
            PE     Q L+  +D +SFG  L+EI  
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 75/283 (26%), Positives = 123/283 (43%), Gaps = 37/283 (13%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLV 592
           F+   ++G G +G+VY+G         AIK  + ++E    E + EI ML K   HR++ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 593 SLIGYCEENC------EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
           +  G   +        ++ LV ++   G++ + +  T+   L       IC    RGL +
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT--HVSTVVKGSFGYLD 704
           LH    H +IHRD+K  N+LL E    K+ DFG+S     LD T    +T + G+  ++ 
Sbjct: 137 LHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFI-GTPYWMA 189

Query: 705 PEYFRRQQLTE-----KSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI 759
           PE     +  +     +SD++S G+   E+    P L    P   + L            
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL------------ 237

Query: 760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
           + +   P LK K   + F  F E    C+    + RPS   +L
Sbjct: 238 IPRNPPPKLKSKKWSKKFIDFIEG---CLVKNYLSRPSTEQLL 277

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 34/220 (15%)

Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RH 588
            T  F+   ++G G +GKVY+         VAIK  + + ++   E + E  +L K   H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNH 62

Query: 589 RHLVSLIG-------YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE------ 635
            ++ +  G          ++ ++ LV +    G++ + +   +K      +RL+      
Sbjct: 63  PNIATFYGAFIKKNPPGNDD-QLWLVMELCGGGSVTDLVKGLRKKG----KRLKEEWIAY 117

Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT--HVS 693
           I     RGL YLH   ++ +IHRD+K  NILL +    K+ DFG+S     LD T    +
Sbjct: 118 ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTLGRRN 171

Query: 694 TVVKGSFGYLDPE-----YFRRQQLTEKSDVYSFGVVLFE 728
           T + G+  ++ PE              +SDV+S G+   E
Sbjct: 172 TFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 65/251 (25%), Positives = 106/251 (42%), Gaps = 51/251 (20%)

Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--------GNPLSEQGVHEFQTEIE 581
              +++    LG G FG+VY+         VA+K+        G P++         EI+
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL------REIK 59

Query: 582 MLSKLRHRHLVSLI--------GYCEENCEMILVYDYMAY---GTLREHLYKTQKPPLP- 629
           +L KL+H ++V LI            +   + +V  YM +   G L     K  +  +  
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC 119

Query: 630 -WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK------ 682
              Q LE       G++YLH    H I+HRD+K  NIL+D + + K++DFGL++      
Sbjct: 120 YMLQLLE-------GINYLH--ENH-ILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169

Query: 683 -----TGPTLDHTHVSTVVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEILCARPAL 736
                 G      + + VV  +  Y  PE     ++ T   D++  G V  E+   RP L
Sbjct: 170 PNPKGGGGGGTRKYTNLVV--TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227

Query: 737 NPTLPKEQVSL 747
                 +Q+ L
Sbjct: 228 QGKSDIDQLHL 238

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 47/201 (23%)

Query: 547 KVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL 606
           K    E D    K+A++               EI ML +LRH +LV+LI        + L
Sbjct: 33  KFLESEDDKMVKKIAMR---------------EIRMLKQLRHENLVNLIEVFRRKKRLYL 77

Query: 607 VYDYMAYGTLREHLYKTQKPP--LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTN 664
           V++++ +  L +     +K P  L   +  +      RG+ + H+   H IIHRD+K  N
Sbjct: 78  VFEFVDHTVLDD----LEKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPEN 130

Query: 665 ILLDEKWVAKVSDFGLSKT--GPTLDHT-HVST--------VVKGSFGYLDPEYFRRQQL 713
           IL+ +  V K+ DFG ++T   P   +T +V+T        +V       D +Y R    
Sbjct: 131 ILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG------DTKYGR---- 180

Query: 714 TEKSDVYSFGVVLFEILCARP 734
               D+++ G ++ E+L   P
Sbjct: 181 --AVDIWAVGCLVTEMLTGEP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 36/211 (17%)

Query: 540 LGVGGFGKVYR------GEIDGATTKVAIKR-----GNPLSEQGVHEFQT-EIEMLSKLR 587
           +G G +G V++      G+I      VAIK+      +P+    + +    EI ML +L+
Sbjct: 9   IGEGSYGVVFKCRNRETGQI------VAIKKFVESEDDPV----IKKIALREIRMLKQLK 58

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H +LV+LI       ++ LV++Y  +  L E L K  +  +P     +I     + +++ 
Sbjct: 59  HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRG-VPEHLIKKIIWQTLQAVNFC 116

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHT-HVSTVVKGSFGYLD 704
           H   KH  IHRDVK  NIL+ ++   K+ DFG ++  TGP  D+T +V+T       Y  
Sbjct: 117 H---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRA 168

Query: 705 PEYF-RRQQLTEKSDVYSFGVVLFEILCARP 734
           PE      Q     DV++ G V  E+L  +P
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEM---LSKLRHR--HLVS 593
            +G G  G+VY+         +A+K+   +   G  E    I M   +    H   ++V 
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQ---MRRTGNKEENKRILMDLDVVLKSHDCPYIVK 78

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
             GY   + ++ +  + M+  T  + L K  + P+P     ++ +   + LHYL    KH
Sbjct: 79  CYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KH 134

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            +IHRDVK +NILLD     K+ DFG+S  G  +D +   T   G   Y+ PE       
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCAAYMAPERIDPPDP 191

Query: 714 TEK----SDVYSFGVVLFEI 729
             K    +DV+S G+ L E+
Sbjct: 192 NPKYDIRADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 23/207 (11%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEI------EMLSKLR 587
           F    +LG GGFG+V   ++       A K+   L ++ + + + E       ++L K+ 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKK---LEKKRIKKRKGEAMALNEKQILEKVN 58

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL----EICIGAARG 643
            R +VSL    E    + LV   M  G L+ H+Y    P    ++ +    EI  G    
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG---- 114

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           L  LH   +  I++RD+K  NILLD+    ++SD GL+   P  +   +   V G+ GY+
Sbjct: 115 LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETIRGRV-GTVGYM 168

Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            PE  + ++ T   D +  G +++E++
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS-KLRHRHLVSL 594
           +LG G FGKV   E+ G     AIK   +   L +  V    TE  +L+   +H  L +L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
               +    +  V +Y+  G L   + +++K   P  +     +  A  L +LH    H 
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--LMFLHR---HG 116

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           +I+RD+K  NILLD +   K++DFG+ K G     T  +T   G+  Y+ PE  +  +  
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELEYG 174

Query: 715 EKSDVYSFGVVLFEILCARP 734
              D ++ GV+++E++  +P
Sbjct: 175 PSVDWWALGVLMYEMMAGQP 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 24/209 (11%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKR---GNPLSEQGVHEFQTEIEMLSKLRHR 589
           NF     +G G F +VYR         VA+K+    + +  +   +   EI++L +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHL--YKTQKPPLP----WKQRLEICIGAARG 643
           +++       E+ E+ +V +    G L   +  +K QK  +P    WK  +++C      
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKGSF 700
           L ++H+     ++HRD+K  N+ +    V K+ D GL +   +  T  H+ V T      
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY---- 171

Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEI 729
            Y+ PE         KSD++S G +L+E+
Sbjct: 172 -YMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 4e-12
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 33/213 (15%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSL- 594
            +G G +G V        T  KVAIK+ +P   Q     +T  EI++L + +H +++ + 
Sbjct: 12  YIGEGAYGMVCSA-THKPTGVKVAIKKISPFEHQ-TFCQRTLREIKILRRFKHENIIGIL 69

Query: 595 -----IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL---EICI---GAARG 643
                  +   N ++ +V + M        LYK  K      Q L    I        RG
Sbjct: 70  DIIRPPSFESFN-DVYIVQELM-----ETDLYKLIK-----TQHLSNDHIQYFLYQILRG 118

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK-TGPTLDHTHVSTVVKGSFGY 702
           L Y+H+     ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y
Sbjct: 119 LKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175

Query: 703 LDPEYFRRQQLTEKS-DVYSFGVVLFEILCARP 734
             PE     +   K+ D++S G +L E+L  RP
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 43/223 (19%)

Query: 532 NNFDEALLLGVGGFGKVYR------GEIDGATTKVAIK--RGNPLSEQGVHEF-QTEIEM 582
           N ++   ++G G +G V +      GEI      VAIK  + +   E  V +    E+++
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEI------VAIKKFKESEDDED-VKKTALREVKV 53

Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR 642
           L +LRH ++V+L         + LV++Y+   TL E L  +     P   R  I     +
Sbjct: 54  LRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYI-WQLLQ 111

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT---GPTLDHT-HVSTVVKG 698
            + Y H    H IIHRD+K  NIL+ E  V K+ DFG ++     P    T +V+T    
Sbjct: 112 AIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVAT---- 164

Query: 699 SFGYLDPEYFRRQQLTEKS-------DVYSFGVVLFEILCARP 734
                   ++R  +L           DV++ G ++ E+L   P
Sbjct: 165 -------RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 68.0 bits (166), Expect = 4e-12
 Identities = 45/131 (34%), Positives = 66/131 (50%), Gaps = 10/131 (7%)

Query: 603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLHYLHTGAKHTIIHRDVK 661
           ++ LV DYM+ G L  HL K  +     + R +  I      L +LH   K+ I++RD+K
Sbjct: 70  DLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLH---KYDIVYRDLK 123

Query: 662 TTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ-LTEKSDVY 720
             NILLD      + DFGLSK    L     +    G+  YL PE    ++  T+  D +
Sbjct: 124 PENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFW 181

Query: 721 SFGVVLFEILC 731
           S GV++FE+ C
Sbjct: 182 SLGVLVFEMCC 192

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 11/200 (5%)

Query: 539 LLGVGGFGKVY--RGEIDGA--TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           ++G G FGKV   + + DG+    KV  K+     ++  H       +L  L+H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
               +   ++  V DY+  G L  HL + +    P  +     + +A G  YLH+     
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG--YLHS---LN 116

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           II+RD+K  NILLD +    ++DFGL K G   + T  ++   G+  YL PE  R++   
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKEPYD 174

Query: 715 EKSDVYSFGVVLFEILCARP 734
              D +  G VL+E+L   P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 6e-12
 Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 43/237 (18%)

Query: 532 NNFDEALLLGVGGFGKVY--RGEIDGA--TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR 587
           ++F+   ++G G FG+V+  R +  G     KV  K       Q  H  + E ++L+   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADAD 59

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL--EICIGAARGLH 645
              +V L    ++   + LV +YM  G L   L +    P    +    E+    A  L 
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV--LA--LD 115

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK----------------------- 682
            +H   K   IHRD+K  NIL+D     K++DFGL K                       
Sbjct: 116 SVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 683 -----TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
                          ++ V G+  Y+ PE  R      + D +S GV+L+E+L   P
Sbjct: 173 VLVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 44/142 (30%), Positives = 61/142 (42%), Gaps = 19/142 (13%)

Query: 606 LVYDYMAYGTLREHLYKTQKP-PLPWKQRLEICIGAAR---GLHYLHTGAKHTIIHRDVK 661
           LV +Y+  G     L KT    P  W          A    G+  LH   +  IIHRD+K
Sbjct: 74  LVMEYLNGGDC-ASLIKTLGGLPEDW-----AKQYIAEVVLGVEDLH---QRGIIHRDIK 124

Query: 662 TTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYS 721
             N+L+D+    K++DFGLS+ G        +    G+  YL PE        + SD +S
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWS 178

Query: 722 FGVVLFEILCARPALNPTLPKE 743
            G V+FE L   P  +   P  
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.6 bits (166), Expect = 6e-12
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 53/224 (23%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLI 595
            +G G +G V    +D  T  KVAIK+ + + +  +   +   EI++L  LRH +++ L+
Sbjct: 7   PIGSGAYGVVCSA-VDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 596 ------GYCEENCEMILVYDYMAYGTLREH-LYKTQKPPLPWKQRLE----------ICI 638
                    + N ++ +V + M      E  L+K  K P    Q L           I  
Sbjct: 66  DILRPPSPEDFN-DVYIVTELM------ETDLHKVIKSP----QPLTDDHIQYFLYQIL- 113

Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVK 697
              RGL YLH+     +IHRD+K +NIL++     K+ DFGL++   P  D     T   
Sbjct: 114 ---RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT--- 164

Query: 698 GSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEILCARP 734
               Y+   ++R         + T+  D++S G +  E+L  +P
Sbjct: 165 ---EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 66.9 bits (163), Expect = 7e-12
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 23/207 (11%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ------TEIEMLSKLR 587
           F    +LG GGFG+V   ++       A K+   L ++ + + +       E  +L K+ 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKK---LEKKRIKKRKGEAMALNEKRILEKVN 58

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL----EICIGAARG 643
            R +VSL    E    + LV   M  G L+ H+Y    P    ++ +    E+C G    
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG---- 114

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           L  L    +  I++RD+K  NILLD++   ++SD GL+   P  +         G+ GY+
Sbjct: 115 LEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYM 168

Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            PE    ++ T   D +  G +++E++
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.9 bits (163), Expect = 7e-12
 Identities = 58/232 (25%), Positives = 106/232 (45%), Gaps = 39/232 (16%)

Query: 540 LGVGGFGKVYRGEIDG----------------ATTKVAIK--RGNPLSEQGVHEFQTEIE 581
           LG G FG+V+  E +G                    VA+K  R +  ++   ++F  EI+
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIK 71

Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL---------YKTQKPPLPWKQ 632
           ++S+L+  +++ L+  C  +  + ++ +YM  G L + L          K     + +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 633 RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV 692
            + +    A G+ YL   +    +HRD+ T N L+ + +  K++DFG+S+   + D+  +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ 744
                    ++  E     + T  SDV++FGV L+EIL        TL KEQ
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL--------TLCKEQ 232

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 66.7 bits (162), Expect = 8e-12
 Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 8/195 (4%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G  G V+         +VAIK+ N   +        EI ++ +L++ ++V+ +    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
              E+ +V +Y+A G+L + + +T    +   Q   +C    + L +LH    + +IHRD
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA---NQVIHRD 140

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +K+ N+LL      K++DFG      T + +  ST+V G+  ++ PE   R+    K D+
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198

Query: 720 YSFGVVLFEILCARP 734
           +S G++  E++   P
Sbjct: 199 WSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 67.0 bits (164), Expect = 8e-12
 Identities = 65/240 (27%), Positives = 97/240 (40%), Gaps = 63/240 (26%)

Query: 532 NNFDEALLLGVGGFGKVY------RGEIDGATTKVAIKRGNPLSEQGVHEFQ------TE 579
            +F     +G GG+G+V+       GEI      VA+KR   + +  + +        TE
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEI------VALKR---MKKSLLFKLNEVRHVLTE 51

Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY-------------GTLREH---LYKT 623
            ++L+  +   LV L+ Y  ++ E +  Y  M Y             G L E     Y  
Sbjct: 52  RDILTTTKSEWLVKLL-YAFQDDEYL--YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA 108

Query: 624 QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT 683
           +               A   LH L        IHRD+K  N L+D     K++DFGLSK 
Sbjct: 109 EM------------FEAVDALHEL------GYIHRDLKPENFLIDASGHIKLTDFGLSKG 150

Query: 684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
             T  ++ V     GS  Y+ PE  R +      D +S G +L+E LC  P  + + P E
Sbjct: 151 IVTYANSVV-----GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 9e-12
 Identities = 58/190 (30%), Positives = 82/190 (43%), Gaps = 25/190 (13%)

Query: 554 DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI-GYCEEN--CEMILVYDY 610
           D    KV +K        G      EI++L  + HR +++LI  Y  ++  C ++  Y  
Sbjct: 116 DEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC 170

Query: 611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK 670
             +       Y  +  PLP +Q + I       L YLH      IIHRDVKT NI LDE 
Sbjct: 171 DLF------TYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEP 221

Query: 671 WVAKVSDFGLS-KTGPTLDHTHVSTVVKGSFGYLD---PEYFRRQQLTEKSDVYSFGVVL 726
             A + DFG + K      H   +    G  G L+   PE         K+D++S G+VL
Sbjct: 222 ENAVLGDFGAACKLD---AHPD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVL 277

Query: 727 FEILCARPAL 736
           FE+      L
Sbjct: 278 FEMSVKNVTL 287

Length = 392

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 67.0 bits (163), Expect = 1e-11
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 539 LLGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           ++G G FGKV    ++ E      KV  K+     ++  H       +L  ++H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
               +   ++  V DY+  G L  HL + +    P  +     I +A G  YLH+     
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG--YLHS---LN 116

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           I++RD+K  NILLD +    ++DFGL K    ++H   ++   G+  YL PE   +Q   
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174

Query: 715 EKSDVYSFGVVLFEILCARP 734
              D +  G VL+E+L   P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 21/201 (10%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           ++G G FG+    +   +  K A+K    P S   V + + E  +L+K++H ++V+    
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL-----EICIGAARGLHYLHTGAK 652
            E +  + +V +Y   G L + + K Q+  L  +  +     ++C+G    + ++H   +
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKI-KLQRGKLFPEDTILQWFVQMCLG----VQHIH---E 118

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
             ++HRD+K+ NI L +    K+ DFG ++  T P     +  T V G+  Y+ PE +  
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV-GTPYYVPPEIWEN 174

Query: 711 QQLTEKSDVYSFGVVLFEILC 731
                KSD++S G +L+E LC
Sbjct: 175 MPYNNKSDIWSLGCILYE-LC 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 28/254 (11%)

Query: 533 NFDEALLLGVGGFGKVYR-GEIDGATT------KVAIKRGNPLSEQGVHEFQTEIEMLSK 585
           NF+   +LG G +GKV+   ++ G  T      KV  K       + V   +TE  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 586 LRHR-HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA-RG 643
           +R    LV+L    +   ++ L+ DY++ G +  HLY+        +  +    G     
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILA 117

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           L +LH   K  I++RD+K  NILLD +    ++DFGLSK   + +     +   G+  Y+
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYM 173

Query: 704 DPEYFRRQQLTEKS-DVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILE 761
            PE  R +    K+ D +S G+++FE+L  A P    TL  E+ + +E +     + IL+
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPF---TLEGERNTQSEVS-----RRILK 225

Query: 762 QIMDPYLKGKIAPE 775
              DP     I PE
Sbjct: 226 --CDPPFPSFIGPE 237

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 11/197 (5%)

Query: 539 LLGVGGFGKVY--RGEIDGATTKVAI-KRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +LG G FGKV   R +  G    V + K+   L +  V    TE  +LS  R+   ++ +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 596 GYCEENCE-MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
             C +  + +  V +++  G L  H+ K+++      +     I +A  L +LH      
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--LMFLHDKG--- 116

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           II+RD+K  N+LLD +   K++DFG+ K G   +    ST   G+  Y+ PE  +     
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEG-IFNGKTTSTFC-GTPDYIAPEILQEMLYG 174

Query: 715 EKSDVYSFGVVLFEILC 731
              D ++ GV+L+E+LC
Sbjct: 175 PSVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 24/209 (11%)

Query: 540 LGVGGFGKVYRG-EIDGATTKVAIKR--------GNPLSEQGVHEFQTEIEMLSKLRHRH 590
           +G G +GKV++  ++      VA+KR        G PLS   + E    +  L    H +
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST--IREVAV-LRHLETFEHPN 65

Query: 591 LVSLIGYC-----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           +V L   C     +   ++ LV++++    L  +L K  +P +P +   ++     RGL 
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           +LH+   H ++HRD+K  NIL+      K++DFGL++           T V  +  Y  P
Sbjct: 125 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAP 178

Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E   +       D++S G +  E+   +P
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 66/262 (25%), Positives = 104/262 (39%), Gaps = 36/262 (13%)

Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIE--MLSKL 586
            A+  +     L  G  G+V+     G    V +K G   +        T IE  +L  +
Sbjct: 63  VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNV 114

Query: 587 RHRHLVSL---IGYCEENCEMILVY--DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
            H  ++ +   +      C ++  Y  D   Y T R         PLP  Q L I     
Sbjct: 115 NHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSR-------PLPIDQALIIEKQIL 167

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
            GL YLH      IIHRDVKT NI +++     + D G ++  P +    +   + G+  
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVE 221

Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE 761
              PE   R +   K+D++S G+VLFE+L A P  +        +  E+   CH      
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEML-AYP--STIFEDPPSTPEEYVKSCHS----- 273

Query: 762 QIMDPYLKGKIAPECFKKFAET 783
            ++      K+ PE F +   +
Sbjct: 274 HLLKIISTLKVHPEEFPRDPGS 295

Length = 357

>gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 31/152 (20%), Positives = 60/152 (39%), Gaps = 19/152 (12%)

Query: 223 VYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPV 282
           V  +N GG + + S        +  D  +  G+A         + T    S   +     
Sbjct: 2   VLAINCGGPEHTDSDGIT----YEADTYFTGGSA-----DYYVSDTNGSSSI--AGTTDP 50

Query: 283 DVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNN 342
           ++Y T R   P    + +Y    +  +++G +Y V LHF E+      + +RVFD+ +  
Sbjct: 51  ELYQTER-YSP---SSFSYY---IPCLENG-NYTVILHFAEIYFGEDGLGRRVFDVYVQG 102

Query: 343 QTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNG 374
           +     FD+     G G   ++++      +G
Sbjct: 103 KLVLKDFDIVAEAGGKGKTAHKEYIPVTVTDG 134

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 14/200 (7%)

Query: 539 LLGVGGFGKV--YRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LLG G FGKV   R +  G    + I R   + ++  V    TE  +L   RH  L +L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--ARGLHYLHTGAKH 653
              + +  +  V +Y   G L  HL + +     + +      GA     L YLH+    
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHS---R 114

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            +++RD+K  N++LD+    K++DFGL K G + D   + T   G+  YL PE       
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFC-GTPEYLAPEVLEDNDY 172

Query: 714 TEKSDVYSFGVVLFEILCAR 733
               D +  GVV++E++C R
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.6 bits (160), Expect = 3e-11
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 47/229 (20%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR--------GNPLSEQ-----GVHEFQT--EIEMLS 584
           LG G +GKV +         VAIK+              Q     G+H F T  E+++++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH-FTTLRELKIMN 75

Query: 585 KLRHRHLVSLIG-YCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR 642
           +++H +++ L+  Y E   + I LV D MA   L++ +   +K  L   Q   I +    
Sbjct: 76  EIKHENIMGLVDVYVEG--DFINLVMDIMAS-DLKKVV--DRKIRLTESQVKCILLQILN 130

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK----------------TGPT 686
           GL+ LH   K   +HRD+   NI ++ K + K++DFGL++                    
Sbjct: 131 GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 687 LDHTHVSTVVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEILCARP 734
            + T  S VV  +  Y  PE     ++     D++S G +  E+L  +P
Sbjct: 188 EEMT--SKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232

Length = 335

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 11/198 (5%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLIG 596
           LGVGGFG+V   ++       A+K      + E G  E   +E E+L +  H  +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
             ++   + ++ +Y   G L   L           +    C+  A    YLH      II
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLA--FEYLHN---RGII 115

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           +RD+K  N+LLD     K+ DFG +K   +   T   T   G+  Y+ PE    +     
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGYDFS 172

Query: 717 SDVYSFGVVLFEILCARP 734
            D +S G++L+E+L  RP
Sbjct: 173 VDYWSLGILLYELLTGRP 190

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 33/159 (20%)

Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST 694
           +I +   + L YLH+  K ++IHRDVK +N+L++     K+ DFG+S  G  +D +   T
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVD-SVAKT 161

Query: 695 VVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEILCAR-PALN------------ 737
           +  G   Y+ PE       ++    KSDV+S G+ + E+   R P  +            
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221

Query: 738 ----PTLPKEQVSL--AEWAAHC-----HKKGILEQIMD 765
               P LP E+ S    ++   C      ++    +++ 
Sbjct: 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 65.2 bits (159), Expect = 4e-11
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 10/198 (5%)

Query: 539 LLGVGGFGKVY--RGEIDGATTKVAI-KRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LLG G FGKV   R +  G    + I K+   +++  V    TE  +L   RH  L +L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
              + +  +  V +Y   G L  HL + +       +     I +A  L YLH+     +
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYLHSC---DV 116

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE 715
           ++RD+K  N++LD+    K++DFGL K G +   T + T   G+  YL PE         
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFC-GTPEYLAPEVLEDNDYGR 174

Query: 716 KSDVYSFGVVLFEILCAR 733
             D +  GVV++E++C R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 4e-11
 Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 32/163 (19%)

Query: 541 GVGGFGKVYRGE-IDGATTKV-AIKRGNPLSEQGVHEFQT---EIEMLSKLRHRHLVSLI 595
           G G +G+VY+ +  +G   K  AIK+     EQ     Q+   EI +L +L+H ++VSL+
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 596 GYCEENCEMI--LVYDYMAYGTLR--EHLYKTQKPPLP--------WKQRLEICIGAARG 643
               E+ +    L++DY  +   +  +   + ++  +P        W Q L        G
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-QILN-------G 120

Query: 644 LHYLHTGAKHTIIHRDVKTTNILL----DEKWVAKVSDFGLSK 682
           +HYLH+   + ++HRD+K  NIL+     E+ V K+ D GL++
Sbjct: 121 VHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.5 bits (157), Expect = 5e-11
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 19/201 (9%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI- 595
           LG G FG+V   +  G     AIK   +   L  + V     E  +L +L H  +V+++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGAARGLHYLHTGAKH 653
            + +EN  +  + +++  G L  HL K  + P    +    E+ +       YLH+    
Sbjct: 86  SFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEYLHS---K 137

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            II+RD+K  N+LLD K   KV+DFG +K  P    T     + G+  YL PE  + +  
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQSKGH 192

Query: 714 TEKSDVYSFGVVLFEILCARP 734
            +  D ++ GV+L+E +   P
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYP 213

Length = 329

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.9 bits (156), Expect = 7e-11
 Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 8/91 (8%)

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
           + L+YL    +  IIHRDVK +NILLD     K+ DFG+S     L  +   T   G   
Sbjct: 118 KALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRP 172

Query: 702 YLDPEY---FRRQQLTEKSDVYSFGVVLFEI 729
           Y+ PE      R     +SDV+S G+ L+E+
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.2 bits (156), Expect = 7e-11
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 11/209 (5%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHR 589
           +F+  ++LG G FGKV   E  G     AIK   +   + +  V     E  +L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 590 HLVSLIGYCEENCE-MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
             ++ +  C +  + +  V +Y+  G L  H+ +  K   P  Q +      + GL +LH
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP--QAVFYAAEISVGLFFLH 118

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
              +  II+RD+K  N++LD +   K++DFG+ K    +D     T   G+  Y+ PE  
Sbjct: 119 ---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH-MVDGVTTRTFC-GTPDYIAPEII 173

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARPALN 737
             Q   +  D +++GV+L+E+L  +P  +
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.0 bits (155), Expect = 7e-11
 Identities = 59/197 (29%), Positives = 104/197 (52%), Gaps = 12/197 (6%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQ-TEIEMLSKLRHRHLVSLIGY 597
           +G G  G VY   ID AT  +VAIK+ N L +Q   E    EI ++ + ++ ++V+ +  
Sbjct: 27  IGQGASGTVYTA-IDIATGQEVAIKQMN-LQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
                E+ +V +Y+A G+L + + +T    +   Q   +C    + L +LH+   + +IH
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS---NQVIH 138

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K+ NILL      K++DFG      T + +  ST+V G+  ++ PE   R+    K 
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 718 DVYSFGVVLFEILCARP 734
           D++S G++  E++   P
Sbjct: 197 DIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.0 bits (158), Expect = 8e-11
 Identities = 50/196 (25%), Positives = 102/196 (52%), Gaps = 5/196 (2%)

Query: 577 QTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI 636
           ++E+  L+   H  +V      + + +++L+ +Y + G L + + +  K  LP+++  E+
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEY-EV 171

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
            +   + +  L       ++HRD+K+ NI L    + K+ DFG SK         V++  
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA-RPALNPTLPK--EQVSLAEWAAH 753
            G+  YL PE + R++ ++K+D++S GV+L+E+L   RP   P+  +  +QV   ++   
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291

Query: 754 -CHKKGILEQIMDPYL 768
            C     ++ ++DP L
Sbjct: 292 PCPVSSGMKALLDPLL 307

Length = 478

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.1 bits (156), Expect = 9e-11
 Identities = 72/270 (26%), Positives = 107/270 (39%), Gaps = 84/270 (31%)

Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FGKV +    G     +   VA+K    G   SE       TE+++L  +  H +
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEY--KALMTELKILIHIGHHLN 72

Query: 591 LVSLIGYC-EENCEMILVYDYMAYGTLREHL---------YKT-------QKPPLPWKQR 633
           +V+L+G C +    ++++ +Y  +G L  +L         Y+         K     KQR
Sbjct: 73  VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132

Query: 634 LE-----------------------------------------IC--IGAARGLHYLHTG 650
           L+                                         I      ARG+ +L   
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL--- 189

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS----FGYLDPE 706
           A    IHRD+   NILL E  V K+ DFGL++      +     V KG       ++ PE
Sbjct: 190 ASRKCIHRDLAARNILLSENNVVKICDFGLARD----IYKDPDYVRKGDARLPLKWMAPE 245

Query: 707 YFRRQQLTEKSDVYSFGVVLFEI--LCARP 734
               +  T +SDV+SFGV+L+EI  L A P
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 63.4 bits (154), Expect = 9e-11
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR--------GNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           +GVG +G VY+     +   VA+K         G PLS   V E    ++ L    H ++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST--VREV-ALLKRLEAFDHPNI 64

Query: 592 VSLIGYC-----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
           V L+  C     +   ++ LV++++    LR +L K   P LP +   ++     RGL +
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           LH    + I+HRD+K  NIL+      K++DFGL++         ++ VV  +  Y  PE
Sbjct: 124 LHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVV-TLWYRAPE 177

Query: 707 YFRRQQLTEKSDVYSFGVVLFEILCARP 734
              +       D++S G +  E+   +P
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.9 bits (155), Expect = 1e-10
 Identities = 74/272 (27%), Positives = 108/272 (39%), Gaps = 85/272 (31%)

Query: 539 LLGVGGFGKVYRGEIDGATTK-----VAIK---RGNPLSEQGVHEFQTEIEMLSKL-RHR 589
           +LG G FGKV      G   K     VA+K    G   SE       +E+++L  +  H 
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEH--KALMSELKILIHIGNHL 71

Query: 590 HLVSLIGYCEE-NCEMILVYDYMAYGTLREHL---------YKTQKPPLP---------- 629
           ++V+L+G C + N  ++++ ++  YG L   L         Y+ + P             
Sbjct: 72  NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131

Query: 630 -----------------------------------WKQRLE----ICIG--AARGLHYLH 648
                                              WK  L     IC     ARG+ +L 
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL- 190

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS----FGYLD 704
             A    IHRD+   NILL E  V K+ DFGL++      +     V KGS      ++ 
Sbjct: 191 --ASRKCIHRDLAARNILLSENNVVKICDFGLARD----IYKDPDYVRKGSARLPLKWMA 244

Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEI--LCARP 734
           PE    +  T +SDV+SFGV+L+EI  L A P
Sbjct: 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 15/213 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIGYC 598
           LG G +  V++G        VA+K      E+G       E+ +L  L+H ++V+L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI-GAARGLHYLHTGAKHTIIH 657
                + LV++Y+    L+++L       L     ++I +    RGL Y H   K  I+H
Sbjct: 73  HTERCLTLVFEYLD-SDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH---KRKILH 126

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+L++EK   K++DFGL++       T+ + VV  +  Y  P+       TE S
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS--TEYS 182

Query: 718 ---DVYSFGVVLFEILCARPALNPTLPKEQVSL 747
              D++  G +L+E+   RP    +  KE++ L
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 16/161 (9%)

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGAARGLHYLH 648
           LV L    +    + LV +Y+  G L  H+ + +K P    +    EICI     L++LH
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LNFLH 113

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
              +  II+RD+K  N+LLD     K++D+G+ K G  L     ++   G+  Y+ PE  
Sbjct: 114 ---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEIL 168

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARPAL-----NPTLPKEQ 744
           R ++     D ++ GV++FE++  R        NP +  E 
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED 209

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 13/198 (6%)

Query: 539 LLGVGGFGKVYRGEIDGATTK---VAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           +LG G FG++ RG +   + +   VAI       S++    F  E   L +  H ++V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
            G       M++V +YM+ G L   L K  +  L   Q + +  G A G+ YL   ++  
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYL---SEMG 127

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL--DPEYFRRQQ 712
            +H+ +    +L++   V K+S F             + T + G    L   PE  +   
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 713 LTEKSDVYSFGVVLFEIL 730
            +  SDV+SFG+V++E++
Sbjct: 185 FSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 27/208 (12%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGY 597
           L+G G +G VYRG+       VA+K  N  +    V + Q E+ +LS+LR     ++  Y
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 598 CEENCEMI-----LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA-----RGLHYL 647
                 +      ++ +Y   G++R  L K            E  I          L Y+
Sbjct: 68  --YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIA-------EKYISVIIREVLVALKYI 117

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H   K  +IHRD+K  NIL+      K+ DFG++      + +  ST V G+  ++ PE 
Sbjct: 118 H---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL-LNQNSSKRSTFV-GTPYWMAPEV 172

Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARP 734
               +    K+D++S G+ ++E+    P
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNP 200

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 30/215 (13%)

Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR-GNPLSEQGV--HEFQTEIEMLSKLR 587
           TN + +   +G+G FG V           VAIK+   P S   +    ++ E+++L  LR
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67

Query: 588 HRHLVSLIG-YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
           H +++SL   +     ++  V + +  GT    L  ++     + Q     I   RGL Y
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQI--LRGLKY 123

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           +H+     ++HRD+K +NIL++E    K+ DFGL++     D            GY+   
Sbjct: 124 VHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ---DPQMT--------GYVSTR 169

Query: 707 YFRR-------QQLTEKSDVYSFGVVLFEILCARP 734
           Y+R        Q+   + D++S G +  E+L  +P
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 540 LGVGGFGKVYRGEI--DGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +G G FGKV  GE+       +V +K  R +  S Q   +F  E +    L+H +L+  +
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQK-----PPLPWKQRLEICIGAARGLHYLHTG 650
           G C E    +LV ++   G L+ +L   +K     P     QR+   I  A GL +LH  
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLH-- 117

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
            K+  IH D+   N LL      K+ D+GLS      D+      +     ++ PE    
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 711 QQ-------LTEKSDVYSFGVVLFEIL 730
                     T++S+V+S GV ++E+ 
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 62.5 bits (152), Expect = 3e-10
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 15/208 (7%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHR 589
           +F+  ++LG G FGKV   E  G     AIK   +   + +  V     E  +L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 590 HLVSLIGYCEENCE-MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--ARGLHY 646
             ++ +  C +  + +  V +Y+  G L  H+ +  K    +K+   +   A  A GL +
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK----FKEPHAVFYAAEIAIGLFF 116

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           LH+     II+RD+K  N++LD +   K++DFG+ K       T  +    G+  Y+ PE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDYIAPE 171

Query: 707 YFRRQQLTEKSDVYSFGVVLFEILCARP 734
               Q   +  D ++FGV+L+E+L  +P
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQP 199

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 15/200 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQT-EIEMLSKLRHRHLVSLIG 596
           LG GGFG+V   ++       A K+ +   L ++   +    E E+L K+    +V+L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
             E    + LV   M  G L+ H+Y   +  L  ++ +        G+ +LH+     I+
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
           +RD+K  N+LLD++   ++SD GL+   K G T+      T   G+ GY+ PE  + +  
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI------TQRAGTNGYMAPEILKEEPY 171

Query: 714 TEKSDVYSFGVVLFEILCAR 733
           +   D ++ G  ++E++  R
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 15/208 (7%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHR 589
           +F+  ++LG G FGKV   E  G     AIK   +   + +  V     E  +L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 590 HLVSLIGYCEENCE-MILVYDYMAYGTLREHLYKTQ--KPPLPWKQRLEICIGAARGLHY 646
             ++ +  C +  + +  V +Y+  G L   + +    K P       EI IG    L +
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFF 116

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           LH+     II+RD+K  N++LD +   K++DFG+ K     D     T   G+  Y+ PE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-MWDGVTTKTFC-GTPDYIAPE 171

Query: 707 YFRRQQLTEKSDVYSFGVVLFEILCARP 734
               Q   +  D ++FGV+L+E+L  + 
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQA 199

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 41/238 (17%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKR--------GNPLSEQGVHEFQTEIEMLSK 585
           FD    +G G +G+VY+         VA+K+        G P++         EI++L +
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI------REIKILRQ 62

Query: 586 LRHRHLVSL----------IGYCEENCEMILVYDYM---AYGTLREHL--YKTQKPPLPW 630
           L HR++V+L          + + ++     LV++YM     G L   L  +         
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122

Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
           KQ LE       GL+Y H   K   +HRD+K +NILL+ K   K++DFGL++   + +  
Sbjct: 123 KQLLE-------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 691 HVSTVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
             +  V  +  Y  PE     ++     DV+S G +L E+   +P         Q+ L
Sbjct: 173 PYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 18/209 (8%)

Query: 533 NFDEALLLGVGGFGKVY-----RGEIDGATTKVAIKRGNPLSEQG--VHEFQTEIEMLSK 585
           NF+   +LG G +GKV+      G   G    + + +   + ++       +TE ++L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 586 LRHR-HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARG 643
           +R    LV+L    + + ++ L+ DY+  G L  HL + ++     +Q ++I  G     
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLA 117

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           L +LH   K  II+RD+K  NILLD      ++DFGLSK     D    +    G+  Y+
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYM 173

Query: 704 DPEYFRRQQLTEKS--DVYSFGVVLFEIL 730
            P+  R          D +S GV+++E+L
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 13/200 (6%)

Query: 539 LLGVGGFGKV--YRGEIDGATTKVAI-KRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LLG G FGKV   + +  G    + I K+   +++  V    TE  +L   RH  L +L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--ARGLHYLHTGAKH 653
              + +  +  V +Y   G L  HL + +     + +      GA     L YLH  ++ 
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERV----FSEDRARFYGAEIVSALDYLH--SEK 115

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            +++RD+K  N++LD+    K++DFGL K G   D   + T   G+  YL PE       
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTFC-GTPEYLAPEVLEDNDY 173

Query: 714 TEKSDVYSFGVVLFEILCAR 733
               D +  GVV++E++C R
Sbjct: 174 GRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.0 bits (150), Expect = 4e-10
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 8/162 (4%)

Query: 577 QTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE 635
           QTE  +  +   H  LV L    +    +  V +Y+  G L  H+ + +K P    +   
Sbjct: 43  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 102

Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
             I  A  L+YLH   +  II+RD+K  N+LLD +   K++D+G+ K G  L     ++ 
Sbjct: 103 AEISLA--LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTST 155

Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
             G+  Y+ PE  R +      D ++ GV++FE++  R   +
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 61.0 bits (149), Expect = 4e-10
 Identities = 37/145 (25%), Positives = 60/145 (41%), Gaps = 12/145 (8%)

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           + + + L          +L+ DY+  G L + L K  +  L   +  +I       L+ L
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD-LLKK-EGKLSEAEVKKIIRQLVEALNDL 125

Query: 648 HTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           H   KH IIH D+K  N+L D  K    + D+GL K           +   G+  Y  PE
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYFSPE 176

Query: 707 YFRRQQLTEKSDVYSFGVVLFEILC 731
             +        D ++ GV+ +E+L 
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLT 201

Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 61.7 bits (149), Expect = 4e-10
 Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 10/196 (5%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ-TEIEMLSKLRHRHLVSLIGYC 598
           +G G  G VY         +VAI++ N L +Q   E    EI ++ + ++ ++V+ +   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
               E+ +V +Y+A G+L + + +T    +   Q   +C    + L +LH+   + +IHR
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHR 140

Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           D+K+ NILL      K++DFG      T + +  ST+V G+  ++ PE   R+    K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198

Query: 719 VYSFGVVLFEILCARP 734
           ++S G++  E++   P
Sbjct: 199 IWSLGIMAIEMIEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 16/180 (8%)

Query: 559 KVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLRE 618
           +VA+K+ +   +Q       E+ ++   +H ++V +        E+ +V +++  G L +
Sbjct: 46  QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD 105

Query: 619 HLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF 678
            +  T+   +  +Q   +C+   + L +LH      +IHRD+K+ +ILL      K+SDF
Sbjct: 106 IVTHTR---MNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDF 159

Query: 679 G----LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           G    +SK  P       S V  G+  ++ PE   R     + D++S G+++ E++   P
Sbjct: 160 GFCAQVSKEVP----RRKSLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 62/239 (25%), Positives = 98/239 (41%), Gaps = 43/239 (17%)

Query: 540 LGVGGFGKVYRGEI--DGATTKVAIKR---GNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           +G G FGKV   EI  D    +V +K         EQ  +EF  + +    L+H +++  
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQC 60

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWK---------QRLEICIGAARGLH 645
           +G C E    +LV++Y   G L+ +L + Q     W          QR+   I A  G+ 
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQ-----WHRRNSQLLLLQRMACEIAA--GVT 113

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           ++H   KH  +H D+   N  L      KV D+G+  +    D+            +L P
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170

Query: 706 EYFRRQQ-------LTEKSDVYSFGVVLFEI----------LCARPALNPTLPKEQVSL 747
           E              T+ S+V++ GV L+E+          L  R  LN  +  +QV L
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL 229

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 21/214 (9%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIGYC 598
           LG G +  VY+G        VA+K      E+G       E+ +L  L+H ++V+L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 599 EENCEMILVYDYMAYGTLREHL------YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
                + LV++Y+    L+++L             L   Q L       RGL+Y H   +
Sbjct: 74  HTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLL-------RGLNYCH---R 122

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE-YFRRQ 711
             ++HRD+K  N+L++E+   K++DFGL++       T+ + VV  +  Y  P+      
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGST 180

Query: 712 QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
             + + D++  G + +E+   RP    +  +EQ+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 62.6 bits (152), Expect = 7e-10
 Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 12/145 (8%)

Query: 543 GGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           G FGKVY G     +   A+K   + + +++  VH+ Q E + L+  +   +V L    +
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 600 ENCEMILVYDYMAYGTLRE--HLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
               + LV +Y+  G ++   H+Y      +  K   E     A  L YLH   +H IIH
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE----VALALDYLH---RHGIIH 127

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSK 682
           RD+K  N+L+  +   K++DFGLSK
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.1 bits (148), Expect = 8e-10
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 23/202 (11%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS-KLRHRHLVSL 594
           +LG G FGKV   E+ G     A+K   +   L +  V     E  +L+    +  L  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI---CIGAAR---GLHYLH 648
               +    +  V +++  G L  H+          K R ++      AA    GL +LH
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQD--------KGRFDLYRATFYAAEIVCGLQFLH 113

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
           +     II+RD+K  N++LD     K++DFG+ K     D+   ++   G+  Y+ PE  
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEIL 168

Query: 709 RRQQLTEKSDVYSFGVVLFEIL 730
           +  + T   D +SFGV+L+E+L
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 60.5 bits (147), Expect = 9e-10
 Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 24/206 (11%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHRHLVSLIGY 597
           +G G +G VY+G        VA+K+    SE +GV      EI +L +L+H ++V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA------RGLHYLHTGA 651
             +   + L++++++   L+++L       LP  Q ++  +  +      +G+ + H   
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYL-----DSLPKGQYMDAELVKSYLYQILQGILFCH--- 118

Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG--PTLDHTHVSTVVKGSFGYLDPEYFR 709
              ++HRD+K  N+L+D K V K++DFGL++    P   +TH   VV  +  Y  PE   
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH--EVV--TLWYRAPEVLL 174

Query: 710 -RQQLTEKSDVYSFGVVLFEILCARP 734
              + +   D++S G +  E+   +P
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.8 bits (148), Expect = 1e-09
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 33/210 (15%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIG- 596
           +G G +G+V          KVAIK+ +   +  +H  +T  E+ +L  + H +++ L+  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 597 YC-----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL---EICIGA---ARGLH 645
           +      E+  ++ LV   M        L    K      Q+L    I        RGL 
Sbjct: 83  FTPASSLEDFQDVYLVTHLMG-----ADLNNIVK-----CQKLSDDHIQFLVYQILRGLK 132

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y+H+     IIHRD+K +NI ++E    K+ DFGL++        +V+T       Y  P
Sbjct: 133 YIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 184

Query: 706 E-YFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E         +  D++S G ++ E+L  + 
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 52/216 (24%), Positives = 106/216 (49%), Gaps = 9/216 (4%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT-EIEMLSKLRHRHL 591
           NF +   LG G +  VY+G        VA+K  +  +E+G       EI ++ +L+H ++
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHL-YKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
           V L        +++LV++YM    L++++     +  L             +G+ + H  
Sbjct: 61  VRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH-- 117

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
            ++ ++HRD+K  N+L++++   K++DFGL++      +T  + VV  +  Y  P+    
Sbjct: 118 -ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLG 174

Query: 711 QQLTEKS-DVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    S D++S G ++ E++  RP    T  ++Q+
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 29/161 (18%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT----EIEMLSKLRHRHLVSLI 595
           +G G FG+V++         VA+K+   L E     F      EI++L  L+H ++V+LI
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 596 GYC------EENCE--MILVYDYMAYGTLREHLYKTQKPPLP-----WKQRLEICIGAAR 642
             C          +    LV+++  +        K  K  L       K  L        
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN------- 130

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT 683
           GL+Y+H    + I+HRD+K  NIL+ +  + K++DFGL++ 
Sbjct: 131 GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARA 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 17/202 (8%)

Query: 539 LLGVGGFGKVYRGEIDGATTKV----AIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVS 593
           ++G G + KV   E+   T ++     IK+     ++ +   QTE  +      H  LV 
Sbjct: 2   VIGRGSYAKVLLVELK-KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGAARGLHYLHTGA 651
           L    +    +  V ++++ G L  H+ + +K P    +    EI +     L++LH   
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHERG 116

Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              II+RD+K  N+LLD +   K++D+G+ K G  +     ++   G+  Y+ PE  R +
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 712 QLTEKSDVYSFGVVLFEILCAR 733
                 D ++ GV++FE++  R
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 35/210 (16%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIGYC 598
           LG G +  V++G        VA+K      E+G       E+ +L  L+H ++V+L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEIC-------------IGAARGLH 645
             +  + LV++Y     L + L          KQ ++ C                 RGL 
Sbjct: 74  HTDKSLTLVFEY-----LDKDL----------KQYMDDCGNIMSMHNVKIFLYQILRGLA 118

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H   +  ++HRD+K  N+L++E+   K++DFGL++       T+ + VV  +  Y  P
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPP 173

Query: 706 EYFR-RQQLTEKSDVYSFGVVLFEILCARP 734
           +      + + + D++  G + FE+   RP
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 16/205 (7%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            D  + +G G  G V          +VA+K+ +   +Q       E+ ++    H ++V 
Sbjct: 24  LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           +        E+ +V +++  G L + +  T+   +  +Q   +C+   R L YLH     
Sbjct: 84  MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHN---Q 137

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFG----LSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            +IHRD+K+ +ILL      K+SDFG    +SK  P          + G+  ++ PE   
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVIS 191

Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           R     + D++S G+++ E++   P
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 27/223 (12%)

Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHR 589
           T+ ++    +G G +GKVY+       +  A+K  +P+S+    E + E  +L  L  H 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHP 79

Query: 590 HLVSLIG--YCEENC---EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE------ICI 638
           ++V   G  Y  +     ++ LV +    G++ E +    K  L   QRL+      I  
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQRLDEAMISYILY 135

Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           GA  GL +LH    + IIHRDVK  NILL  +   K+ DFG+S    T      +T V  
Sbjct: 136 GALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ-LTSTRLRRNTSVGT 191

Query: 699 SFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEILCARPAL 736
            F ++ PE    +Q  + S     DV+S G+   E+    P L
Sbjct: 192 PF-WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 10/207 (4%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           +F+    +G G +G VY+          AIK       +     Q EI M+   +H ++V
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
           +  G      ++ +  ++   G+L++  + T   PL   Q   +     +GL+YLH+  K
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF---R 709
              +HRD+K  NILL +    K++DFG+S           S +  G+  ++ PE     R
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI--GTPYWMAPEVAAVER 182

Query: 710 RQQLTEKSDVYSFGVVLFEILCARPAL 736
           +    +  D+++ G+   E+   +P +
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 14/220 (6%)

Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEI-DGATTKVAIKR---GNPLSEQGVHEFQTEIE 581
           + K    +F+    LG G FG+V      +     VAIKR      + ++ V    +E +
Sbjct: 24  KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERK 83

Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
           +L+ + H   V+L G  ++   + LV +++  G     L + ++ P         C  AA
Sbjct: 84  ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-----CFYAA 138

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
           + +          I++RD+K  N+LLD+    K++DFG +K   T  +T     + G+  
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT-----LCGTPE 193

Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP 741
           Y+ PE        + +D ++ G+ ++EIL   P      P
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 29/213 (13%)

Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKRGN-PLSEQGVHEFQ-TEIEMLSKLRHR-HLVSLI 595
           +G G +GKVY+   D  T K VA+K+    + E+G+      EI +L  L    ++V L+
Sbjct: 9   IGEGTYGKVYKAR-DKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 596 GYCEENCE-------MILVYDYMAYGTLREHL---YKTQKPPLPWKQRLEICIGAARGLH 645
               E+ E       + LV++Y+    L++ +    +    PLP K          +G+ 
Sbjct: 68  --DVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGY 702
           + H   KH ++HRD+K  N+L+D +K + K++D GL +  + P   +TH   +V  +  Y
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH--EIV--TLWY 177

Query: 703 LDPE-YFRRQQLTEKSDVYSFGVVLFEILCARP 734
             PE        +   D++S G +  E+   +P
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 19/164 (11%)

Query: 243 RSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYE 302
           R W   Q   FG+       I     ++  SN P++  P  +Y +A  +  + Q +L+Y 
Sbjct: 218 RFWNRMQT--FGSGSDQA--ISTENVIKKASNAPNFY-PESLYQSA-LVSTDTQPDLSYT 271

Query: 303 LSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPL 362
           +     VD   +Y V LHF E+   IT   +RVFD+L+N  TAF   D+  ++      L
Sbjct: 272 MD----VDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTAL 327

Query: 363 YQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKL 406
             +  V V G    + L + L P   +      AI+N +E+F++
Sbjct: 328 VLNKTVAVSG----RTLTIVLQPKKGTH-----AIINAIEVFEI 362

Length = 623

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 71/277 (25%), Positives = 110/277 (39%), Gaps = 92/277 (33%)

Query: 540 LGVGGFGKVYRGE---IDGATT--KVAIKRGNPLSEQGVHE----FQTEIEMLSKL-RHR 589
           LG G FG+V   +   ID   T   VA+K    L E   H       +E+++L  +  H 
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKM---LKEGATHSEHRALMSELKILIHIGHHL 71

Query: 590 HLVSLIGYC-EENCEMILVYDYMAYGTLREHL---------YKTQKP------------P 627
           ++V+L+G C +    ++++ ++  +G L  +L         YKT+               
Sbjct: 72  NVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDIS 131

Query: 628 LPWKQRLE------------------------------------------ICIG--AARG 643
              K+RL+                                          IC     A+G
Sbjct: 132 EDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKG 191

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---- 699
           + +L   A    IHRD+   NILL E  V K+ DFGL++      +     V KG     
Sbjct: 192 MEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD----IYKDPDYVRKGDARLP 244

Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEI--LCARP 734
             ++ PE    +  T +SDV+SFGV+L+EI  L A P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 27/212 (12%)

Query: 533 NFDEALLLGVGGFGKVY-----RGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL 586
           + +    +G G FG+V+       E   A   +AI     L  EQ VH    E  +L ++
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH---NEKRVLKEV 58

Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK----PPLPWKQRLEICIGAAR 642
            H  ++ L     +   + ++ +Y+  G L  +L  + +      L +   + +C     
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI-VC----- 112

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+     I++RD+K  NILLD++   K++DFG +K     D T     + G+  Y
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTW---TLCGTPEY 164

Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           L PE  + +   +  D ++ G++++E+L   P
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 59.5 bits (144), Expect = 3e-09
 Identities = 65/257 (25%), Positives = 109/257 (42%), Gaps = 40/257 (15%)

Query: 488 LPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGK 547
           +PL L   S S+ S+ +++    A S   +L                +    +G G  G 
Sbjct: 43  VPLPLPPPSSSSSSSSSSSASGSAPSAAKSLS-------------ELERVNRIGSGAGGT 89

Query: 548 VYRGEIDGATTKVAIK--RGNPLSEQGV-HEFQTEIEMLSKLRHRHLVSLIGYCEENCEM 604
           VY+          A+K   GN   E  V  +   EIE+L  + H ++V      + N E+
Sbjct: 90  VYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147

Query: 605 ILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTT 663
            ++ ++M  G+L   H+   Q      +Q L        G+ YLH   +  I+HRD+K +
Sbjct: 148 QVLLEFMDGGSLEGTHIADEQFLADVARQILS-------GIAYLH---RRHIVHRDIKPS 197

Query: 664 NILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE------K 716
           N+L++     K++DFG+S+    T+D  + S    G+  Y+ PE      L         
Sbjct: 198 NLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAYMSPERI-NTDLNHGAYDGYA 253

Query: 717 SDVYSFGVVLFEILCAR 733
            D++S GV + E    R
Sbjct: 254 GDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 14/211 (6%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHRH 590
           NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H +
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
           +V L+       ++ LV++++    L++ +  +    +P            +GL + H+ 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS- 118

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG--PTLDHTHVSTVVKGSFGYLDPEYF 708
             H ++HRD+K  N+L++ +   K++DFGL++    P   +TH   VV  +  Y  PE  
Sbjct: 119 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVV--TLWYRAPEIL 172

Query: 709 RRQQL-TEKSDVYSFGVVLFEILCARPALNP 738
              +  +   D++S G +  E++  R AL P
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.7 bits (142), Expect = 5e-09
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 34/213 (15%)

Query: 539 LLGVGGFGKVYRGE-IDGATT------KVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           +LG GG+GKV++   + GA T      KV  K     +++     + E  +L  ++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHLYK-------TQKPPLPWKQRLEICIGAARGL 644
           V LI   +   ++ L+ +Y++ G L  HL +       T    L      EI +     L
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-----EISLA----L 113

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKGSFG 701
            +LH   +  II+RD+K  NILLD +   K++DFGL K      T+ HT   T+      
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTI-----E 165

Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           Y+ PE   R    +  D +S G +++++L   P
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 17/148 (11%)

Query: 540 LGVGGFGKVYR------GEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           +G G +G VY+      GE+  A   + ++ G+  S       Q EI M+ + +H ++V+
Sbjct: 17  VGSGTYGDVYKARNLHTGEL-AAVKIIKLEPGDDFSL-----IQQEIFMVKECKHCNIVA 70

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
             G      ++ +  +Y   G+L++  + T   PL   Q   +C    +GL YLH+  K 
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGK- 127

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLS 681
             +HRD+K  NILL +    K++DFG++
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 5e-09
 Identities = 60/234 (25%), Positives = 85/234 (36%), Gaps = 51/234 (21%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LLG G  G+V+   + G     A+K   +   +    V    TE E+L+ L H  L +L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR--------GLHYL 647
              +    + LV DY   G L   L + Q       + L      AR         L YL
Sbjct: 68  ASFQTETYLCLVMDYCPGGELF-RLLQRQP-----GKCL--SEEVARFYAAEVLLALEYL 119

Query: 648 HT-GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG----- 701
           H  G    I++RD+K  NILL E     +SDF LSK            + KGS       
Sbjct: 120 HLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 702 ----------------------YLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
                                 Y+ PE           D ++ G++L+E+L   
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 6e-09
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 25/206 (12%)

Query: 540 LGVGGFGKVY--RGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHRHLVSLI 595
           +G G +G VY  R ++ G    VA+K+    +E +GV      EI +L +L H ++V L+
Sbjct: 7   IGEGTYGVVYKARDKLTGEI--VALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64

Query: 596 GYCEENCEMILVYDY--MAYGTLREHLYKTQKPPLPWKQRL-EICIGAARGLHYLHTGAK 652
                  ++ LV+++  +      +    T   P   K  L ++     +G+ Y H+   
Sbjct: 65  DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYCHS--- 117

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-G-PTLDHTHVSTVVKGSFGYLDPEYF-- 708
           H ++HRD+K  N+L+D +   K++DFGL++  G P   +TH   VV  +  Y  PE    
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--EVV--TLWYRAPEILLG 173

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARP 734
            RQ  T   D++S G +  E++  RP
Sbjct: 174 SRQYST-PVDIWSIGCIFAEMVNRRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 18/203 (8%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHRHLVSLIGY 597
           +G G +G VY+         +A+K+     E +GV      EI +L +++H ++V L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL--EICIGAARGLHYLHTGAKHTI 655
                 + LV++Y+    L++H+     P      RL         RG+ Y H+   H +
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRV 123

Query: 656 IHRDVKTTNILLDEKWVA-KVSDFGLSKTG--PTLDHTHVSTVVKGSFGYLDPE-YFRRQ 711
           +HRD+K  N+L+D +  A K++DFGL++    P    TH   VV  +  Y  PE     +
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH--EVV--TLWYRAPEILLGSR 179

Query: 712 QLTEKSDVYSFGVVLFEILCARP 734
             +   D++S G +  E++  +P
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKP 202

Length = 294

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 26/197 (13%)

Query: 543 GGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE 600
                + + +     T VA+K+ N    S++ +   Q EI    +L+H +++  +     
Sbjct: 13  LMIVHLAKHKPTN--TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70

Query: 601 NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI---GAARGLHYLHTGAKHTIIH 657
           + E+ +V   MAYG+  + L       LP    L I          L Y+H       IH
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIH---SKGFIH 124

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS-------FGYLDPEYFRR 710
           R VK ++ILL       +S  GL  +   + H     VV            +L PE  + 
Sbjct: 125 RSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ- 181

Query: 711 QQL---TEKSDVYSFGV 724
           Q L    EKSD+YS G+
Sbjct: 182 QNLQGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 16/205 (7%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            D  + +G G  G V    +  +   VA+K+ +   +Q       E+ ++   +H ++V 
Sbjct: 22  LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           +        E+ +V +++  G L + +  T+   +  +Q   +C+   + L  LH     
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHA---Q 135

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFG----LSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            +IHRD+K+ +ILL      K+SDFG    +SK  P          + G+  ++ PE   
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKSLVGTPYWMAPELIS 189

Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           R     + D++S G+++ E++   P
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 35/147 (23%), Positives = 56/147 (38%), Gaps = 21/147 (14%)

Query: 38  LNCGESSILSDDDKRSWTPDI-----GSKFLLSTKDSTTSKAATQDPSTPTIPYMTARVF 92
           +NCG     +D D  ++  D       + + +S  + ++S A T DP    + Y T R  
Sbjct: 5   INCGGPEH-TDSDGITYEADTYFTGGSADYYVSDTNGSSSIAGTTDP---EL-YQTERYS 59

Query: 93  RSEFTYSFPVVA-GR-----KFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQT 146
            S F+Y  P +  G       F  +YF  +   R      +F V      +LK+F +   
Sbjct: 60  PSSFSYYIPCLENGNYTVILHFAEIYFGEDGLGR-----RVFDVYVQGKLVLKDFDIVAE 114

Query: 147 AEALNYAYVIKEYAIPVDGETLNITFS 173
           A         +   + V   TL I F 
Sbjct: 115 AGGKGKTAHKEYIPVTVTDGTLEIHFY 141

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 74/270 (27%), Positives = 126/270 (46%), Gaps = 34/270 (12%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIG- 596
           LG G  G VY+      T ++   +  PL  + +   +  +E+E+L K    +++   G 
Sbjct: 9   LGHGNGGTVYKA-YHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
           +  EN  + +  ++M  G+L   +Y+  K P     R  I +   +GL YL +     I+
Sbjct: 68  FFVEN-RISICTEFMDGGSL--DVYR--KIPEHVLGR--IAVAVVKGLTYLWS---LKIL 117

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRDVK +N+L++ +   K+ DFG+S     L ++   T V G+  Y+ PE    +Q    
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYV-GTNAYMAPERISGEQYGIH 173

Query: 717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD---PYLK-GKI 772
           SDV+S G+   E+   R    P + K Q SL           +L+ I+D   P L  G+ 
Sbjct: 174 SDVWSLGISFMELALGRFPY-PQIQKNQGSLMPLQ-------LLQCIVDEDPPVLPVGQF 225

Query: 773 APECFKKFAETAMKCVSDQGIERPSMGDVL 802
           +     KF     +C+  Q  ERP+  +++
Sbjct: 226 SE----KFVHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 57.1 bits (138), Expect = 4e-08
 Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 43/226 (19%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR------GNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           L+G GG G+VY       + +VA+K+       NPL ++    F  E ++ + L H  +V
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK---RFLREAKIAADLIHPGIV 65

Query: 593 SLIGYCEENCEMILVYDYMAY--GTLREHLYKT--QKPPLP--------WKQRLEICIGA 640
            +   C +      VY  M Y  G   + L K+  QK  L             L I    
Sbjct: 66  PVYSICSDG---DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDE-------KWVAKVS---------DFGLSKTG 684
              + Y+H+     ++HRD+K  NILL          W A +          D  + +  
Sbjct: 123 CATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                  +   + G+  Y+ PE       +E +D+Y+ GV+L+++L
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 29/219 (13%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP----LSEQGVHEFQTEIEMLSKLR 587
            +F+   L+  G +G VY         + A+K+ N     L  Q + +   E ++L+   
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ-IQQVFVERDILTFAE 59

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYG---TLREHLYKTQKPPLPWKQRLEICIGAARGL 644
           +  +VS+    E    + +V +Y+  G   TL +++       LP              L
Sbjct: 60  NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-----GALPVDMARMYFAETVLAL 114

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-----PTLDHTHVSTVVK-- 697
            YLH    + I+HRD+K  N+L+      K++DFGLSK G       L   H+    +  
Sbjct: 115 EYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171

Query: 698 ------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                 G+  Y+ PE   RQ   +  D ++ G++L+E L
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.5 bits (134), Expect = 5e-08
 Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 40/196 (20%)

Query: 559 KVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL 616
           KVAIK+     +  +   +T  EI++L  L H +++++               Y+ Y  +
Sbjct: 32  KVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM 91

Query: 617 REHLYKTQKPPLPWK---------QRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL 667
              L++  +               Q L       RGL Y+H+     ++HRD+K +N+LL
Sbjct: 92  DTDLHQIIRSSQTLSDDHCQYFLYQLL-------RGLKYIHSA---NVLHRDLKPSNLLL 141

Query: 668 DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF--GYLDPEYFRRQQL-------TEKSD 718
           +     K+ DFGL++T          T  KG F   Y+   ++R  +L       T   D
Sbjct: 142 NANCDLKICDFGLART----------TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAID 191

Query: 719 VYSFGVVLFEILCARP 734
           V+S G +  E+L  +P
Sbjct: 192 VWSVGCIFAELLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 55.1 bits (132), Expect = 6e-08
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 19/206 (9%)

Query: 532 NNFDEALLLGVGGFGKVYRGE--IDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLR 587
           +++++   LG G +  VY+G+  ++G    + + R   L E+    F    E  +L  L+
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLK 61

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L         + LV++Y+ +  L +++ K      P   +L       RGL Y+
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKL-FLFQLLRGLSYI 119

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H   +  I+HRD+K  N+L+ +    K++DFGL++      HT+ + VV  +  Y  P+ 
Sbjct: 120 H---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDV 174

Query: 708 FRRQQLTEKS---DVYSFGVVLFEIL 730
                 TE S   D++  G +  E++
Sbjct: 175 LLGS--TEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 40/211 (18%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           ++G GGFG+VY           A+K    L ++ +   Q E   L++   R ++SL+   
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNE---RIMLSLVS-- 52

Query: 599 EENCEMIL--------------VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
             +C  I+              + D M  G L  HL  +Q      K+          GL
Sbjct: 53  TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGL 110

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL----SKTGPTLDHTHVSTVVKGSF 700
            ++H      +++RD+K  NILLDE    ++SD GL    SK  P     H S    G+ 
Sbjct: 111 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GTH 159

Query: 701 GYLDPEYFRRQQLTEKS-DVYSFGVVLFEIL 730
           GY+ PE  ++    + S D +S G +LF++L
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 19/204 (9%)

Query: 540 LGVGGFGKVYRG--EIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLI 595
           LG G +  VY+G   I+G    VA+K  +  +E+GV  F    E  +L  L+H ++V L 
Sbjct: 13  LGEGSYATVYKGISRINGQL--VALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLH 69

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPP--LPWKQRLEICIGAARGLHYLHTGAKH 653
                   +  V++YM     +   Y  Q P    P+  RL       RGL Y+H     
Sbjct: 70  DIIHTKETLTFVFEYMHTDLAQ---YMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQ 122

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR-RQQ 712
            I+HRD+K  N+L+      K++DFGL++       T+ S VV  +  Y  P+       
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATD 180

Query: 713 LTEKSDVYSFGVVLFEILCARPAL 736
            +   D++  G +  E+L  +PA 
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 24/203 (11%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIG-Y 597
           LG G +G VY+         +A+K     L E   ++   E+++L K    ++V   G +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 598 CEENCEMILVYDYMAYGTLREHLY--KTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
             E    + + +YM  G+L + LY        +P      I     +GL +L    +H I
Sbjct: 69  FIEGAVYMCM-EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG---YLDPEYFR--- 709
           IHRDVK TN+L++     K+ DFG+S          V+++ K + G   Y+ PE  +   
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSG-------NLVASLAKTNIGCQSYMAPERIKSGG 177

Query: 710 ---RQQLTEKSDVYSFGVVLFEI 729
                  T +SDV+S G+ + E+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 27/235 (11%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT---EIEMLSKLRH 588
           N F+   ++G G +G V +         VAIK+    SE+     +T   E++ML  L+ 
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKD-SEENEEVKETTLRELKMLRTLKQ 59

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
            ++V L        ++ LV++Y+    L E L +      P K R  I     + +H+ H
Sbjct: 60  ENIVELKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYI-YQLIKAIHWCH 117

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
              K+ I+HRD+K  N+L+    V K+ DFG ++      + + +  V   + Y  PE  
Sbjct: 118 ---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPELL 173

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARP----------------ALNPTLPKEQVSL 747
                 +  D++S G +L E+   +P                 L P LP EQ+ L
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP-LPAEQMKL 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 8e-08
 Identities = 39/108 (36%), Positives = 57/108 (52%), Gaps = 13/108 (12%)

Query: 627 PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT 686
           PL     L      A+G+ +L   A    IHRDV   N+LL +  VAK+ DFGL++    
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---- 260

Query: 687 LDHTHVST-VVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEI 729
            D  + S  VVKG+      ++ PE       T +SDV+S+G++L+EI
Sbjct: 261 -DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 54.3 bits (130), Expect = 9e-08
 Identities = 47/205 (22%), Positives = 95/205 (46%), Gaps = 16/205 (7%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            +  + +G G  G V       +  +VA+K  +   +Q       E+ ++   +H+++V 
Sbjct: 23  LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           +        E+ ++ +++  G L + + +T+   L  +Q   +C    + L YLH+    
Sbjct: 83  MYKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHS---Q 136

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFG----LSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            +IHRD+K+ +ILL      K+SDFG    +SK  P          + G+  ++ PE   
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVIS 190

Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           R     + D++S G+++ E++   P
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 15/207 (7%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGAT-TKVAIKR-GNPL-SEQGVHEFQTEIEMLSKLRHRH 590
           + +   +G G +G V    +D  T  KVAIK+   P  SE        E+ +L  ++H +
Sbjct: 17  YRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75

Query: 591 LVSLIGYCEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICI-GAARGLHYLH 648
           ++ L+     +  +   +D Y+    +   L K  K     + R++  +    +GL Y+H
Sbjct: 76  VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH 135

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY- 707
                 IIHRD+K  N+ ++E    K+ DFGL++     D      VV  +  Y  PE  
Sbjct: 136 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT---DSEMTGYVV--TRWYRAPEVI 187

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
                 T+  D++S G ++ E+L  +P
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKP 214

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)

Query: 532 NNFDEALLLGVGGFGKVY----RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR 587
            +FD   L+G G FG+V     +   D    KV +K+   L+++ V  F+ E ++LS   
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSISN 59

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL---EICIGAARGL 644
              +  L    ++   + LV +Y   G L   L + +        +    E+ +     +
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA----I 115

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           H +H       +HRD+K  N+L+D     K++DFG S    T +    S +  G+  Y+ 
Sbjct: 116 HSVHQMG---YVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIA 171

Query: 705 PEYFRRQQLTEKS------DVYSFGVVLFEILCAR 733
           PE         K       D +S GV+ +E++  R
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 31/220 (14%)

Query: 536 EALLLGVGGFGKVYRGE-IDGATTK-VAIKR--GNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           E   +G G +G VY+ +  DG   +  A+K+  G  +S     E    I +L +L+H ++
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNV 60

Query: 592 VSL--IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR------- 642
           +SL  +     + ++ L++DY  +     H+ K  +     K+ +++  G  +       
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118

Query: 643 -GLHYLHTGAKHTIIHRDVKTTNILL----DEKWVAKVSDFGLSK--TGPTLDHTHVSTV 695
            G+HYLH    + ++HRD+K  NIL+     E+   K++D G ++    P      +  V
Sbjct: 119 DGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175

Query: 696 VKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEILCARP 734
           V  +F Y  PE     +  T+  D+++ G +  E+L + P
Sbjct: 176 VV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 50/189 (26%), Positives = 86/189 (45%), Gaps = 20/189 (10%)

Query: 558 TKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGT 615
           T V ++  +    +E+ +   Q E+ +    RH ++++          + ++  +MAYG+
Sbjct: 26  TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85

Query: 616 LREHLYKTQKPPLPWKQRL-EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAK 674
               L KT  P    +  +  I  GA RGL+YLH   ++  IHR++K ++IL+    +  
Sbjct: 86  AN-SLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVS 141

Query: 675 VSDFGLSKTGPTLDHTHVSTVV-------KGSFGYLDPEYFRRQQL---TEKSDVYSFGV 724
           +S  GLS     + +   + VV            +L PE   RQ L     KSD+YS G+
Sbjct: 142 LS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL-RQDLYGYNVKSDIYSVGI 198

Query: 725 VLFEILCAR 733
              E+   R
Sbjct: 199 TACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 33/209 (15%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 85  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSAD 140

Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 141 ---IIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 186

Query: 712 QL-------TEKSDVYSFGVVLFEILCAR 733
           ++        +  D++S G ++ E+L  R
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 40/139 (28%), Positives = 60/139 (43%), Gaps = 13/139 (9%)

Query: 608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL 667
           Y   A    R      + P L +   +      A G+ +L   A    +HRD+   N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLI 272

Query: 668 DEKWVAKVSDFGLSKTGPTLDHTHVSTVV-KGS----FGYLDPEYFRRQQLTEKSDVYSF 722
            E  + K+ DFGL++     D    S  + KGS      ++ PE       T  SDV+SF
Sbjct: 273 CEGKLVKICDFGLAR-----DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF 327

Query: 723 GVVLFEILCARPALNPTLP 741
           G++L+EI        P LP
Sbjct: 328 GILLWEIFTLGGTPYPELP 346

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 45/163 (27%), Positives = 65/163 (39%), Gaps = 46/163 (28%)

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL----SKTGPTLDHTHVSTVVKG 698
           GL ++H      +++RD+K  NILLDE    ++SD GL    SK  P     H S    G
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---G 157

Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEIL----------------CARPAL--NPT 739
           + GY+ PE  ++    + S D +S G +LF++L                  R  L     
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 217

Query: 740 LP----KEQVSLAEWAAH--------CHKKGILEQIMDPYLKG 770
           LP     E  SL E            C  +G  E    P+ + 
Sbjct: 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 36/106 (33%), Positives = 56/106 (52%), Gaps = 13/106 (12%)

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST-VVKGS 699
           A+G+ +L   A    IHRD+   NILL    + K+ DFGL++     D  + S  VVKG+
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGN 275

Query: 700 ----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP 741
                 ++ PE       T +SDV+S+G++L+EI     +  P +P
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 70/312 (22%), Positives = 124/312 (39%), Gaps = 68/312 (21%)

Query: 540 LGVGGFGKV---YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           LG+G FG+V    + +         +++ + L+   V   + E ++L++  +  +V L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
             ++   +  V DY+  G +   L + +  P    + L     A   L  + +  K   I
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP----EVLARFYIAELTLA-IESVHKMGFI 123

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH--------THV---------------- 692
           HRD+K  NIL+D     K++DFGL  TG    H        +H+                
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLC-TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 693 ----------------------STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                                 +  + G+  Y+ PE   R+  T+  D +S GV+LFE+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 731 CARPA-LNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVS 789
             +P  L PT  + Q+ +  W    H   I  Q+       K++PE       T + C +
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLH---IPPQV-------KLSPEAVDLI--TKLCCSA 290

Query: 790 DQGIERPSMGDV 801
           ++ + R    D+
Sbjct: 291 EERLGRNGADDI 302

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 53.1 bits (127), Expect = 4e-07
 Identities = 64/273 (23%), Positives = 102/273 (37%), Gaps = 58/273 (21%)

Query: 534 FDEALLLGVGGFGKV--YRGEIDGA--TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHR 589
           F +   LG+G FG+V   R     A    K   K+   L  Q  H  + E ++L++  + 
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAH-VKAERDILAEADNE 61

Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ-RLEICIGAARGLHYLH 648
            +V L    ++   +  V DY+  G +   L +    P    +  +     A   +H   
Sbjct: 62  WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH--- 118

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL---------SKTGPTLDHTHVSTV---- 695
              K   IHRD+K  NIL+D     K++DFGL         SK   + DH    ++    
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175

Query: 696 --------------------------------VKGSFGYLDPEYFRRQQLTEKSDVYSFG 723
                                           + G+  Y+ PE   R   T+  D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235

Query: 724 VVLFEILCARPALNPTLPKE-QVSLAEWAAHCH 755
           V+L+E+L  +P      P E Q+ +  W    H
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLH 268

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 52.6 bits (127), Expect = 4e-07
 Identities = 30/100 (30%), Positives = 54/100 (54%), Gaps = 13/100 (13%)

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
           + L Y+H+G    +IHRD+K +NILL+     K++DFGL+++   L+    + V+     
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT---D 171

Query: 702 YLDPEYFRRQQLTEKSDVYSFGV-------VLFEILCARP 734
           Y+   ++R  ++   S  Y+ GV       +L E+L  +P
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 45/228 (19%)

Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP-PLPWKQRLEICIGA 640
           M+ ++ H+H+V L G C  + E I+V +++ +G L   +++       PWK   ++    
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQL 114

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV-------AKVSDFGLSKTGPTLDHTHVS 693
           A  L YL       ++H +V T NILL  + +        K+SD G+    P    +   
Sbjct: 115 ASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PITVLSRQE 167

Query: 694 TVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAE--- 749
            V +    ++ PE     + L+  +D +SFG  L+EI       N  +P +  +LAE   
Sbjct: 168 CVER--IPWIAPECVEDSKNLSIAADKWSFGTTLWEI-----CYNGEIPLKDKTLAEKER 220

Query: 750 -WAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERP 796
            +   C                 + P C K+ A+    C++    +RP
Sbjct: 221 FYEGQCM---------------LVTPSC-KELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.0 bits (124), Expect = 7e-07
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 27/218 (12%)

Query: 536 EALLLGVGGFGKVYRGE-IDGATTK-VAIKR--GNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           E   +G G +G VY+ +  DG   K  A+K+  G  +S     E    I +L +L+H ++
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNV 60

Query: 592 VSL--IGYCEENCEMILVYDYMAYG---TLREH-LYKTQKPP--LPWKQRLEICIGAARG 643
           ++L  +     + ++ L++DY  +     ++ H   K  K P  LP      +      G
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 644 LHYLHTGAKHTIIHRDVKTTNILL----DEKWVAKVSDFGLSK--TGPTLDHTHVSTVVK 697
           +HYLH    + ++HRD+K  NIL+     E+   K++D G ++    P      +  VV 
Sbjct: 121 IHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 698 GSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEILCARP 734
            +F Y  PE     +  T+  D+++ G +  E+L + P
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 7e-07
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 25/212 (11%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHR 589
           +F+   ++G G FG+V   ++  A    A+K  N    L       F+ E ++L    ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP------WKQRLEICIGAARG 643
            + +L    ++   + LV DY   G L   L K +   LP      +   + I I +   
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQ 120

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           LHY         +HRD+K  NIL+D     +++DFG S      D T  S+V  G+  Y+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYI 170

Query: 704 DPEYFR-----RQQLTEKSDVYSFGVVLFEIL 730
            PE  +     + +   + D +S GV ++E+L
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.1 bits (125), Expect = 7e-07
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 5/107 (4%)

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
           RGL YLH+     I+HRD+K  N+L++   V K+ DFGL++     +  H++  V   + 
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169

Query: 702 YLDPEYFR-RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           Y  PE     +  T   D++S G +  E+L  R       P +Q+ L
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 8e-07
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 49/218 (22%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSL--I 595
           LG G +  VY+G        VA+K      E+G   F    E  +L  L+H ++V+L  I
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHDI 71

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA-------------R 642
            + ++   + LV++Y+                   KQ ++ C G               R
Sbjct: 72  IHTKKT--LTLVFEYLDTDL---------------KQYMDDCGGGLSMHNVRLFLFQLLR 114

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL--SKTGPTLDHTHVSTVVKGSF 700
           GL Y H   +  ++HRD+K  N+L+ E+   K++DFGL  +K+ P+   T+ + VV  + 
Sbjct: 115 GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KTYSNEVV--TL 167

Query: 701 GYLDPEYFRRQQLTEKS---DVYSFGVVLFEILCARPA 735
            Y  P+       TE S   D++  G + +E+   RP 
Sbjct: 168 WYRPPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPL 203

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.6 bits (124), Expect = 9e-07
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 8/97 (8%)

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKG 698
           RGL Y+H+     +IHRD+K +N+L++E    ++ DFG+++   + PT +H +  T    
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-EHKYFMTEYVA 173

Query: 699 SFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEILCARP 734
           +  Y  PE      + T   D++S G +  E+L  R 
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.3 bits (123), Expect = 9e-07
 Identities = 37/152 (24%), Positives = 77/152 (50%), Gaps = 7/152 (4%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHRH 590
            +++   +G G +G V++ +       VA+KR     + +GV      EI +L +L+H++
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
           +V L      + ++ LV++Y     L+++         P   +        +GL + H+ 
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKS-FMFQLLKGLAFCHS- 117

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK 682
             H ++HRD+K  N+L+++    K++DFGL++
Sbjct: 118 --HNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 34/216 (15%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH------------------EFQTEIE 581
           L  G FGK++   +  +T +   +RG   + QG                    + + EI 
Sbjct: 156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL 215

Query: 582 MLSKLRHRHLVSL--IGYCEENCEMILV-YDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
            L +L H +++ +  I   E N  MI   YD+  Y  + +  +  +  PL  + R  I  
Sbjct: 216 ALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMK 274

Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG----LSKTGPTLDHTHVST 694
                + Y+H      +IHRD+K  NI L+      + DFG      K     D+  V T
Sbjct: 275 QLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331

Query: 695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           V   S     PE        E +D++S G++L ++L
Sbjct: 332 VATNS-----PEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 13/95 (13%)

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV-KGS 699
           ARG+ +L   A    +HRD+   N+LL +  + K+ DFGL++     D  H S  V KGS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSNYVSKGS 298

Query: 700 ----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                 ++ PE       T  SDV+S+G++L+EI 
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 21/200 (10%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          KVA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  E   E+ LV + M  G    ++ K QK      Q L   +   RGL Y+H+  
Sbjct: 83  FTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQL--LRGLKYIHSAG 138

Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE-YFRR 710
              IIHRD+K +N+ ++E    ++ DFGL++        +V+T       Y  PE     
Sbjct: 139 ---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNW 190

Query: 711 QQLTEKSDVYSFGVVLFEIL 730
               +  D++S G ++ E+L
Sbjct: 191 MHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 48/222 (21%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLR-HRHLVSLI 595
           +G G F +V + +        AIK         EQ V+  + EI+ L +L  H +++ LI
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLR-EIQALRRLSPHPNILRLI 64

Query: 596 G--YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
              +  +   + LV++ M    L E L K +K PLP K+         + L ++H   ++
Sbjct: 65  EVLFDRKTGRLALVFELMD-MNLYE-LIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RN 119

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKT----GPTLDHT-HVST---------VVKGS 699
            I HRD+K  NIL+ +  + K++DFG  +      P   +T ++ST         +  G 
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGY 175

Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP 741
           +G              K D+++ G V FEIL    +L P  P
Sbjct: 176 YGP-------------KMDIWAVGCVFFEIL----SLFPLFP 200

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 46/293 (15%)

Query: 531 TNNFDEALLLGVGG---------FGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIE 581
           TN +D  L +  GG            +  G  +G   +V +K  +P        F     
Sbjct: 9   TNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETAS 68

Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQ-KPPLPWKQRLEICIGA 640
           ++S++ H HL  + G C    E I+V +++ +G L   L K + + P+ WK  + +    
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--ITVAQQL 126

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA-------KVSDFGLSKTGPTLDHTHVS 693
           A  L YL       ++H +V   NILL    +A       K+SD G+S T  + +   V 
Sbjct: 127 ASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE-RVE 182

Query: 694 TVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAA 752
            +      ++ PE       L+  +D +SFG  L EI       +  +P ++ + +E   
Sbjct: 183 RI-----PWIAPECVPGGNSLSTAADKWSFGTTLLEI-----CFDGEVPLKERTPSEKER 232

Query: 753 HCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
              KK  L +           P C K+ A    +C++ +  +RPS   +L +L
Sbjct: 233 FYEKKHRLPE-----------PSC-KELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 36/124 (29%), Positives = 50/124 (40%), Gaps = 46/124 (37%)

Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV------------------- 692
           K   IHRD+K  N+LLD K   K+SDFGL  TG  L  +H                    
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGLC-TG--LKKSHRTEFYRILSHALPSNFLDFI 175

Query: 693 ----------------------STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                                 STV  G+  Y+ PE F +    ++ D +S GV+++E+L
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTV--GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233

Query: 731 CARP 734
              P
Sbjct: 234 VGYP 237

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 14/211 (6%)

Query: 527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEML 583
           ++    ++D   ++G G FG+V       +    A+K   +   +       F  E +++
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 584 SKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARG 643
           +      +V L    +++  + +V +YM  G L  +L      P  W +     +  A  
Sbjct: 98  AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLA-- 154

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           L  +H+     +IHRDVK  N+LLD+    K++DFG              T V G+  Y+
Sbjct: 155 LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYI 210

Query: 704 DPEYFRRQ----QLTEKSDVYSFGVVLFEIL 730
            PE  + Q        + D +S GV LFE+L
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.6 bits (116), Expect = 7e-06
 Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 26/226 (11%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV------- 592
           LG G  G V+         +VA+K+      Q V     EI+++ +L H ++V       
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 593 -------SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
                    +G   E   + +V +YM    L   L   ++ PL  +          RGL 
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVL---EQGPLSEEHARLFMYQLLRGLK 128

Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSK-TGPTLDHT-HVSTVVKGSFGY 702
           Y+H+     ++HRD+K  N+ ++ E  V K+ DFGL++   P   H  ++S  +   + Y
Sbjct: 129 YIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-Y 184

Query: 703 LDPE-YFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
             P         T+  D+++ G +  E+L  +P        EQ+ L
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 48.6 bits (116), Expect = 9e-06
 Identities = 29/83 (34%), Positives = 41/83 (49%), Gaps = 13/83 (15%)

Query: 656 IHRDVKTTNILLDEKWVAKVSDFG----LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
           IHRDVK  N+LLD+    K++DFG    +   G         T V G+  Y+ PE  + Q
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG----MVRCDTAV-GTPDYISPEVLKSQ 218

Query: 712 ----QLTEKSDVYSFGVVLFEIL 730
                   + D +S GV L+E+L
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (115), Expect = 9e-06
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 12/199 (6%)

Query: 540 LGVGGFGKVYRGEIDGATTKV----AIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +G G FGKV +      T ++     I++ + +S   V     E  +L+++    +V L 
Sbjct: 1   IGKGSFGKVMQVR-KRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
              +   ++ LV  ++  G L  HL +  +  L  + R       A  L  L    K  +
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDL-SRARFYT----AELLCALENLHKFNV 114

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE 715
           I+RD+K  NILLD +    + DFGL K    +     +    G+  YL PE       T+
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172

Query: 716 KSDVYSFGVVLFEILCARP 734
             D ++ GV+L+E+L   P
Sbjct: 173 AVDWWTLGVLLYEMLTGLP 191

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 56/251 (22%), Positives = 101/251 (40%), Gaps = 49/251 (19%)

Query: 533 NFDEALLLGVGGFGKV---YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHR 589
           +F+   ++G G FG+V    + +         +++ + L ++ V   + E ++L +    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ-RLEICIGAARGLHYLH 648
            +V +    ++   + L+ +++  G +   L K         Q  +   + A   +H L 
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL- 120

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG----------PTLDHT-------- 690
                  IHRD+K  N+LLD K   K+SDFGL  TG            L+H+        
Sbjct: 121 -----GFIHRDIKPDNLLLDSKGHVKLSDFGLC-TGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 691 ------------------HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA 732
                               STV  G+  Y+ PE F +    +  D +S GV+++E+L  
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTV--GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Query: 733 RPALNPTLPKE 743
            P      P+E
Sbjct: 233 YPPFCSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 42/162 (25%), Positives = 66/162 (40%), Gaps = 13/162 (8%)

Query: 578 TEIEMLSKLRHRHLVSLIG---YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL 634
           TE  +L  + H  ++ L G   Y +  C ++  Y    Y       Y   K  +     L
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLY------CYLAAKRNIAICDIL 185

Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST 694
            I     R + YLH   ++ IIHRD+K  NI ++      + DFG +   P   + +   
Sbjct: 186 AIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYY 241

Query: 695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPAL 736
              G+     PE   R       D++S G+VLFE+     +L
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 39/225 (17%)

Query: 540 LGVGGFGKVYR--GEIDGATTKVAIKRGNPLSEQGVHEFQTEIE----MLSKLR-HRHLV 592
           +G G +GKV++   + +G  +K A+K  +P     +H+   EIE    +L  L  H ++V
Sbjct: 26  IGKGTYGKVFKVLNKKNG--SKAAVKILDP-----IHDIDEEIEAEYNILKALSDHPNVV 78

Query: 593 SLIG-YCEENC----EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE------ICIGAA 641
              G Y +++     ++ LV +    G++ + +    K  L   +R+E      I   A 
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV----KGFLKRGERMEEPIIAYILHEAL 134

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
            GL +LH    +  IHRDVK  NILL  +   K+ DFG+S    +      ++V  G+  
Sbjct: 135 MGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPF 189

Query: 702 YLDPEYFR-RQQL----TEKSDVYSFGVVLFEILCARPALNPTLP 741
           ++ PE     QQL      + DV+S G+   E+    P L    P
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 6/89 (6%)

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T        V +    Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YY 191

Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILC 731
             PE        E  D++S G ++ E++ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIK 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 59/252 (23%), Positives = 101/252 (40%), Gaps = 49/252 (19%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
           ++F+   ++G G FG+V   +        A+K   + + L ++ V   + E ++L +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ-RLEICIGAARGLHYL 647
             +V +    ++   + L+ +++  G +   L K         Q  +   + A   +H L
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH--------TH-------- 691
                   IHRD+K  N+LLD K   K+SDFGL  TG    H        TH        
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLC-TGLKKAHRTEFYRNLTHNPPSDFSF 173

Query: 692 --------------------VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC 731
                                STV  G+  Y+ PE F +    +  D +S GV+++E+L 
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTV--GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 732 ARPALNPTLPKE 743
             P      P+E
Sbjct: 232 GYPPFCSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.4 bits (110), Expect = 4e-05
 Identities = 37/145 (25%), Positives = 52/145 (35%), Gaps = 55/145 (37%)

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS--------------- 681
           C+ A   +H      K   IHRD+K  NIL+D     K+SDFGLS               
Sbjct: 110 CVLAIEAVH------KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKL 163

Query: 682 ------KTGPTLDHTHV--------------------------STVVKGSFGYLDPEYFR 709
                 K      ++                            STV  G+  Y+ PE F 
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV--GTPDYIAPEIFL 221

Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           +Q   ++ D +S G ++FE L   P
Sbjct: 222 QQGYGQECDWWSLGAIMFECLIGWP 246

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 39/163 (23%), Positives = 61/163 (37%), Gaps = 52/163 (31%)

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGL---------SKTGPTLDHTHVSTV----------- 695
           IHRD+K  NIL+D     K++DFGL         SK     DH    ++           
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 696 ---------------------VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
                                + G+  Y+ PE   R   T+  D +S GV+L+E+L  +P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 735 A-LNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC 776
             L  T  + Q+ +  W          E  +    + K++ E 
Sbjct: 243 PFLADTPAETQLKVINW----------ETTLHIPSQAKLSREA 275

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 45.2 bits (107), Expect = 1e-04
 Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 20/103 (19%)

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK-----TGPTLDHT-HVSTV 695
           R L Y+HT     + HRD+K  NIL +     K+ DFGL++     T   +  T +V+T 
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 696 VKGSFGYLDPE----YFRRQQLTEKSDVYSFGVVLFEILCARP 734
                 Y  PE    +F +   T   D++S G +  E+L  +P
Sbjct: 171 -----WYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKP 206

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 6/88 (6%)

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T     + T    +  Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYY 188

Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 17/209 (8%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRH 588
           ++F+   ++G G FG+V   ++       A+K  N    L       F+ E ++L     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK--PPLPWKQRLEICIGAARGLHY 646
           R + +L    ++   + LV DY   G L   L K +   P    +  L   + A   +H 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L        +HRD+K  N+LLD+    +++DFG S      D T  S V  G+  Y+ PE
Sbjct: 121 LG------YVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 707 YFR-----RQQLTEKSDVYSFGVVLFEIL 730
             +     + +   + D +S GV ++E+L
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 44.7 bits (106), Expect = 2e-04
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 6/91 (6%)

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T        VV  +  Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVV--TRYY 183

Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
             PE        E  D++S G ++ E++   
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 53/197 (26%), Positives = 85/197 (43%), Gaps = 14/197 (7%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIKR-GNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLI 595
            +G G +G V    ID  T  KVAIK+   P  SE        E+ +L  ++H +++ L+
Sbjct: 22  QVGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80

Query: 596 GYCEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
                        D Y+    ++  L K    PL   +   +      GL Y+H+     
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG--- 137

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY-FRRQQL 713
           IIHRD+K  N+ ++E    K+ DFGL++     D      VV  +  Y  PE        
Sbjct: 138 IIHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVV--TRWYRAPEVILNWMHY 192

Query: 714 TEKSDVYSFGVVLFEIL 730
            +  D++S G ++ E+L
Sbjct: 193 NQTVDIWSVGCIMAEML 209

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 8/97 (8%)

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG--- 698
            GL Y+H+     ++HRD+K  N+L++     K+ DFGL++ G + +    +  +     
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVA 171

Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCARP 734
           +  Y  PE     Q   K+ DV+S G +L E+L  +P
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 39/144 (27%), Positives = 61/144 (42%), Gaps = 16/144 (11%)

Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG--AARGLHYL 647
           ++V L  Y      + LV  +   G L  H+ K    P       E C+   AA  +  L
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP-------EECVKRWAAEMVVAL 98

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG-LSKTGPTLDHTHVSTVVKGSFGYLDPE 706
               +  I+ RD+   NILLD++   +++ F   S+   + D   V  +      Y  PE
Sbjct: 99  DALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPE 152

Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
                + TE  D +S G +LFE+L
Sbjct: 153 VGGISEETEACDWWSLGAILFELL 176

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.3 bits (104), Expect = 2e-04
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYY 184

Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.8 bits (103), Expect = 3e-04
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 17/209 (8%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRH 588
           ++F+   ++G G FG+V   ++       A+K  N    L       F+ E  +L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK--PPLPWKQRLEICIGAARGLHY 646
           + + +L    ++   + LV DY   G L   L K +   P    +  +   + A   +H 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           LH       +HRD+K  N+LLD     +++DFG S      D T  S+V  G+  Y+ PE
Sbjct: 121 LH------YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 707 YFRRQQ-----LTEKSDVYSFGVVLFEIL 730
             +  +        + D +S GV ++E+L
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 43.1 bits (101), Expect = 5e-04
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 26/218 (11%)

Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEM 582
           +++    +++   ++G G FG+V            A+K   +   +       F  E ++
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGA 640
           ++      +V L    +++  + +V +YM  G L  +L      P  W +    E+ + A
Sbjct: 97  MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVL-A 154

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG----LSKTGPTLDHTHVSTVV 696
              +H +        IHRDVK  N+LLD+    K++DFG    ++K G     T V    
Sbjct: 155 LDAIHSM------GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV---- 204

Query: 697 KGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEIL 730
            G+  Y+ PE  + Q        + D +S GV L+E+L
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 30/110 (27%), Positives = 57/110 (51%), Gaps = 10/110 (9%)

Query: 539 LLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHL 591
           +LG G FGKV  G   G +      KVA+K   P +     +   +E+++++ L  H ++
Sbjct: 44  ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103

Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK---PPLPWKQRLEICI 638
           V+L+G C ++  + ++ +Y  YG L  +L+K +       P K + ++ I
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDI 153

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 9/102 (8%)

Query: 532 NNFDEALLLGVGGFGKVYR------GEIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLS 584
           +N      LG G FGKV        G+ D    +VA+K     +     E   +E+++LS
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKED-NVLRVAVKMLKASAHTDEREALMSELKILS 96

Query: 585 KL-RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK 625
            L +H+++V+L+G C     ++++ +Y  YG L   L K  +
Sbjct: 97  HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAE 138

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 39/216 (18%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           ++G G FG VY       + KVAIK+      Q       E+ ++  L H +++ L  Y 
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYKNRELLIMKNLNHINIIFLKDYY 128

Query: 599 --------EENCEMILVYDYMAYGTLREHL--YKTQKPPLPWKQRLEICIGAARGLHYLH 648
                   E+N  + +V +++   T+ +++  Y      LP            R L Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 649 TGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSKTGPTLDHTHVSTVVKG--SFGYLDP 705
           +     I HRD+K  N+L+D      K+ DFG +K            ++ G  S  Y+  
Sbjct: 188 S---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-----------NLLAGQRSVSYICS 233

Query: 706 EYFRRQQL-------TEKSDVYSFGVVLFEILCARP 734
            ++R  +L       T   D++S G ++ E++   P
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269

Length = 440

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	893
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	100.0
PLN03150	623	hypothetical protein; Provisional	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.78
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
PRK12274	218	serine/threonine protein kinase; Provisional	99.75
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.75
PRK10345	210	hypothetical protein; Provisional	99.72
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.67
PRK14879	211	serine/threonine protein kinase; Provisional	99.66
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.65
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.65
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.64
smart00090	237	RIO RIO-like kinase.	99.64
PLN03150	623	hypothetical protein; Provisional	99.63
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.56
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.5
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.49
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.43
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	99.41
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.37
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	99.35
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.33
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.18
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.15
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.14
KOG1243	690	consensus Protein kinase [General function predict	99.05
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.99
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.98
KOG3087	229	consensus Serine/threonine protein kinase [General	98.97
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.94
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.94
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.75
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	98.72
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.7
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.58
PRK09902	216	hypothetical protein; Provisional	98.43
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.4
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.3
COG4248	637	Uncharacterized protein with protein kinase and he	98.3
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.22
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.15
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.98
PF01636	239	APH: Phosphotransferase enzyme family This family	97.96
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.89
PLN02876	822	acyl-CoA dehydrogenase	97.78
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.78
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.77
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.61
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.61
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.59
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.44
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.37
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.29
PRK10593	297	hypothetical protein; Provisional	97.29
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.28
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.24
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.22
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.17
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.1
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.83
PRK05231	319	homoserine kinase; Provisional	96.76
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.73
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.4
PLN02236	344	choline kinase	96.15
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.08
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.04
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.95
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.82
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.42
PRK12396	409	5-methylribose kinase; Reviewed	95.22
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.21
PLN02756	418	S-methyl-5-thioribose kinase	94.85
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.78
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	94.74
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.64
COG2334	331	Putative homoserine kinase type II (protein kinase	93.57
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.48
PF04478	154	Mid2: Mid2 like cell wall stress sensor; InterPro:	93.4
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	93.12

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-57  Score=501.36  Aligned_cols=291  Identities=51%  Similarity=0.848  Sum_probs=260.1

Q ss_pred             cccccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEE
Q 036624          518 LCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY  597 (893)
Q Consensus       518 ~~~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~  597 (893)
                      ..+.|++.||+.||++|+..++||+|+||.||+|.+.++ ..||||++.....+..++|.+|++++.+++|||||+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            357899999999999999999999999999999999987 7899998876544315569999999999999999999999


Q ss_pred             EeecC-EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEe
Q 036624          598 CEENC-EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVS  676 (893)
Q Consensus       598 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~  676 (893)
                      |.+.+ +++||||||++|+|.++|+.....+|+|.+|++||.++|+||+|||+.+.++|||||||++|||||+++++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99998 59999999999999999997654379999999999999999999999888899999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc
Q 036624          677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK  756 (893)
Q Consensus       677 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  756 (893)
                      |||+|+..+.. ..+..+...||.+|+|||++..+..|+|+|||||||+|+||+||+.+.+...+.....+.+|++....
T Consensus       220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99999876542 22222211799999999999999999999999999999999999999987666667779999999999


Q ss_pred             ccchhhhcccccc-CCCCh-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          757 KGILEQIMDPYLK-GKIAP-ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       757 ~~~~~~i~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ++.+.+++|+.+. ..... ++..++..++.+|++.+|.+||+|.||+++|+....
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            9999999999987 56664 789999999999999999999999999999965443

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=100.00  E-value=3.5e-54  Score=475.27  Aligned_cols=328  Identities=36%  Similarity=0.587  Sum_probs=252.0

Q ss_pred             EecCCCC----CCCCCCCCccccCCCCc-ccccCCCcccccccCCCCCCCCCCcccceeecCC--ceEEeeec--CCceE
Q 036624           38 LNCGESS----ILSDDDKRSWTPDIGSK-FLLSTKDSTTSKAATQDPSTPTIPYMTARVFRSE--FTYSFPVV--AGRKF  108 (893)
Q Consensus        38 I~CG~~~----~~~~~~~~~w~~D~~~~-~g~~~~~~~~~~~~~~~~~~~~~~y~t~R~f~~~--~cY~~p~~--~g~~y  108 (893)
                      ||||++.    +.|+.+||+|++|.+|+ +|.++.++....   ........+|.|||+||.|  |||+||+.  +|.||
T Consensus         1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~---~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~y   77 (347)
T PF12819_consen    1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPD---SSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKY   77 (347)
T ss_pred             CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccC---CcCCccccccceEEEcCCCCccEEEeeccCCCCceE
Confidence            8999853    45567899999999999 888777732211   1123345679999999954  99999996  46677


Q ss_pred             -EEEEEecCCCCCCC----CCCcceEEEeCC-eEEEeccChhhhhhhhccceeEEEEeeecC-CCcEEEEEeeCCCCCcc
Q 036624          109 -VRLYFYPNSYNRLN----ATDALFSVSTGP-YTLLKNFSVAQTAEALNYAYVIKEYAIPVD-GETLNITFSPMNVSNAY  181 (893)
Q Consensus       109 -vR~~F~~g~yd~~~----~~~~~Fdv~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~-~~~~~i~f~p~~~~~~~  181 (893)
                       ||+||+|||||+++    .+++.|||++|+ +|.+|+.+.+ .     ..++.+|+++.|. ...+.|||.|...+ .+
T Consensus        78 liRl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~-~-----~~~~~~E~ii~v~~~~~l~vclv~~~~g-~~  150 (347)
T PF12819_consen   78 LIRLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNS-P-----SSPVVKEFIINVTWSDTLSVCLVPTGSG-TF  150 (347)
T ss_pred             EEEEEeccccccccccccccCCcceEEEECCceeEEEEecCC-C-----cceEEEEEEEEEcCCCcEEEEEEeCCCC-CC
Confidence             99999999999875    235789999999 9999998752 1     2579999999999 69999999999953 38


Q ss_pred             eeecceeeeecCcccccCCCCceeccCCcccccchhhhhheeeeeccCCcc--cCCCCCccccccccCCCCceecCCCCc
Q 036624          182 AFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKD--ISPSGDTDLFRSWYDDQPYIFGAALGV  259 (893)
Q Consensus       182 ~fv~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~R~n~Gg~~--~~~~~d~d~~r~w~~d~~~~~~~~~~~  259 (893)
                      |||||||+++||+.++.+            .....+.||++++|+||||..  +++.+|+ .+|.|++   |.. . .+ 
T Consensus       151 pFIsaiEl~~lp~~ly~~------------~~~~~s~~L~~~~R~n~G~~~~~iryp~D~-~dR~W~~---~~~-~-~~-  211 (347)
T PF12819_consen  151 PFISAIELRPLPDSLYPD------------TDANSSQALETVYRLNVGGSSSFIRYPDDT-YDRIWQP---YSS-S-PG-  211 (347)
T ss_pred             CceeEEEEEECCccceec------------cccCCCceeEEEEeecCCCcccccCCCCCc-ceeeccc---ccc-C-cc-
Confidence            999999999997766421            123467899999999999988  8888885 5577773   311 1 11 


Q ss_pred             eeecCCCceeecCCCCCcccchhHHHHHhhhcCCCCCcccccceEEEEecCCCCeeEEEEeeeecccCccccccEEEEEE
Q 036624          260 PVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDIL  339 (893)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~P~~v~~tA~~~~~~~~~~~~~~~tw~~~~~~~~~y~v~lhF~e~~~~~~~~~~r~F~i~  339 (893)
                      +.......++......+.|.||.+||+||+++.++   +.++||+|.+ +++++.|+|+||||||+....+.+.|+|+||
T Consensus       212 ~~~ist~~~i~~~~~~~~~~~P~~V~~TA~~~~~~---s~~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F~Iy  287 (347)
T PF12819_consen  212 WSNISTTSNININSSNNPYDAPSAVYQTARTPSNS---SDPLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREFDIY  287 (347)
T ss_pred             ccccccceeeecccCCccCcChHHHHHhhhccccc---ccceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEEEEE
Confidence            11111112232224567899999999999999987   3459999999 9999999999999999974456668999999


Q ss_pred             ecCcccCCccCccc-cccCCCceEEEEEEEEecCCCCcceeEEeecccccCcccccccccccceeeec
Q 036624          340 LNNQTAFPAFDVAG-LTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKL  406 (893)
Q Consensus       340 in~~~~~~~~dv~~-~~~~~~~~l~~~~~~~i~~~~~~~~~~l~l~~n~~~~~~~~~~~ln~l~~~~l  406 (893)
                      |||+.+..  ++.. +......++|.++.+.++.++   .+++.|++..  ++. ++++|||+|++++
T Consensus       288 iN~~~~~~--~~~~~~~~~~~~~~~~d~~~~~~~~~---~~~isL~~t~--~S~-lppiLNalEIy~v  347 (347)
T PF12819_consen  288 INGQTAYS--DVSPPYLGADTVPYYSDYVVNVPDSG---FLNISLGPTP--DST-LPPILNALEIYKV  347 (347)
T ss_pred             ECCeEccC--ccCcccccCcceEeecceEEEecCCC---EEEEEEEeCC--CCC-cCceeEeeeeEeC
Confidence            99998876  4433 455578899999999886543   5678888866  334 4999999999975

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>PLN03150 hypothetical protein; Provisional

Probab=100.00  E-value=2.4e-51  Score=487.05  Aligned_cols=334  Identities=23%  Similarity=0.320  Sum_probs=255.1

Q ss_pred             cccCCCCcEEEecCCCCCC-CCCCCCccccCCCCcccccCCCcccccccCCCCCCCCCCcccceeecC----CceEEeee
Q 036624           28 ADYIPSEQILLNCGESSIL-SDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDPSTPTIPYMTARVFRS----EFTYSFPV  102 (893)
Q Consensus        28 ~~~~~~~~~~I~CG~~~~~-~~~~~~~w~~D~~~~~g~~~~~~~~~~~~~~~~~~~~~~y~t~R~f~~----~~cY~~p~  102 (893)
                      .+++++++|+||||++.+. +|.+||+|++|..|+.|......        .|.....+|.|+|+||.    .|||+||+
T Consensus        18 ~~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~~~~~~~~--------~~~~~~~~~~t~R~F~~~~g~~~cY~~~~   89 (623)
T PLN03150         18 LASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANAT--------RPSFIAPPLKTLRYFPLSDGPENCYNINR   89 (623)
T ss_pred             cccCCCccEEEeCCCCCCcccCCCCCEEcCCcccccCcccccc--------CcccccchhhccccCCcccccccceEeee
Confidence            3445789999999997665 55689999999777533222221        12233456999999995    49999998


Q ss_pred             cCCceE-EEEEEecCCCCCCCCCCcceEEEeCC-eEEEeccChhhhhhhhccceeEEEEeeecCCCcEEEEEeeCCCCCc
Q 036624          103 VAGRKF-VRLYFYPNSYNRLNATDALFSVSTGP-YTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSNA  180 (893)
Q Consensus       103 ~~g~~y-vR~~F~~g~yd~~~~~~~~Fdv~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~i~f~p~~~~~~  180 (893)
                      +++.+| ||+||+|||||+.+ ++|.|||++|| +|.+++.+...     ....+++|+++.+..+.+.|||.|..+  .
T Consensus        90 ~~~g~ylVRl~F~~~~y~~~~-~~~~Fdv~~~~~~~~tv~~~~~~-----~~~~v~~E~i~~~~~~~l~vcf~~~~~--~  161 (623)
T PLN03150         90 VPKGHYSVRVFFGLVAEPNFD-SEPLFDVSVEGTQISSLKSGWSS-----HDEQVFAEALVFLTDGSASICFHSTGH--G  161 (623)
T ss_pred             cCCCcEEEEEEeecCCcCCCC-CCCceEEEECcEEEEEEecCccc-----CCCcEEEEEEEEecCCcEEEEEecCCC--C
Confidence            775455 99999999999988 45999999999 99998754221     124688999999999999999999863  3


Q ss_pred             ceeecceeeeecCcccccCCCCceeccCCcccccchhhhhheeeeeccCCcccCCCCCc--ccc---ccccCCCCceecC
Q 036624          181 YAFVNGIEVMSMPDIYKNTDGDLMIVGQSSPISIDNTTALENVYRLNVGGKDISPSGDT--DLF---RSWYDDQPYIFGA  255 (893)
Q Consensus       181 ~~fv~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~R~n~Gg~~~~~~~d~--d~~---r~w~~d~~~~~~~  255 (893)
                      +|||||||++++|+.++..       +..    ...+.+|++++|+||||+++++..|+  |+|   |.|++|++|+...
T Consensus       162 ~pFIs~iEv~~l~~~~y~~-------~~~----~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~  230 (623)
T PLN03150        162 DPAILSIEILQVDDKAYNF-------GPS----WGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGS  230 (623)
T ss_pred             CCceeEEEEEEcCcccccc-------ccc----ccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCc
Confidence            8999999999997766421       000    11256799999999999877653332  576   7777888887322


Q ss_pred             CCCceeecCCCceeecCCCCCcccchhHHHHHhhhcCCCCCcccccceEEEEecCCCCeeEEEEeeeecccCccccccEE
Q 036624          256 ALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRV  335 (893)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~P~~v~~tA~~~~~~~~~~~~~~~tw~~~~~~~~~y~v~lhF~e~~~~~~~~~~r~  335 (893)
                          +........+.+. ..+++.+|+.||||||++.++     ..+++|.++++++..|+|||||||+++.....+.|+
T Consensus       231 ----~~~~st~~~I~~~-~~~~~~~P~~VyqTA~~~~~~-----~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~  300 (623)
T PLN03150        231 ----DQAISTENVIKKA-SNAPNFYPESLYQSALVSTDT-----QPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRV  300 (623)
T ss_pred             ----ccccccccccccc-cCCCccChHHHhhhhccccCC-----CCceEEEeecCCCCCEEEEEEEEeccCccCCCceEE
Confidence                1112223334432 357789999999999998864     367899999999899999999999986556779999


Q ss_pred             EEEEecCcccCCccCccccccCCCceEEEEEEEEecCCCCcceeEEeecccccCcccccccccccceeeecc
Q 036624          336 FDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNGPQKDLWLGLHPNVASKTQYYDAILNGVEIFKLS  407 (893)
Q Consensus       336 F~i~in~~~~~~~~dv~~~~~~~~~~l~~~~~~~i~~~~~~~~~~l~l~~n~~~~~~~~~~~ln~l~~~~ls  407 (893)
                      |+|||||+.+..++|+..+++....+++.++.+.+..    ..+++.+.+..  +   .++++|++|++++.
T Consensus       301 F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~----g~l~isl~p~~--~---s~pilNaiEI~~~~  363 (623)
T PLN03150        301 FDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSG----RTLTIVLQPKK--G---THAIINAIEVFEII  363 (623)
T ss_pred             EEEEECCEEeecccChhhhcCCcccceEEEeEEeecC----CeEEEEEeeCC--C---Ccceeeeeeeeecc
Confidence            9999999999999999888877778999998886642    34788888754  2   25899999999997

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=411.75  Aligned_cols=253  Identities=36%  Similarity=0.583  Sum_probs=213.2

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh--hhHHHHHHHHHHHhhccccceeeEEEEEeecC-EEEEEEeeccC
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE--QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC-EMILVYDYMAY  613 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~  613 (893)
                      .+.||+|+||+||+|.+.+. ..||||++.....  ...++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            34699999999999999985 4499998775432  22669999999999999999999999999887 79999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCc-eEecCCCCCCEEECCCC-ceeEecccccccCCCCCCcc
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT-IIHRDVKTTNILLDEKW-VAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDlk~~NILld~~~-~~kl~DFGla~~~~~~~~~~  691 (893)
                      |+|.++|++..+..+++..+++|+.|||+||.|||+   .+ |||||||++||||+.++ ++||+|||+++......  .
T Consensus       125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            999999988656679999999999999999999995   55 99999999999999997 99999999998643321  2


Q ss_pred             ceeeeccCcCccChHhhh--hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          692 VSTVVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~--~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      ..+...||+.|||||+++  ...|++|+|||||||+||||+||+.||....+ .+.              ...++....+
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~--------------~~~v~~~~~R  264 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQV--------------ASAVVVGGLR  264 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHH--------------HHHHHhcCCC
Confidence            233467999999999999  66999999999999999999999999976544 111              1122222334


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ..++.+|...+..++.+||+.||+.||++.+++..|+....
T Consensus       265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            45555688899999999999999999999999999997765

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-45  Score=420.22  Aligned_cols=260  Identities=32%  Similarity=0.489  Sum_probs=221.2

Q ss_pred             CCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCCChh-hHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      +....+.||+|+||+||+|+..+     ....||||.++..... ..++|++|+++|..++|||||+|+|+|.+++.++|
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            34455689999999999998643     3367999998876554 78899999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhC--------C----CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCcee
Q 036624          607 VYDYMAYGTLREHLYKT--------Q----KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAK  674 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~--------~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~k  674 (893)
                      |+|||.+|||.++|...        .    ..+|+..+.+.||.|||.||+||-   .+.+|||||..+|+||.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence            99999999999999642        1    234899999999999999999998   58999999999999999999999


Q ss_pred             EecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHH
Q 036624          675 VSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAH  753 (893)
Q Consensus       675 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~  753 (893)
                      |+||||+|.....++.+......-+++||+||.+..++||.+|||||||||||||++ |+-|+.+....+          
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----------  713 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----------  713 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----------
Confidence            999999998877776665544456789999999999999999999999999999997 888886543322          


Q ss_pred             hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       754 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                           .++.+.+..+ -..++.|+.++..|++.||+.+|.+||+++||-..|+...+.
T Consensus       714 -----VIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  714 -----VIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -----HHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                 2233333333 345778999999999999999999999999999999876643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-45  Score=381.43  Aligned_cols=262  Identities=26%  Similarity=0.382  Sum_probs=218.4

Q ss_pred             cccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC-CChhhHHHHHHHHHHHhhccccceeeEEEEE
Q 036624          520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC  598 (893)
Q Consensus       520 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~  598 (893)
                      ..+++.||+.       .+.||+|..|+|||+.++.+++.+|+|.+.. ......+++.+|++++++.+||+||.++|.|
T Consensus        74 ~~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF  146 (364)
T KOG0581|consen   74 NGISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAF  146 (364)
T ss_pred             cccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE
Confidence            3466666654       5589999999999999999999999998743 3455678899999999999999999999999


Q ss_pred             eecC-EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEec
Q 036624          599 EENC-EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSD  677 (893)
Q Consensus       599 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~D  677 (893)
                      .... +..++||||++|+|+..+...+  .+++...-+|+.++++||.|||+  +++||||||||+|||++..|++||||
T Consensus       147 ~~~~~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicD  222 (364)
T KOG0581|consen  147 YSNGEEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICD  222 (364)
T ss_pred             EeCCceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecc
Confidence            9988 5999999999999999997653  49999999999999999999995  58999999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc
Q 036624          678 FGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       678 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  757 (893)
                      ||.++.....    ......||..|||||.+++..|+.++||||||+.|+|+.+|+.|+....+. ..   .|+.     
T Consensus       223 FGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~---~~~~-----  289 (364)
T KOG0581|consen  223 FGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YL---DIFE-----  289 (364)
T ss_pred             ccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CC---CHHH-----
Confidence            9999865332    344567999999999999999999999999999999999999999764211 11   1211     


Q ss_pred             cchhhhccccccCCCCh-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          758 GILEQIMDPYLKGKIAP-ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                       .+..|++... ...+. .+..+++.++..||++||.+||++.|+++|-.-
T Consensus       290 -Ll~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi  338 (364)
T KOG0581|consen  290 -LLCAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI  338 (364)
T ss_pred             -HHHHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence             2333444221 12233 477889999999999999999999999987653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=393.82  Aligned_cols=261  Identities=31%  Similarity=0.428  Sum_probs=218.0

Q ss_pred             cccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEe
Q 036624          520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE  599 (893)
Q Consensus       520 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~  599 (893)
                      -.+..++++.       .+.||+|.||.||.|.+++. ..||+|.++... ...++|.+|+.+|++|+|+|||+++|+|.
T Consensus       201 wei~r~~l~l-------~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~  271 (468)
T KOG0197|consen  201 WEIPREELKL-------IRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCT  271 (468)
T ss_pred             eeecHHHHHH-------HHHhcCCccceEEEEEEcCC-CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence            3556666654       45899999999999999986 679999877642 33567999999999999999999999999


Q ss_pred             ecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccc
Q 036624          600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG  679 (893)
Q Consensus       600 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG  679 (893)
                      ..+.++||||||++|+|.++|+...+..+...+.+.++.|||+||+||+   .+++|||||.++||||+++..+||+|||
T Consensus       272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccc
Confidence            9889999999999999999999877778999999999999999999999   5899999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhccc
Q 036624          680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKG  758 (893)
Q Consensus       680 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  758 (893)
                      |||... .+....+...+-+..|.|||.+..+.++.|||||||||+||||+| |+.|+....      ..+.+..     
T Consensus       349 LAr~~~-d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------n~ev~~~-----  416 (468)
T KOG0197|consen  349 LARLIG-DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------NEEVLEL-----  416 (468)
T ss_pred             cccccC-CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------HHHHHHH-----
Confidence            999432 233334444556789999999999999999999999999999998 677764432      2222222     


Q ss_pred             chhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          759 ILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       759 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                           ++.-.+-..++.|+..+.+|+..||+.+|++|||...+...|+...
T Consensus       417 -----le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  417 -----LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             -----HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence                 2222233456789999999999999999999999999888887654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=373.12  Aligned_cols=202  Identities=30%  Similarity=0.501  Sum_probs=183.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .+|...+.||+|+||+||+|+++..+..||||.+...  ..+..+.+..|+.+|+.++|||||+++++++..+.++||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            5677788899999999999999988899999987654  56667778999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC------CceeEeccccccc
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK------WVAKVSDFGLSKT  683 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~------~~~kl~DFGla~~  683 (893)
                      ||.+|+|.++|+..+  .+++..+..++.|+|.||++||   +++||||||||+||||+..      -.+||+|||+||.
T Consensus        90 yC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             eCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            999999999998775  4999999999999999999999   6999999999999999765      4689999999997


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCc
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP  741 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~  741 (893)
                      ...   ......++|++-|||||+++.++|+.|+|+||.|+|||++++|++||+....
T Consensus       165 L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  165 LQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             CCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            653   3445678999999999999999999999999999999999999999976543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-42  Score=381.85  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=213.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ..|...++||+|||+.||+++....+..||+|++...   .....+...+||+|.+.|+|||||++++++++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4578889999999999999999777799999986642   3445677899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |+|++++|.+++.  .+.++++.++..+..||+.||.|||   +.+|||||||..|+||+++.++||+|||||...... 
T Consensus        98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-  171 (592)
T ss_pred             EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc-
Confidence            9999999999886  4457999999999999999999999   589999999999999999999999999999875432 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                       .......||||.|+|||++.....+..+||||+||+||-||.|++||+...-      .+-...         |...  
T Consensus       172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------kety~~---------Ik~~--  233 (592)
T KOG0575|consen  172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV------KETYNK---------IKLN--  233 (592)
T ss_pred             -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH------HHHHHH---------HHhc--
Confidence             2345678999999999999999999999999999999999999999975421      111111         1110  


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ...++........+||.++|+.+|.+|||+.+|+.+=.+
T Consensus       234 ~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  234 EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence            112333455667889999999999999999999987665

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.2e-41  Score=426.07  Aligned_cols=270  Identities=27%  Similarity=0.462  Sum_probs=224.5

Q ss_pred             ccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEee
Q 036624          521 HFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE  600 (893)
Q Consensus       521 ~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~  600 (893)
                      .++++++.   ..|...++||+|+||.||+|+....+..||||++......    ...|++++++++|||||+++|+|.+
T Consensus       682 ~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~  754 (968)
T PLN00113        682 SITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS  754 (968)
T ss_pred             hhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence            34555543   4577888999999999999998777789999987653322    2356889999999999999999999


Q ss_pred             cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccc
Q 036624          601 NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL  680 (893)
Q Consensus       601 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl  680 (893)
                      .+..++|||||++|+|.++++.     ++|.++.+|+.|+|+||+|||+.+..+|+||||||+||+++.++.+++. ||.
T Consensus       755 ~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~  828 (968)
T PLN00113        755 EKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL  828 (968)
T ss_pred             CCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence            9999999999999999999952     8999999999999999999997777899999999999999999988886 666


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      ......      .....||+.|+|||++.+..++.|+|||||||++|||++|+.|++.... ....+.+|++........
T Consensus       829 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~  901 (968)
T PLN00113        829 PGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHL  901 (968)
T ss_pred             cccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccch
Confidence            543211      1123578999999999999999999999999999999999999964332 345678888877766667


Q ss_pred             hhhccccccC--CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          761 EQIMDPYLKG--KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       761 ~~i~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ..++|+.+..  ..+.++..++.+++.+||+.+|++||+|.||++.|+...+
T Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            7778877644  3455677889999999999999999999999999997664

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-42  Score=364.25  Aligned_cols=256  Identities=27%  Similarity=0.341  Sum_probs=207.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh-------hHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-------GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      +.|...+.||+|+||.|-+|..+.+++.||||+++.....       ......+|+++|++|+|||||++.+++...+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            4566778999999999999999999999999987643111       122357999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC---CceeEeccccc
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK---WVAKVSDFGLS  681 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla  681 (893)
                      |||||||+||+|.+++-.++.  +.+.....++.|++.|+.|||   ++||+||||||+|||+..+   ..+||+|||||
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             EEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            999999999999999976653  778888999999999999999   5999999999999999765   78999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcC---CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG  758 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  758 (893)
                      +....   .......|||+.|.|||++.++.   +..|.|+||+|||||-+|+|.+||......  .++.          
T Consensus       327 K~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~----------  391 (475)
T KOG0615|consen  327 KVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLK----------  391 (475)
T ss_pred             hcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHH----------
Confidence            97542   33455689999999999998654   335789999999999999999999754321  1111          


Q ss_pred             chhhhcccccc--CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          759 ILEQIMDPYLK--GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       759 ~~~~i~d~~l~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                        +++...+..  .....+..++..+++.++|..||++||++.|++++-+...
T Consensus       392 --eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~  442 (475)
T KOG0615|consen  392 --EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD  442 (475)
T ss_pred             --HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence              122222211  1112355677889999999999999999999999988543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-43  Score=350.99  Aligned_cols=257  Identities=23%  Similarity=0.357  Sum_probs=209.2

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEE-EEeecCE-EEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIG-YCEENCE-MILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV~  608 (893)
                      +|.+.++||+|.||+|||+....++..||.|.++-  .+.+..+++..|+.+|++|+|||||++++ .+.+..+ +.|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            46677899999999999999988889999997663  46677888999999999999999999998 4555556 89999


Q ss_pred             eeccCCCHHHHHhh--CCCCCCCHHhHHHHHHHHHHhhhhhhcCCCC-ceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          609 DYMAYGTLREHLYK--TQKPPLPWKQRLEICIGAARGLHYLHTGAKH-TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       609 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      |||..|+|...+..  .++..++++.+++++.|+++||..+|+...+ -|+||||||.||+|+.+|.+||+||||++...
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999998864  4566799999999999999999999964333 37899999999999999999999999999754


Q ss_pred             CCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      .  .........|||.||+||.+....|+.||||||+||++|||..-++||.+.      ++.+.... .+.+.      
T Consensus       180 s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~K-I~qgd------  244 (375)
T KOG0591|consen  180 S--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKK-IEQGD------  244 (375)
T ss_pred             c--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHH-HHcCC------
Confidence            3  223344567999999999999999999999999999999999999999764      22222111 11111      


Q ss_pred             ccccCCCC-hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          766 PYLKGKIA-PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       766 ~~l~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                        . ...+ .-....+.+|+..|+..||+.||+...++..+..
T Consensus       245 --~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  245 --Y-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             --C-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence              1 1122 4467789999999999999999996666655554

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=366.49  Aligned_cols=264  Identities=27%  Similarity=0.447  Sum_probs=218.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh-hHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .+.....++||+|-||.|.+|+..+. ..||||.++..... ..++|..|+++|.+++||||++|+|+|..++.+++|+|
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~-lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGP-LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCc-eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            34456677999999999999999874 78999999876544 45899999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      ||++|+|.++|.+...+.+.-....+||.|||.||+||.+   .++|||||.++|+|+|.++++||+|||++|.....++
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            9999999999988765556777888999999999999994   8999999999999999999999999999998777666


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHh--hCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL--CARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ell--tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                      .+......-+++|||||.+..+++|.++|||+|||.|||++  |...|+.....+.   .++-...+...+.      ..
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~------~~  763 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQG------RQ  763 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCC------cc
Confidence            66665666788999999999999999999999999999985  5677775432211   1111111111111      11


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .....++-|+.++.+++++||..+-++||+.+++...|++
T Consensus       764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            1123456788999999999999999999999999998875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-42  Score=359.28  Aligned_cols=243  Identities=26%  Similarity=0.356  Sum_probs=204.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .++|+..++||+|+||+||.++.+++++..|+|.++..   ...+.+...+|..+|.+++||.||+++..+++.+.++||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            35789999999999999999999999999999987653   334567789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      +||+.||.|..+|.+.+.  +++..+.-.+..|+.||.|||   +.+||||||||+|||||++|+++|+||||++.... 
T Consensus       104 ld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-  177 (357)
T ss_pred             EeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence            999999999999987654  888888888999999999999   69999999999999999999999999999996433 


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                       ....+..++||+.|||||++.+..|+..+|+||+|+++|||++|.+||.....      .++...         +....
T Consensus       178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~---------I~~~k  241 (357)
T KOG0598|consen  178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDK---------ILKGK  241 (357)
T ss_pred             -CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHH---------HhcCc
Confidence             22334458999999999999999999999999999999999999999976542      222222         11111


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCC
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERP  796 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  796 (893)
                      + ...+.-......+++.+.|+.+|++|.
T Consensus       242 ~-~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 L-PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             C-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            1 111222456678899999999999996

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=387.35  Aligned_cols=264  Identities=22%  Similarity=0.394  Sum_probs=221.2

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcc---eEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGAT---TKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~---~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ...+.++||.|.||.||+|+++..+   ..||||.++.. .++...+|..|+.||.++.||||++|.|+.......++|.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            3457789999999999999986543   46999988865 4567789999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |||+||+|+.+|+.+.+ .+.+.+...+.++||.||.||-   +.++|||||.++|||++.+..+||+||||+|......
T Consensus       710 EyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            99999999999998764 4999999999999999999998   7999999999999999999999999999999653322


Q ss_pred             -CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          689 -HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       689 -~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                       .......-+-+.+|.|||.+..+++|.+||||||||||||.++ |.+|+......+               .+.. ++.
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd---------------VIka-Ie~  849 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---------------VIKA-IEQ  849 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---------------HHHH-HHh
Confidence             1122222334679999999999999999999999999999886 888886543322               1111 222


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhchhhh
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAE  816 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~~~~  816 (893)
                      -.+-..+.+|+..|.+|++.||++|-.+||+..+|+..|.+++.-..+.+
T Consensus       850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk  899 (996)
T KOG0196|consen  850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK  899 (996)
T ss_pred             ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence            23345577999999999999999999999999999999999886544443

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-41  Score=396.31  Aligned_cols=259  Identities=29%  Similarity=0.466  Sum_probs=214.8

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcc-----eEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      +....+.||+|+||.||+|...+..     ..||||.+... +.+...+|.+|..+|++++|||||+++|+|.+....++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            3445668999999999999986533     34999987765 56778899999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCC-----CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          607 VYDYMAYGTLREHLYKTQ-----KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      ++|||++|+|..+|++.+     ...|...+.+.||.|||+|+.||+   +.++|||||.++|+||++...+||+|||||
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence            999999999999998762     346899999999999999999999   589999999999999999999999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      |.....++........-..+|||||.++.+.+|.|+|||||||+||||+| |..|+......+      ......+.+  
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~~~~~~gg--  921 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VLLDVLEGG--  921 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HHHHHHhCC--
Confidence            96555444443333345679999999999999999999999999999998 667765433221      011111222  


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                              +-..+..|+.++.+++..||+.+|++||+...+++.+....+
T Consensus       922 --------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  922 --------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             --------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                    223467899999999999999999999999999998776654

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-41  Score=373.20  Aligned_cols=257  Identities=31%  Similarity=0.482  Sum_probs=212.2

Q ss_pred             cceeeeecCcEEEEEEEEcCcc---eE-EEEEeCCC---CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          536 EALLLGVGGFGKVYRGEIDGAT---TK-VAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~~~~---~~-VavK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ..++||+|+||.||+|.++..+   .. ||||..+.   .......+|++|+++|++++|||||+++|++.....++|||
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence            3469999999999999986532   23 89998764   45778899999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |+|.||+|.++|.+... .++..+++.++.++|+||+|||   ..++|||||.++|+|++.++.+||+||||++....  
T Consensus       241 El~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~--  314 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ--  314 (474)
T ss_pred             EecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcc--
Confidence            99999999999987764 6999999999999999999999   58999999999999999999999999999987542  


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                      .........-+.+|+|||.+..+.|+.++|||||||++||+++ |..|+.+....+   +.            ..++...
T Consensus       315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~------------~kI~~~~  379 (474)
T KOG0194|consen  315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VK------------AKIVKNG  379 (474)
T ss_pred             eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HH------------HHHHhcC
Confidence            1111112246789999999999999999999999999999998 777886543321   11            1121112


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhch
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE  813 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~  813 (893)
                      .+...+...+..+..++.+||..+|++||+|.++.+.|+.+..-.+
T Consensus       380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            2233445667788888999999999999999999999997775444

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.4e-41  Score=340.45  Aligned_cols=266  Identities=24%  Similarity=0.309  Sum_probs=205.5

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh--hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE--QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .|+...++|+|+||+||||+++++++.||||++....+  .-.+-.++|+++|++++|+|+|.|+.+|..+..++||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            46777899999999999999999999999998765433  3345568999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      |+..-|.+ |.+..+ .++.+.+.+++.|+++|+.|+|   +++||||||||+||||..++.+||||||+||......  
T Consensus        83 ~dhTvL~e-Le~~p~-G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--  155 (396)
T KOG0593|consen   83 CDHTVLHE-LERYPN-GVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--  155 (396)
T ss_pred             cchHHHHH-HHhccC-CCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--
Confidence            99655554 433332 3889999999999999999999   5899999999999999999999999999999765321  


Q ss_pred             cceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHH--------Hhh-ccc--
Q 036624          691 HVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAA--------HCH-KKG--  758 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~-~~~--  758 (893)
                      ..-+....|.+|.|||.+.+ .+|...+||||.||++.||++|.+-|.+...-++..+..-.-        ... .+.  
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            22234557889999999987 789999999999999999999999887665544433221110        000 111  


Q ss_pred             ---chhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          759 ---ILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       759 ---~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                         .+.+.-++......-+....-+++++..||+.||.+|++-+|++.+-
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~  285 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP  285 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence               11111121111111223345688999999999999999999998553

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.2e-40  Score=366.46  Aligned_cols=262  Identities=25%  Similarity=0.415  Sum_probs=205.6

Q ss_pred             hcCCccceeeeecCcEEEEEEEEc-----CcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhc-cccceeeEEEEEeec-C
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEID-----GATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEEN-C  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~  602 (893)
                      .++|+..++||+|+||.||+|.+.     .....||+|++.... ....+.+.+|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            457888899999999999999753     223579999876432 34456799999999999 899999999998764 4


Q ss_pred             EEEEEEeeccCCCHHHHHhhCC----------------------------------------------------------
Q 036624          603 EMILVYDYMAYGTLREHLYKTQ----------------------------------------------------------  624 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------  624 (893)
                      ..++||||+++|+|.++|....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6899999999999999987532                                                          


Q ss_pred             --CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCc
Q 036624          625 --KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY  702 (893)
Q Consensus       625 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  702 (893)
                        ..++++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134888999999999999999999   589999999999999999999999999999864322111122234467899


Q ss_pred             cChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHH
Q 036624          703 LDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFA  781 (893)
Q Consensus       703 ~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~  781 (893)
                      +|||++.+..++.++|||||||+||||++ |..||.......     ....... .+.         ....+..+...+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~~~-~~~---------~~~~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQRLK-DGT---------RMRAPENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHHHHh-cCC---------CCCCCCCCCHHHH
Confidence            99999999999999999999999999997 999986533211     1111111 110         0112234456788


Q ss_pred             HHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          782 ETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       782 ~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      +++.+||+.+|++||++.||++.|+.+++
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999997764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=364.83  Aligned_cols=266  Identities=29%  Similarity=0.466  Sum_probs=212.8

Q ss_pred             HHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecC
Q 036624          525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC  602 (893)
Q Consensus       525 ~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  602 (893)
                      ++.+...+.+.....||+|.||+||+|.+.++   ||||.++..  .....+.|++|+.++++-+|.||+-++|||....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            33333344455677999999999999999875   999987654  5567889999999999999999999999999887


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      . .+|..+|+|.+|+.+||..+ ..++..+.+.|+.|||+||.|||   ..+|||||||+.||+|.++++|||+||||+.
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             e-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccccee
Confidence            6 99999999999999998765 45899999999999999999999   5899999999999999999999999999986


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhh---cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccc
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI  759 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  759 (893)
                      ....-..........|...|||||+++.   .+|+..+||||||+|+|||+||..|+.... .++..      .+...|.
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dqIi------fmVGrG~  609 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQII------FMVGRGY  609 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhheE------EEecccc
Confidence            5332222222334557889999999974   468999999999999999999999997322 22110      1111111


Q ss_pred             hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       760 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      +  ..|.   ......|++++.+|+..||..++++||...+|+..|+.++.
T Consensus       610 l--~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  610 L--MPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             c--Cccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            0  0111   12344688899999999999999999999999999988775

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-40  Score=358.05  Aligned_cols=258  Identities=23%  Similarity=0.315  Sum_probs=218.0

Q ss_pred             HHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCE
Q 036624          528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCE  603 (893)
Q Consensus       528 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~  603 (893)
                      +...++|...+.||+|+|++|++|+....++.+|||++...   .+...+....|-++|.+| .||.|++|+..+.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            33446788888999999999999999999999999987642   334456678899999999 79999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      +|+|+||++||+|.++|++.+  .+++......+.+|+.||+|||   ..|||||||||+|||||+|+++||+|||-|+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            999999999999999998775  4999999999999999999999   59999999999999999999999999999987


Q ss_pred             CCCCCCc---------cc--eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHH
Q 036624          684 GPTLDHT---------HV--STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAA  752 (893)
Q Consensus       684 ~~~~~~~---------~~--~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  752 (893)
                      .+.....         ..  ...+.||..|++||++..+..+..+|+|+|||+||.|+.|.+||....+..         
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---------  294 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---------  294 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---------
Confidence            5432111         11  145789999999999999999999999999999999999999997654321         


Q ss_pred             HhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          753 HCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       753 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                            ..++|++-  ...+++..++...+|+.+.|..||.+|+|..+|.++.-+
T Consensus       295 ------iFqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF  341 (604)
T KOG0592|consen  295 ------IFQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFF  341 (604)
T ss_pred             ------HHHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccc
Confidence                  23334332  345566666888999999999999999999999877543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=352.56  Aligned_cols=259  Identities=25%  Similarity=0.368  Sum_probs=208.1

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecC--EEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC--EMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~  610 (893)
                      ++...+.||+|+||.||++.....+...|||..........+.+.+|+.+|++++|||||+++|......  .+++.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            4556779999999999999998767889999766543333677999999999999999999999854444  68999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-CCceeEecccccccCCC-CC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPT-LD  688 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~~-~~  688 (893)
                      +++|+|.+++.+.+. .|++..+.....||++||+|||   .++||||||||+||||+. ++.+||+|||+++.... ..
T Consensus        98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            999999999988776 7999999999999999999999   599999999999999999 79999999999886442 11


Q ss_pred             CccceeeeccCcCccChHhhhhcC-CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                      .........||+.|||||++..+. ...++|||||||++.||+||++||...     ....++.-.....        . 
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~--------~-  239 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRE--------D-  239 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhcc--------C-
Confidence            222334577999999999999643 335999999999999999999999643     1111111111111        1 


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ....++........+++.+|++.+|++|||+.+++++..-..
T Consensus       240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            112455556677889999999999999999999998876433

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=358.41  Aligned_cols=251  Identities=31%  Similarity=0.521  Sum_probs=210.4

Q ss_pred             cccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEe
Q 036624          520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE  599 (893)
Q Consensus       520 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~  599 (893)
                      -.+.+++|-       +.+-||.|+-|-||+|++++  +.||||+++...       ..+|+-|++|+|+||+.+.|+|.
T Consensus       119 WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~n--etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt  182 (904)
T KOG4721|consen  119 WEIPFEEIS-------ELEWLGSGAQGAVFLGRLHN--ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT  182 (904)
T ss_pred             ccCCHHHhh-------hhhhhccCcccceeeeeccC--ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence            456666664       35689999999999999987  679999876432       35688899999999999999999


Q ss_pred             ecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccc
Q 036624          600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG  679 (893)
Q Consensus       600 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG  679 (893)
                      ....+|||||||..|.|...|...+  ++.......+..+||.||.|||   .++|||||||+-||||..+-.+||+|||
T Consensus       183 qsPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFG  257 (904)
T KOG4721|consen  183 QSPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFG  257 (904)
T ss_pred             CCceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEecccc
Confidence            9999999999999999999996544  4888899999999999999999   5999999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccc
Q 036624          680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI  759 (893)
Q Consensus       680 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  759 (893)
                      -++.....   ..+..++||..|||||++++...++|+|||||||||||||||..|+...+....    -|         
T Consensus       258 TS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----Iw---------  321 (904)
T KOG4721|consen  258 TSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IW---------  321 (904)
T ss_pred             chHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EE---------
Confidence            98864322   334568899999999999999999999999999999999999999854332110    01         


Q ss_pred             hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       760 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                        -+=.-.|.-..+..|++.|.-|+++||+..|..||++++++.+|+-+.
T Consensus       322 --GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  322 --GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             --eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence              111122344567789999999999999999999999999999997543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.7e-40  Score=356.07  Aligned_cols=249  Identities=28%  Similarity=0.444  Sum_probs=214.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|...+.||+|.||.||||+.+.+.+.||+|.+.+.  .+++.+.+.+|++++++++|||||.++++++...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4677778999999999999999999999999976543  45567789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+.+ +|..+|...+  .++++.+..|+.+++.||.|||   +.+|+|||+||+||||+..+.+|+||||+||....  .
T Consensus        82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N  153 (808)
T ss_pred             hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence            9985 9999997665  4999999999999999999999   59999999999999999999999999999997543  5


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      +...+.++|||.|||||...++.|+..+|+||+||||||+++|++||...      ++...++....        |+   
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~--------d~---  216 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILK--------DP---  216 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhc--------CC---
Confidence            67778899999999999999999999999999999999999999999532      12222222111        11   


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ...+......+..++...|.+||.+|.+..+++.+-
T Consensus       217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence            123446677899999999999999999999998764

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7e-39  Score=348.10  Aligned_cols=260  Identities=21%  Similarity=0.346  Sum_probs=207.1

Q ss_pred             cccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh---hHHHHHHHHHHHhhccccceeeEEE
Q 036624          520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ---GVHEFQTEIEMLSKLRHRHLVSLIG  596 (893)
Q Consensus       520 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g  596 (893)
                      +.++..++     +......||+|++|.||+|.+.+  +.||||+++.....   ..+.|.+|+.+|++++||||++++|
T Consensus        13 ~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g   85 (283)
T PHA02988         13 KCIESDDI-----DKYTSVLIKENDQNSIYKGIFNN--KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG   85 (283)
T ss_pred             eecCHHHc-----CCCCCeEEeeCCceEEEEEEECC--EEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence            44555555     33334689999999999999854  78999987654322   2577889999999999999999999


Q ss_pred             EEee----cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc
Q 036624          597 YCEE----NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV  672 (893)
Q Consensus       597 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~  672 (893)
                      ++.+    ....++||||+++|+|.+++.+..  .++|...++++.|++.||.|||+  ..+++||||||+|||+++++.
T Consensus        86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~  161 (283)
T PHA02988         86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYK  161 (283)
T ss_pred             eEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCc
Confidence            9876    457899999999999999997643  58999999999999999999994  357889999999999999999


Q ss_pred             eeEecccccccCCCCCCccceeeeccCcCccChHhhhh--cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHH
Q 036624          673 AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEW  750 (893)
Q Consensus       673 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  750 (893)
                      +||+|||+++......     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......      ++
T Consensus       162 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~  230 (283)
T PHA02988        162 LKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EI  230 (283)
T ss_pred             EEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HH
Confidence            9999999988543211     12347889999999976  68999999999999999999999999754321      11


Q ss_pred             HHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          751 AAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       751 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ....         .........+..++..+.+++.+||+.+|++|||+.|+++.|+...+
T Consensus       231 ~~~i---------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        231 YDLI---------INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HHHH---------HhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            1111         11111112333567789999999999999999999999999987653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=359.81  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=213.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ..|....+||+|+.|.||.+........||||++........+-+.+|+.+|+..+|+|||.++..+..++++|.|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            45677778999999999999998888999999988766666777899999999999999999999999899999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|.+.+.+..   +++.++..||.++++||+|||   ..+|||||||.+||||+.++.+||+|||++.......  .
T Consensus       353 ~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~  424 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--S  424 (550)
T ss_pred             CCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc--C
Confidence            9999999886554   899999999999999999999   6999999999999999999999999999987654322  2


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ......||+.|||||+.....|..|.||||||++++||+-|.+||-...+-.    +-|.  ...++        ...-.
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr----AlyL--Ia~ng--------~P~lk  490 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALYL--IATNG--------TPKLK  490 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH----HHHH--HhhcC--------CCCcC
Confidence            3445679999999999999999999999999999999999999996433321    1111  11111        11122


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .++.....|.+++.+||+.|+++||++.|+|++--
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF  525 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPF  525 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence            34556678999999999999999999999997643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=341.07  Aligned_cols=264  Identities=23%  Similarity=0.317  Sum_probs=209.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..++||.|..++||+|+....+..||||++... .....+.+++|+..|+.++||||++++..|..+.++|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            5788889999999999999999888899999987643 333468899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC-
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH-  689 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~-  689 (893)
                      |.+|++.+.+...-...+++..+..|.+++++||.|||   ++|.||||||+.||||+++|.+||+|||.+........ 
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            99999999998765556999999999999999999999   69999999999999999999999999998654322211 


Q ss_pred             -ccceeeeccCcCccChHhhhh--cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          690 -THVSTVVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       690 -~~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                       ........||+.|||||+++.  ..|+.|+||||||+...||.+|..||....+.+.. +.    . ..+. .....-.
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-l~----t-Lqn~-pp~~~t~  255 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-LL----T-LQND-PPTLLTS  255 (516)
T ss_pred             eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-HH----H-hcCC-CCCcccc
Confidence             111145679999999999654  46999999999999999999999999765443211 10    0 0000 0000000


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      .+..+-.......+.+++..||++||++|||+++++++-
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~  294 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA  294 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence            111111122334688999999999999999999999653

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-39  Score=324.38  Aligned_cols=237  Identities=25%  Similarity=0.371  Sum_probs=203.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||.|+||.|.+.+.+.++...|+|+++...   .++.+...+|..+|+.+.||+++++.+.|.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46778889999999999999999988999999887543   344566789999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||++||.|.++|++.++  +++..+.-++.||+.||+|||   ...|++|||||+|||||.+|.+||+|||+|+....  
T Consensus       124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--  196 (355)
T ss_pred             eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence            99999999999987764  999999999999999999999   59999999999999999999999999999986432  


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                         .+.+.||||.|+|||+++.+.+..++|.|||||++|||++|.+||....+..               ..+.|+...+
T Consensus       197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---------------iY~KI~~~~v  258 (355)
T KOG0616|consen  197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---------------IYEKILEGKV  258 (355)
T ss_pred             ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---------------HHHHHHhCcc
Confidence               3567899999999999999999999999999999999999999997654411               1222333222


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCC
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIER  795 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~R  795 (893)
                        .++.-....+.+|+.+.|+.|-.+|
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence              2344455667888889999888888

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1e-38  Score=360.73  Aligned_cols=259  Identities=24%  Similarity=0.393  Sum_probs=203.4

Q ss_pred             cCCccceeeeecCcEEEEEEEE-----cCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEI-----DGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  604 (893)
                      ++|+..++||+|+||.||+|..     .+....||||+++.. .....+.+.+|++++..+ +||||++++++|......
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4577788999999999999974     234467999987643 234456789999999999 899999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCC------------------------------------------------------------
Q 036624          605 ILVYDYMAYGTLREHLYKTQ------------------------------------------------------------  624 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------  624 (893)
                      ++||||+++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999999986432                                                            


Q ss_pred             -------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          625 -------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       625 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                                   ...++|..+++++.|+++||+|||   ..+|+||||||+|||+++++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                         124789999999999999999999   5899999999999999999999999999987643322111


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..||.......  .+..+.    ..+         ...
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~----~~~---------~~~  336 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMI----KEG---------YRM  336 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHH----HhC---------ccC
Confidence            1222335678999999999999999999999999999998 888885432211  111111    111         011


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      ..+...+.++.+++.+||+.+|++||++.||+++|++.
T Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            11122345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=335.33  Aligned_cols=270  Identities=26%  Similarity=0.386  Sum_probs=206.7

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhh--ccccceeeEEEEEeecC----EEEEEEee
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK--LRHRHLVSLIGYCEENC----EMILVYDY  610 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~E~  610 (893)
                      .++||+|.||.||||++.+  +.||||++.   .+..+.|.+|-+|.+.  ++|+||++++++-+.+.    +++||+||
T Consensus       215 ~eli~~Grfg~V~KaqL~~--~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLDN--RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             HHHhhcCccceeehhhccC--ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            4479999999999999987  789999976   4566789999888775  58999999999987666    89999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcC------CCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG------AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      .++|+|.++|..+.   ++|....+|+..+++||+|||++      .+++|+|||||++||||..|+++.|+|||||...
T Consensus       290 h~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  290 HPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             ccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            99999999997664   99999999999999999999963      5788999999999999999999999999999865


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcC-CC-----CcchhhhHHHHHHHHhhCCCCCC-CCCccccccHHHHHHHhhcc
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQ-LT-----EKSDVYSFGVVLFEILCARPALN-PTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s-----~ksDV~S~Gvvl~elltG~~p~~-~~~~~~~~~l~~~~~~~~~~  757 (893)
                      .........-...||.+|||||++.+.- +.     .+.||||+|.|||||++....+. +..+..+..+..-+.....-
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            4322222222367999999999997642 22     36999999999999999876664 22222233222222211111


Q ss_pred             cchhh-hccccccCCCCh-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhchh
Q 036624          758 GILEQ-IMDPYLKGKIAP-----ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES  814 (893)
Q Consensus       758 ~~~~~-i~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~~  814 (893)
                      +.+++ ++..+.+..++.     .-+..+.+.+..||..|++.|.|+.=|-+++.++..+.+.
T Consensus       447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            12222 122222222222     3456789999999999999999999999998887766553

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-38  Score=341.69  Aligned_cols=251  Identities=37%  Similarity=0.552  Sum_probs=198.4

Q ss_pred             cceeeeecCcEEEEEEEEc----CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          536 EALLLGVGGFGKVYRGEID----GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~----~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ..+.||.|.||.||+|.+.    .....|+||.++.. .....++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4568999999999999998    34578999998653 344578999999999999999999999999988889999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++|+|.++|.......+++.+++.|+.|+++||+|||+   .+++|+||+++|||+++++.+||+|||+++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            999999999998856679999999999999999999994   78999999999999999999999999998865322222


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+.....      .++....         .+. ..
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~---------~~~-~~  223 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL---------KQG-QR  223 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH---------HTT-EE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc---------ccc-cc
Confidence            22233446789999999999999999999999999999999 6788754321      1122211         111 11


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ...+..++..+.+++.+||+.+|++||++.++++.|
T Consensus       224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            223344667889999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=348.26  Aligned_cols=268  Identities=23%  Similarity=0.303  Sum_probs=209.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh-hHHHHHHHHHHHhhcc-ccceeeEEEEEeecC-EEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLR-HRHLVSLIGYCEENC-EMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~-~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV~  608 (893)
                      ++|...++||.|.||.||+|+-...+..||||+++..-.. +...=.+|+..|++|+ |||||+|..++.+.+ .+++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            4677788999999999999999888889999987754332 2223368999999998 999999999998887 999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |||+ .+|.+++.+. +..+++..+..|+.||++||+|+|   ++|+.||||||+|||+..+..+||+||||||..... 
T Consensus        90 E~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-  163 (538)
T KOG0661|consen   90 EFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-  163 (538)
T ss_pred             Hhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC-
Confidence            9998 7999998776 678999999999999999999999   799999999999999998899999999999975432 


Q ss_pred             CccceeeeccCcCccChHhhh-hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccH-HHHHHHhhcccc-----hh
Q 036624          689 HTHVSTVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL-AEWAAHCHKKGI-----LE  761 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~~~~~~~~-----~~  761 (893)
                        ..-+...-|.+|.|||++. .+.|+.+.|+||+|||++||.+-++-|.+..+.++..- ++....-.++.+     +.
T Consensus       164 --pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  164 --PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             --CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence              2223445788999999875 57899999999999999999999999877665443321 111110000101     11


Q ss_pred             hhcc---cccc----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          762 QIMD---PYLK----GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       762 ~i~d---~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ..+.   |...    ...-+.+..+.++++.+|++.||.+|||+.|++++--+
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pff  294 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFF  294 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccc
Confidence            1111   1111    11222367788999999999999999999999987643

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-38  Score=358.76  Aligned_cols=260  Identities=25%  Similarity=0.407  Sum_probs=203.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  604 (893)
                      ++|+..++||+|+||.||+|+...     ....||+|++... .......+.+|+++++.+ +|+||++++++|......
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            467788899999999999998532     2347999988653 333456789999999999 899999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCC------------------------------------------------------------
Q 036624          605 ILVYDYMAYGTLREHLYKTQ------------------------------------------------------------  624 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------  624 (893)
                      ++||||+++|+|.++++...                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999986431                                                            


Q ss_pred             --------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeee
Q 036624          625 --------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV  696 (893)
Q Consensus       625 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  696 (893)
                              ..++++.++++|+.|+++||+|||   ..+|+||||||+|||+++++.+||+|||+++..............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                    124788999999999999999999   589999999999999999999999999998754322111112223


Q ss_pred             ccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChH
Q 036624          697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPE  775 (893)
Q Consensus       697 ~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~  775 (893)
                      .++..|+|||++.+..++.++|||||||++|||++ |+.||.......     .+..          .+........+..
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-----~~~~----------~~~~~~~~~~~~~  339 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-----KFYK----------MVKRGYQMSRPDF  339 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-----HHHH----------HHHcccCccCCCC
Confidence            35678999999999999999999999999999997 999986532211     0010          0100011111122


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          776 CFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       776 ~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      .+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            3467889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=351.17  Aligned_cols=256  Identities=26%  Similarity=0.338  Sum_probs=210.4

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC----Ch-hhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL----SE-QGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCE  603 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~----~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~  603 (893)
                      ..++|...+.||+|.||+|++|.+...+..||+|.....    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            346788889999999999999999887799999965542    11 23455678999999999 9999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC-CceeEecccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSK  682 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~  682 (893)
                      .++||||+.+|+|.+++.+  ..++.+..+.+++.|++.|++|||   ..+|+||||||+|||||.+ +++||+|||++.
T Consensus        95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            9999999999999999987  345889999999999999999999   5899999999999999999 999999999998


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcC-CC-CcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ-LT-EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      ...  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.....      .....       
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~k-------  234 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRK-------  234 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHH-------
Confidence            753  2233455678999999999999877 76 7899999999999999999999763211      11111       


Q ss_pred             hhhccccccCCCChHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          761 EQIMDPYLKGKIAPEC-FKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                        +....  -.++... ...+..++.+||..+|.+|+++.+|+.+=+...
T Consensus       235 --i~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  235 --IRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             --HhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence              11111  1222223 567889999999999999999999997666543

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.5e-38  Score=344.79  Aligned_cols=263  Identities=26%  Similarity=0.402  Sum_probs=204.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC----------------cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG----------------ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSL  594 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~----------------~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l  594 (893)
                      ++|...++||+|+||.||+|.+..                .+..||+|.+... ......+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467788899999999999998643                2346999987654 34456789999999999999999999


Q ss_pred             EEEEeecCEEEEEEeeccCCCHHHHHhhCC-----------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEe
Q 036624          595 IGYCEENCEMILVYDYMAYGTLREHLYKTQ-----------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH  657 (893)
Q Consensus       595 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  657 (893)
                      ++++.+.+..++||||+++|+|.+++....                 ...++|..+++++.|++.||.|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999886431                 124788999999999999999999   588999


Q ss_pred             cCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh--CCCC
Q 036624          658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC--ARPA  735 (893)
Q Consensus       658 rDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~p  735 (893)
                      |||||+|||+++++.+||+|||+++.....+.........++..|+|||++..+.++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999875433222222223446789999999999999999999999999999986  4566


Q ss_pred             CCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          736 LNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       736 ~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +......   ...+.+........      .......++.++..+.+++.+||+.+|++||+|.+|++.|+
T Consensus       242 ~~~~~~~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDE---QVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHH---HHHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            6543221   11222221111110      00011123456678999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.8e-38  Score=343.86  Aligned_cols=255  Identities=22%  Similarity=0.325  Sum_probs=206.0

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .|+..+.||+|+||.||+|....+++.||+|.+....   ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677889999999999999998877899999865422   2234567899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++|+|..++.......+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            999999999887655556999999999999999999999   5899999999999999999999999999987643211 


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                        ......||..|+|||++.+..++.++|||||||+||||++|+.||.........  ......         +...  .
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~~---------~~~~--~  221 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDRR---------VKED--Q  221 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHHH---------hhcc--c
Confidence              122346899999999999999999999999999999999999999754322110  111100         1010  1


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNLE  806 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L~  806 (893)
                      ..++.+....+.+++.+||+.+|++||+     +.+++++-.
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~  263 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI  263 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence            1223334567889999999999999997     888887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.3e-38  Score=340.89  Aligned_cols=257  Identities=31%  Similarity=0.481  Sum_probs=208.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcc-----eEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      ++|+..+.||+|+||.||+|......     ..|++|.+... ......+|.+|+.++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            35677889999999999999876544     57999987643 3344567999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHhhCCC--------------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC
Q 036624          606 LVYDYMAYGTLREHLYKTQK--------------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW  671 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~  671 (893)
                      ++|||+++|+|.+++.....              ..+++..++.++.|++.||.|||   ..+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            99999999999999975421              45889999999999999999999   58999999999999999999


Q ss_pred             ceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHH
Q 036624          672 VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEW  750 (893)
Q Consensus       672 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  750 (893)
                      .+||+|||+++.....+.........+++.|+|||++.+..++.++|||||||++|||++ |..||......+   +...
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~  238 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM  238 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence            999999999876433222222333456889999999999999999999999999999998 999986543221   1111


Q ss_pred             HHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          751 AAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       751 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                                  +.. ......+..++..+.+++.+||+.+|.+||++.||+++|+.
T Consensus       239 ------------i~~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 ------------IRS-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ------------HHc-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                        111 11122345667889999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-39  Score=315.79  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=214.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|++.+.||+|-||.||.|+.+.....||+|++...   ..+-.+++.+|+++-+.|+||||+++++++.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            5788999999999999999999998899999986542   2233467999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||..+|+|...|......++++.....+..|+|.||.|+|   ..+||||||||+|+|++..+..||+|||.+...+   
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---  175 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---  175 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence            9999999999999777778999999999999999999999   6999999999999999999999999999987643   


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                       .......+||.-|.+||+..+...+.+.|+|++|++.||++.|.+||+.....+               ...++..-  
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---------------tYkrI~k~--  237 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---------------TYKRIRKV--  237 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---------------HHHHHHHc--
Confidence             223456899999999999999999999999999999999999999997543111               11111111  


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .-.++........+++.+|+..+|.+|.+..|++++-+
T Consensus       238 ~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  238 DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence            11233445567889999999999999999999998765

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-38  Score=341.37  Aligned_cols=266  Identities=24%  Similarity=0.290  Sum_probs=204.6

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  606 (893)
                      .+.|+.+++||+|.||.||||+...+++.||+|++....  ........+||.||++|+||||++|.+...+.  ..+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            345777889999999999999999998999999876543  33345568999999999999999999998776  78999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      |+|||+ -+|.-++... .-.++..++..++.|++.||+|+|   ..+|+|||||.+|||||.+|.+||+|||||+....
T Consensus       196 VFeYMd-hDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  196 VFEYMD-HDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEeccc-chhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            999998 5888877543 346999999999999999999999   59999999999999999999999999999996543


Q ss_pred             CCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh-------hccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC-------HKKG  758 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-------~~~~  758 (893)
                      .... ..+...-|++|.|||.+.+. .|+.+.|+||.||||.||+.|++.+.+..+.++...  ..+.|       +...
T Consensus       271 ~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k--IfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  271 SGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK--IFKLCGSPTEDYWPVS  347 (560)
T ss_pred             CCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH--HHHHhCCCChhccccc
Confidence            3222 23444579999999999875 799999999999999999999999987665443321  11111       0000


Q ss_pred             chh--hhccccccCC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          759 ILE--QIMDPYLKGK-----IAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       759 ~~~--~i~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .+.  ..+.+....+     .-.......++|+..+|..||.+|.|+.++++.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            000  1111110000     011223456788999999999999999999854

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-37  Score=335.49  Aligned_cols=256  Identities=22%  Similarity=0.367  Sum_probs=205.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEc---CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEID---GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|+..++||+|+||.||+|.+.   .....||+|..+.. .......|.+|+.++++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46778889999999999999864   33468999987754 334456799999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+|++|||.+......
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999997643 36899999999999999999999   589999999999999999999999999987643211


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      . ........++..|+|||++.+..++.++|||||||++||+++ |+.||......+   +   .... ..+        
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~---~~~~-~~~--------  224 (266)
T cd05064         161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---V---IKAV-EDG--------  224 (266)
T ss_pred             c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H---HHHH-HCC--------
Confidence            1 111112335678999999999999999999999999999875 999986543211   1   1111 111        


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                       .....+..++..+.+++.+||+.+|++||++.++++.|+..
T Consensus       225 -~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 -FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence             11122345677899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-37  Score=346.25  Aligned_cols=266  Identities=24%  Similarity=0.316  Sum_probs=209.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .++|+..+.||+|+||.||+++....+..+|+|..... .....+.+.+|+++|++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            36788999999999999999999988889999987643 33445679999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++|+|.+++....  .+++..+..++.|++.||.|||+  ..+|+||||||+|||+++++.+||+|||+++.....  
T Consensus        84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999997644  48999999999999999999995  457999999999999999999999999998754221  


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc------------
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK------------  757 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------------  757 (893)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +..........            
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence              1223468999999999999999999999999999999999999996543211   11110000000            


Q ss_pred             ----------------------cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          758 ----------------------GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       758 ----------------------~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                                            ..+..+................+.+++.+||+.||++|||+.|++++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~  304 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI  304 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence                                  00000100000001111345678999999999999999999999988764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1e-37  Score=354.10  Aligned_cols=262  Identities=24%  Similarity=0.387  Sum_probs=206.9

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCc-----ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGA-----TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCE  603 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~  603 (893)
                      .++|...++||+|+||.||+|.....     ...||||++... .....+.|.+|+++++++. ||||++++++|.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            45677888999999999999986432     246999988653 3344567999999999996 9999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCC-----------------------------------------------------------
Q 036624          604 MILVYDYMAYGTLREHLYKTQ-----------------------------------------------------------  624 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  624 (893)
                      .+||||||++|+|.++|++..                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999886531                                                           


Q ss_pred             -----------------------------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC
Q 036624          625 -----------------------------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE  669 (893)
Q Consensus       625 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~  669 (893)
                                                         ...+++..++.++.|+++||+|||   ..+|+||||||+|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                               124788899999999999999999   589999999999999999


Q ss_pred             CCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHH
Q 036624          670 KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLA  748 (893)
Q Consensus       670 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~  748 (893)
                      ++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+........  +.
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~  350 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY  350 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence            99999999999875432221112223346788999999999999999999999999999997 8888864322110  00


Q ss_pred             HHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          749 EWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       749 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                          .....+         .....+..++..+.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus       351 ----~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         351 ----NKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ----HHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                000110         1112233456788999999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=352.44  Aligned_cols=246  Identities=25%  Similarity=0.362  Sum_probs=208.4

Q ss_pred             HHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCE
Q 036624          528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCE  603 (893)
Q Consensus       528 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~  603 (893)
                      +...++|...++||+|.||+|+++..+++++..|||.++..   ...+.+..+.|.+|+.... ||.|++|+.++..+++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            33457899999999999999999999999999999987764   4556788899999998885 9999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      +++||||+.||++..+.+   ...+++..+.-++..++.||+|||   +++||+||||.+|||||.+|.+||+||||++.
T Consensus       444 l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccc
Confidence            999999999999544443   235999999999999999999999   69999999999999999999999999999997


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      .-.  ....+.+++|||.|||||++.+..|+..+|+|||||+|||||.|..||.+.++.+               ....|
T Consensus       518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee---------------~FdsI  580 (694)
T KOG0694|consen  518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE---------------VFDSI  580 (694)
T ss_pred             cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHHH
Confidence            543  3335677999999999999999999999999999999999999999998765432               11122


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSM  798 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm  798 (893)
                      +...  ..++.-+..+...|+.++|.++|++|.-+
T Consensus       581 ~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 VNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             hcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            2111  12344566778899999999999999876

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.4e-37  Score=343.57  Aligned_cols=258  Identities=23%  Similarity=0.377  Sum_probs=204.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcce----EEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATT----KVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .+|+..+.||+|+||.||+|++...+.    .||+|.++.. .....+++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468889999999999999998754333    4899987654 344567899999999999999999999999875 5679


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      |+||+++|+|.+++.... ..+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999997653 35889999999999999999999   58999999999999999999999999999986543


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ...........++..|+|||++.+..++.++|||||||++|||++ |+.|+......      ++.... ..        
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~~~~~~-~~--------  226 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EISSIL-EK--------  226 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH-hC--------
Confidence            222111222334678999999999999999999999999999997 99998643221      111111 11        


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                       ......++.+...+.+++.+||+.+|++||++.+++..|..+..
T Consensus       227 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         227 -GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence             11111223455678899999999999999999999999886653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.6e-38  Score=312.57  Aligned_cols=267  Identities=22%  Similarity=0.292  Sum_probs=209.1

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh--hHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ--GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|...++||+|.||.||+|++..+++.||||+++.....  -.....+|+..|+.++|+||+.+++++-..+.+.||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            566778999999999999999999999999987654322  234578999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      |+ .+|...++... ..|+..++..++.++++||+|||   ...|+||||||.|+|+++++.+||+|||+++.....+..
T Consensus        83 m~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   83 MP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             cc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            98 78998886654 46899999999999999999999   589999999999999999999999999999986554332


Q ss_pred             cceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc-c--hhhh---
Q 036624          691 HVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG-I--LEQI---  763 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~--~~~i---  763 (893)
                      .  +...-|.+|.|||.+.+ +.|+...|+||.|||+.||+-|.+-|.+...-++....--+-...... |  +..+   
T Consensus       158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            2  22246889999999876 579999999999999999999998887655444332211110000000 0  1111   


Q ss_pred             ------ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          764 ------MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       764 ------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                            -.+.+.. .-+.+.....+++.+++..||.+|.+++|++++=-+
T Consensus       236 ~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf  284 (318)
T KOG0659|consen  236 VKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF  284 (318)
T ss_pred             HHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhh
Confidence                  1111111 233456667999999999999999999999976553

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=346.54  Aligned_cols=258  Identities=26%  Similarity=0.411  Sum_probs=220.3

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ..-.++||-|.||.||.|.++.-.-.||||.++... -..++|..|..+|+.++|||+|+|+|+|.....+|||.|||.+
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y  347 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY  347 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence            344568999999999999999887889999988643 4578999999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|.++|++..+..++--..+.++.||+.||+||.   +..+|||||.++|+|+.++..+||+||||+|++....++ ..
T Consensus       348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-AH  423 (1157)
T KOG4278|consen  348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-AH  423 (1157)
T ss_pred             ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-cc
Confidence            99999999988888888899999999999999999   689999999999999999999999999999986543322 22


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI  772 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  772 (893)
                      ...+-.+.|.|||-+....++-|+|||+|||+||||.| |..|+.+-      ++.+          +.+++..-.+-+.
T Consensus       424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi------dlSq----------VY~LLEkgyRM~~  487 (1157)
T KOG4278|consen  424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQ----------VYGLLEKGYRMDG  487 (1157)
T ss_pred             cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc------cHHH----------HHHHHhccccccC
Confidence            23445789999999999999999999999999999987 66666432      2222          1222333334455


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhc
Q 036624          773 APECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQ  812 (893)
Q Consensus       773 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~  812 (893)
                      ++.|+.++.+|++.||+.+|.+||+..|+-+.+|.+.+..
T Consensus       488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            7789999999999999999999999999999999887643

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.6e-38  Score=346.73  Aligned_cols=245  Identities=23%  Similarity=0.285  Sum_probs=200.4

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYG  614 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  614 (893)
                      ++||+|+||.||+++....++.+|+|++...   .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999999888889999987642   2334567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcccee
Q 036624          615 TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST  694 (893)
Q Consensus       615 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~  694 (893)
                      +|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~  153 (323)
T cd05571          81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK  153 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence            9999987543  5899999999999999999999   589999999999999999999999999998753221  12233


Q ss_pred             eeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCCh
Q 036624          695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP  774 (893)
Q Consensus       695 ~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  774 (893)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..   .         +....  ..++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~---~---------~~~~~--~~~p~  216 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE---L---------ILMEE--IRFPR  216 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHH---H---------HHcCC--CCCCC
Confidence            4569999999999999999999999999999999999999996532211   111   0         11000  12233


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          775 ECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       775 ~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                      .....+.+++.+||+.||++||     ++.+++++-.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~  253 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF  253 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence            4456788999999999999999     7999886643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-37  Score=360.16  Aligned_cols=252  Identities=20%  Similarity=0.276  Sum_probs=205.9

Q ss_pred             CccceeeeecCcEEEEEEEEcCc-ceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGA-TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~-~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      |...+.||+|+||.||+|..... +..|++|............+.+|+.+|+.++||||+++++++...+..+|||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            77888999999999999987665 57788887665555666778899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          613 YGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       613 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +|+|.++|...  ...++++..+..++.|++.||+|||   ..+|+||||||+||||+.++.+||+|||+++........
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            99999988643  3446899999999999999999999   589999999999999999999999999999864332222


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......      +....         +..... .
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~---------~~~~~~-~  289 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQ---------VLYGKY-D  289 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH---------HHhCCC-C
Confidence            2334567999999999999999999999999999999999999999643221      11111         111110 0


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..+..+...+.+++.+||+.+|++||++.+++.+
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            1222345678899999999999999999999754

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.8e-37  Score=331.66  Aligned_cols=256  Identities=25%  Similarity=0.376  Sum_probs=209.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      .+|+..+.||+|+||.||+|.....+..|++|..... ....+++.+|++++++++|+||+++++++......++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            3467788999999999999999887789999987643 344678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.......+++..++.++.|+++||+|||   +.+++||||||+|||+++++.+||+|||+++........ 
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence            9999999997766667999999999999999999999   589999999999999999999999999998764322111 


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..|+......      ++....          ......
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~----------~~~~~~  224 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELL----------EKGYRM  224 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH----------HCCCCC
Confidence            1112234668999999999999999999999999999998 88888643221      111111          111112


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      ..+..++..+.+++.+||+.+|++||++.++++.|+..
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            23344567799999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.7e-38  Score=338.91  Aligned_cols=258  Identities=20%  Similarity=0.297  Sum_probs=210.1

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      ..++|+.+.+||+|+||.||+|+-++++..+|+|+++..   ...+.+..+.|-.+|....++.||+|+..+.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            457899999999999999999999999999999998764   33456678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||++||++..+|.+.+  .|++..+...+.+++.|++-||   +.|+|||||||+|+|||..|++||+||||+.-...
T Consensus       219 iMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            999999999999997655  5888888889999999999999   79999999999999999999999999999842100


Q ss_pred             ----------------------CCCc----cc-------------------eeeeccCcCccChHhhhhcCCCCcchhhh
Q 036624          687 ----------------------LDHT----HV-------------------STVVKGSFGYLDPEYFRRQQLTEKSDVYS  721 (893)
Q Consensus       687 ----------------------~~~~----~~-------------------~~~~~gt~~y~APE~~~~~~~s~ksDV~S  721 (893)
                                            .+..    ..                   .....|||-|||||++.+..|+..+|+||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence                                  0000    00                   01246999999999999999999999999


Q ss_pred             HHHHHHHHhhCCCCCCCCCccc-cccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCC---
Q 036624          722 FGVVLFEILCARPALNPTLPKE-QVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS---  797 (893)
Q Consensus       722 ~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt---  797 (893)
                      ||||+||||.|.+||....+.+ ...+..|...+.              ..-..++..+..++|.+||. ||++|--   
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~--------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK--------------FPEEVDLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc--------------CCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence            9999999999999998776643 223444443221              11112334677889999999 9999964   


Q ss_pred             HHHHHHHHHH
Q 036624          798 MGDVLWNLEF  807 (893)
Q Consensus       798 m~evl~~L~~  807 (893)
                      +.||.+|-.+
T Consensus       439 ~~EIK~HPfF  448 (550)
T KOG0605|consen  439 AEEIKKHPFF  448 (550)
T ss_pred             HHHHhcCCcc
Confidence            6677665543

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2e-37  Score=345.17  Aligned_cols=261  Identities=26%  Similarity=0.418  Sum_probs=204.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCc-----ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEee-cCE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGA-----TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEE-NCE  603 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~-~~~  603 (893)
                      ++|+..++||+|+||.||+|...+.     .+.||+|+++.. .....+.+..|+.++.++ +|+||++++++|.. ...
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            4678889999999999999975432     367999987643 234456788999999999 89999999998864 456


Q ss_pred             EEEEEeeccCCCHHHHHhhCC-----------------------------------------------------------
Q 036624          604 MILVYDYMAYGTLREHLYKTQ-----------------------------------------------------------  624 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  624 (893)
                      .++++||+++|+|.++|....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            889999999999999886432                                                           


Q ss_pred             CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccC
Q 036624          625 KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD  704 (893)
Q Consensus       625 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A  704 (893)
                      ..+++|..+..++.|++.||+|||   ..+|+||||||+|||+++++.+||+|||+++...............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            126899999999999999999999   58999999999999999999999999999986432221112223446778999


Q ss_pred             hHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHH
Q 036624          705 PEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAET  783 (893)
Q Consensus       705 PE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l  783 (893)
                      ||++.+..++.++|||||||+||||++ |..||......+.  +..    ....+         .....+......+.++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~~~---------~~~~~~~~~~~~~~~l  308 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLKEG---------TRMRAPEYATPEIYSI  308 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHhcc---------CCCCCCccCCHHHHHH
Confidence            999999999999999999999999998 9999865332111  111    11111         0111123345678999


Q ss_pred             HHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          784 AMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       784 ~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      +.+||+.+|++||++.||+++|+.+++
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.2e-38  Score=346.95  Aligned_cols=248  Identities=25%  Similarity=0.349  Sum_probs=204.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||.||+|+....++.||+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            4688889999999999999999888889999986532   2234567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            9999999999997654  4889999999999999999999   589999999999999999999999999998764321 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ...         .+....+
T Consensus       172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~---------~i~~~~~  232 (329)
T PTZ00263        172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IYE---------KILAGRL  232 (329)
T ss_pred             ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HHH---------HHhcCCc
Confidence                123569999999999999999999999999999999999999996533211      111         1111111


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L~  806 (893)
                        .++......+.+++.+||+.||.+||+     +.+++.+-.
T Consensus       233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~  273 (329)
T PTZ00263        233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY  273 (329)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence              112223456789999999999999996     688877654

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-37  Score=330.24  Aligned_cols=257  Identities=25%  Similarity=0.424  Sum_probs=207.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCc---ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|+..+.||+|+||+||+|.....   ...|++|..... ......+|.+|+.++++++|+||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            5688889999999999999998543   357999987654 344556799999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++++|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999997654 36899999999999999999999   589999999999999999999999999999865422


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      ..........+++.|+|||.+.+..++.++||||||+++|||++ |..|+.......   +.+..            .+.
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~------------~~~  224 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV------------EDG  224 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH------------HcC
Confidence            22222223345678999999999999999999999999999998 998885432111   11111            110


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      . ....+..++..+.+++.+|++.+|++||++.+|+++|+.+
T Consensus       225 ~-~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 Y-RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0 1112234567789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-38  Score=340.84  Aligned_cols=249  Identities=20%  Similarity=0.251  Sum_probs=204.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||.||+|.....++.||+|++...   .....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            3688889999999999999999877789999987532   2234567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            9999999999997643  5899999999999999999999   589999999999999999999999999998754221 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ....         +.... 
T Consensus       155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~---------i~~~~-  214 (291)
T cd05612         155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEK---------ILAGK-  214 (291)
T ss_pred             ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH---------HHhCC-
Confidence                123468999999999999999999999999999999999999996543211      1111         11111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNLEF  807 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L~~  807 (893)
                       ..++......+.+++.+||+.||.+||+     +.+++++-..
T Consensus       215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~  257 (291)
T cd05612         215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF  257 (291)
T ss_pred             -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence             1122233456889999999999999995     8888877653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.1e-37  Score=333.06  Aligned_cols=258  Identities=26%  Similarity=0.401  Sum_probs=205.2

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE  603 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~  603 (893)
                      ++++|+..+.||+|+||.||+|...+     ....||+|..... ......+|.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45778999999999999999998653     2357999987543 23445678999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCC--------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeE
Q 036624          604 MILVYDYMAYGTLREHLYKTQ--------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKV  675 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl  675 (893)
                      .++||||+++|+|.+++....        ...+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532        234688999999999999999999   589999999999999999999999


Q ss_pred             ecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHh
Q 036624          676 SDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHC  754 (893)
Q Consensus       676 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  754 (893)
                      +|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.......      .....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~------~~~~~  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------VLRFV  234 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHH
Confidence            99999875433222222222345778999999999999999999999999999999 688886432211      11111


Q ss_pred             hcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          755 HKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       755 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                               ..... ...+..++..+.+++.+||+.+|++||++.|++++|+
T Consensus       235 ---------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 ---------MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ---------HcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                     11100 1123345667899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=345.91  Aligned_cols=256  Identities=26%  Similarity=0.360  Sum_probs=207.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||.||+|+....+..||+|++...   .....+.+..|++++.+++||||+++++++...+..+|||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            4688899999999999999999887789999987642   2234567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++....  .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus        81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            9999999999996543  5899999999999999999999   58999999999999999999999999999875432  


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc-cHHHHHHHhhcccchhhhcccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV-SLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .+..|.      ..   +..+.
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~---~~~~~  221 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK------ET---LQRPV  221 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc------cc---ccCCC
Confidence               223456999999999999999999999999999999999999999754332211 011110      00   00010


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      . ..........+.+++.+||..+|++||++.+++++...
T Consensus       222 ~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~  260 (333)
T cd05600         222 Y-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFF  260 (333)
T ss_pred             C-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCccc
Confidence            0 00012345678889999999999999999999987543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-38  Score=346.40  Aligned_cols=249  Identities=22%  Similarity=0.297  Sum_probs=208.8

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      |+..+.||.|+-|.|-+|++..+++.+|||++...   .......+.+|+.+|+.+.|||+++++++++++.++|||.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            45667899999999999999999999999987654   223345678999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++|.|.++|.+.+  +|++.++.+++.||+.|+.|+|   ..+|+||||||+|+|||..+++||+|||+|.+...   .
T Consensus        94 v~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---g  165 (786)
T KOG0588|consen   94 VPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP---G  165 (786)
T ss_pred             cCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC---C
Confidence            99999999997654  5999999999999999999999   59999999999999999999999999999986432   3


Q ss_pred             cceeeeccCcCccChHhhhhcCCC-CcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      ......||.+.|.|||++++..|. .++||||+|||||.||+|+.||+...      +-...         .++...  .
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LL---------lKV~~G--~  228 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLL---------LKVQRG--V  228 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHH---------HHHHcC--c
Confidence            345567899999999999999885 68999999999999999999997332      11111         111111  1


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      -+.+.....+..+|+.+|+..||++|-|+.||++|..-
T Consensus       229 f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l  266 (786)
T KOG0588|consen  229 FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL  266 (786)
T ss_pred             ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence            12344566778899999999999999999999988763

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.7e-37  Score=333.44  Aligned_cols=262  Identities=28%  Similarity=0.422  Sum_probs=210.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEc-----CcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEID-----GATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      .++|...+.||+|+||+||++...     .....+++|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            357888899999999999999852     334568999887766667788999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHhhCC-----------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCcee
Q 036624          606 LVYDYMAYGTLREHLYKTQ-----------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAK  674 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~k  674 (893)
                      +||||+++++|.+++....           ...+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999999987432           235899999999999999999999   58999999999999999999999


Q ss_pred             EecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHH
Q 036624          675 VSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAH  753 (893)
Q Consensus       675 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~  753 (893)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   +   ...
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~---~~~  234 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V---IEC  234 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHH
Confidence            999999875433222112223335778999999999999999999999999999998 888886443211   1   111


Q ss_pred             hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       754 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      . ..+..         ...+..+...+.+++.+||+.+|.+||++.+|++.|+.+.+.
T Consensus       235 i-~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 I-TQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             H-HcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            1 11110         011123445789999999999999999999999999877643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.2e-37  Score=334.21  Aligned_cols=260  Identities=28%  Similarity=0.423  Sum_probs=210.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .+|...+.||+|+||.||+|+..+     ....+++|..........+.+.+|++++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            356677899999999999998543     335689999877666667789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc
Q 036624          607 VYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV  672 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~  672 (893)
                      ||||+++++|.+++....              ...++|..++.++.|++.||+|||   +.+|+||||||+|||+++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999997532              234899999999999999999999   589999999999999999999


Q ss_pred             eeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHH
Q 036624          673 AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWA  751 (893)
Q Consensus       673 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  751 (893)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......+   ..+  
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~--  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE--  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence            99999999876433222222233446789999999999999999999999999999998 999986543221   111  


Q ss_pred             HHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          752 AHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       752 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                       . ...+..         ......++..+.+++.+||+.+|++||++.+|++.|+.+.+
T Consensus       237 -~-~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 -C-ITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             -H-HhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence             1 111110         11122345678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.1e-37  Score=331.85  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=212.7

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ...+|...++||+|+||.||+|...+ +..+++|.+.........++..|+.++++++|+||+++++++......++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            45568888899999999999999988 57899999876666567789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++++|.+++.......+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++....... 
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-  158 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-  158 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence            999999999998766667999999999999999999999   5889999999999999999999999999987643211 


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                       .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   ....            +. ...
T Consensus       159 -~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~------------~~-~~~  221 (261)
T cd05148         159 -YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQ------------IT-AGY  221 (261)
T ss_pred             -ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH------------HH-hCC
Confidence             11123346778999999999999999999999999999998 888886543211   1111            11 111


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ....+..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            122334566788999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-38  Score=332.62  Aligned_cols=262  Identities=23%  Similarity=0.333  Sum_probs=210.5

Q ss_pred             HHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh--------------hhHHHHHHHHHHHhhccccceee
Q 036624          528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE--------------QGVHEFQTEIEMLSKLRHRHLVS  593 (893)
Q Consensus       528 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~--------------~~~~~f~~E~~~l~~l~H~niv~  593 (893)
                      ....++|+..+.||+|.||.|-+|+....++.||||++.....              ...+...+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            3445789999999999999999999999889999997654211              12357899999999999999999


Q ss_pred             EEEEEeec--CEEEEEEeeccCCCHHHHHhhCCCCC-CCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC
Q 036624          594 LIGYCEEN--CEMILVYDYMAYGTLREHLYKTQKPP-LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK  670 (893)
Q Consensus       594 l~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~  670 (893)
                      |+.+..+.  +.+|||+|||..|.+...   ....+ |++.++.+++.++..||+|||   .++||||||||+|+||+++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCC
Confidence            99998654  679999999999887543   22233 999999999999999999999   4999999999999999999


Q ss_pred             CceeEecccccccCCCC---CCccceeeeccCcCccChHhhhhcC----CCCcchhhhHHHHHHHHhhCCCCCCCCCccc
Q 036624          671 WVAKVSDFGLSKTGPTL---DHTHVSTVVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEILCARPALNPTLPKE  743 (893)
Q Consensus       671 ~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~APE~~~~~~----~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~  743 (893)
                      +++||+|||.+...+..   +.........|||.|+|||.+.++.    .+.+.||||+||.||.|+.|+.||......+
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~  326 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE  326 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence            99999999998754221   1122223356999999999998732    3568999999999999999999996432211


Q ss_pred             cccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          744 QVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       744 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                                     ...+|+...+.-...+++-+.+.+|++++|++||++|.+..+|..+.+-...
T Consensus       327 ---------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  327 ---------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ---------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                           2234454444444455677889999999999999999999999999886554

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.3e-37  Score=335.64  Aligned_cols=261  Identities=26%  Similarity=0.455  Sum_probs=209.1

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCc-----ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecC
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGA-----TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENC  602 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~  602 (893)
                      ..++|+..+.||+|+||.||++...+.     ...+|+|..... ..+...++.+|++++.++ +|+||+++++++....
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            345688889999999999999987543     367999987643 344566789999999999 7999999999999999


Q ss_pred             EEEEEEeeccCCCHHHHHhhC--------------CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC
Q 036624          603 EMILVYDYMAYGTLREHLYKT--------------QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD  668 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld  668 (893)
                      ..++||||+++|+|..++...              ....+++..+++++.|++.||+|||   +.+|+||||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence            999999999999999999642              2346899999999999999999999   58999999999999999


Q ss_pred             CCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccH
Q 036624          669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSL  747 (893)
Q Consensus       669 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  747 (893)
                      +++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+......+    
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  242 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----  242 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence            999999999999986443222222222345678999999999999999999999999999998 888875432211    


Q ss_pred             HHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          748 AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       748 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                        ....          +........+..+...+.+++.+||+.+|++|||+.|+++.|+..+
T Consensus       243 --~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 --LFKL----------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HHHH----------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              0111          1111111233455678899999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.3e-37  Score=332.19  Aligned_cols=257  Identities=27%  Similarity=0.383  Sum_probs=205.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      +++|...+.||+|+||.||+|.+..     ....|++|...... ......|..|+.++++++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678889999999999999999876     56789999876443 44456799999999999999999999999999899


Q ss_pred             EEEEeeccCCCHHHHHhhCCC-----CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC---ceeEe
Q 036624          605 ILVYDYMAYGTLREHLYKTQK-----PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW---VAKVS  676 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~kl~  676 (893)
                      ++||||+++++|.+++.....     ..++|..++.++.|++.||+|||   ..+++||||||+|||++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            999999999999999976532     35899999999999999999999   57899999999999998654   69999


Q ss_pred             cccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhh
Q 036624          677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       677 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+      ......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~  235 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVT  235 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHH
Confidence            9999986432211111112223568999999999999999999999999999997 999986543221      111111


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                                .......+..++..+.+++.+|++.+|++||++.+|+++|+
T Consensus       236 ----------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 ----------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ----------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                      11111223445677899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=337.38  Aligned_cols=249  Identities=24%  Similarity=0.372  Sum_probs=208.5

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      .|...++||+|.||.||||.+....+.||+|.+... .....++.+.|+.+|.+++|+||.+++|.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            355567899999999999999999999999987654 3445788999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      .+|++.+.|....  .+++..+.-|.+++..||.|||   ..+.+|||||+.|||+..+|.+||+|||.+-.......  
T Consensus        94 ~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             cCcchhhhhccCC--CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            9999999996443  3588888889999999999999   48899999999999999999999999999876544322  


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ....+.||+.|||||+++...|+.|+||||||++.+||++|.+|+....+.....            .+.+-.-|.+   
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~PP~L---  231 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAPPRL---  231 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCCCcc---
Confidence            2255779999999999998899999999999999999999999997655422110            1111122233   


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                       ...+...+.+++..||.++|+.||++.+++++
T Consensus       232 -~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  232 -DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             -ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence             23556779999999999999999999999864

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.5e-37  Score=341.38  Aligned_cols=245  Identities=23%  Similarity=0.283  Sum_probs=199.6

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYG  614 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  614 (893)
                      ++||+|+||.||+++....+..||+|.+...   .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999999888889999987542   2334567788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcccee
Q 036624          615 TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST  694 (893)
Q Consensus       615 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~  694 (893)
                      +|..++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~  153 (323)
T cd05595          81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMK  153 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccc
Confidence            9999886543  5899999999999999999999   589999999999999999999999999998753221  11223


Q ss_pred             eeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCCh
Q 036624          695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP  774 (893)
Q Consensus       695 ~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  774 (893)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........      .         ..+....  ..++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~---------~~~~~~~--~~~p~  216 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------F---------ELILMEE--IRFPR  216 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------H---------HHHhcCC--CCCCC
Confidence            45699999999999999999999999999999999999999965432110      0         0111110  11223


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          775 ECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       775 ~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                      .....+.+++.+||+.+|++||     ++.+++++-.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~  253 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  253 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCC
Confidence            3456788999999999999998     8888887643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.1e-37  Score=335.70  Aligned_cols=267  Identities=19%  Similarity=0.228  Sum_probs=203.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..+.||+|+||.||+|+.+.++..+|+|++...  .....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            4688899999999999999999888889999986543  23345678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |++++.|..+...  ...+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            9998777654432  235899999999999999999999   58999999999999999999999999999886432211


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHH---------HHHhhcccch
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEW---------AAHCHKKGIL  760 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~---------~~~~~~~~~~  760 (893)
                       .......||+.|+|||++.+..++.++|||||||++|||++|++||......+.......         ..........
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence             112335689999999999999999999999999999999999999975432221110000         0000000000


Q ss_pred             hhhccccccC------CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          761 EQIMDPYLKG------KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       761 ~~i~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .....+....      .........+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000010000      0111234568999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.5e-37  Score=332.52  Aligned_cols=256  Identities=27%  Similarity=0.423  Sum_probs=204.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEc----CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEID----GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~----~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .+|+..++||+|+||+||+|...    .....+++|..... ......+|.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            35677889999999999999852    23467999987643 34455789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCC---------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC
Q 036624          607 VYDYMAYGTLREHLYKTQ---------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW  671 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~  671 (893)
                      ||||+++++|.+++....               ...+++.+++.++.|++.||+|||   +.+++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999986331               234889999999999999999999   58999999999999999999


Q ss_pred             ceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHH
Q 036624          672 VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEW  750 (893)
Q Consensus       672 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  750 (893)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||......   .+.+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence            999999999976433222222333446778999999998899999999999999999998 88888643221   11111


Q ss_pred             HHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          751 AAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       751 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .             +.......+..+...+.+++.+||+.+|++||++.+|+++|.
T Consensus       239 ~-------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         239 V-------------RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             H-------------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            1             111111123345567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.9e-37  Score=328.56  Aligned_cols=254  Identities=25%  Similarity=0.424  Sum_probs=206.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..++||+|+||.||+|...++ ..|++|...... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNS-TKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCC-ceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            5688889999999999999997655 679999876433 34578999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|.+++.......+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....... .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            9999999998765567899999999999999999999   58999999999999999999999999999976432111 1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......++..|+|||++....++.++|||||||++|||++ |+.||.......   ...+..    .+     .    ..
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~-----~----~~  223 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQ----RG-----Y----RM  223 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cC-----C----CC
Confidence            1222345678999999999999999999999999999998 999986432211   111111    10     0    01


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .....++..+.+++.+|++.+|++||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1112345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=354.35  Aligned_cols=261  Identities=22%  Similarity=0.302  Sum_probs=216.7

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEE-e-----e-c
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYC-E-----E-N  601 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~-~-----~-~  601 (893)
                      ...+.++.+.|.+|||+.||++.....+..+|+|++-..++...+...+||++|++|. |+|||.+++.. .     . .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            3456778899999999999999998877899999987778889999999999999997 99999999932 1     1 3


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      .+.+|.||||.+|.|-+++.......|++.++++|+.|+++|+.+||. ++.+|||||||-+||||..+++.||||||.+
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            578999999999999999987655569999999999999999999995 5788999999999999999999999999998


Q ss_pred             ccCCCCC-Cccce------eeeccCcCccChHhh---hhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHH
Q 036624          682 KTGPTLD-HTHVS------TVVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWA  751 (893)
Q Consensus       682 ~~~~~~~-~~~~~------~~~~gt~~y~APE~~---~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  751 (893)
                      ....... .....      -...-|+.|+|||++   .+...++|+|||+|||+||-|+....||+....-         
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------  264 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------  264 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence            6422111 11100      012358999999987   4778999999999999999999999999765321         


Q ss_pred             HHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          752 AHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       752 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                                .|++....-...+.....|.+||..||+.+|++||++-+|+..+-++..
T Consensus       265 ----------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  265 ----------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ----------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                      2344443333345788999999999999999999999999999887774

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.5e-37  Score=332.52  Aligned_cols=259  Identities=26%  Similarity=0.426  Sum_probs=206.0

Q ss_pred             CCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      +|...+.||+|+||.||+|....     +...+++|..... .......+.+|+.+++.++||||+++++.|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46677899999999999998643     2256888876643 33456789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCC----------------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCC
Q 036624          607 VYDYMAYGTLREHLYKTQ----------------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTN  664 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  664 (893)
                      |+||+.+|+|.+++....                      ...+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999986421                      235889999999999999999999   5899999999999


Q ss_pred             EEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccc
Q 036624          665 ILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKE  743 (893)
Q Consensus       665 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~  743 (893)
                      ||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||....+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999875432221111223346778999999999999999999999999999998 999986543211


Q ss_pred             cccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          744 QVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       744 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                         +.++..             .......+..+...+.+++.+||+.+|++||++.++++.|+++..
T Consensus       238 ---~~~~~~-------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 ---LFNLLK-------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ---HHHHHh-------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence               111111             111112233455678899999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.8e-37  Score=334.56  Aligned_cols=259  Identities=23%  Similarity=0.391  Sum_probs=206.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEc-----CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEID-----GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  604 (893)
                      ++|...+.||+|+||.||++...     .....||+|..+.. .....+.+.+|+++++++ +|+||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            56888899999999999999752     23457999987644 234456799999999999 799999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++||||+++|+|.++++......+++.+++.++.|++.||+|||   +.+|+|+||||+|||+++++.+||+|||+++..
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999997655455899999999999999999999   588999999999999999999999999998754


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      .............++..|+|||++....++.++|||||||++|||++ |+.|+........  +...             
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~-------------  256 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKL-------------  256 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHH-------------
Confidence            33221111222345778999999999999999999999999999998 9998864332110  1111             


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      ++.......+......+.+++.+||..+|++||++.||++.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         257 IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            111011111222346789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1e-36  Score=330.52  Aligned_cols=258  Identities=24%  Similarity=0.385  Sum_probs=202.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcce----EEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATT----KVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .+|+..+.||+|+||+||+|.....+.    .+++|...... .....++..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            356677899999999999999855433    47788765433 3345678889999999999999999999864 45788


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ++||+++|+|.+++.... ..++|..++.++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999999997543 35899999999999999999999   58899999999999999999999999999986433


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ...........++..|+|||++.++.++.++|||||||++|||++ |+.|+....+..   +.++.    ..+.      
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~----~~~~------  228 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDLL----EKGE------  228 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----HCCC------
Confidence            222222334557789999999999999999999999999999998 999986543221   11111    1110      


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                         ....+..+...+.+++.+||..+|++||++.|+++.|..+.+
T Consensus       229 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         229 ---RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence               001112244567889999999999999999999998887553

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.7e-37  Score=335.59  Aligned_cols=266  Identities=23%  Similarity=0.338  Sum_probs=197.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEc-CcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhc---cccceeeEEEEEe-----e
Q 036624          532 NNFDEALLLGVGGFGKVYRGEID-GATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKL---RHRHLVSLIGYCE-----E  600 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~-----~  600 (893)
                      ++|+..+.||+|+||.||+|+.. .++..||+|++....  ......+.+|+.+++++   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888899999999999999874 345789999765322  22234566788777766   6999999999985     3


Q ss_pred             cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccc
Q 036624          601 NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL  680 (893)
Q Consensus       601 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl  680 (893)
                      ....++||||++ ++|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999997 79999997766566999999999999999999999   58999999999999999999999999999


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc-cHHHHHHHhhcccc
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV-SLAEWAAHCHKKGI  759 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~  759 (893)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|||++|++||......+.. .+.+.........+
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            8754321   2233456899999999999999999999999999999999999999765432211 01100000000000


Q ss_pred             h------hhhcccccc---CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          760 L------EQIMDPYLK---GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       760 ~------~~i~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      -      .....+...   ....++....+.+++.+||+.+|++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0      000100000   00112334567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.6e-37  Score=341.99  Aligned_cols=245  Identities=24%  Similarity=0.286  Sum_probs=200.4

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYG  614 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  614 (893)
                      ++||+|+||.||++.....+..||+|++...   .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999999888899999987642   2344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcccee
Q 036624          615 TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST  694 (893)
Q Consensus       615 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~  694 (893)
                      +|..++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~  153 (328)
T cd05593          81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK  153 (328)
T ss_pred             CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence            9999886543  5899999999999999999999   589999999999999999999999999998753221  11223


Q ss_pred             eeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCCh
Q 036624          695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP  774 (893)
Q Consensus       695 ~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  774 (893)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ........       +    ..++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~~~~~-------~----~~~p~  216 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILME-------D----IKFPR  216 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHHhccC-------C----ccCCC
Confidence            4569999999999999999999999999999999999999996532211      11111000       0    11223


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          775 ECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       775 ~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                      .....+.+++.+||+.+|++||     ++.+++++..
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  253 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF  253 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence            3456688899999999999997     8999987744

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=340.55  Aligned_cols=242  Identities=22%  Similarity=0.263  Sum_probs=197.7

Q ss_pred             eeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCH
Q 036624          540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL  616 (893)
Q Consensus       540 LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  616 (893)
                      ||+|+||.||+|.....+..||+|.+...   .......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999888889999986532   334556788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeee
Q 036624          617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV  696 (893)
Q Consensus       617 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  696 (893)
                      .+++....  .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .......
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~  153 (312)
T cd05585          81 FHHLQREG--RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTF  153 (312)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccc
Confidence            99997643  5899999999999999999999   589999999999999999999999999998753221  1223345


Q ss_pred             ccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHH
Q 036624          697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC  776 (893)
Q Consensus       697 ~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  776 (893)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .+.....         ....  ..++...
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~---------~~~~--~~~~~~~  216 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKI---------LQEP--LRFPDGF  216 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHH---------HcCC--CCCCCcC
Confidence            699999999999999999999999999999999999999964322      1111111         1110  1223344


Q ss_pred             HHHHHHHHHHccccCCCCCCC---HHHHHHHH
Q 036624          777 FKKFAETAMKCVSDQGIERPS---MGDVLWNL  805 (893)
Q Consensus       777 ~~~l~~l~~~Cl~~~p~~RPt---m~evl~~L  805 (893)
                      ...+.+++.+||+.+|++||+   +.|++.+-
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp  248 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP  248 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence            567889999999999999985   56666553

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.5e-37  Score=334.16  Aligned_cols=266  Identities=21%  Similarity=0.308  Sum_probs=201.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|...++||+|+||+||+|....++..||+|.++... ......+.+|++++++++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888899999999999999998888899999875432 22345678999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      ++ |+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....... 
T Consensus        85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            98 59999886543 35789999999999999999999   58999999999999999999999999999875432211 


Q ss_pred             cceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHH---------HHhhcccch
Q 036624          691 HVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWA---------AHCHKKGIL  760 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~  760 (893)
                       ......+++.|+|||++.+ ..++.++|||||||++|||++|++||......+........         .........
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence             1223457899999999875 56899999999999999999999999765432221110000         000000000


Q ss_pred             hhhccccccCC----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          761 EQIMDPYLKGK----IAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       761 ~~i~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .....+.....    ..+.....+.+++.+||+.||.+|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            01111110000    011223567899999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-37  Score=327.65  Aligned_cols=255  Identities=28%  Similarity=0.450  Sum_probs=206.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..+.||+|+||.||+|...++ ..||+|..+... ...+++.+|+.++++++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCC-eEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            45688889999999999999997665 679999876533 3456799999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.......+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++....... 
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-  158 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence            99999999997765556999999999999999999999   58999999999999999999999999999876432111 


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      ........+..|+|||++.+..++.++|||||||++|||++ |+.||.......   +.   ...          +....
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~---~~~----------~~~~~  222 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VL---QQV----------DQGYR  222 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH---HHH----------HcCCC
Confidence            11111223458999999999999999999999999999999 998886432211   00   010          01111


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ...+..+...+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            11233456788999999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.4e-37  Score=331.23  Aligned_cols=256  Identities=29%  Similarity=0.442  Sum_probs=206.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCCChh-hHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      ++|...+.||+|+||.||+|....     ....||+|........ ..+.|.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            456777899999999999998743     2467999987755443 5678999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHhhCC------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCce
Q 036624          606 LVYDYMAYGTLREHLYKTQ------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA  673 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~  673 (893)
                      +||||+++++|.+++....            ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999997542            245889999999999999999999   5899999999999999999999


Q ss_pred             eEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHH
Q 036624          674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA  752 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  752 (893)
                      ||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||.......   +.+.. 
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~-  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI-  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH-
Confidence            9999999875432222122223345788999999999999999999999999999998 999986543221   11111 


Q ss_pred             HhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          753 HCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       753 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         ..+.         ....+..++..+.+++.+||+.+|++||++.||++.|+
T Consensus       238 ---~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 ---TQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---HcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               1111         01122345577899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.8e-37  Score=343.10  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=202.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcc-eEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGAT-TKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|...+.||+|+||.||+|.+...+ ..||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            46888899999999999999876543 67999976432   233456788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            99999999999997654  4899999999999999999999   589999999999999999999999999998754221


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+..      ..         ..+....
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~---------~~i~~~~  244 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IY---------QKILEGI  244 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HH---------HHHhcCC
Confidence                 224569999999999999999999999999999999999999997543211      00         1111111


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                      .  .++......+.+++.+||+.+|++|+     ++.+++++-.
T Consensus       245 ~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~  286 (340)
T PTZ00426        245 I--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW  286 (340)
T ss_pred             C--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence            0  12223345678899999999999995     8888887654

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.6e-37  Score=339.68  Aligned_cols=266  Identities=23%  Similarity=0.326  Sum_probs=206.6

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .++|+..++||+|+||.||++.+...+..+|+|.+... .......+.+|++++++++|+||++++++|.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            36788999999999999999999888888999976643 33445679999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++|+|.+++....  .+++..+..++.|++.||.|||+  ..+|+||||||+|||+++++.+||+|||+++.....  
T Consensus        84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999997643  48899999999999999999995  357999999999999999999999999998753221  


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc------------
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK------------  757 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------------  757 (893)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||........   ..........            
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  232 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL---ELMFGCPVEGDPAESETSPRPR  232 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH---HHHhcCcccCCccccccCcccC
Confidence              12234689999999999999999999999999999999999999865432110   0000000000            


Q ss_pred             ----------------cchhhhccccccC---CC-ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          758 ----------------GILEQIMDPYLKG---KI-APECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       758 ----------------~~~~~i~d~~l~~---~~-~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                                      .....+.+.....   .. ......++.+++.+||+.||++||++.|++++-..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~  302 (333)
T cd06650         233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI  302 (333)
T ss_pred             CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence                            0000000000000   00 01123568899999999999999999999977653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7e-37  Score=341.08  Aligned_cols=267  Identities=21%  Similarity=0.269  Sum_probs=199.3

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec-----CEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN-----CEMI  605 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~  605 (893)
                      +|+..++||+|+||.||+|.....+..||+|++...  .......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477888999999999999999888889999987642  223455788999999999999999999988543     3579


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +|||||. ++|.+++....  .+++..+..++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999996 78999886543  4899999999999999999999   5899999999999999999999999999987532


Q ss_pred             CCCC-ccceeeeccCcCccChHhhhh--cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHH---------HHHHH
Q 036624          686 TLDH-THVSTVVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA---------EWAAH  753 (893)
Q Consensus       686 ~~~~-~~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~~~  753 (893)
                      .... ........||+.|+|||++.+  ..++.++|||||||++|||++|++||............         ++...
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2111 111233568999999999876  67899999999999999999999999654322111000         00000


Q ss_pred             hhcccchhhhcc---ccccCC---CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          754 CHKKGILEQIMD---PYLKGK---IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       754 ~~~~~~~~~i~d---~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      . ......+.+.   +.....   ..+.....+.+++.+||+.+|++||++.|++++-.
T Consensus       235 i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~  292 (338)
T cd07859         235 V-RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY  292 (338)
T ss_pred             h-hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence            0 0000000000   000000   00123456789999999999999999999998754

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.7e-37  Score=357.32  Aligned_cols=259  Identities=24%  Similarity=0.316  Sum_probs=208.7

Q ss_pred             HHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEeecC--
Q 036624          527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC--  602 (893)
Q Consensus       527 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--  602 (893)
                      ++...++|...++||+|+||+||+|+....++.||||++..  ........+.+|+.++..++|+||+++...+....  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            34445789999999999999999999887778999998653  34556677899999999999999999987764332  


Q ss_pred             ------EEEEEEeeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCcee
Q 036624          603 ------EMILVYDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAK  674 (893)
Q Consensus       603 ------~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~k  674 (893)
                            .+++||||+++|+|.++|...  ....+++..+..++.|++.||+|||   ..+|+||||||+||||+.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEE
Confidence                  368999999999999998653  2346899999999999999999999   58999999999999999999999


Q ss_pred             EecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh
Q 036624          675 VSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC  754 (893)
Q Consensus       675 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  754 (893)
                      |+|||+++...............||+.|+|||++.+..++.++|||||||+||||++|+.||.....      .+.....
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~  257 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKT  257 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH
Confidence            9999999864332222233456799999999999999999999999999999999999999964322      1221111


Q ss_pred             hcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          755 HKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       755 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                               .... ....++.+...+.+++.+||+.+|.+||++.+++.+
T Consensus       258 ---------~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 ---------LAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ---------hcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                     1110 112234456778999999999999999999999875

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-36  Score=324.94  Aligned_cols=251  Identities=27%  Similarity=0.397  Sum_probs=201.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..+.||+|+||.||++..+.. ..+|+|..... ....++|..|++++++++||||+++++++......++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~-~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccC-ceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            3577788999999999999988765 57999986643 233467899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|.++++... ..+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++....... .
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05114          82 ENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-T  156 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-e
Confidence            9999999987543 35899999999999999999999   58999999999999999999999999999875432111 1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.||......      +..........   .       
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~~~~i~~~~~---~-------  220 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EVVEMISRGFR---L-------  220 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHCCCC---C-------
Confidence            1122335678999999998899999999999999999999 89898644321      11111111100   0       


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ..+......+.+++.+||+.+|++||++.++++.|
T Consensus       221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            11122345789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.3e-36  Score=344.92  Aligned_cols=260  Identities=24%  Similarity=0.397  Sum_probs=204.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCCC-hhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~  604 (893)
                      ++|...++||+|+||.||+|++.+     ....||+|+++... ....+.+..|+++|.++. ||||++++++|......
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            356677899999999999998643     33579999887542 333457899999999997 99999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCC-----------------------------------------------------------
Q 036624          605 ILVYDYMAYGTLREHLYKTQK-----------------------------------------------------------  625 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------------  625 (893)
                      ++|+||+++|+|.++|++...                                                           
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999999999999975321                                                           


Q ss_pred             -------------------------------------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC
Q 036624          626 -------------------------------------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD  668 (893)
Q Consensus       626 -------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld  668 (893)
                                                           ..++|..+++++.|++.||+|||   ..+|+||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence                                                 24678889999999999999999   58999999999999999


Q ss_pred             CCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccH
Q 036624          669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSL  747 (893)
Q Consensus       669 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  747 (893)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+    
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~----  349 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE----  349 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH----
Confidence            999999999999875322111111122346789999999999999999999999999999998 888885432111    


Q ss_pred             HHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          748 AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       748 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                        ........+         .....+..+...+.+++.+||+.+|.+||++.+|++.|+.++
T Consensus       350 --~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 --QFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             --HHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence              001111111         111223345578899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.2e-37  Score=333.95  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=216.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCE-EEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE-MILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~  608 (893)
                      ++|+..+++|+|+||.+++.+++..++.+++|.+..  .+....+....|+.++++++|||||.+.+.+.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            467788899999999999999998889999997553  344555678999999999999999999999998888 99999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      +|++||+|.+.|.+.++..++++.+.+++.|++.|+.|||   +..|+|||||+.||++..+..|||+|||+|+.....+
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999998887778999999999999999999999   5899999999999999999999999999999865533


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                        .....+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|.......      .+         .++.... 
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li---------~ki~~~~-  222 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LI---------LKINRGL-  222 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HH---------HHHhhcc-
Confidence              23445779999999999999999999999999999999999999997543211      11         1111111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ....+......+..++..||+.+|+.||++.+++.+..
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~  260 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPH  260 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChh
Confidence            22345566778999999999999999999999998744

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=326.38  Aligned_cols=256  Identities=25%  Similarity=0.412  Sum_probs=202.4

Q ss_pred             CccceeeeecCcEEEEEEEEcCc---ceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCE-----
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE-----  603 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----  603 (893)
                      |...++||+|+||.||+|.....   ...||+|+++..  .......+.+|++.++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            45677899999999999987543   367999987643  34456789999999999999999999999866554     


Q ss_pred             -EEEEEeeccCCCHHHHHhhC----CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecc
Q 036624          604 -MILVYDYMAYGTLREHLYKT----QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF  678 (893)
Q Consensus       604 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF  678 (893)
                       .++|+||+++|+|..++...    ....+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999988543    2236899999999999999999999   589999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcc
Q 036624          679 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       679 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  757 (893)
                      |+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+......   .+.++.      
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~------  228 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL------  228 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH------
Confidence            99886433222212222335678999999999999999999999999999999 88888543221   111111      


Q ss_pred             cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                            .+.. ....+..+...+.+++.+||+.+|++||++.||++.|+..
T Consensus       229 ------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 ------RHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ------HcCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  1111 1112334567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2e-36  Score=326.35  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=199.9

Q ss_pred             ccceeeeecCcEEEEEEEEcCcce--EEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec------CEE
Q 036624          535 DEALLLGVGGFGKVYRGEIDGATT--KVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------CEM  604 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~~~~~~--~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~  604 (893)
                      ...++||+|+||.||+|.....+.  .+|+|..+..  .....+.+..|++++++++|+||++++++|...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456789999999999999866543  5899976543  455577899999999999999999999988532      246


Q ss_pred             EEEEeeccCCCHHHHHhhC----CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccc
Q 036624          605 ILVYDYMAYGTLREHLYKT----QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL  680 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl  680 (893)
                      ++|+||+++|+|.+++...    ....+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999987432    2235899999999999999999999   58999999999999999999999999999


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccc
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGI  759 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  759 (893)
                      ++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||......      +...... .+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~-~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EIYDYLR-QGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHH-cCC
Confidence            886433221111223346778999999999999999999999999999999 78888543221      1111111 110


Q ss_pred             hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       760 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                               ....++.++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       232 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 ---------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     0112334556789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.6e-36  Score=333.63  Aligned_cols=262  Identities=27%  Similarity=0.437  Sum_probs=208.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCc-------ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecC
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGA-------TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENC  602 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~-------~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~  602 (893)
                      ++|...+.||+|+||.||++...+.       ...+|+|..... ......++..|+++++++ +|+||++++++|....
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            4688889999999999999986432       246999987753 344566788999999999 7999999999999999


Q ss_pred             EEEEEEeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC
Q 036624          603 EMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD  668 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld  668 (893)
                      ..++||||+++|+|.+++....              ...++|.++++++.|++.||+|||   +.+++||||||+|||++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            9999999999999999997542              135899999999999999999999   58999999999999999


Q ss_pred             CCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccH
Q 036624          669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSL  747 (893)
Q Consensus       669 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  747 (893)
                      +++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+.....      
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------  248 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------  248 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence            999999999999875432221111222234578999999999999999999999999999998 8888754321      


Q ss_pred             HHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhc
Q 036624          748 AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQ  812 (893)
Q Consensus       748 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~  812 (893)
                      .+....+..          ......+..+...+.+++.+||+.+|++||+|.+|++.|+.+++..
T Consensus       249 ~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         249 EELFKLLKE----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHHHHHHHc----------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            111111111          0111223345678889999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-36  Score=337.50  Aligned_cols=252  Identities=21%  Similarity=0.313  Sum_probs=200.8

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||.||+++....+..||+|.++..   .....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3699999999999999888889999987642   233456688999999998 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|..++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~  153 (329)
T cd05588          81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT  153 (329)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence            99999886543  5999999999999999999999   589999999999999999999999999998743221  1223


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccc--cccHHHHHHHhhcccchhhhccccccCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE--QVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||+......  .....++.......        ..  ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------~~--~~  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------KQ--IR  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc--------CC--CC
Confidence            34579999999999999999999999999999999999999996432111  11122222221111        11  11


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCC------HHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPS------MGDVLWNLE  806 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPt------m~evl~~L~  806 (893)
                      .+......+.+++.+||+.+|.+||+      +.+++++-.
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~  264 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF  264 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence            22334566889999999999999997      677776543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.7e-36  Score=323.17  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=198.9

Q ss_pred             eeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCHH
Q 036624          539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLR  617 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  617 (893)
                      .||+|+||.||+|.....++.+|+|..... .......|.+|++++++++|+||++++++|......++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            699999999999999877789999976543 3445577999999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeec
Q 036624          618 EHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK  697 (893)
Q Consensus       618 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~  697 (893)
                      +++.... ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...............
T Consensus        82 ~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          82 TFLRTEG-PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9986543 45899999999999999999999   5899999999999999999999999999987533211111111112


Q ss_pred             cCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHH
Q 036624          698 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC  776 (893)
Q Consensus       698 gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  776 (893)
                      .+..|+|||.+.++.++.++|||||||++|||++ |..|+........       ..         .+........+..+
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~---------~~~~~~~~~~~~~~  221 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------RE---------AIEQGVRLPCPELC  221 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HH---------HHHcCCCCCCcccC
Confidence            3457999999999999999999999999999998 8888754322110       00         01111111233345


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          777 FKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       777 ~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +..+.+++.+||+.+|++||++.+|++.|+
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            678899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.1e-36  Score=331.06  Aligned_cols=258  Identities=28%  Similarity=0.454  Sum_probs=205.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcc--eEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGAT--TKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~--~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|+..++||+|+||.||+|.....+  ..+++|.++.. .....+.|.+|++++.++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            46788889999999999999886544  34788877643 344567899999999999 799999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCce
Q 036624          608 YDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA  673 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~  673 (893)
                      +||+++|+|.+++.+..              ...+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999997532              134889999999999999999999   5899999999999999999999


Q ss_pred             eEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHH
Q 036624          674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA  752 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  752 (893)
                      ||+|||++......   ........+..|+|||++.+..++.++|||||||++|||++ |..||.......      ...
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~  229 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYE  229 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence            99999998642211   11111223567999999999999999999999999999997 999986543211      111


Q ss_pred             HhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          753 HCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       753 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      ..          ........+..+...+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus       230 ~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         230 KL----------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             HH----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11          11111122334556788999999999999999999999999877753

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-36  Score=329.74  Aligned_cols=266  Identities=26%  Similarity=0.429  Sum_probs=204.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEc----CcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEee--cCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEID----GATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE--NCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~----~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~  605 (893)
                      ++|+..+.||+|+||.||++...    ..+..|++|++........+.|.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46778889999999999999853    3457899999877777777889999999999999999999998754  35689


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +|+||+++|+|.+++.+.. ..+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++...
T Consensus        84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            9999999999999997543 35899999999999999999999   5899999999999999999999999999998653


Q ss_pred             CCCCcc-ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc------
Q 036624          686 TLDHTH-VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG------  758 (893)
Q Consensus       686 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------  758 (893)
                      ...... ......++..|+|||++.+..++.++|||||||++|||++|..++.....       .+........      
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~  232 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-------EFMRMMGNDKQGQMIV  232 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-------hhhhhcccccccccch
Confidence            322111 11112234569999999999999999999999999999998776532211       0111000000      


Q ss_pred             -chhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          759 -ILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       759 -~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                       .+.+++...........++..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence             01111111111122334567799999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.5e-36  Score=323.63  Aligned_cols=259  Identities=21%  Similarity=0.320  Sum_probs=209.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC---CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||.||+|+...++..||+|....   ........+.+|++++++++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            478889999999999999999987778999997543   23444567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          609 DYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       609 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||+++|+|.+++...  ....+++..++.++.|+++||.|||   +.+++||||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999988532  2345889999999999999999999   58999999999999999999999999999876432


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      ..  .......|++.|+|||++.+..++.++||||||+++|||++|+.|+.....    ...++......      ... 
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~------~~~-  225 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQ------CDY-  225 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhc------CCC-
Confidence            11  111234588899999999988899999999999999999999999854321    11222221111      001 


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                        ...........+.+++.+||+.+|++||++.+|++.|+++
T Consensus       226 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         226 --PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             --CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence              1111224457789999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-37  Score=322.81  Aligned_cols=252  Identities=24%  Similarity=0.327  Sum_probs=212.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      .+|++.+.||+|.||.|-++.....++.||||.++..   ++++.-.+++|++||+.|+||||+.++.+|+.++...|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4677788999999999999998777799999976543   4566667899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||..+|.|.+++.+.+  .|++.....++.||..|++|+|   +++++|||||.+|||||+|+++||+||||+-...   
T Consensus       133 EYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~---  204 (668)
T KOG0611|consen  133 EYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---  204 (668)
T ss_pred             EecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc---
Confidence            9999999999997654  5999999999999999999999   7999999999999999999999999999987532   


Q ss_pred             CccceeeeccCcCccChHhhhhcCCC-CcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                      .....+.+||++-|.+||++.+..|. ...|-|||||+||-|+.|..||++.+-.      ..+++         |-...
T Consensus       205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvrQ---------Is~Ga  269 (668)
T KOG0611|consen  205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVRQ---------ISRGA  269 (668)
T ss_pred             cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHHH---------hhccc
Confidence            23345678999999999999999885 5799999999999999999999865321      11222         21111


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                         ...++.+....-||+|||..||++|.|+.+|..+.+--+
T Consensus       270 ---YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  270 ---YREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             ---ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence               122344555677899999999999999999998877433

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.4e-36  Score=342.12  Aligned_cols=204  Identities=23%  Similarity=0.373  Sum_probs=176.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||+||++.....++.+|+|++...   .......+..|+.++.+++|+||+++++.+.+....+|||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4788899999999999999999888889999987542   2233457889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++.+..  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            9999999999997643  5899999999999999999999   5899999999999999999999999999987532110


Q ss_pred             C---------------------------------ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCC
Q 036624          689 H---------------------------------THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPA  735 (893)
Q Consensus       689 ~---------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p  735 (893)
                      .                                 ........||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0                                 0011235799999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 036624          736 LNPTL  740 (893)
Q Consensus       736 ~~~~~  740 (893)
                      |....
T Consensus       236 f~~~~  240 (363)
T cd05628         236 FCSET  240 (363)
T ss_pred             CCCCC
Confidence            97543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-36  Score=344.65  Aligned_cols=256  Identities=23%  Similarity=0.305  Sum_probs=199.6

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .|+..++||+|+||+||+|+....+..+|+|++...   .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999999888899999987542   23445678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++|+|.+++.+..  .+++..+..++.|++.||+|||   ..+|+||||||+||||+.++.+||+|||+++.......
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999997654  4889999999999999999999   58999999999999999999999999999753210000


Q ss_pred             ---------------------------------------------ccceeeeccCcCccChHhhhhcCCCCcchhhhHHH
Q 036624          690 ---------------------------------------------THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGV  724 (893)
Q Consensus       690 ---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gv  724 (893)
                                                                   ........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                         00012346999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHH--ccccCCCCCCCHHHHH
Q 036624          725 VLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMK--CVSDQGIERPSMGDVL  802 (893)
Q Consensus       725 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPtm~evl  802 (893)
                      ++|||++|+.||.........      ......       ...+...........+.+++.+  |+..++..||++.+++
T Consensus       237 il~elltG~~Pf~~~~~~~~~------~~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQ------LKVINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHH------HHHHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            999999999999754332111      000000       0000000111223456667766  5566677799999999


Q ss_pred             HHHH
Q 036624          803 WNLE  806 (893)
Q Consensus       803 ~~L~  806 (893)
                      .+-.
T Consensus       304 ~hp~  307 (381)
T cd05626         304 AHPF  307 (381)
T ss_pred             cCcc
Confidence            8754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3e-36  Score=321.71  Aligned_cols=251  Identities=25%  Similarity=0.371  Sum_probs=207.6

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|+..+.||+|+||.||+|.....+..|++|....  .......++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            46778899999999999999988788999997653  3455677899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.......+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++......  
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--  155 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--  155 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence            99999999998765567999999999999999999999   5899999999999999999999999999987543221  


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.||.......   .   ...         +.... ..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~---------~~~~~-~~  219 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---L---ILK---------IIRGV-FP  219 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---H---HHH---------HHcCC-CC
Confidence            11233468899999999999999999999999999999999999996543211   1   111         11000 11


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .........+.+++.+||+.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1222445678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-37  Score=344.40  Aligned_cols=256  Identities=21%  Similarity=0.284  Sum_probs=206.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||+||+|+....++.||+|++...   .......+..|++++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            4688899999999999999999877789999987542   2234567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++.+.  ..+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999765  45899999999999999999999   5899999999999999999999999999987543221


Q ss_pred             ---------------------------CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCc
Q 036624          689 ---------------------------HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP  741 (893)
Q Consensus       689 ---------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~  741 (893)
                                                 .........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                       00112345689999999999999999999999999999999999999975432


Q ss_pred             cccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHH
Q 036624          742 KEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS-MGDVLWNLE  806 (893)
Q Consensus       742 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-m~evl~~L~  806 (893)
                      ..      .......  ..     ..+...........+.+++.+|++ +|.+||+ +.+++++..
T Consensus       236 ~~------~~~~i~~--~~-----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~  287 (350)
T cd05573         236 QE------TYNKIIN--WK-----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF  287 (350)
T ss_pred             HH------HHHHHhc--cC-----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence            11      1111110  00     111111111245678889999997 9999999 999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.8e-37  Score=339.99  Aligned_cols=246  Identities=22%  Similarity=0.279  Sum_probs=199.4

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYG  614 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  614 (893)
                      +.||+|+||.||++.....+..||+|.+...   .......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999999888889999986542   2334567788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcccee
Q 036624          615 TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST  694 (893)
Q Consensus       615 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~  694 (893)
                      +|..++....  .+++..+..++.|++.||+|||+  ..+|+||||||+|||+++++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~  154 (325)
T cd05594          81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMK  154 (325)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Ccccc
Confidence            9999886543  58999999999999999999994  378999999999999999999999999998753221  11223


Q ss_pred             eeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCCh
Q 036624          695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP  774 (893)
Q Consensus       695 ~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  774 (893)
                      ...||+.|+|||++.+..++.++|||||||+||||++|+.||.......      ....         +....  ..++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~~---------i~~~~--~~~p~  217 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFEL---------ILMEE--IRFPR  217 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------HHHH---------HhcCC--CCCCC
Confidence            4569999999999999999999999999999999999999996543211      1111         11000  11222


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          775 ECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       775 ~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                      .....+.+++.+||+.+|++|+     ++.+++++..
T Consensus       218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  254 (325)
T cd05594         218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF  254 (325)
T ss_pred             CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence            3445688899999999999996     8999987754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=344.73  Aligned_cols=256  Identities=21%  Similarity=0.293  Sum_probs=202.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||+||+|+....++.||||++...   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4788999999999999999999888889999987542   2234566889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            9999999999997643  5899999999999999999999   5899999999999999999999999999986432110


Q ss_pred             Cc------------------------------------cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhC
Q 036624          689 HT------------------------------------HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA  732 (893)
Q Consensus       689 ~~------------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG  732 (893)
                      ..                                    .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                    001124599999999999999999999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHH
Q 036624          733 RPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS---MGDVLWNLE  806 (893)
Q Consensus       733 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt---m~evl~~L~  806 (893)
                      +.||........      .......       ...+...........+.+++.+|+. +|.+|++   +.|++++-.
T Consensus       236 ~~Pf~~~~~~~~------~~~i~~~-------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~  298 (364)
T cd05599         236 YPPFCSDNPQET------YRKIINW-------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF  298 (364)
T ss_pred             CCCCCCCCHHHH------HHHHHcC-------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence            999975432211      1110000       0000000011234567788888986 8999997   999987654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.6e-36  Score=331.49  Aligned_cols=264  Identities=25%  Similarity=0.437  Sum_probs=209.9

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcC-------cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeec
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDG-------ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEEN  601 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~  601 (893)
                      .++|...+.||+|+||.||+|+..+       ....|++|..... .....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            3567778899999999999997532       2346999987643 345567899999999999 899999999999999


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL  667 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  667 (893)
                      ...++||||+++|+|.+++....              ...++|.+++.++.|+++||.|||   +.+|+||||||+|||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999997542              235789999999999999999999   5899999999999999


Q ss_pred             CCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCcccccc
Q 036624          668 DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVS  746 (893)
Q Consensus       668 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  746 (893)
                      ++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+....      
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------  244 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------  244 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence            9999999999999986543222222223346778999999999999999999999999999998 777775432      


Q ss_pred             HHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhch
Q 036624          747 LAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE  813 (893)
Q Consensus       747 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~  813 (893)
                      ..++........          ....+..+...+.+++.+||+.+|++||+|.||++.|++...+..
T Consensus       245 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         245 VEELFKLLKEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             HHHHHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            222222211111          111233456788899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-36  Score=337.47  Aligned_cols=247  Identities=24%  Similarity=0.325  Sum_probs=196.9

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHH---hhccccceeeEEEEEeecCEEEEE
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEML---SKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      |+..++||+|+||.||+|.....++.||||+++..   .....+.+..|++++   ++++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            56678999999999999999888889999987532   223345667776665   566799999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++|+|..++.+   ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999988854   35999999999999999999999   589999999999999999999999999998753221


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                        ........|++.|+|||++.+..++.++|||||||++|||++|+.||.......      ....         +....
T Consensus       155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~---------i~~~~  217 (324)
T cd05589         155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDS---------IVNDE  217 (324)
T ss_pred             --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHH---------HHhCC
Confidence              122234569999999999999999999999999999999999999996543211      1111         11110


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNL  805 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L  805 (893)
                        ...+......+.+++.+||+.+|.+||     ++.+++++.
T Consensus       218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence              112233456678999999999999999     466666543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.4e-36  Score=327.74  Aligned_cols=256  Identities=29%  Similarity=0.426  Sum_probs=205.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEc-----CcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEID-----GATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++...++||+|+||.||++...     .....+++|..........+.|.+|++++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            35667789999999999999743     2346799998877777777889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCC-------------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCce
Q 036624          607 VYDYMAYGTLREHLYKTQK-------------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA  673 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~  673 (893)
                      |+||+++|+|.+++.....             ..+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            9999999999999875421             35899999999999999999999   5899999999999999999999


Q ss_pred             eEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHH
Q 036624          674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA  752 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  752 (893)
                      ||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |++||........      ..
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------IE  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------HH
Confidence            9999999875432222111222335788999999999999999999999999999998 8888854322111      11


Q ss_pred             HhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          753 HCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       753 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                               .+.... ....+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus       236 ---------~~~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 ---------CITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ---------HHHcCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                     111110 11122345567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.7e-37  Score=345.31  Aligned_cols=255  Identities=22%  Similarity=0.275  Sum_probs=204.1

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      ..++|+..++||+|+||.||+++....+..+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            356789999999999999999999888889999987532   22344567899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++|+|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus       121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999998653   3788889999999999999999   58999999999999999999999999999875432


Q ss_pred             CCCccceeeeccCcCccChHhhhhc----CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                      ... .......||+.|+|||++.+.    .++.++|||||||+||||++|+.||.......               ....
T Consensus       195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---------------~~~~  258 (370)
T cd05596         195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---------------TYSK  258 (370)
T ss_pred             CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---------------HHHH
Confidence            111 112345699999999998753    48899999999999999999999997543211               1111


Q ss_pred             hcccc--ccCCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 036624          763 IMDPY--LKGKIAPECFKKFAETAMKCVSDQGIE--RPSMGDVLWNLE  806 (893)
Q Consensus       763 i~d~~--l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPtm~evl~~L~  806 (893)
                      +++..  +.-.........+.+++.+||+.+|++  ||++.+++++-.
T Consensus       259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~  306 (370)
T cd05596         259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF  306 (370)
T ss_pred             HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence            11111  111111134567888999999999988  999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-36  Score=329.80  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=203.6

Q ss_pred             CCccceeeeecCcEEEEEEEEcCc-----ceEEEEEeCCCCCh-hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGA-----TTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~VavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      +|+..+.||+|+||.||+|...+.     ...||+|+...... ...+.|..|+.++++++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            355667899999999999987542     36799998875433 335678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhC--------------CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc
Q 036624          607 VYDYMAYGTLREHLYKT--------------QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV  672 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~  672 (893)
                      ++||+.+++|.+++...              ....+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            99999999999998532              1235889999999999999999999   589999999999999999999


Q ss_pred             eeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHH
Q 036624          673 AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWA  751 (893)
Q Consensus       673 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  751 (893)
                      +||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..|+.....      .++.
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVI  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHHH
Confidence            99999999886433222222223446789999999998999999999999999999998 7778754322      1121


Q ss_pred             HHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          752 AHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       752 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..         +.+.. ....+.+++..+.+++.+||+.+|++||++.+|+..|+
T Consensus       237 ~~---------i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         237 EM---------IRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             HH---------HHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            11         11111 11234456777899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=330.21  Aligned_cols=256  Identities=23%  Similarity=0.323  Sum_probs=206.0

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      +|+..++||+|+||+||++.....+..||+|++....   ......+.+|+.++++++|+||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778889999999999999988777899999875432   2233557889999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++|+|.+++.......+++..+..++.|++.||+|||   ..+|+||||||+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999999987665567999999999999999999999   5899999999999999999999999999987643211 


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                        ......|++.|+|||++.+..++.++|||||||++|||++|+.||........  ..+...         .+..  ..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~~~---------~~~~--~~  221 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEVER---------RVKE--DQ  221 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHHHH---------Hhhh--cc
Confidence              11234689999999999999999999999999999999999999975432110  001100         0100  01


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLEF  807 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~~  807 (893)
                      ..++......+.+++.+||+.||++||     ++.+++++-..
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~  264 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF  264 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCc
Confidence            122334556788999999999999999     78888776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-36  Score=326.60  Aligned_cols=257  Identities=26%  Similarity=0.407  Sum_probs=207.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcc-----eEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      .++|...+.||+|+||.||+|......     ..|++|..... .......+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            357888899999999999999886433     67999987644 334556789999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCC--------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEe
Q 036624          605 ILVYDYMAYGTLREHLYKTQ--------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVS  676 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~  676 (893)
                      ++||||+++|+|.+++....        ...++|..++.++.|++.||.|||   +.+++||||||+|||+++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986532        234789999999999999999999   5899999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhh
Q 036624          677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       677 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      |||+++.....+.........++..|+|||.+.++.++.++|||||||++|||++ |+.|+.......   +..+.    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~----  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFV----  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHH----
Confidence            9999875433222222233446789999999998899999999999999999998 888886433211   11111    


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                              .+.. ....+..++..+.+++.+||+.+|++|||+.+++..|+
T Consensus       235 --------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 --------IDGG-HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             --------hcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                    1110 11223345678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.9e-36  Score=336.26  Aligned_cols=250  Identities=22%  Similarity=0.338  Sum_probs=198.8

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||.||++.....++.+|+|.++..   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            3799999999999999888889999986642   234456688899988877 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|..++....  .+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~  153 (329)
T cd05618          81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTT  153 (329)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcc
Confidence            99999886543  5899999999999999999999   589999999999999999999999999998753221  1122


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccc--cccHHHHHHHhhcccchhhhccccccCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE--QVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .....++.......        ..  ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------~~--~~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------KQ--IR  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--------CC--CC
Confidence            34579999999999999999999999999999999999999996422111  11112222221111        11  12


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPS------MGDVLWN  804 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPt------m~evl~~  804 (893)
                      ++......+.+++.+||+.+|++||+      +.+++++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            33344567889999999999999998      5677655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.1e-36  Score=336.35  Aligned_cols=249  Identities=21%  Similarity=0.295  Sum_probs=195.3

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      |+..++||+|+||.||+|++...++.||+|.+... .....+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  155 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD  155 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence            44567899999999999999877789999987543 33445678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      +|+|....      .+.+..+..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++......  ..
T Consensus       156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  224 (353)
T PLN00034        156 GGSLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DP  224 (353)
T ss_pred             CCcccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cc
Confidence            99986532      3567788899999999999999   5899999999999999999999999999987643211  11


Q ss_pred             eeeeccCcCccChHhhhh-----cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          693 STVVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                      .....||..|+|||++..     ...+.++|||||||+||||++|+.||......      +|......      +.. .
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~------~~~~~~~~------~~~-~  291 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWASLMCA------ICM-S  291 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHHHH------Hhc-c
Confidence            223468999999998743     33456899999999999999999999732221      12111100      000 0


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ........+...+.+++.+||+.+|++||++.|++++-.
T Consensus       292 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~  330 (353)
T PLN00034        292 QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF  330 (353)
T ss_pred             CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            011223345567899999999999999999999998654

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.3e-36  Score=323.17  Aligned_cols=258  Identities=24%  Similarity=0.400  Sum_probs=206.3

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcc---eEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGAT---TKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~---~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++|+..+.||+|+||.||+|.....+   ..+++|..... .....+++..|++++++++|+||+++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            357788899999999999999986433   36999987654 34456789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++++|.+++.... ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999997543 46899999999999999999999   58999999999999999999999999999875432


Q ss_pred             CCCccc-eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          687 LDHTHV-STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       687 ~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ...... ......+..|+|||++....++.++|||||||++|||++ |+.||......      ++......        
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~~--------  225 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAIND--------  225 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhc--------
Confidence            211111 111223467999999999999999999999999999997 99998643221      11111111        


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                       . .......+++..+.+++.+|++.+|++||+|.+|++.|+++
T Consensus       226 -~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         226 -G-FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -C-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             0 11112234567789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=330.90  Aligned_cols=263  Identities=23%  Similarity=0.393  Sum_probs=203.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCc--------------ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGA--------------TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIG  596 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~--------------~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g  596 (893)
                      ++|+..++||+|+||.||++...+.              ...||+|..... .......|.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5688888999999999999886532              235899987654 3445567999999999999999999999


Q ss_pred             EEeecCEEEEEEeeccCCCHHHHHhhCC----------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEE
Q 036624          597 YCEENCEMILVYDYMAYGTLREHLYKTQ----------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNIL  666 (893)
Q Consensus       597 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIL  666 (893)
                      ++......++||||+++++|.+++....          ...+++..++.++.|+++||+|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999986432          124789999999999999999999   589999999999999


Q ss_pred             ECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh--CCCCCCCCCcccc
Q 036624          667 LDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC--ARPALNPTLPKEQ  744 (893)
Q Consensus       667 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~~  744 (893)
                      +++++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++  |..||....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            99999999999999875433222222223345778999999999999999999999999999988  556665432211 


Q ss_pred             ccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          745 VSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       745 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                        ............      ........++.++..+.+++.+||+.+|++||+|.+|++.|+
T Consensus       241 --~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 --VIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --HHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              111111111000      000011122234568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.7e-36  Score=326.94  Aligned_cols=255  Identities=26%  Similarity=0.372  Sum_probs=203.5

Q ss_pred             HHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEeec------
Q 036624          529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEEN------  601 (893)
Q Consensus       529 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~------  601 (893)
                      .+++.|+..+.||+|+||.||+|.....++.||+|+..... .....+..|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45677888889999999999999998888899999875432 3456788999999998 699999999998653      


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      ...++||||+++++|.+++.......+++..+..++.|++.||+|||   ..+|+||||||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            46899999999999999998765567999999999999999999999   489999999999999999999999999998


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK  756 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  756 (893)
                      +......  .......|+..|+|||++.     +..++.++|||||||++|||++|+.|+....+...     +... . 
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~~~~-~-  229 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLI-P-  229 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----HHHH-h-
Confidence            7543211  1223456899999999986     34688899999999999999999999964332111     1000 0 


Q ss_pred             ccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          757 KGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       757 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                           ....+.   .....+...+.+++.+||..+|.+||++.+++++
T Consensus       230 -----~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         230 -----RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -----cCCCCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                 000111   1122345678899999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2e-36  Score=335.47  Aligned_cols=248  Identities=24%  Similarity=0.306  Sum_probs=199.3

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      +|+..+.||+|+||.||+|+...++..||+|.+...   .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            477889999999999999999888889999986642   223345677788888877 5899999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|..++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence            9999999999986553  4899999999999999999999   589999999999999999999999999998753221 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +   ..         .+.... 
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~---~~---------~i~~~~-  217 (323)
T cd05616         155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L---FQ---------SIMEHN-  217 (323)
T ss_pred             -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H---HH---------HHHhCC-
Confidence             112234569999999999999999999999999999999999999997543211   1   11         111111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSM-----GDVLWN  804 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm-----~evl~~  804 (893)
                       ..++......+.+++.+||+.+|++|++.     .+++++
T Consensus       218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence             11223345677899999999999999984     555543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-36  Score=337.39  Aligned_cols=256  Identities=20%  Similarity=0.252  Sum_probs=204.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||+||++.....+..||+|+++..   .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4688899999999999999999888889999987642   2234567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++.+.. ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999999997652 35999999999999999999999   5899999999999999999999999999987643221


Q ss_pred             CccceeeeccCcCccChHhhh------hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          689 HTHVSTVVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                       ........||+.|+|||++.      ...++.++|||||||++|||++|+.||.......      .........    
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~----  225 (330)
T cd05601         157 -MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQ----  225 (330)
T ss_pred             -ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCC----
Confidence             11223456899999999987      4567899999999999999999999996543211      111111110    


Q ss_pred             hccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          763 IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       763 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         ..+.....+.....+.+++.+|++ +|.+||++.+++.+-.
T Consensus       226 ---~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~  265 (330)
T cd05601         226 ---RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF  265 (330)
T ss_pred             ---CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence               001111112345667889999998 9999999999987643

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-36  Score=342.05  Aligned_cols=258  Identities=21%  Similarity=0.277  Sum_probs=203.3

Q ss_pred             HHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCE
Q 036624          527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE  603 (893)
Q Consensus       527 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~  603 (893)
                      +....++|+..++||+|+||.||+++...++..+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+...
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            333457899999999999999999999888889999986531   22344568899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      .++||||+++|+|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence            99999999999999998643   3888999999999999999999   58999999999999999999999999999976


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhhc----CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccc
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI  759 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  759 (893)
                      ...... .......||+.|+|||++.+.    .++.++|||||||+||||++|+.||.......               .
T Consensus       192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---------------~  255 (370)
T cd05621         192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---------------T  255 (370)
T ss_pred             cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---------------H
Confidence            432111 112345699999999999764    37899999999999999999999997543211               1


Q ss_pred             hhhhccccccCCCC--hHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 036624          760 LEQIMDPYLKGKIA--PECFKKFAETAMKCVSDQGIE--RPSMGDVLWNLE  806 (893)
Q Consensus       760 ~~~i~d~~l~~~~~--~~~~~~l~~l~~~Cl~~~p~~--RPtm~evl~~L~  806 (893)
                      ...+++......++  ......+.+++.+|++.++.+  ||++.|++++-.
T Consensus       256 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~  306 (370)
T cd05621         256 YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF  306 (370)
T ss_pred             HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence            11122211111111  123556778888999865544  899999998755

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.2e-36  Score=335.28  Aligned_cols=248  Identities=25%  Similarity=0.333  Sum_probs=199.4

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhcccc-ceeeEEEEEeecCEEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHR-HLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~  608 (893)
                      +|+..+.||+|+||.||+|+..+.++.||+|++...   .....+.+..|++++..++|+ +|+++.+++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            477889999999999999999888889999987542   234456788999999999764 5888999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence            9999999999986543  4899999999999999999999   589999999999999999999999999998743221 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +   .         ..+.... 
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~---~---------~~i~~~~-  217 (324)
T cd05587         155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L---F---------QSIMEHN-  217 (324)
T ss_pred             -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---H---------HHHHcCC-
Confidence             112334569999999999999999999999999999999999999997543211   1   1         1111111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSM-----GDVLWN  804 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm-----~evl~~  804 (893)
                       ..++......+.+++.+||+.+|.+|++.     .+++++
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence             11223345668899999999999999976     555544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.1e-36  Score=323.03  Aligned_cols=259  Identities=22%  Similarity=0.318  Sum_probs=208.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC---CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||.||++....++..++||....   .......++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            357778899999999999999877778999997653   23344568899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          609 DYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       609 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||+++++|.+++...  ....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988642  3346899999999999999999999   58999999999999999999999999999875432


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      ..  .......|+..|+|||++.+..++.++||||||+++|||++|..||......    ..++....      .....+
T Consensus       159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~------~~~~~~  226 (267)
T cd08229         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI------EQCDYP  226 (267)
T ss_pred             CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh------hcCCCC
Confidence            11  1122345889999999999999999999999999999999999998643221    11111111      111111


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      .   .........+.+++.+||+.+|++||||.+|++.++++
T Consensus       227 ~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 P---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             C---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            1   11223556789999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.7e-36  Score=325.09  Aligned_cols=258  Identities=22%  Similarity=0.352  Sum_probs=203.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcce----EEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATT----KVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      ++|+..++||+|+||+||+|+....+.    .||+|..... .....+++.+|+.+++.++|+||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            567888899999999999998754433    4899987643 344567889999999999999999999999764 5779


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ++||+++|+|.++++... ..+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999987543 35899999999999999999999   58999999999999999999999999999886432


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ...........+++.|+|||.+.+..++.++|||||||++|||++ |..|+......   .+..+...            
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~------------  226 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLEK------------  226 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHC------------
Confidence            211111112235678999999999999999999999999999998 88888643221   12221111            


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                       ......+..+...+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus       227 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         227 -GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             -CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence             00111123455678899999999999999999999999886654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-36  Score=336.20  Aligned_cols=245  Identities=23%  Similarity=0.328  Sum_probs=197.2

Q ss_pred             eeeeecCcEEEEEEEEc---CcceEEEEEeCCCC----ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          538 LLLGVGGFGKVYRGEID---GATTKVAIKRGNPL----SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~---~~~~~VavK~~~~~----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++||+|+||.||+++..   ..++.||+|.+...    .......+.+|+++|++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999863   34578999986532    223345678999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++|+|.+++....  .+.+..+..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.....  .
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  154 (323)
T cd05584          82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--G  154 (323)
T ss_pred             CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--C
Confidence            99999999986543  4788899999999999999999   589999999999999999999999999998743221  1


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      .         +..+....  .
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~---------~~~~~~~~--~  217 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------T---------IDKILKGK--L  217 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------H---------HHHHHcCC--C
Confidence            12234569999999999999999999999999999999999999996543211      1         11111111  1


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                      .+++.....+.+++.+||+.+|++||     ++.+++++-.
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~  258 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF  258 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence            22334456788999999999999999     7888877543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4e-36  Score=328.41  Aligned_cols=264  Identities=27%  Similarity=0.427  Sum_probs=206.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcc----------------eEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGAT----------------TKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVS  593 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~----------------~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~  593 (893)
                      ..+|+..+.||+|+||.||++.....+                ..||+|.+... .....+++.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357888899999999999999875432                45899987654 3445678999999999999999999


Q ss_pred             EEEEEeecCEEEEEEeeccCCCHHHHHhhCC---------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCC
Q 036624          594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQ---------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTN  664 (893)
Q Consensus       594 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  664 (893)
                      +++++......++|+||+++++|.+++....         ...+++..++.++.|++.||+|||   +.+|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999997643         125899999999999999999999   5899999999999


Q ss_pred             EEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh--CCCCCCCCCcc
Q 036624          665 ILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC--ARPALNPTLPK  742 (893)
Q Consensus       665 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~p~~~~~~~  742 (893)
                      |++++++.+||+|||+++.....+.........++..|+|||++.+..++.++|||||||++|||++  +..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876433322222334456789999999999899999999999999999998  66676533211


Q ss_pred             ccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          743 EQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       743 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         ..............      .......+..++..+.+++.+||+.+|++||++.||++.|+
T Consensus       241 ---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 ---QVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ---HHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence               11111111111110      01111122334567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.4e-36  Score=325.41  Aligned_cols=261  Identities=24%  Similarity=0.363  Sum_probs=208.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcC----cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEee-cCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDG----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE-NCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~----~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~  604 (893)
                      .++|...++||+|+||.||+|....    ....|++|++... .....+.+.+|+.++++++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678888999999999999999865    2477999987643 34556778999999999999999999998866 4678


Q ss_pred             EEEEeeccCCCHHHHHhhCCC------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecc
Q 036624          605 ILVYDYMAYGTLREHLYKTQK------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF  678 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF  678 (893)
                      ++++||+++|+|.+++.....      ..+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            999999999999999875422      45899999999999999999999   589999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcc
Q 036624          679 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       679 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  757 (893)
                      |+++.....+.........++..|+|||++.+..++.++|||||||++||+++ |+.||....+.   .+..+..   ..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~---~~  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK---DG  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH---cC
Confidence            99985433222212223346778999999999999999999999999999998 99998654321   1222111   11


Q ss_pred             cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .          .......++..+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus       236 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         236 Y----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             C----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            0          011122345678999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-36  Score=335.99  Aligned_cols=245  Identities=22%  Similarity=0.310  Sum_probs=198.1

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||.||+|+....+..||+|.+...   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            3699999999999999888889999987642   233456678899998876 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|...+....  .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~  153 (321)
T cd05591          81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTT  153 (321)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC--Cccc
Confidence            99999887554  4899999999999999999999   589999999999999999999999999998753221  1122


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ....         +....  ...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~---------i~~~~--~~~p  216 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFES---------ILHDD--VLYP  216 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHH---------HHcCC--CCCC
Confidence            34569999999999999999999999999999999999999997543211      1111         11110  0112


Q ss_pred             hHHHHHHHHHHHHccccCCCCCC-------CHHHHHHHHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERP-------SMGDVLWNLE  806 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RP-------tm~evl~~L~  806 (893)
                      ......+.+++.+||+.+|++||       ++.+++++-.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~  256 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF  256 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence            22345678899999999999999       7888886643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.9e-36  Score=330.49  Aligned_cols=243  Identities=26%  Similarity=0.360  Sum_probs=193.7

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||.||+|+..+.+..||+|.++..   .....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999999888889999987542   223345566677777654 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|..++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~  153 (316)
T cd05592          81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA  153 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence            99999987543  5899999999999999999999   5899999999999999999999999999987532211  223


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ....         +...  ...++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~---------i~~~--~~~~~  216 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDS---------ILND--RPHFP  216 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHH---------HHcC--CCCCC
Confidence            34569999999999999999999999999999999999999997543211      1111         1100  11122


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSMG-DVLWN  804 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm~-evl~~  804 (893)
                      ..+...+.+++.+||+.+|++||++. +++++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            33445678899999999999999975 55443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.7e-36  Score=321.73  Aligned_cols=251  Identities=29%  Similarity=0.404  Sum_probs=200.9

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      +|...+.||+|+||+||+|...+. ..+|+|...... ....+|.+|+.++++++||||+++++++......++||||+.
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCC-CcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            466778999999999999988764 569999876432 334679999999999999999999999999889999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      +|+|.+++..... .+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++....... ..
T Consensus        83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05113          83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS  157 (256)
T ss_pred             CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence            9999999976443 6899999999999999999999   58999999999999999999999999999875432211 11


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||.......      .........          ...
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~----------~~~  221 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKVSQGL----------RLY  221 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHhcCC----------CCC
Confidence            112235678999999998899999999999999999998 999986433211      111111100          011


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .+......+.+++.+||+.+|++||++.++++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11223567899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.7e-36  Score=335.39  Aligned_cols=237  Identities=22%  Similarity=0.312  Sum_probs=192.9

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||+||+|+.+..++.||+|++...   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999999888889999987532   223456678888988877 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|..++.+..  .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....  ....
T Consensus        81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~  153 (320)
T cd05590          81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT  153 (320)
T ss_pred             chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence            99999887654  4899999999999999999999   589999999999999999999999999998753221  1223


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ....         +....  ...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~---------i~~~~--~~~~  216 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEA---------ILNDE--VVYP  216 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHH---------HhcCC--CCCC
Confidence            34569999999999999999999999999999999999999997543211      1111         11110  0112


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSM  798 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm  798 (893)
                      ......+.+++.+||+.||++||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            2344567899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.7e-36  Score=328.66  Aligned_cols=267  Identities=20%  Similarity=0.251  Sum_probs=200.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh-hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .++|+..+.||+|+||.||+|+....++.||+|.+..... .....+.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            4678899999999999999999987778999998764322 223457889999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+. ++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...... 
T Consensus        84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  157 (303)
T cd07869          84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-  157 (303)
T ss_pred             CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence            996 78888876543 35889999999999999999999   5899999999999999999999999999987532211 


Q ss_pred             ccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc---cch---hh
Q 036624          690 THVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK---GIL---EQ  762 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~---~~  762 (893)
                       .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+. ........   ...   ..
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QLE-RIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHH-HHHHHhCCCChhhccchhh
Confidence             11223458899999999875 4588999999999999999999999975432111 011 01000000   000   00


Q ss_pred             --hcccc-ccCCCCh---------HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          763 --IMDPY-LKGKIAP---------ECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       763 --i~d~~-l~~~~~~---------~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                        ..++. .....+.         .....+.+++.+||+.||++|||+.|++++-.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~  290 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY  290 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence              00000 0000000         11245778999999999999999999997654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.4e-36  Score=329.58  Aligned_cols=259  Identities=29%  Similarity=0.461  Sum_probs=204.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcc--eEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGAT--TKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~--~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++|+..+.||+|+||.||+|.+...+  ..+++|..... .......+.+|++++.++ +|+||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            356788889999999999999976544  35678876543 344567889999999999 89999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc
Q 036624          607 VYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV  672 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~  672 (893)
                      |+||+++|+|.++++...              ...+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999997542              235889999999999999999999   589999999999999999999


Q ss_pred             eeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHH
Q 036624          673 AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWA  751 (893)
Q Consensus       673 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  751 (893)
                      +||+|||+++.....   .......++..|+|||++.+..++.++|||||||+||||++ |..||......      +..
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~  233 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY  233 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHH
Confidence            999999998642111   11112234668999999998889999999999999999998 99998643221      111


Q ss_pred             HHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          752 AHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       752 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      ....         . ......+..+...+.+++.+||+.+|++||++.+++.+|+.+++-
T Consensus       234 ~~~~---------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         234 EKLP---------Q-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             HHHh---------c-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1110         0 001111223445688999999999999999999999999876643

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=343.36  Aligned_cols=256  Identities=20%  Similarity=0.235  Sum_probs=199.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|...++||+|+||+||++.....++.||+|++...   .....+.+.+|++++++++||||+++++++.+....+|||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999999888899999986532   2334567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9999999999997543  5889999999999999999999   5899999999999999999999999999986321100


Q ss_pred             C-------------c--------------------------------cceeeeccCcCccChHhhhhcCCCCcchhhhHH
Q 036624          689 H-------------T--------------------------------HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFG  723 (893)
Q Consensus       689 ~-------------~--------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~G  723 (893)
                      .             .                                .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            0             0                                000124699999999999999999999999999


Q ss_pred             HHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCC---CCHHH
Q 036624          724 VVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIER---PSMGD  800 (893)
Q Consensus       724 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ptm~e  800 (893)
                      |+||||++|+.||......+.      .......      . ..+.-.........+.+++.+||+ +|.+|   +++.|
T Consensus       236 vil~elltG~~Pf~~~~~~~~------~~~i~~~------~-~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHET------YRKIINW------R-ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHH------HHHHHcc------C-CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            999999999999965433211      0010000      0 000000011234567888999997 66664   69999


Q ss_pred             HHHHHH
Q 036624          801 VLWNLE  806 (893)
Q Consensus       801 vl~~L~  806 (893)
                      ++++-.
T Consensus       302 ~l~hp~  307 (377)
T cd05629         302 IKSHPF  307 (377)
T ss_pred             HhcCCC
Confidence            998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3e-36  Score=327.00  Aligned_cols=249  Identities=24%  Similarity=0.333  Sum_probs=199.1

Q ss_pred             eeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCH
Q 036624          540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL  616 (893)
Q Consensus       540 LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  616 (893)
                      ||+|+||+||++.....++.+|+|.+....   ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999998877899999875422   22345678899999999999999999999999999999999999999


Q ss_pred             HHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcccee
Q 036624          617 REHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST  694 (893)
Q Consensus       617 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~  694 (893)
                      ..++...  ....+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++......  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence            9888543  3356999999999999999999999   5899999999999999999999999999987543221  1223


Q ss_pred             eeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCCh
Q 036624          695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP  774 (893)
Q Consensus       695 ~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  774 (893)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....         ..+....  ...+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~---------~~~~~~~--~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELK---------QRILNDS--VTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHH---------HhhcccC--CCCcc
Confidence            35689999999999999999999999999999999999999965432110  00111         1111111  12233


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          775 ECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       775 ~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                      .....+.+++.+||+.+|++||     ++.+++++-.
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~  259 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL  259 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence            4556788999999999999999     7788887644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.9e-36  Score=343.60  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=196.7

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .|+..++||+|+||+||+|+....+..+|+|++...   .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999999888889999987642   23345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC-
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD-  688 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~-  688 (893)
                      ||++|+|.+++.+..  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            999999999997653  4888999999999999999999   5899999999999999999999999999975321000 


Q ss_pred             --------------------------------------------CccceeeeccCcCccChHhhhhcCCCCcchhhhHHH
Q 036624          689 --------------------------------------------HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGV  724 (893)
Q Consensus       689 --------------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gv  724 (893)
                                                                  .........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                        000112346999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCC---HHHH
Q 036624          725 VLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS---MGDV  801 (893)
Q Consensus       725 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt---m~ev  801 (893)
                      +||||++|+.||....+.+..      .....       ....+...........+.+++.+|+ .+|++|++   +.++
T Consensus       237 il~elltG~~Pf~~~~~~~~~------~~i~~-------~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQ------MKVIN-------WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHH------HHHHc-------cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            999999999999754332110      00000       0000110111122344556666665 48999987   8888


Q ss_pred             HHHH
Q 036624          802 LWNL  805 (893)
Q Consensus       802 l~~L  805 (893)
                      +.+-
T Consensus       303 ~~hp  306 (382)
T cd05625         303 KAHP  306 (382)
T ss_pred             hcCC
Confidence            7653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.5e-36  Score=336.29  Aligned_cols=261  Identities=24%  Similarity=0.397  Sum_probs=201.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEc-----CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeec-CE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEID-----GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEEN-CE  603 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~~  603 (893)
                      ++|+..++||+|+||.||+|...     ...+.||||+++.. .......+.+|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            46888899999999999999853     23468999987653 234456788999999999 689999999988654 56


Q ss_pred             EEEEEeeccCCCHHHHHhhCC-----------------------------------------------------------
Q 036624          604 MILVYDYMAYGTLREHLYKTQ-----------------------------------------------------------  624 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  624 (893)
                      .++||||+++|+|.++++...                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999986432                                                           


Q ss_pred             ------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeecc
Q 036624          625 ------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG  698 (893)
Q Consensus       625 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  698 (893)
                            ...+++.++..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++...............+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                  124788899999999999999999   58999999999999999999999999999876432211111222345


Q ss_pred             CcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHH
Q 036624          699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECF  777 (893)
Q Consensus       699 t~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~  777 (893)
                      +..|+|||++.+..++.++|||||||++|||++ |..|+........     .... ..++.         ....+....
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~-~~~~~---------~~~~~~~~~  308 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRR-LKEGT---------RMRAPDYTT  308 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-----HHHH-HhccC---------CCCCCCCCC
Confidence            678999999999999999999999999999997 8888854322110     0111 11110         011111233


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          778 KKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       778 ~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ..+.+++.+||+.+|++||++.||+++|+.+.+
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.7e-36  Score=325.54  Aligned_cols=261  Identities=25%  Similarity=0.389  Sum_probs=206.0

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE  603 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~  603 (893)
                      .+++|+..++||+|+||.||+|..++     ....||+|...... ......+.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            35678889999999999999997642     23579999866432 3344568899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCC--------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeE
Q 036624          604 MILVYDYMAYGTLREHLYKTQ--------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKV  675 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl  675 (893)
                      .++||||+++|+|.+++.+..        ...+++..+..++.|++.||.|||   +++|+||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999997532        234678889999999999999999   589999999999999999999999


Q ss_pred             ecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHh
Q 036624          676 SDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHC  754 (893)
Q Consensus       676 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  754 (893)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..|+......      ++... 
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~-  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKF-  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-
Confidence            99999885433222222222345678999999999999999999999999999998 77787543221      11111 


Q ss_pred             hcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          755 HKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       755 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                              +.+... ...+..+...+.+++.+||+.+|++||++.++++.|+..+
T Consensus       234 --------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         234 --------VMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             --------HHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                    111111 1122344578999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.2e-36  Score=325.47  Aligned_cols=268  Identities=26%  Similarity=0.371  Sum_probs=204.3

Q ss_pred             ccceeeeecCcEEEEEEEE----cCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEEEEE
Q 036624          535 DEALLLGVGGFGKVYRGEI----DGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEMILV  607 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~----~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV  607 (893)
                      ...+.||+|+||+||++..    ...+..||+|...... ......|.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6778999999999988653    2345679999876542 34567789999999999999999999998653  468999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++++|.+++...   .+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus        87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            9999999999999654   3999999999999999999999   589999999999999999999999999998864332


Q ss_pred             CCc-cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          688 DHT-HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       688 ~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      ... .......++..|+|||++....++.++|||||||++|||++|+.|+....... ..+..+.........+.+.++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhc
Confidence            111 11122335667999999998999999999999999999999999985432211 1111111100111112222222


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ......+..++..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2222334456678999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-37  Score=332.27  Aligned_cols=255  Identities=27%  Similarity=0.450  Sum_probs=213.1

Q ss_pred             CccceeeeecCcEEEEEEEEc----CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          534 FDEALLLGVGGFGKVYRGEID----GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~----~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ....++||+|.||.||+|.+.    +..-.||||..+.. .....+.|+.|.-+|+.++|||||+|+|+|.+. ..|+||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            344568999999999999874    33456999987763 445577899999999999999999999999875 789999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |.++-|.|..+|..+. ..|+.......|.||+.+|.||||   .++|||||..+|||+...-.+||+||||+|......
T Consensus       470 EL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             ecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            9999999999998664 458999999999999999999995   889999999999999999999999999999765544


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                      +.+. +..+-+..|||||.+.-.++|.++|||-|||++|||+. |..||.+-...+               .+..+ ..-
T Consensus       546 yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---------------VI~~i-EnG  608 (974)
T KOG4257|consen  546 YYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---------------VIGHI-ENG  608 (974)
T ss_pred             hhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------------eEEEe-cCC
Confidence            4333 34556789999999999999999999999999999985 899997643222               11111 111


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      -+...++.|+..+..|+.+||..+|.+||...++...|...++
T Consensus       609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            1235678899999999999999999999999999999988876

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.1e-36  Score=325.42  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=197.6

Q ss_pred             eeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCH
Q 036624          540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL  616 (893)
Q Consensus       540 LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  616 (893)
                      ||+|+||.||+++....+..+|+|.+....   ......+..|++++++++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999998878899999875321   12234566799999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeee
Q 036624          617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV  696 (893)
Q Consensus       617 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  696 (893)
                      .+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++......   ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence            99987766667999999999999999999999   589999999999999999999999999998754321   112334


Q ss_pred             ccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHH
Q 036624          697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC  776 (893)
Q Consensus       697 ~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  776 (893)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||.......  ...+....         ........ .....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~---------~~~~~~~~-~~~~~  222 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRR---------TLEDEVKF-EHQNF  222 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHH---------hhcccccc-ccccC
Confidence            68999999999999999999999999999999999999986432211  11111111         11111100 01123


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          777 FKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       777 ~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..++.+++.+||+.+|++||++.|+++.+.
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            456889999999999999999977764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.2e-36  Score=322.23  Aligned_cols=256  Identities=23%  Similarity=0.394  Sum_probs=204.8

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcc---eEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGAT---TKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~---~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      +|+..+.||+|+||.||+|.....+   ..|++|..... .....++|..|+.++++++||||+++++++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            4667889999999999999986543   36999987654 4555678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++.... ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999987543 45899999999999999999999   5899999999999999999999999999987543221


Q ss_pred             Ccccee-eec--cCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          689 HTHVST-VVK--GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       689 ~~~~~~-~~~--gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ...... ...  .+..|+|||++.+..++.++|||||||++||+++ |..||......   ...++...           
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~-----------  226 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQ-----------  226 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHc-----------
Confidence            111111 111  2457999999999999999999999999999886 99998654321   11222110           


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                        ......+.+++..+.+++.+||+.+|++||+|.+|+..|+.+
T Consensus       227 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 --DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              001112345567788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.5e-36  Score=333.09  Aligned_cols=250  Identities=21%  Similarity=0.316  Sum_probs=199.0

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||+||+|....++..+|+|++...   .....+.+..|+.++.++ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3799999999999999888889999987643   233456688999999888 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|..++....  .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (327)
T cd05617          81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT  153 (327)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence            99999886543  4999999999999999999999   589999999999999999999999999998753221  1223


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....||+.|+|||++.+..++.++|||||||+||||++|+.||............++.......        ..  ..++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~--~~~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--------KP--IRIP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--------CC--CCCC
Confidence            3466999999999999999999999999999999999999999653322222222222221111        10  1122


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSM------GDVLWN  804 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm------~evl~~  804 (893)
                      ......+.+++.+||+.+|++|+++      .+++++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            3344667899999999999999984      566544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-36  Score=339.50  Aligned_cols=264  Identities=21%  Similarity=0.222  Sum_probs=201.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..++||+|+||.||++.....++.||+|...      ...+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999998888999999743      23468999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +. ++|..++....  .+++..++.|+.|+++||+|||   +.+||||||||+|||++.++.+||+|||+++...... .
T Consensus       165 ~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~  237 (391)
T PHA03212        165 YK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A  237 (391)
T ss_pred             CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence            96 78988886543  4899999999999999999999   5899999999999999999999999999987532211 1


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccc-----ccHHHHHHHhh---------c
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ-----VSLAEWAAHCH---------K  756 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-----~~l~~~~~~~~---------~  756 (893)
                      .......||+.|+|||++.+..++.++|||||||+||||++|+.|+........     ..+........         .
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            122345699999999999999999999999999999999999987754321110     00110000000         0


Q ss_pred             ccchhhhc---------cccccCC--CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          757 KGILEQIM---------DPYLKGK--IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       757 ~~~~~~i~---------d~~l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ...+.++.         .+.....  ...+.+..+.+++.+||+.||++|||+.|++++-..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f  379 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF  379 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence            00001000         0000000  001235578899999999999999999999976653

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.9e-36  Score=320.33  Aligned_cols=254  Identities=29%  Similarity=0.425  Sum_probs=204.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..++||+|+||.||+|.+.+. ..|++|++.... ...+.|.+|++++++++|+||+++++++.+ ...++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            4688889999999999999988766 569999877432 234678999999999999999999998754 4578999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|.+++.+.....+++..+..++.|+++||+|||   +.+++||||||+||++++++.+||+|||+++....... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            9999999998655556899999999999999999999   58999999999999999999999999999875432211 1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......++..|+|||+..+..++.++|||||||++|||++ |+.||........      ...         +.. ....
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------~~~---------~~~-~~~~  222 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQ---------VER-GYRM  222 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------HHH---------Hhc-CCCC
Confidence            1122346678999999999999999999999999999999 7888864432110      000         000 0011


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      ....+++..+.+++.+|++.+|++||++.++++.|+..
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            22345667889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.4e-36  Score=319.97  Aligned_cols=253  Identities=28%  Similarity=0.415  Sum_probs=202.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..++||+|+||.||+|...++ ..+++|....... ..+.|.+|+.++++++|+|++++++++.+ ...++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCC-ceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            4577788999999999999987755 5699998765332 34679999999999999999999998854 5678999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.+.....+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-c
Confidence            9999999998765566899999999999999999999   58899999999999999999999999999875432111 1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.||......      +......          .....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~----------~~~~~  222 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQVE----------RGYRM  222 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHH----------cCCCC
Confidence            1122235678999999999999999999999999999999 88888643221      1111111          01111


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ..+...+..+.+++.+|++.+|++|||+.++++.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2233455679999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-35  Score=327.94  Aligned_cols=260  Identities=25%  Similarity=0.454  Sum_probs=205.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC-------cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecC
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG-------ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENC  602 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~  602 (893)
                      .+|...++||+|+||.||+++..+       ....+|+|..+.. ......++..|+++++++ +||||++++++|....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            467788899999999999997532       2356899987643 344567789999999999 6999999999999999


Q ss_pred             EEEEEEeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC
Q 036624          603 EMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD  668 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld  668 (893)
                      ..++||||+++|+|.+++....              ...++|.+++.++.|++.||.|||   +.+++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence            9999999999999999997532              235899999999999999999999   58999999999999999


Q ss_pred             CCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccH
Q 036624          669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSL  747 (893)
Q Consensus       669 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  747 (893)
                      +++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||......+    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----  244 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE----  244 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            999999999999986433221111122234568999999999999999999999999999999 888885432211    


Q ss_pred             HHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          748 AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       748 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                        ...... .+         .....+..+...+.+++.+||+.+|++||++.++++.|+....
T Consensus       245 --~~~~~~-~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 --LFKLLR-EG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             --HHHHHH-cC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence              111111 10         0112234456678899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.6e-36  Score=322.08  Aligned_cols=255  Identities=22%  Similarity=0.320  Sum_probs=203.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      .+|+..+.||+|+||.||+|+....+..||+|+...........+.+|+.++++++||||+++++++......++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46888899999999999999998777899999876554455667889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.++++...  .+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++......  .
T Consensus        89 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06646          89 GGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A  161 (267)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence            9999999986543  5899999999999999999999   5899999999999999999999999999987543211  1


Q ss_pred             ceeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          692 VSTVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      ......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+....+.....      . ...   .....+..
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~-~~~---~~~~~~~~  231 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-MSK---SNFQPPKL  231 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------e-eec---CCCCCCCC
Confidence            122345889999999984   4457889999999999999999999985432211100      0 000   00011111


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      .  ........+.+++.+||+.+|++||++.+++++|
T Consensus       232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1  1123346788999999999999999999999765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-36  Score=310.40  Aligned_cols=267  Identities=23%  Similarity=0.269  Sum_probs=203.7

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh-h-HHHHHHHHHHHhhccccceeeEEEEEee--cCEEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-G-VHEFQTEIEMLSKLRHRHLVSLIGYCEE--NCEMILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~-~-~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~  608 (893)
                      .|+..+.|++|.||.||+|+++.++..||+|+++-..+. + --.-.+||.+|.+++|||||.+-.+...  -+..+|||
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM  156 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM  156 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence            467788999999999999999999999999988753321 1 1134799999999999999999888754  36799999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |||+ -+|...+.... .++...++..+..|+++||+|||   .+.|+|||||++|+|+...|.+||+||||||..... 
T Consensus       157 e~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-  230 (419)
T KOG0663|consen  157 EYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-  230 (419)
T ss_pred             HHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence            9998 69999987665 56899999999999999999999   699999999999999999999999999999975442 


Q ss_pred             CccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh------
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE------  761 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------  761 (893)
                       ....+...-|.+|.|||.+.+. .|++..|+||+|||+.||+++++-|.+....++.+..--......+....      
T Consensus       231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence             2223455679999999998864 69999999999999999999999987765544332211000000000000      


Q ss_pred             --------hhccccccCCCChH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          762 --------QIMDPYLKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       762 --------~i~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                              +-.-..++..+... ..+.-.+++...|..||.+|-|+.|.+++=.
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~  363 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY  363 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence                    00001112222221 2355678889999999999999999987644

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-36  Score=317.92  Aligned_cols=255  Identities=27%  Similarity=0.317  Sum_probs=213.7

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      +|+..+.||.|.-|+||++++.+.....|+|++...   ..+.......|-+||+.+.||.+..|++.++.....|||||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            455667899999999999999999899999987754   34455678889999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC---
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT---  686 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~---  686 (893)
                      ||+||+|..+++++....+++..+.-.+..++-||+|||   -.|||.|||||+||||.++|++.|+||.|+.....   
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            999999999999998889999999999999999999999   69999999999999999999999999998743110   


Q ss_pred             ------------------------------CCC---------------------ccceeeeccCcCccChHhhhhcCCCC
Q 036624          687 ------------------------------LDH---------------------THVSTVVKGSFGYLDPEYFRRQQLTE  715 (893)
Q Consensus       687 ------------------------------~~~---------------------~~~~~~~~gt~~y~APE~~~~~~~s~  715 (893)
                                                    ...                     ...+..+.||-.|+|||++++..-+.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                          000                     01122356899999999999999999


Q ss_pred             cchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCC
Q 036624          716 KSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIER  795 (893)
Q Consensus       716 ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R  795 (893)
                      ++|+|+|||+|||||.|..||.+....+               .+..|+...+.-...++....+.+||++.|.+||.+|
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR  379 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR  379 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence            9999999999999999999997765432               3444444444333334667889999999999999999


Q ss_pred             CC----HHHHHHHH
Q 036624          796 PS----MGDVLWNL  805 (893)
Q Consensus       796 Pt----m~evl~~L  805 (893)
                      ..    +.||.++-
T Consensus       380 lg~~rGA~eIK~Hp  393 (459)
T KOG0610|consen  380 LGSKRGAAEIKRHP  393 (459)
T ss_pred             hccccchHHhhcCc
Confidence            87    77777653

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=317.29  Aligned_cols=270  Identities=23%  Similarity=0.286  Sum_probs=208.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCC--CCChhhHHHHHHHHHHHhhccccceeeEEEEEee-----cCE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE-----NCE  603 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~--~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~  603 (893)
                      ...|...+.||+|+||.|+.+..+.++..||||++.  -......+.-.+|+++|++++|+||+.+.+.+..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            344555678999999999999999998999999877  3355567788999999999999999999998754     467


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      .++|+|+|+ .+|...|+.+.  .|+...+..+..|+++||.|+||   .+|+||||||+|+|++.+...||+||||||.
T Consensus       101 vYiV~elMe-tDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceee
Confidence            899999995 78888886543  39999999999999999999995   8999999999999999999999999999997


Q ss_pred             CCCCCCccceeeeccCcCccChHhhh-hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                      ..........+....|.+|.|||.+. ...||...||||.|||+.||++|++-|.+...-.+..+.--.-....+..+..
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            64332233334556789999999875 46899999999999999999999999987655444333221111111111111


Q ss_pred             hc--------c--cccc----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          763 IM--------D--PYLK----GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       763 i~--------d--~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +-        .  +...    ...-+.......+++.+||..||.+|+|+.|.+++--
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY  312 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY  312 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence            11        0  0000    0011133455788999999999999999999997754

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-36  Score=320.09  Aligned_cols=254  Identities=24%  Similarity=0.364  Sum_probs=205.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-----hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-----EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      ++|...+.||+|++|.||+|.....+..+++|......     ....+.+.+|++++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            47888999999999999999988777899999765321     2234678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      |+||+++++|.+++....  .+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            999999999999987543  4889999999999999999999   58999999999999999999999999999875432


Q ss_pred             CCCcc-ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTH-VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ..... ......|+..|+|||++.+..++.++|||||||++|||++|+.||........     ..          ....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~----------~~~~  221 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-----IF----------KIAT  221 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-----HH----------HHhc
Confidence            11111 11234578899999999999999999999999999999999999864322110     00          0111


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      .......+..+...+.+++.+||..+|++||++.+++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence            1111223444566788999999999999999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-36  Score=343.70  Aligned_cols=256  Identities=20%  Similarity=0.270  Sum_probs=199.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||.||+++....++.||+|.+....   ......+.+|+++|++++|+||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999998888999999875421   223466889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++.+..  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++.......
T Consensus        81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999997643  4888999999999999999999   5899999999999999999999999999974211000


Q ss_pred             -----------------------------------------CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHH
Q 036624          689 -----------------------------------------HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLF  727 (893)
Q Consensus       689 -----------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~  727 (893)
                                                               .........||+.|+|||++.+..++.++|||||||+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                     000112356999999999999999999999999999999


Q ss_pred             HHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 036624          728 EILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERP---SMGDVLWN  804 (893)
Q Consensus       728 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---tm~evl~~  804 (893)
                      ||++|+.||....+.+.      .......       ...+...........+.+++.+|+ .+|.+|+   ++.+++.+
T Consensus       236 ell~G~~Pf~~~~~~~~------~~~i~~~-------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPAET------QLKVINW-------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHHHH------HHHHhcc-------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999999976543221      1110000       000000111123445666777766 4999999   89999877


Q ss_pred             HH
Q 036624          805 LE  806 (893)
Q Consensus       805 L~  806 (893)
                      -.
T Consensus       302 ~~  303 (376)
T cd05598         302 PF  303 (376)
T ss_pred             CC
Confidence            44

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.3e-36  Score=332.90  Aligned_cols=243  Identities=24%  Similarity=0.326  Sum_probs=197.6

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||+||++.....+..||+|.+...   .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999999888889999987642   233456678899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|..++.+..  .+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++......  ...
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (318)
T cd05570          81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT  153 (318)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence            99999887653  5999999999999999999999   5899999999999999999999999999987532211  122


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......      +....         +....  ..++
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~---------i~~~~--~~~~  216 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQS---------ILEDE--VRYP  216 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHH---------HHcCC--CCCC
Confidence            3456899999999999999999999999999999999999999654321      11111         11111  1122


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSM-----GDVLWN  804 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm-----~evl~~  804 (893)
                      ......+.+++.+||+.+|.+||++     .+++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            3345678899999999999999999     777755

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-36  Score=319.79  Aligned_cols=250  Identities=28%  Similarity=0.395  Sum_probs=199.8

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      +|+..+.||+|+||.||+|..+. ...+++|...... .....|.+|++++++++|+||+++++++...+..++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecC-CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            46677899999999999998875 3679999875432 234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      +++|.+++..... .+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++...... ...
T Consensus        83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~  157 (256)
T cd05059          83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTS  157 (256)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccc
Confidence            9999999976543 6899999999999999999999   5889999999999999999999999999987543211 111


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+   .   ..... .         .....
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~~-~---------~~~~~  221 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V---VESVS-A---------GYRLY  221 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H---HHHHH-c---------CCcCC
Confidence            111224458999999999999999999999999999999 788886432211   1   11110 0         01112


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      .+..++..+.+++.+||+.+|++||+|.|+++.|
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            2234567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.4e-36  Score=331.43  Aligned_cols=243  Identities=25%  Similarity=0.342  Sum_probs=194.2

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      +.||+|+||+||+|+....+..||+|.++..   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999999888889999986542   123345567788888764 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|..++...  ..+++.++..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (316)
T cd05619          81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKT  153 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCce
Confidence            9999998754  34899999999999999999999   589999999999999999999999999998753221  1122


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +   .....       ...+    .++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~---~~~i~-------~~~~----~~~  216 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---L---FQSIR-------MDNP----CYP  216 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---H---HHHHH-------hCCC----CCC
Confidence            34569999999999999999999999999999999999999997543211   1   11110       0011    112


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSMG-DVLWN  804 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm~-evl~~  804 (893)
                      ......+.+++.+||+.+|++||++. ++.++
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence            22345678899999999999999997 55543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.6e-36  Score=324.58  Aligned_cols=257  Identities=30%  Similarity=0.458  Sum_probs=205.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      .++|+..+.||+|+||.||++...+     ....+|+|.+... .....++|.+|+.++++++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            4678889999999999999998753     4478999987653 344567799999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCC--------------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCC
Q 036624          605 ILVYDYMAYGTLREHLYKTQ--------------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTN  664 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  664 (893)
                      ++|+||+++|+|.+++....                    ...+++..++.++.|++.||+|||   ..+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999997431                    134789999999999999999999   5899999999999


Q ss_pred             EEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccc
Q 036624          665 ILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKE  743 (893)
Q Consensus       665 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~  743 (893)
                      ||+++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||.....  
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--  238 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--  238 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999875432222111222335678999999999999999999999999999997 8778754322  


Q ss_pred             cccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          744 QVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       744 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                          .++..... .+        ... ..+..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus       239 ----~~~~~~~~-~~--------~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         239 ----EEVIYYVR-DG--------NVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             ----HHHHHHHh-cC--------CCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                12221111 11        110 112344577899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-35  Score=319.85  Aligned_cols=259  Identities=24%  Similarity=0.377  Sum_probs=207.7

Q ss_pred             HHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       526 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      |++.+++++.....||+|+||.||+|.+..++..|++|..........+.+.+|+.++++++|+||+++++++...+..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            34556788888889999999999999988877889999887766667788999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCC--CHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-CCceeEecccccc
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPL--PWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSK  682 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~  682 (893)
                      +|+||+++++|.+++..... .+  ++..+..++.|+++||.|||   ..+|+||||||+||+++. ++.+||+|||++.
T Consensus        82 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            99999999999999976432 34  88889999999999999999   589999999999999986 6799999999987


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcC--CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      .......  ......|+..|+|||++.+..  ++.++|||||||++|||++|+.|+........   ..|.....     
T Consensus       158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~-----  227 (268)
T cd06624         158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF-----  227 (268)
T ss_pred             ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh-----
Confidence            5432111  122335789999999987643  78999999999999999999999864322110   11110000     


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                            .....++......+.+++.+||+.+|++||++.|++.+
T Consensus       228 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 ------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                  01112334455678899999999999999999999865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=9.4e-36  Score=325.74  Aligned_cols=263  Identities=22%  Similarity=0.365  Sum_probs=202.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC----------------cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG----------------ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSL  594 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~----------------~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l  594 (893)
                      ++|+..++||+|+||.||++...+                ....+|+|..... .....++|.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            468888999999999999986432                2346899987654 34456789999999999999999999


Q ss_pred             EEEEeecCEEEEEEeeccCCCHHHHHhhCCC---------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCE
Q 036624          595 IGYCEENCEMILVYDYMAYGTLREHLYKTQK---------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNI  665 (893)
Q Consensus       595 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI  665 (893)
                      ++++...+..++||||+++|+|.+++.....         ..+++.+++.++.|++.||+|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            9999999999999999999999999976421         24778899999999999999999   58999999999999


Q ss_pred             EECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh--CCCCCCCCCccc
Q 036624          666 LLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC--ARPALNPTLPKE  743 (893)
Q Consensus       666 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~  743 (893)
                      |+++++.+||+|||+++...............++..|+|||+..++.++.++|||||||++|||++  |..|+......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999875432221111222334678999999998999999999999999999998  667775432211


Q ss_pred             cccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          744 QVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       744 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         .............      .......+..++..+.+++.+||+.+|++||+|.+|++.|+
T Consensus       242 ---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 ---VIENTGEFFRDQG------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ---HHHHHHHHHhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence               1111111110000      00011122345678899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.6e-35  Score=317.13  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=196.8

Q ss_pred             eeeecCcEEEEEEEEc--CcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCC
Q 036624          539 LLGVGGFGKVYRGEID--GATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGT  615 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~--~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  615 (893)
                      .||+|+||.||+|.+.  +.+..||+|...... ....++|.+|+.++++++|+||+++++++.. ...++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999764  334579999876543 3345679999999999999999999999864 57899999999999


Q ss_pred             HHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc-cee
Q 036624          616 LREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH-VST  694 (893)
Q Consensus       616 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~  694 (893)
                      |.+++.... ..+++..+++++.|+++||+|||   +.+++||||||+|||++.++.+||+|||+++......... ...
T Consensus        81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            999986543 45899999999999999999999   5899999999999999999999999999987533221111 112


Q ss_pred             eeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       695 ~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ...++..|+|||++.+..++.++|||||||++|||++ |..||......+      +.... ..+         .....+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~-~~~---------~~~~~~  220 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMSFI-EQG---------KRLDCP  220 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHH-HCC---------CCCCCC
Confidence            2234678999999998899999999999999999996 999986543211      11111 111         112234


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ..+..++.+++.+||..+|++||++.+|.+.|+.
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            4566788899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.5e-35  Score=316.65  Aligned_cols=258  Identities=21%  Similarity=0.338  Sum_probs=209.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC---CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||.||+|....++..|++|..+.   ......+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            578888999999999999999987778899997643   23334678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          609 DYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       609 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||+++|+|..++...  ....+++.+++.++.|+++||.|||   +.+|+||||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998653  3345899999999999999999999   58999999999999999999999999999875432


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      ..  .......++..|+|||++.+..++.++|||||||++|||++|+.|+....    ..+.++...... +        
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~-~--------  223 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEK-C--------  223 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhc-C--------
Confidence            11  11223458889999999999999999999999999999999999985432    122222211110 0        


Q ss_pred             cccCCCC-hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          767 YLKGKIA-PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       767 ~l~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      . ....+ ......+.+++.+||..+|++||++.+|++.|+.+
T Consensus       224 ~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         224 D-YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             C-CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            0 11111 24456788999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-35  Score=318.26  Aligned_cols=247  Identities=27%  Similarity=0.383  Sum_probs=196.7

Q ss_pred             eeeecCcEEEEEEEE--cCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCC
Q 036624          539 LLGVGGFGKVYRGEI--DGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYG  614 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~--~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  614 (893)
                      .||+|+||.||+|.+  ...+..+|+|+++..  .....+++..|+.++++++|+||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999975  344578999987543  23456789999999999999999999999864 5678999999999


Q ss_pred             CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc-cce
Q 036624          615 TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT-HVS  693 (893)
Q Consensus       615 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~-~~~  693 (893)
                      +|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++........ ...
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            9999996543  5899999999999999999999   589999999999999999999999999998764332211 111


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI  772 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  772 (893)
                      ....++..|+|||.+....++.++|||||||++|||++ |+.||......      ++.... ..+         .....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~i-~~~---------~~~~~  219 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------EVTQMI-ESG---------ERMEC  219 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-HCC---------CCCCC
Confidence            22234679999999988889999999999999999998 99998654321      111111 111         11123


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          773 APECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       773 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      +..++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            34456778899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.6e-36  Score=332.59  Aligned_cols=255  Identities=24%  Similarity=0.298  Sum_probs=199.8

Q ss_pred             CCccceeeeecCcEEEEEEEEc---CcceEEEEEeCCCC----ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEID---GATTKVAIKRGNPL----SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~---~~~~~VavK~~~~~----~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  604 (893)
                      +|+..++||+|+||+||+++..   ..+..||+|++...    .....+.+..|+.++.++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778899999999999998863   34578999976532    223345688999999999 499999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++||||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            99999999999999997543  4899999999999999999999   589999999999999999999999999998753


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      .... ........||+.|+|||++.+. .++.++|||||||+||||++|+.||........  ..........       
T Consensus       156 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~-------  225 (332)
T cd05614         156 LSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILK-------  225 (332)
T ss_pred             cccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhc-------
Confidence            2221 1122345699999999999865 478999999999999999999999964332111  1111111110       


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                      .++    .++......+.+++.+||+.+|++||     ++.+++++-.
T Consensus       226 ~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         226 CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence            111    22233456678899999999999999     7778886643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-35  Score=327.24  Aligned_cols=264  Identities=25%  Similarity=0.343  Sum_probs=206.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..+.||+|+||.||++.....+..+++|..... ......++.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            4688899999999999999999888788999987643 334456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.+.  ..+++..+..++.|+++||.|||+  ..+++||||||+|||+++++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999999765  358999999999999999999995  468999999999999999999999999998753221   


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc------------
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG------------  758 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------------  758 (893)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.|+.......   +..+........            
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCC
Confidence             1223468899999999998889999999999999999999999986432211   111111000000            


Q ss_pred             ------------chhhhccccccCCCC-hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          759 ------------ILEQIMDPYLKGKIA-PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       759 ------------~~~~i~d~~l~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                                  ....++... ....+ ......+.+++.+||+.+|++||++.+|+++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  290 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI  290 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence                        000000000 00001 1134568899999999999999999999988765

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.7e-36  Score=332.07  Aligned_cols=243  Identities=23%  Similarity=0.297  Sum_probs=194.3

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||.||+|+....+..||+|.++...   ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            37999999999999998888899999875421   23345667788888765 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|..++...  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (316)
T cd05620          81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRA  153 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCce
Confidence            9999998654  35899999999999999999999   589999999999999999999999999998743211  1223


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ...... .      ..+    .++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~------~~~~~~-~------~~~----~~~  216 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE------LFESIR-V------DTP----HYP  216 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHH-h------CCC----CCC
Confidence            44679999999999999999999999999999999999999996543211      111100 0      011    112


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSMG-DVLWN  804 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm~-evl~~  804 (893)
                      ......+.+++.+||+.||++||++. +++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            22445678899999999999999985 56544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=320.10  Aligned_cols=250  Identities=30%  Similarity=0.476  Sum_probs=198.5

Q ss_pred             eeeeecCcEEEEEEEEcCcce--EEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATT--KVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~--~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||.||+|...+++.  .+++|..... .....+.+..|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999999876543  5788877643 344567899999999999 799999999999999999999999999


Q ss_pred             CCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccc
Q 036624          614 GTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG  679 (893)
Q Consensus       614 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG  679 (893)
                      |+|.+++....              ...+++.++..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999997542              134889999999999999999999   5899999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhccc
Q 036624          680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKG  758 (893)
Q Consensus       680 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  758 (893)
                      +++....   .........+..|+|||++....++.++|||||||++|||++ |..||......      +.......  
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~~--  226 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLPQ--  226 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHHhC--
Confidence            9863221   111112234668999999998999999999999999999997 99998543211      11111110  


Q ss_pred             chhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          759 ILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       759 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                              ......+..+...+.+++.+|++.+|.+||++.+++..|+.++
T Consensus       227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 --------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             --------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                    0111122234567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-35  Score=354.67  Aligned_cols=262  Identities=23%  Similarity=0.313  Sum_probs=206.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||.||+|.....++.||+|++...   .....+.|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            4788899999999999999999887889999987642   2334567999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhC---------CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccc
Q 036624          609 DYMAYGTLREHLYKT---------QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG  679 (893)
Q Consensus       609 E~~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG  679 (893)
                      ||+++|+|.+++...         ....+++..+++++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988642         1234677889999999999999999   5899999999999999999999999999


Q ss_pred             ccccCCCCCC----------------ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccc
Q 036624          680 LSKTGPTLDH----------------THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE  743 (893)
Q Consensus       680 la~~~~~~~~----------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~  743 (893)
                      +++.......                ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9875411100                001123469999999999999999999999999999999999999996532211


Q ss_pred             cccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHh
Q 036624          744 QVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERP-SMGDVLWNLEFALQ  810 (893)
Q Consensus       744 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-tm~evl~~L~~~~~  810 (893)
                      ..    +      .   ..+.++... ....+.+..+.+++.+|++.+|++|| ++.++++.|+..++
T Consensus       239 i~----~------~---~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 IS----Y------R---DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hh----h------h---hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            00    0      0   011111100 00123456688999999999999995 67788888887665

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.8e-36  Score=324.62  Aligned_cols=255  Identities=24%  Similarity=0.333  Sum_probs=205.2

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      |+..++||+|+||+||++.....++.+|+|.+....   ....+.+..|+.++++++|+|++.+++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677789999999999999999888999999765422   22345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.......+++..++.++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999997665556999999999999999999999   5899999999999999999999999999987543211  


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||........  ...+ ..         +.+. ...
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~-~~---------~~~~-~~~  222 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEV-ER---------LVKE-VQE  222 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHH-Hh---------hhhh-hhh
Confidence             11234689999999999999999999999999999999999999975432110  0000 00         0000 001


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNLEF  807 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L~~  807 (893)
                      .........+.+++.+||+.+|++||+     +.|++++-..
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~  264 (285)
T cd05630         223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF  264 (285)
T ss_pred             hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence            122234456889999999999999999     8899887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-35  Score=317.53  Aligned_cols=250  Identities=25%  Similarity=0.395  Sum_probs=201.6

Q ss_pred             eeeeecCcEEEEEEEEcC-c--ceEEEEEeCCCCCh-hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDG-A--TTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~-~--~~~VavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|++|.||+|.+.. .  ...||+|....... ...+.+..|+.++++++|+||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998754 2  23699998876655 567789999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc-cc
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT-HV  692 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~-~~  692 (893)
                      |+|.+++.......++|..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++........ ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997765356899999999999999999999   589999999999999999999999999998865332211 11


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.|+......+      .........         ....
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~---------~~~~  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEG---------ERLE  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcC---------CcCC
Confidence            223457789999999999999999999999999999998 999986432211      111111000         0111


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            22334567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=335.72  Aligned_cols=249  Identities=24%  Similarity=0.386  Sum_probs=209.7

Q ss_pred             ceeeeecCcEEEEEEEEcC---cceEEEEEeCCCCChh-hHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          537 ALLLGVGGFGKVYRGEIDG---ATTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~---~~~~VavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      .++||+|.||.|++|.++.   ....||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+..+ ..++||+|+++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            4589999999999999854   3356999998876544 67899999999999999999999999988 67899999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc-
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH-  691 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~-  691 (893)
                      .|+|.+.|++..+..|-......+|.|||.||.||.   .+++|||||..+|+||-....+||+||||.|.....+... 
T Consensus       194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv  270 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV  270 (1039)
T ss_pred             cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence            999999999866777888999999999999999999   4899999999999999999999999999999765443332 


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      .....+-...|.|||.++...++.++|||+|||.||||++ |..||-+....                .+.+.+|..-+-
T Consensus       271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD~~erL  334 (1039)
T KOG0199|consen  271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNIDAGERL  334 (1039)
T ss_pred             ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhccccccC
Confidence            2233445779999999999999999999999999999998 66777554322                123334444444


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ..++.|.+.+.++++.||..+|.+|||+..|.+.+
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            56778999999999999999999999999997443

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-35  Score=319.95  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=193.0

Q ss_pred             eeeecCcEEEEEEEEcC--cceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCC
Q 036624          539 LLGVGGFGKVYRGEIDG--ATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGT  615 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~--~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  615 (893)
                      .||+|+||.||+|...+  ....+++|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            69999999999998654  33568999876543 3344578999999999999999999999999999999999999999


Q ss_pred             HHHHHhhCC---CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          616 LREHLYKTQ---KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       616 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      |.++++...   ...+++..+..++.|+++||+|||   +.+++||||||+||++++++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999997542   234678888999999999999999   58999999999999999999999999999875433222222


Q ss_pred             eeeeccCcCccChHhhhhc-------CCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          693 STVVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~-------~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      .....++..|+|||++.+.       .++.++|||||||++|||++ |+.||......+.   ..+.    ..+....+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYT----VREQQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH----hhcccCCCC
Confidence            2334578899999998642       35789999999999999996 9999965432211   0110    001111122


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ++.+.    ......+.+++..|+ .+|++||++.||++.|+
T Consensus       232 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22221    123445778889998 57999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-35  Score=316.74  Aligned_cols=250  Identities=32%  Similarity=0.496  Sum_probs=205.3

Q ss_pred             eeeeecCcEEEEEEEEcCc---ceEEEEEeCCCCChh-hHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||.||+|.....   ...+++|........ ..+.+.+|++++++++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            3699999999999998764   688999987765433 367899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCC-------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          614 GTLREHLYKTQ-------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       614 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ++|.+++....       ...+++..+..++.|+++||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999997652       356999999999999999999999   58999999999999999999999999999987544


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ...........++..|+|||.+....++.++|||||||++|||++ |+.||......      +.......         
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~---------  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLEYLRK---------  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHc---------
Confidence            322222334557889999999998899999999999999999999 58888654221      11111111         


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      . .....+..+...+.+++.+||+.+|++||++.|++++|+
T Consensus       223 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 G-YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C-CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            0 011223345678899999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.9e-36  Score=333.03  Aligned_cols=238  Identities=26%  Similarity=0.377  Sum_probs=190.8

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHH-HHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIE-MLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||+||+|....+++.||+|++...   .....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            3699999999999999888889999987542   1223344555555 56789999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|..++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....  .....
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~  153 (323)
T cd05575          81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTT  153 (323)
T ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCcc
Confidence            99999987543  5899999999999999999999   58999999999999999999999999999875322  11223


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......      +....         +.....  ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~---------i~~~~~--~~~  216 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDN---------ILNKPL--RLK  216 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHH---------HHcCCC--CCC
Confidence            3456999999999999999999999999999999999999999654221      11111         111111  122


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSMG  799 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm~  799 (893)
                      +.....+.+++.+||+.+|.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            23456788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.3e-36  Score=338.01  Aligned_cols=264  Identities=20%  Similarity=0.258  Sum_probs=206.0

Q ss_pred             HHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEee
Q 036624          524 FAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE  600 (893)
Q Consensus       524 ~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~  600 (893)
                      +.++....++|+..+.||+|+||.||+++...+++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            444555668999999999999999999999988899999986531   22344568899999999999999999999999


Q ss_pred             cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccc
Q 036624          601 NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL  680 (893)
Q Consensus       601 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl  680 (893)
                      ....++||||+++|+|.+++...   .++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            99999999999999999998653   3788899999999999999999   58999999999999999999999999999


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhhhc----CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK  756 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  756 (893)
                      ++...... ........||+.|+|||++...    .++.++|||||||+||||++|+.||.......      .......
T Consensus       189 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~  261 (371)
T cd05622         189 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMN  261 (371)
T ss_pred             eeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHc
Confidence            87643221 1122345699999999999754    37899999999999999999999997543211      1111110


Q ss_pred             ccchhhhccccccCCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHH
Q 036624          757 KGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIE--RPSMGDVLWNLEF  807 (893)
Q Consensus       757 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPtm~evl~~L~~  807 (893)
                      ..       ..+.-.........+.+++.+||..++.+  ||++.+++++...
T Consensus       262 ~~-------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         262 HK-------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             CC-------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            00       00000111234566788899999854443  7899999988753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.7e-35  Score=318.62  Aligned_cols=257  Identities=24%  Similarity=0.396  Sum_probs=204.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCc---ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .+|+..+.||+|+||.||+|.....   ...+|+|.++.. .....+.|..|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            4677888999999999999987522   347999987643 234467899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++++|.+++.... ..+++.+++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999997653 35899999999999999999999   589999999999999999999999999998864332


Q ss_pred             CCcc-ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          688 DHTH-VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       688 ~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      .... ......++..|+|||++.+..++.++|||||||++||+++ |+.||......+   ...+..            +
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~------------~  224 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIE------------E  224 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHh------------C
Confidence            1111 1111223568999999999999999999999999999886 999986543221   111111            1


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      . ........++..+.+++.+|++.+|++||+|.++++.|+.+
T Consensus       225 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 G-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C-CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            0 01112234456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.5e-35  Score=324.29  Aligned_cols=252  Identities=21%  Similarity=0.304  Sum_probs=205.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      .+|+..+.||+|+||.||+|.....+..+++|.+........+.+.+|+.++++++|+||+++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            46788889999999999999987777899999876655555677899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++...   .+++.++..++.|++.||+|||   ..+|+||||||+|||+++++.+||+|||+++......  .
T Consensus       100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~  171 (296)
T cd06654         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (296)
T ss_pred             CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence            999999998643   4899999999999999999999   5899999999999999999999999999987532211  1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+...     +... .        ........
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~~~~-~--------~~~~~~~~  237 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLI-A--------TNGTPELQ  237 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----HHHH-h--------cCCCCCCC
Confidence            12234588999999999998899999999999999999999999965433111     1100 0        00000011


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      .+......+.+++.+||..+|++||++.+++++-
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~  271 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ  271 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence            1233456788999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=316.29  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=198.7

Q ss_pred             eeeeecCcEEEEEEEEcCcc---eEEEEEeCCCCCh-hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGAT---TKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~---~~VavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||.||+|......   ..+|+|....... ...+++..|+.+++++.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            36999999999999875544   6899998775433 35567999999999999999999999886 4568999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc-c
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH-V  692 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~-~  692 (893)
                      |+|.+++....  .+++..++.++.|++.||+|||   ..+++||||||+|||++.++.+||+|||+++......... .
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999997654  5899999999999999999999   5889999999999999999999999999987543221111 1


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......   .+..+...   ..          ...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~---~~----------~~~  218 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLES---GE----------RLP  218 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc---CC----------cCC
Confidence            112224568999999999999999999999999999998 99998654321   12222111   00          112


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      .+..++..+.+++.+||..+|++||++.++++.|+..
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            2334557889999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-35  Score=316.67  Aligned_cols=249  Identities=29%  Similarity=0.470  Sum_probs=205.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..+.||+|+||.||+|...+  +.|++|....... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~~--~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYRG--QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEecC--cEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            467778899999999999998864  6799998875544 5678999999999999999999999999899999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.......+++..+..++.|++.||.|||   ..+++||||||+||++++++.+||+|||+++.....    
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~----  155 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----  155 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc----
Confidence            9999999998766557999999999999999999999   589999999999999999999999999998864221    


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                       ......+..|+|||++....++.++||||||+++||+++ |+.||.......   +.+..    ..         ....
T Consensus       156 -~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~---------~~~~  218 (256)
T cd05039         156 -QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----EK---------GYRM  218 (256)
T ss_pred             -cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hc---------CCCC
Confidence             112335668999999998899999999999999999997 998886432211   11111    00         0111


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ..+..++..+.+++.+||..+|++||++.+++++|+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            2233445778899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2e-35  Score=316.62  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=202.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..+.||+|+||.||+|...++ ..+++|+..... ...+.+.+|++++++++|+|++++++++.. +..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence            3577788999999999999998776 469999876433 334678999999999999999999998854 5678999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|.++++......+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-c
Confidence            9999999998765556899999999999999999999   58899999999999999999999999999875432111 1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......++..|+|||++.+..++.++|||||||++|||++ |+.|+......+   ..++.   ...          ...
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~---~~~----------~~~  222 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV---ERG----------YRM  222 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---HcC----------CCC
Confidence            1122346678999999999999999999999999999999 888886533211   11111   000          011


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ..+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1233456778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-35  Score=317.53  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=204.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..++||+|+||.||+|...++ ..+|+|.+.... ....++.+|+.++++++|+||+++++++. .+..++||||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~-~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCC-ceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            35678889999999999999997765 679999876433 33567899999999999999999999874 4568999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.......+++.+++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++....... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence            99999999998766667999999999999999999999   58999999999999999999999999999875432111 


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......++..|+|||++....++.++|||||||++|||++ |+.||......+      ...... .         ...
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~-~---------~~~  221 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------VIQNLE-R---------GYR  221 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------HHHHHH-c---------CCC
Confidence            11223346778999999999999999999999999999999 999986443211      111110 0         001


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ...+...+..+.+++.+|++.+|++||++.+++..|+.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11222345679999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.1e-36  Score=330.47  Aligned_cols=242  Identities=24%  Similarity=0.331  Sum_probs=195.6

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~  608 (893)
                      +|+..++||+|+||+||+|+...++..||+|++...   .....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            467788999999999999999888889999987642   2234566788999998886 577888999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence            9999999999986543  4999999999999999999999   589999999999999999999999999998753221 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ..         ..+.... 
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~---------~~i~~~~-  217 (323)
T cd05615         155 -GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LF---------QSIMEHN-  217 (323)
T ss_pred             -CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HH---------HHHHhCC-
Confidence             112234569999999999999999999999999999999999999997543211      11         1111111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSM  798 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm  798 (893)
                       ...+......+.+++.+||+.+|.+|++.
T Consensus       218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence             11223345667889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2e-35  Score=315.54  Aligned_cols=251  Identities=20%  Similarity=0.333  Sum_probs=205.8

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC-CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      +|+..++||+|+||.||++....++..+++|..+. ......+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            46778899999999999999988888999997643 23445677889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|.+++.......+++..++.++.|++.||.|||   +.+|+|+||||+||++++++.++|+|||+++......  .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence            9999999987665566899999999999999999999   5899999999999999999999999999987543211  1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......      ....... .+.         ...
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~-~~~---------~~~  219 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKVC-QGS---------YKP  219 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHHh-cCC---------CCC
Confidence            123356889999999999999999999999999999999999999643221      1111111 010         011


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .+......+.+++.+||+.+|++||++.+++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            223345678899999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=300.06  Aligned_cols=265  Identities=21%  Similarity=0.288  Sum_probs=211.6

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEee-----cCEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE-----NCEMI  605 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~  605 (893)
                      .++|.+.+.||+|||+-||+++.-.++..+|+|++...+.++.+..++|++..++++|||++++++++..     +.+.+
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            3578899999999999999999877778999999887777888999999999999999999999988743     34589


Q ss_pred             EEEeeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          606 LVYDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      |+++|...|+|.+.+...  ++..+++.+.+.|+.++++||++||+ ...++.||||||.|||+.+.+.++|.|||.++.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            999999999999998754  34469999999999999999999995 345699999999999999999999999999875


Q ss_pred             CCCCCCccc-------eeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH
Q 036624          684 GPTLDHTHV-------STVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH  753 (893)
Q Consensus       684 ~~~~~~~~~-------~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  753 (893)
                      .+..-....       -....-|.-|.|||.+.   +...++++|||||||+||+|+.|..||+..... +.++      
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSl------  251 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSL------  251 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeE------
Confidence            432111100       01233578999999985   556899999999999999999999999754331 1111      


Q ss_pred             hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       754 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                            ...+..+.+.-.......+.+.+++.+|++.||.+||++.+++..++.++
T Consensus       252 ------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  252 ------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                  01122222222222236788999999999999999999999999887643

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.6e-35  Score=322.19  Aligned_cols=253  Identities=23%  Similarity=0.344  Sum_probs=202.7

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      |+..++||+|+||+||+|.....++.+|+|.+....   ......+.+|++++++++|+||+.+.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999998888899999875432   22344578899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999999987665557999999999999999999999   5899999999999999999999999999987533211  


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||........  ...+...         +...  ..
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~---------~~~~--~~  222 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRR---------VLET--EE  222 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHh---------hhcc--cc
Confidence             11234689999999999999999999999999999999999999975432111  1111111         1110  01


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNL  805 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L  805 (893)
                      .+..+....+.+++.+|++.+|++||+     +.+++.+-
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~  262 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHP  262 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcCh
Confidence            122334556788999999999999999     66666553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.7e-35  Score=316.44  Aligned_cols=248  Identities=30%  Similarity=0.463  Sum_probs=201.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEe-ecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE-ENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~  610 (893)
                      .+|...+.||+|+||.||++...+  ..+++|..+..  ...+.|.+|+.++++++|+|++++++++. .....++|+||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcC--CcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            367788899999999999998764  57899987643  23567899999999999999999999764 45678999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.......+++..++.++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999999998766666899999999999999999999   5899999999999999999999999999987532211  


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                         ....++..|+|||++.+..++.++|||||||++|||++ |+.|+....      +.+....... +         ..
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~-~---------~~  217 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEK-G---------YK  217 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhc-C---------CC
Confidence               12335668999999999999999999999999999997 888885332      2222221111 0         11


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ......++..+.+++.+|++.+|++||++.++++.|+.
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            12233456788999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-35  Score=339.84  Aligned_cols=264  Identities=20%  Similarity=0.208  Sum_probs=198.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      .+|...+.||+|+||.||+|.+...+..||||....      ..+.+|+++|++++|+|||++++++...+..+||||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            468899999999999999999988888999996432      34678999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      . ++|..++.... ..++|.+++.|+.|+++||+|||   ..+||||||||+||||+.++.+||+|||+++.........
T Consensus       243 ~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        243 R-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             C-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            5 78988886543 36999999999999999999999   5899999999999999999999999999997643222222


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcc-c-c---ccHHHHHHHhhc--cc------
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPK-E-Q---VSLAEWAAHCHK--KG------  758 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~-~-~---~~l~~~~~~~~~--~~------  758 (893)
                      ......||+.|+|||++.+..++.++|||||||+||||++|..++...... . .   ..+.........  ..      
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            233456999999999999999999999999999999999988665332110 1 0   111111111000  00      


Q ss_pred             -ch-hhhcc---ccccCCCCh-------HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          759 -IL-EQIMD---PYLKGKIAP-------ECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       759 -~~-~~i~d---~~l~~~~~~-------~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                       .+ .....   .........       .....+.+|+.+||+.||.+|||+.|++++-.
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~  457 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL  457 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence             00 00000   000000000       11235778999999999999999999998643

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.5e-36  Score=338.57  Aligned_cols=265  Identities=23%  Similarity=0.326  Sum_probs=201.7

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecC-----EEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC-----EMI  605 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  605 (893)
                      +|+..++||+|+||.||++.....+..||+|++...  .....+.+.+|+++++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999998877789999987643  2334567899999999999999999999998776     789


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +|+||+. ++|.+.+...  ..+++..+..++.|++.||+|||   ..+|+||||||+|||+++++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999997 6888877543  35899999999999999999999   5899999999999999999999999999997643


Q ss_pred             CCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHH----------HHHHHh
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA----------EWAAHC  754 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~----------~~~~~~  754 (893)
                      .... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||....+.......          ++....
T Consensus       155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            2211 122234578999999999874 5799999999999999999999999765433221110          000000


Q ss_pred             hcccchhhhcccccc-------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          755 HKKGILEQIMDPYLK-------GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       755 ~~~~~~~~i~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                        .+....+......       .....+....+.+++.+||+.||++|||+.|++.+-.
T Consensus       234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  290 (372)
T cd07853         234 --EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY  290 (372)
T ss_pred             --HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence              0000000000000       0112223567889999999999999999999998754

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.1e-35  Score=342.16  Aligned_cols=271  Identities=20%  Similarity=0.299  Sum_probs=201.0

Q ss_pred             HHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccc------cceeeEEEEE
Q 036624          525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH------RHLVSLIGYC  598 (893)
Q Consensus       525 ~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H------~niv~l~g~~  598 (893)
                      +++...+++|+..++||+|+||+||+|.+...+..||||+++... ....++..|+.++++++|      .+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            345556789999999999999999999998877899999876432 234456778888877765      4588899888


Q ss_pred             eec-CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC------
Q 036624          599 EEN-CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW------  671 (893)
Q Consensus       599 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~------  671 (893)
                      ... ...++|||++ +++|.+++.+.  ..+++..+..|+.||+.||+|||+  +.+||||||||+|||++.++      
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccc
Confidence            654 5789999988 67898888654  359999999999999999999994  36899999999999998765      


Q ss_pred             ----------ceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCc
Q 036624          672 ----------VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP  741 (893)
Q Consensus       672 ----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~  741 (893)
                                .+||+|||++....     .......||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                      49999999876422     123346799999999999999999999999999999999999999976543


Q ss_pred             cccccHH---------HHHHHhhcccchhhhcccc--ccCCCCh---------------HHHHHHHHHHHHccccCCCCC
Q 036624          742 KEQVSLA---------EWAAHCHKKGILEQIMDPY--LKGKIAP---------------ECFKKFAETAMKCVSDQGIER  795 (893)
Q Consensus       742 ~~~~~l~---------~~~~~~~~~~~~~~i~d~~--l~~~~~~---------------~~~~~l~~l~~~Cl~~~p~~R  795 (893)
                      .+...+.         +|...+... ...++++..  +.....+               .....+.+|+.+||+.||++|
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTE-EARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccch-hHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            2221111         111110000 000010000  0000000               113457899999999999999


Q ss_pred             CCHHHHHHHHHH
Q 036624          796 PSMGDVLWNLEF  807 (893)
Q Consensus       796 Ptm~evl~~L~~  807 (893)
                      ||+.|++++-..
T Consensus       430 ~ta~e~L~Hp~~  441 (467)
T PTZ00284        430 LNARQMTTHPYV  441 (467)
T ss_pred             CCHHHHhcCccc
Confidence            999999987653

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-35  Score=318.73  Aligned_cols=258  Identities=23%  Similarity=0.370  Sum_probs=205.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcc----eEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGAT----TKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~----~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .+|+..+.||+|+||.||+|.....+    ..+++|...... .....++.+|+.++++++|+||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45677789999999999999875433    358999876543 3456789999999999999999999999987 78899


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      |+||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999997653 34899999999999999999999   58999999999999999999999999999986543


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ...........++..|+|||.+....++.++|||||||++|||++ |+.||+.....      ++.......        
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~--------  227 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPDLLEKG--------  227 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhCC--------
Confidence            222111122224578999999998999999999999999999998 99998654321      121111110        


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                        .....+..+...+.+++.+||..+|.+||++.++++.|+.+.+
T Consensus       228 --~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         228 --ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              0111223345678899999999999999999999999997754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-35  Score=329.16  Aligned_cols=261  Identities=25%  Similarity=0.436  Sum_probs=206.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC-------cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecC
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG-------ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENC  602 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~  602 (893)
                      .+|...+.||+|+||.||++...+       ....||+|..... .....+++.+|+++++++ +|+||++++++|....
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            357788899999999999997532       1236899987643 344567899999999999 7999999999999999


Q ss_pred             EEEEEEeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC
Q 036624          603 EMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD  668 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld  668 (893)
                      ..++|+||+++|+|.+++....              ...++|.+++.++.|++.||.|||   +.+|+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999997532              235889999999999999999999   58999999999999999


Q ss_pred             CCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccH
Q 036624          669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSL  747 (893)
Q Consensus       669 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  747 (893)
                      +++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....      
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------  242 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------  242 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence            999999999999875433221111222334568999999999999999999999999999998 8888754321      


Q ss_pred             HHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          748 AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       748 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      .++.......          .....+..+...+.+++.+||+.+|++||+|.|+++.|+.....
T Consensus       243 ~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         243 EELFKLLKEG----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             HHHHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            2222211111          11122334566788999999999999999999999999877643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-35  Score=323.59  Aligned_cols=263  Identities=24%  Similarity=0.337  Sum_probs=197.6

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhc---cccceeeEEEEEee-----cC
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKL---RHRHLVSLIGYCEE-----NC  602 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----~~  602 (893)
                      +|+..+.||+|+||+||+|....+++.||+|.+....  ......+.+|+++++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778889999999999999998888899999765422  22233456777777665   69999999998864     34


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ..++||||+. ++|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5799999998 58999887765566999999999999999999999   5899999999999999999999999999987


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh---hcccc
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC---HKKGI  759 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~---~~~~~  759 (893)
                      ......   ......||..|+|||++.+..++.++|||||||++|||++|++||........  +.......   ....+
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~  231 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPEDDW  231 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChhhC
Confidence            643211   12234588999999999999999999999999999999999999965432211  11111100   00000


Q ss_pred             hhh------hccccc---cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          760 LEQ------IMDPYL---KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       760 ~~~------i~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      -..      ...+..   .....++....+.+++.+||+.||++|||+.|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000      000000   001112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3e-35  Score=313.10  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=197.8

Q ss_pred             eeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCHH
Q 036624          539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLR  617 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  617 (893)
                      +||+|+||.||+|...+ +..+|+|...... ......|.+|++++++++||||+++++++......++||||+++++|.
T Consensus         2 ~ig~g~~g~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           2 LLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             ccCCCCCceEEEEEecC-CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            69999999999998765 4789999876543 334457899999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeec
Q 036624          618 EHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK  697 (893)
Q Consensus       618 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~  697 (893)
                      +++.... ..+++..++.++.|++.+|.|||   +.+++||||||+||++++++.+||+|||+++....... .......
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~  155 (250)
T cd05085          81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQ  155 (250)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCC
Confidence            9986543 35899999999999999999999   58999999999999999999999999999875322111 1111223


Q ss_pred             cCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHH
Q 036624          698 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC  776 (893)
Q Consensus       698 gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  776 (893)
                      ++..|+|||++.+..++.++|||||||++||+++ |..||.......   .   ... ...         ......+..+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~---~~~-~~~---------~~~~~~~~~~  219 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---A---REQ-VEK---------GYRMSCPQKC  219 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---H---HHH-HHc---------CCCCCCCCCC
Confidence            4678999999999999999999999999999998 998986432211   0   011 001         0111223345


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          777 FKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       777 ~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +..+.+++.+|++.+|++||++.|+++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.8e-36  Score=337.53  Aligned_cols=255  Identities=20%  Similarity=0.318  Sum_probs=198.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||+||++.....+..||+|++...   .......+..|+.++.+++|+||+++++.+.+.+..+|||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4688899999999999999999888889999987532   2334567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++.+..  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            9999999999997543  4899999999999999999999   5899999999999999999999999999986432110


Q ss_pred             C---------------------------------ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCC
Q 036624          689 H---------------------------------THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPA  735 (893)
Q Consensus       689 ~---------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p  735 (893)
                      .                                 ........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                 0011234699999999999999999999999999999999999999


Q ss_pred             CCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH
Q 036624          736 LNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS---MGDVLWNL  805 (893)
Q Consensus       736 ~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt---m~evl~~L  805 (893)
                      |....+..      .........  ..+.   ....  ......+.+++.+|+. +|.+|++   +.+++++-
T Consensus       236 f~~~~~~~------~~~~i~~~~--~~~~---~p~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp  294 (360)
T cd05627         236 FCSETPQE------TYRKVMNWK--ETLV---FPPE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHP  294 (360)
T ss_pred             CCCCCHHH------HHHHHHcCC--Ccee---cCCC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCC
Confidence            97544321      111111000  0000   0000  1123456677777664 9999985   67777654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-35  Score=315.50  Aligned_cols=255  Identities=30%  Similarity=0.455  Sum_probs=206.6

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|...++||+|+||.||+|..++. ..+++|.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~-~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCC-ceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            46788889999999999999998755 779999876433 3456799999999999999999999999998999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.......+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||+++...... .
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence            99999999998766567999999999999999999999   5889999999999999999999999999987543211 1


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.......   ..+.            +.. ...
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~------------~~~-~~~  222 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQ------------VER-GYR  222 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH------------HHc-CCC
Confidence            11122234678999999999999999999999999999998 999985432211   1111            000 011


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ...+..++..+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            12223345678999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.8e-35  Score=318.50  Aligned_cols=249  Identities=29%  Similarity=0.465  Sum_probs=197.9

Q ss_pred             eeeecCcEEEEEEEEcCcc------eEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          539 LLGVGGFGKVYRGEIDGAT------TKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~~------~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      .||+|+||.||+|+.....      ..+++|...... .....++.+|+.++++++||||+++++++......++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            6999999999999876432      578999765432 345678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCC-----CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC-----ceeEeccccc
Q 036624          612 AYGTLREHLYKTQ-----KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW-----VAKVSDFGLS  681 (893)
Q Consensus       612 ~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-----~~kl~DFGla  681 (893)
                      ++++|.+++....     ...+++.+++.++.|++.||+|||   +.+++|+||||+||+++.+.     .+||+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999997532     234889999999999999999999   58899999999999999877     8999999998


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      +.....+.........++..|+|||++.++.++.++|||||||++|||++ |+.||......+   .   .......   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~---~~~~~~~---  229 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---V---LQHVTAG---  229 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---H---HHHHhcC---
Confidence            75432222222222345678999999999999999999999999999998 999886432211   1   1111000   


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                             .....+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       230 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         230 -------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                   011223345677889999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-35  Score=326.64  Aligned_cols=269  Identities=20%  Similarity=0.308  Sum_probs=202.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|...++||+|+||.||+|+....+..||+|.++... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46888899999999999999998877899999876432 22334678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      ++ ++|.+++.... ..+++..+..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++....... 
T Consensus        86 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          86 LD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence            98 58888886543 35889999999999999999999   58999999999999999999999999999875322111 


Q ss_pred             cceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch---------
Q 036624          691 HVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL---------  760 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---------  760 (893)
                       ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.................         
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence             1223457899999999865 56899999999999999999999999755432221111000000000000         


Q ss_pred             hhhccccccC----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          761 EQIMDPYLKG----KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       761 ~~i~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ...-.+....    ...+.....+.+++.+||+.||.+|||+.|++++-..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  289 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF  289 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence            0000000000    0112234567899999999999999999999986654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.7e-35  Score=319.62  Aligned_cols=253  Identities=25%  Similarity=0.356  Sum_probs=203.9

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      |+..+.||+|+||.||+|.....+..+++|..........+.+.+|+++++.++|+||+++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            45567899999999999999888888999988766667778899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      ++|..++.+.. .++++..+..++.|+++||.|||   +.+++||||||+|||++.++.+||+|||+++.....  ....
T Consensus        87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~  160 (282)
T cd06643          87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR  160 (282)
T ss_pred             CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence            99999886533 46999999999999999999999   589999999999999999999999999998753221  1122


Q ss_pred             eeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          694 TVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      ....++..|+|||++.     +..++.++|||||||++|||++|++||........      .......      ..+.+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~------~~~~~  228 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS------EPPTL  228 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhc------CCCCC
Confidence            3345889999999984     45678899999999999999999999864332110      0000000      00010


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                        ..+......+.+++.+||+.+|++||++.+++++-.
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence              112234567889999999999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.8e-35  Score=327.47  Aligned_cols=238  Identities=24%  Similarity=0.315  Sum_probs=189.9

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHH-HHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIE-MLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||.||+|+....+..+|+|++...   .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3799999999999999888889999986532   1223344555554 57889999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|..++...  ..+++..+..++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (321)
T cd05603          81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT  153 (321)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence            9999888654  34888999999999999999999   589999999999999999999999999998753221  1223


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......      .....         +....  ...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~---------i~~~~--~~~~  216 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDN---------ILHKP--LQLP  216 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHH---------HhcCC--CCCC
Confidence            3456899999999999999999999999999999999999999654211      11111         11111  1223


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSMG  799 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm~  799 (893)
                      +.....+.+++.+||+.+|.+||+..
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            34456788999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.2e-36  Score=332.40  Aligned_cols=241  Identities=25%  Similarity=0.336  Sum_probs=191.8

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHH-HHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIE-MLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||+||+|+...++..+|+|++...   .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3699999999999999887889999986532   2233445566655 46778999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|..++....  .+++..+..++.||++||+|||   +.+|+||||||+|||+++++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  153 (325)
T cd05604          81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT  153 (325)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence            99999886543  5899999999999999999999   589999999999999999999999999998753221  1223


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ....         +....+  ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~---------~~~~~~--~~~  216 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDN---------ILHKPL--VLR  216 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHH---------HHcCCc--cCC
Confidence            34569999999999999999999999999999999999999996543211      1111         111111  112


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSMGDVL  802 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm~evl  802 (893)
                      +.....+.+++.+|++.+|.+||++.+.+
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            23445678899999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.5e-36  Score=331.84  Aligned_cols=239  Identities=26%  Similarity=0.291  Sum_probs=192.6

Q ss_pred             eeeeecCcEEEEEEEEc---CcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          538 LLLGVGGFGKVYRGEID---GATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~---~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      +.||+|+||.||+++..   ..+..+|+|++....  ......+..|++++++++||||+++++++......++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            57999999999998762   345789999876422  2234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      +|+|.+++.+..  .+++..+..++.|+++||+|||   ..+|+||||||+|||+++++.+||+|||+++.....  ...
T Consensus        82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~  154 (318)
T cd05582          82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK  154 (318)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCc
Confidence            999999996543  5899999999999999999999   589999999999999999999999999998754321  112


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCC
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI  772 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  772 (893)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ....         +....  ..+
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~---------i~~~~--~~~  217 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTM---------ILKAK--LGM  217 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHH---------HHcCC--CCC
Confidence            234569999999999999999999999999999999999999996543211      1111         11111  112


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHH
Q 036624          773 APECFKKFAETAMKCVSDQGIERPSMGD  800 (893)
Q Consensus       773 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~e  800 (893)
                      +......+.+++.+||+.+|++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            3334566889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.3e-36  Score=331.18  Aligned_cols=241  Identities=24%  Similarity=0.335  Sum_probs=191.1

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHH-HHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIE-MLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      +.||+|+||+||+|+...++..+|+|++....   ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999998888899999865321   222334444444 56788999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|.+++....  .+.+..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~  153 (325)
T cd05602          81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTT  153 (325)
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCc
Confidence            99999997643  4788888999999999999999   58999999999999999999999999999875322  11223


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ....         +....  ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~---------i~~~~--~~~~  216 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDN---------ILNKP--LQLK  216 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHH---------HHhCC--cCCC
Confidence            34569999999999999999999999999999999999999996543211      1111         11110  1122


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSMGDVL  802 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm~evl  802 (893)
                      +.....+.+++.+||+.+|.+||++.+.+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            34456788999999999999999877543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.9e-35  Score=317.01  Aligned_cols=253  Identities=22%  Similarity=0.333  Sum_probs=190.3

Q ss_pred             eeeecCcEEEEEEEEcC--cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCC
Q 036624          539 LLGVGGFGKVYRGEIDG--ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGT  615 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~--~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  615 (893)
                      .||+|+||.||+|....  ....+++|..... .......|.+|+++++.++|+||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            59999999999997543  2346888876543 33445678999999999999999999999999999999999999999


Q ss_pred             HHHHHhhCCC---CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          616 LREHLYKTQK---PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       616 L~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      |.+++.....   ...++...+.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999976532   23568888999999999999999   58999999999999999999999999999875332211111


Q ss_pred             eeeeccCcCccChHhhhh-------cCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          693 STVVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~-------~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||....+.+  .+    ....... ...+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~----~~~~~~~-~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VL----KQVVREQ-DIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HH----HHHhhcc-CccCC
Confidence            223345678999999753       356889999999999999999 777775432211  01    1111111 01111


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ++    ..+......+.+++..|+ .+|++||++.+|++.|.
T Consensus       232 ~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            22    223344566677888888 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.9e-35  Score=313.40  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=207.4

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|+..++||+|+||.||.++....+..+++|.....  .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            477889999999999999998887788999975532  445567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.......+++.++..++.|+++||.|||   +.+++||||||+||++++++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            99999999998765567899999999999999999999   58899999999999999999999999999876433221 


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                       ......|++.|+|||++.+..++.++||||||+++|||++|+.||......      +.....         ...... 
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~---------~~~~~~-  219 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKI---------VQGNYT-  219 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH---------HcCCCC-
Confidence             123345899999999999888999999999999999999999998653321      111111         111111 


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      .........+.+++.+||+.+|++||++.++++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11234456788999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.3e-35  Score=319.76  Aligned_cols=253  Identities=22%  Similarity=0.288  Sum_probs=201.4

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      +|+..++||+|+||.||+|.....+..+|+|..... .....+++.+|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577788999999999999998877889999986543 3445567999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|..+.      .+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||++......    
T Consensus        82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            999997552      3788899999999999999999   589999999999999999999999999998753221    


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc-cHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV-SLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||......... ....+.         ..+.++....
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---------~~~~~~~~~~  219 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL---------QCIVDEDPPV  219 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH---------HHHhccCCCC
Confidence            122346899999999999999999999999999999999999999653321111 001111         1111111111


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .........+.+++.+|++.+|++||++.|++++...
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~  256 (279)
T cd06619         220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI  256 (279)
T ss_pred             CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence            1112234568899999999999999999999987553

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.1e-35  Score=320.90  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=203.5

Q ss_pred             CCccceeeeecCcEEEEEEEEc----CcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEID----GATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEMI  605 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~----~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  605 (893)
                      .|...+.||+|+||.||++...    ..+..|++|.+.... ......+.+|++++++++|+||+++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            4677889999999999999853    345789999876543 44556899999999999999999999998775  5689


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +||||+++++|.+++.+.. ..++|..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++...
T Consensus        85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            9999999999999986543 35899999999999999999999   5899999999999999999999999999988643


Q ss_pred             CCCC-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcc---------ccccHHHHHHHhh
Q 036624          686 TLDH-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPK---------EQVSLAEWAAHCH  755 (893)
Q Consensus       686 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~~~~~  755 (893)
                      .... ........++..|+|||++.+..++.++|||||||++|||++++.|.......         .......+...  
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  238 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV--  238 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH--
Confidence            2211 11122345677899999999889999999999999999999987664322110         00111111111  


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                             +.+. ........+...+.+++.+||+.+|++||++.++++.|+.+
T Consensus       239 -------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 -------LEEG-KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             -------HHcC-ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence                   0010 01112334567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=341.77  Aligned_cols=263  Identities=21%  Similarity=0.260  Sum_probs=196.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeec--------C
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--------C  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------~  602 (893)
                      ..+|...++||+|+||.||+|.....+..||||++....    ....+|+.+|++++|+||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999998877899999875422    2345799999999999999999876432        2


Q ss_pred             EEEEEEeeccCCCHHHHHhh--CCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC-ceeEeccc
Q 036624          603 EMILVYDYMAYGTLREHLYK--TQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW-VAKVSDFG  679 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFG  679 (893)
                      .+++||||++ ++|.+++..  .....+++..+..++.|+++||+|||   ..+|+||||||+||||+.++ .+||+|||
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            4679999998 577776653  23456999999999999999999999   58999999999999999664 79999999


Q ss_pred             ccccCCCCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc
Q 036624          680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG  758 (893)
Q Consensus       680 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  758 (893)
                      +++......   ......||+.|+|||++.+. .++.++|||||||+||||++|++||......+.  +...... ....
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~-~~~p  290 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQV-LGTP  290 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHH-hCCC
Confidence            998643211   12234589999999998764 689999999999999999999999976543221  1111110 0000


Q ss_pred             c---h-------hh-----hccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          759 I---L-------EQ-----IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       759 ~---~-------~~-----i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .   +       .+     +....+...++...+.++.+++.+||+.+|.+|||+.|++++-..
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f  354 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF  354 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence            0   0       00     000111111222345678899999999999999999999987664

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-35  Score=320.82  Aligned_cols=268  Identities=26%  Similarity=0.409  Sum_probs=206.1

Q ss_pred             CCccceeeeecCcEEEEEEEEcC----cceEEEEEeCCCCChh-hHHHHHHHHHHHhhccccceeeEEEEEee--cCEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDG----ATTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEE--NCEMI  605 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~----~~~~VavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~  605 (893)
                      .|...+.||+|+||.||++.+..    .+..+|+|.+...... ..++|.+|++++++++|+||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            45667799999999999998653    3578999987755443 56789999999999999999999999977  56789


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +||||+++++|.+++.... ..+++..++.++.|++.||+|||   ..+++||||||+||+++.++.+||+|||++....
T Consensus        85 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999997654 25999999999999999999999   5899999999999999999999999999988654


Q ss_pred             CCCCc-cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh---cccchh
Q 036624          686 TLDHT-HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH---KKGILE  761 (893)
Q Consensus       686 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~---~~~~~~  761 (893)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........    +.....   ....+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~  236 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQGQMIVTRLL  236 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccccccccHHHHH
Confidence            22111 1111223556799999999899999999999999999999999987543221100    000000   000111


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      +.+........+..++.++.+++.+||+.+|++||+|.||+++|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111111222334567899999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=330.88  Aligned_cols=247  Identities=27%  Similarity=0.414  Sum_probs=209.0

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCHH
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLR  617 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  617 (893)
                      -+||+|.||+||-|++..+...+|||.+.....+..+-+..||.+.++|+|.|||+++|.|.+++.+-+.||.++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            38999999999999999999999999988887788888999999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCC--CHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-CCceeEecccccccCCCCCCcccee
Q 036624          618 EHLYKTQKPPL--PWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPTLDHTHVST  694 (893)
Q Consensus       618 ~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~  694 (893)
                      ++|+..= +++  ++.+.-....||++||.|||   ++.|||||||-+|+|++. .|.+||+|||-++....  -...+.
T Consensus       661 sLLrskW-GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE  734 (1226)
T KOG4279|consen  661 SLLRSKW-GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE  734 (1226)
T ss_pred             HHHHhcc-CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence            9997553 345  67788889999999999999   699999999999999975 68999999999876433  233455


Q ss_pred             eeccCcCccChHhhhhc--CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCC
Q 036624          695 VVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI  772 (893)
Q Consensus       695 ~~~gt~~y~APE~~~~~--~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  772 (893)
                      .+.||..|||||++..+  .|..++|||||||.+.||.||++||.........        +.+-|      .-.....+
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVG------myKvHP~i  800 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVG------MYKVHPPI  800 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhc------ceecCCCC
Confidence            67799999999999865  5889999999999999999999999754432110        01111      11224567


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          773 APECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       773 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      +.+...+...++++|+.++|.+||+++++++.
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            77888899999999999999999999999853

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.8e-35  Score=323.20  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=201.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcce----EEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATT----KVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      ++|+..+.||+|+||.||+|.....+.    .||+|...... .....++.+|+.++++++||||++++|+|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            457778899999999999998754433    57888776543 33345789999999999999999999999764 4679


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ++||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999987543 35899999999999999999999   58999999999999999999999999999986432


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ...........++..|+|||++.+..++.++|||||||++|||++ |+.|+.......   +.++..    .+       
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~-------  227 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLE----KG-------  227 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----CC-------
Confidence            221111222345778999999999999999999999999999997 888886432211   111111    10       


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                        .....++.+...+.+++.+||..+|++||++.++++.|+.+.
T Consensus       228 --~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         228 --ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              001112334567889999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.1e-35  Score=313.61  Aligned_cols=252  Identities=26%  Similarity=0.423  Sum_probs=194.8

Q ss_pred             eeeeecCcEEEEEEEEcC---cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEe-ecCEEEEEEeecc
Q 036624          538 LLLGVGGFGKVYRGEIDG---ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE-ENCEMILVYDYMA  612 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~---~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~  612 (893)
                      +.||+|+||.||+|....   ....||+|+.... .....+.+..|+.+++.++||||+++++++. .....++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998643   3357999987543 3455678899999999999999999999875 4556789999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc--
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT--  690 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~--  690 (893)
                      +|+|.+++.+.. ..+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++........  
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999997543 34788889999999999999999   589999999999999999999999999998753221110  


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhC-CCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA-RPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......++..|+|||++.+..++.++|||||||++|||++| .+|+.....      .+.........          .
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~----------~  220 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQGR----------R  220 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhcCC----------C
Confidence            111233467789999999999999999999999999999995 555543221      11111111110          0


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ...+..++..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            0111223467889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.6e-35  Score=325.57  Aligned_cols=258  Identities=20%  Similarity=0.246  Sum_probs=200.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|...++||+|+||+||+++....++.||+|.+...   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4788899999999999999999888889999987542   2233456889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++.+.. ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD-  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-
Confidence            9999999999997643 35899999999999999999999   589999999999999999999999999998754321 


Q ss_pred             CccceeeeccCcCccChHhhhh-----cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      .........||+.|+|||++.+     +.++.++|||||||+||||++|+.||......      +..........  ..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~--~~  227 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEE--RF  227 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCC--cc
Confidence            1112234569999999999876     56889999999999999999999999654321      11111111000  00


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIE--RPSMGDVLWNLE  806 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPtm~evl~~L~  806 (893)
                         .+ .....+....+.+++.+|+...+.+  |+++.+++++..
T Consensus       228 ---~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~  268 (331)
T cd05624         228 ---QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF  268 (331)
T ss_pred             ---cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence               00 0111123466788888988865544  568888887644

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2e-35  Score=319.49  Aligned_cols=240  Identities=26%  Similarity=0.400  Sum_probs=189.0

Q ss_pred             eeeecCcEEEEEEEEcC------------------------cceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeE
Q 036624          539 LLGVGGFGKVYRGEIDG------------------------ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL  594 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~------------------------~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l  594 (893)
                      .||+|+||.||+|....                        ....|++|.+.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997531                        124588998876555556678999999999999999999


Q ss_pred             EEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC---
Q 036624          595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW---  671 (893)
Q Consensus       595 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---  671 (893)
                      +++|.+....++||||+++|+|..++.+. ...+++..++.++.|+++||+|||   +.+|+||||||+|||+++.+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999988654 345899999999999999999999   58999999999999997643   


Q ss_pred             ----ceeEecccccccCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHh-hCCCCCCCCCccccc
Q 036624          672 ----VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEIL-CARPALNPTLPKEQV  745 (893)
Q Consensus       672 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~~  745 (893)
                          .+|++|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+....+... 
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-  230 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-  230 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence                4899999987643211      12246788999998875 56899999999999999994 78888865432211 


Q ss_pred             cHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          746 SLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       746 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                        ..+..    .       ..    ..+......+.+++.+||+.+|++||++.+|++.|.
T Consensus       231 --~~~~~----~-------~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 --ERFYE----K-------KH----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HHHHH----h-------cc----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              11100    0       00    011112346889999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6e-35  Score=314.11  Aligned_cols=252  Identities=25%  Similarity=0.367  Sum_probs=197.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-----ChhhHHHHHHHHHHHhhccccceeeEEEEEee--cCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-----SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE--NCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~  604 (893)
                      .+|...+.||+|+||.||+|.....+..+++|+....     ..+..+.+.+|+.++++++|+||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4788899999999999999999877789999976432     22345678999999999999999999998865  3678


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++++||+++++|.+++....  .+++..++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            89999999999999997543  4899999999999999999999   588999999999999999999999999998754


Q ss_pred             CCCC-CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          685 PTLD-HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       685 ~~~~-~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      .... .........++..|+|||++.+..++.++|||||||++|||++|+.||.......     . ...         .
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~-~~~---------~  221 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----A-IFK---------I  221 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----H-HHH---------H
Confidence            2211 1111123458899999999999999999999999999999999999996432211     0 001         0


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ........++......+.+++ +||..+|++||++.||+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         222 ATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             hcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            000001122333344556665 7888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.5e-36  Score=314.14  Aligned_cols=262  Identities=25%  Similarity=0.310  Sum_probs=197.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecC-----EEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC-----EMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~l  606 (893)
                      -.|...+++|.|+||.||+|........||||+.-...+    .-.+|+.+|+++.|||||+|+-++....     ...|
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            346678899999999999999988888999998654332    2357999999999999999998885432     3468


Q ss_pred             EEeeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC-CceeEeccccccc
Q 036624          607 VYDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSKT  683 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~  683 (893)
                      |||||+ -+|.+.++..  .+..++...+.-+..||.+||.|||   ..+|+||||||.|+|+|.+ +.+||||||.|+.
T Consensus       100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            999998 7999988742  3345777788889999999999999   5999999999999999966 9999999999997


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh--hcccch
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC--HKKGIL  760 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--~~~~~~  760 (893)
                      ....+..   ....-|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....++  +.+..+-+  ..++.+
T Consensus       176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDI  250 (364)
T ss_pred             eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHH
Confidence            5432221   22335679999999876 4799999999999999999999999977544333  23332211  001111


Q ss_pred             h-------hhcccccc-----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          761 E-------QIMDPYLK-----GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       761 ~-------~i~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .       +...+.+.     ..+......+.++++.++|+.+|.+|.++.|++.+--
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f  308 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF  308 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence            0       11112111     1133345667889999999999999999999997643

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-35  Score=311.21  Aligned_cols=248  Identities=27%  Similarity=0.438  Sum_probs=199.1

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh-hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCH
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL  616 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  616 (893)
                      ++||+|+||.||++...+ ++.|++|....... .....+.+|++++++++|+||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            369999999999999887 68899998765433 3567899999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeee
Q 036624          617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV  696 (893)
Q Consensus       617 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  696 (893)
                      .+++.+.. ..+++..++.++.+++.||+|||   +.+++||||||+|||++.++.+||+|||+++..............
T Consensus        80 ~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          80 LTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99997643 35889999999999999999999   589999999999999999999999999998754321111111122


Q ss_pred             ccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChH
Q 036624          697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPE  775 (893)
Q Consensus       697 ~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~  775 (893)
                      .++..|+|||.+.++.++.++|||||||++|||++ |..|+.......      ....          +........+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~~~~----------~~~~~~~~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRER----------IESGYRMPAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------HHHH----------HhcCCCCCCCcc
Confidence            24567999999998999999999999999999999 788875433211      1111          111111122334


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          776 CFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       776 ~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ++..+.+++.+|++.+|++||++.||++.|+
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            5678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-35  Score=315.06  Aligned_cols=254  Identities=28%  Similarity=0.458  Sum_probs=201.5

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHH--HHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH--EFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~--~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      |+..+.||+|+||+||++.....+..+|+|...........  ....|+.++++++|+||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            45678999999999999999998889999987765443322  3456999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.++|...  ..+++..++.++.|+++||++||+   .+|+|+||||+||++++++.++|+|||.+....  ....
T Consensus        81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNE  153 (260)
T ss_dssp             TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTS
T ss_pred             cccccccccccc--cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccc
Confidence            999999999733  348999999999999999999994   899999999999999999999999999987431  1222


Q ss_pred             ceeeeccCcCccChHhhh-hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~-~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......++..|+|||++. +..++.++||||+|+++|+|++|+.|+...........   ......    .......   
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~~----~~~~~~~---  223 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI---IEKILK----RPLPSSS---  223 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH---HHHHHH----THHHHHT---
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh---hhhccc----ccccccc---
Confidence            334456899999999998 88999999999999999999999999975521111111   100000    0000000   


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .........+.+++.+||+.+|++||++.+++++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0001113789999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=311.35  Aligned_cols=269  Identities=25%  Similarity=0.376  Sum_probs=202.1

Q ss_pred             HHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhh--ccccceeeEEEEEeec----C
Q 036624          529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK--LRHRHLVSLIGYCEEN----C  602 (893)
Q Consensus       529 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~----~  602 (893)
                      ....+....+.||+|.||.||+|.+++  ..||||++...+   .+.+.+|.++.+.  |+|+||+.+++.-..+    .
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wrG--e~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWRG--EDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             hhhheeEEEEEecCccccceeeccccC--CceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            334566778899999999999999998  579999976543   4567788888765  5999999999876433    4


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhh-----cCCCCceEecCCCCCCEEECCCCceeEec
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH-----TGAKHTIIHRDVKTTNILLDEKWVAKVSD  677 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~ivHrDlk~~NILld~~~~~kl~D  677 (893)
                      +++||.+|.++|||.++|.+.   .++....++++..+|.||++||     ++.++.|.|||||+.|||+..++.+.|+|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            789999999999999999764   4999999999999999999999     35688999999999999999999999999


Q ss_pred             ccccccCCCC-C-CccceeeeccCcCccChHhhhhcC----C--CCcchhhhHHHHHHHHhhC----------CCCCCCC
Q 036624          678 FGLSKTGPTL-D-HTHVSTVVKGSFGYLDPEYFRRQQ----L--TEKSDVYSFGVVLFEILCA----------RPALNPT  739 (893)
Q Consensus       678 FGla~~~~~~-~-~~~~~~~~~gt~~y~APE~~~~~~----~--s~ksDV~S~Gvvl~elltG----------~~p~~~~  739 (893)
                      +|||-..... + -.-......||-+|||||++...-    +  =..+||||||.|+||+...          +.||...
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            9998653322 1 111223456999999999986431    1  1359999999999999853          2455433


Q ss_pred             CccccccHHHHHHHhhcccchhhhcccccc-CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          740 LPKEQVSLAEWAAHCHKKGILEQIMDPYLK-GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       740 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      .+.+. ++.+     +++-...+-+.|.+. .....+++..+.++++.||..+|..|-|+--+.+.|.++.+.
T Consensus       440 Vp~DP-s~ee-----MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  440 VPSDP-SFEE-----MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             CCCCC-CHHH-----HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            22211 1111     011111111222221 223457899999999999999999999999999998876653

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-36  Score=323.42  Aligned_cols=246  Identities=28%  Similarity=0.395  Sum_probs=203.1

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh---hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE---QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      -|...+.||.|+||-||.+++..+...||||++....+   ...+++..|++.|.+++|||+|.+.||+......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            36677789999999999999988889999999875433   345688999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      ||- |+-.+.|.-.. .++.+..+..|+.+.+.||+|||+   .+.||||||+.||||.+.+.|||+|||.+.+...   
T Consensus       107 YCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            997 78777775443 468999999999999999999995   8899999999999999999999999999876433   


Q ss_pred             ccceeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          690 THVSTVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                         ...+.|||.|||||++.   .++|+-|+||||||+...||.-.++|+-.+..-.      -..+..      +--.|
T Consensus       179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS------ALYHIA------QNesP  243 (948)
T KOG0577|consen  179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA------QNESP  243 (948)
T ss_pred             ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH------HHHHHH------hcCCC
Confidence               23467999999999985   5789999999999999999999999985432211      001111      11112


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .+.   ..+....+++++..||++-|.+|||..+++++
T Consensus       244 tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  244 TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            222   45677889999999999999999999888754

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=326.32  Aligned_cols=258  Identities=21%  Similarity=0.257  Sum_probs=198.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC---CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||+||+++....++.||+|.+..   ......+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            468889999999999999999988888999998753   12234566889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++.+. ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999999653 235899999999999999999999   5899999999999999999999999999986532211


Q ss_pred             CccceeeeccCcCccChHhhhh-----cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                       ........||+.|+|||++..     ..++.++|||||||++|||++|+.||.....      .+............. 
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~-  228 (331)
T cd05597         157 -TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQ-  228 (331)
T ss_pred             -CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCccc-
Confidence             112233469999999999973     4678899999999999999999999964322      111111111100000 


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQ--GIERPSMGDVLWNLE  806 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~--p~~RPtm~evl~~L~  806 (893)
                          +. .........+.+++.+|+...  +..||++.+++++-.
T Consensus       229 ----~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~  268 (331)
T cd05597         229 ----FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF  268 (331)
T ss_pred             ----CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence                00 011123456677777766543  344889999998754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-36  Score=299.96  Aligned_cols=258  Identities=24%  Similarity=0.312  Sum_probs=207.8

Q ss_pred             HHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--------hhhHHHHHHHHHHHhhc-cccceeeEEEEE
Q 036624          528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--------EQGVHEFQTEIEMLSKL-RHRHLVSLIGYC  598 (893)
Q Consensus       528 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--------~~~~~~f~~E~~~l~~l-~H~niv~l~g~~  598 (893)
                      +..-++|+..++||.|..++|-++.++.++...|+|++....        ..-.++-..|+.||+++ -||+|+.+.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            344567788889999999999999999888999999754321        12234557899999998 599999999999


Q ss_pred             eecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecc
Q 036624          599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF  678 (893)
Q Consensus       599 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF  678 (893)
                      +....+++|+|.|+.|.|.++|...  -.++++...+|+.|+.+|++|||   ...||||||||+|||+|++.++||+||
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecc
Confidence            9999999999999999999999654  35999999999999999999999   699999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeeccCcCccChHhhhh------cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHH
Q 036624          679 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAA  752 (893)
Q Consensus       679 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  752 (893)
                      |+++....   .......||||+|+|||.+..      ..|+...|+|++||++|.||.|.+||....   +.       
T Consensus       168 GFa~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---Qm-------  234 (411)
T KOG0599|consen  168 GFACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QM-------  234 (411)
T ss_pred             ceeeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HH-------
Confidence            99987543   234567899999999999863      357889999999999999999999995321   00       


Q ss_pred             HhhcccchhhhccccccCC--CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          753 HCHKKGILEQIMDPYLKGK--IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       753 ~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                           -.+.-|+.....-.  --.+......+++.+||+.||++|-|..|++.+-.+.
T Consensus       235 -----lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  235 -----LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             -----HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence                 01222222222111  1123455678999999999999999999999887653

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.6e-35  Score=311.68  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=204.2

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEee-cCEEEEEEe
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE-NCEMILVYD  609 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E  609 (893)
                      +|+..+.||+|++|.||++....+++.+++|++...  .....+.+..|++++++++|+|++++++.+.. ....++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            477889999999999999999887788999986532  34456678999999999999999999988764 446789999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++++|.+++.......+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            999999999998765566999999999999999999999   5899999999999999999999999999987543211 


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                       .......+++.|+|||++.+..++.++|||||||+++||++|+.||.....      ..+..... .+.+         
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~-~~~~---------  219 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRII-EGKL---------  219 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH-hcCC---------
Confidence             122345588999999999999999999999999999999999999864321      11111111 1111         


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ...+......+.+++.+|++.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11223455678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.1e-35  Score=318.60  Aligned_cols=253  Identities=24%  Similarity=0.330  Sum_probs=204.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      +.|+..++||+|+||.||+|+....+..+++|..........+.+.+|+.++++++|+||+++++++......++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            45778889999999999999998888899999987777777888999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|..++.+.. ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......  ..
T Consensus        92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~  165 (292)
T cd06644          92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ  165 (292)
T ss_pred             CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence            9999998876543 35899999999999999999999   589999999999999999999999999998653221  11


Q ss_pred             ceeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          692 VSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      ......+++.|+|||++.     ...++.++|||||||++|||++|+.|+....+..      .......      ...+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~------~~~~  233 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAK------SEPP  233 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhc------CCCc
Confidence            123455888999999984     3457889999999999999999999986433211      1111100      0001


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .  ...+......+.+++.+||+.+|++||++.+++++
T Consensus       234 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         234 T--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             c--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1  01122345678899999999999999999999865

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3e-35  Score=319.21  Aligned_cols=262  Identities=26%  Similarity=0.374  Sum_probs=208.6

Q ss_pred             cCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEee
Q 036624          522 FSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEE  600 (893)
Q Consensus       522 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~  600 (893)
                      .++.++..+.+.|+..+.||+|+||.||+|.....++.+|+|..... .....++..|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            46667777888999999999999999999999887789999987543 33456788999999998 69999999999853


Q ss_pred             ------cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCcee
Q 036624          601 ------NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAK  674 (893)
Q Consensus       601 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~k  674 (893)
                            ....++||||+++|+|.+++.......+++..+..++.|++.||.|||   ..+|+||||||+||++++++.+|
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence                  467899999999999999997765566889999999999999999999   58999999999999999999999


Q ss_pred             EecccccccCCCCCCccceeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHH
Q 036624          675 VSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAE  749 (893)
Q Consensus       675 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  749 (893)
                      |+|||+++......  .......|++.|+|||.+.     +..++.++|||||||++|||++|+.||....+.....   
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---  236 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---  236 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence            99999987532211  1122355889999999986     3568889999999999999999999996543211110   


Q ss_pred             HHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          750 WAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       750 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                                  .+............+...+.+++.+||+.+|.+||++.|++++
T Consensus       237 ------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         237 ------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                        0000000111122345678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.6e-36  Score=318.86  Aligned_cols=240  Identities=26%  Similarity=0.391  Sum_probs=191.3

Q ss_pred             eeeecCcEEEEEEEEcCcc-------eEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          539 LLGVGGFGKVYRGEIDGAT-------TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~~-------~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      .||+|+||.||+|.....+       ..+++|..........+.+.+|+.+++.++||||+++++++......++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            6999999999999875433       348888876555556678999999999999999999999999989999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc--------eeEeccccccc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV--------AKVSDFGLSKT  683 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~--------~kl~DFGla~~  683 (893)
                      ++|+|.+++..... .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.        +|++|||++..
T Consensus        82 ~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          82 KFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999976543 5899999999999999999999   589999999999999987765        69999998764


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCC-CCCCCCCccccccHHHHHHHhhcccchh
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCAR-PALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      ...      .....+++.|+|||++.+ ..++.++|||||||++|||++|. .|+.......      .... .      
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~~~-~------  218 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KLQF-Y------  218 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HHHH-H------
Confidence            322      123457889999999986 45899999999999999999995 5543222111      0000 0      


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         ..  ....+.....++.+++.+||+.+|++||++.++++.|+
T Consensus       219 ---~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         219 ---ED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---Hc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               00  11122233467899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-35  Score=319.97  Aligned_cols=259  Identities=22%  Similarity=0.319  Sum_probs=207.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..+.||+|+||+||++.....+..+|+|..... .....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            4567778999999999999999877788999976543 234567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.+.+  .+++..+..++.+++.||.|||+  ..+++||||||+||++++++.++|+|||++......   
T Consensus        85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            99999999886543  58999999999999999999995  468999999999999999999999999998643211   


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccc-----ccHHHHHHHhhcccchhhhcc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ-----VSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-----~~l~~~~~~~~~~~~~~~i~d  765 (893)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.     ..+.++...         +..
T Consensus       158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~  227 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ---------IVQ  227 (284)
T ss_pred             -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH---------Hhh
Confidence             11234689999999999888999999999999999999999999975433211     111111111         111


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .........+++..+.+++.+|++.+|++||++.|++++...
T Consensus       228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            111111112355678899999999999999999999987654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.1e-35  Score=327.10  Aligned_cols=258  Identities=20%  Similarity=0.254  Sum_probs=199.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||.||+++.+..++.+|+|.+...   .......+..|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4688899999999999999999988889999987532   2233455889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++.+.. ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-  155 (332)
T ss_pred             eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC-
Confidence            9999999999997643 35899999999999999999999   589999999999999999999999999998753221 


Q ss_pred             CccceeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          689 HTHVSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      .........||+.|+|||++.     ...++.++|||||||+||||++|+.||.....      .+..........  ..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~--~~  227 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKE--RF  227 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCc--cc
Confidence            112223456999999999986     35688999999999999999999999965422      111111111100  00


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIE--RPSMGDVLWNLE  806 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPtm~evl~~L~  806 (893)
                         .. ......+...+.+++.+|+..++.+  |+++.|++++-.
T Consensus       228 ---~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~  268 (332)
T cd05623         228 ---QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF  268 (332)
T ss_pred             ---cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence               00 0111234556778888877654443  789999997743

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.6e-35  Score=320.55  Aligned_cols=252  Identities=21%  Similarity=0.300  Sum_probs=205.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      .+|...+.||+|+||.||+|.....+..||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            57888899999999999999987777899999876555555677899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.+.   .+++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++.......  .
T Consensus        99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~  170 (297)
T cd06656          99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  170 (297)
T ss_pred             CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--c
Confidence            999999998643   4889999999999999999999   5899999999999999999999999999987533211  1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+..... .      .       .........
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~------~-------~~~~~~~~~  236 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-L------I-------ATNGTPELQ  236 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-e------e-------ccCCCCCCC
Confidence            1223458889999999999999999999999999999999999996543321110 0      0       000000011


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      .+......+.+++.+||+.+|++||++.+++++=
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (297)
T cd06656         237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP  270 (297)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            1233446678899999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.6e-35  Score=314.12  Aligned_cols=254  Identities=24%  Similarity=0.392  Sum_probs=202.2

Q ss_pred             CCccceeeeecCcEEEEEEEEcC-cceEEEEEeCCC----------CChhhHHHHHHHHHHHhh-ccccceeeEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDG-ATTKVAIKRGNP----------LSEQGVHEFQTEIEMLSK-LRHRHLVSLIGYCEE  600 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~-~~~~VavK~~~~----------~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~  600 (893)
                      +|+..+.||+|+||.||+|.... .+..+|+|.+..          .......++..|+.++.+ ++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46777899999999999999877 567899997542          223345667889988875 799999999999999


Q ss_pred             cCEEEEEEeeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecc
Q 036624          601 NCEMILVYDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF  678 (893)
Q Consensus       601 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF  678 (893)
                      .+..++||||+++++|.+++...  ....+++..+++++.|++.||.|||+  ..+++|+||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999988542  34468999999999999999999994  468999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc
Q 036624          679 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG  758 (893)
Q Consensus       679 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  758 (893)
                      |++.......   ......|+..|+|||++.+..++.++||||||+++|||++|+.|+......      .....     
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~-----  224 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATK-----  224 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHH-----
Confidence            9987643321   233456889999999999989999999999999999999999998643211      11111     


Q ss_pred             chhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          759 ILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       759 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                          +.+..............+.+++.+||+.+|++||++.||..+++
T Consensus       225 ----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         225 ----IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ----HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                11111111111123467889999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3e-35  Score=318.40  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=203.3

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      |+..+.||+|+||.||+|.+...+..||+|..... .....+.+.+|++++++++|+||+++++++......++|+||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            45567899999999999998877788999987643 24456689999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      +++|.+++..   ..+++..+..++.|+++||.|||   ..+++|+||+|+||++++++.+||+|||+++......  ..
T Consensus        86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          86 GGSALDLLKP---GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            9999998854   35899999999999999999999   5899999999999999999999999999987543221  11


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCC
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI  772 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  772 (893)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+....+..      +...          +........
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~----------~~~~~~~~~  221 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR------VLFL----------IPKNSPPTL  221 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh------HHhh----------hhcCCCCCC
Confidence            223457889999999999999999999999999999999999986433211      0100          000111122


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          773 APECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       773 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ...+...+.+++.+||+.+|++||+|.+|+++-.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF  255 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence            3345567889999999999999999999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.2e-35  Score=320.67  Aligned_cols=254  Identities=21%  Similarity=0.315  Sum_probs=207.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      .+|+..+.||.|+||.||+|.....+..|++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46888899999999999999987777899999876555555678899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|..++...   .+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++.......  .
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~  170 (296)
T cd06655          99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--S  170 (296)
T ss_pred             CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--c
Confidence            999999988643   4899999999999999999999   5899999999999999999999999999987543221  1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ......++..|+|||.+.+..++.++|||||||++|||++|+.||....+....      ...... .     .+.  ..
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~-~-----~~~--~~  236 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATN-G-----TPE--LQ  236 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhc-C-----Ccc--cC
Confidence            122345889999999999999999999999999999999999999654432211      000000 0     000  01


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .+......+.+++.+||..+|++||++.+++++=..
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~  272 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL  272 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence            122345678889999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.5e-35  Score=314.53  Aligned_cols=239  Identities=23%  Similarity=0.373  Sum_probs=189.3

Q ss_pred             eeeecCcEEEEEEEEcCc------------ceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          539 LLGVGGFGKVYRGEIDGA------------TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~------------~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .||+|+||.||+|+....            ...|++|.+..........|.+|+.+++.++||||+++++++......++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            689999999999985422            23588998776555566688999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc-------eeEeccc
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV-------AKVSDFG  679 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~-------~kl~DFG  679 (893)
                      ||||+++|+|..++.... ..+++..+++++.|+++||+|||   +.+|+||||||+|||++.++.       +|++|||
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          82 VEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999886543 35899999999999999999999   589999999999999987654       8999999


Q ss_pred             ccccCCCCCCccceeeeccCcCccChHhhh-hcCCCCcchhhhHHHHHHHHh-hCCCCCCCCCccccccHHHHHHHhhcc
Q 036624          680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEIL-CARPALNPTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       680 la~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~  757 (893)
                      ++......      ....++..|+|||++. +..++.++|||||||++|||+ .|+.|+......+      ... ..  
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~-~~--  222 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------KER-FY--  222 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------HHH-HH--
Confidence            98753221      1234788999999987 567899999999999999998 5777775432111      000 00  


Q ss_pred             cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                             ....  .........+.+++.+||+.+|++||++.+|++.|
T Consensus       223 -------~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         223 -------EGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -------hcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                   0000  01112245688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.5e-35  Score=315.81  Aligned_cols=256  Identities=27%  Similarity=0.455  Sum_probs=203.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCCChh-hHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      .+|+....||+|+||.||+|+.+.     ....+++|........ ..+++.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            568888899999999999999643     3457999987654443 4678999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHhhCCC-------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecc
Q 036624          606 LVYDYMAYGTLREHLYKTQK-------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF  678 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF  678 (893)
                      +||||+++|+|.+++.....       ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999976541       25899999999999999999999   588999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcc
Q 036624          679 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       679 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  757 (893)
                      |+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......      ....    
T Consensus       162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~~----  230 (275)
T cd05046         162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNR----  230 (275)
T ss_pred             ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHHH----
Confidence            998753221111 1122346778999999998889999999999999999998 777875322111      1111    


Q ss_pred             cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                           +....+.......++..+.+++.+||+.+|++||++.|++..|+
T Consensus       231 -----~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 -----LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -----HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                 11111111122345568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.4e-35  Score=311.41  Aligned_cols=251  Identities=26%  Similarity=0.372  Sum_probs=205.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..+.||+|+||.||+|.....+..+++|.+.....  .+++.+|++++++++|+||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            568888899999999999999988778899998765322  678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.... ..+++..+..++.|+++||.|||   ..+++||||+|+||++++++.+||+|||++.......  .
T Consensus        81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~  154 (256)
T cd06612          81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--A  154 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--c
Confidence            9999999986543 46899999999999999999999   5899999999999999999999999999987643221  1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.|+....+....     .  ....     ...+.  ..
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-----~--~~~~-----~~~~~--~~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-----F--MIPN-----KPPPT--LS  220 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-----h--hhcc-----CCCCC--CC
Confidence            223345788999999999999999999999999999999999998754322111     0  0000     00000  11


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .+......+.+++.+||+.+|++||++.||+++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            122344678899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.2e-35  Score=311.84  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=206.4

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|+..+.||+|+||.||++....++..+++|++..  ......+++.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            47788999999999999999987778999997653  2344566899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.......+++.+++.++.|++.||.|||   +.+++|+||+|+|||++.++.++|+|||++.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--  155 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--  155 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence            99999999997665556899999999999999999999   5899999999999999999999999999987543221  


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      .......|++.|+|||++.+..++.++|||||||+++||++|+.|+.....      .+......         ... ..
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~---------~~~-~~  219 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKII---------RGS-YP  219 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHh---------cCC-CC
Confidence            112234588899999999999999999999999999999999999864322      11111111         110 01


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..+......+.+++.+||+.+|++||+|.+|+++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1233455678999999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.2e-35  Score=328.35  Aligned_cols=261  Identities=20%  Similarity=0.254  Sum_probs=200.0

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec------C
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------C  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~  602 (893)
                      .++|+..+.||+|+||.||++.....+..||+|++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            46899999999999999999999887889999987532  334456788999999999999999999998644      3


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ..++||||++ ++|...++.    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876         100 DVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             eeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence            5799999997 466666642    3788999999999999999999   5899999999999999999999999999987


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc----
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG----  758 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----  758 (893)
                      ....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......     .|.......+    
T Consensus       172 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-----~~~~~~~~~~~~~~  243 (359)
T cd07876         172 TACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-----QWNKVIEQLGTPSA  243 (359)
T ss_pred             cccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcCCCcH
Confidence            5322   112233468999999999999999999999999999999999999997543211     1111000000    


Q ss_pred             -----------------------chhhhccccccC---CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          759 -----------------------ILEQIMDPYLKG---KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       759 -----------------------~~~~i~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                                             ...+........   .........+.+++.+||+.||++|||+.|++.+-..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  318 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI  318 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence                                   000000000000   0111224567899999999999999999999987653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.8e-35  Score=315.66  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=202.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|...+.||+|+||.||+|.....++.+++|.++.........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46677779999999999999998888899999876655555667889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++....  .+++.+++.++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||++.....  ...
T Consensus        89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~~  161 (267)
T cd06645          89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIA  161 (267)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--ccc
Confidence            9999999986544  5899999999999999999999   58999999999999999999999999999865322  111


Q ss_pred             ceeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          692 VSTVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      ......|+..|+|||++.   ...++.++|||||||++|||++|+.|+....+....  .    .....    ....+..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~----~~~~~----~~~~~~~  231 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F----LMTKS----NFQPPKL  231 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--H----hhhcc----CCCCCcc
Confidence            223446899999999985   456889999999999999999999998644322111  0    00000    0001111


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..  .......+.+++.+||+.+|++||++.+|+++
T Consensus       232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            11  11234568899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.2e-35  Score=328.49  Aligned_cols=193  Identities=27%  Similarity=0.373  Sum_probs=167.0

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ...+|+..+.||+|+||.||+|...+.+..||+|.....      ....|+.++++++|+||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            346799999999999999999999888889999975432      23568999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      ++. ++|.+++.... ..+++..++.|+.|++.||.|||   ..+||||||||+|||++.++.+||+|||+++....   
T Consensus       138 ~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---  209 (357)
T PHA03209        138 HYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---  209 (357)
T ss_pred             ccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence            995 78888886543 46999999999999999999999   58999999999999999999999999999875321   


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCC
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPAL  736 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~  736 (893)
                      ........||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            11123456899999999999999999999999999999999866554

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.8e-35  Score=313.45  Aligned_cols=257  Identities=24%  Similarity=0.358  Sum_probs=204.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCc---ceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|...++||+|+||.||+|.....   ...|++|...... ....+.+.+|+.++++++|+||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4577788999999999999987543   3468999876544 4556789999999999999999999999876 457899


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999997643 35899999999999999999999   589999999999999999999999999998754332


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      .. .......++..|+|||.+....++.++|||||||++||+++ |+.||......+   ...+.   ....        
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~---~~~~--------  225 (270)
T cd05056         161 SY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGRI---ENGE--------  225 (270)
T ss_pred             cc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH---HcCC--------
Confidence            11 11122334568999999998899999999999999999986 999986543221   11111   0000        


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                        ....+..++..+.+++.+|+..+|++||++.++++.|+....
T Consensus       226 --~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         226 --RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence              011234456788999999999999999999999999997553

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-35  Score=315.60  Aligned_cols=251  Identities=26%  Similarity=0.354  Sum_probs=205.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..+.||.|+||.||+|.....+..+++|...... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35777889999999999999998888899999876432 44556789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++...   ++++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||+++......  
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  152 (274)
T cd06609          81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--  152 (274)
T ss_pred             eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence            9999999998754   6899999999999999999999   5889999999999999999999999999987643321  


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      .......+++.|+|||++.+..++.++|||||||++|||++|+.||....+..      .... ....     ..+.   
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~-~~~~-----~~~~---  217 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFL-IPKN-----NPPS---  217 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHH-hhhc-----CCCC---
Confidence            12233458889999999999899999999999999999999999996543211      1110 0000     1111   


Q ss_pred             CCChH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          771 KIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       771 ~~~~~-~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                       .... ....+.+++.+||..+|++||++++++++-.
T Consensus       218 -~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~  253 (274)
T cd06609         218 -LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKF  253 (274)
T ss_pred             -CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence             1111 4456888999999999999999999987644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-34  Score=310.94  Aligned_cols=253  Identities=26%  Similarity=0.422  Sum_probs=203.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..++||+|+||.||++..... ..+++|..... ....+.|.+|++++++++|+||+++.+++.. ...+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~-~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCC-ccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            5678889999999999999987654 56999987643 3345678999999999999999999999887 6789999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.+.....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence            9999999998766667899999999999999999999   58999999999999999999999999999875432111 1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......++..|+|||++....++.++|||||||++||+++ |+.||.......   +..+.    ..+         ...
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~---------~~~  222 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----ERG---------YRM  222 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hCC---------CCC
Confidence            1122335678999999999899999999999999999998 898886432211   11111    111         011


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1223345678899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.2e-34  Score=313.67  Aligned_cols=251  Identities=24%  Similarity=0.357  Sum_probs=207.1

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      .|+..++||+|+||.||+|.....+..||+|..... .....+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            456677899999999999999877789999986543 3455678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|.+++..   .++++.++..++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06640          85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I  156 (277)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence            99999999864   34889999999999999999999   5899999999999999999999999999987543322  1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ......++..|+|||++.+..++.++|||||||++|||++|..|+....+....      .          .+.......
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~----------~~~~~~~~~  220 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------F----------LIPKNNPPT  220 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------h----------hhhcCCCCC
Confidence            223345788999999999989999999999999999999999998654322110      0          011111123


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ....++..+.+++.+||+.+|++||++.+++.+-..
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  256 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI  256 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence            344567789999999999999999999999987553

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.4e-35  Score=313.23  Aligned_cols=239  Identities=26%  Similarity=0.410  Sum_probs=190.9

Q ss_pred             eeeeecCcEEEEEEEEcCcc----------eEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          538 LLLGVGGFGKVYRGEIDGAT----------TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~----------~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      +.||+|+||.||+|.+....          ..+++|........ ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            36999999999999987654          35788876544333 6789999999999999999999999988 778999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC-------ceeEecccc
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW-------VAKVSDFGL  680 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-------~~kl~DFGl  680 (893)
                      |||+++|+|.+++..... .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999976543 6899999999999999999999   58999999999999999887       799999999


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhhhc--CCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcc
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  757 (893)
                      ++....      .....++..|+|||++...  .++.++|||||||++|||++ |..|+.......      +.....  
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~~~~~~--  220 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KERFYQ--  220 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------HHHHHh--
Confidence            875432      1223467789999999876  78999999999999999999 466665432211      111100  


Q ss_pred             cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                             ...   ..+......+.+++.+||..+|++||++.+|++.|+
T Consensus       221 -------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 -------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   000   001111267889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.9e-35  Score=312.66  Aligned_cols=250  Identities=24%  Similarity=0.373  Sum_probs=200.6

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh---------hhHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE---------QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~---------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      |.....||+|+||.||+|.....+..+++|.......         ...+.+.+|+.++++++||||+++++++.+....
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            5566799999999999999877778899997653221         2235688999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++|+||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999999999999999654  35889999999999999999999   589999999999999999999999999998764


Q ss_pred             CCCCC----ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          685 PTLDH----THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       685 ~~~~~----~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      .....    ........|+..|+|||.+.+..++.++|||||||++|||++|+.||.......  .    .         
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~----~---------  221 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--A----I---------  221 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--H----H---------
Confidence            32111    111123458889999999999999999999999999999999999996532211  0    0         


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..+.. ......+......+.+++.+||+.+|++||++.+|+++
T Consensus       222 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         222 FKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             HHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            00001 11112233456778899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.2e-35  Score=320.67  Aligned_cols=266  Identities=22%  Similarity=0.343  Sum_probs=202.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|...++||+|+||.||+|.....+..||+|.+.... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888899999999999999998877899999865432 22345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      ++ ++|.+++.... ..+++..+..++.|+++||+|||   ..+|+||||||+|||+++++.+||+|||+++....... 
T Consensus        86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            97 69998887543 35889999999999999999999   58999999999999999999999999999875322111 


Q ss_pred             cceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc---ccchhhhcc-
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK---KGILEQIMD-  765 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~i~d-  765 (893)
                       ......+++.|+|||++.+. .++.++|||||||++|||++|++||......+..   ........   ......+++ 
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChhhchhhhcc
Confidence             11223468899999998754 5788999999999999999999999754332211   11111000   000011100 


Q ss_pred             --------ccccC----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          766 --------PYLKG----KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       766 --------~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                              +....    ...+.....+.+++.+||+.+|.+|||+.|++++-..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f  289 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF  289 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence                    10000    0112234567899999999999999999999976553

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.6e-35  Score=328.96  Aligned_cols=266  Identities=20%  Similarity=0.226  Sum_probs=200.0

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec------
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------  601 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------  601 (893)
                      ..++|...+.||+|+||.||++.....+..||+|++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            456899999999999999999998877789999987643  334456788999999999999999999988543      


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      ...++||||++ ++|.+.+..    .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence            35799999997 567766643    3889999999999999999999   589999999999999999999999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccH---------HHH--
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL---------AEW--  750 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l---------~~~--  750 (893)
                      +....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+....         .++  
T Consensus       167 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             ccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            85422   1122334689999999999999999999999999999999999999975432111000         000  


Q ss_pred             -----HHHhhcc-cchhhhccccc--------cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          751 -----AAHCHKK-GILEQIMDPYL--------KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       751 -----~~~~~~~-~~~~~i~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                           ....... .....+..+..        ...........+.+++.+||+.||++|||+.|++++-.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~  313 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY  313 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence                 0000000 00000000000        00111123456789999999999999999999998754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.7e-35  Score=318.30  Aligned_cols=264  Identities=23%  Similarity=0.320  Sum_probs=206.5

Q ss_pred             cCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEe-
Q 036624          522 FSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCE-  599 (893)
Q Consensus       522 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~-  599 (893)
                      +.+..+..++++|+..+.||+|+||.||++.....++.+++|...... ....++.+|+.+++++ +|+||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            445667778899999999999999999999998888899999876432 2345688999999999 6999999999884 


Q ss_pred             ----ecCEEEEEEeeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCce
Q 036624          600 ----ENCEMILVYDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA  673 (893)
Q Consensus       600 ----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~  673 (893)
                          .+...++||||+++++|.+++...  ....+++..+..++.|+++||.|||   ..+++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                345689999999999999987642  3346899999999999999999999   5899999999999999999999


Q ss_pred             eEecccccccCCCCCCccceeeeccCcCccChHhhhh-----cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHH
Q 036624          674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA  748 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  748 (893)
                      ||+|||+++......  .......|++.|+|||++..     ..++.++|||||||++|||++|+.|+....+...    
T Consensus       164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~----  237 (286)
T cd06638         164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA----  237 (286)
T ss_pred             EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH----
Confidence            999999987543211  12223458999999999853     4578899999999999999999999865432111    


Q ss_pred             HHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          749 EWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       749 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                       +.. . ..     ...+.+  ..+..+...+.+++.+||+.+|++||++.|+++++
T Consensus       238 -~~~-~-~~-----~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         238 -LFK-I-PR-----NPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -Hhh-c-cc-----cCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence             000 0 00     000000  01112345688999999999999999999999865

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=310.87  Aligned_cols=255  Identities=25%  Similarity=0.361  Sum_probs=207.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..+.||+|+||.||+|.....+..+++|..........+.+.+|++++++++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888899999999999999998777889999877655556788999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.... ..+++.++..++.|++.||.|||   +.+|+|+||||+||++++++.+||+|||++.......  .
T Consensus        83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  156 (262)
T cd06613          83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A  156 (262)
T ss_pred             CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence            9999999886542 35899999999999999999999   5899999999999999999999999999987543211  1


Q ss_pred             ceeeeccCcCccChHhhhhc---CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          692 VSTVVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~---~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      ......++..|+|||.+.+.   .++.++|||||||++|||++|+.|+....+....  ...    ...    ....+. 
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--~~~----~~~----~~~~~~-  225 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--FLI----SKS----NFPPPK-  225 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH----Hhc----cCCCcc-
Confidence            22334688899999999877   8899999999999999999999999654332211  000    000    000011 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                       ..........+.+++.+||+.+|.+||++.+|+.+
T Consensus       226 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         226 -LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             -ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             11223445678999999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.4e-35  Score=317.71  Aligned_cols=263  Identities=25%  Similarity=0.342  Sum_probs=207.2

Q ss_pred             cCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEee
Q 036624          522 FSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEE  600 (893)
Q Consensus       522 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~  600 (893)
                      +.+.++..++++|+..+.||+|+||.||++.....++.+|+|...... ....++.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            556677778899999999999999999999998888899999876432 2345678899999999 79999999999875


Q ss_pred             c-----CEEEEEEeeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCce
Q 036624          601 N-----CEMILVYDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA  673 (893)
Q Consensus       601 ~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~  673 (893)
                      .     ...++|+||+++++|.++++..  ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            4     3589999999999999988642  3346899999999999999999999   5899999999999999999999


Q ss_pred             eEecccccccCCCCCCccceeeeccCcCccChHhhhhc-----CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHH
Q 036624          674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA  748 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  748 (893)
                      ||+|||+++.......  ......|+..|+|||++...     .++.++|||||||++|||++|+.|+.......  .+.
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~  243 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLF  243 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHH
Confidence            9999999875432211  12234588999999998644     36899999999999999999999986543211  111


Q ss_pred             HHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          749 EWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       749 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .+.     ....     +.+  ..+++....+.+++.+||+.+|++||++.|++++
T Consensus       244 ~~~-----~~~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 KIP-----RNPP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHh-----cCCC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            110     0000     001  1122344568999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.1e-35  Score=331.09  Aligned_cols=265  Identities=25%  Similarity=0.261  Sum_probs=200.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcC--cceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDG--ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~--~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ..+|+..+.||+|+||.||++...+  ....|++|.+...     +.+.+|+++|++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            3579999999999999999997643  3467999986542     23568999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |++. ++|.+++..  ...+++..++.++.|++.||.|||   ..+||||||||+|||++.++.+||+|||+++......
T Consensus       166 e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        166 PKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9996 788888843  346999999999999999999999   5899999999999999999999999999987543322


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccc-ccHHHHHHHhhcccc--------
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ-VSLAEWAAHCHKKGI--------  759 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~--------  759 (893)
                      .........||+.|+|||++.+..++.++|||||||+||||++|+.||........ ..+...... .....        
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~-~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC-MQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH-hccCccccCCccc
Confidence            22223345699999999999999999999999999999999999999975433211 111111110 00000        


Q ss_pred             --h-hhh--ccccccCCC--C-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          760 --L-EQI--MDPYLKGKI--A-----PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       760 --~-~~i--~d~~l~~~~--~-----~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                        + ...  .....+...  +     ......+.+++.+||+.+|++||++.|++.+-..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f  378 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF  378 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence              0 000  000000000  0     0123457789999999999999999999987654

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.8e-35  Score=316.25  Aligned_cols=264  Identities=20%  Similarity=0.273  Sum_probs=198.9

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|+..+.||+|+||.||+|+....+..|++|++...  .....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            467788999999999999999877789999986543  223346788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCC-CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          611 MAYGTLREHLYKTQ-KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       611 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      ++ ++|.+++.... ...+++..+..++.|++.||.|||   ..+++||||||+|||+++++.+||+|||+++...... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 78988886543 356899999999999999999999   5899999999999999999999999999987532211 


Q ss_pred             ccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc--c---------
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK--K---------  757 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~---------  757 (893)
                       .......+++.|+|||++.+. .++.++|||||||++|||++|++||........  +.........  +         
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhh
Confidence             111223468899999998754 578999999999999999999999975432111  0000000000  0         


Q ss_pred             cchhhhccccccC---CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          758 GILEQIMDPYLKG---KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       758 ~~~~~i~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .......+.....   ........++.+++.+||+.||++|||+.+|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000000000000   0011234567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-34  Score=308.80  Aligned_cols=251  Identities=30%  Similarity=0.493  Sum_probs=202.9

Q ss_pred             ccceeeeecCcEEEEEEEEcCcc----eEEEEEeCCCCChh-hHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          535 DEALLLGVGGFGKVYRGEIDGAT----TKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~~~~~----~~VavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ...+.||+|+||.||++.....+    ..||+|........ ..+.+..|++++.+++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            45678999999999999987755    78999988765433 57789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++++|.+++.......+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            999999999997654433899999999999999999999   58999999999999999999999999999876543221


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      .. .....+++.|+|||.+.+..++.++|||||||+++||++ |+.|+.....      .+.........          
T Consensus       159 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~~~----------  221 (258)
T smart00219      159 YK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEYLKKGY----------  221 (258)
T ss_pred             cc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcCC----------
Confidence            11 112337789999999988899999999999999999998 7888754221      11111111110          


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ........+..+.+++.+|+..+|++|||+.|+++.|
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1112223566788999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-34  Score=312.63  Aligned_cols=256  Identities=23%  Similarity=0.354  Sum_probs=201.0

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC----------hhhHHHHHHHHHHHhhccccceeeEEEEEeecC
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS----------EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC  602 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~----------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  602 (893)
                      +|...+.||+|+||.||+|.....+..+|+|..+...          ....+.+..|+.++++++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3566789999999999999987777889999764311          112356888999999999999999999999999


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ..++||||+++++|.+++.+.  ..+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999999765  35899999999999999999999   5899999999999999999999999999987


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcC--CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      ...............|+..|+|||.+....  ++.++||||||+++||+++|..|+......     ..+.. .... . 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~-~-  228 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFK-LGNK-R-  228 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHH-hhcc-c-
Confidence            643222222233456889999999987654  899999999999999999999998532211     11110 0000 0 


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                         ..+.+......++...+.+++.+||+.+|++||++.+|+++
T Consensus       229 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 ---SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ---cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence               01111112223446778899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-35  Score=315.55  Aligned_cols=255  Identities=25%  Similarity=0.361  Sum_probs=206.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..+.||+|+||.||+|.....+..+++|..........+.|..|++++++++|+||+++++.+......++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            46778889999999999999998777899999887666667788999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.+.. ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......  .
T Consensus        85 ~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~  158 (280)
T cd06611          85 DGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q  158 (280)
T ss_pred             CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence            9999999987643 35999999999999999999999   5899999999999999999999999999986543211  1


Q ss_pred             ceeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          692 VSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      ......+++.|+|||++.     ...++.++|||||||++|||++|+.||.......  .+..+    . .+     ..+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~~----~-~~-----~~~  226 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLKI----L-KS-----EPP  226 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHHH----h-cC-----CCC
Confidence            223456899999999985     3457789999999999999999999996543211  01110    0 00     001


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .+  ..+..+...+.+++.+||+.+|.+||++.+++++-.
T Consensus       227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (280)
T cd06611         227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF  264 (280)
T ss_pred             Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence            11  112234567889999999999999999999997744

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-34  Score=309.45  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=199.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-----ChhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-----SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~  604 (893)
                      .+|+..++||+|+||.||+|.....+..|++|.+...     .....+.+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4688889999999999999999887889999976421     223456789999999999999999999988663  567


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++||||+++++|.+++....  .+++..+++++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            89999999999999987543  4888999999999999999999   588999999999999999999999999998753


Q ss_pred             CCCCC-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          685 PTLDH-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       685 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      ..... ........|+..|+|||.+.+..++.++|||||||++|||++|+.||.......     ..          .+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~----------~~~  221 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----AI----------FKI  221 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----HH----------HHH
Confidence            22111 111223458899999999998889999999999999999999999986432111     00          011


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .........+......+.+++.+|+. +|++||++.||+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         222 ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            11111122344455677888899985 89999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-34  Score=320.95  Aligned_cols=261  Identities=20%  Similarity=0.261  Sum_probs=198.3

Q ss_pred             ceeeeec--CcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          537 ALLLGVG--GFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       537 ~~~LG~G--~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      .++||+|  +|++||++....++..||+|++...  .....+.+.+|+++++.++||||+++++++...+..++|+||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4589999  7899999999888899999987643  23345667889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC---
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH---  689 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~---  689 (893)
                      +|+|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.++++||+..........   
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            999999997654456899999999999999999999   58899999999999999999999999986543211100   


Q ss_pred             --ccceeeeccCcCccChHhhhh--cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          690 --THVSTVVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       690 --~~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                        ........++..|+|||++.+  ..++.++|||||||++|||++|+.||....... . ......     +.+....+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~-~~~~~~-----~~~~~~~~  232 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-M-LLEKLN-----GTVPCLLD  232 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-H-HHHHhc-----CCcccccc
Confidence              001112346778999999976  468999999999999999999999996432111 0 000000     00000000


Q ss_pred             -------------------c-----------------cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          766 -------------------P-----------------YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       766 -------------------~-----------------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                                         .                 .............+.+++.+||+.||++|||+.|++++-..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f  310 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  310 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence                               0                 00001112334578899999999999999999999987654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-35  Score=322.57  Aligned_cols=252  Identities=23%  Similarity=0.284  Sum_probs=211.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh---hhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE---QGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~---~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l  606 (893)
                      ...|+..+.||+|.||.||+++.+.++..+|+|.+.....   ...+.+.+|+.+|+++. |||||.+.+.++.....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            3456677899999999999999999889999997665432   24568999999999998 9999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC----CceeEecccccc
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK----WVAKVSDFGLSK  682 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~----~~~kl~DFGla~  682 (893)
                      |||++.||.|.+.|...   .+++..+..++.|++.++.|||   ..+|+||||||+|+|+...    +.+|++|||++.
T Consensus       114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999999999776   2999999999999999999999   5999999999999999643    579999999998


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                      ....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.........               ..
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~---------------~~  249 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF---------------LA  249 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH---------------HH
Confidence            7543   33456788999999999999999999999999999999999999999765432211               11


Q ss_pred             hccc--cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          763 IMDP--YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       763 i~d~--~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +...  ......-+.......+++..|+..||.+|+|+.+++++-+
T Consensus       250 i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  250 ILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             HHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence            1111  1122223345677889999999999999999999999754

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.2e-35  Score=306.38  Aligned_cols=265  Identities=23%  Similarity=0.285  Sum_probs=201.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh--hHHHHHHHHHHHhhccccc-eeeEEEEEeecC------
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ--GVHEFQTEIEMLSKLRHRH-LVSLIGYCEENC------  602 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~--~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~------  602 (893)
                      ..|...++||+|.||+||+|+....++.||+|++....+.  .-....+|+.+|++++|+| |++|.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3455667899999999999999988899999987654332  2345689999999999999 999999998877      


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCC--CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQK--PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL  680 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl  680 (893)
                      .++||+||++ -+|..++.....  ..++...+..+..|+++||+|||   .++|+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            7899999997 799999976543  35777889999999999999999   59999999999999999999999999999


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh---hc
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC---HK  756 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~---~~  756 (893)
                      |+.......  ..+...+|..|.|||++.+. .|+...||||+|||+.||+++++-|.+..+.++..  ...+.+   ..
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~--~If~~lGtP~e  242 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF--RIFRLLGTPNE  242 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH--HHHHHcCCCCc
Confidence            996432222  13344588999999999876 79999999999999999999998887655432211  111100   00


Q ss_pred             ccchh--hhccc--cccCC-----CChHH---HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          757 KGILE--QIMDP--YLKGK-----IAPEC---FKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       757 ~~~~~--~i~d~--~l~~~-----~~~~~---~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      +.|-.  ...+-  .....     .....   .....+++.+||+.+|.+|.|+..++.+
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11100  00110  00000     00111   1357889999999999999999999976

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=9.9e-35  Score=310.08  Aligned_cols=247  Identities=30%  Similarity=0.471  Sum_probs=199.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|...+.||+|+||.||+|...+  ..+++|......  ..+.+.+|+.++++++|||++++++++... ..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTG--QKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCC--CceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            357778899999999999998644  679999876432  346789999999999999999999998765 479999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....    
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            9999999998766566899999999999999999999   589999999999999999999999999998753221    


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                       ......+..|+|||++.+..++.++|||||||++|||++ |+.||......      ++.... ..+         ...
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~-~~~---------~~~  216 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKECV-EKG---------YRM  216 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHHH-hCC---------CCC
Confidence             112234568999999999999999999999999999997 99988644321      111111 111         111


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .....++..+.+++.+||+.+|++||++.++++.|+.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1223445678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-34  Score=308.63  Aligned_cols=249  Identities=25%  Similarity=0.383  Sum_probs=201.8

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-----hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-----EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      +|+..+.||+|+||+||+|.....+..|++|......     .+..+.+.+|+.++++++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3566789999999999999998666889999754322     34567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      +||+++++|.+++.+..  .+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999997553  5899999999999999999999   589999999999999999999999999998754322


Q ss_pred             CCccceeeeccCcCccChHhhhhcC-CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      .   ......|+..|+|||.+.... ++.++|+|||||++|||++|+.||.......      .........        
T Consensus       156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~--------  218 (258)
T cd06632         156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSK--------  218 (258)
T ss_pred             c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcc--------
Confidence            1   223455889999999998776 8999999999999999999999986543211      111100000        


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                       .....+......+.+++.+||+.+|++||++.+++.+
T Consensus       219 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         219 -ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence             0112233445678889999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=318.72  Aligned_cols=255  Identities=24%  Similarity=0.299  Sum_probs=204.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||.||+|...+.+..+|+|......   ....+.+..|++++++++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999998877899999876432   235567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+.+++|.+++.......+++..+..++.|++.||+|||   ..+++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999997665567999999999999999999999   5899999999999999999999999999976432111


Q ss_pred             Cc---------------------------cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCc
Q 036624          689 HT---------------------------HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP  741 (893)
Q Consensus       689 ~~---------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~  741 (893)
                      ..                           .......||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            00                           001123578899999999999999999999999999999999999965432


Q ss_pred             cccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 036624          742 KEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS----MGDVLWN  804 (893)
Q Consensus       742 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt----m~evl~~  804 (893)
                      ...               +.++.+..............+.+++.+||+.+|++||+    +.+++.+
T Consensus       238 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         238 DET---------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             HHH---------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            210               11111111111111124677899999999999999999    6666554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.6e-34  Score=308.64  Aligned_cols=258  Identities=25%  Similarity=0.349  Sum_probs=206.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..+.||.|+||+||+|.....+..+++|+..... ....+.+.+|+++++.++|+||+++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999988777889999875432 33567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCC-CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          611 MAYGTLREHLYKTQK-PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      +++++|.+++..... ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999976432 56899999999999999999999   58999999999999999999999999999875433222


Q ss_pred             c--cceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          690 T--HVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       690 ~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      .  .......|+..|+|||++... .++.++|||||||++|||++|+.||.......  .+.+...    .      ..+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~----~------~~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQ----N------DPP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhc----C------CCC
Confidence            1  122344688999999999877 78999999999999999999999996543211  1111111    0      011


Q ss_pred             cccCCC-ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          767 YLKGKI-APECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       767 ~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .+.... .......+.+++.+||+.+|++||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            111111 12445778899999999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.8e-34  Score=310.81  Aligned_cols=253  Identities=24%  Similarity=0.341  Sum_probs=190.2

Q ss_pred             eeeecCcEEEEEEEEcCc--ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCC
Q 036624          539 LLGVGGFGKVYRGEIDGA--TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGT  615 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~--~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  615 (893)
                      .||+|+||.||+|.....  ...+++|..... .....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975433  234667765543 33456789999999999999999999999999999999999999999


Q ss_pred             HHHHHhhCC--CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          616 LREHLYKTQ--KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       616 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |.+++.+..  ...+++..+..++.|+++||+|||   +.+++||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997642  234677788899999999999999   588999999999999999999999999998643222221222


Q ss_pred             eeeccCcCccChHhhhh-------cCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          694 TVVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~-------~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..|+......      +.......+ ....+.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~-~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIKD-QQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhh-cccccCC
Confidence            34557889999999853       345789999999999999997 46676533221      111111111 1122233


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +.+...    ....+.+++..|+ .+|++||++.+|++.|.
T Consensus       232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            333222    3356777888999 57999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-34  Score=308.11  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=204.7

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|+..+.||+|+||.||++.....+..+++|.....  .....+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477888999999999999999888889999976543  344567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC-CceeEecccccccCCCCCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~~~~~~~  689 (893)
                      +++++|.+++.......+++..+.+++.|+++||+|||   +.+++||||||+||+++++ ..+||+|||+++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999998766566899999999999999999999   5899999999999999855 468999999987643221 


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                        ......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+......      ..+......         . .
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~---------~-~  218 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSG---------T-F  218 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhc---------C-C
Confidence              122345888999999999988999999999999999999999998654321      111111100         0 1


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ...+......+.+++.+||+.+|++|||+.|++.+
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            11223345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.3e-34  Score=307.38  Aligned_cols=251  Identities=28%  Similarity=0.427  Sum_probs=199.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      .+|+..+.||+|+||.||++....+ ..+++|...... ....+|.+|++++++++|||++++++++......++|+||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~-~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCC-CeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            3567788999999999999988654 679999876432 23457899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  156 (256)
T cd05112          82 EHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-T  156 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-c
Confidence            9999999987543 35899999999999999999999   58899999999999999999999999999875432111 1


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......++.+|+|||++.++.++.++|||||||++|||++ |+.||......      +.........   ...      
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~---~~~------  221 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETINAGF---RLY------  221 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHhCCC---CCC------
Confidence            1112235678999999999999999999999999999998 89988643321      1111111000   001      


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                       .+......+.+++.+||+.+|++||++.+|+++|
T Consensus       222 -~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         222 -KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence             1112346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=331.97  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=209.8

Q ss_pred             cceeeeecCcEEEEEEEEcCcc----eEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          536 EALLLGVGGFGKVYRGEIDGAT----TKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~~~~----~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ..++||+|+||+||||.+-..+    .+||+|++... ..+...++.+|+-+|.+++||||++|+|+|.... +.||.+|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            4669999999999999874322    46888876554 4556788999999999999999999999998776 8899999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      |+.|+|.++++.. +.++.-+..+.++.|||+||.|||   ++++|||||.++|||+.+-..+||.|||+++.....+..
T Consensus       779 mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  779 MPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             cccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            9999999999865 346889999999999999999999   699999999999999999999999999999987665544


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      ......+-.+.|||-|.++...|+.++|||||||.+||++| |..|+++....+.                .+++..-.+
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------~dlle~geR  918 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------PDLLEKGER  918 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------hHHHhcccc
Confidence            44444556789999999999999999999999999999998 8888765432221                111211112


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      -.-++-|...+..++.+||..|+..||+++++...+....
T Consensus       919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            3346778899999999999999999999999998876554

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.5e-34  Score=325.85  Aligned_cols=263  Identities=19%  Similarity=0.221  Sum_probs=199.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec------C
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------C  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~  602 (893)
                      .++|...+.||+|+||.||++.....++.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            46889999999999999999998887789999987642  334456788999999999999999999987543      3


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ..++||||++ ++|...+..    .+++..+..++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         103 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             eEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            5799999997 577777643    3889999999999999999999   5899999999999999999999999999997


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH---------
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH---------  753 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~---------  753 (893)
                      .....   .......||..|+|||++.+..++.++|||||||+||||++|+.||......+..  ......         
T Consensus       175 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~  249 (364)
T cd07875         175 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW--NKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCCHHHH
Confidence            54321   1223346899999999999999999999999999999999999999754322110  000000         


Q ss_pred             --h-------hcc-c-----chhhhccccc---cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          754 --C-------HKK-G-----ILEQIMDPYL---KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       754 --~-------~~~-~-----~~~~i~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                        .       ... .     ...++....+   ...........+.+++.+||+.||.+|||+.|++++-.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~  320 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  320 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence              0       000 0     0000000000   00011112356789999999999999999999998754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-34  Score=307.95  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=205.3

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEee--cCEEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE--NCEMILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~  608 (893)
                      +|+..+.||.|+||.||++.....+..+++|.+..  ......+.+..|++++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            46778899999999999999887778899997653  344556778999999999999999999998753  45689999


Q ss_pred             eeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCC--CCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          609 DYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGA--KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       609 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ||+++++|.+++...  ...++++..++.++.|++.||.|||..+  ..+++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653  2456999999999999999999999432  588999999999999999999999999998865


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      .....  ......+++.|+|||++.+..++.++||||||+++++|++|+.|+.....      .+..... ..+      
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~------  225 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLASKI-KEG------  225 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHHHHH-hcC------
Confidence            43221  12234589999999999999999999999999999999999999975431      1111111 111      


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                         .....+......+.+++.+|++.+|++||++.+|+++
T Consensus       226 ---~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 ---KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence               1112334556788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.2e-34  Score=310.67  Aligned_cols=256  Identities=27%  Similarity=0.409  Sum_probs=199.4

Q ss_pred             CccceeeeecCcEEEEEEEEcC---cceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecC------
Q 036624          534 FDEALLLGVGGFGKVYRGEIDG---ATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC------  602 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~---~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------  602 (893)
                      |...++||+|+||.||+|.+..   .+..||+|++...  .....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            4566789999999999998643   3478999976543  3445678999999999999999999999886432      


Q ss_pred             EEEEEEeeccCCCHHHHHhhCC----CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQ----KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF  678 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF  678 (893)
                      ..++++||+.+|+|..++....    ...+++..+++++.|++.||+|||   +.+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            3478899999999998875331    235789999999999999999999   588999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcc
Q 036624          679 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       679 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  757 (893)
                      |+++...............+++.|++||.+....++.++|||||||++|||++ |++|+......   .+..+..   ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI---KG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH---cC
Confidence            99886433222112223345678999999999999999999999999999999 88888643221   1111111   10


Q ss_pred             cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      ..          ...++.+...+.+++.+||+.+|++||++.++++.|+.+
T Consensus       232 ~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             Cc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00          011234557899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-34  Score=314.94  Aligned_cols=255  Identities=24%  Similarity=0.335  Sum_probs=204.3

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      +|+..+.||+|+||.||++.....+..+|+|.+... .......+.+|++++++++|+||+++++++...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            567788999999999999999877789999976543 3445578999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCC-CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          612 AYGTLREHLYKTQ-KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       612 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      ++++|..++.... ...+++..+..++.|++.||.|||+  +.+|+||||||+||+++.++.+||+|||++......   
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  156 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---  156 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence            9999999887542 2368999999999999999999995  468999999999999999999999999998753221   


Q ss_pred             cceeeeccCcCccChHhhhhc------CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~------~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                       ......++..|+|||.+.+.      .++.++|||||||++|||++|+.||.......      +..      .+..+.
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------~~~------~~~~~~  223 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN------IFA------QLSAIV  223 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh------HHH------HHHHHh
Confidence             12234578899999998654      35889999999999999999999996432211      000      011111


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +.. ....++++...+.+++.+||+.+|++||++.+++.+-.
T Consensus       224 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~  264 (286)
T cd06622         224 DGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW  264 (286)
T ss_pred             hcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence            111 11234456677889999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.8e-34  Score=310.86  Aligned_cols=264  Identities=23%  Similarity=0.289  Sum_probs=200.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+....||+|+||.||+|.....+..||+|+.....  ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36788889999999999999998777899999765322  2234568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |++++.|..++....  .+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            999988888765433  4899999999999999999999   58999999999999999999999999999886433221


Q ss_pred             ccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc-----------c
Q 036624          690 THVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK-----------K  757 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-----------~  757 (893)
                        ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.  +..+......           .
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChHHhhhcccc
Confidence              1223447889999999876 5688999999999999999999999975443221  1111110000           0


Q ss_pred             cchhhhccccccCCCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          758 GILEQIMDPYLKGKIA-----PECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ........+......+     +.....+.+++.+||+.+|++||++.|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0000000111000000     1224568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.1e-34  Score=316.54  Aligned_cols=257  Identities=23%  Similarity=0.320  Sum_probs=203.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||.||++.....+..|++|.+....   ....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888899999999999999998888899999876532   234567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            9999999999996543  5899999999999999999999   5899999999999999999999999999987421100


Q ss_pred             -------------CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          689 -------------HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       689 -------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                                   .........++..|+|||++.+..++.++|||||||++|||++|+.||......      ++.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~  229 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVI  229 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence                         001112245788999999999889999999999999999999999998643221      1111111


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ..    .+..+..    ....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       230 ~~----~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SD----DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hc----ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            10    0111111    11345668899999999999999997666665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3e-34  Score=308.29  Aligned_cols=252  Identities=23%  Similarity=0.424  Sum_probs=199.0

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC------hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS------EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      +|...+.||+|+||.||+|.... +..+|+|.+....      ......+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~-~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcC-CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            36677899999999999998754 4789999765321      2334568999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      |+||+++++|.+++.+..  ++++..+..++.|++.||+|||   +.+|+|+||||+||++++++.+||+|||+++....
T Consensus        80 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          80 FMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999996543  4889999999999999999999   58899999999999999999999999999875321


Q ss_pred             CC----CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          687 LD----HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       687 ~~----~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                      ..    .........|+..|+|||++.+..++.++|||||||++|||++|+.||........     .........    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~~~~~~~~----  225 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----MFYIGAHRG----  225 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----HHHhhhccC----
Confidence            11    11112234588999999999999999999999999999999999999964322110     000000000    


Q ss_pred             hccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          763 IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       763 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                       .    ....+......+.+++.+||+.+|++||++.+++.+
T Consensus       226 -~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         226 -L----MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             -C----CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             0    111223345668899999999999999999999853

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=311.15  Aligned_cols=256  Identities=26%  Similarity=0.373  Sum_probs=202.5

Q ss_pred             HHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecC-----
Q 036624          529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENC-----  602 (893)
Q Consensus       529 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~-----  602 (893)
                      .++++|+..+.||+|+||.||+|.....+..+++|....... ..+++.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            356889999999999999999999987778899998765433 456799999999999 6999999999997644     


Q ss_pred             -EEEEEEeeccCCCHHHHHhhCC--CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccc
Q 036624          603 -EMILVYDYMAYGTLREHLYKTQ--KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG  679 (893)
Q Consensus       603 -~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG  679 (893)
                       ..++||||+++++|.+++....  ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999887543  456899999999999999999999   5899999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeeccCcCccChHhhhh-----cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh
Q 036624          680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC  754 (893)
Q Consensus       680 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  754 (893)
                      ++......  ........|+..|+|||++..     ..++.++|||||||+|+||++|+.||.......  .+..    .
T Consensus       159 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~----~  230 (275)
T cd06608         159 VSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFK----I  230 (275)
T ss_pred             cceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHH----h
Confidence            98753321  112233458899999999853     347789999999999999999999996432211  0100    0


Q ss_pred             hcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          755 HKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       755 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      . ..     ..+.  ..........+.+++.+||..+|++|||+.+++++
T Consensus       231 ~-~~-----~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         231 P-RN-----PPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             h-cc-----CCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0 00     0011  11122355678899999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=346.65  Aligned_cols=256  Identities=21%  Similarity=0.322  Sum_probs=200.8

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEee--cCEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE--NCEMI  605 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~  605 (893)
                      ..++|.+.++||+|+||+||++........+|+|.+...  .......|..|+.+|++|+|||||++++++..  ...++
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            456899999999999999999999888889999976532  34456779999999999999999999998754  45789


Q ss_pred             EEEeeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCC----CCceEecCCCCCCEEECC----------
Q 036624          606 LVYDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGA----KHTIIHRDVKTTNILLDE----------  669 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivHrDlk~~NILld~----------  669 (893)
                      |||||+++|+|.++|...  ....+++..++.|+.||+.||+|||+..    ..+||||||||+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999999753  2346999999999999999999999522    146999999999999964          


Q ss_pred             -------CCceeEecccccccCCCCCCccceeeeccCcCccChHhhhh--cCCCCcchhhhHHHHHHHHhhCCCCCCCCC
Q 036624          670 -------KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEILCARPALNPTL  740 (893)
Q Consensus       670 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~  740 (893)
                             ...+||+|||+++.....   .......||+.|+|||++.+  ..++.++|||||||+||||++|+.||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   235899999999764321   12234569999999999864  458999999999999999999999996432


Q ss_pred             ccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          741 PKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       741 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .     +......+...        +.+.   .......+.+|+.+||+.+|.+||++.|++.+
T Consensus       248 ~-----~~qli~~lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        248 N-----FSQLISELKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             c-----HHHHHHHHhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            2     11111111100        1110   11234668899999999999999999999964

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=303.85  Aligned_cols=248  Identities=24%  Similarity=0.374  Sum_probs=209.4

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      |++..+||+|+||.|||+.++..+..||+|....  +.+.+++..|+.+|+++..|++|+++|.+.....+++|||||.-
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            6677899999999999999999999999998765  34578999999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |++.+.++-. +.+|.+..+..|+...++||+|||   ...-||||||+.||||+.+|.+||+|||.+-....  .-...
T Consensus       113 GSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR  186 (502)
T KOG0574|consen  113 GSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR  186 (502)
T ss_pred             CcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence            9999988654 457999999999999999999999   57889999999999999999999999999875432  22234


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh-ccccccCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI-MDPYLKGKI  772 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i-~d~~l~~~~  772 (893)
                      ..+.||+-|||||++..-.|..++||||||+...||..|++|+..-.+-...               --+ -.|...-..
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------------FMIPT~PPPTF~K  251 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------------FMIPTKPPPTFKK  251 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------------EeccCCCCCCCCC
Confidence            4578999999999999999999999999999999999999999654331100               000 011111233


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          773 APECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       773 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      +++....+-+++++||-++|++|-|+.+++++
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            55677889999999999999999999988865

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.1e-34  Score=305.20  Aligned_cols=253  Identities=25%  Similarity=0.369  Sum_probs=208.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh-hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..+.||+|++|.||++.....+..+++|+...... .....+.+|+.++.+++|+||+++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            468888999999999999999998778999998765443 4567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCC-CceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK-HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      +++++|.+++...  ..+++..++.++.|+++||+|||   . .+++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999999765  45899999999999999999999   6 8999999999999999999999999999876433221


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..........+..+            +.... .
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~------------~~~~~-~  220 (264)
T cd06623         156 --QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA------------ICDGP-P  220 (264)
T ss_pred             --cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH------------HhcCC-C
Confidence              11234578899999999999999999999999999999999999965532111111111            11111 1


Q ss_pred             CCCChH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          770 GKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       770 ~~~~~~-~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ...+.. ....+.+++.+||+.+|++||++.+++++
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            112223 56789999999999999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=296.76  Aligned_cols=252  Identities=23%  Similarity=0.298  Sum_probs=201.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+.-++||+|.|+.||++....+++..|+|.++.  .+..+.+++.+|++|.+.|+|||||+|.....+....+||+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            456666789999999999999988888888886543  344477889999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC---CCceeEecccccccCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE---KWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~~~~~  686 (893)
                      +|.|++|..-|-..  ...++..+-....||+++|.|+|   .++|||||+||+|+||..   .--+||+|||++.....
T Consensus        91 ~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             cccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            99999998766543  34677788889999999999999   599999999999999953   34699999999987652


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                         ...-....|||+|||||+++..+|+..+|||+.|||||-||.|++||.+.....               ..++|+..
T Consensus       166 ---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---------------lye~I~~g  227 (355)
T KOG0033|consen  166 ---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---------------LYEQIKAG  227 (355)
T ss_pred             ---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---------------HHHHHhcc
Confidence               222334669999999999999999999999999999999999999997643211               11112111


Q ss_pred             cc--cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          767 YL--KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       767 ~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..  .+..-+...+...+|+.+||..||.+|-|+.|.+.+-+
T Consensus       228 ~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW  269 (355)
T KOG0033|consen  228 AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW  269 (355)
T ss_pred             ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence            11  11111233456778999999999999999999986654

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=324.90  Aligned_cols=244  Identities=24%  Similarity=0.272  Sum_probs=189.6

Q ss_pred             eeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc---cccceeeEEEEEeecCEEEEEEeeccC
Q 036624          540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL---RHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       540 LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ||+|+||+||+|+....+..||+|++...   .......+..|..++.++   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999888889999987532   122334456677777665   699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|..++.+..  .+++..+..++.||++||+|||   ..+|+||||||+|||+++++.+||+|||+++......  ...
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~  153 (330)
T cd05586          81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT  153 (330)
T ss_pred             ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence            99999987543  5899999999999999999999   5899999999999999999999999999987532211  122


Q ss_pred             eeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI  772 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  772 (893)
                      ....||+.|+|||++.+. .++.++|||||||++|||++|+.||......      +...... .+      +..+..  
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~-~~------~~~~~~--  218 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIA-FG------KVRFPK--  218 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHH-cC------CCCCCC--
Confidence            345699999999999765 4899999999999999999999999654321      1111110 00      001111  


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCC----CHHHHHHHHH
Q 036624          773 APECFKKFAETAMKCVSDQGIERP----SMGDVLWNLE  806 (893)
Q Consensus       773 ~~~~~~~l~~l~~~Cl~~~p~~RP----tm~evl~~L~  806 (893)
                       ......+.+++.+||+.+|.+||    ++.+++++-.
T Consensus       219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~  255 (330)
T cd05586         219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF  255 (330)
T ss_pred             -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence             12345677899999999999998    5666665433

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.2e-34  Score=307.71  Aligned_cols=248  Identities=24%  Similarity=0.363  Sum_probs=202.5

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      |+..+.||+|+||.||+|.....+..+|+|..... .....+.+.+|+.++++++|+||+++++++..+...++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            56677999999999999998777789999986543 23445678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      +++|.+++..   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.......  ..
T Consensus        86 ~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          86 GGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            9999999864   34899999999999999999999   5899999999999999999999999999987543221  11


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCC
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI  772 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  772 (893)
                      .....++..|+|||++.+..++.++|||||||++|||++|..|+......      .+......          ......
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~----------~~~~~~  221 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPK----------NNPPTL  221 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhc----------CCCCCC
Confidence            22345788999999999888999999999999999999999998643221      11111100          001122


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          773 APECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       773 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ...+...+.+++.+||+.+|++||++.+++++-
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~  254 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  254 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence            334556788999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=298.55  Aligned_cols=265  Identities=23%  Similarity=0.333  Sum_probs=215.9

Q ss_pred             HHHHHHHhcCCccceeeeecCcEEEEEEEEcCcc-----eEEEEEeCCC-CChhhHHHHHHHHHHHhhccccceeeEEEE
Q 036624          524 FAEIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGY  597 (893)
Q Consensus       524 ~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~VavK~~~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~  597 (893)
                      .+||.....+++...++-+|.||.||+|.+...+     +.|.+|.++. .+.-+...|..|.-.+..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4556666677888889999999999999765432     3466775443 455567789999999999999999999999


Q ss_pred             Eeec-CEEEEEEeeccCCCHHHHHhhC------CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC
Q 036624          598 CEEN-CEMILVYDYMAYGTLREHLYKT------QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK  670 (893)
Q Consensus       598 ~~~~-~~~~lV~E~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~  670 (893)
                      +.+. ...+.+|.++.-|+|..+|...      ....+...+...++.|++.||+|||   +.+|||.||.++|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhh
Confidence            8654 5678889999999999999832      2234777888999999999999999   6999999999999999999


Q ss_pred             CceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHH
Q 036624          671 WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAE  749 (893)
Q Consensus       671 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~  749 (893)
                      .++||+|=.|+|.....++......-..+..||+||.+....|+.++|||||||+||||+| |+.|+..-++.+..    
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----  508 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----  508 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH----
Confidence            9999999999998777777666666667889999999999999999999999999999997 88888655554321    


Q ss_pred             HHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          750 WAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       750 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                         ...++|        . +-.-+-.|+.++..++.-||...|++||+.+|++.-|.+
T Consensus       509 ---~ylkdG--------y-RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  509 ---HYLKDG--------Y-RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ---HHHhcc--------c-eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence               111111        1 112245789999999999999999999999999998864

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-33  Score=307.92  Aligned_cols=262  Identities=23%  Similarity=0.292  Sum_probs=205.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~  608 (893)
                      ++|+..+.||.|++|.||++.+...+..+|+|..... .......+.+|++++++++||||++++++|...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4688899999999999999999888889999987643 234567789999999999999999999998643  4689999


Q ss_pred             eeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          609 DYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       609 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||+++++|.+++...  ....+++..+..++.|+++||.|||   ..+++|+||+|+||++++++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999887542  3445899999999999999999999   58999999999999999999999999999875322


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcc--ccccHHHHHHHhhcccchhhhc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPK--EQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ..    .....++..|+|||.+.+..++.++|||||||++|||++|+.|+......  ....+..|.....    ...+.
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~  229 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP----NPELK  229 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC----chhhc
Confidence            11    12345788999999999999999999999999999999999999754321  1111222211100    00010


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      +.   ..........+.+++.+||+.+|++|||+.|++++-..
T Consensus       230 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~  269 (287)
T cd06621         230 DE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI  269 (287)
T ss_pred             cC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence            00   00011245678999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-34  Score=316.33  Aligned_cols=248  Identities=20%  Similarity=0.322  Sum_probs=201.0

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCH
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL  616 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  616 (893)
                      ...||+|+||.||++.....+..||+|++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            45799999999999998877789999987765556677899999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeee
Q 036624          617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV  696 (893)
Q Consensus       617 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  696 (893)
                      .+++...   .+++..+..++.|++.||.|||   ..+|+||||||+||++++++.+||+|||++.......  ......
T Consensus       107 ~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~  178 (292)
T cd06658         107 TDIVTHT---RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSL  178 (292)
T ss_pred             HHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCcee
Confidence            9988543   4899999999999999999999   4799999999999999999999999999987532211  112234


Q ss_pred             ccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHH
Q 036624          697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC  776 (893)
Q Consensus       697 ~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  776 (893)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||........  +    ..      +...+.+.+..  ....
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~----~~------~~~~~~~~~~~--~~~~  244 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--M----RR------IRDNLPPRVKD--SHKV  244 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HH------HHhcCCCcccc--cccc
Confidence            588999999999988999999999999999999999999865332111  0    00      11111111111  1123


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          777 FKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       777 ~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ...+.+++.+|+..+|.+|||+.+++++-.
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~  274 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQHPF  274 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence            456788999999999999999999997644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.5e-35  Score=316.14  Aligned_cols=266  Identities=24%  Similarity=0.354  Sum_probs=200.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..++||+|+||.||+|.....++.+|+|+.....  ....+.+.+|++++++++|+||+++++++......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36788899999999999999998777899999765422  2235678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++++|..+.....  .++|.+++.++.|+++||.|||   +.+++||||+|+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            999999988765433  4899999999999999999999   5899999999999999999999999999987543322 


Q ss_pred             ccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc-cHHHHHHHh-------hccc-c
Q 036624          690 THVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV-SLAEWAAHC-------HKKG-I  759 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~-------~~~~-~  759 (893)
                       .......++..|+|||++.+ ..++.++|||||||++|||++|++||......+.. .+..+....       .... .
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence             11223457889999999875 45788999999999999999999988643321100 000000000       0000 0


Q ss_pred             hhhhccccccC-----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          760 LEQIMDPYLKG-----KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       760 ~~~i~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ......+....     ...+.....+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00000010000     0112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-34  Score=324.56  Aligned_cols=262  Identities=20%  Similarity=0.259  Sum_probs=198.0

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec------
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------  601 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------  601 (893)
                      ..++|...+.||+|+||+||+|.....+..||||++...  .....+.+.+|++++++++|+||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            457889999999999999999999888789999987643  223445678999999999999999999887533      


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      ...++++|++ +++|.+++..   ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence            4578999988 6899887753   34999999999999999999999   589999999999999999999999999998


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc----
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK----  756 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----  756 (893)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........  +..+......    
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~  238 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTPSPE  238 (343)
T ss_pred             eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence            864321     223458999999999977 5789999999999999999999999965432111  1111100000    


Q ss_pred             ------ccchhhhccccccCCCCh--------HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          757 ------KGILEQIMDPYLKGKIAP--------ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       757 ------~~~~~~i~d~~l~~~~~~--------~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                            ......... .+. ..+.        .....+.+++.+||+.||++|||+.|++.+-..
T Consensus       239 ~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~  301 (343)
T cd07878         239 VLKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF  301 (343)
T ss_pred             HHHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence                  000000000 000 0000        112346789999999999999999999987553

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=312.25  Aligned_cols=250  Identities=24%  Similarity=0.340  Sum_probs=205.8

Q ss_pred             HHHHHh-cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeec
Q 036624          526 EIKAAT-NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN  601 (893)
Q Consensus       526 el~~at-~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~  601 (893)
                      |+...| +.|+.-++||+||||.||-++.+.+++..|.|++...   ..++.....+|..+|.+++.+.||.+-..++.+
T Consensus       178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk  257 (591)
T KOG0986|consen  178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK  257 (591)
T ss_pred             HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence            333333 5688889999999999999999999999999876532   234555678999999999999999999999999


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      +.+|||+..|.||+|.-||+..+.+.+++..+.-.+.+|+.||++||   +.+||.|||||+|||||+.|+++|+|.|||
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceE
Confidence            99999999999999999999888888999999999999999999999   699999999999999999999999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      ...+...   ......||.+|||||++.++.|+...|+||+||+||||+.|+.||........     |           
T Consensus       335 vei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----~-----------  395 (591)
T KOG0986|consen  335 VEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----R-----------  395 (591)
T ss_pred             EecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----H-----------
Confidence            8755422   12233699999999999999999999999999999999999999965432211     1           


Q ss_pred             hhccccc---cCCCChHHHHHHHHHHHHccccCCCCCCC
Q 036624          762 QIMDPYL---KGKIAPECFKKFAETAMKCVSDQGIERPS  797 (893)
Q Consensus       762 ~i~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt  797 (893)
                      +-+|.+.   ..+++....++...|....|++||.+|..
T Consensus       396 eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  396 EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            0011111   12334445566777888999999999974

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.5e-34  Score=322.82  Aligned_cols=265  Identities=22%  Similarity=0.230  Sum_probs=207.5

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-c-----cceeeEEEEEeecCEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-H-----RHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l  606 (893)
                      +|++.++||+|.||.|-+|.+..+++.||||+++.. ..-..+-..|+.+|.+|+ |     -|+|++++++...+++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            788899999999999999999999999999998864 334556688999999997 4     489999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC--CceeEecccccccC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK--WVAKVSDFGLSKTG  684 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~--~~~kl~DFGla~~~  684 (893)
                      |+|.+. -+|.++|..+.-..++...+..|+.||+.||..||   +.+|||+||||+||||.+-  ..+||+|||.|+..
T Consensus       266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999886 89999999887778999999999999999999999   6999999999999999754  47999999999864


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHH------------
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAA------------  752 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~------------  752 (893)
                      ...-     .....+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+..+.++....--+.            
T Consensus       342 ~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  342 SQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             CCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            3211     13446779999999999999999999999999999999988887665544332111000            


Q ss_pred             ---Hhhcc--cch-----hh----------------hccccccC--------CCChHHHHHHHHHHHHccccCCCCCCCH
Q 036624          753 ---HCHKK--GIL-----EQ----------------IMDPYLKG--------KIAPECFKKFAETAMKCVSDQGIERPSM  798 (893)
Q Consensus       753 ---~~~~~--~~~-----~~----------------i~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm  798 (893)
                         .....  +..     .+                ..+.....        ......-..+.+++++||..||.+|+|.
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence               00000  000     00                00100000        0111233568999999999999999999


Q ss_pred             HHHHHHHHH
Q 036624          799 GDVLWNLEF  807 (893)
Q Consensus       799 ~evl~~L~~  807 (893)
                      .+.+++-..
T Consensus       497 ~qal~Hpfl  505 (586)
T KOG0667|consen  497 AQALNHPFL  505 (586)
T ss_pred             HHHhcCccc
Confidence            999987653

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.1e-34  Score=306.77  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=203.5

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC------hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS------EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      +|+..+.||+|+||.||+|....++..+++|.+....      ....+.+..|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4677889999999999999987777899999775422      2235678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC-ceeEecccccccCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW-VAKVSDFGLSKTGP  685 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~  685 (893)
                      |+||+++++|.+++.+..  ++++..+..++.|++.||.|||   +.+++|+||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            999999999999997543  5899999999999999999999   58999999999999998775 69999999987543


Q ss_pred             CCCC--ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          686 TLDH--THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       686 ~~~~--~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      ....  ........|+..|+|||.+.+..++.++||||+||+++||++|+.||.........   ....         ++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~---------~~  223 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIF---------KI  223 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHH---------HH
Confidence            2211  11122345888999999999889999999999999999999999998643221111   1110         11


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .........++.....+.+++.+|++.+|++||++.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            11111123344556778899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-34  Score=312.38  Aligned_cols=267  Identities=22%  Similarity=0.292  Sum_probs=203.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..++||+|+||.||+|....++..|++|+++..  .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3688889999999999999999887789999986542  23345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |++++.|..++...  ..+++..+..++.|++.||.|||   ..+++||||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99987776655433  34899999999999999999999   58999999999999999999999999999876443221


Q ss_pred             ccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHH-HHH--------hhcccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEW-AAH--------CHKKGI  759 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~-~~~--------~~~~~~  759 (893)
                       .......++..|+|||++.+. .++.++||||||+++|||++|++||......+....... ...        ......
T Consensus       156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence             122334578899999999888 889999999999999999999999865432211100000 000        000000


Q ss_pred             hh-----hhcccc-ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          760 LE-----QIMDPY-LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       760 ~~-----~i~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..     +..++. .....+..+..++.+++.+||..+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            00     000000 0001122346779999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.8e-34  Score=308.26  Aligned_cols=256  Identities=25%  Similarity=0.340  Sum_probs=205.8

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      +|+..+.||+|+||.||++.....++.+++|++.... ....+++.+|++++++++||||+++++++...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5677789999999999999998777899999876543 345677899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.... ..+++..+..++.|++.||+|||+  ..+++|+||||+||++++++.+||+|||++.......   
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---  155 (265)
T cd06605          82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---  155 (265)
T ss_pred             CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence            9999999987653 468999999999999999999993  2899999999999999999999999999986432111   


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                       .....++..|+|||++.+..++.++||||||+++|+|++|+.|+....... ....+.....         ..... ..
T Consensus       156 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~---------~~~~~-~~  223 (265)
T cd06605         156 -AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYI---------VNEPP-PR  223 (265)
T ss_pred             -hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHH---------hcCCC-CC
Confidence             111568889999999999999999999999999999999999996543211 1111211111         11110 11


Q ss_pred             CChH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          772 IAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       772 ~~~~-~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .+.. ....+.+++.+||..+|++||++.+++.+-.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  259 (265)
T cd06605         224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF  259 (265)
T ss_pred             CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence            1111 4567889999999999999999999987644

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-34  Score=311.78  Aligned_cols=266  Identities=20%  Similarity=0.294  Sum_probs=197.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..+.||+|+||.||+|..+..++.|++|...... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999998777899999865432 22234577899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +. ++|.+++.+... .+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++....... 
T Consensus        85 ~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          85 LD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             CC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            98 599998876543 6899999999999999999999   58999999999999999999999999999875322111 


Q ss_pred             cceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCcc-ccccHHHHHHHhhcccchhhhc----
Q 036624          691 HVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPK-EQVSLAEWAAHCHKKGILEQIM----  764 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~i~----  764 (893)
                       ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... +...................+.    
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             1122346789999999875 45899999999999999999999999654311 1110000000000000000000    


Q ss_pred             ----------cccccCCCC-hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          765 ----------DPYLKGKIA-PECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       765 ----------d~~l~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                                ...+..... ......+.+++.+||+.+|++||++.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                      000000000 0112567789999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.7e-34  Score=309.93  Aligned_cols=249  Identities=20%  Similarity=0.326  Sum_probs=202.3

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      |...++||+|++|.||++.....+..+++|+.........+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44567899999999999998777789999987655555567789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      ++|.+++..   .++++..+..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||++......  ....
T Consensus       101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~  172 (285)
T cd06648         101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRR  172 (285)
T ss_pred             CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccc
Confidence            999999876   34899999999999999999999   589999999999999999999999999987653321  1112


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||....+.      ........      ...+...  ..
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~------~~~~~~~--~~  238 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRD------NLPPKLK--NL  238 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHh------cCCCCCc--cc
Confidence            2345889999999999889999999999999999999999998643221      11111110      0011111  11


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..+...+.+++.+||+.+|++||++.+++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            2245678999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.7e-34  Score=316.30  Aligned_cols=197  Identities=24%  Similarity=0.371  Sum_probs=159.5

Q ss_pred             ceeeeecCcEEEEEEEEcC--cceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEee--cCEEEEEEeecc
Q 036624          537 ALLLGVGGFGKVYRGEIDG--ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE--NCEMILVYDYMA  612 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~--~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~  612 (893)
                      .++||+|+||+||+|+...  ....+|+|.+....  ....+.+|++++++++||||+++++++..  ....++|+||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            3589999999999999753  44789999876432  23457889999999999999999998854  456899999986


Q ss_pred             CCCHHHHHhhC-------CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE----CCCCceeEeccccc
Q 036624          613 YGTLREHLYKT-------QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL----DEKWVAKVSDFGLS  681 (893)
Q Consensus       613 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----d~~~~~kl~DFGla  681 (893)
                       ++|.+++...       ....+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5888877532       1235889999999999999999999   5899999999999999    45679999999999


Q ss_pred             ccCCCCCC-ccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCC
Q 036624          682 KTGPTLDH-THVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPT  739 (893)
Q Consensus       682 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~  739 (893)
                      +....... ........||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            76432211 112234568999999999976 45899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.3e-34  Score=306.12  Aligned_cols=251  Identities=23%  Similarity=0.414  Sum_probs=204.3

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|+..+.||+|+||.||+|..+..+..+++|.....  .....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            477888999999999999999887788999986542  223456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC-ceeEecccccccCCCCCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW-VAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~~~~~  689 (893)
                      +++++|.+++.......+++..+..++.|+++||.|||   ..+++|+||||+||++++++ .+||+|||.+......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--  155 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--  155 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--
Confidence            99999999998765556899999999999999999999   58999999999999999885 5699999998764321  


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      ........|++.|+|||++.+..++.++|||||||++|||++|+.|+....      ..++......         ... 
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~---------~~~-  219 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ---------GYF-  219 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc---------ccC-
Confidence            112223458899999999998899999999999999999999999986432      1222222111         111 


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ....+.....+.+++.+|++.+|++||++.|++++
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11223344678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=319.22  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=207.6

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      .|+++..||.|+||.||++..+......|.|.+...+....++|+-||+||+.+.||+||+|++.|.-.+.+++..|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            35567789999999999999988777778898888888899999999999999999999999999988899999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      ||-.+..+..-++ .|.+.++..+|.|++.||.|||   ..+|||||||+.|||+.-+|.++|+|||.+.....  ....
T Consensus       113 GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qk  186 (1187)
T KOG0579|consen  113 GGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQK  186 (1187)
T ss_pred             CchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh--HHhh
Confidence            9999988766543 5999999999999999999999   58999999999999999999999999999754322  2223


Q ss_pred             eeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          693 STVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                      ...+.|||+|||||+..     ..+|+.++||||||+.|.||..+.+|-....+-      ..         +..+....
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RV---------llKiaKSe  251 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RV---------LLKIAKSE  251 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HH---------HHHHhhcC
Confidence            44678999999999864     578999999999999999999999887543321      11         11111111


Q ss_pred             ccC-CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          768 LKG-KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       768 l~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ... --+......+.+++.+||.+||..||++.+++++-
T Consensus       252 PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp  290 (1187)
T KOG0579|consen  252 PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP  290 (1187)
T ss_pred             CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence            001 11335667899999999999999999999999654

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-34  Score=307.42  Aligned_cols=251  Identities=24%  Similarity=0.356  Sum_probs=201.4

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhcc---ccceeeEEEEEeecCEEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLR---HRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~  608 (893)
                      .|+..+.||+|+||.||+|.....+..+++|.+... .....+++.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            466778999999999999999877789999987543 3445677899999999997   999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++++|.+++...   .+++..++.++.|++.||.|||   +.+|+||||+|+||++++++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999988643   5899999999999999999999   5899999999999999999999999999987643322


Q ss_pred             CccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                        .......|+..|+|||++.++ .++.++|||||||++|||++|+.||.......      +...      +.....+.
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~------~~~~~~~~  221 (277)
T cd06917         156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMML------IPKSKPPR  221 (277)
T ss_pred             --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhc------cccCCCCC
Confidence              112234588999999998754 57899999999999999999999996532211      1110      00001111


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +..   ......+.+++.+||+.+|++||++.+++++-.
T Consensus       222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~  257 (277)
T cd06917         222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLKSKW  257 (277)
T ss_pred             CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence            111   114567889999999999999999999987644

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.1e-34  Score=311.64  Aligned_cols=253  Identities=22%  Similarity=0.305  Sum_probs=205.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|...+.||+|+||.||++.....+..+++|..........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888889999999999999987767889999876555555677899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.+.   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++........  
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            999999998653   3789999999999999999999   58999999999999999999999999998865432211  


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ......|++.|+|||++....++.++|||||||++||+++|+.||..........      ...        ..+.....
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~--------~~~~~~~~  236 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIA--------TNGTPELQ  236 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehh--------cCCCCCCC
Confidence            1223458889999999998889999999999999999999999996543321110      000        00000011


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ........+.+++.+||+.+|++||++.+++.+-.
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~  271 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            12234456889999999999999999999997754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.4e-34  Score=314.82  Aligned_cols=250  Identities=20%  Similarity=0.301  Sum_probs=200.8

Q ss_pred             ccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCC
Q 036624          535 DEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYG  614 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  614 (893)
                      +....||+|+||.||++.....+..|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            33457999999999999987777899999876544455667889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcccee
Q 036624          615 TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST  694 (893)
Q Consensus       615 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~  694 (893)
                      +|..++..   ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++......  ....
T Consensus       104 ~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  175 (297)
T cd06659         104 ALTDIVSQ---TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK  175 (297)
T ss_pred             CHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence            99998754   24899999999999999999999   5899999999999999999999999999987533211  1123


Q ss_pred             eeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCCh
Q 036624          695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP  774 (893)
Q Consensus       695 ~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~  774 (893)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||....+....      .... .     ...+..  ....
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~-~-----~~~~~~--~~~~  241 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------KRLR-D-----SPPPKL--KNAH  241 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHh-c-----cCCCCc--cccC
Confidence            356899999999999989999999999999999999999999654322110      1100 0     000000  1112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       775 ~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .....+.+++.+||+.+|++||++.+++++-.
T Consensus       242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~  273 (297)
T cd06659         242 KISPVLRDFLERMLTREPQERATAQELLDHPF  273 (297)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence            23456788999999999999999999998644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2e-34  Score=313.06  Aligned_cols=264  Identities=20%  Similarity=0.298  Sum_probs=200.2

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|+..+.||+|+||.||+|+....+..|++|++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5788899999999999999998777899999876432  22345788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +. ++|..++.......+++..+..++.|+++||+|||   ..+++||||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 68999987766667999999999999999999999   58999999999999999999999999999875432111 


Q ss_pred             cceeeeccCcCccChHhhhhcC-CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc-cc----hhhh-
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK-GI----LEQI-  763 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~----~~~i-  763 (893)
                       ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||.......  .+.......... ..    ...+ 
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHH
Confidence             112234688999999887644 6889999999999999999999986543211  111111100000 00    0000 


Q ss_pred             -----ccccccC---CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          764 -----MDPYLKG---KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       764 -----~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                           +......   ...+.....+.+++.+||+.||++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                 0000000   0011223557789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.5e-34  Score=312.02  Aligned_cols=250  Identities=27%  Similarity=0.365  Sum_probs=200.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ..|+..+.||+|+||+||+|.....+..|++|.....   .....+++.+|++++++++||||+++.++|...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4577788999999999999999877789999976532   2344567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+. |+|.+.+.... ..+++..+..++.|++.||.|||   ..+|+||||+|+||++++++.+||+|||++...... 
T Consensus        95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9997 67777765433 35899999999999999999999   589999999999999999999999999998754321 


Q ss_pred             CccceeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                           ....++..|+|||++.   ...++.++||||||+++|||++|+.|+.......      ........        
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~~~~--------  229 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN--------  229 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHHhcC--------
Confidence                 2245788999999874   4668899999999999999999999986432211      01110000        


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                       .........+...+.+++.+||+.+|++||++.+|+.+...
T Consensus       230 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  270 (307)
T cd06607         230 -DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV  270 (307)
T ss_pred             -CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence             00011122356678999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.8e-34  Score=308.52  Aligned_cols=258  Identities=23%  Similarity=0.342  Sum_probs=197.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHH-HhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEM-LSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..+.||+|+||.||++....++..||+|+.+... ......+..|+.+ ++.++||||+++++++......++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999998888999999876432 2334455666665 566789999999999999999999999


Q ss_pred             eccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          610 YMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       610 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |++ |+|.+++...  ....+++..++.++.|++.||+|||+  ..+++||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 7888877643  33468999999999999999999994  238999999999999999999999999998754221


Q ss_pred             CCccceeeeccCcCccChHhhhh----cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                         ...+...|+..|+|||.+.+    ..++.++|+|||||++|||++|+.|+......    ..... ....      -
T Consensus       158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~-~~~~------~  223 (283)
T cd06617         158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQLK-QVVE------E  223 (283)
T ss_pred             ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHHHH-HHHh------c
Confidence               11223458889999999864    45688999999999999999999998642211    11100 0000      0


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ..+.+   .....+..+.+++.+||..+|++||++.+++++-....
T Consensus       224 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  266 (283)
T cd06617         224 PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL  266 (283)
T ss_pred             CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence            01111   11123567889999999999999999999997655433

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.1e-34  Score=311.56  Aligned_cols=263  Identities=22%  Similarity=0.271  Sum_probs=199.7

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh-----hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-----QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      +|+..+.||+|+||.||+|.....++.|++|++.....     .....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            46777899999999999999887778999998764322     2345678899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+ +|+|.+++.... ..+++..+..++.|+++||.|||   ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 899999997654 36999999999999999999999   589999999999999999999999999998764332


Q ss_pred             CCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc--c------c
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK--K------G  758 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~------~  758 (893)
                      ..  ......+++.|+|||.+.+ ..++.++|||||||++|||++|.++|......+.  +.........  .      .
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhhcc
Confidence            11  1122346788999999865 4678999999999999999999888765432111  1111000000  0      0


Q ss_pred             chhhhccccccC-----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          759 ILEQIMDPYLKG-----KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       759 ~~~~i~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .+..........     .........+.+++.+||+.+|++||++.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            000000000000     0112335678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.1e-34  Score=303.98  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=202.0

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh--hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE--QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|...+.||+|+||.||+|.....+..+++|.+.....  ...+.+..|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            46778899999999999999887778899998664433  3678899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++....  .+++..+..|+.|+++||.|||   +.+|+|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            99999999987543  4889999999999999999999   589999999999999999999999999998764332211


Q ss_pred             cc--eeeeccCcCccChHhhhhcC---CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          691 HV--STVVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       691 ~~--~~~~~gt~~y~APE~~~~~~---~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ..  .....++..|+|||++.+..   .+.++||||||+++||+++|+.||........     ....... +     ..
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~~~~~~-~-----~~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMFHVGA-G-----HK  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HHHHHhc-C-----CC
Confidence            11  11345788999999998766   89999999999999999999999964432110     1100000 0     01


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      +.+.  ........+.+++.+||+.+|++||++.+++.+
T Consensus       225 ~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         225 PPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            1111  011235667899999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-34  Score=320.63  Aligned_cols=242  Identities=24%  Similarity=0.394  Sum_probs=195.2

Q ss_pred             eeeecCcEEEEEEEEcCcceEEEEEeCC----CCChhhHHHHHHHHHHHhhccccceeeEEEEEeecC--EEEEEEeecc
Q 036624          539 LLGVGGFGKVYRGEIDGATTKVAIKRGN----PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC--EMILVYDYMA  612 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~~~~VavK~~~----~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~~~  612 (893)
                      +||+|+|-+||||.+...+..||--.++    .......+.|..|+++|+.|+|+||++++.++.+..  ...+|.|.|.
T Consensus        47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T  126 (632)
T KOG0584|consen   47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT  126 (632)
T ss_pred             hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence            7999999999999998877777743211    124455688999999999999999999999987654  4789999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC-CceeEecccccccCCCCCCcc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~~~~~~~~~  691 (893)
                      .|+|..++.+.++  ++.+.+..+|+||++||.|||++ .++|||||||.+||+|+.+ |.|||+|+|||.....   .+
T Consensus       127 SGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~---s~  200 (632)
T KOG0584|consen  127 SGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK---SH  200 (632)
T ss_pred             CCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc---cc
Confidence            9999999987664  88899999999999999999974 6899999999999999754 8999999999987532   22


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc---cchhhhccccc
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK---GILEQIMDPYL  768 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~i~d~~l  768 (893)
                      . ..+.|||.|||||+.. ..|++..||||||++++||+|+..|+..     ..+-+...+.....   ..+..+-    
T Consensus       201 a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~n~AQIYKKV~SGiKP~sl~kV~----  269 (632)
T KOG0584|consen  201 A-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CTNPAQIYKKVTSGIKPAALSKVK----  269 (632)
T ss_pred             c-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hCCHHHHHHHHHcCCCHHHhhccC----
Confidence            2 2378999999999998 8899999999999999999999999953     33334433332211   1111121    


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                              ..++.++|.+||.. .++|||+.|+|.+--
T Consensus       270 --------dPevr~fIekCl~~-~~~R~sa~eLL~d~F  298 (632)
T KOG0584|consen  270 --------DPEVREFIEKCLAT-KSERLSAKELLKDPF  298 (632)
T ss_pred             --------CHHHHHHHHHHhcC-chhccCHHHHhhChh
Confidence                    13577899999999 999999999997644

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.4e-33  Score=311.73  Aligned_cols=250  Identities=27%  Similarity=0.384  Sum_probs=200.0

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      |+..+.||+|+||.||+++...++..+++|++...   .......+..|++++++++|+|++++++++.+....++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            66777999999999999998877789999987532   233456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +. |+|.+.+... ..+++|.++..++.|++.||.|||   +.+|+||||+|+||+++.++.+||+|||++.....    
T Consensus       107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----  177 (317)
T cd06635         107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----  177 (317)
T ss_pred             CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence            97 5887777543 345899999999999999999999   58999999999999999999999999999875322    


Q ss_pred             cceeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          691 HVSTVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                        .....|++.|+|||++.   .+.++.++|||||||++|||++|+.|+........  +    ..         +....
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~----~~---------~~~~~  240 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----YH---------IAQNE  240 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--H----HH---------HHhcc
Confidence              12345888999999984   46789999999999999999999999864321110  0    11         11111


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ............+.+++.+||+.+|.+||++.++++++....
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            111112234567899999999999999999999998876544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.6e-34  Score=310.21  Aligned_cols=247  Identities=24%  Similarity=0.356  Sum_probs=203.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|...+.||+|+||.||++.....++.+|+|.....   .....+.+.+|++++++++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            4678889999999999999999887789999986532   2234567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||   +.+++||||+|+|||+++++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            9999999999997653  5899999999999999999999   589999999999999999999999999998764332 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                          .....|++.|+|||.+.+...+.++||||||+++|||++|+.||.......     .          ...+.... 
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~----------~~~~~~~~-  214 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-----I----------YEKILEGK-  214 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-----H----------HHHHhcCC-
Confidence                233468899999999998889999999999999999999999986443110     0          00111111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNL  805 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L  805 (893)
                       ..++......+.+++.+||+.+|.+|+     ++.|++++-
T Consensus       215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~  255 (290)
T cd05580         215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP  255 (290)
T ss_pred             -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence             112233356788999999999999999     777777653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-33  Score=307.11  Aligned_cols=258  Identities=23%  Similarity=0.342  Sum_probs=208.5

Q ss_pred             HHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       529 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ..+++|+..+.||+|+||.||+|.+...+..+++|.+..... ..+.+.+|++++++++|+|++++++++......++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            345677888899999999999999986678899998775444 5677899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++++|.+++.... ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.+||+|||++.......
T Consensus        95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999999998654 36999999999999999999999   5999999999999999999999999999876533211


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                        .......++..|++||++.+..++.++|||||||++|||++|+.|+....+...      ....... .    ..   
T Consensus       171 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~~~-~----~~---  234 (286)
T cd06614         171 --SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLITTK-G----IP---  234 (286)
T ss_pred             --hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc-C----CC---
Confidence              112234578899999999988999999999999999999999999864332111      0000000 0    00   


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .......+...+.+++.+|++.+|.+||++.+++++...
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  273 (286)
T cd06614         235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL  273 (286)
T ss_pred             CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHh
Confidence            001112245678899999999999999999999976554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-33  Score=308.23  Aligned_cols=268  Identities=21%  Similarity=0.253  Sum_probs=198.6

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++.+|...+.||+|+||.||+|.....+..+++|+..... ......+.+|+.++++++|+||+++.+++......++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578899999999999999999988777899999875432 223346788999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+. ++|.+.+.... ..+.+..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9996 77877765443 35788999999999999999999   5899999999999999999999999999987533221


Q ss_pred             CccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh-hccc--------
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC-HKKG--------  758 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-~~~~--------  758 (893)
                      ..  .....+++.|+|||++.+. .++.++|||||||++|||++|+.||.............|.... ....        
T Consensus       158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         158 QT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             CC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence            11  1223478899999998754 5788999999999999999999999754332111111110000 0000        


Q ss_pred             --chhhhccccccCCC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          759 --ILEQIMDPYLKGKI-----APECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       759 --~~~~i~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                        ...+..........     .......+.+++.+|++.+|.+|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence              00000000000000     00113567889999999999999999998854

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.9e-34  Score=313.54  Aligned_cols=197  Identities=23%  Similarity=0.372  Sum_probs=159.1

Q ss_pred             ceeeeecCcEEEEEEEEcC--cceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEe--ecCEEEEEEeecc
Q 036624          537 ALLLGVGGFGKVYRGEIDG--ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE--ENCEMILVYDYMA  612 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~--~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~~~  612 (893)
                      ..+||+|+||+||+|+..+  ....+|+|.+....  ....+.+|++++++++||||+++++++.  .....++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3589999999999999754  34679999876432  2345789999999999999999999884  3567899999987


Q ss_pred             CCCHHHHHhhC-------CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE----CCCCceeEeccccc
Q 036624          613 YGTLREHLYKT-------QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL----DEKWVAKVSDFGLS  681 (893)
Q Consensus       613 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----d~~~~~kl~DFGla  681 (893)
                       ++|.+++...       ....+++..+..++.|++.||.|||   +.+|+||||||+|||+    ++++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             5777776422       1235889999999999999999999   5899999999999999    56679999999999


Q ss_pred             ccCCCCCC-ccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCC
Q 036624          682 KTGPTLDH-THVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPT  739 (893)
Q Consensus       682 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~  739 (893)
                      +....... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            86432211 111233468999999999976 45899999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.8e-33  Score=299.86  Aligned_cols=253  Identities=25%  Similarity=0.380  Sum_probs=207.7

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEMILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~  608 (893)
                      +|...+.||+|++|.||+|.....+..|++|......  ....+.+.+|+.++++++|+||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999998777899999876543  35677899999999999999999999999988  8999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++++|.+++....  .+++..+..++.|+++||+|||   +.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999997654  6999999999999999999999   5899999999999999999999999999987654322


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      .........++..|+|||.+.+...+.++||||||+++++|++|+.||......     .....         .+.....
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~---------~~~~~~~  221 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALY---------KIGSSGE  221 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHH---------hccccCC
Confidence            211123456888999999999888999999999999999999999999754411     01111         1111111


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ....+......+.+++.+|++.+|++||++.+++++
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            223344456789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.8e-34  Score=308.90  Aligned_cols=264  Identities=22%  Similarity=0.271  Sum_probs=202.8

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|+..+.||+|+||.||+|.....+..|++|++....  ......+.+|+.++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677889999999999999998777899999866433  33456799999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      + +++|.+++.... ..+++.++..++.|+++||+|||   ..+++|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 999999987554 46999999999999999999999   58999999999999999999999999999886433221 


Q ss_pred             cceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc-----------
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG-----------  758 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----------  758 (893)
                      .......|+..|+|||++.+. .++.++|||||||+++||++|++++.......   ...+........           
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCc
Confidence            112234588999999998654 46899999999999999999988775433211   111111100000           


Q ss_pred             -chhhhcccccc----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          759 -ILEQIMDPYLK----GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       759 -~~~~i~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                       ....+..+...    ....++....+.+++.+||+.+|++||++.+++.+-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence             00000000000    011123457889999999999999999999998763

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=306.36  Aligned_cols=246  Identities=21%  Similarity=0.315  Sum_probs=208.7

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      |+..+.||+|.|..|-++++--++..||||++....  ......+..|++-|+.++|||||+|+.+......+|||+|+=
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            455668999999999999988888999999876543  334456889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC-CCCceeEecccccccCCCCCCc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      .+|+|+++|.+... .+.+....+.+.||..|+.|+|   +..+|||||||+|+.+- .-|-+||.|||++-...   ..
T Consensus       100 D~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~---PG  172 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ---PG  172 (864)
T ss_pred             CCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC---Cc
Confidence            99999999987654 3899999999999999999999   79999999999998775 55899999999986432   23


Q ss_pred             cceeeeccCcCccChHhhhhcCCC-CcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      ...+..||.+.|-|||++.+..|+ .+.||||||||||.|+||++||+.....+               .+..|+|=.  
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDCK--  235 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDCK--  235 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhccc--
Confidence            345668999999999999998887 47999999999999999999998654433               344555532  


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLW  803 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~  803 (893)
                      ...+.....++.+||..||..||.+|.+..||+.
T Consensus       236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            3456667788999999999999999999999884

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.5e-33  Score=297.44  Aligned_cols=251  Identities=26%  Similarity=0.411  Sum_probs=205.5

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      +|+..+.||+|++|.||++.....+..+++|+.........+.+.+|++++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            36677899999999999999987778899999876655567889999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      +++|.+++.... ..+++..+..++.|+++||.|||   ..+++||||+|+||++++++.+||+|||.+........   
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            999999987653 46899999999999999999999   58999999999999999999999999999876443221   


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCC
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI  772 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  772 (893)
                      .....++..|++||++....++.++||||||+++++|++|+.|+........      ...... .....+       ..
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~~~-------~~  219 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LFKIAT-NGPPGL-------RN  219 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHh-cCCCCc-------Cc
Confidence            2345688999999999988899999999999999999999999864422111      100000 000000       01


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          773 APECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       773 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .......+.+++.+||+.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11125678999999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6e-34  Score=309.98  Aligned_cols=257  Identities=23%  Similarity=0.305  Sum_probs=199.1

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|...++||+|+||.||++.....+..+|+|...... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4455668999999999999998888999999876432 345567899999999996 99999999999999999999999


Q ss_pred             ccCCCHHH---HHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          611 MAYGTLRE---HLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       611 ~~~gsL~~---~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      +. ++|.+   .+.......+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            87 45544   3333344569999999999999999999995  458999999999999999999999999998753221


Q ss_pred             CCccceeeeccCcCccChHhhhhc---CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~---~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      .   ......|+..|+|||++.+.   .++.++|||||||++|||++|+.||.....     ..+-......      ..
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~------~~  227 (288)
T cd06616         162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK------GD  227 (288)
T ss_pred             C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC------CC
Confidence            1   11223588899999999876   689999999999999999999999864321     1111111100      01


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .+.+.......+...+.+++.+||+.+|++||++.+|+.+-.
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~  269 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF  269 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            122222222345677899999999999999999999997654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.5e-34  Score=309.53  Aligned_cols=263  Identities=19%  Similarity=0.263  Sum_probs=197.3

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|+..+.||+|+||.||+|.....+..+++|++...  .......+.+|++++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            467788999999999999999877789999986542  222335678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      ++ ++|.+++.... ..+++..++.++.|+++||.|||   ..+|+||||||+||+++.++.+||+|||+++......  
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--  153 (284)
T cd07839          81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--  153 (284)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence            97 68888876543 35899999999999999999999   5899999999999999999999999999987532211  


Q ss_pred             cceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc---c---chhhh
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK---G---ILEQI  763 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~---~~~~i  763 (893)
                      .......+++.|+|||++.+. .++.++|||||||++|||++|+.|+........ .+. ........   .   .+.++
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLK-RIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHH-HHHHHhCCCChHHhHHhhhc
Confidence            111223478899999998765 478999999999999999999988643322111 010 00000000   0   00011


Q ss_pred             ccccc----c-----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          764 MDPYL----K-----GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       764 ~d~~l----~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .+...    .     ....+.....+.+++.+||+.+|.+|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            11000    0     01112345678899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-33  Score=307.83  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=196.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCE-----
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCE-----  603 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~-----  603 (893)
                      ++|+..+.||+|+||.||+|.....+..||+|......  ......+.+|+.++++++ |+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999998878899999765432  223457888999999995 6999999999877655     


Q ss_pred             EEEEEeeccCCCHHHHHhhCC---CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-CCceeEeccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQ---KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFG  679 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFG  679 (893)
                      .++||||+++ +|.+++....   ...+++..++.++.|+++||.|||   ..+|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 8988886542   246899999999999999999999   589999999999999998 8899999999


Q ss_pred             ccccCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc--
Q 036624          680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK--  756 (893)
Q Consensus       680 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--  756 (893)
                      +++.......  ......+++.|+|||++.+ ..++.++|||||||++|||++|..||........  +.........  
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPT  232 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence            9875322111  1122346789999998865 4579999999999999999999999865332111  0000000000  


Q ss_pred             ccchhhhc---c----cc----ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          757 KGILEQIM---D----PY----LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       757 ~~~~~~i~---d----~~----l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ......+.   +    +.    ......+.....+.+++.+||+.+|.+||++.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000000   0    00    0000112345668899999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.8e-34  Score=304.78  Aligned_cols=248  Identities=25%  Similarity=0.309  Sum_probs=204.0

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      +|+..++||.|+||.||+|.....+..+++|.....   .....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            477889999999999999999877789999987542   22456789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+.+++|..++...  .++++..+..++.|+++||.|||   ..+++|+||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999999765  46899999999999999999999   5899999999999999999999999999987643321 


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                        ......|+..|+|||++.+..++.++|+||||+++|+|++|+.|+.......    .++.......          ..
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~  218 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------AD  218 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------cc
Confidence              1233458889999999998889999999999999999999999997554321    1111111110          11


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSM--GDVL  802 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm--~evl  802 (893)
                      ...++..+..+.+++.+||+.+|.+||+.  .|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            22334455788899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.9e-33  Score=301.52  Aligned_cols=246  Identities=23%  Similarity=0.272  Sum_probs=199.8

Q ss_pred             eeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCH
Q 036624          540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL  616 (893)
Q Consensus       540 LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  616 (893)
                      ||.|+||.||++.....+..+++|.....   .....+.+.+|+.++++++|+||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            68999999999999877789999986542   223456799999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeee
Q 036624          617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV  696 (893)
Q Consensus       617 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  696 (893)
                      .+++.+..  .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++......   .....
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          81 WTILRDRG--LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            99997653  4899999999999999999999   5899999999999999999999999999988653321   12234


Q ss_pred             ccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHH
Q 036624          697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC  776 (893)
Q Consensus       697 ~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  776 (893)
                      .++..|++||.+.+..++.++|+||||+++|||++|..|+.......    .+..         ..+.+.......+...
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~---------~~~~~~~~~~~~~~~~  219 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIY---------NDILKGNGKLEFPNYI  219 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHH---------HHHhccCCCCCCCccc
Confidence            58889999999998889999999999999999999999997543211    1111         1122111122333444


Q ss_pred             HHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 036624          777 FKKFAETAMKCVSDQGIERPS-----MGDVLWNLE  806 (893)
Q Consensus       777 ~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L~  806 (893)
                      ...+.+++.+||+.+|++||+     +.|++++-.
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~  254 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW  254 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence            678999999999999999999     667665433

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-34  Score=316.11  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=199.3

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeec-----CEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN-----CEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  604 (893)
                      +++|+..++||+|+||.||+|.....+..||+|.+.... ......+..|+.++++++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999998878899999876432 33456688999999999999999999987544     357


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++|+||+. ++|...+..   ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            99999997 588877743   34899999999999999999999   589999999999999999999999999998754


Q ss_pred             CCCC-CccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc---cc
Q 036624          685 PTLD-HTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK---GI  759 (893)
Q Consensus       685 ~~~~-~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~  759 (893)
                      .... .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........  +..+ ......   ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~--~~~~-~~~~~~~~~~~  233 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ--LNLI-LGVLGTPSQED  233 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HHHcCCCCHHH
Confidence            3211 1111223468899999998754 5689999999999999999999999965432111  1111 000000   01


Q ss_pred             hhhhccccc---------cCC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          760 LEQIMDPYL---------KGK-----IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       760 ~~~i~d~~l---------~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +..+.+...         ...     ..+.....+.+++.+||+.+|++||++.|++++-.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~  294 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY  294 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            111111000         000     01123456889999999999999999999998743

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.4e-33  Score=303.21  Aligned_cols=265  Identities=21%  Similarity=0.307  Sum_probs=200.0

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh-hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      +|+..++||+|++|.||+|+...++..||+|++..... .....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            57888999999999999999987778999998765432 23456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCC-CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          612 AYGTLREHLYKTQ-KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       612 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      + ++|.+++.... ...+++..+..++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++......  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            8 58888886543 346899999999999999999999   5889999999999999999999999999987532211  


Q ss_pred             cceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCcccccc-HHHHHHHhhcccchhhhcc-cc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS-LAEWAAHCHKKGILEQIMD-PY  767 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~i~d-~~  767 (893)
                      .......++..|++||++.+. .++.++|||||||++|||++|+.||......+... +.+... .........+.+ +.
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG-TPTESTWPGISQLPE  233 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCChhhHHHHhcCch
Confidence            111223468899999998664 57899999999999999999999997544322110 000000 000000000000 00


Q ss_pred             cc-----------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          768 LK-----------GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       768 l~-----------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      +.           ....+.....+.+++.+|++.+|.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00           01112335668899999999999999999999854

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-33  Score=298.42  Aligned_cols=252  Identities=24%  Similarity=0.336  Sum_probs=200.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-----ChhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-----SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~  604 (893)
                      .+|+..+.||+|+||.||+|.....+..+++|.....     .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788899999999999999999887789999975321     234556889999999999999999999998664  468


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++|+||+++++|.+++....  .+++.....++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            89999999999999987543  4889999999999999999999   589999999999999999999999999998754


Q ss_pred             CCCC-CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          685 PTLD-HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       685 ~~~~-~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      .... .........++..|+|||++.+..++.++|||||||++|||++|+.||........               +.++
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~  221 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA---------------IFKI  221 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH---------------HHHH
Confidence            2211 11112234588999999999998899999999999999999999999864321110               0111


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ........++......+.+++.+|++ +|..||+..+++.+
T Consensus       222 ~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         222 ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            11111123344556778999999999 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-33  Score=306.77  Aligned_cols=266  Identities=21%  Similarity=0.300  Sum_probs=199.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV  607 (893)
                      ++|+..+.||+|+||.||+|.....++.+++|.++...  ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46777889999999999999998777889999875432  22234577899999999999999999998877  889999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      +||+. ++|.+++.... ..+++..++.++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++.....
T Consensus        85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            99998 59999886543 36899999999999999999999   588999999999999999999999999998764332


Q ss_pred             CCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCcccccc-H---------HHHHHHh--
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS-L---------AEWAAHC--  754 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l---------~~~~~~~--  754 (893)
                      ..  ......+++.|+|||.+.+. .++.++|||||||++|||++|++||.......... +         ..|....  
T Consensus       160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            11  11233478899999998754 46899999999999999999999997543221100 0         0010000  


Q ss_pred             --hcccchhhhccccccCCCChH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          755 --HKKGILEQIMDPYLKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       755 --~~~~~~~~i~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                        .............+...++.. ....+.+++.+||+.+|++||++.|++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence              000000001111111122222 35668899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=333.00  Aligned_cols=259  Identities=27%  Similarity=0.454  Sum_probs=207.2

Q ss_pred             CCccceeeeecCcEEEEEEEEcC-------cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDG-------ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCE  603 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~  603 (893)
                      ++...+.||+|.||.|++|...+       ....||||.++.. ...+.+.+..|+++|+.+ +|+||+.++|+|..++.
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            33445599999999999998642       1467999987753 445678899999999999 69999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCC------------C--CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC
Q 036624          604 MILVYDYMAYGTLREHLYKTQ------------K--PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE  669 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~  669 (893)
                      .++|.||+.+|+|.++|+..+            .  ..|...+.+.++.|||.||+||+   ..++|||||.++|||+.+
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITK  453 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecC
Confidence            999999999999999998765            0  13889999999999999999999   588999999999999999


Q ss_pred             CCceeEecccccccCCCCCCccce-eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccH
Q 036624          670 KWVAKVSDFGLSKTGPTLDHTHVS-TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSL  747 (893)
Q Consensus       670 ~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  747 (893)
                      +..+||+|||++|.....+..... ....-...|||||.+....|+.|+|||||||+||||++ |..|+.+.....  .+
T Consensus       454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~--~l  531 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE--EL  531 (609)
T ss_pred             CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH--HH
Confidence            999999999999975543333211 11113557999999999999999999999999999998 666664321111  11


Q ss_pred             HHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          748 AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       748 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      .++    .++|         .+-+.+..|..++.++++.||+.+|++||+..++++.++..+
T Consensus       532 ~~~----l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  532 LEF----LKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             HHH----HhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            111    1111         122345667889999999999999999999999999999854

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.1e-33  Score=305.41  Aligned_cols=265  Identities=19%  Similarity=0.276  Sum_probs=198.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..+.||+|++|+||+|.....++.|++|+.....  ....+.+.+|++++++++|+||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999998777899999865432  2334678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-CCceeEecccccccCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~~~~  688 (893)
                      |++ ++|.+++.......+++..+..++.|++.||+|||   +.+++||||||+||++++ ++.+||+|||+++......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 68888886655545788899999999999999999   589999999999999985 5679999999987543211


Q ss_pred             CccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc---c-----
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG---I-----  759 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~-----  759 (893)
                        .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+..  .... ......   .     
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~  232 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL--FKIF-RILGTPNEETWPGVT  232 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-HHhCCCChhhccccc
Confidence              11122346889999999876 45789999999999999999999999654322111  0000 000000   0     


Q ss_pred             -hhhhcc--ccccC----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          760 -LEQIMD--PYLKG----KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       760 -~~~i~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                       +.+...  +....    ...+.....+.+++.+|++.+|++||++.+++++-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~  285 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE  285 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence             000000  00000    01122345688999999999999999999999753

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.8e-33  Score=296.63  Aligned_cols=251  Identities=26%  Similarity=0.408  Sum_probs=206.9

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|+..+.||+|+||.||++....++..+++|+.....  ....+++.+|++++++++|+|++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999998777899999876542  35667889999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCC--CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          611 MAYGTLREHLYKTQ--KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       611 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      +++++|.+++....  ...+++..+..++.+++.||.|||   +.+++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999997653  456999999999999999999999   5799999999999999999999999999987643321


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                        .......|++.|+|||.+.+..++.++||||||+++++|++|+.|+.....      .+.......         .. 
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~---------~~-  219 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILK---------GQ-  219 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhc---------CC-
Confidence              122334688999999999999999999999999999999999999864431      111111111         10 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ....+..+...+.+++.+||..+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            112233455778899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-33  Score=314.57  Aligned_cols=268  Identities=23%  Similarity=0.306  Sum_probs=200.4

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhc-cccceeeEEEEEeec--CEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEEN--CEM  604 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~--~~~  604 (893)
                      ..++|+..+.||+|+||.||+|....++..+++|++..  ........+.+|+.+++++ +|+||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            34678888899999999999999887778899997643  2334456678899999999 999999999998643  468


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++||||++ ++|..++...   .++|..+..++.|++.||+|||   ..+|+||||||+||++++++.+||+|||+++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999997 6999888654   5899999999999999999999   589999999999999999999999999998764


Q ss_pred             CCCCCc---cceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh-----
Q 036624          685 PTLDHT---HVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH-----  755 (893)
Q Consensus       685 ~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-----  755 (893)
                      ......   .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||...................     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            332211   12233558899999998754 567899999999999999999999996543322110000000000     


Q ss_pred             ---cccchhhhccccc------cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          756 ---KKGILEQIMDPYL------KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       756 ---~~~~~~~i~d~~l------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                         ......++++...      .....+.+...+.+++.+||+.+|++||++.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence               0000011111000      001112245678999999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.8e-33  Score=304.87  Aligned_cols=259  Identities=16%  Similarity=0.187  Sum_probs=186.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCc---ceEEEEEeCCCCChhhH-----------HHHHHHHHHHhhccccceeeEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPLSEQGV-----------HEFQTEIEMLSKLRHRHLVSLIGY  597 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~~~~~~-----------~~f~~E~~~l~~l~H~niv~l~g~  597 (893)
                      ++|...++||+|+||+||+|...+.   ...+++|..........           .....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5788899999999999999998766   45677775332221110           112233445566789999999998


Q ss_pred             EeecC----EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCce
Q 036624          598 CEENC----EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA  673 (893)
Q Consensus       598 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~  673 (893)
                      +....    ..++++|++. .++.+.+...  ...++..+..|+.|+++||+|||   +.+|+||||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            76543    3467778764 4666665433  23578889999999999999999   5899999999999999999999


Q ss_pred             eEecccccccCCCCCC-----ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHH
Q 036624          674 KVSDFGLSKTGPTLDH-----THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA  748 (893)
Q Consensus       674 kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  748 (893)
                      ||+|||+++.......     ........||+.|+|||++.+..++.++|||||||+||||++|+.||.........  .
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~--~  243 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL--I  243 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH--H
Confidence            9999999875422111     11122346999999999999999999999999999999999999999754221111  0


Q ss_pred             HHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          749 EWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       749 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      .   . ...+.+..+..+.+.   .+.++..+.+++..|++.+|++||++.++++.|
T Consensus       244 ~---~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 H---A-AKCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             H---H-hHHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0   0 001111222211111   223457788999999999999999999999876

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-33  Score=306.28  Aligned_cols=253  Identities=22%  Similarity=0.336  Sum_probs=203.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCC--CCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~--~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ..|++.++||+||.+.||++...+. ..+|+|+..  ..+.+....|..|+..|.+|+ |.+||+|++|-..++.+||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3477788999999999999987765 567777533  346677788999999999996 999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||= .-+|..+|.+.......| .+..+..|++.++.++|   +.+|||.||||.|+|+-. |.+||+|||+|.......
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence            964 579999998876666667 67788999999999999   699999999999999975 589999999998776654


Q ss_pred             CccceeeeccCcCccChHhhhhc-----------CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  757 (893)
                      ..-.....+||+.||+||.+...           +.+.++||||+|||||+|+.|++||..-.       ..|+      
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~a------  580 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIA------  580 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHH------
Confidence            55556678899999999998642           25689999999999999999999995321       1222      


Q ss_pred             cchhhhccccccCCCChH-HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          758 GILEQIMDPYLKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                       .+..|.||...-+++.- ...++.+++..||+.||++||+..++|++-
T Consensus       581 -Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp  628 (677)
T KOG0596|consen  581 -KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP  628 (677)
T ss_pred             -HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence             35566777432222221 112389999999999999999999999764

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=305.78  Aligned_cols=263  Identities=21%  Similarity=0.267  Sum_probs=198.9

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      |+..+.||.|++|.||+|.....+..|++|++....  ......+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            556789999999999999988777899999875432  223457889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      + ++|.+++.......+++..++.++.|+++||+|||   +.+++||||+|+||++++++.+||+|||+++.......  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 79999987665456999999999999999999999   58999999999999999999999999999875322111  


Q ss_pred             ceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc--------chhh
Q 036624          692 VSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG--------ILEQ  762 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------~~~~  762 (893)
                      ......++..|+|||++.+. .++.++|||||||++|||++|+.||.......  .+.+.........        .+.+
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchh
Confidence            11223468899999988654 57899999999999999999999996543211  1111111100000        0000


Q ss_pred             hccc--c----ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          763 IMDP--Y----LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       763 i~d~--~----l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ....  .    ......+.....+.+++.+|++.+|++||++.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000  0    0001112233568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-33  Score=307.09  Aligned_cols=268  Identities=21%  Similarity=0.271  Sum_probs=197.9

Q ss_pred             CCccceeeeecCcEEEEEEEEcC--cceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDG--ATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEMI  605 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~--~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  605 (893)
                      .|+..++||+|+||.||+|....  .+..+|+|.+....   ....+.+.+|+.++++++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            36778899999999999999977  67899999876532   33346678899999999999999999999888  8899


Q ss_pred             EEEeeccCCCHHHHHhhC---CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC----CCceeEecc
Q 036624          606 LVYDYMAYGTLREHLYKT---QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE----KWVAKVSDF  678 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~----~~~~kl~DF  678 (893)
                      +||||++ ++|.+.+...   ....+++..+..++.|++.||+|||   ..+|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999998 4677766432   2236899999999999999999999   588999999999999999    999999999


Q ss_pred             cccccCCCCCC-ccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCcccc-------ccHHH
Q 036624          679 GLSKTGPTLDH-THVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ-------VSLAE  749 (893)
Q Consensus       679 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-------~~l~~  749 (893)
                      |+++....... ........+++.|+|||++.+. .++.++|||||||+|+||++|++||........       ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99886432211 1112234578899999988764 589999999999999999999999975433220       11111


Q ss_pred             HHHHhhcc-----------cchhhhccccccCCCC----h-------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          750 WAAHCHKK-----------GILEQIMDPYLKGKIA----P-------ECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       750 ~~~~~~~~-----------~~~~~i~d~~l~~~~~----~-------~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ....+...           .......+.......+    .       .....+.+++.+||+.+|++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            11110000           0000000000000111    0       223468899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.6e-33  Score=302.22  Aligned_cols=248  Identities=23%  Similarity=0.338  Sum_probs=196.9

Q ss_pred             eeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCH
Q 036624          540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL  616 (893)
Q Consensus       540 LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  616 (893)
                      ||+|+||+||++.....++.+++|.+....   ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999988777899999765321   22345678899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeee
Q 036624          617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV  696 (893)
Q Consensus       617 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  696 (893)
                      .+++.+.....+++..+..++.|++.||.|||   ..+++||||+|+||++++++.+||+|||+++....   .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence            99998766557999999999999999999999   58999999999999999999999999999875432   1112234


Q ss_pred             ccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHH
Q 036624          697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC  776 (893)
Q Consensus       697 ~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  776 (893)
                      .++..|+|||++.+..++.++|||||||+++||++|+.||........  .......         +..  .....+...
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~---------~~~--~~~~~~~~~  221 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEELKRR---------TLE--MAVEYPDKF  221 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHHHHhc---------ccc--ccccCCccC
Confidence            578899999999988899999999999999999999999965432111  0110000         000  011222334


Q ss_pred             HHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          777 FKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       777 ~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                      ...+.+++.+||+.+|++||     +..+++.+-.
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~  256 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPL  256 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHhChh
Confidence            56788999999999999999     6666765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.3e-33  Score=302.06  Aligned_cols=246  Identities=22%  Similarity=0.286  Sum_probs=190.7

Q ss_pred             eeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHh---hccccceeeEEEEEeecCEEEEEEeecc
Q 036624          539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLS---KLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      +||+|+||.||++.....+..+|+|......   ......+.+|..+++   ..+|+||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999998877899999765321   122233445544443   3479999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      +|+|.+++....  .+++..+..++.|++.||+|||   ..+|+||||||+|||+++++.+||+|||++......    .
T Consensus        81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~  151 (279)
T cd05633          81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K  151 (279)
T ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence            999999886543  5999999999999999999999   588999999999999999999999999998753221    1


Q ss_pred             eeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          693 STVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..........    .....          ......
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~----------~~~~~~  217 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMT----------LTVNVE  217 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHh----------hcCCcC
Confidence            123458999999999874 568999999999999999999999997543222111    11100          001112


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLEF  807 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~~  807 (893)
                      .++.....+.+++.+||+.+|++||     ++.+++++..+
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~  258 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF  258 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence            3344566788999999999999999     59999887653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.4e-33  Score=306.19  Aligned_cols=267  Identities=23%  Similarity=0.300  Sum_probs=199.1

Q ss_pred             HHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecC----
Q 036624          529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC----  602 (893)
Q Consensus       529 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----  602 (893)
                      .+.++|+..+.||+|+||.||+|.....+..|++|+++...  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678899999999999999999998777899999875432  223456788999999999999999999987654    


Q ss_pred             ------EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEe
Q 036624          603 ------EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVS  676 (893)
Q Consensus       603 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~  676 (893)
                            ..++|+||+++ +|...+... ...+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999985 777777544 346899999999999999999999   5899999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       677 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      |||+++....... .......++..|+|||.+.+ ..++.++|||||||++|||++|++||.......  .+......+.
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~~~~~~~  235 (302)
T cd07864         159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLELISRLCG  235 (302)
T ss_pred             cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhC
Confidence            9999876433221 11122345778999998865 457899999999999999999999997543211  1111111100


Q ss_pred             cc--cchhhhc--------cc------cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          756 KK--GILEQIM--------DP------YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       756 ~~--~~~~~i~--------d~------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..  .....+.        ++      .... .....+..+.+++.+||+.+|.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00  0000000        00      0000 011235678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2e-33  Score=301.00  Aligned_cols=245  Identities=24%  Similarity=0.308  Sum_probs=197.5

Q ss_pred             eeecCcEEEEEEEEcCcceEEEEEeCCCCCh---hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCH
Q 036624          540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSE---QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL  616 (893)
Q Consensus       540 LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  616 (893)
                      ||+|+||.||+++....+..+++|.......   ...+.+.+|++++++++|+||+++++.+......++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999987778999998764432   4566789999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC------c
Q 036624          617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH------T  690 (893)
Q Consensus       617 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~------~  690 (893)
                      .+++.+..  .+++..+..++.|+++||+|||   +.+++||||+|+||++++++.+||+|||++........      .
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99997654  5899999999999999999999   58999999999999999999999999999875432211      1


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      .......++..|+|||.+.....+.++||||||+++|||++|+.||......      +.......         ...  
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~---------~~~--  218 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN---------GKI--  218 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc---------CCc--
Confidence            1223455788999999999888999999999999999999999999654321      11111111         000  


Q ss_pred             CCChH--HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          771 KIAPE--CFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       771 ~~~~~--~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..+..  ....+.+++.+||+.+|++||++.++.+.|+
T Consensus       219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            11112  2567889999999999999999955555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.4e-33  Score=309.34  Aligned_cols=264  Identities=21%  Similarity=0.311  Sum_probs=198.6

Q ss_pred             eeeec--CcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCC
Q 036624          539 LLGVG--GFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYG  614 (893)
Q Consensus       539 ~LG~G--~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  614 (893)
                      .||+|  +||+||++++...++.||+|.....  .....+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            56766  8999999999877799999986542  3344578899999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc----
Q 036624          615 TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT----  690 (893)
Q Consensus       615 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~----  690 (893)
                      +|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++||+.+.........    
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9999988765556899999999999999999999   589999999999999999999999999864321110000    


Q ss_pred             -cceeeeccCcCccChHhhhhc--CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH--------------
Q 036624          691 -HVSTVVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH--------------  753 (893)
Q Consensus       691 -~~~~~~~gt~~y~APE~~~~~--~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------------  753 (893)
                       .......++..|+|||++.+.  .++.++|||||||++|||++|+.||........  +......              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccchh
Confidence             001112345679999999764  478999999999999999999999975432111  1100000              


Q ss_pred             ------------------hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          754 ------------------CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       754 ------------------~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                                        .........+.+..+.......+...+.+++.+||+.+|++|||+.|++++-..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~  311 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF  311 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence                              000000001111122222234566789999999999999999999999987764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.5e-33  Score=296.99  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=205.1

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|+..++||+|+||.||+++....+..+++|.....  ......++.+|++++++++|+||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477888999999999999998877788999986542  344566788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          611 MAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       611 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      +++++|.+++.+.  ....+++..+..++.|+++||.|||   ..+++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998663  2346899999999999999999999   589999999999999999999999999998765432 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                         ......++..|++||.+.+..++.++|+||||+++|||++|+.||.......   +   .... ..         ..
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~---~~~~-~~---------~~  217 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---L---RYKV-QR---------GK  217 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHH-hc---------CC
Confidence               1222457889999999999999999999999999999999999996543211   1   1110 01         11


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ....+......+.+++.+|++.+|++||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            112233556778999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-33  Score=294.39  Aligned_cols=248  Identities=26%  Similarity=0.414  Sum_probs=204.1

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh--hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE--QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|+..+.||+|++|.||++.....+..+++|.......  ...+.+.+|++++++++|+|++++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            46778899999999999999887778899998765543  4667899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++...  ..+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-  154 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence            9999999998755  45999999999999999999999   58999999999999999999999999999876433221 


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......    ..|...   .         ....
T Consensus       155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~~---~---------~~~~  217 (254)
T cd06627         155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRIV---Q---------DDHP  217 (254)
T ss_pred             -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHh---c---------cCCC
Confidence             1233458889999999988889999999999999999999999986433111    011100   0         0011


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLW  803 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~  803 (893)
                      ..+......+.+++.+||..+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            223334567889999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.1e-33  Score=311.44  Aligned_cols=266  Identities=20%  Similarity=0.220  Sum_probs=201.0

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec------
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------  601 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------  601 (893)
                      ..++|+..+.||+|+||.||+|.....+..||+|.+...  .......+.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            347899999999999999999999888889999987532  334456778899999999999999999988543      


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      ...++||||+. ++|.+.+...    +++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            35799999996 6888877532    889999999999999999999   589999999999999999999999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccccc---------HHHHHH
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS---------LAEWAA  752 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~---------l~~~~~  752 (893)
                      +......   ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..........         ..++..
T Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8643211   1223457889999999999999999999999999999999999996543211100         000000


Q ss_pred             H-------hhcc------cchhhhccccc----cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          753 H-------CHKK------GILEQIMDPYL----KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       753 ~-------~~~~------~~~~~i~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .       ....      ..+.++....+    ...........+.+++.+||+.||++||++.|++.+-.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~  313 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY  313 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence            0       0000      00011111100    00111234567889999999999999999999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-33  Score=304.11  Aligned_cols=263  Identities=23%  Similarity=0.296  Sum_probs=198.7

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEEEEEEe
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEMILVYD  609 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E  609 (893)
                      |+..+.||+|+||.||+|.....+..+++|++....  ......+.+|++++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556789999999999999998877899999876542  33446788999999999999999999999887  89999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |++ ++|.+++.... ..+++..++.++.|+++||+|||   +.+++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            998 58988886543 46899999999999999999999   58899999999999999999999999999876433221


Q ss_pred             ccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh--cccchh---h-
Q 036624          690 THVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH--KKGILE---Q-  762 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--~~~~~~---~-  762 (893)
                       .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..........  .....+.  ......   + 
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE--KIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCchhhccccccc
Confidence             11223346788999998764 467899999999999999999999997544322111  0000000  000000   0 


Q ss_pred             ----------hccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          763 ----------IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       763 ----------i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                                .....+...+...+...+.+++.+||+.+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                      000000011111135678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=292.51  Aligned_cols=242  Identities=25%  Similarity=0.322  Sum_probs=199.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|.||.|-+++.+..++.+|+|+++..   .+.+...-..|-++|+..+||.+..|...++..+.+|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            5788889999999999999999999999999987753   3344555678999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+.||.|.-||.+.+  .+++....-.-..|..||.|||+   .+||.||||.+|+|||.+|++||+||||++..-.  
T Consensus       248 eyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--  320 (516)
T KOG0690|consen  248 EYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--  320 (516)
T ss_pred             EEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc--
Confidence            9999999999997654  47777777888899999999995   8999999999999999999999999999987443  


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      .......+||||.|+|||++....|....|+|.+|||+|||+||+.||...+...   |-+..       .++++   + 
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLI-------l~ed~---k-  386 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELI-------LMEDL---K-  386 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHH-------Hhhhc---c-
Confidence            3344567899999999999999999999999999999999999999996543221   11110       11222   2 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCC
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPS  797 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt  797 (893)
                         ++.....+...|+...|.++|.+|..
T Consensus       387 ---FPr~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  387 ---FPRTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             ---CCccCCHHHHHHHHHHhhcChHhhcC
Confidence               22233344556777899999999963

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.7e-33  Score=300.42  Aligned_cols=259  Identities=23%  Similarity=0.252  Sum_probs=194.6

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhcc-ccceeeEEEEEeec--CEEEEEEe
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEEN--CEMILVYD  609 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E  609 (893)
                      |+..++||+|+||.||+|.....+..+|+|+.+... .........|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456778999999999999998777899999876432 222234457889999885 99999999999887  88999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |++ |+|.+++.... ..++|..+..++.|++.||+|||   ..+++||||||+||+++. +.+||+|||+++.......
T Consensus        81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            997 68888876543 46899999999999999999999   589999999999999999 9999999999876432111


Q ss_pred             ccceeeeccCcCccChHhhh-hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc-----------
Q 036624          690 THVSTVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK-----------  757 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~-~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-----------  757 (893)
                         .....++..|+|||++. ++.++.++|||||||++|||++|+.||......+   ...+.......           
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence               12244788999999765 4567899999999999999999999997543321   11111111100           


Q ss_pred             cchhhhccccccC----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          758 GILEQIMDPYLKG----KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       758 ~~~~~i~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ........+....    ...+.....+.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0000000000000    0112346789999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.2e-33  Score=303.47  Aligned_cols=245  Identities=20%  Similarity=0.326  Sum_probs=198.9

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCHH
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLR  617 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  617 (893)
                      .+||+|+||.||++.....+..|++|+...........+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            47999999999999998878899999876555556677999999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeec
Q 036624          618 EHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK  697 (893)
Q Consensus       618 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~  697 (893)
                      +++...   .+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||++.......  .......
T Consensus       106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         106 DIVTHT---RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            987532   4899999999999999999999   5899999999999999999999999999987543211  1123345


Q ss_pred             cCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHH
Q 036624          698 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECF  777 (893)
Q Consensus       698 gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~  777 (893)
                      |++.|+|||++.+..++.++|||||||++|||++|..||.........   ...         .+...+.+.  ....+.
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~~---------~~~~~~~~~--~~~~~~  243 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMI---------RDNLPPKLK--NLHKVS  243 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH---------HhhCCcccC--CcccCC
Confidence            889999999998888999999999999999999999998643321110   000         001111111  112234


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          778 KKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       778 ~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..+.+++.+||+.+|.+||++.+++++
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            567889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5e-33  Score=305.81  Aligned_cols=268  Identities=20%  Similarity=0.307  Sum_probs=195.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecC-------
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC-------  602 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-------  602 (893)
                      ++|+..++||+|+||.||+|.....+..||+|.+....  ......+.+|++++++++||||++++++|....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            46888999999999999999998888899999765322  222345678999999999999999999986654       


Q ss_pred             -EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          603 -EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       603 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                       ..++||||+. ++|.+.+.... ..+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence             4599999997 58888776543 35899999999999999999999   589999999999999999999999999998


Q ss_pred             ccCCCCCCc--cceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc
Q 036624          682 KTGPTLDHT--HVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG  758 (893)
Q Consensus       682 ~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  758 (893)
                      .........  .......++..|+|||++.+. .++.++||||||+++|||++|+.|+......................
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            754322111  112234578899999998764 47889999999999999999999987654322211111110000000


Q ss_pred             chhh-----hcc----cc-----ccCCC-ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          759 ILEQ-----IMD----PY-----LKGKI-APECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       759 ~~~~-----i~d----~~-----l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ....     ..+    +.     ..... ...+...+.+++.+||+.+|++||++.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            0000     000    00     00000 00112456789999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.8e-33  Score=306.28  Aligned_cols=268  Identities=25%  Similarity=0.298  Sum_probs=198.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  606 (893)
                      .++|+..+.||+|+||.||+|.....+..||+|......  ......+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357888999999999999999998877899999765322  22233567899999999999999999998654  56899


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+. ++|.+++.... ..+++.++..++.|+++||+|||   ..+++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            999997 58888886543 46899999999999999999999   58899999999999999999999999999886433


Q ss_pred             CCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc--ccchhhh
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK--KGILEQI  763 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~i  763 (893)
                      ....  .....+++.|+|||.+.+ ..++.++|||||||++|||++|++||.........  .........  ......+
T Consensus       161 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         161 PAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL--DLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             ccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCChhhchhh
Confidence            2111  122235788999999875 56799999999999999999999999754332211  100000000  0000000


Q ss_pred             cc----c--cccCC----C---ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          764 MD----P--YLKGK----I---APECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       764 ~d----~--~l~~~----~---~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .+    .  .+...    .   .......+.+++.+||+.||++|||+.+++.+-..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f  293 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF  293 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence            00    0  00000    0   01124567889999999999999999999976553

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-33  Score=312.14  Aligned_cols=267  Identities=21%  Similarity=0.296  Sum_probs=200.6

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec-----CE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN-----CE  603 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~  603 (893)
                      .++|...+.||+|+||+||+|.....+..||+|.+...  .......+.+|+.++++++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35788899999999999999999888889999986542  233455678899999999999999999987644     35


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      .++|+||+. ++|.+++...  ..+++..+..++.|++.||.|||   ..+++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            799999996 7898888654  35999999999999999999999   58999999999999999999999999999886


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccH-HHHHH-------Hh
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL-AEWAA-------HC  754 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~-------~~  754 (893)
                      .....  .......++..|+|||.+.. ..++.++|||||||++|||++|+.||........... .+...       ..
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            43321  11223457889999998865 5689999999999999999999999965432111100 00000       00


Q ss_pred             hcccchhhhc-------cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          755 HKKGILEQIM-------DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       755 ~~~~~~~~i~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .......+.+       ++... ...+.+...+.+++.+||+.+|++||++.+++++-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~  293 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY  293 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence            0000000000       00000 111234567889999999999999999999998844

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-33  Score=326.19  Aligned_cols=274  Identities=19%  Similarity=0.232  Sum_probs=191.9

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceE-EEE------------------EeCCCCChhhHHHHHHHHHHHhhccccc
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTK-VAI------------------KRGNPLSEQGVHEFQTEIEMLSKLRHRH  590 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~-Vav------------------K~~~~~~~~~~~~f~~E~~~l~~l~H~n  590 (893)
                      ..++|+..++||+|+||+||+|..+..... .++                  |... ........+.+|+.+|++++|+|
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            457899999999999999999876432111 111                  1111 12234556889999999999999


Q ss_pred             eeeEEEEEeecCEEEEEEeeccCCCHHHHHhhCC---CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE
Q 036624          591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQ---KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL  667 (893)
Q Consensus       591 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  667 (893)
                      |+++++++...+..++|+|++. ++|.+++....   ........+..|+.|++.||+|||   ..+||||||||+||||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence            9999999999999999999986 67777775432   122345667789999999999999   5899999999999999


Q ss_pred             CCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCC-CCCCCcccccc
Q 036624          668 DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPA-LNPTLPKEQVS  746 (893)
Q Consensus       668 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~  746 (893)
                      +.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||+||||++|+.+ +..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            999999999999997643221 1122335699999999999999999999999999999999998754 43222211111


Q ss_pred             HHHHHHHhh--ccc------chhhhcccc-cc---CCCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          747 LAEWAAHCH--KKG------ILEQIMDPY-LK---GKIA-----PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       747 l~~~~~~~~--~~~------~~~~i~d~~-l~---~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      +.+......  .+.      .+.+.++.. +.   ..+.     ......+.+++.+||+.||.+|||+.|++.+-.+..
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~  459 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA  459 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence            211111100  000      000000000 00   0000     012235677899999999999999999998766533

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=284.26  Aligned_cols=255  Identities=24%  Similarity=0.402  Sum_probs=200.5

Q ss_pred             ccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhcc-ccceeeEEEEE
Q 036624          521 HFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLR-HRHLVSLIGYC  598 (893)
Q Consensus       521 ~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~  598 (893)
                      .....||+.       +..||.|..|+|++++.+..+..+|||.+... +..+.+.+...++++.+-+ .|.||+.+||+
T Consensus        88 ~~dindl~~-------l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF  160 (391)
T KOG0983|consen   88 QADINDLEN-------LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF  160 (391)
T ss_pred             ccChHHhhh-------HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence            445555543       45799999999999999998899999977654 4556677788888777665 89999999999


Q ss_pred             eecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecc
Q 036624          599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF  678 (893)
Q Consensus       599 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF  678 (893)
                      ......++.||.|. ..++.+| +.-..++++.-+-++...+..||.||.+  +++|||||+||+|||+|+.|++|+|||
T Consensus       161 i~n~dV~IcMelMs-~C~ekLl-krik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDF  236 (391)
T KOG0983|consen  161 ITNTDVFICMELMS-TCAEKLL-KRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDF  236 (391)
T ss_pred             eeCchHHHHHHHHH-HHHHHHH-HHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecc
Confidence            99999999999994 3444444 4444568988888999999999999997  899999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeeccCcCccChHhhhh---cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          679 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       679 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      |++-..-   .....+...|.+.|||||.+.-   ..|+-++||||||+.|+||.||+.|+.....+-.           
T Consensus       237 GIsGrlv---dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-----------  302 (391)
T KOG0983|consen  237 GISGRLV---DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-----------  302 (391)
T ss_pred             cccceee---cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-----------
Confidence            9986532   2233445679999999999863   4688899999999999999999999976433211           


Q ss_pred             cccchhhhcc---ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          756 KKGILEQIMD---PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       756 ~~~~~~~i~d---~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                         .+..+++   |.+.+.  ......+.+++..||++|+.+||...+++++-
T Consensus       303 ---~ltkvln~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  303 ---VLTKVLNEEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             ---HHHHHHhcCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence               1222222   223221  12456789999999999999999999998764

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7.5e-33  Score=302.80  Aligned_cols=255  Identities=23%  Similarity=0.356  Sum_probs=197.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..+.||+|+||.||+|.....+..||||..+... .....++..|+.++.+.. |+||++++++|.+....++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            45777889999999999999998777899999876432 234456777888777775 9999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+. ++|.+++.... ..+++..+..++.|+++||+|||+  ..+|+||||+|+||++++++.+||+|||++....... 
T Consensus        95 ~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~-  169 (296)
T cd06618          95 LMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK-  169 (296)
T ss_pred             ccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence            986 57777665433 369999999999999999999995  3689999999999999999999999999987532211 


Q ss_pred             ccceeeeccCcCccChHhhhhcC----CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~----~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                        ......++..|+|||++.+..    ++.++||||||+++|||++|+.||.......     +...         .+++
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~---------~~~~  233 (296)
T cd06618         170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLT---------KILQ  233 (296)
T ss_pred             --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHH---------HHhc
Confidence              112234788999999997654    8899999999999999999999986422110     1111         1111


Q ss_pred             ccccC-CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          766 PYLKG-KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       766 ~~l~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ..... .....+...+.+++.+||+.+|++||++.+++++...
T Consensus       234 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~  276 (296)
T cd06618         234 EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI  276 (296)
T ss_pred             CCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence            11000 0111245678999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.5e-33  Score=312.12  Aligned_cols=271  Identities=20%  Similarity=0.254  Sum_probs=202.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEee----cCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE----NCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~  604 (893)
                      ..+|+..+.||+|+||.||+|.....+..|++|++....  ....+.+.+|+.++++++|+||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888999999999999999998878899999876432  2345667889999999999999999988753    3568


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++|+||+. |+|.+++....  .+++..+..++.|+++||.|||   ..+|+||||||+||++++++.+||+|||+++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999996 68999886543  4899999999999999999999   589999999999999999999999999998754


Q ss_pred             CCCCC--ccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHH--------HH
Q 036624          685 PTLDH--THVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWA--------AH  753 (893)
Q Consensus       685 ~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~  753 (893)
                      .....  ........|+..|+|||++.+ ..++.++|||||||++|||++|+.||.............-.        ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            32211  111233468899999999865 56899999999999999999999999654332211000000        00


Q ss_pred             hhcccchhhhccccc-cCC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          754 CHKKGILEQIMDPYL-KGK-----IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       754 ~~~~~~~~~i~d~~l-~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ......+.+..+... ...     ..+.....+.+++.+||+.+|++||++.+++.+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~  297 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL  297 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence            000001111111000 000     112345778999999999999999999999987664

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=299.04  Aligned_cols=262  Identities=25%  Similarity=0.335  Sum_probs=197.2

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhc---cccceeeEEEEEeecCE-----
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKL---RHRHLVSLIGYCEENCE-----  603 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~-----  603 (893)
                      |+..+.||+|+||.||+|+....+..+|+|+....  .......+.+|+.++.++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            56678999999999999999876789999987632  222234567788877766   59999999999988776     


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      .+++|||+. ++|.+++.......+++..+..++.|+++||.|||   +.+++|+||+|+||++++++.+||+|||+++.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999997 58999887655556999999999999999999999   58899999999999999999999999999876


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch---
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL---  760 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---  760 (893)
                      .....   ......++..|+|||++.+..++.++|||||||++|||++|++||......+  .+..+..........   
T Consensus       157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcC
Confidence            43221   1122347889999999999999999999999999999999999986543221  111111111000000   


Q ss_pred             ------hhhcccccc---CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          761 ------EQIMDPYLK---GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       761 ------~~i~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                            .........   ....++....+.+++.+||+.+|++||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                  000000000   11112334667899999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5e-33  Score=301.47  Aligned_cols=262  Identities=22%  Similarity=0.288  Sum_probs=200.5

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh--hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE--QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      |+..+.||+|++|.||+|....++..+++|+......  .....+..|++++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            4556789999999999999987778999998664322  34567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      + ++|.+++.... ..+++..+..++.|++.||.|||   ..+|+|+||||+||++++++.+||+|||.+.......  .
T Consensus        81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~  153 (283)
T cd05118          81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R  153 (283)
T ss_pred             C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence            7 58888886643 46999999999999999999999   5899999999999999999999999999987654322  1


Q ss_pred             ceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc--ccchhhhcc---
Q 036624          692 VSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK--KGILEQIMD---  765 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~i~d---  765 (893)
                      ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....  .......  ......+.+   
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK--IFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHcCCCchHhcccchhhhh
Confidence            11223477899999999876 789999999999999999999999865432211100  0000000  000000000   


Q ss_pred             ------cc----ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          766 ------PY----LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       766 ------~~----l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                            +.    ......+....++.+++.+||+.+|.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                  00    0011123456789999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.9e-32  Score=295.12  Aligned_cols=252  Identities=20%  Similarity=0.223  Sum_probs=195.6

Q ss_pred             HHHHHHHhcCCccceee--eecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEee
Q 036624          524 FAEIKAATNNFDEALLL--GVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEE  600 (893)
Q Consensus       524 ~~el~~at~~f~~~~~L--G~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~  600 (893)
                      ..++....++|+..+.+  |+|+||.||++.....+..+++|........   +  .|+.....+ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEec
Confidence            34445555677776666  9999999999999888888999986542211   1  122222222 69999999999999


Q ss_pred             cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC-ceeEeccc
Q 036624          601 NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW-VAKVSDFG  679 (893)
Q Consensus       601 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFG  679 (893)
                      .+..++||||+++++|.+++....  .+++.++..++.|+++||.|||   +.+++||||||+||+++.++ .++|+|||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            999999999999999999997654  6999999999999999999999   58899999999999999998 99999999


Q ss_pred             ccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccc
Q 036624          680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI  759 (893)
Q Consensus       680 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  759 (893)
                      +++.....      ....++..|+|||++.+..++.++|||||||++|||++|+.||..... .......|....     
T Consensus       156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~-----  223 (267)
T PHA03390        156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ-----  223 (267)
T ss_pred             cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh-----
Confidence            98754221      123588999999999999999999999999999999999999974332 222233332221     


Q ss_pred             hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 036624          760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS-MGDVLWN  804 (893)
Q Consensus       760 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-m~evl~~  804 (893)
                           ...  ..........+.+++.+||+.+|.+||+ +.+++++
T Consensus       224 -----~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        224 -----QKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -----ccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                 000  0112245567889999999999999996 6888854

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.4e-32  Score=302.42  Aligned_cols=250  Identities=27%  Similarity=0.366  Sum_probs=198.6

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCC---CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      |+..+.||+|+||.||+|+....+..+++|....   ......+++.+|++++++++|+|++++++++......++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            5566789999999999999987778899997653   2334456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +. |+|.+.+.... .++++.++..++.|++.||.|||   ..+++||||||+|||++.++.+||+|||++.....    
T Consensus        97 ~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----  167 (308)
T cd06634          97 CL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (308)
T ss_pred             cC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence            97 68887775443 45899999999999999999999   58999999999999999999999999999875332    


Q ss_pred             cceeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          691 HVSTVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                        .....++..|+|||++.   ...++.++|||||||++|||++|+.|+.......      ........ .     .+.
T Consensus       168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~-~-----~~~  233 (308)
T cd06634         168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN-E-----SPA  233 (308)
T ss_pred             --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHhhc-C-----CCC
Confidence              12345788999999985   3568889999999999999999999985432111      11111000 0     011


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                         .........+.+++.+||+.+|++||++.+++.+.....
T Consensus       234 ---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         234 ---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             ---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence               112234567889999999999999999999998766444

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-32  Score=308.63  Aligned_cols=273  Identities=21%  Similarity=0.236  Sum_probs=205.3

Q ss_pred             cccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEE
Q 036624          520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY  597 (893)
Q Consensus       520 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~  597 (893)
                      ++....++...+++|...+.||+|+||.||+|.....+..||+|++...  .....+.+.+|++++++++|+||++++++
T Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~   84 (345)
T cd07877           5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   84 (345)
T ss_pred             hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence            4556677888899999999999999999999998777789999987643  23335668889999999999999999998


Q ss_pred             Eeec------CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC
Q 036624          598 CEEN------CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW  671 (893)
Q Consensus       598 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~  671 (893)
                      +...      ...+++++++ +++|.+++...   .+++..+..++.|+++||+|||   +.+|+||||||+||++++++
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             eeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCC
Confidence            8543      3467888877 68998877543   4899999999999999999999   58999999999999999999


Q ss_pred             ceeEecccccccCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHH
Q 036624          672 VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEW  750 (893)
Q Consensus       672 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  750 (893)
                      .+||+|||+++....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........  +...
T Consensus       158 ~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~  230 (345)
T cd07877         158 ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLI  230 (345)
T ss_pred             CEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH
Confidence            999999999875322     1223457889999999876 5688999999999999999999999864332111  1110


Q ss_pred             HHHhh--cccchhhh-----------ccccccCCC---ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          751 AAHCH--KKGILEQI-----------MDPYLKGKI---APECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       751 ~~~~~--~~~~~~~i-----------~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .....  .......+           +.......+   .......+.+++.+|++.+|.+||++.+++.+-.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  302 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  302 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence            00000  00000000           000000000   0012456789999999999999999999998754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=295.04  Aligned_cols=243  Identities=22%  Similarity=0.275  Sum_probs=189.2

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHH-hhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEML-SKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      +.||+|+||.||+|.....++.||+|......   ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46999999999999998777899999876432   22233445555544 455899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      ++|.+++....  .+++..+..++.|++.||.|||   ..+++||||+|+||++++++.+||+|||+++....      .
T Consensus        82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~  150 (260)
T cd05611          82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N  150 (260)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence            99999997543  4889999999999999999999   58999999999999999999999999999875322      2


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                      ....|+..|+|||.+.+..++.++||||||+++|||++|..||.......      ...... .+.    .  .......
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~----~--~~~~~~~  217 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNIL-SRR----I--NWPEEVK  217 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hcc----c--CCCCccc
Confidence            23458889999999998889999999999999999999999996543211      111100 000    0  0011122


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..+...+.+++.+||+.+|++||++.++.+.
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            2355778999999999999999976544433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.7e-32  Score=300.93  Aligned_cols=245  Identities=27%  Similarity=0.399  Sum_probs=195.4

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      |...+.||+|+||+||+|+....+..|++|++...   .......+.+|++++++++|+|++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55567899999999999998877789999986532   233456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +. |+|.+.+.... .++++.+++.++.|++.||.|||   ..+++||||||+||++++++.+||+|||++.....    
T Consensus       103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            96 67877775433 45899999999999999999999   58999999999999999999999999999864321    


Q ss_pred             cceeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          691 HVSTVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                        .....|+..|+|||++.   ...++.++|||||||++|||++|..|+.......      .........      .+ 
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~------~~-  238 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQND------SP-  238 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC------CC-
Confidence              12345888999999984   4668899999999999999999999986543211      111111000      01 


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                        ..........+.+++.+||+.+|.+||++.+++.+
T Consensus       239 --~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 --TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              11122234568889999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.3e-33  Score=308.95  Aligned_cols=268  Identities=21%  Similarity=0.283  Sum_probs=197.0

Q ss_pred             HHHHHHHh----cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEE
Q 036624          524 FAEIKAAT----NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY  597 (893)
Q Consensus       524 ~~el~~at----~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~  597 (893)
                      .+|+..++    ++|...+.||+|+||.||+|.....+..||+|++...  .......+.+|+.++++++|+||++++++
T Consensus         3 ~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~   82 (342)
T cd07879           3 REEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV   82 (342)
T ss_pred             hhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhhe
Confidence            34554443    7899999999999999999998877789999986532  22334568899999999999999999999


Q ss_pred             Eeec------CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC
Q 036624          598 CEEN------CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW  671 (893)
Q Consensus       598 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~  671 (893)
                      +...      ...++|+||+. .+|..++.    ..+++..+..++.|+++||+|||   +.+++||||||+|||++.++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~  154 (342)
T cd07879          83 FTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDC  154 (342)
T ss_pred             ecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCC
Confidence            8654      35699999997 47776552    24899999999999999999999   58899999999999999999


Q ss_pred             ceeEecccccccCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHH
Q 036624          672 VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEW  750 (893)
Q Consensus       672 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  750 (893)
                      .+||+|||+++.....     .....++..|+|||++.+ ..++.++|||||||++|||++|+.||............-.
T Consensus       155 ~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~  229 (342)
T cd07879         155 ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK  229 (342)
T ss_pred             CEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999998754221     123357889999999876 4689999999999999999999999975432111100000


Q ss_pred             HHHhh--------cccchhhhcc--ccc-cCC---CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          751 AAHCH--------KKGILEQIMD--PYL-KGK---IAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       751 ~~~~~--------~~~~~~~i~d--~~l-~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .....        ..........  +.. ...   ..+.....+.+++.+||+.+|++||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             hcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000        0000000000  000 000   001234567899999999999999999999976

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-33  Score=306.82  Aligned_cols=250  Identities=24%  Similarity=0.315  Sum_probs=208.4

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ....|.+...||+|.|++|.+|++...+..||+|.+...  +....+.+.+|+++|..++|||||+++.+......+++|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            346788889999999999999999988899999987654  233345589999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+.+|.++++|.+..+  .....+..++.|+.++++|||   ...|||||||++||||+.+.++||+|||++....  
T Consensus       134 ~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--  206 (596)
T ss_pred             EEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec--
Confidence            999999999999987764  556888899999999999999   5899999999999999999999999999997643  


Q ss_pred             CCccceeeeccCcCccChHhhhhcCC-CCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                       ........+|++.|.|||++.+.+| ..++|+||+|++||-|++|..||++..-.                   ++-++
T Consensus       207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr~r  266 (596)
T KOG0586|consen  207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELRPR  266 (596)
T ss_pred             -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------cccch
Confidence             3445667889999999999998876 46899999999999999999999764321                   11122


Q ss_pred             cccCC--CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          767 YLKGK--IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       767 ~l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .+.+.  ++.-....+.++++++|-.+|.+|+++.++.++-+
T Consensus       267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence            22221  22233455677889999999999999999986644

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=298.88  Aligned_cols=264  Identities=23%  Similarity=0.327  Sum_probs=197.8

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh-hhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEEeec
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      |...+.||+|+||+||+|.....+..|++|++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            4567799999999999999987778899998654322 22334567999999999 999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                       +|+|.+++.......+++.+++.++.|++.+|.|||   +.+++|+||+|+||++++++.+||+|||+++......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             789999987765556899999999999999999999   5899999999999999999999999999987543211   


Q ss_pred             ceeeeccCcCccChHhhh-hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccccc-H---------HHHHHHhhcccch
Q 036624          692 VSTVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS-L---------AEWAAHCHKKGIL  760 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~-~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l---------~~~~~~~~~~~~~  760 (893)
                      ......++..|+|||++. ...++.++||||||++++||++|++||......+... .         ..|.........+
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            112234788999999875 4568999999999999999999999986543221110 0         0011110000000


Q ss_pred             hhhcccccc---CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          761 EQIMDPYLK---GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       761 ~~i~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ...+.....   ....+.....+.+++.+||+.+|++||++.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000000   00011124678899999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.1e-32  Score=295.17  Aligned_cols=245  Identities=21%  Similarity=0.269  Sum_probs=189.5

Q ss_pred             eeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHH---HhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEM---LSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      +||+|+||.||++.....++.||+|.+....   ......+..|..+   ++...||||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999988777899999765421   1222234445443   444579999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      +|+|..++...  ..+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++......    
T Consensus        81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----  151 (278)
T cd05606          81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (278)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence            99999988654  35999999999999999999999   5889999999999999999999999999987532211    


Q ss_pred             eeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          693 STVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      .....|+..|+|||++.++ .++.++|||||||++|||++|+.||...........    ....      ...+    ..
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~------~~~~----~~  217 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT------LTMA----VE  217 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHh------hccC----CC
Confidence            1234589999999999754 689999999999999999999999975432211100    0000      0011    12


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                      .+......+.+++.+|+..+|.+||     ++.+++++-.
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~  257 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF  257 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence            2233456788999999999999999     9999986544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1e-32  Score=298.36  Aligned_cols=251  Identities=23%  Similarity=0.348  Sum_probs=204.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|...+.||+|+||.||+|.....+..|++|.....   .....+.+..|++++++++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4678889999999999999999877789999986542   3344567889999999998 99999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++++|.+++.+..  .+++..+..|+.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999997654  5999999999999999999999   589999999999999999999999999998753322


Q ss_pred             CC------------------ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHH
Q 036624          688 DH------------------THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAE  749 (893)
Q Consensus       688 ~~------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  749 (893)
                      ..                  ........++..|+|||++.+..++.++||||||++++|+++|+.|+.......  .   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~---  230 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--T---  230 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--H---
Confidence            11                  012223457889999999998889999999999999999999999997543110  0   


Q ss_pred             HHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 036624          750 WAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSM----GDVLWN  804 (893)
Q Consensus       750 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm----~evl~~  804 (893)
                                ...+.+  .....+......+.+++.+||+.+|++||++    .+++++
T Consensus       231 ----------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         231 ----------FQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ----------HHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                      011111  1112333446678999999999999999999    777653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.5e-32  Score=301.16  Aligned_cols=259  Identities=23%  Similarity=0.258  Sum_probs=191.4

Q ss_pred             CcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCHHHHHh
Q 036624          544 GFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLY  621 (893)
Q Consensus       544 ~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  621 (893)
                      ++|.||.++....++.||+|+....  .....+.+..|++++++++|+||+++++++.+.+..+++|||+++|+|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            3444555555555688999987543  44566789999999999999999999999999999999999999999999998


Q ss_pred             hCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC-----ccceeee
Q 036624          622 KTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH-----THVSTVV  696 (893)
Q Consensus       622 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~-----~~~~~~~  696 (893)
                      ......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||.+........     .......
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~  168 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS  168 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence            765556899999999999999999999   58999999999999999999999999998864322111     1112234


Q ss_pred             ccCcCccChHhhhh--cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh----ccc-------chhh-
Q 036624          697 KGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH----KKG-------ILEQ-  762 (893)
Q Consensus       697 ~gt~~y~APE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----~~~-------~~~~-  762 (893)
                      .++..|+|||++..  ..++.++|||||||++|||++|+.||.......  .+.+-.....    ...       .+.. 
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
T cd08216         169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQS  246 (314)
T ss_pred             cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcc
Confidence            57789999999976  358899999999999999999999997543211  1111000000    000       0000 


Q ss_pred             ---hccccc----cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          763 ---IMDPYL----KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       763 ---i~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                         ..++..    ...........+.+++.+||+.+|++||++.+++++-..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~  298 (314)
T cd08216         247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF  298 (314)
T ss_pred             cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence               000000    011122334578899999999999999999999987664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.6e-32  Score=303.01  Aligned_cols=268  Identities=22%  Similarity=0.271  Sum_probs=201.4

Q ss_pred             HHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEee-cC
Q 036624          526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE-NC  602 (893)
Q Consensus       526 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~  602 (893)
                      ++...+++|+..+.||+|+||.||++.....+..||+|++..  ......+.+..|++++++++||||+++.+++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            344567899999999999999999999888888999997643  223345678899999999999999999998865 56


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ..++|+||+. ++|..++...   ++++..+..++.|+++||.|||   ..+|+||||||+|||+++++.+||+|||+++
T Consensus        84 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELLG-TDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehhc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            7899999984 6898887543   4788899999999999999999   5899999999999999999999999999987


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccccc-H--------HHHHH
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS-L--------AEWAA  752 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l--------~~~~~  752 (893)
                      .....     .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... +        .+|..
T Consensus       157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            53221     122346889999998766 578999999999999999999999996543211110 0        11111


Q ss_pred             HhhcccchhhhccccccCCCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          753 HCHKKGILEQIMDPYLKGKIA-----PECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       753 ~~~~~~~~~~i~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ..........+..-......+     +.+...+.+++.+||+.+|++||++.+++.+-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~  289 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP  289 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence            111111111111100011111     12346789999999999999999999998663

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-33  Score=309.33  Aligned_cols=203  Identities=32%  Similarity=0.472  Sum_probs=174.1

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecC------EEEE
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC------EMIL  606 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l  606 (893)
                      +...+.||+||||.||+|+++..++.||||..+.. .....+...+|+++|++++|+|||++++.-++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            33456899999999999999988899999987653 3345567889999999999999999999876543      5689


Q ss_pred             EEeeccCCCHHHHHhhCCC-CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC--CCC--ceeEeccccc
Q 036624          607 VYDYMAYGTLREHLYKTQK-PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD--EKW--VAKVSDFGLS  681 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld--~~~--~~kl~DFGla  681 (893)
                      |||||.+|||+..|.+..+ ..|++.+.+.+..+++.||.|||   +++||||||||.||++-  +++  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999987643 45999999999999999999999   69999999999999983  333  5799999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCcc
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPK  742 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~  742 (893)
                      |....   ....+.+.||..|++||.+.+ +.|+..+|.|||||++||.+||..||.+....
T Consensus       172 rel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            97543   335667889999999999995 88999999999999999999999999875543

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.4e-32  Score=307.23  Aligned_cols=267  Identities=20%  Similarity=0.304  Sum_probs=196.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeec----------
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN----------  601 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----------  601 (893)
                      .+|...+.||+|+||.||+|.....+..|++|+.........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            5788899999999999999999888889999987665556667889999999999999999999776543          


Q ss_pred             ----CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC-CCCceeEe
Q 036624          602 ----CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVS  676 (893)
Q Consensus       602 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-~~~~~kl~  676 (893)
                          ...++|+||++ ++|.+++...   .+++..+..++.|++.||.|||   +.+|+||||||+||+++ +++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                35789999997 6898887532   4899999999999999999999   58999999999999997 55689999


Q ss_pred             cccccccCCCCC-CccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh
Q 036624          677 DFGLSKTGPTLD-HTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC  754 (893)
Q Consensus       677 DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  754 (893)
                      |||+++...... .........++..|+|||++.. ..++.++|||||||++|||++|+.||....+.............
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999987542211 1111122357889999998754 56889999999999999999999999754332211000000000


Q ss_pred             hcc----c---chhh-hccccccC-----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          755 HKK----G---ILEQ-IMDPYLKG-----KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       755 ~~~----~---~~~~-i~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ...    .   .+.. ........     ...+.....+.+++.+||+.+|++||++.+++.+-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~  301 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP  301 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCC
Confidence            000    0   0000 00000000     01112345688999999999999999999999653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.4e-32  Score=292.69  Aligned_cols=250  Identities=25%  Similarity=0.357  Sum_probs=195.9

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC-----CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP-----LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~-----~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      +|...+.||+|+||+||++........+++|..+.     .......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            36677899999999999998876545555554332     1223345677899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          608 YDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +||+++++|.+++...  ....+++..++.++.|+++||.|||   +.+++|+||||+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642  3456999999999999999999999   589999999999999986 469999999987643


Q ss_pred             CCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ...  .......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+.....      ......         +..
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~---------~~~  219 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLR---------IVE  219 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH---------HHc
Confidence            211  122334588899999999888899999999999999999999999853321      111111         111


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      . .....+..+...+.+++.+||+.+|++||++.+++++
T Consensus       220 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         220 G-PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             C-CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            0 0112234556788999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-32  Score=305.15  Aligned_cols=266  Identities=22%  Similarity=0.292  Sum_probs=203.5

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecC-----EEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC-----EMI  605 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  605 (893)
                      +|...++||+|+||.||+|+....+..+++|++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4777889999999999999998777899999876543  345567999999999999999999999987765     789


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +||||++ ++|.+++....  .+++..++.++.|+++||+|||   ..+|+||||||+|||+++++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999998 58988886543  6999999999999999999999   5899999999999999999999999999987643


Q ss_pred             CCCC-ccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc-------
Q 036624          686 TLDH-THVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK-------  756 (893)
Q Consensus       686 ~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-------  756 (893)
                      .... ........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+...   .......       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~  231 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN---LIVEVLGTPSEEDL  231 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHhcCCCChhHh
Confidence            3211 0112234578899999999887 89999999999999999999999997554321110   0000000       


Q ss_pred             ----ccchhhhccc-cc-----cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          757 ----KGILEQIMDP-YL-----KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       757 ----~~~~~~i~d~-~l-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                          .....+.+.. ..     .....+.....+.+++.+||+.+|++||++.+++.+-..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  292 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL  292 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence                0000000000 00     001112245678899999999999999999999987543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2e-32  Score=301.10  Aligned_cols=267  Identities=25%  Similarity=0.283  Sum_probs=195.3

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeec-------
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN-------  601 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-------  601 (893)
                      .++|+..++||+|+||.||+|.....+..+++|++....  ......+.+|++++++++|+||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468899999999999999999998877889999764322  22234578899999999999999999987443       


Q ss_pred             -CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccc
Q 036624          602 -CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL  680 (893)
Q Consensus       602 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl  680 (893)
                       ..+++|+||+. ++|...+... ...+++..+..++.|+++||.|||   ..+|+||||||+||++++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence             34699999997 5777777543 346999999999999999999999   58999999999999999999999999999


Q ss_pred             cccCCCCCC---------ccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHH
Q 036624          681 SKTGPTLDH---------THVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEW  750 (893)
Q Consensus       681 a~~~~~~~~---------~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  750 (893)
                      ++.......         ....+...+++.|+|||.+.+ ..++.++|||||||++|||++|++||.........  ...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~--~~~  239 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL--HLI  239 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH
Confidence            875322111         111223457889999998865 45899999999999999999999999754432211  111


Q ss_pred             HHHhh--ccc------chhhhccccccCCCC-------hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          751 AAHCH--KKG------ILEQIMDPYLKGKIA-------PECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       751 ~~~~~--~~~------~~~~i~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .....  ...      .+....+.......+       ......+.+++.+||+.+|++|||+.|++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            10000  000      000000000000000       1123568899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=335.28  Aligned_cols=254  Identities=23%  Similarity=0.288  Sum_probs=202.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCC--CCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~--~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      +-++.....||.|.||.||-|...+++...|+|.++  .......+...+|+.++..|+|||+|+.+|+-.+.++.+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            455667789999999999999998888999999644  333455677899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |||++|+|.+.+...+.  +++.....+..|++.|+.|||   +.+||||||||.||+|+.+|.+|++|||.|.......
T Consensus      1314 EyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            99999999999976543  555566677889999999999   6999999999999999999999999999987643321


Q ss_pred             --CccceeeeccCcCccChHhhhhcC---CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          689 --HTHVSTVVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       689 --~~~~~~~~~gt~~y~APE~~~~~~---~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                        .........||+.|||||++.+..   -..+.||||+|||++||+||+.||...+.       +|+--.       .+
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy-------~V 1454 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMY-------HV 1454 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHh-------HH
Confidence              122233567999999999997643   34689999999999999999999965432       333211       11


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      -. --...++.....+=.+++.+||+.||++|.++.|++++
T Consensus      1455 ~~-gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AA-GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hc-cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            11 11234455566667889999999999999998877654

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.3e-32  Score=301.90  Aligned_cols=267  Identities=21%  Similarity=0.245  Sum_probs=194.4

Q ss_pred             CCccceeeeecCcEEEEEEEEcCc--ceEEEEEeCCCC--ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeec----CE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGA--TTKVAIKRGNPL--SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEEN----CE  603 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~--~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----~~  603 (893)
                      +|+..+.||+|+||.||++.....  +..+|+|++...  .....+.+.+|+++++++ +|+||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            467788999999999999998876  788999986642  222356788999999999 599999999976432    45


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      .++++||+. ++|.+++...  ..+++..+..++.|++.||+|||   ..+|+||||||+|||+++++.+||+|||+++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788899886 7899988643  35899999999999999999999   58999999999999999999999999999875


Q ss_pred             CCCCCC--ccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccH---------HHHH
Q 036624          684 GPTLDH--THVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL---------AEWA  751 (893)
Q Consensus       684 ~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l---------~~~~  751 (893)
                      ......  ........|+..|+|||++.+ ..++.++|||||||++|+|++|++||...........         .++.
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            432111  111223468999999998865 5689999999999999999999999875432111000         0000


Q ss_pred             HHhhcccc--hhhhccccc---cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          752 AHCHKKGI--LEQIMDPYL---KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       752 ~~~~~~~~--~~~i~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ..+.....  .........   .....+.+...+.+++.+||+.+|++||++.+++.+=
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~  293 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP  293 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            00000000  000000000   0001112345788999999999999999999998653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.5e-32  Score=303.00  Aligned_cols=261  Identities=23%  Similarity=0.269  Sum_probs=194.9

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhh--------------HHHHHHHHHHHhhccccceeeEEEEEeecC
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG--------------VHEFQTEIEMLSKLRHRHLVSLIGYCEENC  602 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~--------------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  602 (893)
                      .+.||+|+||+||+|.....++.||+|.........              ...+.+|++++++++|+||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            357999999999999988777899999765432111              124778999999999999999999999999


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ..++||||+. |+|.+++...  ..+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~  167 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR  167 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCcccee
Confidence            9999999997 7999988653  34899999999999999999999   5899999999999999999999999999987


Q ss_pred             cCCCCC------------CccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHH
Q 036624          683 TGPTLD------------HTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAE  749 (893)
Q Consensus       683 ~~~~~~------------~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  749 (893)
                      ......            .........+++.|+|||++.+. .++.++|||||||++|||++|+.||......+..   .
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~  244 (335)
T PTZ00024        168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL---G  244 (335)
T ss_pred             ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence            533100            01111223468899999998764 4789999999999999999999999755432211   1


Q ss_pred             HHHHhhcccc---hhhh------------ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          750 WAAHCHKKGI---LEQI------------MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       750 ~~~~~~~~~~---~~~i------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ..........   ..+.            ..+... .....+...+.+++.+||+.+|++||++.|++.+-..
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence            1111000000   0000            000000 0111234668899999999999999999999976553

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=5.7e-32  Score=302.28  Aligned_cols=264  Identities=21%  Similarity=0.306  Sum_probs=198.8

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecC-----
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC-----  602 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----  602 (893)
                      ..++|...+.||+|+||.||++.....+..||||+....  .......+.+|++++++++|+||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            457899999999999999999998877789999986532  2334556889999999999999999999986543     


Q ss_pred             -EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          603 -EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       603 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                       ..++||||+ +++|..++..   ..+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||++
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence             468999999 6799888753   34899999999999999999999   589999999999999999999999999998


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc---------cHHHHH
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV---------SLAEWA  751 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~---------~l~~~~  751 (893)
                      +.....     .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.........         ...+|.
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         166 RQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             cccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            754221     123457889999999876 46889999999999999999999999754321100         000111


Q ss_pred             HHhhcccchhhhcc--cccc----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          752 AHCHKKGILEQIMD--PYLK----GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       752 ~~~~~~~~~~~i~d--~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ....... ......  +...    ....+.+...+.+++.+|++.+|++|||+.+++.+-.
T Consensus       241 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~  300 (343)
T cd07880         241 QKLQSED-AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY  300 (343)
T ss_pred             Hhhcchh-HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            1110000 000000  0000    0111233456889999999999999999999996543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=1.1e-31  Score=292.64  Aligned_cols=253  Identities=23%  Similarity=0.285  Sum_probs=196.2

Q ss_pred             CCccceeeeecCcEEEEEEEEc---CcceEEEEEeCCCCC----hhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEID---GATTKVAIKRGNPLS----EQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~---~~~~~VavK~~~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  604 (893)
                      +|+..+.||+|+||.||++...   ..+..||+|++....    ....+.+.+|+++++++ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4677889999999999999874   245789999876422    22346688999999999 599999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++|+||+++++|.+++....  .+++..+..++.|+++||.|||   +.+++||||||+|||+++++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            99999999999999997543  5889999999999999999999   589999999999999999999999999998754


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhc--CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                      .... ........|+..|+|||++...  .++.++||||||+++|||++|+.|+.....  .....++.......     
T Consensus       156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~-----  227 (290)
T cd05613         156 HEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRILKS-----  227 (290)
T ss_pred             cccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhhcc-----
Confidence            3211 1112234588999999998753  468899999999999999999999864321  11122222211111     


Q ss_pred             hccccccCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 036624          763 IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWN  804 (893)
Q Consensus       763 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~  804 (893)
                            ....+..+...+.+++.+||+.+|++||     ++.+++.+
T Consensus       228 ------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         228 ------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                  0112334456788999999999999997     66666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=9e-32  Score=292.96  Aligned_cols=256  Identities=25%  Similarity=0.288  Sum_probs=198.5

Q ss_pred             CCccceeeeecCcEEEEEEEEcC---cceEEEEEeCCCCC----hhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDG---ATTKVAIKRGNPLS----EQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~---~~~~VavK~~~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  604 (893)
                      +|+..+.||+|+||.||+++...   .+..+|||.+....    ....+.+..|+.++.++ +|+||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            36678899999999999998642   34679999765321    22345688999999999 599999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++||||+++|+|.+++....  .+++..+..++.|+++||.|||   ..+++||||||+||+++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            99999999999999986543  5899999999999999999999   589999999999999999999999999998764


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcC--CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                      .... ........|+..|+|||.+.+..  .+.++||||||+++|||++|..|+......  ....++.....       
T Consensus       156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~-------  225 (288)
T cd05583         156 LAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRIL-------  225 (288)
T ss_pred             cccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHH-------
Confidence            3221 11222345889999999987665  788999999999999999999998643211  11111111111       


Q ss_pred             hccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          763 IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       763 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                        ..  ....+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       226 --~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         226 --KS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             --cc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence              10  011222344567889999999999999998888776653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=6e-32  Score=292.85  Aligned_cols=261  Identities=24%  Similarity=0.307  Sum_probs=199.0

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      |+..+.||+|+||.||+|+....++.+++|......  ....+.+..|+.++++++|+||+++++++.+....++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999998877899999876542  334567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      + ++|.+++.... ..+++..+..++.|+++||+|||   +.+|+||||+|+||++++++.+||+|||+++.......  
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            8 69999997653 35999999999999999999999   58999999999999999999999999999876433211  


Q ss_pred             ceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc---ccch-------
Q 036624          692 VSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK---KGIL-------  760 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~-------  760 (893)
                      ......++..|+|||++.+. .++.++|||||||++|||++|++||......+.   .........   +...       
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcccc
Confidence            12223457789999999776 889999999999999999999999865432111   000000000   0000       


Q ss_pred             --hhhccccccC---CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          761 --EQIMDPYLKG---KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       761 --~~i~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                        ..........   ...+.....+.+++.+||+.+|++||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence              0000000000   0111224678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.98  E-value=2.3e-32  Score=319.75  Aligned_cols=253  Identities=26%  Similarity=0.372  Sum_probs=190.9

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEee--------
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE--------  600 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------  600 (893)
                      -.++|++.++||+||||.|||++.+-+++.+|||++... +........+|+.+|++|+|||||+++..+.+        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            446788999999999999999999988899999987654 44555678899999999999999998764311        


Q ss_pred             -----------------------------------------------c--------------------------------
Q 036624          601 -----------------------------------------------N--------------------------------  601 (893)
Q Consensus       601 -----------------------------------------------~--------------------------------  601 (893)
                                                                     .                                
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                           0                                


Q ss_pred             --------------------------------CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhc
Q 036624          602 --------------------------------CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT  649 (893)
Q Consensus       602 --------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~  649 (893)
                                                      ..+||=||||+...|+++++.+... -.....++++.+|++||.|+| 
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH-  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIH-  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHH-
Confidence                                            1146778999987787777655321 145678899999999999999 


Q ss_pred             CCCCceEecCCCCCCEEECCCCceeEecccccccCC------------C----CCCccceeeeccCcCccChHhhhhcC-
Q 036624          650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP------------T----LDHTHVSTVVKGSFGYLDPEYFRRQQ-  712 (893)
Q Consensus       650 ~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~------------~----~~~~~~~~~~~gt~~y~APE~~~~~~-  712 (893)
                        +.+||||||||.||+||++..|||+|||+|+...            .    .......+...||.-|+|||.+.+.. 
T Consensus       715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence              5889999999999999999999999999997511            0    00111235567999999999997654 


Q ss_pred             --CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC--CChHHHHHHHHHHHHcc
Q 036624          713 --LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK--IAPECFKKFAETAMKCV  788 (893)
Q Consensus       713 --~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~l~~~Cl  788 (893)
                        |+.|+|+||+||||+||+.-   |....+.        +      ..+..+.++.+...  +.......=..++++++
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~yP---F~TsMER--------a------~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLYP---FGTSMER--------A------SILTNLRKGSIPEPADFFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhcc---CCchHHH--------H------HHHHhcccCCCCCCcccccccchHHHHHHHHHh
Confidence              99999999999999999843   5433221        1      12223333333222  22233344567899999


Q ss_pred             ccCCCCCCCHHHHHH
Q 036624          789 SDQGIERPSMGDVLW  803 (893)
Q Consensus       789 ~~~p~~RPtm~evl~  803 (893)
                      +.||.+|||+.|+|.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999883

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=5.2e-32  Score=307.89  Aligned_cols=263  Identities=25%  Similarity=0.355  Sum_probs=216.4

Q ss_pred             cCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEee
Q 036624          522 FSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEE  600 (893)
Q Consensus       522 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~  600 (893)
                      ..++.+...++-|++.++||.|.+|.||+++....++.+|+|++.... ...++...|.++|+.+ +|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            344445555778999999999999999999998888889999877543 3446678899999988 69999999999853


Q ss_pred             -----cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeE
Q 036624          601 -----NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKV  675 (893)
Q Consensus       601 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl  675 (893)
                           ++++|||||||.+||..+++.+.....+.|..+..|++.+++||.+||   +..+||||||-.||||++++.+||
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEE
Confidence                 478999999999999999998877778999999999999999999999   799999999999999999999999


Q ss_pred             ecccccccCCCCCCccceeeeccCcCccChHhhhh-----cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHH
Q 036624          676 SDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEW  750 (893)
Q Consensus       676 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  750 (893)
                      +|||++.......  .......||+.|||||++..     ..|+.++|+||||++..||.-|.+|+....+....     
T Consensus       165 vDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-----  237 (953)
T KOG0587|consen  165 VDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----  237 (953)
T ss_pred             eeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-----
Confidence            9999988654322  22334569999999999863     34778999999999999999999999766542210     


Q ss_pred             HHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          751 AAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       751 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                               +.-...|...-.-+....+++.++|..||.+|.++||++.+++++
T Consensus       238 ---------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  238 ---------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ---------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                     111122333334456788999999999999999999999999854

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=7.3e-32  Score=272.41  Aligned_cols=253  Identities=22%  Similarity=0.288  Sum_probs=203.0

Q ss_pred             HhcCCccc-eeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEee----cCE
Q 036624          530 ATNNFDEA-LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEE----NCE  603 (893)
Q Consensus       530 at~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~  603 (893)
                      .|++|.+. ++||-|-.|.|-.+..+.+++..|+|++...     ...++|+++.-+. .|||||.++++++.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45666654 5899999999999999999999999987643     2347888887666 59999999998753    466


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC---CCceeEecccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE---KWVAKVSDFGL  680 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGl  680 (893)
                      +++|||.|+||.|.+.+...+...++++++.+|..||+.|+.|||   ..+|.||||||+|+|...   |-.+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            789999999999999999988888999999999999999999999   599999999999999964   45799999999


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      |+....   .......+-|+.|.|||++...+|+...|+||+||++|-||||.+||.......           ...|.-
T Consensus       211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----------ispgMk  276 (400)
T KOG0604|consen  211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------ISPGMK  276 (400)
T ss_pred             ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----------CChhHH
Confidence            986432   223445678999999999999999999999999999999999999997543211           111111


Q ss_pred             hhhccccccCCCChHH----HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          761 EQIMDPYLKGKIAPEC----FKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~----~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .+|...  ...++.++    .+...++++.+|..+|++|.|+.+++.+-+
T Consensus       277 ~rI~~g--qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw  324 (400)
T KOG0604|consen  277 RRIRTG--QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW  324 (400)
T ss_pred             hHhhcc--CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence            122211  12344433    455678999999999999999999997655

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.9e-32  Score=303.62  Aligned_cols=263  Identities=20%  Similarity=0.260  Sum_probs=198.4

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCE----
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE----  603 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----  603 (893)
                      ..++|+..+.||+|+||.||+|....++..||+|++...  .....+.+.+|+.++++++|+||+++++++.....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            457899999999999999999999887789999987542  23344667889999999999999999988765554    


Q ss_pred             --EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          604 --MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       604 --~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                        .++|+||+ +++|.+++..   ..+++..+..++.|+++||+|||   ..+|+||||||+||++++++.+||+|||++
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence              89999998 5799998864   35899999999999999999999   589999999999999999999999999998


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccccc-H--------HHHH
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS-L--------AEWA  751 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l--------~~~~  751 (893)
                      ......     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +        ..+.
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            754321     223457889999999875 467899999999999999999999996543221100 0        0000


Q ss_pred             HHhhcccchhhhcccccc---CC---CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          752 AHCHKKGILEQIMDPYLK---GK---IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       752 ~~~~~~~~~~~i~d~~l~---~~---~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ...... .....+.....   ..   ........+.+++.+||+.+|++|||+.+|+.+-
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~  299 (343)
T cd07851         241 QKISSE-SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP  299 (343)
T ss_pred             hhccch-hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence            000000 00000000000   00   0012256788999999999999999999998663

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.6e-31  Score=320.24  Aligned_cols=146  Identities=29%  Similarity=0.408  Sum_probs=131.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|...++||+|+||+||+|.+...+..||+|++...   .......+..|+.++..++|+||+++++++......+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            5788899999999999999999877789999987542   2334567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ||+.+++|.+++....  .+++..++.|+.||+.||+|||   ..+||||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999997543  4889999999999999999999   4799999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-31  Score=284.06  Aligned_cols=237  Identities=26%  Similarity=0.320  Sum_probs=193.9

Q ss_pred             eeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCH
Q 036624          540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL  616 (893)
Q Consensus       540 LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  616 (893)
                      ||+|+||.||++.....+..+++|.+....   ......+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999998777899999765432   23456889999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeee
Q 036624          617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV  696 (893)
Q Consensus       617 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  696 (893)
                      .+++....  .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  153 (250)
T cd05123          81 FSHLSKEG--RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF  153 (250)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence            99997654  4899999999999999999999   5899999999999999999999999999987643221  122345


Q ss_pred             ccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHH
Q 036624          697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC  776 (893)
Q Consensus       697 ~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  776 (893)
                      .++..|++||...+...+.++|+||||+++|||++|+.||.....      ......         +...  ...++...
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~---------~~~~--~~~~~~~~  216 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEK---------ILKD--PLRFPEFL  216 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHH---------HhcC--CCCCCCCC
Confidence            578899999999988899999999999999999999999964432      111111         1111  11223333


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHH
Q 036624          777 FKKFAETAMKCVSDQGIERPSMGD  800 (893)
Q Consensus       777 ~~~l~~l~~~Cl~~~p~~RPtm~e  800 (893)
                      ...+.+++.+||..+|++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            567889999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=286.80  Aligned_cols=242  Identities=25%  Similarity=0.354  Sum_probs=201.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .+|..+.+||+|+||.|-+|..+++.+.+|||+++..   ...+.+--+.|.++|+.. +-|.++++..+++.-+.+++|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            4678888999999999999999999999999987753   223344456788888776 578999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+.||+|--+++.-++  +.+..+.-.|..||-||-+||   ..+||.||||.+|||||.+|.+||+|||+++..-..
T Consensus       429 MEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            999999999999977654  778888999999999999999   599999999999999999999999999999874332


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                        ...+...+||+.|+|||++..++|...+|+|||||+|||||.|.+||++.++.+               ..+.|++..
T Consensus       504 --~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---------------lF~aI~ehn  566 (683)
T KOG0696|consen  504 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---------------LFQAIMEHN  566 (683)
T ss_pred             --CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHHHHHcc
Confidence              233557899999999999999999999999999999999999999998765432               223344433


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCC
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPS  797 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt  797 (893)
                      .  .++.....+...+....|.+.|.+|..
T Consensus       567 v--syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  567 V--SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             C--cCcccccHHHHHHHHHHhhcCCccccC
Confidence            2  234455666778888999999999963

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-32  Score=275.64  Aligned_cols=259  Identities=22%  Similarity=0.317  Sum_probs=203.6

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEEeeccCCC
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVYDYMAYGT  615 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs  615 (893)
                      .++||+|+|+.|--+..-.++..+|||++............+|++++.+.+ |+||++|+.++++...+|||||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            458999999999999887777899999988776677788999999999996 9999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC---ceeEecccccccCC-C----C
Q 036624          616 LREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGP-T----L  687 (893)
Q Consensus       616 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~kl~DFGla~~~~-~----~  687 (893)
                      |..+|++..  .+++.++.++..+||.||.+||   ..+|.||||||+|||-.+..   -+|||||.|..-.. .    .
T Consensus       163 lLshI~~~~--~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  163 LLSHIQKRK--HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHHHHhh--hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            999998765  4899999999999999999999   69999999999999986543   48999998864311 1    1


Q ss_pred             CCccceeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH----hhccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH----CHKKG  758 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~----~~~~~  758 (893)
                      ..+......+|+..|||||+..     ...|+.+.|.||||||||-||+|.+||.+.-..+.    .|-+.    .-++.
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----GWdrGe~Cr~CQ~~  313 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----GWDRGEVCRVCQNK  313 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----CccCCCccHHHHHH
Confidence            1122234567899999999874     34689999999999999999999999987544332    22111    00111


Q ss_pred             chhhhccccccCCCChHHH----HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          759 ILEQIMDPYLKGKIAPECF----KKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       759 ~~~~i~d~~l~~~~~~~~~----~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..+.|-+.  +.+++++.+    .+..+++...+..++.+|.++.+++.+-+
T Consensus       314 LFesIQEG--kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  314 LFESIQEG--KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             HHHHHhcc--CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence            22233332  234555443    34567888888999999999999997544

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-32  Score=289.52  Aligned_cols=246  Identities=24%  Similarity=0.321  Sum_probs=202.4

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCC
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYG  614 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  614 (893)
                      .++||+|.||+||-|+++.+++.||||.+...  ..++..++++|+.||+.++||.||.+...|+..+..+.|||-+. |
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence            46899999999999999999999999976643  34455789999999999999999999999999999999999996 7


Q ss_pred             CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC---CceeEecccccccCCCCCCcc
Q 036624          615 TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK---WVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       615 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla~~~~~~~~~~  691 (893)
                      +..+.|-..++.+|++..-..+..||+.||.|||   ..+|+|+||||+||||.+.   -++||||||+||+.+...   
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence            7777776777778999999999999999999999   5899999999999999643   479999999999865432   


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ....+.||+.|+|||+++++.|...-|+||.|||+|--|+|..||+......                 ++|....+...
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-----------------dQIQNAaFMyP  784 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-----------------DQIQNAAFMYP  784 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-----------------HHhhccccccC
Confidence            2345779999999999999999999999999999999999999997542211                 11111111111


Q ss_pred             C--ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          772 I--APECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       772 ~--~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .  -.+.....+++|...|+..-.+|-+..+.+.+.+
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W  821 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW  821 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence            1  1234456778899999999999999988886654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-33  Score=278.79  Aligned_cols=262  Identities=24%  Similarity=0.299  Sum_probs=202.0

Q ss_pred             cccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhc-cccceeeEEEE
Q 036624          520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKL-RHRHLVSLIGY  597 (893)
Q Consensus       520 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~  597 (893)
                      ..|+.++|+.       ...||.|+||+|+|-.++..++.+|||+++... ..+.+++..|.++..+- +.||||+++|.
T Consensus        59 ~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   59 HTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            3455555543       457999999999999999999999999887654 36677888898876555 68999999999


Q ss_pred             EeecCEEEEEEeeccCCCHHH---HHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCcee
Q 036624          598 CEENCEMILVYDYMAYGTLRE---HLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAK  674 (893)
Q Consensus       598 ~~~~~~~~lV~E~~~~gsL~~---~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~k  674 (893)
                      +...+..|+.||+|. -||+.   +++.-.+..+++.-.-.|.....+||.||.+  +..|||||+||+|||||..|.+|
T Consensus       132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEe
Confidence            999999999999996 56554   3444455679999999999999999999997  78999999999999999999999


Q ss_pred             EecccccccCCCCCCccceeeeccCcCccChHhhhh--cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHH
Q 036624          675 VSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAA  752 (893)
Q Consensus       675 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  752 (893)
                      |||||++-...   .+-..+...|...|||||.+..  ..|+-+|||||||+.|+|+.||+.|+.....     ..+-..
T Consensus       209 LCDFGIcGqLv---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~  280 (361)
T KOG1006|consen  209 LCDFGICGQLV---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLC  280 (361)
T ss_pred             eecccchHhHH---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHH
Confidence            99999986532   2233455668889999999863  3588999999999999999999999864322     111111


Q ss_pred             Hhhcccchhhhccc-ccc-CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          753 HCHKKGILEQIMDP-YLK-GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       753 ~~~~~~~~~~i~d~-~l~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .....       |+ .+. ..-..+....+..++-.||.+|-.+||...+++++--
T Consensus       281 ~Vv~g-------dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f  329 (361)
T KOG1006|consen  281 QVVIG-------DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF  329 (361)
T ss_pred             HHHcC-------CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence            11111       11 111 1111234567899999999999999999999886543

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-32  Score=314.47  Aligned_cols=262  Identities=24%  Similarity=0.289  Sum_probs=213.5

Q ss_pred             HHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEee
Q 036624          524 FAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE  600 (893)
Q Consensus       524 ~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~  600 (893)
                      ..+++...++|++.++||+|+||.|...+++.+++.+|+|+++..   ......-|..|-.+|..-+.+-|+++.-.+.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            456666778999999999999999999999999999999998763   34455679999999999999999999999999


Q ss_pred             cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccc
Q 036624          601 NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL  680 (893)
Q Consensus       601 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl  680 (893)
                      ...+|||||||+||+|-.++.+..  +++++.+...+..|+-||.-||   +.|+|||||||+|||||..|++||+|||.
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchh
Confidence            999999999999999999997766  5888888889999999999999   69999999999999999999999999998


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhh----h-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFR----R-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      +-.... +..-......|||-|++||+++    + +.|...+|+||+||++|||+.|..||...      ++++-     
T Consensus       222 Clkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveT-----  289 (1317)
T KOG0612|consen  222 CLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVET-----  289 (1317)
T ss_pred             HHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHH-----
Confidence            765433 2333344567999999999996    2 67899999999999999999999999532      22222     


Q ss_pred             cccchhhhccccccCCCC--hHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHHH
Q 036624          756 KKGILEQIMDPYLKGKIA--PECFKKFAETAMKCVSDQGIERPS---MGDVLWNLEF  807 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~--~~~~~~l~~l~~~Cl~~~p~~RPt---m~evl~~L~~  807 (893)
                          ...|++..-.-.+|  .+..+...+||.+.+. +|+.|..   +.++..|..+
T Consensus       290 ----Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF  341 (1317)
T KOG0612|consen  290 ----YGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF  341 (1317)
T ss_pred             ----HHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc
Confidence                23344432222233  3456677888888776 4777776   8888877654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=6.2e-31  Score=278.00  Aligned_cols=221  Identities=20%  Similarity=0.159  Sum_probs=178.3

Q ss_pred             cCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCHHHHHhh
Q 036624          543 GGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYK  622 (893)
Q Consensus       543 G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  622 (893)
                      |.||.||++....+++.+|+|++....     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999998888999999876532     234555666666799999999999999999999999999999999865


Q ss_pred             CCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCc
Q 036624          623 TQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY  702 (893)
Q Consensus       623 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  702 (893)
                      ..  .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.++++|||++......     .....++..|
T Consensus        79 ~~--~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y  148 (237)
T cd05576          79 FL--NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY  148 (237)
T ss_pred             hc--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence            43  4899999999999999999999   589999999999999999999999999987643221     1223456789


Q ss_pred             cChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHH
Q 036624          703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAE  782 (893)
Q Consensus       703 ~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~  782 (893)
                      +|||.+.+..++.++||||+||++|||++|+.|+.......                 ..    ......+......+.+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~----~~~~~~~~~~~~~~~~  207 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NT----HTTLNIPEWVSEEARS  207 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------cc----ccccCCcccCCHHHHH
Confidence            99999988889999999999999999999998764321100                 00    0000122234466888


Q ss_pred             HHHHccccCCCCCCCHH
Q 036624          783 TAMKCVSDQGIERPSMG  799 (893)
Q Consensus       783 l~~~Cl~~~p~~RPtm~  799 (893)
                      ++.+|++.||++||++.
T Consensus       208 li~~~l~~dp~~R~~~~  224 (237)
T cd05576         208 LLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHccCCHHHhcCCC
Confidence            99999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=294.56  Aligned_cols=244  Identities=21%  Similarity=0.263  Sum_probs=198.9

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++.|.....+|.|+|+.|-++.+....+..++|++...    ..+-.+|+.++.+. +||||+++.+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            45667777899999999999999988889999987654    22346778777666 69999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE-CCCCceeEecccccccCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL-DEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl-d~~~~~kl~DFGla~~~~~~~  688 (893)
                      .+.++-|.+.+.....   ....+..|+.+|+.++.|||   .+++|||||||+|||+ ++.++++|+|||.++..... 
T Consensus       397 ~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            9999998888865543   22777789999999999999   5999999999999999 68899999999999875432 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                          ....+-|..|.|||++....|++++||||||++|||||+|+.|+......  ..            ....+.    
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e------------i~~~i~----  527 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE------------IHTRIQ----  527 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH------------HHHhhc----
Confidence                22345688999999999999999999999999999999999999754322  00            111121    


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .+++.........+|+.+||+.+|.+||+|.++..+-+.
T Consensus       528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            223334455677889999999999999999999877664

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=3.3e-30  Score=271.41  Aligned_cols=238  Identities=28%  Similarity=0.329  Sum_probs=194.1

Q ss_pred             CcEEEEEEEEcCcceEEEEEeCCCCChhh-HHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCHHHHHhh
Q 036624          544 GFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYK  622 (893)
Q Consensus       544 ~fG~Vy~g~~~~~~~~VavK~~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  622 (893)
                      +||.||+|...+.+..+++|+........ .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999998877899999887654444 68899999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCc
Q 036624          623 TQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY  702 (893)
Q Consensus       623 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  702 (893)
                      ...  +++..+..++.+++++|.|||   +.+++|+||+|+||++++++.++|+|||++.......   ......++..|
T Consensus        81 ~~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  152 (244)
T smart00220       81 RGR--LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY  152 (244)
T ss_pred             ccC--CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence            543  899999999999999999999   5799999999999999999999999999988654321   22345578899


Q ss_pred             cChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC-CChHHHHHHH
Q 036624          703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK-IAPECFKKFA  781 (893)
Q Consensus       703 ~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~  781 (893)
                      ++||.+....++.++||||||++++||++|..|+.......  .+.++.            ........ ........+.
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~------------~~~~~~~~~~~~~~~~~~~  218 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKI------------GKPKPPFPPPEWKISPEAK  218 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHH------------hccCCCCccccccCCHHHH
Confidence            99999998889999999999999999999999986532111  111111            01110000 0001456789


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 036624          782 ETAMKCVSDQGIERPSMGDVLW  803 (893)
Q Consensus       782 ~l~~~Cl~~~p~~RPtm~evl~  803 (893)
                      +++.+|+..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            9999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=4.3e-30  Score=302.19  Aligned_cols=263  Identities=20%  Similarity=0.234  Sum_probs=172.4

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCc----ceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEE------Ee
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY------CE  599 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~----~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~------~~  599 (893)
                      ..++|+..++||+|+||.||+|.+...    +..||+|++......  +.+..|  .+.+..+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            467899999999999999999999877    788999986643221  111111  1122222222222111      35


Q ss_pred             ecCEEEEEEeeccCCCHHHHHhhCCCC------------------CCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCC
Q 036624          600 ENCEMILVYDYMAYGTLREHLYKTQKP------------------PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVK  661 (893)
Q Consensus       600 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk  661 (893)
                      ...+.+|||||+++++|.+++......                  ......+..|+.|+++||+|||   +.+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            667899999999999999998654211                  1123345679999999999999   5899999999


Q ss_pred             CCCEEECC-CCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhc----------------------CCCCcch
Q 036624          662 TTNILLDE-KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ----------------------QLTEKSD  718 (893)
Q Consensus       662 ~~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~s~ksD  718 (893)
                      |+|||+++ ++.+||+|||+++..... .........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 579999999999754321 12223446789999999976422                      2445679


Q ss_pred             hhhHHHHHHHHhhCCCCCCCCCc-------cccccHHHHHHHhhcccchhhhccccccC--CCChHHHHHHHHHHHHccc
Q 036624          719 VYSFGVVLFEILCARPALNPTLP-------KEQVSLAEWAAHCHKKGILEQIMDPYLKG--KIAPECFKKFAETAMKCVS  789 (893)
Q Consensus       719 V~S~Gvvl~elltG~~p~~~~~~-------~~~~~l~~~~~~~~~~~~~~~i~d~~l~~--~~~~~~~~~l~~l~~~Cl~  789 (893)
                      ||||||+||||+++..+.+....       .....+..|.......      ..+.+..  +..........+|+.+||+
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence            99999999999997765432110       0011122222111100      0000000  0000012234589999999


Q ss_pred             cCCCCCCCHHHHHHHHH
Q 036624          790 DQGIERPSMGDVLWNLE  806 (893)
Q Consensus       790 ~~p~~RPtm~evl~~L~  806 (893)
                      .||++|||+.|++++-.
T Consensus       436 ~dP~kR~ta~e~L~Hpf  452 (566)
T PLN03225        436 FKGRQRISAKAALAHPY  452 (566)
T ss_pred             CCcccCCCHHHHhCCcC
Confidence            99999999999998754

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=8.4e-31  Score=265.72  Aligned_cols=205  Identities=25%  Similarity=0.371  Sum_probs=166.3

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcc----eEEEEEeCCCCChh-h-HHHHHHHHHHHhhccccceeeEEEEEee-cCE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGAT----TKVAIKRGNPLSEQ-G-VHEFQTEIEMLSKLRHRHLVSLIGYCEE-NCE  603 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~----~~VavK~~~~~~~~-~-~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~  603 (893)
                      ...|+....||+|.||.||||...++.    +.+|+|+++...+. + -....+|+.+++.++|+||+.|..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            346888889999999999999654432    36889987654221 2 2456799999999999999999998876 788


Q ss_pred             EEEEEeeccCCCHHHHHhhC---CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC----CceeEe
Q 036624          604 MILVYDYMAYGTLREHLYKT---QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK----WVAKVS  676 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~----~~~kl~  676 (893)
                      .+|++||.+ -+|.+.|+..   ....++...+..|..||+.|++|||   .+-|+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence            999999998 5888877633   2346899999999999999999999   4889999999999999877    899999


Q ss_pred             cccccccCCCCCCc-cceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCC
Q 036624          677 DFGLSKTGPTLDHT-HVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPT  739 (893)
Q Consensus       677 DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~  739 (893)
                      |||++|.....-.. .....+.-|..|.|||.+.+. .||.+.||||.|||..||++-++-|.+.
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            99999975432211 123345678999999998864 6999999999999999999998877653

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.2e-31  Score=274.47  Aligned_cols=269  Identities=21%  Similarity=0.276  Sum_probs=209.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccc--c----ceeeEEEEEeecCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH--R----HLVSLIGYCEENCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H--~----niv~l~g~~~~~~~~  604 (893)
                      +++|.+...+|+|.||.|-.+.+...+..||||+++..... .+..+-|+++|+++.+  |    -+|.+.+++.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            67889999999999999999999888889999998765433 4556789999999943  2    367788889999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC---------------
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE---------------  669 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---------------  669 (893)
                      |+|+|.| |-|+.++|..+.-.+++..++..|+.|+++++++||   +.+++|-||||+|||+-+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999988 359999999888888999999999999999999999   699999999999999921               


Q ss_pred             -----CCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccc
Q 036624          670 -----KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ  744 (893)
Q Consensus       670 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  744 (893)
                           +..+||+|||.|+....   .+  ..+..|..|.|||++.+-.++.++||||+||||.||.+|..-|......+.
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e---~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHE---HH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eccCCCcceEEEecCCcceecc---Cc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                 34689999999985322   11  445678999999999999999999999999999999999999987665444


Q ss_pred             ccHHHHHHH--------------hhcccch-----------hhhcccc--c--cCCCChHHHHHHHHHHHHccccCCCCC
Q 036624          745 VSLAEWAAH--------------CHKKGIL-----------EQIMDPY--L--KGKIAPECFKKFAETAMKCVSDQGIER  795 (893)
Q Consensus       745 ~~l~~~~~~--------------~~~~~~~-----------~~i~d~~--l--~~~~~~~~~~~l~~l~~~Cl~~~p~~R  795 (893)
                      ..+.+.+..              ....+.+           ..+.++-  +  .-.-...+..+|.+|+.++|..||.+|
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence            333332211              0111111           1111110  0  001233556779999999999999999


Q ss_pred             CCHHHHHHHHHHHH
Q 036624          796 PSMGDVLWNLEFAL  809 (893)
Q Consensus       796 Ptm~evl~~L~~~~  809 (893)
                      +|+.|++++--+.+
T Consensus       398 iTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  398 ITLREALSHPFFAR  411 (415)
T ss_pred             ccHHHHhcCHHhhc
Confidence            99999998766543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.2e-29  Score=291.11  Aligned_cols=262  Identities=21%  Similarity=0.220  Sum_probs=182.6

Q ss_pred             hcCCccceeeeecCcEEEEEEEEc----------------CcceEEEEEeCCCCChhhHHHH--------------HHHH
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEID----------------GATTKVAIKRGNPLSEQGVHEF--------------QTEI  580 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~----------------~~~~~VavK~~~~~~~~~~~~f--------------~~E~  580 (893)
                      .++|++.++||+|+||+||+|.+.                ..++.||||++........++|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            678999999999999999999752                1235799998765443333333              4467


Q ss_pred             HHHhhccccce-----eeEEEEEee--------cCEEEEEEeeccCCCHHHHHhhCC----------------------C
Q 036624          581 EMLSKLRHRHL-----VSLIGYCEE--------NCEMILVYDYMAYGTLREHLYKTQ----------------------K  625 (893)
Q Consensus       581 ~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~----------------------~  625 (893)
                      .++.+++|.++     ++++++|..        ....+|||||+++|+|.++|+...                      .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777876654     677888753        356899999999999999987431                      1


Q ss_pred             CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccCh
Q 036624          626 PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP  705 (893)
Q Consensus       626 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  705 (893)
                      ..++|..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++....... .......+|+.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence            23567889999999999999999   58899999999999999999999999999875432111 111122357899999


Q ss_pred             HhhhhcC----------------------CCCcchhhhHHHHHHHHhhCCC-CCCCCCcc------ccccHHHHHHHhhc
Q 036624          706 EYFRRQQ----------------------LTEKSDVYSFGVVLFEILCARP-ALNPTLPK------EQVSLAEWAAHCHK  756 (893)
Q Consensus       706 E~~~~~~----------------------~s~ksDV~S~Gvvl~elltG~~-p~~~~~~~------~~~~l~~~~~~~~~  756 (893)
                      |.+....                      ...+.||||+||+++||++|.. |+......      ....+..|...  .
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~  457 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--K  457 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--c
Confidence            9875422                      1235799999999999999875 55321100      01112222111  0


Q ss_pred             ccchhhhccccccCCCChHHHHHHHHHHHHccccCC---CCCCCHHHHHHHHH
Q 036624          757 KGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQG---IERPSMGDVLWNLE  806 (893)
Q Consensus       757 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPtm~evl~~L~  806 (893)
                      ..        ...-...........+++.++|..+|   .+|+|+.|+++|-.
T Consensus       458 ~~--------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~  502 (507)
T PLN03224        458 GQ--------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF  502 (507)
T ss_pred             cc--------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence            00        00011112334667788899998766   68999999998754

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-30  Score=263.30  Aligned_cols=249  Identities=22%  Similarity=0.354  Sum_probs=203.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC---CChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~---~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++|+...+||+|+|.+|..++++.+.+.+|+|+++.   ....++.-.+.|..+..+. +||.+|.|..++.....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            3678899999999999999999999989999997653   2445566778888888776 69999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      |.||++||+|--++++.++  |+++.+......|.-||.|||   +.+||.||||..|+|||..|.+||.|+|+++..-.
T Consensus       329 vieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            9999999999888876554  999999999999999999999   59999999999999999999999999999987543


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCC-ccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTL-PKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                        ....+..++|||.|+|||++++..|....|+|++||+++||+.|+.||+-.. ...+.+-.++.-+..        +.
T Consensus       404 --~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--------le  473 (593)
T KOG0695|consen  404 --PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--------LE  473 (593)
T ss_pred             --CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--------hh
Confidence              2334567899999999999999999999999999999999999999998432 112233334433322        11


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCC
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERP  796 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  796 (893)
                      ..+  .++.....+...++..-|.+||.+|.
T Consensus       474 kqi--riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  474 KQI--RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             hcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence            111  12333445566788899999999985

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=6.9e-30  Score=239.92  Aligned_cols=266  Identities=19%  Similarity=0.226  Sum_probs=194.3

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +|...++||+|.||+||||+...+.+.||+|+.+..  .+.--....+|+-+|+.++|+|||+++++....+.+-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            455567899999999999999999899999976543  333345678999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      |. -+|..+... -+..++.+.+..++.|+++||.++|   .+.+.||||||.|.||+.+|+.|++|||+++.....-..
T Consensus        83 cd-qdlkkyfds-lng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   83 CD-QDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             hh-HHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            96 577776543 3456899999999999999999999   488999999999999999999999999999864432111


Q ss_pred             cceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCC-CCCCCccccccHHHHHHHhhccc---chhhhcc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPA-LNPTLPKEQVSLAEWAAHCHKKG---ILEQIMD  765 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~---~~~~i~d  765 (893)
                        -....-|..|.+|.++-+. -|+...|+||-||++.||.....| |.+.+-.++..-.-|......++   .+.++.|
T Consensus       158 --ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             --eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence              1223368899999998765 589999999999999999865444 44333322221111221111111   1223333


Q ss_pred             ccccCCCCh---------HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          766 PYLKGKIAP---------ECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       766 ~~l~~~~~~---------~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      -....-++.         ..-..=.++..+.+.-+|.+|-++.+.+++-
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp  284 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP  284 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence            222222221         1112235677788888899999988877653

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.1e-29  Score=275.27  Aligned_cols=242  Identities=24%  Similarity=0.372  Sum_probs=191.5

Q ss_pred             HHHHHh---cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEe
Q 036624          526 EIKAAT---NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE  599 (893)
Q Consensus       526 el~~at---~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~  599 (893)
                      -|+++.   .-|..++.||-|+||.|.++.-.++...+|+|.++..   ..........|-.||.....+-||+|+-.|.
T Consensus       620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ  699 (1034)
T KOG0608|consen  620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ  699 (1034)
T ss_pred             HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence            344443   4477889999999999999998888788999976643   2334556788999999999999999999999


Q ss_pred             ecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccc
Q 036624          600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG  679 (893)
Q Consensus       600 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG  679 (893)
                      +++.+|+||||++||++-.+|.+.+-  +.+..+...+..++.|+++.|   +.|+|||||||+|||||.+|.+||.|||
T Consensus       700 DkdnLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  700 DKDNLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             cCCceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeecc
Confidence            99999999999999999999987653  777877778889999999999   7999999999999999999999999999


Q ss_pred             ccccC---------CCCCCccc-------------------------------eeeeccCcCccChHhhhhcCCCCcchh
Q 036624          680 LSKTG---------PTLDHTHV-------------------------------STVVKGSFGYLDPEYFRRQQLTEKSDV  719 (893)
Q Consensus       680 la~~~---------~~~~~~~~-------------------------------~~~~~gt~~y~APE~~~~~~~s~ksDV  719 (893)
                      |+.-.         ...++.+.                               .-...||+.|+|||++....++..+|+
T Consensus       775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw  854 (1034)
T KOG0608|consen  775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW  854 (1034)
T ss_pred             ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence            98521         00000000                               013569999999999999999999999


Q ss_pred             hhHHHHHHHHhhCCCCCCCCCccc-cccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHH
Q 036624          720 YSFGVVLFEILCARPALNPTLPKE-QVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAE  782 (893)
Q Consensus       720 ~S~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~  782 (893)
                      ||.|||||||+.|++||....+.+ +..+..|..          .++-..++.+..||...+.+
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~----------~l~~~~~~~ls~e~~~li~k  908 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPGETQYKVINWRN----------FLHIPYQGNLSKEALDLIQK  908 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh----------ccccccccccCHHHHHHHHH
Confidence            999999999999999998765543 333444543          23333455666666654443

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.8e-31  Score=280.75  Aligned_cols=252  Identities=21%  Similarity=0.301  Sum_probs=207.0

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC---CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      +++.+..||-||||.|=+...+......|+|.++.   ......+....|-++|...+.|.||+++-.+.+....|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            33445579999999999999887655578776554   344455677889999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      -|-||.|+..|++.+  .++..+..-++..+.+|++|||   ..+||.|||||+|++||.+|-+||.|||+|+....   
T Consensus       501 aClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---  572 (732)
T KOG0614|consen  501 ACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---  572 (732)
T ss_pred             hhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhcc---
Confidence            999999999997665  4888888899999999999999   59999999999999999999999999999986543   


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      ...+..++||+.|+|||++.++..+.++|.||||+++||||+|.+||...++-...++            +..-+|.   
T Consensus       573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~------------ILkGid~---  637 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL------------ILKGIDK---  637 (732)
T ss_pred             CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH------------HHhhhhh---
Confidence            3446679999999999999999999999999999999999999999987765432211            1111111   


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNLEF  807 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L~~  807 (893)
                      -.++........+++++.+..+|.+|..     +.+|.++-++
T Consensus       638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf  680 (732)
T KOG0614|consen  638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF  680 (732)
T ss_pred             hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence            1234445566778999999999999975     7788777764

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-30  Score=272.25  Aligned_cols=255  Identities=24%  Similarity=0.327  Sum_probs=194.6

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---Chh----hHHHHHHHHHHHhhccccceeeEEEEEe-ecCEEE
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQ----GVHEFQTEIEMLSKLRHRHLVSLIGYCE-ENCEMI  605 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~  605 (893)
                      |-..++||+|||+.|||+.+-...+.||||+-...   .+.    -.+...+|.+|.+.|.||.||++++|+. +.+.+|
T Consensus       465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC  544 (775)
T KOG1151|consen  465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC  544 (775)
T ss_pred             HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence            44567899999999999998777789999974321   111    1234678999999999999999999985 557789


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC---CCCceeEecccccc
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSK  682 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld---~~~~~kl~DFGla~  682 (893)
                      -|+|||+|.+|+-+|....  .++++.+..|+.||+.||.||.+ .+.+|||-||||.||||-   ..|.+||.||||++
T Consensus       545 TVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  545 TVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             eeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            9999999999999997654  48999999999999999999985 578999999999999995   45889999999999


Q ss_pred             cCCCCCCc-----cceeeeccCcCccChHhhhh----cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH
Q 036624          683 TGPTLDHT-----HVSTVVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH  753 (893)
Q Consensus       683 ~~~~~~~~-----~~~~~~~gt~~y~APE~~~~----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  753 (893)
                      +.....+.     ..+....||.+|++||.+.-    -+.+.|+||||.|||+|..+.|+.||.......  ++      
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dI------  693 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DI------  693 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HH------
Confidence            86443222     33455779999999998753    357889999999999999999999997543321  11      


Q ss_pred             hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 036624          754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL  802 (893)
Q Consensus       754 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl  802 (893)
                       ..+..+.....  ..-...+....+...+|++||+..-++|-...++.
T Consensus       694 -LqeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  694 -LQENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -Hhhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence             11111111111  11111223445667889999999999998766654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=285.07  Aligned_cols=259  Identities=25%  Similarity=0.362  Sum_probs=194.3

Q ss_pred             CCccceeeeecCcEE-EEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGK-VYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~-Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      -|...+++|.|.-|+ ||+|...+  +.||||++-..   -..-..+|+..|+.- +|||||++++.-.+....|+..|.
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye~--R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYEG--REVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeCC--ceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            356667899999876 89999986  68999986532   223457899999888 599999999999999999999999


Q ss_pred             ccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-----CCceeEeccccccc
Q 036624          611 MAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-----KWVAKVSDFGLSKT  683 (893)
Q Consensus       611 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-----~~~~kl~DFGla~~  683 (893)
                      |. .+|.+++...  ......-.....+..|++.||++||+   .+||||||||.||||+.     ..+++|+|||+++.
T Consensus       585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            97 8999999764  11112214456788999999999994   99999999999999975     35899999999987


Q ss_pred             CCCCCCc-cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhC-CCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          684 GPTLDHT-HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA-RPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       684 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      ....... .......||-+|+|||++....-+.++||||+|||+|+.++| ..||......+.. +      +..+..+.
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-I------l~~~~~L~  733 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-I------LTGNYTLV  733 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-h------hcCcccee
Confidence            6543222 224456799999999999999889999999999999999987 7888654322110 0      00000000


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHH---------HHHHHHHhhchhhh
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL---------WNLEFALQLQESAE  816 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl---------~~L~~~~~~~~~~~  816 (893)
                      .       -+..++|  ...+||.+|+..+|..||++.+|+         ++|++++.+....|
T Consensus       734 ~-------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE  788 (903)
T KOG1027|consen  734 H-------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVE  788 (903)
T ss_pred             e-------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhh
Confidence            0       0111223  678899999999999999999999         45666655444333

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.5e-30  Score=255.19  Aligned_cols=271  Identities=23%  Similarity=0.328  Sum_probs=194.5

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-Chh-hHHHHHHHHHHHhhccccceeeEEEEEee--------cCE
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEE--------NCE  603 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------~~~  603 (893)
                      |+...+||+|.||.||+|+.+.+++.||+|+.--. .+. --..-.+|+++|..++|+|++.++..|..        ...
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            44456899999999999999998899999863321 111 12345789999999999999999988853        245


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      ++||+++|+ -+|...|... ...++..++.++..++..||.|+|   ...|+|||+|+.|+||+.++.+||+|||++|.
T Consensus        99 ~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   99 FYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             eeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            899999998 5888887543 346889999999999999999999   58999999999999999999999999999975


Q ss_pred             CCCCCC--ccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHH--------H
Q 036624          684 GPTLDH--THVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWA--------A  752 (893)
Q Consensus       684 ~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~  752 (893)
                      ....+.  ...-+...-|..|.+||.+.+ .+|+.+.|||+-|||+.||.++.+-+.+.....+..+..-.        |
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            432211  111223335899999999875 57999999999999999999999888765443322221110        0


Q ss_pred             Hhhcccchhhhc--cccccCCC--ChHHH------HHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          753 HCHKKGILEQIM--DPYLKGKI--APECF------KKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       753 ~~~~~~~~~~i~--d~~l~~~~--~~~~~------~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      .-..+-.+-+-+  .|...+.+  -++..      ...++++.+++..||.+|+...+++.+-.+-.
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            000000011111  11111110  01111      24678899999999999999999997766543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-29  Score=240.87  Aligned_cols=204  Identities=24%  Similarity=0.343  Sum_probs=169.0

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      .++......||+|++|.|=+-++...+...|+|++... ..+..+...+|+.+..+. .+|.+|.++|...+....++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            34445566899999999999999888899999987643 456667788888886655 6999999999999999999999


Q ss_pred             eeccCCCHHHHHhh--CCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          609 DYMAYGTLREHLYK--TQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       609 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      |.|. .||+.+-.+  ..+..+++.-.-+|+..+.+||.|||+  +..+||||+||+||||+.+|++|+||||.+-... 
T Consensus       125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~-  200 (282)
T KOG0984|consen  125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV-  200 (282)
T ss_pred             HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeeh-
Confidence            9997 677665432  134468899999999999999999997  7899999999999999999999999999986532 


Q ss_pred             CCCccceeeeccCcCccChHhhh----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCC
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFR----RQQLTEKSDVYSFGVVLFEILCARPALNPTL  740 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~  740 (893)
                        .+-..+...|...|||||.+.    ...|+-|+||||||+.+.||.+++.|++...
T Consensus       201 --dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  201 --DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             --hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence              222334456888999999985    3478999999999999999999999996543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-27  Score=254.48  Aligned_cols=266  Identities=22%  Similarity=0.272  Sum_probs=198.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-----c---cceeeEEEEEee---
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-----H---RHLVSLIGYCEE---  600 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-----H---~niv~l~g~~~~---  600 (893)
                      .+|...++||-|.|++||+|.+....+.||+|+.+... .-.+..+.||++|++++     |   ..||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            56888899999999999999999998999999977532 23455689999999984     2   479999999864   


Q ss_pred             -cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC---------
Q 036624          601 -NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK---------  670 (893)
Q Consensus       601 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---------  670 (893)
                       +.+.|||+|++ |-+|..+|....-..++...+.+||.|++.||.|||.  +.+|||-||||+||||..+         
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~e~~~~~~~~  233 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCSTEIDPAKDAR  233 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeeccccchhhhhh
Confidence             56899999988 4789999988877779999999999999999999998  6799999999999999100         


Q ss_pred             --------------------------------------------------------------------------------
Q 036624          671 --------------------------------------------------------------------------------  670 (893)
Q Consensus       671 --------------------------------------------------------------------------------  670 (893)
                                                                                                      
T Consensus       234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~  313 (590)
T KOG1290|consen  234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE  313 (590)
T ss_pred             hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence                                                                                            


Q ss_pred             -----------------------------------------------------------------------------Cce
Q 036624          671 -----------------------------------------------------------------------------WVA  673 (893)
Q Consensus       671 -----------------------------------------------------------------------------~~~  673 (893)
                                                                                                   .++
T Consensus       314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v  393 (590)
T KOG1290|consen  314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV  393 (590)
T ss_pred             cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence                                                                                         012


Q ss_pred             eEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcc----ccccHHH
Q 036624          674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPK----EQVSLAE  749 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~----~~~~l~~  749 (893)
                      ||+|||-|+-..     +..+.-..|..|.|||++.+..|+..+|||||+|++|||+||-.-|++....    ++..++.
T Consensus       394 KIaDlGNACW~~-----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~  468 (590)
T KOG1290|consen  394 KIADLGNACWVH-----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL  468 (590)
T ss_pred             EEeeccchhhhh-----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence            333333222110     0011223467899999999999999999999999999999999888764322    2222222


Q ss_pred             HHHH------------------hhcccchhhhc--cc-----cc--cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 036624          750 WAAH------------------CHKKGILEQIM--DP-----YL--KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL  802 (893)
Q Consensus       750 ~~~~------------------~~~~~~~~~i~--d~-----~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl  802 (893)
                      ....                  ..+.|.+..|-  .+     .|  +.+++.+...++.+++.-||+.+|++|||+.+++
T Consensus       469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl  548 (590)
T KOG1290|consen  469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL  548 (590)
T ss_pred             HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence            2211                  11122222211  11     11  2357788899999999999999999999999999


Q ss_pred             HHHH
Q 036624          803 WNLE  806 (893)
Q Consensus       803 ~~L~  806 (893)
                      ++-+
T Consensus       549 ~hPw  552 (590)
T KOG1290|consen  549 KHPW  552 (590)
T ss_pred             cCcc
Confidence            7765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=9.1e-27  Score=238.89  Aligned_cols=212  Identities=36%  Similarity=0.549  Sum_probs=183.9

Q ss_pred             eeecCcEEEEEEEEcCcceEEEEEeCCCCChh-hHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCHHH
Q 036624          540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLRE  618 (893)
Q Consensus       540 LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  618 (893)
                      ||+|++|.||++...+.+..+++|+....... ..+.+.+|++.+++++|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999876788999987754432 45779999999999999999999999999999999999999999999


Q ss_pred             HHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-CCceeEecccccccCCCCCCccceeeec
Q 036624          619 HLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPTLDHTHVSTVVK  697 (893)
Q Consensus       619 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~~  697 (893)
                      ++.... ..+++..+..++.+++++|.+||   ..+++|+||+|.||+++. ++.++|+|||.+........  ......
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV  154 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence            987553 35899999999999999999999   579999999999999999 89999999999876433211  122344


Q ss_pred             cCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHH
Q 036624          698 GSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC  776 (893)
Q Consensus       698 gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~  776 (893)
                      +...|++||.+... ..+.+.|+|++|+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            77899999999887 888999999999999999                                               


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          777 FKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       777 ~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                       ..+.+++.+|++.+|++||++.++++.|
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence             4677899999999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-29  Score=250.33  Aligned_cols=265  Identities=24%  Similarity=0.325  Sum_probs=196.0

Q ss_pred             ccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec-----CEEEEE
Q 036624          535 DEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN-----CEMILV  607 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV  607 (893)
                      +..+.||.|+||.||...+...++.|+.|++...  +-...+.+-+|+++|.-++|.|++..++...-.     .++|.+
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4466899999999999999888899999987653  233456788999999999999999998876543     356788


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      .|.|. .+|...|-..  ..|+-..+.-+..||++||.|||+   .+|.||||||.|+|++.|...|||||||+|.....
T Consensus       136 TELmQ-SDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHH-hhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchh
Confidence            88886 6777766443  358888999999999999999994   89999999999999999999999999999975443


Q ss_pred             CCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHH--------Hhhccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAA--------HCHKKG  758 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~  758 (893)
                      +..+. +...-|..|.|||++++. .|+.+.||||.|||+.||+..+.-|....+.++..+..-..        +..-+|
T Consensus       210 ~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  210 DRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            33333 333468899999999874 69999999999999999999998888776665544322110        111111


Q ss_pred             chhhhccccccC-------CC--ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          759 ILEQIMDPYLKG-------KI--APECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       759 ~~~~i~d~~l~~-------~~--~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .-..++....+.       .+  +...-.+-..+..+++..+|++|-+..+.+.++-
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            111121111100       00  1122234456777889999999999888887654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=3e-27  Score=257.25  Aligned_cols=197  Identities=22%  Similarity=0.357  Sum_probs=167.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--------ChhhHHHHHHHHHHHhhcc---ccceeeEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--------SEQGVHEFQTEIEMLSKLR---HRHLVSLIGYCEE  600 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--------~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~  600 (893)
                      .+|...+.||+|+||.|++|.++.....|+||.+...        .+...-....|+.||+.++   |+||+++++++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            3578889999999999999999988889999965431        1122224677999999997   9999999999999


Q ss_pred             cCEEEEEEeec-cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccc
Q 036624          601 NCEMILVYDYM-AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG  679 (893)
Q Consensus       601 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG  679 (893)
                      .+.++|++|-. ++-+|.++|...  +.+++..+..|+.|++.|+++||   ..+|||||||-+|+.++.+|.+||+|||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence            99999999975 455899998654  45999999999999999999999   6999999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeeccCcCccChHhhhhcCCC-CcchhhhHHHHHHHHhhCCCCCC
Q 036624          680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEILCARPALN  737 (893)
Q Consensus       680 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~  737 (893)
                      .+....    ......+.||..|.|||++.+.+|- ..-|||++|++||.++....|+.
T Consensus       716 saa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            876432    2234467899999999999998875 45899999999999999888874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=9e-26  Score=235.22  Aligned_cols=200  Identities=33%  Similarity=0.448  Sum_probs=172.9

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh-hHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      |+..+.||+|++|+||++...+.+..+++|........ ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            45667899999999999999886788999987765444 67789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      +++|.+++...... +++..+..++.+++++|.+||   +.+++|+||+++||+++.++.++|+|||++........ ..
T Consensus        81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~  155 (225)
T smart00221       81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-AL  155 (225)
T ss_pred             CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cc
Confidence            99999998765422 889999999999999999999   57999999999999999999999999999876543210 12


Q ss_pred             eeeeccCcCccChHhh-hhcCCCCcchhhhHHHHHHHHhhCCCCCCC
Q 036624          693 STVVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEILCARPALNP  738 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~-~~~~~s~ksDV~S~Gvvl~elltG~~p~~~  738 (893)
                      .....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2334578899999999 677788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-26  Score=230.38  Aligned_cols=254  Identities=19%  Similarity=0.282  Sum_probs=191.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEE-EeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGY-CEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E  609 (893)
                      +.|.+.+.||+|.||.+-++++++..+.+++|-... .....++|.+|..---.| .|.||+..++. ++..+...+++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            467888899999999999999999999999997653 344578899998776566 58999987765 566778889999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC--CCCceeEecccccccCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD--EKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld--~~~~~kl~DFGla~~~~~~  687 (893)
                      |++.|+|.+-+...+   +.+....+++.|++.||.|+|+   ..+||||||.+||||-  +..++||||||+.+.....
T Consensus       103 ~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  103 FAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             cCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            999999999886543   7888899999999999999994   8899999999999993  3458999999998753321


Q ss_pred             CCccceeeeccCcCccChHhhhhc-----CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                           .....-+..|.+||.+...     .....+|||.||++++..|||+.||+. ....+..+++|.....+...  .
T Consensus       177 -----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~~rk~~--~  248 (378)
T KOG1345|consen  177 -----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWLKRKNP--A  248 (378)
T ss_pred             -----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHhcccCc--c
Confidence                 1223345689999987532     356789999999999999999999984 33345556666554322211  1


Q ss_pred             hccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          763 IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       763 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                        -|..-..+    .+++..+-++-+..++++|-...++.++-.
T Consensus       249 --~P~~F~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  249 --LPKKFNPF----SEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             --Cchhhccc----CHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence              11111222    234555667888999999966666655543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-27  Score=262.10  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=203.6

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+...++|.|.||.|||+++...++..|+|.++.......+-.+.|+-+++..+|+||+.++|.+...+.+++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            46788889999999999999999988899999988766666677788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      |.+|+|++.-+.  ..+|++.++..+|+...+||+|||+   .+-+|||||-.|||+.+.+.+|++|||.+-....  .-
T Consensus        94 cgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti  166 (829)
T KOG0576|consen   94 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI  166 (829)
T ss_pred             cCCCcccceeee--cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence            999999986544  3469999999999999999999994   7889999999999999999999999999765332  12


Q ss_pred             cceeeeccCcCccChHhh---hhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc-
Q 036624          691 HVSTVVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP-  766 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~---~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~-  766 (893)
                      .....+.||+.|||||+.   +.+.|.+++|||+.|+...|+---.+|.....+....       .+..+    ...+| 
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-------~LmTk----S~~qpp  235 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-------FLMTK----SGFQPP  235 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-------HHhhc----cCCCCC
Confidence            223457799999999986   4667999999999999999998777776443321111       11111    11222 


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLW  803 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~  803 (893)
                      .++.  .....+.+-++++.|+.++|++||+...++.
T Consensus       236 ~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 TLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1111  1234566889999999999999999887764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=3.2e-26  Score=234.43  Aligned_cols=257  Identities=21%  Similarity=0.245  Sum_probs=192.0

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEeec------CEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------CEM  604 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~  604 (893)
                      +|.....+|.|.- .|--+.+.-.++.||+|+...  ......+...+|...+..++|+||++++.++.-.      .+.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4445567888876 666666665668899997543  2233455678999999999999999999998432      467


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++|||+|. .+|...++-    .++-+.+..|..|++.|++|||   ..+|+||||||+||++..+..+||.|||+++..
T Consensus        97 y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   97 YLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc
Confidence            99999997 789888862    3777889999999999999999   599999999999999999999999999999864


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc------
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG------  758 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------  758 (893)
                      ..   ....+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.+-     +..|.+-...-|      
T Consensus       169 ~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----idQ~~ki~~~lgtpd~~F  240 (369)
T KOG0665|consen  169 DT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-----IDQWNKIIEQLGTPDPSF  240 (369)
T ss_pred             Cc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-----HHHHHHHHHHhcCCCHHH
Confidence            32   2344556678899999999988899999999999999999999988864332     223322111000      


Q ss_pred             ---------------------chhhh-ccccccC--CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          759 ---------------------ILEQI-MDPYLKG--KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       759 ---------------------~~~~i-~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                                           ...+. .|.....  +.++-......+++.+||-.+|++|-+..++|++--
T Consensus       241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY  312 (369)
T KOG0665|consen  241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY  312 (369)
T ss_pred             HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence                                 01111 1111111  112223456788999999999999999999997643

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=6.8e-26  Score=221.03  Aligned_cols=263  Identities=19%  Similarity=0.256  Sum_probs=194.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeec--CEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEEN--CEMILV  607 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV  607 (893)
                      .++|++.+++|+|.++.||.|..-.....++||.+++..   .+.+.+|+.+|..|+ ||||++|++...+.  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            357888899999999999999977777899999988653   456889999999998 99999999998654  567899


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-CCceeEecccccccCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~~  686 (893)
                      +||+.+.+...+-     +.|+...+...+.+++.||.|+||   .||+|||+||.|++||. ....+|+|+|||.....
T Consensus       114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            9999988876543     236777888899999999999995   99999999999999995 46799999999986433


Q ss_pred             CCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc--------
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK--------  757 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--------  757 (893)
                      .....   ....+..|.-||.+-. +.|+..-|+|||||+|.+|+..+.||-......+ .|+..+.-+-.+        
T Consensus       186 ~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  186 GKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             Cceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHHHHHHHH
Confidence            22111   1124557788999865 5688899999999999999999988865433221 133333221111        


Q ss_pred             ------cchhhhccccccCC--------CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          758 ------GILEQIMDPYLKGK--------IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       758 ------~~~~~i~d~~l~~~--------~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                            .....++....+..        ...-...+..+++.+.|..|-.+|||+.|...+--+.
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence                  11122222111110        0001125677899999999999999999998776543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=1.3e-25  Score=241.54  Aligned_cols=273  Identities=22%  Similarity=0.235  Sum_probs=202.7

Q ss_pred             cCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc------ccceeeEE
Q 036624          522 FSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR------HRHLVSLI  595 (893)
Q Consensus       522 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~------H~niv~l~  595 (893)
                      +.+.|+  .-..|......|+|-|++|.+|.+...+..||||++... +.-.+.=..|+++|++|+      -.|+++|+
T Consensus       424 v~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  424 VRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             Eehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            334444  345788888899999999999998877789999998753 333455578999999995      35789999


Q ss_pred             EEEeecCEEEEEEeeccCCCHHHHHhhCC-CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC-Cce
Q 036624          596 GYCEENCEMILVYDYMAYGTLREHLYKTQ-KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK-WVA  673 (893)
Q Consensus       596 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~  673 (893)
                      -.|...+++|||+|-+. .+|.+.|.+.+ +..|....+...+.|+.-||..|.   +.+|+|.||||.|||+++. ..+
T Consensus       501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCccee
Confidence            99999999999999775 89999998764 345888999999999999999999   7999999999999999976 468


Q ss_pred             eEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHH-
Q 036624          674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAA-  752 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-  752 (893)
                      ||||||.|......+.+    ...-+.-|.|||++.+..|+...|+||.||+||||.||+.-|.+.......-+.--+. 
T Consensus       577 KLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG  652 (752)
T KOG0670|consen  577 KLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG  652 (752)
T ss_pred             eeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence            99999998764432221    1123447999999999999999999999999999999998887644332221111000 


Q ss_pred             ----Hhhcccch-h--------------------------hhccc------cccC--CC---ChHHHHHHHHHHHHcccc
Q 036624          753 ----HCHKKGIL-E--------------------------QIMDP------YLKG--KI---APECFKKFAETAMKCVSD  790 (893)
Q Consensus       753 ----~~~~~~~~-~--------------------------~i~d~------~l~~--~~---~~~~~~~l~~l~~~Cl~~  790 (893)
                          .+.+++.+ .                          ..+.|      .+..  .+   .+.....|.+|+.+|+..
T Consensus       653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L  732 (752)
T KOG0670|consen  653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL  732 (752)
T ss_pred             CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence                01111100 0                          00111      0111  12   224556788999999999


Q ss_pred             CCCCCCCHHHHHHHH
Q 036624          791 QGIERPSMGDVLWNL  805 (893)
Q Consensus       791 ~p~~RPtm~evl~~L  805 (893)
                      ||++|-|..+.|++-
T Consensus       733 dP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  733 DPEKRITVNQALKHP  747 (752)
T ss_pred             ChhhcCCHHHHhcCC
Confidence            999999999988753

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=2.5e-25  Score=274.97  Aligned_cols=198  Identities=18%  Similarity=0.246  Sum_probs=140.8

Q ss_pred             hccc-cceeeEEEEE-------eecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceE
Q 036624          585 KLRH-RHLVSLIGYC-------EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII  656 (893)
Q Consensus       585 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  656 (893)
                      +++| .||++++++|       .+...+++++|++ +++|.++|... ...+++.+++.++.||++||+|||   ..+||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            4556 5888888877       2334577889987 47999999754 345999999999999999999999   58999


Q ss_pred             ecCCCCCCEEECC-------------------CCceeEecccccccCCCCCC--------------ccceeeeccCcCcc
Q 036624          657 HRDVKTTNILLDE-------------------KWVAKVSDFGLSKTGPTLDH--------------THVSTVVKGSFGYL  703 (893)
Q Consensus       657 HrDlk~~NILld~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~  703 (893)
                      ||||||+||||+.                   ++.+||+|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   45566777777653211000              00011235788999


Q ss_pred             ChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHH
Q 036624          704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAET  783 (893)
Q Consensus       704 APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l  783 (893)
                      |||++.+..++.++|||||||+||||++|.+|+....    ..+..+.         ...+.+..     .........+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~---------~~~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLR---------HRVLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHH---------HhhcChhh-----hhcCHHHHHH
Confidence            9999999999999999999999999999988764211    0011110         01111111     1122345678


Q ss_pred             HHHccccCCCCCCCHHHHHHHH
Q 036624          784 AMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       784 ~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      +.+||+.+|.+||+|.||+++-
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhch
Confidence            8999999999999999998643

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=3.6e-24  Score=227.59  Aligned_cols=268  Identities=22%  Similarity=0.263  Sum_probs=197.5

Q ss_pred             HHHhcCCccceeeeecCcEEEEEEEEcC---cceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCE
Q 036624          528 KAATNNFDEALLLGVGGFGKVYRGEIDG---ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCE  603 (893)
Q Consensus       528 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~  603 (893)
                      ....+.|..+++||+|.|++||++.+..   ....||+|.+...+.  .....+|+++|..+. +.||+++.+++...+.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3345678899999999999999998765   668899998765443  345889999999995 9999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-CCceeEecccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSK  682 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~  682 (893)
                      .++|+||+++-.-.++...     ++...+...+..+..||.++|   ..|||||||||+|+|.+. .+.-.|.|||||.
T Consensus       110 v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence            9999999999998888753     667888899999999999999   699999999999999974 4678899999986


Q ss_pred             cCCCC-------C---------------------------C--------ccceeeeccCcCccChHhhhh-cCCCCcchh
Q 036624          683 TGPTL-------D---------------------------H--------THVSTVVKGSFGYLDPEYFRR-QQLTEKSDV  719 (893)
Q Consensus       683 ~~~~~-------~---------------------------~--------~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV  719 (893)
                      .....       .                           .        ........||+||.|||++.. ...+.++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            10000       0                           0        000112459999999999875 457889999


Q ss_pred             hhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH-----------hhcc------c---chhhhccc-------c-----
Q 036624          720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH-----------CHKK------G---ILEQIMDP-------Y-----  767 (893)
Q Consensus       720 ~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----------~~~~------~---~~~~i~d~-------~-----  767 (893)
                      ||.|||++-+++++.||-.... +...+++.+--           ....      .   .+.++...       .     
T Consensus       262 ws~GVI~Lslls~~~PFf~a~d-d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKD-DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeccceeehhhccccccccCcc-ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            9999999999999999965432 22223332111           0000      0   00011000       0     


Q ss_pred             ---ccCC-CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          768 ---LKGK-IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       768 ---l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         .... ..+..+..+.++..+|+..||.+|-|+++.|++--
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF  383 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF  383 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence               0000 11112236789999999999999999999997653

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=1.2e-23  Score=211.47  Aligned_cols=168  Identities=23%  Similarity=0.248  Sum_probs=126.3

Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      |+|.+++...+ .+++|.+++.|+.|+++||+|||+   .+      ||+|||+++++.+|+  ||+++.....      
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc------
Confidence            78999997543 459999999999999999999995   33      999999999999999  9998764321      


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA  773 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~  773 (893)
                       ...||+.|||||++.+..++.++|||||||++|||++|+.||....... ..+..+.......       ++. .....
T Consensus        63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~-------~~~-~~~~~  132 (176)
T smart00750       63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPAD-------DPR-DRSNL  132 (176)
T ss_pred             -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhccC-------Ccc-ccccH
Confidence             1258899999999999999999999999999999999999986432211 1111111111000       000 00111


Q ss_pred             hHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          774 PECFK--KFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       774 ~~~~~--~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      .....  .+.+++.+||+.+|++||++.|+++++....
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            22222  6899999999999999999999999998654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=209.56  Aligned_cols=244  Identities=21%  Similarity=0.364  Sum_probs=193.8

Q ss_pred             eeeecCcEEEEEEEEcCcceEEEEEeCC--CCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCH
Q 036624          539 LLGVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL  616 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~~~~VavK~~~--~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  616 (893)
                      +|.+...|..|+|++.+.  .+++|++.  ......-++|..|.-.|+-+.||||+.++|.|.....+.++..||+.|+|
T Consensus       197 kl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  197 KLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            688889999999999876  35666544  33444556899999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEe--cccccccCCCCCCcccee
Q 036624          617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVS--DFGLSKTGPTLDHTHVST  694 (893)
Q Consensus       617 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~--DFGla~~~~~~~~~~~~~  694 (893)
                      ...||+.....++-.++.+++.++|+|++|||+ .++-|.---|.+..+++|++.+++|+  |--++...         .
T Consensus       275 ynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad~kfsfqe---------~  344 (448)
T KOG0195|consen  275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---------V  344 (448)
T ss_pred             HHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheecccceeeeec---------c
Confidence            999999887778889999999999999999997 23334455799999999999998884  22111110         1


Q ss_pred             eeccCcCccChHhhhhcCCC---CcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          695 VVKGSFGYLDPEYFRRQQLT---EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       695 ~~~gt~~y~APE~~~~~~~s---~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ...-.+.||+||.++.++.+   +++|+|||.++||||.|...||..-.+-+..      .         ++.-.-++..
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------m---------kialeglrv~  409 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------M---------KIALEGLRVH  409 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------h---------hhhhcccccc
Confidence            11235789999999877644   4799999999999999999999755443221      1         1122234556


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      +++.....+.+++.-|+..||.+||....|+-.||+..
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            77888888999999999999999999999999998653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=3.1e-22  Score=220.73  Aligned_cols=168  Identities=23%  Similarity=0.163  Sum_probs=128.4

Q ss_pred             HHhcCCccceeeeecCcEEEEEEEEcC-cceEEEEEeCCCC-----ChhhHHHHHHHHHHHhhccccceeeEEEEEeecC
Q 036624          529 AATNNFDEALLLGVGGFGKVYRGEIDG-ATTKVAIKRGNPL-----SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC  602 (893)
Q Consensus       529 ~at~~f~~~~~LG~G~fG~Vy~g~~~~-~~~~VavK~~~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  602 (893)
                      ..-++|...++||+|+||+||+|.+.. ++..||||+....     .....+.|.+|+++|++++|+|++..+..+   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            344678899999999999999998764 4566899975432     223456799999999999999999533222   4


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCC-CCCCEEECCCCceeEeccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDV-KTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-k~~NILld~~~~~kl~DFGla  681 (893)
                      ..+|||||+++++|.. +. ..    .   ...++.+++++|.|||   ..+|+|||| ||+|||++.++.+||+|||++
T Consensus        92 ~~~LVmE~~~G~~L~~-~~-~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-AR-PH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CcEEEEEccCCCCHHH-hC-cc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            5799999999999963 21 11    1   1467889999999999   589999999 999999999999999999999


Q ss_pred             ccCCCCCCc------cceeeeccCcCccChHhhhhc
Q 036624          682 KTGPTLDHT------HVSTVVKGSFGYLDPEYFRRQ  711 (893)
Q Consensus       682 ~~~~~~~~~------~~~~~~~gt~~y~APE~~~~~  711 (893)
                      +........      ...+...+++.|+|||++...
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            864322110      111356788999999998643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.9e-21  Score=214.89  Aligned_cols=262  Identities=18%  Similarity=0.198  Sum_probs=195.4

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcc-eEEEEEeCCCCChhhHHHHHHHHHHHhhccc----cceeeEEEEE-eecCEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH----RHLVSLIGYC-EENCEMIL  606 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~-~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l  606 (893)
                      +|...++||+|+||.||++...... ..+|+|............+..|+.++..+.+    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7889999999999999999987653 5788887554333222367889999998873    5888899888 47778899


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC-----CceeEeccccc
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK-----WVAKVSDFGLS  681 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-----~~~kl~DFGla  681 (893)
                      ||+.+ |.+|.++........++..+.++|+.|++.+|++||   +.++|||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99976 589999876655567999999999999999999999   6999999999999999854     46999999999


Q ss_pred             c--cCCCCCC---ccc---eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH
Q 036624          682 K--TGPTLDH---THV---STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH  753 (893)
Q Consensus       682 ~--~~~~~~~---~~~---~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  753 (893)
                      +  .......   ...   .....||.+|.++....+.+.+.+.|+||++.++.|++.|..||........  .......
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~~~~  252 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKFEKD  252 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHHHHH
Confidence            8  3111111   111   2345699999999999999999999999999999999999999865332211  0110000


Q ss_pred             hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       754 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                           ........     .....+..+.++...+-..+..++|....+...|+.+..
T Consensus       253 -----~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  253 -----PRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             -----hhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence                 00111111     112233455666666666899999999999998876654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=9.1e-20  Score=199.79  Aligned_cols=256  Identities=29%  Similarity=0.417  Sum_probs=195.1

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh---hHHHHHHHHHHHhhcccc-ceeeEEEEEeecCEEEEEEe
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ---GVHEFQTEIEMLSKLRHR-HLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~---~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E  609 (893)
                      |...+.||.|+||.||++...   ..+++|.+......   ....|.+|+.+++.+.|+ +++++.+++......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            556778999999999999987   56888876654222   467899999999999988 79999999977777899999


Q ss_pred             eccCCCHHHHHhhCCC-CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC-ceeEecccccccCCCC
Q 036624          610 YMAYGTLREHLYKTQK-PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW-VAKVSDFGLSKTGPTL  687 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~~~  687 (893)
                      ++.+++|.+++..... ..+.......+..|++.++.|+|   ..+++|||+||+||+++... .++++|||+++.....
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999966654432 25889999999999999999999   57899999999999999988 7999999998754332


Q ss_pred             CCc----cceeeeccCcCccChHhhhh---cCCCCcchhhhHHHHHHHHhhCCCCCCCCCcc-ccccHHHHHHHhhcccc
Q 036624          688 DHT----HVSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPK-EQVSLAEWAAHCHKKGI  759 (893)
Q Consensus       688 ~~~----~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~  759 (893)
                      ...    .......|+..|+|||.+..   ...+...|+||+|++++++++|..|+...... ......+.....     
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-----  230 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-----  230 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc-----
Confidence            221    12356679999999999987   68899999999999999999999996544321 000111111110     


Q ss_pred             hhhhccccccCCCC----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          760 LEQIMDPYLKGKIA----PECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       760 ~~~i~d~~l~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                          ..+.......    ......+.+++..|+..+|..|.++.+....
T Consensus       231 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         231 ----PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ----CCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                0000011111    2223568889999999999999999987765

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=5.4e-20  Score=181.44  Aligned_cols=260  Identities=19%  Similarity=0.169  Sum_probs=192.9

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccc-cceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ..+|..+++||.|+||.+|.|..-..+..||||.-...  ....++.-|..+...|+| ..|..+..|..++..-.||||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            35788999999999999999998888899999975432  223457889999999975 678888888888888999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC---CceeEecccccccCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK---WVAKVSDFGLSKTGPT  686 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla~~~~~  686 (893)
                      .+ |-+|.++..-. ...++.++.+-++-|++.-++|+|   ..++|||||||+|+|+.-+   ..+.++|||||+....
T Consensus        92 LL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             cc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            87 57888876543 345899999999999999999999   6899999999999999743   4789999999985322


Q ss_pred             CC-C----ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          687 LD-H----THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       687 ~~-~----~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      .. .    ........||.+|.+-....+.+.+.+.|+-|+|.+|..+.-|..||++-.......-.+-..+..-.-.++
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie  246 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE  246 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence            11 1    122345669999999998888888999999999999999999999998754433221111111100000111


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                           .+.    ...+.++...+.-|-..--++-|...-+-+.+.
T Consensus       247 -----~LC----~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  247 -----VLC----KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             -----HHh----CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence                 112    223456677777888888888888655544443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=3.8e-21  Score=225.74  Aligned_cols=257  Identities=19%  Similarity=0.208  Sum_probs=189.2

Q ss_pred             cceeeeecCcEEEEEEEEcCcceEEEEEeCC-----CCChhhH-HHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          536 EALLLGVGGFGKVYRGEIDGATTKVAIKRGN-----PLSEQGV-HEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~-----~~~~~~~-~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ..+++|.|++|.|+...........+.|...     ....... ..+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4568999999977777654443434444221     1112211 226677778888999999888887777766666699


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      ||++ +|..++...  ..+.-..+..++.|+.+|+.|||   ..+|.|||||++|+++..++.+||+|||.+........
T Consensus       402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            9998 999998654  24788889999999999999999   59999999999999999999999999999876443333


Q ss_pred             c--cceeeeccCcCccChHhhhhcCCCC-cchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          690 T--HVSTVVKGSFGYLDPEYFRRQQLTE-KSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       690 ~--~~~~~~~gt~~y~APE~~~~~~~s~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      .  +.....+|+..|+|||++.+.+|.. ..||||.|+++..|++|+.||......+....        ......+.-..
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--------~~~~~~~~~~~  547 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--------TNNYSDQRNIF  547 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh--------hhccccccccc
Confidence            3  5667788999999999999999876 48999999999999999999976554433210        00000000000


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .-...+....+.....++.++|+.+|.+|-||.+|++.=+
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW  587 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence            0011122345566788999999999999999999986544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=3.1e-19  Score=183.70  Aligned_cols=262  Identities=17%  Similarity=0.196  Sum_probs=193.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      -+|...++||+|.||..+.|+.--.++.||||.-...+  +.-++..|.+..+.|. .++|...+-+..++..-.||+|+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            36778899999999999999987777999999754332  3456788988888885 68999999888888889999998


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC-----CceeEecccccccCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK-----WVAKVSDFGLSKTGP  685 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-----~~~kl~DFGla~~~~  685 (893)
                      + |-||+++..-. ...++.++++.||+|+..-++|+|   ...+|.|||||+|+||..-     ..+.|+|||+|+...
T Consensus       106 L-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  106 L-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             h-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            7 47888866433 446999999999999999999999   5889999999999999643     468999999998632


Q ss_pred             CCC-----CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHH--HHhhccc
Q 036624          686 TLD-----HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWA--AHCHKKG  758 (893)
Q Consensus       686 ~~~-----~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--~~~~~~~  758 (893)
                      ...     .........||.+||+-....+.+.+.+.|+-|+|-+++..|-|..||.+-......  ..+-  ....+.-
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK--~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK--EKYEKIGETKRST  258 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH--HHHHHhccccccC
Confidence            211     112234567999999999999999999999999999999999999999864321110  0010  0000111


Q ss_pred             chhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          759 ILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       759 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      .++++         ....+.++..-+.-.-..+-++-|...-+...+..++..
T Consensus       259 ~i~~L---------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  259 PIEVL---------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             CHHHH---------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence            11111         112234455555555556777888887776666666543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=2.8e-19  Score=200.45  Aligned_cols=218  Identities=25%  Similarity=0.387  Sum_probs=162.2

Q ss_pred             HhhccccceeeEEEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCC
Q 036624          583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKT  662 (893)
Q Consensus       583 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~  662 (893)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....++|.-...+..+++.||+|||+  ..-..|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence            4578999999999999999999999999999999999976 34569999999999999999999995  22238999999


Q ss_pred             CCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhc-------CCCCcchhhhHHHHHHHHhhCCCC
Q 036624          663 TNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLFEILCARPA  735 (893)
Q Consensus       663 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~s~ksDV~S~Gvvl~elltG~~p  735 (893)
                      +|+++|..+.+||+|||+.................-..-|.|||.++..       ..+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998765321111111122234579999999763       247789999999999999999999


Q ss_pred             CCCCCcccc-ccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          736 LNPTLPKEQ-VSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       736 ~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      |........ ..++.++..     .-.....|.+...  .+....+..++..||..+|++||++.+|-..++....
T Consensus       158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            976433222 122222211     0111112221111  1344468899999999999999999998877776554

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=3.9e-19  Score=182.58  Aligned_cols=171  Identities=14%  Similarity=0.143  Sum_probs=131.5

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh---hhHHH------HHHHHHHHhhccccceeeEEEEEee
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE---QGVHE------FQTEIEMLSKLRHRHLVSLIGYCEE  600 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~---~~~~~------f~~E~~~l~~l~H~niv~l~g~~~~  600 (893)
                      ..++|+..++||.|+||.||+....  ...+++|.+.+...   .....      +.+|+..+.+++|++|..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTD--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecC--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3688999999999999999997663  35799998764322   22222      6899999999999999999888553


Q ss_pred             c--------CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc
Q 036624          601 N--------CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV  672 (893)
Q Consensus       601 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~  672 (893)
                      .        ...+|||||++|.+|.++..      ++.    ....+++.+|..||   ..+++|||+||+||+++.++ 
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-
Confidence            2        35789999999999988631      222    34568999999999   69999999999999999988 


Q ss_pred             eeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHh
Q 036624          673 AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL  730 (893)
Q Consensus       673 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ell  730 (893)
                      ++|+|||..+.....  ..            -..+.....+..++|+|+|||.+..+.
T Consensus       173 i~liDfg~~~~~~e~--~a------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQR--KA------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccch--hh------------HHHHHHHhHhcccccccceeEeehHHH
Confidence            999999987643211  00            011445556778999999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.78  E-value=5.5e-19  Score=179.38  Aligned_cols=139  Identities=16%  Similarity=0.123  Sum_probs=105.6

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh--h-------HH-----------------HHHHHHHHHhhccccc
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ--G-------VH-----------------EFQTEIEMLSKLRHRH  590 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~--~-------~~-----------------~f~~E~~~l~~l~H~n  590 (893)
                      ...||+|+||.||+|... .++.||||+.+.....  .       ..                 ....|++.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            357999999999999987 5589999986543110  0       11                 2235999999998877


Q ss_pred             eeeEEEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC
Q 036624          591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK  670 (893)
Q Consensus       591 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~  670 (893)
                      +.....+..  ...+|||||+++++|...+...  ..+++.....++.|++.+|.|||+  ..+|+||||||+|||+++ 
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~~-  153 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYHD-  153 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEEC-
Confidence            643332222  2238999999988776553322  358899999999999999999942  579999999999999984 


Q ss_pred             CceeEeccccccc
Q 036624          671 WVAKVSDFGLSKT  683 (893)
Q Consensus       671 ~~~kl~DFGla~~  683 (893)
                      +.++|+|||++..
T Consensus       154 ~~v~LiDFG~a~~  166 (190)
T cd05147         154 GKLYIIDVSQSVE  166 (190)
T ss_pred             CcEEEEEcccccc
Confidence            7899999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.76  E-value=7.1e-18  Score=171.74  Aligned_cols=141  Identities=15%  Similarity=0.110  Sum_probs=108.7

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh--------------------------hHHHHHHHHHHHhhccccc
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ--------------------------GVHEFQTEIEMLSKLRHRH  590 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~--------------------------~~~~f~~E~~~l~~l~H~n  590 (893)
                      ...||+|+||.||+|... +++.||||+.+.....                          ....+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            457999999999999987 5589999976643210                          0122467899999999998


Q ss_pred             eeeEEEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC
Q 036624          591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK  670 (893)
Q Consensus       591 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~  670 (893)
                      +.....+...  ..+|||||++++++...+...  ..++......++.|++.+|.+||+  ..+|+||||||+|||++ +
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~  153 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-C
Confidence            7544443332  248999999988654432222  347788999999999999999994  38999999999999999 7


Q ss_pred             CceeEecccccccCC
Q 036624          671 WVAKVSDFGLSKTGP  685 (893)
Q Consensus       671 ~~~kl~DFGla~~~~  685 (893)
                      +.++|+|||+++...
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=9.8e-18  Score=177.33  Aligned_cols=231  Identities=18%  Similarity=0.271  Sum_probs=150.0

Q ss_pred             ccceeeeecCcEEEEEEEEcCcceEEEEEeCC---CCChhhHHHHHHHHHHHhhcc----------ccceeeEEEEEe--
Q 036624          535 DEALLLGVGGFGKVYRGEIDGATTKVAIKRGN---PLSEQGVHEFQTEIEMLSKLR----------HRHLVSLIGYCE--  599 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~---~~~~~~~~~f~~E~~~l~~l~----------H~niv~l~g~~~--  599 (893)
                      ...+.||.|+++.||.+++..+++.+|+|...   .......+++.+|.-....+.          |-.++--++...  
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            35678999999999999999999999999633   223345677777765555432          322322222221  


Q ss_pred             -------ec---C-----EEEEEEeeccCCCHHHHHh---hCC--CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecC
Q 036624          600 -------EN---C-----EMILVYDYMAYGTLREHLY---KTQ--KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD  659 (893)
Q Consensus       600 -------~~---~-----~~~lV~E~~~~gsL~~~l~---~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  659 (893)
                             ..   .     ..+++|+-+. ++|.+.+.   ...  ...+....++.+..|+.+.+++||   ..++||+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence                   11   1     1367788775 88888754   222  223556677888899999999999   49999999


Q ss_pred             CCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhc--------CCCCcchhhhHHHHHHHHhh
Q 036624          660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ--------QLTEKSDVYSFGVVLFEILC  731 (893)
Q Consensus       660 lk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--------~~s~ksDV~S~Gvvl~ellt  731 (893)
                      |||+|++++.+|.++|+||+........     ......+..|.+||.....        .+|.+.|.|++|++||.|.|
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999999999999876543221     1112345789999987543        57889999999999999999


Q ss_pred             CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCC
Q 036624          732 ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIER  795 (893)
Q Consensus       732 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R  795 (893)
                      ++.||....+.....   |                .+ .... +.++.+..|+..+|+.+|++|
T Consensus       246 ~~lPf~~~~~~~~~~---~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPE---W----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSG---G----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCcccccc---c----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999997653322110   0                11 1222 677889999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.1e-17  Score=168.24  Aligned_cols=186  Identities=18%  Similarity=0.122  Sum_probs=137.6

Q ss_pred             cceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh----hHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEEee
Q 036624          536 EALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ----GVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~----~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ....|++|+||+||.+..  .+..++.+.+......    ....|.+|+++|++|. |+++.+++++    +..+++|||
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            456899999999997765  3366776665543221    1225889999999995 5889999886    346999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCC-CCCCEEECCCCceeEecccccccCCCCCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDV-KTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-k~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      +.|.+|...+..         ....++.|++++|+++|   ..+|+|||| ||+|||+++++.++|+|||++........
T Consensus        80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             ecCccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            999998754321         12357789999999999   589999999 79999999999999999999985432211


Q ss_pred             c----------cc-eeeeccCcCccChHhhhhc-CCC-CcchhhhHHHHHHHHhhCCCCCCCC
Q 036624          690 T----------HV-STVVKGSFGYLDPEYFRRQ-QLT-EKSDVYSFGVVLFEILCARPALNPT  739 (893)
Q Consensus       690 ~----------~~-~~~~~gt~~y~APE~~~~~-~~s-~ksDV~S~Gvvl~elltG~~p~~~~  739 (893)
                      .          +. +...+.++.|++|+...-- ..+ ...+.++-|+-+|.++|++.+.-..
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            0          00 1123367889999865432 333 4679999999999999999876543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.75  E-value=7.1e-19  Score=204.95  Aligned_cols=246  Identities=22%  Similarity=0.269  Sum_probs=175.6

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHH--HhhccccceeeEEEEEeecCEEEEEEe
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEM--LSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++...+.||.+.|=+|.+|++..+  .|+||++-... .-..+.|.++++-  ...++|||.+++.-+-......+||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            566677899999999999999876  37888643322 2334444444433  445689999999888777777889999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC--CCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG--PTL  687 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~--~~~  687 (893)
                      |+. -+|++.|.  .++-|...+..-|+.|++.||.-+|   +.+|+|||||.+||||+.-.-+.|+||.--+..  +..
T Consensus       102 yvk-hnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  102 YVK-HNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHh-hhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            886 58888883  4556888888999999999999999   699999999999999999888999999865532  111


Q ss_pred             ---CCccceeeeccCcCccChHhhhhc-----------CCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHH
Q 036624          688 ---DHTHVSTVVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA  752 (893)
Q Consensus       688 ---~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  752 (893)
                         +..........-..|+|||.+-..           ..+.+.||||+||++.||++ |+++|+-.      .|..+..
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~  249 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRS  249 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhc
Confidence               111111222233489999987431           26788999999999999998 57777421      1111111


Q ss_pred             H--hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          753 H--CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       753 ~--~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .  ...+..+++|-|            ..++++++.|++.||++|-++.+.++.
T Consensus       250 ~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  250 GNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0  000111222222            257889999999999999999999976

>PRK10345 hypothetical protein; Provisional

Probab=99.72  E-value=3.7e-17  Score=167.58  Aligned_cols=136  Identities=21%  Similarity=0.230  Sum_probs=105.8

Q ss_pred             ccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-----cccceeeEEEEEeecC---E-EE
Q 036624          535 DEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-----RHRHLVSLIGYCEENC---E-MI  605 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~  605 (893)
                      ....+||+|+||.||.  +..... .+||+.........+.+.+|+.+++++     .||||++++|++++..   . ..
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            4566899999999996  444433 468876654444567899999999999     5799999999998763   3 44


Q ss_pred             EEEee--ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhh-hhhhcCCCCceEecCCCCCCEEECC----CCceeEecc
Q 036624          606 LVYDY--MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL-HYLHTGAKHTIIHRDVKTTNILLDE----KWVAKVSDF  678 (893)
Q Consensus       606 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDlk~~NILld~----~~~~kl~DF  678 (893)
                      +|+||  +.+|+|.+++.+.   .+++.  ..++.+++.++ +|||   +.+||||||||+|||++.    +..++|+||
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            78999  5589999999653   25555  35677888777 9999   599999999999999974    348999995


Q ss_pred             ccc
Q 036624          679 GLS  681 (893)
Q Consensus       679 Gla  681 (893)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.72  E-value=2.1e-18  Score=192.90  Aligned_cols=226  Identities=24%  Similarity=0.271  Sum_probs=173.6

Q ss_pred             eeeecCcEEEEEEEE---cCcceEEEEEeCCCCChh--hHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEEeecc
Q 036624          539 LLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQ--GVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~---~~~~~~VavK~~~~~~~~--~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      ++|+|.||.|++..-   .+.+...|+|.+......  .......|-.++..++ ||.+|++.-.++.....+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999996542   223355666654432211  1124567788888887 9999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccc
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      +|.|..++.+...  ............++-+++++|   +.+|+|||+|++||+++.+|.+|+.|||+++..-...    
T Consensus        81 gg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM--FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----  151 (612)
T ss_pred             cchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence            9999998866543  666666677778888999999   6999999999999999999999999999998643211    


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCC
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI  772 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  772 (893)
                        ..|||..|||||++.  .....+|.||||++++||++|..||..          +         .+..|+..  ....
T Consensus       152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~---------~~~~Il~~--~~~~  206 (612)
T KOG0603|consen  152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------D---------TMKRILKA--ELEM  206 (612)
T ss_pred             --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------H---------HHHHHhhh--ccCC
Confidence              118999999999998  557789999999999999999999964          1         11112211  1234


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCH
Q 036624          773 APECFKKFAETAMKCVSDQGIERPSM  798 (893)
Q Consensus       773 ~~~~~~~l~~l~~~Cl~~~p~~RPtm  798 (893)
                      +.+.......++..++..+|..|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            55666777788888899999998754

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=9.8e-17  Score=191.76  Aligned_cols=199  Identities=20%  Similarity=0.227  Sum_probs=155.4

Q ss_pred             HHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc---ccceeeEEEEEeecC
Q 036624          526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR---HRHLVSLIGYCEENC  602 (893)
Q Consensus       526 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~  602 (893)
                      +++.....|.+...||+|+||+||+|...+ ++.||+|.-++.+..+   |--=.+++.||+   -+.|..+..++.-.+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence            344445678889999999999999999988 5899999866543321   100112233333   123344444445556


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC-------CCCceeE
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD-------EKWVAKV  675 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-------~~~~~kl  675 (893)
                      ..+||+||.+-|+|.+++.  .....+|...+.|+.|+++-++.||   ..+|||+||||+|+||.       ++..++|
T Consensus       768 ~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             cceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEE
Confidence            7799999999999999997  3445999999999999999999999   69999999999999993       3457999


Q ss_pred             ecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCC
Q 036624          676 SDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR  733 (893)
Q Consensus       676 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~  733 (893)
                      +|||.+-.+............++|-.+-.+|+..++.++...|.|.+.-+++-||.|+
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            9999987644333334556778999999999999999999999999999999999986

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=4.8e-17  Score=190.05  Aligned_cols=210  Identities=23%  Similarity=0.331  Sum_probs=147.0

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ..+|+.++.|..|+||.||..+++...+++|+|+-+. +.     +.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l-----ilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL-----ILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccccc-ch-----hhhc--cccccCCccee------------------
Confidence            3678999999999999999999998878888854221 11     0100  22222333333                  


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC--
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD--  688 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~--  688 (893)
                         |+....+...+.  ++-..        +.+++|||   ..+|+|||+||+|.||..-|.+|+.|||+++.+....  
T Consensus       136 ---gDc~tllk~~g~--lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP--LPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ---chhhhhcccCCC--Ccchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence               566666644433  33222        67799999   5999999999999999999999999999987532110  


Q ss_pred             -----------CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc
Q 036624          689 -----------HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       689 -----------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  757 (893)
                                 .......++||+.|+|||++..+.|...+|+|++|+|+||.+-|+.||.+..+++-.      ..+...
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------g~visd  273 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVISD  273 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------hhhhhh
Confidence                       111124578999999999999999999999999999999999999999876554311      111100


Q ss_pred             cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCC
Q 036624          758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERP  796 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  796 (893)
                          ++.-    .+-++....+..+++.+.|+.+|.+|-
T Consensus       274 ----~i~w----pE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  274 ----DIEW----PEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ----hccc----cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                0111    111333455678889999999999995

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.67  E-value=2.4e-17  Score=181.17  Aligned_cols=173  Identities=25%  Similarity=0.356  Sum_probs=128.3

Q ss_pred             EEEEEEeeccCCCHHHHHhhC-CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKT-QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      .+++.|++|...+|.++|.+. .....+|...+.++.|++.|++|      .+.+|||+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999744 44567899999999999999999      57899999999999999999999999997


Q ss_pred             ccCCCCC----CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhC-CCCCCCCCccccccHHHHHHHhhc
Q 036624          682 KTGPTLD----HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA-RPALNPTLPKEQVSLAEWAAHCHK  756 (893)
Q Consensus       682 ~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~  756 (893)
                      .......    .....+...||..||+||.+.+..|+.|+||||||++|+||+.- ..+++                  .
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------------r  465 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------------R  465 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------------H
Confidence            6533222    12234556799999999999999999999999999999999962 11111                  1


Q ss_pred             ccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHH
Q 036624          757 KGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGD  800 (893)
Q Consensus       757 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~e  800 (893)
                      .+.+.++-|..+...+-.+.+ +=..+..+++...|.+||+..+
T Consensus       466 ~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  466 IATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             HHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHH
Confidence            112233333222211111111 1245788999999999994433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=5.2e-16  Score=160.86  Aligned_cols=134  Identities=25%  Similarity=0.340  Sum_probs=111.5

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh--------hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE--------QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      +.||+|++|.||+|...+  ..|++|+......        .....+.+|++++.+++|+++.....++......++|||
T Consensus         2 ~~l~~G~~~~vy~~~~~~--~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLG--IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEeeCC--CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            479999999999998854  4678886443211        123467889999999999999887777777778899999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      |++|++|.+.+....     + .+..++.+++.+|.+||   ..+++|||++|.|||++ ++.++|+|||+++.
T Consensus        80 ~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999885432     2 88899999999999999   58999999999999999 78999999998864

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.65  E-value=4.3e-16  Score=183.99  Aligned_cols=138  Identities=22%  Similarity=0.267  Sum_probs=111.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC------hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS------EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      ..|...++||+|+||+||+|.+.+....+.++..+...      ....+.+.+|++++.+++|++++....++......+
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            34456779999999999999887653322222222111      122356889999999999999998888887777889


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      +||||+++++|.+++.          .+..++.+++++|.|||   +.+++||||||+|||+ +++.++|+|||+++.
T Consensus       413 lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999999999885          45789999999999999   5899999999999999 677999999999875

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.65  E-value=7.7e-16  Score=162.06  Aligned_cols=198  Identities=20%  Similarity=0.218  Sum_probs=139.1

Q ss_pred             cccceeeEEEEEee---------------------------cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHH
Q 036624          587 RHRHLVSLIGYCEE---------------------------NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG  639 (893)
Q Consensus       587 ~H~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  639 (893)
                      +|||||++.+++.+                           ...++|||.-.+ -+|+++|..+.   .+...+.-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence            59999999887632                           345789998776 68999986554   556667778999


Q ss_pred             HHHhhhhhhcCCCCceEecCCCCCCEEE--CCCC--ceeEecccccccCCC--C--CCccceeeeccCcCccChHhhhhc
Q 036624          640 AARGLHYLHTGAKHTIIHRDVKTTNILL--DEKW--VAKVSDFGLSKTGPT--L--DHTHVSTVVKGSFGYLDPEYFRRQ  711 (893)
Q Consensus       640 ia~gL~yLH~~~~~~ivHrDlk~~NILl--d~~~--~~kl~DFGla~~~~~--~--~~~~~~~~~~gt~~y~APE~~~~~  711 (893)
                      +++|+.|||   +++|.|||+|++||||  |+|.  ...|+|||++-....  .  .+..-.....|...-||||+....
T Consensus       350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999   7999999999999998  4443  578999998643211  1  111111223478889999998643


Q ss_pred             C------CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHH
Q 036624          712 Q------LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAM  785 (893)
Q Consensus       712 ~------~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~  785 (893)
                      +      --.|+|.|+.|-+.||+++...||....+ ...+...          .++---    ...+..++..+.+++.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~----------Yqe~qL----Palp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRT----------YQESQL----PALPSRVPPVARQLVF  491 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhh----------hhhhhC----CCCcccCChHHHHHHH
Confidence            2      12589999999999999999999976322 1111111          111111    2234556677889999


Q ss_pred             HccccCCCCCCCHHHHHHHHH
Q 036624          786 KCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       786 ~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..|+.||.+|++..-....|.
T Consensus       492 ~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHhcCCccccCCccHHHhHHH
Confidence            999999999998655444443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.64  E-value=8.7e-16  Score=157.63  Aligned_cols=130  Identities=26%  Similarity=0.355  Sum_probs=105.0

Q ss_pred             eeeecCcEEEEEEEEcCcceEEEEEeCCCCC--------hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--------EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .||+|+||.||+|...+  ..|++|......        ......+.+|++++..++|+++.....++......++||||
T Consensus         1 ~ig~G~~~~vy~~~~~~--~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLG--LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeecCC--ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            48999999999999654  568888643221        11235678999999999988766555555566677899999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      ++|++|.+.+.....         .++.+++++|.+||   ..+++|||++|+||+++ ++.+++.|||+++.
T Consensus        79 ~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND---------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH---------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999998754321         78999999999999   58999999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.64  E-value=8.3e-16  Score=161.47  Aligned_cols=141  Identities=18%  Similarity=0.146  Sum_probs=108.6

Q ss_pred             CCccceeeeecCcEEEEEEE-EcCcceEEEEEeCCCCChh------------------------hHHHHHHHHHHHhhcc
Q 036624          533 NFDEALLLGVGGFGKVYRGE-IDGATTKVAIKRGNPLSEQ------------------------GVHEFQTEIEMLSKLR  587 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~~VavK~~~~~~~~------------------------~~~~f~~E~~~l~~l~  587 (893)
                      .|...+.||+|+||.||+|. ....+..||+|........                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788899999999999998 5445688999976532110                        1123578999999997


Q ss_pred             ccc--eeeEEEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCc-eEecCCCCCC
Q 036624          588 HRH--LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT-IIHRDVKTTN  664 (893)
Q Consensus       588 H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDlk~~N  664 (893)
                      +..  +.+.+++    ...+|||||+++++|...+...  ..+.......++.|++.+|++||   ..+ |+||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhh
Confidence            633  3444543    2348999999998887654222  23566677899999999999999   578 9999999999


Q ss_pred             EEECCCCceeEeccccccc
Q 036624          665 ILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       665 ILld~~~~~kl~DFGla~~  683 (893)
                      |+++ ++.++|+|||++..
T Consensus       180 Ili~-~~~i~LiDFg~a~~  197 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             EEEE-CCCEEEEEChhhhc
Confidence            9999 78999999999874

>PLN03150 hypothetical protein; Provisional

Probab=99.63  E-value=8.4e-15  Score=174.88  Aligned_cols=155  Identities=23%  Similarity=0.275  Sum_probs=106.1

Q ss_pred             cEEEecCCCC------CCCCCC--CCccccCCCCcccccCCCc--ccccccCCCC-CCCCCCcccceeecC---CceEEe
Q 036624           35 QILLNCGESS------ILSDDD--KRSWTPDIGSKFLLSTKDS--TTSKAATQDP-STPTIPYMTARVFRS---EFTYSF  100 (893)
Q Consensus        35 ~~~I~CG~~~------~~~~~~--~~~w~~D~~~~~g~~~~~~--~~~~~~~~~~-~~~~~~y~t~R~f~~---~~cY~~  100 (893)
                      .+|||||+..      +.+|.-  +|.|.+|..|..+....++  ..+..+...+ ..+..-|+|+|.+..   ...|.+
T Consensus       193 ~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~  272 (623)
T PLN03150        193 AKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTM  272 (623)
T ss_pred             EEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCccChHHHhhhhccccCCCCceEEEe
Confidence            4699999732      112222  6999999887633222222  1111111111 112334999999875   379999


Q ss_pred             eecC-CceEEEEEEecCCCCCCCCCCcceEEEeCCeEEEeccChhhhhhhhccceeEEEEeeecCCCcEEEEEeeCCCCC
Q 036624          101 PVVA-GRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPMNVSN  179 (893)
Q Consensus       101 p~~~-g~~yvR~~F~~g~yd~~~~~~~~Fdv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~i~f~p~~~~~  179 (893)
                      ++.+ |.|+||+||++..........++|||+++|.....+|+....++ ....++++++.+.+..++++|+|.|..++ 
T Consensus       273 ~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g-~~~~~~~~~~~v~~~~g~l~isl~p~~~s-  350 (623)
T PLN03150        273 DVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSG-ERYTALVLNKTVAVSGRTLTIVLQPKKGT-  350 (623)
T ss_pred             ecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcC-CcccceEEEeEEeecCCeEEEEEeeCCCC-
Confidence            9976 55559999999875433434589999999987888888653332 23468888999988888899999998733 


Q ss_pred             cceeecceeeeec
Q 036624          180 AYAFVNGIEVMSM  192 (893)
Q Consensus       180 ~~~fv~~~e~~~~  192 (893)
                       .|++|||||+++
T Consensus       351 -~pilNaiEI~~~  362 (623)
T PLN03150        351 -HAIINAIEVFEI  362 (623)
T ss_pred             -cceeeeeeeeec
Confidence             699999999999

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.62  E-value=2.3e-15  Score=154.46  Aligned_cols=143  Identities=20%  Similarity=0.113  Sum_probs=109.1

Q ss_pred             HHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh----------------------hhHHHHHHHHHH
Q 036624          525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE----------------------QGVHEFQTEIEM  582 (893)
Q Consensus       525 ~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~----------------------~~~~~f~~E~~~  582 (893)
                      .++......|...+.||+|+||.||++.... +..||||+......                      .....+..|+.+
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPD-GNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCC-CCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            3444444446777899999999999998864 57899997443210                      011236788999


Q ss_pred             Hhhccccc--eeeEEEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCC
Q 036624          583 LSKLRHRH--LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDV  660 (893)
Q Consensus       583 l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  660 (893)
                      +..+.|++  +...++.    ...++||||+++++|......        .....++.+++.++.++|   ..+|+||||
T Consensus        87 l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl  151 (198)
T cd05144          87 LKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDL  151 (198)
T ss_pred             HHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCC
Confidence            99998874  4445442    345899999999998765421        345678999999999999   589999999


Q ss_pred             CCCCEEECCCCceeEeccccccc
Q 036624          661 KTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       661 k~~NILld~~~~~kl~DFGla~~  683 (893)
                      ||+||++++++.++|+|||++..
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             CcccEEEcCCCcEEEEECCcccc
Confidence            99999999999999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.56  E-value=2.5e-14  Score=138.86  Aligned_cols=135  Identities=19%  Similarity=0.187  Sum_probs=114.8

Q ss_pred             cceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccc--cceeeEEEEEeecCEEEEEEeeccC
Q 036624          536 EALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH--RHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      +.+.||+|.++.||++...+  ..+++|.......  ...+..|+.++..++|  .++.+++++....+..++++||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35689999999999999865  5789998765433  5678999999999987  5899999998888889999999998


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      +.+...         +......++.+++++|.+||.....+++|+|++|+||++++.+.+++.|||+++.
T Consensus        78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777543         5567788999999999999964446899999999999999989999999998875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.50  E-value=8.1e-14  Score=141.46  Aligned_cols=135  Identities=18%  Similarity=0.159  Sum_probs=96.3

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh--hhHHH----------------------HHHHHHHHhhccccc--
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE--QGVHE----------------------FQTEIEMLSKLRHRH--  590 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~--~~~~~----------------------f~~E~~~l~~l~H~n--  590 (893)
                      .+.||+|+||+||+|... .+..||||+......  .....                      ...|.+.+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            357999999999999987 457899997654211  11111                      135666666665443  


Q ss_pred             eeeEEEEEeecCEEEEEEeeccCCCHHHH-HhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC
Q 036624          591 LVSLIGYCEENCEMILVYDYMAYGTLREH-LYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE  669 (893)
Q Consensus       591 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~  669 (893)
                      +.+.+++    ...++||||++++.+... +....   .. .....++.+++.++.++|+  ..+|+||||||+||+++ 
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence            4445543    235899999998554321 21111   11 5678899999999999993  38999999999999999 


Q ss_pred             CCceeEeccccccc
Q 036624          670 KWVAKVSDFGLSKT  683 (893)
Q Consensus       670 ~~~~kl~DFGla~~  683 (893)
                      ++.++|+|||.+..
T Consensus       150 ~~~~~liDfg~a~~  163 (187)
T cd05119         150 DGKVYIIDVPQAVE  163 (187)
T ss_pred             CCcEEEEECccccc
Confidence            88999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.49  E-value=2.1e-13  Score=143.64  Aligned_cols=135  Identities=18%  Similarity=0.166  Sum_probs=104.4

Q ss_pred             ceeee-ecCcEEEEEEEEcCcceEEEEEeCCCC-------------ChhhHHHHHHHHHHHhhccccce--eeEEEEEee
Q 036624          537 ALLLG-VGGFGKVYRGEIDGATTKVAIKRGNPL-------------SEQGVHEFQTEIEMLSKLRHRHL--VSLIGYCEE  600 (893)
Q Consensus       537 ~~~LG-~G~fG~Vy~g~~~~~~~~VavK~~~~~-------------~~~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~  600 (893)
                      ..+|| .||.|+||+....+  ..++||+....             .......+.+|++++.+++|++|  +..++++..
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~--~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPG--VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeCC--ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45798 89999999998864  56888865421             11233567889999999998885  677776543


Q ss_pred             cC----EEEEEEeeccC-CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeE
Q 036624          601 NC----EMILVYDYMAY-GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKV  675 (893)
Q Consensus       601 ~~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl  675 (893)
                      ..    ..++|+|++++ .+|.+++...   +++..    .+.+++.+|.+||   +.+|+||||||+|||++.++.++|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEE
Confidence            32    23599999997 6898887542   34443    3568899999999   699999999999999999889999


Q ss_pred             eccccccc
Q 036624          676 SDFGLSKT  683 (893)
Q Consensus       676 ~DFGla~~  683 (893)
                      +|||.++.
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=2e-14  Score=169.34  Aligned_cols=257  Identities=21%  Similarity=0.253  Sum_probs=187.7

Q ss_pred             CccceeeeecCcEEEEEEEEcC-cceEEEEEeCCCCC--hhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEEe
Q 036624          534 FDEALLLGVGGFGKVYRGEIDG-ATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~-~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      |...+.||+|+|+.|-...... ....+++|......  .........|..+-..+. |+|++.+++........+++.|
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~  101 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS  101 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence            4445569999999999877633 33457777655432  223334455777777776 9999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC-ceeEecccccccCCC-C
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW-VAKVSDFGLSKTGPT-L  687 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~~-~  687 (893)
                      |..++++.+.+........+....-..+.|+..++.|+|.  ..++.||||||+|.+++..+ ..|++|||+|..... .
T Consensus       102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             cccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence            9999999998842322235566777889999999999994  48899999999999999999 999999999987554 3


Q ss_pred             CCccceeeecc-CcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          688 DHTHVSTVVKG-SFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       688 ~~~~~~~~~~g-t~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      .........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++...... .....|....   +.      
T Consensus       180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~---~~------  249 (601)
T KOG0590|consen  180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK---GR------  249 (601)
T ss_pred             CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc---cc------
Confidence            33344445668 9999999999874 45678999999999999999999997654433 2222222211   00      


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                        .....-........++..+++..+|..|.+.+++...
T Consensus       250 --~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  250 --FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             --cccCccccCChhhhhcccccccCCchhcccccccccc
Confidence              0000111223445667788888999999998887643

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=99.41  E-value=4.5e-13  Score=133.44  Aligned_cols=137  Identities=27%  Similarity=0.318  Sum_probs=83.1

Q ss_pred             EEEecCCCCCCCCCCCCccccCCCCcccccC-CCc------ccccccCCCCCCCCCCcccceeecCCceEEee-ecCCce
Q 036624           36 ILLNCGESSILSDDDKRSWTPDIGSKFLLST-KDS------TTSKAATQDPSTPTIPYMTARVFRSEFTYSFP-VVAGRK  107 (893)
Q Consensus        36 ~~I~CG~~~~~~~~~~~~w~~D~~~~~g~~~-~~~------~~~~~~~~~~~~~~~~y~t~R~f~~~~cY~~p-~~~g~~  107 (893)
                      ++||||+..+ ++..|+.|.+|..|.+|... ...      ...............-|+|.|.-+..+.|.|| +++|.|
T Consensus         3 ~~IN~Gg~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~ip~~~~G~Y   81 (174)
T PF11721_consen    3 LRINAGGPAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPSSFSYDIPVVPNGTY   81 (174)
T ss_dssp             EEEEETSSSE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SSSEEEEEE--S-EEE
T ss_pred             EEEECCCCcc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCCceEEEEecCCCcEE
Confidence            7899998877 77779999999999755440 000      00000000011112349999986667999999 566776


Q ss_pred             EEEEEEecCCCCC----CCCCCcceEEEeCCeEEEeccChhhhhhhhccceeEEEE-eeecCCCcEEEEEee
Q 036624          108 FVRLYFYPNSYNR----LNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEY-AIPVDGETLNITFSP  174 (893)
Q Consensus       108 yvR~~F~~g~yd~----~~~~~~~Fdv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~v~~~~~~i~f~p  174 (893)
                      -|||||.+..+..    .....++|||+++|...+.||+....++... ..+.+++ -+.|+.+.|.|+|..
T Consensus        82 ~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~-~~~~~~~~~v~v~dg~L~i~f~~  152 (174)
T PF11721_consen   82 TVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFN-KAAVRRFFNVTVTDGTLNIQFVW  152 (174)
T ss_dssp             EEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS----EEEEEEEEEETTEEETTEEE
T ss_pred             EEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCc-eEEEEEEEEEEEeCCcEEEEEEe
Confidence            6999999988776    3344589999999999999999988776322 3566666 578888889998873

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=3.5e-13  Score=139.35  Aligned_cols=203  Identities=23%  Similarity=0.367  Sum_probs=140.7

Q ss_pred             HHhhccccceeeEEEEEeec-----CEEEEEEeeccCCCHHHHHhhCC--CCCCCHHhHHHHHHHHHHhhhhhhcCCCCc
Q 036624          582 MLSKLRHRHLVSLIGYCEEN-----CEMILVYDYMAYGTLREHLYKTQ--KPPLPWKQRLEICIGAARGLHYLHTGAKHT  654 (893)
Q Consensus       582 ~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  654 (893)
                      -|-.+-|.|||++..|+.+.     .+..++.|||..|+|..+|++..  ...+..+...+++.||..||.|||+ |.++
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence            34556799999999987543     45789999999999999998653  3457778888999999999999996 6799


Q ss_pred             eEecCCCCCCEEECCCCceeEecccccccCCCCC--CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhC
Q 036624          655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD--HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA  732 (893)
Q Consensus       655 ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG  732 (893)
                      |+|+++..+-|++..++-+||+--.-....+...  ....+..-.+-++|.|||+-.....+..+|||+||.+.+||..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999988884221111111100  11112223467899999998888889999999999999999887


Q ss_pred             CCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          733 RPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       733 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..-..........           +..+..++-. +..       ..-+.++.+|++.+|..||+|++++.+
T Consensus       279 Eiq~tnseS~~~~-----------ee~ia~~i~~-len-------~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  279 EIQSTNSESKVEV-----------EENIANVIIG-LEN-------GLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             eeccCCCcceeeh-----------hhhhhhheee-ccC-------ccccCcCcccccCCCCCCcchhhhhcC
Confidence            6432111110000           0001110000 000       011345779999999999999998854

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=99.35  E-value=9.7e-13  Score=131.08  Aligned_cols=135  Identities=27%  Similarity=0.362  Sum_probs=80.2

Q ss_pred             eeeeccCCcccCCCCCccccccccCCCCceecCCCCceeecCC--CceeecCCCCCcccchhHHHHHhhhcCCCCCcccc
Q 036624          223 VYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGP--NMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLN  300 (893)
Q Consensus       223 ~~R~n~Gg~~~~~~~d~d~~r~w~~d~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~P~~v~~tA~~~~~~~~~~~~  300 (893)
                      ++|+|+||+..    ++.....|.+|..|..+..   .+....  ............+..++.||||+|....       
T Consensus         2 ~~~IN~Gg~~~----~~~~g~~w~~D~~~~~g~~---~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~-------   67 (174)
T PF11721_consen    2 VLRINAGGPAY----TDSSGIVWEADQYYTGGSW---GYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS-------   67 (174)
T ss_dssp             EEEEEETSSSE----EETTTEEE-SSSSSTTSS--------------SSTTS--TTS-HHHHHTTT-----SS-------
T ss_pred             EEEEECCCCcc----cCCCCCEEcCCCCCCCCCc---ccccccccccccccccccccCCCchhhhHhhcCCCC-------
Confidence            68999999877    2224589999988863321   011110  0000111233447788899999999432       


Q ss_pred             cceEEEEe-cCCCCeeEEEEeeeecccCc----cccccEEEEEEecCcccCCccCccccccCCCceEEEEE-EEEecCC
Q 036624          301 YELSWVFS-VDSGFSYLVRLHFCEVLPEI----TKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDF-AVFVPGN  373 (893)
Q Consensus       301 ~~~tw~~~-~~~~~~y~v~lhF~e~~~~~----~~~~~r~F~i~in~~~~~~~~dv~~~~~~~~~~l~~~~-~~~i~~~  373 (893)
                       +|+|.+| +.+| .|.|+|||||+...-    ...+.|+|||++||+.+.+++|+.+.++....++.+.+ .+.|...
T Consensus        68 -~f~Y~ip~~~~G-~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg  144 (174)
T PF11721_consen   68 -SFSYDIPVVPNG-TYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDG  144 (174)
T ss_dssp             -SEEEEEE--S-E-EEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETT
T ss_pred             -ceEEEEecCCCc-EEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCC
Confidence             5889999 6666 899999999997521    33899999999999999999999999987775666665 5667543

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.33  E-value=5.6e-12  Score=144.22  Aligned_cols=139  Identities=19%  Similarity=0.202  Sum_probs=98.6

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhH----------------------------------------HHHH
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGV----------------------------------------HEFQ  577 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~----------------------------------------~~f~  577 (893)
                      +.||.|++|.||+|++.++ +.||||+.++......                                        -+|.
T Consensus       123 ~plasaSigQVh~A~l~~G-~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDG-KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEecCC-CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5799999999999999865 7899998765321110                                        1255


Q ss_pred             HHHHHHhhcc----ccceeeEEEEE-eecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHH-hhhhhhcCC
Q 036624          578 TEIEMLSKLR----HRHLVSLIGYC-EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR-GLHYLHTGA  651 (893)
Q Consensus       578 ~E~~~l~~l~----H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~  651 (893)
                      .|.+.+.+++    |.+-+.+-.++ ......+|||||++|++|.+.+..... .+   .+.+++..+++ .+..+|   
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~---  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVL---  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHH---
Confidence            5666666653    22223332222 223457999999999999887653221 12   34566766666 467888   


Q ss_pred             CCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       652 ~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ..+++|+|+||.||+++++++++++|||++...
T Consensus       275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            589999999999999999999999999998754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.18  E-value=3e-11  Score=136.15  Aligned_cols=248  Identities=19%  Similarity=0.192  Sum_probs=176.0

Q ss_pred             CCccceeeee--cCcEEEEEEEE--cCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEE
Q 036624          533 NFDEALLLGV--GGFGKVYRGEI--DGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       533 ~f~~~~~LG~--G~fG~Vy~g~~--~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  605 (893)
                      .|.....+|.  |.+|.||.+..  ......+|+|+-+..  .......=.+|+...++++ |+|.++....+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3455668999  99999999988  666678999873322  2222333356777777775 999999888899999999


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHH----hhhhhhcCCCCceEecCCCCCCEEECCC-CceeEecccc
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR----GLHYLHTGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGL  680 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGl  680 (893)
                      +-.|++. .+|..+.+.... .++......+..+..+    ||.++|   ...++|-|+||.||++.++ ..++++|||+
T Consensus       195 iqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence            9999886 788888765432 3566677777777777    999999   4899999999999999999 8999999999


Q ss_pred             cccCCCCCCc---cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc
Q 036624          681 SKTGPTLDHT---HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       681 a~~~~~~~~~---~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  757 (893)
                      ..........   .......|...|++||..++ .++.++|+|++|.+.+|..++..........      .|..     
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~-----  337 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQ-----  337 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccc-----
Confidence            8764433311   22223357889999998864 5688999999999999999887655432111      1110     


Q ss_pred             cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 036624          758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL  802 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl  802 (893)
                        +....   +..++...-..++...+..+++.+|..|++.+.+.
T Consensus       338 --~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  338 --LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             --ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence              00111   11111111223455578899999999999877765

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.15  E-value=1.5e-10  Score=115.25  Aligned_cols=131  Identities=19%  Similarity=0.127  Sum_probs=95.7

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcccccee-eEEEEEeecCEEEEEEeeccCCC
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV-SLIGYCEENCEMILVYDYMAYGT  615 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gs  615 (893)
                      .+.|+.|.++.||+++..+  ..+++|....... ....+..|+.++..+.+.+++ +++.+..  ...++||||+++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~~--~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVAN--KKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEECC--eEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            4578899999999998763  6799998654322 223568899999999766655 4444432  33579999999988


Q ss_pred             HHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCC--CCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          616 LREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA--KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       616 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      +...    .   .   ....++.+++++|+.||...  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        78 l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            7643    0   1   11345678999999999522  22369999999999999 56899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.14  E-value=1.6e-10  Score=133.63  Aligned_cols=142  Identities=16%  Similarity=0.135  Sum_probs=93.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhh----------------------------------H----
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG----------------------------------V----  573 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~----------------------------------~----  573 (893)
                      ..|+. +.||+|++|+||+|+++++++.||||+.++.-...                                  .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 68999999999999998856899999876532110                                  0    


Q ss_pred             --HHHHHHHHHHhhcc----ccceeeEEEEEee-cCEEEEEEeeccCCCHHHH--HhhCCC--CCCCHHhHHHHHHHHHH
Q 036624          574 --HEFQTEIEMLSKLR----HRHLVSLIGYCEE-NCEMILVYDYMAYGTLREH--LYKTQK--PPLPWKQRLEICIGAAR  642 (893)
Q Consensus       574 --~~f~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~--l~~~~~--~~l~~~~~~~i~~~ia~  642 (893)
                        -+|.+|+.-+.+++    +.+.+.+-.++.+ ..+.+|||||+.|+.|.+.  +...+.  ..+.......++.|   
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence              12455555555553    3333443333332 4567899999999999874  322211  01222222222233   


Q ss_pred             hhhhhhcCCCCceEecCCCCCCEEECCCC----ceeEecccccccC
Q 036624          643 GLHYLHTGAKHTIIHRDVKTTNILLDEKW----VAKVSDFGLSKTG  684 (893)
Q Consensus       643 gL~yLH~~~~~~ivHrDlk~~NILld~~~----~~kl~DFGla~~~  684 (893)
                          ++   ..+++|+|+||.||+++.++    ++++.|||+....
T Consensus       276 ----if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        276 ----VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             ----HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence                23   47899999999999999888    9999999998754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.05  E-value=2.1e-09  Score=122.23  Aligned_cols=171  Identities=15%  Similarity=0.184  Sum_probs=125.9

Q ss_pred             EEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCC
Q 036624          550 RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP  629 (893)
Q Consensus       550 ~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~  629 (893)
                      .|..+..+..|.|+..+...........+-++.|+.+|||||++++...+..+..|||.|-+.  .|..++.+..     
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----
Confidence            344444556677776554444334456677888999999999999999999999999999984  6777775433     


Q ss_pred             HHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhh
Q 036624          630 WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR  709 (893)
Q Consensus       630 ~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~  709 (893)
                      .......+.||+.||.+||.  +.+++|++|....|++++.|..||++|.++........  ......--..|..|+.+.
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID  178 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC
Confidence            45566678899999999996  78899999999999999999999999998764322111  111111122566777654


Q ss_pred             hcCCCCcchhhhHHHHHHHHhhCC
Q 036624          710 RQQLTEKSDVYSFGVVLFEILCAR  733 (893)
Q Consensus       710 ~~~~s~ksDV~S~Gvvl~elltG~  733 (893)
                      ...  -..|.|-|||+++|++.|.
T Consensus       179 ~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  179 PSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccc--cchhhhhHHHHHHHHhCcc
Confidence            322  2469999999999999993

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.99  E-value=3.5e-09  Score=106.85  Aligned_cols=135  Identities=14%  Similarity=0.116  Sum_probs=96.3

Q ss_pred             eeeeecCcEEEEEEEEcC------cceEEEEEeCCCC-------------C---------hhhHHHH----HHHHHHHhh
Q 036624          538 LLLGVGGFGKVYRGEIDG------ATTKVAIKRGNPL-------------S---------EQGVHEF----QTEIEMLSK  585 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~------~~~~VavK~~~~~-------------~---------~~~~~~f----~~E~~~l~~  585 (893)
                      ..||.|--+.||.|...+      .+..+|||..+..             .         ....+.+    .+|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            368999999999997653      2368999943210             0         0112233    389999999


Q ss_pred             ccc--cceeeEEEEEeecCEEEEEEeeccCCCHHH-HHhhCCCCCCCHHhHHHHHHHHHHhhhhh-hcCCCCceEecCCC
Q 036624          586 LRH--RHLVSLIGYCEENCEMILVYDYMAYGTLRE-HLYKTQKPPLPWKQRLEICIGAARGLHYL-HTGAKHTIIHRDVK  661 (893)
Q Consensus       586 l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlk  661 (893)
                      +..  -++...+++    ...+|||||+.+..+.. .|.+   ..++..+...+..+++.+|..| |   +.+|||+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            964  455666654    45689999998654432 2322   1245566778889999999999 6   6899999999


Q ss_pred             CCCEEECCCCceeEeccccccc
Q 036624          662 TTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       662 ~~NILld~~~~~kl~DFGla~~  683 (893)
                      +.|||+++ +.+.|+|||.+..
T Consensus       153 ~~NIL~~~-~~v~iIDF~qav~  173 (197)
T cd05146         153 EYNMLWHD-GKVWFIDVSQSVE  173 (197)
T ss_pred             HHHEEEEC-CcEEEEECCCcee
Confidence            99999974 6899999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.98  E-value=2.9e-09  Score=110.84  Aligned_cols=143  Identities=22%  Similarity=0.344  Sum_probs=110.5

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh-hhHHHHHHHHHHHhhccc--cceeeEEEEEeecC---EEEEEEeec
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRH--RHLVSLIGYCEENC---EMILVYDYM  611 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~-~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~E~~  611 (893)
                      +.|+.|..+.||++...++ ..+++|....... .....+..|+++++.+++  .++.+++.++....   ..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g-~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGG-RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCC-cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            5689999999999988653 5788997654322 235578999999999976  44577888876643   568999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcC-----------------------------------------
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG-----------------------------------------  650 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------------  650 (893)
                      ++.+|.+.+..   ..++..++..++.++++.|..||+.                                         
T Consensus        83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99888775532   2477788888899999999999842                                         


Q ss_pred             ------------CCCceEecCCCCCCEEECC--CCceeEecccccccC
Q 036624          651 ------------AKHTIIHRDVKTTNILLDE--KWVAKVSDFGLSKTG  684 (893)
Q Consensus       651 ------------~~~~ivHrDlk~~NILld~--~~~~kl~DFGla~~~  684 (893)
                                  ....++|+|+++.||+++.  ++.+.|+||+.+...
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                        1356799999999999998  667899999987653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.97  E-value=9.6e-09  Score=99.31  Aligned_cols=143  Identities=22%  Similarity=0.237  Sum_probs=106.8

Q ss_pred             cceeeeecCcEEEEEEEEcCcceEEEEEe-CCCC-------ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          536 EALLLGVGGFGKVYRGEIDGATTKVAIKR-GNPL-------SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~~~~~~VavK~-~~~~-------~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ...+|-+|+-+.|+++.+.+  +...||. ....       ..-..+...+|+++|.+++--.|..-.-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~G--e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSG--EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccCC--ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            45689999999999999887  4556663 2211       111245678899999999866666555555555666889


Q ss_pred             EeeccC-CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC---ceeEeccccccc
Q 036624          608 YDYMAY-GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW---VAKVSDFGLSKT  683 (893)
Q Consensus       608 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~kl~DFGla~~  683 (893)
                      |||+++ .++.+++...............++..|-+.+.-||   ...|||+||..+||+|..++   .+.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999985 37888887665444444444789999999999999   69999999999999996543   468999999865

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=6.8e-09  Score=101.06  Aligned_cols=130  Identities=24%  Similarity=0.300  Sum_probs=100.4

Q ss_pred             eeeecCcEEEEEEEEcCcceEEEEEe-CCCC-Ch------hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          539 LLGVGGFGKVYRGEIDGATTKVAIKR-GNPL-SE------QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~~~~VavK~-~~~~-~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .+++|+-+.+|.+.+.+.  .+.+|. ..+. ..      -....-.+|+++|.+++--.|..-+=+..+.....|+|||
T Consensus         3 ~i~~GAEa~i~~~~~~g~--~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGL--PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             hhhCCcceeEEeeeccCc--ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            578999999999987664  366663 2211 11      1123567899999999876666656566677788999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      ++|-.|.+.|...         +..++..+-+-+.-||   +.+|||+||.++||++.... +.++||||+..
T Consensus        81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888654         3567777888888899   69999999999999998774 99999999874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.94  E-value=1.9e-10  Score=135.57  Aligned_cols=249  Identities=19%  Similarity=0.248  Sum_probs=165.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC---CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .+.|.+.+-+-+|.++.++.+.-.+.+...+.|....   ......+....+-.++-..+||-+++..--+.......||
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            4566677778889999999877655543333332211   1111223333343444344556666555444556778999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc-cCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK-TGPT  686 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~-~~~~  686 (893)
                      ++|+.+++|...|+...  +++..........+..+++|||+   ..++|||++|.|+|...++..+++|||... ....
T Consensus       883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccc
Confidence            99999999999998765  34444444445557788999994   558999999999999999999999998432 1000


Q ss_pred             ---CC-------------------------CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCC
Q 036624          687 ---LD-------------------------HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNP  738 (893)
Q Consensus       687 ---~~-------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~  738 (893)
                         .+                         .........||+.|.+||.+.+......+|+|++|++++|.++|.+||+.
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence               00                         00112345689999999999999999999999999999999999999986


Q ss_pred             CCccccccHHHHHHHhhcccchhhhcccccc-CCCChHHHHHHHHHHHHccccCCCCCCCHH
Q 036624          739 TLPKEQVSLAEWAAHCHKKGILEQIMDPYLK-GKIAPECFKKFAETAMKCVSDQGIERPSMG  799 (893)
Q Consensus       739 ~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~  799 (893)
                      ..+....               +.+...... ...+.+......+++...+..+|.+|-.|.
T Consensus      1038 ~tpq~~f---------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIF---------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cchhhhh---------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            5543211               111111110 112233445567778888889999997665

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.94  E-value=1.1e-09  Score=123.54  Aligned_cols=249  Identities=17%  Similarity=0.164  Sum_probs=174.7

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEc-CcceEEEEEeCCCCChhhHHH--HHHHHHHHhhc-cccceeeEEEEEeecCEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEID-GATTKVAIKRGNPLSEQGVHE--FQTEIEMLSKL-RHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~-~~~~~VavK~~~~~~~~~~~~--f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  605 (893)
                      -+.+|..+..||.|.|+.|++...+ .++..+++|.+.........+  -..|+-+...+ .|.++++....+..-...+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            3567889999999999999998765 456778888765433222222  24455555555 4888888777777777778


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC-CceeEecccccccC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSKTG  684 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~~  684 (893)
                      +=-||++++++...+.-  ...++...++++..|++.++.++|   ...++|+|+||+||++..+ +..+++|||+....
T Consensus       343 ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             CchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence            88999999998776622  234778889999999999999999   5899999999999999876 88999999987632


Q ss_pred             CCCCCccceeeeccCcCcc--ChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          685 PTLDHTHVSTVVKGSFGYL--DPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~--APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                      ...     .....+.-+++  +++......+-.+.|++|||.-+.|.+++..-.....        .|..  ...+.   
T Consensus       418 ~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~--i~~~~---  479 (524)
T KOG0601|consen  418 AFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT--IRSGD---  479 (524)
T ss_pred             cee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee--eeccc---
Confidence            111     11112233444  5666667788899999999999999998875432111        1110  00110   


Q ss_pred             hccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          763 IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       763 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                        -+     ..+.....+..++..+...++..||...++..+.+..
T Consensus       480 --~p-----~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  480 --TP-----NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             --cc-----CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence              01     1112235667778889999999999998887766643

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.75  E-value=1.6e-07  Score=100.28  Aligned_cols=141  Identities=14%  Similarity=0.077  Sum_probs=101.1

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh-hHH----------HHHHHHHHHhhcccccee--eEEEEEee----
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-GVH----------EFQTEIEMLSKLRHRHLV--SLIGYCEE----  600 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~-~~~----------~f~~E~~~l~~l~H~niv--~l~g~~~~----  600 (893)
                      +.+-+.....|.+....+  +.+.||+....... ..+          .+.+|.+.+.++...+|.  ..+++...    
T Consensus        28 e~v~~~~~rrvvr~~~~g--~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFELAG--KSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEECC--EEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            344444445577776654  57999975433211 111          378999999988644433  44556543    


Q ss_pred             -cCEEEEEEeeccCC-CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-------CC
Q 036624          601 -NCEMILVYDYMAYG-TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-------KW  671 (893)
Q Consensus       601 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-------~~  671 (893)
                       ....+||+|++++- +|.+++......+.+...+..++.++++.+.-||   ..+|+|+|++++|||++.       +.
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCc
Confidence             23578999999976 7998885432234566777899999999999999   699999999999999975       57


Q ss_pred             ceeEeccccccc
Q 036624          672 VAKVSDFGLSKT  683 (893)
Q Consensus       672 ~~kl~DFGla~~  683 (893)
                      .+.++||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998753

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=98.72  E-value=4e-08  Score=109.20  Aligned_cols=151  Identities=25%  Similarity=0.303  Sum_probs=98.0

Q ss_pred             cEEEecCCCC----CCCCCCCCccccCCCCccccc----CCCc-ccccccCCCCCCCCCCcccceeecCC-----ceEEe
Q 036624           35 QILLNCGESS----ILSDDDKRSWTPDIGSKFLLS----TKDS-TTSKAATQDPSTPTIPYMTARVFRSE-----FTYSF  100 (893)
Q Consensus        35 ~~~I~CG~~~----~~~~~~~~~w~~D~~~~~g~~----~~~~-~~~~~~~~~~~~~~~~y~t~R~f~~~-----~cY~~  100 (893)
                      .+|+|||+..    +.+|.-+|.|.+.........    ..+. ......+..|  ..+ |.|||.-...     ..|.+
T Consensus       180 ~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P--~~V-~~TA~~~~~~s~~~nltw~~  256 (347)
T PF12819_consen  180 VYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAP--SAV-YQTARTPSNSSDPLNLTWSF  256 (347)
T ss_pred             EEeecCCCcccccCCCCCcceeeccccccCccccccccceeeecccCCccCcCh--HHH-HHhhhcccccccceEEEecc
Confidence            5799999753    556667999996421110001    1111 0011111111  223 8999976544     34555


Q ss_pred             eecCCceE-EEEEEecCCCCCCCCCCcceEEEeCC-eEEEeccChhhhhhhhccceeEEEEeeecCC-CcEEEEEeeCCC
Q 036624          101 PVVAGRKF-VRLYFYPNSYNRLNATDALFSVSTGP-YTLLKNFSVAQTAEALNYAYVIKEYAIPVDG-ETLNITFSPMNV  177 (893)
Q Consensus       101 p~~~g~~y-vR~~F~~g~yd~~~~~~~~Fdv~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~-~~~~i~f~p~~~  177 (893)
                       +.++..| ||+||+.-..-..+...+.|||++|| .|.- +++..+..  ....+++..+++.+.+ ..+.|+++|...
T Consensus       257 -~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~-~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~isL~~t~~  332 (347)
T PF12819_consen  257 -VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS-DVSPPYLG--ADTVPYYSDYVVNVPDSGFLNISLGPTPD  332 (347)
T ss_pred             -CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccC-ccCccccc--CcceEeecceEEEecCCCEEEEEEEeCCC
Confidence             6777655 99999998875434434899999999 4543 66653322  2356678888888864 578999999998


Q ss_pred             CCcceeecceeeeec
Q 036624          178 SNAYAFVNGIEVMSM  192 (893)
Q Consensus       178 ~~~~~fv~~~e~~~~  192 (893)
                      +..-|++||+|++.+
T Consensus       333 S~lppiLNalEIy~v  347 (347)
T PF12819_consen  333 STLPPILNALEIYKV  347 (347)
T ss_pred             CCcCceeEeeeeEeC
Confidence            877899999999875

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.70  E-value=2.2e-07  Score=102.84  Aligned_cols=169  Identities=17%  Similarity=0.226  Sum_probs=127.7

Q ss_pred             cEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEe----ecCEEEEEEeeccC-CCHHHH
Q 036624          545 FGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE----ENCEMILVYDYMAY-GTLREH  619 (893)
Q Consensus       545 fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~  619 (893)
                      -.+.||+...-++..+++|+++....+.......-+++++++.|.|+|++..++.    ....++|||+|.++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578999988777899999985444333334456688999999999999988875    34568999999885 467664


Q ss_pred             HhhC-------------CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          620 LYKT-------------QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       620 l~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      -...             .+..+++..++.++.|+..||.++|+   .|+.-+-|.+++||++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321             22347788999999999999999995   7888899999999999999999998887654332


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCC
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPA  735 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p  735 (893)
                      ..              .  |-+..   -.+-|.=.||.+|+-|.||..-
T Consensus       446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            11              0  11111   1357899999999999999754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.58  E-value=4.5e-07  Score=91.27  Aligned_cols=124  Identities=22%  Similarity=0.208  Sum_probs=80.6

Q ss_pred             EEEEEEEcCcceEEEEEeCCCC--------------------------ChhhHHHHHHHHHHHhhcccc--ceeeEEEEE
Q 036624          547 KVYRGEIDGATTKVAIKRGNPL--------------------------SEQGVHEFQTEIEMLSKLRHR--HLVSLIGYC  598 (893)
Q Consensus       547 ~Vy~g~~~~~~~~VavK~~~~~--------------------------~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~  598 (893)
                      .||.|...++ ..+|+|..+..                          .........+|.+.|.++..-  ++.+.+++.
T Consensus         1 ~Vy~~~~~~~-~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPDG-EEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECTT-EEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECCCC-CEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899987655 68999943210                          001123567899999999865  455666443


Q ss_pred             eecCEEEEEEeecc--CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhh-hhcCCCCceEecCCCCCCEEECCCCceeE
Q 036624          599 EENCEMILVYDYMA--YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY-LHTGAKHTIIHRDVKTTNILLDEKWVAKV  675 (893)
Q Consensus       599 ~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivHrDlk~~NILld~~~~~kl  675 (893)
                          ..+|||||++  +..+..+.. ..   ++......++.++++.+.. +|   +.+|||+||.+.|||++++ .+.|
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~-~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKD-VD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHH-CG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred             ----CCEEEEEecCCCccchhhHHh-cc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence                3379999998  555544332 21   2245567778888886666 46   6899999999999999988 9999


Q ss_pred             eccccccc
Q 036624          676 SDFGLSKT  683 (893)
Q Consensus       676 ~DFGla~~  683 (893)
                      +|||.+..
T Consensus       148 IDf~qav~  155 (188)
T PF01163_consen  148 IDFGQAVD  155 (188)
T ss_dssp             --GTTEEE
T ss_pred             EecCccee
Confidence            99998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=98.43  E-value=2.9e-06  Score=85.97  Aligned_cols=139  Identities=17%  Similarity=0.129  Sum_probs=105.0

Q ss_pred             eeecCcEEEEEEEEcCcceEEEEEeCCCC-----C-hhhHHHHHHHHHHHhhcccc--ceeeEEEEEee----cCEEEEE
Q 036624          540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL-----S-EQGVHEFQTEIEMLSKLRHR--HLVSLIGYCEE----NCEMILV  607 (893)
Q Consensus       540 LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-----~-~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~----~~~~~lV  607 (893)
                      -|+||-+.|++-.+.+.  .+-+|+-...     . .-+...|.+|+..|.++...  .+.+.+.+...    ....+||
T Consensus        26 ~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            46789999999877664  5888875411     1 33567899999999999643  34444422222    1346899


Q ss_pred             EeeccC-CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc--eeEeccccccc
Q 036624          608 YDYMAY-GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV--AKVSDFGLSKT  683 (893)
Q Consensus       608 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~--~kl~DFGla~~  683 (893)
                      +|-+++ -+|.+++.+....+.+...+..+..++++.+.-||   ..++.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 48888886655456778888999999999999999   699999999999999986666  99999987664

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.40  E-value=1e-07  Score=109.16  Aligned_cols=151  Identities=17%  Similarity=0.273  Sum_probs=101.5

Q ss_pred             HHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC-C-----CCc-cceeeeccCcCccChHhhh
Q 036624          637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-L-----DHT-HVSTVVKGSFGYLDPEYFR  709 (893)
Q Consensus       637 ~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~-~-----~~~-~~~~~~~gt~~y~APE~~~  709 (893)
                      +.+++.||.|+|.  ..++||+.|.|++|.++.++..||+.|+.+..... .     ..+ ...........|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3445699999996  68899999999999999999999999998654322 1     111 1111122355899999999


Q ss_pred             hcCCCCcchhhhHHHHHHHHhhCCCCC-CCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHcc
Q 036624          710 RQQLTEKSDVYSFGVVLFEILCARPAL-NPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCV  788 (893)
Q Consensus       710 ~~~~s~ksDV~S~Gvvl~elltG~~p~-~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl  788 (893)
                      ....+.++|+||+||++|-+..|..+. .........     .        ...-.+..-......+.+.++.+=+.+.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-----~--------~~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-----S--------FSRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchh-----h--------hhhcccccccccccccCcHHHHHHHHHHh
Confidence            988899999999999999999554443 222111100     0        00011111111222345566777788999


Q ss_pred             ccCCCCCCCHHHHH
Q 036624          789 SDQGIERPSMGDVL  802 (893)
Q Consensus       789 ~~~p~~RPtm~evl  802 (893)
                      ..++.-||++.++.
T Consensus       250 ~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLL  263 (700)
T ss_pred             cCCcccCcchhhhh
Confidence            99999999877765

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.30  E-value=5.8e-06  Score=85.21  Aligned_cols=106  Identities=25%  Similarity=0.254  Sum_probs=84.5

Q ss_pred             HHHHHHHHHHHhhcccc--ceeeEEEEEeec----CEEEEEEeeccCC-CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhh
Q 036624          573 VHEFQTEIEMLSKLRHR--HLVSLIGYCEEN----CEMILVYDYMAYG-TLREHLYKTQKPPLPWKQRLEICIGAARGLH  645 (893)
Q Consensus       573 ~~~f~~E~~~l~~l~H~--niv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~  645 (893)
                      .....+|.+.+.+++..  ...+.+++....    ...+||+|++++- +|.+++.....  ++......++.++++.+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence            44678899988888643  344566666553    2458999999874 79998875333  566778899999999999


Q ss_pred             hhhcCCCCceEecCCCCCCEEECCCC---ceeEeccccccc
Q 036624          646 YLHTGAKHTIIHRDVKTTNILLDEKW---VAKVSDFGLSKT  683 (893)
Q Consensus       646 yLH~~~~~~ivHrDlk~~NILld~~~---~~kl~DFGla~~  683 (893)
                      -||   ..+|+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999   69999999999999999887   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.30  E-value=1.5e-05  Score=86.26  Aligned_cols=257  Identities=14%  Similarity=0.135  Sum_probs=150.3

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEE-------eecCEEEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYC-------EENCEMILVY  608 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~-------~~~~~~~lV~  608 (893)
                      ...||+|+-+.+|---.-.+   .+.|+...-......+   .++.|... .||-+-.-+.+=       ..+...-+.|
T Consensus        16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CccccCCccceeeecchhhc---hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            45799999999995332221   2334433222221122   22333333 455333312221       1122256677


Q ss_pred             eeccCCC-HHHHHh----hCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          609 DYMAYGT-LREHLY----KTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       609 E~~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      ..+++.. ...++.    +..-+..+|.-.++.+..+|.+.+-||   +.|.+-+|+.++|+|+.++..+.|.|=..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence            7776542 222221    112345889999999999999999999   68999999999999999999999987543322


Q ss_pred             CCCCCCccceeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhC-CCCCCCCCcc--ccccHH-HHHHHh
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCA-RPALNPTLPK--EQVSLA-EWAAHC  754 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~--~~~~l~-~~~~~~  754 (893)
                      .   ..........|...|.+||...     +..-+...|.|.+||++++||.| +.||.+-...  ....+. +.+.  
T Consensus       167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~--  241 (637)
T COG4248         167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH--  241 (637)
T ss_pred             c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc--
Confidence            1   1112223345888999999865     34456789999999999999887 8888752111  111111 1111  


Q ss_pred             hcccchhhhccccc-----cCCCChH-HHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHHHh
Q 036624          755 HKKGILEQIMDPYL-----KGKIAPE-CFKKFAETAMKCVSDQ--GIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       755 ~~~~~~~~i~d~~l-----~~~~~~~-~~~~l~~l~~~Cl~~~--p~~RPtm~evl~~L~~~~~  810 (893)
                         +....--|...     ...++-+ .+..+..+..+|+...  +.-||+.+..+..|..+.+
T Consensus       242 ---g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         242 ---GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             ---ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence               11111111110     0111112 2344666677888764  5689999998888776554

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.22  E-value=4.9e-06  Score=86.12  Aligned_cols=131  Identities=23%  Similarity=0.173  Sum_probs=89.0

Q ss_pred             cceeeeecCcEEEEEEEEcCcceEEEEEeCCC----------C----------C--hhhHHHHHHHHHHHhhcccc--ce
Q 036624          536 EALLLGVGGFGKVYRGEIDGATTKVAIKRGNP----------L----------S--EQGVHEFQTEIEMLSKLRHR--HL  591 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~----------~----------~--~~~~~~f~~E~~~l~~l~H~--ni  591 (893)
                      ...+||.|--+.||.|....+ ..++||.-+.          .          +  ........+|.++|.+|.-.  .+
T Consensus        95 iG~~IGvGKEsdVY~~~~~~g-~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDPKG-RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hccccccCccceEEEEECCCC-CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            456899999999999998755 6899993211          0          0  11233467889999988644  55


Q ss_pred             eeEEEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC
Q 036624          592 VSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW  671 (893)
Q Consensus       592 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~  671 (893)
                      .+-+++    +...+||||+++-.|...-       ++-+..-.|+..|++-+.-+-   ..||||+|+..-||++++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            565543    4568999999986665432       122223333333333333333   37899999999999999999


Q ss_pred             ceeEeccccc
Q 036624          672 VAKVSDFGLS  681 (893)
Q Consensus       672 ~~kl~DFGla  681 (893)
                      .+.++||--+
T Consensus       240 ~~~vIDwPQ~  249 (304)
T COG0478         240 DIVVIDWPQA  249 (304)
T ss_pred             CEEEEeCccc
Confidence            9999999644

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.15  E-value=3.1e-05  Score=80.97  Aligned_cols=140  Identities=18%  Similarity=0.177  Sum_probs=85.9

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccce--eeEEEEEeecCEEEEEEeeccCCC
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL--VSLIGYCEENCEMILVYDYMAYGT  615 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~lV~E~~~~gs  615 (893)
                      ..||+|..+.||+..   + ...++|......  ......+|.++++.+..-.+  .+.++++...+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~~---~-~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTHK---T-GKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEec---C-CCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            479999999999842   2 346788765432  23456889999999875444  577888877778889999999863


Q ss_pred             -HHHH---------------------HhhCCCCCCCHHhHH-HHHHH----------HHH-hhhhhhc-CCCCceEecCC
Q 036624          616 -LREH---------------------LYKTQKPPLPWKQRL-EICIG----------AAR-GLHYLHT-GAKHTIIHRDV  660 (893)
Q Consensus       616 -L~~~---------------------l~~~~~~~l~~~~~~-~i~~~----------ia~-gL~yLH~-~~~~~ivHrDl  660 (893)
                       +...                     ||............. .+..+          +.+ ...+|.. .....++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             2111                     121110111111100 00000          000 1122221 12345789999


Q ss_pred             CCCCEEECCCCceeEecccccccC
Q 036624          661 KTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       661 k~~NILld~~~~~kl~DFGla~~~  684 (893)
                      .|.||++++++ +.|+||+.+..+
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~G  183 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGYG  183 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCcC
Confidence            99999999888 999999987653

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.98  E-value=3.6e-05  Score=89.07  Aligned_cols=139  Identities=17%  Similarity=0.202  Sum_probs=90.3

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhh----------------------------------------HHHHH
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG----------------------------------------VHEFQ  577 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~----------------------------------------~~~f~  577 (893)
                      +.|+.++-|.||+|++..+ +.||||+.++.-...                                        .-++.
T Consensus       131 ~PiAsASIaQVH~A~L~sG-~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKSG-EEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecCC-CEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            4789999999999999975 889999765421110                                        11245


Q ss_pred             HHHHHHhhcc-----ccceeeEEEEE-eecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCC
Q 036624          578 TEIEMLSKLR-----HRHLVSLIGYC-EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA  651 (893)
Q Consensus       578 ~E~~~l~~l~-----H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~  651 (893)
                      .|..-+.+++     .+++. +=.+| +-.....|+|||++|-.+.+...-.. ..++.+.+.....++.  +..+-   
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~---  282 (517)
T COG0661         210 REAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLL---  282 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHH---
Confidence            5555555553     23322 22233 23456799999999999888743222 2255333333222222  12222   


Q ss_pred             CCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       652 ~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ..+++|.|..|.||+++.++++.+.|||+....
T Consensus       283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence            368999999999999999999999999997643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.98  E-value=9.5e-07  Score=100.10  Aligned_cols=182  Identities=18%  Similarity=0.117  Sum_probs=132.1

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccc-eeeEEEEEeecCEEEEEEeeccCC-C
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH-LVSLIGYCEENCEMILVYDYMAYG-T  615 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g-s  615 (893)
                      +-+++|++++++|.+..... ...++.+...     ....-++++|.+++||| .++.++-+..+...+++++++..+ +
T Consensus       248 h~fvK~altknpKkRptaek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHhcCCCccCCChhh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            34789999999998766552 3335543321     44567899999999999 777777777788889999999877 2


Q ss_pred             HHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceee
Q 036624          616 LREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV  695 (893)
Q Consensus       616 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~  695 (893)
                      -..-.. .....+...+...++..-++++++||+   ..=+|||    ||+..+ ...|..||+.........   ....
T Consensus       322 ~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t  389 (829)
T KOG0576|consen  322 SALEMT-VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRT  389 (829)
T ss_pred             ccccCC-hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---cccc
Confidence            111110 011124445566788888999999995   3358998    777766 588999999877544322   3345


Q ss_pred             eccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCC
Q 036624          696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALN  737 (893)
Q Consensus       696 ~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~  737 (893)
                      ..+|+.|+|||+.....+..+.|+|++|+---++--|-+|-.
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            679999999999999999999999999987777777766553

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.96  E-value=7.8e-05  Score=77.96  Aligned_cols=143  Identities=20%  Similarity=0.179  Sum_probs=86.3

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccc--eeeEEEEEe---ecCEEEEEEeec
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH--LVSLIGYCE---ENCEMILVYDYM  611 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~---~~~~~~lV~E~~  611 (893)
                      ++.|+.|..+.||+....+  ..+++|.....  .....+..|..+++.+....  +.+++.++.   .....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            4579999999999999877  37889986543  45677889999999886443  456666543   234578999999


Q ss_pred             cCCCHHH----------------HH---hhC--CCCCCCHHh---------HHHH------------HHHHHH-hhhhhh
Q 036624          612 AYGTLRE----------------HL---YKT--QKPPLPWKQ---------RLEI------------CIGAAR-GLHYLH  648 (893)
Q Consensus       612 ~~gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH  648 (893)
                      ++..+..                .+   +..  ......+..         ....            ...+.+ .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9888777                11   111  111111110         0000            111222 233333


Q ss_pred             c----CCCCceEecCCCCCCEEEC-CCCceeEeccccccc
Q 036624          649 T----GAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKT  683 (893)
Q Consensus       649 ~----~~~~~ivHrDlk~~NILld-~~~~~kl~DFGla~~  683 (893)
                      .    .....++|+|+.+.|||++ +++.+.|.||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2    2356799999999999999 666668999987653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.89  E-value=0.00013  Score=77.32  Aligned_cols=139  Identities=18%  Similarity=0.139  Sum_probs=85.1

Q ss_pred             eeecCc-EEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEEeeccCCCHH
Q 036624          540 LGVGGF-GKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVYDYMAYGTLR  617 (893)
Q Consensus       540 LG~G~f-G~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  617 (893)
                      |-.|.. ..||+....+  ..+.+|+.....   ..++.+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus         6 ~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGKN--PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCCC--CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            445555 7899987653  568888866443   345778999998884 434557777777666779999999988776


Q ss_pred             HHH-------------------hhCCC--CCCC--HHhHHHHHHH--------------------HHHhhhhhh----cC
Q 036624          618 EHL-------------------YKTQK--PPLP--WKQRLEICIG--------------------AARGLHYLH----TG  650 (893)
Q Consensus       618 ~~l-------------------~~~~~--~~l~--~~~~~~i~~~--------------------ia~gL~yLH----~~  650 (893)
                      ...                   |....  .+..  ....+.-+..                    +...+..|-    ..
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            431                   11110  0111  0011100000                    011111111    11


Q ss_pred             CCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       651 ~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            245689999999999999987889999997754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=97.78  E-value=0.00024  Score=88.54  Aligned_cols=148  Identities=16%  Similarity=0.266  Sum_probs=91.7

Q ss_pred             ceeeeecCcEEEEEEEEcCcc--eEEEEEeCCCCC-hhhHHHHHHHHHHHhhcc-ccce--eeEEEEEeec---CEEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDGAT--TKVAIKRGNPLS-EQGVHEFQTEIEMLSKLR-HRHL--VSLIGYCEEN---CEMILV  607 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~--~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV  607 (893)
                      ...|+.|.+..+|+....+++  ..+++|+..... ......+.+|+++|+.+. |.++  .+++++|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567889999999998776542  356777654322 123456889999999996 6665  7888888764   457899


Q ss_pred             EeeccCCCHHH-----------------------HHhhCCC---------CCCCH--HhHHHHH---------------H
Q 036624          608 YDYMAYGTLRE-----------------------HLYKTQK---------PPLPW--KQRLEIC---------------I  638 (893)
Q Consensus       608 ~E~~~~gsL~~-----------------------~l~~~~~---------~~l~~--~~~~~i~---------------~  638 (893)
                      |||+++..+.+                       .||....         .+..+  .++..+.               -
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99999764321                       1222110         01111  0111111               1


Q ss_pred             HHHHhhhhhhcCC--------CCceEecCCCCCCEEECC-CC-ceeEecccccccC
Q 036624          639 GAARGLHYLHTGA--------KHTIIHRDVKTTNILLDE-KW-VAKVSDFGLSKTG  684 (893)
Q Consensus       639 ~ia~gL~yLH~~~--------~~~ivHrDlk~~NILld~-~~-~~kl~DFGla~~~  684 (893)
                      .+.+.+++|....        ...+||+|+++.|||++. +. .+-|.||+++...
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            1233456664211        245999999999999985 33 3579999998754

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.78  E-value=6.8e-05  Score=75.83  Aligned_cols=103  Identities=23%  Similarity=0.291  Sum_probs=82.2

Q ss_pred             HHHHHHHhhccc-cceeeEEEEEeecCEEEEEEeeccCCCHHHHHhh-CCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCc
Q 036624          577 QTEIEMLSKLRH-RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYK-TQKPPLPWKQRLEICIGAARGLHYLHTGAKHT  654 (893)
Q Consensus       577 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  654 (893)
                      ..|.-+|+.+++ +++.+++|+|-.    ++|.||...+++...-.. ..-..-+|..|.+||.++++.+++|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468888999976 699999999933    679999987766432000 01123689999999999999999999766566


Q ss_pred             eEecCCCCCCEEECCCCceeEeccccccc
Q 036624          655 IIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       655 ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      +...|++++|+-+++++++|+.|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            88899999999999999999999987543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.77  E-value=0.00027  Score=72.02  Aligned_cols=137  Identities=18%  Similarity=0.194  Sum_probs=90.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHH---------HHHHHHHHhhcccc---ceeeEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHE---------FQTEIEMLSKLRHR---HLVSLIGYC  598 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~---------f~~E~~~l~~l~H~---niv~l~g~~  598 (893)
                      .++|...+++-......|.+-..++  ....+|..........+.         ..+++..+.+++..   ....++.++
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~~--~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEIDG--KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEECC--cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            5678888888877777777776665  568888765533322222         23444444455322   222323332


Q ss_pred             e-----ecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCce
Q 036624          599 E-----ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA  673 (893)
Q Consensus       599 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~  673 (893)
                      .     -....+|+|||++|-.|.+...      ++.    .++..+++.+.-||   +.|+.|+|..|.|+++.++ .+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cE
Confidence            2     2245679999999988766531      222    24456777899999   6999999999999999966 49


Q ss_pred             eEeccccccc
Q 036624          674 KVSDFGLSKT  683 (893)
Q Consensus       674 kl~DFGla~~  683 (893)
                      ++.||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.61  E-value=0.00057  Score=70.43  Aligned_cols=153  Identities=16%  Similarity=0.180  Sum_probs=97.1

Q ss_pred             cccCHHHHHHHhcCCccceee---eecCcEEEEEEEEcCcceEEEEEeCCCCChh-------------------h-----
Q 036624          520 RHFSFAEIKAATNNFDEALLL---GVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-------------------G-----  572 (893)
Q Consensus       520 ~~~~~~el~~at~~f~~~~~L---G~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~-------------------~-----  572 (893)
                      ...++..|......-.+....   ..|--+.||+|...+. ..+|||+.......                   .     
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~-~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDG-RYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCC-ceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            345566666666666655554   4566778999987544 78999965432110                   0     


Q ss_pred             HHHHHHHHHHHhhcc--ccceeeEEEEEeecCEEEEEEeeccCCCH-HHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhc
Q 036624          573 VHEFQTEIEMLSKLR--HRHLVSLIGYCEENCEMILVYDYMAYGTL-REHLYKTQKPPLPWKQRLEICIGAARGLHYLHT  649 (893)
Q Consensus       573 ~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~  649 (893)
                      ..-...|..-|.++.  +-.+.+-+++.    .-.|||||+...-+ .-.|..-   ++.......+..++++.+.-|-.
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~  184 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK  184 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH
Confidence            011345666666664  33444445443    33799999964311 1112111   12333566677778888887773


Q ss_pred             CCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       650 ~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                        ..++||+||+.=|||+. ++.+.|+|||-|..
T Consensus       185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             --hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence              58899999999999999 77999999997754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.61  E-value=0.0011  Score=67.54  Aligned_cols=132  Identities=23%  Similarity=0.323  Sum_probs=90.3

Q ss_pred             cceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC----------------hhhHHHHHHHHHHHhhcc------ccceee
Q 036624          536 EALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS----------------EQGVHEFQTEIEMLSKLR------HRHLVS  593 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~----------------~~~~~~f~~E~~~l~~l~------H~niv~  593 (893)
                      ....||+|+.-.||.--  .. ...+||+.....                ....++..+|+.-...+.      +.+|.+
T Consensus         5 ~~~~i~~G~~R~cy~HP--~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQHP--DD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEECC--CC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            45589999999999632  22 457788765544                223456677777666555      889999


Q ss_pred             EEEEEeecCEEEEEEeeccC--C----CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE
Q 036624          594 LIGYCEENCEMILVYDYMAY--G----TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL  667 (893)
Q Consensus       594 l~g~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  667 (893)
                      ++|+.++..-.-+|+|.+.+  |    +|.+++.+..   ++. ...+.+.+..   +||-   +..|+.+||+|.||++
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~f~---~~l~---~~~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDEFK---RYLL---DHHIVIRDLNPHNIVV  151 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHHHH---HHHH---HcCCeecCCCcccEEE
Confidence            99999999999999998743  2    4777774432   554 4444444444   4554   4679999999999999


Q ss_pred             CCC---C-ceeEec-ccc
Q 036624          668 DEK---W-VAKVSD-FGL  680 (893)
Q Consensus       668 d~~---~-~~kl~D-FGl  680 (893)
                      ..+   . .+.|+| ||-
T Consensus       152 ~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EecCCCceEEEEEeCCCC
Confidence            543   2 566666 453

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.59  E-value=0.00024  Score=81.95  Aligned_cols=138  Identities=17%  Similarity=0.174  Sum_probs=88.5

Q ss_pred             eeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhh-------------------------------------HHHHHHHH
Q 036624          538 LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-------------------------------------VHEFQTEI  580 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~-------------------------------------~~~f~~E~  580 (893)
                      +.||.-+.|.||+|+++++ +.||||+-++.-+..                                     .-+|..|.
T Consensus       167 ~piaaASlaQVhrA~L~~G-~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNG-EDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecCC-CEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            4689999999999999985 889999755421111                                     11355555


Q ss_pred             HHHhhc----cccceee---EEEEEe-ecCEEEEEEeeccCCCHHHH--HhhCCCCCCCHHhHHHHHHHHHHhhhhhhcC
Q 036624          581 EMLSKL----RHRHLVS---LIGYCE-ENCEMILVYDYMAYGTLREH--LYKTQKPPLPWKQRLEICIGAARGLHYLHTG  650 (893)
Q Consensus       581 ~~l~~l----~H~niv~---l~g~~~-~~~~~~lV~E~~~~gsL~~~--l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  650 (893)
                      +-..++    .|-++..   +=.++. -.....|+||||+|..+.+.  |.+.+   ++-..+..-+.++..-+- +   
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~~qI-f---  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYLEQI-F---  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHHHHH-H---
Confidence            544444    3444111   112222 23567999999999887764  33333   554544443333322122 2   


Q ss_pred             CCCceEecCCCCCCEEECC----CCceeEecccccccC
Q 036624          651 AKHTIIHRDVKTTNILLDE----KWVAKVSDFGLSKTG  684 (893)
Q Consensus       651 ~~~~ivHrDlk~~NILld~----~~~~kl~DFGla~~~  684 (893)
                       ..|++|.|-.|.||+++.    ++++.+-|||+....
T Consensus       319 -~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  319 -KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             -hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence             367999999999999984    678999999997653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.44  E-value=0.00075  Score=71.12  Aligned_cols=139  Identities=19%  Similarity=0.209  Sum_probs=77.2

Q ss_pred             eeeeecCcE-EEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcccc---ceeeEEEEEeec---CEEEEEEee
Q 036624          538 LLLGVGGFG-KVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHR---HLVSLIGYCEEN---CEMILVYDY  610 (893)
Q Consensus       538 ~~LG~G~fG-~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~E~  610 (893)
                      +.|+.||.. .||+.   +  ..+++|....  ......+.+|.++|..+...   -+.+.++.+...   ...+++||+
T Consensus         3 ~~~~~gG~~n~vy~~---~--~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL---G--DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc---C--CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            467877776 48975   1  2466776443  22345788999999888532   334445444332   234789999


Q ss_pred             ccCCCHHHH------------------HhhCCCCC--C-------------CHHhHH--HHH-------HHHHHh-hh-h
Q 036624          611 MAYGTLREH------------------LYKTQKPP--L-------------PWKQRL--EIC-------IGAARG-LH-Y  646 (893)
Q Consensus       611 ~~~gsL~~~------------------l~~~~~~~--l-------------~~~~~~--~i~-------~~ia~g-L~-y  646 (893)
                      ++|.++.+.                  ||.-....  .             .|....  .+.       .+.... ++ +
T Consensus        76 i~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  155 (235)
T cd05155          76 LEGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAA  155 (235)
T ss_pred             ecCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHH
Confidence            998776321                  22111000  0             011110  000       011111 01 1


Q ss_pred             hhc--CCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          647 LHT--GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       647 LH~--~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      ++.  .....++|+|+.+.|||++++...-|.||+.+..
T Consensus       156 ~~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         156 LRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             hcccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            111  1245589999999999999776667999998764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.37  E-value=0.0027  Score=64.14  Aligned_cols=132  Identities=29%  Similarity=0.362  Sum_probs=92.9

Q ss_pred             cccCHHHHHHHhcCCccceeeeecCc-EEEEEEEEcCcceEEEEEeCCC------------CCh---------hhHHHHH
Q 036624          520 RHFSFAEIKAATNNFDEALLLGVGGF-GKVYRGEIDGATTKVAIKRGNP------------LSE---------QGVHEFQ  577 (893)
Q Consensus       520 ~~~~~~el~~at~~f~~~~~LG~G~f-G~Vy~g~~~~~~~~VavK~~~~------------~~~---------~~~~~f~  577 (893)
                      +.|+.     .+.+++..+.||+|.- |.|||.+..+  ..+|+|....            ...         .-...|.
T Consensus        30 ~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~g--~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~  102 (207)
T PF13095_consen   30 EPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEIDG--RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN  102 (207)
T ss_pred             CCcCC-----CCCcEeeeeecCCCCceeEEEEEEECC--eEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence            45665     2378888999999999 9999999987  5899997221            000         1123588


Q ss_pred             HHHHHHhhcc---ccce--eeEEEEEeec------------------CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHH
Q 036624          578 TEIEMLSKLR---HRHL--VSLIGYCEEN------------------CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL  634 (893)
Q Consensus       578 ~E~~~l~~l~---H~ni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~  634 (893)
                      .|.+...+|+   +.++  |+++||..-.                  ..+.||.||++...           .+...   
T Consensus       103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~---  168 (207)
T PF13095_consen  103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR---  168 (207)
T ss_pred             HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh---
Confidence            9999988885   4466  8999987321                  12467888776433           12223   


Q ss_pred             HHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       635 ~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                       -+.++.+-|.-+|   +.+|+-+|+|+.|..     .-||+|||.+
T Consensus       169 -~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  169 -DIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             -HHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence             3445666688899   799999999999985     4589999854

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.29  E-value=0.0032  Score=70.89  Aligned_cols=77  Identities=18%  Similarity=0.163  Sum_probs=54.0

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-------hhhHHHHHHHHHHHhhcc---ccceeeEEEEEeecCEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-------EQGVHEFQTEIEMLSKLR---HRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-------~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l  606 (893)
                      .+.||.|.+..||+....++.+.+.||...+..       .-..+.+..|.+.|..+.   ..++.+++.+..  ...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence            347899999999999987665579999743211       123456777888888763   245666776643  45689


Q ss_pred             EEeeccCCC
Q 036624          607 VYDYMAYGT  615 (893)
Q Consensus       607 V~E~~~~gs  615 (893)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998644

>PRK10593 hypothetical protein; Provisional

Probab=97.29  E-value=0.0036  Score=68.36  Aligned_cols=78  Identities=9%  Similarity=0.006  Sum_probs=56.5

Q ss_pred             ccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccc---cceeeEEEEEeec---CEEEEEE
Q 036624          535 DEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH---RHLVSLIGYCEEN---CEMILVY  608 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~  608 (893)
                      ...+.||.|..+.||+-...++  .+.+|..+..  .....|..|.+.|+.|.-   -.+.+++++|...   +..+|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~--~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG--NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC--CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            3456799999999999876554  3566663321  123578999999998853   3677888888543   6689999


Q ss_pred             eeccCCCH
Q 036624          609 DYMAYGTL  616 (893)
Q Consensus       609 E~~~~gsL  616 (893)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.28  E-value=0.00084  Score=81.89  Aligned_cols=201  Identities=19%  Similarity=0.221  Sum_probs=136.5

Q ss_pred             hHHHHHHHHHHHhhccccceeeEEEEEeecCEEE----EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhh
Q 036624          572 GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI----LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL  647 (893)
Q Consensus       572 ~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL  647 (893)
                      .......|+..+.++.|+|++.+++|..+....-    +..|++..-++...+....  .++......+..++.+||.|+
T Consensus       225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHH
Confidence            3444566778888999999999999986654333    3357788888888886544  477888889999999999999


Q ss_pred             hcCCCCceEecCCCCC---CEEECCCCceeEe--cccccccCCCCCCccceeeeccCcCccChHhhhhcCCCC--cchhh
Q 036624          648 HTGAKHTIIHRDVKTT---NILLDEKWVAKVS--DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE--KSDVY  720 (893)
Q Consensus       648 H~~~~~~ivHrDlk~~---NILld~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~--ksDV~  720 (893)
                      |+   ....|.-|..+   +-..+..+...++  ||+.++..+.......   ..-+..|.+||......+..  ..|+|
T Consensus       303 h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  303 HS---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HH---hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHH
Confidence            95   34445444444   4445666777777  8888776544332211   22345678888876655544  47999


Q ss_pred             hHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHH
Q 036624          721 SFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGD  800 (893)
Q Consensus       721 S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~e  800 (893)
                      .+|..+..+..|..+.....                  ....+++..        +...+.+...+|+..++++|++..+
T Consensus       377 ~lgll~~~~~~~~~i~~~~~------------------~~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSA------------------VPVSLLDVL--------STSELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHHHhhhhhcCccccccc------------------chhhhhccc--------cchhhhhhhhhhcchhhhhccchhh
Confidence            99999999998875432111                  111111111        1114566778999999999999999


Q ss_pred             HHHHHH
Q 036624          801 VLWNLE  806 (893)
Q Consensus       801 vl~~L~  806 (893)
                      ++.+.-
T Consensus       431 ll~~~f  436 (1351)
T KOG1035|consen  431 LLTHPF  436 (1351)
T ss_pred             hhhchh
Confidence            997654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.24  E-value=0.0029  Score=66.53  Aligned_cols=142  Identities=18%  Similarity=0.202  Sum_probs=81.2

Q ss_pred             ceeeeecCcEEEEEEEEcC-cceEEEEEeCCCCChhhHHHHHHHHHHHhhcccccee-eEEEEEeecCEEEEEEeeccCC
Q 036624          537 ALLLGVGGFGKVYRGEIDG-ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV-SLIGYCEENCEMILVYDYMAYG  614 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~-~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~g  614 (893)
                      .+.|..|-...+|+....+ ....+++|........ ..+..+|+.++..+...+++ ++++.+. .   .+||||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCC
Confidence            3467778888999987653 2356888875543221 12335788899888654444 4444332 2   4799999987


Q ss_pred             CHHHH-----------------HhhCCCC---------CC-CHHhHHHHH-------------------------HHHHH
Q 036624          615 TLREH-----------------LYKTQKP---------PL-PWKQRLEIC-------------------------IGAAR  642 (893)
Q Consensus       615 sL~~~-----------------l~~~~~~---------~l-~~~~~~~i~-------------------------~~ia~  642 (893)
                      ++...                 +|.....         .. -|..+..+.                         .+.+.
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            65321                 1111110         11 122211111                         11111


Q ss_pred             hhh-hhhc-CCCCceEecCCCCCCEEECC-CCceeEeccccccc
Q 036624          643 GLH-YLHT-GAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKT  683 (893)
Q Consensus       643 gL~-yLH~-~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~  683 (893)
                      .|. .+.. .....++|+|+.+.|||+++ +..+.|+||..+..
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            111 1111 12457899999999999998 57899999988764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.22  E-value=0.0014  Score=63.92  Aligned_cols=126  Identities=21%  Similarity=0.245  Sum_probs=85.6

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceee-EEEEEeecCEEEEEEeeccCCC
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS-LIGYCEENCEMILVYDYMAYGT  615 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~E~~~~gs  615 (893)
                      .+.|++|.+|.||+|.+.+.  .+|+|.-...+  ....+..|+++|..+.-.++-+ ++.|-.+    .+.|||+.|-.
T Consensus        27 ~~~L~KG~~s~Vyl~~~~~~--~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          27 EKELAKGTTSVVYLGEWRGG--EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhcccccEEEEeeccCc--eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            45799999999999999874  78888755433  3567899999999998776664 4443322    45599999888


Q ss_pred             HHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCC-CC-CEEECCCCceeEeccccccc
Q 036624          616 LREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVK-TT-NILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       616 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk-~~-NILld~~~~~kl~DFGla~~  683 (893)
                      |.+.-...     +-++.+.+    ++.---|-   ..+|-|+.|. |. ||++.+ ..+.|+||.-|+.
T Consensus        99 L~~~~~~~-----~rk~l~~v----lE~a~~LD---~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG-----DRKHLLRV----LEKAYKLD---RLGIEHGELSRPWKNVLVND-RDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc-----cHHHHHHH----HHHHHHHH---HhccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence            87765321     22333333    33322233   4678888887 44 555554 4999999998874

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.17  E-value=0.0018  Score=69.22  Aligned_cols=137  Identities=18%  Similarity=0.179  Sum_probs=77.7

Q ss_pred             eeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcccccee-eEEEEEeecCEEEEEEeeccCCCHHH
Q 036624          540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV-SLIGYCEENCEMILVYDYMAYGTLRE  618 (893)
Q Consensus       540 LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL~~  618 (893)
                      +..|-...+|+....  +..+++|..........-...+|.++++.+....++ ++++.+.    -.+||||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~~--~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEHP--GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEeC--CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            455777889988743  356778865432222112357899999988654443 4444432    268999999866532


Q ss_pred             -----------------HHhhCC--CCCCCHHhHH-HHHHH---------HHHhhhhhhc-----CCCCceEecCCCCCC
Q 036624          619 -----------------HLYKTQ--KPPLPWKQRL-EICIG---------AARGLHYLHT-----GAKHTIIHRDVKTTN  664 (893)
Q Consensus       619 -----------------~l~~~~--~~~l~~~~~~-~i~~~---------ia~gL~yLH~-----~~~~~ivHrDlk~~N  664 (893)
                                       .||...  ..+++...++ ....+         +.+-+..+-.     .....++|+|+.+.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence                             122221  1122222111 11101         1111111111     113468999999999


Q ss_pred             EEECCCCceeEeccccccc
Q 036624          665 ILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       665 ILld~~~~~kl~DFGla~~  683 (893)
                      |++++++ ++|+||+.+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999876 78999998765

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.10  E-value=0.0024  Score=69.73  Aligned_cols=142  Identities=20%  Similarity=0.168  Sum_probs=85.4

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccc--eeeEEEE------EeecCEEEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH--LVSLIGY------CEENCEMILVY  608 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~  608 (893)
                      .+.|..|....+|+....++  .+++|+...   ........|++++..+++.+  +.+.+..      ....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~~--~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG--RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCCC--cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            45677777789999876543  578887654   22355677888888886433  4444432      12234568999


Q ss_pred             eeccCCCHHH--------------HHhhCC----C-----CCCCHHhHH----------HHHHHHHHhhhhhhc----CC
Q 036624          609 DYMAYGTLRE--------------HLYKTQ----K-----PPLPWKQRL----------EICIGAARGLHYLHT----GA  651 (893)
Q Consensus       609 E~~~~gsL~~--------------~l~~~~----~-----~~l~~~~~~----------~i~~~ia~gL~yLH~----~~  651 (893)
                      ++++|..+..              .||...    .     ....|....          .....+...+.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999876521              112110    0     112232211          011112333444432    22


Q ss_pred             CCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       652 ~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      ..+++|+|+.|.|||++++..+.|.||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            45799999999999999987788999997754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.83  E-value=0.007  Score=66.33  Aligned_cols=141  Identities=21%  Similarity=0.249  Sum_probs=83.4

Q ss_pred             eeeeecCcEEEEEEEEcCc------ceEEEEEeCCCCChhhHHHHHHHHHHHhhcccccee-eEEEEEeecCEEEEEEee
Q 036624          538 LLLGVGGFGKVYRGEIDGA------TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV-SLIGYCEENCEMILVYDY  610 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~~------~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~  610 (893)
                      +.|..|-...+|+....++      +..+++|+..... ....+..+|.+++..+...++. ++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            4566666778998876542      3578888755432 2234567888888888644444 45555542    358999


Q ss_pred             ccCCCHHHH-----------------HhhCCCC-------C--CCHHhHHH--------------------------HHH
Q 036624          611 MAYGTLREH-----------------LYKTQKP-------P--LPWKQRLE--------------------------ICI  638 (893)
Q Consensus       611 ~~~gsL~~~-----------------l~~~~~~-------~--l~~~~~~~--------------------------i~~  638 (893)
                      ++|..+...                 ||.....       .  .-|....+                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988776431                 1221111       0  01111111                          111


Q ss_pred             HHHHhhhhhh------cCCCCceEecCCCCCCEEECCC----CceeEeccccccc
Q 036624          639 GAARGLHYLH------TGAKHTIIHRDVKTTNILLDEK----WVAKVSDFGLSKT  683 (893)
Q Consensus       639 ~ia~gL~yLH------~~~~~~ivHrDlk~~NILld~~----~~~kl~DFGla~~  683 (893)
                      .+.+-+.+|-      ......++|+|+.+.|||++++    +.++++||..+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            2222233333      1235678999999999999985    7899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=96.76  E-value=0.03  Score=61.79  Aligned_cols=157  Identities=15%  Similarity=0.152  Sum_probs=85.1

Q ss_pred             cCHHHHHHHhcCCcc-----ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccc--eeeE
Q 036624          522 FSFAEIKAATNNFDE-----ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH--LVSL  594 (893)
Q Consensus       522 ~~~~el~~at~~f~~-----~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l  594 (893)
                      .+.++++.....|..     .+.|+.|....+|+....++  .+++|+.....   .+....|+.++..|...+  +.+.
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g--~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~   81 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG--EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAP   81 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC--cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcc
Confidence            445555554445543     34566677778999876554  57788765222   233445666666664222  2233


Q ss_pred             EE------EEeecCEEEEEEeeccCCCHH-----------HH---HhhCCC---------CCCCH-HhHHHH--------
Q 036624          595 IG------YCEENCEMILVYDYMAYGTLR-----------EH---LYKTQK---------PPLPW-KQRLEI--------  636 (893)
Q Consensus       595 ~g------~~~~~~~~~lV~E~~~~gsL~-----------~~---l~~~~~---------~~l~~-~~~~~i--------  636 (893)
                      +.      +....+..++++||++|..+.           ..   +|....         ..+.| .....-        
T Consensus        82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (319)
T PRK05231         82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE  161 (319)
T ss_pred             eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence            32      122345678999999987531           11   121110         01112 211111        


Q ss_pred             ----HHH-HHHhhhhhhc----CCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          637 ----CIG-AARGLHYLHT----GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       637 ----~~~-ia~gL~yLH~----~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                          ..+ +...++.+..    ....++||+|+.+.|||++++...-|.||+.+..
T Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence                111 1111222221    1346899999999999999776668999998764

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.73  E-value=0.00068  Score=84.12  Aligned_cols=161  Identities=15%  Similarity=0.058  Sum_probs=113.7

Q ss_pred             HHHHHHHHHHhhccccceeeEEEEEe--ecCEEEEEEeeccCCCHHHHHhhCC--CCCCCHHhHHHHHHHHHHhhhhhhc
Q 036624          574 HEFQTEIEMLSKLRHRHLVSLIGYCE--ENCEMILVYDYMAYGTLREHLYKTQ--KPPLPWKQRLEICIGAARGLHYLHT  649 (893)
Q Consensus       574 ~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~  649 (893)
                      +....|...++...|+++.....-..  +..+.+.+++|+..|.+.+.|-+..  .++++..-+...-.+......-.|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            33444555566678888877655442  3456688999999999999887652  2344444444443443444445453


Q ss_pred             --CCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHH
Q 036624          650 --GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLF  727 (893)
Q Consensus       650 --~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~  727 (893)
                        ....-.+|++||+-|.+|..+..+|++++|+.++...  .........+++.|++|+....-+++.++|+|..|+.+|
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence              2234578999999999999999999999999984322  111222344678899999999999999999999999999


Q ss_pred             HHhhCCCCC
Q 036624          728 EILCARPAL  736 (893)
Q Consensus       728 elltG~~p~  736 (893)
                      ++-.|..++
T Consensus      1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred             HHhcccHHH
Confidence            988776654

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.40  E-value=0.044  Score=60.22  Aligned_cols=157  Identities=17%  Similarity=0.146  Sum_probs=88.4

Q ss_pred             CHHHHHHHhcCCcc-----ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccc--eeeEE
Q 036624          523 SFAEIKAATNNFDE-----ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH--LVSLI  595 (893)
Q Consensus       523 ~~~el~~at~~f~~-----~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~  595 (893)
                      +.++|+.....|..     ...++.|--..+|+....++  ..++|+.....  ...+...|.+++..|....  +.+.+
T Consensus         8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~--~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i   83 (307)
T TIGR00938         8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG--RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPV   83 (307)
T ss_pred             CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC--cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            34555554444433     34566666678998875543  46678654321  1234566777887775322  34444


Q ss_pred             EEE------eecCEEEEEEeeccCCCHH-----------H---HHhhCCC----C------CCCHHhHHH----------
Q 036624          596 GYC------EENCEMILVYDYMAYGTLR-----------E---HLYKTQK----P------PLPWKQRLE----------  635 (893)
Q Consensus       596 g~~------~~~~~~~lV~E~~~~gsL~-----------~---~l~~~~~----~------~l~~~~~~~----------  635 (893)
                      ...      ...+..++++||++|..+.           .   .+|....    .      .-.|.....          
T Consensus        84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~  163 (307)
T TIGR00938        84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE  163 (307)
T ss_pred             cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence            322      2235678999999875532           0   1221100    0      011221110          


Q ss_pred             --HHHHHHHhhhhhhc----CCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          636 --ICIGAARGLHYLHT----GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       636 --i~~~ia~gL~yLH~----~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                        ....+.+.+++|..    ....+++|+|+.+.||++++++.+.|.||+.+..
T Consensus       164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence              11123334555532    2357899999999999999887778999997753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=96.15  E-value=0.041  Score=61.45  Aligned_cols=140  Identities=16%  Similarity=0.155  Sum_probs=81.7

Q ss_pred             eeeecCcEEEEEEEEcC----cceEEEEEeCCCCChhhHHHHHHHHHHHhhcccccee-eEEEEEeecCEEEEEEeeccC
Q 036624          539 LLGVGGFGKVYRGEIDG----ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV-SLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~----~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      .|-.|-.-.+|+....+    .+..+++|........... -..|..++..+...++. ++++.+..+    .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            45456677899887533    2357888876554332222 37789999988755555 455655332    57999987


Q ss_pred             CCHHHH-----------------HhhCCC----CCCCHHhHHHHHHHH-----------------HHhhhhh----hc-C
Q 036624          614 GTLREH-----------------LYKTQK----PPLPWKQRLEICIGA-----------------ARGLHYL----HT-G  650 (893)
Q Consensus       614 gsL~~~-----------------l~~~~~----~~l~~~~~~~i~~~i-----------------a~gL~yL----H~-~  650 (893)
                      .+|...                 +|....    ....|.+..++..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            676421                 222110    012233332222111                 1111122    21 2


Q ss_pred             CCCceEecCCCCCCEEECC-CCceeEeccccccc
Q 036624          651 AKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKT  683 (893)
Q Consensus       651 ~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~  683 (893)
                      ....++|+|+++.|||+++ ++.++|+||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2456889999999999986 47899999988764

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.08  E-value=0.06  Score=59.53  Aligned_cols=80  Identities=16%  Similarity=0.152  Sum_probs=48.8

Q ss_pred             eeeecCcEEEEEEEEcCcceEEEEEeCCC-------CChhhHHHHHHHHHHHhhcc--cccee-eEEEEEeecCEEEEEE
Q 036624          539 LLGVGGFGKVYRGEIDGATTKVAIKRGNP-------LSEQGVHEFQTEIEMLSKLR--HRHLV-SLIGYCEENCEMILVY  608 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~~~~VavK~~~~-------~~~~~~~~f~~E~~~l~~l~--H~niv-~l~g~~~~~~~~~lV~  608 (893)
                      .||-|....||++...++.+.|+||...+       .-.-......-|.+.|+...  -|..+ +++.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            47889999999999865546799995321       11223344556777776653  34444 3443  3344557999


Q ss_pred             eeccCC-CHHHHH
Q 036624          609 DYMAYG-TLREHL  620 (893)
Q Consensus       609 E~~~~g-sL~~~l  620 (893)
                      |+++.. .|+..|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            999653 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.04  E-value=0.051  Score=59.24  Aligned_cols=34  Identities=24%  Similarity=0.437  Sum_probs=30.2

Q ss_pred             CCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       652 ~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      ...++|+|+.+.||+++.+.-+=|.||+++..+.
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            4679999999999999998889999999988653

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.95  E-value=0.07  Score=57.60  Aligned_cols=32  Identities=28%  Similarity=0.487  Sum_probs=26.5

Q ss_pred             CceEecCCCCCCEEECCCCc-eeEecccccccC
Q 036624          653 HTIIHRDVKTTNILLDEKWV-AKVSDFGLSKTG  684 (893)
Q Consensus       653 ~~ivHrDlk~~NILld~~~~-~kl~DFGla~~~  684 (893)
                      ..++|+|+++.|||+++++. .-|.||+.+..+
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            45899999999999997554 569999988753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.82  E-value=0.0088  Score=63.80  Aligned_cols=143  Identities=17%  Similarity=0.166  Sum_probs=90.5

Q ss_pred             cCHHHHHHHhcC---CccceeeeecCcEEEEEEEEcCcceEEEEEeCC--CCC----------------hh----hHHHH
Q 036624          522 FSFAEIKAATNN---FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN--PLS----------------EQ----GVHEF  576 (893)
Q Consensus       522 ~~~~el~~at~~---f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~--~~~----------------~~----~~~~f  576 (893)
                      +.+-.|+..+++   ++..+.||-|--+.||.+-...+ .+.++|.-+  ..+                ..    ..-..
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G-~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEG-NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCC-CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            445555555443   45678999999999999988765 567777311  000                00    01134


Q ss_pred             HHHHHHHhhcc-cc-ceeeEEEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCc
Q 036624          577 QTEIEMLSKLR-HR-HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT  654 (893)
Q Consensus       577 ~~E~~~l~~l~-H~-niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  654 (893)
                      .+|...|+.|. |- -+.+.+++    +..++|||++.+-.|...-+-     .+..++..-++++   +--|-   ++|
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~---Iv~la---~~G  222 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGL---IVRLA---NHG  222 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHHHHHHHH---HHHHH---HcC
Confidence            56777787775 22 23344443    456899999988887654321     2223333333222   22233   589


Q ss_pred             eEecCCCCCCEEECCCCceeEecccc
Q 036624          655 IIHRDVKTTNILLDEKWVAKVSDFGL  680 (893)
Q Consensus       655 ivHrDlk~~NILld~~~~~kl~DFGl  680 (893)
                      +||+|..-=||+++++..++++||--
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQ  248 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQ  248 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechH
Confidence            99999999999999999999999953

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.42  E-value=0.018  Score=65.05  Aligned_cols=48  Identities=17%  Similarity=0.325  Sum_probs=36.9

Q ss_pred             HHHHHHHHHhhccccceeeEEEEEeecC-EEEEEEeeccCCCHHHHHhhC
Q 036624          575 EFQTEIEMLSKLRHRHLVSLIGYCEENC-EMILVYDYMAYGTLREHLYKT  623 (893)
Q Consensus       575 ~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~  623 (893)
                      +..-...+++.+.|+|+...+.+..... ...+|+|++. .+|.+.+...
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~   76 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTG   76 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhc
Confidence            3556677888899999999999886553 4678899885 7888887543

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.22  E-value=0.097  Score=58.66  Aligned_cols=75  Identities=15%  Similarity=0.155  Sum_probs=47.7

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCC------CChhhHHHHHHHHHHHhhcc--ccceee-EEEEEeecCEEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNP------LSEQGVHEFQTEIEMLSKLR--HRHLVS-LIGYCEENCEMILV  607 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~------~~~~~~~~f~~E~~~l~~l~--H~niv~-l~g~~~~~~~~~lV  607 (893)
                      .+.||-|.-.-||++....+...|+||...+      .-.-..+...-|.+.|+...  -|..|+ ++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3478999999999999853335799995321      11223455667777777663  354444 4433  33455788


Q ss_pred             EeeccC
Q 036624          608 YDYMAY  613 (893)
Q Consensus       608 ~E~~~~  613 (893)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999854

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.21  E-value=0.055  Score=58.54  Aligned_cols=140  Identities=19%  Similarity=0.267  Sum_probs=72.0

Q ss_pred             ccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc---ccceeeEEEEEeecCEEEEEEeec
Q 036624          535 DEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR---HRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ...+.++.|....+|+..  ..+..+.||...   ......|..|.+-|+.|.   --.+.+.+++....+..+||+||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            345678888899999877  344678888754   334456889999888884   345678888887777779999999


Q ss_pred             cCCC--------HH---HHHhh-CCCCC-------------------CCHHh-----HHHHHH--------------HHH
Q 036624          612 AYGT--------LR---EHLYK-TQKPP-------------------LPWKQ-----RLEICI--------------GAA  641 (893)
Q Consensus       612 ~~gs--------L~---~~l~~-~~~~~-------------------l~~~~-----~~~i~~--------------~ia  641 (893)
                      +.+.        |-   ..||. .....                   -+|..     |+.-..              .+.
T Consensus        95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~  174 (288)
T PF03881_consen   95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV  174 (288)
T ss_dssp             ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence            8771        11   12343 21111                   12321     111111              111


Q ss_pred             Hh-hhhhh-cCCCCceEecCCCCCCEEECCCCceeEeccc
Q 036624          642 RG-LHYLH-TGAKHTIIHRDVKTTNILLDEKWVAKVSDFG  679 (893)
Q Consensus       642 ~g-L~yLH-~~~~~~ivHrDlk~~NILld~~~~~kl~DFG  679 (893)
                      +. ...|+ ....+-++|+||-+.|++.+.++.+.|.|=.
T Consensus       175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence            11 11222 1235679999999999999999889998843

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.85  E-value=0.34  Score=54.68  Aligned_cols=73  Identities=16%  Similarity=0.156  Sum_probs=48.3

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCC----Ch---hhHHHHHHHHHHHhhcc---ccceeeEEEEEeecCEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL----SE---QGVHEFQTEIEMLSKLR---HRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~----~~---~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l  606 (893)
                      .+.||.|.-..||+....+  ..++||+-...    ..   -....-..|.+.|+.+.   ...+.+++.+|.+  ..++
T Consensus        37 ~~eiggGn~N~VyrV~~~~--~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSS--GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcCC--ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            4578999999999987643  46889964411    11   12233344566666553   3477889988874  4578


Q ss_pred             EEeeccC
Q 036624          607 VYDYMAY  613 (893)
Q Consensus       607 V~E~~~~  613 (893)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.78  E-value=0.28  Score=53.83  Aligned_cols=31  Identities=29%  Similarity=0.327  Sum_probs=26.5

Q ss_pred             CCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       652 ~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      ..+++|+|+.+.||+++. +.+.|.||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            467899999999999988 5789999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=94.74  E-value=0.19  Score=55.81  Aligned_cols=140  Identities=16%  Similarity=0.229  Sum_probs=79.5

Q ss_pred             eeeecCcEEEEEEEEcCc---ceEEEEEeCCCCChhhHHHHHHHHHHHhhcccccee-eEEEEEeecCEEEEEEeeccCC
Q 036624          539 LLGVGGFGKVYRGEIDGA---TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV-SLIGYCEENCEMILVYDYMAYG  614 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~g  614 (893)
                      .|..|=.-.+|+....+.   ...+++|........ .-.-.+|..+++.+...++. ++++++..+    +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence            454466677888876542   236888876544332 22346889999998766664 556655322    589999776


Q ss_pred             CHHH-----------------HHhhCCC----CCCCHHhHHHHHHHH----------------------HHhhhh----h
Q 036624          615 TLRE-----------------HLYKTQK----PPLPWKQRLEICIGA----------------------ARGLHY----L  647 (893)
Q Consensus       615 sL~~-----------------~l~~~~~----~~l~~~~~~~i~~~i----------------------a~gL~y----L  647 (893)
                      .|..                 .||....    .+--|....+...++                      .+-+..    +
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            6521                 1122111    011233322222211                      111111    1


Q ss_pred             hc-CCCCceEecCCCCCCEEECC-CCceeEeccccccc
Q 036624          648 HT-GAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKT  683 (893)
Q Consensus       648 H~-~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~  683 (893)
                      .+ ....-++|.|+.+.|||+++ ++.++++||..|..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11 11234679999999999975 57899999998754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.64  E-value=0.31  Score=49.58  Aligned_cols=136  Identities=13%  Similarity=0.145  Sum_probs=82.9

Q ss_pred             EEEEeCCCCChh-hHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHH
Q 036624          560 VAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI  638 (893)
Q Consensus       560 VavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~  638 (893)
                      ..+|++....-. ...-|..+.+++++++  .|+++..-  ..-..-++.|+|-.-.            ..   -..++.
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------------i~---~~N~i~  148 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------------IN---FSNFIT  148 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------------cc---hhHHHH
Confidence            455554433222 3455788899998886  56777622  3345668888874211            10   111222


Q ss_pred             HHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcch
Q 036624          639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD  718 (893)
Q Consensus       639 ~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksD  718 (893)
                      .=...|.-.|++ ..+.+|+|-.|+||+-|..|.+||.|=+..-..              +.-|.--|   ....|.++.
T Consensus       149 agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~~vN~~---Y~~lT~~aE  210 (308)
T PF07387_consen  149 AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVNMVNIE---YESLTQEAE  210 (308)
T ss_pred             HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhh--------------eeeEEeee---ccccChHHH
Confidence            114567888864 578999999999999999999999997643210              01122211   123466777


Q ss_pred             hhhHHHHHHHHhhC
Q 036624          719 VYSFGVVLFEILCA  732 (893)
Q Consensus       719 V~S~Gvvl~elltG  732 (893)
                      +=+|=.-++++...
T Consensus       211 ~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  211 VKVFVKSCLKLVEK  224 (308)
T ss_pred             HHHHHHHHHHHHHH
Confidence            77777777777654

The function of this family is unknown.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=93.57  E-value=0.47  Score=52.35  Aligned_cols=136  Identities=21%  Similarity=0.226  Sum_probs=79.1

Q ss_pred             CcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccc------eeeEEEE----EeecCEEEEEEeeccC
Q 036624          544 GFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH------LVSLIGY----CEENCEMILVYDYMAY  613 (893)
Q Consensus       544 ~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~----~~~~~~~~lV~E~~~~  613 (893)
                      .-..+|+....++.  .++|.....  ....+...|...|..|.-..      +..+-|-    .......+-|++|++|
T Consensus        37 ~eN~~f~~~~~~g~--~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G  112 (331)
T COG2334          37 EENSNFRVQTEDGR--YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG  112 (331)
T ss_pred             ccCceEEEEecCCC--eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence            44578888877653  378876654  34456777888888774221      2222222    1111367788999998


Q ss_pred             CCHHH-----H----------HhhC----C------CCCCCHHh-------------HHHHHHHHHHhhhhhhc----CC
Q 036624          614 GTLRE-----H----------LYKT----Q------KPPLPWKQ-------------RLEICIGAARGLHYLHT----GA  651 (893)
Q Consensus       614 gsL~~-----~----------l~~~----~------~~~l~~~~-------------~~~i~~~ia~gL~yLH~----~~  651 (893)
                      ..+..     .          ||..    .      .....|..             ......++...+..+.+    ..
T Consensus       113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l  192 (331)
T COG2334         113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL  192 (331)
T ss_pred             cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence            88772     1          1110    0      11234431             01122233333333332    12


Q ss_pred             CCc---eEecCCCCCCEEECCCCc-eeEeccccccc
Q 036624          652 KHT---IIHRDVKTTNILLDEKWV-AKVSDFGLSKT  683 (893)
Q Consensus       652 ~~~---ivHrDlk~~NILld~~~~-~kl~DFGla~~  683 (893)
                      ...   +||+|+.+.|||++++.. +.+.||+-+..
T Consensus       193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             CcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            233   999999999999999875 89999997763

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.48  E-value=0.66  Score=50.96  Aligned_cols=33  Identities=15%  Similarity=0.285  Sum_probs=29.3

Q ss_pred             CCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       652 ~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ..+++|+|+.+.|+|+++++.+.|+||..+...
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            467999999999999999999999999987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region

Probab=93.40  E-value=0.084  Score=49.97  Aligned_cols=31  Identities=29%  Similarity=0.271  Sum_probs=18.8

Q ss_pred             eEEEecccchhhhhHHHHhhhhhhhhhcccC
Q 036624          444 KAIIGGGVGGGIALALVVGFCVFAASRCRRQ  474 (893)
Q Consensus       444 ~~ii~~~v~~~i~v~lvv~~~~~~~~~~r~~  474 (893)
                      .++||++||+++.+++++++++|++++|+++
T Consensus        49 nIVIGvVVGVGg~ill~il~lvf~~c~r~kk   79 (154)
T PF04478_consen   49 NIVIGVVVGVGGPILLGILALVFIFCIRRKK   79 (154)
T ss_pred             cEEEEEEecccHHHHHHHHHhheeEEEeccc
Confidence            5788888887766665555444444443333

The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway [].

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=93.12  E-value=0.63  Score=47.84  Aligned_cols=59  Identities=20%  Similarity=0.262  Sum_probs=44.7

Q ss_pred             cceEEEEEeCCCCChhhHHHHHHHHHHHhhcc---ccceeeEEEEEeecCEEEEEEeeccCCCHH
Q 036624          556 ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR---HRHLVSLIGYCEENCEMILVYDYMAYGTLR  617 (893)
Q Consensus       556 ~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  617 (893)
                      +...+-||+-   .......|.+|+.-|..|.   .-++.+.+.+-......+||+||++-|.+.
T Consensus        38 g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          38 GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            3467888863   2344567889988777764   456778888888899999999999987665

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	893
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-97
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-96
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-52
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-51
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-37
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-27
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-24
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-24
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-24
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-23
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-22
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-22
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-22
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-21
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-21
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-21
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-21
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-21
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-21
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-21
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-21
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-21
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-21
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-21
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-21
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-21
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-21
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-21
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-20
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-20
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-20
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-20
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-20
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-20
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-20
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-20
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-20
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-20
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-20
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-20
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-19
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-19
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-19
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		8e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-16
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-05
3soa_A	444	Full-Length Human Camkii Length = 444		1e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  352 bits (904), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 188/324 (58%), Positives = 231/324 (71%), Gaps = 13/324 (4%)
Query: 500 GSAKTNTTGSYASSLPSNLCRHFS-----FAEIKAATNNFDEALLLGVGGFGKVYRGEI- 553
           GS  +  T S   +L S+    F        +++ ATNNFD   L+G G FGKVY+G + 
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 554 DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY 613
           DGA  KVA+KR  P S QG+ EF+TEIE LS  RH HLVSLIG+C+E  EMIL+Y YM  
Sbjct: 62  DGA--KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119
Query: 614 GTLREHLYKTQKP--PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW 671
           G L+ HLY +  P   + W+QRLEICIGAARGLHYLHT A   IIHRDVK+ NILLDE +
Sbjct: 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENF 176
Query: 672 VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC 731
           V K++DFG+SK G  LD TH+  VVKG+ GY+DPEYF + +LTEKSDVYSFGVVLFE+LC
Sbjct: 177 VPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
Query: 732 ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQ 791
           AR A+  +LP+E V+LAEWA   H  G LEQI+DP L  KI PE  +KF +TA+KC++  
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296
Query: 792 GIERPSMGDVLWNLEFALQLQESA 815
             +RPSMGDVLW LE+AL+LQES 
Sbjct: 297 SEDRPSMGDVLWKLEYALRLQESV 320

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  349 bits (896), Expect = 3e-96,   Method: Compositional matrix adjust.
 Identities = 187/324 (57%), Positives = 230/324 (70%), Gaps = 13/324 (4%)
Query: 500 GSAKTNTTGSYASSLPSNLCRHFS-----FAEIKAATNNFDEALLLGVGGFGKVYRGEI- 553
           GS  +  T S   +L S+    F        +++ ATNNFD   L+G G FGKVY+G + 
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 554 DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY 613
           DGA  KVA+KR  P S QG+ EF+TEIE LS  RH HLVSLIG+C+E  EMIL+Y YM  
Sbjct: 62  DGA--KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119
Query: 614 GTLREHLYKTQKP--PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW 671
           G L+ HLY +  P   + W+QRLEICIGAARGLHYLHT A   IIHRDVK+ NILLDE +
Sbjct: 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENF 176
Query: 672 VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC 731
           V K++DFG+SK G  L  TH+  VVKG+ GY+DPEYF + +LTEKSDVYSFGVVLFE+LC
Sbjct: 177 VPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
Query: 732 ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQ 791
           AR A+  +LP+E V+LAEWA   H  G LEQI+DP L  KI PE  +KF +TA+KC++  
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296
Query: 792 GIERPSMGDVLWNLEFALQLQESA 815
             +RPSMGDVLW LE+AL+LQES 
Sbjct: 297 SEDRPSMGDVLWKLEYALRLQESV 320

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  203 bits (516), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 119/293 (40%), Positives = 171/293 (58%), Gaps = 9/293 (3%)
Query: 520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEI-DGATTKVAIKRGNPLSEQGVH-EFQ 577
           + FS  E++ A++NF    +LG GGFGKVY+G + DG  T VA+KR      QG   +FQ
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG--TLVAVKRLKEERXQGGELQFQ 83
Query: 578 TEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYK--TQKPPLPWKQRLE 635
           TE+EM+S   HR+L+ L G+C    E +LVY YMA G++   L +    +PPL W +R  
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
           I +G+ARGL YLH      IIHRDVK  NILLDE++ A V DFGL+K     D  HV   
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXXA 202
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPA--LNPTLPKEQVSLAEWAAH 753
           V+G+ G++ PEY    + +EK+DV+ +GV+L E++  + A  L      + V L +W   
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
             K+  LE ++D  L+G    E  ++  + A+ C     +ERP M +V+  LE
Sbjct: 263 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  201 bits (510), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 118/293 (40%), Positives = 169/293 (57%), Gaps = 9/293 (3%)
Query: 520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEI-DGATTKVAIKRGNPLSEQGVH-EFQ 577
           + FS  E++ A++NF    +LG GGFGKVY+G + DG    VA+KR      QG   +FQ
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXL--VAVKRLKEERTQGGELQFQ 75
Query: 578 TEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYK--TQKPPLPWKQRLE 635
           TE+EM+S   HR+L+ L G+C    E +LVY YMA G++   L +    +PPL W +R  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
           I +G+ARGL YLH      IIHRDVK  NILLDE++ A V DFGL+K     D  HV   
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXXA 194
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPA--LNPTLPKEQVSLAEWAAH 753
           V+G  G++ PEY    + +EK+DV+ +GV+L E++  + A  L      + V L +W   
Sbjct: 195 VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
             K+  LE ++D  L+G    E  ++  + A+ C     +ERP M +V+  LE
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  165 bits (418), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 92/227 (40%), Positives = 138/227 (60%), Gaps = 17/227 (7%)
Query: 522 FSFAEIKAATNNFDEALL------LGVGGFGKVYRGEIDGATTKVAIKRGNPL----SEQ 571
           FSF E+K  TNNFDE  +      +G GGFG VY+G ++  T  VA+K+   +    +E+
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 72
Query: 572 GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQ-KPPLPW 630
              +F  EI++++K +H +LV L+G+  +  ++ LVY YM  G+L + L      PPL W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
             R +I  GAA G+++LH       IHRD+K+ NILLDE + AK+SDFGL++       T
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
            + + + G+  Y+ PE   R ++T KSD+YSFGVVL EI+   PA++
Sbjct: 190 VMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  164 bits (416), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 92/227 (40%), Positives = 137/227 (60%), Gaps = 17/227 (7%)
Query: 522 FSFAEIKAATNNFDEALL------LGVGGFGKVYRGEIDGATTKVAIKRGNPL----SEQ 571
           FSF E+K  TNNFDE  +      +G GGFG VY+G ++  T  VA+K+   +    +E+
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 72
Query: 572 GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQ-KPPLPW 630
              +F  EI++++K +H +LV L+G+  +  ++ LVY YM  G+L + L      PPL W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
             R +I  GAA G+++LH       IHRD+K+ NILLDE + AK+SDFGL++       T
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
            +   + G+  Y+ PE   R ++T KSD+YSFGVVL EI+   PA++
Sbjct: 190 VMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  162 bits (410), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 91/227 (40%), Positives = 136/227 (59%), Gaps = 17/227 (7%)
Query: 522 FSFAEIKAATNNFDEALL------LGVGGFGKVYRGEIDGATTKVAIKRGNPL----SEQ 571
           FSF E+K  TNNFDE  +      +G GGFG VY+G ++  T  VA+K+   +    +E+
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 66
Query: 572 GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQ-KPPLPW 630
              +F  EI++++K +H +LV L+G+  +  ++ LVY YM  G+L + L      PPL W
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
             R +I  GAA G+++LH       IHRD+K+ NILLDE + AK+SDFGL++        
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
            +   + G+  Y+ PE   R ++T KSD+YSFGVVL EI+   PA++
Sbjct: 184 VMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 229

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  155 bits (391), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 90/227 (39%), Positives = 132/227 (58%), Gaps = 17/227 (7%)
Query: 522 FSFAEIKAATNNFDEALL------LGVGGFGKVYRGEIDGATTKVAIKRGNPL----SEQ 571
           FSF E+K  TNNFDE  +       G GGFG VY+G ++  T  VA+K+   +    +E+
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 63
Query: 572 GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQ-KPPLPW 630
              +F  EI++ +K +H +LV L+G+  +  ++ LVY Y   G+L + L      PPL W
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
             R +I  GAA G+++LH       IHRD+K+ NILLDE + AK+SDFGL++        
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
              + + G+  Y  PE   R ++T KSD+YSFGVVL EI+   PA++
Sbjct: 181 VXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  121 bits (303), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 110/191 (57%), Gaps = 4/191 (2%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG V+R E  G+   V I        + V+EF  E+ ++ +LRH ++V  +G   
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 600 ENCEMILVYDYMAYGTLREHLYKT-QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
           +   + +V +Y++ G+L   L+K+  +  L  ++RL +    A+G++YLH      I+HR
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHR 163
Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           D+K+ N+L+D+K+  KV DFGLS+   +      S    G+  ++ PE  R +   EKSD
Sbjct: 164 DLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 719 VYSFGVVLFEI 729
           VYSFGV+L+E+
Sbjct: 222 VYSFGVILWEL 232

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  119 bits (298), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 65/191 (34%), Positives = 111/191 (58%), Gaps = 4/191 (2%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG V+R E  G+   V I        + V+EF  E+ ++ +LRH ++V  +G   
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 600 ENCEMILVYDYMAYGTLREHLYKT-QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
           +   + +V +Y++ G+L   L+K+  +  L  ++RL +    A+G++YLH      I+HR
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHR 163
Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           ++K+ N+L+D+K+  KV DFGLS+   +   +  S    G+  ++ PE  R +   EKSD
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPSNEKSD 221
Query: 719 VYSFGVVLFEI 729
           VYSFGV+L+E+
Sbjct: 222 VYSFGVILWEL 232

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 113/215 (52%), Gaps = 19/215 (8%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE--QGVHEFQTEIEML 583
           EI  A    +E  ++G+GGFGKVYR    G    V   R +P  +  Q +   + E ++ 
Sbjct: 3   EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 584 SKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARG 643
           + L+H ++++L G C +   + LV ++   G L   L   + PP      +   +  ARG
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP---DILVNWAVQIARG 117
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKW--------VAKVSDFGLSKTGPTLDHTHVSTV 695
           ++YLH  A   IIHRD+K++NIL+ +K         + K++DFGL++      H      
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMS 173
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             G++ ++ PE  R    ++ SDV+S+GV+L+E+L
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL 208

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 137/276 (49%), Gaps = 32/276 (11%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG VY+G+  G    VA+K  N    + Q +  F+ E+ +L K RH +++  +GY
Sbjct: 20  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +  ++ +V  +    +L  HL+ ++      K+ ++I    ARG+ YLH     +IIH
Sbjct: 77  STK-PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIH 131
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LT 714
           RD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     +
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI----MDPYLKG 770
            +SDVY+FG+VL+E++  +      LP   ++        ++  I+E +    + P L  
Sbjct: 192 FQSDVYAFGIVLYELMTGQ------LPYSNIN--------NRDQIIEMVGRGSLSPDL-S 236
Query: 771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
           K+   C K+      +C+  +  ERPS   +L  +E
Sbjct: 237 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 137/276 (49%), Gaps = 32/276 (11%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG VY+G+  G    VA+K  N    + Q +  F+ E+ +L K RH +++  +GY
Sbjct: 32  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +  ++ +V  +    +L  HL+ ++      K+ ++I    ARG+ YLH     +IIH
Sbjct: 89  STK-PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LT 714
           RD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI----MDPYLKG 770
            +SDVY+FG+VL+E++  +      LP   ++        ++  I+E +    + P L  
Sbjct: 204 FQSDVYAFGIVLYELMTGQ------LPYSNIN--------NRDQIIEMVGRGSLSPDL-S 248
Query: 771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
           K+   C K+      +C+  +  ERPS   +L  +E
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 32/276 (11%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG VY+G+  G    VA+K  N    + Q +  F+ E+ +L K RH +++  +GY
Sbjct: 32  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
                ++ +V  +    +L  HL+ ++      K+ ++I    ARG+ YLH     +IIH
Sbjct: 89  STA-PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LT 714
           RD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI----MDPYLKG 770
            +SDVY+FG+VL+E++  +      LP   ++        ++  I+E +    + P L  
Sbjct: 204 FQSDVYAFGIVLYELMTGQ------LPYSNIN--------NRDQIIEMVGRGSLSPDL-S 248
Query: 771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
           K+   C K+      +C+  +  ERPS   +L  +E
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTK-----VAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV+  E      +     VA+K     SE    +FQ E E+L+ L+H+H+V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKP--------------PLPWKQRLEICIGA 640
            G C E   +++V++YM +G L   L ++  P              PL   Q L +    
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFL-RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           A G+ YL   A    +HRD+ T N L+ +  V K+ DFG+S+   + D+  V        
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            ++ PE    ++ T +SDV+SFGVVL+EI 
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  105 bits (261), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTK-----VAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV+  E      +     VA+K     SE    +FQ E E+L+ L+H+H+V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKP--------------PLPWKQRLEICIGA 640
            G C E   +++V++YM +G L   L ++  P              PL   Q L +    
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFL-RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           A G+ YL   A    +HRD+ T N L+ +  V K+ DFG+S+   + D+  V        
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            ++ PE    ++ T +SDV+SFGVVL+EI 
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIF 231

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  105 bits (261), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTK-----VAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV+  E      +     VA+K     SE    +FQ E E+L+ L+H+H+V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKP--------------PLPWKQRLEICIGA 640
            G C E   +++V++YM +G L   L ++  P              PL   Q L +    
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFL-RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           A G+ YL   A    +HRD+ T N L+ +  V K+ DFG+S+   + D+  V        
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            ++ PE    ++ T +SDV+SFGVVL+EI 
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIF 225

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 106/194 (54%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG V+ G       KVAIK  R   +SE+   +F  E E++ KL H  LV L G 
Sbjct: 15  IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 70
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C E   + LV+++M +G L ++L +TQ+     +  L +C+    G+ YL      ++IH
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA---SVIH 126
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV-STVVKGSFGYLDPEYFRRQQLTEK 716
           RD+   N L+ E  V KVSDFG+++    LD  +  ST  K    +  PE F   + + K
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFGV+++E+ 
Sbjct: 185 SDVWSFGVLMWEVF 198

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 105/194 (54%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG V+ G       KVAIK  R   +SE+   +F  E E++ KL H  LV L G 
Sbjct: 15  IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 70
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C E   + LV+++M +G L ++L +TQ+     +  L +C+    G+ YL       +IH
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV-STVVKGSFGYLDPEYFRRQQLTEK 716
           RD+   N L+ E  V KVSDFG+++    LD  +  ST  K    +  PE F   + + K
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFGV+++E+ 
Sbjct: 185 SDVWSFGVLMWEVF 198

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 105/194 (54%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG V+ G       KVAIK  R   +SE+   +F  E E++ KL H  LV L G 
Sbjct: 13  IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 68
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C E   + LV+++M +G L ++L +TQ+     +  L +C+    G+ YL       +IH
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV-STVVKGSFGYLDPEYFRRQQLTEK 716
           RD+   N L+ E  V KVSDFG+++    LD  +  ST  K    +  PE F   + + K
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFGV+++E+ 
Sbjct: 183 SDVWSFGVLMWEVF 196

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 540 LGVGGFGKVYRGEI-----DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV+  E      +     VA+K     S+    +F  E E+L+ L+H H+V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 595 IGYCEENCEMILVYDYMAYGTL----REH-----LYKTQKPP--LPWKQRLEICIGAARG 643
            G C E   +I+V++YM +G L    R H     L     PP  L   Q L I    A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           + YL   A    +HRD+ T N L+ E  + K+ DFG+S+   + D+  V         ++
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            PE    ++ T +SDV+S GVVL+EI 
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIF 224

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 105/194 (54%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG V+ G       KVAIK  R   +SE+   +F  E E++ KL H  LV L G 
Sbjct: 18  IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 73
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C E   + LV+++M +G L ++L +TQ+     +  L +C+    G+ YL       +IH
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV-STVVKGSFGYLDPEYFRRQQLTEK 716
           RD+   N L+ E  V KVSDFG+++    LD  +  ST  K    +  PE F   + + K
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFGV+++E+ 
Sbjct: 188 SDVWSFGVLMWEVF 201

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG VY+G+  G    VA+K  N    + Q +  F+ E+ +L K RH +++  +GY
Sbjct: 21  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +  ++ +V  +    +L  HL+  +       + ++I    A+G+ YLH     +IIH
Sbjct: 78  STKP-QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIH 132
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LT 714
           RD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     +
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            +SDVY+FG+VL+E++  +      LP   ++  +       +G L     P L  K+  
Sbjct: 193 FQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLS----PDL-SKVRS 241
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF 807
            C K       +C+  +  ERP    +L ++E 
Sbjct: 242 NCPKAMKRLMAECLKKKRDERPLFPQILASIEL 274

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 20/271 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG VY+G+  G      +K  +P  EQ    F+ E+ +L K RH +++  +GY  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQ-FQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           ++  + +V  +    +L +HL+  Q+      Q ++I    A+G+ YLH      IIHRD
Sbjct: 103 KD-NLAIVTQWCEGSSLYKHLH-VQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRD 157
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LTEK 716
           +K+ NI L E    K+ DFGL+        +       GS  ++ PE  R Q     + +
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217
Query: 717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC 776
           SDVYS+G+VL+E++      +    ++Q+       +            P L  K+   C
Sbjct: 218 SDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA----------SPDL-SKLYKNC 266
Query: 777 FKKFAETAMKCVSDQGIERPSMGDVLWNLEF 807
            K        CV     ERP    +L ++E 
Sbjct: 267 PKAMKRLVADCVKKVKEERPLFPQILSSIEL 297

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 142/313 (45%), Gaps = 24/313 (7%)
Query: 500 GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK 559
           GS   +  GS   +    L R  S  + +           +G G FG VY+G+  G    
Sbjct: 4   GSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---D 60
Query: 560 VAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLR 617
           VA+K  N    + Q +  F+ E+ +L K RH +++  +GY  +  ++ +V  +    +L 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 119
Query: 618 EHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSD 677
            HL+  +       + ++I    A+G+ YLH     +IIHRD+K+ NI L E    K+ D
Sbjct: 120 HHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGD 175
Query: 678 FGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEILCARP 734
           FGL+        +H    + GS  ++ PE  R Q     + +SDVY+FG+VL+E++  + 
Sbjct: 176 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ- 234
Query: 735 ALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIE 794
                LP   ++  +       +G L     P L  K+   C K       +C+  +  E
Sbjct: 235 -----LPYSNINNRDQIIFMVGRGYLS----PDL-SKVRSNCPKAMKRLMAECLKKKRDE 284
Query: 795 RPSMGDVLWNLEF 807
           RP    +L ++E 
Sbjct: 285 RPLFPQILASIEL 297

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG VY+G+  G    VA+K  N    + Q +  F+ E+ +L K RH +++  +GY
Sbjct: 21  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +  ++ +V  +    +L  HL+  +       + ++I    A+G+ YLH     +IIH
Sbjct: 78  STKP-QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIH 132
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LT 714
           RD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     +
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            +SDVY+FG+VL+E++  +      LP   ++  +       +G L     P L  K+  
Sbjct: 193 FQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLS----PDL-SKVRS 241
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF 807
            C K       +C+  +  ERP    +L ++E 
Sbjct: 242 NCPKAMKRLMAECLKKKRDERPLFPQILASIEL 274

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG VY+G+  G    VA+K  N    + Q +  F+ E+ +L K RH +++  +GY
Sbjct: 16  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +  ++ +V  +    +L  HL+  +       + ++I    A+G+ YLH     +IIH
Sbjct: 73  STKP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LT 714
           RD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            +SDVY+FG+VL+E++  +      LP   ++  +       +G L     P L  K+  
Sbjct: 188 FQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDL-SKVRS 236
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF 807
            C K       +C+  +  ERP    +L ++E 
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG VY+G+  G    VA+K  N    + Q +  F+ E+ +L K RH +++  +GY
Sbjct: 18  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +  ++ +V  +    +L  HL+  +       + ++I    A+G+ YLH     +IIH
Sbjct: 75  STKP-QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIH 129
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LT 714
           RD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     +
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 189
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            +SDVY+FG+VL+E++  +      LP   ++  +       +G L     P L  K+  
Sbjct: 190 FQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDL-SKVRS 238
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF 807
            C K       +C+  +  ERP    +L ++E 
Sbjct: 239 NCPKAMKRLMAECLKKKRDERPLFPQILASIEL 271

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG VY+G+  G    VA+K  N    + Q +  F+ E+ +L K RH +++  +GY
Sbjct: 43  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +  ++ +V  +    +L  HL+  +       + ++I    A+G+ YLH     +IIH
Sbjct: 100 STK-PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIH 154
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LT 714
           RD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     +
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 214
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            +SDVY+FG+VL+E++  +      LP   ++  +       +G L     P L  K+  
Sbjct: 215 FQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLS----PDL-SKVRS 263
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF 807
            C K       +C+  +  ERP    +L ++E 
Sbjct: 264 NCPKAMKRLMAECLKKKRDERPLFPQILASIEL 296

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 142/313 (45%), Gaps = 24/313 (7%)
Query: 500 GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK 559
           GS   +  GS   +    L R  S  + +           +G G FG VY+G+  G    
Sbjct: 4   GSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---D 60
Query: 560 VAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLR 617
           VA+K  N    + Q +  F+ E+ +L K RH +++  +GY  +  ++ +V  +    +L 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 119
Query: 618 EHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSD 677
            HL+  +       + ++I    A+G+ YLH     +IIHRD+K+ NI L E    K+ D
Sbjct: 120 HHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGD 175
Query: 678 FGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEILCARP 734
           FGL+        +H    + GS  ++ PE  R Q     + +SDVY+FG+VL+E++  + 
Sbjct: 176 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ- 234
Query: 735 ALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIE 794
                LP   ++  +       +G L     P L  K+   C K       +C+  +  E
Sbjct: 235 -----LPYSNINNRDQIIFMVGRGYLS----PDL-SKVRSNCPKAMKRLMAECLKKKRDE 284
Query: 795 RPSMGDVLWNLEF 807
           RP    +L ++E 
Sbjct: 285 RPLFPQILASIEL 297

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG VY+G+  G    VA+K  N    + Q +  F+ E+ +L K RH +++  +GY
Sbjct: 16  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +  ++ +V  +    +L  HL+  +       + ++I    A+G+ YLH     +IIH
Sbjct: 73  STKP-QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LT 714
           RD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            +SDVY+FG+VL+E++  +      LP   ++  +       +G L     P L  K+  
Sbjct: 188 FQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDL-SKVRS 236
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF 807
            C K       +C+  +  ERP    +L ++E 
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 130/273 (47%), Gaps = 24/273 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG VY+G+  G    VA+K  N    + Q +  F+ E+ +L K RH +++  +GY
Sbjct: 16  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
                ++ +V  +    +L  HL+  +       + ++I    A+G+ YLH     +IIH
Sbjct: 73  STAP-QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LT 714
           RD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            +SDVY+FG+VL+E++  +      LP   ++  +       +G L     P L  K+  
Sbjct: 188 FQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDL-SKVRS 236
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF 807
            C K       +C+  +  ERP    +L ++E 
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 26/229 (11%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G         TKVA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW--------------KQRLEI 636
           +++L+G C ++  + ++ +Y + G LRE+L   + P L +              K  +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
           +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E++
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG VY+G+  G    VA+K  N    + Q +  F+ E+ +L K RH +++  +GY
Sbjct: 36  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +  ++ +V  +    +L  HL+  +       + ++I    A+G+ YLH     +IIH
Sbjct: 93  STKP-QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIH 147
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LT 714
           RD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     +
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 207
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            +SDVY+FG+VL+E++  +      LP   ++  +       +G L     P L  K+  
Sbjct: 208 FQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLS----PDL-SKVRS 256
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF 807
            C K       +C+  +  ERP    +L ++E 
Sbjct: 257 NCPKAMKRLMAECLKKKRDERPLFPQILASIEL 289

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 26/229 (11%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G         TKVA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW--------------KQRLEI 636
           +++L+G C ++  + ++ +Y + G LRE+L   + P L +              K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
           +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E++
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 26/229 (11%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G         TKVA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW--------------KQRLEI 636
           +++L+G C ++  + ++ +Y + G LRE+L   + P L +              K  +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
           +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E++
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 254

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 26/229 (11%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G         TKVA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW--------------KQRLEI 636
           +++L+G C ++  + ++ +Y + G LRE+L   + P L +              K  +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
           +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E++
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 253

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 26/229 (11%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G         TKVA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW--------------KQRLEI 636
           +++L+G C ++  + ++ +Y + G LRE+L   + P L +              K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
           +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E++
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 104/194 (53%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG V+ G       KVAIK  R   +SE+   +F  E E++ KL H  LV L G 
Sbjct: 16  IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 71
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C E   + LV ++M +G L ++L +TQ+     +  L +C+    G+ YL       +IH
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV-STVVKGSFGYLDPEYFRRQQLTEK 716
           RD+   N L+ E  V KVSDFG+++    LD  +  ST  K    +  PE F   + + K
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFGV+++E+ 
Sbjct: 186 SDVWSFGVLMWEVF 199

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 26/229 (11%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G         TKVA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW--------------KQRLEI 636
           +++L+G C ++  + ++ +Y + G LRE+L   + P L +              K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
           +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E++
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 26/229 (11%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G         TKVA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW--------------KQRLEI 636
           +++L+G C ++  + ++ +Y + G LRE+L   + P L +              K  +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
           +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E++
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 250

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 120/230 (52%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G         TKVA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               L  K  + 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D    +T 
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E++
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 26/229 (11%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G         TKVA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW--------------KQRLEI 636
           +++L+G C ++  + ++ +Y + G LRE+L   + P L +              K  +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
           +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E++
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 69/194 (35%), Positives = 104/194 (53%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG V+ G       KVAIK  +   +SE    +F  E E++ KL H  LV L G 
Sbjct: 35  IGSGQFGLVHLGYWLN-KDKVAIKTIKEGSMSED---DFIEEAEVMMKLSHPKLVQLYGV 90
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C E   + LV+++M +G L ++L +TQ+     +  L +C+    G+ YL       +IH
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV-STVVKGSFGYLDPEYFRRQQLTEK 716
           RD+   N L+ E  V KVSDFG+++    LD  +  ST  K    +  PE F   + + K
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 204
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFGV+++E+ 
Sbjct: 205 SDVWSFGVLMWEVF 218

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 92  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 207
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTHVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++       D  H  T  K    ++ 
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELM 290

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 120/230 (52%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               + +K  + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 120/230 (52%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               + +K  + 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 120/230 (52%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               + +K  + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 119/230 (51%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               + +K  + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D    +T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 119/230 (51%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               + +K  + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D    +T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTHVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++       D  H  T  K    ++ 
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 38  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ +
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 153
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTHVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++       D  H  T  K    ++ 
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELM 236

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ +
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++       D  H  T  K    ++ 
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ +
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTHVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++       D  H  T  K    ++ 
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTHVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++       D  H  T  K    ++ 
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ +
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 146
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTHVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++       D  H  T  K    ++ 
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 119/230 (51%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           ++ L+G C ++  + ++ +Y + G LRE+L + ++PP               + +K  + 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 120/230 (52%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               + +K  + 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 154 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 260

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 120/230 (52%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               + +K  + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V +++DFGL++    +D+   +T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 120/230 (52%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               + +K  + 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 151 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 257

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 120/230 (52%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               + +K  + 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 149 CTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 255

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 119/230 (51%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++  Y + G LRE+L + ++PP               + +K  + 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 119/230 (51%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++  Y + G LRE+L + ++PP               + +K  + 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 120/230 (52%), Gaps = 28/230 (12%)
Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K   +  +E+ + +  +E+EM+  + +H++
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP---------------LPWKQRLE 635
           +++L+G C ++  + ++ +Y + G LRE+L + ++PP               + +K  + 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            +    ++ PE    +  T +SDV+SFGV+++EI     +  P +P E++
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 141/299 (47%), Gaps = 49/299 (16%)
Query: 539 LLGVGGFGKVYRGEI--DGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHR-HLVSL 594
           ++G G FG+V +  I  DG     AIKR    + +  H +F  E+E+L KL H  ++++L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGA 640
           +G CE    + L  +Y  +G L + L K++                 L  +Q L      
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           ARG+ YL   ++   IHRD+   NIL+ E +VAK++DFGLS+             VK + 
Sbjct: 142 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 190
Query: 701 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH 755
           G L   +   + L     T  SDV+S+GV+L+EI+    +L  T P   ++ AE      
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SLGGT-PYCGMTCAELYEKLP 245
Query: 756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
           +   LE+ ++          C  +  +   +C  ++  ERPS   +L +L   L+ +++
Sbjct: 246 QGYRLEKPLN----------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 294

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 112/206 (54%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 51  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ Y
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 166
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH--THVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++     ++   H  T  K    ++ 
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELM 249

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 112/206 (54%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 52  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ Y
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 167
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH--THVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++     ++   H  T  K    ++ 
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELM 250

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 141/299 (47%), Gaps = 49/299 (16%)
Query: 539 LLGVGGFGKVYRGEI--DGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHR-HLVSL 594
           ++G G FG+V +  I  DG     AIKR    + +  H +F  E+E+L KL H  ++++L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGA 640
           +G CE    + L  +Y  +G L + L K++                 L  +Q L      
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           ARG+ YL   ++   IHRD+   NIL+ E +VAK++DFGLS+             VK + 
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 200
Query: 701 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH 755
           G L   +   + L     T  SDV+S+GV+L+EI+    +L  T P   ++ AE      
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SLGGT-PYCGMTCAELYEKLP 255
Query: 756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
           +   LE+ ++          C  +  +   +C  ++  ERPS   +L +L   L+ +++
Sbjct: 256 QGYRLEKPLN----------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 112/206 (54%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 25  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ Y
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 140
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH--THVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++     ++   H  T  K    ++ 
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELM 223

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 540 LGVGGFGKVYRGEI-DGATTK----VAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV+  E  + + TK    VA+K     +     +FQ E E+L+ L+H H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 595 IGYCEENCEMILVYDYMAYGTLREHLY--------------KTQKPPLPWKQRLEICIGA 640
            G C +   +I+V++YM +G L + L               +  K  L   Q L I    
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           A G+ YL   A    +HRD+ T N L+    + K+ DFG+S+   + D+  V        
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            ++ PE    ++ T +SDV+SFGV+L+EI 
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTHVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++          H  T  K    ++ 
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 112/206 (54%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH--THVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++     ++   H  T  K    ++ 
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 112/206 (54%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ Y
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 145
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH--THVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++     ++   H  T  K    ++ 
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELM 228

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 112/206 (54%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ Y
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 146
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH--THVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++     ++   H  T  K    ++ 
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 112/206 (54%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH--THVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++     ++   H  T  K    ++ 
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 112/206 (54%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 28  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ Y
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 143
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH--THVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++     ++   H  T  K    ++ 
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELM 226

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 112/206 (54%), Gaps = 15/206 (7%)
Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHY 646
            +++SL+G C       ++V  YM +G LR  +  +T  P +  K  +   +  A+G+ Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH--THVSTVVKGSFGYLD 704
           L   A    +HRD+   N +LDEK+  KV+DFGL++     ++   H  T  K    ++ 
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 133/271 (49%), Gaps = 32/271 (11%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    +RG+ D A     IK G+ +SE    EF  E +++  L H  LV L 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGS-MSED---EFIEEAKVMMNLSHEKLVQLY 85
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G C +   + ++ +YMA G L  +L +  +     +Q LE+C      + YL +      
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 141
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-VKGSFGYLDPEYFRRQQLT 714
           +HRD+   N L++++ V KVSDFGLS+    LD  + S+V  K    +  PE     + +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            KSD+++FGV+++EI          +P E+ + +E A H   +G+  ++  P+L      
Sbjct: 200 SKSDIWAFGVLMWEIYSL-----GKMPYERFTNSETAEHI-AQGL--RLYRPHLAS---- 247
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
              +K       C  ++  ERP+   +L N+
Sbjct: 248 ---EKVYTIMYSCWHEKADERPTFKILLSNI 275

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 141/299 (47%), Gaps = 49/299 (16%)
Query: 539 LLGVGGFGKVYRGEI--DGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHR-HLVSL 594
           ++G G FG+V +  I  DG     AIKR    + +  H +F  E+E+L KL H  ++++L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGA 640
           +G CE    + L  +Y  +G L + L K++                 L  +Q L      
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           ARG+ YL   ++   IHR++   NIL+ E +VAK++DFGLS+             VK + 
Sbjct: 149 ARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 197
Query: 701 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH 755
           G L   +   + L     T  SDV+S+GV+L+EI+    +L  T P   ++ AE      
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SLGGT-PYCGMTCAELYEKLP 252
Query: 756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
           +   LE+ ++          C  +  +   +C  ++  ERPS   +L +L   L+ +++
Sbjct: 253 QGYRLEKPLN----------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 301

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 133/271 (49%), Gaps = 32/271 (11%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    +RG+ D A     IK G+ +SE    EF  E +++  L H  LV L 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGS-MSED---EFIEEAKVMMNLSHEKLVQLY 70
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G C +   + ++ +YMA G L  +L +  +     +Q LE+C      + YL +      
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 126
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-VKGSFGYLDPEYFRRQQLT 714
           +HRD+   N L++++ V KVSDFGLS+    LD  + S+V  K    +  PE     + +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            KSD+++FGV+++EI          +P E+ + +E A H   +G+  ++  P+L      
Sbjct: 185 SKSDIWAFGVLMWEIYSL-----GKMPYERFTNSETAEHI-AQGL--RLYRPHLAS---- 232
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
              +K       C  ++  ERP+   +L N+
Sbjct: 233 ---EKVYTIMYSCWHEKADERPTFKILLSNI 260

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK-RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY- 597
           +G G FG V  G+  G   KVA+K   N  + Q    F  E  ++++LRH +LV L+G  
Sbjct: 29  IGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 83
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            EE   + +V +YMA G+L ++L    +  L     L+  +     + YL     +  +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 140
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+   N+L+ E  VAKVSDFGL+K   +   T      K    +  PE  R ++ + KS
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREKKFSTKS 195
Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQV 745
           DV+SFG++L+EI        P +P + V
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDV 223

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 133/271 (49%), Gaps = 32/271 (11%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    +RG+ D A     IK G+ +SE    EF  E +++  L H  LV L 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGS-MSED---EFIEEAKVMMNLSHEKLVQLY 76
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G C +   + ++ +YMA G L  +L +  +     +Q LE+C      + YL +      
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 132
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-VKGSFGYLDPEYFRRQQLT 714
           +HRD+   N L++++ V KVSDFGLS+    LD  + S+V  K    +  PE     + +
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 190
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            KSD+++FGV+++EI          +P E+ + +E A H   +G+  ++  P+L      
Sbjct: 191 SKSDIWAFGVLMWEIYSL-----GKMPYERFTNSETAEHI-AQGL--RLYRPHLAS---- 238
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
              +K       C  ++  ERP+   +L N+
Sbjct: 239 ---EKVYTIMYSCWHEKADERPTFKILLSNI 266

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 132/271 (48%), Gaps = 32/271 (11%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    +RG+ D A     IK G+ +SE    EF  E +++  L H  LV L 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGS-MSED---EFIEEAKVMMNLSHEKLVQLY 85
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G C +   + ++ +YMA G L  +L +  +     +Q LE+C      + YL +      
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 141
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-VKGSFGYLDPEYFRRQQLT 714
           +HRD+   N L++++ V KVSDFGLS+    LD    S+V  K    +  PE     + +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEETSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            KSD+++FGV+++EI          +P E+ + +E A H   +G+  ++  P+L      
Sbjct: 200 SKSDIWAFGVLMWEIYSL-----GKMPYERFTNSETAEHI-AQGL--RLYRPHLAS---- 247
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
              +K       C  ++  ERP+   +L N+
Sbjct: 248 ---EKVYTIMYSCWHEKADERPTFKILLSNI 275

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 133/271 (49%), Gaps = 32/271 (11%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    +RG+ D A     IK G+ +SE    EF  E +++  L H  LV L 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGS-MSED---EFIEEAKVMMNLSHEKLVQLY 69
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G C +   + ++ +YMA G L  +L +  +     +Q LE+C      + YL +      
Sbjct: 70  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 125
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-VKGSFGYLDPEYFRRQQLT 714
           +HRD+   N L++++ V KVSDFGLS+    LD  + S+V  K    +  PE     + +
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 183
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            KSD+++FGV+++EI          +P E+ + +E A H   +G+  ++  P+L      
Sbjct: 184 SKSDIWAFGVLMWEIYSL-----GKMPYERFTNSETAEHI-AQGL--RLYRPHLAS---- 231
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
              +K       C  ++  ERP+   +L N+
Sbjct: 232 ---EKVYTIMYSCWHEKADERPTFKILLSNI 259

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 133/271 (49%), Gaps = 32/271 (11%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    +RG+ D A     IK G+ +SE    EF  E +++  L H  LV L 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGS-MSED---EFIEEAKVMMNLSHEKLVQLY 65
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G C +   + ++ +YMA G L  +L +  +     +Q LE+C      + YL +      
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-VKGSFGYLDPEYFRRQQLT 714
           +HRD+   N L++++ V KVSDFGLS+    LD  + S+V  K    +  PE     + +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            KSD+++FGV+++EI          +P E+ + +E A H   +G+  ++  P+L      
Sbjct: 180 SKSDIWAFGVLMWEIYSL-----GKMPYERFTNSETAEHI-AQGL--RLYRPHLAS---- 227
Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
              +K       C  ++  ERP+   +L N+
Sbjct: 228 ---EKVYTIMYSCWHEKADERPTFKILLSNI 255

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTEIEMLSK 585
           NN +    +G G FG+V++    G       T VA+K     +   +  +FQ E  ++++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQ--------------------- 624
             + ++V L+G C     M L+++YMAYG L E L                         
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 625 -KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT 683
             PPL   ++L I    A G+ YL   ++   +HRD+ T N L+ E  V K++DFGLS+ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             + D+            ++ PE     + T +SDV+++GVVL+EI 
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK-RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY- 597
           +G G FG V  G+  G   KVA+K   N  + Q    F  E  ++++LRH +LV L+G  
Sbjct: 14  IGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            EE   + +V +YMA G+L ++L    +  L     L+  +     + YL     +  +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 125
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+   N+L+ E  VAKVSDFGL+K   +   T      K    +  PE  R ++ + KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREKKFSTKS 180
Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQV 745
           DV+SFG++L+EI        P +P + V
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDV 208

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK-RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY- 597
           +G G FG V  G+  G   KVA+K   N  + Q    F  E  ++++LRH +LV L+G  
Sbjct: 201 IGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 255
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            EE   + +V +YMA G+L ++L    +  L     L+  +     + YL     +  +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 312
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+   N+L+ E  VAKVSDFGL+K   +   T      K    +  PE  R ++ + KS
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREKKFSTKS 367
Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQV 745
           DV+SFG++L+EI        P +P + V
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDV 395

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 120/259 (46%), Gaps = 22/259 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 275 LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 333 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 492
Query: 780 FAETAMKCVSDQGIERPSM 798
             +   +C   +  ERP+ 
Sbjct: 493 LHDLMCQCWRKEPEERPTF 511

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 13/207 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY-C 598
           +G G FG V  G+  G   KVA+K     ++     F  E  ++++LRH +LV L+G   
Sbjct: 20  IGKGEFGDVMLGDYRG--NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
           EE   + +V +YMA G+L ++L    +  L     L+  +     + YL     +  +HR
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 132
Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           D+   N+L+ E  VAKVSDFGL+K   +   T      K    +  PE  R    + KSD
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREAAFSTKSD 187
Query: 719 VYSFGVVLFEILCARPALNPTLPKEQV 745
           V+SFG++L+EI        P +P + V
Sbjct: 188 VWSFGILLWEIYSFGRVPYPRIPLKDV 214

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 134/273 (49%), Gaps = 36/273 (13%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    +RG+ D A     IK G+ +SE    EF  E +++  L H  LV L 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGS-MSED---EFIEEAKVMMNLSHEKLVQLY 70
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G C +   + ++ +YMA G L  +L +  +     +Q LE+C      + YL +      
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 126
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQ 712
           +HRD+   N L++++ V KVSDFGLS+    LD  + S+  +GS     +  PE     +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSS--RGSKFPVRWSPPEVLMYSK 182
Query: 713 LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI 772
            + KSD+++FGV+++EI          +P E+ + +E A H   +G+  ++  P+L    
Sbjct: 183 FSSKSDIWAFGVLMWEIYSL-----GKMPYERFTNSETAEHI-AQGL--RLYRPHLAS-- 232
Query: 773 APECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
                +K       C  ++  ERP+   +L N+
Sbjct: 233 -----EKVYTIMYSCWHEKADERPTFKILLSNI 260

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 120/259 (46%), Gaps = 22/259 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 192 LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 250 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 409
Query: 780 FAETAMKCVSDQGIERPSM 798
             +   +C   +  ERP+ 
Sbjct: 410 LHDLMCQCWRKEPEERPTF 428

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 120/259 (46%), Gaps = 22/259 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 192 LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 250 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 409
Query: 780 FAETAMKCVSDQGIERPSM 798
             +   +C   +  ERP+ 
Sbjct: 410 LHDLMCQCWRKEPEERPTF 428

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 123
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+   T +S    G+  YL P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDYLPP 176
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 120/259 (46%), Gaps = 22/259 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 192 LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 250 EE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 409
Query: 780 FAETAMKCVSDQGIERPSM 798
             +   +C   +  ERP+ 
Sbjct: 410 LHDLMCQCWRKEPEERPTF 428

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 118/259 (45%), Gaps = 22/259 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 193 LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 251 EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 306
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL +     ++T      K    +  PE     + T KSDV
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 366 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 410
Query: 780 FAETAMKCVSDQGIERPSM 798
             +   +C      ERP+ 
Sbjct: 411 LHDLMCQCWRKDPEERPTF 429

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 120/258 (46%), Gaps = 22/258 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 19  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 77  EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 132
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 192 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 236
Query: 780 FAETAMKCVSDQGIERPS 797
             +   +C   +  ERP+
Sbjct: 237 LHDLMCQCWRKEPEERPT 254

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 122/261 (46%), Gaps = 28/261 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 16  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 74  EE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 129
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEK 716
           ++  NIL+ E  V KV+DFGL++    L   +  T  +G+     +  PE     + T K
Sbjct: 130 LRAANILVGENLVCKVADFGLAR----LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC 776
           SDV+SFG++L E+        P +   +V              L+Q+   Y +    PEC
Sbjct: 186 SDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPEC 230
Query: 777 FKKFAETAMKCVSDQGIERPS 797
            +   +   +C   +  ERP+
Sbjct: 231 PESLHDLMCQCWRKEPEERPT 251

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 109 GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 163
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 223 SKFSVASDVWSFGVVLYELF 242

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 148
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P    +   T + G+  YL P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 201
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 122
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+   T +     G+  YL P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTLDYLPP 175
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 83  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 137
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 138 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 197 SKFSVASDVWSFGVVLYELF 216

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 82  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 136
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 137 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 196 SKFSVASDVWSFGVVLYELF 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 84  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 138
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 139 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 198 SKFSVASDVWSFGVVLYELF 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 85  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 139
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 140 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 199 SKFSVASDVWSFGVVLYELF 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 81  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 135
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 136 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 195 SKFSVASDVWSFGVVLYELF 214

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 102/196 (52%), Gaps = 17/196 (8%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    ++G+ D A     IK G+ +SE    EF  E + + KL H  LV   
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVK--MIKEGS-MSED---EFFQEAQTMMKLSHPKLVKFY 69
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G C +   + +V +Y++ G L  +L    K   P  Q LE+C     G+ +L +   H  
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP-SQLLEMCYDVCEGMAFLES---HQF 125
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-VKGSFGYLDPEYFRRQQLT 714
           IHRD+   N L+D     KVSDFG+++    LD  +VS+V  K    +  PE F   + +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 715 EKSDVYSFGVVLFEIL 730
            KSDV++FG++++E+ 
Sbjct: 184 SKSDVWAFGILMWEVF 199

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 77  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK- 132
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 133 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 191 SKFSVASDVWSFGVVLYELF 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 78  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 192 SKFSVASDVWSFGVVLYELF 211

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 78  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 192 SKFSVASDVWSFGVVLYELF 211

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 17  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 75  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 130
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 190 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 234
Query: 780 FAETAMKCVSDQGIERPS 797
             +   +C      ERP+
Sbjct: 235 LHDLMCQCWRKDPEERPT 252

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +++ YG+LRE+L K  K  +   + L+      +G+ YL T  
Sbjct: 81  GVCYSAGRRNLKLIM--EFLPYGSLREYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 135
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 136 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 195 SKFSVASDVWSFGVVLYELF 214

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 76  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 130
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 131 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 190 SKFSVASDVWSFGVVLYELF 209

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 84  EE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 243
Query: 780 FAETAMKCVSDQGIERPS 797
             +   +C      ERP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 129/286 (45%), Gaps = 32/286 (11%)
Query: 539 LLGVGGFGKVYRGEI---DGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           +LG G FG V  G +   DG + KVA+K  + +  S++ + EF +E   +    H +++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 594 LIGYCEENCEM-----ILVYDYMAYGTLREHLY----KTQKPPLPWKQRLEICIGAARGL 644
           L+G C E         +++  +M YG L  +L     +T    +P +  L+  +  A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
            YL   +    +HRD+   N +L +     V+DFGLSK   + D+     + K    ++ 
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM 764
            E    +  T KSDV++FGV ++EI  A   + P    +   + ++  H H+   L+Q  
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEI--ATRGMTPYPGVQNHEMYDYLLHGHR---LKQPE 272
Query: 765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           D          C  +  E    C     ++RP+   +   LE  L+
Sbjct: 273 D----------CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 84  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 243
Query: 780 FAETAMKCVSDQGIERPS 797
             +   +C      ERP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPSQVY---------------ELLEKDYRMERPEGCPEK 238
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 282

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 15  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 73  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 128
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 188 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 232
Query: 780 FAETAMKCVSDQGIERPS 797
             +   +C      ERP+
Sbjct: 233 LHDLMCQCWRKDPEERPT 250

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 96  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 150
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 151 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 210 SKFSVASDVWSFGVVLYELF 229

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 122
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+   T +     G+  YL P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPP 175
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 122
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P    +   T + G+  YL P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 175
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK------RGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG GG   VY  E      KVAIK      R     E+ +  F+ E+   S+L H+++VS
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE---KEETLKRFEREVHNSSQLSHQNIVS 75
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           +I   EE+    LV +Y+   TL E  Y     PL     +        G+ + H     
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSE--YIESHGPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            I+HRD+K  NIL+D     K+ DFG++K       T  + V+ G+  Y  PE  + +  
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEAT 189
Query: 714 TEKSDVYSFGVVLFEILCARPALN 737
            E +D+YS G+VL+E+L   P  N
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 123
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+   T +     G+  YL P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPP 176
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 96  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 150
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 151 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 210 SKFSVASDVWSFGVVLYELF 229

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 84  EE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 243
Query: 780 FAETAMKCVSDQGIERPS 797
             +   +C      ERP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 139
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P    +   T + G+  YL P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 192
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 221

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 121/261 (46%), Gaps = 28/261 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 84  EE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEK 716
           ++  NIL+ E  V KV+DFGL++    L   +  T  +G+     +  PE     + T K
Sbjct: 140 LRAANILVGENLVCKVADFGLAR----LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC 776
           SDV+SFG++L E+        P +   +V              L+Q+   Y +    PEC
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPEC 240
Query: 777 FKKFAETAMKCVSDQGIERPS 797
            +   +   +C      ERP+
Sbjct: 241 PESLHDLMCQCWRKDPEERPT 261

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 78  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 192 SKFSVASDVWSFGVVLYELF 211

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 127
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P    +   T + G+  YL P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 180
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 14/214 (6%)
Query: 525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIE 581
           A+ + A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA- 640
           + S LRH +++ L GY  ++  + L+ +Y   GT+   L K  K     +QR    I   
Sbjct: 61  IQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITEL 117
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           A  L Y H+     +IHRD+K  N+LL      K++DFG S   P    +     + G+ 
Sbjct: 118 ANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTL 170
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            YL PE    +   EK D++S GV+ +E L  +P
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 127
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+   T +     G+  YL P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPP 180
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 23  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM  G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 81  EE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 196 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 240
Query: 780 FAETAMKCVSDQGIERPS 797
             +   +C   +  ERP+
Sbjct: 241 LHDLMCQCWRKEPEERPT 258

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 125
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P    +   T + G+  YL P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 178
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 118/258 (45%), Gaps = 22/258 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 84  EE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 243
Query: 780 FAETAMKCVSDQGIERPS 797
             +   +C      ERP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 122
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+   T +     G+  YL P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPP 175
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 126
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P    +   T + G+  YL P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 179
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 122
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+   T +     G+  YL P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTLDYLPP 175
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHR+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 447
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 491

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 14/218 (6%)
Query: 521 HFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQ 577
           H    + + A  +F+    LG G FG VY      +   +A+K      L + GV H+ +
Sbjct: 2   HXESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 578 TEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEIC 637
            E+E+ S LRH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATY 118
Query: 638 IGA-ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
           I   A  L Y H+     +IHRD+K  N+LL      K++DFG S   P    +   T +
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTL 171
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            G+  YL PE    +   EK D++S GV+ +E L  +P
Sbjct: 172 CGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 121
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P    +   T + G+  YL P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 174
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 203

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 245
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 289

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 118/258 (45%), Gaps = 22/258 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 84  EE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 243
Query: 780 FAETAMKCVSDQGIERPS 797
             +   +C      ERP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK-------RGNPLSEQGVHEFQTEIEM 582
           A N  +    +G GGFG V++G +    + VAIK        G     +   EFQ E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR 642
           +S L H ++V L G       M++  +++  G L   L     P + W  +L + +  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILL---DEKW--VAKVSDFGLSKTGPTLDHTHVSTVVK 697
           G+ Y+       I+HRD+++ NI L   DE     AKV+DFGLS+        H  + + 
Sbjct: 134 GIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLL 187
Query: 698 GSFGYLDPEYF--RRQQLTEKSDVYSFGVVLFEIL 730
           G+F ++ PE      +  TEK+D YSF ++L+ IL
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 197 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 241
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 242 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 285

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L K  K  +   + L+      +G+ YL T  
Sbjct: 79  GVCYSAGRRNLKLIM--EYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT-- 133
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHR++ T NIL++ +   K+ DFGL+K  P   ++  V    +    +  PE    
Sbjct: 134 -KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 193 SKFSVASDVWSFGVVLYELF 212

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 118/258 (45%), Gaps = 22/258 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 84  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 243
Query: 780 FAETAMKCVSDQGIERPS 797
             +   +C      ERP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ K+RH  LV L     
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 84  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 243
Query: 780 FAETAMKCVSDQGIERPS 797
             +   +C      ERP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 125
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P    +   T + G+  YL P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 178
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 240
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 284

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 121/261 (46%), Gaps = 28/261 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 23  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM  G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 81  EE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEK 716
           ++  NIL+ E  V KV+DFGL++    L   +  T  +G+     +  PE     + T K
Sbjct: 137 LRAANILVGENLVCKVADFGLAR----LIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC 776
           SDV+SFG++L E+        P +   +V              L+Q+   Y +    PEC
Sbjct: 193 SDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPEC 237
Query: 777 FKKFAETAMKCVSDQGIERPS 797
            +   +   +C   +  ERP+
Sbjct: 238 PESLHDLMCQCWRKEPEERPT 258

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 24/286 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 660 VKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           +   N L+ E  + KV+DFGLS+  TG T    H     K    +  PE     + + KS
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTFT-AHAGA--KFPIKWTAPESLAYNKFSIKS 191
Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECF 777
           DV++FGV+L+EI     +  P +   QV                ++++   + +    C 
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQVY---------------ELLEKDYRMERPEGCP 236
Query: 778 KKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
           +K  E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 237 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 282

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 240
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 284

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHR+
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 382
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 442 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 486
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 487 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 530

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 240
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 284

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 201 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 245
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 289

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 148
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+     +     G+  YL P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPP 201
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 240
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 284

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 242
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 286

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 197 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 241
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 242 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 285

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 149
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 208
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 209 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 253
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 254 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 297

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY          +A+K      L + GV H+ + E+E+ S L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 119
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P    +   T + G+  YL P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 172
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 201

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 125
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P    +     + G+  YL P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPP 178
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 242
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 286

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 9/204 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 720 YSFGVVLFEI----LCARPALNPT 739
           ++FGV+L+EI    +   P ++P+
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIE 581
           A+ + A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA- 640
           + S LRH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITEL 117
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           A  L Y H+     +IHRD+K  N+LL      K++DFG S   P+     +     G+ 
Sbjct: 118 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTL 170
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            YL PE    +   EK D++S GV+ +E L  +P
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 20/284 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           ++FGV+L+EI     +  P +   QV                ++++   + +    C +K
Sbjct: 198 WAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERPEGCPEK 242
Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
             E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 286

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 124
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K+++FG S   P    +   T + G+  YL P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLCGTLDYLPP 177
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 206

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTK----VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           ++G G FG+VY+G +  ++ K    VAIK      +E+   +F  E  ++ +  H +++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L G   +   M+++ +YM  G L + L + +       Q + +  G A G+ YL   A  
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             +HRD+   NIL++   V KVSDFGLS+      + T+ ++  K    +  PE    ++
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 713 LTEKSDVYSFGVVLFEILC--ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG 770
            T  SDV+SFG+V++E++    RP               W    H+  +++ I D + + 
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERPY--------------WELSNHE--VMKAINDGF-RL 269
Query: 771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
               +C     +  M+C   +   RP   D++
Sbjct: 270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIV 301

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   G + + L K  K     +QR    I   A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD---EQRTATYITELANALS 127
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P    +   T + G+  YL P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 180
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 124
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+     +     G+  YL P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPP 177
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 206

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 123
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+   +   T+  G+  YL P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRDTLC-GTLDYLPP 176
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 125
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+     +     G+  YL P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPP 178
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 596 GYC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           G C      N ++I+  +Y+ YG+LR++L +     +   + L+      +G+ YL T  
Sbjct: 81  GVCYSAGRRNLKLIM--EYLPYGSLRDYL-QAHAERIDHIKLLQYTSQICKGMEYLGT-- 135
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRR 710
               IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE    
Sbjct: 136 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + +  SDV+SFGVVL+E+ 
Sbjct: 195 SKFSVASDVWSFGVVLYELF 214

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 130/270 (48%), Gaps = 35/270 (12%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           ++G G FG V + +       VAIK+    SE+    F  E+  LS++ H ++V L G C
Sbjct: 16  VVGRGAFGVVCKAKWRA--KDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGAC 71
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPW---KQRLEICIGAARGLHYLHTGAKHTI 655
                + LV +Y   G+L   L+  +  PLP+      +  C+  ++G+ YLH+     +
Sbjct: 72  LN--PVCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 656 IHRDVKTTNILLDEK-WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           IHRD+K  N+LL     V K+ DFG +        TH+ T  KGS  ++ PE F     +
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHM-TNNKGSAAWMAPEVFEGSNYS 182
Query: 715 EKSDVYSFGVVLFEILCARPALNPT-LPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA 773
           EK DV+S+G++L+E++  R   +    P  ++    WA H   +        P +K    
Sbjct: 183 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGTR-------PPLIKN--- 229
Query: 774 PECFKKFAETAM-KCVSDQGIERPSMGDVL 802
                K  E+ M +C S    +RPSM +++
Sbjct: 230 ---LPKPIESLMTRCWSKDPSQRPSMEEIV 256

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 125
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K+++FG S   P    +   T + G+  YL P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLCGTLDYLPP 178
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 122
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+     +     G+  YL P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPP 175
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKLRH 588
            +FD    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S LRH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLHYL 647
            +++ L GY  +   + L+ +Y   GT+   L K  +     +QR    I   A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD---EQRTATYITELANALSYC 128
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+     +IHRD+K  N+LL      K++DFG S   P    +   T + G+  YL PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEM 181
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   EK D++S GV+ +E L   P
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMP 208

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK-------RGNPLSEQGVHEFQTEIEM 582
           A N  +    +G GGFG V++G +    + VAIK        G     +   EFQ E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR 642
           +S L H ++V L G       M++  +++  G L   L     P + W  +L + +  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILL---DEKW--VAKVSDFGLSKTGPTLDHTHVSTVVK 697
           G+ Y+       I+HRD+++ NI L   DE     AKV+DFG S+        H  + + 
Sbjct: 134 GIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-----VHSVSGLL 187
Query: 698 GSFGYLDPEYF--RRQQLTEKSDVYSFGVVLFEIL 730
           G+F ++ PE      +  TEK+D YSF ++L+ IL
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   GT+   L K  K     +QR    I   A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANALS 125
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P+     +     G+  YL P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPP 178
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 5/190 (2%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 720 YSFGVVLFEI 729
           ++FGV+L+EI
Sbjct: 201 WAFGVLLWEI 210

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK-------RGNPLSEQGVHEFQTEIEM 582
           A N  +    +G GGFG V++G +    + VAIK        G     +   EFQ E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR 642
           +S L H ++V L G       M++  +++  G L   L     P + W  +L + +  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILL---DEKW--VAKVSDFGLSKTGPTLDHTHVSTVVK 697
           G+ Y+       I+HRD+++ NI L   DE     AKV+DF LS+        H  + + 
Sbjct: 134 GIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-----VHSVSGLL 187
Query: 698 GSFGYLDPEYF--RRQQLTEKSDVYSFGVVLFEIL 730
           G+F ++ PE      +  TEK+D YSF ++L+ IL
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 17/199 (8%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           ++G G FG V + +       VAIK+    SE+    F  E+  LS++ H ++V L G C
Sbjct: 15  VVGRGAFGVVCKAKWRA--KDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGAC 70
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPW---KQRLEICIGAARGLHYLHTGAKHTI 655
                + LV +Y   G+L   L+  +  PLP+      +  C+  ++G+ YLH+     +
Sbjct: 71  LN--PVCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 656 IHRDVKTTNILLDEK-WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           IHRD+K  N+LL     V K+ DFG +        TH+ T  KGS  ++ PE F     +
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHM-TNNKGSAAWMAPEVFEGSNYS 181
Query: 715 EKSDVYSFGVVLFEILCAR 733
           EK DV+S+G++L+E++  R
Sbjct: 182 EKCDVFSWGIILWEVITRR 200

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/190 (32%), Positives = 94/190 (49%), Gaps = 5/190 (2%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 +V +YM YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  V KV+DFGLS+   T D        K    +  PE       + KSDV
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 720 YSFGVVLFEI 729
           ++FGV+L+EI
Sbjct: 215 WAFGVLLWEI 224

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 5/190 (2%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 720 YSFGVVLFEI 729
           ++FGV+L+EI
Sbjct: 201 WAFGVLLWEI 210

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 5/190 (2%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 720 YSFGVVLFEI 729
           ++FGV+L+EI
Sbjct: 201 WAFGVLLWEI 210

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKL 586
           A  +F+    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLH 645
           RH +++ L GY  +   + L+ +Y   G + + L K  K     +QR    I   A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD---EQRTATYITELANALS 127
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H+     +IHRD+K  N+LL      K++DFG S   P    +     + G+  YL P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLXGTLDYLPP 180
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++S GV+ +E L  +P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 5/190 (2%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 140
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 720 YSFGVVLFEI 729
           ++FGV+L+EI
Sbjct: 200 WAFGVLLWEI 209

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +  +TKVA+K   P     V  F  E  ++  L+H  LV L     
Sbjct: 21  LGAGQFGEVWMGYYNN-STKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
               + ++ +YMA G+L + L   +   +   + ++     A G+ Y+    +   IHRD
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 135
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  N+L+ E  + K++DFGL++     ++T      K    +  PE       T KSDV
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 720 YSFGVVLFEIL 730
           +SFG++L+EI+
Sbjct: 195 WSFGILLYEIV 205

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 5/190 (2%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 720 YSFGVVLFEI 729
           ++FGV+L+EI
Sbjct: 196 WAFGVLLWEI 205

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 5/190 (2%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G +G+VY G     +  VA+K     + + V EF  E  ++ +++H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
                 ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           +   N L+ E  + KV+DFGLS+   T D        K    +  PE     + + KSDV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 720 YSFGVVLFEI 729
           ++FGV+L+EI
Sbjct: 196 WAFGVLLWEI 205

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 117/251 (46%), Gaps = 31/251 (12%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G  TKVAIK   P        F  E +++ KL+H  LV L     
Sbjct: 17  LGNGQFGEVWMGTWNG-NTKVAIKTLKP-GTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM  G+L + L   +   L     +++    A G+ Y+    +   IHRD
Sbjct: 75  EE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEK 716
           +++ NIL+    + K++DFGL++    L   +  T  +G+     +  PE     + T K
Sbjct: 131 LRSANILVGNGLICKIADFGLAR----LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 717 SDVYSFGVVLFEILCA----RPALNPTLPKEQV--------------SLAEWAAHCHKKG 758
           SDV+SFG++L E++       P +N     EQV              SL E   HC KK 
Sbjct: 187 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKD 246
Query: 759 ILEQIMDPYLK 769
             E+    YL+
Sbjct: 247 PEERPTFEYLQ 257

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 539 LLGVGGFGKVYRGE-IDGATTKV--AIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVSL 594
           ++G G FG VY GE ID A  ++  AIK  + ++E Q V  F  E  ++  L H ++++L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 595 IGYC--EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
           IG     E    +L+  YM +G L + +   Q+ P   K  +   +  ARG+ YL   A+
Sbjct: 88  IGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTV-KDLISFGLQVARGMEYL---AE 142
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD--------HTHVSTVVKGSFGYLD 704
              +HRD+   N +LDE +  KV+DFGL++    LD        H H    VK    +  
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVK----WTA 196
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEIL 730
            E  +  + T KSDV+SFGV+L+E+L
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGV-HEFQTEIEMLSKLRH 588
            +FD    LG G FG VY      +   +A+K      L + GV H+ + E+E+ S LRH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-ARGLHYL 647
            +++ L GY  +   + L+ +Y   GT+   L K  +     +QR    I   A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD---EQRTATYITELANALSYC 128
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+     +IHRD+K  N+LL      K++DFG S   P+   +   T+  G+  YL PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPS---SRRDTLC-GTLDYLPPEM 181
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   EK D++S GV+ +E L   P
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMP 208

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 121/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SKL H+++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 280
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 281 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 319

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 12/213 (5%)
Query: 528 KAATNNFDEALLLGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGV-HEFQTEIEMLS 584
           K   ++FD    LG G FG VY  R + +     + +   + L ++GV H+ + EIE+ S
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
            LRH +++ +  Y  +   + L+ ++   G L + L K  +     ++        A  L
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADAL 127
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           HY H   +  +IHRD+K  N+L+  K   K++DFG S   P+L    +     G+  YL 
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLP 180
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
           PE    +   EK D++  GV+ +E L   P  +
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 12/213 (5%)
Query: 528 KAATNNFDEALLLGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGV-HEFQTEIEMLS 584
           K   ++FD    LG G FG VY  R + +     + +   + L ++GV H+ + EIE+ S
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
            LRH +++ +  Y  +   + L+ ++   G L + L K  +     ++        A  L
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADAL 128
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           HY H   +  +IHRD+K  N+L+  K   K++DFG S   P+L    +     G+  YL 
Sbjct: 129 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLP 181
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
           PE    +   EK D++  GV+ +E L   P  +
Sbjct: 182 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 121/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SKL H+++V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 266
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 267 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 305

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 20/222 (9%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQTEIEMLSK 585
           NN      LG G FGKV      G     A  KVA+K     +     E   +E++++S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 586 L-RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP--------PLPWKQRLEI 636
           L +H ++V+L+G C     ++++ +Y  YG L   L +  +         PL  +  L  
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               A+G+ +L   A    IHRDV   N+LL    VAK+ DFGL++      +  V    
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNP 738
           +    ++ PE       T +SDV+S+G++L+EI      LNP
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL--GLNP 254

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/225 (33%), Positives = 106/225 (47%), Gaps = 26/225 (11%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKR----GNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           LG G FGKV    Y    DG    VA+K       P    G   ++ EI++L  L H H+
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTLYHEHI 95
Query: 592 VSLIGYCEEN--CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           +   G CE+     + LV +Y+  G+LR++L    +  +   Q L        G+ YLH 
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH- 151
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPE 706
            A+H  IHRD+   N+LLD   + K+ DFGL+K  P   H        G    F Y  PE
Sbjct: 152 -AQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEXYRVREDGDSPVFWYA-PE 207
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL--CARPALNPTLPKEQVSLAE 749
             +  +    SDV+SFGV L+E+L  C      PT   E + +A+
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 97/191 (50%), Gaps = 6/191 (3%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +  +TKVA+K   P     V  F  E  ++  L+H  LV L     
Sbjct: 20  LGAGQFGEVWMGYYNN-STKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ ++MA G+L + L   +   +   + ++     A G+ Y+    +   IHRD
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 134
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  N+L+ E  + K++DFGL++     ++T      K    +  PE       T KS+V
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 720 YSFGVVLFEIL 730
           +SFG++L+EI+
Sbjct: 194 WSFGILLYEIV 204

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/225 (33%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKR----GNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           LG G FGKV    Y    DG    VA+K       P    G   ++ EI++L  L H H+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---WKQEIDILRTLYHEHI 78
Query: 592 VSLIGYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           +   G CE+  E  + LV +Y+  G+LR++L    +  +   Q L        G+ YLH 
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH- 134
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPE 706
            A+H  IHR++   N+LLD   + K+ DFGL+K  P   H +      G    F Y  PE
Sbjct: 135 -AQH-YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYA-PE 190
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL--CARPALNPTLPKEQVSLAE 749
             +  +    SDV+SFGV L+E+L  C      PT   E + +A+
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 235

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 20/222 (9%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQTEIEMLSK 585
           NN      LG G FGKV      G     A  KVA+K     +     E   +E++++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 586 L-RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP--------PLPWKQRLEI 636
           L +H ++V+L+G C     ++++ +Y  YG L   L +  +         PL  +  L  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               A+G+ +L   A    IHRDV   N+LL    VAK+ DFGL++      +  V    
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNP 738
           +    ++ PE       T +SDV+S+G++L+EI      LNP
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL--GLNP 262

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV    Y  E D    +VA+K   P S    + + + EIE+L  L H ++V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 595 IGYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            G C E+    + L+ +++  G+L+E+L K  K  +  KQ+L+  +   +G+ YL     
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYL---GS 144
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS--FGYLDPEYFRR 710
              +HRD+   N+L++ +   K+ DFGL+K   T          + S  F Y  PE   +
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECLMQ 203
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            +    SDV+SFGV L E+L
Sbjct: 204 SKFYIASDVWSFGVTLHELL 223

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 280
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 281 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 319

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 165 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 272
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 273 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 311

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 266
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 267 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 305

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 121/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K    + SEQ   +F  E  ++SK  H+++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 280
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 281 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 319

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 150 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 257
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 258 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 296

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV    Y  E D    +VA+K   P S    + + + EIE+L  L H ++V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 595 IGYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            G C E+    + L+ +++  G+L+E+L K  K  +  KQ+L+  +   +G+ YL     
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYL---GS 132
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS--FGYLDPEYFRR 710
              +HRD+   N+L++ +   K+ DFGL+K   T          + S  F Y  PE   +
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECLMQ 191
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            +    SDV+SFGV L E+L
Sbjct: 192 SKFYIASDVWSFGVTLHELL 211

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 515 PSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK---VAIK--RGNPLS 569
           P+   R F+  EI  +    +E  ++G G FG+V RG +     K   VAIK  +G   +
Sbjct: 2   PNEAVREFA-KEIDVSYVKIEE--VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG-YT 57
Query: 570 EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP 629
           E+   EF +E  ++ +  H +++ L G    +  ++++ ++M  G L   L +       
Sbjct: 58  ERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-RLNDGQFT 116
Query: 630 WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTL 687
             Q + +  G A G+ YL   A+ + +HRD+   NIL++   V KVSDFGLS+     + 
Sbjct: 117 VIQLVGMLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSS 173
Query: 688 DHTHVSTV-VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           D T  S++  K    +  PE    ++ T  SD +S+G+V++E++
Sbjct: 174 DPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 217

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 266
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 267 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 305

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           LGVG FGKV  G+ +    KVA+K   R    S   V + + EI+ L   RH H++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 ++ +V +Y++ G L +++ K  +  L  K+   +      G+ Y H   +H ++
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCH---RHMVV 138
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR-RQQLTE 715
           HRD+K  N+LLD    AK++DFGLS      +    S    GS  Y  PE    R     
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPEVISGRLYAGP 195
Query: 716 KSDVYSFGVVLFEILCA 732
           + D++S GV+L+ +LC 
Sbjct: 196 EVDIWSSGVILYALLCG 212

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 106/225 (47%), Gaps = 26/225 (11%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKR----GNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           LG G FGKV    Y    DG    VA+K       P    G   ++ EI++L  L H H+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---WKQEIDILRTLYHEHI 78
Query: 592 VSLIGYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           +   G CE+  E  + LV +Y+  G+LR++L    +  +   Q L        G+ YLH+
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPE 706
                 IHR++   N+LLD   + K+ DFGL+K  P   H +      G    F Y  PE
Sbjct: 136 ---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYA-PE 190
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL--CARPALNPTLPKEQVSLAE 749
             +  +    SDV+SFGV L+E+L  C      PT   E + +A+
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 235

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 158 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 265
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 266 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 199 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 306
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 307 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 158 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 265
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 266 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 175 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 282
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 283 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 321

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/204 (35%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKR----GNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           LG G FGKV    Y    DG    VA+K       P    G   +Q EIE+L  L H H+
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG---WQREIEILRTLYHEHI 73
Query: 592 VSLIGYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           V   G CE+  E  + LV +Y+  G+LR++L    +  +   Q L        G+ YLH 
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLH- 129
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPE 706
            A+H  IHR +   N+LLD   + K+ DFGL+K  P   H +      G    F Y  PE
Sbjct: 130 -AQH-YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYA-PE 185
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
             +  +    SDV+SFGV L+E+L
Sbjct: 186 CLKECKFYYASDVWSFGVTLYELL 209

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 32/285 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++  IHRD+   N LL       VAK+ DFG+++      +            ++ P
Sbjct: 176 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E F     T K+D +SFGV+L+EI        P   K    + E+     +       MD
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR-------MD 283
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 284 P------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 322

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 26/228 (11%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQTEIEMLSK 585
           NN      LG G FGKV      G     A  KVA+K     +     E   +E++++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 586 L-RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW-------------- 630
           L +H ++V+L+G C     ++++ +Y  YG L   L + + P L +              
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
           +  L      A+G+ +L   A    IHRDV   N+LL    VAK+ DFGL++      + 
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNP 738
            V    +    ++ PE       T +SDV+S+G++L+EI      LNP
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL--GLNP 268

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/204 (35%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKR----GNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           LG G FGKV    Y    DG    VA+K       P    G   +Q EIE+L  L H H+
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG---WQREIEILRTLYHEHI 72
Query: 592 VSLIGYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           V   G CE+  E  + LV +Y+  G+LR++L    +  +   Q L        G+ YLH 
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLH- 128
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPE 706
            A+H  IHR +   N+LLD   + K+ DFGL+K  P   H +      G    F Y  PE
Sbjct: 129 -AQH-YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYA-PE 184
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
             +  +    SDV+SFGV L+E+L
Sbjct: 185 CLKECKFYYASDVWSFGVTLYELL 208

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 113/238 (47%), Gaps = 32/238 (13%)
Query: 508 GSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVY--RGEIDGATTKVAIKRG 565
           GS+ ++ PS+L   +   EI            LG GG  +V+  R   D     V + R 
Sbjct: 1   GSHMTT-PSHLSDRYELGEI------------LGFGGMSEVHLARDLRDHRDVAVKVLRA 47
Query: 566 NPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIGYCEENCEM----ILVYDYMAYGTLREHL 620
           +   +   +  F+ E +  + L H  +V++    E          +V +Y+   TLR+ +
Sbjct: 48  DLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-I 106
Query: 621 YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL 680
             T+ P  P K+ +E+   A + L++ H   ++ IIHRDVK  NIL+      KV DFG+
Sbjct: 107 VHTEGPMTP-KRAIEVIADACQALNFSH---QNGIIHRDVKPANILISATNAVKVVDFGI 162
Query: 681 SK----TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           ++    +G ++  T     V G+  YL PE  R   +  +SDVYS G VL+E+L   P
Sbjct: 163 ARAIADSGNSVXQT---AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 123/290 (42%), Gaps = 42/290 (14%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++ G     +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L +T+  P     L     L +    A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 649 TGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG---- 701
              ++  IHRD+   N LL       VAK+ DFG+++     D    S   KG       
Sbjct: 185 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 236
Query: 702 -YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL 760
            ++ PE F     T K+D +SFGV+L+EI        P   K    + E+     +    
Sbjct: 237 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL--GYMPYPSKSNQEVLEFVTSGGR---- 290
Query: 761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
              MDP         C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 291 ---MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 331

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 113/238 (47%), Gaps = 32/238 (13%)
Query: 508 GSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVY--RGEIDGATTKVAIKRG 565
           GS+ ++ PS+L   +   EI            LG GG  +V+  R   D     V + R 
Sbjct: 1   GSHMTT-PSHLSDRYELGEI------------LGFGGMSEVHLARDLRDHRDVAVKVLRA 47
Query: 566 NPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIGYCEENCEM----ILVYDYMAYGTLREHL 620
           +   +   +  F+ E +  + L H  +V++    E          +V +Y+   TLR+ +
Sbjct: 48  DLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-I 106
Query: 621 YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL 680
             T+ P  P K+ +E+   A + L++ H   ++ IIHRDVK  NI++      KV DFG+
Sbjct: 107 VHTEGPMTP-KRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 681 SK----TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           ++    +G ++  T     V G+  YL PE  R   +  +SDVYS G VL+E+L   P
Sbjct: 163 ARAIADSGNSVTQT---AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 113/238 (47%), Gaps = 32/238 (13%)
Query: 508 GSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVY--RGEIDGATTKVAIKRG 565
           GS+ ++ PS+L   +   EI            LG GG  +V+  R   D     V + R 
Sbjct: 1   GSHMTT-PSHLSDRYELGEI------------LGFGGMSEVHLARDLRDHRDVAVKVLRA 47
Query: 566 NPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIGYCEENCEM----ILVYDYMAYGTLREHL 620
           +   +   +  F+ E +  + L H  +V++    E          +V +Y+   TLR+ +
Sbjct: 48  DLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-I 106
Query: 621 YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL 680
             T+ P  P K+ +E+   A + L++ H   ++ IIHRDVK  NI++      KV DFG+
Sbjct: 107 VHTEGPMTP-KRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 681 SK----TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           ++    +G ++  T     V G+  YL PE  R   +  +SDVYS G VL+E+L   P
Sbjct: 163 ARAIADSGNSVTQT---AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 539 LLGVGGFGKVYRGEIDGATTK---VAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           ++G G FG+V RG +     K   VAIK  +G   +E+   EF +E  ++ +  H +++ 
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG-YTERQRREFLSEASIMGQFEHPNIIR 79
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L G    +  ++++ ++M  G L   L +         Q + +  G A G+ YL   A+ 
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFL-RLNDGQFTVIQLVGMLRGIASGMRYL---AEM 135
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTV-VKGSFGYLDPEYFRR 710
           + +HRD+   NIL++   V KVSDFGLS+     + D T+ S++  K    +  PE    
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SD +S+G+V++E++
Sbjct: 196 RKFTSASDAWSYGIVMWEVM 215

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 109/232 (46%), Gaps = 7/232 (3%)
Query: 516 SNLCRHFSFAEIKAATNNFDEAL--LLGVGGFGKVYRGEIDGATTKVAIKRGNP-LSEQG 572
           S +  H +  + K   N+ D  L   +G G FG+V+ G +    T VA+K     L    
Sbjct: 96  SGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL 155
Query: 573 VHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ 632
             +F  E  +L +  H ++V LIG C +   + +V + +  G     L +T+   L  K 
Sbjct: 156 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKT 214
Query: 633 RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV 692
            L++   AA G+ YL +      IHRD+   N L+ EK V K+SDFG+S+      +   
Sbjct: 215 LLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271
Query: 693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ 744
             + +    +  PE     + + +SDV+SFG++L+E      +  P L  +Q
Sbjct: 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 12/230 (5%)
Query: 527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQG-VHEFQTEIEML 583
           I     +F    LLG G F  VYR E      +VAIK      + + G V   Q E+++ 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 584 SKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARG 643
            +L+H  ++ L  Y E++  + LV +    G +  +L K +  P    +          G
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITG 124
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           + YLH+   H I+HRD+  +N+LL      K++DFGL+ T   + H    T+  G+  Y+
Sbjct: 125 MLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLC-GTPNYI 179
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPK---EQVSLAEW 750
            PE   R     +SDV+S G + + +L  RP  +    K    +V LA++
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 540 LGVGGFGKVYRGE----IDG-ATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G     I G A T+VA+K  N   S +   EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQ--------KPPLPWKQRLEICIGAARGLH 645
           L+G   +    ++V + MA+G L+ +L   +        +PP   ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG---- 701
           YL+       +HRD+   N ++   +  K+ DFG+++     D        KG  G    
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIXETDXXRKGGKGLLPV 196
Query: 702 -YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            ++ PE  +    T  SD++SFGVVL+EI          L  EQV
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 241

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 540 LGVGGFGKVYRGE----IDG-ATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G     I G A T+VA+K  N   S +   EF  E  ++      H+V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQ--------KPPLPWKQRLEICIGAARGLH 645
           L+G   +    ++V + MA+G L+ +L   +        +PP   ++ +++    A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG---- 701
           YL+       +HRD+   N ++   +  K+ DFG+++     D        KG  G    
Sbjct: 142 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIXETDXXRKGGKGLLPV 193
Query: 702 -YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            ++ PE  +    T  SD++SFGVVL+EI          L  EQV
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 238

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 540 LGVGGFGKVYRGE----IDG-ATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G     I G A T+VA+K  N   S +   EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQ--------KPPLPWKQRLEICIGAARGLH 645
           L+G   +    ++V + MA+G L+ +L   +        +PP   ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG---- 701
           YL+       +HRD+   N ++   +  K+ DFG+++     D        KG  G    
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIXETDXXRKGGKGLLPV 196
Query: 702 -YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            ++ PE  +    T  SD++SFGVVL+EI          L  EQV
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 241

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 113/238 (47%), Gaps = 32/238 (13%)
Query: 508 GSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK--RG 565
           GS+ ++ PS+L   +   EI            LG GG  +V+          VA+K  R 
Sbjct: 1   GSHMTT-PSHLSDRYELGEI------------LGFGGMSEVHLARDLRLHRDVAVKVLRA 47
Query: 566 NPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIGYCEENCEM----ILVYDYMAYGTLREHL 620
           +   +   +  F+ E +  + L H  +V++    E          +V +Y+   TLR+ +
Sbjct: 48  DLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRD-I 106
Query: 621 YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL 680
             T+ P  P K+ +E+   A + L++ H   ++ IIHRDVK  NI++      KV DFG+
Sbjct: 107 VHTEGPMTP-KRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 681 SK----TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           ++    +G ++  T     V G+  YL PE  R   +  +SDVYS G VL+E+L   P
Sbjct: 163 ARAIADSGNSVTQT---AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 130/301 (43%), Gaps = 58/301 (19%)
Query: 540 LGVGGFGKV-------YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           LG G FGKV        +G     T  V + + N  S   + +  +E  +L ++ H H++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVI 89
Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQK----------------------PPLPW 630
            L G C ++  ++L+ +Y  YG+LR  L +++K                        L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
              +      ++G+ YL   A+ +++HRD+   NIL+ E    K+SDFGLS+     D  
Sbjct: 150 GDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSR-----DVY 201
Query: 691 HVSTVVKGSFGYLDPEYFRRQQL-----TEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
              + VK S G +  ++   + L     T +SDV+SFGV+L+EI+       P +P E++
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 746 SLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
                  H  ++                  C ++     ++C   +  +RP   D+  +L
Sbjct: 262 FNLLKTGHRMER---------------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306
Query: 806 E 806
           E
Sbjct: 307 E 307

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +LG G FG+  +         + +K      E+    F  E++++  L H +++  IG  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
            ++  +  + +Y+  GTLR  + K+     PW QR+      A G+ YLH+     IIHR
Sbjct: 77  YKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 659 DVKTTNILLDEKWVAKVSDFGLS------KTGP-------TLDHTHVSTVVKGSFGYLDP 705
           D+ + N L+ E     V+DFGL+      KT P         D     TVV   + ++ P
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY-WMAP 191
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEIL 730
           E    +   EK DV+SFG+VL EI+
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 108/232 (46%), Gaps = 7/232 (3%)
Query: 516 SNLCRHFSFAEIKAATNNFDEAL--LLGVGGFGKVYRGEIDGATTKVAIKRGNP-LSEQG 572
           S +  H +  + K   N+ D  L   +G G FG+V+ G +    T VA+K     L    
Sbjct: 96  SGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL 155
Query: 573 VHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ 632
             +F  E  +L +  H ++V LIG C +   + +V + +  G     L +T+   L  K 
Sbjct: 156 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKT 214
Query: 633 RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV 692
            L++   AA G+ YL +      IHRD+   N L+ EK V K+SDFG+S+          
Sbjct: 215 LLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAAS 271
Query: 693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ 744
             + +    +  PE     + + +SDV+SFG++L+E      +  P L  +Q
Sbjct: 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 33/235 (14%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQTEIEMLSK 585
           NN      LG G FGKV      G     A  KVA+K     +     E   +E++++S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 586 L-RHRHLVSLIGYCEENCEMILVYDYMAYGTLR---------------------EHLYKT 623
           L +H ++V+L+G C     ++++ +Y  YG L                      E L K 
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 624 QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT 683
              PL  +  L      A+G+ +L   A    IHRDV   N+LL    VAK+ DFGL++ 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNP 738
                +  V    +    ++ PE       T +SDV+S+G++L+EI      LNP
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL--GLNP 260

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 11/193 (5%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+    +   TKVA+K   P S   V  F  E  ++  L+H  LV L     
Sbjct: 23  LGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQ--KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           +   + ++ ++MA G+L + L   +  K PLP  + ++     A G+ ++    +   IH
Sbjct: 81  KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNYIH 134
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD++  NIL+    V K++DFGL++     ++T      K    +  PE       T KS
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKS 193
Query: 718 DVYSFGVVLFEIL 730
           DV+SFG++L EI+
Sbjct: 194 DVWSFGILLMEIV 206

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           LGVG FGKV  GE      KVA+K   R    S   V + + EI+ L   RH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +  +V +Y++ G L +++ K  +      +RL   I +A  + Y H   +H ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA--VDYCH---RHMVV 133
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR-RQQLTE 715
           HRD+K  N+LLD    AK++DFGLS      +    S    GS  Y  PE    R     
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYAGP 190
Query: 716 KSDVYSFGVVLFEILCARPALN----PTLPKE 743
           + D++S GV+L+ +LC     +    PTL K+
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKK 222

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 539 LLGVGGFGKVYRGEI--DGATTK--VAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVS 593
           +LG G FG VY+G    +G T K  VAIK  N  +    + EF  E  +++ + H HLV 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L+G C     + LV   M +G L E++++  K  +  +  L  C+  A+G+ YL    + 
Sbjct: 82  LLGVCLSPT-IQLVTQLMPHGCLLEYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---ER 136
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            ++HRD+   N+L+      K++DFGL++     +  + +   K    ++  E    ++ 
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 714 TEKSDVYSFGVVLFEIL 730
           T +SDV+S+GV ++E++
Sbjct: 197 THQSDVWSYGVTIWELM 213

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 540 LGVGGFGKVYRGE----IDG-ATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G     I G A T+VA+K  N   S +   EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQ--------KPPLPWKQRLEICIGAARGLH 645
           L+G   +    ++V + MA+G L+ +L   +        +PP   ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG---- 701
           YL+       +HRD+   N ++   +  K+ DFG+++     D    +   KG  G    
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETAYYRKGGKGLLPV 196
Query: 702 -YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            ++ PE  +    T  SD++SFGVVL+EI          L  EQV
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 241

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 113/238 (47%), Gaps = 32/238 (13%)
Query: 508 GSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK--RG 565
           GS+ ++ PS+L   +   EI            LG GG  +V+          VA+K  R 
Sbjct: 1   GSHMTT-PSHLSDRYELGEI------------LGFGGMSEVHLARDLRLHRDVAVKVLRA 47
Query: 566 NPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIGYCEENCEM----ILVYDYMAYGTLREHL 620
           +   +   +  F+ E +  + L H  +V++    E          +V +Y+   TLR+ +
Sbjct: 48  DLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-I 106
Query: 621 YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL 680
             T+ P  P K+ +E+   A + L++ H   ++ IIHRDVK  NI++      KV DFG+
Sbjct: 107 VHTEGPMTP-KRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 681 SK----TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           ++    +G ++  T     V G+  YL PE  R   +  +SDVYS G VL+E+L   P
Sbjct: 163 ARAIADSGNSVTQT---AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQTEIEMLSK 585
           NN      LG G FGKV      G     A  KVA+K     +     E   +E++++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 586 L-RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK------------PPLPWKQ 632
           L +H ++V+L+G C     ++++ +Y  YG L   L +  +              L  + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 633 RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV 692
            L      A+G+ +L   A    IHRDV   N+LL    VAK+ DFGL++      +  V
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNP 738
               +    ++ PE       T +SDV+S+G++L+EI      LNP
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL--GLNP 266

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 95/193 (49%), Gaps = 21/193 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+    +   TKVA+K   P S   V  F  E  ++  L+H  LV L     
Sbjct: 190 LGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQ--KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           +   + ++ ++MA G+L + L   +  K PLP  + ++     A G+ ++    +   IH
Sbjct: 248 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNYIH 301
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD++  NIL+    V K++DFGL++ G            K    +  PE       T KS
Sbjct: 302 RDLRAANILVSASLVCKIADFGLARVG-----------AKFPIKWTAPEAINFGSFTIKS 350
Query: 718 DVYSFGVVLFEIL 730
           DV+SFG++L EI+
Sbjct: 351 DVWSFGILLMEIV 363

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 58/301 (19%)
Query: 540 LGVGGFGKV-------YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           LG G FGKV        +G     T  V + + N  S   + +  +E  +L ++ H H++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVI 89
Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQK----------------------PPLPW 630
            L G C ++  ++L+ +Y  YG+LR  L +++K                        L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
              +      ++G+ YL   A+  ++HRD+   NIL+ E    K+SDFGLS+     D  
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVY 201
Query: 691 HVSTVVKGSFGYLDPEYFRRQQL-----TEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
              + VK S G +  ++   + L     T +SDV+SFGV+L+EI+       P +P E++
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 746 SLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
                  H  ++                  C ++     ++C   +  +RP   D+  +L
Sbjct: 262 FNLLKTGHRMER---------------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306
Query: 806 E 806
           E
Sbjct: 307 E 307

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 540 LGVGGFGKVYRGE----IDG-ATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G     I G A T+VA+K  N   S +   EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQ--------KPPLPWKQRLEICIGAARGLH 645
           L+G   +    ++V + MA+G L+ +L   +        +PP   ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG---- 701
           YL+       +HRD+   N ++   +  K+ DFG+++     D+       KG  G    
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLPV 196
Query: 702 -YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            ++ PE  +    T  SD++SFGVVL+EI          L  EQV
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 241

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 16/245 (6%)
Query: 493 YGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGE 552
           +GN H            +    P+     F+  E+ A   + D+  ++G G FG+V  G 
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFEDPTQTVHEFA-KELDATNISIDK--VVGAGEFGEVCSGR 65
Query: 553 IDGATTK---VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   + K   VAIK      +E+   +F  E  ++ +  H +++ L G   ++  +++V 
Sbjct: 66  LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +YM  G+L   L K         Q + +  G A G+ YL   +    +HRD+   NIL++
Sbjct: 126 EYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILIN 181
Query: 669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEKSDVYSFGVV 725
              V KVSDFGLS+     D    +   +G      +  PE    ++ T  SDV+S+G+V
Sbjct: 182 SNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 726 LFEIL 730
           L+E++
Sbjct: 240 LWEVM 244

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 58/301 (19%)
Query: 540 LGVGGFGKV-------YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           LG G FGKV        +G     T  V + + N  S   + +  +E  +L ++ H H++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVI 89
Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQK----------------------PPLPW 630
            L G C ++  ++L+ +Y  YG+LR  L +++K                        L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
              +      ++G+ YL   A+  ++HRD+   NIL+ E    K+SDFGLS+     D  
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVY 201
Query: 691 HVSTVVKGSFGYLDPEYFRRQQL-----TEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
              + VK S G +  ++   + L     T +SDV+SFGV+L+EI+       P +P E++
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 746 SLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
                  H  ++                  C ++     ++C   +  +RP   D+  +L
Sbjct: 262 FNLLKTGHRMER---------------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306
Query: 806 E 806
           E
Sbjct: 307 E 307

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 540 LGVGGFGKVYRGE----IDG-ATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G     I G A T+VA+K  N   S +   EF  E  ++      H+V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQ--------KPPLPWKQRLEICIGAARGLH 645
           L+G   +    ++V + MA+G L+ +L   +        +PP   ++ +++    A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG---- 701
           YL+       +HRD+   N ++   +  K+ DFG+++     D+       KG  G    
Sbjct: 144 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLPV 195
Query: 702 -YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            ++ PE  +    T  SD++SFGVVL+EI          L  EQV
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 240

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 114/223 (51%), Gaps = 14/223 (6%)
Query: 515 PSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK---VAIKR-GNPLSE 570
           P+   R F+  EI  +    ++  ++G G FG+V  G +     +   VAIK   +  +E
Sbjct: 19  PNEAVREFA-KEIDISCVKIEQ--VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 75
Query: 571 QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW 630
           +   +F +E  ++ +  H +++ L G   ++  ++++ ++M  G+L   L +        
Sbjct: 76  KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTV 134
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLD 688
            Q + +  G A G+ YL   A    +HRD+   NIL++   V KVSDFGLS+     T D
Sbjct: 135 IQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 191
Query: 689 HTHVSTV-VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            T+ S +  K    +  PE  + ++ T  SDV+S+G+V++E++
Sbjct: 192 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 109/227 (48%), Gaps = 19/227 (8%)
Query: 511 ASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--GNPL 568
           +S  P  L RHF+        ++F+    LG G FG VY      +   VA+K    + +
Sbjct: 9   SSGTPDILTRHFTI-------DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQI 61
Query: 569 SEQGV-HEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP 627
            ++GV H+ + EIE+ + L H +++ L  Y  +   + L+ +Y   G L + L K+    
Sbjct: 62  EKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT-- 119
Query: 628 LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL 687
              ++   I    A  L Y H G K  +IHRD+K  N+LL  K   K++DFG S   P+L
Sbjct: 120 FDEQRTATIMEELADALMYCH-GKK--VIHRDIKPENLLLGLKGELKIADFGWSVHAPSL 176
Query: 688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
                   + G+  YL PE    +   EK D++  GV+ +E+L   P
Sbjct: 177 R----RKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNP 219

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 539 LLGVGGFGKVYRGEI--DGATTK--VAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVS 593
           +LG G FG VY+G    +G T K  VAIK  N  +    + EF  E  +++ + H HLV 
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L+G C     + LV   M +G L E++++  K  +  +  L  C+  A+G+ YL    + 
Sbjct: 105 LLGVCLSPT-IQLVTQLMPHGCLLEYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---ER 159
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            ++HRD+   N+L+      K++DFGL++     +  + +   K    ++  E    ++ 
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 714 TEKSDVYSFGVVLFEIL 730
           T +SDV+S+GV ++E++
Sbjct: 220 THQSDVWSYGVTIWELM 236

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 113/238 (47%), Gaps = 32/238 (13%)
Query: 508 GSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK--RG 565
           GS+ ++ PS+L   +   EI            LG GG  +V+          VA+K  R 
Sbjct: 18  GSHMTT-PSHLSDRYELGEI------------LGFGGMSEVHLARDLRLHRDVAVKVLRA 64
Query: 566 NPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIGYCEENCEM----ILVYDYMAYGTLREHL 620
           +   +   +  F+ E +  + L H  +V++    E          +V +Y+   TLR+ +
Sbjct: 65  DLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-I 123
Query: 621 YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL 680
             T+ P  P K+ +E+   A + L++ H   ++ IIHRDVK  NI++      KV DFG+
Sbjct: 124 VHTEGPMTP-KRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 179
Query: 681 SK----TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           ++    +G ++  T     V G+  YL PE  R   +  +SDVYS G VL+E+L   P
Sbjct: 180 ARAIADSGNSVTQT---AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 234

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 110/234 (47%), Gaps = 25/234 (10%)
Query: 517 NLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQ 571
           N  +     EI  +   F E L  G   FGKVY+G + G      T  VAIK     +E 
Sbjct: 13  NQHKQAKLKEISLSAVRFMEEL--GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG 70
Query: 572 GVHE-FQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLY--------- 621
            + E F+ E  + ++L+H ++V L+G   ++  + +++ Y ++G L E L          
Sbjct: 71  PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 130
Query: 622 -----KTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVS 676
                +T K  L     + +    A G+ YL   + H ++H+D+ T N+L+ +K   K+S
Sbjct: 131 STDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKIS 187
Query: 677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           D GL +     D+  +         ++ PE     + +  SD++S+GVVL+E+ 
Sbjct: 188 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 94/191 (49%), Gaps = 7/191 (3%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+    +   TKVA+K   P S   V  F  E  ++  L+H  LV L     
Sbjct: 196 LGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ ++MA G+L + L   +    P  + ++     A G+ ++    +   IHRD
Sbjct: 254 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 309
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+    V K++DFGL++     ++T      K    +  PE       T KSDV
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 720 YSFGVVLFEIL 730
           +SFG++L EI+
Sbjct: 369 WSFGILLMEIV 379

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 16/245 (6%)
Query: 493 YGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGE 552
           +GN H            +    P+     F+  E+ A   + D+  ++G G FG+V  G 
Sbjct: 9   FGNGHLKLPGLRTYVDPHTYEDPTQTVHEFA-KELDATNISIDK--VVGAGEFGEVCSGR 65
Query: 553 IDGATTK---VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   + K   VAIK      +E+   +F  E  ++ +  H +++ L G   ++  +++V 
Sbjct: 66  LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +YM  G+L   L K         Q + +  G A G+ YL   +    +HRD+   NIL++
Sbjct: 126 EYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181
Query: 669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEKSDVYSFGVV 725
              V KVSDFGLS+     D    +   +G      +  PE    ++ T  SDV+S+G+V
Sbjct: 182 SNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 726 LFEIL 730
           L+E++
Sbjct: 240 LWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 16/245 (6%)
Query: 493 YGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGE 552
           +GN H            +    P+     F+  E+ A   + D+  ++G G FG+V  G 
Sbjct: 7   FGNGHLKLPGLRTYVDPHTYEDPTQTVHEFA-KELDATNISIDK--VVGAGEFGEVCSGR 63
Query: 553 IDGATTK---VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   + K   VAIK      +E+   +F  E  ++ +  H +++ L G   ++  +++V 
Sbjct: 64  LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 123
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +YM  G+L   L K         Q + +  G A G+ YL   +    +HRD+   NIL++
Sbjct: 124 EYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 179
Query: 669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEKSDVYSFGVV 725
              V KVSDFGLS+     D    +   +G      +  PE    ++ T  SDV+S+G+V
Sbjct: 180 SNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 237
Query: 726 LFEIL 730
           L+E++
Sbjct: 238 LWEVM 242

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 16/245 (6%)
Query: 493 YGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGE 552
           +GN H            +    P+     F+  E+ A   + D+  ++G G FG+V  G 
Sbjct: 9   FGNGHLKLPGLRTFVDPHTYEDPTQTVHEFA-KELDATNISIDK--VVGAGEFGEVCSGR 65
Query: 553 IDGATTK---VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   + K   VAIK      +E+   +F  E  ++ +  H +++ L G   ++  +++V 
Sbjct: 66  LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +YM  G+L   L K         Q + +  G A G+ YL   +    +HRD+   NIL++
Sbjct: 126 EYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181
Query: 669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEKSDVYSFGVV 725
              V KVSDFGLS+     D    +   +G      +  PE    ++ T  SDV+S+G+V
Sbjct: 182 SNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 726 LFEIL 730
           L+E++
Sbjct: 240 LWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 16/245 (6%)
Query: 493 YGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGE 552
           +GN H            +    P+     F+  E+ A   + D+  ++G G FG+V  G 
Sbjct: 9   FGNGHLKLPGLRTYVDPHTFEDPTQTVHEFA-KELDATNISIDK--VVGAGEFGEVCSGR 65
Query: 553 IDGATTK---VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   + K   VAIK      +E+   +F  E  ++ +  H +++ L G   ++  +++V 
Sbjct: 66  LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +YM  G+L   L K         Q + +  G A G+ YL   +    +HRD+   NIL++
Sbjct: 126 EYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181
Query: 669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEKSDVYSFGVV 725
              V KVSDFGLS+     D    +   +G      +  PE    ++ T  SDV+S+G+V
Sbjct: 182 SNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 726 LFEIL 730
           L+E++
Sbjct: 240 LWEVM 244

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 16/245 (6%)
Query: 493 YGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGE 552
           +GN H            +    P+     F+  E+ A   + D+  ++G G FG+V  G 
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFEDPTQTVHEFA-KELDATNISIDK--VVGAGEFGEVCSGR 65
Query: 553 IDGATTK---VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   + K   VAIK      +E+   +F  E  ++ +  H +++ L G   ++  +++V 
Sbjct: 66  LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +YM  G+L   L K         Q + +  G A G+ YL   +    +HRD+   NIL++
Sbjct: 126 EYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181
Query: 669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEKSDVYSFGVV 725
              V KVSDFGLS+     D    +   +G      +  PE    ++ T  SDV+S+G+V
Sbjct: 182 SNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 726 LFEIL 730
           L+E++
Sbjct: 240 LWEVM 244

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 17/210 (8%)
Query: 528 KAATNNFDEALLLGVGGFGKVY--RGEIDGATTKVAI-KRGNPLSEQGVHEFQTEIEMLS 584
           K +  +F     LG G FG+V+  R   +G    + + K+   +  + V     E  MLS
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGAAR 642
            + H  ++ + G  ++  ++ ++ DY+  G L   L K+Q+ P P  +    E+C+    
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA--- 118
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+     II+RD+K  NILLD+    K++DFG +K  P      V+  + G+  Y
Sbjct: 119 -LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDY 169
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCA 732
           + PE    +   +  D +SFG++++E+L  
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           LGVG FGKV  GE      KVA+K   R    S   V + + EI+ L   RH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +  +V +Y++ G L +++ K  +      +RL   I +A  + Y H   +H ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA--VDYCH---RHMVV 133
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR-RQQLTE 715
           HRD+K  N+LLD    AK++DFGLS      +    S    GS  Y  PE    R     
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPEVISGRLYAGP 190
Query: 716 KSDVYSFGVVLFEILCARPALN----PTLPKE 743
           + D++S GV+L+ +LC     +    PTL K+
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKK 222

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 25/227 (11%)
Query: 524 FAEIKAATNNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQ 577
             EI  +   F E L  G   FGKVY+G + G      T  VAIK     +E  + E F+
Sbjct: 3   LKEISLSAVRFMEEL--GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 578 TEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLY--------------KT 623
            E  + ++L+H ++V L+G   ++  + +++ Y ++G L E L               +T
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 624 QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT 683
            K  L     + +    A G+ YL   + H ++H+D+ T N+L+ +K   K+SD GL + 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
               D+  +         ++ PE     + +  SD++S+GVVL+E+ 
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 29/240 (12%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTE 579
           E + A      +  LG G FG VY G   G       T+VAIK  N  +      EF  E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---------PLPW 630
             ++ +    H+V L+G   +    +++ + M  G L+ +L ++ +P         P   
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSL 131
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
            + +++    A G+ YL+    +  +HRD+   N ++ E +  K+ DFG+++     D  
Sbjct: 132 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIX 183
Query: 691 HVSTVVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
                 KG  G     ++ PE  +    T  SDV+SFGVVL+EI          L  EQV
Sbjct: 184 ETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 243

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 540 LGVGGFGKVYRGEID---GATTKVAIKRGNP--LSE-QGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG V RGE D   G T  VA+K   P  LS+ + + +F  E+  +  L HR+L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L G       M +V +    G+L + L K Q   L         +  A G+ YL +    
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLES---K 140
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP-TLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             IHRD+   N+LL  + + K+ DFGL +  P   DH  +    K  F +  PE  + + 
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 200
Query: 713 LTEKSDVYSFGVVLFEIL 730
            +  SD + FGV L+E+ 
Sbjct: 201 FSHASDTWMFGVTLWEMF 218

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 39/284 (13%)
Query: 488 LPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEI------KAATNNFDEALLLG 541
           L + LY       +++      YAS  P     +FS A++      + A      +  LG
Sbjct: 1   LVIMLYVFHRKRNNSRLGNGVLYASVNPE----YFSAADVYVPDEWEVAREKITMSRELG 56
Query: 542 VGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVSLI 595
            G FG VY G   G       T+VAIK  N  +      EF  E  ++ +    H+V L+
Sbjct: 57  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 116
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKP---------PLPWKQRLEICIGAARGLHY 646
           G   +    +++ + M  G L+ +L ++ +P         P    + +++    A G+ Y
Sbjct: 117 GVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAY 175
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG----- 701
           L+    +  +HRD+   N ++ E +  K+ DFG+++     D+       KG  G     
Sbjct: 176 LNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLPVR 227
Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
           ++ PE  +    T  SDV+SFGVVL+EI          L  EQV
Sbjct: 228 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 271

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 15/217 (6%)
Query: 521 HFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK---VAIKRGNP-LSEQGVHEF 576
           H    E+ A   + D+  ++G G FG+V  G +   + K   VAIK      +E+   +F
Sbjct: 24  HEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 81
Query: 577 QTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI 636
             E  ++ +  H +++ L G   ++  +++V +YM  G+L   L K         Q + +
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGM 140
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
             G A G+ YL   +    +HRD+   NIL++   V KVSDFGLS+     D    +   
Sbjct: 141 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTT 195
Query: 697 KGS---FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           +G      +  PE    ++ T  SDV+S+G+VL+E++
Sbjct: 196 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 232

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 540 LGVGGFGKVYRGEID---GATTKVAIKRGNP--LSE-QGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG V RGE D   G T  VA+K   P  LS+ + + +F  E+  +  L HR+L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L G       M +V +    G+L + L K Q   L         +  A G+ YL +    
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLES---K 134
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP-TLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             IHRD+   N+LL  + + K+ DFGL +  P   DH  +    K  F +  PE  + + 
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 713 LTEKSDVYSFGVVLFEIL 730
            +  SD + FGV L+E+ 
Sbjct: 195 FSHASDTWMFGVTLWEMF 212

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 15/217 (6%)
Query: 521 HFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK---VAIKRGNP-LSEQGVHEF 576
           H    E+ A   + D+  ++G G FG+V  G +   + K   VAIK      +E+   +F
Sbjct: 7   HEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 577 QTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI 636
             E  ++ +  H +++ L G   ++  +++V +YM  G+L   L K         Q + +
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGM 123
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
             G A G+ YL   +    +HRD+   NIL++   V KVSDFGLS+     D    +   
Sbjct: 124 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTT 178
Query: 697 KGS---FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           +G      +  PE    ++ T  SDV+S+G+VL+E++
Sbjct: 179 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 29/240 (12%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTE 579
           E + A      +  LG G FG VY G   G       T+VAIK  N  +      EF  E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---------PLPW 630
             ++ +    H+V L+G   +    +++ + M  G L+ +L ++ +P         P   
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSL 122
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
            + +++    A G+ YL+    +  +HRD+   N ++ E +  K+ DFG+++     D  
Sbjct: 123 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIX 174
Query: 691 HVSTVVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
                 KG  G     ++ PE  +    T  SDV+SFGVVL+EI          L  EQV
Sbjct: 175 ETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 234

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 540 LGVGGFGKVYRGEID---GATTKVAIKRGNP--LSE-QGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG V RGE D   G T  VA+K   P  LS+ + + +F  E+  +  L HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L G       M +V +    G+L + L K Q   L         +  A G+ YL +    
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLES---K 130
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP-TLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             IHRD+   N+LL  + + K+ DFGL +  P   DH  +    K  F +  PE  + + 
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 190
Query: 713 LTEKSDVYSFGVVLFEIL 730
            +  SD + FGV L+E+ 
Sbjct: 191 FSHASDTWMFGVTLWEMF 208

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 540 LGVGGFGKVYRGE----IDG-ATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G     I G A T+VA+K  N   S +   EF  E  ++      H+V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQ--------KPPLPWKQRLEICIGAARGLH 645
           L+G   +    ++V + MA+G L+ +L   +        +PP   ++ +++    A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG---- 701
           YL+       +HR++   N ++   +  K+ DFG+++     D+       KG  G    
Sbjct: 146 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLPV 197
Query: 702 -YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            ++ PE  +    T  SD++SFGVVL+EI          L  EQV
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 242

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 29/226 (12%)
Query: 540 LGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G   G       T+VAIK  N  +      EF  E  ++ +    H+V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---------PLPWKQRLEICIGAARGL 644
           L+G   +    +++ + M  G L+ +L ++ +P         P    + +++    A G+
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG--- 701
            YL+    +  +HRD+   N ++ E +  K+ DFG+++     D+       KG  G   
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLP 203
Query: 702 --YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
             ++ PE  +    T  SDV+SFGVVL+EI          L  EQV
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 540 LGVGGFGKVYRGE----IDG-ATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G     I G A T+VA+K  N   S +   EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQ--------KPPLPWKQRLEICIGAARGLH 645
           L+G   +    ++V + MA+G L+ +L   +        +PP   ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG---- 701
           YL+       +HR++   N ++   +  K+ DFG+++     D+       KG  G    
Sbjct: 145 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLPV 196
Query: 702 -YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
            ++ PE  +    T  SD++SFGVVL+EI          L  EQV
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 241

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTE 579
           E + A      +  LG G FG VY G   G       T+VAIK  N  +      EF  E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---------PLPW 630
             ++ +    H+V L+G   +    +++ + M  G L+ +L ++ +P         P   
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSL 131
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
            + +++    A G+ YL+    +  +HRD+   N ++ E +  K+ DFG+++     D+ 
Sbjct: 132 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 691 HVSTVVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
                 KG  G     ++ PE  +    T  SDV+SFGVVL+EI          L  EQV
Sbjct: 189 R-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 243

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 29/226 (12%)
Query: 540 LGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G   G       T+VAIK  N  +      EF  E  ++ +    H+V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---------PLPWKQRLEICIGAARGL 644
           L+G   +    +++ + M  G L+ +L ++ +P         P    + +++    A G+
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG--- 701
            YL+    +  +HRD+   N ++ E +  K+ DFG+++     D+       KG  G   
Sbjct: 145 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLP 196
Query: 702 --YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
             ++ PE  +    T  SDV+SFGVVL+EI          L  EQV
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 242

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTE 579
           E + A      +  LG G FG VY G   G       T+VAIK  N  +      EF  E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---------PLPW 630
             ++ +    H+V L+G   +    +++ + M  G L+ +L ++ +P         P   
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSL 127
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
            + +++    A G+ YL+    +  +HRD+   N ++ E +  K+ DFG+++     D+ 
Sbjct: 128 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 691 HVSTVVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
                 KG  G     ++ PE  +    T  SDV+SFGVVL+EI          L  EQV
Sbjct: 185 R-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 239

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 114/245 (46%), Gaps = 16/245 (6%)
Query: 493 YGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGE 552
           +GN H            +    P+     F+  E+ A   + D+  ++G G FG+V  G 
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFEDPTQTVHEFA-KELDATNISIDK--VVGAGEFGEVCSGR 65
Query: 553 IDGATTK---VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   + K   VAIK      +E+   +F  E  ++ +  H +++ L G   ++  +++V 
Sbjct: 66  LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +YM  G+L   L K         Q + +  G A G+ YL   +    +HRD+   NIL++
Sbjct: 126 EYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181
Query: 669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEKSDVYSFGVV 725
              V KVSDFGL++     D    +   +G      +  PE    ++ T  SDV+S+G+V
Sbjct: 182 SNLVCKVSDFGLARV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 726 LFEIL 730
           L+E++
Sbjct: 240 LWEVM 244

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 540 LGVGGFGKVYRGEID---GATTKVAIKRGNP--LSE-QGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG V RGE D   G T  VA+K   P  LS+ + + +F  E+  +  L HR+L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L G       M +V +    G+L + L K Q   L         +  A G+ YL +    
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLES---K 140
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP-TLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             IHRD+   N+LL  + + K+ DFGL +  P   DH  +    K  F +  PE  + + 
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 713 LTEKSDVYSFGVVLFEIL 730
            +  SD + FGV L+E+ 
Sbjct: 201 FSHASDTWMFGVTLWEMF 218

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQTEIEMLSK 585
           NN      LG G FGKV      G     A  KVA+K     +     E   +E++++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 586 L-RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK-----PPLPW-------KQ 632
           L +H ++V+L+G C     ++++ +Y  YG L   L +  +     P           + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 633 RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV 692
            L      A+G+ +L   A    IHRDV   N+LL    VAK+ DFGL++      +  V
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNP 738
               +    ++ PE       T +SDV+S+G++L+EI      LNP
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL--GLNP 266

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTE 579
           E + A      +  LG G FG VY G   G       T+VAIK  N  +      EF  E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---------PLPW 630
             ++ +    H+V L+G   +    +++ + M  G L+ +L ++ +P         P   
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSL 130
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
            + +++    A G+ YL+    +  +HRD+   N ++ E +  K+ DFG+++     D+ 
Sbjct: 131 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 691 HVSTVVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
                 KG  G     ++ PE  +    T  SDV+SFGVVL+EI          L  EQV
Sbjct: 188 R-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 242

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTE 579
           E + A      +  LG G FG VY G   G       T+VAIK  N  +      EF  E
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---------PLPW 630
             ++ +    H+V L+G   +    +++ + M  G L+ +L ++ +P         P   
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSL 128
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
            + +++    A G+ YL+    +  +HRD+   N ++ E +  K+ DFG+++     D+ 
Sbjct: 129 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 185
Query: 691 HVSTVVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
                 KG  G     ++ PE  +    T  SDV+SFGVVL+EI          L  EQV
Sbjct: 186 R-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 240

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTE 579
           E + A      +  LG G FG VY G   G       T+VAIK  N  +      EF  E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---------PLPW 630
             ++ +    H+V L+G   +    +++ + M  G L+ +L ++ +P         P   
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSL 137
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
            + +++    A G+ YL+    +  +HRD+   N ++ E +  K+ DFG+++     D+ 
Sbjct: 138 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 691 HVSTVVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
                 KG  G     ++ PE  +    T  SDV+SFGVVL+EI          L  EQV
Sbjct: 195 R-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 540 LGVGGFGKVYRGEID---GATTKVAIKRGNP--LSE-QGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG V RGE D   G T  VA+K   P  LS+ + + +F  E+  +  L HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L G       M +V +    G+L + L K Q   L         +  A G+ YL +    
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLES---K 130
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP-TLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             IHRD+   N+LL  + + K+ DFGL +  P   DH  +    K  F +  PE  + + 
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 713 LTEKSDVYSFGVVLFEIL 730
            +  SD + FGV L+E+ 
Sbjct: 191 FSHASDTWMFGVTLWEMF 208

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTE 579
           E + A      +  LG G FG VY G   G       T+VAIK  N  +      EF  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---------PLPW 630
             ++ +    H+V L+G   +    +++ + M  G L+ +L ++ +P         P   
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSL 124
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
            + +++    A G+ YL+    +  +HRD+   N ++ E +  K+ DFG+++     D+ 
Sbjct: 125 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 691 HVSTVVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
                 KG  G     ++ PE  +    T  SDV+SFGVVL+EI          L  EQV
Sbjct: 182 R-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 236

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 113/245 (46%), Gaps = 16/245 (6%)
Query: 493 YGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGE 552
           +GN H            +    P+     F+  E+ A   + D+  ++G G FG+V  G 
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFEDPTQTVHEFA-KELDATNISIDK--VVGAGEFGEVCSGR 65
Query: 553 IDGATTK---VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   + K   VAIK      +E+   +F  E  ++ +  H +++ L G   ++  +++V 
Sbjct: 66  LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +YM  G+L   L K         Q + +  G A G+ YL   +    +HRD+   NIL++
Sbjct: 126 EYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181
Query: 669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEKSDVYSFGVV 725
              V KVSDFGL +     D    +   +G      +  PE    ++ T  SDV+S+G+V
Sbjct: 182 SNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 726 LFEIL 730
           L+E++
Sbjct: 240 LWEVM 244

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 540 LGVGGFGKVYRGEID---GATTKVAIKRGNP--LSE-QGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG V RGE D   G T  VA+K   P  LS+ + + +F  E+  +  L HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L G       M +V +    G+L + L K Q   L         +  A G+ YL +    
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLES---K 130
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP-TLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             IHRD+   N+LL  + + K+ DFGL +  P   DH  +    K  F +  PE  + + 
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 713 LTEKSDVYSFGVVLFEIL 730
            +  SD + FGV L+E+ 
Sbjct: 191 FSHASDTWMFGVTLWEMF 208

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 113/272 (41%), Gaps = 56/272 (20%)
Query: 508 GSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR-GN 566
           G  + SLP+  C  +   E             LG GGFG V R        +VAIK+   
Sbjct: 3   GGRSPSLPTQTCGPWEMKE------------RLGTGGFGYVLRWIHQDTGEQVAIKQCRQ 50
Query: 567 PLSEQGVHEFQTEIEMLSKLRHRHLVSL------IGYCEENCEMILVYDYMAYGTLREHL 620
            LS +    +  EI+++ KL H ++VS       +     N   +L  +Y   G LR++L
Sbjct: 51  ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL 110
Query: 621 YKTQKPPLPWKQRLEICIGAARG------------LHYLHTGAKHTIIHRDVKTTNILLD 668
                       + E C G   G            L YLH   ++ IIHRD+K  NI+L 
Sbjct: 111 -----------NQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQ 156
Query: 669 ---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 725
              ++ + K+ D G +K    LD   + T   G+  YL PE   +++ T   D +SFG +
Sbjct: 157 PGPQRLIHKIIDLGYAKE---LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTL 213
Query: 726 LFEILCARPALNPTLPKEQVSLAEWAAHCHKK 757
            FE +       P LP  Q    +W     +K
Sbjct: 214 AFECIT---GFRPFLPNWQP--VQWHGKVREK 240

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 113/272 (41%), Gaps = 56/272 (20%)
Query: 508 GSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR-GN 566
           G  + SLP+  C  +   E             LG GGFG V R        +VAIK+   
Sbjct: 2   GGRSPSLPTQTCGPWEMKE------------RLGTGGFGYVLRWIHQDTGEQVAIKQCRQ 49
Query: 567 PLSEQGVHEFQTEIEMLSKLRHRHLVSL------IGYCEENCEMILVYDYMAYGTLREHL 620
            LS +    +  EI+++ KL H ++VS       +     N   +L  +Y   G LR++L
Sbjct: 50  ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL 109
Query: 621 YKTQKPPLPWKQRLEICIGAARG------------LHYLHTGAKHTIIHRDVKTTNILLD 668
                       + E C G   G            L YLH   ++ IIHRD+K  NI+L 
Sbjct: 110 -----------NQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQ 155
Query: 669 ---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 725
              ++ + K+ D G +K    LD   + T   G+  YL PE   +++ T   D +SFG +
Sbjct: 156 PGPQRLIHKIIDLGYAKE---LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTL 212
Query: 726 LFEILCARPALNPTLPKEQVSLAEWAAHCHKK 757
            FE +       P LP  Q    +W     +K
Sbjct: 213 AFECIT---GFRPFLPNWQP--VQWHGKVREK 239

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 540 LGVGGFGKVYRGEID---GATTKVAIKRGNP--LSE-QGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG V RGE D   G T  VA+K   P  LS+ + + +F  E+  +  L HR+L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L G       M +V +    G+L + L K Q   L         +  A G+ YL +    
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLES---K 134
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP-TLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             IHRD+   N+LL  + + K+ DFGL +  P   DH  +    K  F +  PE  + + 
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 713 LTEKSDVYSFGVVLFEIL 730
            +  SD + FGV L+E+ 
Sbjct: 195 FSHASDTWMFGVTLWEMF 212

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 112/221 (50%), Gaps = 14/221 (6%)
Query: 518 LCRHFSFAEIKAATNNFDEALLLGVGGFGKVYR-GEIDGATTK----VAIKRGNPLSEQG 572
           +  H      KA  + F+   +LG G FGKV+   +I G+  +    + + +   L  + 
Sbjct: 10  ITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD 69
Query: 573 VHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ 632
               + E ++L ++ H  +V L    +   ++ L+ D++  G L     +  K  +  ++
Sbjct: 70  RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEE 126
Query: 633 RLEICIGA-ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH 691
            ++  +   A  L +LH+     II+RD+K  NILLDE+   K++DFGLSK   ++DH  
Sbjct: 127 DVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEK 181
Query: 692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA 732
            +    G+  Y+ PE   R+  T+ +D +SFGV++FE+L  
Sbjct: 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 115/231 (49%), Gaps = 14/231 (6%)
Query: 508 GSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYR-GEIDGATTK----VAI 562
           G+  S     +  H      KA  + F+   +LG G FGKV+   +I G+  +    + +
Sbjct: 1   GAMGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV 60
Query: 563 KRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYK 622
            +   L  +     + E ++L ++ H  +V L    +   ++ L+ D++  G L     +
Sbjct: 61  LKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTR 117
Query: 623 TQKPPLPWKQRLEICIGA-ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS 681
             K  +  ++ ++  +   A  L +LH+     II+RD+K  NILLDE+   K++DFGLS
Sbjct: 118 LSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS 174
Query: 682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA 732
           K   ++DH   +    G+  Y+ PE   R+  T+ +D +SFGV++FE+L  
Sbjct: 175 KE--SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 14/237 (5%)
Query: 517 NLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEI-----DGATTKVAIKRGNPLSEQ 571
           ++  H      KA  ++F+   +LG G FGKV+          G    + + +   L  +
Sbjct: 13  SITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVR 72
Query: 572 GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWK 631
                + E ++L+ + H  +V L    +   ++ L+ D++  G L     +  K  +  +
Sbjct: 73  DRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTE 129
Query: 632 QRLEICIGA-ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
           + ++  +   A GL +LH+     II+RD+K  NILLDE+   K++DFGLSK    +DH 
Sbjct: 130 EDVKFYLAELALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEA--IDHE 184
Query: 691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
             +    G+  Y+ PE   RQ  +  +D +S+GV++FE+L           KE ++L
Sbjct: 185 KKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTL 241

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 111/234 (47%), Gaps = 18/234 (7%)
Query: 515 PSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEI------DGATTKVAIKRGNPL 568
           P    R F+  EI+A+  + ++  ++G G  G+V  G +      D      A+K G   
Sbjct: 35  PGRAGRSFT-REIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--Y 89
Query: 569 SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPL 628
           +E+   +F +E  ++ +  H +++ L G        ++V +YM  G+L   L +T     
Sbjct: 90  TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQF 148
Query: 629 PWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTL 687
              Q + +  G   G+ YL   +    +HRD+   N+L+D   V KVSDFGLS+      
Sbjct: 149 TIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
Query: 688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC--ARPALNPT 739
           D  + +T  K    +  PE    +  +  SDV+SFGVV++E+L    RP  N T
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 114/246 (46%), Gaps = 18/246 (7%)
Query: 493 YGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGE 552
           +GN H            +    P+     F+  E+ A   + D+  ++G G FG+V  G 
Sbjct: 9   FGNGHLKLPGLRTFVDPHTFEDPTQTVHEFA-KELDATNISIDK--VVGAGEFGEVCSGR 65
Query: 553 IDGATTK---VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   + K   VAIK      +E+   +F  E  ++ +  H +++ L G   ++  +++V 
Sbjct: 66  LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH-TGAKHTIIHRDVKTTNILL 667
           + M  G+L   L K         Q + +  G A G+ YL   GA    +HRD+   NIL+
Sbjct: 126 EXMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGA----VHRDLAARNILI 180
Query: 668 DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEKSDVYSFGV 724
           +   V KVSDFGLS+     D    +   +G      +  PE    ++ T  SDV+S+G+
Sbjct: 181 NSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 725 VLFEIL 730
           VL+E++
Sbjct: 239 VLWEVM 244

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 113/245 (46%), Gaps = 16/245 (6%)
Query: 493 YGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGE 552
           +GN H            +    P+     F+  E+ A   + D+  ++G G FG+V  G 
Sbjct: 9   FGNGHLKLPGLRTYVDPHTYEDPTQTVHEFA-KELDATNISIDK--VVGAGEFGEVCSGR 65
Query: 553 IDGATTK---VAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   + K   VAIK      +E+   +F  E  ++ +  H +++ L G   ++  +++V 
Sbjct: 66  LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           + M  G+L   L K         Q + +  G A G+ YL   +    +HRD+   NIL++
Sbjct: 126 EXMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181
Query: 669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEKSDVYSFGVV 725
              V KVSDFGLS+     D    +   +G      +  PE    ++ T  SDV+S+G+V
Sbjct: 182 SNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 726 LFEIL 730
           L+E++
Sbjct: 240 LWEVM 244

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 112/221 (50%), Gaps = 14/221 (6%)
Query: 518 LCRHFSFAEIKAATNNFDEALLLGVGGFGKVYR-GEIDGATTK----VAIKRGNPLSEQG 572
           +  H      KA  + F+   +LG G FGKV+   +I G+  +    + + +   L  + 
Sbjct: 10  ITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD 69
Query: 573 VHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ 632
               + E ++L ++ H  +V L    +   ++ L+ D++  G L     +  K  +  ++
Sbjct: 70  RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEE 126
Query: 633 RLEICIGA-ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH 691
            ++  +   A  L +LH+     II+RD+K  NILLDE+   K++DFGLSK   ++DH  
Sbjct: 127 DVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEK 181
Query: 692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA 732
            +    G+  Y+ PE   R+  T+ +D +SFGV++FE+L  
Sbjct: 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 29/240 (12%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQGVH-EFQTE 579
           E + A      +  LG G FG VY G   G       T+VAIK  N  +      EF  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---------PLPW 630
             ++ +    H+V L+G   +    +++ + M  G L+ +L ++ +P         P   
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSL 124
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
            + +++    A G+ YL+    +  +HRD+   N  + E +  K+ DFG+++     D+ 
Sbjct: 125 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 691 HVSTVVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
                 KG  G     ++ PE  +    T  SDV+SFGVVL+EI          L  EQV
Sbjct: 182 R-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 236

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 540 LGVGGFGKVYRG--EIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIG 596
           LG G FG V +G   +      VAIK     +E+    E   E +++ +L + ++V LIG
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
            C+    ++LV +    G L + L   ++  +P     E+    + G+ YL    +   +
Sbjct: 78  VCQAEA-LMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE 715
           HRD+   N+LL  +  AK+SDFGLSK  G    +    +  K    +  PE    ++ + 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 716 KSDVYSFGVVLFEIL 730
           +SDV+S+GV ++E L
Sbjct: 193 RSDVWSYGVTMWEAL 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVH-EFQTEIEMLSK 585
           A   N+     LG G FGKV          KVA+K  N   L++  +    + EI  L  
Sbjct: 10  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 69
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           LRH H++ L    +   E+I+V +Y A   L +++ +  K      +R    I +A  + 
Sbjct: 70  LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VE 126
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H   +H I+HRD+K  N+LLDE    K++DFGLS      +    S    GS  Y  P
Sbjct: 127 YCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAP 180
Query: 706 EYFRRQQLT-EKSDVYSFGVVLFEILCAR 733
           E    +     + DV+S GV+L+ +LC R
Sbjct: 181 EVISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVH-EFQTEIEMLSK 585
           A   N+     LG G FGKV          KVA+K  N   L++  +    + EI  L  
Sbjct: 11  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 70
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           LRH H++ L    +   E+I+V +Y A   L +++ +  K      +R    I +A  + 
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VE 127
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H   +H I+HRD+K  N+LLDE    K++DFGLS      +    S    GS  Y  P
Sbjct: 128 YCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAP 181
Query: 706 EYFRRQQLT-EKSDVYSFGVVLFEILCAR 733
           E    +     + DV+S GV+L+ +LC R
Sbjct: 182 EVISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 16/223 (7%)
Query: 515 PSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK---VAIKRGNP-LSE 570
           P+   R F+  EI A+    ++  ++GVG FG+V  G +     +   VAIK      ++
Sbjct: 15  PNQAVREFA-KEIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTD 71
Query: 571 QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW 630
           +   +F +E  ++ +  H +++ L G   +   ++++ +YM  G+L   L K        
Sbjct: 72  KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTV 130
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
            Q + +  G   G+ YL   +  + +HRD+   NIL++   V KVSDFG+S+     D  
Sbjct: 131 IQLVGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRV--LEDDP 185
Query: 691 HVSTVVKGS---FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             +   +G      +  PE    ++ T  SDV+S+G+V++E++
Sbjct: 186 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 228

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 13/217 (5%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR----GNPLSEQGVHEFQ-TEI 580
           ++K+    +++   LG G F  VY+         VAIK+        ++ G++     EI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 581 EMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA 640
           ++L +L H +++ L+        + LV+D+M   T  E + K     L         +  
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
            +GL YLH   +H I+HRD+K  N+LLDE  V K++DFGL+K+  + +  +   VV  + 
Sbjct: 122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TR 176
Query: 701 GYLDPE-YFRRQQLTEKSDVYSFGVVLFEILCARPAL 736
            Y  PE  F  +      D+++ G +L E+L   P L
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVH-EFQTEIEMLSK 585
           A   N+     LG G FGKV          KVA+K  N   L++  +    + EI  L  
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           LRH H++ L    +   E+I+V +Y A   L +++ +  K      +R    I +A  + 
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VE 117
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H   +H I+HRD+K  N+LLDE    K++DFGLS      +    S    GS  Y  P
Sbjct: 118 YCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAP 171
Query: 706 EYFRRQQLT-EKSDVYSFGVVLFEILCAR 733
           E    +     + DV+S GV+L+ +LC R
Sbjct: 172 EVISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVH-EFQTEIEMLSK 585
           A   N+     LG G FGKV          KVA+K  N   L++  +    + EI  L  
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 64
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           LRH H++ L    +   E+I+V +Y A   L +++ +  K      +R    I +A  + 
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VE 121
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           Y H   +H I+HRD+K  N+LLDE    K++DFGLS      +    S    GS  Y  P
Sbjct: 122 YCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAP 175
Query: 706 EYFRRQQLT-EKSDVYSFGVVLFEILCAR 733
           E    +     + DV+S GV+L+ +LC R
Sbjct: 176 EVISGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 18/234 (7%)
Query: 515 PSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEI------DGATTKVAIKRGNPL 568
           P    R F+  EI+A+  + ++  ++G G  G+V  G +      D      A+K G   
Sbjct: 35  PGRAGRSFT-REIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--Y 89
Query: 569 SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPL 628
           +E+   +F +E  ++ +  H +++ L G        ++V +YM  G+L   L +T     
Sbjct: 90  TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQF 148
Query: 629 PWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTL 687
              Q + +  G   G+ YL   +    +HRD+   N+L+D   V KVSDFGLS+      
Sbjct: 149 TIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
Query: 688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC--ARPALNPT 739
           D    +T  K    +  PE    +  +  SDV+SFGVV++E+L    RP  N T
Sbjct: 206 DAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 83/335 (24%), Positives = 149/335 (44%), Gaps = 40/335 (11%)
Query: 509 SYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL 568
           S AS  P+        + ++     F+   L+G G +G+VY+G         AIK  +  
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 569 SEQGVHEFQTEIEMLSKL-RHRHLVSLIG-YCEENC-----EMILVYDYMAYGTLREHLY 621
            ++   E + EI ML K   HR++ +  G + ++N      ++ LV ++   G++ + + 
Sbjct: 61  GDEE-EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 622 KTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS 681
            T+   L  +    IC    RGL +LH   +H +IHRD+K  N+LL E    K+ DFG+S
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 682 KTGPTLDHT--HVSTVVKGSFGYLDPEYFRRQQLTE-----KSDVYSFGVVLFEILCARP 734
                LD T    +T + G+  ++ PE     +  +     KSD++S G+   E+    P
Sbjct: 177 ---AQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 735 ALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAM------KCV 788
            L    P   + L            + +   P LK K   + F+ F E+ +      +  
Sbjct: 233 PLCDMHPMRALFL------------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPA 280
Query: 789 SDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
           ++Q ++ P + D     +  +QL++  + + K  G
Sbjct: 281 TEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRG 315

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 15/217 (6%)
Query: 521 HFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK---VAIKRGNP-LSEQGVHEF 576
           H    E+ A   + D+  ++G G FG+V  G +   + K   VAIK      +E+   +F
Sbjct: 7   HEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 577 QTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI 636
             E  ++ +  H +++ L G   ++  +++V + M  G+L   L K         Q + +
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK-HDAQFTVIQLVGM 123
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
             G A G+ YL   +    +HRD+   NIL++   V KVSDFGLS+     D    +   
Sbjct: 124 LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTT 178
Query: 697 KGS---FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           +G      +  PE    ++ T  SDV+S+G+VL+E++
Sbjct: 179 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 95/191 (49%), Gaps = 7/191 (3%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 27  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 85  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 140
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ +    K++DFGL++     ++T      K    +  PE       T KSDV
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 720 YSFGVVLFEIL 730
           +SFG++L EI+
Sbjct: 200 WSFGILLTEIV 210

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 95/191 (49%), Gaps = 7/191 (3%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ +    K++DFGL++     ++T      K    +  PE       T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 720 YSFGVVLFEIL 730
           +SFG++L EI+
Sbjct: 194 WSFGILLTEIV 204

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 110/237 (46%), Gaps = 31/237 (13%)
Query: 533 NFDEALLLGVGGFGKV-----YRGEIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKL 586
           N +   +LG G FGKV     Y     G + +VA+K     ++    E   +E++M+++L
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 587 -RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL-------------YKTQKP------ 626
             H ++V+L+G C  +  + L+++Y  YG L  +L             Y+ QK       
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 627 --PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG 684
              L ++  L      A+G+ +L      + +HRD+   N+L+    V K+ DFGL++  
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP 741
            +  +  V    +    ++ PE       T KSDV+S+G++L+EI        P +P
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 95/191 (49%), Gaps = 7/191 (3%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 16  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 74  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 129
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ +    K++DFGL++     ++T      K    +  PE       T KSDV
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 720 YSFGVVLFEIL 730
           +SFG++L EI+
Sbjct: 189 WSFGILLTEIV 199

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 95/191 (49%), Gaps = 7/191 (3%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 26  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 84  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 139
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ +    K++DFGL++     ++T      K    +  PE       T KSDV
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 720 YSFGVVLFEIL 730
           +SFG++L EI+
Sbjct: 199 WSFGILLTEIV 209

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 95/191 (49%), Gaps = 7/191 (3%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 31  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 89  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 144
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ +    K++DFGL++     ++T      K    +  PE       T KSDV
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 203
Query: 720 YSFGVVLFEIL 730
           +SFG++L EI+
Sbjct: 204 WSFGILLTEIV 214

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 123/294 (41%), Gaps = 41/294 (13%)
Query: 532 NNFDEALLLGVGGFGKVYRGEI---DGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKL 586
             F    +LG G FG V   ++   DG+  KVA+K  + + ++   + EF  E   + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 587 RHRHLVSLIGYCEENCEM------ILVYDYMAYGTLREHLYKTQ--KPP--LPWKQRLEI 636
            H H+  L+G    +         +++  +M +G L   L  ++  + P  LP +  +  
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
            +  A G+ YL   +    IHRD+   N +L E     V+DFGLS+   + D+       
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK 756
           K    +L  E       T  SDV++FGV ++EI          + + Q   A        
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEI----------MTRGQTPYA-------- 241
Query: 757 KGILEQIMDPYLKG----KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
            GI    +  YL G    K  PEC ++  +   +C S    +RPS   +   LE
Sbjct: 242 -GIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 539 LLGVGGFGKVYRGEIDGATTK---VAIKR-GNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           ++G G FG+V  G +     +   VAIK   +  +E+   +F +E  ++ +  H +++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
            G   ++  ++++ ++M  G+L   L +         Q + +  G A G+ YL   A   
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTV-VKGSFGYLDPEYFRRQ 711
            +HR +   NIL++   V KVSDFGLS+     T D T+ S +  K    +  PE  + +
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 712 QLTEKSDVYSFGVVLFEIL 730
           + T  SDV+S+G+V++E++
Sbjct: 190 KFTSASDVWSYGIVMWEVM 208

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 30  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 88  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 143
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEK 716
           ++  NIL+ +    K++DFGL++    L   +  T  +G+     +  PE       T K
Sbjct: 144 LRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFG++L EI+
Sbjct: 200 SDVWSFGILLTEIV 213

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 29  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 87  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 142
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEK 716
           ++  NIL+ +    K++DFGL++    L   +  T  +G+     +  PE       T K
Sbjct: 143 LRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFG++L EI+
Sbjct: 199 SDVWSFGILLTEIV 212

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 27  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 85  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 140
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEK 716
           ++  NIL+ +    K++DFGL++    L   +  T  +G+     +  PE       T K
Sbjct: 141 LRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFG++L EI+
Sbjct: 197 SDVWSFGILLTEIV 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEK 716
           ++  NIL+ +    K++DFGL++    L   +  T  +G+     +  PE       T K
Sbjct: 135 LRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFG++L EI+
Sbjct: 191 SDVWSFGILLTEIV 204

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 23  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 81  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 136
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEK 716
           ++  NIL+ +    K++DFGL++    L   +  T  +G+     +  PE       T K
Sbjct: 137 LRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFG++L EI+
Sbjct: 193 SDVWSFGILLTEIV 206

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEK 716
           ++  NIL+ +    K++DFGL++    L   +  T  +G+     +  PE       T K
Sbjct: 135 LRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFG++L EI+
Sbjct: 191 SDVWSFGILLTEIV 204

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 22  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 80  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 135
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS---FGYLDPEYFRRQQLTEK 716
           ++  NIL+ +    K++DFGL++    L   +  T  +G+     +  PE       T K
Sbjct: 136 LRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 717 SDVYSFGVVLFEIL 730
           SDV+SFG++L EI+
Sbjct: 192 SDVWSFGILLTEIV 205

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 540 LGVGGFGKVYRG--EIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIG 596
           LG G FG V +G   +      VAIK     +E+    E   E +++ +L + ++V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
            C+    ++LV +    G L + L   ++  +P     E+    + G+ YL    +   +
Sbjct: 404 VCQAEA-LMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 458
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE 715
           HR++   N+LL  +  AK+SDFGLSK  G    +    +  K    +  PE    ++ + 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 716 KSDVYSFGVVLFEIL 730
           +SDV+S+GV ++E L
Sbjct: 519 RSDVWSYGVTMWEAL 533

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 17/218 (7%)
Query: 518 LCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEI--DGATTKVAIKRGNPLSEQGVHE 575
           L R F   E++          +LG G FG V++G    +G + K+ +       + G   
Sbjct: 24  LARIFKETELRKLK-------VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS 76
Query: 576 FQT---EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ 632
           FQ     +  +  L H H+V L+G C     + LV  Y+  G+L +H+ +  +  L  + 
Sbjct: 77  FQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHV-RQHRGALGPQL 134
Query: 633 RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV 692
            L   +  A+G++YL    +H ++HR++   N+LL      +V+DFG++   P  D   +
Sbjct: 135 LLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 191
Query: 693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            +  K    ++  E     + T +SDV+S+GV ++E++
Sbjct: 192 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ---TEIEMLSKLRHRHLVSLI 595
           +LG GGFG+V+  ++       A K+ N    +    +Q    E ++L+K+  R +VSL 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--ARGLHYLHTGAKH 653
              E   ++ LV   M  G +R H+Y   +    +++   I   A    GL +LH   + 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QR 308
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
            II+RD+K  N+LLD+    ++SD GL+   K G T    +      G+ G++ PE    
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTPGFMAPELLLG 363
Query: 711 QQLTEKSDVYSFGVVLFEILCAR 733
           ++     D ++ GV L+E++ AR
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ---TEIEMLSKLRHRHLVSLI 595
           +LG GGFG+V+  ++       A K+ N    +    +Q    E ++L+K+  R +VSL 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--ARGLHYLHTGAKH 653
              E   ++ LV   M  G +R H+Y   +    +++   I   A    GL +LH   + 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QR 308
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
            II+RD+K  N+LLD+    ++SD GL+   K G T    +      G+ G++ PE    
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTPGFMAPELLLG 363
Query: 711 QQLTEKSDVYSFGVVLFEILCAR 733
           ++     D ++ GV L+E++ AR
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ---TEIEMLSKLRHRHLVSLI 595
           +LG GGFG+V+  ++       A K+ N    +    +Q    E ++L+K+  R +VSL 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--ARGLHYLHTGAKH 653
              E   ++ LV   M  G +R H+Y   +    +++   I   A    GL +LH   + 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QR 308
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
            II+RD+K  N+LLD+    ++SD GL+   K G T    +      G+ G++ PE    
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTPGFMAPELLLG 363
Query: 711 QQLTEKSDVYSFGVVLFEILCAR 733
           ++     D ++ GV L+E++ AR
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 7/191 (3%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 17  LGAGQFGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHR+
Sbjct: 75  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRN 130
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ +    K++DFGL++     ++T      K    +  PE       T KSDV
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 720 YSFGVVLFEIL 730
           +SFG++L EI+
Sbjct: 190 WSFGILLTEIV 200

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 539 LLGVGGFGKVYRGEI------DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++G G FG+V  G +      D A     +K G   +E+   +F  E  ++ +  H ++V
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVG--YTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            L G       +++V ++M  G L   L K         Q + +  G A G+ YL   A 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRK-HDGQFTVIQLVGMLRGIAAGMRYL---AD 163
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF--GYLDPEYFRR 710
              +HRD+   NIL++   V KVSDFGLS+     D   V T   G     +  PE  + 
Sbjct: 164 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIED-DPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SDV+S+G+V++E++
Sbjct: 223 RKFTSASDVWSYGIVMWEVM 242

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ---TEIEMLSKLRHRHLVSLI 595
           +LG GGFG+V+  ++       A K+ N    +    +Q    E ++L+K+  R +VSL 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--ARGLHYLHTGAKH 653
              E   ++ LV   M  G +R H+Y   +    +++   I   A    GL +LH   + 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QR 308
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
            II+RD+K  N+LLD+    ++SD GL+   K G T    +      G+ G++ PE    
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTPGFMAPELLLG 363
Query: 711 QQLTEKSDVYSFGVVLFEILCAR 733
           ++     D ++ GV L+E++ AR
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 87/165 (52%), Gaps = 8/165 (4%)
Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L +    ++V   G    + E+ +  ++M  G+L + L K  +  +P +   ++ I
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 173
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              +GL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D    S V  G
Sbjct: 174 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV--G 227
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           +  Y+ PE  +    + +SD++S G+ L E+   R  + P   KE
Sbjct: 228 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 272

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 43/229 (18%)
Query: 533 NFDEALLLGVGGFGKVYRGE--IDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH 590
           +F E  L+G GGFG+V++ +  IDG T    I+R    +E+     + E++ L+KL H +
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKT--YVIRRVKYNNEKA----EREVKALAKLDHVN 66
Query: 591 LVSLIG--------------------YCEENCE---------MILVYDYMAYGTLREHLY 621
           +V   G                    Y  EN +         + +  ++   GTL + + 
Sbjct: 67  IVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 126
Query: 622 KTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS 681
           K +   L     LE+     +G+ Y+H+     +IHRD+K +NI L +    K+ DFGL 
Sbjct: 127 KRRGEKLDKVLALELFEQITKGVDYIHSKK---LIHRDLKPSNIFLVDTKQVKIGDFGLV 183
Query: 682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
               +L +    T  KG+  Y+ PE    Q   ++ D+Y+ G++L E+L
Sbjct: 184 ---TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 539 LLGVGGFGKVYRGEI--DGATTKVAIKRGNPLSEQGVHEFQT---EIEMLSKLRHRHLVS 593
           +LG G FG V++G    +G + K+ +       + G   FQ     +  +  L H H+V 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L+G C     + LV  Y+  G+L +H+ +  +  L  +  L   +  A+G++YL    +H
Sbjct: 80  LLGLCP-GSSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLE---EH 134
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            ++HR++   N+LL      +V+DFG++   P  D   + +  K    ++  E     + 
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 714 TEKSDVYSFGVVLFEIL 730
           T +SDV+S+GV ++E++
Sbjct: 195 THQSDVWSYGVTVWELM 211

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 14/214 (6%)
Query: 525 AEIKAATNNFDEALLLGVGGFGKV--YRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIE 581
           A  K   N+FD   LLG G FGKV   R +  G    + I R   + ++  V    TE  
Sbjct: 1   ARAKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 60
Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA- 640
           +L   RH  L +L    + +  +  V +Y   G L  HL + +     + +      GA 
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAE 116
Query: 641 -ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
               L YLH+     +++RD+K  N++LD+    K++DFGL K G + D   + T   G+
Sbjct: 117 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFC-GT 171
Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
             YL PE           D +  GVV++E++C R
Sbjct: 172 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI-GYC 598
           LG G FGKVY+ +    +   A K  +  SE+ + ++  EI++L+   H ++V L+  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
            EN   IL+ ++ A G +   + + ++ PL   Q   +C      L+YLH    + IIHR
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH---DNKIIHR 159
Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF-----RRQQL 713
           D+K  NIL       K++DFG+S           S +  G+  ++ PE       + +  
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 217
Query: 714 TEKSDVYSFGVVLFEILCARP---ALNP 738
             K+DV+S G+ L E+    P    LNP
Sbjct: 218 DYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK---VAIKRGNP-LSEQGVHE 575
           R F+  EI A+    ++  ++GVG FG+V  G +     +   VAIK      +++   +
Sbjct: 5   REFA-KEIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD 61
Query: 576 FQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE 635
           F +E  ++ +  H +++ L G   +   ++++ +YM  G+L   L K         Q + 
Sbjct: 62  FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVG 120
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
           +  G   G+ YL   +  + +HRD+   NIL++   V KVSDFG+S+     D    +  
Sbjct: 121 MLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRV--LEDDPEAAYT 175
Query: 696 VKGS---FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            +G      +  PE    ++ T  SDV+S+G+V++E++
Sbjct: 176 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 213

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V         T+VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL---EICI---GAARGLHYLHTGAK 652
             +    +   Y+    +   LYK  K      Q+L    IC       RGL Y+H+   
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLK-----SQQLSNDHICYFLYQILRGLKYIHSA-- 163
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
             ++HRD+K +N+L++     K+ DFGL++   P  DHT   T    +  Y  PE     
Sbjct: 164 -NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNS 222
Query: 712 Q-LTEKSDVYSFGVVLFEILCARP 734
           +  T+  D++S G +L E+L  RP
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI-GYC 598
           LG G FGKVY+ +    +   A K  +  SE+ + ++  EI++L+   H ++V L+  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
            EN   IL+ ++ A G +   + + ++ PL   Q   +C      L+YLH    + IIHR
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH---DNKIIHR 159
Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF-----RRQQL 713
           D+K  NIL       K++DFG+S           S +  G+  ++ PE       + +  
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 217
Query: 714 TEKSDVYSFGVVLFEILCARP---ALNP 738
             K+DV+S G+ L E+    P    LNP
Sbjct: 218 DYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 539 LLGVGGFGKVYRGEI---DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           +LG G FG+VY G      G    VA+K      +     +F +E  ++  L H H+V L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQ---KPPLPWKQRLEICIGAARGLHYLHTGA 651
           IG  EE    I++  Y  YG L  +L + +   K        L+IC    + + YL +  
Sbjct: 91  IGIIEEEPTWIIMELY-PYGELGHYLERNKNSLKVLTLVLYSLQIC----KAMAYLES-- 143
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
               +HRD+   NIL+      K+ DFGLS+     D+ + ++V +    ++ PE    +
Sbjct: 144 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFR 201
Query: 712 QLTEKSDVYSFGVVLFEIL 730
           + T  SDV+ F V ++EIL
Sbjct: 202 RFTTASDVWMFAVCMWEIL 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 539 LLGVGGFGKVYRGEI---DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           +LG G FG+VY G      G    VA+K      +     +F +E  ++  L H H+V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQ---KPPLPWKQRLEICIGAARGLHYLHTGA 651
           IG  EE    I++  Y  YG L  +L + +   K        L+IC    + + YL +  
Sbjct: 79  IGIIEEEPTWIIMELY-PYGELGHYLERNKNSLKVLTLVLYSLQIC----KAMAYLES-- 131
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
               +HRD+   NIL+      K+ DFGLS+     D+ + ++V +    ++ PE    +
Sbjct: 132 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFR 189
Query: 712 QLTEKSDVYSFGVVLFEIL 730
           + T  SDV+ F V ++EIL
Sbjct: 190 RFTTASDVWMFAVCMWEIL 208

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 35/284 (12%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ---TEIEMLSKLRHRH 590
           F +   +G G FG VY       +  VAIK+ +   +Q   ++Q    E+  L KLRH +
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
            +   G         LV +Y   G+  + L +  K PL   +   +  GA +GL YLH+ 
Sbjct: 116 TIQYRGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 172
Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFG-LSKTGPTLDHTHVSTVVKGSFGYLDPEY-- 707
             H +IHRDVK  NILL E  + K+ DFG  S   P       +    G+  ++ PE   
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVIL 223
Query: 708 -FRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP 766
                Q   K DV+S G+   E+   +P L         ++   +A  H    + Q   P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPL--------FNMNAMSALYH----IAQNESP 271
Query: 767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
            L+     E F+ F ++   C+     +RP+  +VL    F L+
Sbjct: 272 ALQSGHWSEYFRNFVDS---CLQKIPQDRPT-SEVLLKHRFVLR 311

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 87/165 (52%), Gaps = 8/165 (4%)
Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L +    ++V   G    + E+ +  ++M  G+L + L K  +  +P +   ++ I
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 111
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              +GL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D    S V  G
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV--G 165
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           +  Y+ PE  +    + +SD++S G+ L E+   R  + P   KE
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 87/165 (52%), Gaps = 8/165 (4%)
Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L +    ++V   G    + E+ +  ++M  G+L + L K  +  +P +   ++ I
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 111
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              +GL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D    S V  G
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV--G 165
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           +  Y+ PE  +    + +SD++S G+ L E+   R  + P   KE
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 539 LLGVGGFGKVYRGEI---DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           +LG G FG+VY G      G    VA+K      +     +F +E  ++  L H H+V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQ---KPPLPWKQRLEICIGAARGLHYLHTGA 651
           IG  EE    I++  Y  YG L  +L + +   K        L+IC    + + YL +  
Sbjct: 75  IGIIEEEPTWIIMELY-PYGELGHYLERNKNSLKVLTLVLYSLQIC----KAMAYLESI- 128
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
               +HRD+   NIL+      K+ DFGLS+     D+ + ++V +    ++ PE    +
Sbjct: 129 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFR 185
Query: 712 QLTEKSDVYSFGVVLFEIL 730
           + T  SDV+ F V ++EIL
Sbjct: 186 RFTTASDVWMFAVCMWEIL 204

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 15/212 (7%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK---VAIKRGNP-LSEQGVHEFQTEIE 581
           EI A+    ++  ++GVG FG+V  G +     +   VAIK      +++   +F +E  
Sbjct: 4   EIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEAS 61
Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
           ++ +  H +++ L G   +   ++++ +YM  G+L   L K         Q + +  G  
Sbjct: 62  IMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVGMLRGIG 120
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS-- 699
            G+ YL   +  + +HRD+   NIL++   V KVSDFG+S+     D    +   +G   
Sbjct: 121 SGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRV--LEDDPEAAYTTRGGKI 175
Query: 700 -FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
              +  PE    ++ T  SDV+S+G+V++E++
Sbjct: 176 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 207

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 88/165 (53%), Gaps = 8/165 (4%)
Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L +    ++V   G    + E+ +  ++M  G+L + L + ++  +P +   ++ I
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSI 121
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              RGL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D    S V  G
Sbjct: 122 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV--G 175
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           +  Y+ PE  +    + +SD++S G+ L E+   R  + P   KE
Sbjct: 176 TRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKE 220

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVA-----IKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            LG GGF K +  EI  A TK       + +   L      +   EI +   L H+H+V 
Sbjct: 28  FLGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 85
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
             G+ E+N  + +V +     +L E L+K +K     + R  +      G  YLH   ++
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL-RQIVLGCQYLH---RN 140
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            +IHRD+K  N+ L+E    K+ DFGL+ T    D     T+  G+  Y+ PE   ++  
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLC-GTPNYIAPEVLSKKGH 198
Query: 714 TEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           + + DV+S G +++ +L  +P    +  KE
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPPFETSCLKE 228

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 529 AATNNFDEALLLGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLS 584
           A  ++F    ++G G FGKV    ++ E      KV  K+     ++  H       +L 
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
            ++H  LV L    +   ++  V DY+  G L  HL + +    P  +     I +A G 
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG- 153
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
            YLH+     I++RD+K  NILLD +    ++DFGL K    ++H   ++   G+  YL 
Sbjct: 154 -YLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN--IEHNSTTSTFCGTPEYLA 207
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE   +Q      D +  G VL+E+L   P
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 87/165 (52%), Gaps = 8/165 (4%)
Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L +    ++V   G    + E+ +  ++M  G+L + L K  +  +P +   ++ I
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 111
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              +GL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D    S V  G
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV--G 165
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           +  Y+ PE  +    + +SD++S G+ L E+   R  + P   KE
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 14/211 (6%)
Query: 528 KAATNNFDEALLLGVGGFGKV--YRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLS 584
           K   N+FD   LLG G FGKV   R +  G    + I R   + ++  V    TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--AR 642
             RH  L +L    + +  +  V +Y   G L  HL + +     + +      GA    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVS 116
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+     +++RD+K  N++LD+    K++DFGL K G + D   + T   G+  Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFC-GTPEY 171
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVA-----IKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            LG GGF K +  EI  A TK       + +   L      +   EI +   L H+H+V 
Sbjct: 24  FLGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 81
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
             G+ E+N  + +V +     +L E L+K +K     + R  +      G  YLH   ++
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL-RQIVLGCQYLH---RN 136
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            +IHRD+K  N+ L+E    K+ DFGL+ T    D     T+  G+  Y+ PE   ++  
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLC-GTPNYIAPEVLSKKGH 194
Query: 714 TEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           + + DV+S G +++ +L  +P    +  KE
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 14/211 (6%)
Query: 528 KAATNNFDEALLLGVGGFGKV--YRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLS 584
           K   N+FD   LLG G FGKV   R +  G    + I R   + ++  V    TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--AR 642
             RH  L +L    + +  +  V +Y   G L  HL + +     + +      GA    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVS 116
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+     +++RD+K  N++LD+    K++DFGL K G + D   + T   G+  Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFC-GTPEY 171
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G  G+V+ G  +G T KVA+K     S      F  E  ++ +L+H+ LV L     
Sbjct: 21  LGAGQAGEVWMGYYNGHT-KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHRD
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ +    K++DFGL++     + T      K    +  PE       T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 720 YSFGVVLFEIL 730
           +SFG++L EI+
Sbjct: 194 WSFGILLTEIV 204

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 87/165 (52%), Gaps = 8/165 (4%)
Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L +    ++V   G    + E+ +  ++M  G+L + L K  +  +P +   ++ I
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 111
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              +GL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D    S V  G
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV--G 165
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           +  Y+ PE  +    + +SD++S G+ L E+   R  + P   KE
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 87/165 (52%), Gaps = 8/165 (4%)
Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L +    ++V   G    + E+ +  ++M  G+L + L K  +  +P +   ++ I
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 111
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              +GL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D    S V  G
Sbjct: 112 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV--G 165
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           +  Y+ PE  +    + +SD++S G+ L E+   R  + P   KE
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVA-----IKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            LG GGF K +  EI  A TK       + +   L      +   EI +   L H+H+V 
Sbjct: 24  FLGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 81
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
             G+ E+N  + +V +     +L E L+K +K     + R  +      G  YLH   ++
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL-RQIVLGCQYLH---RN 136
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            +IHRD+K  N+ L+E    K+ DFGL+ T    D     T+  G+  Y+ PE   ++  
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLC-GTPNYIAPEVLSKKGH 194
Query: 714 TEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           + + DV+S G +++ +L  +P    +  KE
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 32/217 (14%)
Query: 533 NFDEALLLGVGGFGKVYRGE--IDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH 590
           +F E  L+G GGFG+V++ +  IDG T    IKR    +E+     + E++ L+KL H +
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKT--YVIKRVKYNNEKA----EREVKALAKLDHVN 65
Query: 591 LVSLIG-----------------YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQR 633
           +V   G                   +  C + +  ++   GTL + + K +   L     
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKC-LFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 634 LEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS 693
           LE+     +G+ Y+H+     +I+RD+K +NI L +    K+ DFGL     +L +    
Sbjct: 125 LELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLV---TSLKNDGKR 178
Query: 694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
              KG+  Y+ PE    Q   ++ D+Y+ G++L E+L
Sbjct: 179 XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 87/165 (52%), Gaps = 8/165 (4%)
Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L +    ++V   G    + E+ +  ++M  G+L + L K  +  +P +   ++ I
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 138
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              +GL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D    S V  G
Sbjct: 139 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV--G 192
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           +  Y+ PE  +    + +SD++S G+ L E+   R  + P   KE
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           FD    LG G +G VY+  I   T ++   +  P+ E  + E   EI ++ +    H+V 
Sbjct: 31  FDVLEKLGEGSYGSVYKA-IHKETGQIVAIKQVPV-ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
             G   +N ++ +V +Y   G++ + + + +   L   +   I     +GL YLH   K 
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK- 146
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
             IHRD+K  NILL+ +  AK++DFG++  G   D       V G+  ++ PE  +    
Sbjct: 147 --IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 714 TEKSDVYSFGVVLFEILCARP 734
              +D++S G+   E+   +P
Sbjct: 203 NCVADIWSLGITAIEMAEGKP 223

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVA-----IKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            LG GGF K +  EI  A TK       + +   L      +   EI +   L H+H+V 
Sbjct: 48  FLGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
             G+ E+N  + +V +     +L E L+K +K     + R  +      G  YLH   ++
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL-RQIVLGCQYLH---RN 160
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            +IHRD+K  N+ L+E    K+ DFGL+ T    D      V+ G+  Y+ PE   ++  
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGER-KKVLCGTPNYIAPEVLSKKGH 218
Query: 714 TEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           + + DV+S G +++ +L  +P    +  KE
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKE 248

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVA-----IKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            LG GGF K +  EI  A TK       + +   L      +   EI +   L H+H+V 
Sbjct: 46  FLGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 103
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
             G+ E+N  + +V +     +L E L+K +K     + R  +      G  YLH   ++
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL-RQIVLGCQYLH---RN 158
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            +IHRD+K  N+ L+E    K+ DFGL+ T    D      V+ G+  Y+ PE   ++  
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGER-KKVLCGTPNYIAPEVLSKKGH 216
Query: 714 TEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           + + DV+S G +++ +L  +P    +  KE
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPPFETSCLKE 246

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 33/217 (15%)
Query: 540 LGVGGFGKVYRGE---IDGATT--KVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +   ID   T   VA+K     +    H    +E+++L  +  H ++V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 593 SLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE------------IC-- 637
           +L+G C +    ++++ ++  +G L  +L   +   +P+K+  E            IC  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
              A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++      +     V K
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPDYVRK 209
Query: 698 GS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           G       ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 210 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 246

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 517 NLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-------- 568
           N   H    EI+A+    +   ++G G FG+V  G +     K+  KR  P+        
Sbjct: 9   NQAVHEFAKEIEASCITIER--VIGAGEFGEVCSGRL-----KLPGKRELPVAIKTLKVG 61
Query: 569 -SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP 627
            +E+   +F  E  ++ +  H +++ L G   ++  +++V +YM  G+L   L K     
Sbjct: 62  YTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL-KKNDGQ 120
Query: 628 LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL 687
               Q + +  G + G+ YL   +    +HRD+   NIL++   V KVSDFGLS+     
Sbjct: 121 FTVIQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV--LE 175
Query: 688 DHTHVSTVVKGS---FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           D    +   +G      +  PE    ++ T  SDV+S+G+V++E++
Sbjct: 176 DDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVV 221

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 540 LGVGGFGKVYRGEIDGATTKV-AIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG+V++G ID  T KV AIK  +   +E  + + Q EI +LS+    ++    G 
Sbjct: 35  IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 93
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             ++ ++ ++ +Y+  G+  + L   +  PL   Q   I     +GL YLH+  K   IH
Sbjct: 94  YLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK---IH 147
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+LL E    K++DFG++  G   D         G+  ++ PE  ++     K+
Sbjct: 148 RDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 205
Query: 718 DVYSFGVVLFEILCARP 734
           D++S G+   E+    P
Sbjct: 206 DIWSLGITAIELARGEP 222

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI-GYC 598
           LG G FGKVY+ +    +   A K  +  SE+ + ++  EI++L+   H ++V L+  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
            EN   IL+ ++ A G +   + + ++ PL   Q   +C      L+YLH    + IIHR
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH---DNKIIHR 159
Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF-----RRQQL 713
           D+K  NIL       K++DFG+S             +  G+  ++ PE       + +  
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI--GTPYWMAPEVVMCETSKDRPY 217
Query: 714 TEKSDVYSFGVVLFEILCARP---ALNP 738
             K+DV+S G+ L E+    P    LNP
Sbjct: 218 DYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 126/285 (44%), Gaps = 37/285 (12%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ---TEIEMLSKLRHRH 590
           F +   +G G FG VY       +  VAIK+ +   +Q   ++Q    E+  L KLRH +
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 591 LVSLIG-YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
            +   G Y  E+    LV +Y   G+  + L +  K PL   +   +  GA +GL YLH+
Sbjct: 77  TIQYRGCYLREHTAW-LVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFG-LSKTGPTLDHTHVSTVVKGSFGYLDPEY- 707
              H +IHRDVK  NILL E  + K+ DFG  S   P       +    G+  ++ PE  
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVI 183
Query: 708 --FRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
                 Q   K DV+S G+   E+   +P L         ++   +A  H    + Q   
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL--------FNMNAMSALYH----IAQNES 231
Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           P L+     E F+ F ++   C+     +RP+  +VL    F L+
Sbjct: 232 PALQSGHWSEYFRNFVDS---CLQKIPQDRPT-SEVLLKHRFVLR 272

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVA-----IKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            LG GGF K +  EI  A TK       + +   L      +   EI +   L H+H+V 
Sbjct: 22  FLGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 79
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
             G+ E+N  + +V +     +L E L+K +K     + R  +      G  YLH   ++
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL-RQIVLGCQYLH---RN 134
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            +IHRD+K  N+ L+E    K+ DFGL+ T    D      V+ G+  Y+ PE   ++  
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGER-KKVLCGTPNYIAPEVLSKKGH 192
Query: 714 TEKSDVYSFGVVLFEILCARPALNPTLPKE 743
           + + DV+S G +++ +L  +P    +  KE
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 78  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 79  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 137 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELM 217

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 539 LLGVGGFGKVYRGEI--DGATTK--VAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           +LG G FG VY+G    DG   K  VAIK  R N  S +   E   E  +++ +   ++ 
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVS 82
Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            L+G C  +  + LV   M YG L +H+ +  +  L  +  L  C+  A+G+ YL     
Sbjct: 83  RLLGICLTST-VQLVTQLMPYGCLLDHV-RENRGRLGSQDLLNWCMQIAKGMSYLE---D 137
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             ++HRD+   N+L+      K++DFGL++     +  + +   K    ++  E   R++
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 713 LTEKSDVYSFGVVLFEIL 730
            T +SDV+S+GV ++E++
Sbjct: 198 FTHQSDVWSYGVTVWELM 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 76  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 134 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELM 214

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 31/233 (13%)
Query: 531 TNNFDEALLLGVGGFGKVY--RGEIDGATTKVAI-KRGNPLSEQGVHEFQTEIEMLSKLR 587
           ++ +     LG G +G+V   + ++ GA   + I K+ +  +         E+ +L +L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK-----PPLPWKQRLEICIGAAR 642
           H +++ L  + E+     LV +    G L + +   QK       +  KQ L        
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS------- 132
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEK---WVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
           G  YLH   KH I+HRD+K  N+LL+ K    + K+ DFGLS       H  V   +K  
Sbjct: 133 GTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA------HFEVGGKMKER 183
Query: 700 FG---YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAE 749
            G   Y+ PE  R+ +  EK DV+S GV+L+ +LC  P       +E +   E
Sbjct: 184 LGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE 235

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 76  DNPHVCRLLGICLTST-VQLIMQLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 134 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELM 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELM 215

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+          +FQ EI++L  L    +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 596 G--YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           G  Y     E+ LV +Y+  G LR+ L +  +  L   + L       +G+ YL  G++ 
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL--GSRR 131
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP-TLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            + HRD+   NIL++ +   K++DFGL+K  P   D   V    +    +  PE      
Sbjct: 132 CV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 713 LTEKSDVYSFGVVLFEIL 730
            + +SDV+SFGVVL+E+ 
Sbjct: 191 FSRQSDVWSFGVVLYELF 208

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 540 LGVGGFGKVYRGEIDGATTKV-AIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG+V++G ID  T KV AIK  +   +E  + + Q EI +LS+    ++    G 
Sbjct: 30  IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             ++ ++ ++ +Y+  G+  + L   +  PL   Q   I     +GL YLH+  K   IH
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK---IH 142
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+LL E    K++DFG++  G   D         G+  ++ PE  ++     K+
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 200
Query: 718 DVYSFGVVLFEILCARP 734
           D++S G+   E+    P
Sbjct: 201 DIWSLGITAIELARGEP 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 100 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 158 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 214
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 215 SILHRIYTHQSDVWSYGVTVWELM 238

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 133/293 (45%), Gaps = 43/293 (14%)
Query: 540 LGVGGFGKVYRGE---IDGATTK--VAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +   ID   T   VA+K     +    H    +E+++L  +  H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 593 SLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE--------IC--IGAA 641
           +L+G C +    ++++ ++  +G L  +L   +   +P+K   +        IC     A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS-- 699
           +G+ +L   A    IHRD+   NILL EK V K+ DFGL++      +     V KG   
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPDYVRKGDAR 207
Query: 700 --FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK 757
               ++ PE    +  T +SDV+SFGV+L+EI     +     P   V + E      K+
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLKE 262
Query: 758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           G   +  D        PE +    +T + C   +  +RP+  +++ +L   LQ
Sbjct: 263 GTRMRAPD-----YTTPEMY----QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 24/234 (10%)
Query: 508 GSYASSLPSNLCRHFSFAEIKAATNN-FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN 566
             Y  S+  N    + + E +  T N F +  +LG GGFG+V   ++       A K+  
Sbjct: 159 ADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE 218
Query: 567 PLSEQ---GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKT 623
               +   G      E ++L K+  R +VSL    E    + LV   M  G L+ H+Y  
Sbjct: 219 KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM 278
Query: 624 QKPPLPWKQRL----EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG 679
            +   P  + +    EIC G    L  LH   +  I++RD+K  NILLD+    ++SD G
Sbjct: 279 GQAGFPEARAVFYAAEICCG----LEDLH---RERIVYRDLKPENILLDDHGHIRISDLG 331
Query: 680 LSKTGPTLDHTHVSTVVK---GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           L+       H      +K   G+ GY+ PE  + ++ T   D ++ G +L+E++
Sbjct: 332 LAV------HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 82  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELM 220

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 81  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 139 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 195
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 196 SILHRIYTHQSDVWSYGVTVWELM 219

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 31/233 (13%)
Query: 531 TNNFDEALLLGVGGFGKVY--RGEIDGATTKVAI-KRGNPLSEQGVHEFQTEIEMLSKLR 587
           ++ +     LG G +G+V   + ++ GA   + I K+ +  +         E+ +L +L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK-----PPLPWKQRLEICIGAAR 642
           H +++ L  + E+     LV +    G L + +   QK       +  KQ L        
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS------- 115
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEK---WVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
           G  YLH   KH I+HRD+K  N+LL+ K    + K+ DFGLS       H  V   +K  
Sbjct: 116 GTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA------HFEVGGKMKER 166
Query: 700 FG---YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAE 749
            G   Y+ PE  R+ +  EK DV+S GV+L+ +LC  P       +E +   E
Sbjct: 167 LGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE 218

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 540 LGVGGFGKVYRGEIDGATTKV-AIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG+V++G ID  T KV AIK  +   +E  + + Q EI +LS+    ++    G 
Sbjct: 15  IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             ++ ++ ++ +Y+  G+  + L   +  PL   Q   I     +GL YLH+  K   IH
Sbjct: 74  YLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK---IH 127
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+LL E    K++DFG++  G   D         G+  ++ PE  ++     K+
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 185
Query: 718 DVYSFGVVLFEILCARP 734
           D++S G+   E+    P
Sbjct: 186 DIWSLGITAIELARGEP 202

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 151
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 152 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 212 GYTKSIDIWSVGCILAEMLSNRP 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 143
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 144 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRP 226

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 143
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 144 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRP 226

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 14/211 (6%)
Query: 528 KAATNNFDEALLLGVGGFGKV--YRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLS 584
           K   N+FD   LLG G FGKV   R +  G    + I R   + ++  V    TE  +L 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--AR 642
             RH  L +L    + +  +  V +Y   G L  HL + +     + +      GA    
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVS 121
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+     +++RD+K  N++LD+    K++DFGL K G +   T       G+  Y
Sbjct: 122 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEY 176
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           L PE           D +  GVV++E++C R
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 143
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRP 226

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 145
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 146 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRP 228

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 78  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELM 216

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 148
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 149 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRP 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 149
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 150 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 210 GYTKSIDIWSVGCILAEMLSNRP 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 140
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 141 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 201 GYTKSIDIWSVGCILAEMLSNRP 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 147
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRP 230

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 78  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELM 216

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ-TEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q   +    EI++L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 147
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 148 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 24/234 (10%)
Query: 508 GSYASSLPSNLCRHFSFAEIKAATNN-FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN 566
             Y  S+  N    + + E +  T N F +  +LG GGFG+V   ++       A K+  
Sbjct: 159 ADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE 218
Query: 567 PLSEQ---GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKT 623
               +   G      E ++L K+  R +VSL    E    + LV   M  G L+ H+Y  
Sbjct: 219 KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM 278
Query: 624 QKPPLPWKQRL----EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG 679
            +   P  + +    EIC G    L  LH   +  I++RD+K  NILLD+    ++SD G
Sbjct: 279 GQAGFPEARAVFYAAEICCG----LEDLH---RERIVYRDLKPENILLDDHGHIRISDLG 331
Query: 680 LSKTGPTLDHTHVSTVVK---GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           L+       H      +K   G+ GY+ PE  + ++ T   D ++ G +L+E++
Sbjct: 332 LAV------HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 14/211 (6%)
Query: 528 KAATNNFDEALLLGVGGFGKV--YRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLS 584
           K   N+FD   LLG G FGKV   R +  G    + I R   + ++  V    TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--AR 642
             RH  L +L    + +  +  V +Y   G L  HL + +     + +      GA    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVS 116
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+     +++RD+K  N++LD+    K++DFGL K G +   T       G+  Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEY 171
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 78  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELM 216

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 163
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 164 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRP 246

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 143
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRP 226

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 143
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRP 226

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 141
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 142 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNRP 224

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 133/293 (45%), Gaps = 43/293 (14%)
Query: 540 LGVGGFGKVYRGE---IDGATTK--VAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +   ID   T   VA+K     +    H    +E+++L  +  H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 593 SLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ------RLEICIG----AA 641
           +L+G C +    ++++ ++  +G L  +L   +   +P+K        LE  I      A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS-- 699
           +G+ +L   A    IHRD+   NILL EK V K+ DFGL++      +     V KG   
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARD----IYKDPDYVRKGDAR 207
Query: 700 --FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK 757
               ++ PE    +  T +SDV+SFGV+L+EI     +     P   V + E      K+
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFXRRLKE 262
Query: 758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           G   +  D        PE +    +T + C   +  +RP+  +++ +L   LQ
Sbjct: 263 GTRMRAPD-----YTTPEMY----QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 540 LGVGGFGKVYRGE---IDGATT--KVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +   ID   T   VA+K     +    H    +E+++L  +  H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 593 SLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE------------IC-- 637
           +L+G C +    ++++ ++  +G L  +L   +   +P+K   E            IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
              A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++      +     V K
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPDXVRK 207
Query: 698 GS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           G       ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 14/211 (6%)
Query: 528 KAATNNFDEALLLGVGGFGKV--YRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLS 584
           K   N+FD   LLG G FGKV   R +  G    + I R   + ++  V    TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--AR 642
             RH  L +L    + +  +  V +Y   G L  HL + +     + +      GA    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVS 116
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+     +++RD+K  N++LD+    K++DFGL K G +   T       G+  Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEY 171
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 147
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 148 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 141
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 142 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNRP 224

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 85  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 143 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 199
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 200 SILHRIYTHQSDVWSYGVTVWELM 223

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 540 LGVGGFGKVYRGEIDGATTKV-AIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG+V++G ID  T KV AIK  +   +E  + + Q EI +LS+    ++    G 
Sbjct: 15  IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 73
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             ++ ++ ++ +Y+  G+  + L   +  PL   Q   I     +GL YLH+  K   IH
Sbjct: 74  YLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK---IH 127
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+LL E    K++DFG++  G   D         G+  ++ PE  ++     K+
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 185
Query: 718 DVYSFGVVLFEILCARP 734
           D++S G+   E+    P
Sbjct: 186 DIWSLGITAIELARGEP 202

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+          +FQ EI++L  L    +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 596 G--YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           G  Y      + LV +Y+  G LR+ L +  +  L   + L       +G+ YL      
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL---GSR 133
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             +HRD+   NIL++ +   K++DFGL+K  P   D+  V    +    +  PE      
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 713 LTEKSDVYSFGVVLFEIL 730
            + +SDV+SFGVVL+E+ 
Sbjct: 194 FSRQSDVWSFGVVLYELF 211

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 14/211 (6%)
Query: 528 KAATNNFDEALLLGVGGFGKV--YRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLS 584
           K   N+FD   LLG G FGKV   R +  G    + I R   + ++  V    TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--AR 642
             RH  L +L    + +  +  V +Y   G L  HL + +     + +      GA    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVS 116
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+     +++RD+K  N++LD+    K++DFGL K G +   T       G+  Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEY 171
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           L PE           D +  GVV++E++C R
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+          +FQ EI++L  L    +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 596 G--YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           G  Y      + LV +Y+  G LR+ L +  +  L   + L       +G+ YL      
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL---GSR 146
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             +HRD+   NIL++ +   K++DFGL+K  P   D+  V    +    +  PE      
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 713 LTEKSDVYSFGVVLFEIL 730
            + +SDV+SFGVVL+E+ 
Sbjct: 207 FSRQSDVWSFGVVLYELF 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 540 LGVGGFGKV----YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V    Y    D     VA+K+          +FQ EI++L  L    +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 596 G--YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           G  Y      + LV +Y+  G LR+ L +  +  L   + L       +G+ YL      
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL---GSR 134
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             +HRD+   NIL++ +   K++DFGL+K  P   D+  V    +    +  PE      
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 713 LTEKSDVYSFGVVLFEIL 730
            + +SDV+SFGVVL+E+ 
Sbjct: 195 FSRQSDVWSFGVVLYELF 212

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 512 SSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ 571
           SS   NL    +FAE       ++   +LG G FG+V + +      + A+K  N  S +
Sbjct: 8   SSGRENLYFQGTFAE------RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 572 G--VHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP 629
                    E+E+L KL H +++ L    E++    +V +    G L + + K ++    
Sbjct: 62  NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH 121
Query: 630 WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV---AKVSDFGLSKTGPT 686
              R  I      G+ Y+H   KH I+HRD+K  NILL+ K      K+ DFGLS     
Sbjct: 122 DAAR--IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             +T +   + G+  Y+ PE   R    EK DV+S GV+L+ +L   P
Sbjct: 177 --NTKMKDRI-GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTP 220

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 540 LGVGGFGK--VYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FGK  + +   DG    +     + +S +   E + E+ +L+ ++H ++V     
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            EEN  + +V DY   G L + +   +       Q L+  +     L ++H      I+H
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILH 148
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT-HVSTVVKGSFGYLDPEYFRRQQLTEK 716
           RD+K+ NI L +    ++ DFG+++    L+ T  ++    G+  YL PE    +    K
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIAR---VLNSTVELARACIGTPYYLSPEICENKPYNNK 205
Query: 717 SDVYSFGVVLFEILCARPAL 736
           SD+++ G VL+E+   + A 
Sbjct: 206 SDIWALGCVLYELCTLKHAF 225

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 540 LGVGGFGKVYRGE---IDGATT--KVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +   ID   T   VA+K     +    H    +E+++L  +  H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 593 SLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE------------IC-- 637
           +L+G C +    ++++ ++  +G L  +L   +   +P+K   E            IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
              A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++              +
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 698 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
               ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEM 582
           +IK    +F+   +LG G FGKV+  E        AIK   +   L +  V     E  +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 583 LS-KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
           LS    H  L  +    +    +  V +Y+  G L  H+    K  L           AA
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAA 126
Query: 642 R---GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
               GL +LH+     I++RD+K  NILLD+    K++DFG+ K     D    +    G
Sbjct: 127 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCG 181
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           +  Y+ PE    Q+     D +SFGV+L+E+L  +
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 69  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELM 207

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 131/295 (44%), Gaps = 35/295 (11%)
Query: 533 NFDEALLL---GVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKL 586
           NFD   +L   G G FGKV   + +      A+K  N    +    V     E++++  L
Sbjct: 13  NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ---RLEICIGAARG 643
            H  LV+L    ++  +M +V D +  G LR HL +     + +K+   +L IC      
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN----VHFKEETVKLFIC-ELVMA 127
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           L YL       IIHRD+K  NILLDE     ++DF ++   P    T ++T+  G+  Y+
Sbjct: 128 LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITTMA-GTKPYM 181
Query: 704 DPEYFRRQQLTEKS---DVYSFGVVLFEILCARPALN---PTLPKEQVSLAEWAAHCHKK 757
            PE F  ++    S   D +S GV  +E+L  R   +    T  KE V   E     +  
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241
Query: 758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSD-QGIERPSMGDVLWNLEFALQL 811
               Q M   LK  + P   ++F++     +SD Q    P M D+ W+  F  +L
Sbjct: 242 A-WSQEMVSLLKKLLEPNPDQRFSQ-----LSDVQNF--PYMNDINWDAVFQKRL 288

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 540 LGVGGFGKVYRGE---IDGATT--KVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +   ID   T   VA+K     +    H    +E+++L  +  H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 593 SLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE------------IC-- 637
           +L+G C +    ++++ ++  +G L  +L   +   +P+K   E            IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
              A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++      +     V K
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPDYVRK 207
Query: 698 GS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           G       ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L   RH +++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 145
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 146 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRP 228

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 540 LGVGGFGKVYRGE---IDGATT--KVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +   ID   T   VA+K     +    H    +E+++L  +  H ++V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 593 SLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE------------IC-- 637
           +L+G C +    ++++ ++  +G L  +L   +   +P+K   E            IC  
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
              A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++      +     V K
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPDYVRK 244
Query: 698 GS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           G       ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 281

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL---EICI---GAARGLHYLHTGAK 652
                  +   Y+    +   LYK  K      Q L    IC       RGL Y+H+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKC-----QHLSNDHICYFLYQILRGLKYIHSA-- 147
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
             ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     
Sbjct: 148 -NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 712 Q-LTEKSDVYSFGVVLFEILCARP 734
           +  T+  D++S G +L E+L  RP
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAI++ +P   Q        EI++L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 147
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 36/288 (12%)
Query: 540 LGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G +G+V   R ++      + I R   +S     +   E+ +L  L H +++ L  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQK-----PPLPWKQRLEICIGAARGLHYLHTGAK 652
            E+     LV +    G L + +    K       +  KQ L        G+ YLH   K
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS-------GVTYLH---K 154
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
           H I+HRD+K  N+LL+ K    + K+ DFGLS      ++        G+  Y+ PE  R
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKERLGTAYYIAPEVLR 211
Query: 710 RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK-----------KG 758
           + +  EK DV+S GV+LF +L   P       +E +   E   +              K 
Sbjct: 212 K-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270
Query: 759 ILEQIMDPYLKGKI-APECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
           +++Q++    + +I A +  +      M    + GIE PS+ + + N+
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENM 318

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 540 LGVGGFGKVYRGE---IDGATT--KVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +   ID   T   VA+K     +    H    +E+++L  +  H ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 593 SLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE------------IC-- 637
           +L+G C +    ++++ ++  +G L  +L   +   +P+K   E            IC  
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
              A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++              +
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 698 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
               ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 540 LGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK     +   V E F  E   + +  H H+V LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN  + ++ +    G LR  L + +K  L     +      +  L YL +      
Sbjct: 78  GVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLES---KRF 132
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-----YLDPEYFRR 710
           +HRD+   N+L+      K+ DFGLS+      +   ST  K S G     ++ PE    
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTXXKASKGKLPIKWMAPESINF 186
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SDV+ FGV ++EIL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 540 LGVGGFGKVYRGE---IDGATT--KVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +   ID   T   VA+K     +    H    +E+++L  +  H ++V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 593 SLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ---------RLE--IC--I 638
           +L+G C +    ++++ ++  +G L  +L   +   +P+K           LE  IC   
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
             A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++              + 
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
              ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL-EIC 637
           E+++L +    ++V   G    + E+ +  ++M  G+L + L K  + P   +Q L ++ 
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVS 129
Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
           I   +GL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D    S V  
Sbjct: 130 IAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV-- 183
Query: 698 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           G+  Y+ PE  +    + +SD++S G+ L E+   R
Sbjct: 184 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 540 LGVGGFGKVYRGE---IDGATT--KVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +   ID   T   VA+K     +    H    +E+++L  +  H ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 593 SLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE------------IC-- 637
           +L+G C +    ++++ ++  +G L  +L   +   +P+K   E            IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
              A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++      +     V K
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPDYVRK 198
Query: 698 GS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           G       ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A G++Y
Sbjct: 72  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAEGMNY 129
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 130 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 186
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 187 SILHRIYTHQSDVWSYGVTVWELM 210

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 540 LGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK     +   V E F  E   + +  H H+V LI
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN  + ++ +    G LR  L + +K  L     +      +  L YL +      
Sbjct: 106 GVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---KRF 160
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-----YLDPEYFRR 710
           +HRD+   N+L+      K+ DFGLS+      +   ST  K S G     ++ PE    
Sbjct: 161 VHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINF 214
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SDV+ FGV ++EIL
Sbjct: 215 RRFTSASDVWMFGVCMWEIL 234

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L   RH +++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 145
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +
Sbjct: 146 NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRP 228

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FGKV      G     A   VA+K   P +     E   +E+++LS L  H ++V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG------------- 639
           +L+G C      +++ +Y  YG L   L + +   +  K    I                
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 640 ---AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               A+G+ +L   A    IHRD+   NILL    + K+ DFGL++      +  V    
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP 741
           +    ++ PE       T +SDV+S+G+ L+E+     +  P +P
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 540 LGVGGFGKVYRGE---IDGATT--KVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +   ID   T   VA+K     +    H    +E+++L  +  H ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 593 SLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE------------IC-- 637
           +L+G C +    ++++ ++  +G L  +L   +   +P+K   E            IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
              A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++              +
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 698 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
               ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 540 LGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK     +   V E F  E   + +  H H+V LI
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN  + ++ +    G LR  L + +K  L     +      +  L YL +      
Sbjct: 83  GVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---KRF 137
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-----YLDPEYFRR 710
           +HRD+   N+L+      K+ DFGLS+      +   ST  K S G     ++ PE    
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SDV+ FGV ++EIL
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 540 LGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK     +   V E F  E   + +  H H+V LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN  + ++ +    G LR  L + +K  L     +      +  L YL +      
Sbjct: 78  GVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---KRF 132
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-----YLDPEYFRR 710
           +HRD+   N+L+      K+ DFGLS+      +   ST  K S G     ++ PE    
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SDV+ FGV ++EIL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 540 LGVGGFGKVYRGE---IDGATT--KVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +   ID   T   VA+K     +    H    +E+++L  +  H ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 593 SLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE------------IC-- 637
           +L+G C +    ++++ ++  +G L  +L   +   +P+K   E            IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
              A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++      +     V K
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPDYVRK 198
Query: 698 GS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           G       ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKM 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEILCA 732
           E  +R++   E  DV+S G+VL  +L  
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 131/294 (44%), Gaps = 43/294 (14%)
Query: 540 LGVGGFGKVYRGE---IDGATTK--VAIKRGNPLSEQGVHE----FQTEIEMLSKL-RHR 589
           LG G FG+V   +   ID   T   VA+K    L E   H       +E+++L  +  H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKM---LKEGATHSEHRALMSELKILIHIGHHL 93
Query: 590 HLVSLIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQR--------LEICIG- 639
           ++V+L+G C +    ++++ ++  +G L  +L   +   +P+K          LE  I  
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 640 ---AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++              
Sbjct: 154 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK 756
           +    ++ PE    +  T +SDV+SFGV+L+EI     +     P   V + E      K
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLK 265
Query: 757 KGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           +G   +  D        PE +    +T + C   +  +RP+  +++ +L   LQ
Sbjct: 266 EGTRMRAPD-----YTTPEMY----QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKM 61
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEILCA 732
           E  +R++   E  DV+S G+VL  +L  
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FGKV      G     A   VA+K   P +     E   +E+++LS L  H ++V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG------------- 639
           +L+G C      +++ +Y  YG L   L + +   +  K    I                
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 640 ---AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               A+G+ +L   A    IHRD+   NILL    + K+ DFGL++      +  V    
Sbjct: 167 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP 741
           +    ++ PE       T +SDV+S+G+ L+E+     +  P +P
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 268

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 540 LGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK     +   V E F  E   + +  H H+V LI
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN  + ++ +    G LR  L + +K  L     +      +  L YL +      
Sbjct: 80  GVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---KRF 134
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-----YLDPEYFRR 710
           +HRD+   N+L+      K+ DFGLS+      +   ST  K S G     ++ PE    
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINF 188
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SDV+ FGV ++EIL
Sbjct: 189 RRFTSASDVWMFGVCMWEIL 208

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEM 582
           +IK    +F    +LG G FGKV+  E        AIK   +   L +  V     E  +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 583 LS-KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
           LS    H  L  +    +    +  V +Y+  G L  H+    K  L           AA
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAA 125
Query: 642 R---GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
               GL +LH+     I++RD+K  NILLD+    K++DFG+ K     D    +    G
Sbjct: 126 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCG 180
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           +  Y+ PE    Q+     D +SFGV+L+E+L  +
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 540 LGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK     +   V E F  E   + +  H H+V LI
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN  + ++ +    G LR  L + +K  L     +      +  L YL +      
Sbjct: 75  GVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---KRF 129
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-----YLDPEYFRR 710
           +HRD+   N+L+      K+ DFGLS+      +   ST  K S G     ++ PE    
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SDV+ FGV ++EIL
Sbjct: 184 RRFTSASDVWMFGVCMWEIL 203

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIG 596
           LG G FGKV          KVA+K      L +  +H   + EI  L  LRH H++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 ++++V +Y A G L +++ + ++      +R    I  A  + Y H   +H I+
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCH---RHKIV 130
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT-E 715
           HRD+K  N+LLD+    K++DFGLS      +    S    GS  Y  PE    +     
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVINGKLYAGP 187
Query: 716 KSDVYSFGVVLFEILCAR 733
           + DV+S G+VL+ +L  R
Sbjct: 188 EVDVWSCGIVLYVMLVGR 205

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 540 LGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK     +   V E F  E   + +  H H+V LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN  + ++ +    G LR  L + +K  L     +      +  L YL +      
Sbjct: 78  GVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---KRF 132
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-----YLDPEYFRR 710
           +HRD+   N+L+      K+ DFGLS+      +   ST  K S G     ++ PE    
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SDV+ FGV ++EIL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL---EICI---GAARGLHYLHTGAK 652
                  +   Y+    +   LYK  K      Q L    IC       RGL Y+H+   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-- 163
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
             ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     
Sbjct: 164 -NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 712 Q-LTEKSDVYSFGVVLFEILCARP 734
           +  T+  D++S G +L E+L  RP
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 82/155 (52%), Gaps = 8/155 (5%)
Query: 579 EIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
           E+++L +    ++V   G    + E+ +  ++M  G+L + L K  +  +P +   ++ I
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 114
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              +GL YL    KH I+HRDVK +NIL++ +   K+ DFG+S  G  +D      V  G
Sbjct: 115 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDEMANEFV--G 168
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           +  Y+ PE  +    + +SD++S G+ L E+   R
Sbjct: 169 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +L  G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 82  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELM 220

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 15/224 (6%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLV 592
           +D   +LG G F +V   E       VAIK     + +G     + EI +L K++H ++V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
           +L    E    + L+   ++ G L + +   +K     +    +       + YLH    
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLG- 136
Query: 653 HTIIHRDVKTTNIL---LDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+L   LDE     +SDFGLSK     D   V +   G+ GY+ PE   
Sbjct: 137 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLA 191
Query: 710 RQQLTEKSDVYSFGVVLFEILCARPAL---NPTLPKEQVSLAEW 750
           ++  ++  D +S GV+ + +LC  P     N     EQ+  AE+
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY 235

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEM-LSKL 586
           +A  N+ +    +G G  G+V++         +A+K+   +   G  E    I M L  +
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ---MRRSGNKEENKRILMDLDVV 77
Query: 587 RHRH----LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR 642
              H    +V   G    N ++ +  + M  GT  E L K  + P+P +   ++ +   +
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L+YL    KH +IHRDVK +NILLDE+   K+ DFG+S  G  +D         G   Y
Sbjct: 136 ALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS--GRLVD-DKAKDRSAGCAAY 190
Query: 703 LDPEYFRRQQLTE-----KSDVYSFGVVLFEI 729
           + PE       T+     ++DV+S G+ L E+
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 540 LGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK     +   V E F  E   + +  H H+V LI
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN  + ++ +    G LR  L + +K  L     +      +  L YL +      
Sbjct: 81  GVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES---KRF 135
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-----YLDPEYFRR 710
           +HRD+   N+L+      K+ DFGLS+      +   ST  K S G     ++ PE    
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINF 189
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SDV+ FGV ++EIL
Sbjct: 190 RRFTSASDVWMFGVCMWEIL 209

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FGKV      G     A   VA+K   P +     E   +E+++LS L  H ++V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG------------- 639
           +L+G C      +++ +Y  YG L   L + +   +  K    I                
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 640 ---AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               A+G+ +L   A    IHRD+   NILL    + K+ DFGL++      +  V    
Sbjct: 169 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP 741
           +    ++ PE       T +SDV+S+G+ L+E+     +  P +P
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 270

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FGKV      G     A   VA+K   P +     E   +E+++LS L  H ++V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG------------- 639
           +L+G C      +++ +Y  YG L   L + +   +  K    I                
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 640 ---AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               A+G+ +L   A    IHRD+   NILL    + K+ DFGL++      +  V    
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP 741
           +    ++ PE       T +SDV+S+G+ L+E+     +  P +P
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 275

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 147
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT        +  Y  PE     +
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRP 230

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 599 -----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                E+  ++ +V D M     +  L KTQ   L             RGL Y+H+    
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYK--LLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 148
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG-PTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            ++HRD+K +N+LL+     K+ DFGL++   P  DHT        +  Y  PE     +
Sbjct: 149 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 713 -LTEKSDVYSFGVVLFEILCARP 734
             T+  D++S G +L E+L  RP
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRP 231

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFG +K     +  + +   K    ++  E
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 20/228 (8%)
Query: 512 SSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ 571
           SS   NL    +FAE       ++   +LG G FG+V + +      + A+K  N  S +
Sbjct: 8   SSGRENLYFQGTFAE------RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 572 G--VHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP 629
                    E+E+L KL H +++ L    E++    +V +    G L + + K ++    
Sbjct: 62  NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FS 119
Query: 630 WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV---AKVSDFGLSKTGPT 686
                 I      G+ Y+H   KH I+HRD+K  NILL+ K      K+ DFGLS     
Sbjct: 120 EHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ- 175
Query: 687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             +T +   + G+  Y+ PE   R    EK DV+S GV+L+ +L   P
Sbjct: 176 -QNTKMKDRI-GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTP 220

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 540 LGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK     +   V E F  E   + +  H H+V LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN  + ++ +    G LR  L + +K  L     +      +  L YL +      
Sbjct: 78  GVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLES---KRF 132
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-----YLDPEYFRR 710
           +HRD+   N+L+      K+ DFGLS+      +   ST  K S G     ++ PE    
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SDV+ FGV ++EIL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFG +K     +  + +   K    ++  E
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 79  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFG +K     +  + +   K    ++  E
Sbjct: 137 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELM 217

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 26/231 (11%)
Query: 512 SSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ 571
           SS   NL    +FAE       ++   +LG G FG+V + +      + A+K  N  S +
Sbjct: 8   SSGRENLYFQGTFAE------RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 572 G--VHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP 629
                    E+E+L KL H +++ L    E++    +V +    G L + + K ++    
Sbjct: 62  NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FS 119
Query: 630 WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV---AKVSDFGLSKTGPT 686
                 I      G+ Y+H   KH I+HRD+K  NILL+ K      K+ DFGLS     
Sbjct: 120 EHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 687 LDHTHVSTVVKGSFG---YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
                 +T +K   G   Y+ PE   R    EK DV+S GV+L+ +L   P
Sbjct: 177 ------NTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTP 220

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIGY 597
           +LG G F +V   E       VAIK     + +G     + EI +L K++H ++V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            E    + L+   ++ G L + +   +K     +    +       + YLH      I+H
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLG---IVH 139
Query: 658 RDVKTTNIL---LDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           RD+K  N+L   LDE     +SDFGLSK     D   V +   G+ GY+ PE   ++  +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 715 EKSDVYSFGVVLFEILCARPAL---NPTLPKEQVSLAEW 750
           +  D +S GV+ + +LC  P     N     EQ+  AE+
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY 235

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKL-RHRHLV 592
           LG G FGKV      G     A   VA+K   P +     E   +E+++LS L  H ++V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG------------- 639
           +L+G C      +++ +Y  YG L   L + +   +  K    I                
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 640 ---AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               A+G+ +L   A    IHRD+   NILL    + K+ DFGL++      +  V    
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP 741
           +    ++ PE       T +SDV+S+G+ L+E+     +  P +P
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 275

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +L  G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 82  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELM 220

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIGY 597
           +LG G F +V   E       VAIK     + +G     + EI +L K++H ++V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            E    + L+   ++ G L + +   +K     +    +       + YLH      I+H
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLG---IVH 139
Query: 658 RDVKTTNIL---LDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           RD+K  N+L   LDE     +SDFGLSK     D   V +   G+ GY+ PE   ++  +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 715 EKSDVYSFGVVLFEILCARPAL---NPTLPKEQVSLAEW 750
           +  D +S GV+ + +LC  P     N     EQ+  AE+
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY 235

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 540 LGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK     +   V E F  E   + +  H H+V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN  + ++ +    G LR  L + +K  L     +      +  L YL +      
Sbjct: 458 GVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLES---KRF 512
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-----YLDPEYFRR 710
           +HRD+   N+L+      K+ DFGLS+      +   ST  K S G     ++ PE    
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SDV+ FGV ++EIL
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEILCA 732
           E  +R++   E  DV+S G+VL  +L  
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 82  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFG +K     +  + +   K    ++  E
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELM 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 17/217 (7%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
           +    +F+  ++LG G FGKV   +  G     AIK   +   + +  V     E  +L+
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLA 74
Query: 585 KLRHRHLVSLIGYCEENCE-MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARG 643
            L     ++ +  C +  + +  V +Y+  G L  H+ +  K   P  Q +      + G
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP--QAVFYAAEISIG 132
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK---GSF 700
           L +LH   K  II+RD+K  N++LD +   K++DFG+ K     +H       +   G+ 
Sbjct: 133 LFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMMDGVTTREFCGTP 184
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
            Y+ PE    Q   +  D +++GV+L+E+L  +P  +
Sbjct: 185 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 17/215 (7%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVH-EFQTEIEMLSKLR 587
           AT+ ++    +GVG +G VY+     +   VA+K    P  E+G+      E+ +L +L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 588 ---HRHLVSLIGYC-----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG 639
              H ++V L+  C     +   ++ LV++++    LR +L K   P LP +   ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
             RGL +LH    + I+HRD+K  NIL+      K++DFGL++      +      V  +
Sbjct: 121 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALAPVVVT 174
Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             Y  PE   +       D++S G +  E+   +P
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFG +K     +  + +   K    ++  E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFG +K     +  + +   K    ++  E
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEILCA 732
           E  +R++   E  DV+S G+VL  +L  
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKL 586
             F +  +L  G FG VY+G    E +     VAIK      S +   E   E  +++ +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRHLVSLIGY 597
           +LG G F +V   E       VAIK     + +G     + EI +L K++H ++V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            E    + L+   ++ G L + +   +K     +    +       + YLH      I+H
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLG---IVH 139
Query: 658 RDVKTTNIL---LDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           RD+K  N+L   LDE     +SDFGLSK     D   V +   G+ GY+ PE   ++  +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 715 EKSDVYSFGVVLFEILCARPAL---NPTLPKEQVSLAEW 750
           +  D +S GV+ + +LC  P     N     EQ+  AE+
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY 235

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKM 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEILCA 732
           E  +R++   E  DV+S G+VL  +L  
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 522 FSFAEIKAATNNFDEALL------LGVGGFGKVYRG----EIDGATTKVAIKRGNPLSEQ 571
            +  EI+      D  LL      LG G FG V +G    +    T  V I +       
Sbjct: 1   MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 572 GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWK 631
              E   E  ++ +L + ++V +IG CE    M LV +    G L ++L   Q   +  K
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDK 117
Query: 632 QRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH 691
             +E+    + G+ YL    +   +HRD+   N+LL  +  AK+SDFGLSK     D  +
Sbjct: 118 NIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENY 173
Query: 692 VSTVVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFE 728
                 G +   +  PE     + + KSDV+SFGV+++E
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 17/215 (7%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVH-EFQTEIEMLSKLR 587
           AT+ ++    +GVG +G VY+     +   VA+K    P  E+G+      E+ +L +L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 588 ---HRHLVSLIGYC-----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG 639
              H ++V L+  C     +   ++ LV++++    LR +L K   P LP +   ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
             RGL +LH    + I+HRD+K  NIL+      K++DFGL++      +      V  +
Sbjct: 121 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALDPVVVT 174
Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             Y  PE   +       D++S G +  E+   +P
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 540 LGVGGFGKVYRG---EIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK     +   V E F  E   + +  H H+V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN  + ++ +    G LR  L + +K  L     +      +  L YL +      
Sbjct: 458 GVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLES---KRF 512
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG-----YLDPEYFRR 710
           +HRD+   N+L+      K+ DFGLS+      +   ST  K S G     ++ PE    
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
           ++ T  SDV+ FGV ++EIL
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 540 LGVGGFGKVYRGEIDGATTKV-AIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG+V++G ID  T +V AIK  +   +E  + + Q EI +LS+    ++    G 
Sbjct: 31  IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGS 89
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +  ++ ++ +Y+  G+  + L   +  P    Q   +     +GL YLH+  K   IH
Sbjct: 90  YLKGSKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLHSEKK---IH 143
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+LL E+   K++DFG++  G   D         G+  ++ PE  ++     K+
Sbjct: 144 RDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 201
Query: 718 DVYSFGVVLFEILCARP 734
           D++S G+   E+    P
Sbjct: 202 DIWSLGITAIELAKGEP 218

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 526 EIKAATNNFDEALL------LGVGGFGKVYRG----EIDGATTKVAIKRGNPLSEQGVHE 575
           EI+      D  LL      LG G FG V +G    +    T  V I +          E
Sbjct: 15  EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 74
Query: 576 FQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE 635
              E  ++ +L + ++V +IG CE    M LV +    G L ++L   Q   +  K  +E
Sbjct: 75  LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIE 131
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
           +    + G+ YL    +   +HRD+   N+LL  +  AK+SDFGLSK     D  +    
Sbjct: 132 LVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQ 187
Query: 696 VKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFE 728
             G +   +  PE     + + KSDV+SFGV+++E
Sbjct: 188 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 526 EIKAATNNFDEALL------LGVGGFGKVYRG----EIDGATTKVAIKRGNPLSEQGVHE 575
           EI+      D  LL      LG G FG V +G    +    T  V I +          E
Sbjct: 15  EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 74
Query: 576 FQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE 635
              E  ++ +L + ++V +IG CE    M LV +    G L ++L   Q   +  K  +E
Sbjct: 75  LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIE 131
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
           +    + G+ YL    +   +HRD+   N+LL  +  AK+SDFGLSK     D  +    
Sbjct: 132 LVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQ 187
Query: 696 VKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFE 728
             G +   +  PE     + + KSDV+SFGV+++E
Sbjct: 188 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 115/253 (45%), Gaps = 31/253 (12%)
Query: 539 LLGVGGFGKVYRGEIDGATTK-----VAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            LG GGF K Y  EI    TK       + +   L      +  TEI +   L + H+V 
Sbjct: 49  FLGKGGFAKCY--EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQK----PPLPWKQRLEICIGAARGLHYLHT 649
             G+ E++  + +V +     +L E L+K +K    P   +  R  I     +G+ YLH 
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLHN 160
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              + +IHRD+K  N+ L++    K+ DFGL+ T    D     T+  G+  Y+ PE   
Sbjct: 161 ---NRVIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKTLC-GTPNYIAPEVLC 215
Query: 710 RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE---QVSLAEWAAHCHKKGILEQIM-- 764
           ++  + + D++S G +L+ +L  +P    +  KE   ++   E++   H   +   ++  
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRR 275
Query: 765 ----DPYLKGKIA 773
               DP L+  +A
Sbjct: 276 MLHADPTLRPSVA 288

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI + + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINAM 61
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 526 EIKAATNNFDEALL------LGVGGFGKVYRG----EIDGATTKVAIKRGNPLSEQGVHE 575
           EI+      D  LL      LG G FG V +G    +    T  V I +          E
Sbjct: 13  EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 72
Query: 576 FQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE 635
              E  ++ +L + ++V +IG CE    M LV +    G L ++L   Q   +  K  +E
Sbjct: 73  LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIE 129
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
           +    + G+ YL        +HRD+   N+LL  +  AK+SDFGLSK     D  +    
Sbjct: 130 LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQ 185
Query: 696 VKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFE 728
             G +   +  PE     + + KSDV+SFGV+++E
Sbjct: 186 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 220

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRG----EIDGATTKVAI-KRGNPLSEQGVHEFQTEIEMLSKL 586
             F +  +LG G FG VY+G    E +     VAI +     S +   E   E  +++ +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            + H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++Y
Sbjct: 109 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNY 166
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
           L       ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E
Sbjct: 167 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 707 YFRRQQLTEKSDVYSFGVVLFEIL 730
               +  T +SDV+S+GV ++E++
Sbjct: 224 SILHRIYTHQSDVWSYGVTVWELM 247

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 526 EIKAATNNFDEALL------LGVGGFGKVYRG----EIDGATTKVAIKRGNPLSEQGVHE 575
           EI+      D  LL      LG G FG V +G    +    T  V I +          E
Sbjct: 357 EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 416
Query: 576 FQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE 635
              E  ++ +L + ++V +IG CE    M LV +    G L ++L   Q   +  K  +E
Sbjct: 417 LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIE 473
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVST 694
           +    + G+ YL    +   +HRD+   N+LL  +  AK+SDFGLSK      ++    T
Sbjct: 474 LVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530
Query: 695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 728
             K    +  PE     + + KSDV+SFGV+++E
Sbjct: 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 564

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 526 EIKAATNNFDEALL------LGVGGFGKVYRG----EIDGATTKVAIKRGNPLSEQGVHE 575
           EI+      D  LL      LG G FG V +G    +    T  V I +          E
Sbjct: 358 EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 417
Query: 576 FQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE 635
              E  ++ +L + ++V +IG CE    M LV +    G L ++L   Q   +  K  +E
Sbjct: 418 LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIE 474
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
           +    + G+ YL    +   +HRD+   N+LL  +  AK+SDFGLSK     D  +    
Sbjct: 475 LVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ 530
Query: 696 VKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFE 728
             G +   +  PE     + + KSDV+SFGV+++E
Sbjct: 531 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 565

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKV-AIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG+VY+G ID  T +V AIK  +   +E  + + Q EI +LS+    ++    G 
Sbjct: 27  IGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKP-PLPWKQRLEICIGAARGLHYLHTGAKHTII 656
             ++ ++ ++ +Y+  G+  + L    KP PL       I     +GL YLH+  K   I
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK---I 138
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+K  N+LL E+   K++DFG++  G   D         G+  ++ PE  ++     K
Sbjct: 139 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFK 196
Query: 717 SDVYSFGVVLFEILCARP 734
           +D++S G+   E+    P
Sbjct: 197 ADIWSLGITAIELAKGEP 214

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 17/215 (7%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVH-EFQTEIEMLSKLR 587
           AT+ ++    +GVG +G VY+     +   VA+K    P  E+G+      E+ +L +L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 588 ---HRHLVSLIGYC-----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG 639
              H ++V L+  C     +   ++ LV++++    LR +L K   P LP +   ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
             RGL +LH    + I+HRD+K  NIL+      K++DFGL++      +      V  +
Sbjct: 121 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALFPVVVT 174
Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             Y  PE   +       D++S G +  E+   +P
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHE--FQTEIEMLSKLRHRHLVSLIGY 597
           LG G F +V   E + AT K+   +  P       E   + EI +L K++H ++V+L   
Sbjct: 30  LGTGAFSEVVLAE-EKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDI 88
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            E    + LV   ++ G L + +   +K     K    +       ++YLH   +  I+H
Sbjct: 89  YESPNHLYLVMQLVSGGELFDRI--VEKGFYTEKDASTLIRQVLDAVYYLH---RMGIVH 143
Query: 658 RDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           RD+K  N+L    DE+    +SDFGLSK     D   V +   G+ GY+ PE   ++  +
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPGYVAPEVLAQKPYS 200
Query: 715 EKSDVYSFGVVLFEILCARPAL---NPTLPKEQVSLAEW 750
           +  D +S GV+ + +LC  P     N +   EQ+  AE+
Sbjct: 201 KAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEY 239

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 59
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 117
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 118 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAML 200

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 92/187 (49%), Gaps = 22/187 (11%)
Query: 559 KVAIKRGNPLSEQGVHE-FQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVYDYMAYGTL 616
           +V  +R +P   + V E  + E  +L ++  H H+++LI   E +  M LV+D M  G L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVS 676
            ++L  T+K  L  K+   I       + +LH      I+HRD+K  NILLD+    ++S
Sbjct: 188 FDYL--TEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242
Query: 677 DFGLS---KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ------LTEKSDVYSFGVVLF 727
           DFG S   + G  L        + G+ GYL PE  +           ++ D+++ GV+LF
Sbjct: 243 DFGFSCHLEPGEKLRE------LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
Query: 728 EILCARP 734
            +L   P
Sbjct: 297 TLLAGSP 303

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 119
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G +G+V        E   A   V +KR     E      + EI +   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 540 LGVGGFGKVYRG----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V +G    +    T  V I +          E   E  ++ +L + ++V +I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G CE    M LV +    G L ++L   Q   +  K  +E+    + G+ YL    +   
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 132
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF--GYLDPEYFRRQQL 713
           +HRD+   N+LL  +  AK+SDFGLSK     D  +      G +   +  PE     + 
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYKF 191
Query: 714 TEKSDVYSFGVVLFE 728
           + KSDV+SFGV+++E
Sbjct: 192 SSKSDVWSFGVLMWE 206

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--------RG-----NPLSEQGVHEFQTEIEMLSKL 586
           LG G +G+V   +     ++ AIK        +G     N   E+   E   EI +L  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            H +++ L    E+     LV ++   G L E +    K          I      G+ Y
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICY 161
Query: 647 LHTGAKHTIIHRDVKTTNILLDEK---WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           LH   KH I+HRD+K  NILL+ K      K+ DFGLS +  + D+     +  G+  Y+
Sbjct: 162 LH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLS-SFFSKDYKLRDRL--GTAYYI 215
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE  ++ +  EK DV+S GV+++ +LC  P
Sbjct: 216 APEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 11/194 (5%)
Query: 540 LGVGGFGKVYRG----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V +G    +    T  V I +          E   E  ++ +L + ++V +I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G CE    M LV +    G L ++L   Q   +  K  +E+    + G+ YL    +   
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 132
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH-VSTVVKGSFGYLDPEYFRRQQLT 714
           +HRD+   N+LL  +  AK+SDFGLSK     ++ +   T  K    +  PE     + +
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 715 EKSDVYSFGVVLFE 728
            KSDV+SFGV+++E
Sbjct: 193 SKSDVWSFGVLMWE 206

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 540 LGVGGFGKVYRG----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V +G    +    T  V I +          E   E  ++ +L + ++V +I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G CE    M LV +    G L ++L   Q   +  K  +E+    + G+ YL    +   
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 126
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF--GYLDPEYFRRQQL 713
           +HRD+   N+LL  +  AK+SDFGLSK     D  +      G +   +  PE     + 
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYKF 185
Query: 714 TEKSDVYSFGVVLFE 728
           + KSDV+SFGV+++E
Sbjct: 186 SSKSDVWSFGVLMWE 200

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 540 LGVGGFGKVYRG----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V +G    +    T  V I +          E   E  ++ +L + ++V +I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G CE    M LV +    G L ++L   Q   +  K  +E+    + G+ YL    +   
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 128
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF--GYLDPEYFRRQQL 713
           +HRD+   N+LL  +  AK+SDFGLSK     D  +      G +   +  PE     + 
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 714 TEKSDVYSFGVVLFE 728
           + KSDV+SFGV+++E
Sbjct: 188 SSKSDVWSFGVLMWE 202

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRG---NPLSEQGVHEFQTEIEMLSKLRHR 589
           NF     +G G F +VYR         VA+K+    + +  +   +   EI++L +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHL--YKTQKPPLP----WKQRLEICIGAARG 643
           +++       E+ E+ +V +    G L   +  +K QK  +P    WK  +++C      
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC----SA 148
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKGSF 700
           L ++H+     ++HRD+K  N+ +    V K+ D GL +   +  T  H+ V     G+ 
Sbjct: 149 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-----GTP 200
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEI 729
            Y+ PE         KSD++S G +L+E+
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FGKVY+ +        A K     SE+ + ++  EIE+L+   H ++V L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
            + ++ ++ ++   G +   + +  +  L   Q   +C      L++LH+     IIHRD
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHS---KRIIHRD 134
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE---- 715
           +K  N+L+  +   +++DFG+S           S +  G+  ++ PE    + + +    
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMKDTPYD 192
Query: 716 -KSDVYSFGVVLFEILCARP---ALNP 738
            K+D++S G+ L E+    P    LNP
Sbjct: 193 YKADIWSLGITLIEMAQIEPPHHELNP 219

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 532 NNFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-R 587
            +FD   ++G G + KV    +   D       +K+     ++ +   QTE  +  +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H  LV L    +    +  V +Y+  G L  H+ + +K P    +     I  A  L+YL
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYL 169
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H   +  II+RD+K  N+LLD +   K++D+G+ K G  L     ++   G+  Y+ PE 
Sbjct: 170 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEI 224
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCAR 733
            R +      D ++ GV++FE++  R
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 532 NNFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-R 587
            +FD   ++G G + KV    +   D       +K+     ++ +   QTE  +  +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H  LV L    +    +  V +Y+  G L  H+ + +K P    +     I  A  L+YL
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYL 126
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H   +  II+RD+K  N+LLD +   K++D+G+ K G  L     ++   G+  Y+ PE 
Sbjct: 127 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXFCGTPNYIAPEI 181
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCAR 733
            R +      D ++ GV++FE++  R
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 113/250 (45%), Gaps = 22/250 (8%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEI----DGATTKVAIKRGNPLSEQGVHEFQTEIEML 583
           +   +NF+   +LG G FGKV    +    D    KV +K+   L +  V    TE  +L
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV-LKKDVILQDDDVECTMTEKRIL 77
Query: 584 SKLRHRHLVSLIGYCEENCE-MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR 642
           S  R+   ++ +  C +  + +  V +++  G L  H+ K+++      +     I +A 
Sbjct: 78  SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA- 136
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L +LH      II+RD+K  N+LLD +   K++DFG+ K G  + +   +    G+  Y
Sbjct: 137 -LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG--ICNGVTTATFCGTPDY 190
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCARPA--------LNPTLPKEQVSLAEWAAHC 754
           + PE  +        D ++ GV+L+E+LC            L   +  ++V    W  H 
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW-LHE 249
Query: 755 HKKGILEQIM 764
              GIL+  M
Sbjct: 250 DATGILKSFM 259

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 12/213 (5%)
Query: 540 LGVGGFGKV--YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G +G+    R + DG            ++E       +E+ +L +L+H ++V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 598 C--EENCEMILVYDYMAYGTLREHLYK--TQKPPLPWKQRLEICIGAARGLHYLH--TGA 651
                N  + +V +Y   G L   + K   ++  L  +  L +       L   H  +  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH-THVSTVVKGSFGYLDPEYFRR 710
            HT++HRD+K  N+ LD K   K+ DFGL++    L+H T  +    G+  Y+ PE   R
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNHDTSFAKAFVGTPYYMSPEQMNR 190
Query: 711 QQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
               EKSD++S G +L+E+    P       KE
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FGKVY+ +        A K     SE+ + ++  EIE+L+   H ++V L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
            + ++ ++ ++   G +   + +  +  L   Q   +C      L++LH+     IIHRD
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHS---KRIIHRD 142
Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE---- 715
           +K  N+L+  +   +++DFG+S           S +  G+  ++ PE    + + +    
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMKDTPYD 200
Query: 716 -KSDVYSFGVVLFEILCARP---ALNP 738
            K+D++S G+ L E+    P    LNP
Sbjct: 201 YKADIWSLGITLIEMAQIEPPHHELNP 227

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 12/213 (5%)
Query: 540 LGVGGFGKV--YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G +G+    R + DG            ++E       +E+ +L +L+H ++V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 598 C--EENCEMILVYDYMAYGTLREHLYK--TQKPPLPWKQRLEICIGAARGLHYLH--TGA 651
                N  + +V +Y   G L   + K   ++  L  +  L +       L   H  +  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH-THVSTVVKGSFGYLDPEYFRR 710
            HT++HRD+K  N+ LD K   K+ DFGL++    L+H T  +    G+  Y+ PE   R
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 711 QQLTEKSDVYSFGVVLFEILCARPALNPTLPKE 743
               EKSD++S G +L+E+    P       KE
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G  G VY   +D AT  +VAI++ N   +        EI ++ + ++ ++V+ +   
Sbjct: 28  IGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
               E+ +V +Y+A G+L + + +T    +   Q   +C    + L +LH+   + +IHR
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHR 140
Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           D+K+ NILL      K++DFG      T + +  ST+V G+  ++ PE   R+    K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 719 VYSFGVVLFEILCARP 734
           ++S G++  E++   P
Sbjct: 199 IWSLGIMAIEMIEGEP 214

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 532 NNFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-R 587
            +FD   ++G G + KV    +   D       +K+     ++ +   QTE  +  +   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H  LV L    +    +  V +Y+  G L  H+ + +K P    +     I  A  L+YL
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYL 122
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H   +  II+RD+K  N+LLD +   K++D+G+ K G  L     ++   G+  Y+ PE 
Sbjct: 123 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXFCGTPNYIAPEI 177
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCAR 733
            R +      D ++ GV++FE++  R
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           LG G FG V+  E   +  +  IK  N   S+  + + + EIE+L  L H +++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQK--PPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
           E+   M +V +    G L E +   Q     L      E+       L Y H+     ++
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVV 146
Query: 657 HRDVKTTNILLDE---KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
           H+D+K  NIL  +       K+ DFGL++   + +H   ST   G+  Y+ PE F+R  +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFKRD-V 202
Query: 714 TEKSDVYSFGVVLFEIL 730
           T K D++S GVV++ +L
Sbjct: 203 TFKCDIWSAGVVMYFLL 219

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR---GNPLSEQGVHEFQT--EIEMLS 584
           AT+ ++    +GVG +G VY+     +   VA+K     N     G     T  E+ +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 585 KLR---HRHLVSLIGYC-----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI 636
           +L    H ++V L+  C     +   ++ LV++++    LR +L K   P LP +   ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDL 125
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
                RGL +LH    + I+HRD+K  NIL+      K++DFGL++      +    T V
Sbjct: 126 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALTPV 179
Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             +  Y  PE   +       D++S G +  E+   +P
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 532 NNFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-R 587
            +FD   ++G G + KV    +   D       +K+     ++ +   QTE  +  +   
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H  LV L    +    +  V +Y+  G L  H+ + +K P    +     I  A  L+YL
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYL 137
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H   +  II+RD+K  N+LLD +   K++D+G+ K G  L     ++   G+  Y+ PE 
Sbjct: 138 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXFCGTPNYIAPEI 192
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCAR 733
            R +      D ++ GV++FE++  R
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 12/225 (5%)
Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT-EIEMLSKLR 587
           ++++ F +   LG G +  VY+G        VA+K     SE+G       EI ++ +L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEIC----IGAARG 643
           H ++V L        ++ LV+++M    L++++        P    L +         +G
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           L + H   ++ I+HRD+K  N+L++++   K+ DFGL++      +T  S VV  +  Y 
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYR 175
Query: 704 DPEYFRRQQLTEKS-DVYSFGVVLFEILCARPALNPTLPKEQVSL 747
            P+     +    S D++S G +L E++  +P    T  +EQ+ L
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL 220

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 114/253 (45%), Gaps = 31/253 (12%)
Query: 539 LLGVGGFGKVYRGEIDGATTK-----VAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            LG GGF K Y  EI    TK       + +   L      +  TEI +   L + H+V 
Sbjct: 49  FLGKGGFAKCY--EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQK----PPLPWKQRLEICIGAARGLHYLHT 649
             G+ E++  + +V +     +L E L+K +K    P   +  R  I     +G+ YLH 
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLHN 160
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              + +IHRD+K  N+ L++    K+ DFGL+ T    D      +  G+  Y+ PE   
Sbjct: 161 ---NRVIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKXLC-GTPNYIAPEVLC 215
Query: 710 RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE---QVSLAEWAAHCHKKGILEQIM-- 764
           ++  + + D++S G +L+ +L  +P    +  KE   ++   E++   H   +   ++  
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRR 275
Query: 765 ----DPYLKGKIA 773
               DP L+  +A
Sbjct: 276 MLHADPTLRPSVA 288

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 536 EALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           + ++LG G +G VY G       ++AIK       +       EI +   L+H+++V  +
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG-----AARGLHYLHTG 650
           G   EN  + +  + +  G+L   L +++  PL   +  E  IG        GL YLH  
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSA-LLRSKWGPL---KDNEQTIGFYTKQILEGLKYLHD- 140
Query: 651 AKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             + I+HRD+K  N+L++    V K+SDFG SK    ++    +    G+  Y+ PE   
Sbjct: 141 --NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIID 196
Query: 710 R--QQLTEKSDVYSFGVVLFEILCARP 734
           +  +   + +D++S G  + E+   +P
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKP 223

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 536 EALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           + ++LG G +G VY G       ++AIK       +       EI +   L+H+++V  +
Sbjct: 12  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG-----AARGLHYLHTG 650
           G   EN  + +  + +  G+L   L +++  PL   +  E  IG        GL YLH  
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSA-LLRSKWGPL---KDNEQTIGFYTKQILEGLKYLHD- 126
Query: 651 AKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             + I+HRD+K  N+L++    V K+SDFG SK    ++    +    G+  Y+ PE   
Sbjct: 127 --NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIID 182
Query: 710 R--QQLTEKSDVYSFGVVLFEILCARP 734
           +  +   + +D++S G  + E+   +P
Sbjct: 183 KGPRGYGKAADIWSLGCTIIEMATGKP 209

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 114/253 (45%), Gaps = 31/253 (12%)
Query: 539 LLGVGGFGKVYRGEIDGATTK-----VAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            LG GGF K Y  EI    TK       + +   L      +  TEI +   L + H+V 
Sbjct: 49  FLGKGGFAKCY--EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQK----PPLPWKQRLEICIGAARGLHYLHT 649
             G+ E++  + +V +     +L E L+K +K    P   +  R  I     +G+ YLH 
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLHN 160
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              + +IHRD+K  N+ L++    K+ DFGL+ T    D      +  G+  Y+ PE   
Sbjct: 161 ---NRVIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKDLC-GTPNYIAPEVLC 215
Query: 710 RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE---QVSLAEWAAHCHKKGILEQIM-- 764
           ++  + + D++S G +L+ +L  +P    +  KE   ++   E++   H   +   ++  
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRR 275
Query: 765 ----DPYLKGKIA 773
               DP L+  +A
Sbjct: 276 MLHADPTLRPSVA 288

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY-- 597
           +G G +G+V+RG   G +  VA+K  +   EQ     +TEI     LRH +++  I    
Sbjct: 16  VGKGRYGEVWRGLWHGES--VAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDM 72
Query: 598 --CEENCEMILVYDYMAYGTLREHLYK-TQKPPLPWKQRLEICIGAARGLHYLH-----T 649
                + ++ L+  Y  +G+L + L + T +P L     L + + AA GL +LH     T
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLHVEIFGT 128
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGL----SKTGPTLDHTHVSTVVKGSFGYLDP 705
             K  I HRD K+ N+L+       ++D GL    S+    LD  +   V  G+  Y+ P
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV--GTKRYMAP 186
Query: 706 EYFRRQQLTE------KSDVYSFGVVLFEI 729
           E    Q  T+       +D+++FG+VL+EI
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRG-----EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
             ++D    LG G  G+V        E   A   V +KR     E      + EI +   
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L H ++V   G+  E     L  +Y + G L + +      P P  QR    + A  G+ 
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVV 118
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 706 EYFRRQQL-TEKSDVYSFGVVLFEIL 730
           E  +R++   E  DV+S G+VL  +L
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 102/197 (51%), Gaps = 17/197 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR----GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V+R  ++ AT +V + +      PL +  V   + EI ++++L H  L++L 
Sbjct: 59  LGSGAFGVVHRC-VEKATGRVFVAKFINTPYPLDKYTV---KNEISIMNQLHHPKLINLH 114
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
              E+  EM+L+ ++++ G L + +   +   +   + +     A  GL ++H   +H+I
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMH---EHSI 170
Query: 656 IHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
           +H D+K  NI+ + K  +  K+ DFGL+     L+   +  V   +  +  PE   R+ +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 714 TEKSDVYSFGVVLFEIL 730
              +D+++ GV+ + +L
Sbjct: 228 GFYTDMWAIGVLGYVLL 244

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 9/203 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           +++D    LG G FG V+R          A K      E      + EI+ +S LRH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           V+L    E++ EM+++Y++M+ G L E +   +   +   + +E      +GL ++H   
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMH--- 272
Query: 652 KHTIIHRDVKTTNILLDEKWV--AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
           ++  +H D+K  NI+   K     K+ DFGL+     LD      V  G+  +  PE   
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 710 RQQLTEKSDVYSFGVVLFEILCA 732
            + +   +D++S GV+ + +L  
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 30/207 (14%)
Query: 543 GGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE-- 600
           G FG V++ ++      V I    P+ ++   + + E+  L  ++H +++  IG  +   
Sbjct: 35  GRFGCVWKAQLLNEYVAVKI---FPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 601 --NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT-------GA 651
             + ++ L+  +   G+L + L   +   + W +   I    ARGL YLH        G 
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFGYLDPEY- 707
           K  I HRD+K+ N+LL     A ++DFGL+   + G +   TH      G+  Y+ PE  
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV---GTRRYMAPEVL 205
Query: 708 -----FRRQQLTEKSDVYSFGVVLFEI 729
                F+R     + D+Y+ G+VL+E+
Sbjct: 206 EGAINFQRDAFL-RIDMYAMGLVLWEL 231

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 114/253 (45%), Gaps = 31/253 (12%)
Query: 539 LLGVGGFGKVYRGEIDGATTK-----VAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            LG GGF K Y  EI    TK       + +   L      +  TEI +   L + H+V 
Sbjct: 33  FLGKGGFAKCY--EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 90
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQK----PPLPWKQRLEICIGAARGLHYLHT 649
             G+ E++  + +V +     +L E L+K +K    P   +  R  I     +G+ YLH 
Sbjct: 91  FHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLHN 144
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              + +IHRD+K  N+ L++    K+ DFGL+ T    D      +  G+  Y+ PE   
Sbjct: 145 ---NRVIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKDLC-GTPNYIAPEVLC 199
Query: 710 RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE---QVSLAEWAAHCHKKGILEQIM-- 764
           ++  + + D++S G +L+ +L  +P    +  KE   ++   E++   H   +   ++  
Sbjct: 200 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRR 259
Query: 765 ----DPYLKGKIA 773
               DP L+  +A
Sbjct: 260 MLHADPTLRPSVA 272

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 30/223 (13%)
Query: 524 FAEIKAATNNFDEALLLGVGGFGKVYRG---EIDG----ATTKVAIKRGNPLSEQGVHEF 576
           F +I+     F+E+L  G G F K+++G   E+        T+V +K  +         F
Sbjct: 2   FHKIRNEDLIFNESL--GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF 59
Query: 577 QTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP-PLPWKQRLE 635
                M+SKL H+HLV   G C    E ILV +++ +G+L  +L K +    + WK  LE
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LE 117
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILL----DEKW----VAKVSDFGLSKTGPTL 687
           +    A  +H+L    ++T+IH +V   NILL    D K       K+SD G+S T    
Sbjct: 118 VAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 688 DHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEI 729
           D      +++    ++ PE     + L   +D +SFG  L+EI
Sbjct: 175 D------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 9/203 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           +++D    LG G FG V+R          A K      E      + EI+ +S LRH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           V+L    E++ EM+++Y++M+ G L E +   +   +   + +E      +GL ++H   
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMH--- 166
Query: 652 KHTIIHRDVKTTNILLDEKWV--AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
           ++  +H D+K  NI+   K     K+ DFGL+     LD      V  G+  +  PE   
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAE 223
Query: 710 RQQLTEKSDVYSFGVVLFEILCA 732
            + +   +D++S GV+ + +L  
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSG 246

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 13/211 (6%)
Query: 528 KAATNNFDEALLLGVGGFGKV--YRGEIDGATTKVAI-KRGNPLSEQGVHEFQTEIEMLS 584
           +   N F+   LLG G FGKV   + +  G    + I K+   +++  V    TE  +L 
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--AR 642
             RH  L +L    + +  +  V +Y   G L  HL + +     + +      GA    
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVS 259
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+  +  +++RD+K  N++LD+    K++DFGL K G   D   + T   G+  Y
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTFC-GTPEY 315
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           L PE           D +  GVV++E++C R
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 13/211 (6%)
Query: 528 KAATNNFDEALLLGVGGFGKV--YRGEIDGATTKVAI-KRGNPLSEQGVHEFQTEIEMLS 584
           +   N F+   LLG G FGKV   + +  G    + I K+   +++  V    TE  +L 
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--AR 642
             RH  L +L    + +  +  V +Y   G L  HL + +     + +      GA    
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVS 262
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+  +  +++RD+K  N++LD+    K++DFGL K G   D   + T   G+  Y
Sbjct: 263 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTFC-GTPEY 318
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           L PE           D +  GVV++E++C R
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 13/214 (6%)
Query: 525 AEIKAATNNFDEALLLGVGGFGKV--YRGEIDGATTKVAI-KRGNPLSEQGVHEFQTEIE 581
           A  +   N F+   LLG G FGKV   + +  G    + I K+   +++  V    TE  
Sbjct: 2   AMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 61
Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA- 640
           +L   RH  L +L    + +  +  V +Y   G L  HL + +     + +      GA 
Sbjct: 62  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAE 117
Query: 641 -ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
               L YLH+  +  +++RD+K  N++LD+    K++DFGL K G  +          G+
Sbjct: 118 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKXFCGT 173
Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
             YL PE           D +  GVV++E++C R
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 13/211 (6%)
Query: 528 KAATNNFDEALLLGVGGFGKV--YRGEIDGATTKVAI-KRGNPLSEQGVHEFQTEIEMLS 584
           +   N F+   LLG G FGKV   + +  G    + I K+   +++  V    TE  +L 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--AR 642
             RH  L +L    + +  +  V +Y   G L  HL + +     + +      GA    
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVS 121
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+  +  +++RD+K  N++LD+    K++DFGL K G  +          G+  Y
Sbjct: 122 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKXFCGTPEY 177
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           L PE           D +  GVV++E++C R
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 30/223 (13%)
Query: 524 FAEIKAATNNFDEALLLGVGGFGKVYRG---EIDG----ATTKVAIKRGNPLSEQGVHEF 576
           F +I+     F+E+L  G G F K+++G   E+        T+V +K  +         F
Sbjct: 2   FHKIRNEDLIFNESL--GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF 59
Query: 577 QTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP-PLPWKQRLE 635
                M+SKL H+HLV   G C    E ILV +++ +G+L  +L K +    + WK  LE
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LE 117
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILL----DEKW----VAKVSDFGLSKTGPTL 687
           +    A  +H+L    ++T+IH +V   NILL    D K       K+SD G+S T    
Sbjct: 118 VAKQLAWAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 688 DHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEI 729
           D      +++    ++ PE     + L   +D +SFG  L+EI
Sbjct: 175 D------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 530 ATNNFDEALLLGVGGFGKVYRG-EIDGATTKVAIKR--------GNPLSEQGVHEFQTEI 580
           A   ++    +G G +GKV++  ++      VA+KR        G PLS   + E    +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS--TIREVAV-L 65
Query: 581 EMLSKLRHRHLVSLIGYC-----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE 635
             L    H ++V L   C     +   ++ LV++++    L  +L K  +P +P +   +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKD 124
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
           +     RGL +LH+   H ++HRD+K  NIL+      K++DFGL++   +      S V
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVV 180
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           V  +  Y  PE   +       D++S G +  E+   +P
Sbjct: 181 V--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 13/211 (6%)
Query: 528 KAATNNFDEALLLGVGGFGKV--YRGEIDGATTKVAI-KRGNPLSEQGVHEFQTEIEMLS 584
           +   N F+   LLG G FGKV   + +  G    + I K+   +++  V    TE  +L 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA--AR 642
             RH  L +L    + +  +  V +Y   G L  HL + +     + +      GA    
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVS 119
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L YLH+  +  +++RD+K  N++LD+    K++DFGL K G  +          G+  Y
Sbjct: 120 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKXFCGTPEY 175
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           L PE           D +  GVV++E++C R
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G  G VY   +D AT  +VAI++ N   +        EI ++ + ++ ++V+ +   
Sbjct: 28  IGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
               E+ +V +Y+A G+L + + +T    +   Q   +C    + L +LH+   + +IHR
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHR 140
Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           D+K+ NILL      K++DFG      T + +  S +V G+  ++ PE   R+    K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 719 VYSFGVVLFEILCARP 734
           ++S G++  E++   P
Sbjct: 199 IWSLGIMAIEMIEGEP 214

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 530 ATNNFDEALLLGVGGFGKVYRG-EIDGATTKVAIKR--------GNPLSEQGVHEFQTEI 580
           A   ++    +G G +GKV++  ++      VA+KR        G PLS   + E    +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST--IREVAV-L 65
Query: 581 EMLSKLRHRHLVSLIGYC-----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE 635
             L    H ++V L   C     +   ++ LV++++    L  +L K  +P +P +   +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKD 124
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
           +     RGL +LH+   H ++HRD+K  NIL+      K++DFGL++   +      S V
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVV 180
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           V  +  Y  PE   +       D++S G +  E+   +P
Sbjct: 181 V--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G  G VY   +D AT  +VAI++ N   +        EI ++ + ++ ++V+ +   
Sbjct: 28  IGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
               E+ +V +Y+A G+L + + +T    +   Q   +C    + L +LH+   + +IHR
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHR 140
Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           D+K+ NILL      K++DFG      T + +  S +V G+  ++ PE   R+    K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSEMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 719 VYSFGVVLFEILCARP 734
           ++S G++  E++   P
Sbjct: 199 IWSLGIMAIEMIEGEP 214

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G  G VY   +D AT  +VAI++ N   +        EI ++ + ++ ++V+ +   
Sbjct: 29  IGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
               E+ +V +Y+A G+L + + +T    +   Q   +C    + L +LH+   + +IHR
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHR 141
Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           D+K+ NILL      K++DFG      T + +  S +V G+  ++ PE   R+    K D
Sbjct: 142 DIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKVD 199
Query: 719 VYSFGVVLFEILCARP 734
           ++S G++  E++   P
Sbjct: 200 IWSLGIMAIEMIEGEP 215

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G  G VY   +D AT  +VAI++ N   +        EI ++ + ++ ++V+ +   
Sbjct: 29  IGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
               E+ +V +Y+A G+L + + +T    +   Q   +C    + L +LH+   + +IHR
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHR 141
Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           ++K+ NILL      K++DFG      T + +  ST+V G+  ++ PE   R+    K D
Sbjct: 142 NIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 199
Query: 719 VYSFGVVLFEILCARP 734
           ++S G++  E++   P
Sbjct: 200 IWSLGIMAIEMIEGEP 215

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 29/223 (13%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHL 591
           +F+    LG GGFG V+  +        AIKR   P  E    +   E++ L+KL H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 592 VSLI-GYCEENCEMIL------VYDYMAYGTLREHLYK---TQKPPLPWKQR---LEICI 638
           V     + E+N    L      VY Y+     R+   K     +  +  ++R   L I +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK- 697
             A  + +LH+     ++HRD+K +NI      V KV DFGL  T    D    + +   
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV-TAMDQDEEEQTVLTPM 181
Query: 698 ----------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                     G+  Y+ PE       + K D++S G++LFE+L
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH 588
           A ++ F+    LG G    VYR +  G     A+K      ++ +   +TEI +L +L H
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSH 107
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARG 643
            +++ L    E   E+ LV + +  G L + +     Y  +      KQ LE        
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE-------A 160
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDE---KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           + YLH   ++ I+HRD+K  N+L          K++DFGLSK    ++H  +   V G+ 
Sbjct: 161 VAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTP 214
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEILC 731
           GY  PE  R      + D++S G++ + +LC
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLC 245

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 530 ATNNFDEALLLGVGGFGKVYRG-EIDGATTKVAIKR--------GNPLSEQGVHEFQTEI 580
           A   ++    +G G +GKV++  ++      VA+KR        G PLS   + E    +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS--TIREVAV-L 65
Query: 581 EMLSKLRHRHLVSLIGYC-----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE 635
             L    H ++V L   C     +   ++ LV++++    L  +L K  +P +P +   +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKD 124
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
           +     RGL +LH+   H ++HRD+K  NIL+      K++DFGL++   +      S V
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVV 180
Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           V  +  Y  PE   +       D++S G +  E+   +P
Sbjct: 181 V--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 540 LGVGGFGKV--YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G +G+    R + DG            ++E       +E+ +L +L+H ++V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 598 C--EENCEMILVYDYMAYGTLREHLYK--TQKPPLPWKQRLEICIGAARGLHYLH--TGA 651
                N  + +V +Y   G L   + K   ++  L  +  L +       L   H  +  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH-VSTVVKGSFGYLDPEYFRR 710
            HT++HRD+K  N+ LD K   K+ DFGL++    L+H    +    G+  Y+ PE   R
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNHDEDFAKEFVGTPYYMSPEQMNR 190
Query: 711 QQLTEKSDVYSFGVVLFEILCA 732
               EKSD++S G +L+E LCA
Sbjct: 191 MSYNEKSDIWSLGCLLYE-LCA 211

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 539 LLGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           +LG G F +V+  +  + G    +   + +P         + EI +L K++H ++V+L  
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVLKKIKHENIVTLED 73
Query: 597 YCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
             E      LV   ++ G L + +     Y  +   L  +Q L         + YLH   
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS-------AVKYLHENG 126
Query: 652 KHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
              I+HRD+K  N+L    +E     ++DFGLSK    ++   + +   G+ GY+ PE  
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGYVAPEVL 179
Query: 709 RRQQLTEKSDVYSFGVVLFEILCARP 734
            ++  ++  D +S GV+ + +LC  P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYP 205

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 531 TNNFDEALLLGVGGFGKVYR--GEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH 588
           ++N+D    LG G F  V R   +  G      I     LS +   + + E  +  KL+H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARG 643
            ++V L    +E     LV+D +  G L E +     Y         +Q LE        
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------S 140
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           + Y H+     I+HR++K  N+LL  K      K++DFGL+     ++ +       G+ 
Sbjct: 141 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTP 194
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           GYL PE  ++   ++  D+++ GV+L+ +L   P
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 131/280 (46%), Gaps = 32/280 (11%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG+V+RG+  G   +VA+K  +   E+     + EI     LRH +++  I    
Sbjct: 50  IGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 106
Query: 600 EN----CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH-----TG 650
           ++     ++ LV DY  +G+L ++L    +  +  +  +++ +  A GL +LH     T 
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLS----KTGPTLDHTHVSTVVKGSFGYLDPE 706
            K  I HRD+K+ NIL+ +     ++D GL+        T+D      V  G+  Y+ PE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTKRYMAPE 221
Query: 707 YF------RRQQLTEKSDVYSFGVVLFEIL--CARPALNP--TLPKEQVSLAEWAAHCHK 756
                   +  +  +++D+Y+ G+V +EI   C+   ++    LP   +  ++ +    +
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 757 KGILEQIMDPYLKGKI-APECFKKFAETAMKCVSDQGIER 795
           K + EQ + P +  +  + E  +  A+   +C    G  R
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 534 FDEALLLGVGGFGKVYR-GEIDGATT------KVAIKRGNPLSEQGVHEFQTEIEMLSKL 586
           F+   +LG GG+GKV++  ++ GA T      KV  K     + +     + E  +L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTL-----REHLYKTQKPPLPWKQRLEICIGAA 641
           +H  +V LI   +   ++ L+ +Y++ G L     RE ++  +     +   + + +G  
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF-MEDTACFYLAEISMALG-- 135
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
               +LH   +  II+RD+K  NI+L+ +   K++DFGL K   ++    V+    G+  
Sbjct: 136 ----HLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGTIE 186
Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           Y+ PE   R       D +S G +++++L   P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 531 TNNFDEALLLGVGGFGKVYR--GEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH 588
           ++N+D    LG G F  V R   +  G      I     LS +   + + E  +  KL+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARG 643
            ++V L    +E     LV+D +  G L E +     Y         +Q LE        
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------S 117
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           + Y H+     I+HR++K  N+LL  K      K++DFGL+     ++ +       G+ 
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTP 171
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           GYL PE  ++   ++  D+++ GV+L+ +L   P
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 15/196 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAI--KRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F  VY+G     T +VA    +   L++     F+ E E L  L+H ++V     
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 598 CEENCE----MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
            E   +    ++LV +    GTL+ +L + +   +  K     C    +GL +LHT    
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKI--KVLRSWCRQILKGLQFLHTRTP- 150
Query: 654 TIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            IIHRD+K  NI +       K+ D GL+    TL     +  V G+  +  PE +  ++
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPEFXAPEXY-EEK 205
Query: 713 LTEKSDVYSFGVVLFE 728
             E  DVY+FG    E
Sbjct: 206 YDESVDVYAFGXCXLE 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 107/228 (46%), Gaps = 22/228 (9%)
Query: 516 SNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYR-GEIDGATT------KVAIKRGNPL 568
           +NL  H   AE K    NF+   +LG G +GKV+   +I G  T      KV  K     
Sbjct: 42  ANLTGH---AE-KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 97
Query: 569 SEQGVHEFQTEIEMLSKLRHR-HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP 627
             +     +TE ++L  +R    LV+L    +   ++ L+ DY+  G L  HL + ++  
Sbjct: 98  KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT 157
Query: 628 LPWKQRLEICIGA-ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT 686
              +  ++I +G     L +LH   K  II+RD+K  NILLD      ++DFGLSK    
Sbjct: 158 ---EHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FV 210
Query: 687 LDHTHVSTVVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFEILCA 732
            D T  +    G+  Y+ P+  R       +  D +S GV+++E+L  
Sbjct: 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 534 FDEALLLGVGGFGKVYR-GEIDGATT------KVAIKRGNPLSEQGVHEFQTEIEMLSKL 586
           F+   +LG GG+GKV++  ++ GA T      KV  K     + +     + E  +L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTL-----REHLYKTQKPPLPWKQRLEICIGAA 641
           +H  +V LI   +   ++ L+ +Y++ G L     RE ++  +     +   + + +G  
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF-MEDTACFYLAEISMALG-- 135
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK---G 698
               +LH   +  II+RD+K  NI+L+ +   K++DFGL K     +  H  TV     G
Sbjct: 136 ----HLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHDGTVTHXFCG 183
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           +  Y+ PE   R       D +S G +++++L   P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 531 TNNFDEALLLGVGGFGKVYR--GEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH 588
           ++N+D    LG G F  V R   +  G      I     LS +   + + E  +  KL+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARG 643
            ++V L    +E     LV+D +  G L E +     Y         +Q LE        
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------S 117
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           + Y H+     I+HR++K  N+LL  K      K++DFGL+     ++ +       G+ 
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTP 171
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           GYL PE  ++   ++  D+++ GV+L+ +L   P
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 132/278 (47%), Gaps = 28/278 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG+V+RG+  G   +VA+K  +   E+     + EI     LRH +++  I    
Sbjct: 37  IGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 93
Query: 600 EN----CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH-----TG 650
           ++     ++ LV DY  +G+L ++L    +  +  +  +++ +  A GL +LH     T 
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLS-KTGPTLDHTHVSTVVK-GSFGYLDPEYF 708
            K  I HRD+K+ NIL+ +     ++D GL+ +     D   ++   + G+  Y+ PE  
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 210
Query: 709 ------RRQQLTEKSDVYSFGVVLFEIL--CARPALNP--TLPKEQVSLAEWAAHCHKKG 758
                 +  +  +++D+Y+ G+V +EI   C+   ++    LP   +  ++ +    +K 
Sbjct: 211 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 270
Query: 759 ILEQIMDPYLKGKI-APECFKKFAETAMKCVSDQGIER 795
           + EQ + P +  +  + E  +  A+   +C    G  R
Sbjct: 271 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 308

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTK------VAIKRGNPLSEQGVHEFQ----TEIE 581
            N++   +LG  G   V R  I   T K      + +  G   S + V E +     E++
Sbjct: 4   ENYEPKEILG-RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 62
Query: 582 MLSKLR-HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA 640
           +L K+  H +++ L    E N    LV+D M  G L ++L  T+K  L  K+  +I    
Sbjct: 63  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRAL 120
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
              +  LH   K  I+HRD+K  NILLD+    K++DFG S     LD       V G+ 
Sbjct: 121 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTP 174
Query: 701 GYLDPEYFRRQQ------LTEKSDVYSFGVVLFEILCARP 734
            YL PE              ++ D++S GV+++ +L   P
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 214

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 531 TNNFDEALLLGVGGFGKVYR--GEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH 588
           ++N+D    LG G F  V R   +  G      I     LS +   + + E  +  KL+H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARG 643
            ++V L    +E     LV+D +  G L E +     Y         +Q LE        
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------S 116
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           + Y H+     I+HR++K  N+LL  K      K++DFGL+     ++ +       G+ 
Sbjct: 117 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTP 170
Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           GYL PE  ++   ++  D+++ GV+L+ +L   P
Sbjct: 171 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 204

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 44/241 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAI----KRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           L+G G +G VY+G +D     V +     R N ++E+ ++        +  + H ++   
Sbjct: 20  LIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYR-------VPLMEHDNIARF 72
Query: 595 IGYCEE-----NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           I   E        E +LV +Y   G+L ++L         W     +     RGL YLHT
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD---WVSSCRLAHSVTRGLAYLHT 129
Query: 650 GA------KHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTL------DHTHVSTV 695
                   K  I HRD+ + N+L+       +SDFGLS   TG  L      D+  +S V
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 696 VKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEILCARPALNP--TLPKEQVS 746
             G+  Y+ PE           +   ++ D+Y+ G++ +EI      L P  ++P+ Q++
Sbjct: 190 --GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 747 L 747
Sbjct: 248 F 248

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTK------VAIKRGNPLSEQGVHEFQ----TEIE 581
            N++   +LG  G   V R  I   T K      + +  G   S + V E +     E++
Sbjct: 17  ENYEPKEILG-RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 582 MLSKLR-HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA 640
           +L K+  H +++ L    E N    LV+D M  G L ++L  T+K  L  K+  +I    
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRAL 133
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
              +  LH   K  I+HRD+K  NILLD+    K++DFG S     LD       V G+ 
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLRSVCGTP 187
Query: 701 GYLDPEYFRRQQ------LTEKSDVYSFGVVLFEILCARP 734
            YL PE              ++ D++S GV+++ +L   P
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 129 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 183
Query: 710 -RQQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTRR-ALFP 212

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 131/280 (46%), Gaps = 32/280 (11%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG+V+RG+  G   +VA+K  +   E+     + EI     LRH +++  I    
Sbjct: 12  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 68
Query: 600 EN----CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH-----TG 650
           ++     ++ LV DY  +G+L ++L    +  +  +  +++ +  A GL +LH     T 
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLS----KTGPTLDHTHVSTVVKGSFGYLDPE 706
            K  I HRD+K+ NIL+ +     ++D GL+        T+D      V  G+  Y+ PE
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTKRYMAPE 183
Query: 707 YF------RRQQLTEKSDVYSFGVVLFEIL--CARPALNP--TLPKEQVSLAEWAAHCHK 756
                   +  +  +++D+Y+ G+V +EI   C+   ++    LP   +  ++ +    +
Sbjct: 184 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 243
Query: 757 KGILEQIMDPYLKGKI-APECFKKFAETAMKCVSDQGIER 795
           K + EQ + P +  +  + E  +  A+   +C    G  R
Sbjct: 244 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 283

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG+V+RG+  G   +VA+K  +   E+     + EI     LRH +++  I    
Sbjct: 17  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 73
Query: 600 EN----CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH-----TG 650
           ++     ++ LV DY  +G+L ++L    +  +  +  +++ +  A GL +LH     T 
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLS----KTGPTLDHTHVSTVVKGSFGYLDPE 706
            K  I HRD+K+ NIL+ +     ++D GL+        T+D      V  G+  Y+ PE
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTKRYMAPE 188
Query: 707 YF------RRQQLTEKSDVYSFGVVLFEI 729
                   +  +  +++D+Y+ G+V +EI
Sbjct: 189 VLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG+V+RG+  G   +VA+K  +   E+     + EI     LRH +++  I    
Sbjct: 14  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 70
Query: 600 EN----CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH-----TG 650
           ++     ++ LV DY  +G+L ++L    +  +  +  +++ +  A GL +LH     T 
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLS----KTGPTLDHTHVSTVVKGSFGYLDPE 706
            K  I HRD+K+ NIL+ +     ++D GL+        T+D      V  G+  Y+ PE
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTKRYMAPE 185
Query: 707 YF------RRQQLTEKSDVYSFGVVLFEI 729
                   +  +  +++D+Y+ G+V +EI
Sbjct: 186 VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTK------VAIKRGNPLSEQGVHEFQ----TEIE 581
            N++   +LG  G   V R  I   T K      + +  G   S + V E +     E++
Sbjct: 17  ENYEPKEILG-RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 582 MLSKLR-HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA 640
           +L K+  H +++ L    E N    LV+D M  G L ++L  T+K  L  K+  +I    
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRAL 133
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
              +  LH   K  I+HRD+K  NILLD+    K++DFG S     LD       V G+ 
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTP 187
Query: 701 GYLDPEYFRRQQ------LTEKSDVYSFGVVLFEILCARP 734
            YL PE              ++ D++S GV+++ +L   P
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV+++++   L++ +  +    +P            +GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 122 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 207

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG+V+RG+  G   +VA+K  +   E+     + EI     LRH +++  I    
Sbjct: 11  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 67
Query: 600 EN----CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH-----TG 650
           ++     ++ LV DY  +G+L ++L    +  +  +  +++ +  A GL +LH     T 
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLS----KTGPTLDHTHVSTVVKGSFGYLDPE 706
            K  I HRD+K+ NIL+ +     ++D GL+        T+D      V  G+  Y+ PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTKRYMAPE 182
Query: 707 YF------RRQQLTEKSDVYSFGVVLFEI 729
                   +  +  +++D+Y+ G+V +EI
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV+++++   L++ +  +    +P            +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 710 -RQQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRR-ALFP 205

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 35/219 (15%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      QG      E++++ KL H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQGKAFKNRELQIMRKLDHCNIV 76
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG--SFGY 702
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K            +V+G  +  Y
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSY 182
Query: 703 LDPEYFRRQQL-------TEKSDVYSFGVVLFEILCARP 734
           +   Y+R  +L       T   DV+S G VL E+L  +P
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       ++ V G+  Y+ PE 
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPEL 205
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +  ++ SD+++ G ++++++   P
Sbjct: 206 LTEKSASKSSDLWALGCIIYQLVAGLP 232

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH--- 588
           ++F+E  +LG G FG+V +      +   AIK+    +E+ +    +E+ +L+ L H   
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYV 64
Query: 589 ----------RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYK---TQKPPLPWKQRLE 635
                     R+ V  +   ++   + +  +Y   GTL + ++     Q+    W+   +
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK-TGPTLDHTHVS- 693
           I       L Y+H+     IIHRD+K  NI +DE    K+ DFGL+K    +LD   +  
Sbjct: 125 IL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 694 ----------TVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEIL 730
                     T   G+  Y+  E         EK D+YS G++ FE++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 35/219 (15%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      QG      E++++ KL H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQGKAFKNRELQIMRKLDHCNIV 76
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG--SFGY 702
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K            +V+G  +  Y
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSY 182
Query: 703 LDPEYFRRQQL-------TEKSDVYSFGVVLFEILCARP 734
           +   Y+R  +L       T   DV+S G VL E+L  +P
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV+++++   L++ +  +    +P            +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 121 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 175
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 206

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 129 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 183
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 212

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 122 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 207

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV+++++   L++ +  +    +P            +GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 121 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 206

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 208

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 208

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 122 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 207

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 205

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 111/250 (44%), Gaps = 27/250 (10%)
Query: 497 HSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVY--RGEID 554
           H+AG+  +   G +  + P    +H +       ++ +    +LG G FG+V   + +I 
Sbjct: 21  HAAGT--SGGPGDHLHATPGMFVQHST----AIFSDRYKGQRVLGKGSFGEVILCKDKIT 74
Query: 555 GATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY 613
           G    V +     + ++   E    E+++L +L H +++ L  + E+     LV +    
Sbjct: 75  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 134
Query: 614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV- 672
           G L + +   ++       R  I      G+ Y+H   K+ I+HRD+K  N+LL+ K   
Sbjct: 135 GELFDEIISRKRFSEVDAAR--IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKD 189
Query: 673 --AKVSDFGLSKTGPTLDHTHVSTVVKGSFG---YLDPEYFRRQQLTEKSDVYSFGVVLF 727
              ++ DFGLS       H   S  +K   G   Y+ PE        EK DV+S GV+L+
Sbjct: 190 ANIRIIDFGLST------HFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILY 242
Query: 728 EILCARPALN 737
            +L   P  N
Sbjct: 243 ILLSGCPPFN 252

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 124 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 178
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 209

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 122 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 207

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 111/250 (44%), Gaps = 27/250 (10%)
Query: 497 HSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVY--RGEID 554
           H+AG+  +   G +  + P    +H +       ++ +    +LG G FG+V   + +I 
Sbjct: 20  HAAGT--SGGPGDHLHATPGMFVQHST----AIFSDRYKGQRVLGKGSFGEVILCKDKIT 73
Query: 555 GATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY 613
           G    V +     + ++   E    E+++L +L H +++ L  + E+     LV +    
Sbjct: 74  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 133
Query: 614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV- 672
           G L + +   ++       R  I      G+ Y+H   K+ I+HRD+K  N+LL+ K   
Sbjct: 134 GELFDEIISRKRFSEVDAAR--IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKD 188
Query: 673 --AKVSDFGLSKTGPTLDHTHVSTVVKGSFG---YLDPEYFRRQQLTEKSDVYSFGVVLF 727
              ++ DFGLS       H   S  +K   G   Y+ PE        EK DV+S GV+L+
Sbjct: 189 ANIRIIDFGLST------HFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILY 241
Query: 728 EILCARPALN 737
            +L   P  N
Sbjct: 242 ILLSGCPPFN 251

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 205

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 205

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 121 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 206

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 121 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 206

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 205

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 205

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 204

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 23/221 (10%)
Query: 539 LLGVGGFGKVYRGEIDG--ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           L+G G FG+VY G   G  A   + I+R N   E  +  F+ E+    + RH ++V  +G
Sbjct: 40  LIGKGRFGQVYHGRWHGEVAIRLIDIERDN---EDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
            C     + ++       TL   + +  K  L   +  +I     +G+ YLH      I+
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYS-VVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK---GSFGYLDPEYFRRQQ- 712
           H+D+K+ N+  D   V  ++DFGL      L        ++   G   +L PE  R+   
Sbjct: 153 HKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 713 --------LTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
                    ++ SDV++ G + +E L AR     T P E +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYE-LHAREWPFKTQPAEAI 251

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 175
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 204

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 175
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 204

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 155
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG--SFGY 702
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K            +V+G  +  Y
Sbjct: 216 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSY 261
Query: 703 LDPEYFRRQQL-------TEKSDVYSFGVVLFEILCARP 734
           +   Y+R  +L       T   DV+S G VL E+L  +P
Sbjct: 262 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 300

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 126 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 180
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 209

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 112
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG--SFGY 702
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K            +V+G  +  Y
Sbjct: 173 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSY 218
Query: 703 LDPEYFRRQQL-------TEKSDVYSFGVVLFEILCARP 734
           +   Y+R  +L       T   DV+S G VL E+L  +P
Sbjct: 219 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 257

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 114
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG--SFGY 702
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K            +V+G  +  Y
Sbjct: 175 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSY 220
Query: 703 LDPEYFRRQQL-------TEKSDVYSFGVVLFEILCARP 734
           +   Y+R  +L       T   DV+S G VL E+L  +P
Sbjct: 221 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 259

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHR 589
            NF +   +G G +G VY  R ++ G    +   R +  +E        EI +L +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 205

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHR 589
            NF +   +G G +G VY  R ++ G    +   R +  +E        EI +L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 204

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 104
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG--SFGY 702
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K            +V+G  +  Y
Sbjct: 165 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSY 210
Query: 703 LDPEYFRRQQL-------TEKSDVYSFGVVLFEILCARP 734
           +   Y+R  +L       T   DV+S G VL E+L  +P
Sbjct: 211 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 249

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L++ +  +    +P            +GL + H+
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 123 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 177
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 206

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 150
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       ++ V G+  Y+ PE 
Sbjct: 151 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPEL 206
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLP 233

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 101/212 (47%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++ +  L+  +  +    +P            +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 208

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 110
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG--SFGY 702
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K            +V+G  +  Y
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSY 216
Query: 703 LDPEYFRRQQL-------TEKSDVYSFGVVLFEILCARP 734
           +   Y+R  +L       T   DV+S G VL E+L  +P
Sbjct: 217 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 81
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG--SFGY 702
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K            +V+G  +  Y
Sbjct: 142 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSY 187
Query: 703 LDPEYFRRQQL-------TEKSDVYSFGVVLFEILCARP 734
           +   Y+R  +L       T   DV+S G VL E+L  +P
Sbjct: 188 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 226

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY-- 597
           +G G +G+V+RG   G    VA+K  +   E+     +TE+     LRH +++  I    
Sbjct: 45  VGKGRYGEVWRGSWQGE--NVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDM 101
Query: 598 --CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH-----TG 650
                + ++ L+  Y   G+L ++L   Q   L     L I +  A GL +LH     T 
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGL----SKTGPTLDHTHVSTVVKGSFGYLDPE 706
            K  I HRD+K+ NIL+ +     ++D GL    S++   LD  +   V  G+  Y+ PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV--GTKRYMAPE 216
Query: 707 YFRRQQLTE------KSDVYSFGVVLFEI 729
                   +      + D+++FG+VL+E+
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 10/211 (4%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
           K    +F    +LG G F  V        + + AIK   + + + E  V     E +++S
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
           +L H   V L    +++ ++     Y   G L +++ K         +     I +A  L
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--L 123
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYL 703
            YLH      IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+
Sbjct: 124 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYV 179
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE    +   + SD+++ G ++++++   P
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLP 210

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHRHLVSLIGY 597
           +G G +G VY+ + D     VA+KR    +E +G+      EI +L +L H ++VSLI  
Sbjct: 29  VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
                 + LV+++M      + +    K  L   Q         RG+ + H   +H I+H
Sbjct: 88  IHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILH 142
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTG--PTLDHTHVSTVVKGSFGYLDPEYFR-RQQLT 714
           RD+K  N+L++     K++DFGL++    P   +TH   VV  +  Y  P+     ++ +
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH--EVV--TLWYRAPDVLMGSKKYS 198
Query: 715 EKSDVYSFGVVLFEILCARP 734
              D++S G +  E++  +P
Sbjct: 199 TSVDIWSIGCIFAEMITGKP 218

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 9/208 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGV-HEFQTEIEMLSKLRHRHLVSLIGYC 598
           LG G +  VY+G+       VA+K      E+G       E+ +L  L+H ++V+L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
                + LV++Y+    L+++L            +L       RGL Y H   +  ++HR
Sbjct: 70  HTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKL-FLFQLLRGLAYCH---RQKVLHR 124
Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR-RQQLTEKS 717
           D+K  N+L++E+   K++DFGL++       T+ + VV  +  Y  P+        + + 
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYSTQI 182
Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQV 745
           D++  G + +E+   RP    +  +EQ+
Sbjct: 183 DMWGVGCIFYEMATGRPLFPGSTVEEQL 210

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHRHLVSLIGY 597
           +G G +G VY+ + D     VA+KR    +E +G+      EI +L +L H ++VSLI  
Sbjct: 29  VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
                 + LV+++M      + +    K  L   Q         RG+ + H   +H I+H
Sbjct: 88  IHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILH 142
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTG--PTLDHTHVSTVVKGSFGYLDPEYFR-RQQLT 714
           RD+K  N+L++     K++DFGL++    P   +TH   VV  +  Y  P+     ++ +
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH--EVV--TLWYRAPDVLMGSKKYS 198
Query: 715 EKSDVYSFGVVLFEILCARP 734
              D++S G +  E++  +P
Sbjct: 199 TSVDIWSIGCIFAEMITGKP 218

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 10/211 (4%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
           K    +F    +LG G F  V        + + AIK   + + + E  V     E +++S
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
           +L H   V L    +++ ++     Y   G L +++ K         +     I +A  L
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--L 122
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYL 703
            YLH      IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+
Sbjct: 123 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYV 178
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE    +   + SD+++ G ++++++   P
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLP 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            D  + +G G  G V    +  +   VA+K+ +   +Q       E+ ++   +H ++V 
Sbjct: 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           +        E+ +V +++  G L + +  T+   +  +Q   +C+   + L  LH     
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHA---Q 266
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFG----LSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            +IHRD+K+ +ILL      K+SDFG    +SK  P          + G+  ++ PE   
Sbjct: 267 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELIS 320
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           R     + D++S G+++ E++   P
Sbjct: 321 RLPYGPEVDIWSLGIMVIEMVDGEP 345

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY-- 597
           +G G +G+V+RG   G    VA+K  +   E+     +TE+     LRH +++  I    
Sbjct: 16  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDM 72
Query: 598 --CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH-----TG 650
                + ++ L+  Y   G+L ++L   Q   L     L I +  A GL +LH     T 
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGL----SKTGPTLDHTHVSTVVKGSFGYLDPE 706
            K  I HRD+K+ NIL+ +     ++D GL    S++   LD  +   V  G+  Y+ PE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV--GTKRYMAPE 187
Query: 707 YFRRQQLTE------KSDVYSFGVVLFEI 729
                   +      + D+++FG+VL+E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 539 LLGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +LG G FG+V   + +I G    V +     + ++   E    E+++L +L H +++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
            + E+     LV +    G L + +   ++       R  I      G+ Y+H   K+ I
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMH---KNKI 147
Query: 656 IHRDVKTTNILLDEKWV---AKVSDFGLSKTGPTLDHTHVSTVVKGSFG---YLDPEYFR 709
           +HRD+K  N+LL+ K      ++ DFGLS       H   S  +K   G   Y+ PE   
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLST------HFEASKKMKDKIGTAYYIAPEVL- 200
Query: 710 RQQLTEKSDVYSFGVVLFEILCARPALN 737
                EK DV+S GV+L+ +L   P  N
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 152
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 153 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 208
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 209 LTEKSACKSSDLWALGCIIYQLVAGLP 235

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-GTAQYVSPEL 203
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 114/241 (47%), Gaps = 40/241 (16%)
Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT----EIEMLSKL 586
            + +++   +G G FG+V++        KVA+K+   L E     F      EI++L  L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLL 74
Query: 587 RHRHLVSLIGYCE------ENCE--MILVYDYMAY---GTLREHLYKTQKPPLPWKQRLE 635
           +H ++V+LI  C         C+  + LV+D+  +   G L   L K     +  K+ ++
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQ 132
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT----H 691
           + +    GL+Y+H   ++ I+HRD+K  N+L+    V K++DFGL++      ++    +
Sbjct: 133 MLLN---GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 692 VSTVVKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEILCARPALNPTLPKEQVS 746
            + VV  +  Y  PE      L E+      D++  G ++ E+    P +     + Q++
Sbjct: 187 XNRVV--TLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 240
Query: 747 L 747
           L
Sbjct: 241 L 241

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 150
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 151 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 206
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLP 233

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 89
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG--SFGY 702
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K            +V+G  +  Y
Sbjct: 150 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSY 195
Query: 703 LDPEYFRRQQL-------TEKSDVYSFGVVLFEILCARP 734
           +   Y+R  +L       T   DV+S G VL E+L  +P
Sbjct: 196 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 234

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 10/211 (4%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
           K    +F    +LG G F  V        + + AIK   + + + E  V     E +++S
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
           +L H   V L    +++ ++     Y   G L +++ K         +     I +A  L
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--L 120
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYL 703
            YLH      IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+
Sbjct: 121 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYV 176
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE    +   + SD+++ G ++++++   P
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLP 207

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQLVAGLP 232

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 521 HFSFAEIKAA----------TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE 570
           H S  + +AA           +  D  + +G G  G V    +  +   VA+K+ +   +
Sbjct: 3   HMSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ 62
Query: 571 QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPW 630
           Q       E+ ++   +H ++V +        E+ +V +++  G L + +  T+   +  
Sbjct: 63  QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNE 119
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG----LSKTGPT 686
           +Q   +C+   + L  LH      +IHRD+K+ +ILL      K+SDFG    +SK  P 
Sbjct: 120 EQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 176
Query: 687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
                    + G+  ++ PE   R     + D++S G+++ E++   P
Sbjct: 177 ------RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 218

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            D  + +G G  G V    +  +   VA+K+ +   +Q       E+ ++   +H ++V 
Sbjct: 33  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           +        E+ +V +++  G L + +  T+   +  +Q   +C+   + L  LH     
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHA---Q 146
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFG----LSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            +IHRD+K+ +ILL      K+SDFG    +SK  P          + G+  ++ PE   
Sbjct: 147 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELIS 200
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           R     + D++S G+++ E++   P
Sbjct: 201 RLPYGPEVDIWSLGIMVIEMVDGEP 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            D  + +G G  G V    +  +   VA+K+ +   +Q       E+ ++   +H ++V 
Sbjct: 76  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           +        E+ +V +++  G L + +  T+   +  +Q   +C+   + L  LH     
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHA---Q 189
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFG----LSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            +IHRD+K+ +ILL      K+SDFG    +SK  P          + G+  ++ PE   
Sbjct: 190 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELIS 243
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           R     + D++S G+++ E++   P
Sbjct: 244 RLPYGPEVDIWSLGIMVIEMVDGEP 268

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 10/211 (4%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
           K    +F    +LG G F  V        + + AIK   + + + E  V     E +++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
           +L H   V L    +++ ++     Y   G L +++ K         +     I +A  L
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--L 121
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYL 703
            YLH      IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+
Sbjct: 122 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYV 177
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE    +   + SD+++ G ++++++   P
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLP 208

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 114/241 (47%), Gaps = 40/241 (16%)
Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT----EIEMLSKL 586
            + +++   +G G FG+V++        KVA+K+   L E     F      EI++L  L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLL 74
Query: 587 RHRHLVSLIGYCE------ENCE--MILVYDYMAY---GTLREHLYKTQKPPLPWKQRLE 635
           +H ++V+LI  C         C+  + LV+D+  +   G L   L K     +  K+ ++
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQ 132
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT----H 691
           + +    GL+Y+H   ++ I+HRD+K  N+L+    V K++DFGL++      ++    +
Sbjct: 133 MLLN---GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 692 VSTVVKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEILCARPALNPTLPKEQVS 746
            + VV  +  Y  PE      L E+      D++  G ++ E+    P +     + Q++
Sbjct: 187 XNRVV--TLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 240
Query: 747 L 747
           L
Sbjct: 241 L 241

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            D  + +G G  G V    +  +   VA+K+ +   +Q       E+ ++   +H ++V 
Sbjct: 22  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           +        E+ +V +++  G L + +  T+   +  +Q   +C+   + L  LH     
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHA---Q 135
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFG----LSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            +IHRD+K+ +ILL      K+SDFG    +SK  P          + G+  ++ PE   
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELIS 189
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           R     + D++S G+++ E++   P
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEP 214

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY-- 597
           +G G +G+V+RG   G    VA+K  +   E+     +TE+     LRH +++  I    
Sbjct: 16  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDM 72
Query: 598 --CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH-----TG 650
                + ++ L+  Y   G+L ++L   Q   L     L I +  A GL +LH     T 
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGL----SKTGPTLDHTHVSTVVKGSFGYLDPE 706
            K  I HRD+K+ NIL+ +     ++D GL    S++   LD  +   V  G+  Y+ PE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV--GTKRYMAPE 187
Query: 707 YFRRQQLTE------KSDVYSFGVVLFEI 729
                   +      + D+++FG+VL+E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 154
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 155 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 210
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 211 LTEKSACKSSDLWALGCIIYQLVAGLP 237

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 203
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            D  + +G G  G V    +  +   VA+K+ +   +Q       E+ ++   +H ++V 
Sbjct: 31  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           +        E+ +V +++  G L + +  T+   +  +Q   +C+   + L  LH     
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHA---Q 144
Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFG----LSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            +IHRD+K+ +ILL      K+SDFG    +SK  P          + G+  ++ PE   
Sbjct: 145 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTPYWMAPELIS 198
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           R     + D++S G+++ E++   P
Sbjct: 199 RLPYGPEVDIWSLGIMVIEMVDGEP 223

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 203
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 150 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 40/224 (17%)
Query: 540 LGVGGFGKVYRGEIDGATTKV-AIKRGNPLSEQGVHEFQT--EIEMLSKLR-HRHLVSLI 595
           LG G +G V++  ID  T +V A+K+     +      +T  EI +L++L  H ++V+L+
Sbjct: 17  LGKGAYGIVWKS-IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 596 GY--CEENCEMILVYDYMA---YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
                + + ++ LV+DYM    +  +R ++ +         Q +++       + YLH+G
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKV-------IKYLHSG 128
Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL-------------------DHTH 691
               ++HRD+K +NILL+ +   KV+DFGLS++   +                   D   
Sbjct: 129 G---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 692 VSTVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEILCARP 734
           + T    +  Y  PE      + T+  D++S G +L EILC +P
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      QG      E++++ KL H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQGKAFKNRELQIMRKLDHCNIV 76
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K        +VS +   S  Y  
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXIC--SRYYRA 190
Query: 705 PEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  F     T   DV+S G VL E+L  +P
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 114/241 (47%), Gaps = 40/241 (16%)
Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT----EIEMLSKL 586
            + +++   +G G FG+V++        KVA+K+   L E     F      EI++L  L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLL 74
Query: 587 RHRHLVSLIGYCE------ENCE--MILVYDYMAY---GTLREHLYKTQKPPLPWKQRLE 635
           +H ++V+LI  C         C+  + LV+D+  +   G L   L K     +  K+ ++
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQ 132
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT----H 691
           + +    GL+Y+H   ++ I+HRD+K  N+L+    V K++DFGL++      ++    +
Sbjct: 133 MLLN---GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 692 VSTVVKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEILCARPALNPTLPKEQVS 746
            + VV  +  Y  PE      L E+      D++  G ++ E+    P +     + Q++
Sbjct: 187 XNRVV--TLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 240
Query: 747 L 747
           L
Sbjct: 241 L 241

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 146
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       ++ V G+  Y+ PE 
Sbjct: 147 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPEL 202
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLP 229

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 114/241 (47%), Gaps = 40/241 (16%)
Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT----EIEMLSKL 586
            + +++   +G G FG+V++        KVA+K+   L E     F      EI++L  L
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLL 73
Query: 587 RHRHLVSLIGYCE------ENCE--MILVYDYMAY---GTLREHLYKTQKPPLPWKQRLE 635
           +H ++V+LI  C         C+  + LV+D+  +   G L   L K     +  K+ ++
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQ 131
Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT----H 691
           + +    GL+Y+H   ++ I+HRD+K  N+L+    V K++DFGL++      ++    +
Sbjct: 132 MLLN---GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 692 VSTVVKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEILCARPALNPTLPKEQVS 746
            + VV  +  Y  PE      L E+      D++  G ++ E+    P +     + Q++
Sbjct: 186 XNRVV--TLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239
Query: 747 L 747
           L
Sbjct: 240 L 240

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR-----GNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           +G G +G V++         VAIK+      +P+ ++       EI ML +L+H +LV+L
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA---LREIRMLKQLKHPNLVNL 67
Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
           +        + LV++Y  +  L E L + Q+  +P      I     + +++ H   KH 
Sbjct: 68  LEVFRRKRRLHLVFEYCDHTVLHE-LDRYQRG-VPEHLVKSITWQTLQAVNFCH---KHN 122
Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFR-RQ 711
            IHRDVK  NIL+ +  V K+ DFG ++  TGP+ D+       +    Y  PE      
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYYDDEVATR---WYRSPELLVGDT 178
Query: 712 QLTEKSDVYSFGVVLFEILCARP 734
           Q     DV++ G V  E+L   P
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVP 201

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 14/209 (6%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRHRH 590
           ++++   ++G G    V          KVAIKR N    +  + E   EI+ +S+  H +
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLRE---HLY---KTQKPPLPWKQRLEICIGAARGL 644
           +VS         E+ LV   ++ G++ +   H+    + +   L       I      GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFG 701
            YLH   K+  IHRDVK  NILL E    +++DFG+S    TG  +    V     G+  
Sbjct: 130 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 702 YLDPEYFRRQQLTE-KSDVYSFGVVLFEI 729
           ++ PE   + +  + K+D++SFG+   E+
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIEL 215

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 110/248 (44%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLXGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 14/209 (6%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRHRH 590
           ++++   ++G G    V          KVAIKR N    +  + E   EI+ +S+  H +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLRE---HLY---KTQKPPLPWKQRLEICIGAARGL 644
           +VS         E+ LV   ++ G++ +   H+    + +   L       I      GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFG 701
            YLH   K+  IHRDVK  NILL E    +++DFG+S    TG  +    V     G+  
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 702 YLDPEYFRRQQLTE-KSDVYSFGVVLFEI 729
           ++ PE   + +  + K+D++SFG+   E+
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIEL 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 76
Query: 593 SLI------GYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG--SFGY 702
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K            +V+G  +  Y
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSY 182
Query: 703 LDPEYFRRQQL-------TEKSDVYSFGVVLFEILCARP 734
           +   Y+R  +L       T   DV+S G VL E+L  +P
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 110/248 (44%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLAGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPAFV 184
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRG-NPLSEQGVHEF-QTEIEMLSKLRHRHLVSLIG 596
           L+G G +G V +         VAIK+      ++ V +    EI++L +LRH +LV+L+ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 597 YCEENCEMILVYDYMAYGTLRE-HLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
            C++     LV++++ +  L +  L+      L ++   +       G+ + H+   H I
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHS---HNI 145
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE 715
           IHRD+K  NIL+ +  V K+ DFG ++T       +   V   +  Y  PE         
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--ATRWYRAPELLVGDVKYG 203
Query: 716 KS-DVYSFGVVLFEILCARP 734
           K+ DV++ G ++ E+    P
Sbjct: 204 KAVDVWAIGCLVTEMFMGEP 223

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 110/249 (44%), Gaps = 15/249 (6%)
Query: 491 SLYGNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKV 548
           S  GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V
Sbjct: 19  SHMGNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV 78
Query: 549 YRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI 605
              +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + 
Sbjct: 79  MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 138
Query: 606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNI 665
           +V +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+
Sbjct: 139 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENL 193
Query: 666 LLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 725
           L+D++   +V+DFG +K       T     + G+  YL PE    +   +  D ++ GV+
Sbjct: 194 LIDQQGYIQVTDFGFAKRVKGATWT-----LCGTPEYLAPEIILSKGYNKAVDWWALGVL 248
Query: 726 LFEILCARP 734
           ++E+    P
Sbjct: 249 IYEMAAGYP 257

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 543 GGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK--LRHRHLVSLIGYCEE 600
           G FG V++ ++      V I    PL ++    +Q+E E+ S   ++H +L+  I   + 
Sbjct: 26  GRFGCVWKAQLMNDFVAVKI---FPLQDK--QSWQSEREIFSTPGMKHENLLQFIAAEKR 80
Query: 601 ----NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT------- 649
                 E+ L+  +   G+L ++L   +   + W +   +    +RGL YLH        
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 650 -GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFGYLDP 705
            G K +I HRD K+ N+LL     A ++DFGL+   + G     TH      G+  Y+ P
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV---GTRRYMAP 194
Query: 706 EY------FRRQQLTEKSDVYSFGVVLFEIL 730
           E       F+R     + D+Y+ G+VL+E++
Sbjct: 195 EVLEGAINFQRDAFL-RIDMYAMGLVLWELV 224

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 10/210 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLRHR 589
            NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L+       ++ LV++++ +  L+  +  +    +P            +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 710 R-QQLTEKSDVYSFGVVLFEILCARPALNP 738
             +  +   D++S G +  E++  R AL P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 204

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 44/245 (17%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G +G+V+ G+  G   KVA+K     +E+     +TEI     +RH +++  I    
Sbjct: 45  IGKGRYGEVWMGKWRGE--KVAVKVFFT-TEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 600 ENC----EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT-----G 650
           +      ++ L+ DY   G+L ++L  T    L  K  L++   +  GL +LHT      
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLS-KTGPTLDHTHVSTVVK-GSFGYLDPEYF 708
            K  I HRD+K+ NIL+ +     ++D GL+ K     +   +    + G+  Y+ PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 709 RRQ------QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ 762
                    Q    +D+YSFG++L+E+                     A  C   GI+E+
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEV---------------------ARRCVSGGIVEE 257
Query: 763 IMDPY 767
              PY
Sbjct: 258 YQLPY 262

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 101/212 (47%), Gaps = 10/212 (4%)
Query: 530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQT-EIEMLSKLR 587
           +  NF +   +G G +G VY+         VA+K+    +E +GV      EI +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++    L++ +  +    +P            +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H+   H ++HRD+K  N+L++ +   K++DFGL++       T+   VV  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 708 FRR-QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  +   D++S G +  E++  R AL P
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFP 208

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 49/234 (20%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           ++F+E  +LG G FG+V +      +   AIK+    +E+ +    +E+ +L+ L H+++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYV 64
Query: 592 V----------------------SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP 629
           V                      S +    E CE   +YD +    L       Q+    
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENL------NQQRDEY 118
Query: 630 WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK-TGPTLD 688
           W+   +I       L Y+H+     IIHRD+K  NI +DE    K+ DFGL+K    +LD
Sbjct: 119 WRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 689 HTHVS-----------TVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEIL 730
              +            T   G+  Y+  E         EK D+YS G++ FE++
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR-GNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +G G +G V +     +   +A+KR  + + E+   +   +++++ +     ++V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 597 -YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
            + E +C + +     ++    +++Y      +P +   +I +   + L++L    K  I
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--I 147
Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF----RRQ 711
           IHRD+K +NILLD     K+ DFG+S  G  +D     T   G   Y+ PE       RQ
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSI-AKTRDAGCRPYMAPERIDPSASRQ 204
Query: 712 QLTEKSDVYSFGVVLFEILCAR 733
               +SDV+S G+ L+E+   R
Sbjct: 205 GYDVRSDVWSLGITLYELATGR 226

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 146
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 147 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 202
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLP 229

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 86/199 (43%), Gaps = 12/199 (6%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE----QGVHEFQTEIEMLSKLRHRHLVSL 594
           LLG G +GKV          + A+K            G    + EI++L +LRH++++ L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 595 IG--YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
           +   Y EE  +M +V +Y   G ++E L    +   P  Q          GL YLH+   
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS--- 127
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             I+H+D+K  N+LL      K+S  G+++              +GS  +  PE      
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD 187
Query: 713 LTE--KSDVYSFGVVLFEI 729
                K D++S GV L+ I
Sbjct: 188 TFSGFKVDIWSAGVTLYNI 206

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F  V        + + AIK   + + + E  V     E +++S+L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 131
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 132 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 187
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 188 LTEKSACKSSDLWALGCIIYQLVAGLP 214

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 531 TNNFDEALLLGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLR 587
           ++ +    +LG G FG+V   + +I G    V +     + ++   E    E+++L +L 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H +++ L  + E+     LV +    G L + +   ++       R  I      G+ Y+
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYM 148
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV---AKVSDFGLSKTGPTLDHTHVSTVVKGSFG--- 701
           H   K+ I+HRD+K  N+LL+ K      ++ DFGLS       H   S  +K   G   
Sbjct: 149 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS------THFEASKKMKDKIGTAY 199
Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
           Y+ PE        EK DV+S GV+L+ +L   P  N
Sbjct: 200 YIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 110
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K        +VS +   S  Y  
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXIC--SRYYRA 224
Query: 705 PEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  F     T   DV+S G VL E+L  +P
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 528 KAATNNF---DEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLS 584
           + A N+F    +  +LG G FG+V++ E      K+A K       +   E + EI +++
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL---EICIGAA 641
           +L H +L+ L    E   +++LV +Y+  G L + +             L   +IC G  
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG-I 200
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           R +H ++      I+H D+K  NIL    D K + K+ DFGL++     +   V+    G
Sbjct: 201 RHMHQMY------ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNF---G 250
Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           +  +L PE      ++  +D++S GV+ + +L
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 110/248 (44%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 540 LGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLRHRHLVS 593
           LG G F  V +    G       K   KR    S +GV   E + E+ +L ++RH ++++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L    E   +++L+ + ++ G L + L   +K  L   +  +       G+HYLH+    
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHS---K 134
Query: 654 TIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFG---YLDPE 706
            I H D+K  NI+L +K V     K+ DFG++               K  FG   ++ PE
Sbjct: 135 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK------IEAGNEFKNIFGTPEFVAPE 188
Query: 707 YFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPT 739
               + L  ++D++S GV+ + +L  A P L  T
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGET 222

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G  G V          +VA+K+ +   +Q       E+ ++    H ++V +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
              E+ +V +++  G L + +  T+   +  +Q   +C+   R L YLH      +IHRD
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQG---VIHRD 166
Query: 660 VKTTNILLDEKWVAKVSDFG----LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE 715
           +K+ +ILL      K+SDFG    +SK  P          + G+  ++ PE   R     
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------RKXLVGTPYWMAPEVISRLPYGT 220
Query: 716 KSDVYSFGVVLFEILCARP 734
           + D++S G+++ E++   P
Sbjct: 221 EVDIWSLGIMVIEMIDGEP 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSK 585
           A  + FD    LG G FG+V   +   +    A+K   +   +  + +     E  +L  
Sbjct: 25  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           +    LV L    ++N  + +V +Y+A G +  HL +  +   P  +     I       
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 142
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYL 703
           YLH+     +I+RD+K  N+L+DE+   +V+DFG +K   G T         + G+  YL
Sbjct: 143 YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYL 192
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE    +   +  D ++ GV+++E+    P
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 223

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 110/248 (44%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 110/248 (44%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 61
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 62  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 121
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 122 EYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 176
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 177 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 230 YEMAAGYP 237

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 540 LGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F KV   R  + G    V I     L+   + +   E+ ++  L H ++V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            E    + LV +Y + G + ++L      K ++    ++Q           + Y H   +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-------IVSAVQYCH---Q 131
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKT---GPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+LLD     K++DFG S     G  LD         GS  Y  PE F+
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------TFCGSPPYAAPELFQ 185
Query: 710 RQQLT-EKSDVYSFGVVLFEIL 730
            ++    + DV+S GV+L+ ++
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLV 207

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 540 LGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLRHRHLVS 593
           LG G F  V +    G       K   KR    S +GV   E + E+ +L ++RH ++++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L    E   +++L+ + ++ G L + L   +K  L   +  +       G+HYLH+    
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHS---K 148
Query: 654 TIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFG---YLDPE 706
            I H D+K  NI+L +K V     K+ DFG++               K  FG   ++ PE
Sbjct: 149 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK------IEAGNEFKNIFGTPEFVAPE 202
Query: 707 YFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPT 739
               + L  ++D++S GV+ + +L  A P L  T
Sbjct: 203 IVNYEPLGLEADMWSIGVITYILLSGASPFLGET 236

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 29/229 (12%)
Query: 527 IKAATNNFDEALLLGVGGFG--KVYRGEIDGATTKVA-IKRGNPLSEQGVHEFQTEIEML 583
           I   ++ +D    +G G FG  ++ R ++      V  I+RG  + E      Q EI   
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINH 70
Query: 584 SKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICI 638
             LRH ++V           + ++ +Y + G L E +     +   +    ++Q L    
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS--- 127
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVV 696
               G+ Y H+     I HRD+K  N LLD       K+ DFG SK+  ++ H+   + V
Sbjct: 128 ----GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTV 178
Query: 697 KGSFGYLDPEYFRRQQLTEK-SDVYSFGVVLFEILC-ARPALNPTLPKE 743
            G+  Y+ PE   RQ+   K +DV+S GV L+ +L  A P  +P  P++
Sbjct: 179 -GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 540 LGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLRHRHLVS 593
           LG G F  V +    G       K   KR    S +GV   E + E+ +L ++RH ++++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L    E   +++L+ + ++ G L + L   +K  L   +  +       G+HYLH+    
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHS---K 127
Query: 654 TIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFG---YLDPE 706
            I H D+K  NI+L +K V     K+ DFG++               K  FG   ++ PE
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK------IEAGNEFKNIFGTPEFVAPE 181
Query: 707 YFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPT 739
               + L  ++D++S GV+ + +L  A P L  T
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 540 LGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F KV   R  + G    V I     L+   + +   E+ ++  L H ++V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            E    + LV +Y + G + ++L      K ++    ++Q           + Y H   +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-------IVSAVQYCH---Q 131
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKT---GPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+LLD     K++DFG S     G  LD         GS  Y  PE F+
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------TFCGSPPYAAPELFQ 185
Query: 710 RQQLT-EKSDVYSFGVVLFEILCA 732
            ++    + DV+S GV+L+ ++  
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 111/251 (44%), Gaps = 19/251 (7%)
Query: 491 SLYGNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKV 548
           S  GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V
Sbjct: 19  SHMGNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV 78
Query: 549 YRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI 605
              +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + 
Sbjct: 79  MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 138
Query: 606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNI 665
           +V +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+
Sbjct: 139 MVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENL 193
Query: 666 LLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFG 723
           L+D++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ G
Sbjct: 194 LIDQQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALG 246
Query: 724 VVLFEILCARP 734
           V+++E+    P
Sbjct: 247 VLIYEMAAGYP 257

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 129
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 130 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 183
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 230

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 10/207 (4%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F    +LG G F           + + AIK   + + + E  V     E +++S+L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
              V L    +++ ++     Y   G L +++ K         +     I +A  L YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEY 707
                 IIHRD+K  NILL+E    +++DFG +K   P       +  V G+  Y+ PE 
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 203
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              +   + SD+++ G ++++++   P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 540 LGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F KV   R  + G    V I     L+   + +   E+ ++  L H ++V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            E    + LV +Y + G + ++L      K ++    ++Q           + Y H   +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-------IVSAVQYCH---Q 131
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKT---GPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+LLD     K++DFG S     G  LD         GS  Y  PE F+
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------TFCGSPPYAAPELFQ 185
Query: 710 RQQLT-EKSDVYSFGVVLFEILCA 732
            ++    + DV+S GV+L+ ++  
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 110/248 (44%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 540 LGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F KV   R  + G    V I     L+   + +   E+ ++  L H ++V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            E    + LV +Y + G + ++L      K ++    ++Q           + Y H   +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-------IVSAVQYCH---Q 131
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKT---GPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+LLD     K++DFG S     G  LD         GS  Y  PE F+
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE------FCGSPPYAAPELFQ 185
Query: 710 RQQLT-EKSDVYSFGVVLFEILCA 732
            ++    + DV+S GV+L+ ++  
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 20/226 (8%)
Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSK 585
           A  + FD    LG G FG+V   +   +    A+K   +   +  + +     E  +L  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           +    LV L    ++N  + +V +Y+A G +  HL +  +   P  +     I       
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 155
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYL 703
           YLH+     +I+RD+K  N+L+D++   +V+DFG +K   G T         + G+  YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYL 205
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAE 749
            PE    +   +  D ++ GV+++E+    P   P    E + + E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP---PFFADEPIQIYE 248

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 88
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K        +VS +   S  Y  
Sbjct: 149 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXIC--SRYYRA 202
Query: 705 PEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  F     T   DV+S G VL E+L  +P
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 95
Query: 593 SLI------GYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K        +VS +   S  Y  
Sbjct: 156 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXIC--SRYYRA 209
Query: 705 PEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  F     T   DV+S G VL E+L  +P
Sbjct: 210 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 240

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 84
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K        +VS +   S  Y  
Sbjct: 145 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXIC--SRYYRA 198
Query: 705 PEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  F     T   DV+S G VL E+L  +P
Sbjct: 199 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 229

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 129
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 130 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 183
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 230

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 50/285 (17%)
Query: 540 LGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F KV   R  + G    + I     L+   + +   E+ ++  L H ++V L   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            E    + L+ +Y + G + ++L      K ++    ++Q           + Y H   +
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ-------IVSAVQYCH---Q 129
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+LLD     K++DFG S     G  LD         GS  Y  PE F+
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD------TFCGSPPYAAPELFQ 183
Query: 710 RQQLT-EKSDVYSFGVVLFEILCAR---PALNPTLPKEQVSLAEW------AAHCH---- 755
            ++    + DV+S GV+L+ ++         N    +E+V   ++      +  C     
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 243
Query: 756 --------KKGILEQIM-DPYLKGKIAPECFKKFAETAMKCVSDQ 791
                   K+G LEQIM D ++      +  K F E  +  +SDQ
Sbjct: 244 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELD-ISDQ 287

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 88
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K        +VS +   S  Y  
Sbjct: 149 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXIC--SRYYRA 202
Query: 705 PEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  F     T   DV+S G VL E+L  +P
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 111/255 (43%), Gaps = 19/255 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAACKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARPALNPTLP 741
           +E+    P      P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 110/248 (44%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 540 LGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F KV   R  + G    V I     L+   + +   E+ ++  L H ++V L   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            E    + LV +Y + G + ++L      K ++    ++Q           + Y H   +
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-------IVSAVQYCH---Q 132
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+LLD     K++DFG S     G  LD         GS  Y  PE F+
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLD------TFCGSPPYAAPELFQ 186
Query: 710 RQQLT-EKSDVYSFGVVLFEILCA 732
            ++    + DV+S GV+L+ ++  
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSK 585
           A  + FD    LG G FG+V   +   +    A+K   +   +  + +     E  +L  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           +    LV L    ++N  + +V +Y+A G +  HL +  +   P  +     I       
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQI--VLTFE 155
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYL 703
           YLH+     +I+RD+K  N+L+D++   +V+DFG +K   G T         + G+  YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYL 205
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE    +   +  D ++ GV+++E+    P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 540 LGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F KV   R  + G    V I     L+   + +   E+ ++  L H ++V L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            E    + LV +Y + G + ++L      K ++    ++Q           + Y H   +
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQ-------IVSAVQYCH---Q 124
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKT---GPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+LLD     K++DFG S     G  LD         GS  Y  PE F+
Sbjct: 125 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------TFCGSPPYAAPELFQ 178
Query: 710 RQQLT-EKSDVYSFGVVLFEIL 730
            ++    + DV+S GV+L+ ++
Sbjct: 179 GKKYDGPEVDVWSLGVILYTLV 200

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSK 585
           A  + FD    LG G FG+V   +   +    A+K   +   +  + +     E  +L  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           +    LV L    ++N  + +V +Y+A G +  HL +  +   P  +     I       
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFE 155
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYL 703
           YLH+     +I+RD+K  N+L+D++   +V+DFG +K   G T         + G+  YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYL 205
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE    +   +  D ++ GV+++E+    P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 80
Query: 593 SLI------GYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K        +VS +   S  Y  
Sbjct: 141 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXIC--SRYYRA 194
Query: 705 PEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  F     T   DV+S G VL E+L  +P
Sbjct: 195 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 225

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 113/255 (44%), Gaps = 23/255 (9%)
Query: 494 GNSHSAGSAKTNTTGSYASSLPSNLC--RHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           G++   G  K     + AS    NL   +  SF       + ++    +G G +G V   
Sbjct: 15  GSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSA 74
Query: 552 EIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSL-------IGYCEENC 602
                  +VAIK+     +   +  +T  E+++L   +H +++++       + Y E   
Sbjct: 75  RRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 134
Query: 603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKT 662
            + +V D M    L + ++ +Q  PL  +          RGL Y+H+     +IHRD+K 
Sbjct: 135 -VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKP 187
Query: 663 TNILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKGSFGYLDPE-YFRRQQLTEKSD 718
           +N+L++E    K+ DFG+++   T P  +H +  T    +  Y  PE      + T+  D
Sbjct: 188 SNLLVNENCELKIGDFGMARGLCTSPA-EHQYFMTEYVATRWYRAPELMLSLHEYTQAID 246
Query: 719 VYSFGVVLFEILCAR 733
           ++S G +  E+L  R
Sbjct: 247 LWSVGCIFGEMLARR 261

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 77
Query: 593 SLI------GYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K        +VS +   S  Y  
Sbjct: 138 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXIC--SRYYRA 191
Query: 705 PEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  F     T   DV+S G VL E+L  +P
Sbjct: 192 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 222

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
           +    +F+  ++LG G FGKV   E  G     A+K   +   + +  V     E  +L+
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 585 KLRHRHLVSLIGYCEENCE-MILVYDYMAYGTLREHLYKTQ--KPPLPWKQRLEICIGAA 641
                  ++ +  C +  + +  V +Y+  G L  H+ +    K P       EI IG  
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG-- 133
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
             L +L +     II+RD+K  N++LD +   K++DFG+ K    +     +    G+  
Sbjct: 134 --LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKXFCGTPD 186
Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           Y+ PE    Q   +  D ++FGV+L+E+L  +
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 76
Query: 593 SLI------GYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K        +VS +   S  Y  
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXIC--SRYYRA 190
Query: 705 PEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  F     T   DV+S G VL E+L  +P
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 76
Query: 593 SL------IGYCEENCEMILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L       G  ++   + LV DY+     R    Y   K  LP            R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K        +VS +   S  Y  
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXIC--SRYYRA 190
Query: 705 PEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  F     T   DV+S G VL E+L  +P
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 540 LGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F KV   R  + G    V I     L+   + +   E+ ++  L H ++V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            E    + LV +Y + G + ++L      K ++    ++Q           + Y H   +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-------IVSAVQYCH---Q 131
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKT---GPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+LLD     K++DFG S     G  LD         G+  Y  PE F+
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------AFCGAPPYAAPELFQ 185
Query: 710 RQQLT-EKSDVYSFGVVLFEIL 730
            ++    + DV+S GV+L+ ++
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLV 207

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 22/230 (9%)
Query: 534 FDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLR 587
           +D    LG G F  V +            K   KR    S +GV   + + E+ +L +++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++++L    E   ++IL+ + +A G L + L   +K  L  ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H+     I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            PE    + L  ++D++S GV+ + +L  A P L  T   +Q +LA  +A
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 539 LLGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLI 595
           +LG G FG+V   + +I G    V +     + ++   E    E+++L +L H ++  L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
            + E+     LV +    G L + +   ++       R  I      G+ Y H   K+ I
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYXH---KNKI 147
Query: 656 IHRDVKTTNILLDEKWV---AKVSDFGLSKTGPTLDHTHVSTVVKGSFG---YLDPEYFR 709
           +HRD+K  N+LL+ K      ++ DFGLS       H   S   K   G   Y+ PE   
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLST------HFEASKKXKDKIGTAYYIAPEVL- 200
Query: 710 RQQLTEKSDVYSFGVVLFEILCARPALN 737
                EK DV+S GV+L+ +L   P  N
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSK 585
           A  + FD    LG G FG+V   +   +    A+K   +   +  + +     E  +L  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           +    LV L    ++N  + +V +Y+A G +  HL +  +   P  +     I       
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFE 155
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYL 703
           YLH+     +I+RD+K  N+L+D++   +V+DFG +K   G T         + G+  YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYL 205
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE    +   +  D ++ GV+++E+    P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 111/255 (43%), Gaps = 19/255 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+++D
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLIID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIIISKGYNKAVDWWALGVLI 228
Query: 727 FEILCARPALNPTLP 741
           +E+    P      P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 51/280 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQT---EIEMLSKLR----H 588
           LLG GGFG V+ G       +VAIK   R   L    + +  T   E+ +L K+     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 589 RHLVSLIGYCEENCEMILVYDY-MAYGTLREHLYKTQKPPL---PWKQRLEICIGAARGL 644
             ++ L+ + E     +LV +  +    L +  Y T+K PL   P +      + A +  
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFD--YITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 645 HYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           H         ++HRD+K  NIL+D  +  AK+ DFG       L H    T   G+  Y 
Sbjct: 156 H------SRGVVHRDIKDENILIDLRRGCAKLIDFGSG----ALLHDEPYTDFDGTRVYS 205
Query: 704 DPEYFRRQQLTE-KSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ 762
            PE+  R Q     + V+S G++L++++C        +P E+            + ILE 
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCG------DIPFER-----------DQEILEA 248
Query: 763 IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
            +  +    ++P+C         +C++ +   RPS+ ++L
Sbjct: 249 EL--HFPAHVSPDC----CALIRRCLAPKPSSRPSLEEIL 282

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 110/248 (44%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +++    P
Sbjct: 229 YQMAAGYP 236

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKRGN-PLSEQGVHEFQT-EIEMLSKLRHRHLVSLIG 596
           LG G +G+VY+  ID  T + VAIKR      E+GV      E+ +L +L+HR+++ L  
Sbjct: 42  LGEGTYGEVYKA-IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
               N  + L+++Y A   L++  Y  + P +  +           G+++ H+      +
Sbjct: 101 VIHHNHRLHLIFEY-AENDLKK--YMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCL 154
Query: 657 HRDVKTTNILL-----DEKWVAKVSDFGLSKTG--PTLDHTHVSTVVKGSFGYLDPEYFR 709
           HRD+K  N+LL      E  V K+ DFGL++    P    TH       +  Y  PE   
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII----TLWYRPPEILL 210
Query: 710 -RQQLTEKSDVYSFGVVLFEILCARP 734
             +  +   D++S   +  E+L   P
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLMKTP 236

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 17/218 (7%)
Query: 529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSK 585
           A  + FD    LG G FG+V   +   +    A+K   +   +  + +     E  +L  
Sbjct: 33  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 92
Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           +    LV L    ++N  + +V +Y+A G +  HL +  +   P  +     I       
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFE 150
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYL 703
           YLH+     +I+RD+K  N+L+D++   +V+DFG +K   G T         + G+  YL
Sbjct: 151 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYL 200
Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP 741
            PE    +   +  D ++ GV+++E+    P      P
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
           +    +F+  ++LG G FGKV   E  G     A+K   +   + +  V     E  +L+
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 585 KLRHRHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQ--KPPLPWKQRLEICIGAA 641
                  ++ +  C +  + +  V +Y+  G L  H+ +    K P       EI IG  
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG-- 454
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
             L +L +     II+RD+K  N++LD +   K++DFG+ K    +     +    G+  
Sbjct: 455 --LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKXFCGTPD 507
Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
           Y+ PE    Q   +  D ++FGV+L+E+L  +
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 50/285 (17%)
Query: 540 LGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F KV   R  + G    + I     L+   + +   E+ ++  L H ++V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            E    + L+ +Y + G + ++L      K ++    ++Q           + Y H   +
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ-------IVSAVQYCH---Q 132
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+LLD     K++DFG S     G  LD         G+  Y  PE F+
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD------AFCGAPPYAAPELFQ 186
Query: 710 RQQLT-EKSDVYSFGVVLFEILCAR---PALNPTLPKEQVSLAEW------AAHCH---- 755
            ++    + DV+S GV+L+ ++         N    +E+V   ++      +  C     
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 246
Query: 756 --------KKGILEQIM-DPYLKGKIAPECFKKFAETAMKCVSDQ 791
                   K+G LEQIM D ++      +  K F E  +  +SDQ
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELD-ISDQ 290

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 111/254 (43%), Gaps = 21/254 (8%)
Query: 494 GNSHSAGSAKTNTTGSYASSLPSNLC--RHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           G++   G  K     + AS    NL   +  SF       + ++    +G G +G V   
Sbjct: 14  GSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSA 73
Query: 552 EIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGYCE------ENCE 603
                  +VAIK+     +   +  +T  E+++L   +H +++++           E   
Sbjct: 74  RRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133
Query: 604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTT 663
           + +V D M    L + ++ +Q  PL  +          RGL Y+H+     +IHRD+K +
Sbjct: 134 VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPS 187
Query: 664 NILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKGSFGYLDPE-YFRRQQLTEKSDV 719
           N+L++E    K+ DFG+++   T P  +H +  T    +  Y  PE      + T+  D+
Sbjct: 188 NLLVNENCELKIGDFGMARGLCTSPA-EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 246
Query: 720 YSFGVVLFEILCAR 733
           +S G +  E+L  R
Sbjct: 247 WSVGCIFGEMLARR 260

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 76
Query: 593 SLIGYCEENCE------MILVYDYMAYGTLR-EHLYKTQKPPLPWKQRLEICIGAARGLH 645
            L  +   + E      + LV DY+     R    Y   K  LP            R L 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           Y+H+     I HRD+K  N+LLD +  V K+ DFG +K        +VS +   S  Y  
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXIC--SRYYRA 190
Query: 705 PEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  F     T   DV+S G VL E+L  +P
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 49/234 (20%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           ++F+E  +LG G FG+V +      +   AIK+    +E+ +    +E+ +L+ L H+++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVXLLASLNHQYV 64
Query: 592 V----------------------SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP 629
           V                      S +    E CE   +YD +    L       Q+    
Sbjct: 65  VRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENL------NQQRDEY 118
Query: 630 WKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK-TGPTLD 688
           W+   +I       L Y+H+     IIHR++K  NI +DE    K+ DFGL+K    +LD
Sbjct: 119 WRLFRQIL----EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 689 HTHVS-----------TVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEIL 730
              +            T   G+  Y+  E         EK D YS G++ FE +
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 102 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 156
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 203
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G F  V R      T + A K  N   LS +   + + E  +   L+H ++V L   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
             E     LV+D +  G L E +     Y          Q LE        ++++H   +
Sbjct: 99  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILE-------SVNHIH---Q 148
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
           H I+HRD+K  N+LL  K      K++DFGL+                G+ GYL PE  R
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG--FAGTPGYLSPEVLR 206
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           +    +  D+++ GV+L+ +L   P
Sbjct: 207 KDPYGKPVDIWACGVILYILLVGYP 231

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 88  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 142
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 143 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 189
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 232

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 113 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 167
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 168 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMX-----GYVATRWYRAP 214
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 257

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 101/230 (43%), Gaps = 23/230 (10%)
Query: 516 SNLCRHFSF-AEIKAATNNFDEALLL------GVGGFGKVYRGEIDGATTKVAIKRGNPL 568
           S +  H  F A ++   +  D  LLL      G G  G V       +  +VA+K  +  
Sbjct: 22  SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR 81
Query: 569 SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPL 628
            +Q       E+ ++   +H ++V +        E+ ++ +++  G L + + + +   L
Sbjct: 82  KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---L 138
Query: 629 PWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG----LSKTG 684
             +Q   +C    + L YLH      +IHRD+K+ +ILL      K+SDFG    +SK  
Sbjct: 139 NEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195
Query: 685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           P          + G+  ++ PE   R     + D++S G+++ E++   P
Sbjct: 196 PK------RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 109/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL P     +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPAIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    +G G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +YM  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYMPGGDMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   KV+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIKVADFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  S A+  A  + F+    LG G FG+V   
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLV 61
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 62  KHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 121
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 122 EYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 176
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 177 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 230 YEMAAGYP 237

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 95  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 149
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 196
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 109/251 (43%), Gaps = 19/251 (7%)
Query: 491 SLYGNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKV 548
           S  GN+ +A  GS + +     A +    L +  S A+  A  + F+    LG G FG+V
Sbjct: 19  SHMGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRV 78
Query: 549 YRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI 605
              +        A+K   +   +  + +     E  +L  +    LV L    ++N  + 
Sbjct: 79  MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 138
Query: 606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNI 665
           +V +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+
Sbjct: 139 MVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENL 193
Query: 666 LLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFG 723
           L+D++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ G
Sbjct: 194 LIDQQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALG 246
Query: 724 VVLFEILCARP 734
           V+++E+    P
Sbjct: 247 VLIYEMAAGYP 257

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 92  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 146
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 193
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 86  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 140
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 187
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 102 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 156
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 203
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  S A+  A  + F+    LG G FG+V   
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLV 61
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 62  KHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 121
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y   G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+++D
Sbjct: 122 EYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLMID 176
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   KV+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 177 QQGYIKVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 230 YEMAAGYP 237

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 102 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 156
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 203
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  S A+  A  + F+    LG G FG+V   
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLV 61
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 62  KHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 121
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 122 EYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 176
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 177 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 230 YEMAAGYP 237

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 92  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 146
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 193
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 97  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 151
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 198
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDXELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 87  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 141
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 188
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 231

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 110/255 (43%), Gaps = 19/255 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARPALNPTLP 741
           +E+    P      P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 87  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 141
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 188
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 231

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 95  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 149
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 196
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 89  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 143
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 144 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 190
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 233

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 92  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 146
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 193
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 101 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 155
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 156 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 202
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 245

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 86  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 140
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 187
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 95  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 149
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 196
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 97  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 151
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HT-----ADEMTGYVATRWYRAP 198
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 109 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 163
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 210
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 253

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 97  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 151
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HT-----ADEMTGYVATRWYRAP 198
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 110 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 164
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 211
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 95  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 149
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 196
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 101 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 155
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 156 --DIIHRDLKPSNLAVNEDXELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 202
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 245

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 56/110 (50%), Gaps = 11/110 (10%)
Query: 625 KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG 684
           K P+  +  +      ARG+ +L +      IHRD+   NILL E  V K+ DFGL++  
Sbjct: 193 KEPITMEDLISYSFQVARGMEFLSS---RKCIHRDLAARNILLSENNVVKICDFGLARD- 248
Query: 685 PTLDHTHVSTVVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
               + +   V KG       ++ PE    +  + KSDV+S+GV+L+EI 
Sbjct: 249 ---IYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIF 295

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 92  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 146
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 147 --DIIHRDLKPSNLAVNEDSELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 193
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 27/204 (13%)
Query: 540 LGVGGFGKVY--RGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F KV   R  + G    V I     L+   + +   E+ +   L H ++V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 598 CEENCEMILVYDYMAYGTLREHLY-----KTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            E    + LV +Y + G + ++L      K ++    ++Q           + Y H   +
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ-------IVSAVQYCH---Q 131
Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKT---GPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+LLD     K++DFG S     G  LD         G+  Y  PE F+
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLD------AFCGAPPYAAPELFQ 185
Query: 710 RQQLT-EKSDVYSFGVVLFEILCA 732
            ++    + DV+S GV+L+ ++  
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 97  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 151
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HT-----ADEMTGYVATRWYRAP 198
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 113 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 167
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 168 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 214
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 257

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 100 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 154
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 155 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 201
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 244

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K+QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL +      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDSELKILDFGLCR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 96  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 150
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 197
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 110 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 164
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 211
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 109 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 163
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 210
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 253

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 96  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 150
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 151 --DIIHRDLKPSNLAVNEDSELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 197
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 11/95 (11%)
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
            A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++      +     V KG 
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPDYVRKGD 261
Query: 700 ----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                 ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 262 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 296

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 11/95 (11%)
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
            A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++      +     V KG 
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPDYVRKGD 259
Query: 700 ----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                 ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 260 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 294

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 109/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+   L PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 109/255 (42%), Gaps = 19/255 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARPALNPTLP 741
           +E+    P      P
Sbjct: 229 YEMAAGYPPFFADQP 243

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 540 LGVGGFGKV--YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG GGF  V    G  DG     A+KR     +Q   E Q E +M     H +++ L+ Y
Sbjct: 37  LGEGGFSYVDLVEGLHDGHF--YALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 598 CEE----NCEMILVYDYMAYGTLREHLYKTQKPP--LPWKQRLEICIGAARGLHYLHTGA 651
           C        E  L+  +   GTL   + + +     L   Q L + +G  RGL  +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFG-LSKTGPTLDHTHVSTVV------KGSFGYLD 704
                HRD+K TNILL ++    + D G +++    ++ +  +  +      + +  Y  
Sbjct: 155 ---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 705 PEYFRRQQ---LTEKSDVYSFGVVLFEIL 730
           PE F  Q    + E++DV+S G VL+ ++
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG---YLDPE-Y 707
              IIHRD+K +N+ ++E    K+ DFGL++        H    + G      Y  PE  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMTGXVATRWYRAPEIM 194
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
                  +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 11/95 (11%)
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
            A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++      +     V KG 
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPDYVRKGD 254
Query: 700 ----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                 ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 96  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 150
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 197
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 575 EFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREH------LYKTQKPPL 628
           +F+ E+++++ +++ + ++  G      E+ ++Y+YM   ++ +       L K     +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 629 PWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD 688
           P +    I         Y+H   +  I HRDVK +NIL+D+    K+SDFG S       
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGES------- 199
Query: 689 HTHVSTVVKGSFG---YLDPEYFRRQQLTE--KSDVYSFGVVLF 727
              V   +KGS G   ++ PE+F  +      K D++S G+ L+
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 11/95 (11%)
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
            A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++      +     V KG 
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPDYVRKGD 252
Query: 700 ----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                 ++ PE    +  T +SDV+SFGV+L+EI 
Sbjct: 253 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 287

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y   G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+++D
Sbjct: 121 EYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLMID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   KV+DFGL+K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIKVTDFGLAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 96  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 150
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 197
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIE 581
           A+  A  + F+    +G G FG+V   +        A+K   +   +  + +     E  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
           +L  +    LV L    ++N  + +V +YM  G +  HL +  +   P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGS 699
               YLH+     +I+RD+K  N+L+D++   KV+DFG +K   G T         + G+
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW-------XLCGT 201
Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             YL PE    +   +  D ++ GV+++E+    P
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 86  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 140
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          G++   ++R  
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMA-----GFVATRWYRAP 187
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 110 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 164
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG---YLDPE-Y 707
              IIHRD+K +N+ ++E    K+ DFGL++        H    + G      Y  PE  
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMXGXVATRWYRAPEIM 214
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
                  +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 14/213 (6%)
Query: 527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEML 583
           ++    ++D   ++G G FG+V       +    A+K   +   +       F  E +++
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 584 SKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARG 643
           +      +V L    +++  + +V +YM  G L  +L      P  W +     +  A  
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLA-- 186
Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           L  +H+     +IHRDVK  N+LLD+    K++DFG           H  T V G+  Y+
Sbjct: 187 LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYI 242
Query: 704 DPEYFRRQ----QLTEKSDVYSFGVVLFEILCA 732
            PE  + Q        + D +S GV LFE+L  
Sbjct: 243 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 35/241 (14%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--------GNPLSEQGVHEFQTE 579
           KA  + +  +  LG G  G+V          KVAIK         G+          +TE
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRL 634
           IE+L KL H  ++ +  + +   +  +V + M  G L + +      K     L + Q L
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTH 691
                    + YLH   ++ IIHRD+K  N+LL   +E  + K++DFG SK    L  T 
Sbjct: 125 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETS 171
Query: 692 VSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA 748
           +   + G+  YL PE              D +S GV+LF  L   P  +    + QVSL 
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVSLK 229
Query: 749 E 749
           +
Sbjct: 230 D 230

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 107/246 (43%), Gaps = 15/246 (6%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 61
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 62  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 121
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 122 EYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 176
Query: 669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 728
           ++   +V+DFG +K       T     + G+  YL PE    +   +  D ++ GV+++E
Sbjct: 177 QQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 729 ILCARP 734
           +    P
Sbjct: 232 MAAGYP 237

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 11/167 (6%)
Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLRHR 589
           +N++   L+G G +G VY      A   VAIK+ N + E  +       EI +L++L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 590 HLVSLIGYCEENCEMILVYD--YMAYGTLREHLYKTQKPP--LPWKQRLEICIGAARGLH 645
           +++ L        E +L +D  Y+        L K  K P  L  +    I      G  
Sbjct: 88  YIIRLHDLIIP--EDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEK 145
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV 692
           ++H      IIHRD+K  N LL++    K+ DFGL++T  +    H+
Sbjct: 146 FIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHI 189

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ D+GL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDYGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 13/160 (8%)
Query: 573 VHEFQTEIEMLSKLRHRHLVSLIGYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPW 630
           + +   EI +L KL H ++V L+   ++  E  + +V++ +  G + E    T KP L  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTLKP-LSE 136
Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
            Q         +G+ YLH      IIHRD+K +N+L+ E    K++DFG+S      D  
Sbjct: 137 DQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 691 HVSTVVKGSFGYLDPEYFR--RQQLTEKS-DVYSFGVVLF 727
             +TV  G+  ++ PE     R+  + K+ DV++ GV L+
Sbjct: 194 LSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 35/241 (14%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--------GNPLSEQGVHEFQTE 579
           KA  + +  +  LG G  G+V          KVAIK         G+          +TE
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 71
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRL 634
           IE+L KL H  ++ +  + +   +  +V + M  G L + +      K     L + Q L
Sbjct: 72  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 130
Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTH 691
                    + YLH   ++ IIHRD+K  N+LL   +E  + K++DFG SK    L  T 
Sbjct: 131 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETS 177
Query: 692 VSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA 748
           +   + G+  YL PE              D +S GV+LF  L   P  +    + QVSL 
Sbjct: 178 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVSLK 235
Query: 749 E 749
           +
Sbjct: 236 D 236

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 35/241 (14%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--------GNPLSEQGVHEFQTE 579
           KA  + +  +  LG G  G+V          KVAIK         G+          +TE
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRL 634
           IE+L KL H  ++ +  + +   +  +V + M  G L + +      K     L + Q L
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTH 691
                    + YLH   ++ IIHRD+K  N+LL   +E  + K++DFG SK    L  T 
Sbjct: 125 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETS 171
Query: 692 VSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA 748
           +   + G+  YL PE              D +S GV+LF  L   P  +    + QVSL 
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVSLK 229
Query: 749 E 749
           +
Sbjct: 230 D 230

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEM 582
           +++    +F+   ++G G FG+V   ++  A    A+K  N    L       F+ E ++
Sbjct: 68  QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV 127
Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP------WKQRLEI 636
           L     + + +L    +++  + LV DY   G L   L K +   LP      +   + I
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVI 186
Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
            I +   LHY         +HRD+K  NIL+D     +++DFG S      D T  S+V 
Sbjct: 187 AIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVA 236
Query: 697 KGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEIL 730
            G+  Y+ PE  +     + +   + D +S GV ++E+L
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  G  + +     A +    L +  S A+  A  + F+    LG G FG+V   
Sbjct: 2   GNAAAAKKGXEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLV 61
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 62  KHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 121
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 122 EYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 176
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 177 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 230 YEMAAGYP 237

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 35/241 (14%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--------GNPLSEQGVHEFQTE 579
           KA  + +  +  LG G  G+V          KVAIK         G+          +TE
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRL 634
           IE+L KL H  ++ +  + +   +  +V + M  G L + +      K     L + Q L
Sbjct: 65  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 123
Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTH 691
                    + YLH   ++ IIHRD+K  N+LL   +E  + K++DFG SK    L  T 
Sbjct: 124 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETS 170
Query: 692 VSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA 748
           +   + G+  YL PE              D +S GV+LF  L   P  +    + QVSL 
Sbjct: 171 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVSLK 228
Query: 749 E 749
           +
Sbjct: 229 D 229

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 101/241 (41%), Gaps = 35/241 (14%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAI----KR----GNPLSEQGVHEFQTE 579
           KA  + +  +  LG G  G+V          KVAI    KR    G+          +TE
Sbjct: 145 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 204
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRL 634
           IE+L KL H  ++ +  + +   +  +V + M  G L + +      K     L + Q L
Sbjct: 205 IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 263
Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTH 691
                    + YLH      IIHRD+K  N+LL   +E  + K++DFG SK    L  T 
Sbjct: 264 -------LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETS 310
Query: 692 VSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA 748
           +   + G+  YL PE              D +S GV+LF  L   P  +    + QVSL 
Sbjct: 311 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVSLK 368
Query: 749 E 749
           +
Sbjct: 369 D 369

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 35/241 (14%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR--------GNPLSEQGVHEFQTE 579
           KA  + +  +  LG G  G+V          KVAIK         G+          +TE
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRL 634
           IE+L KL H  ++ +  + +   +  +V + M  G L + +      K     L + Q L
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTH 691
                    + YLH   ++ IIHRD+K  N+LL   +E  + K++DFG SK    L  T 
Sbjct: 125 -------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETS 171
Query: 692 VSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA 748
           +   + G+  YL PE              D +S GV+LF  L   P  +    + QVSL 
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVSLK 229
Query: 749 E 749
           +
Sbjct: 230 D 230

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSL--- 594
           +L  GGF  VY  +  G+  + A+KR     E+       E+  + KL  H ++V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 595 --IGYCEEN---CEMILVYDYMAYGTLREHLYKTQ-KPPLPWKQRLEICIGAARGLHYLH 648
             IG  E +    E +L+ + +  G L E L K + + PL     L+I     R + ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH-------THVSTVVKGSFG 701
              K  IIHRD+K  N+LL  +   K+ DFG   +  T+ H            +V+    
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFG---SATTISHYPDYSWSAQRRALVEEEIT 209
Query: 702 ------YLDPE---YFRRQQLTEKSDVYSFGVVLFEILCAR 733
                 Y  PE    +    + EK D+++ G +L+ +LC R
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY-LLCFR 249

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 101/241 (41%), Gaps = 35/241 (14%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAI----KR----GNPLSEQGVHEFQTE 579
           KA  + +  +  LG G  G+V          KVAI    KR    G+          +TE
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 580 IEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRL 634
           IE+L KL H  ++ +  + +   +  +V + M  G L + +      K     L + Q L
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTH 691
                    + YLH      IIHRD+K  N+LL   +E  + K++DFG SK    L  T 
Sbjct: 250 -------LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETS 296
Query: 692 VSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA 748
           +   + G+  YL PE              D +S GV+LF  L   P  +    + QVSL 
Sbjct: 297 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH--RTQVSLK 354
Query: 749 E 749
           +
Sbjct: 355 D 355

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          G++   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMA-----GFVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    +G G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   KV+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIKVADFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          G++   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMA-----GFVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKR-GNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           +G G +G V    +DG T  KVAIK+   P  SE        E+ +L  +RH +++ L+ 
Sbjct: 33  VGSGAYGAVCSA-VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 597 Y------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI-GAARGLHYLHT 649
                   ++  +  LV  +M  GT    L K +K     + R++  +    +GL Y+H 
Sbjct: 92  VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLG---EDRIQFLVYQMLKGLRYIHA 146
Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY-F 708
                IIHRD+K  N+ ++E    K+ DFGL++     D      VV  +  Y  PE   
Sbjct: 147 AG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMXGXVV--TRWYRAPEVIL 198
Query: 709 RRQQLTEKSDVYSFGVVLFEILCAR 733
              + T+  D++S G ++ E++  +
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V       +  K+A+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 119 FTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 173
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 174 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 220
Query: 712 QL-------TEKSDVYSFGVVLFEILCAR 733
           ++           D++S G ++ E+L  R
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 26/226 (11%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL----- 594
           LG GG G V+    +    +VAIK+      Q V     EI+++ +L H ++V +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 595 ---------IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
                    +G   E   + +V +YM            Q P L    RL       RGL 
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLAN---VLEQGPLLEEHARL-FMYQLLRGLK 134
Query: 646 YLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKT-GPTLDHT-HVSTVVKGSFGY 702
           Y+H+     ++HRD+K  N+ ++ E  V K+ DFGL++   P   H  H+S  +   + Y
Sbjct: 135 YIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW-Y 190
Query: 703 LDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
             P         T+  D+++ G +  E+L  +         EQ+ L
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIE 581
           A+  A  + F+    LG G FG+V   +        A+K   +   +  + +     E  
Sbjct: 27  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKR 86
Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
           +L  +    LV L    ++N  + +V +Y+  G +  HL +  +   P  +     I   
Sbjct: 87  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--V 144
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGS 699
               YLH+     +I+RD+K  N+L+D++   +V+DFG +K   G T         + G+
Sbjct: 145 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------XLCGT 194
Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             YL PE    +   +  D ++ GV+++E+    P
Sbjct: 195 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 91/184 (49%), Gaps = 15/184 (8%)
Query: 563 KRGNPLSEQGV--HEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL 620
           KR +  S +GV   E + E+ +L ++ H ++++L    E   +++L+ + ++ G L + L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 621 YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV----AKVS 676
              QK  L  ++          G++YLHT     I H D+K  NI+L +K +     K+ 
Sbjct: 107 --AQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161
Query: 677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPA 735
           DFGL+      D      +  G+  ++ PE    + L  ++D++S GV+ + +L  A P 
Sbjct: 162 DFGLAH--EIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 736 LNPT 739
           L  T
Sbjct: 219 LGDT 222

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 61
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 62  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 121
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 122 EYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 176
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 177 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 230 YEMAAGYP 237

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y   G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+++D
Sbjct: 121 EYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLMID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   KV+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIKVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 61
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 62  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 121
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 122 EYVPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 176
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 177 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 230 YEMAAGYP 237

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 540 LGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLRHRHLVS 593
           LG G F  V +            K   KR +  S +GV   E + E+ +L ++ H ++++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L    E   +++L+ + ++ G L + L   QK  L  ++          G++YLHT    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 654 TIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            I H D+K  NI+L +K +     K+ DFGL+      D      +  G+  ++ PE   
Sbjct: 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIF-GTPEFVAPEIVN 191
Query: 710 RQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            + L  ++D++S GV+ + +L  A P L  T   +Q +LA   A
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITA 232

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 109/251 (43%), Gaps = 25/251 (9%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  G  + +     A +    L +  S A+  A  + F+    LG G FG+V   
Sbjct: 2   GNAAAAKKGXEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIRTLGTGSFGRVMLV 61
Query: 552 EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH------LVSLIGYCEENCEMI 605
           +        A+K    L +Q V + +     L++ R +       LV L    ++N  + 
Sbjct: 62  KHKETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLY 118
Query: 606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNI 665
           +V +Y   G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+
Sbjct: 119 MVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENL 173
Query: 666 LLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFG 723
           L+D++   KV+DFG +K   G T         + G+  YL PE    +   +  D ++ G
Sbjct: 174 LIDQQGYIKVADFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 724 VVLFEILCARP 734
           V+++E+    P
Sbjct: 227 VLIYEMAAGYP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+  G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+L+D
Sbjct: 121 EYVPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 540 LGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLRHRHLVS 593
           LG G F  V +            K   KR +  S +GV   E + E+ +L ++ H ++++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L    E   +++L+ + ++ G L + L   QK  L  ++          G++YLHT    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 654 TIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            I H D+K  NI+L +K +     K+ DFGL+      D      +  G+  ++ PE   
Sbjct: 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIF-GTPEFVAPEIVN 191
Query: 710 RQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            + L  ++D++S GV+ + +L  A P L  T   +Q +LA   A
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITA 232

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y   G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+++D
Sbjct: 121 EYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLMID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFGL+K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGLAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y   G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+++D
Sbjct: 121 EYAPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLMID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   KV+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIKVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIE 581
           A+  A  + F+    LG G FG+V   +        A+K   +   +  + +     E  
Sbjct: 27  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKR 86
Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
           +L  +    LV L    ++N  + +V +Y+  G +  HL +  +   P  +     I   
Sbjct: 87  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI--V 144
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGS 699
               YLH+     +I+RD+K  N+L+D++   +V+DFG +K   G T         + G+
Sbjct: 145 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------XLCGT 194
Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             YL PE    +   +  D ++ GV+++E+    P
Sbjct: 195 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 28/157 (17%)
Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST 694
           +I +   + L +LH+  K ++IHRDVK +N+L++     K+ DFG+S  G  +D     T
Sbjct: 157 KIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDSV-AKT 211
Query: 695 VVKGSFGYLDPEY----FRRQQLTEKSDVYSFGVVLFEILCAR----------------- 733
           +  G   Y+ PE       ++  + KSD++S G+ + E+   R                 
Sbjct: 212 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 271
Query: 734 PALNPTLPKEQVS--LAEWAAHCHKKGILEQIMDPYL 768
              +P LP ++ S    ++ + C KK   E+   P L
Sbjct: 272 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 308

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K  K      Q L   I   RGL Y+H+  
Sbjct: 86  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQI--LRGLKYIHSA- 140
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DFGL++      HT          GY+   ++R  
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMT-----GYVATRWYRAP 187
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 540 LGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLRHRHLVS 593
           LG G F  V +            K   KR +  S +GV   E + E+ +L ++ H ++++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L    E   +++L+ + ++ G L + L   QK  L  ++          G++YLHT    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 654 TIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            I H D+K  NI+L +K +     K+ DFGL+      D      +  G+  ++ PE   
Sbjct: 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIF-GTPEFVAPEIVN 191
Query: 710 RQQLTEKSDVYSFGVVLFEILC-ARPALNPT 739
            + L  ++D++S GV+ + +L  A P L  T
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDT 222

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 540 LGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLRHRHLVS 593
           LG G F  V +            K   KR +  S +GV   E + E+ +L ++ H ++++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L    E   +++L+ + ++ G L + L   QK  L  ++          G++YLHT    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 654 TIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            I H D+K  NI+L +K +     K+ DFGL+      D      +  G+  ++ PE   
Sbjct: 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIF-GTPEFVAPEIVN 191
Query: 710 RQQLTEKSDVYSFGVVLFEILC-ARPALNPT 739
            + L  ++D++S GV+ + +L  A P L  T
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDT 222

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 13/213 (6%)
Query: 525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIE 581
           A+  A  + F+    LG G FG+V   +        A+K   +   +  + +     E  
Sbjct: 20  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 79
Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
           +L  +    LV L    ++N  + +V +Y+  G +  HL +  +   P  +     I   
Sbjct: 80  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--V 137
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
               YLH+     +I+RD+K  N+L+D++   +V+DFG +K       T     + G+  
Sbjct: 138 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPE 189
Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           YL PE    +   +  D ++ GV+++E+    P
Sbjct: 190 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 222

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          KVA+K+ +   +  +H  +T  E+ +L  L+H +++ L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  E+  E+ LV   M  G    ++ K+Q       Q L       RGL Y+H+  
Sbjct: 96  FTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFL--VYQLLRGLKYIHSAG 151
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE-YFRR 710
              IIHRD+K +N+ ++E    ++ DFGL++        +V+T       Y  PE     
Sbjct: 152 ---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVAT-----RWYRAPEIMLNW 203
Query: 711 QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  D++S G ++ E+L  + AL P
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGK-ALFP 230

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+  FGL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILGFGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIE 581
           A+  A  + F+    LG G FG+V   +        A+K   +   +  + +     E  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
           +L  +    LV L    ++N  + +V +Y+  G +  HL +  +   P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--V 151
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGS 699
               YLH+     +I+RD+K  N+L+D++   +V+DFG +K   G T         + G+
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------XLCGT 201
Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             YL PE    +   +  D ++ GV+++E+    P
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          KVA+K+ +   +  +H  +T  E+ +L  L+H +++ L+  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  E+  E+ LV   M  G    ++ K Q       Q L       RGL Y+H+  
Sbjct: 88  FTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFL--VYQLLRGLKYIHSAG 143
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE-YFRR 710
              IIHRD+K +N+ ++E    ++ DFGL++        +V+T       Y  PE     
Sbjct: 144 ---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVAT-----RWYRAPEIMLNW 195
Query: 711 QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  D++S G ++ E+L  + AL P
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGK-ALFP 222

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 107/248 (43%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 60
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y   G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+++D
Sbjct: 121 EYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLMID 175
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   +V+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 229 YEMAAGYP 236

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ D GL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDAGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIE 581
           A+  A  + F+    LG G FG+V   +        A+K   +   +  + +     E  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
           +L  +    LV L    ++N  + +V +Y+  G +  HL +  +   P  +     I   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI--V 151
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGS 699
               YLH+     +I+RD+K  N+L+D++   +V+DFG +K   G T         + G+
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------XLCGT 201
Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             YL PE    +   +  D ++ GV+++E+    P
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ DF L++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFYLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ D GL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDRGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 61
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    L  L    ++N  + +V 
Sbjct: 62  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVM 121
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y   G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+++D
Sbjct: 122 EYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLMID 176
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   KV+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 177 QQGYIKVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 230 YEMAAGYP 237

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 540 LGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLRHRHLVS 593
           LG G F  V +            K   KR +  S +GV   E + E+ +L ++ H ++++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L    E   +++L+ + ++ G L + L   QK  L  ++          G++YLHT    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 654 TIIHRDVKTTNILLDEKWV----AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
            I H D+K  NI+L +K +     K+ DFGL+      D      +  G+  ++ PE   
Sbjct: 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIF-GTPEFVAPEIVN 191
Query: 710 RQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA 752
            + L  ++D++S GV+ + +L  A P L  T   +Q +LA   A
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITA 232

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K QK      Q L   I   RGL Y+H+  
Sbjct: 90  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSA- 144
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
              IIHRD+K +N+ ++E    K+ D GL++      HT          GY+   ++R  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDGGLAR------HTDDEMT-----GYVATRWYRAP 191
Query: 712 QL-------TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
           ++        +  D++S G ++ E+L  R     T   +Q+ L
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 19/248 (7%)
Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + A+  A  + F+    LG G FG+V   
Sbjct: 2   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLV 61
Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +        A+K   +   +  + +     E  +L  +    L  L    ++N  + +V 
Sbjct: 62  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVM 121
Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y   G +  HL +  +   P  +     I       YLH+     +I+RD+K  N+++D
Sbjct: 122 EYAPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLHS---LDLIYRDLKPENLMID 176
Query: 669 EKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 726
           ++   KV+DFG +K   G T         + G+  YL PE    +   +  D ++ GV++
Sbjct: 177 QQGYIKVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 727 FEILCARP 734
           +E+    P
Sbjct: 230 YEMAAGYP 237

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           +G G FG         A   VA+K   RG  + E      + EI     LRH ++V    
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDEN----VKREIINHRSLRHPNIVRFKE 82
Query: 597 YCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  + +V +Y + G L E +     +   +    ++Q +        G+ Y H   
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYAHA-- 133
Query: 652 KHTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              + HRD+K  N LLD       K++DFG SK   ++ H+   + V G+  Y+ PE   
Sbjct: 134 -MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA--SVLHSQPKSAV-GTPAYIAPEVLL 189
Query: 710 RQQLTEK-SDVYSFGVVLFEILC-ARPALNPTLPK 742
           +++   K +DV+S GV L+ +L  A P  +P  PK
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G +G V          KVA+K+ +   +  +H  +T  E+ +L  L+H +++ L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 598 ------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  E+  E+ LV   M  G    ++ K Q       Q L       RGL Y+H+  
Sbjct: 96  FTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFL--VYQLLRGLKYIHSAG 151
Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE-YFRR 710
              IIHRD+K +N+ ++E    ++ DFGL++        +V+T       Y  PE     
Sbjct: 152 ---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVAT-----RWYRAPEIMLNW 203
Query: 711 QQLTEKSDVYSFGVVLFEILCARPALNP 738
               +  D++S G ++ E+L  + AL P
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGK-ALFP 230

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +LG+G  GKV +        K A+K       Q   + + E+E+  +     H+V ++  
Sbjct: 39  VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 93
Query: 597 ----YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
               Y    C +++V + +  G L   +          ++  EI       + YLH+   
Sbjct: 94  YENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 150
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I HRDVK  N+L   K    + K++DFG +K   T  H  ++T     + Y+ PE   
Sbjct: 151 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCYTPY-YVAPEVLG 206
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D++S GV+++ +LC  P
Sbjct: 207 PEKYDKSCDMWSLGVIMYILLCGYP 231

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQT----EIEMLSKLRH--RH 590
           LLG GGFG VY G        VAIK    + +S+ G     T    E+ +L K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W Q LE    
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 121
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 122 AVRHCH------NXGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 171
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 19/110 (17%)
Query: 634 LEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH---- 689
           L I I  A  + +LH+     ++HRD+K +NI      V KV DFGL  T    D     
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV-TAMDQDEEEQT 222
Query: 690 ---------THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                    TH   V  G+  Y+ PE       + K D++S G++LFE+L
Sbjct: 223 VLTPMPAYATHXGQV--GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 95/216 (43%), Gaps = 16/216 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRH 588
           +++F    LLG G +G V           VAIK+  P  ++ +   +T  EI++L   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKH 68
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI-GAARGLHYL 647
            +++++      +        Y+    ++  L++     +     ++  I    R +  L
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTHVSTVVKGSFGYLDP 705
           H      +IHRD+K +N+L++     KV DFGL++       D++  +    G   Y+  
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 706 EYFRRQQLTEKS-------DVYSFGVVLFEILCARP 734
            ++R  ++   S       DV+S G +L E+   RP
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 22/205 (10%)
Query: 540 LGVGGFGKVYR--GEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G F  V R    + G      I     LS +   + + E  +   L+H ++V L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
             E     L++D +  G L E +     Y         +Q LE        LH    G  
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV------LHCHQMG-- 141
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             ++HRD+K  N+LL  K      K++DFGL+                G+ GYL PE  R
Sbjct: 142 --VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLR 197
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           +    +  D+++ GV+L+ +L   P
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYP 222

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 40/223 (17%)
Query: 527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL 586
           I    N+F    ++G GGFG+VY           A+K    L ++ +   Q E   L++ 
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNE- 239
Query: 587 RHRHLVSLIGYCEENCEMIL--------------VYDYMAYGTLREHLYKTQKPPLPWKQ 632
             R ++SL+     +C  I+              + D M  G L  HL  +Q        
Sbjct: 240 --RIMLSLVSTG--DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAD 293
Query: 633 RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL----SKTGPTLD 688
                     GL ++H      +++RD+K  NILLDE    ++SD GL    SK  P   
Sbjct: 294 MRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 347
Query: 689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEIL 730
             H S    G+ GY+ PE  ++    + S D +S G +LF++L
Sbjct: 348 --HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 7/149 (4%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLRHRHLVSLIG 596
           L+G G +G VY          VAIK+ N + E  +       EI +L++L+  +++ L  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPP--LPWKQRLEICIGAARGLHYLHTGAKHT 654
               +  +     Y+        L K  K P  L  +    I      G +++H      
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--- 149
Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKT 683
           IIHRD+K  N LL++    KV DFGL++T
Sbjct: 150 IIHRDLKPANCLLNQDCSVKVCDFGLART 178

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 40/223 (17%)
Query: 527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL 586
           I    N+F    ++G GGFG+VY           A+K    L ++ +   Q E   L++ 
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNE- 238
Query: 587 RHRHLVSLIGYCEENCEMIL--------------VYDYMAYGTLREHLYKTQKPPLPWKQ 632
             R ++SL+     +C  I+              + D M  G L  HL  +Q        
Sbjct: 239 --RIMLSLVSTG--DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAD 292
Query: 633 RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL----SKTGPTLD 688
                     GL ++H      +++RD+K  NILLDE    ++SD GL    SK  P   
Sbjct: 293 MRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 346
Query: 689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEIL 730
             H S    G+ GY+ PE  ++    + S D +S G +LF++L
Sbjct: 347 --HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 40/223 (17%)
Query: 527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL 586
           I    N+F    ++G GGFG+VY           A+K    L ++ +   Q E   L++ 
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNE- 239
Query: 587 RHRHLVSLIGYCEENCEMIL--------------VYDYMAYGTLREHLYKTQKPPLPWKQ 632
             R ++SL+     +C  I+              + D M  G L  HL  +Q        
Sbjct: 240 --RIMLSLVSTG--DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAD 293
Query: 633 RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL----SKTGPTLD 688
                     GL ++H      +++RD+K  NILLDE    ++SD GL    SK  P   
Sbjct: 294 MRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 347
Query: 689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEIL 730
             H S    G+ GY+ PE  ++    + S D +S G +LF++L
Sbjct: 348 --HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 40/223 (17%)
Query: 527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL 586
           I    N+F    ++G GGFG+VY           A+K    L ++ +   Q E   L++ 
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNE- 239
Query: 587 RHRHLVSLIGYCEENCEMIL--------------VYDYMAYGTLREHLYKTQKPPLPWKQ 632
             R ++SL+     +C  I+              + D M  G L  HL  +Q        
Sbjct: 240 --RIMLSLVSTG--DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAD 293
Query: 633 RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL----SKTGPTLD 688
                     GL ++H      +++RD+K  NILLDE    ++SD GL    SK  P   
Sbjct: 294 MRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 347
Query: 689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEIL 730
             H S    G+ GY+ PE  ++    + S D +S G +LF++L
Sbjct: 348 --HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +LG+G  GKV +        K A+K       Q   + + E+E+  +     H+V ++  
Sbjct: 31  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 85
Query: 597 ----YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
               Y    C +++V + +  G L   +          ++  EI       + YLH+   
Sbjct: 86  YENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 142
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I HRDVK  N+L   K    + K++DFG +K   T  H  ++T     + Y+ PE   
Sbjct: 143 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCYTPY-YVAPEVLG 198
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D++S GV+++ +LC  P
Sbjct: 199 PEKYDKSCDMWSLGVIMYILLCGYP 223

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +LG+G  GKV +        K A+K       Q   + + E+E+  +     H+V ++  
Sbjct: 30  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 84
Query: 597 ----YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
               Y    C +++V + +  G L   +          ++  EI       + YLH+   
Sbjct: 85  YENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 141
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I HRDVK  N+L   K    + K++DFG +K   T  H  ++T     + Y+ PE   
Sbjct: 142 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCYTPY-YVAPEVLG 197
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D++S GV+++ +LC  P
Sbjct: 198 PEKYDKSCDMWSLGVIMYILLCGYP 222

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +LG+G  GKV +        K A+K       Q   + + E+E+  +     H+V ++  
Sbjct: 29  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 83
Query: 597 ----YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
               Y    C +++V + +  G L   +          ++  EI       + YLH+   
Sbjct: 84  YENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 140
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I HRDVK  N+L   K    + K++DFG +K   T  H  ++T     + Y+ PE   
Sbjct: 141 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCYTPY-YVAPEVLG 196
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D++S GV+++ +LC  P
Sbjct: 197 PEKYDKSCDMWSLGVIMYILLCGYP 221

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 17/215 (7%)
Query: 525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIE 581
           A+  A  + F+    LG G FG+V   +        A+K   +   +  + +     E  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAA 641
           +L  +    L  L    ++N  + +V +Y   G +  HL +  +   P  +     I   
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--V 152
Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGS 699
               YLH+     +I+RD+K  N+++D++   KV+DFG +K   G T         + G+
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW-------XLCGT 202
Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             YL PE    +   +  D ++ GV+++E+    P
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +LG+G  GKV +        K A+K       Q   + + E+E+  +     H+V ++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 597 ----YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
               Y    C +++V + +  G L   +          ++  EI       + YLH+   
Sbjct: 124 YENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 180
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I HRDVK  N+L   K    + K++DFG +K   T  H  ++T     + Y+ PE   
Sbjct: 181 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCYTPY-YVAPEVLG 236
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D++S GV+++ +LC  P
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYP 261

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQT----EIEMLSKLRH--RH 590
           LLG GGFG VY G        VAIK    + +S+ G     T    E+ +L K+      
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W Q LE    
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 124
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 125 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 174
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 175 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQT----EIEMLSKLRH--RH 590
           LLG GGFG VY G        VAIK    + +S+ G     T    E+ +L K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W Q LE    
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW-QVLE---- 121
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 122 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 171
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 95/216 (43%), Gaps = 16/216 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRH 588
           +++F    LLG G +G V           VAIK+  P  ++ +   +T  EI++L   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKH 68
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI-GAARGLHYL 647
            +++++      +        Y+    ++  L++     +     ++  I    R +  L
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTHVSTVVKGSFGYLDP 705
           H      +IHRD+K +N+L++     KV DFGL++       D++  +    G   ++  
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 706 EYFRRQQLTEKS-------DVYSFGVVLFEILCARP 734
            ++R  ++   S       DV+S G +L E+   RP
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +LG+G  GKV +        K A+K       Q   + + E+E+  +     H+V ++  
Sbjct: 24  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 78
Query: 597 ----YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
               Y    C +++V + +  G L   +          ++  EI       + YLH+   
Sbjct: 79  YENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 135
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I HRDVK  N+L   K    + K++DFG +K   T  H  ++T     + Y+ PE   
Sbjct: 136 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCYTPY-YVAPEVLG 191
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D++S GV+++ +LC  P
Sbjct: 192 PEKYDKSCDMWSLGVIMYILLCGYP 216

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +LG+G  GKV +        K A+K       Q   + + E+E+  +     H+V ++  
Sbjct: 75  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 129
Query: 597 ----YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
               Y    C +++V + +  G L   +          ++  EI       + YLH+   
Sbjct: 130 YENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 186
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I HRDVK  N+L   K    + K++DFG +K   T  H  ++T     + Y+ PE   
Sbjct: 187 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCYTPY-YVAPEVLG 242
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D++S GV+++ +LC  P
Sbjct: 243 PEKYDKSCDMWSLGVIMYILLCGYP 267

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +LG+G  GKV +        K A+K       Q   + + E+E+  +     H+V ++  
Sbjct: 23  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 597 ----YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
               Y    C +++V + +  G L   +          ++  EI       + YLH+   
Sbjct: 78  YENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 134
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I HRDVK  N+L   K    + K++DFG +K   T  H  ++T     + Y+ PE   
Sbjct: 135 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCYTPY-YVAPEVLG 190
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D++S GV+++ +LC  P
Sbjct: 191 PEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +LG+G  GKV +        K A+K       Q   + + E+E+  +     H+V ++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 597 ----YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
               Y    C +++V + +  G L   +          ++  EI       + YLH+   
Sbjct: 80  YENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 136
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I HRDVK  N+L   K    + K++DFG +K   T  H  ++T     + Y+ PE   
Sbjct: 137 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCYTPY-YVAPEVLG 192
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D++S GV+++ +LC  P
Sbjct: 193 PEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 95/217 (43%), Gaps = 18/217 (8%)
Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRH 588
           +++F    LLG G +G V           VAIK+  P  ++ +   +T  EI++L   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKH 68
Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI-GAARGLHYL 647
            +++++      +        Y+    ++  L++     +     ++  I    R +  L
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK---------TGPTLDHTHVSTVVKG 698
           H      +IHRD+K +N+L++     KV DFGL++         + PT   + ++  V  
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVAT 185
Query: 699 SFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEILCARP 734
            + Y  PE      + +   DV+S G +L E+   RP
Sbjct: 186 RW-YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/187 (20%), Positives = 85/187 (45%), Gaps = 7/187 (3%)
Query: 546 GKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE--NCE 603
           G++++G   G    V + +    S +   +F  E   L    H +++ ++G C+      
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTT 663
             L+  +M YG+L   L++     +   Q ++  +  ARG+ +LHT  +  I    + + 
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSR 142
Query: 664 NILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFG 723
           ++++DE   A++S   +  +  +    +    V        PE   R+     +D++SF 
Sbjct: 143 SVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRS----ADMWSFA 198
Query: 724 VVLFEIL 730
           V+L+E++
Sbjct: 199 VLLWELV 205

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +LG+G  GKV +        K A+K       Q   + + E+E+  +     H+V ++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 597 ----YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
               Y    C +++V + +  G L   +          ++  EI       + YLH+   
Sbjct: 80  YENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 136
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I HRDVK  N+L   K    + K++DFG +K   T  H  ++T     + Y+ PE   
Sbjct: 137 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCYTPY-YVAPEVLG 192
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D++S GV+++ +LC  P
Sbjct: 193 PEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 540 LGVGGFG--KVYRGEIDGATTKVA-IKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           +G G FG  ++ R +       V  I+RG  + E      + EI     LRH ++V    
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN----VKREIINHRSLRHPNIVRFKE 81
Query: 597 YCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  + +V +Y + G L E +     +   +    ++Q +        G+ Y H   
Sbjct: 82  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYCHA-- 132
Query: 652 KHTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              + HRD+K  N LLD       K+ DFG SK+  ++ H+   + V G+  Y+ PE   
Sbjct: 133 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTV-GTPAYIAPEVLL 188
Query: 710 RQQLTEK-SDVYSFGVVLFEILC-ARPALNPTLPK 742
           +++   K +DV+S GV L+ +L  A P  +P  PK
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 223

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 55/103 (53%), Gaps = 9/103 (8%)
Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST 694
           +I +   + L +LH+  K ++IHRDVK +N+L++     K+ DFG+S  G  +D      
Sbjct: 113 KIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDV-AKD 167
Query: 695 VVKGSFGYLDPEY----FRRQQLTEKSDVYSFGVVLFEILCAR 733
           +  G   Y+ PE       ++  + KSD++S G+ + E+   R
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 591 LVSLIGYCEENCEMILVYDYM-----------AYGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+ + M             G L+E L ++      W+      + 
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 125
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 126 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 175
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 22/205 (10%)
Query: 540 LGVGGFGKVYR--GEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F  V R      G      I     LS +   + + E  +   L+H ++V L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
             E     LV+D +  G L E +     Y         +Q LE        LH    G  
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV------LHCHQMG-- 123
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             ++HRD+K  N+LL  K      K++DFGL+                G+ GYL PE  R
Sbjct: 124 --VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLR 179
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           ++   +  D+++ GV+L+ +L   P
Sbjct: 180 KEAYGKPVDIWACGVILYILLVGYP 204

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 168
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 169 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 218
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 141
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 142 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 191
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 140
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 141 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 190
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 154
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 155 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 204
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 153
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 154 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 203
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 141
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 142 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 191
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 154
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 155 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 204
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 140
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 141 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 190
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 154
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 155 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 204
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 153
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 154 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 203
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 153
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 154 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 203
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 154
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 155 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 204
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 168
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 169 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 218
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 153
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 154 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 203
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 160
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 161 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 210
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 126
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 127 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 176
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 173
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 174 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 223
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 224 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 141
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 142 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 191
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 126
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 127 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 176
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 125
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 126 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 175
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT-EIEMLSKLRHRHLVSLIGYC 598
           +G G +G VY+ + +   T    K      ++G+      EI +L +L+H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR-------------GLH 645
                ++LV+         EHL +        K+ L++C G                G+ 
Sbjct: 70  HTKKRLVLVF---------EHLDQD------LKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG--PTLDHTHVSTVVKGSFGYL 703
           Y H      ++HRD+K  N+L++ +   K++DFGL++    P   +TH   VV  +  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EVV--TLWYR 167
Query: 704 DPEYFR-RQQLTEKSDVYSFGVVLFEILCARP 734
            P+     ++ +   D++S G +  E++   P
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGAP 199

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 92/212 (43%), Gaps = 39/212 (18%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT-EIEMLSKLRHRHLVSLIGYC 598
           +G G +G VY+ + +   T    K      ++G+      EI +L +L+H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR-------------GLH 645
                ++LV++++                   K+ L++C G                G+ 
Sbjct: 70  HTKKRLVLVFEHLDQDL---------------KKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG--PTLDHTHVSTVVKGSFGYL 703
           Y H      ++HRD+K  N+L++ +   K++DFGL++    P   +TH   VV  +  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EVV--TLWYR 167
Query: 704 DPEYFR-RQQLTEKSDVYSFGVVLFEILCARP 734
            P+     ++ +   D++S G +  E++   P
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 126
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 127 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 176
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 22/205 (10%)
Query: 540 LGVGGFGKVYR--GEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G F  V R    + G      I     LS +   + + E  +   L+H ++V L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
             E     L++D +  G L E +     Y         +Q LE        LH    G  
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV------LHCHQMG-- 130
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             ++HR++K  N+LL  K      K++DFGL+                G+ GYL PE  R
Sbjct: 131 --VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLR 186
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           +    +  D+++ GV+L+ +L   P
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYP 211

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/198 (22%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYC 598
           +GVG + +  R        + A+K    + ++   +   EIE+L +  +H ++++L    
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVK----VIDKSKRDPSEEIEILLRYGQHPNIITLKDVY 90
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
           ++   + LV + M  G L + + + +      ++   +     + + YLH+     ++HR
Sbjct: 91  DDGKHVYLVTELMRGGELLDKILRQKF--FSEREASFVLHTIGKTVEYLHSQG---VVHR 145
Query: 659 DVKTTNIL-LDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           D+K +NIL +DE       ++ DFG +K     +   ++     +F  + PE  +RQ   
Sbjct: 146 DLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF--VAPEVLKRQGYD 203
Query: 715 EKSDVYSFGVVLFEILCA 732
           E  D++S G++L+ +L  
Sbjct: 204 EGCDIWSLGILLYTMLAG 221

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 98  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 148
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 149 AVRHCHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 198
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 199 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTK-VAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIG 596
           LLG G + KV +G +     K  A+K     +         E+E L + + +++++ LI 
Sbjct: 20  LLGEGAYAKV-QGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
           + E++    LV++ +  G++  H+ K +      ++   +    A  L +LHT     I 
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHIQKQKH--FNEREASRVVRDVAAALDFLHTKG---IA 133
Query: 657 HRDVKTTNILLD--EKWV-AKVSDFGLSKTGPTLDHTHVS------TVVKGSFGYLDPEY 707
           HRD+K  NIL +  EK    K+ DF L  +G  L+++         T   GS  Y+ PE 
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLG-SGMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 708 FR--RQQLT---EKSDVYSFGVVLFEILCARP 734
                 Q T   ++ D++S GVVL+ +L   P
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYP 224

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/212 (21%), Positives = 90/212 (42%), Gaps = 39/212 (18%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT-EIEMLSKLRHRHLVSLIGYC 598
           +G G +G VY+ + +   T    K      ++G+      EI +L +L+H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR-------------GLH 645
                ++LV++++                   K+ L++C G                G+ 
Sbjct: 70  HTKKRLVLVFEHLDQDL---------------KKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG--PTLDHTHVSTVVKGSFGYL 703
           Y H      ++HRD+K  N+L++ +   K++DFGL++    P   +TH       +  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYR 167
Query: 704 DPEYFR-RQQLTEKSDVYSFGVVLFEILCARP 734
            P+     ++ +   D++S G +  E++   P
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T        V +    Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTR---YY 191
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
             PE        E  D++S G ++ E++C +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/198 (22%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYC 598
           +GVG + +  R        + A+K    + ++   +   EIE+L +  +H ++++L    
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVK----VIDKSKRDPSEEIEILLRYGQHPNIITLKDVY 90
Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
           ++   + LV + M  G L + + + +      ++   +     + + YLH+     ++HR
Sbjct: 91  DDGKHVYLVTELMRGGELLDKILRQKF--FSEREASFVLHTIGKTVEYLHSQG---VVHR 145
Query: 659 DVKTTNIL-LDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           D+K +NIL +DE       ++ DFG +K     +   ++     +F  + PE  +RQ   
Sbjct: 146 DLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF--VAPEVLKRQGYD 203
Query: 715 EKSDVYSFGVVLFEILCA 732
           E  D++S G++L+ +L  
Sbjct: 204 EGCDIWSLGILLYTMLAG 221

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 22/205 (10%)
Query: 540 LGVGGFGKVYRGEI--DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G F  V R      G      I     LS +   + + E  +   L+H ++V L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
             E     LV+D +  G L E +     Y         +Q LE        +++ H    
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------SVNHCHLNG- 123
Query: 653 HTIIHRDVKTTNILLDEK---WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+LL  K      K++DFGL+                G+ GYL PE  R
Sbjct: 124 --IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLR 179
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           +    +  D+++ GV+L+ +L   P
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYP 204

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +LG+G  GKV +        K A+K       Q   + + E+E+  +     H+V ++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALK-----XLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 597 ----YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
               Y    C +++V + +  G L   +          ++  EI       + YLH+   
Sbjct: 124 YENLYAGRKC-LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSI-- 180
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I HRDVK  N+L   K    + K++DFG +K   T  H  ++T     + Y+ PE   
Sbjct: 181 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPCYTPY-YVAPEVLG 236
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D +S GV+ + +LC  P
Sbjct: 237 PEKYDKSCDXWSLGVIXYILLCGYP 261

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQTEIEMLSKLRHR------H 590
           LLG GGFG VY G        VAIK    + +S+ G     T + M   L  +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 591 LVSLIGYCEENCEMILV----------YDYMA-YGTLREHLYKTQKPPLPWKQRLEICIG 639
           ++ L+ + E     +L+          +D++   G L+E L ++      W+      + 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 121
Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
           A R  H         ++HRD+K  NIL+D  +   K+ DFG   +G  L  T V T   G
Sbjct: 122 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDG 171
Query: 699 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCA 732
           +  Y  PE+ R  +   +S  V+S G++L++++C 
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 125/288 (43%), Gaps = 61/288 (21%)
Query: 494 GNSHSAGSAKTNTTGS----------------YASSLPS-NLCRHFSFAEIKAATNNFDE 536
           G+SH A +A+ + +G+                + SS P+ ++ R  S  +I    + ++ 
Sbjct: 1   GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEI 57
Query: 537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGV--HEFQTEIEMLSKLRHRHLVSL 594
             L+G G +G V           VAIK+   + E  +       EI +L++L H H+V +
Sbjct: 58  RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 595 IGY-----CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI-GAARGLHYLH 648
           +        E+  E+ +V + +A    ++ L++T  P    +  ++  +     G+ Y+H
Sbjct: 118 LDIVIPKDVEKFDELYVVLE-IADSDFKK-LFRT--PVYLTELHIKTLLYNLLVGVKYVH 173
Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-------------GPTLDHT----- 690
           +     I+HRD+K  N L+++    KV DFGL++T              P  D       
Sbjct: 174 SAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 691 -HVSTVVKGSFGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEIL 730
            H   + +   G++   ++R  +L       TE  DV+S G +  E+L
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG V R   D  + ++   +     E+     + EI     LRH ++V       
Sbjct: 27  IGSGNFG-VARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVIL 85
Query: 600 ENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
               + +V +Y + G L E +     +   +    ++Q +        G+ Y H      
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYCHA---MQ 135
Query: 655 IIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
           + HRD+K  N LLD       K+ DFG SK+  ++ H+   + V G+  Y+ PE   +++
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTV-GTPAYIAPEVLLKKE 192
Query: 713 LTEK-SDVYSFGVVLFEILC-ARPALNPTLPK 742
              K +DV+S GV L+ +L  A P  +P  PK
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G +G+V      G   + A K+      + V  F+ EIE++  L H +++ L    E
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 93
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +N ++ LV +    G L E +    K          I       + Y H   K  + HRD
Sbjct: 94  DNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRD 148
Query: 660 VKTTNILL---DEKWVAKVSDFGLS---KTGPTLDHTHVST-------VVKGSFGYLDPE 706
           +K  N L          K+ DFGL+   K G  +  T V T       V++G +G   PE
Sbjct: 149 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKVGTPYYVSPQVLEGLYG---PE 204
Query: 707 YFRRQQLTEKSDVYSFGVVLFEILCARP 734
                      D +S GV+++ +LC  P
Sbjct: 205 ----------CDEWSAGVMMYVLLCGYP 222

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIG- 596
           +LG+G  GKV +        K A+K       Q   + + E+E+  +     H+V ++  
Sbjct: 23  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 597 ----YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
               Y    C +++V + +  G L   +          ++  EI       + YLH+   
Sbjct: 78  YENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 134
Query: 653 HTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I HRDVK  N+L   K    + K++DFG +K   T  H  ++      + Y+ PE   
Sbjct: 135 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTEPCYTPY-YVAPEVLG 190
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D++S GV+++ +LC  P
Sbjct: 191 PEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 46/100 (46%), Gaps = 7/100 (7%)
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRDVK  NIL+     A + DFG++        T +   V G+  Y  PE F     T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK 756
           +D+Y+   VL+E L   P      P +   L+   AH ++
Sbjct: 216 ADIYALTCVLYECLTGSP------PYQGDQLSVXGAHINQ 249

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 84/176 (47%), Gaps = 23/176 (13%)
Query: 579 EIEMLSKLRHRHLVSL--IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI 636
           EI +L +L+H +++SL  +     + ++ L++DY  +     H+ K  +     K+ +++
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQL 125
Query: 637 CIGAAR--------GLHYLHTGAKHTIIHRDVKTTNILL----DEKWVAKVSDFGLSK-- 682
             G  +        G+HYLH      ++HRD+K  NIL+     E+   K++D G ++  
Sbjct: 126 PRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 683 TGPTLDHTHVSTVVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEILCARPALN 737
             P      +  VV  +F Y  PE     +  T+  D+++ G +  E+L + P  +
Sbjct: 183 NSPLKPLADLDPVV-VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G +G+V      G   + A K+      + V  F+ EIE++  L H +++ L    E
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +N ++ LV +    G L E +    K          I       + Y H   K  + HRD
Sbjct: 77  DNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRD 131
Query: 660 VKTTNILL---DEKWVAKVSDFGLS---KTGPTLDHTHVST-------VVKGSFGYLDPE 706
           +K  N L          K+ DFGL+   K G  +  T V T       V++G +G   PE
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKVGTPYYVSPQVLEGLYG---PE 187
Query: 707 YFRRQQLTEKSDVYSFGVVLFEILCARP 734
                      D +S GV+++ +LC  P
Sbjct: 188 ----------CDEWSAGVMMYVLLCGYP 205

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEM 582
           E++    +F+   ++G G FG+V   ++       A+K  N    L       F+ E ++
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 127
Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI--CIGA 640
           L     + + +L    ++   + LV DY   G L   L K +        R  I   + A
Sbjct: 128 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 187
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
              +H LH       +HRD+K  N+LLD     +++DFG S      D T  S+V  G+ 
Sbjct: 188 IDSIHQLH------YVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTP 240
Query: 701 GYLDPEYFRRQQ-----LTEKSDVYSFGVVLFEIL 730
            Y+ PE  +  +        + D +S GV ++E+L
Sbjct: 241 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 275

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEM 582
           E++    +F+   ++G G FG+V   ++       A+K  N    L       F+ E ++
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 143
Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI--CIGA 640
           L     + + +L    ++   + LV DY   G L   L K +        R  I   + A
Sbjct: 144 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 203
Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
              +H LH       +HRD+K  N+LLD     +++DFG S      D T  S+V  G+ 
Sbjct: 204 IDSIHQLH------YVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTP 256
Query: 701 GYLDPEYFRRQQ-----LTEKSDVYSFGVVLFEIL 730
            Y+ PE  +  +        + D +S GV ++E+L
Sbjct: 257 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 291

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 22/205 (10%)
Query: 540 LGVGGFGKVYRGEI--DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G F  V R      G      I     LS +   + + E  +   L+H ++V L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 598 CEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
             E     LV+D +  G L E +     Y         +Q LE        +++ H    
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------SVNHCHLNG- 123
Query: 653 HTIIHRDVKTTNILLDEK---WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
             I+HRD+K  N+LL  K      K++DFGL+                G+ GYL PE  R
Sbjct: 124 --IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLR 179
Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
           +    +  D+++ GV+L+ +L   P
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYP 204

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR-GNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G +G V       +  KVAIK+   P  SE        E+ +L  ++H +++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 598 CEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +   YD Y+    ++  L K        ++   +     +GL Y+H+     ++
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VV 166
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL--- 713
           HRD+K  N+ ++E    K+ DFGL++      H           GY+   ++R  ++   
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLAR------HADAEMT-----GYVVTRWYRAPEVILS 215
Query: 714 ----TEKSDVYSFGVVLFEILCAR 733
                +  D++S G ++ E+L  +
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGV-HEFQTEIEMLSKLRHRHLVSLI 595
           +LG+G  GKV          K A+K    +P + Q V H +Q            H+V ++
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQAS-------GGPHIVCIL 88
Query: 596 GYCE-----ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
              E     + C ++++ + M  G L   + +        ++  EI       + +LH+ 
Sbjct: 89  DVYENMHHGKRC-LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS- 146
Query: 651 AKHTIIHRDVKTTNILLDEK---WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
             H I HRDVK  N+L   K    V K++DFG +K         + T     + Y+ PE 
Sbjct: 147 --HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQTPCYTPY-YVAPEV 200
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              ++  +  D++S GV+++ +LC  P
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFP 227

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 143 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYY 196
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
             PE        E  D++S G ++ E++C +
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T        V +    Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTR---YY 191
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
             PE        E  D++S G ++ E++C +
Sbjct: 192 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYY 185
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
             PE        E  D++S G ++ E++C +
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR-GNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G +G V       +  KVAIK+   P  SE        E+ +L  ++H +++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 598 CEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +   YD Y+    ++  L K        ++   +     +GL Y+H+     ++
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VV 148
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL--- 713
           HRD+K  N+ ++E    K+ DFGL++      H           GY+   ++R  ++   
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLAR------HADAEMT-----GYVVTRWYRAPEVILS 197
Query: 714 ----TEKSDVYSFGVVLFEILCAR 733
                +  D++S G ++ E+L  +
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 540 LGVGGFGKVYR------GEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G F  V +      G+   A      +RG     + +HE    +  L+K   R +++
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA--VLELAKSCPR-VIN 93
Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L    E   E+IL+ +Y A G +           +     + +      G++YLH   ++
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QN 150
Query: 654 TIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
            I+H D+K  NILL   +     K+ DFG+S+    + H      + G+  YL PE    
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLAPEILNY 207
Query: 711 QQLTEKSDVYSFGVVLFEIL 730
             +T  +D+++ G++ + +L
Sbjct: 208 DPITTATDMWNIGIIAYMLL 227

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGV-HEFQTEIEMLSKLRHRHLVSLI 595
           +LG+G  GKV          K A+K    +P + Q V H +Q            H+V ++
Sbjct: 17  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQAS-------GGPHIVCIL 69
Query: 596 GYCE-----ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
              E     + C ++++ + M  G L   + +        ++  EI       + +LH+ 
Sbjct: 70  DVYENMHHGKRC-LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS- 127
Query: 651 AKHTIIHRDVKTTNILLDEK---WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
             H I HRDVK  N+L   K    V K++DFG +K         + T     + Y+ PE 
Sbjct: 128 --HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET---TQNALQTPCYTPY-YVAPEV 181
Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              ++  +  D++S GV+++ +LC  P
Sbjct: 182 LGPEKYDKSCDMWSLGVIMYILLCGFP 208

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGV-HEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G +G V++ +       VA+KR      ++GV      EI +L +L+H+++V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
              + ++ LV+++       +  + +    L  +          +GL + H+     ++H
Sbjct: 70  LHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLH 124
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+L++     K++DFGL++        + + VV  +  Y  P+     +L   S
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTS 182
Query: 718 -DVYSFGVVLFEIL-CARP 734
            D++S G +  E+   ARP
Sbjct: 183 IDMWSAGCIFAELANAARP 201

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 540 LGVGGFG--KVYRGEIDGATTKVA-IKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           +G G FG  ++ R +       V  I+RG  + E      + EI     LRH ++V    
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN----VKREIINHRSLRHPNIVRFKE 82
Query: 597 YCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  + +V +Y + G L E +     +   +    ++Q +        G+ Y H   
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYCHA-- 133
Query: 652 KHTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              + HRD+K  N LLD       K+  FG SK+  ++ H+   + V G+  Y+ PE   
Sbjct: 134 -MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS--SVLHSQPKSTV-GTPAYIAPEVLL 189
Query: 710 RQQLTEK-SDVYSFGVVLFEILC-ARPALNPTLPK 742
           +++   K +DV+S GV L+ +L  A P  +P  PK
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHR-------- 589
           ++G G FG+V +         VA+K     +E+  H +   EI +L  LR +        
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 590 -HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI--CIGAARGLHY 646
            H++    +    C    +     Y  ++++ ++    PL  K    I  C+ A      
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA------ 215
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           LH   K+ IIH D+K  NILL ++  +  KV DFG S      +H  V T ++  F Y  
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTXIQSRF-YRA 267
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARPAL 736
           PE     +     D++S G +L E+L   P L
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGYPLL 299

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 28/157 (17%)
Query: 635 EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST 694
           +I +   + L +LH+  K ++IHRDVK +N+L++     K  DFG+S  G  +D      
Sbjct: 140 KIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKXCDFGIS--GYLVDDV-AKD 194
Query: 695 VVKGSFGYLDPEY----FRRQQLTEKSDVYSFGVVLFEILCAR----------------- 733
           +  G   Y  PE       ++  + KSD++S G+   E+   R                 
Sbjct: 195 IDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVV 254
Query: 734 PALNPTLPKEQVS--LAEWAAHCHKKGILEQIMDPYL 768
              +P LP ++ S    ++ + C KK   E+   P L
Sbjct: 255 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 14/214 (6%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEM 582
           +++    +++   ++G G FG+V            A+K   +   +       F  E ++
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR 642
           ++      +V L    +++  + +V +YM  G L  +L      P  W +     +  A 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLA- 180
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L  +H+      IHRDVK  N+LLD+    K++DFG              T V G+  Y
Sbjct: 181 -LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDY 235
Query: 703 LDPEYFRRQ----QLTEKSDVYSFGVVLFEILCA 732
           + PE  + Q        + D +S GV L+E+L  
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHR-------- 589
           ++G G FG+V +         VA+K     +E+  H +   EI +L  LR +        
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 590 -HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI--CIGAARGLHY 646
            H++    +    C    +     Y  ++++ ++    PL  K    I  C+ A      
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA------ 215
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           LH   K+ IIH D+K  NILL ++  +  KV DFG S      +H  V T ++  F Y  
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTXIQSRF-YRA 267
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARPAL 736
           PE     +     D++S G +L E+L   P L
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGYPLL 299

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 14/214 (6%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEM 582
           +++    +++   ++G G FG+V            A+K   +   +       F  E ++
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR 642
           ++      +V L    +++  + +V +YM  G L  +L      P  W +     +  A 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLA- 185
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L  +H+      IHRDVK  N+LLD+    K++DFG              T V G+  Y
Sbjct: 186 -LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDY 240
Query: 703 LDPEYFRRQ----QLTEKSDVYSFGVVLFEILCA 732
           + PE  + Q        + D +S GV L+E+L  
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 16/164 (9%)
Query: 575 EFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL 634
           + + E  +   L+H H+V L+     +  + +V+++M    L   + K       + + +
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 635 --EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA---KVSDFGLSKTGPTLDH 689
                      L Y H    + IIHRDVK  N+LL  K  +   K+ DFG++     +  
Sbjct: 132 ASHYMRQILEALRYCHD---NNIIHRDVKPENVLLASKENSAPVKLGDFGVA-----IQL 183
Query: 690 THVSTVVKGSFG---YLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                V  G  G   ++ PE  +R+   +  DV+  GV+LF +L
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILL 227

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 14/214 (6%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEM 582
           +++    +++   ++G G FG+V            A+K   +   +       F  E ++
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR 642
           ++      +V L    +++  + +V +YM  G L  +L      P  W +     +  A 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLA- 185
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            L  +H+      IHRDVK  N+LLD+    K++DFG              T V G+  Y
Sbjct: 186 -LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDY 240
Query: 703 LDPEYFRRQ----QLTEKSDVYSFGVVLFEILCA 732
           + PE  + Q        + D +S GV L+E+L  
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 540 LGVGGFG--KVYRGEIDGATTKVA-IKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           +G G FG  ++ R +       V  I+RG  + E      + EI     LRH ++V    
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN----VKREIINHRSLRHPNIVRFKE 82
Query: 597 YCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  + +V +Y + G L E +     +   +    ++Q +        G+ Y H   
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYCHA-- 133
Query: 652 KHTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
              + HRD+K  N LLD       K+  FG SK+  ++ H+     V G+  Y+ PE   
Sbjct: 134 -MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS--SVLHSQPKDTV-GTPAYIAPEVLL 189
Query: 710 RQQLTEK-SDVYSFGVVLFEILC-ARPALNPTLPK 742
           +++   K +DV+S GV L+ +L  A P  +P  PK
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 81/174 (46%), Gaps = 9/174 (5%)
Query: 560 VAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGYCEENCEMILVYD-YMAYGTL 616
           VAIK+ +   +   H  +   E+ ++  + H++++SL+        +    D Y+    +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVS 676
             +L +  +  L  ++   +      G+ +LH+     IIHRD+K +NI++      K+ 
Sbjct: 112 DANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKIL 168
Query: 677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           DFGL++T  T   + + T    +  Y  PE        E  D++S G ++ E++
Sbjct: 169 DFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           ++G G FG V++ ++   + +VAIK+      Q       E++++  ++H ++V L  + 
Sbjct: 47  VIGNGSFGVVFQAKL-VESDEVAIKK----VLQDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 599 EENCE------MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI------GAARGLHY 646
             N +      + LV +Y+      E +Y+  +     KQ + + +         R L Y
Sbjct: 102 YSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 647 LHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           +H+     I HRD+K  N+LLD    V K+ DFG +K        +VS +   S  Y  P
Sbjct: 157 IHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSXIC--SRYYRAP 210
Query: 706 EY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           E  F     T   D++S G V+ E++  +P
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQP 240

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G  G V           VAIK+ +   +   H  +   E+ ++  + H++++SL+  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 598 CEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +    D Y+    +  +L +  +  L  ++   +      G+ +LH+     II
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---II 186
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+K +NI++      K+ DFGL++T  T   + + T    +  Y  PE        E 
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKEN 243
Query: 717 SDVYSFGVVLFEIL 730
            D++S G ++ E++
Sbjct: 244 VDIWSVGCIMGEMV 257

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYY 191
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S GV++ E++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYY 191
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S GV++ E++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/187 (20%), Positives = 81/187 (43%), Gaps = 7/187 (3%)
Query: 546 GKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE--NCE 603
           G++++G   G    V + +    S +   +F  E   L    H +++ ++G C+      
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTT 663
             L+  +  YG+L   L++     +   Q ++  +  ARG  +LHT  +  I    + + 
Sbjct: 84  PTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT-LEPLIPRHALNSR 142
Query: 664 NILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFG 723
           ++ +DE   A++S   +  +  +    +    V        PE   R+     +D +SF 
Sbjct: 143 SVXIDEDXTARISXADVKFSFQSPGRXYAPAWVAPEALQKKPEDTNRRS----ADXWSFA 198
Query: 724 VVLFEIL 730
           V+L+E++
Sbjct: 199 VLLWELV 205

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G  G V           VAIK+ +   +   H  +   E+ ++  + H++++SL+  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 598 CEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +    D Y+    +  +L +  +  L  ++   +      G+ +LH+     II
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAG---II 141
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+K +NI++      K+ DFGL++T  T   + + T    +  Y  PE        E 
Sbjct: 142 HRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 717 SDVYSFGVVLFEIL 730
            D++S G ++ E++
Sbjct: 199 VDIWSVGCIMGEMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G  G V           VAIK+ +   +   H  +   E+ ++  + H++++SL+  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 598 CEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +    D Y+    +  +L +  +  L  ++   +      G+ +LH+     II
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAG---II 148
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+K +NI++      K+ DFGL++T  T   + + T    +  Y  PE        E 
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 717 SDVYSFGVVLFEIL 730
            D++S G ++ E++
Sbjct: 206 VDIWSVGCIMGEMV 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 81/174 (46%), Gaps = 9/174 (5%)
Query: 560 VAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGYCEENCEMILVYD-YMAYGTL 616
           VAIK+ +   +   H  +   E+ ++  + H++++SL+        +    D Y+    +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVS 676
             +L +  +  L  ++   +      G+ +LH+     IIHRD+K +NI++      K+ 
Sbjct: 112 DANLXQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKIL 168
Query: 677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
           DFGL++T  T   + + T    +  Y  PE        E  D++S G ++ E++
Sbjct: 169 DFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYY 192
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMI 220

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G  G V           VAIK+ +   +   H  +   E+ ++  + H++++SL+  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 598 CEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +    D Y+    +  +L +  +  L  ++   +      G+ +LH+     II
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---II 186
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+K +NI++      K+ DFGL++T  T   + + T    +  Y  PE        E 
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKEN 243
Query: 717 SDVYSFGVVLFEIL 730
            D++S G ++ E++
Sbjct: 244 VDIWSVGCIMGEMV 257

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYY 191
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGV-HEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G +G V++ +       VA+KR      ++GV      EI +L +L+H+++V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
              + ++ LV+++       +  + +    L  +          +GL + H+     ++H
Sbjct: 70  LHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLH 124
Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+L++     K+++FGL++        + + VV  +  Y  P+     +L   S
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTS 182
Query: 718 -DVYSFGVVLFEILCARPALNP 738
            D++S G +  E+  A   L P
Sbjct: 183 IDMWSAGCIFAELANAGRPLFP 204

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T     V  VV  +  Y
Sbjct: 140 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMVPFVV--TRYY 193
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMI 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPEVVTRYY 191
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYY 191
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYY 191
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G  G V           VAIK+ +   +   H  +   E+ ++  + H++++SL+  
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 598 CEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +    D Y+    +  +L +  +  L  ++   +      G+ +LH+     II
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---II 149
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+K +NI++      K+ DFGL++T  T   + + T    +  Y  PE        E 
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 717 SDVYSFGVVLFEIL 730
            D++S G ++ E++
Sbjct: 207 VDIWSVGCIMGEMV 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G  G V           VAIK+ +   +   H  +   E+ ++  + H++++SL+  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 598 CEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +    D Y+    +  +L +  +  L  ++   +      G+ +LH+     II
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---II 148
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+K +NI++      K+ DFGL++T  T   + + T    +  Y  PE        E 
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 717 SDVYSFGVVLFEIL 730
            D++S G ++ E++
Sbjct: 206 VDIWSVGCIMGEMV 219

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHR-------- 589
           ++G G FG+V +         VA+K     +E+  H +   EI +L  LR +        
Sbjct: 104 VIGKGXFGQVVKAYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 590 -HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEI--CIGAARGLHY 646
            H++    +    C    +     Y  ++++ ++    PL  K    I  C+ A      
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA------ 215
Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           LH   K+ IIH D+K  NILL ++  +  KV DFG S      +H  V   ++  F Y  
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYXXIQSRF-YRA 267
Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARPAL 736
           PE     +     D++S G +L E+L   P L
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGYPLL 299

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 82/179 (45%), Gaps = 19/179 (10%)
Query: 560 VAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY------CEENCEMILVYDYM 611
           VAIK+ +   +   H  +   E+ ++  + H++++SL+         EE  ++ LV + M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW 671
                +    +     + +     +C     G+ +LH+     IIHRD+K +NI++    
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDX 163
Query: 672 VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             K+ DFGL++T  T   + + T    +  Y  PE        E  D++S G ++ E++
Sbjct: 164 TLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G  G V           VAIK+ +   +   H  +   E+ ++  + H++++SL+  
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 598 CEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +    D Y+    +  +L +  +  L  ++   +      G+ +LH+     II
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---II 142
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+K +NI++      K+ DFGL++T  T   + + T    +  Y  PE        E 
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 717 SDVYSFGVVLFEIL 730
            D++S G ++ E++
Sbjct: 200 VDIWSVGCIMGEMV 213

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G  G V           VAIK+ +   +   H  +   E+ ++  + H++++SL+  
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 598 CEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +    D Y+    +  +L +  +  L  ++   +      G+ +LH+     II
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---II 142
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+K +NI++      K+ DFGL++T  T   + + T    +  Y  PE        E 
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 717 SDVYSFGVVLFEIL 730
            D++S G ++ E++
Sbjct: 200 VDIWSVGCIMGEMV 213

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G  G V           VAIK+ +   +   H  +   E+ ++  + H++++SL+  
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 598 CEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +    D Y+    +  +L +  +  L  ++   +      G+ +LH+     II
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---II 147
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+K +NI++      K+ DFGL++T  T   + + T    +  Y  PE        E 
Sbjct: 148 HRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKEN 204
Query: 717 SDVYSFGVVLFEIL 730
            D++S G ++ E++
Sbjct: 205 VDIWSVGCIMGEMV 218

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 32/216 (14%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEM-LS 584
           E+  AT+     L LG G FG+V+R E      + A+K+        +  F+ E  M  +
Sbjct: 91  EVHWATHQ----LRLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACA 140
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
            L    +V L G   E   + +  + +  G+L + L K Q   LP  + L     A  GL
Sbjct: 141 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQG-CLPEDRALYYLGQALEGL 198
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWV-AKVSDF---------GLSKTGPTLDHTHVST 694
            YLH+     I+H DVK  N+LL      A + DF         GL K+  T D+     
Sbjct: 199 EYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY----- 250
Query: 695 VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            + G+  ++ PE    +    K DV+S   ++  +L
Sbjct: 251 -IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHML 285

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIGY 597
           +G G  G V           VAIK+ +   +   H  +   E+ ++  + H++++SL+  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 598 CEENCEMILVYD-YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                 +    D Y+    +  +L +  +  L  ++   +      G+ +LH+     II
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---II 148
Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+K +NI++      K+ DFGL++T  T   + + T    +  Y  PE        E 
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 717 SDVYSFGVVLFEIL 730
            D++S G ++ E++
Sbjct: 206 VDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYY 192
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHR 589
           T+ ++    +GVG +    R        + A+K    + ++   +   EIE+L +  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK----IIDKSKRDPTEEIEILLRYGQHP 76
Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++++L    ++   + +V + M  G L + + + +      ++   +     + + YLH 
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHA 134
Query: 650 GAKHTIIHRDVKTTNIL-LDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
                ++HRD+K +NIL +DE       ++ DFG +K     +   ++     +F  + P
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF--VAP 189
Query: 706 EYFRRQQLTEKSDVYSFGVVLFEIL 730
           E   RQ      D++S GV+L+ +L
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTML 214

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYY 184
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 579 EIEMLSKLRHRHLVSLIGY------CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ 632
           E+ +L  + H++++SL+         EE  ++ LV + M     +    +     + +  
Sbjct: 71  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLL 130
Query: 633 RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV 692
              +C     G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T     +
Sbjct: 131 YQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAST---NFM 179
Query: 693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
            T    +  Y  PE        E  D++S G ++ E++
Sbjct: 180 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 217

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYY 191
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYY 191
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 17/218 (7%)
Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR 587
           +   + F    + G G FG V  G+       VAIK+          E Q  ++ L+ L 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLH 77
Query: 588 HRHLVSLIGYC-------EENCEMILVYDYMAYGTLR--EHLYKTQKPPLPWKQRLEICI 638
           H ++V L  Y          +  + +V +Y+     R   + Y+ Q  P P   ++    
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLF 136
Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
              R +  LH  +   + HRD+K  N+L++E     K+ DFG +K    L  +  +    
Sbjct: 137 QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAK---KLSPSEPNVAYI 192
Query: 698 GSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
            S  Y  PE  F  Q  T   D++S G +  E++   P
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T   + + T    +  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYY 191
Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             PE        E  D++S G ++ E++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 22/211 (10%)
Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEM-LS 584
           E+  AT+     L LG G FG+V+R E      + A+K+        +  F+ E  M  +
Sbjct: 72  EVHWATHQ----LRLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACA 121
Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
            L    +V L G   E   + +  + +  G+L + L K Q   LP  + L     A  GL
Sbjct: 122 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQG-CLPEDRALYYLGQALEGL 179
Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWV-AKVSDFG----LSKTGPTLDHTHVSTVVKGS 699
            YLH+     I+H DVK  N+LL      A + DFG    L   G   D       + G+
Sbjct: 180 EYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKD-LLTGDYIPGT 235
Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEIL 730
             ++ PE    +    K DV+S   ++  +L
Sbjct: 236 ETHMAPEVVLGRSCDAKVDVWSSCCMMLHML 266
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	893
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	0.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-132
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-123
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-84
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-65
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-65
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-64
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-64
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-62
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-62
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-59
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-52
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-45
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-39
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-39
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-39
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-39
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-39
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-38
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-38
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-37
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-37
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-36
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-36
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-36
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-36
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-36
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-35
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-33
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-32
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-30
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	1e-29
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	3e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-28
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-25
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-24
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-24
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-23
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-23
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-12
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-11
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-06

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  584 bits (1508), Expect = 0.0
 Identities = 185/324 (57%), Positives = 230/324 (70%), Gaps = 7/324 (2%)

Query: 494 GNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEI 553
           G+ +S  +   N   S +  +P          +++ ATNNFD   L+G G FGKVY+G +
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFE-SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60

Query: 554 DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY 613
                KVA+KR  P S QG+ EF+TEIE LS  RH HLVSLIG+C+E  EMIL+Y YM  
Sbjct: 61  RD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119

Query: 614 GTLREHLYKTQKP--PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW 671
           G L+ HLY +  P   + W+QRLEICIGAARGLHYLHT A   IIHRDVK+ NILLDE +
Sbjct: 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENF 176

Query: 672 VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC 731
           V K++DFG+SK G  LD TH+STVVKG+ GY+DPEYF + +LTEKSDVYSFGVVLFE+LC
Sbjct: 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236

Query: 732 ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQ 791
           AR A+  +LP+E V+LAEWA   H  G LEQI+DP L  KI PE  +KF +TA+KC++  
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296

Query: 792 GIERPSMGDVLWNLEFALQLQESA 815
             +RPSMGDVLW LE+AL+LQES 
Sbjct: 297 SEDRPSMGDVLWKLEYALRLQESV 320

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  396 bits (1021), Expect = e-132
 Identities = 101/307 (32%), Positives = 162/307 (52%), Gaps = 21/307 (6%)

Query: 513 SLPSNLCRHFSFAEIKAATNNFDEAL------LLGVGGFGKVYRGEIDGATTKVAIKR-- 564
            +       FSF E+K  TNNFDE         +G GGFG VY+G ++   T VA+K+  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLA 63

Query: 565 --GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLY- 621
              +  +E+   +F  EI++++K +H +LV L+G+  +  ++ LVY YM  G+L + L  
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123

Query: 622 KTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS 681
               PPL W  R +I  GAA G+++LH       IHRD+K+ NILLDE + AK+SDFGL+
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180

Query: 682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLP 741
           +       T +++ + G+  Y+ PE   R ++T KSD+YSFGVVL EI+   PA++    
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

Query: 742 KEQVSLAEWAAHCHK-KGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGD 800
            +   L +        +  +E  +D  +         +     A +C+ ++  +RP +  
Sbjct: 240 PQ--LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296

Query: 801 VLWNLEF 807
           V   L+ 
Sbjct: 297 VQQLLQE 303

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  375 bits (964), Expect = e-123
 Identities = 119/293 (40%), Positives = 171/293 (58%), Gaps = 9/293 (3%)

Query: 520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEI-DGATTKVAIKRGNPLSEQGV-HEFQ 577
           + FS  E++ A++NF    +LG GGFGKVY+G + DG  T VA+KR      QG   +FQ
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG--TLVAVKRLKEERTQGGELQFQ 75

Query: 578 TEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLY--KTQKPPLPWKQRLE 635
           TE+EM+S   HR+L+ L G+C    E +LVY YMA G++   L      +PPL W +R  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
           I +G+ARGL YLH      IIHRDVK  NILLDE++ A V DFGL+K       THV+T 
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTA 194

Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ--VSLAEWAAH 753
           V+G+ G++ PEY    + +EK+DV+ +GV+L E++  + A +         V L +W   
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254

Query: 754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
             K+  LE ++D  L+G    E  ++  + A+ C     +ERP M +V+  LE
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  272 bits (698), Expect = 2e-84
 Identities = 66/329 (20%), Positives = 126/329 (38%), Gaps = 33/329 (10%)

Query: 508 GSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP 567
           G +     S +        +   +       +   G FG V++ ++      VA+K    
Sbjct: 2   GHHHHHHSSGV--DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPI 57

Query: 568 LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE----NCEMILVYDYMAYGTLREHLYKT 623
             +Q   + + E+  L  ++H +++  IG  +     + ++ L+  +   G+L + L   
Sbjct: 58  QDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--- 113

Query: 624 QKPPLPWKQRLEICIGAARGLHYLHT-------GAKHTIIHRDVKTTNILLDEKWVAKVS 676
           +   + W +   I    ARGL YLH        G K  I HRD+K+ N+LL     A ++
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173

Query: 677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILC 731
           DFGL+           +    G+  Y+ PE        ++    + D+Y+ G+VL+E+  
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

Query: 732 ARPALNPTLPKEQVSLAEWAAHCH-----KKGILEQIMDPYLKGKIAP-ECFKKFAETAM 785
              A +  + +  +   E           ++ ++ +   P L+             ET  
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293

Query: 786 KCVSDQGIERPSMGDVLWNLEFALQLQES 814
           +C       R S G V   +    Q+Q  
Sbjct: 294 ECWDHDAEARLSAGCVGERIT---QMQRL 319

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  221 bits (565), Expect = 1e-65
 Identities = 77/271 (28%), Positives = 137/271 (50%), Gaps = 25/271 (9%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG V+R E  G  + VA+K         + V+EF  E+ ++ +LRH ++V  +G 
Sbjct: 45  IGAGSFGTVHRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQ-KPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
             +   + +V +Y++ G+L   L+K+  +  L  ++RL +    A+G++YLH      I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS-TVVKGSFGYLDPEYFRRQQLTE 715
           HR++K+ N+L+D+K+  KV DFGLS+       T +S     G+  ++ PE  R +   E
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 716 KSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPE 775
           KSDVYSFGV+L+E+   +       P   ++ A+  A      +  +        +I   
Sbjct: 219 KSDVYSFGVILWELATLQ------QPWGNLNPAQVVA-----AVGFKCKRL----EIPRN 263

Query: 776 CFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
              + A     C +++  +RPS   ++  L 
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  220 bits (562), Expect = 6e-65
 Identities = 67/332 (20%), Positives = 116/332 (34%), Gaps = 45/332 (13%)

Query: 522 FSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIE 581
            + +E     +N     L+G G +G VY+G +D     VA+K     S      F  E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKV---FSFANRQNFINEKN 57

Query: 582 M--LSKLRHRHLVSLIGYCEENC-----EMILVYDYMAYGTLREHLYKTQKPPLPWKQRL 634
           +  +  + H ++   I   E        E +LV +Y   G+L ++L         W    
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSC 114

Query: 635 EICIGAARGLHYLHT------GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT----- 683
            +     RGL YLHT        K  I HRD+ + N+L+       +SDFGLS       
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 684 -GPTLDHTHVSTVVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEILCARPA 735
                +  + +    G+  Y+ PE           +   ++ D+Y+ G++ +EI      
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 736 LNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPE----------CFKKFAETAM 785
           L P     +  +A +          E +     + K  P+            +   ET  
Sbjct: 235 LFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 786 KCVSDQGIERPSMGDVLWNLEFALQLQESAEE 817
            C       R +       +   + + E  + 
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKS 325

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  218 bits (557), Expect = 1e-64
 Identities = 75/289 (25%), Positives = 123/289 (42%), Gaps = 35/289 (12%)

Query: 523 SFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEM 582
           S   I       +   ++G G FG V + +       VAIK+    SE     F  E+  
Sbjct: 1   SLHMIDY--KEIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQ--IESESERKAFIVELRQ 54

Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP-LPWKQRLEICIGAA 641
           LS++ H ++V L G C       LV +Y   G+L   L+  +  P       +  C+  +
Sbjct: 55  LSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKW-VAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           +G+ YLH+     +IHRD+K  N+LL     V K+ DFG +      D     T  KGS 
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSA 167

Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL 760
            ++ PE F     +EK DV+S+G++L+E++  R       P +++    +          
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAF---------- 211

Query: 761 EQIMDPYLKGK---IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
            +IM     G    +     K       +C S    +RPSM +++  + 
Sbjct: 212 -RIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  216 bits (552), Expect = 4e-64
 Identities = 80/275 (29%), Positives = 130/275 (47%), Gaps = 30/275 (10%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG VY+G+  G    VA+K  N    + Q +  F+ E+ +L K RH +++  +GY
Sbjct: 32  IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
                  I V  +    +L  HL    +     K+ ++I    ARG+ YLH     +IIH
Sbjct: 89  STAPQLAI-VTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHA---KSIIH 143

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL---T 714
           RD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203

Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK---GK 771
            +SDVY+FG+VL+E++  +      LP        ++   ++  I+E +    L     K
Sbjct: 204 FQSDVYAFGIVLYELMTGQ------LP--------YSNINNRDQIIEMVGRGSLSPDLSK 249

Query: 772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
           +   C K+      +C+  +  ERPS   +L  +E
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  209 bits (535), Expect = 7e-62
 Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 36/279 (12%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR----GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +G+GGFGKVYR    G   +VA+K      +    Q +   + E ++ + L+H ++++L 
Sbjct: 15  IGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G C +   + LV ++   G L   L       +P    +   +  ARG++YLH  A   I
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 656 IHRDVKTTNILLDEK--------WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           IHRD+K++NIL+ +K         + K++DFGL++      H        G++ ++ PE 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPEV 185

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY 767
            R    ++ SDV+S+GV+L+E+L         +P   +     A                
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYGVAMNK--------- 230

Query: 768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
           L   I   C + FA+    C +     RPS  ++L  L 
Sbjct: 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  209 bits (534), Expect = 8e-62
 Identities = 50/274 (18%), Positives = 113/274 (41%), Gaps = 32/274 (11%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           L     G++++G   G    + +K  +    S +   +F  E   L    H +++ ++G 
Sbjct: 18  LNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 598 CEE--NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           C+        L+  +M YG+L   L++     +   Q ++  +  ARG+ +LHT  +  I
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLI 134

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL-- 713
               + + ++++DE   A++S   +         +  S     +  ++ PE  +++    
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDT 187

Query: 714 -TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI 772
               +D++SF V+L+E++         +P   +S  E         +  + + P     I
Sbjct: 188 NRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGM-----KVALEGLRP----TI 232

Query: 773 APECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
            P      ++    C+++   +RP    ++  LE
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  208 bits (531), Expect = 9e-61
 Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 41/283 (14%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG+VY G   G   +VAI+  +    +E  +  F+ E+    + RH ++V  +G 
Sbjct: 41  IGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C     + ++       TL   +    K  L   +  +I     +G+ YLH      I+H
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILH 153

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSK---TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL- 713
           +D+K+ N+  D      ++DFGL                 +  G   +L PE  R+    
Sbjct: 154 KDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 714 --------TEKSDVYSFGVVLFEILCARPALNP--TLPKEQVSLAEWAAHCHKKGILEQI 763
                   ++ SDV++ G + +E+        P  T P E +    W      K  L   
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREW---PFKTQPAEAII---WQMGTGMKPNL--- 263

Query: 764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
                         K+ ++  + C + +  ERP+   ++  LE
Sbjct: 264 --------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  207 bits (528), Expect = 1e-60
 Identities = 75/312 (24%), Positives = 129/312 (41%), Gaps = 47/312 (15%)

Query: 511 ASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKR------ 564
            S  P +     +  EI+     +++   +G GGFG V++G +    + VAIK       
Sbjct: 5   GSEFPKSRLPTLADNEIE-----YEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57

Query: 565 -GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKT 623
            G     +   EFQ E+ ++S L H ++V L G       M++  +++  G L   L   
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLD- 114

Query: 624 QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW-----VAKVSDF 678
           +  P+ W  +L + +  A G+ Y+       I+HRD+++ NI L          AKV+DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 679 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL--TEKSDVYSFGVVLFEILCARPAL 736
           GLS+        H  + + G+F ++ PE    ++   TEK+D YSF ++L+ IL      
Sbjct: 174 GLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG-- 226

Query: 737 NP--TLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIE 794
            P       ++           +        P     I  +C  +       C S    +
Sbjct: 227 -PFDEYSYGKIKFINMIREEGLR--------P----TIPEDCPPRLRNVIELCWSGDPKK 273

Query: 795 RPSMGDVLWNLE 806
           RP    ++  L 
Sbjct: 274 RPHFSYIVKELS 285

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  202 bits (517), Expect = 6e-59
 Identities = 70/282 (24%), Positives = 112/282 (39%), Gaps = 36/282 (12%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+  +         + +K      E+    F  E++++  L H +++  IG   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           ++  +  + +Y+  GTLR  + K+     PW QR+      A G+ YLH      IIHRD
Sbjct: 78  KDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133

Query: 660 VKTTNILLDEKWVAKVSDFGLSK------------TGPTLDHTHVSTVVKGSFGYLDPEY 707
           + + N L+ E     V+DFGL++                         V G+  ++ PE 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

Query: 708 FRRQQLTEKSDVYSFGVVLFEILC---ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM 764
              +   EK DV+SFG+VL EI+    A P   P      +              +   +
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR----TMDFGL---------NVRGFL 240

Query: 765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
           D Y      P C   F    ++C      +RPS   +   LE
Sbjct: 241 DRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  195 bits (498), Expect = 5e-56
 Identities = 63/302 (20%), Positives = 121/302 (40%), Gaps = 35/302 (11%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEM--LSKLRHRHLVSLIG 596
            +G G +G+V+ G+  G   KVA+K            +  E E+     +RH +++  I 
Sbjct: 44  QIGKGRYGEVWMGKWRG--EKVAVKV---FFTTEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 597 YCEENC----EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT--- 649
              +      ++ L+ DY   G+L ++L   +   L  K  L++   +  GL +LHT   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 650 --GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS--KTGPTLDHTHVSTVVKGSFGYLDP 705
               K  I HRD+K+ NIL+ +     ++D GL+      T +         G+  Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 706 E------YFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH---- 755
           E           Q    +D+YSFG++L+E+     +       +        +       
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275

Query: 756 KKGILEQIMDPYL-KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
           ++ +  + + P       + EC ++  +   +C +     R +   V   L    ++ ES
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA---KMSES 332

Query: 815 AE 816
            +
Sbjct: 333 QD 334

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  191 bits (486), Expect = 9e-55
 Identities = 61/298 (20%), Positives = 110/298 (36%), Gaps = 44/298 (14%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEM--LSKLRHRHLVSLIG 596
            +G G +G+V+RG   G    VA+K     S +    +  E E+     LRH +++  I 
Sbjct: 15  CVGKGRYGEVWRGSWQG--ENVAVKI---FSSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 597 YC----EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT--- 649
                   + ++ L+  Y   G+L ++L   Q   L     L I +  A GL +LH    
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 650 --GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS--KTGPTLDHTHVSTVVKGSFGYLDP 705
               K  I HRD+K+ NIL+ +     ++D GL+   +  T      +    G+  Y+ P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 706 E------YFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE---------QVSLAE- 749
           E              ++ D+++FG+VL+E+     +       +           S  + 
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 750 WAAHCHKKGILEQIMDPYLKGKIAP-ECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
               C  +        P +  +          A+   +C       R +   +   L 
Sbjct: 247 RKVVCVDQ------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  186 bits (474), Expect = 1e-52
 Identities = 69/300 (23%), Positives = 133/300 (44%), Gaps = 35/300 (11%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEM--LSKLRHRHLVSLIG 596
            +G G FG+V+RG+  G   +VA+K     S +    +  E E+     LRH +++  I 
Sbjct: 49  SIGKGRFGEVWRGKWRG--EEVAVKI---FSSREERSWFREAEIYQTVMLRHENILGFIA 103

Query: 597 YCEENC----EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH---- 648
              ++     ++ LV DY  +G+L ++L    +  +  +  +++ +  A GL +LH    
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 649 -TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS--KTGPTLDHTHVSTVVKGSFGYLDP 705
            T  K  I HRD+K+ NIL+ +     ++D GL+      T           G+  Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 706 E------YFRRQQLTEKSDVYSFGVVLFEIL--CARPALNPT--LPKEQVSLAEWAAHCH 755
           E        +  +  +++D+Y+ G+V +EI   C+   ++    LP   +  ++ +    
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280

Query: 756 KKGILEQIMDPYL-KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
           +K + EQ + P +     + E  +  A+   +C    G  R +   +   L    QL + 
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS---QLSQQ 337

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  166 bits (422), Expect = 3e-45
 Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 32/274 (11%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G FG+V+ G +    T VA+K     L      +F  E  +L +  H ++V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
            +   + +V + +  G     L +T+   L  K  L++   AA G+ YL        IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237

Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY--LDPEYFRRQQLTEK 716
           D+   N L+ EK V K+SDFG+S+     D  + ++            PE     + + +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

Query: 717 SDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY-LKGKIA 773
           SDV+SFG++L+E   L A P   P L  +Q                E +     L     
Sbjct: 296 SDVWSFGILLWETFSLGASPY--PNLSNQQT--------------REFVEKGGRLP---C 336

Query: 774 PE-CFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
           PE C         +C + +  +RPS   +   L+
Sbjct: 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  158 bits (401), Expect = 2e-41
 Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 24/286 (8%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G +G+VY G     +  VA+K  + + +  +   EF  E  ++ +++H +LV L+G 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGV 284

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C       ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 341

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           R++   N L+ E  + KV+DFGLS+     D        K    +  PE     + + KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400

Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECF 777
           DV++FGV+L+EI     +  P +   QV               E +   Y + +    C 
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQV--------------YELLEKDY-RMERPEGCP 445

Query: 778 KKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGKVLG 823
           +K  E    C      +RPS  ++    E   Q    ++E  K LG
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 491

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  149 bits (378), Expect = 8e-40
 Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 10/196 (5%)

Query: 540 LGVGGFGKVYRG----EIDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FG VY+G    E +     VAIK      S +   E   E  +++ + + H+  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
           +G C  +   + +   M +G L +++ +  K  +  +  L  C+  A+G++YL       
Sbjct: 83  LGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E    +  T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197

Query: 715 EKSDVYSFGVVLFEIL 730
            +SDV+S+GV ++E++
Sbjct: 198 HQSDVWSYGVTVWELM 213

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  147 bits (373), Expect = 1e-39
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 12/198 (6%)

Query: 540 LGVGGFGKVYRGE---IDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG V RGE     G T  VA+K          + + +F  E+  +  L HR+L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L G        + V +    G+L + L +  +            +  A G+ YL      
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL---ESK 140

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             IHRD+   N+LL  + + K+ DFGL +      DH  +    K  F +  PE  + + 
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200

Query: 713 LTEKSDVYSFGVVLFEIL 730
            +  SD + FGV L+E+ 
Sbjct: 201 FSHASDTWMFGVTLWEMF 218

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  147 bits (373), Expect = 2e-39
 Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 19/202 (9%)

Query: 540 LGVGGFGKVYRGE---IDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +G G FG VY G     DG     A+K  N +     V +F TE  ++    H +++SL+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92

Query: 596 GYC--EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           G C   E   ++++  YM +G LR  + + +      K  +   +  A+G+ YL   A  
Sbjct: 93  GICLRSEGSPLVVL-PYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL---ASK 147

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL-----DPEYF 708
             +HRD+   N +LDEK+  KV+DFGL++    +      +V   +   L       E  
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 709 RRQQLTEKSDVYSFGVVLFEIL 730
           + Q+ T KSDV+SFGV+L+E++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELM 226

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  151 bits (383), Expect = 2e-39
 Identities = 79/282 (28%), Positives = 123/282 (43%), Gaps = 24/282 (8%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P +      F  E +++ KLRH  LV L     
Sbjct: 192 LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E    I V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 305

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     +        K    +  PE     + T KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364

Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPE-CFK 778
           +SFG++L E+        P +   +V              L+Q+   Y      P  C +
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGYRMPC--PPECPE 408

Query: 779 KFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGK 820
              +   +C   +  ERP+   +   LE      E   + G+
Sbjct: 409 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  147 bits (374), Expect = 2e-39
 Identities = 81/301 (26%), Positives = 121/301 (40%), Gaps = 52/301 (17%)

Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV+  E            VA+K     SE    +FQ E E+L+ L+H+H+V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 595 IGYCEENCEMILVYDYMAYGTLREHL-------------YKTQKPPLPWKQRLEICIGAA 641
            G C E   +++V++YM +G L   L                   PL   Q L +    A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
            G+ YL   A    +HRD+ T N L+ +  V K+ DFG+S+   + D+        G   
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----VGGRT 220

Query: 702 YL-----DPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWAAHC 754
            L      PE    ++ T +SDV+SFGVVL+EI     +P     L   +          
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW--YQLSNTEA--------- 269

Query: 755 HKKGILEQIMDPYLKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE 813
                ++ I       +  P  C  +       C   +  +R S+ DV   L+   Q   
Sbjct: 270 -----IDCITQGRELER--PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322

Query: 814 S 814
            
Sbjct: 323 V 323

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  149 bits (377), Expect = 2e-39
 Identities = 86/377 (22%), Positives = 157/377 (41%), Gaps = 65/377 (17%)

Query: 472 RRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAAT 531
           R+      SS + +   PL       S+ +      G     LP +    F   ++    
Sbjct: 28  RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLT--- 84

Query: 532 NNFDEALLLGVGGFGKVYRGEIDG-------ATTKVAIKRGNPL-SEQGVHEFQTEIEML 583
               +   LG G FG+V   E  G           VA+K      +E+ + +  +E+EM+
Sbjct: 85  --LGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 584 SKL-RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL--------------YKTQKPPL 628
             + +H+++++L+G C ++  + ++ +Y + G LRE+L               +  +  +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 629 PWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD 688
            +K  +      ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++     D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----D 252

Query: 689 HTHVSTVVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLP 741
             ++    K + G L      PE    +  T +SDV+SFGV+++EI  L   P   P +P
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIP 310

Query: 742 KEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGD 800
            E++               + + + +   K  P  C  +       C      +RP+   
Sbjct: 311 VEEL--------------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQ 354

Query: 801 VLWNLEFALQLQESAEE 817
           ++ +L+  L    + EE
Sbjct: 355 LVEDLDRILT-LTTNEE 370

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  147 bits (373), Expect = 3e-39
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 34/214 (15%)

Query: 539 LLGVGGFGKVYRGEI--DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKL-RHRHLVSL 594
           ++G G FG+V +  I  DG     AIKR     S+    +F  E+E+L KL  H ++++L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 595 IGYCEENCEMILVYDYMAYGTLREHL--------------YKTQKPPLPWKQRLEICIGA 640
           +G CE    + L  +Y  +G L + L                +    L  +Q L      
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           ARG+ YL   ++   IHRD+   NIL+ E +VAK++DFGLS+             VK + 
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 200

Query: 701 GYL-----DPEYFRRQQLTEKSDVYSFGVVLFEI 729
           G L       E       T  SDV+S+GV+L+EI
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  146 bits (370), Expect = 4e-39
 Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 42/215 (19%)

Query: 540 LGVGGFGKVYRG-------EIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           LG G F K+++G             T+V +K  +         F     M+SKL H+HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
              G C    E ILV +++ +G+L  +L K  K  +    +LE+    A  +H+L    +
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFL---EE 131

Query: 653 HTIIHRDVKTTNILLDEKW--------VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           +T+IH +V   NILL  +           K+SD G+S              V       +
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI------------TVLPKDILQE 179

Query: 705 P---------EYFRRQQLTEKSDVYSFGVVLFEIL 730
                     E  +   L   +D +SFG  L+EI 
Sbjct: 180 RIPWVPPECIENPKN--LNLATDKWSFGTTLWEIC 212

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  146 bits (370), Expect = 5e-39
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 13/199 (6%)

Query: 540 LGVGGFGKVYRGE---IDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +G G FG VY GE         + AIK  + +   Q V  F  E  ++  L H ++++LI
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88

Query: 596 GYC--EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           G     E    +L+  YM +G L + + ++ +     K  +   +  ARG+ YL   A+ 
Sbjct: 89  GIMLPPEGLPHVLL-PYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL---AEQ 143

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF--GYLDPEYFRRQ 711
             +HRD+   N +LDE +  KV+DFGL++     ++  V           +   E  +  
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203

Query: 712 QLTEKSDVYSFGVVLFEIL 730
           + T KSDV+SFGV+L+E+L
Sbjct: 204 RFTTKSDVWSFGVLLWELL 222

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  147 bits (372), Expect = 5e-39
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 13/204 (6%)

Query: 540 LGVGGFGKVYRGEIDGA----TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V     D         VA+K+          +FQ EI++L  L    +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 596 GYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           G         + LV +Y+  G LR+ L +  +  L   + L       +G+ YL      
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG---SR 146

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             +HRD+   NIL++ +   K++DFGL+K      D+  V    +    +  PE      
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206

Query: 713 LTEKSDVYSFGVVLFEI--LCARP 734
            + +SDV+SFGVVL+E+   C + 
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKS 230

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  146 bits (371), Expect = 5e-39
 Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 28/211 (13%)

Query: 540 LGVGGFGKVYRGE---IDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FG V   +    DG+  KVA+K  + + ++   + EF  E   + +  H H+  L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 595 IGYCEEN------CEMILVYDYMAYGTLREHL----YKTQKPPLPWKQRLEICIGAARGL 644
           +G    +         +++  +M +G L   L           LP +  +   +  A G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL- 703
            YL   +    IHRD+   N +L E     V+DFGLS+              +G    L 
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASKLP 202

Query: 704 ----DPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                 E       T  SDV++FGV ++EI+
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  145 bits (369), Expect = 6e-39
 Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)

Query: 540 LGVGGFGKVYRGE----IDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V         D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 596 GYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           G C       + L+ +Y+ YG+LR++L +  K  +   + L+      +G+ YL      
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLG---TK 133

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             IHRD+ T NIL++ +   K+ DFGL+K  P   +   V    +    +  PE     +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193

Query: 713 LTEKSDVYSFGVVLFEIL 730
            +  SDV+SFGVVL+E+ 
Sbjct: 194 FSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  146 bits (371), Expect = 6e-39
 Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 13/248 (5%)

Query: 490 LSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVY 549
           +S Y + H        T   Y      +        + +     F +   LG G FG V 
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQ--QLGKGNFGSVE 58

Query: 550 RGE----IDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE-- 603
                   D     VA+K+    +E+ + +F+ EIE+L  L+H ++V   G C       
Sbjct: 59  MCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118

Query: 604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTT 663
           + L+ +Y+ YG+LR++L +  K  +   + L+      +G+ YL        IHRD+ T 
Sbjct: 119 LKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATR 174

Query: 664 NILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSF 722
           NIL++ +   K+ DFGL+K  P   ++  V    +    +  PE     + +  SDV+SF
Sbjct: 175 NILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSF 234

Query: 723 GVVLFEIL 730
           GVVL+E+ 
Sbjct: 235 GVVLYELF 242

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  146 bits (370), Expect = 7e-39
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 27/210 (12%)

Query: 540 LGVGGFGKVYRGE---IDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FG V  G     DG + KVA+K  + +  S++ + EF +E   +    H +++ L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 595 IGYCEEN-----CEMILVYDYMAYGTLREHL----YKTQKPPLPWKQRLEICIGAARGLH 645
           +G C E       + +++  +M YG L  +L     +T    +P +  L+  +  A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL-- 703
           YL   +    +HRD+   N +L +     V+DFGLSK              +G    +  
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKMPV 213

Query: 704 ---DPEYFRRQQLTEKSDVYSFGVVLFEIL 730
                E    +  T KSDV++FGV ++EI 
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  145 bits (367), Expect = 8e-39
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 19/198 (9%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G +G+VY G     +  VA+K  + + +  +   EF  E  ++ +++H +LV L+G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGV 77

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C       ++ ++M YG L ++L +  +  +     L +    +  + YL    K   IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 134

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-----VKGSFGYLDPEYFRRQQ 712
           RD+   N L+ E  + KV+DFGLS+       T+ +       +K    +  PE     +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIK----WTAPESLAYNK 188

Query: 713 LTEKSDVYSFGVVLFEIL 730
            + KSDV++FGV+L+EI 
Sbjct: 189 FSIKSDVWAFGVLLWEIA 206

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  147 bits (373), Expect = 9e-39
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 19/202 (9%)

Query: 540 LGVGGFGKVYRGE---IDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +G G FG VY G     DG     A+K  N +     V +F TE  ++    H +++SL+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156

Query: 596 GYC--EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           G C   E   ++++  YM +G LR  + + +      K  +   +  A+G+ +L   A  
Sbjct: 157 GICLRSEGSPLVVL-PYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL---ASK 211

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL-----DPEYF 708
             +HRD+   N +LDEK+  KV+DFGL++    +      +V   +   L       E  
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 709 RRQQLTEKSDVYSFGVVLFEIL 730
           + Q+ T KSDV+SFGV+L+E++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELM 290

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  144 bits (366), Expect = 2e-38
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)

Query: 540 LGVGGFGKVYRGE----IDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV         D    +VA+K   P      + + + EIE+L  L H ++V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 595 IGYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            G C E+    + L+ +++  G+L+E+L    K  +  KQ+L+  +   +G+ YL     
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL---GS 144

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT-LDHTHVSTVVKGSFGYLDPEYFRRQ 711
              +HRD+   N+L++ +   K+ DFGL+K   T  ++  V         +  PE   + 
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204

Query: 712 QLTEKSDVYSFGVVLFEIL 730
           +    SDV+SFGV L E+L
Sbjct: 205 KFYIASDVWSFGVTLHELL 223

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  150 bits (379), Expect = 2e-38
 Identities = 81/281 (28%), Positives = 127/281 (45%), Gaps = 22/281 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P +      F  E +++ KLRH  LV L     
Sbjct: 275 LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E    I V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 333 EEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 388

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     ++T      K    +  PE     + T KSDV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 447

Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +V              L+Q+   Y +    PEC + 
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGY-RMPCPPECPES 492

Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEESGK 820
             +   +C   +  ERP+   +   LE      E   + G+
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 533

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  144 bits (366), Expect = 3e-38
 Identities = 78/292 (26%), Positives = 120/292 (41%), Gaps = 46/292 (15%)

Query: 540 LGVGGFGKVYRGEI-----DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++     D +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L       +Q   L     L +    A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156

Query: 649 TGAKHTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL-- 703
              ++  IHRD+   N LL       VAK+ DFG+++      +       KG    L  
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-----RKGGCAMLPV 209

Query: 704 ---DPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWAAHCHKKG 758
               PE F     T K+D +SFGV+L+EI  L   P   P+   ++V             
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEV------------- 254

Query: 759 ILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
            LE +            C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 255 -LEFVTSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  144 bits (365), Expect = 4e-38
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)

Query: 540 LGVGGFGKVYRG----EIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG V++G    E +     V IK         Q        +  +  L H H+V 
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L+G C  +   + V  Y+  G+L +H+ +  +  L  +  L   +  A+G++YL    +H
Sbjct: 80  LLGLCPGSSLQL-VTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYL---EEH 134

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            ++HR++   N+LL      +V+DFG++   P  D   + +  K    ++  E     + 
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194

Query: 714 TEKSDVYSFGVVLFEIL 730
           T +SDV+S+GV ++E++
Sbjct: 195 THQSDVWSYGVTVWELM 211

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  143 bits (363), Expect = 4e-38
 Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 53/294 (18%)

Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV+  E            VA+K     +     +FQ E E+L+ L+H H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 595 IGYCEENCEMILVYDYMAYGTLREHL--------------YKTQKPPLPWKQRLEICIGA 640
            G C +   +I+V++YM +G L + L               +  K  L   Q L I    
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           A G+ YL   A    +HRD+ T N L+    + K+ DFG+S+   + D+        G  
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-----VGGH 194

Query: 701 GYL-----DPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWAAH 753
             L      PE    ++ T +SDV+SFGV+L+EI     +P     L   +V        
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW--FQLSNTEV-------- 244

Query: 754 CHKKGILEQIMDPYLKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
                 +E I    +  +  P  C K+  +  + C   +  +R ++ ++   L 
Sbjct: 245 ------IECITQGRVLER--PRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  143 bits (362), Expect = 4e-38
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 540 LGVGGFGKVYRGE--IDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V +G   +      VA+K  +          E   E  ++ +L + ++V +I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G CE    M+ V +    G L ++L + +   +  K  +E+    + G+ YL    +   
Sbjct: 85  GICEAESWML-VMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL---EESNF 138

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-----VKGSFGYLDPEYFRR 710
           +HRD+   N+LL  +  AK+SDFGLSK     ++ + +       VK    +  PE    
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK----WYAPECINY 194

Query: 711 QQLTEKSDVYSFGVVLFEIL 730
            + + KSDV+SFGV+++E  
Sbjct: 195 YKFSSKSDVWSFGVLMWEAF 214

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  144 bits (364), Expect = 4e-38
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 16/218 (7%)

Query: 540 LGVGGFGKVYRGEI----DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FGKV         DG    VA+K        Q    ++ EI++L  L H H++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 595 IGYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
            G CE+     + LV +Y+  G+LR++L    +  +   Q L        G+ YLH  A+
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH--AQ 153

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP-TLDHTHVSTVVKGSFGYLDPEYFRRQ 711
           H  IHRD+   N+LLD   + K+ DFGL+K  P   ++  V         +  PE  +  
Sbjct: 154 H-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212

Query: 712 QLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSL 747
           +    SDV+SFGV L+E+   C      PT   E + +
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  142 bits (360), Expect = 4e-38
 Identities = 70/198 (35%), Positives = 106/198 (53%), Gaps = 21/198 (10%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG V+ G       KVAIK  R   +SE+   +F  E E++ KL H  LV L G 
Sbjct: 16  IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 71

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C E   + LV ++M +G L ++L +TQ+     +  L +C+    G+ YL    +  +IH
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-----VKGSFGYLDPEYFRRQQ 712
           RD+   N L+ E  V KVSDFG+++    LD  + S+      VK    +  PE F   +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVK----WASPEVFSFSR 181

Query: 713 LTEKSDVYSFGVVLFEIL 730
            + KSDV+SFGV+++E+ 
Sbjct: 182 YSSKSDVWSFGVLMWEVF 199

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  142 bits (361), Expect = 5e-38
 Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 14/197 (7%)

Query: 540 LGVGGFGKVYRGE---IDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG+VY G      G    VA+K      +     +F +E  ++  L H H+V LI
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G  EE    I + +   YG L  +L +  K  L     +   +   + + YL        
Sbjct: 80  GIIEEEPTWI-IMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYL---ESINC 134

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF--GYLDPEYFRRQQL 713
           +HRD+   NIL+      K+ DFGLS+    ++               ++ PE    ++ 
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSR---YIEDEDYYKASVTRLPIKWMSPESINFRRF 191

Query: 714 TEKSDVYSFGVVLFEIL 730
           T  SDV+ F V ++EIL
Sbjct: 192 TTASDVWMFAVCMWEIL 208

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  142 bits (360), Expect = 7e-38
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)

Query: 540 LGVGGFGKVYRGE--IDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           LG G FG V +G   +      VAIK       +    E   E +++ +L + ++V LIG
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
            C+    M+ V +    G L + L   ++  +P     E+    + G+ YL    +   +
Sbjct: 78  VCQAEALML-VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFV 132

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-----VKGSFGYLDPEYFRRQ 711
           HRD+   N+LL  +  AK+SDFGLSK     D  + +       +K    +  PE    +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECINFR 188

Query: 712 QLTEKSDVYSFGVVLFEIL 730
           + + +SDV+S+GV ++E L
Sbjct: 189 KFSSRSDVWSYGVTMWEAL 207

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  143 bits (363), Expect = 8e-38
 Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 10/196 (5%)

Query: 540 LGVGGFGKVYRG----EIDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           LG G FG VY+G    E +     VAIK      S +   E   E  +++ + + H+  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
           +G C  +   + +   M +G L +++ +  K  +  +  L  C+  A+G++YL       
Sbjct: 83  LGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL---EDRR 137

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E    +  T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197

Query: 715 EKSDVYSFGVVLFEIL 730
            +SDV+S+GV ++E++
Sbjct: 198 HQSDVWSYGVTVWELM 213

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  141 bits (358), Expect = 1e-37
 Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 11/193 (5%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G FG+V+ G  +G  TKVA+K  +   +S      F  E  ++ +L+H+ LV L   
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYAV 76

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +    I + +YM  G+L + L       L   + L++    A G+ ++    +   IH
Sbjct: 77  VTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD++  NIL+ +    K++DFGL++     ++T      K    +  PE       T KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKS 191

Query: 718 DVYSFGVVLFEIL 730
           DV+SFG++L EI+
Sbjct: 192 DVWSFGILLTEIV 204

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  144 bits (364), Expect = 1e-37
 Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 48/293 (16%)

Query: 540 LGVGGFGKVYRGEI-----DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG+VY G++     D +  +VA+K      SEQ   +F  E  ++SK  H+++V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHL-----YKTQKPPLPWKQRLEICIGAARGLHYLH 648
            IG   ++    ++ + MA G L+  L       +Q   L     L +    A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197

Query: 649 TGAKHTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL-- 703
              ++  IHRD+   N LL       VAK+ DFG+++      +       KG    L  
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-----RKGGCAMLPV 250

Query: 704 ---DPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWAAHCHKKG 758
               PE F     T K+D +SFGV+L+EI  L   P   P+   ++V             
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEV------------- 295

Query: 759 ILEQIMDPYLKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
            LE +          P+ C         +C   Q  +RP+   +L  +E+  Q
Sbjct: 296 -LEFVTSGGRMDP--PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  142 bits (361), Expect = 2e-37
 Identities = 76/308 (24%), Positives = 138/308 (44%), Gaps = 57/308 (18%)

Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G           VA+K      +E+ + +  +E+EM+  + +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHL--------------YKTQKPPLPWKQRLEI 636
           +++L+G C ++  + ++ +Y + G LRE+L               +  +  + +K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++     D  ++    
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYK 214

Query: 697 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAE 749
           K + G L      PE    +  T +SDV+SFGV+++EI  L   P   P +P E++    
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL---- 268

Query: 750 WAAHCHKKGILEQIMDPYLKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA 808
                      + + + +   K  P  C  +       C      +RP+   ++ +L+  
Sbjct: 269 ----------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

Query: 809 LQLQESAE 816
           L L  + E
Sbjct: 317 LTLTTNEE 324

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  141 bits (357), Expect = 2e-37
 Identities = 72/304 (23%), Positives = 123/304 (40%), Gaps = 51/304 (16%)

Query: 532 NNFDEALLLGVGGFGKVYRGE--IDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHR 589
            +F E  L+G GGFG+V++ +  IDG      IKR    + +       E++ L+KL H 
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDG--KTYVIKR-VKYNNEKAER---EVKALAKLDHV 64

Query: 590 HLVSLIGYCEE----------------NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQR 633
           ++V   G  +                    + +  ++   GTL + + K +   L     
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 634 LEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS 693
           LE+     +G+ Y+H      +I+RD+K +NI L +    K+ DFGL     +L +    
Sbjct: 125 LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKR 178

Query: 694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH 753
           T  KG+  Y+ PE    Q   ++ D+Y+ G++L E+L            E          
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTDL-- 231

Query: 754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE 813
             + GI+  I D   K  +  +   K  E           +RP+  ++L  L    +  E
Sbjct: 232 --RDGIISDIFDKKEKTLLQ-KLLSKKPE-----------DRPNTSEILRTLTVWKKSPE 277

Query: 814 SAEE 817
             E 
Sbjct: 278 KNER 281

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  145 bits (367), Expect = 2e-37
 Identities = 75/274 (27%), Positives = 124/274 (45%), Gaps = 40/274 (14%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG V  G+  G   KVA+K  + +  ++     F  E  ++++LRH +LV L+G 
Sbjct: 201 IGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 254

Query: 598 CEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
             E    + +V +YMA G+L ++L    +  L     L+  +     + YL     +  +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           HRD+   N+L+ E  VAKVSDFGL+K     + +      K    +  PE  R ++ + K
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 366

Query: 717 SDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY-LKGKIA 773
           SDV+SFG++L+EI      P   P +P + V              + ++   Y +    A
Sbjct: 367 SDVWSFGILLWEIYSFGRVP--YPRIPLKDV--------------VPRVEKGYKMD---A 407

Query: 774 PE-CFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
           P+ C     +    C       RP+   +   LE
Sbjct: 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  140 bits (355), Expect = 3e-37
 Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 14/197 (7%)

Query: 540 LGVGGFGKVYRGE---IDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK      S+    +F  E   + +  H H+V LI
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN   I + +    G LR  L + +K  L     +      +  L YL        
Sbjct: 83  GVITENPVWI-IMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYL---ESKRF 137

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF--GYLDPEYFRRQQL 713
           +HRD+   N+L+      K+ DFGLS+    ++ +      KG     ++ PE    ++ 
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 714 TEKSDVYSFGVVLFEIL 730
           T  SDV+ FGV ++EIL
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  140 bits (354), Expect = 3e-37
 Identities = 66/198 (33%), Positives = 101/198 (51%), Gaps = 21/198 (10%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G FG V  G+  G    VA+K  +   +SE    EF  E + + KL H  LV   G 
Sbjct: 16  LGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C +   + +V +Y++ G L  +L ++    L   Q LE+C     G+ +L     H  IH
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-----VKGSFGYLDPEYFRRQQ 712
           RD+   N L+D     KVSDFG+++    LD  +VS+V     VK    +  PE F   +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFPVK----WSAPEVFHYFK 181

Query: 713 LTEKSDVYSFGVVLFEIL 730
            + KSDV++FG++++E+ 
Sbjct: 182 YSSKSDVWAFGILMWEVF 199

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  140 bits (355), Expect = 3e-37
 Identities = 62/192 (32%), Positives = 98/192 (51%), Gaps = 13/192 (6%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG V  G+  G   KVA+K     +      F  E  ++++LRH +LV L+G   
Sbjct: 29  IGKGEFGDVMLGDYRG--NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 600 ENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
           E    + +V +YMA G+L ++L    +  L     L+  +     + YL     +  +HR
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 141

Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           D+   N+L+ E  VAKVSDFGL+K     + +      K    +  PE  R ++ + KSD
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196

Query: 719 VYSFGVVLFEIL 730
           V+SFG++L+EI 
Sbjct: 197 VWSFGILLWEIY 208

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  144 bits (366), Expect = 4e-37
 Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 7/191 (3%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+    +   TKVA+K   P     V  F  E  ++  L+H  LV L     
Sbjct: 196 LGAGQFGEVWMATYNK-HTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +    I + ++MA G+L + L   +    P  + ++     A G+ ++    +   IHRD
Sbjct: 254 KEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRD 309

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+    V K++DFGL++     ++T      K    +  PE       T KSDV
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDV 368

Query: 720 YSFGVVLFEIL 730
           +SFG++L EI+
Sbjct: 369 WSFGILLMEIV 379

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  140 bits (355), Expect = 4e-37
 Identities = 68/295 (23%), Positives = 119/295 (40%), Gaps = 54/295 (18%)

Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG   FGKVY+G + G      T  VAIK            EF+ E  + ++L+H ++V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHL--------------YKTQKPPLPWKQRLEICIG 639
           L+G   ++  + +++ Y ++G L E L               +T K  L     + +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
            A G+ YL   + H ++H+D+ T N+L+ +K   K+SD GL +     +           
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKLLG 188

Query: 700 FGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWAA 752
              L      PE     + +  SD++S+GVVL+E+     +P        + V       
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY--CGYSNQDV------- 239

Query: 753 HCHKKGILEQIMDPYLKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
                  +E I +  +     P+ C        ++C ++    RP   D+   L 
Sbjct: 240 -------VEMIRNRQVLPC--PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  140 bits (354), Expect = 4e-37
 Identities = 65/198 (32%), Positives = 101/198 (51%), Gaps = 21/198 (10%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G FG V  G+  G    VAIK  +   +SE    EF  E +++  L H  LV L G 
Sbjct: 32  LGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
           C +   + ++ +YMA G L  +L +  +     +Q LE+C      + YL        +H
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-----VKGSFGYLDPEYFRRQQ 712
           RD+   N L++++ V KVSDFGLS+    LD  + S+V     V+    +  PE     +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVR----WSPPEVLMYSK 197

Query: 713 LTEKSDVYSFGVVLFEIL 730
            + KSD+++FGV+++EI 
Sbjct: 198 FSSKSDIWAFGVLMWEIY 215

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  142 bits (359), Expect = 4e-37
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)

Query: 539 LLGVGGFGKVYRGE--IDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
            +G G FGK    +   DG   +  IK    + +S +   E + E+ +L+ ++H ++V  
Sbjct: 31  KIGEGSFGKAILVKSTEDG--RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
               EEN  + +V DY   G L + +   +       Q L+  +     L ++H      
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRK 145

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV--STVVKGSFGYLDPEYFRRQQ 712
           I+HRD+K+ NI L +    ++ DFG+++    L+ T       + G+  YL PE    + 
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIAR---VLNSTVELARACI-GTPYYLSPEICENKP 201

Query: 713 LTEKSDVYSFGVVLFEILCARPA 735
              KSD+++ G VL+E+   + A
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA 224

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  141 bits (357), Expect = 4e-37
 Identities = 77/293 (26%), Positives = 121/293 (41%), Gaps = 48/293 (16%)

Query: 540 LGVGGFGKVYRGEI-----DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G       D   T+VAIK  N   S +   EF  E  ++ +    H+V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHL--------YKTQKPPLPWKQRLEICIGAARGLH 645
           L+G   +    +++ + M  G L+ +L              P    + +++    A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL-- 703
           YL     +  +HRD+   N ++ E +  K+ DFG+++     D        KG  G L  
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLPV 204

Query: 704 ---DPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAEWAAHCHKKG 758
               PE  +    T  SDV+SFGVVL+EI  L  +P     L  EQV             
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQV------------- 249

Query: 759 ILEQIMDPYLKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
            L  +M+  L  K  P+ C     E    C       RPS  +++ +++  ++
Sbjct: 250 -LRFVMEGGLLDK--PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  140 bits (354), Expect = 8e-37
 Identities = 54/242 (22%), Positives = 103/242 (42%), Gaps = 19/242 (7%)

Query: 504 TNTTGSYASSLPSNLCRHFSFAEIKAAT-NNFDEALLLGVGGFGKVYRGE--IDGATTKV 560
             + G     +P    +     ++   T  NF     +G G F +VYR    +DG    V
Sbjct: 3   EQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDG--VPV 60

Query: 561 AIKR---GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLR 617
           A+K+    + +  +   +   EI++L +L H +++       E+ E+ +V +    G L 
Sbjct: 61  ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120

Query: 618 EHL--YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKV 675
             +  +K QK  +P +   +  +     L ++H      ++HRD+K  N+ +    V K+
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKL 177

Query: 676 SDFGLSKTGPTLDHT--HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 733
            D GL +             ++V G+  Y+ PE         KSD++S G +L+E+   +
Sbjct: 178 GDLGLGR---FFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233

Query: 734 PA 735
             
Sbjct: 234 SP 235

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  139 bits (353), Expect = 1e-36
 Identities = 55/214 (25%), Positives = 83/214 (38%), Gaps = 21/214 (9%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
            LG GGF  V   E        A+KR     +Q   E Q E +M     H +++ L+ YC
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 599 EE----NCEMILVYDYMAYGTLREHL--YKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
                   E  L+  +   GTL   +   K +   L   Q L + +G  RGL  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK--------GSFGYLD 704
               HRD+K TNILL ++    + D G       +        +          +  Y  
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ-ACIHVEGSRQALTLQDWAAQRCTISYRA 211

Query: 705 PEYF---RRQQLTEKSDVYSFGVVLFEILCARPA 735
           PE F       + E++DV+S G VL+ ++     
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  138 bits (350), Expect = 1e-36
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 14/207 (6%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
            +G G +G+  +         +  K  +   ++E       +E+ +L +L+H ++V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 597 --YCEENCEMILVYDYMAYGTLREHL--YKTQKPPLPWKQRLEICIGAARGLHYLHT--G 650
                 N  + +V +Y   G L   +     ++  L  +  L +       L   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV--STVVKGSFGYLDPEYF 708
             HT++HRD+K  N+ LD K   K+ DFGL++    L+H      T V G+  Y+ PE  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNHDTSFAKTFV-GTPYYMSPEQM 188

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARPA 735
            R    EKSD++S G +L+E+    P 
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPP 215

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  140 bits (354), Expect = 2e-36
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 32/214 (14%)

Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLV 592
           LG G FGKV      G     A  KVA+K               +E++++S L +H ++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113

Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHL------------YKTQKPPLPWKQRLEICIGA 640
           +L+G C     ++++ +Y  YG L   L            +         +  L      
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
           A+G+ +L   A    IHRDV   N+LL    VAK+ DFGL++     D  + S  +    
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGN 225

Query: 701 GYL-----DPEYFRRQQLTEKSDVYSFGVVLFEI 729
             L      PE       T +SDV+S+G++L+EI
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  139 bits (352), Expect = 2e-36
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 9/196 (4%)

Query: 540 LGVGGFGKVYRGEI---DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +G G  G+V  G +         VAIK      +E+   +F +E  ++ +  H +++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G        ++V +YM  G+L   L +T        Q + +  G   G+ YL   +    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGY 172

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           +HRD+   N+L+D   V KVSDFGLS+      D  + +T  K    +  PE    +  +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232

Query: 715 EKSDVYSFGVVLFEIL 730
             SDV+SFGVV++E+L
Sbjct: 233 SASDVWSFGVVMWEVL 248

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  145 bits (368), Expect = 2e-36
 Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 14/197 (7%)

Query: 540 LGVGGFGKVYRGE---IDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +G G FG V++G     +     VAIK      S+    +F  E   + +  H H+V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   EN   I + +    G LR  L + +K  L     +      +  L YL        
Sbjct: 458 GVITENPVWI-IMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYL---ESKRF 512

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF--GYLDPEYFRRQQL 713
           +HRD+   N+L+      K+ DFGLS+    ++ +      KG     ++ PE    ++ 
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 714 TEKSDVYSFGVVLFEIL 730
           T  SDV+ FGV ++EIL
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  138 bits (351), Expect = 2e-36
 Identities = 60/218 (27%), Positives = 91/218 (41%), Gaps = 36/218 (16%)

Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLV 592
           LG G FGKV      G     A   VA+K   P           +E+++LS L  H ++V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHL----------------YKTQKPPLPWKQRLEI 636
           +L+G C      +++ +Y  YG L   L                 +  +  L  +  L  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               A+G+ +L   A    IHRD+   NILL    + K+ DFGL++     D  + S  V
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDSNYV 202

Query: 697 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEI 729
                 L      PE       T +SDV+S+G+ L+E+
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  138 bits (351), Expect = 2e-36
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 41/223 (18%)

Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FGKV +            T VA+K      S   + +  +E  +L ++ H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHL----------------------YKTQKPPLPWK 631
           L G C ++  ++L+ +Y  YG+LR  L                          +  L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 632 QRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH 691
             +      ++G+ YL   A+  ++HRD+   NIL+ E    K+SDFGLS+     D   
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVYE 202

Query: 692 VSTVVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEI 729
             + VK S G +       E       T +SDV+SFGV+L+EI
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  139 bits (353), Expect = 2e-36
 Identities = 76/314 (24%), Positives = 123/314 (39%), Gaps = 62/314 (19%)

Query: 540 LGVGGFGKVYRGEI-----DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           +G G FG+V++            T VA+K      S     +FQ E  ++++  + ++V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHL----------------------YKTQKPPLPWK 631
           L+G C     M L+++YMAYG L E L                           PPL   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 632 QRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH 691
           ++L I    A G+ YL   ++   +HRD+ T N L+ E  V K++DFGLS+     +   
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYS 226

Query: 692 VSTVVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQ 744
                      +      PE     + T +SDV+++GVVL+EI     +P     +  E+
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY--YGMAHEE 284

Query: 745 VSLAEWAAHCHKKGILEQIMDPYLKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLW 803
           V              +  + D  +     PE C  +       C S    +RPS   +  
Sbjct: 285 V--------------IYYVRDGNILAC--PENCPLELYNLMRLCWSKLPADRPSFCSIHR 328

Query: 804 NLEFALQLQESAEE 817
            L+   +  E    
Sbjct: 329 ILQRMCERAEGTVG 342

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  140 bits (355), Expect = 3e-36
 Identities = 80/310 (25%), Positives = 138/310 (44%), Gaps = 57/310 (18%)

Query: 540 LGVGGFGKVYRGEIDG-------ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRH 590
           LG G FG+V   E  G         TKVA+K      +E+ + +  +E+EM+  + +H++
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHL--------------YKTQKPPLPWKQRLEI 636
           +++L+G C ++  + ++ +Y + G LRE+L                  +  L  K  +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               ARG+ YL   A    IHRD+   N+L+ E  V K++DFGL++     D  H+    
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 248

Query: 697 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEI--LCARPALNPTLPKEQVSLAE 749
           K + G L      PE    +  T +SDV+SFGV+L+EI  L   P   P +P E++    
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL---- 302

Query: 750 WAAHCHKKGILEQIMDPYLKGKIAPE-CFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA 808
                      + + + +   K  P  C  +       C      +RP+   ++ +L+  
Sbjct: 303 ----------FKLLKEGHRMDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

Query: 809 LQLQESAEES 818
           + L  + E  
Sbjct: 351 VALTSNQEMG 360

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  137 bits (346), Expect = 9e-36
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 35/217 (16%)

Query: 540 LGVGGFGKVYRGEI-----DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKL-RHRHLV 592
           LG G FG+V   +            VA+K      +        +E+++L  +  H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 593 SLIGYC-EENCEMILVYDYMAYGTLREHL--------------YKTQKPPLPWKQRLEIC 637
           +L+G C +    ++++ ++  +G L  +L                  K  L  +  +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
              A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++     D       V+
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVR 206

Query: 698 GSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEI 729
                L      PE    +  T +SDV+SFGV+L+EI
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  137 bits (346), Expect = 2e-35
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 18/201 (8%)

Query: 540 LGVGGFGKVYRGEIDGAT----TKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           +G G FG+VY+G +  ++      VAIK      +E+   +F  E  ++ +  H +++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
            G   +   M+++ +YM  G L + L + +       Q + +  G A G+ YL   A   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYL---ANMN 167

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL-----DPEYFR 709
            +HRD+   NIL++   V KVSDFGLS+     D    +    G  G +      PE   
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSG--GKIPIRWTAPEAIS 223

Query: 710 RQQLTEKSDVYSFGVVLFEIL 730
            ++ T  SDV+SFG+V++E++
Sbjct: 224 YRKFTSASDVWSFGIVMWEVM 244

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  137 bits (348), Expect = 2e-35
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 9/196 (4%)

Query: 540 LGVGGFGKVYRGEI---DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +G G FG+V  G +         VAIK      +E+   +F  E  ++ +  H +++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G   ++  +++V +YM  G+L   L +         Q + +  G A G+ YL   +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGY 168

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           +HRD+   NIL++   V KVSDFGL +      +  + +   K    +  PE    ++ T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228

Query: 715 EKSDVYSFGVVLFEIL 730
             SDV+S+G+VL+E++
Sbjct: 229 SASDVWSYGIVLWEVM 244

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  137 bits (346), Expect = 2e-35
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 41/223 (18%)

Query: 540 LGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLV 592
           LG G FGKV      G      + +VA+K               +E++M+++L  H ++V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHL---------------------YKTQKPPLPWK 631
           +L+G C  +  + L+++Y  YG L  +L                      +     L ++
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 632 QRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH 691
             L      A+G+ +L      + +HRD+   N+L+    V K+ DFGL++     D   
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIMS 224

Query: 692 VSTVVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEI 729
            S  V      L      PE       T KSDV+S+G++L+EI
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  140 bits (355), Expect = 6e-35
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 17/199 (8%)

Query: 540 LGVGGFGKVYRGE--IDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           LG G FG V +G   +      VAIK       +    E   E +++ +L + ++V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
            C+    M+ V +    G L + L   ++  +P     E+    + G+ YL    +   +
Sbjct: 404 VCQAEALML-VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFV 458

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV-----VKGSFGYLDPEYFRRQ 711
           HR++   N+LL  +  AK+SDFGLSK     D  + +       +K    +  PE    +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECINFR 514

Query: 712 QLTEKSDVYSFGVVLFEIL 730
           + + +SDV+S+GV ++E L
Sbjct: 515 KFSSRSDVWSYGVTMWEAL 533

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  133 bits (337), Expect = 8e-35
 Identities = 67/267 (25%), Positives = 113/267 (42%), Gaps = 31/267 (11%)

Query: 539 LLGVGGFGKVYRGEIDGATTK-VAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
            +G G F  VY+G +D  TT  VA    +   L++     F+ E EML  L+H ++V   
Sbjct: 33  EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 596 GY----CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  +    ++LV + M  GTL+ +L + +   +  K     C    +GL +LHT  
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-R 148

Query: 652 KHTIIHRDVKTTNILLDEK-WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
              IIHRD+K  NI +       K+ D GL+     L     +  V G+  ++ PE +  
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMY-E 203

Query: 711 QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG 770
           ++  E  DVY+FG+ + E+  +    +      Q+          K    +++  P +K 
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVKPASFDKVAIPEVKE 261

Query: 771 KIAPECFKKFAETAMKCVSDQGIERPS 797
            I   C ++  +           ER S
Sbjct: 262 IIE-GCIRQNKD-----------ERYS 276

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  131 bits (331), Expect = 7e-34
 Identities = 53/230 (23%), Positives = 98/230 (42%), Gaps = 37/230 (16%)

Query: 531 TNNFDEALLLGVGGFGKVYRGE--IDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH 588
            ++F+E  +LG G FG+V +    +D      AIK+    +E+ +    +E+ +L+ L H
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDS--RYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61

Query: 589 RHLVSLIG-YCEENCEMI------------LVYDYMAYGTLREHLYKTQKPPLPWKQRLE 635
           +++V     + E    +             +  +Y   GTL + +  ++       +   
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWR 120

Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK------------- 682
           +       L Y+H      IIHRD+K  NI +DE    K+ DFGL+K             
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEILC 731
                   ++++ + G+  Y+  E         EK D+YS G++ FE++ 
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  130 bits (329), Expect = 2e-33
 Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 33/216 (15%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRH--RHLVSL 594
            +G GG  KV++  ++      AIK  N      Q +  ++ EI  L+KL+     ++ L
Sbjct: 35  QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP-----WKQRLEICIGAARGLHYLHT 649
             Y   +  + +V +      L   L K +          WK  LE        +H +H 
Sbjct: 94  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------AVHTIH- 144

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE--- 706
             +H I+H D+K  N L+ +  + K+ DFG++        + V     G+  Y+ PE   
Sbjct: 145 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 707 --------YFRRQQLTEKSDVYSFGVVLFEILCARP 734
                      + +++ KSDV+S G +L+ +   + 
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  130 bits (330), Expect = 2e-33
 Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 33/216 (15%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRH--RHLVSL 594
            +G GG  KV++  ++      AIK  N      Q +  ++ EI  L+KL+     ++ L
Sbjct: 16  QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP-----WKQRLEICIGAARGLHYLHT 649
             Y   +  + +V +      L   L K +          WK  LE        +H +H 
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------AVHTIH- 125

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE--- 706
             +H I+H D+K  N L+ +  + K+ DFG++        + V     G+  Y+ PE   
Sbjct: 126 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 707 --------YFRRQQLTEKSDVYSFGVVLFEILCARP 734
                      + +++ KSDV+S G +L+ +   + 
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  131 bits (330), Expect = 2e-33
 Identities = 43/220 (19%), Positives = 88/220 (40%), Gaps = 33/220 (15%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK-----------------RGNPLSEQGVHEFQTEIEM 582
           L  G F K+   E D      A+K                       +    +F+ E+++
Sbjct: 39  LNQGKFNKIILCEKDN--KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA-- 640
           ++ +++ + ++  G      E+ ++Y+YM   ++ +           +   + I +    
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 641 ----ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
                    Y+H   +  I HRDVK +NIL+D+    K+SDFG S+         +    
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD---KKIKGSR 211

Query: 697 KGSFGYLDPEYFRRQQLT--EKSDVYSFGVVLFEILCARP 734
            G++ ++ PE+F  +      K D++S G+ L+ +     
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  129 bits (327), Expect = 3e-33
 Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 11/200 (5%)

Query: 539 LLGVGGFGKVYRGEIDGATT-KVAIK--RGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSL 594
           L+G GG G VY  E D      VA+K       S+       Q E     +L+  H+V +
Sbjct: 41  LVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
             + E + ++ +    +    L   L   ++ PL   + + I       L   H      
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
             HRDVK  NIL+     A + DFG++        T +   V G+  Y+ PE F     T
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESHAT 213

Query: 715 EKSDVYSFGVVLFEILCARP 734
            ++D+Y+   VL+E L   P
Sbjct: 214 YRADIYALTCVLYECLTGSP 233

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  129 bits (326), Expect = 3e-33
 Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 9/199 (4%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLI 595
            LG GG   VY  E      KVAIK     P  ++  +  F+ E+   S+L H+++VS+I
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
              EE+    LV +Y+   TL E++      PL     +        G+ + H      I
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE 715
           +HRD+K  NIL+D     K+ DFG++K       T  + V+ G+  Y  PE  + +   E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEATDE 191

Query: 716 KSDVYSFGVVLFEILCARP 734
            +D+YS G+VL+E+L   P
Sbjct: 192 CTDIYSIGIVLYEMLVGEP 210

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  129 bits (325), Expect = 5e-33
 Identities = 56/227 (24%), Positives = 88/227 (38%), Gaps = 31/227 (13%)

Query: 532 NNFDEALLLGVGGFGKVYRGE--IDGATTKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRH 588
            +F+    LG GGFG V+  +  +D      AIKR   P  E    +   E++ L+KL H
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDD--CNYAIKRIRLPNRELAREKVMREVKALAKLEH 62

Query: 589 RHLVSLIGYCEENCEM---------ILVYDYMAY---GTLREHL-YKTQKPPLPWKQRLE 635
             +V       E             + +Y  M       L++ +  +           L 
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK----------TGP 685
           I +  A  + +LH      ++HRD+K +NI      V KV DFGL               
Sbjct: 123 IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA 732
            +      T   G+  Y+ PE       + K D++S G++LFE+L  
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  131 bits (330), Expect = 6e-33
 Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 33/216 (15%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRH--RHLVSL 594
            +G GG  KV++  ++      AIK  N      Q +  ++ EI  L+KL+     ++ L
Sbjct: 63  QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP-----WKQRLEICIGAARGLHYLHT 649
             Y   +  + +V +      L   L K +          WK  LE        +H +H 
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------AVHTIH- 172

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE--- 706
             +H I+H D+K  N L+ +  + K+ DFG++        + V     G+  Y+ PE   
Sbjct: 173 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 707 --------YFRRQQLTEKSDVYSFGVVLFEILCARP 734
                      + +++ KSDV+S G +L+ +   + 
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  127 bits (322), Expect = 7e-33
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 16/208 (7%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F+    LG G FG VY      +   +A+K   +         H+ + E+E+ S LRH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL--EICIGAARGLHY 646
            +++ L GY  +   + L+ +Y   GT+   L K  K           E+       L Y
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA----NALSY 124

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE 706
            H      +IHRD+K  N+LL      K++DFG S   P+   T    +  G+  YL PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---DLC-GTLDYLPPE 177

Query: 707 YFRRQQLTEKSDVYSFGVVLFEILCARP 734
               +   EK D++S GV+ +E L  +P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  126 bits (319), Expect = 3e-32
 Identities = 51/207 (24%), Positives = 79/207 (38%), Gaps = 16/207 (7%)

Query: 533 NFDEALLLGVGGFGKVYRGE--IDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKL-R 587
           +F     LG G +G+V++     DG     A+KR        +       E+    K+ +
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRL--YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H   V L    EE   + L  +     +L++H        LP  Q           L +L
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHL 173

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H      ++H DVK  NI L  +   K+ DFGL      L       V +G   Y+ PE 
Sbjct: 174 H---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPEL 227

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
             +      +DV+S G+ + E+ C   
Sbjct: 228 L-QGSYGTAADVFSLGLTILEVACNME 253

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  124 bits (314), Expect = 1e-31
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 18/209 (8%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
           ++FD    LG G FG VY          +A+K   +     E   H+ + EIE+ S LRH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL--EICIGAARGLHY 646
            +++ +  Y  +   + L+ ++   G L + L K  +           E+    A  LHY
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----ADALHY 129

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD-HTHVSTVVKGSFGYLDP 705
            H   +  +IHRD+K  N+L+  K   K++DFG S   P+L   T     + G+  YL P
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT-----MCGTLDYLPP 181

Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           E    +   EK D++  GV+ +E L   P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  125 bits (315), Expect = 1e-31
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 27/211 (12%)

Query: 539 LLGVGGFGKVYRGEIDGATT---KVAIK------RGNPLSEQGVHEFQTEIEMLSKLRHR 589
           +LG GG  +V+    D        VA+K        +P        F+ E +  + L H 
Sbjct: 19  ILGFGGMSEVHLAR-D--LRDHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHP 72

Query: 590 HLVSLIGYCEEN-CEMILVYDYMAY---GTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
            +V++    E       L Y  M Y    TLR+ +    + P+  K+ +E+   A + L+
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALN 130

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYL 703
           + H   ++ IIHRDVK  NI++      KV DFG+++         T  + V+ G+  YL
Sbjct: 131 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYL 186

Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE  R   +  +SDVYS G VL+E+L   P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  130 bits (329), Expect = 2e-31
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 20/219 (9%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLI--- 595
           LG GGFG V R        +VAIK+    LS +    +  EI+++ KL H ++VS     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 596 ---GYCEENCEMILVYDYMAYGTLREHLYKTQKP-PLPWKQRLEICIGAARGLHYLHTGA 651
                   N   +L  +Y   G LR++L + +    L       +    +  L YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138

Query: 652 KHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
           ++ IIHRD+K  NI+L    ++ + K+ D G +K    LD   + T   G+  YL PE  
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEFVGTLQYLAPELL 195

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
            +++ T   D +SFG + FE +       P LP  Q   
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFR---PFLPNWQPVQ 231

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  125 bits (316), Expect = 2e-31
 Identities = 36/228 (15%), Positives = 68/228 (29%), Gaps = 22/228 (9%)

Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATT-----KVAIKRGNPLSEQGVHEFQTEI 580
           E +  +       LLG G F +VY              K  +K   P +    +     +
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118

Query: 581 EMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---PLPWKQRLEIC 637
           E L        +            +LV +  +YGTL   +   +      +P    +   
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA-----------KVSDFGLSKTGPT 686
           +     +  +H      IIH D+K  N +L   ++             + D G S     
Sbjct: 179 MRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235

Query: 687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
                + T    + G+   E    +    + D +     ++ +L    
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  124 bits (312), Expect = 3e-31
 Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 22/212 (10%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLIGY 597
           +LG G    V+RG         AIK  N +S     +    E E+L KL H+++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 598 CEE--NCEMILVYDYMAYGTLREHLYKTQKP-PLPWKQRLEICIGAARGLHYLHTGAKHT 654
            EE      +L+ ++   G+L   L +      LP  + L +      G+++L    ++ 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 655 IIHRDVKTTNILL----DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
           I+HR++K  NI+     D + V K++DFG ++    L+       + G+  YL P+ + R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYER 189

Query: 711 QQL--------TEKSDVYSFGVVLFEILCARP 734
             L            D++S GV  +       
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (307), Expect = 9e-31
 Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 12/200 (6%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
            LG GGF K +    D  T    A K   +   L      +   EI +   L H+H+V  
Sbjct: 22  FLGKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
            G+ E+N  + +V +     +L E   + +    P  +          G  YLH   ++ 
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY--YLRQIVLGCQYLH---RNR 135

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           +IHRD+K  N+ L+E    K+ DFGL+             V+ G+  Y+ PE   ++  +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHS 193

Query: 715 EKSDVYSFGVVLFEILCARP 734
            + DV+S G +++ +L  +P
Sbjct: 194 FEVDVWSIGCIMYTLLVGKP 213

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  126 bits (319), Expect = 2e-30
 Identities = 42/205 (20%), Positives = 75/205 (36%), Gaps = 26/205 (12%)

Query: 539 LLGVGGFGKVYRGE---IDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSL 594
            +  GG G +Y      ++G    V +K      +         E + L+++ H  +V +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRP--VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 595 IGYCEENCEMILVYDY--MAY---GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
             + E          Y  M Y    +L+          LP  + +   +     L YLH 
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH- 199

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
                +++ D+K  NI+L E+ + K+ D G               +  G+ G+  PE  R
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSR-----INSFGYLY-GTPGFQAPEIVR 250

Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
               T  +D+Y+ G  L  +    P
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLP 274

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  120 bits (303), Expect = 3e-30
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 15/202 (7%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LLG G F  VYR E      +VAIK   +        V   Q E+++  +L+H  ++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQR---LEICIGAARGLHYLHTGAK 652
            Y E++  + LV +    G +  +L    KP    + R    +I      G+ YLH    
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI----ITGMLYLH---S 130

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
           H I+HRD+  +N+LL      K++DFGL+         H  T+  G+  Y+ PE   R  
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YTLC-GTPNYISPEIATRSA 188

Query: 713 LTEKSDVYSFGVVLFEILCARP 734
              +SDV+S G + + +L  RP
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRP 210

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  121 bits (306), Expect = 3e-30
 Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 14/201 (6%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
            LG GGF K +           A K   +   L      +   EI +   L H+H+V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL--EICIGAARGLHYLHTGAKH 653
           G+ E+N  + +V +     +L E   + +    P  +    +I      G  YLH   ++
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---RN 160

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            +IHRD+K  N+ L+E    K+ DFGL+             V+ G+  Y+ PE   ++  
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGH 218

Query: 714 TEKSDVYSFGVVLFEILCARP 734
           + + DV+S G +++ +L  +P
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKP 239

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  122 bits (308), Expect = 4e-30
 Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 22/212 (10%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLIGY 597
           +LG G    V+RG         AIK  N +S     +    E E+L KL H+++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 598 CEE--NCEMILVYDYMAYGTLREHLYKTQKP-PLPWKQRLEICIGAARGLHYLHTGAKHT 654
            EE      +L+ ++   G+L   L +      LP  + L +      G+++L    ++ 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 655 IIHRDVKTTNILL----DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
           I+HR++K  NI+     D + V K++DFG ++    L+       + G+  YL P+ + R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYER 189

Query: 711 QQL--------TEKSDVYSFGVVLFEILCARP 734
             L            D++S GV  +       
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (305), Expect = 4e-30
 Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 27/221 (12%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGY 597
           +L  GGF  VY  +  G+  + A+KR     E+       E+  + KL  H ++V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 598 C--------EENCEMILVYDYMAYGTLREHLYKTQ-KPPLPWKQRLEICIGAARGLHYLH 648
                        E +L+ +    G L E L K + + PL     L+I     R + ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK----------- 697
              K  IIHRD+K  N+LL  +   K+ DFG + T  +    +  +  +           
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA-TTISHYPDYSWSAQRRALVEEEITRN 211

Query: 698 GSFGYLDPE---YFRRQQLTEKSDVYSFGVVLFEILCARPA 735
            +  Y  PE    +    + EK D+++ G +L+ +   +  
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score =  115 bits (288), Expect = 1e-29
 Identities = 28/192 (14%), Positives = 57/192 (29%), Gaps = 27/192 (14%)

Query: 218 TALENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPS 277
            A + ++ +N GG+             +  D         G     G  + +     + S
Sbjct: 2   LADKVIWAVNAGGESHVDVHG----IHYRKDPLEGRV---GRASDYGMKLPI-----LRS 49

Query: 278 YVAPVDVYATARQMGPNPQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFD 337
                 +Y T R    +          +   +     Y++ L F E      +  Q+VFD
Sbjct: 50  NPEDQVLYQTERYNEDS--------FGYDIPIKEEGEYVLVLKFAE--VYFAQSQQKVFD 99

Query: 338 ILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGN----GPQKDLWLGLHPNVASKTQY 393
           + +N  T     D+     G+     +   + +         +   + G       K  Y
Sbjct: 100 VRVNGHTVVKDLDIFDRV-GHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYY 158

Query: 394 YDAILNGVEIFK 405
            +  +  + I K
Sbjct: 159 DNPKVCALFIMK 170

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score = 93.9 bits (233), Expect = 3e-22
 Identities = 23/166 (13%), Positives = 46/166 (27%), Gaps = 17/166 (10%)

Query: 38  LNCGESSILSDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDPSTPTIPYMTARVFRSEFT 97
           +N G  S   D     +  D     +    D        +      + Y T R     F 
Sbjct: 10  VNAGGESH-VDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSFG 68

Query: 98  YSFPVVA-GRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVI 156
           Y  P+   G   + L F    + +      +F V    +T++K+  +       +     
Sbjct: 69  YDIPIKEEGEYVLVLKFAEVYFAQSQ--QKVFDVRVNGHTVVKDLDIF--DRVGHSTAHD 124

Query: 157 KEYAIPVDGETLNITFSPMNVS-----------NAYAFVNGIEVMS 191
           +   I +    L++       +                V  + +M 
Sbjct: 125 EIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMK 170

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (298), Expect = 4e-29
 Identities = 25/232 (10%), Positives = 48/232 (20%), Gaps = 45/232 (19%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
            L VG    V+    D       A+K    G   S   +          ++L        
Sbjct: 69  PLRVGDRSVVFLV-RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 595 IGYC-----------------------EENCEMILVYDYM--AYGTLRE-----HLYKTQ 624
                                      +++  +      M  A   L             
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 625 KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG 684
           +          +     R    L       ++H      N+ +       + D       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 685 PTLDHTHVSTVVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEILCARP 734
            T        V      Y   E+        T   + +  G+ ++ + C   
Sbjct: 245 GTRGPASSVPV-----TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  118 bits (298), Expect = 2e-28
 Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 23/211 (10%)

Query: 533 NFDEALLLGVGGFGK-VYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRH 590
           +F    +LG G  G  VYRG  D     VA+KR   +  +       E+++L +   H +
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDN--RDVAVKR---ILPECFSFADREVQLLRESDEHPN 79

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
           ++      ++     +  +  A  TL+E   + +       + + +      GL +LH  
Sbjct: 80  VIRYFCTEKDRQFQYIAIELCA-ATLQE-YVEQKDFAHLGLEPITLLQQTTSGLAHLH-- 135

Query: 651 AKHTIIHRDVKTTNILLDEK-----WVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYL 703
               I+HRD+K  NIL+          A +SDFGL K         +  S V  G+ G++
Sbjct: 136 -SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWI 193

Query: 704 DPEYFRR---QQLTEKSDVYSFGVVLFEILC 731
            PE       +  T   D++S G V + ++ 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  114 bits (288), Expect = 3e-28
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 27/209 (12%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +LG G +G VY G  D +   ++AIK       +       EI +   L+H+++V  +G 
Sbjct: 29  VLGKGTYGIVYAG-RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPW---------KQRLEICIGAARGLHYLH 648
             EN  + +  + +  G+L   L +++  PL           KQ LE       GL YLH
Sbjct: 88  FSENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILE-------GLKYLH 139

Query: 649 TGAKHTIIHRDVKTTNILLDEKW-VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
               + I+HRD+K  N+L++    V K+SDFG SK          +    G+  Y+ PE 
Sbjct: 140 ---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEI 194

Query: 708 FRRQQL--TEKSDVYSFGVVLFEILCARP 734
             +      + +D++S G  + E+   +P
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  114 bits (288), Expect = 9e-28
 Identities = 64/295 (21%), Positives = 120/295 (40%), Gaps = 44/295 (14%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G  G V++     +   +A K            ++   E+++L +    ++V   G 
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
              + E+ +  ++M  G+L + + K     +P +   ++ I   +GL YL    KH I+H
Sbjct: 100 FYSDGEISICMEHMDGGSL-DQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMH 155

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RDVK +NIL++ +   K+ DFG+S     L  +  ++ V G+  Y+ PE  +    + +S
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHYSVQS 211

Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG------------------- 758
           D++S G+ L E+   R  + P   KE   +                              
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271

Query: 759 --------ILEQIMD---PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
                   +L+ I++   P L   +    F+ F     KC+     ER  +  ++
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPAERADLKQLM 323

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  115 bits (288), Expect = 1e-27
 Identities = 34/242 (14%), Positives = 72/242 (29%), Gaps = 56/242 (23%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIK----------------------------RGNPLS 569
           +LG            D  T     +                               N   
Sbjct: 80  VLGQEDPYAYLEA-TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 570 EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM-AYGTLREHL-----YKT 623
            +    F    +++   + + ++ +     +   +   + Y      L+        + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 624 QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT 683
               L    RL++ +   R L  LH    + ++H  ++  +I+LD++    ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254

Query: 684 GPTLDHTHVSTVVKGSFGYLDPEYF-----------RRQQLTEKSDVYSFGVVLFEILCA 732
                      V   S G+  PE             RR  +T   D ++ G+V++ I CA
Sbjct: 255 -----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 733 RP 734
             
Sbjct: 310 DL 311

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (289), Expect = 1e-27
 Identities = 29/236 (12%), Positives = 67/236 (28%), Gaps = 45/236 (19%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIK---RGNPLSEQGVHEFQTEIEMLSKLR------- 587
           +LG            D  T     +             + + + E+  L  LR       
Sbjct: 85  VLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 588 ------------------HRHLVSLIGYCEENCEMILVYDYM-AYGTLREHL-----YKT 623
                              + ++ +     +   +   + Y      L+        + +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 624 QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT 683
               L    RL++ +   R L  LH    + ++H  ++  +I+LD++    ++ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQ-----LTEKSDVYSFGVVLFEILCARP 734
                 + +                   Q     +T   D ++ G+ ++ I CA  
Sbjct: 261 DGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  114 bits (287), Expect = 2e-27
 Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 23/201 (11%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           LG G FG V+R  ++ AT      K  N       +  + EI ++++L H  L++L    
Sbjct: 59  LGSGAFGVVHRC-VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117

Query: 599 EENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
           E+  EM+L+ ++++ G L       ++     +     +Q  E       GL ++H   +
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------GLKHMH---E 167

Query: 653 HTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
           H+I+H D+K  NI+ + K  +  K+ DFGL+     L+   +  V   +  +  PE   R
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDR 224

Query: 711 QQLTEKSDVYSFGVVLFEILC 731
           + +   +D+++ GV+ + +L 
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLS 245

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  115 bits (289), Expect = 2e-27
 Identities = 49/223 (21%), Positives = 88/223 (39%), Gaps = 40/223 (17%)

Query: 539 LLGVGGFGKV-YRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIG 596
           +LG G  G V ++G   G    VA+KR   +          EI++L++   H +++    
Sbjct: 22  ILGYGSSGTVVFQGSFQG--RPVAVKR---MLIDFCDIALMEIKLLTESDDHPNVIRYYC 76

Query: 597 YCEENCEMILVYDYMAYGTL-----REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
               +  + +  +      L      +++             + +    A G+ +LH   
Sbjct: 77  SETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132

Query: 652 KHTIIHRDVKTTNILLDEKWV-------------AKVSDFGLSK---TGPTLDHTHVSTV 695
              IIHRD+K  NIL+                    +SDFGL K   +G +   T+++  
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 696 VKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEILC 731
             G+ G+  PE          +++LT   D++S G V + IL 
Sbjct: 193 S-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  111 bits (279), Expect = 6e-27
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 26/206 (12%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +LG G F +V+       T    A+K             + EI +L K++H ++V+L   
Sbjct: 16  VLGSGAFSEVFLV-KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 598 CEENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
            E      LV   ++ G L      R   Y  +   L  +Q L         + YLH   
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGV-YTEKDASLVIQQVLS-------AVKYLH--- 123

Query: 652 KHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
           ++ I+HRD+K  N+L    +E     ++DFGLSK    ++   + +   G+ GY+ PE  
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGYVAPEVL 179

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARP 734
            ++  ++  D +S GV+ + +LC  P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYP 205

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  114 bits (287), Expect = 7e-27
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 15/201 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           LG G FG+V   +      + A+K   +     +        E+++L +L H +++ L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
           + E+     LV +    G L + +    +          I      G+ Y+H   K+ I+
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITYMH---KNKIV 148

Query: 657 HRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
           HRD+K  N+LL    +    ++ DFGLS      + +       G+  Y+ PE       
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPEVLHG-TY 204

Query: 714 TEKSDVYSFGVVLFEILCARP 734
            EK DV+S GV+L+ +L   P
Sbjct: 205 DEKCDVWSTGVILYILLSGCP 225

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  114 bits (287), Expect = 8e-27
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G +G+V          + AIK  R   +S     +   E+ +L  L H +++ L  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            E+     LV +    G L + +    +          I      G+ YLH   KH I+H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVH 159

Query: 658 RDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           RD+K  N+LL   ++  + K+ DFGLS      ++        G+  Y+ PE  R+ +  
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKERLGTAYYIAPEVLRK-KYD 215

Query: 715 EKSDVYSFGVVLFEILCARP 734
           EK DV+S GV+LF +L   P
Sbjct: 216 EKCDVWSIGVILFILLAGYP 235

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (276), Expect = 2e-26
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 12/206 (5%)

Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH 590
              FD    LG G +G VY+         VAIK+     E  + E   EI ++ +    H
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
           +V   G   +N ++ +V +Y   G++ + + + +   L   +   I     +GL YLH  
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLH-- 142

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV--STVVKGSFGYLDPEYF 708
                IHRD+K  NILL+ +  AK++DFG++     L  T    +TV+ G+  ++ PE  
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAG---QLTDTMAKRNTVI-GTPFWMAPEVI 197

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARP 734
           +       +D++S G+   E+   +P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKP 223

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  108 bits (272), Expect = 4e-26
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 23/206 (11%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           LG G FGKVY+   +  T    A K     SE+ + ++  EIE+L+   H ++V L+G  
Sbjct: 27  LGDGAFGKVYKA-KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
             + ++ ++ ++   G +   +       L   Q   +C      L++LH      IIHR
Sbjct: 86  YHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHR 141

Query: 659 DVKTTNILLDEKWVAKVSDFGLS-KTGPTLD--HTHVST-------VVKGSFGYLDPEYF 708
           D+K  N+L+  +   +++DFG+S K   TL    + + T       VV         E  
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM-------CETM 194

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARP 734
           +      K+D++S G+ L E+    P
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEP 220

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  107 bits (270), Expect = 9e-26
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 36/213 (16%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIK-------RGNPLSEQGVHEFQTEIEMLSKLRHRH 590
           LLG G +GKV     D  T  + A+K       R  P  E  V   + EI++L +LRH++
Sbjct: 12  LLGEGSYGKVKEVL-DSETLCRRAVKILKKKKLRRIPNGEANV---KKEIQLLRRLRHKN 67

Query: 591 LVSL--IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR------ 642
           ++ L  + Y EE  +M +V +Y     ++E L    +   P  Q        A       
Sbjct: 68  VIQLVDVLYNEEKQKMYMVMEY-CVCGMQEMLDSVPEKRFPVCQ--------AHGYFCQL 118

Query: 643 --GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
             GL YLH      I+H+D+K  N+LL      K+S  G+++              +GS 
Sbjct: 119 IDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 701 GYLDPEYFRRQQLTE--KSDVYSFGVVLFEILC 731
            +  PE           K D++S GV L+ I  
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  111 bits (279), Expect = 9e-26
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 25/211 (11%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK-------------RGNPLSEQGVHEFQTEIEMLSKL 586
           LG G +G+V   +     ++ AIK               N   E+   E   EI +L  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
            H +++ L    E+     LV ++   G L E +    K          I      G+ Y
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICY 161

Query: 647 LHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           LH   KH I+HRD+K  NILL   +     K+ DFGLS         +      G+  Y+
Sbjct: 162 LH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRLGTAYYI 215

Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE  ++ +  EK DV+S GV+++ +LC  P
Sbjct: 216 APEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (269), Expect = 1e-25
 Identities = 44/238 (18%), Positives = 84/238 (35%), Gaps = 50/238 (21%)

Query: 531 TNNFDEALLLGVGGFGKVYRGE--IDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKL 586
           T  F E   +G G FG V++    +DG     AIKR                E+   + L
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCI--YAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 587 -RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL--YKTQKPPLPWKQRLEICIGAARG 643
            +H H+V       E+  M++  +Y   G+L + +             +  ++ +   RG
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDE-------------------KWVAKVSDFGLSKTG 684
           L Y+H     +++H D+K +NI +                     K + K+ D G     
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 685 PTLDHTHVST-------VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPA 735
            +               V++ ++ +L            K+D+++  + +     A P 
Sbjct: 185 -SSPQVEEGDSRFLANEVLQENYTHL-----------PKADIFALALTVVCAAGAEPL 230

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  108 bits (272), Expect = 2e-25
 Identities = 48/249 (19%), Positives = 76/249 (30%), Gaps = 58/249 (23%)

Query: 541 GVGGFGKVYRGEIDGATTKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           G      V           V ++R N    S + V   Q E+ +     H ++V      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKP-PLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             + E+ +V  +MAYG+ +  L  T     +       I  G  + L Y+H       +H
Sbjct: 96  IADNELWVVTSFMAYGSAK-DLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVH 151

Query: 658 RDVKTTNILLDEKWVAKVSDFGLS----------KTGPTLDHTHVST-------VVK-GS 699
           R VK ++IL+       +S    +          +         V         V++   
Sbjct: 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211

Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGV-------------------VLFEILCARPALNPTL 740
            GY             KSD+YS G+                   +L E L       P L
Sbjct: 212 QGY-----------DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV---PCL 257

Query: 741 PKEQVSLAE 749
                  AE
Sbjct: 258 LDTSTIPAE 266

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  107 bits (269), Expect = 2e-25
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 33/206 (16%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F KV          +VAIK      L+   + +   E+ ++  L H ++V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR--------GLHYLHT 649
            E    + L+ +Y + G + ++L            R++     AR         + Y H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVA--------HGRMKE--KEARSKFRQIVSAVQYCH- 131

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFGYLDPE 706
             +  I+HRD+K  N+LLD     K++DFG S     G  L          G+  Y  PE
Sbjct: 132 --QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL-DAFC-----GAPPYAAPE 183

Query: 707 YFRRQQLT-EKSDVYSFGVVLFEILC 731
            F+ ++    + DV+S GV+L+ ++ 
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVS 209

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  110 bits (276), Expect = 2e-25
 Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 14/200 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G FG+V + +      + A+K         +       E+E+L KL H +++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            E++    +V +    G L + +   ++          I      G+ Y+H   KH I+H
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMH---KHNIVH 144

Query: 658 RDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           RD+K  NILL   ++    K+ DFGLS                G+  Y+ PE  R     
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEVLRG-TYD 200

Query: 715 EKSDVYSFGVVLFEILCARP 734
           EK DV+S GV+L+ +L   P
Sbjct: 201 EKCDVWSAGVILYILLSGTP 220

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  110 bits (276), Expect = 2e-25
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
           + F +  +LG GGFG+V+  ++       A K   +      +G      E ++L+K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 589 RHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQRL------EICIGAA 641
           R +VSL  Y  E    + LV   M  G +R H+Y   +    +++        +I  G  
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
             L +LH   +  II+RD+K  N+LLD+    ++SD GL+                G+ G
Sbjct: 302 --LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPG 354

Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           ++ PE    ++     D ++ GV L+E++ AR 
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  107 bits (270), Expect = 3e-25
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 23/208 (11%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL 591
              +  +LG G FG+V++   + AT  K+A K       +   E + EI ++++L H +L
Sbjct: 90  TVSKTEILGGGRFGQVHKC-EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148

Query: 592 VSLIGYCEENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARGLH 645
           + L    E   +++LV +Y+  G L        +        L  KQ  E       G+ 
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------GIR 201

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           ++H   +  I+H D+K  NIL   +     K+ DFGL++            V  G+  +L
Sbjct: 202 HMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKLKVNFGTPEFL 255

Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILC 731
            PE      ++  +D++S GV+ + +L 
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLS 283

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  106 bits (267), Expect = 3e-25
 Identities = 65/236 (27%), Positives = 110/236 (46%), Gaps = 24/236 (10%)

Query: 509 SYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-TKVAIKRGNP 567
           S AS  P+        + ++     F+   L+G G +G+VY+G     T    AIK  + 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVKTGQLAAIKVMD- 58

Query: 568 LSEQGVHEFQTEIEMLSKL-RHRHLVSLIG------YCEENCEMILVYDYMAYGTLREHL 620
           ++     E + EI ML K   HR++ +  G          + ++ LV ++   G++ + +
Sbjct: 59  VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118

Query: 621 YKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL 680
             T+   L  +    IC    RGL +LH   +H +IHRD+K  N+LL E    K+ DFG+
Sbjct: 119 KNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV 175

Query: 681 SKTGPTLDHTHV--STVVKGSFGYLDPEYFRRQQLTE-----KSDVYSFGVVLFEI 729
           S     LD T    +T + G+  ++ PE     +  +     KSD++S G+   E+
Sbjct: 176 SA---QLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  110 bits (276), Expect = 3e-25
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 19/211 (9%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
           N F +  +LG GGFG+V   ++       A K   +      +G      E ++L K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 589 RHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQRL----EICIGAARG 643
           R +VSL  Y  E  + + LV   M  G L+ H+Y   +   P  + +    EIC G    
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG---- 298

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           L  LH   +  I++RD+K  NILLD+    ++SD GL+   P          V G+ GY+
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYM 352

Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE  + ++ T   D ++ G +L+E++  + 
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  104 bits (263), Expect = 5e-25
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 27/207 (13%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           LG G F  V R  +   T  + A K  N   LS +   + + E  +  KL+H ++V L  
Sbjct: 14  LGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 597 YCEENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
             +E     LV+D +  G L      RE  Y         +Q LE        + Y H  
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILE-------SIAYCH-- 122

Query: 651 AKHTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
             + I+HR++K  N+LL  K      K++DFGL+     ++ +       G+ GYL PE 
Sbjct: 123 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEV 178

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
            ++   ++  D+++ GV+L+ +L   P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYP 205

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  104 bits (263), Expect = 5e-25
 Identities = 48/198 (24%), Positives = 80/198 (40%), Gaps = 12/198 (6%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G +G+V      G   + A K+      + V  F+ EIE++  L H +++ L    E
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           +N ++ LV +    G L E +    K          I       + Y H   K  + HRD
Sbjct: 77  DNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRD 131

Query: 660 VKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           +K  N L          K+ DFGL+          +     G+  Y+ P+         +
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVLEG-LYGPE 187

Query: 717 SDVYSFGVVLFEILCARP 734
            D +S GV+++ +LC  P
Sbjct: 188 CDEWSAGVMMYVLLCGYP 205

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  107 bits (269), Expect = 7e-25
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 25/210 (11%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIK--------RGNPLSEQGVHEFQTEIEMLSKLRHRH 590
           LG G  G+V     +  T  KVAI+         G+          +TEIE+L KL H  
Sbjct: 143 LGSGACGEVKLA-FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
           ++ +  + +   +  +V + M  G L + +       L               + YLH  
Sbjct: 202 IIKIKNFFDAE-DYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH-- 256

Query: 651 AKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE- 706
            ++ IIHRD+K  N+LL   +E  + K++DFG SK     + + + T+  G+  YL PE 
Sbjct: 257 -ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEV 312

Query: 707 --YFRRQQLTEKSDVYSFGVVLFEILCARP 734
                        D +S GV+LF  L   P
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYP 342

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  105 bits (263), Expect = 8e-25
 Identities = 57/194 (29%), Positives = 98/194 (50%), Gaps = 15/194 (7%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG+V++G ID  T   VAIK  +   +E  + + Q EI +LS+    ++    G 
Sbjct: 30  IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             ++ ++ ++ +Y+  G+    L +    PL   Q   I     +GL YLH       IH
Sbjct: 89  YLKDTKLWIIMEYLGGGSAL-DLLEPG--PLDETQIATILREILKGLDYLH---SEKKIH 142

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV--STVVKGSFGYLDPEYFRRQQLTE 715
           RD+K  N+LL E    K++DFG++     L  T +  +T V G+  ++ PE  ++     
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 198

Query: 716 KSDVYSFGVVLFEI 729
           K+D++S G+   E+
Sbjct: 199 KADIWSLGITAIEL 212

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  104 bits (262), Expect = 8e-25
 Identities = 49/197 (24%), Positives = 92/197 (46%), Gaps = 12/197 (6%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           +     +G G  G VY         +VAI++ N   +        EI ++ + ++ ++V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
            +       E+ +V +Y+A G+L + + +T    +   Q   +C    + L +LH    +
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SN 135

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV--STVVKGSFGYLDPEYFRRQ 711
            +IHRD+K+ NILL      K++DFG       +       ST+V G+  ++ PE   R+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 712 QLTEKSDVYSFGVVLFE 728
               K D++S G++  E
Sbjct: 192 AYGPKVDIWSLGIMAIE 208

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  103 bits (260), Expect = 1e-24
 Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 34/208 (16%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
            LGVG FGKV  GE      KVA+K   R    S   V + + EI+ L   RH H++ L 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR--------GLHYL 647
                  +  +V +Y++ G L +++ K          R+E     AR         + Y 
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICK--------HGRVEE--MEARRLFQQILSAVDYC 127

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFGYLD 704
           H   +H ++HRD+K  N+LLD    AK++DFGLS     G  L  T       GS  Y  
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-RTSC-----GSPNYAA 178

Query: 705 PEYFRRQQLT-EKSDVYSFGVVLFEILC 731
           PE    +     + D++S GV+L+ +LC
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLC 206

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  105 bits (263), Expect = 1e-24
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 32/209 (15%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIK------RGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           LG G F  V +   + +T  + A K                 E + E+ +L ++ H +++
Sbjct: 20  LGSGQFAIVKKC-REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 593 SLIGYCEENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARGLHY 646
           +L    E   +++L+ + ++ G L      +E L + +      KQ L+       G++Y
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNY 130

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVA----KVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           LH      I H D+K  NI+L +K +     K+ DFGL+     ++       + G+  +
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEF 184

Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILC 731
           + PE    + L  ++D++S GV+ + +L 
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLS 213

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  104 bits (261), Expect = 2e-24
 Identities = 44/197 (22%), Positives = 87/197 (44%), Gaps = 12/197 (6%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            D  + +G G  G V       +  +VA+K  +   +Q       E+ ++   +H ++V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           +        E+ ++ +++  G L + + +     L  +Q   +C    + L YLH     
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH---AQ 160

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV--STVVKGSFGYLDPEYFRRQ 711
            +IHRD+K+ +ILL      K+SDFG       +        ++V G+  ++ PE   R 
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLV-GTPYWMAPEVISRS 216

Query: 712 QLTEKSDVYSFGVVLFE 728
               + D++S G+++ E
Sbjct: 217 LYATEVDIWSLGIMVIE 233

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  103 bits (258), Expect = 2e-24
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 32/209 (15%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIK------RGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           LG G F  V +      T  + A K        +        E + E+ +L ++RH +++
Sbjct: 13  LGSGQFAIVRKC-RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 593 SLIGYCEENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARGLHY 646
           +L    E   +++L+ + ++ G L      +E L + +      KQ L+       G+HY
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQILD-------GVHY 123

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVA----KVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           LH      I H D+K  NI+L +K V     K+ DFG++     ++  +    + G+  +
Sbjct: 124 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIFGTPEF 177

Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILC 731
           + PE    + L  ++D++S GV+ + +L 
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLS 206

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  104 bits (261), Expect = 2e-24
 Identities = 50/212 (23%), Positives = 96/212 (45%), Gaps = 32/212 (15%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIK------RGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           LG G F  V +   + +T  + A K        +        + + E+ +L +++H +++
Sbjct: 19  LGSGQFAVVKKC-REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 593 SLIGYCEENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARGLHY 646
           +L    E   ++IL+ + +A G L      +E L + +      KQ L        G++Y
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILN-------GVYY 129

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVA----KVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           LH      I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEF 183

Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           + PE    + L  ++D++S GV+ + +L    
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  103 bits (258), Expect = 2e-24
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 13/201 (6%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           LG G FG V+  E   +  +  IK  N   S+  + + + EIE+L  L H +++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQR--LEICIGAARGLHYLHTGAKHTII 656
           E+   M +V +    G L E +   Q       +    E+       L Y H      ++
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146

Query: 657 HRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
           H+D+K  NIL          K+ DFGL++          ST   G+  Y+ PE F+R  +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEVFKR-DV 202

Query: 714 TEKSDVYSFGVVLFEILCARP 734
           T K D++S GVV++ +L    
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCL 223

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  102 bits (257), Expect = 3e-24
 Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 14/200 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           LG G FG+V + +      + A+K         +       E+E+L KL H +++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            E++    +V +    G L + +   ++          I      G+ Y+H   KH I+H
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMH---KHNIVH 144

Query: 658 RDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           RD+K  NILL   ++    K+ DFGLS                G+  Y+ PE  R     
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEVLRG-TYD 200

Query: 715 EKSDVYSFGVVLFEILCARP 734
           EK DV+S GV+L+ +L   P
Sbjct: 201 EKCDVWSAGVILYILLSGTP 220

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  104 bits (261), Expect = 3e-24
 Identities = 57/243 (23%), Positives = 99/243 (40%), Gaps = 31/243 (12%)

Query: 508 GSYASSLPSNLCRHFSFAEIKAATNNFDEAL----LLGVGGFGKVYRGEIDGAT-TKVAI 562
           G + +S+            +  A+  F +       LG G F  V R  +   T  + A 
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAA 59

Query: 563 KRGN--PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL---- 616
           K  N   LS +   + + E  +  KL+H ++V L    +E     LV+D +  G L    
Sbjct: 60  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 119

Query: 617 --REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW--- 671
             RE   +                     + Y H    + I+HR++K  N+LL  K    
Sbjct: 120 VAREFYSE--------ADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGA 168

Query: 672 VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC 731
             K++DFGL+     ++ +       G+ GYL PE  ++   ++  D+++ GV+L+ +L 
Sbjct: 169 AVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225

Query: 732 ARP 734
             P
Sbjct: 226 GYP 228

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  103 bits (259), Expect = 3e-24
 Identities = 65/244 (26%), Positives = 97/244 (39%), Gaps = 49/244 (20%)

Query: 512 SSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-TKVAIK------- 563
           S  P  L   +  ++             LG G  G+V     +  T  KVAIK       
Sbjct: 2   SVYPKALRDEYIMSKT------------LGSGACGEVKLA-FERKTCKKVAIKIISKRKF 48

Query: 564 -RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTL------ 616
             G+          +TEIE+L KL H  ++ +  + +   +  +V + M  G L      
Sbjct: 49  AIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG 107

Query: 617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVA 673
            +   K     L + Q L         + YLH   ++ IIHRD+K  N+LL   +E  + 
Sbjct: 108 NKR-LKEATCKLYFYQMLL-------AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLI 156

Query: 674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE---YFRRQQLTEKSDVYSFGVVLFEIL 730
           K++DFG SK    L  T +   + G+  YL PE              D +S GV+LF  L
Sbjct: 157 KITDFGHSK---ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213

Query: 731 CARP 734
              P
Sbjct: 214 SGYP 217

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  103 bits (259), Expect = 4e-24
 Identities = 51/245 (20%), Positives = 87/245 (35%), Gaps = 54/245 (22%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK-----RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
           +G G +G V     +      AIK     +   ++ + V   +TE+ ++ KL H ++  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 595 IGYCEENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIG--------- 639
               E+   + LV +    G L             +      K ++  C           
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 640 ----------------AAR-------GLHYLHTGAKHTIIHRDVKTTNILL--DEKWVAK 674
                            +         LHYLH      I HRD+K  N L   ++ +  K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 675 VSDFGLSK---TGPTLDHTHVSTVVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFEI 729
           + DFGLSK        ++  ++T   G+  ++ PE      +    K D +S GV+L  +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269

Query: 730 LCARP 734
           L    
Sbjct: 270 LMGAV 274

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  103 bits (260), Expect = 4e-24
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 32/209 (15%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIK------RGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           LG G F  V +   + +T  + A K                 E + E+ +L ++ H +++
Sbjct: 20  LGSGQFAIVKKC-REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 593 SLIGYCEENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARGLHY 646
           +L    E   +++L+ + ++ G L      +E L + +      KQ L+       G++Y
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNY 130

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVA----KVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
           LH      I H D+K  NI+L +K +     K+ DFGL+     ++       + G+  +
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEF 184

Query: 703 LDPEYFRRQQLTEKSDVYSFGVVLFEILC 731
           + PE    + L  ++D++S GV+ + +L 
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLS 213

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  103 bits (258), Expect = 4e-24
 Identities = 39/204 (19%), Positives = 86/204 (42%), Gaps = 24/204 (11%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           LG G FG V+R  ++ ++      K    +        + EI +L+  RHR+++ L    
Sbjct: 13  LGRGEFGIVHRC-VETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 599 EENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
           E   E+++++++++   +             ++      Q  E        L +LH    
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-------ALQFLH---S 120

Query: 653 HTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
           H I H D++  NI+   +  +  K+ +FG ++    L       ++  +  Y  PE  + 
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 711 QQLTEKSDVYSFGVVLFEILCARP 734
             ++  +D++S G +++ +L    
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGIN 201

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  105 bits (264), Expect = 6e-24
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 34/208 (16%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
            LGVG FGKV  G+ +    KVA+K   R    S   V + + EI+ L   RH H++ L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR--------GLHYL 647
                  ++ +V +Y++ G L +++ K          RL+     +R        G+ Y 
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICK--------NGRLDE--KESRRLFQQILSGVDYC 132

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFGYLD 704
           H   +H ++HRD+K  N+LLD    AK++DFGLS     G  L  T       GS  Y  
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-RTSC-----GSPNYAA 183

Query: 705 PEYFRRQQLT-EKSDVYSFGVVLFEILC 731
           PE    +     + D++S GV+L+ +LC
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLC 211

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  105 bits (264), Expect = 9e-24
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 23/204 (11%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           LG G FG V+R   + AT    A K      E      + EI+ +S LRH  LV+L    
Sbjct: 165 LGTGAFGVVHRV-TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223

Query: 599 EENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
           E++ EM+++Y++M+ G L        +     +     +Q  +       GL ++H   +
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK-------GLCHMH---E 273

Query: 653 HTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
           +  +H D+K  NI+   K     K+ DFGL+     LD      V  G+  +  PE    
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEG 330

Query: 711 QQLTEKSDVYSFGVVLFEILCARP 734
           + +   +D++S GV+ + +L    
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLS 354

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  102 bits (256), Expect = 9e-24
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 28/206 (13%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHR-HLVSLI 595
           LG G F  V +  I  +T  + A K  +     +    E   EI +L   +    +++L 
Sbjct: 37  LGRGKFAVVRQC-ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP-------WKQRLEICIGAARGLHYLH 648
              E   E+IL+ +Y A G +           +         KQ LE       G++YLH
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE-------GVYYLH 148

Query: 649 TGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
              ++ I+H D+K  NILL         K+ DFG+S+    + H      + G+  YL P
Sbjct: 149 ---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLAP 202

Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILC 731
           E      +T  +D+++ G++ + +L 
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLT 228

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  102 bits (255), Expect = 1e-23
 Identities = 45/248 (18%), Positives = 82/248 (33%), Gaps = 38/248 (15%)

Query: 569 SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL-YKTQKPP 627
           S   +     +I  +     ++ V  +        + +         L++ +  +     
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 628 LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK----- 682
                 L I I  A  + +LH      ++HRD+K +NI      V KV DFGL       
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217

Query: 683 -----TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 737
                    +      T   G+  Y+ PE       + K D++S G++LFE+L +     
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277

Query: 738 PTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAM---KCVSDQGIE 794
                             +  I+  +       K      +K+ +  M     +S    E
Sbjct: 278 -----------------ERVRIITDVR----NLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316

Query: 795 RPSMGDVL 802
           RP   D++
Sbjct: 317 RPEATDII 324

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  102 bits (256), Expect = 1e-23
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 25/205 (12%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
            LG G    VYR +  G     A+K             +TEI +L +L H +++ L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 599 EENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
           E   E+ LV + +  G L      + + Y  +      KQ LE        + YLH   +
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGY-YSERDAADAVKQILE-------AVAYLH---E 166

Query: 653 HTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
           + I+HRD+K  N+L          K++DFGLSK    ++H  +   V G+ GY  PE  R
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILR 223

Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
                 + D++S G++ + +LC   
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFE 248

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  102 bits (255), Expect = 1e-23
 Identities = 50/202 (24%), Positives = 81/202 (40%), Gaps = 18/202 (8%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
            +G G FG+V+R   D  T  + A+K+   L          E+   + L    +V L G 
Sbjct: 65  RVGRGSFGEVHRM-KDKQTGFQCAVKK-VRLEVFR----VEELVACAGLSSPRIVPLYGA 118

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             E   + +  + +  G+L + +   Q   LP  + L     A  GL YLHT     I+H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHT---RRILH 173

Query: 658 RDVKTTNILLDEK-WVAKVSDFGLSK----TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            DVK  N+LL      A + DFG +      G          +  G+  ++ PE    + 
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP-GTETHMAPEVVMGKP 232

Query: 713 LTEKSDVYSFGVVLFEILCARP 734
              K D++S   ++  +L    
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCH 254

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (252), Expect = 2e-23
 Identities = 59/218 (27%), Positives = 86/218 (39%), Gaps = 38/218 (17%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGN-PLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
           +G G    V          KVAIKR N    +  + E   EI+ +S+  H ++VS     
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL--EICIGAA-----RGLHYLHTGA 651
               E+ LV   ++ G++   + K        K  +  E  I         GL YLH   
Sbjct: 83  VVKDELWLVMKLLSGGSVL-DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138

Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFG----LSKTGPTLD----HTHVST-------VV 696
           K+  IHRDVK  NILL E    +++DFG    L+  G         T V T       V+
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198

Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           +   GY             K+D++SFG+   E+     
Sbjct: 199 EQVRGY-----------DFKADIWSFGITAIELATGAA 225

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  101 bits (254), Expect = 2e-23
 Identities = 62/210 (29%), Positives = 91/210 (43%), Gaps = 35/210 (16%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
            LG G FGKV          KVA+K   R            + EI  L  LRH H++ L 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR--------GLHYL 647
                  ++++V +Y A G L +++ +        K+R+       R         + Y 
Sbjct: 76  DVITTPTDIVMVIEY-AGGELFDYIVE--------KKRMTE--DEGRRFFQQIICAIEYC 124

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDHTHVSTVVKGSFGYLD 704
           H   +H I+HRD+K  N+LLD+    K++DFGLS     G  L  T       GS  Y  
Sbjct: 125 H---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL-KTSC-----GSPNYAA 175

Query: 705 PEYFRRQQLT-EKSDVYSFGVVLFEILCAR 733
           PE    +     + DV+S G+VL+ +L  R
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (258), Expect = 2e-23
 Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 26/207 (12%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
           LG G F  V R  +      + A        LS +   + + E  +   L+H ++V L  
Sbjct: 19  LGKGAFSVVRRC-VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 597 YCEENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
              E     L++D +  G L      RE+  +                     + + H  
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAREYYSE--------ADASHCIQQILEAVLHCH-- 127

Query: 651 AKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
            +  ++HR++K  N+LL    +    K++DFGL+      +         G+ GYL PE 
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFA-GTPGYLSPEV 184

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
            R+    +  D+++ GV+L+ +L   P
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYP 211

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  102 bits (255), Expect = 2e-23
 Identities = 59/210 (28%), Positives = 86/210 (40%), Gaps = 36/210 (17%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
            +G G FG       D  T   VA+K   RG  + E      Q EI     LRH ++V  
Sbjct: 27  DIGSGNFGVARLMR-DKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRF 81

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR--------GLHY 646
                    + ++ +Y + G L E +            R       AR        G+ Y
Sbjct: 82  KEVILTPTHLAIIMEYASGGELYERICN--------AGRFSE--DEARFFFQQLLSGVSY 131

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVA--KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
            H      I HRD+K  N LLD       K+ DFG SK+  ++ H+   + V G+  Y+ 
Sbjct: 132 CH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTV-GTPAYIA 185

Query: 705 PEYFRRQQLT-EKSDVYSFGVVLFEILCAR 733
           PE   RQ+   + +DV+S GV L+ +L   
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  102 bits (255), Expect = 3e-23
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 22/213 (10%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
           ++F+    +G G FGKV   + +      A+K   +   +    V     E++++  L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 589 RHLVSLIGYC---EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEIC-IGAARGL 644
             LV+L  Y    EE+  M++  D +  G LR HL +          +L IC +  A  L
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVV--DLLLGGDLRYHLQQNVHFKEE-TVKLFICELVMA--L 128

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
            YL       IIHRD+K  NILLDE     ++DF ++   P        T+  G+  Y+ 
Sbjct: 129 DYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT--TMA-GTKPYMA 182

Query: 705 PEYFRRQQLTEKS---DVYSFGVVLFEILCARP 734
           PE F  ++    S   D +S GV  +E+L  R 
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 98.8 bits (247), Expect = 5e-23
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 35/209 (16%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIK-----RGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
            LG G +G+V    ++  T   VA+K     R     E      + EI +   L H ++V
Sbjct: 14  TLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVV 68

Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR--------GL 644
              G+  E     L  +Y + G L + +             +      A+        G+
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEP--------DIGMPE--PDAQRFFHQLMAGV 118

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV-STVVKGSFGYL 703
            YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   + + +  G+  Y+
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174

Query: 704 DPEYFRRQQLT-EKSDVYSFGVVLFEILC 731
            PE  +R++   E  DV+S G+VL  +L 
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLA 203

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 56/218 (25%), Positives = 87/218 (39%), Gaps = 38/218 (17%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIK---------RGNPLSEQGVHEFQTEIEMLSKL-RH 588
           LG G    V R  I   T  + A+K               ++       E+++L K+  H
Sbjct: 25  LGRGVSSVVRRC-IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAAR 642
            +++ L    E N    LV+D M  G L      +      ++     +  LE       
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLE------- 135

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY 702
            +  LH   K  I+HRD+K  NILLD+    K++DFG S     LD       V G+  Y
Sbjct: 136 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSY 189

Query: 703 LDPE------YFRRQQLTEKSDVYSFGVVLFEILCARP 734
           L PE              ++ D++S GV+++ +L   P
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  100 bits (251), Expect = 6e-23
 Identities = 49/213 (23%), Positives = 83/213 (38%), Gaps = 31/213 (14%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIK-----RGNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           +G G F  V R  I+  T  + A+K     +          + + E  +   L+H H+V 
Sbjct: 32  IGKGPFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP---------WKQRLEICIGAARGL 644
           L+     +  + +V+++M    L   + K                 +Q LE        L
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-------AL 143

Query: 645 HYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
            Y H    + IIHRDVK   +LL   +     K+  FG++              V G+  
Sbjct: 144 RYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRV-GTPH 198

Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           ++ PE  +R+   +  DV+  GV+LF +L    
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  100 bits (250), Expect = 6e-23
 Identities = 61/202 (30%), Positives = 86/202 (42%), Gaps = 19/202 (9%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKR---GNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +G G FG VY    D      VAIK+       S +   +   E+  L KLRH + +   
Sbjct: 62  IGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G         LV +Y         L +  K PL   +   +  GA +GL YLH    H +
Sbjct: 121 GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNM 175

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE---YFRRQQ 712
           IHRDVK  NILL E  + K+ DFG +           ++ V G+  ++ PE        Q
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANSFV-GTPYWMAPEVILAMDEGQ 229

Query: 713 LTEKSDVYSFGVVLFEILCARP 734
              K DV+S G+   E+   +P
Sbjct: 230 YDGKVDVWSLGITCIELAERKP 251

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 99.8 bits (249), Expect = 8e-23
 Identities = 45/223 (20%), Positives = 80/223 (35%), Gaps = 60/223 (26%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--------RGNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           LG G FG V+         +V +K            + +  + +   EI +LS++ H ++
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 592 VSLIGYCEENCEMILV----------YDY-MAYGTLREHLYKTQKPPLPWKQRLEICIGA 640
           + ++   E      LV          + +   +  L E L                    
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL-------------------- 131

Query: 641 AR--------GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS---KTGPTLDH 689
           A          + YL       IIHRD+K  NI++ E +  K+ DFG +   + G    +
Sbjct: 132 ASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF-Y 187

Query: 690 THVSTVVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEILC 731
           T       G+  Y  PE          + +++S GV L+ ++ 
Sbjct: 188 TFC-----GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 35/209 (16%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIK-----RGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
            LG G +G+V    ++  T   VA+K     R     E      + EI +   L H ++V
Sbjct: 14  TLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVV 68

Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAAR--------GL 644
              G+  E     L  +Y + G L + +             +      A+        G+
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEP--------DIGMPE--PDAQRFFHQLMAGV 118

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV-STVVKGSFGYL 703
            YLH      I HRD+K  N+LLDE+   K+SDFGL+      +   + + +  G+  Y+
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174

Query: 704 DPEYFRRQQLT-EKSDVYSFGVVLFEILC 731
            PE  +R++   E  DV+S G+VL  +L 
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLA 203

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 62/275 (22%), Positives = 115/275 (41%), Gaps = 37/275 (13%)

Query: 540 LGVGGFGKVYRGEIDGATTKV-AIKRGNP-LSEQGVHEFQTEIEMLSKL-RHRHLVSLIG 596
           +G G  G+V++      T  V A+K+     +++       +++++ K     ++V   G
Sbjct: 33  MGSGTCGQVWKM-RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
               N ++ +  + M     +  L K  + P+P +   ++ +   + L+YL    KH +I
Sbjct: 92  TFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVI 147

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE- 715
           HRDVK +NILLDE+   K+ DFG+S     L          G   Y+ PE       T+ 
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204

Query: 716 ----KSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD---PYL 768
               ++DV+S G+ L E+   +          +V              L +++    P L
Sbjct: 205 DYDIRADVWSLGISLVELATGQFPYKNCKTDFEV--------------LTKVLQEEPPLL 250

Query: 769 KGKIA-PECFKKFAETAMKCVSDQGIERPSMGDVL 802
            G +     F+ F +    C++    +RP    +L
Sbjct: 251 PGHMGFSGDFQSFVK---DCLTKDHRKRPKYNKLL 282

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  101 bits (254), Expect = 2e-22
 Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 24/218 (11%)

Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
               N+F    ++G GGFG+VY           A+K   +     +QG      E  MLS
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244

Query: 585 KL---RHRHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQRL---EIC 637
            +       +V +  Y     + +  + D M  G L  HL +          R    EI 
Sbjct: 245 LVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEII 302

Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
           +G    L ++H      +++RD+K  NILLDE    ++SD GL+         H    V 
Sbjct: 303 LG----LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPH--ASV- 351

Query: 698 GSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEILCARP 734
           G+ GY+ PE  ++    + S D +S G +LF++L    
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 98.2 bits (245), Expect = 4e-22
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 39/218 (17%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIK--------RGNPLSEQGVHEFQTEIEMLSKLR-HR 589
           +G G    V R  +  AT  + A+K              E+     + E  +L ++  H 
Sbjct: 102 IGRGVSSVVRRC-VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTL------REHLYKTQKPPLPWKQRLEICIGAARG 643
           H+++LI   E +  M LV+D M  G L      +      ++     +  LE        
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA-LSEKETRSIMRSLLE-------A 212

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV-STVVKGSFGY 702
           + +LH    + I+HRD+K  NILLD+    ++SDFG S     L+       +  G+ GY
Sbjct: 213 VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELC-GTPGY 265

Query: 703 LDPEYFRRQQL------TEKSDVYSFGVVLFEILCARP 734
           L PE  +           ++ D+++ GV+LF +L   P
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 54/260 (20%), Positives = 96/260 (36%), Gaps = 44/260 (16%)

Query: 495 NSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGE-- 552
           + H   S         A     +  +     E +   + +    LLG GGFG VY G   
Sbjct: 6   HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRV 65

Query: 553 IDGATTKVAIKR------GNPLSEQGVHEFQTEIEMLSKLRHR--HLVSLIGYCEENCEM 604
            D     VAIK        +            E+ +L K+      ++ L+ + E     
Sbjct: 66  SDN--LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123

Query: 605 ILVYDYMAYGTLREHL--YKTQKPPLPWKQRLEICIGAAR--------GLHYLHTGAKHT 654
           +L+   +      + L  + T++  L  +         AR         + + H      
Sbjct: 124 VLI---LERPEPVQDLFDFITERGALQEEL--------ARSFFWQVLEAVRHCH---NCG 169

Query: 655 IIHRDVKTTNILLD-EKWVAKVSDFGLS-KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
           ++HRD+K  NIL+D  +   K+ DFG       T+          G+  Y  PE+ R  +
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-----GTRVYSPPEWIRYHR 224

Query: 713 LT-EKSDVYSFGVVLFEILC 731
                + V+S G++L++++C
Sbjct: 225 YHGRSAAVWSLGILLYDMVC 244

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 58/276 (21%), Positives = 113/276 (40%), Gaps = 38/276 (13%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNP-LSEQGVHEFQTEIEM-LSKLRHRHLVSLIG 596
           LG G +G V +      +   +A+KR    ++ Q       ++++ +  +     V+  G
Sbjct: 15  LGRGAYGVVEKM-RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKT---QKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
                 ++ +  + M   +L +  YK    +   +P     +I +   + L +LH+  K 
Sbjct: 74  ALFREGDVWICMELMD-TSL-DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KL 129

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE----YFR 709
           ++IHRDVK +N+L++     K+ DFG+S     L       +  G   Y+ PE       
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPELN 186

Query: 710 RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD---P 766
           ++  + KSD++S G+ + E+   R    P           W         L+Q+++   P
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRF---P--------YDSWG---TPFQQLKQVVEEPSP 232

Query: 767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
            L        F  F     +C+     ERP+  +++
Sbjct: 233 QLPADKFSAEFVDFTS---QCLKKNSKERPTYPELM 265

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 96.6 bits (241), Expect = 7e-22
 Identities = 48/204 (23%), Positives = 91/204 (44%), Gaps = 15/204 (7%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNP-LSEQGVHEFQTEIE-MLSKLRHRHLVSLIG 596
           +G G +G V +  +   +   +A+KR    + E+   +   +++ ++      ++V   G
Sbjct: 30  IGRGAYGSVNKM-VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 597 YCEENCEMILVYDYMAYGTLR--EHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
                 +  +  + M+    +  +++Y      +P +   +I +   + L++L       
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLK 146

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE----YFRR 710
           IIHRD+K +NILLD     K+ DFG+S     L  +   T   G   Y+ PE       R
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASR 203

Query: 711 QQLTEKSDVYSFGVVLFEILCARP 734
           Q    +SDV+S G+ L+E+   R 
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRF 227

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 96.2 bits (240), Expect = 9e-22
 Identities = 56/227 (24%), Positives = 88/227 (38%), Gaps = 64/227 (28%)

Query: 539 LLGVGGFGKVYRGE--IDGATTKVAIK---RGNPLSEQGVHEFQT---EIEMLSKLR--- 587
           LLG GGFG V+ G    D    +VAIK   R   L    + +  T   E+ +L K+    
Sbjct: 38  LLGKGGFGTVFAGHRLTDR--LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95

Query: 588 -HRHLVSLIGYCEENCEMILV----------YDY-MAYGTLREHLYKTQKPPLPWKQRLE 635
            H  ++ L+ + E     +LV          +DY    G L E                 
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP--------------- 140

Query: 636 ICIGAAR--------GLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLS-KTGP 685
                +R         + + H      ++HRD+K  NIL+D  +  AK+ DFG       
Sbjct: 141 -----SRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD 192

Query: 686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEILC 731
                       G+  Y  PE+  R Q     + V+S G++L++++C
Sbjct: 193 EPYTDFD-----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 44/200 (22%), Positives = 81/200 (40%), Gaps = 16/200 (8%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGY 597
           LG G F    +  +   +    A+K    +S++     Q EI  L     H ++V L   
Sbjct: 19  LGEGSFSICRKC-VHKKSNQAFAVKI---ISKRMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
             +     LV + +  G L E +   +K      +   I       + ++H      ++H
Sbjct: 75  FHDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSAVSHMH---DVGVVH 129

Query: 658 RDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           RD+K  N+L    ++    K+ DFG ++  P  +   + T    +  Y  PE   +    
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPELLNQNGYD 187

Query: 715 EKSDVYSFGVVLFEILCARP 734
           E  D++S GV+L+ +L  + 
Sbjct: 188 ESCDLWSLGVILYTMLSGQV 207

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 56/240 (23%), Positives = 90/240 (37%), Gaps = 67/240 (27%)

Query: 539 LLGVGGFGKVY--RGEIDGATTKVAIK---------------RGNPLSEQGVHEFQT--- 578
            +G G +G V     E D   T  A+K               R  P   +          
Sbjct: 20  EIGKGSYGVVKLAYNENDN--TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 579 --------EIEMLSKLRHRHLVSL---IGYCEENCEMILVYDYMAYGTLREHLYKTQKPP 627
                   EI +L KL H ++V L   +    E+  + +V++ +  G +   +      P
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPV---MEVPTLKP 133

Query: 628 LPWKQRLEICIGAAR--------GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG 679
           L   Q        AR        G+ YLH      IIHRD+K +N+L+ E    K++DFG
Sbjct: 134 LSEDQ--------ARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 680 LS---KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT---EKSDVYSFGVVLFEILCAR 733
           +S   K    L    V     G+  ++ PE     +     +  DV++ GV L+  +  +
Sbjct: 183 VSNEFKGSDALLSNTV-----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 19/237 (8%)

Query: 508 GSYASSLPSNLCRHFSF---AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKV-AIK 563
           G+ A   P       +       K    +F    +LG G F  V     + AT++  AIK
Sbjct: 3   GTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLAR-ELATSREYAIK 61

Query: 564 ---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHL 620
              + + + E  V     E +++S+L H   V L    +++ ++     Y   G L +++
Sbjct: 62  ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 121

Query: 621 YKTQKPPLPWKQRL---EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSD 677
            K          R    EI       L YLH      IIHRD+K  NILL+E    +++D
Sbjct: 122 RKIGSFDET-CTRFYTAEIVSA----LEYLH---GKGIIHRDLKPENILLNEDMHIQITD 173

Query: 678 FGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           FG +K          +    G+  Y+ PE    +   + SD+++ G ++++++   P
Sbjct: 174 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 94.3 bits (235), Expect = 5e-21
 Identities = 57/250 (22%), Positives = 95/250 (38%), Gaps = 27/250 (10%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIG 596
           +LG G   +V    I+  T  + A+K               E+EML + + HR+++ LI 
Sbjct: 20  VLGEGAHARVQTC-INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
           + EE     LV++ M  G++  H+   ++      +   +    A  L +LH      I 
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVVQDVASALDFLH---NKGIA 133

Query: 657 HRDVKTTNILL---DEKWVAKVSDFGLSK------TGPTLDHTHVSTVVKGSFGYLDPEY 707
           HRD+K  NIL    ++    K+ DF L            +    + T   GS  Y+ PE 
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPEV 192

Query: 708 FRRQQLTEKS-----DVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ 762
                          D++S GV+L+ +L   P        +       A    +  + E 
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252

Query: 763 IMDPYLKGKI 772
           I     +GK 
Sbjct: 253 I----QEGKY 258

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 37/263 (14%), Positives = 78/263 (29%), Gaps = 51/263 (19%)

Query: 539 LLGVGGFGKVYRGEIDGATTK-VAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSL 594
             G     + ++   D A  + VA+        L +  + E  +    LS++    +  +
Sbjct: 38  FHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
           +         ++V +++  G+L+E        P P    +      A      H   +  
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSP-VGAIRAMQSLAAAADAAH---RAG 149

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           +       + +         VS  G               VV      +           
Sbjct: 150 VALSIDHPSRVR--------VSIDG--------------DVVLAYPATMPDA-------N 180

Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            + D+   G  L+ +L  R  L     +  ++ AE       +    Q ++P     I  
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPIEP---ADIDR 230

Query: 775 ECFKKFAETAMKCVSDQGIERPS 797
           +   + +  A + V   G  R +
Sbjct: 231 DIPFQISAVAARSVQGDGGIRSA 253

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 22/205 (10%)

Query: 539 LLGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIG 596
           +LG+G  GKV        T  K A+K           + + E++   +     H+V ++ 
Sbjct: 36  VLGLGVNGKVLEC-FHRRTGQKCALK-----LLYDSPKARQEVDHHWQASGGPHIVCILD 89

Query: 597 YCEENCEMI----LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
             E          ++ + M  G L   + +        ++  EI       + +LH    
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---S 146

Query: 653 HTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
           H I HRDVK  N+L    ++  V K++DFG +K         + T    +  Y+ PE   
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQTPC-YTPYYVAPEVLG 202

Query: 710 RQQLTEKSDVYSFGVVLFEILCARP 734
            ++  +  D++S GV+++ +LC  P
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGFP 227

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 44/201 (21%), Positives = 89/201 (44%), Gaps = 18/201 (8%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGY 597
           +GVG +    R  I  AT  + A+K  +            EIE+L +  +H ++++L   
Sbjct: 30  IGVGSYSVCKRC-IHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDV 84

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            ++   + +V + M  G L + +   ++     ++   +     + + YLH      ++H
Sbjct: 85  YDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAVLFTITKTVEYLH---AQGVVH 139

Query: 658 RDVKTTNILLDEK----WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
           RD+K +NIL  ++       ++ DFG +K     +   + T    +  ++ PE   RQ  
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YTANFVAPEVLERQGY 197

Query: 714 TEKSDVYSFGVVLFEILCARP 734
               D++S GV+L+ +L    
Sbjct: 198 DAACDIWSLGVLLYTMLTGYT 218

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 90.6 bits (225), Expect = 3e-19
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 17/214 (7%)

Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
           +   N F+   LLG G FGKV   +        A+K   +   +++  V    TE  +L 
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203

Query: 585 KLRHRHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQRL---EICIGA 640
             RH  L +L  Y  +  + +  V +Y   G L  HL + +      + R    EI    
Sbjct: 204 NSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSA- 260

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
              L YLH  ++  +++RD+K  N++LD+    K++DFGL K G     T + T   G+ 
Sbjct: 261 ---LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTFC-GTP 313

Query: 701 GYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            YL PE           D +  GVV++E++C R 
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 89.8 bits (223), Expect = 5e-19
 Identities = 49/223 (21%), Positives = 92/223 (41%), Gaps = 25/223 (11%)

Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEM 582
           +++    +F+   ++G G FG+V   ++  A    A+K   +   L       F+ E ++
Sbjct: 68  QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV 127

Query: 583 LSKLRHRHLVSLIGYC---EENCEMILVYDYMAYGTLREHLYKTQKP-PLPWKQ--RLEI 636
           L     + + +L  Y    + N  +++  DY   G L   L K +   P    +    E+
Sbjct: 128 LVNGDSKWITTLH-YAFQDDNNLYLVM--DYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
            I     +  +H   +   +HRD+K  NIL+D     +++DFG             S  V
Sbjct: 185 VIA----IDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237

Query: 697 KGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEILCARP 734
            G+  Y+ PE  +  +  +       D +S GV ++E+L    
Sbjct: 238 -GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.0 bits (221), Expect = 7e-19
 Identities = 49/225 (21%), Positives = 87/225 (38%), Gaps = 27/225 (12%)

Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEM 582
           E++   ++F+   ++G G F +V   ++       A+K   + + L    V  F+ E ++
Sbjct: 55  EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114

Query: 583 LSKLRHRHLVSLIGYC---EENCEMILVYDYMAYGTLREHLYKTQKP-PLPWKQ--RLEI 636
           L     R +  L  +    E    + LV +Y   G L   L K  +  P    +    EI
Sbjct: 115 LVNGDRRWITQLH-FAFQDENY--LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
            +     +  +H   +   +HRD+K  NILLD     +++DFG                V
Sbjct: 172 VMA----IDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224

Query: 697 KGSFGYLDPEYFRRQQLTEKSDVY-------SFGVVLFEILCARP 734
            G+  YL PE  +       +  Y       + GV  +E+   + 
Sbjct: 225 -GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 88.1 bits (219), Expect = 8e-19
 Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 21/249 (8%)

Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60

Query: 552 EIDGATTKVAIKRGNPLSEQGVHEFQ------TEIEMLSKLRHRHLVSLIGYCEENCEMI 605
           +   +    A+K    L +Q V + +       E  +L  +    LV L    ++N  + 
Sbjct: 61  KHKESGNHYAMKI---LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117

Query: 606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNI 665
           +V +Y+A G +  HL +  +   P  +     I       YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLH---SLDLIYRDLKPENL 172

Query: 666 LLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 725
           L+D++   +V+DFG +K       T   T        L PE    +   +  D ++ GV+
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGRTWTLCGTP-----EALAPEIILSKGYNKAVDWWALGVL 227

Query: 726 LFEILCARP 734
           ++E+    P
Sbjct: 228 IYEMAAGYP 236

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 86.4 bits (215), Expect = 2e-18
 Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 30/232 (12%)

Query: 517 NLCRHFSFAEIKAATNNFDEALLLGVGGFGKVY--RGEIDGATTKV----AIKRGNPLSE 570
            +  H      KA  + F+   +LG G FGKV+  +        ++     +K+      
Sbjct: 9   AITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR 68

Query: 571 QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLP 629
             V   + E ++L ++ H  +V L  Y  +    + L+ D++  G L   L K       
Sbjct: 69  DRVRT-KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE 126

Query: 630 WKQRL---EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT 686
              +    E+ +     L +LH      II+RD+K  NILLDE+   K++DFGLSK    
Sbjct: 127 DV-KFYLAELALA----LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178

Query: 687 LDHTHVSTVVKGSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            +          SF G   Y+ PE   R+  T+ +D +SFGV++FE+L    
Sbjct: 179 HEKK---A---YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 16/213 (7%)

Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
           K   N+FD   LLG G FGKV            A+K   +   +++  V    TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 585 KLRHRHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGAA 641
             RH  L +L  Y  +  + +  V +Y   G L  HL + +       +    EI     
Sbjct: 61  NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA-- 117

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFG 701
             L YLH      +++RD+K  N++LD+    K++DFGL K G +   T + T   G+  
Sbjct: 118 --LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFC-GTPE 170

Query: 702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           YL PE           D +  GVV++E++C R 
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 58/271 (21%), Positives = 104/271 (38%), Gaps = 27/271 (9%)

Query: 479 SSSDAQSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAE-IKAATNNFDEA 537
           S+S  QS  +P           +       +     P      F     ++   N   + 
Sbjct: 3   SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD 62

Query: 538 L-----LLGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRH 590
                 +LG+G  GKV +   +  T  K A+K       Q   + + E+E+  +  +  H
Sbjct: 63  YKVTSQVLGLGINGKVLQI-FNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPH 116

Query: 591 LVSLIGYCEENCEMI----LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
           +V ++   E          +V + +  G L   +          ++  EI       + Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 647 LHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           LH      I HRDVK  N+L        + K++DFG +K   T  H  ++T    +  Y+
Sbjct: 177 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPC-YTPYYV 230

Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            PE    ++  +  D++S GV+++ +LC  P
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 86.1 bits (213), Expect = 3e-18
 Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 13/162 (8%)

Query: 573 VHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ 632
             + +  +  +     R L S+           +    ++     E      K  L  + 
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194

Query: 633 RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHV 692
            +      A+G+ +L   A    IHRD+   NILL EK V K+ DFGL++     D    
Sbjct: 195 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKD 246

Query: 693 STVVKGSFGYLD-----PEYFRRQQLTEKSDVYSFGVVLFEI 729
              V+     L      PE    +  T +SDV+SFGV+L+EI
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 84.5 bits (210), Expect = 6e-18
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIG 596
           +G G +G V++   +  T   VAIK+     +  V +     EI ML +L+H +LV+L+ 
Sbjct: 11  IGEGSYGVVFKC-RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                  + LV++Y  + T+   L    +  +P      I     + +++ H   KH  I
Sbjct: 70  VFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCI 124

Query: 657 HRDVKTTNILLDEKWVAKVSDFGL--SKTGPTLDHTH-VST 694
           HRDVK  NIL+ +  V K+ DFG     TGP+  +   V+T
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.9 bits (213), Expect = 7e-18
 Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 18/218 (8%)

Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEM 582
           +++    +++   ++G G FG+V            A+K   +   +       F  E ++
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122

Query: 583 LSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGA 640
           ++      +V L    +++  + +V +YM  G L   +      P  W +    E+ +  
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLA- 180

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
              L  +H       IHRDVK  N+LLD+    K++DFG              T V G+ 
Sbjct: 181 ---LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTP 233

Query: 701 GYLDPEYFRRQQLTEK----SDVYSFGVVLFEILCARP 734
            Y+ PE  + Q          D +S GV L+E+L    
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 84.5 bits (210), Expect = 9e-18
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 30/222 (13%)

Query: 528 KAATNNFDEALLLGVGGFGKVY--RGEIDGATTKV-AIK--RGNPLSEQGVHEFQTEIE- 581
           K     F+   +LG GG+GKV+  R      T K+ A+K  +   +         T+ E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72

Query: 582 -MLSKLRHRHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQRL---EI 636
            +L +++H  +V LI Y  +    + L+ +Y++ G L   L +               EI
Sbjct: 73  NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-TACFYLAEI 130

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
            +     L +LH   +  II+RD+K  NI+L+ +   K++DFGL K           T  
Sbjct: 131 SMA----LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---T-- 178

Query: 697 KGSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             +F G   Y+ PE   R       D +S G +++++L   P
Sbjct: 179 -HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 45/161 (27%), Positives = 83/161 (51%), Gaps = 12/161 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLIG 596
           +G G +G V +   +  T + VAIK+     +  + +     EI++L +LRH +LV+L+ 
Sbjct: 33  VGEGSYGMVMKC-RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
            C++     LV++++ + T+ + L +     L ++   +       G+ + H    H II
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCH---SHNII 146

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTH-VST 694
           HRD+K  NIL+ +  V K+ DFG ++T   P   +   V+T
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 25/216 (11%)

Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQ------TEIE 581
           K +  +F     LG G FG+V+           A+K    L ++ V   +       E  
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV---LKKEIVVRLKQVEHTNDERL 58

Query: 582 MLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL---EICI 638
           MLS + H  ++ + G  ++  ++ ++ DY+  G L   L K+Q+ P P   +    E+C+
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-VAKFYAAEVCL 117

Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
                L YLH      II+RD+K  NILLD+    K++DFG +K  P + +T   T    
Sbjct: 118 A----LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP--- 167

Query: 699 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
              Y+ PE    +   +  D +SFG++++E+L    
Sbjct: 168 --DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 86.2 bits (213), Expect = 2e-17
 Identities = 64/302 (21%), Positives = 114/302 (37%), Gaps = 17/302 (5%)

Query: 440 NSKQKAIIGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSA 499
           +   +    G +  GI+     G   +     + +G+  +      G             
Sbjct: 249 DLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFER 308

Query: 500 GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK 559
                 T      +  +      +    +    +F+  ++LG G FGKV   E  G    
Sbjct: 309 AKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDEL 368

Query: 560 VAIK---RGNPLSEQGVHEFQTEIEMLSK-LRHRHLVSLIGYCEENCEMI-LVYDYMAYG 614
            A+K   +   + +  V     E  +L+   +   L  L   C +  + +  V +Y+  G
Sbjct: 369 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGG 427

Query: 615 TLREHLYKTQKPPLPWKQ--RLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV 672
            L  H+ +  +   P       EI IG    L +L       II+RD+K  N++LD +  
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQ---SKGIIYRDLKLDNVMLDSEGH 480

Query: 673 AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA 732
            K++DFG+ K       T   T   G+  Y+ PE    Q   +  D ++FGV+L+E+L  
Sbjct: 481 IKIADFGMCKENIWDGVT-TKTFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538

Query: 733 RP 734
           + 
Sbjct: 539 QA 540

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 15/161 (9%)

Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKRGNPLSEQGVHEFQT---EIEMLSKLRHRHLVSLI 595
           LG G +  VY+G ++  T   VA+K     SE+G     T   EI ++ +L+H ++V L 
Sbjct: 13  LGNGTYATVYKG-LNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKELKHENIVRLY 69

Query: 596 GYCEENCEMILVYDYMAY---GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
                  ++ LV+++M       +           L             +GL + H   +
Sbjct: 70  DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---E 126

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGL--SKTGPTLDHTH 691
           + I+HRD+K  N+L++++   K+ DFGL  +   P    + 
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 50/219 (22%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT----EIEMLSKLRHRHLVSLI 595
           +G G FG V++      + +VAIK+        V + +     E++++  ++H ++V L 
Sbjct: 48  IGNGSFGVVFQA-KLVESDEVAIKK--------VLQDKRFKNRELQIMRIVKHPNVVDLK 98

Query: 596 GYCEENCEMI------LVYDYMAYGTLREHLYKTQKPPLPWKQRLE----------ICIG 639
            +   N +        LV +Y+      E +Y+  +     KQ +           +   
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLL-- 151

Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVST--VV 696
             R L Y+H+     I HRD+K  N+LLD    V K+ DFG +K    L     +   + 
Sbjct: 152 --RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK---ILIAGEPNVSYIC 203

Query: 697 KGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEILCARP 734
             S  Y  PE  F     T   D++S G V+ E++  +P
Sbjct: 204 --SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSK-LR 587
            +FD   ++G G + KV    +       A+K   +     ++ +   QTE  +  +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 588 HRHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGAARGL 644
           H  LV L   C +    +  V +Y+  G L  H+ + +K P    +    EI +     L
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----L 123

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           +YLH   +  II+RD+K  N+LLD +   K++D+G+ K G     T  ST   G+  Y+ 
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFC-GTPNYIA 178

Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  R +      D ++ GV++FE++  R 
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 208

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 64/218 (29%), Positives = 93/218 (42%), Gaps = 25/218 (11%)

Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
           K    +F    +LG G FGKV+  E        AIK   +   L +  V     E  +LS
Sbjct: 13  KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72

Query: 585 K-LRHRHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGA 640
               H  L  +     +  E +  V +Y+  G L  H+    K  L        EI +G 
Sbjct: 73  LAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG- 130

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
              L +LH      I++RD+K  NILLD+    K++DFG+ K     D     T    +F
Sbjct: 131 ---LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---T---NTF 178

Query: 701 -G---YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            G   Y+ PE    Q+     D +SFGV+L+E+L  + 
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 80.9 bits (200), Expect = 3e-16
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSK-LR 587
            +FD   ++G G + KV    +       A++   +     ++ +   QTE  +  +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 588 HRHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGAARGL 644
           H  LV L   C +    +  V +Y+  G L  H+ + +K P    +    EI +     L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----L 166

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           +YLH   +  II+RD+K  N+LLD +   K++D+G+ K G     T  ST   G+  Y+ 
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFC-GTPNYIA 221

Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           PE  R +      D ++ GV++FE++  R 
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 251

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 79.1 bits (196), Expect = 4e-16
 Identities = 41/166 (24%), Positives = 78/166 (46%), Gaps = 28/166 (16%)

Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKR--------GNPLSEQGVHEFQT---EIEMLSKLR 587
           +G G +G VY+   +  T + VA+K+        G P          T   EI +L +L 
Sbjct: 11  IGEGTYGVVYKA-RNKLTGEVVALKKIRLDTETEGVPS---------TAIREISLLKELN 60

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H ++V L+       ++ LV++++    L++ +  +    +P            +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTH 691
           H    H ++HRD+K  N+L++ +   K++DFGL++    P   +TH
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 25/218 (11%)

Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
           +    +F+  ++LG G FGKV   E  G     A+K   +   + +  V     E  +L+
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75

Query: 585 K-LRHRHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGA 640
              +   L  L   C +  + +  V +Y+  G L  H+ +  +   P       EI IG 
Sbjct: 76  LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG- 133

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF 700
              L +L       II+RD+K  N++LD +   K++DFG+ K       T   T    +F
Sbjct: 134 ---LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---T---KTF 181

Query: 701 -G---YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            G   Y+ PE    Q   +  D ++FGV+L+E+L  + 
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 80.0 bits (198), Expect = 4e-16
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 29/220 (13%)

Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
            A  ++F    ++G G FGKV            A+K   +   L ++      +E  +L 
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93

Query: 585 K-LRHRHLVSLIGYC---EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICI 638
           K ++H  LV L  +     +   +  V DY+  G L  HL + +    P  +    EI  
Sbjct: 94  KNVKHPFLVGLH-FSFQTADK--LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS 150

Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
                L YLH      I++RD+K  NILLD +    ++DFGL K     + T   T    
Sbjct: 151 A----LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---T---S 197

Query: 699 SF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           +F G   YL PE   +Q      D +  G VL+E+L   P
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 79.2 bits (196), Expect = 5e-16
 Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 20/169 (11%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT---EIEMLSKLRH 588
             + +   LG G +  VY+G+       VA+K      E+G     T   E+ +L  L+H
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKH 59

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREH----LYKTQKPPLPWKQRLEICIGAARGL 644
            ++V+L         + LV++Y+      +             +             RGL
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL--SKTGPTLDHTH 691
            Y H   +  ++HRD+K  N+L++E+   K++DFGL  +K+ PT  + +
Sbjct: 114 AYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 79.6 bits (197), Expect = 6e-16
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 25/214 (11%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSK-LR 587
           +NF+   +LG G FGKV    +       A+K   +   L +  V    TE  +LS    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 588 HRHLVSLIGYCEENCEMI-LVYDYMAYGTLREHLYKTQKPPLPWKQ--RLEICIGAARGL 644
           H  L  L   C +  + +  V +++  G L  H+ K+++      +    EI       L
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA----L 137

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSF-G-- 701
            +LH      II+RD+K  N+LLD +   K++DFG+ K G     T   T    +F G  
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---T---ATFCGTP 188

Query: 702 -YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
            Y+ PE  +        D ++ GV+L+E+LC   
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 79.2 bits (196), Expect = 7e-16
 Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 26/166 (15%)

Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKR----GNPLSEQGVHEFQT---EIEMLSKLRHRHL 591
           LG G F  VY+   D  T + VAIK+        ++ G++  +T   EI++L +L H ++
Sbjct: 18  LGEGQFATVYKA-RDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALREIKLLQELSHPNI 74

Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREH----LYKTQKPPLPWKQRLEICIGAARGLHYL 647
           + L+        + LV+D+M      E     + K     L         +   +GL YL
Sbjct: 75  IGLLDAFGHKSNISLVFDFM------ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT--GPTLDHTH 691
           H   +H I+HRD+K  N+LLDE  V K++DFGL+K+   P   +TH
Sbjct: 129 H---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 79.3 bits (196), Expect = 8e-16
 Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 28/223 (12%)

Query: 528 KAATNNFDEALLLGVGGFGKVY--RGEIDGATTKV-AIK--RGNPLSEQGVHEFQTEIE- 581
           K    NF+   +LG G +GKV+  R      T K+ A+K  +   + ++      T  E 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109

Query: 582 -MLSKLRHRH-LVSLIGYC---EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRL-- 634
            +L  +R    LV+L  Y    E    +IL  DY+  G L  HL + ++       ++  
Sbjct: 110 QVLEHIRQSPFLVTLH-YAFQTETKLHLIL--DYINGGELFTHLSQRERFTEHEV-QIYV 165

Query: 635 -EICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS 693
            EI +     L +LH   K  II+RD+K  NILLD      ++DFGLSK     +     
Sbjct: 166 GEIVLA----LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218

Query: 694 TVVKGSFGYLDPEYFRRQQL--TEKSDVYSFGVVLFEILCARP 734
               G+  Y+ P+  R       +  D +S GV+++E+L    
Sbjct: 219 DFC-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 79.8 bits (197), Expect = 8e-16
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 39/214 (18%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT----EIEMLSKLRHRHLVSLI 595
           +G G FG VY+ ++  +   VAIK+        V + +     E++++ KL H ++V L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHCNIVRLR 113

Query: 596 GYCEENCEMI------LVYDYMA---YGTLREHLYKTQKPPLPWKQRL--EICIGAARGL 644
            +   + E        LV DY+    Y   R +    Q  P+ + +    ++     R L
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF----RSL 169

Query: 645 HYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVST--VVKGSFG 701
            Y+H+     I HRD+K  N+LLD +  V K+ DFG +K    L     +   +   S  
Sbjct: 170 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEPNVSYIC--SRY 221

Query: 702 YLDPEY-FRRQQLTEKSDVYSFGVVLFEILCARP 734
           Y  PE  F     T   DV+S G VL E+L  +P
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 36/159 (22%), Positives = 76/159 (47%), Gaps = 15/159 (9%)

Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKRGNPLSEQ-GVHEFQT---EIEMLSKLRHRHLVSL 594
           +G G +G V++   +  T + VA+KR     +  GV    +   EI +L +L+H+++V L
Sbjct: 10  IGEGTYGTVFKA-KNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELKHKNIVRL 66

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
                 + ++ LV+++     L+++   +    L  +          +GL + H      
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGL--SKTGPTLDHTH 691
           ++HRD+K  N+L++     K+++FGL  +   P   ++ 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 22/172 (12%)

Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKRGNPLSEQ-GVHEF-QT---EIEMLSKLR---HRH 590
           +GVG +G VY+   D  +   VA+K     +   G      +   E+ +L +L    H +
Sbjct: 17  IGVGAYGTVYKA-RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 591 LVSLI-----GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           +V L+        +   ++ LV++++    LR +L K   P LP +   ++     RGL 
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVV 696
           +LH    + I+HRD+K  NIL+      K++DFGL++     +  T V  VV
Sbjct: 135 FLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV--VV 181

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 14/158 (8%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-GVHEFQT---EIEMLSKLRHRHLVSLI 595
           +G G +G VY+   D     VA+KR    +E  G+    T   EI +L +L H ++VSLI
Sbjct: 29  VGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIP--STAIREISLLKELHHPNIVSLI 85

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
                   + LV+++M    L++ L    K  L   Q         RG+ + H   +H I
Sbjct: 86  DVIHSERCLTLVFEFMEKD-LKKVL-DENKTGLQDSQIKIYLYQLLRGVAHCH---QHRI 140

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGL--SKTGPTLDHTH 691
           +HRD+K  N+L++     K++DFGL  +   P   +TH
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 77.9 bits (192), Expect = 3e-15
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 29/177 (16%)

Query: 540 LGVGGFGKVYRG-EIDGATTK-VAIKR----GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
           +G G +G VY+    DG   K  A+K+    G  +S         EI +L +L+H +++S
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 82

Query: 594 LIGYCEENCEMI--LVYDYMAY------GTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           L      + +    L++DY  +         R      +   LP      +      G+H
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 646 YLHTGAKHTIIHRDVKTTNILL----DEKWVAKVSDFGLSK--TGPTLDHTHVSTVV 696
           YLH    + ++HRD+K  NIL+     E+   K++D G ++    P      +  VV
Sbjct: 143 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.0 bits (190), Expect = 5e-15
 Identities = 46/227 (20%), Positives = 81/227 (35%), Gaps = 56/227 (24%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR--GNPLSEQGVHEFQT---------EIEMLSKLRH 588
           +  G +G V  G +D     VAIKR        + V+             EI +L+   H
Sbjct: 30  ISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 589 RHLVSLI-----GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWK-------QRLEI 636
            +++ L             ++ LV + M   T    +   Q+  +  +         L  
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHIL-- 144

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT--HVST 694
                 GLH LH      ++HRD+   NILL +     + DF L++      +   +V+ 
Sbjct: 145 -----LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196

Query: 695 -------VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
                  +V    G+           T+  D++S G V+ E+   + 
Sbjct: 197 RWYRAPELVMQFKGF-----------TKLVDMWSAGCVMAEMFNRKA 232

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 76.7 bits (189), Expect = 5e-15
 Identities = 56/293 (19%), Positives = 109/293 (37%), Gaps = 50/293 (17%)

Query: 539 LLGVGGFGKVYRGEIDGATTK-VAIK--RGNPL-SEQGVHEFQTEIEMLSKLR------- 587
            LG G F  V+    D      VA+K  RG+ + +E      + EI++L ++        
Sbjct: 26  KLGWGHFSTVWLA-KDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDADNTKE 80

Query: 588 ----HRHLVSLIG---YCEENCE-MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIG 639
                 H++ L+    +   N   +++V++ +    L   + K +   +P     +I   
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDE------KWVAKVSDFGLSKTGPTLDHTHVS 693
              GL Y+H      IIH D+K  N+L++           K++D G +         H +
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYT 193

Query: 694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH 753
             ++    Y  PE          +D++S   ++FE++       P          +   H
Sbjct: 194 NSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD---H 249

Query: 754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
                 + QI++  L G++     +   +      + +G+ R       W LE
Sbjct: 250 ------IAQIIE--LLGELPSYLLRN-GKYTRTFFNSRGLLRNISKLKFWPLE 293

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 39/165 (23%), Positives = 73/165 (44%), Gaps = 28/165 (16%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKR--------GNPLSEQGVHEFQT---EIEMLSKLRH 588
           +G G +G VY+   +      A+K+        G P          T   EI +L +L+H
Sbjct: 10  IGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPS---------TTIREISILKELKH 59

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
            ++V L         ++LV++++    L++ L    +  L         +    G+ Y H
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTH 691
                 ++HRD+K  N+L++ +   K++DFGL++    P   +TH
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 74.5 bits (184), Expect = 2e-14
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 38/179 (21%)

Query: 540 LGVGGFGKVYRGEIDGATTK--VAIKR--------GNPLSEQGVHEFQT---EIEMLSKL 586
           +G G +GKV++   D       VA+KR        G PL         +   E+ +L  L
Sbjct: 19  IGEGAYGKVFKA-RDLKNGGRFVALKRVRVQTGEEGMPL---------STIREVAVLRHL 68

Query: 587 R---HRHLVSLI-----GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICI 638
               H ++V L         +   ++ LV++++    L  +L K  +P +P +   ++  
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMF 127

Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVV 696
              RGL +LH    H ++HRD+K  NIL+      K++DFGL++     +  T V  VV
Sbjct: 128 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VV 181

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 74.6 bits (184), Expect = 3e-14
 Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 43/165 (26%)

Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKR--------GNPLSEQGVHEFQT---EIEMLSKLR 587
           +G G FG+V++      T + VA+K+        G P+         T   EI++L  L+
Sbjct: 25  IGQGTFGEVFKA-RHRKTGQKVALKKVLMENEKEGFPI---------TALREIKILQLLK 74

Query: 588 HRHLVSLIG--------YCEENCEMILVYDYMAYGTLREH----LYKTQKPPLPWKQRLE 635
           H ++V+LI         Y      + LV+D+       EH    L           +   
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKR 128

Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL 680
           +      GL+Y+H   ++ I+HRD+K  N+L+    V K++DFGL
Sbjct: 129 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 45/171 (26%), Positives = 76/171 (44%), Gaps = 35/171 (20%)

Query: 540 LGVGGFGKVYRGEIDGATTK-VAIKR--------GNPLSEQGVHEFQT---EIEMLSKLR 587
           LG G +G+VY+  ID  T + VAIKR        G P          T   E+ +L +L+
Sbjct: 42  LGEGTYGEVYKA-IDTVTNETVAIKRIRLEHEEEGVPG---------TAIREVSLLKELQ 91

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           HR+++ L      N  + L+++Y     L++++   + P +  +           G+++ 
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVSMRVIKSFLYQLINGVNFC 148

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVA-----KVSDFGL--SKTGPTLDHTH 691
           H       +HRD+K  N+LL     +     K+ DFGL  +   P    TH
Sbjct: 149 H---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 50/225 (22%), Positives = 88/225 (39%), Gaps = 55/225 (24%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVH--------EFQTEIEMLSKLRHRHL 591
            G G FG V  G+       VAIK+        V         E Q  ++ L+ L H ++
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKK--------VIQDPRFRNRELQ-IMQDLAVLHHPNI 81

Query: 592 VSLIGY----CEENCEMI---LVYDYMA---YGTLREHLYKTQKPPLPWKQRL--EICIG 639
           V L  Y     E +   I   +V +Y+    +   R +  +   PP    +    ++   
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI-- 139

Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSKT-GPTLDHTH-VST-- 694
             R +  LH  +   + HRD+K  N+L++E     K+ DFG +K   P+  +   + +  
Sbjct: 140 --RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196

Query: 695 -----VVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
                ++ G+  Y           T   D++S G +  E++   P
Sbjct: 197 YRAPELIFGNQHY-----------TTAVDIWSVGCIFAEMMLGEP 230

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 33/219 (15%)

Query: 531 TNNFDEALLLGVGGFGKVYRGEIDGAT-TKVAIKR-GNPLSEQGVHEFQT--EIEMLSKL 586
              +     +G G  G V     D      VAIK+   P   Q  H  +   E+ ++  +
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAA-YDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCV 81

Query: 587 RHRHLVSLI------GYCEENCEMILVYDYMA---YGTLREHLYKTQKPPLPWKQRLEIC 637
            H++++ L+         EE  ++ +V + M       ++  L   +   L + Q L   
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY-QML--- 137

Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT--HVSTV 695
                G+ +LH+     IIHRD+K +NI++      K+ DFGL++T  T      +V T 
Sbjct: 138 ----CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190

Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
                 Y  PE        E  D++S G ++ E++    
Sbjct: 191 Y-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 46/215 (21%), Positives = 88/215 (40%), Gaps = 44/215 (20%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKR-GNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLI 595
           +G G +G V    ID  +  KVAIK+   P   + +   +   E+ +L  ++H +++ L+
Sbjct: 32  VGSGAYGSVCSA-IDKRSGEKVAIKKLSRPFQSE-IFAKRAYRELLLLKHMQHENVIGLL 89

Query: 596 ------GYCEENCEMILVYDYMA---YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHY 646
                        +  LV  +M       +     + +   L + Q L       +GL Y
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY-QML-------KGLKY 141

Query: 647 LHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST-------VVKGS 699
           +H+     ++HRD+K  N+ ++E    K+ DFGL++        +V T       V+   
Sbjct: 142 IHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSW 198

Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
             Y            +  D++S G ++ E+L  + 
Sbjct: 199 MHY-----------NQTVDIWSVGCIMAEMLTGKT 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 73.0 bits (179), Expect = 1e-13
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 27/207 (13%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKR-GNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLI 595
           +G G  G V     D      VAIK+   P   Q  H  +   E+ ++  + H++++SL+
Sbjct: 70  IGSGAQGIVCAA-YDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLL 127

Query: 596 ------GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
                    EE  ++ LV + M       +L +  +  L  ++   +      G+ +LH+
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDA-----NLCQVIQMELDHERMSYLLYQMLCGIKHLHS 182

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT--HVSTVVKGSFGYLDPEY 707
                IIHRD+K +NI++      K+ DFGL++T  T      +V T       Y  PE 
Sbjct: 183 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEV 234

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
                  E  D++S G ++ E++  + 
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKI 261

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 45/249 (18%), Positives = 89/249 (35%), Gaps = 77/249 (30%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT----EIEMLSKLRHRHLVSLI 595
           LG G FG V       +  + A+K+        V +       E++++  L H +++ L+
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKK--------VLQDPRYKNRELDIMKVLDHVNIIKLV 66

Query: 596 GY--------------------------------------CEENCEMILVYDYMAYGTLR 617
            Y                                        +N  + ++ +Y+      
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP----- 121

Query: 618 EHLYKTQKPPLPWKQRLE----------ICIGAARGLHYLHTGAKHTIIHRDVKTTNILL 667
           + L+K  K  +   + +           +     R + ++H+     I HRD+K  N+L+
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHS---LGICHRDIKPQNLLV 174

Query: 668 D-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVV 725
           + +    K+ DFG +K         V+ +   S  Y  PE      + T   D++S G V
Sbjct: 175 NSKDNTLKLCDFGSAKKLIP-SEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCV 231

Query: 726 LFEILCARP 734
             E++  +P
Sbjct: 232 FGELILGKP 240

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 49/207 (23%), Positives = 81/207 (39%), Gaps = 22/207 (10%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNP-LSEQGVHEFQTEIEMLSKLRHR------ 589
           L+G G FG+V +         VAIK  +       Q     Q E+ +L  +         
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKY 116

Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           ++V L  +      + LV++ ++Y  L + L  T    +      +        L +L T
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175

Query: 650 GAKHTIIHRDVKTTNILL--DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
             + +IIH D+K  NILL   ++   K+ DFG S          +   ++  F Y  PE 
Sbjct: 176 -PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRF-YRSPEV 229

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
                     D++S G +L E+    P
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGEP 256

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 71.3 bits (175), Expect = 5e-13
 Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 24/207 (11%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNP-LSEQGVHEFQTEIEMLSKLRHR------ 589
           ++G G FG+V +         VA+K  R       Q       EI +L  LR +      
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTM 159

Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           +++ ++        + + ++ ++   L E + K +          +      + L  LH 
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH- 217

Query: 650 GAKHTIIHRDVKTTNILLDE--KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
             K+ IIH D+K  NILL +  +   KV DFG S      +H  V T ++  F Y  PE 
Sbjct: 218 --KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF-YRAPEV 270

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
               +     D++S G +L E+L   P
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGYP 297

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 44/204 (21%), Positives = 77/204 (37%), Gaps = 42/204 (20%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGY 597
           LG+G  GKV +   +  T  K A+K       Q   + + E+E+  +  +  H+V ++  
Sbjct: 26  LGLGINGKVLQI-FNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 79

Query: 598 CEENCEMI----LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
            E          +V + +  G L   +          ++  EI       + YLH     
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 136

Query: 654 TIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
            I HRDVK  N+L        + K++DFG +K                 +          
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTGEKYD--------- 176

Query: 711 QQLTEKSDVYSFGVVLFEILCARP 734
               +  D++S GV+++ +LC  P
Sbjct: 177 ----KSCDMWSLGVIMYILLCGYP 196

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.4 bits (173), Expect = 6e-13
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 51/221 (23%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLI- 595
           +G G +G V     D     +VAIK+ +P   Q  +  +T  EI++L + RH +++ +  
Sbjct: 35  IGEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGIND 92

Query: 596 ----GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLE----------ICIGAA 641
                  E+  ++ +V D M        LYK  K      Q L           I     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-----DLYKLLK-----TQHLSNDHICYFLYQIL---- 138

Query: 642 RGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK-TGPTLDHTHVSTVVKGSF 700
           RGL Y+H+     ++HRD+K +N+LL+     K+ DFGL++   P  DHT   T      
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT------ 189

Query: 701 GYLDPEYFR-------RQQLTEKSDVYSFGVVLFEILCARP 734
            Y+   ++R        +  T+  D++S G +L E+L  RP
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.0 bits (172), Expect = 8e-13
 Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 52/225 (23%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLI- 595
           LG G +G V        T   VAIK+  P  +  +   +T  EI++L   +H +++++  
Sbjct: 19  LGEGAYGVVCSA-THKPTGEIVAIKKIEPFDKP-LFALRTLREIKILKHFKHENIITIFN 76

Query: 596 ----GYCEENCEMILVYDYMA---YGTLR------EH----LYKTQKPPLPWKQRLEICI 638
                  E   E+ ++ + M    +  +       +H    +Y          Q L    
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY----------QTL---- 122

Query: 639 GAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKG 698
              R +  LH      +IHRD+K +N+L++     KV DFGL++        +     + 
Sbjct: 123 ---RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 699 SF--GYLDPEYFR-------RQQLTEKSDVYSFGVVLFEILCARP 734
           S    ++   ++R         + +   DV+S G +L E+   RP
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 69.5 bits (170), Expect = 2e-12
 Identities = 49/257 (19%), Positives = 91/257 (35%), Gaps = 50/257 (19%)

Query: 494 GNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAA--------------TNNFDEALL 539
           G+SH A +A+ + +G+  +   S            +                + ++   L
Sbjct: 1   GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLI- 595
           +G G +G V     D      VAIK+   + E  +   +   EI +L++L H H+V ++ 
Sbjct: 61  IGTGSYGHVCEA-YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119

Query: 596 ----GYCEENCEMILVYDYMAYGT-LREHLYKTQKPPLPWK-------QRLEICIGAARG 643
                  E+  E+ +V +     +  ++         L            L        G
Sbjct: 120 IVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPV--YLTELHIKTLLYNLL-------VG 168

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS-----KTGPTLDHTHVSTVVKG 698
           + Y+H+     I+HRD+K  N L+++    KV DFGL+                      
Sbjct: 169 VKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 699 SFGYLDPEYFRRQQLTE 715
           +          ++QLT 
Sbjct: 226 NLVTFPHTKNLKRQLTG 242

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 49/210 (23%), Positives = 91/210 (43%), Gaps = 33/210 (15%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLI-- 595
           +G G +G V          +VA+K+ +   +  +H  +T  E+ +L  ++H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96

Query: 596 ----GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
                  EE  ++ LV   M  G    ++ K Q   L       +     RGL Y+H+  
Sbjct: 97  FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD 152

Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST-------VVKGSFGYLD 704
              IIHRD+K +N+ ++E    K+ DFGL++        +V+T       ++     Y  
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHY-- 207

Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
                     +  D++S G ++ E+L  R 
Sbjct: 208 ---------NQTVDIWSVGCIMAELLTGRT 228

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 68.2 bits (167), Expect = 4e-12
 Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 43/198 (21%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLI- 595
           +G G +G VY    D  T   VAIK+ N + E  +   +   EI +L++L+  +++ L  
Sbjct: 34  IGRGSYGYVYLA-YDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92

Query: 596 ----GYCEENCEMILVYDYMA---YGTLR-------EH----LYKTQKPPLPWKQRLEIC 637
                   +  E+ +V +          +       EH    LY            L   
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY----------NLL--- 139

Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVK 697
                G +++H      IIHRD+K  N LL++    KV DFGL++T  +   T++   ++
Sbjct: 140 ----LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192

Query: 698 GSFGYLDPEYFRRQQLTE 715
            +          ++QLT 
Sbjct: 193 ENEEPGPHNKNLKKQLTS 210

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 45/212 (21%), Positives = 93/212 (43%), Gaps = 39/212 (18%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSL--I 595
           LG G + +V+   I+     KV +K   P+ ++   + + EI++L  LR   ++++L  I
Sbjct: 44  LGRGKYSEVFEA-INITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADI 99

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLP-------WKQRLEICIGAARGLHYLH 648
                +    LV++++     ++         L          + L       + L Y H
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL-------KALDYCH 147

Query: 649 TGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTG-PTLDHTH-VSTVVKGSFGYLDP 705
           +     I+HRDVK  N+++D E    ++ D+GL++   P  ++   V++       +  P
Sbjct: 148 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199

Query: 706 EYFRRQQLTEKS-DVYSFGVVLFEILCARPAL 736
           E     Q+ + S D++S G +L  ++  +   
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 67.4 bits (165), Expect = 5e-12
 Identities = 54/232 (23%), Positives = 84/232 (36%), Gaps = 56/232 (24%)

Query: 539 LLGVGGFGKVYRGEIDGATTK--VAIK--RGNP-LSEQGVHEFQTEIEMLSKLRHR---- 589
            LG G FGKV    +D A  K  VA+K  R      E      + EI +L K++ +    
Sbjct: 26  NLGEGTFGKVVEC-LDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKEN 80

Query: 590 --HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
               V +  +   +  M + ++ +      E L +    P P      +       L +L
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVA-------------------KVSDFGLSKTGPTLD 688
           H   ++ + H D+K  NIL                          +V+DFG +    T D
Sbjct: 140 H---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFD 192

Query: 689 HTHVSTVVKGSFGYLDPE------YFRRQQLTEKSDVYSFGVVLFEILCARP 734
           H H +T+V     Y  PE      +       +  DV+S G +LFE      
Sbjct: 193 HEHHTTIVATRH-YRPPEVILELGW------AQPCDVWSIGCILFEYYRGFT 237

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.0 bits (164), Expect = 7e-12
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 51/219 (23%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKR-GNPLSEQGVHEFQT--EIEMLSKLRHRHLVSLI 595
           +G G +G V    +DG T  KVAIK+   P   + +   +   E+ +L  +RH +++ L+
Sbjct: 33  VGSGAYGAVCSA-VDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHENVIGLL 90

Query: 596 ------GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWK-------QRLEICIGAAR 642
                    ++  +  LV  +M  GT    L K +   L          Q L       +
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE--KLGEDRIQFLVYQML-------K 139

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVST-------V 695
           GL Y+H      IIHRD+K  N+ ++E    K+ DFGL++   +    +V T       V
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 196

Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           +     Y           T+  D++S G ++ E++  + 
Sbjct: 197 ILNWMRY-----------TQTVDIWSVGCIMAEMITGKT 224

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.3 bits (158), Expect = 2e-11
 Identities = 34/213 (15%), Positives = 59/213 (27%), Gaps = 52/213 (24%)

Query: 518 LCRH---FSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK--------RGN 566
            C       F+     T        +G G FG+V++   D   T VAIK          N
Sbjct: 4   ECSQKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIADH--TPVAIKIIAIEGPDLVN 60

Query: 567 PLSEQGVHEFQTEIEMLSKL---------RHRHLVSLIGY--CEENCEMILVYDYMAYGT 615
              ++   E   EI +  +L         R    + L      + +   +L+  +  Y +
Sbjct: 61  GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120

Query: 616 LREH-------------------------LYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
            +                           L + +           I       L      
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA- 179

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT 683
                 HRD+   N+LL +  + K+      K+
Sbjct: 180 -SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKS 211

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 49/226 (21%), Positives = 85/226 (37%), Gaps = 56/226 (24%)

Query: 539 LLGVGGFGKVYRGEIDGATTK--VAIK--RGNP-LSEQGVHEFQTEIEMLSKLRHR---- 589
            LG G FGKV    ID       VA+K  +      E      ++EI++L  L       
Sbjct: 21  TLGEGAFGKVVEC-IDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNS 75

Query: 590 --HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
               V ++ + E +  + +V++ +   +  + + +    P       ++     + +++L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVA-------------------KVSDFGLSKTGPTLD 688
           H    + + H D+K  NIL  +                       KV DFG +    T D
Sbjct: 135 H---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA----TYD 187

Query: 689 HTHVSTVVKGSFGYLDPE------YFRRQQLTEKSDVYSFGVVLFE 728
             H ST+V     Y  PE      +      ++  DV+S G +L E
Sbjct: 188 DEHHSTLVSTRH-YRAPEVILALGW------SQPCDVWSIGCILIE 226

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 47/229 (20%), Positives = 84/229 (36%), Gaps = 58/229 (25%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNP-LSEQGVHEFQTEIEMLSKLRHR-----H 590
            +G G FG+V   +        A+K  R     +       + E ++L K+++      +
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
           +V   G       M L+++ +   +L E + +        +     CI   + L+YL   
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR-- 154

Query: 651 AKHTIIHRDVKTTNILLDEKWVA-------------------------KVSDFGLSKTGP 685
            K ++ H D+K  NILLD+ +                           K+ DFG +    
Sbjct: 155 -KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA---- 209

Query: 686 TLDHTHVSTVVKGSFGYLDPE------YFRRQQLTEKSDVYSFGVVLFE 728
           T    +  +++     Y  PE      +         SD++SFG VL E
Sbjct: 210 TFKSDYHGSIINTRQ-YRAPEVILNLGW------DVSSDMWSFGCVLAE 251

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 59/236 (25%), Positives = 106/236 (44%), Gaps = 64/236 (27%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKR-GNPLSEQGVHEFQT--EIEMLSKLR-HRHLVSL 594
           LG G +G V++  ID  T   VA+K+  +          +T  EI +L++L  H ++V+L
Sbjct: 17  LGKGAYGIVWKS-IDRRTGEVVAVKKIFDAFQNS-TDAQRTFREIMILTELSGHENIVNL 74

Query: 595 --IGYCEENCEMILVYDYMA---YGTLR------EH----LYKTQKPPLPWKQRLEICIG 639
             +   + + ++ LV+DYM    +  +R       H    +Y          Q +     
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY----------QLI----- 119

Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGS 699
             + + YLH+G    ++HRD+K +NILL+ +   KV+DFGLS++   +     +  +  +
Sbjct: 120 --KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 700 FGYLDPEYFRRQQLTE--------------------KS-DVYSFGVVLFEILCARP 734
               + +   +  LT+                    K  D++S G +L EILC +P
Sbjct: 175 ENTENFDD-DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.7 bits (148), Expect = 5e-10
 Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 74/237 (31%)

Query: 540 LGVGGFGKVYRGEIDGAT-TKVAIKR---GNPLSEQGVHEFQT--EIEMLSKLRHRHLVS 593
           LG GG G V+   +D     +VAIK+    +P S +         EI+++ +L H ++V 
Sbjct: 19  LGCGGNGLVFSA-VDNDCDKRVAIKKIVLTDPQSVK-----HALREIKIIRRLDHDNIVK 72

Query: 594 LI--------------GYCEENCEMILVYDYMAY--------GTL-REH----LYKTQKP 626
           +               G   E   + +V +YM          G L  EH    +Y     
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY----- 127

Query: 627 PLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKT-G 684
                Q L       RGL Y+H+     ++HRD+K  N+ ++ E  V K+ DFGL++   
Sbjct: 128 -----QLL-------RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 685 PTLDHTHVSTVVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEILCARP 734
           P   H    +        L  +++R           T+  D+++ G +  E+L  + 
Sbjct: 173 PHYSHKGHLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 60.3 bits (145), Expect = 3e-09
 Identities = 76/476 (15%), Positives = 143/476 (30%), Gaps = 144/476 (30%)

Query: 392 QYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGN--------SKQ 443
           QY D +    + F   + +       P     ++ +D  +    + SG         SKQ
Sbjct: 17  QYKDILSVFEDAFV-DNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75

Query: 444 KAIIGGGVGGGIALALVVGFCVFAASRCRRQGKDPSSSDAQSGWLPLSLYGNSHSAGSAK 503
           + ++   V     L +   F     S  + + + PS        +   +Y         +
Sbjct: 76  EEMVQKFVEE--VLRINYKFL---MSPIKTEQRQPS--------MMTRMYIEQRD----R 118

Query: 504 TNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEA---LLLGVGGFGK------VYRGEID 554
                   +    N+ R   + +++ A      A   L+ GV G GK      V      
Sbjct: 119 LYNDNQVFA--KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSY-- 174

Query: 555 GATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM 611
               KV  K       L+ +  +  +T +EML KL ++ +     +   +       D+ 
Sbjct: 175 ----KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ-IDP--NWTSRS-------DHS 220

Query: 612 AYGTLREHLYKTQKPPLPWKQRLEIC------IGAARGLHYLHTGAKHTIIHRDVKTTNI 665
           +   LR H  + +   L   +  E C      +  A+  +  +   K  +  R  + T+ 
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDF 280

Query: 666 L------------------LDE------KWVAKVSDFGLS----KTGPTL---------D 688
           L                   DE      K++       L      T P           D
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYL-DCRPQDLPREVLTTNPRRLSIIAESIRD 339

Query: 689 HTH------------VSTVVKGSFGYLDPEYFRRQQLTEKSDVY-SFGVVLF-------- 727
                          ++T+++ S   L+P  +R+         +    V  F        
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM--------FDRLSV--FPPSAHIPT 389

Query: 728 EILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ--------IMDPYLKGKIAPE 775
            +L     +   + K  V         HK  ++E+        I   YL+ K+  E
Sbjct: 390 ILLS---LIWFDVIKSDVM--VVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE 440

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 5e-05
 Identities = 64/464 (13%), Positives = 128/464 (27%), Gaps = 137/464 (29%)

Query: 36  ILLNCGESSI---LSDDDKRSWTPDIGSKFLLSTKDSTTSKAATQDPSTPTIPYMTARVF 92
            LL+  E  +   + +  + ++      KFL+S       K   + PS  T  Y+  R  
Sbjct: 70  TLLSKQEEMVQKFVEEVLRINY------KFLMSP-----IKTEQRQPSMMTRMYIEQR-- 116

Query: 93  RSEFTYSFPVVAGRKFV-RLYFYPNSYNRLNATDALFSVSTGPYTLL-------KNFSVA 144
             +  Y+   V  +  V R       Y +L    AL  +      L+       K +   
Sbjct: 117 --DRLYNDNQVFAKYNVSR----LQPYLKL--RQALLELRPAKNVLIDGVLGSGKTWVAL 168

Query: 145 QTAEA-------------LNYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGI---- 187
               +             LN         +    + L     P   S +    N      
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228

Query: 188 -------EVMSMPDIYKNTDGDLMIVGQSSPISIDN------------------TTALEN 222
                   ++     Y+N    L++        + N                  TT  + 
Sbjct: 229 SIQAELRRLLKSKP-YENC---LLV--------LLNVQNAKAWNAFNLSCKILLTTRFKQ 276

Query: 223 VYRLNVGGKDISPSGDTDLFRSWYDDQPY-IFGAALGVPVTIGPNMTVRYPSNIPS---Y 278
           V            S D     +   D+   +    L              P ++P     
Sbjct: 277 VTDFLSAATTTHISLD-HHSMTLTPDEVKSLLLKYLDCR-----------PQDLPREVLT 324

Query: 279 VAP--VDVYATARQMGPN-----PQINLNYELSWVF--SVDSGFSYLVRLHF--CEVLPE 327
             P  + + A + + G         +N + +L+ +   S++       R  F    V P 
Sbjct: 325 TNPRRLSIIAESIRDGLATWDNWKHVNCD-KLTTIIESSLNVLEPAEYRKMFDRLSVFPP 383

Query: 328 ITKINQRVFDILLNNQTAFPAFDVA------GLTKGNGIPLYQDFAVFVPGNGPQKDLWL 381
              I   +  ++  +        V        L +       ++  + +P       ++L
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ----PKESTISIP------SIYL 433

Query: 382 GLHPNVASKTQYYDAILNGVEIFKLSDPNSNLAGPNPIPAPKQD 425
            L   + ++   + +I++   I K  D +        +  P  D
Sbjct: 434 ELKVKLENEYALHRSIVDHYNIPKTFDSDD-------LIPPYLD 470

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 4e-04
 Identities = 60/466 (12%), Positives = 120/466 (25%), Gaps = 181/466 (38%)

Query: 37  LLNCGESSILSDD--DKRSWTP-DIGSKFLLSTKDSTTSKAATQDPSTPTIPYMTARVFR 93
           LL      +L  +  + ++W   ++  K LL+T+                          
Sbjct: 247 LL------VL-LNVQNAKAWNAFNLSCKILLTTRFK------------------------ 275

Query: 94  SEFTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTL---LKNFSVAQTAEAL 150
                                         TD L + +T   +L       +  +    L
Sbjct: 276 ----------------------------QVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 151 NYAYVIKEYAIPVDGETLNITFSPMNVSNAYAFVNGIEVMSMPDIYKNTDGD-LMIVGQS 209
                 +   +P   E L    +P  +S     +   + ++  D +K+ + D L  + +S
Sbjct: 308 LKYLDCRPQDLPR--EVLTT--NPRRLSIIAESI--RDGLATWDNWKHVNCDKLTTIIES 361

Query: 210 SPISIDNTTALEN--------VYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPV 261
              S++     E         V+  +     I       L   W+D             +
Sbjct: 362 ---SLNVLEPAEYRKMFDRLSVFPPSA---HIPT--IL-LSLIWFDVIKS-------DVM 405

Query: 262 TI-------------GPNMTVRYPSNIPSYVAP-----------VDVYATARQMGPN--- 294
            +                 T+  PS                   VD Y   +    +   
Sbjct: 406 VVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI 465

Query: 295 PQINLNYELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGL 354
           P     Y   +       +S++   H   +        +R+        T F        
Sbjct: 466 PPYLDQY---F-------YSHIGH-HLKNIEHP-----ERM--------TLFRM------ 495

Query: 355 TKGNGIPLYQDFAVFV-----------PGNGPQKDLWLGLH---PNVASKTQYYDAILNG 400
                  ++ DF  F+             +G   +    L    P +      Y+ ++N 
Sbjct: 496 -------VFLDFR-FLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNA 547

Query: 401 VEIFKLSDPNSNLAGPNPIPAPKQDVVDPSLALPSSSSGNSKQKAI 446
           +  F L     NL     I +   D++  +L     +      K +
Sbjct: 548 ILDF-LPKIEENL-----ICSKYTDLLRIALMAEDEAIFEEAHKQV 587

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 27/165 (16%), Positives = 57/165 (34%), Gaps = 27/165 (16%)

Query: 540 LGVGGFGKVYRGE--------IDGATTKVAIK----RGNPLSEQGVHEFQTEIEMLSKLR 587
                 G +Y                 K ++K     G   +EQ   +   +   ++K +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 588 HRHLVSLIG-----YCEENCEM--ILVYDYMAYGT-LREHLYKTQKPPLPWKQRLEICIG 639
             +   L+          + +    LV      G  L+  L  + K  L  +  L++   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 640 AARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKV--SDFGLSK 682
               L +LH   ++  +H +V   NI +D +  ++V  + +G + 
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.5 bits (131), Expect = 9e-08
 Identities = 51/266 (19%), Positives = 77/266 (28%), Gaps = 90/266 (33%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLR--------H 588
           LG G F  V+          VA+K        +E  + E    I +L  +R         
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDE----IRLLKSVRNSDPNDPNR 100

Query: 589 RHLVSLIGYCEEN-------CEMILVYDYMAYGTLREHLYKTQK----PPLPWKQRLEIC 637
             +V L+   + +       C   +V++      L  HL K         LP     +I 
Sbjct: 101 EMVVQLLDDFKISGVNGTHIC---MVFE-----VLGHHLLKWIIKSNYQGLPLPCVKKII 152

Query: 638 IGAARGLHYLHTGAKHTIIHRDVKTTNILL------------------------------ 667
               +GL YLHT  +  IIH D+K  NILL                              
Sbjct: 153 QQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 668 -------------------DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
                               EK   K++D G +          + T       Y   E  
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVL 265

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARP 734
                   +D++S   + FE+     
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDY 291

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 33/164 (20%), Positives = 68/164 (41%), Gaps = 23/164 (14%)

Query: 539 LLGVGGFGKVYRGEIDGAT-----TKVAIK---RGNP--LSEQGVHEFQTEIEMLSKLRH 588
            +G GGFG +Y  +++ +          +K     N    +E   ++   + E + K   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 589 RHLVSLIG-----YCEENCEMILVYDYMA---YGTLREHLYKTQKPPLPWKQRLEICIGA 640
              +  +G         + +    Y +M    +G+  + +Y+        K  L++ +  
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKV--SDFGLSK 682
              L Y+H   +H  +H D+K +N+LL+ K   +V   D+GL+ 
Sbjct: 162 LDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 34/147 (23%), Positives = 57/147 (38%), Gaps = 11/147 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIGYC 598
           +G G FG +Y G    A  +VAIK     ++        E ++   ++    + ++    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCG 74

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
            E    ++V + +  G   E L+         K  L +       + Y+H       IHR
Sbjct: 75  AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129

Query: 659 DVKTTNILLDEKWVAK---VSDFGLSK 682
           DVK  N L+          + DFGL+K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 31/149 (20%), Positives = 55/149 (36%), Gaps = 13/149 (8%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIGYC 598
           +G G FG ++ G       +VAIK     S+    + + E      L     + ++  + 
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
           +E    +LV D +  G   E L          K            +  +H   + ++++R
Sbjct: 76  QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 130

Query: 659 DVKTTNILLDEKWVAK-----VSDFGLSK 682
           D+K  N L+            V DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 36/147 (24%), Positives = 63/147 (42%), Gaps = 11/147 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYC 598
           +G G FG++Y G       +VAIK  N  ++     +  E ++   L+    + ++  + 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
            E    +LV D +  G   E L+      L  K  L +       + ++H     + +HR
Sbjct: 73  VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127

Query: 659 DVKTTNILLDEKWVAK---VSDFGLSK 682
           D+K  N L+     A    + DFGL+K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 33/150 (22%), Positives = 55/150 (36%), Gaps = 15/150 (10%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIGYC 598
           +G G FG++  G+       VAIK     S         E     +L     +  +  + 
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ--LHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
                  +V + +  G   E L+         K  L I I     + Y+H      +I+R
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129

Query: 659 DVKTTNILL------DEKWVAKVSDFGLSK 682
           DVK  N L+       ++ +  + DF L+K
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 35/162 (21%), Positives = 59/162 (36%), Gaps = 22/162 (13%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK------RGNP--LSEQGVHEFQTEIEMLSKLRHRH 590
            +G GGFG +Y         K A        + N    SE   ++   + + + K   R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 591 LVSLIG-----YCEENCEMILVYDYMA---YGTLREHLYKTQKPPLPWKQRLEICIGAAR 642
            +  +G                Y +M     G   + +   Q         L++ I    
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG-QNGTFKKSTVLQLGIRMLD 162

Query: 643 GLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKV--SDFGLSK 682
            L Y+H   ++  +H D+K  N+LL  K   +V  +D+GLS 
Sbjct: 163 VLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	893
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	99.82
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	99.8
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.53
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.98
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.83
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.77
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.39
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.34
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.31
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.22
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.06
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.93
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.8
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.67
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.29
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.29
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.18
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.85
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.73
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.68
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.53
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.46
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.38
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.32
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.08
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.64
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.38
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.8
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	94.65
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	93.66
3mes_A	424	Choline kinase; malaria, structural genomics, stru	91.79
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.35
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	88.06
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	86.51

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.6e-53  Score=465.86  Aligned_cols=261  Identities=30%  Similarity=0.430  Sum_probs=211.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      ++|...++||+|+||+||+|++.+     .+..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456778899999999999999753     357899999988888888899999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCC-------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCce
Q 036624          607 VYDYMAYGTLREHLYKTQ-------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA  673 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~  673 (893)
                      |||||++|+|.++|++..             ..+++|.++++|+.|||+||+|||   ..+||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997642             246999999999999999999999   4889999999999999999999


Q ss_pred             eEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHH
Q 036624          674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA  752 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  752 (893)
                      ||+|||+++.....+.........||+.|||||++.+..++.++|||||||+||||+| |+.||......+      ...
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------~~~  271 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------AID  271 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH------HHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence            9999999987544444444456679999999999999999999999999999999999 899997543211      111


Q ss_pred             HhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          753 HCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       753 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      ... .+         .....+..++..+.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus       272 ~i~-~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 CIT-QG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHH-HT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHH-cC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            111 11         11233456677899999999999999999999999999987653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.6e-53  Score=462.41  Aligned_cols=260  Identities=28%  Similarity=0.407  Sum_probs=217.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      ++|...+.||+|+||+||+|++.+     .+..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            467788899999999999998753     357899999988888888899999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCC-----------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeE
Q 036624          607 VYDYMAYGTLREHLYKTQ-----------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKV  675 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl  675 (893)
                      |||||++|+|.++|+...           ...++|.+++.|+.|||+||+|||+   ++||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997642           3469999999999999999999994   89999999999999999999999


Q ss_pred             ecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHh
Q 036624          676 SDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHC  754 (893)
Q Consensus       676 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  754 (893)
                      +|||+|+.....+.........||+.|||||++.++.|+.|+|||||||+||||+| |+.||......      +.....
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~i  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIECI  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH
Confidence            99999986543333333344569999999999999999999999999999999998 89999754321      111111


Q ss_pred             hcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          755 HKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       755 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                               .... ....+..++..+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus       244 ---------~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          244 ---------TQGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             ---------HHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------HcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                     1111 123345677889999999999999999999999999987654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.5e-53  Score=459.02  Aligned_cols=256  Identities=25%  Similarity=0.378  Sum_probs=211.6

Q ss_pred             CCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      +++..++||+|+||+||+|++.+     .++.||||+++.. .....++|.+|+.+|++++|||||+++|+|.+.+.++|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            34556799999999999999743     3478999998654 33456789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc
Q 036624          607 VYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV  672 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~  672 (893)
                      |||||++|+|.++|+...              ...++|.++++|+.|||+||+|||+   .+||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence            999999999999997532              2459999999999999999999994   88999999999999999999


Q ss_pred             eeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHH
Q 036624          673 AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWA  751 (893)
Q Consensus       673 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  751 (893)
                      +||+|||+++.....+.........||++|||||++.++.++.++|||||||+||||+| |+.||......+   +..  
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~--  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVE--  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHH--
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence            99999999986544333334455679999999999999999999999999999999998 899997543211   111  


Q ss_pred             HHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          752 AHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       752 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                       .         +.+. .....+++|+..+.+|+.+||+.||++||||.||+++|+.
T Consensus       259 -~---------i~~~-~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          259 -M---------IRNR-QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             -H---------HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -H---------HHcC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence             1         1111 1123456678889999999999999999999999999984

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.8e-52  Score=449.26  Aligned_cols=259  Identities=28%  Similarity=0.494  Sum_probs=206.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      +++...++||+|+||+||+|++.+   .||||+++.  .+....++|.+|+++|++++|||||+++|+|.+ +.++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            466778899999999999998765   489997754  345667889999999999999999999999875 46899999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      ||++|+|.++|+... .+++|.+++.|+.|||+||+|||+   .+||||||||+||||++++.+||+|||+|+.......
T Consensus       112 y~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          112 WCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999997653 469999999999999999999994   8999999999999999999999999999987544333


Q ss_pred             ccceeeeccCcCccChHhhhh---cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      .......+||+.|||||++.+   +.|+.|+|||||||+||||+||+.||........      .......+    ...|
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~----~~~p  257 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRG----YASP  257 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTT----CCCC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcC----CCCC
Confidence            344456789999999999974   4589999999999999999999999975433211      11111111    1122


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      .+ ...+.+++..+.+|+.+||+.+|++||||.||+++|+.+.
T Consensus       258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            11 2334567788999999999999999999999999998654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.4e-51  Score=452.89  Aligned_cols=266  Identities=24%  Similarity=0.388  Sum_probs=218.3

Q ss_pred             HHHhcCCccceeeeecCcEEEEEEEEcCc-----ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccc-cceeeEEEEEee
Q 036624          528 KAATNNFDEALLLGVGGFGKVYRGEIDGA-----TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRH-RHLVSLIGYCEE  600 (893)
Q Consensus       528 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~  600 (893)
                      +...++|+..++||+|+||+||+|.+.+.     .+.||||++... .....++|.+|+++|.+++| ||||+++|+|.+
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            33457899999999999999999997653     257999987654 34456789999999999965 899999999976


Q ss_pred             c-CEEEEEEeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCE
Q 036624          601 N-CEMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNI  665 (893)
Q Consensus       601 ~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI  665 (893)
                      . +.++||||||++|+|.++|+...              ...++|.+++.|+.|||+||+|||+   .+||||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccce
Confidence            4 67899999999999999997542              3458999999999999999999994   8999999999999


Q ss_pred             EECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCcccc
Q 036624          666 LLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQ  744 (893)
Q Consensus       666 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~  744 (893)
                      ||++++.+||+|||+|+..............+||+.|||||++.++.|+.++|||||||+||||+| |+.||........
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999997654333334456779999999999999999999999999999999998 8999975432211


Q ss_pred             ccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          745 VSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       745 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                        +    .....++         .+...+..++.++.+++.+||+.||++|||+.||+++|+.+++.
T Consensus       297 --~----~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          297 --F----CRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             --H----HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --H----HHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence              1    1111111         11233455667889999999999999999999999999988763

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.4e-51  Score=447.78  Aligned_cols=257  Identities=22%  Similarity=0.335  Sum_probs=210.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..++||+|+||+||+|++...++.||||++..  ......+.|.+|+++|++++|||||++++++.+.+.++||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            579999999999999999999988889999998653  345567789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      ||++|+|.++|...+...+++.+++.|+.||+.||+|||   +.+||||||||+||||++++.+||+|||+|+....  .
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence            999999999998777677899999999999999999999   58999999999999999999999999999986432  1


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      ....+..+||+.|||||++.+..|+.++|||||||+||||++|+.||......      +....         ++.... 
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~---------i~~~~~-  242 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLK---------IISGSF-  242 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHH---------HHHTCC-
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHH---------HHcCCC-
Confidence            12234567999999999999999999999999999999999999999754321      11111         111111 


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ...+..+...+.+|+.+||+.||++|||+.|++++-....
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            1223345567889999999999999999999998755433

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.8e-50  Score=438.71  Aligned_cols=255  Identities=22%  Similarity=0.235  Sum_probs=210.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      +.|+..++||+|+||+||+|+++..++.||||+++....     +.+|+.+|++++|||||++++++.+.+.++||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            467888899999999999999998889999998764321     257999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC-ceeEecccccccCCCCCCc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW-VAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~~~~~~  690 (893)
                      ++|+|.++|.+.+  .+++..+..++.||+.||+|||   ..+||||||||+||||+.++ .+||+|||+|+........
T Consensus       133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            9999999997654  5999999999999999999999   58999999999999999987 6999999999865332211


Q ss_pred             ---cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc-c
Q 036624          691 ---HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD-P  766 (893)
Q Consensus       691 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d-~  766 (893)
                         .....++||+.|||||++.+..|+.++|||||||+||||++|+.||........  +             ..+.. +
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~-------------~~i~~~~  272 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--C-------------LKIASEP  272 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--H-------------HHHHHSC
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--H-------------HHHHcCC
Confidence               122346799999999999999999999999999999999999999976443221  1             11111 1


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      .....+++.+...+.+++.+||+.||++|||+.|++++|..+++-
T Consensus       273 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            111234455667889999999999999999999999999887753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.8e-50  Score=441.41  Aligned_cols=253  Identities=20%  Similarity=0.306  Sum_probs=211.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ..|+..++||+|+||+||+|++..+++.||||++........+.+.+|+++|++++|||||++++++.+.+.++||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46889999999999999999999888999999876544445567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|.+++.+.   .+++.++..++.||+.||+|||   +.+||||||||+||||+.++.+||+|||+|+.....  ..
T Consensus       154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~  225 (346)
T 4fih_A          154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VP  225 (346)
T ss_dssp             TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SC
T ss_pred             CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC--CC
Confidence            999999999753   4999999999999999999999   589999999999999999999999999999865332  22


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      .....+||+.|||||++.+..|+.++|||||||+||||++|++||......+      .....      .+...+.+  .
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i------~~~~~~~~--~  291 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMI------RDNLPPRL--K  291 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHH------HHSSCCCC--S
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHH------HcCCCCCC--C
Confidence            3345789999999999999999999999999999999999999997543221      11111      11111111  1


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ....+...+.+|+.+||+.||++|||+.|++++-.
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~  326 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF  326 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            22345567889999999999999999999987654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5e-50  Score=437.42  Aligned_cols=267  Identities=24%  Similarity=0.340  Sum_probs=201.4

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecC----EEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC----EMILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~  608 (893)
                      ++...++||+|+||+||+|++.+  +.||||+++.... ....+..|+..+.+++|||||+++|+|.+.+    .++|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~g--~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETT--EEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECC--EEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            46677899999999999999864  7899999864322 2223345666677899999999999998653    689999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcC-----CCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG-----AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      |||++|+|.++|+..   +++|..+++|+.|+|+||+|||+.     .+.+||||||||+||||++++++||+|||+++.
T Consensus        81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            999999999999764   499999999999999999999963     245999999999999999999999999999986


Q ss_pred             CCCCCC--ccceeeeccCcCccChHhhhhc------CCCCcchhhhHHHHHHHHhhCCCCCCCCCccc---------ccc
Q 036624          684 GPTLDH--THVSTVVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEILCARPALNPTLPKE---------QVS  746 (893)
Q Consensus       684 ~~~~~~--~~~~~~~~gt~~y~APE~~~~~------~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~---------~~~  746 (893)
                      ......  ........||+.|||||++.+.      .++.|+|||||||+||||+||++|+.......         ...
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            433221  1122345799999999999764      46789999999999999999988775322111         011


Q ss_pred             HHHHHHHhhcccchhhhccccccCC-CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          747 LAEWAAHCHKKGILEQIMDPYLKGK-IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       747 l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ..++...     ...+.++|.+... ...+++..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus       238 ~~~~~~~-----~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          238 VEEMRKV-----VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHH-----HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHH-----HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            1111111     1111222222111 234677889999999999999999999999999997654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-49  Score=427.03  Aligned_cols=249  Identities=26%  Similarity=0.414  Sum_probs=199.4

Q ss_pred             ccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEee----cCEEEEEE
Q 036624          535 DEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE----NCEMILVY  608 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~  608 (893)
                      +..++||+|+||+||+|.+...+..||+|++..  ......+.|.+|+++|++++|||||++++++.+    ...++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            445689999999999999998889999998653  345566789999999999999999999999865    35689999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-CCceeEecccccccCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~~~  687 (893)
                      |||++|+|.++|.+..  .+++..+..|+.||++||+|||+. ..+||||||||+||||+. ++.+||+|||+|+.... 
T Consensus       109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence            9999999999997654  599999999999999999999951 124999999999999984 79999999999986432 


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                         ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.......     ....... .+     ..+ 
T Consensus       185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~~i~-~~-----~~~-  248 (290)
T 3fpq_A          185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVT-SG-----VKP-  248 (290)
T ss_dssp             ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHT-TT-----CCC-
T ss_pred             ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HHHHHHH-cC-----CCC-
Confidence               22345689999999999865 69999999999999999999999996543211     1111111 11     001 


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                        ..++..+...+.+++.+||+.||++|||+.|++++-
T Consensus       249 --~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp  284 (290)
T 3fpq_A          249 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA  284 (290)
T ss_dssp             --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence              111222334688999999999999999999998764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.4e-50  Score=433.19  Aligned_cols=251  Identities=22%  Similarity=0.294  Sum_probs=211.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||+||+|++..+++.||||++...   .....+.+.+|+++|++++|||||++++++.+.+.++|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999999988899999987532   2234567999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |||++|+|.++|.+.+  .+++..+..++.||+.||+|||   +.+||||||||+||||++++.+||+|||+|+......
T Consensus       112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999999997654  4999999999999999999999   5899999999999999999999999999998754333


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      ........+||+.|||||++.+..|+.++||||+||+||||++|+.||......+      ...         .+.... 
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~---------~i~~~~-  250 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL------IFA---------KIIKLE-  250 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH---------HHHHTC-
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHH---------HHHcCC-
Confidence            3334456789999999999999999999999999999999999999997543211      111         111111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                       ..++......+.+++.+||+.||++|||+.|++.+
T Consensus       251 -~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          251 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             -CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence             12233445668899999999999999999987543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.7e-49  Score=443.24  Aligned_cols=253  Identities=20%  Similarity=0.306  Sum_probs=212.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      +.|+..++||+|+||+||+|++..+++.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999999888999999876555555667899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|.+++...   .+++.++..|+.||+.||+|||   ..+||||||||+||||+.++.+||+|||+|+.....  ..
T Consensus       231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~~  302 (423)
T 4fie_A          231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VP  302 (423)
T ss_dssp             TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--CC
T ss_pred             CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC--Cc
Confidence            999999999654   3999999999999999999999   489999999999999999999999999999864332  22


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      .....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+      .....      .....+.+  .
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i------~~~~~~~~--~  368 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMI------RDNLPPRL--K  368 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHH------HHSCCCCC--S
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHH------HcCCCCCC--c
Confidence            3345789999999999999999999999999999999999999997543221      11111      11111111  1


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ....+...+.+|+.+||+.||++|||+.|++++-.
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~  403 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF  403 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHH
Confidence            12334567889999999999999999999987644

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.4e-48  Score=414.02  Aligned_cols=250  Identities=25%  Similarity=0.339  Sum_probs=195.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||+||+|+...+++.||+|++...   .....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999999888899999987532   2334567999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+ +|+|.++|.+..  ++++.++..++.|++.||+|||   +++||||||||+||||++++.+||+|||+|+....  
T Consensus        93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--  164 (275)
T ss_dssp             ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence            999 589999997654  5999999999999999999999   58999999999999999999999999999986432  


Q ss_pred             CccceeeeccCcCccChHhhhhcCC-CCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                       .......+||+.|||||++.+..+ +.++||||+||+||||++|+.||.....      .+.....         ....
T Consensus       165 -~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i---------~~~~  228 (275)
T 3hyh_A          165 -GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNI---------SNGV  228 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH---------HHTC
T ss_pred             -CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH---------HcCC
Confidence             122345679999999999998876 5799999999999999999999965322      1111111         1111


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                        ..++......+.+++.+||+.||++|||+.|++++-+.
T Consensus       229 --~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~  266 (275)
T 3hyh_A          229 --YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF  266 (275)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred             --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence              11223345668899999999999999999999987664

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-48  Score=423.06  Aligned_cols=250  Identities=25%  Similarity=0.281  Sum_probs=198.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEc---CcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEID---GATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      ++|+..++||+|+||+||+|+..   ..++.||||+++..  .......+.+|+++|++++|||||++++++.+.+.++|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999873   34578999987542  22234468899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      |||||++|+|.++|.+..  .+++.++..++.|++.||+|||   +.+||||||||+|||+++++.+||+|||+|+....
T Consensus       104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            999999999999997654  5999999999999999999999   58999999999999999999999999999986432


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      .  .......+||+.|||||++.+..|+.++|||||||+||||+||+.||......+      ....         +...
T Consensus       179 ~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~---------i~~~  241 (304)
T 3ubd_A          179 H--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTM---------ILKA  241 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH---------HHHC
T ss_pred             C--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHH---------HHcC
Confidence            1  222345679999999999999999999999999999999999999997543221      1111         1111


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNL  805 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L  805 (893)
                      .  ..++..+...+.+++.+||+.||++|||     +.|++++-
T Consensus       242 ~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp  283 (304)
T 3ubd_A          242 K--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS  283 (304)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred             C--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCc
Confidence            1  1223345567889999999999999998     46776553

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.4e-47  Score=410.60  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=190.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecC--------
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC--------  602 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--------  602 (893)
                      ++|+..+.||+|+||+||+|+.+.+++.||||+++.. .....+.+.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4689999999999999999999888899999987543 3445678999999999999999999999987554        


Q ss_pred             ----EEEEEEeeccCCCHHHHHhhCCC-CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEec
Q 036624          603 ----EMILVYDYMAYGTLREHLYKTQK-PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSD  677 (893)
Q Consensus       603 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~D  677 (893)
                          .++||||||++|+|.+++..... ...++..++.|+.||++||+|||   +.+||||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                37899999999999999976543 23567778999999999999999   48999999999999999999999999


Q ss_pred             ccccccCCCCCCc----------cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccH
Q 036624          678 FGLSKTGPTLDHT----------HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL  747 (893)
Q Consensus       678 FGla~~~~~~~~~----------~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l  747 (893)
                      ||+|+........          ...+..+||+.|||||++.+..|+.++|||||||+||||++   ||....  +.   
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~---  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ER---  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH---
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HH---
Confidence            9999864332111          11234579999999999999999999999999999999996   663211  00   


Q ss_pred             HHHHHHhhcccchhhhccccccCCCCh---HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          748 AEWAAHCHKKGILEQIMDPYLKGKIAP---ECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       748 ~~~~~~~~~~~~~~~i~d~~l~~~~~~---~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..         .+..+..    ..+++   +....+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~---------~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          234 VR---------TLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HH---------HHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HH---------HHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            00         0111111    11122   233456789999999999999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.2e-46  Score=411.65  Aligned_cols=291  Identities=61%  Similarity=1.051  Sum_probs=256.3

Q ss_pred             cccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEe
Q 036624          520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE  599 (893)
Q Consensus       520 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~  599 (893)
                      .++++.++..++++|+..+.||+|+||+||+|.+.. +..||||+.........+.+.+|++++++++||||+++++++.
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTT-CCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECC-CCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            456666777889999999999999999999999764 4789999988776677888999999999999999999999999


Q ss_pred             ecCEEEEEEeeccCCCHHHHHhhCC--CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEec
Q 036624          600 ENCEMILVYDYMAYGTLREHLYKTQ--KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSD  677 (893)
Q Consensus       600 ~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~D  677 (893)
                      +.+..++||||+++|+|.+++....  ...++|..++.++.|+++||+|||   ..+|+||||||+|||++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEee
Confidence            9999999999999999999997653  235999999999999999999999   48999999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc
Q 036624          678 FGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       678 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  757 (893)
                      ||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+...+..|.......
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN  262 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred             cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence            99998644333333344566899999999999999999999999999999999999999887777777888888777777


Q ss_pred             cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhchh
Q 036624          758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES  814 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~~  814 (893)
                      +.+.+++++.+.....++++..+.+++.+||+.+|++||++.||+++|+.+++++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~  319 (321)
T 2qkw_B          263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES  319 (321)
T ss_dssp             TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred             ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence            778888888887888899999999999999999999999999999999999876653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=407.98  Aligned_cols=267  Identities=20%  Similarity=0.266  Sum_probs=205.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEee------cCE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE------NCE  603 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~  603 (893)
                      ++|+..++||+|+||+||+|++..+++.||||+++..  .....+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999999988899999987643  34456778999999999999999999999754      367


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      ++||||||+ |+|.++|.+.  .++++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            899999996 7899999654  35999999999999999999999   58999999999999999999999999999986


Q ss_pred             CCCCC--CccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh--ccc
Q 036624          684 GPTLD--HTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH--KKG  758 (893)
Q Consensus       684 ~~~~~--~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--~~~  758 (893)
                      .....  ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+....+....  ......  ...
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~--I~~~~g~p~~~  285 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL--IMMVLGTPSPA  285 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH--HHHHHCCCCGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH--HHHhcCCCChH
Confidence            43221  22234457899999999998875 569999999999999999999999976543322111  111000  000


Q ss_pred             --------chhhhccccc-cCCC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          759 --------ILEQIMDPYL-KGKI-----APECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       759 --------~~~~i~d~~l-~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                              .....+.... ....     .+.....+.+|+.+||+.||++|||+.|++++-.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  347 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF  347 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence                    0000000000 0000     1122356789999999999999999999998755

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.3e-44  Score=393.52  Aligned_cols=287  Identities=40%  Similarity=0.697  Sum_probs=247.6

Q ss_pred             ccccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh-hhHHHHHHHHHHHhhccccceeeEEEE
Q 036624          519 CRHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-QGVHEFQTEIEMLSKLRHRHLVSLIGY  597 (893)
Q Consensus       519 ~~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~  597 (893)
                      ...+++.++..++++|+..++||+|+||.||+|.... +..||||++..... .....+.+|++++++++||||++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS-SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecC-CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3689999999999999999999999999999998765 47899998765432 223368999999999999999999999


Q ss_pred             EeecCEEEEEEeeccCCCHHHHHhhCC--CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeE
Q 036624          598 CEENCEMILVYDYMAYGTLREHLYKTQ--KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKV  675 (893)
Q Consensus       598 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl  675 (893)
                      +......++||||+++|+|.+++....  ...++|..+..|+.|++.||+|||+.+..+|+||||||+|||+++++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999998653  345999999999999999999999644449999999999999999999999


Q ss_pred             ecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCC--CccccccHHHHHHH
Q 036624          676 SDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPT--LPKEQVSLAEWAAH  753 (893)
Q Consensus       676 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~--~~~~~~~l~~~~~~  753 (893)
                      +|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...  .......+.+|...
T Consensus       176 ~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            999999865332 222334456999999999999999999999999999999999999999631  22344567788888


Q ss_pred             hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       754 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ......+..+.+..+......++...+.+++.+||+.+|.+|||+.||+++|+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            778888888888888888899999999999999999999999999999999985

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.1e-43  Score=392.36  Aligned_cols=202  Identities=22%  Similarity=0.358  Sum_probs=170.9

Q ss_pred             HHhcCCccceeeeecCcEEEEEEEEc---CcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEE
Q 036624          529 AATNNFDEALLLGVGGFGKVYRGEID---GATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       529 ~at~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  604 (893)
                      ...+.|+..++||+|+||+||+|+.+   ..++.||+|++....  ....+.+|+++|+++ +|||||++++++.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34678999999999999999999874   345789999876533  345688999999998 699999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC-CceeEeccccccc
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSKT  683 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~  683 (893)
                      +||||||++|+|.+++.     .+++.++..++.|++.||+|||   +.+||||||||+||||+.+ +.+||+|||+|+.
T Consensus        96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            99999999999999983     3899999999999999999999   5899999999999999877 7999999999975


Q ss_pred             CCCCCC--------------------------ccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCC
Q 036624          684 GPTLDH--------------------------THVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPAL  736 (893)
Q Consensus       684 ~~~~~~--------------------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~  736 (893)
                      ......                          ....+..+||+.|||||++.+. .++.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            322110                          0112345799999999999876 5899999999999999999999999


Q ss_pred             CCCC
Q 036624          737 NPTL  740 (893)
Q Consensus       737 ~~~~  740 (893)
                      ....
T Consensus       248 ~~~~  251 (361)
T 4f9c_A          248 YKAS  251 (361)
T ss_dssp             SCCS
T ss_pred             CCCC
Confidence            6543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.4e-43  Score=416.69  Aligned_cols=255  Identities=22%  Similarity=0.283  Sum_probs=212.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..+.||+|+||+||+|+++..++.||+|++........+.+.+|+++|++++|||||++++++.+.+.++||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            68999999999999999999999888999999887766667788999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC--CceeEecccccccCCCCCC
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK--WVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~--~~~kl~DFGla~~~~~~~~  689 (893)
                      ++|+|.++|.... ..+++.++..++.||+.||+|||   +.+|+||||||+||||+.+  +.+||+|||+++....   
T Consensus       237 ~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~---  309 (573)
T 3uto_A          237 SGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---  309 (573)
T ss_dssp             CCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---
T ss_pred             CCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC---
Confidence            9999999986443 35999999999999999999999   5899999999999999854  8999999999987533   


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......+||+.|||||++.+..|+.++|||||||+||||++|+.||......+      ........       +..+.
T Consensus       310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~~~i~~~-------~~~~~  376 (573)
T 3uto_A          310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSC-------DWNMD  376 (573)
T ss_dssp             TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTT-------CCCCC
T ss_pred             CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHhC-------CCCCC
Confidence            223345679999999999999999999999999999999999999997543321      11111100       00111


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..........+.+|+.+||+.||.+|||+.|+++|-.
T Consensus       377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw  413 (573)
T 3uto_A          377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW  413 (573)
T ss_dssp             SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence            1111223456788999999999999999999998643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.6e-43  Score=410.11  Aligned_cols=252  Identities=21%  Similarity=0.265  Sum_probs=202.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHH---HHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEF---QTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f---~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      ++|+..++||+|+||+||+|+...+++.||||++....   ......+   ..++.+++.++|||||++++++.+.+.++
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999999988999999875311   1112223   34466777889999999999999999999


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      ||||||+||+|.++|.+..  .+++..+..++.||+.||+|||   ..+||||||||+||||+.++.+||+|||+|+...
T Consensus       269 lVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999999999999997654  4999999999999999999999   5999999999999999999999999999998643


Q ss_pred             CCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ..    .....+||+.|||||++.+ ..|+.++|||||||+||||++|++||........   .+....         +.
T Consensus       344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~---------i~  407 (689)
T 3v5w_A          344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRM---------TL  407 (689)
T ss_dssp             SC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHH---------HH
T ss_pred             CC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHh---------hc
Confidence            21    1234689999999999975 5799999999999999999999999965332221   111111         11


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNLE  806 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L~  806 (893)
                      ...  ..++......+.+|+.+||+.||.+|++     +.||++|-.
T Consensus       408 ~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf  452 (689)
T 3v5w_A          408 TMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  452 (689)
T ss_dssp             HCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred             CCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence            111  1223344566889999999999999998     688887654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6e-42  Score=385.23  Aligned_cols=264  Identities=25%  Similarity=0.438  Sum_probs=217.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcC-------cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeec
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDG-------ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEEN  601 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~  601 (893)
                      .++|...+.||+|+||+||+|++.+       .+..||||+++.. .....+.+.+|+++++++ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            3678889999999999999998742       3457999988754 445567899999999999 899999999999999


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL  667 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  667 (893)
                      +..++||||+++|+|.+++....              ...+++..++.++.|+++||+|||   ..+|+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999997653              235899999999999999999999   4899999999999999


Q ss_pred             CCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCcccccc
Q 036624          668 DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVS  746 (893)
Q Consensus       668 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  746 (893)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999986443332222334557889999999999999999999999999999999 999987543221   


Q ss_pred             HHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhch
Q 036624          747 LAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE  813 (893)
Q Consensus       747 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~  813 (893)
                      +....             ........+..+...+.+++.+||+.+|++||++.|+++.|+.++.+..
T Consensus       314 ~~~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          314 LFKLL-------------KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             HHHHH-------------HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHH-------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            11111             0111122344566789999999999999999999999999999887544

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.2e-42  Score=374.87  Aligned_cols=261  Identities=26%  Similarity=0.399  Sum_probs=216.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|...++||+|+||+||+|.+..++..||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            56888999999999999999998888999999887777778889999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc-
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT-  690 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~-  690 (893)
                      ++|+|.+++.... ..+++.+++.|+.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++........ 
T Consensus        90 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           90 KGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             TTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999997643 45999999999999999999999   489999999999999999999999999999764322111 


Q ss_pred             -----------cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccc
Q 036624          691 -----------HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI  759 (893)
Q Consensus       691 -----------~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  759 (893)
                                 .......||+.|+|||++.+..++.++|||||||++|||++|..|+..........          ...
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----------~~~  235 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------GLN  235 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----------SBC
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----------hhh
Confidence                       01114569999999999999999999999999999999999999986543322110          000


Q ss_pred             hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       760 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .....+.    ..++.++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus       236 ~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          236 VRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1111111    1233445668899999999999999999999999987764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7e-42  Score=377.33  Aligned_cols=273  Identities=21%  Similarity=0.312  Sum_probs=210.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecC----EEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC----EMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~l  606 (893)
                      .++|+..++||+|+||+||+|+..+  +.||||++... ......+..|+.++++++||||+++++++....    .+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEETT--EEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEECC--CEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3578899999999999999999874  78999998643 333455677999999999999999999998743    4799


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCC----------ceEecCCCCCCEEECCCCceeEe
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH----------TIIHRDVKTTNILLDEKWVAKVS  676 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~ivHrDlk~~NILld~~~~~kl~  676 (893)
                      ||||+++|+|.+++...   .++|..++.|+.|+++||+|||+   .          +|+||||||+|||++.++.+||+
T Consensus       100 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            99999999999999764   39999999999999999999994   5          99999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeeccCcCccChHhhhh-----cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHH
Q 036624          677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWA  751 (893)
Q Consensus       677 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  751 (893)
                      |||+++...............||+.|+|||++.+     ..++.++|||||||++|||++|+.||...............
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            9999976443222222334569999999999987     45667899999999999999999999765433322221111


Q ss_pred             HHhhcccchhh-hccccccCC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhc
Q 036624          752 AHCHKKGILEQ-IMDPYLKGK-----IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQ  812 (893)
Q Consensus       752 ~~~~~~~~~~~-i~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~  812 (893)
                      ........+.+ +........     ....++..+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            10000000111 111111111     12356778999999999999999999999999999877643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.8e-41  Score=366.35  Aligned_cols=281  Identities=36%  Similarity=0.646  Sum_probs=231.3

Q ss_pred             cccCHHHHHHHhcCCccc------eeeeecCcEEEEEEEEcCcceEEEEEeCCCC----ChhhHHHHHHHHHHHhhcccc
Q 036624          520 RHFSFAEIKAATNNFDEA------LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL----SEQGVHEFQTEIEMLSKLRHR  589 (893)
Q Consensus       520 ~~~~~~el~~at~~f~~~------~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~----~~~~~~~f~~E~~~l~~l~H~  589 (893)
                      ..|++.++..++++|...      ++||+|+||.||+|...+  ..||+|++...    .....+.+.+|+.++++++||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSS--CEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECC--ceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            679999999999999988      899999999999998743  68999976542    234567899999999999999


Q ss_pred             ceeeEEEEEeecCEEEEEEeeccCCCHHHHHhhC-CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC
Q 036624          590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKT-QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD  668 (893)
Q Consensus       590 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld  668 (893)
                      ||+++++++.+.+..++||||+++|+|.+++... ...++++..++.++.|+++||+|||   +.+|+||||||+|||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999999754 3456999999999999999999999   48999999999999999


Q ss_pred             CCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHH
Q 036624          669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA  748 (893)
Q Consensus       669 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  748 (893)
                      +++.+||+|||+++...............||+.|+|||.+.+ .++.++|||||||++|||++|+.||.......  .+.
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~  244 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLL  244 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BTT
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HHH
Confidence            999999999999886543322223334569999999999875 48999999999999999999999997643322  222


Q ss_pred             HHHHHhhc-ccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          749 EWAAHCHK-KGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       749 ~~~~~~~~-~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      .+...... ...+.+.+++.+ ...+..+...+.+++.+||+.+|.+||++.+|+++|+.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            33322222 223445555544 3456778889999999999999999999999999999754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-41  Score=381.26  Aligned_cols=271  Identities=23%  Similarity=0.368  Sum_probs=218.1

Q ss_pred             cCHHHHHHHhcCCccceeeeecCcEEEEEEEE-----cCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeE
Q 036624          522 FSFAEIKAATNNFDEALLLGVGGFGKVYRGEI-----DGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSL  594 (893)
Q Consensus       522 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l  594 (893)
                      +...+.....++|+..++||+|+||.||+|++     ...++.||||++... .....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            44555566678999999999999999999984     445578999988754 444567899999999999 79999999


Q ss_pred             EEEEeecC-EEEEEEeeccCCCHHHHHhhCCC------------------------------------------------
Q 036624          595 IGYCEENC-EMILVYDYMAYGTLREHLYKTQK------------------------------------------------  625 (893)
Q Consensus       595 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------  625 (893)
                      +++|.+.+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998754 48999999999999999976532                                                


Q ss_pred             ----------------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          626 ----------------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       626 ----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                                      ..+++..++.++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                            12899999999999999999999   48999999999999999999999999999986543333


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |+.||........  +..    ...         ...
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~----~~~---------~~~  313 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLK---------EGT  313 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHH----HHH---------HTC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHH----HHH---------cCC
Confidence            333445668999999999999999999999999999999998 9999975433221  111    010         111


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ....+..+...+.+++.+||+.+|.+||++.||+++|+.+++
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            112233445678899999999999999999999999998775

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.4e-41  Score=368.58  Aligned_cols=254  Identities=21%  Similarity=0.306  Sum_probs=211.3

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..++||+|+||+||+|.....++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            35788999999999999999998888899999987655445567789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++|+|.+++.+.   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  
T Consensus        99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  170 (297)
T 3fxz_A           99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (297)
T ss_dssp             CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence            9999999999765   4899999999999999999999   4899999999999999999999999999987643322  


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||........      ........        ....
T Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~--------~~~~  236 (297)
T 3fxz_A          171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG--------TPEL  236 (297)
T ss_dssp             CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHC--------SCCC
T ss_pred             cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC--------CCCC
Confidence            223345699999999999999999999999999999999999999965433211      11100000        0011


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..+..+...+.+++.+||+.||++|||+.|++++-.
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  272 (297)
T 3fxz_A          237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF  272 (297)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence            223345567889999999999999999999997654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=373.01  Aligned_cols=263  Identities=23%  Similarity=0.375  Sum_probs=213.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCc---ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++|+..++||+|+||+||+|.+...   +..||||++... .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            35688889999999999999998643   345999987754 45566789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++|+|.+++.... ..+++..++.|+.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++....
T Consensus       128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            999999999999996543 45999999999999999999999   48999999999999999999999999999986433


Q ss_pred             CC-CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          687 LD-HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       687 ~~-~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      .. .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......      ....         +.
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~---------~~  268 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISS---------VE  268 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHH---------HH
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHH---------HH
Confidence            21 1122233456889999999999999999999999999999999 999996543221      1111         11


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhch
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE  813 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~  813 (893)
                      . ......+..++..+.+++.+||+.+|++||++.+|++.|+.+++..+
T Consensus       269 ~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          269 E-GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             c-CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            1 11122344566789999999999999999999999999998876433

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.1e-41  Score=369.10  Aligned_cols=266  Identities=20%  Similarity=0.280  Sum_probs=218.9

Q ss_pred             cccCHHHHHHHhcC----------CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcccc
Q 036624          520 RHFSFAEIKAATNN----------FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHR  589 (893)
Q Consensus       520 ~~~~~~el~~at~~----------f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~  589 (893)
                      ..++.++++.+++.          |+..+.||+|+||.||+|+....++.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            46889999998865          67778999999999999999877789999988766666677899999999999999


Q ss_pred             ceeeEEEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC
Q 036624          590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE  669 (893)
Q Consensus       590 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~  669 (893)
                      ||+++++++...+..++||||+++|+|.+++...   .+++..+..++.|+++||+|||   +.+|+||||||+|||++.
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTL  176 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECC
Confidence            9999999999999999999999999999998643   4999999999999999999999   489999999999999999


Q ss_pred             CCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHH
Q 036624          670 KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAE  749 (893)
Q Consensus       670 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  749 (893)
                      ++.+||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~------  248 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------  248 (321)
T ss_dssp             TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------
T ss_pred             CCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence            9999999999987643321  12234569999999999999999999999999999999999999996543211      


Q ss_pred             HHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          750 WAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       750 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .....      .....+.+  .........+.+++.+||+.||++||++.|++++...
T Consensus       249 ~~~~~------~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~  298 (321)
T 2c30_A          249 AMKRL------RDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL  298 (321)
T ss_dssp             HHHHH------HHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             HHHHH------hcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            11111      11111111  1122345678899999999999999999999986553

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-41  Score=383.61  Aligned_cols=260  Identities=24%  Similarity=0.362  Sum_probs=212.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .++|...+.||+|+||.||+|.+..++..||||.++.. .....++|.+|+++|++++||||++++++|...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            35788889999999999999999877789999987654 33445679999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++|+|.+++.... ..+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus       193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            999999999997543 35899999999999999999999   48999999999999999999999999999986432111


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      ........+++.|+|||++.++.++.++|||||||+||||++ |+.||.......   ..+..             ....
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~~~-------------~~~~  332 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREFV-------------EKGG  332 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHHHH-------------HTTC
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-------------HcCC
Confidence            111122335778999999999999999999999999999998 999986543211   11111             1111


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ....+..++..+.+++.+||+.+|++|||+.+|++.|+.+.+
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            122334466788999999999999999999999999997654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=382.66  Aligned_cols=264  Identities=27%  Similarity=0.384  Sum_probs=212.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEc-----CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEID-----GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      .++|...++||+|+||+||+|+..     ..+..||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357888999999999999999954     34568999998654 455667899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCC-----CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC---ceeEe
Q 036624          605 ILVYDYMAYGTLREHLYKTQ-----KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW---VAKVS  676 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~kl~  676 (893)
                      ++||||+++|+|.+++....     ...+++..++.++.|+++||+|||   +.+|+||||||+||||+.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997643     245999999999999999999999   48999999999999999554   59999


Q ss_pred             cccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhh
Q 036624          677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       677 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      |||+++...............||+.|+|||++.+..++.++|||||||+||||++ |+.||......+      ......
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~------~~~~i~  300 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFVT  300 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH
Confidence            9999974322112222334568999999999999999999999999999999998 999996543211      111111


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhch
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE  813 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~  813 (893)
                      ..          .....+..++..+.+++.+||+.+|++||++.+|+++|+.+.+...
T Consensus       301 ~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          301 SG----------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             cC----------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            11          1112234456678999999999999999999999999998876443

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.3e-41  Score=371.84  Aligned_cols=258  Identities=23%  Similarity=0.392  Sum_probs=205.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcce----EEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATT----KVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      ++|+..++||+|+||+||+|++...+.    .||+|.+... .....++|.+|+.++++++||||++++++|.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            568889999999999999999865544    3688877543 3345678999999999999999999999998765 789


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      |+||+.+|+|.+++.... ..+++..++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999997654 45999999999999999999999   48999999999999999999999999999986443


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......   +..             .+.
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~-------------~~~  233 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS-------------ILE  233 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH-------------HHH
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH-------------HHH
Confidence            333333344557889999999999999999999999999999999 999997543322   111             111


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .......+..+...+.+++.+||+.+|++||++.+++++|+.+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            111122344566788999999999999999999999999997764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6e-41  Score=367.63  Aligned_cols=262  Identities=29%  Similarity=0.467  Sum_probs=206.4

Q ss_pred             HHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       527 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      +....++|+..++||+|+||+||+|+..+  ..||||++...  .....++|.+|++++++++||||+++++++......
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEETT--EEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEECC--CcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            33345688999999999999999998854  67999986543  345567899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCC-CCCCHHhHHHHHHHHHHhhhhhhcCCCCc--eEecCCCCCCEEECCCCceeEeccccc
Q 036624          605 ILVYDYMAYGTLREHLYKTQK-PPLPWKQRLEICIGAARGLHYLHTGAKHT--IIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      ++||||+++|+|.+++..... ..+++..++.++.|+++||+|||   +.+  |+||||||+|||++.++.+||+|||++
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            999999999999999976432 24899999999999999999999   467  999999999999999999999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      +.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......      .....       
T Consensus       187 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~-------  251 (309)
T 3p86_A          187 RLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAV-------  251 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHH-------
T ss_pred             cccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-------
Confidence            753321  112334569999999999999999999999999999999999999997543321      11110       


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                        .........+..+...+.+++.+||+.+|++||++.++++.|+..++
T Consensus       252 --~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          252 --GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             --HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             --HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence              00011122344456678999999999999999999999999998775

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.4e-41  Score=377.79  Aligned_cols=261  Identities=24%  Similarity=0.387  Sum_probs=203.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEc---CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEID---GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|+..++||+|+||.||+|++.   ..+..||||+++.. .....++|.+|+.++++++||||+++++++.+....++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57888999999999999999876   34567999988754 445667899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++|+|.+++.... ..+++.+++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999997543 45999999999999999999999   489999999999999999999999999999864332


Q ss_pred             CC-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          688 DH-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       688 ~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      .. ........+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+      ....          ++
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~------~~~~----------i~  264 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIKA----------VD  264 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH------HHHH----------HH
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH----------HH
Confidence            11 111222345788999999999999999999999999999998 999996543211      1111          11


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhc
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQ  812 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~  812 (893)
                      .......+..++..+.+++.+||+.+|++||++.+|++.|+.+++..
T Consensus       265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            11122234456678999999999999999999999999999887543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.1e-41  Score=370.70  Aligned_cols=268  Identities=26%  Similarity=0.414  Sum_probs=210.9

Q ss_pred             cCCccceeeeecCcEEEEEEEE----cCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEI----DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  605 (893)
                      ++|+..++||+|+||+||+|++    ...+..||||++........+.|.+|++++++++||||+++++++...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            5788899999999999999984    445688999998877777788999999999999999999999998653  5589


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        90 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999997653 35999999999999999999999   4899999999999999999999999999998643


Q ss_pred             CCCC-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc------
Q 036624          686 TLDH-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG------  758 (893)
Q Consensus       686 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------  758 (893)
                      .... ........++..|+|||.+.+..++.++|||||||++|||++|..|+.....       ++........      
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-------EFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-------HHHHHHCTTCCTHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH-------HHHhhhcCccccchhH
Confidence            3221 1222334577889999999999999999999999999999999998853211       1111000000      


Q ss_pred             -chhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          759 -ILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       759 -~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                       .+.+.+........+..++..+.+++.+||+.+|++|||+.|+++.|+.+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence             0111111112223345667889999999999999999999999999997764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=376.01  Aligned_cols=264  Identities=26%  Similarity=0.427  Sum_probs=216.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcC-------cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeec
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDG-------ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEEN  601 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~  601 (893)
                      .++|...++||+|+||+||+|+..+       ....||||++... .....+.+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4678889999999999999999743       2257999987654 445567899999999999 899999999999999


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL  667 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  667 (893)
                      +..++||||+++|+|.+++....              ...+++..++.|+.|+++||+|||   +.+|+||||||+||||
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999998654              245999999999999999999999   4899999999999999


Q ss_pred             CCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCcccccc
Q 036624          668 DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVS  746 (893)
Q Consensus       668 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  746 (893)
                      ++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......    
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~----  300 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----  300 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence            9999999999999986543332233344567889999999999999999999999999999999 99998654321    


Q ss_pred             HHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhch
Q 036624          747 LAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE  813 (893)
Q Consensus       747 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~  813 (893)
                        +...... .         ......+..+...+.+++.+||+.+|++||++.||+++|+.+.....
T Consensus       301 --~~~~~~~-~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          301 --ELFKLLK-E---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             --HHHHHHH-T---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             --HHHHHHH-c---------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence              1111111 1         11122234456778999999999999999999999999998876443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.3e-41  Score=369.45  Aligned_cols=251  Identities=21%  Similarity=0.293  Sum_probs=209.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      .++|+..+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+++|++++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45799999999999999999999888899999986532  4455678899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++....  .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-  167 (328)
T ss_dssp             CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred             ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence            9999999999997654  4999999999999999999999   489999999999999999999999999999754321 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCC-CcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                        ......+||+.|+|||++.+..++ .++|||||||++|||++|+.||......      +.....         ....
T Consensus       168 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i---------~~~~  230 (328)
T 3fe3_A          168 --GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERV---------LRGK  230 (328)
T ss_dssp             --CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH---------HHCC
T ss_pred             --CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHH---------HhCC
Confidence              223446799999999999988875 7899999999999999999999754321      111111         1111


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                        ...+......+.+++.+||+.||.+|||+.|++++-.
T Consensus       231 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~  267 (328)
T 3fe3_A          231 --YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW  267 (328)
T ss_dssp             --CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred             --CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence              1123334566889999999999999999999987644

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.3e-41  Score=392.00  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=217.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ..+|...++||+|+||.||+|.+...+..||||.++... ...++|.+|+++|++++||||++++++|......+|||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            356788899999999999999999877899999987543 3467899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      |++|+|.++|.......+++..++.|+.|+++||+|||   +.+|+||||||+||||++++.+||+|||+++...... .
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence            99999999998776667999999999999999999999   4899999999999999999999999999998653321 1


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......+++.|+|||++....++.++|||||||+||||++ |+.||.......   +.+.             +.....
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~-------------~~~~~~  437 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL-------------LEKDYR  437 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH-------------HHTTCC
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------HHcCCC
Confidence            12223446789999999999999999999999999999999 999987543221   1111             111112


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ...+..++..+.+|+.+||+.+|++||++.+|++.|+...+
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            23345567789999999999999999999999999997654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2e-40  Score=363.59  Aligned_cols=261  Identities=26%  Similarity=0.418  Sum_probs=214.9

Q ss_pred             hcCCccceeeeecCcEEEEEEEEc-----CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEID-----GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      .++|...+.||+|+||.||+|...     .++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            467888999999999999999873     33478999987653 445667899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCC----------------------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCC
Q 036624          605 ILVYDYMAYGTLREHLYKTQK----------------------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKT  662 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~  662 (893)
                      ++||||+++|+|.+++.....                      ..+++..++.++.|+++||+|||   +.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            999999999999999986532                      34899999999999999999999   48999999999


Q ss_pred             CCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCc
Q 036624          663 TNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLP  741 (893)
Q Consensus       663 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~  741 (893)
                      +|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999986543322222334457889999999999999999999999999999999 9999975443


Q ss_pred             cccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          742 KEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       742 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ..   +.....             .......+..+...+.+++.+||+.+|++||++.+++++|+.++.
T Consensus       259 ~~---~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          259 ER---LFNLLK-------------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GG---HHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH---HHHHhh-------------cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            22   111111             111112334456778999999999999999999999999998764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.9e-40  Score=363.65  Aligned_cols=262  Identities=23%  Similarity=0.389  Sum_probs=214.6

Q ss_pred             hcCCccceeeeecCcEEEEEEEE-----cCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEI-----DGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCE  603 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~  603 (893)
                      .++|+..+.||+|+||.||+|+.     ...+..||+|++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            45788899999999999999985     3455789999876543 34567899999999999 89999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCCC----------------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE
Q 036624          604 MILVYDYMAYGTLREHLYKTQK----------------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL  667 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  667 (893)
                      .++||||+++|+|.+++.....                ..+++..++.++.|+++||+|||   +.+|+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999976542                25899999999999999999999   4899999999999999


Q ss_pred             CCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCcccccc
Q 036624          668 DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVS  746 (893)
Q Consensus       668 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  746 (893)
                      +.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||........  
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence            9999999999999986544332222334557889999999999999999999999999999999 9999875432211  


Q ss_pred             HHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          747 LAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       747 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      +..             .+........+..++..+.+++.+||+.+|.+||++.|++++|+..++
T Consensus       257 ~~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          257 FYK-------------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             HHH-------------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHH-------------HhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            111             111111112233455678999999999999999999999999998775

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2e-40  Score=360.77  Aligned_cols=261  Identities=26%  Similarity=0.389  Sum_probs=208.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC---CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .++|+..+.||+|+||.||+|++...+..||+|.+..   ......+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            3578899999999999999999988888999997632   2345567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++++|.+++....  ++++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            99999999999997654  5999999999999999999999   489999999999999999999999999999864322


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                      . ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......      ..........      +.
T Consensus       165 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~------~~  231 (294)
T 4eqm_A          165 S-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDSV------PN  231 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSCC------CC
T ss_pred             c-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhccC------CC
Confidence            1 122234569999999999999999999999999999999999999997543211      1111111100      11


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERP-SMGDVLWNLEFAL  809 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-tm~evl~~L~~~~  809 (893)
                      ......++++..+.+++.+||+.+|.+|| ++.++.+.|+..+
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            11122334557789999999999999998 8999998888554

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-40  Score=369.47  Aligned_cols=265  Identities=28%  Similarity=0.437  Sum_probs=215.4

Q ss_pred             HHHHhcCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEee
Q 036624          527 IKAATNNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE  600 (893)
Q Consensus       527 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~  600 (893)
                      +....++|+..+.||+|+||.||+|+..+     .+..||+|.+... .....+.|.+|+.++++++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            33446789999999999999999999864     3478999998754 34456789999999999999999999999999


Q ss_pred             cCEEEEEEeeccCCCHHHHHhhCC----------------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEec
Q 036624          601 NCEMILVYDYMAYGTLREHLYKTQ----------------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR  658 (893)
Q Consensus       601 ~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  658 (893)
                      .+..++||||+++|+|.+++....                      ...+++.+++.|+.|+++||+|||   +.+|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            999999999999999999997642                      156999999999999999999999   4899999


Q ss_pred             CCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCC
Q 036624          659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALN  737 (893)
Q Consensus       659 Dlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~  737 (893)
                      ||||+|||+++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999875432222222334568899999999999999999999999999999999 999986


Q ss_pred             CCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          738 PTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       738 ~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .....      +....         +.+... ...+..++..+.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus       279 ~~~~~------~~~~~---------~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          279 GMAHE------EVIYY---------VRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TSCHH------HHHHH---------HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCChH------HHHHH---------HhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            54321      11111         111111 12234456778999999999999999999999999997664

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-40  Score=369.37  Aligned_cols=263  Identities=24%  Similarity=0.380  Sum_probs=211.3

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEc-----CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecC
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEID-----GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENC  602 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~  602 (893)
                      ..++|...+.||+|+||.||+|.+.     +.+..||+|.+... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3468889999999999999999972     34568999987643 233456799999999999 8999999999999999


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCC---------------------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCC
Q 036624          603 EMILVYDYMAYGTLREHLYKTQK---------------------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVK  661 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk  661 (893)
                      ..++||||+++|+|.+++.....                     ..+++..++.++.|+++||+|||   ..+|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999976532                     24899999999999999999999   4899999999


Q ss_pred             CCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCC
Q 036624          662 TTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTL  740 (893)
Q Consensus       662 ~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~  740 (893)
                      |+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+||||++ |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999986433222223334567889999999999999999999999999999998 999997543


Q ss_pred             ccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          741 PKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       741 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ...  .+...             +........+..+...+.+++.+||+.+|.+||++.+++++|+..+.
T Consensus       280 ~~~--~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          280 VDA--NFYKL-------------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CSH--HHHHH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cHH--HHHHH-------------HhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            221  11111             11111122334456778999999999999999999999999997664

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.8e-40  Score=367.85  Aligned_cols=252  Identities=24%  Similarity=0.299  Sum_probs=209.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||+||+|+....++.||+|+++..   .....+.+.+|+++|++++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            5788999999999999999999888899999987542   2234567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|..++....  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        85 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  158 (337)
T 1o6l_A           85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence            9999999999997654  4899999999999999999999   589999999999999999999999999999863321 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......      +....         +.... 
T Consensus       159 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~---------i~~~~-  221 (337)
T 1o6l_A          159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFEL---------ILMEE-  221 (337)
T ss_dssp             -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH---------HHHCC-
T ss_pred             -CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHH---------HHcCC-
Confidence             12234567999999999999999999999999999999999999999654321      11111         11111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLEF  807 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~~  807 (893)
                       ..++......+.+++.+||+.+|++||     ++.|++++-..
T Consensus       222 -~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f  264 (337)
T 1o6l_A          222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence             112334456788999999999999999     89999877543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-40  Score=366.81  Aligned_cols=258  Identities=22%  Similarity=0.354  Sum_probs=205.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceE----EEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTK----VAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~----VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      ++|+..++||+|+||+||+|.+...+..    |++|.+... .....+.+.+|+.++++++||||++++++|.+ ...++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence            4688899999999999999998765544    788876433 23334567899999999999999999999874 56889


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++|+|.+++... ...+++..++.++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++....
T Consensus        92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999999999764 345899999999999999999999   48999999999999999999999999999987654


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ...........||+.|+|||++.+..++.++|||||||++|||++ |+.||.......   +.+...             
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~-------------  231 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLLE-------------  231 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHHH-------------
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHHH-------------
Confidence            333333455668899999999999999999999999999999999 999997543322   111111             


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .......+..+...+.+++.+||+.+|.+||++.+++++|+.+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            001112223344567889999999999999999999999997764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.6e-40  Score=358.13  Aligned_cols=264  Identities=25%  Similarity=0.384  Sum_probs=221.1

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ..++|+..+.||+|+||+||+|.+...+..||+|.+... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            356788899999999999999999988889999988753 3456789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++++|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence            999999999998877777999999999999999999999   4899999999999999999999999999998654322 


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......   +.+.             +....
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~-------------~~~~~  229 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL-------------LEKDY  229 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH-------------HHTTC
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------HhccC
Confidence            222334557889999999999999999999999999999999 999986543321   1111             11111


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhchh
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES  814 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~~  814 (893)
                      ....+..++..+.+++.+||+.+|.+||++.++++.|+.+.+-...
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~  275 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI  275 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            2223345567789999999999999999999999999988764443

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3e-40  Score=364.04  Aligned_cols=262  Identities=26%  Similarity=0.403  Sum_probs=197.9

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcce---EEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATT---KVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~---~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      ..++|+..+.||+|+||+||+|.+...+.   .||||++...  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45689999999999999999999876543   7999987653  345577899999999999999999999999877655


Q ss_pred             ------EEEEeeccCCCHHHHHhhCC----CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCcee
Q 036624          605 ------ILVYDYMAYGTLREHLYKTQ----KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAK  674 (893)
Q Consensus       605 ------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~k  674 (893)
                            ++||||+++|+|.+++....    ...+++..++.|+.|+++||+|||   +.+|+||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999986432    225999999999999999999999   48999999999999999999999


Q ss_pred             EecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHH
Q 036624          675 VSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAH  753 (893)
Q Consensus       675 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~  753 (893)
                      |+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......   +..    
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----  250 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN----  250 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH----
Confidence            999999986443332233334557889999999999999999999999999999999 899987543322   111    


Q ss_pred             hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       754 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                              .+.... ....++.+...+.+++.+||+.+|++||++.++++.|++++.
T Consensus       251 --------~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          251 --------YLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             --------HHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------HHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                    111110 112234556778999999999999999999999999998875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.3e-40  Score=379.13  Aligned_cols=252  Identities=29%  Similarity=0.435  Sum_probs=209.3

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecC-EEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC-EMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E  609 (893)
                      .++|+..++||+|+||.||+|.+.+  ..||||.++...  ..+.|.+|+++|++++||||+++++++.+.. ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~~--~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT--EEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEecC--CeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3568888999999999999999874  689999887543  4578999999999999999999999987665 7999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      ||++|+|.++|.......+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            999999999998776666899999999999999999999   489999999999999999999999999999853221  


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                         .....+++.|+|||++.+..++.++|||||||+||||++ |+.||......+   +....    ..         ..
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i----~~---------~~  403 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EK---------GY  403 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHH----HT---------TC
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----Hc---------CC
Confidence               122357889999999999999999999999999999998 999997543321   11111    01         11


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ....+..++..+.+++.+||+.+|++|||+.++++.|+....
T Consensus       404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            123345567789999999999999999999999999987653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.5e-40  Score=353.70  Aligned_cols=256  Identities=27%  Similarity=0.394  Sum_probs=209.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..+.||+|+||.||+|....+ ..||+|++.... ...+++.+|++++++++||||+++++++.+....++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCC-CeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            5688889999999999999998765 679999877543 23467999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.... ..+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        88 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  162 (269)
T 4hcu_A           88 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  162 (269)
T ss_dssp             TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence            9999999996543 46999999999999999999999   5899999999999999999999999999998643211 11


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......      .....         ... ...
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~---------~~~-~~~  226 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDI---------STG-FRL  226 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHH---------HTT-CCC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHH---------hcC-ccC
Confidence            2223456788999999999999999999999999999999 999986543221      11111         110 111


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ..+......+.+++.+||+.+|++||++.+++++|+++.+
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            1223345678899999999999999999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.5e-41  Score=368.40  Aligned_cols=257  Identities=23%  Similarity=0.293  Sum_probs=206.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..++||+|+||+||+|.....++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57899999999999999999998888999999865432 22346689999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++|+|.+++...  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus        87 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            9999999998654  34999999999999999999999   589999999999999999999999999999754322222


Q ss_pred             cceeeeccCcCccChHhhhhcCC-CCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....|...             ...
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~-------------~~~  227 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK-------------KTY  227 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTT-------------CTT
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcc-------------ccc
Confidence            23345679999999999988775 789999999999999999999997543321 111221111             000


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ..........+.+++.+||+.||++|||+.|++++-..
T Consensus       228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~  265 (323)
T 3tki_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  265 (323)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence            01112345667889999999999999999999977654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.7e-40  Score=366.05  Aligned_cols=263  Identities=25%  Similarity=0.371  Sum_probs=213.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcc-----eEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCE  603 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~  603 (893)
                      .++|...+.||+|+||.||+|.....+     ..||+|.+... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            568899999999999999999986543     37999987654 344567899999999999 89999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCC------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC
Q 036624          604 MILVYDYMAYGTLREHLYKTQ------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW  671 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~  671 (893)
                      .++||||+++|+|.+++....            ...+++..++.++.|++.||+|||   ..+|+||||||+|||++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCC
Confidence            999999999999999997532            345899999999999999999999   48999999999999999999


Q ss_pred             ceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHH
Q 036624          672 VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEW  750 (893)
Q Consensus       672 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  750 (893)
                      .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||........  +...
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~~  279 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYKL  279 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HHHH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HHHH
Confidence            999999999985432222222334557889999999999999999999999999999998 9999875432211  1111


Q ss_pred             HHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          751 AAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       751 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      .             ........+..++..+.+++.+||+.+|.+||++.||+++|+...+-
T Consensus       280 ~-------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          280 V-------------KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             H-------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H-------------hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            1             11111122333456788999999999999999999999999977653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=365.35  Aligned_cols=247  Identities=22%  Similarity=0.286  Sum_probs=196.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||+||+|++...++.||||++...  .......+..|+..+.++ +|+||++++++|.+.+..+|||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            5799999999999999999999877789999976542  334445566676666666 8999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+ +++|.+++.... ..++|..++.|+.|++.||+|||+   .+|+||||||+||||+.++.+||+|||+++..... 
T Consensus       137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-  210 (311)
T ss_dssp             ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence            999 679999887654 459999999999999999999994   78999999999999999999999999998764322 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                        .......||+.|+|||++.+ .++.++|||||||++|||++|..++....        .|..  ...+    ...+. 
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~~~--~~~~----~~~~~-  272 (311)
T 3p1a_A          211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GWQQ--LRQG----YLPPE-  272 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HHHH--HTTT----CCCHH-
T ss_pred             --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHH--Hhcc----CCCcc-
Confidence              22334569999999999876 79999999999999999999977664211        1111  0111    01111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                         ....+...+.+++.+||+.+|++|||+.|++++-
T Consensus       273 ---~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  306 (311)
T 3p1a_A          273 ---FTAGLSSELRSVLVMMLEPDPKLRATAEALLALP  306 (311)
T ss_dssp             ---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             ---cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence               1122346788999999999999999999999753

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.1e-40  Score=385.40  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=210.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|...++||+|+||+||+|.+..+ ..||||+++... ...+.|.+|+++|++++||||+++++++. .+..++||||
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTT-EEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCc-cEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            46788899999999999999999764 679999887543 35678999999999999999999999987 5678999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      |++|+|.++|.......+++..++.++.|+++||+|||+   .+|+||||||+||||+.++.+||+|||+++...... .
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y  339 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-H
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-e
Confidence            999999999986544468999999999999999999994   899999999999999999999999999998643211 1


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......+|+.|+|||++....++.++|||||||+||||++ |+.||......+      ...... .         ...
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~-~---------~~~  403 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALE-R---------GYR  403 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHH-H---------TCC
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-c---------CCC
Confidence            11223446789999999999999999999999999999999 999996543211      111111 0         011


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ...+..++..+.+++.+||+.+|++|||+.+|++.|+...
T Consensus       404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            1223456678999999999999999999999999998654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=369.69  Aligned_cols=252  Identities=22%  Similarity=0.303  Sum_probs=204.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++|+..++||+|+||+||+|+....++.||+|++...   .....+.+.+|.++++.+ +||||+++++++.+.+..+|
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            46899999999999999999999988899999987642   233456788999999988 69999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++|+|..++.+..  .+++..+..++.|++.||+|||   +.+|+||||||+||||+.++.+||+|||+++....
T Consensus       102 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            999999999999997654  4999999999999999999999   48999999999999999999999999999985332


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      .  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ...         .+...
T Consensus       177 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~---------~i~~~  239 (353)
T 3txo_A          177 N--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFE---------AILND  239 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH---------HHHHC
T ss_pred             C--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHH---------HHHcC
Confidence            1  223345679999999999999999999999999999999999999997543221      111         11111


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSM------GDVLWNLE  806 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm------~evl~~L~  806 (893)
                      .  ..++......+.+++.+||+.+|++||++      .|++++-.
T Consensus       240 ~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~  283 (353)
T 3txo_A          240 E--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF  283 (353)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred             C--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence            1  12233345668899999999999999998      77776644

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-40  Score=381.44  Aligned_cols=269  Identities=20%  Similarity=0.271  Sum_probs=213.7

Q ss_pred             cCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEE
Q 036624          522 FSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYC  598 (893)
Q Consensus       522 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~  598 (893)
                      +.+.+++..+++|+..++||+|+||+||+|++..+++.||+|++....   ....+.+.+|+.++.+++||||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345666677889999999999999999999999888999999875321   11223488999999999999999999999


Q ss_pred             eecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecc
Q 036624          599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF  678 (893)
Q Consensus       599 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF  678 (893)
                      .+.+.++||||||++|+|.++|.+.. ..+++..+..++.|++.||+|||   +.+||||||||+||||+.++.+||+||
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcch
Confidence            99999999999999999999997642 35999999999999999999999   589999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH
Q 036624          679 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH  753 (893)
Q Consensus       679 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  753 (893)
                      |+++..... ........+||+.|+|||++.     ...++.++|||||||+||||++|+.||......+.      ...
T Consensus       220 Gla~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------~~~  292 (437)
T 4aw2_A          220 GSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGK  292 (437)
T ss_dssp             TTCEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH
T ss_pred             hhhhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------HHh
Confidence            999764332 222334467999999999997     46789999999999999999999999975432211      111


Q ss_pred             hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHH
Q 036624          754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIE--RPSMGDVLWNLEF  807 (893)
Q Consensus       754 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPtm~evl~~L~~  807 (893)
                      .....  ....-|    .........+.+++.+||+.+|++  ||++.|++++-..
T Consensus       293 i~~~~--~~~~~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff  342 (437)
T 4aw2_A          293 IMNHK--ERFQFP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF  342 (437)
T ss_dssp             HHTHH--HHCCCC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred             hhhcc--ccccCC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence            11000  000001    111224566888999999888888  9999999987654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-40  Score=360.51  Aligned_cols=257  Identities=17%  Similarity=0.213  Sum_probs=210.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|...+.||+|+||+||+|....++..+|+|.+... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            46788999999999999999999988899999987643 34556789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC--CCceeEecccccccCCCCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE--KWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~--~~~~kl~DFGla~~~~~~~  688 (893)
                      +++|+|.+++.... ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.  ++.+||+|||+++..... 
T Consensus        83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-  157 (321)
T 1tki_A           83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence            99999999996543 35999999999999999999999   489999999999999987  789999999999864322 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ..........   ..+...
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~---~~~~~~  226 (321)
T 1tki_A          158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEY---TFDEEA  226 (321)
T ss_dssp             --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC---CCCHHH
T ss_pred             --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHcCCC---CCChhh
Confidence              22345679999999999999889999999999999999999999997543211      1111111000   000000


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                          .+.....+.+++.+||+.||.+|||+.|++++-...
T Consensus       227 ----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  262 (321)
T 1tki_A          227 ----FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             ----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence                012346688999999999999999999999987754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.7e-40  Score=362.40  Aligned_cols=264  Identities=25%  Similarity=0.435  Sum_probs=214.9

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcC-------cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeec
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDG-------ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEEN  601 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~  601 (893)
                      .++|...+.||+|+||.||+|+..+       .+..||+|++... .....+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            4678899999999999999999752       3467999988754 445567899999999999 899999999999999


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCCC--------------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQK--------------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL  667 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  667 (893)
                      +..++||||+++|+|.+++.....              ..+++..++.++.|+++||+|||   +.+|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999976532              34899999999999999999999   4899999999999999


Q ss_pred             CCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCcccccc
Q 036624          668 DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVS  746 (893)
Q Consensus       668 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  746 (893)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......    
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  266 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  266 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----
Confidence            9999999999999986543322222334457889999999999999999999999999999999 99998654321    


Q ss_pred             HHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhch
Q 036624          747 LAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE  813 (893)
Q Consensus       747 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~  813 (893)
                        +........          .....+..+...+.+++.+||+.+|.+||++.|+++.|+.+.....
T Consensus       267 --~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          267 --ELFKLLKEG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             --HHHHHHHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             --HHHHHHhcC----------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence              111111100          0112234456778999999999999999999999999998886544

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.2e-39  Score=360.50  Aligned_cols=262  Identities=16%  Similarity=0.164  Sum_probs=209.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..++||+|+||+||+|+....++.||||.+.....  .+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            578899999999999999999988889999998654322  34588999999999 899999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc-----eeEecccccccCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV-----AKVSDFGLSKTGP  685 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~-----~kl~DFGla~~~~  685 (893)
                      + +++|.+++... ...+++..++.|+.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++...
T Consensus        87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           87 L-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            9 89999999765 346999999999999999999999   489999999999999998887     9999999998643


Q ss_pred             CCCCc-----cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          686 TLDHT-----HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       686 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      .....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........................
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            22111     1124567999999999999999999999999999999999999999765332211111111000000000


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .     .    ....++ .+.+++.+||+.+|.+||++.+|++.|+.+.+
T Consensus       242 ~-----~----~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          242 E-----V----LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             H-----H----HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             H-----H----HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            0     0    011133 78999999999999999999999999987664

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.1e-40  Score=365.63  Aligned_cols=251  Identities=20%  Similarity=0.257  Sum_probs=207.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh------hhHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE------QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      .++|+..+.||+|+||+||+|....++..||+|.+.....      ...+.+.+|+.+|++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            4678899999999999999999998889999997654322      1357899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC----ceeEecccc
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW----VAKVSDFGL  680 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~----~~kl~DFGl  680 (893)
                      ++||||+++|+|.+++...  ..+++..+..++.|++.||+|||   ..+|+||||||+|||+++++    .+||+|||+
T Consensus        91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            9999999999999999654  35999999999999999999999   48999999999999998876    799999999


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ....       
T Consensus       166 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~-------  229 (361)
T 2yab_A          166 AHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLAN-------  229 (361)
T ss_dssp             CEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHH-------
T ss_pred             ceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-------
Confidence            9864331   12234569999999999999999999999999999999999999997543211      1111       


Q ss_pred             hhhccccccCCCC----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          761 EQIMDPYLKGKIA----PECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       761 ~~i~d~~l~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                        +....  ..++    ......+.+++.+||+.||++|||+.|++++-.
T Consensus       230 --i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  275 (361)
T 2yab_A          230 --ITAVS--YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (361)
T ss_dssp             --HHTTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             --HHhcC--CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence              11100  0111    123456889999999999999999999997654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.4e-39  Score=352.25  Aligned_cols=264  Identities=16%  Similarity=0.149  Sum_probs=211.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .++|+..+.||+|+||.||+|.....++.||+|++....  ..+.+.+|+++++++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            357889999999999999999988778999999865432  234588999999999 79999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc-----eeEecccccccC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV-----AKVSDFGLSKTG  684 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~-----~kl~DFGla~~~  684 (893)
                      |+ +++|.+++.... .++++..+..|+.|+++||+|||   +.+|+||||||+|||++.++.     +||+|||+++..
T Consensus        87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99 899999997653 35999999999999999999999   589999999999999987766     999999999864


Q ss_pred             CCCCCc-----cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccc
Q 036624          685 PTLDHT-----HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI  759 (893)
Q Consensus       685 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  759 (893)
                      ......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            322111     123456799999999999999999999999999999999999999976543222111111111000001


Q ss_pred             hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       760 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ..+         ....++..+.+++.+||+.+|++||++.+|++.|+.+.+
T Consensus       242 ~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          242 LRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            111         112345678899999999999999999999999998775

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=354.97  Aligned_cols=270  Identities=20%  Similarity=0.271  Sum_probs=213.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecC--EEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC--EMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~  608 (893)
                      ++|...++||+|+||+||+|.....++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999999878899999876432 334677889999999999999999999997665  789999


Q ss_pred             eeccCCCHHHHHhhCCC-CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE----CCCCceeEeccccccc
Q 036624          609 DYMAYGTLREHLYKTQK-PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL----DEKWVAKVSDFGLSKT  683 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----d~~~~~kl~DFGla~~  683 (893)
                      ||+++|+|.+++..... ..+++..++.++.|+++||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999976532 34999999999999999999999   4899999999999999    8888999999999986


Q ss_pred             CCCCCCccceeeeccCcCccChHhhh--------hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFR--------RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      .....   ......||+.|+|||++.        +..++.++|||||||++|||++|+.||.........  .+......
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~  240 (319)
T 4euu_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII  240 (319)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHH
T ss_pred             cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHh
Confidence            43321   223456999999999987        478899999999999999999999999754332211  11111111


Q ss_pred             ccc---chhhhc-----------cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          756 KKG---ILEQIM-----------DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       756 ~~~---~~~~i~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ...   .+..+.           +..............+.+++.+||+.||++|||+.|++++.....
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            110   000000           001112445678888999999999999999999999999988543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1e-39  Score=368.74  Aligned_cols=259  Identities=22%  Similarity=0.341  Sum_probs=206.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++|+..++||+|+||+||+|+...+++.||+|+++..   .....+.+.+|..++.++ +||||+++++++.+.+..+|
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            35789999999999999999999988899999986542   223345688999999887 89999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++|+|..++.+..  .+++..+..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++....
T Consensus       131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            999999999999997654  4999999999999999999999   58999999999999999999999999999985322


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc--cHHHHHHHhhcccchhhhc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV--SLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~i~  764 (893)
                      .  .......+||+.|+|||++.+..++.++|||||||+||||++|+.||.........  ...++..        ..+.
T Consensus       206 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~--------~~i~  275 (396)
T 4dc2_A          206 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------QVIL  275 (396)
T ss_dssp             T--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH--------HHHH
T ss_pred             C--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH--------HHHh
Confidence            1  22344567999999999999999999999999999999999999999753321110  0011111        1111


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSM------GDVLWNLE  806 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm------~evl~~L~  806 (893)
                      ...  ..++......+.+++.+||+.||.+||++      .||+++-.
T Consensus       276 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf  321 (396)
T 4dc2_A          276 EKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  321 (396)
T ss_dssp             HCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred             ccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence            111  12334455678899999999999999985      56665544

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.7e-39  Score=353.84  Aligned_cols=264  Identities=22%  Similarity=0.352  Sum_probs=202.3

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhh--ccccceeeEEEEEee----cCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK--LRHRHLVSLIGYCEE----NCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~----~~~~  604 (893)
                      .++|+..++||+|+||+||+|+..  ++.||||++..   .....+..|.+++..  ++||||+++++++..    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            467889999999999999999985  37899998764   334556677777766  799999999999754    3568


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCC-----CCceEecCCCCCCEEECCCCceeEeccc
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA-----KHTIIHRDVKTTNILLDEKWVAKVSDFG  679 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlk~~NILld~~~~~kl~DFG  679 (893)
                      ++||||+++|+|.+++...   .+++..++.|+.|+++||+|||+..     +.+|+||||||+|||++.++.+||+|||
T Consensus        82 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            9999999999999999543   5999999999999999999999321     4899999999999999999999999999


Q ss_pred             ccccCCCCCCc--cceeeeccCcCccChHhhhhc------CCCCcchhhhHHHHHHHHhhC----------CCCCCCCCc
Q 036624          680 LSKTGPTLDHT--HVSTVVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEILCA----------RPALNPTLP  741 (893)
Q Consensus       680 la~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~------~~s~ksDV~S~Gvvl~elltG----------~~p~~~~~~  741 (893)
                      +++........  .......||+.|+|||++.+.      .++.++|||||||++|||++|          +.||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            98753221111  112234699999999999876      455799999999999999999          788765433


Q ss_pred             cccccHHHHHHHhhcccchhhhccccc-cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          742 KEQVSLAEWAAHCHKKGILEQIMDPYL-KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       742 ~~~~~l~~~~~~~~~~~~~~~i~d~~l-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      ... .............     ..+.+ .......+...+.+++.+||+.||++|||+.||++.|+.+
T Consensus       239 ~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          239 NDP-SFEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SSC-CHHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCc-chhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            221 1222211111111     11111 1112345778899999999999999999999999999863

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.5e-40  Score=349.97  Aligned_cols=256  Identities=26%  Similarity=0.372  Sum_probs=208.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..+.||+|+||.||+|...++ ..||+|++.... ...+++.+|++++.+++||||+++++++.+....++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCc-eeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            45788899999999999999988865 679999877543 2346799999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~  159 (268)
T 3sxs_A           85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-Y  159 (268)
T ss_dssp             CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-E
T ss_pred             cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-h
Confidence            99999999997653 35899999999999999999999   4899999999999999999999999999998643321 1


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......      ........          ..
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~----------~~  223 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQG----------HR  223 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTT----------CC
T ss_pred             hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcC----------CC
Confidence            12233446778999999999999999999999999999999 999996543221      11111100          01


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ...+......+.+++.+||+.+|++|||+.+++++|+.+.
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1112233457889999999999999999999999998654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.9e-40  Score=359.62  Aligned_cols=271  Identities=23%  Similarity=0.377  Sum_probs=216.3

Q ss_pred             cCHHHHHHHhcCCccceeeeecCcEEEEEEEEc-----CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeE
Q 036624          522 FSFAEIKAATNNFDEALLLGVGGFGKVYRGEID-----GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSL  594 (893)
Q Consensus       522 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l  594 (893)
                      +...+.....++|...+.||+|+||+||+|...     ..++.||||++... .....+.+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            344444555688999999999999999999853     34578999987654 344567899999999999 79999999


Q ss_pred             EEEEeecC-EEEEEEeeccCCCHHHHHhhCCC--------------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecC
Q 036624          595 IGYCEENC-EMILVYDYMAYGTLREHLYKTQK--------------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD  659 (893)
Q Consensus       595 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  659 (893)
                      ++++...+ ..++||||+++|+|.+++.....              ..+++..++.++.|+++||+|||   +.+|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence            99987654 58999999999999999976542              23889999999999999999999   48999999


Q ss_pred             CCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCC
Q 036624          660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNP  738 (893)
Q Consensus       660 lk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~  738 (893)
                      |||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999986543322223334568899999999999999999999999999999998 9999965


Q ss_pred             CCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          739 TLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       739 ~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ......  +   ..... .+         .....+..+...+.+++.+||+.+|.+||++.|++++|+.+++
T Consensus       254 ~~~~~~--~---~~~~~-~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          254 VKIDEE--F---CRRLK-EG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             CCCSHH--H---HHHHH-HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHH--H---HHHhc-cC---------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            432211  1   11100 00         0111223345678899999999999999999999999998875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.8e-40  Score=380.58  Aligned_cols=256  Identities=29%  Similarity=0.428  Sum_probs=206.3

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|...++||+|+||.||+|.+.++ ..||||.++... ...++|.+|+++|++++||||+++++++.+ +..++||||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            35678889999999999999999875 679999987543 335689999999999999999999999976 678999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      |++|+|.++|.......+++..++.|+.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++...... .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence            99999999997654456999999999999999999999   4899999999999999999999999999998643221 1


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......+|+.|+|||++....++.++|||||||+||||++ |+.||......+      ...... .         ...
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~-~---------~~~  399 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVE-R---------GYR  399 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHH-T---------TCC
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-c---------CCC
Confidence            12233457889999999999999999999999999999999 999986543211      111111 1         111


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ...+..++..+.+++.+||+.+|++|||+.+|++.|+...
T Consensus       400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            2234566778999999999999999999999999998655

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-39  Score=349.80  Aligned_cols=252  Identities=29%  Similarity=0.482  Sum_probs=196.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC----hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS----EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|+..++||+|+||.||+|.+.+  ..||||+.....    ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEETT--EEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEcC--CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            578889999999999999999864  689999876432    23356789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC--------CCceeEeccc
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE--------KWVAKVSDFG  679 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~--------~~~~kl~DFG  679 (893)
                      |||+++++|.+++..   ..+++..++.++.|+++||+|||+....+|+||||||+|||++.        ++.+||+|||
T Consensus        85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            999999999999853   35999999999999999999999622223999999999999986        7789999999


Q ss_pred             ccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccc
Q 036624          680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI  759 (893)
Q Consensus       680 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  759 (893)
                      +++.....    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........      .        
T Consensus       162 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~--------  223 (271)
T 3dtc_A          162 LAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------A--------  223 (271)
T ss_dssp             C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------H--------
T ss_pred             cccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H--------
Confidence            99754321    12234689999999999999999999999999999999999999975432110      1        


Q ss_pred             hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       760 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                       ..+.........+..++..+.+++.+||+.+|++||++.|++++|+.
T Consensus       224 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          224 -YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             -HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             -HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence             11111112223344556789999999999999999999999999974

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.3e-40  Score=367.31  Aligned_cols=275  Identities=22%  Similarity=0.244  Sum_probs=214.4

Q ss_pred             cccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-----ccceeeE
Q 036624          520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-----HRHLVSL  594 (893)
Q Consensus       520 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-----H~niv~l  594 (893)
                      ..+++.+.....++|...++||+|+||+||+|+....++.||||++.. .....+.+..|++++++++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            456666666667899999999999999999999988888999999874 3445667888999999986     9999999


Q ss_pred             EEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-----
Q 036624          595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-----  669 (893)
Q Consensus       595 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-----  669 (893)
                      ++++...+..++||||+ +++|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||+++     
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccc
Confidence            99999999999999999 899999998877667999999999999999999999   589999999999999985     


Q ss_pred             --------------------CCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHH
Q 036624          670 --------------------KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEI  729 (893)
Q Consensus       670 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~el  729 (893)
                                          ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                789999999999863321     2345689999999999999999999999999999999


Q ss_pred             hhCCCCCCCCCccccccHHHHH---------HHhhcccchhhhccccccCCCC--------------------hHHHHHH
Q 036624          730 LCARPALNPTLPKEQVSLAEWA---------AHCHKKGILEQIMDPYLKGKIA--------------------PECFKKF  780 (893)
Q Consensus       730 ltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~~~i~d~~l~~~~~--------------------~~~~~~l  780 (893)
                      ++|+.||......+........         ...........+....+....+                    ......+
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            9999999765432211111000         0000000000000000000000                    0011567


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHH
Q 036624          781 AETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       781 ~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .+++.+||+.||++|||+.|++++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHhcCChhhCCCHHHHhcC
Confidence            899999999999999999999865

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-40  Score=377.10  Aligned_cols=262  Identities=21%  Similarity=0.277  Sum_probs=211.4

Q ss_pred             HHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEee
Q 036624          524 FAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE  600 (893)
Q Consensus       524 ~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~  600 (893)
                      +.+++...++|+..++||+|+||+||+|+...+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3455556789999999999999999999999888999999865311   1122348899999999999999999999999


Q ss_pred             cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccc
Q 036624          601 NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL  680 (893)
Q Consensus       601 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl  680 (893)
                      ...++||||||++|+|.+++.+.   .+++..+..++.|++.||+|||   +.+|+||||||+||||+.++.+||+|||+
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccce
Confidence            99999999999999999999754   4899999999999999999999   48999999999999999999999999999


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhhhcC----CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK  756 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  756 (893)
                      ++...... .......+||+.|+|||++.+..    ++.++|||||||+||||++|+.||.......      ..     
T Consensus       215 a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~-----  282 (410)
T 3v8s_A          215 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TY-----  282 (410)
T ss_dssp             CEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-----
T ss_pred             eEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------HH-----
Confidence            98643321 11233567999999999998765    8899999999999999999999997543221      11     


Q ss_pred             ccchhhhcccc--ccCCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHH
Q 036624          757 KGILEQIMDPY--LKGKIAPECFKKFAETAMKCVSDQGIE--RPSMGDVLWNLEF  807 (893)
Q Consensus       757 ~~~~~~i~d~~--l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPtm~evl~~L~~  807 (893)
                          ..++...  +...........+.+++.+||+.+|.+  ||++.||+++-.+
T Consensus       283 ----~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f  333 (410)
T 3v8s_A          283 ----SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  333 (410)
T ss_dssp             ----HHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred             ----HHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence                1111111  011111234567889999999999988  9999999988664

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-39  Score=363.64  Aligned_cols=256  Identities=22%  Similarity=0.278  Sum_probs=208.4

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ..++|+..+.||+|+||.||+|.....+..||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            356799999999999999999999888899999986542  445667899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC---CceeEecccccccC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK---WVAKVSDFGLSKTG  684 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla~~~  684 (893)
                      |||+++|+|.+++...  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.+   +.+||+|||+++..
T Consensus       107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999999998654  35899999999999999999999   4899999999999999865   45999999999864


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......      +...... .+.    .
T Consensus       182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i~-~~~----~  247 (362)
T 2bdw_A          182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIK-AGA----Y  247 (362)
T ss_dssp             TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HTC----C
T ss_pred             cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hCC----C
Confidence            3221   223457999999999999999999999999999999999999999654321      1111111 000    0


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +  ........+...+.+++.+||+.||++||++.|++++-.
T Consensus       248 ~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  287 (362)
T 2bdw_A          248 D--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW  287 (362)
T ss_dssp             C--CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred             C--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            0  000111234567889999999999999999999997754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=360.53  Aligned_cols=259  Identities=23%  Similarity=0.384  Sum_probs=204.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceE----EEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTK----VAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~----VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      .++|+..++||+|+||+||+|.+...+..    |++|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            35788999999999999999998655443    577766433 3445678999999999999999999999998765 78


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +|+||+.+|+|.+++.... ..+++..++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            9999999999999997653 35999999999999999999999   4899999999999999999999999999998654


Q ss_pred             CCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......   +...             +
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~-------------~  232 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI-------------L  232 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH-------------H
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH-------------H
Confidence            3333233334557889999999999999999999999999999999 999997654322   1111             1


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ........+..+...+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus       233 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          233 EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1111122334456678999999999999999999999999998775

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8e-40  Score=361.49  Aligned_cols=254  Identities=20%  Similarity=0.262  Sum_probs=206.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh------hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE------QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      ++|...+.||+|+||.||+|....++..||+|.+.....      ...+.+.+|+.++++++||||+++++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            568899999999999999999988888999997654321      23678999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC----ceeEeccccc
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW----VAKVSDFGLS  681 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~----~~kl~DFGla  681 (893)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||+|||   ..+|+||||||+|||+++++    .+||+|||++
T Consensus        91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999654  35999999999999999999999   58999999999999999887    8999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ........    
T Consensus       166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~----  232 (326)
T 2y0a_A          166 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAV----  232 (326)
T ss_dssp             EECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHT----
T ss_pred             eECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHHhc----
Confidence            8643221   1234569999999999999999999999999999999999999996543211      11110000    


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         ...........+...+.+++.+||+.||++|||+.|++++-.
T Consensus       233 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  274 (326)
T 2y0a_A          233 ---NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW  274 (326)
T ss_dssp             ---CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             ---CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence               000000001123456889999999999999999999998654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=371.66  Aligned_cols=257  Identities=20%  Similarity=0.231  Sum_probs=207.4

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ..++|+..++||+|+||+||+|.....+..+|+|++...  .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            356799999999999999999999888899999976543  344567799999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC---CCCceeEecccccccC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTG  684 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld---~~~~~kl~DFGla~~~  684 (893)
                      |||+++|+|.+.+....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++   +++.+||+|||+++..
T Consensus        89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            99999999999997654  4999999999999999999999   48999999999999998   4578999999999764


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ...  ........||+.|+|||++.+..++.++|||||||++|||++|++||.......      ...... .+.    .
T Consensus       164 ~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~------~~~~i~-~~~----~  230 (444)
T 3soa_A          164 EGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR------LYQQIK-AGA----Y  230 (444)
T ss_dssp             CTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHH-HTC----C
T ss_pred             cCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH------HHHHHH-hCC----C
Confidence            332  122234679999999999999999999999999999999999999996543211      111110 000    0


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +  ............+.+++.+||+.||++|||+.|++++-.
T Consensus       231 ~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~  270 (444)
T 3soa_A          231 D--FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW  270 (444)
T ss_dssp             C--CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred             C--CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence            0  001111234567889999999999999999999997643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-39  Score=352.49  Aligned_cols=257  Identities=28%  Similarity=0.394  Sum_probs=207.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..+.||+|+||+||+|...++ ..||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTT-EEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCC-CeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            45788899999999999999998864 6799998875432 346799999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...... .
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~  175 (283)
T 3gen_A          101 MANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-Y  175 (283)
T ss_dssp             CTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-H
T ss_pred             cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-c
Confidence            99999999997632 35999999999999999999999   5899999999999999999999999999998643211 1


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......      .....         .. ...
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~---------~~-~~~  239 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHI---------AQ-GLR  239 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHH---------HT-TCC
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHHH---------hc-ccC
Confidence            11223446788999999999999999999999999999998 999996543221      11111         10 011


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ...+..+...+.+++.+||+.+|++||++.+++++|+.+..
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            11223345678899999999999999999999999997764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=358.34  Aligned_cols=248  Identities=24%  Similarity=0.330  Sum_probs=207.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||+||+++....++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57889999999999999999998888999999875421   134567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus        86 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence            9999999999997654  4899999999999999999999   58999999999999999999999999999986432  


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                         .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ...         .++... 
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~---------~i~~~~-  219 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYE---------KILNAE-  219 (318)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH---------HHHHCC-
T ss_pred             ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHH---------HHHhCC-
Confidence               1234579999999999999999999999999999999999999996543211      111         111111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                       ..++......+.+++.+||+.+|++||     ++.|++++-.
T Consensus       220 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~  261 (318)
T 1fot_A          220 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW  261 (318)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             -CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence             112333456788999999999999999     8888887654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.5e-39  Score=351.17  Aligned_cols=258  Identities=24%  Similarity=0.352  Sum_probs=200.3

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCc---ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++|+..+.||+|+||.||+|.+...   ...||+|..... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-CccEE
Confidence            35788899999999999999998543   356999987653 44556789999999999999999999999854 56889


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++|+|.+++.... ..+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            999999999999997653 45999999999999999999999   48999999999999999999999999999986433


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   +...            +..
T Consensus       169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~------------i~~  232 (281)
T 1mp8_A          169 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR------------IEN  232 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH------------HHT
T ss_pred             ccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHH------------HHc
Confidence            211 12233457889999999999999999999999999999996 999997543322   1111            111


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      . .....++.++..+.+++.+||+.+|++||++.|+++.|+.+++
T Consensus       233 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          233 G-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            0 0112334556778999999999999999999999999998765

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-39  Score=366.50  Aligned_cols=256  Identities=20%  Similarity=0.265  Sum_probs=210.9

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..+.||+|+||.||+|....++..||+|.+..........+.+|+++|++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46799999999999999999999888889999988766666677899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC--CCceeEecccccccCCCCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE--KWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~--~~~~kl~DFGla~~~~~~~  688 (893)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++..... 
T Consensus       130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-  204 (387)
T 1kob_A          130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  204 (387)
T ss_dssp             CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence            99999999986543 35999999999999999999999   489999999999999974  478999999999865332 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ........       +...
T Consensus       205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~i~~~-------~~~~  269 (387)
T 1kob_A          205 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRC-------DWEF  269 (387)
T ss_dssp             --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHC-------CCCC
T ss_pred             --cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH------HHHHHHhC-------CCCC
Confidence              22334579999999999999999999999999999999999999997543211      11111100       0001


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ...........+.+++.+||+.||++|||+.|++++-.
T Consensus       270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~  307 (387)
T 1kob_A          270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW  307 (387)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence            11122234567889999999999999999999997644

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.9e-39  Score=347.53  Aligned_cols=251  Identities=19%  Similarity=0.312  Sum_probs=206.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV  607 (893)
                      ++|...+.||+|+||+||+|++.+  ..||+|++...  .....+.|.+|+.++++++||||+++++++.+.  ...++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEETT--EEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEECC--eeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            468889999999999999999874  67999986643  455667899999999999999999999999877  788999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCc--eEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT--IIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      |||+++|+|.+++.......+++..++.++.|+++||+|||+   .+  |+||||||+|||+++++.+||+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999987766679999999999999999999994   66  9999999999999999999999998865422


Q ss_pred             CCCCccceeeeccCcCccChHhhhhcCCCC---cchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTE---KSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~---ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                      .       ....||+.|+|||.+.+..++.   ++|||||||++|||++|+.||.......      ....         
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~---------  222 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMK---------  222 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHH---------
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHH---------
Confidence            1       1235899999999998765544   8999999999999999999996543211      1111         


Q ss_pred             hccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          763 IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       763 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      +.........+..+...+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          223 VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            11111122334455677899999999999999999999999998754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-39  Score=352.59  Aligned_cols=252  Identities=28%  Similarity=0.488  Sum_probs=204.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh---h----HHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ---G----VHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~---~----~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      ++|+..+.||+|+||+||+|++..+++.||+|++......   .    .+.+.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            5788899999999999999999888899999987543221   1    167899999999999999999999997765  


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCc--eEecCCCCCCEEECCCCc-----eeEec
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT--IIHRDVKTTNILLDEKWV-----AKVSD  677 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlk~~NILld~~~~-----~kl~D  677 (893)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||+|||   ..+  |+||||||+|||++.++.     +||+|
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            69999999999999886543 46999999999999999999999   467  999999999999988776     99999


Q ss_pred             ccccccCCCCCCccceeeeccCcCccChHhh--hhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          678 FGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF--RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       678 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~--~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      ||+++....     ......||+.|+|||++  ....++.++|||||||++|||++|+.||........    .+...  
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~--  241 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINM--  241 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHH--
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHH--
Confidence            999975322     23345699999999998  455678999999999999999999999975433221    11111  


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                             +.........+..++..+.+++.+||+.+|++||++.|+++.|+.
T Consensus       242 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          242 -------IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             -------HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -------HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence                   111112223344566789999999999999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.1e-40  Score=357.44  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=198.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh--------------------------hhHHHHHHHHHHHhh
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE--------------------------QGVHEFQTEIEMLSK  585 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~--------------------------~~~~~f~~E~~~l~~  585 (893)
                      ++|+..+.||+|+||.||+|.....++.||||++.....                          ...+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            578899999999999999999988889999998654321                          123568999999999


Q ss_pred             ccccceeeEEEEEee--cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCC
Q 036624          586 LRHRHLVSLIGYCEE--NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTT  663 (893)
Q Consensus       586 l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~  663 (893)
                      ++||||+++++++.+  ....++||||+++++|.+++.   ...+++..+..++.|+++||+|||   ..+|+||||||+
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            999999999999986  578999999999999988653   235999999999999999999999   489999999999


Q ss_pred             CEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcC---CCCcchhhhHHHHHHHHhhCCCCCCCCC
Q 036624          664 NILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEILCARPALNPTL  740 (893)
Q Consensus       664 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~ksDV~S~Gvvl~elltG~~p~~~~~  740 (893)
                      |||++.++.+||+|||+++......  .......||+.|+|||++.+..   ++.++|||||||++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9999999999999999998643321  2233456999999999998765   3778999999999999999999996532


Q ss_pred             ccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          741 PKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       741 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .      ..+......         ........+.....+.+++.+||+.||++||++.|++++-.
T Consensus       245 ~------~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~  295 (298)
T 2zv2_A          245 I------MCLHSKIKS---------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW  295 (298)
T ss_dssp             H------HHHHHHHHH---------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred             H------HHHHHHHhc---------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence            1      111111111         11111112234567889999999999999999999987644

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5e-40  Score=362.01  Aligned_cols=266  Identities=25%  Similarity=0.378  Sum_probs=214.4

Q ss_pred             HHHHHhcCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEe
Q 036624          526 EIKAATNNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE  599 (893)
Q Consensus       526 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~  599 (893)
                      +.+...++|...+.||+|+||.||+|...+     .+..||+|.+... .......+.+|+.++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            344456789999999999999999998763     4578999987654 3445667999999999999999999999999


Q ss_pred             ecCEEEEEEeeccCCCHHHHHhhCC--------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC
Q 036624          600 ENCEMILVYDYMAYGTLREHLYKTQ--------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW  671 (893)
Q Consensus       600 ~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~  671 (893)
                      +.+..++||||+++|+|.+++....        ...+++..++.++.|+++||+|||   +.+|+||||||+|||++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCC
Confidence            9999999999999999999987532        245799999999999999999999   48999999999999999999


Q ss_pred             ceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHH
Q 036624          672 VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEW  750 (893)
Q Consensus       672 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  750 (893)
                      .+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......      +.
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~  249 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QV  249 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------HH
Confidence            999999999875432222222233457889999999999999999999999999999999 88888654321      11


Q ss_pred             HHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          751 AAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       751 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .......         .. ...+..++..+.+++.+||+.+|++||++.|++++|+..+.
T Consensus       250 ~~~~~~~---------~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          250 LRFVMEG---------GL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHTT---------CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHcC---------Cc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1111111         10 12233456778999999999999999999999999987654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.1e-40  Score=363.85  Aligned_cols=275  Identities=24%  Similarity=0.336  Sum_probs=214.8

Q ss_pred             cCCccceeeeecCcEEEEEEEE----cCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEe--ecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEI----DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE--ENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~  605 (893)
                      ++|+..+.||+|+||.||+|++    ...+..||||++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788899999999999999994    4556889999988777777788999999999999999999999886  556789


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +||||+++++|.+++.... ..+++..++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            9999999999999997643 25999999999999999999999   4899999999999999999999999999998654


Q ss_pred             CCCC-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          686 TLDH-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       686 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      .... ........||+.|+|||++.+..++.++|||||||++|||++|+.|+....... .....+.........+.+.+
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-LRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHCC----CCHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh-hhhcccccccccHHHHHHHh
Confidence            3221 112234458888999999999999999999999999999999999985321100 00000000000001111222


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      ........+..+...+.+++.+||+.+|++||++.|++++|+.+...
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            22223334556678899999999999999999999999999977653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=361.66  Aligned_cols=258  Identities=22%  Similarity=0.331  Sum_probs=204.3

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccc--cceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRH--RHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~l  606 (893)
                      .++|+..+.||+|+||.||++.... +..||||++..  ......+.+.+|+.+|.+++|  +||+++++++......++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            3568899999999999999998865 47899997643  345566789999999999976  999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||| +.+|+|.+++....  .+++..+..++.|+++||+|||   +.+|+||||||+|||++ ++.+||+|||+++....
T Consensus        87 v~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEe-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            999 56789999998654  5899999999999999999999   48999999999999997 57899999999986543


Q ss_pred             CCCccceeeeccCcCccChHhhhh-----------cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......    .       
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~-------  228 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----S-------  228 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----H-------
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH----H-------
Confidence            322223345679999999999976           778999999999999999999999996532211    0       


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                         .+..++++.....++......+.+++.+||+.||.+|||+.|++++.....+
T Consensus       229 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          229 ---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             ---HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ---HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence               1222333333334444445678899999999999999999999998876543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.1e-39  Score=359.40  Aligned_cols=258  Identities=22%  Similarity=0.345  Sum_probs=207.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|+..++||+|+||.||+|+...+++.||+|++...   .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            5788999999999999999999988899999987542   344567789999999988 899999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999997654  4999999999999999999999   489999999999999999999999999999863221


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc--cHHHHHHHhhcccchhhhcc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV--SLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~i~d  765 (893)
                        .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ...+...        ..+..
T Consensus       164 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~~i~~  233 (345)
T 3a8x_A          164 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------QVILE  233 (345)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH--------HHHHH
T ss_pred             --CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH--------HHHHc
Confidence              12234567999999999999999999999999999999999999999753221110  0001111        11111


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSM------GDVLWNLE  806 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm------~evl~~L~  806 (893)
                      ..  ..++......+.+++.+||+.||++||++      .|++++-.
T Consensus       234 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~  278 (345)
T 3a8x_A          234 KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  278 (345)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence            11  12334455678899999999999999995      66665543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-39  Score=363.09  Aligned_cols=252  Identities=23%  Similarity=0.284  Sum_probs=207.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++|+..++||+|+||+||+|+....++.||+|++...   .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            46899999999999999999999988889999987542   123456788999999988 79999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+||||+.++.+||+|||+++....
T Consensus        99 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            999999999999997654  4999999999999999999999   48999999999999999999999999999985322


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      .  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......      +...         .++..
T Consensus       174 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~---------~i~~~  236 (353)
T 2i0e_A          174 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQ---------SIMEH  236 (353)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH---------HHHHC
T ss_pred             C--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHH---------HHHhC
Confidence            1  12234567999999999999999999999999999999999999999754321      1111         11111


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNLE  806 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L~  806 (893)
                      .  ..++......+.+++.+||+.+|.+||+     +.+++++-.
T Consensus       237 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~  279 (353)
T 2i0e_A          237 N--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  279 (353)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred             C--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence            1  1223345567889999999999999995     577776543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.3e-40  Score=365.21  Aligned_cols=255  Identities=24%  Similarity=0.289  Sum_probs=207.5

Q ss_pred             HHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCE
Q 036624          528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCE  603 (893)
Q Consensus       528 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~  603 (893)
                      +...++|...++||+|+||.||+|+.+.+++.||+|+++...   ....+.+..|.+++.++ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999999888999999875421   23456688899999887 89999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      .++||||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            999999999999999997654  4899999999999999999999   48999999999999999999999999999985


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      ....  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......      .....         
T Consensus       168 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i---------  230 (345)
T 1xjd_A          168 NMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSI---------  230 (345)
T ss_dssp             CCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH---------
T ss_pred             cccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHHH---------
Confidence            4321  122345679999999999999999999999999999999999999997543211      11111         


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHH-HHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMG-DVLWNLE  806 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~-evl~~L~  806 (893)
                      ....  ..++......+.+++.+||+.+|++||++. +++++-.
T Consensus       231 ~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~  272 (345)
T 1xjd_A          231 RMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL  272 (345)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred             HhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence            1000  112233456788999999999999999997 7765443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=354.39  Aligned_cols=255  Identities=27%  Similarity=0.444  Sum_probs=200.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..++||+|+||+||+|+..+  +.||+|++...  ...+.|.+|++++++++||||+++++++.+  ..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETT--EEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEECC--eeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            467888999999999999999864  67999998643  346789999999999999999999999874  478999999


Q ss_pred             cCCCHHHHHhhCCC-CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc-eeEecccccccCCCCCC
Q 036624          612 AYGTLREHLYKTQK-PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV-AKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       612 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~-~kl~DFGla~~~~~~~~  689 (893)
                      ++|+|.+++..... ..+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||+++.....  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999976543 34789999999999999999999543378999999999999998876 799999998753221  


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||........    ........ +     .    .
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~-~-----~----~  222 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVHN-G-----T----R  222 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHHT-T-----C----C
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHhc-C-----C----C
Confidence               2234589999999999999999999999999999999999999975432211    11111100 0     0    1


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      ......++..+.+++.+||+.+|++|||+.++++.|+...+.
T Consensus       223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            112233456788999999999999999999999999987654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.2e-40  Score=355.34  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=205.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcc-------eEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGAT-------TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-------~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      ++|...+.||+|+||+||+|.....+       ..||+|.+........+.+.+|++++++++||||+++++++.+.+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            57888999999999999999987644       46999998776667778899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc--------eeEe
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV--------AKVS  676 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~--------~kl~  676 (893)
                      ++||||+++|+|.+++.... ..+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.        +||+
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999997653 34899999999999999999999   588999999999999998887        9999


Q ss_pred             cccccccCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       677 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      |||+++....      .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+........     ......
T Consensus       164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-----~~~~~~  232 (289)
T 4fvq_A          164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-----KLQFYE  232 (289)
T ss_dssp             CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHH
T ss_pred             cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-----HHHHhh
Confidence            9999875322      123458899999999987 7799999999999999999996555433222110     000000


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .            ....+......+.+++.+||+.+|++|||+.+++++|+.+..
T Consensus       233 ~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          233 D------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             T------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             c------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            0            011122224457889999999999999999999999996554

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.6e-39  Score=365.24  Aligned_cols=271  Identities=18%  Similarity=0.224  Sum_probs=207.8

Q ss_pred             hcCCccceeeeec--CcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVG--GFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G--~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++|+..++||+|  +||+||+|+....++.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3578899999999  9999999999988899999986543  34556778999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      |||||++|+|.+++.......+++..+..|+.|+++||+|||   ..+|+||||||+||||+.++.+||+|||++.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999998776567999999999999999999999   48999999999999999999999999998764211


Q ss_pred             CC-----CccceeeeccCcCccChHhhhh--cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc---
Q 036624          687 LD-----HTHVSTVVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK---  756 (893)
Q Consensus       687 ~~-----~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---  756 (893)
                      ..     .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.........  .........   
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~  258 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLL  258 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC---------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCccc
Confidence            11     1111223468999999999987  67999999999999999999999999764332211  000000000   


Q ss_pred             -------------------ccchhhhcc---c------cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          757 -------------------KGILEQIMD---P------YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       757 -------------------~~~~~~i~d---~------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                                         ...+.+.+.   +      .............+.+++.+||+.||++|||+.|++++-.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence                               000000000   0      0000122234466889999999999999999999997644

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-39  Score=356.55  Aligned_cols=262  Identities=26%  Similarity=0.423  Sum_probs=205.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCc----ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGA----TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~----~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      ++|...++||+|+||+||+|.....    ...||+|.+... .......+.+|++++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            4567788999999999999987643    245999987654 44456689999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++|+|.+++.... ..+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus       124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999997643 45999999999999999999999   48999999999999999999999999999986432


Q ss_pred             CCC-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          687 LDH-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       687 ~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+      ....         +.
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~~---------~~  264 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKA---------IN  264 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHH---------HH
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH------HHHH---------HH
Confidence            211 111223346789999999999999999999999999999999 999996543211      1111         11


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhch
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE  813 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~  813 (893)
                      +. .....+..+...+.+++.+||+.+|++||++.+++++|+.+.+...
T Consensus       265 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          265 DG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             TT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             CC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            11 1112234456778999999999999999999999999998876433

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.9e-39  Score=356.04  Aligned_cols=265  Identities=25%  Similarity=0.435  Sum_probs=203.0

Q ss_pred             HHHHhcCCccceeeeecCcEEEEEEEEcC---cceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec
Q 036624          527 IKAATNNFDEALLLGVGGFGKVYRGEIDG---ATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN  601 (893)
Q Consensus       527 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~  601 (893)
                      +....++|...+.||+|+||.||+|....   .+..||+|.+...  .....+.+.+|+.++++++||||+++++++.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            33445778889999999999999998754   3457999987643  445567899999999999999999999999765


Q ss_pred             CE-----EEEEEeeccCCCHHHHHhhC----CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc
Q 036624          602 CE-----MILVYDYMAYGTLREHLYKT----QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV  672 (893)
Q Consensus       602 ~~-----~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~  672 (893)
                      ..     .++||||+++|+|.+++...    ....+++..++.++.|+++||.|||   ..+|+||||||+|||+++++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCc
Confidence            43     59999999999999998532    3356999999999999999999999   589999999999999999999


Q ss_pred             eeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHH
Q 036624          673 AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWA  751 (893)
Q Consensus       673 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  751 (893)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......   +....
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~  262 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDYL  262 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHH
Confidence            99999999986433222223344567889999999999999999999999999999999 888886543321   11111


Q ss_pred             HHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          752 AHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       752 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                                  .... ....+..++..+.+++.+||+.+|.+||++.+++++|+.+.+
T Consensus       263 ------------~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          263 ------------LHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             ------------HTTC-CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------HcCC-CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                        1110 112234455778999999999999999999999999998775

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-39  Score=363.34  Aligned_cols=257  Identities=21%  Similarity=0.249  Sum_probs=205.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-----ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-----SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      +.|+..+.||+|+||+||+|....+++.||||++...     .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            5688999999999999999999888899999976421     11235779999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc---eeEeccccc
Q 036624          607 VYDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV---AKVSDFGLS  681 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~---~kl~DFGla  681 (893)
                      ||||+++|+|.+.+...  ....+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999999887643  3345899999999999999999999   489999999999999987654   999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      +.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....    .+   ...... +.. 
T Consensus       181 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~---~~~i~~-~~~-  249 (351)
T 3c0i_A          181 IQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RL---FEGIIK-GKY-  249 (351)
T ss_dssp             EECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HH---HHHHHH-TCC-
T ss_pred             eEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HH---HHHHHc-CCC-
Confidence            864332  1223345699999999999999999999999999999999999999965311    01   111000 000 


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                       ...+...    ......+.+++.+||+.||++||++.|++++-..
T Consensus       250 -~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~  290 (351)
T 3c0i_A          250 -KMNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNHPWL  290 (351)
T ss_dssp             -CCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             -CCCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence             0000000    1234568899999999999999999999987553

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.3e-39  Score=359.92  Aligned_cols=264  Identities=27%  Similarity=0.392  Sum_probs=207.9

Q ss_pred             hcCCccceeeeecCcEEEEEEEE-----cCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEI-----DGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      .++|...+.||+|+||.||+|+.     ...+..||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46788999999999999999984     344568999988643 455667899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCC-----CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC---CCceeEe
Q 036624          605 ILVYDYMAYGTLREHLYKTQK-----PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE---KWVAKVS  676 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~  676 (893)
                      ++||||+++|+|.+++.....     ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999986532     35899999999999999999999   489999999999999984   4569999


Q ss_pred             cccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhh
Q 036624          677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       677 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.......      ......
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~  259 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFVT  259 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------HHHHHh
Confidence            9999874322222222234557899999999999999999999999999999998 999986543211      111111


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhch
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE  813 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~  813 (893)
                      ..          .....+..+...+.+++.+||+.+|.+||++.+++++|+.+.+...
T Consensus       260 ~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          260 SG----------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             cC----------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence            11          0112233455678899999999999999999999999998776443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-40  Score=373.92  Aligned_cols=268  Identities=21%  Similarity=0.249  Sum_probs=211.5

Q ss_pred             cCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEE
Q 036624          522 FSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYC  598 (893)
Q Consensus       522 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~  598 (893)
                      +.+.+++...++|+..++||+|+||+||+++.+.+++.||+|++....   ....+.+.+|..++.+++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            445566667789999999999999999999998888999999875421   12234588999999999999999999999


Q ss_pred             eecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecc
Q 036624          599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF  678 (893)
Q Consensus       599 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF  678 (893)
                      .+.+.++|||||+++|+|.++|.+.. ..+++..+..++.|++.||+|||   +.+||||||||+||||+.++.+||+||
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeec
Confidence            99999999999999999999997643 35999999999999999999999   589999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeeccCcCccChHhhhh-------cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHH
Q 036624          679 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWA  751 (893)
Q Consensus       679 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  751 (893)
                      |+++..... ........+||+.|+|||++..       ..++.++|||||||++|||++|+.||......+      ..
T Consensus       207 Gla~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~  279 (412)
T 2vd5_A          207 GSCLKLRAD-GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------TY  279 (412)
T ss_dssp             TTCEECCTT-SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH
T ss_pred             hhheeccCC-CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------HH
Confidence            999864332 1122334679999999999973       578999999999999999999999997543221      11


Q ss_pred             HHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCC---CCHHHHHHHHHH
Q 036624          752 AHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIER---PSMGDVLWNLEF  807 (893)
Q Consensus       752 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ptm~evl~~L~~  807 (893)
                      .......  ..+.-+.    ........+.+++.+||+ +|++|   |++.|++++-.+
T Consensus       280 ~~i~~~~--~~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff  331 (412)
T 2vd5_A          280 GKIVHYK--EHLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF  331 (412)
T ss_dssp             HHHHTHH--HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred             HHHHhcc--cCcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence            1111000  0000111    112345678899999999 99998   689999876553

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.1e-39  Score=346.95  Aligned_cols=261  Identities=23%  Similarity=0.359  Sum_probs=208.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcC---cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDG---ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++|...+.||+|+||+||+|.+..   ....||+|..... .....+.|.+|+.++++++||||+++++++.+. ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4678889999999999999998653   2346999987754 445567899999999999999999999998764 5689


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++++|.+++.... ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999999997643 35899999999999999999999   58999999999999999999999999999986433


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......   .......   .        
T Consensus       166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~~---~--------  230 (281)
T 3cc6_A          166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLEK---G--------  230 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHHH---T--------
T ss_pred             ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHhc---C--------
Confidence            211 12233457889999999999999999999999999999998 999996543322   1111110   0        


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhch
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE  813 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~  813 (893)
                        .....+..+...+.+++.+||+.+|++||++.|++++|+.+.+...
T Consensus       231 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  276 (281)
T 3cc6_A          231 --DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK  276 (281)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             --CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence              0111223345678899999999999999999999999998887544

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=365.33  Aligned_cols=253  Identities=22%  Similarity=0.273  Sum_probs=202.0

Q ss_pred             ccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccCC
Q 036624          535 DEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYG  614 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  614 (893)
                      ...++||+|+||.||+|.....+..||+|++........+++.+|+++|++++||||+++++++.+.+..+|||||+++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            34568999999999999998878899999987766677788999999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE--CCCCceeEecccccccCCCCCCccc
Q 036624          615 TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL--DEKWVAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       615 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl--d~~~~~kl~DFGla~~~~~~~~~~~  692 (893)
                      +|.+++.... ..+++..++.++.|+++||+|||   +.+|+||||||+|||+  ++++.+||+|||+++......   .
T Consensus       172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~  244 (373)
T 2x4f_A          172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K  244 (373)
T ss_dssp             EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred             cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence            9999887543 35899999999999999999999   4899999999999999  667899999999998643322   1


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCC
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI  772 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~  772 (893)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .........     .+  +....
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~-----~~--~~~~~  311 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILACR-----WD--LEDEE  311 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-----CC--SCSGG
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcc-----CC--CChhh
Confidence            233469999999999999999999999999999999999999997543221      111111100     00  00011


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          773 APECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       773 ~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .......+.+++.+||+.+|.+||++.|++++-..
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~  346 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWL  346 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCc
Confidence            12334678899999999999999999999987553

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=360.73  Aligned_cols=255  Identities=22%  Similarity=0.279  Sum_probs=193.5

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ..++|+..++||+|+||+||+|+....++.||||++....  ..+.+.+|++++++++||||+++++++......++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4577999999999999999999999888899999876432  34678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC---CCceeEecccccccCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE---KWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~~~~~  686 (893)
                      |+++|+|.+++...  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.   ++.+||+|||+++....
T Consensus       129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            99999999999654  35899999999999999999999   489999999999999975   88999999999986432


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                         ........||+.|+|||++.+..++.++|||||||++|||++|+.||........  +   ........       .
T Consensus       204 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~---~~~i~~~~-------~  268 (349)
T 2w4o_A          204 ---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M---FRRILNCE-------Y  268 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H---HHHHHTTC-------C
T ss_pred             ---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H---HHHHHhCC-------C
Confidence               1223345699999999999999999999999999999999999999965432210  0   11111000       0


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ........+....+.+++.+||+.||++|||+.|++++-.
T Consensus       269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  308 (349)
T 2w4o_A          269 YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW  308 (349)
T ss_dssp             CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            0111122344567889999999999999999999987543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-39  Score=358.29  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=198.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecC-------
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC-------  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-------  602 (893)
                      .++|+..++||+|+||.||+|++..+++.||||++... .....+.+.+|+++|++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            35788999999999999999999877789999987543 3345678999999999999999999999986543       


Q ss_pred             --------------------------------------------------EEEEEEeeccCCCHHHHHhhCCC-CCCCHH
Q 036624          603 --------------------------------------------------EMILVYDYMAYGTLREHLYKTQK-PPLPWK  631 (893)
Q Consensus       603 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~  631 (893)
                                                                        ..++||||+++|+|.+++..... ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37999999999999999976532 346677


Q ss_pred             hHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc----------cceeeeccCcC
Q 036624          632 QRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT----------HVSTVVKGSFG  701 (893)
Q Consensus       632 ~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~  701 (893)
                      .++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999   589999999999999999999999999999864332111          12234569999


Q ss_pred             ccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHH
Q 036624          702 YLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFA  781 (893)
Q Consensus       702 y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~  781 (893)
                      |+|||++.+..++.++|||||||++|||++|..|+.     ...   ...         ..+..... ..........+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~---~~~---------~~~~~~~~-~~~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERV---RII---------TDVRNLKF-PLLFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHH---HHH---------HHHHTTCC-CHHHHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHH---HHH---------HHhhccCC-CcccccCChhHH
Confidence            999999999999999999999999999999876541     100   000         00111000 001123446678


Q ss_pred             HHHHHccccCCCCCCCHHHHHHH
Q 036624          782 ETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       782 ~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      +++.+||+.||++||++.|++++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCCCCcCCCHHHHhhc
Confidence            99999999999999999999875

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.8e-39  Score=360.26  Aligned_cols=251  Identities=27%  Similarity=0.373  Sum_probs=204.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      +.|+..+.||+|+||+||+|+....+..||||++...   .....+.+.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588899999999999999999877899999987543   2334567999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+. |+|.+++.... ..+++..+..++.|+++||+|||   ..+|+||||||+|||+++++.+||+|||+++....  
T Consensus       134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            9998 78888876443 45999999999999999999999   48999999999999999999999999999976432  


Q ss_pred             CccceeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                          .....||+.|+|||++.   .+.++.++|||||||++|||++|+.||.......      .........      .
T Consensus       207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~~------~  270 (348)
T 1u5q_A          207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE------S  270 (348)
T ss_dssp             ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC------C
T ss_pred             ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC------C
Confidence                12356999999999985   5678999999999999999999999996543211      111111110      1


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      +.+   ....+...+.+++.+||+.+|++|||+.+++++....
T Consensus       271 ~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~  310 (348)
T 1u5q_A          271 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  310 (348)
T ss_dssp             CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence            111   1223456688999999999999999999999876643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.2e-39  Score=361.22  Aligned_cols=248  Identities=20%  Similarity=0.279  Sum_probs=207.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||.||+|+....+..||+|++....   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57889999999999999999998888999999875321   234567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++.+..  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            9999999999997654  4899999999999999999999   589999999999999999999999999999864321 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                          ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......      +....         +.... 
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~---------i~~~~-  254 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEK---------IVSGK-  254 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH---------HHHCC-
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHH---------HHcCC-
Confidence                23457999999999999999999999999999999999999999754321      11111         11111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L~  806 (893)
                       ..++......+.+++.+||+.||.+||+     +.||+++-.
T Consensus       255 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~  296 (350)
T 1rdq_E          255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence             1223344567889999999999999998     888887654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=354.37  Aligned_cols=268  Identities=24%  Similarity=0.324  Sum_probs=203.9

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-----hhhHHHHHHHHHHHhhcc---ccceeeEEEEEeec
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-----EQGVHEFQTEIEMLSKLR---HRHLVSLIGYCEEN  601 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-----~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~  601 (893)
                      ..++|+..++||+|+||+||+|++...++.||+|++....     ......+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3578999999999999999999988888899999764211     112345677888877775   99999999999775


Q ss_pred             C-----EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEe
Q 036624          602 C-----EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVS  676 (893)
Q Consensus       602 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~  676 (893)
                      .     ..++||||+. |+|.+++.......+++..+..|+.|+++||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5899999998 69999998776667999999999999999999999   4889999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh-
Q 036624          677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH-  755 (893)
Q Consensus       677 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-  755 (893)
                      |||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  +........ 
T Consensus       163 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~  237 (308)
T 3g33_A          163 DFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGL  237 (308)
T ss_dssp             SCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH--HHHHHHHHCC
T ss_pred             eCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCC
Confidence            99999864321   223445789999999999999999999999999999999999999976543221  111111100 


Q ss_pred             -cccch-hh------hcccc---ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          756 -KKGIL-EQ------IMDPY---LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       756 -~~~~~-~~------i~d~~---l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                       ..... ..      .+.+.   ......++....+.+++.+||+.||++|||+.|++++-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~  299 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY  299 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence             00000 00      00000   000011234567889999999999999999999997643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.1e-39  Score=363.91  Aligned_cols=256  Identities=22%  Similarity=0.328  Sum_probs=203.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhcc--ccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLR--HRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV  607 (893)
                      .+|+..++||+|+||+||+|.... +..||||++..  ......+.+.+|+.+|.+++  |+||+++++++...+..+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            458899999999999999999876 57899997643  34556788999999999996  59999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      || +.+++|.+++....  .+++..+..|+.||++||+|||   +.+|+||||||+|||++ ++.+||+|||+++.....
T Consensus       135 ~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             Ee-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            99 66799999997654  5899999999999999999999   58999999999999996 579999999999865432


Q ss_pred             CCccceeeeccCcCccChHhhhh-----------cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK  756 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  756 (893)
                      ..........||+.|+|||++.+           ..++.++|||||||+||||++|+.||.......     .       
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~-------  275 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S-------  275 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----H-------
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----H-------
Confidence            22222345679999999999975           468999999999999999999999996532211     1       


Q ss_pred             ccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          757 KGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       757 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                        .+..++++.....++......+.+++.+||+.||++||++.|++++.....
T Consensus       276 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~  326 (390)
T 2zmd_A          276 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  326 (390)
T ss_dssp             --HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             --HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence              122233333333333334567889999999999999999999998877543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8e-39  Score=350.59  Aligned_cols=268  Identities=22%  Similarity=0.265  Sum_probs=202.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..++||+|+||+||+|.....++.||+|++...  .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            5788999999999999999999887889999976543  33345678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++++|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        83 ~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  155 (311)
T 4agu_A           83 YCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--  155 (311)
T ss_dssp             CCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--
Confidence            999999999886543  4899999999999999999999   589999999999999999999999999999764321  


Q ss_pred             ccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHH---------HHhhcccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWA---------AHCHKKGI  759 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~  759 (893)
                      ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+........         ........
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence            112234568999999999986 67899999999999999999999999765433221111100         00000000


Q ss_pred             hhhhccccccCCC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          760 LEQIMDPYLKGKI-----APECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       760 ~~~i~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .....-+......     .+.....+.+++.+||+.||++|||+.|++++-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  287 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY  287 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence            0000000000000     0234456889999999999999999999997644

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.2e-39  Score=352.55  Aligned_cols=266  Identities=22%  Similarity=0.272  Sum_probs=202.3

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      .++|+..++||+|+||+||+|+... ++.||+|++...  .....+.+.+|++++++++||||+++++++.+....++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            3678899999999999999999876 478999987643  2233567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||++ |+|.+.+.... ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        99 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-  172 (311)
T 3niz_A           99 EFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-  172 (311)
T ss_dssp             ECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-
T ss_pred             cCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-
Confidence            9998 58888886543 45999999999999999999999   589999999999999999999999999999864321 


Q ss_pred             CccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc--cchhh---
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK--GILEQ---  762 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~---  762 (893)
                       ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.  +..........  .....   
T Consensus       173 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          173 -VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             -CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCCCCTTTSGGGTT
T ss_pred             -cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCCCChHHhhhhhc
Confidence             112234568999999999976 5689999999999999999999999976543321  11111111000  00000   


Q ss_pred             ---hc-------cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          763 ---IM-------DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       763 ---i~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         ..       +........+....++.+++.+||+.||++|||+.|++++-.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  303 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY  303 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence               00       000000011223456889999999999999999999997543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.6e-39  Score=374.92  Aligned_cols=254  Identities=23%  Similarity=0.289  Sum_probs=200.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .++|+..++||+|+||.||+|.....+..||||++...   .......+.+|++++++++||||+++++++...+..+||
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999999888899999987532   333456788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      ||||++|+|.+++....  .+++..+..++.|+++||+|||+  ..+||||||||+||||+.++.+||+|||+++.....
T Consensus       227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999997654  59999999999999999999994  378999999999999999999999999999863321


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                        ........||+.|+|||++.+..++.++|||||||+||||++|+.||.......      ....         +....
T Consensus       303 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~---------i~~~~  365 (446)
T 4ejn_A          303 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFEL---------ILMEE  365 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH---------HHHCC
T ss_pred             --CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHH---------HHhCC
Confidence              222344679999999999999999999999999999999999999996543211      1111         11111


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLEF  807 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~~  807 (893)
                        ..++......+.+++.+||+.||.+||     ++.|++++-..
T Consensus       366 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f  408 (446)
T 4ejn_A          366 --IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF  408 (446)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             --CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence              112334456788999999999999999     99999976553

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.7e-39  Score=361.84  Aligned_cols=270  Identities=15%  Similarity=0.181  Sum_probs=207.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCc-----ceEEEEEeCCCCChhhH-----------HHHHHHHHHHhhccccceeeE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGA-----TTKVAIKRGNPLSEQGV-----------HEFQTEIEMLSKLRHRHLVSL  594 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~VavK~~~~~~~~~~-----------~~f~~E~~~l~~l~H~niv~l  594 (893)
                      .++|...++||+|+||+||+|.+..+     ++.||||++........           ..+..|+..+..++|+||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            46799999999999999999998664     36799998765442211           123445666777889999999


Q ss_pred             EEEEeec----CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC--
Q 036624          595 IGYCEEN----CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD--  668 (893)
Q Consensus       595 ~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld--  668 (893)
                      ++++...    ...+|||||+ +++|.+++... ...+++..++.|+.|++.||+|||+   .+|+||||||+||||+  
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence            9998764    4589999999 99999999764 3469999999999999999999994   7999999999999999  


Q ss_pred             CCCceeEecccccccCCCCCC-----ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccc
Q 036624          669 EKWVAKVSDFGLSKTGPTLDH-----THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKE  743 (893)
Q Consensus       669 ~~~~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~  743 (893)
                      .++.+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            889999999999975432111     111234559999999999999999999999999999999999999997532221


Q ss_pred             cccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          744 QVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       744 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                        ....+..... ...+.+++++.+..   ..++..+.+++.+||+.+|++||++.+|++.|+.+++-
T Consensus       269 --~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          269 --KYVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             --HHHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence              1111111111 12334444443321   23356788999999999999999999999999987753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.6e-39  Score=346.38  Aligned_cols=253  Identities=20%  Similarity=0.279  Sum_probs=208.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|...++||+|+||+||+|.....+..||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            45788999999999999999999988889999987655455577899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE---CCCCceeEecccccccCCCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~~~  687 (893)
                      +++++|.+++....  .+++..+..|+.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++.....
T Consensus        88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            99999999987654  4899999999999999999999   5899999999999999   78899999999998764322


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                      .   ......||+.|+|||++.+. ++.++|||||||++|||++|+.||......+      ........         .
T Consensus       163 ~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~---------~  223 (277)
T 3f3z_A          163 K---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKIREG---------T  223 (277)
T ss_dssp             S---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC---------C
T ss_pred             c---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhC---------C
Confidence            1   22345699999999998764 8999999999999999999999997543211      11111000         0


Q ss_pred             ccCCCCh----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          768 LKGKIAP----ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       768 l~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                        ...+.    .+...+.+++.+||+.+|++||++.+++++-....
T Consensus       224 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          224 --FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             --CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             --CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence              01111    23467889999999999999999999998765433

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.1e-39  Score=349.34  Aligned_cols=260  Identities=30%  Similarity=0.541  Sum_probs=197.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      .++|+..++||+|+||+||+|+..+   .||+|+++.  ......+.|.+|++++++++||||+++++++. ....++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence            3578889999999999999998764   488887653  34556678999999999999999999999764 45689999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++++|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        99 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999999996543 45999999999999999999999   4899999999999999999999999999997643322


Q ss_pred             CccceeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      .........||+.|+|||++.   +..++.++|||||||++|||++|+.||........  +.+...    .+.    ..
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~----~~~----~~  244 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVG----RGS----LS  244 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHH----HTS----CC
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhc----ccc----cC
Confidence            233334567999999999996   66788899999999999999999999975433221  111111    111    11


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      +. .......++..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus       245 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          245 PD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            11 11223456678999999999999999999999999999765

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.7e-39  Score=347.67  Aligned_cols=267  Identities=18%  Similarity=0.246  Sum_probs=204.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..++||+|+||+||+|....+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            4788999999999999999999888899999976532  33445778999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++ +|.+.+.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--  154 (292)
T ss_dssp             CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--
T ss_pred             cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--
Confidence            9985 6666655432 45999999999999999999999   489999999999999999999999999999864321  


Q ss_pred             ccceeeeccCcCccChHhhhhcC-CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc--cc---hhhh
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK--GI---LEQI  763 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~---~~~i  763 (893)
                      ........||+.|+|||++.+.. ++.++|||||||++|||++|+.|+........ .+..........  ..   +.+.
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhccc
Confidence            12223456899999999998766 89999999999999999999888644332211 111111111000  00   0000


Q ss_pred             ccc---------cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          764 MDP---------YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       764 ~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .+.         .......+.....+.+++.+||+.||++|||+.|++++-.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  285 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence            000         0001122345567889999999999999999999987643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-39  Score=357.73  Aligned_cols=257  Identities=24%  Similarity=0.347  Sum_probs=197.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecC----EE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC----EM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~  604 (893)
                      ++|+..++||+|+||.||+|++...++.||||++...   .......+.+|+.++++++||||+++++++....    ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            5788999999999999999999888899999987653   3344567899999999999999999999987654    34


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++||||+++|+|.+++....  .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            99999999999999997654  5999999999999999999999   489999999999999999999999999999764


Q ss_pred             CCCCC-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          685 PTLDH-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       685 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      ..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ..........    
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~----  236 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDP----  236 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCC----
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCC----
Confidence            33211 122234568999999999999999999999999999999999999997543321      1111111110    


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..+.   .....+...+.+++.+||+.||++||+..+++.+-.
T Consensus       237 ~~~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  276 (311)
T 3ork_A          237 IPPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL  276 (311)
T ss_dssp             CCHH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             CCcc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence            0000   001224467889999999999999998777665433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.7e-39  Score=362.35  Aligned_cols=259  Identities=21%  Similarity=0.229  Sum_probs=200.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..+.||+|+||+||+++....++.||+|++.... ...+.+.+|+.++++++||||+++++++......++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            357889999999999999999999888999999876432 2335688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc--eeEecccccccCCCCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV--AKVSDFGLSKTGPTLD  688 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~--~kl~DFGla~~~~~~~  688 (893)
                      +++|+|.+++....  .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.  +||+|||+++..... 
T Consensus        98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-  171 (361)
T 3uc3_A           98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  171 (361)
T ss_dssp             CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence            99999999997654  4999999999999999999999   589999999999999987765  999999998743221 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCc-chhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEK-SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~k-sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                        .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.......  .+.....         .+....
T Consensus       172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~---------~~~~~~  238 (361)
T 3uc3_A          172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQ---------RILSVK  238 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHH---------HHHTTC
T ss_pred             --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHH---------HHhcCC
Confidence              12234569999999999998888766 899999999999999999997543221  1111111         111111


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ............+.+++.+||+.+|++|||+.|++++-....
T Consensus       239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            111111123467889999999999999999999999877644

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.2e-39  Score=350.08  Aligned_cols=263  Identities=20%  Similarity=0.298  Sum_probs=202.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC---CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||.||+|.....+..||+|++..   ......+.+.+|+.++++++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            578899999999999999999987778999998764   24456678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          609 DYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       609 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||+++|+|.+++...  ....+++..++.++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            999999999998642  3456999999999999999999999   58999999999999999999999999999875432


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      .  ........|++.|+|||++.+..++.++|||||||++|||++|+.||.....    ....+.......         
T Consensus       189 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~---------  253 (310)
T 2wqm_A          189 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQC---------  253 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTT---------
T ss_pred             C--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhcc---------
Confidence            1  1122345689999999999999999999999999999999999999964322    111222111110         


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhc
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQ  812 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~  812 (893)
                      .........+...+.+++.+||+.||++||++.+|++.|+.+....
T Consensus       254 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            0111111234567889999999999999999999999999877543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.6e-40  Score=385.26  Aligned_cols=256  Identities=29%  Similarity=0.428  Sum_probs=210.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..++||+|+||.||+|.+.++ ..||||+++... ...++|.+|+++|++++|+||+++++++.+ +..+|||||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            45678889999999999999999875 679999887543 335689999999999999999999999976 678999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      |++|+|.++|.......+++.+++.|+.||++||+|||   +.+||||||||+||||++++.+||+|||+++...... .
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  418 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence            99999999997654456999999999999999999999   5899999999999999999999999999998643211 1


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......++..|+|||++....++.++|||||||+||||++ |+.||......+      ...... .         ...
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~------~~~~i~-~---------~~~  482 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVE-R---------GYR  482 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH------HHHHHH-T---------TCC
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-c---------CCC
Confidence            11223457789999999999999999999999999999999 899986543211      111111 1         111


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ...+..+...+.+|+.+||+.+|++||++.+|++.|+...
T Consensus       483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            2234456778999999999999999999999999998654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.4e-39  Score=350.25  Aligned_cols=270  Identities=26%  Similarity=0.398  Sum_probs=208.2

Q ss_pred             cCCccceeeeecCcEEEEEEEE----cCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeec--CEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEI----DGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN--CEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~  604 (893)
                      +.|+..+.||+|+||.||+|++    ...++.||+|++... .....+.+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578889999999999999994    445688999987643 334567899999999999999999999999876  668


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            99999999999999996543 35999999999999999999999   589999999999999999999999999999865


Q ss_pred             CCCCC-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc---ch
Q 036624          685 PTLDH-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG---IL  760 (893)
Q Consensus       685 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~  760 (893)
                      ..... ........||..|+|||++.+..++.++|||||||++|||++|+.|+.....    .............   .+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCHHHH
Confidence            43221 1223345688899999999999999999999999999999999988632110    0000000000000   01


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ...+........+..+...+.+++.+||+.+|.+|||+.++++.|+.++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1111111122334456678999999999999999999999999999765

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-38  Score=350.74  Aligned_cols=274  Identities=23%  Similarity=0.338  Sum_probs=205.6

Q ss_pred             HHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc--cccceeeEEEEEeec-
Q 036624          525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL--RHRHLVSLIGYCEEN-  601 (893)
Q Consensus       525 ~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l--~H~niv~l~g~~~~~-  601 (893)
                      ..-....++|+..++||+|+||.||+|+..  +..||||++...   ....+..|.+++..+  +||||+++++++... 
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            333445578999999999999999999987  378999987532   234455666666554  899999999999877 


Q ss_pred             ---CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCC-----CCceEecCCCCCCEEECCCCce
Q 036624          602 ---CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA-----KHTIIHRDVKTTNILLDEKWVA  673 (893)
Q Consensus       602 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlk~~NILld~~~~~  673 (893)
                         ...++||||+++|+|.+++...   .+++..++.++.|++.||+|||+.+     +.+|+||||||+|||++.++.+
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence               7899999999999999999654   4999999999999999999999521     2299999999999999999999


Q ss_pred             eEecccccccCCCCCCc--cceeeeccCcCccChHhhhhcCCCCc------chhhhHHHHHHHHhhC----------CCC
Q 036624          674 KVSDFGLSKTGPTLDHT--HVSTVVKGSFGYLDPEYFRRQQLTEK------SDVYSFGVVLFEILCA----------RPA  735 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~k------sDV~S~Gvvl~elltG----------~~p  735 (893)
                      ||+|||+++........  .......||+.|+|||++.+...+.+      +|||||||++|||++|          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            99999999754322111  11224569999999999988777765      9999999999999999          555


Q ss_pred             CCCCCccccccHHHHHHHhhcccchhhhccccccC-CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhc
Q 036624          736 LNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG-KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQ  812 (893)
Q Consensus       736 ~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~  812 (893)
                      |....... .....+......     ....+.+.. ....+++..+.+++.+||+.||++||++.||+++|+.+.+.+
T Consensus       262 ~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          262 YHDLVPSD-PSYEDMREIVCI-----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTTTSCSS-CCHHHHHHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             HhhhcCCC-CchhhhHHHHhh-----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            54432221 111111111100     001111111 112378889999999999999999999999999999877643

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-39  Score=347.87  Aligned_cols=259  Identities=24%  Similarity=0.368  Sum_probs=205.3

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcc---eEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEE-EEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGAT---TKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM-ILV  607 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~---~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV  607 (893)
                      .|...++||+|+||+||+|.+....   ..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3556689999999999999875433   37999987653 445567899999999999999999999999876655 999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+.+|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus       102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999999764 346899999999999999999999   489999999999999999999999999999754322


Q ss_pred             C--CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          688 D--HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       688 ~--~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      .  .........+|+.|+|||.+.+..++.++|||||||++|||++|+.|+.......  .+......            
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~------------  243 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFLAQ------------  243 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHHHHT------------
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHHhhc------------
Confidence            1  1122234567899999999999999999999999999999999665543322211  11111111            


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                       ......+..+...+.+++.+||+.+|.+|||+.++++.|+.+.+
T Consensus       244 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          244 -GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             01112233445678899999999999999999999999998765

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.5e-39  Score=349.41  Aligned_cols=251  Identities=26%  Similarity=0.389  Sum_probs=206.7

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEee---------
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE---------  600 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~---------  600 (893)
                      ...+|+..+.||+|+||.||+|.....++.||+|++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467899999999999999999998777899999876543    346789999999999999999998854         


Q ss_pred             -------cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCce
Q 036624          601 -------NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA  673 (893)
Q Consensus       601 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~  673 (893)
                             ....++||||+++|+|.+++.......+++..++.++.|+++||.|||   +.+|+||||||+|||+++++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence                   456899999999999999998765567999999999999999999999   4899999999999999999999


Q ss_pred             eEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH
Q 036624          674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH  753 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  753 (893)
                      ||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|..|+...        ..+.  
T Consensus       162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~--  228 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFF--  228 (284)
T ss_dssp             EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHH--
T ss_pred             EECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHH--
Confidence            999999987643321   123456999999999999999999999999999999999998876310        1111  


Q ss_pred             hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       754 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                             ..+.+..    .+......+.+++.+||+.+|++||++.|++++|+...+.
T Consensus       229 -------~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          229 -------TDLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             -------HHHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             -------HHhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence                   1111111    1222345678899999999999999999999999976643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.5e-39  Score=354.77  Aligned_cols=257  Identities=29%  Similarity=0.472  Sum_probs=206.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceE--EEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTK--VAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~--VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|+..+.||+|+||.||+|+....+..  |++|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            5788899999999999999998766554  488876543 334556799999999999 899999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCce
Q 036624          608 YDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA  673 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~  673 (893)
                      |||+++|+|.+++....              ...+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997643              246999999999999999999999   5899999999999999999999


Q ss_pred             eEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHH
Q 036624          674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAA  752 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  752 (893)
                      ||+|||+++....   ........+++.|+|||++.+..++.++|||||||++|||++ |+.||......      +...
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE  252 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHHH
Confidence            9999999874321   112233457889999999999999999999999999999998 99999654321      1111


Q ss_pred             HhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          753 HCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       753 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ... .         ......+..+...+.+++.+||+.+|.+||++.+++++|+.+++
T Consensus       253 ~~~-~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          253 KLP-Q---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             HGG-G---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Hhh-c---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            111 0         11112233455778999999999999999999999999998775

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.2e-39  Score=355.14  Aligned_cols=252  Identities=22%  Similarity=0.311  Sum_probs=197.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEc---CcceEEEEEeCCCCC----hhhHHHHHHHHHHHhhccccceeeEEEEEeecCE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEID---GATTKVAIKRGNPLS----EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE  603 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~VavK~~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~  603 (893)
                      .++|+..++||+|+||.||+++..   ..++.||+|+++...    ......+.+|+.+|++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            357889999999999999999984   456889999876532    2345568899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      .++||||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999999999999997654  4899999999999999999999   48999999999999999999999999999875


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      ....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ....         +
T Consensus       171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~---------i  233 (327)
T 3a62_A          171 SIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TIDK---------I  233 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHH---------H
T ss_pred             cccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HHHH---------H
Confidence            3221  112234569999999999999999999999999999999999999997543211      1111         1


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                      ....  ..+++.....+.+++.+||+.+|++||     ++.|++++-.
T Consensus       234 ~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~  279 (327)
T 3a62_A          234 LKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF  279 (327)
T ss_dssp             HHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred             HhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence            1111  122334456788999999999999999     7788887655

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=363.72  Aligned_cols=252  Identities=25%  Similarity=0.312  Sum_probs=206.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||.||++....+++.||+|.+...   .....+.+.+|+++|++++||||+++++++.+....++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            5788999999999999999999988899999986532   1234567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+.+|+|..++...  ..+++..+..++.|++.||+|||   +.+|+||||||+||||+.++.+||+|||+++..... 
T Consensus        95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            999999999999764  35999999999999999999999   589999999999999999999999999999864322 


Q ss_pred             CccceeeeccCcCccChHhhhh---cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                        ......+||+.|+|||++..   ..++.++|||||||+||||++|+.||.........   +......         .
T Consensus       169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~---~~~~~~~---------~  234 (384)
T 4fr4_A          169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK---EIVHTFE---------T  234 (384)
T ss_dssp             --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH---HHHHHHH---------H
T ss_pred             --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH---HHHHHHh---------h
Confidence              22345679999999999974   45899999999999999999999999754332211   1111100         0


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPS-MGDVLWNL  805 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-m~evl~~L  805 (893)
                      .  ...++..+...+.+++.+||+.+|.+||+ +.+|+++-
T Consensus       235 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp  273 (384)
T 4fr4_A          235 T--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP  273 (384)
T ss_dssp             C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSG
T ss_pred             c--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcCh
Confidence            0  11233445577899999999999999998 77776543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.3e-39  Score=357.48  Aligned_cols=252  Identities=22%  Similarity=0.312  Sum_probs=207.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|...+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++......++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57889999999999999999998888999999865321   112356899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+ +|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-  161 (336)
T ss_dssp             CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred             ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence            999 689999887654  4999999999999999999999   489999999999999999999999999999864322 


Q ss_pred             CccceeeeccCcCccChHhhhhcCC-CCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                        ......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........               ...+... 
T Consensus       162 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~-  223 (336)
T 3h4j_B          162 --NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSC-  223 (336)
T ss_dssp             --BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSS-
T ss_pred             --cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcC-
Confidence              22234579999999999988776 7899999999999999999999965432110               0111110 


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                       ....+......+.+++.+||+.||.+|||+.|++++-....
T Consensus       224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence             11223344567889999999999999999999999877643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6e-39  Score=343.24  Aligned_cols=256  Identities=27%  Similarity=0.385  Sum_probs=209.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..+.||+|+||.||+|....+ ..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCC-CeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            5688889999999999999998754 6899998775432 3467999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++++|.+++.... ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~  160 (267)
T 3t9t_A           86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  160 (267)
T ss_dssp             TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence            9999999997653 45899999999999999999999   5899999999999999999999999999987643211 11


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.......      ........          ...
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~i~~~----------~~~  224 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTG----------FRL  224 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTT----------CCC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHHHhcC----------CcC
Confidence            1223457789999999999999999999999999999999 899986543211      11111100          011


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ..+..+...+.+++.+||+.+|++||++.+++++|+.+.+
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1223345678899999999999999999999999998764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.5e-39  Score=346.83  Aligned_cols=258  Identities=25%  Similarity=0.391  Sum_probs=208.9

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..+.||+|+||.||+|...++ ..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCC-cEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            35788899999999999999998764 679999876543 345789999999999999999999999875 458999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.......+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++...... .
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y  164 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-c
Confidence            99999999997544346999999999999999999999   5899999999999999999999999999998643321 1


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+      ....... +         ..
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~-~---------~~  228 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLER-G---------YR  228 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHT-T---------CC
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHHhc-c---------cC
Confidence            11223446789999999999999999999999999999999 899986543211      1111110 0         11


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      ...+..+...+.+++.+||+.+|++||++.++++.|+.....
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            122334556789999999999999999999999999987653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.2e-39  Score=355.17  Aligned_cols=264  Identities=21%  Similarity=0.287  Sum_probs=192.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .++|+..+.||+|+||+||+|.....++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357888999999999999999998888899999875432 2334678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCC----CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          610 YMAYGTLREHLYKTQ----KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      |++ |+|.+++....    ...+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 69999886532    245899999999999999999999   5899999999999999999999999999998643


Q ss_pred             CCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc--ccc---
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK--KGI---  759 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~---  759 (893)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..  .........  ...   
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL--KLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCTTTCGG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCCChhHhhh
Confidence            211  11233468999999999986 46899999999999999999999999765432211  111111000  000   


Q ss_pred             ------------------hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          760 ------------------LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       760 ------------------~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                                        +.+.+.+.    ........+.+++.+||+.||++|||+.|++++-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~  296 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPH----TKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW  296 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGG----CSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hhhhhhcccccccccchhHHHhhccc----ccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence                              00011111    11123456889999999999999999999987654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-39  Score=360.52  Aligned_cols=265  Identities=22%  Similarity=0.211  Sum_probs=204.7

Q ss_pred             HHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-----ChhhHHHHHHHHHHHhhccccceeeEEEEEeec
Q 036624          527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-----SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN  601 (893)
Q Consensus       527 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~  601 (893)
                      +....++|+..++||+|+||+||+|.....+..||+|++...     .....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            455677899999999999999999999888889999976432     334567899999999999999999999999999


Q ss_pred             CEEEEEEeeccCCCHHHHHhhC--------------------------------------CCCCCCHHhHHHHHHHHHHh
Q 036624          602 CEMILVYDYMAYGTLREHLYKT--------------------------------------QKPPLPWKQRLEICIGAARG  643 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~g  643 (893)
                      +..++||||+++|+|.+++...                                      ....+++..+..|+.|+++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999998521                                      01124577888999999999


Q ss_pred             hhhhhcCCCCceEecCCCCCCEEECCCC--ceeEecccccccCCCCC--CccceeeeccCcCccChHhhhh--cCCCCcc
Q 036624          644 LHYLHTGAKHTIIHRDVKTTNILLDEKW--VAKVSDFGLSKTGPTLD--HTHVSTVVKGSFGYLDPEYFRR--QQLTEKS  717 (893)
Q Consensus       644 L~yLH~~~~~~ivHrDlk~~NILld~~~--~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~~~~--~~~s~ks  717 (893)
                      |+|||   +.+|+||||||+|||++.++  .+||+|||+++......  .........||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999   47999999999999998776  89999999997532211  1112344569999999999975  6789999


Q ss_pred             hhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCC
Q 036624          718 DVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS  797 (893)
Q Consensus       718 DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt  797 (893)
                      |||||||++|||++|+.||......+      ..........       .............+.+++.+||+.+|.+||+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence            99999999999999999996543221      1111111100       0000111124567889999999999999999


Q ss_pred             HHHHHHHHHH
Q 036624          798 MGDVLWNLEF  807 (893)
Q Consensus       798 m~evl~~L~~  807 (893)
                      +.|++++-..
T Consensus       325 ~~~~l~hp~~  334 (345)
T 3hko_A          325 AMRALQHPWI  334 (345)
T ss_dssp             HHHHHHSHHH
T ss_pred             HHHHhcChhh
Confidence            9999987653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=345.07  Aligned_cols=259  Identities=25%  Similarity=0.386  Sum_probs=209.1

Q ss_pred             cCCccce-eeeecCcEEEEEEEEc--CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEAL-LLGVGGFGKVYRGEID--GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~-~LG~G~fG~Vy~g~~~--~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|...+ .||+|+||.||+|.+.  ..+..||+|++... .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4555665 8999999999999864  34578999987764 445677899999999999999999999999 45668999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++++|.+++... ...+++..++.++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999999999654 345999999999999999999999   589999999999999999999999999999865332


Q ss_pred             CC-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          688 DH-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       688 ~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      .. ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   +....   . .        
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i---~-~--------  228 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFI---E-Q--------  228 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHH---H-T--------
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH---h-c--------
Confidence            21 111223456889999999999999999999999999999998 999997543321   11111   0 0        


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                       ......+..++..+.+++.+||+.+|++||++.+++++|+.+...
T Consensus       229 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          229 -GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence             011223445667899999999999999999999999999987753

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=381.49  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=204.7

Q ss_pred             CCccce-eeeecCcEEEEEEEEc--CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          533 NFDEAL-LLGVGGFGKVYRGEID--GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       533 ~f~~~~-~LG~G~fG~Vy~g~~~--~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++...+ .||+|+||.||+|.+.  ..+..||||+++.. .....++|.+|+++|++++||||++++++|.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999875  34467999998764 33457889999999999999999999999976 5689999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |||++|+|.++|... ...+++..++.|+.|+++||+|||   +.+||||||||+||||++++.+||+|||+++......
T Consensus       415 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             ECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            999999999999754 346999999999999999999999   4899999999999999999999999999998653322


Q ss_pred             C-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          689 H-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       689 ~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      . ........+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+   +....    ..+        
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i----~~~--------  555 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFI----EQG--------  555 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHH----HTT--------
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcC--------
Confidence            1 111223346789999999999999999999999999999998 999997654322   11111    111        


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                       .....+..++..+.+++.+||+.+|++||++.+|++.|+....
T Consensus       556 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          556 -KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence             1123345667889999999999999999999999999997664

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5e-39  Score=348.93  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=207.6

Q ss_pred             hcCCccce-eeeecCcEEEEEEEE--cCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          531 TNNFDEAL-LLGVGGFGKVYRGEI--DGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       531 t~~f~~~~-~LG~G~fG~Vy~g~~--~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      .++|...+ .||+|+||+||+|.+  ...+..||||++....  ....+++.+|++++++++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 999999999999954  4556789999876532  33467899999999999999999999999 566789


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +||||+++++|.+++....  .+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        94 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            9999999999999997653  4999999999999999999999   4899999999999999999999999999997643


Q ss_pred             CCCCc-cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          686 TLDHT-HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       686 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      ..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.......   +....    ..+     
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~-----  236 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAML----EKG-----  236 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----HTT-----
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcC-----
Confidence            32211 11223446789999999999999999999999999999999 999997543211   11111    010     


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhch
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE  813 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~  813 (893)
                          .....+..++..+.+++.+||+.+|++||++.+|++.|+.......
T Consensus       237 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          237 ----ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                1112334556789999999999999999999999999998775433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.3e-39  Score=363.32  Aligned_cols=256  Identities=19%  Similarity=0.288  Sum_probs=197.0

Q ss_pred             cCCccc-eeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhh-ccccceeeEEEEEee----cCEEE
Q 036624          532 NNFDEA-LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK-LRHRHLVSLIGYCEE----NCEMI  605 (893)
Q Consensus       532 ~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~  605 (893)
                      ++|... ++||+|+||+||+|.+..++..||||++..     ...+.+|++++.+ .+||||+++++++..    ...++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 689999999999999988889999998753     2356788888755 489999999999875    56789


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC---CCceeEecccccc
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE---KWVAKVSDFGLSK  682 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~  682 (893)
                      ||||||++|+|.+++.......+++..+..|+.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999998766567999999999999999999999   489999999999999998   7899999999998


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc-cHHHHHHHhhcccchh
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV-SLAEWAAHCHKKGILE  761 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~  761 (893)
                      .....   ......+||+.|+|||++.+..++.++|||||||+||||++|+.||......... .+.....    .+.  
T Consensus       213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~--  283 (400)
T 1nxk_A          213 ETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQ--  283 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTC--
T ss_pred             ccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCc--
Confidence            64321   1234567899999999999999999999999999999999999999764432211 0111110    000  


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                       .   .+.......+...+.+++.+||+.||++|||+.|++++....
T Consensus       284 -~---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  326 (400)
T 1nxk_A          284 -Y---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  326 (400)
T ss_dssp             -C---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             -c---cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence             0   000111123456788999999999999999999999987754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-39  Score=361.65  Aligned_cols=258  Identities=26%  Similarity=0.437  Sum_probs=197.4

Q ss_pred             CCccceeeeecCcEEEEEEEEcCc---ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEee-cCEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE-NCEMILV  607 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV  607 (893)
                      .|...++||+|+||+||+|.+...   ...||+|.++.. .....++|.+|+.++++++||||++++++|.+ .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            466778999999999999987432   346899987653 34566789999999999999999999998754 4678999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++|+|.+++.... ..+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus       170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            99999999999997543 45899999999999999999999   489999999999999999999999999999854322


Q ss_pred             CC--ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          688 DH--THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       688 ~~--~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ..  ........+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+   +......    +      
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~~~----~------  312 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQ----G------  312 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHHHT----T------
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHHHc----C------
Confidence            11  112234557889999999999999999999999999999999 667775433221   1111110    0      


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                        . ....+..++..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       313 --~-~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          313 --R-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             --C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --C-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              0 111233456778999999999999999999999999998775

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.6e-39  Score=353.35  Aligned_cols=268  Identities=22%  Similarity=0.246  Sum_probs=201.0

Q ss_pred             cCCccc-eeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEA-LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      +.|... ++||+|+||+||+|.....++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            456663 6899999999999998877789999988665555677899999999985 79999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc---eeEecccccccCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV---AKVSDFGLSKTGPT  686 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~---~kl~DFGla~~~~~  686 (893)
                      |+++|+|.+++....  .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.   +||+|||+++....
T Consensus        92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            999999999997653  4899999999999999999999   489999999999999998766   99999999875422


Q ss_pred             CCC-----ccceeeeccCcCccChHhhhh-----cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc
Q 036624          687 LDH-----THVSTVVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK  756 (893)
Q Consensus       687 ~~~-----~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  756 (893)
                      ...     ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||......+.............
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            111     111223459999999999975     5689999999999999999999999976543221100000000000


Q ss_pred             ccchhhhccccccCCCCh----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          757 KGILEQIMDPYLKGKIAP----ECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       757 ~~~~~~i~d~~l~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ......+.....  .++.    .....+.+++.+||+.||++|||+.|++++-.
T Consensus       247 ~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  298 (316)
T 2ac3_A          247 NMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW  298 (316)
T ss_dssp             HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred             HHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence            000111111111  1111    23457889999999999999999999997644

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.1e-38  Score=344.29  Aligned_cols=265  Identities=18%  Similarity=0.217  Sum_probs=205.0

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEE-eecCEEEEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC-EENCEMILVY  608 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~  608 (893)
                      ..++|+..+.||+|+||+||+|+....++.||||+.....  ....+.+|++++++++|++++..++.+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            3578999999999999999999998888999999754322  223588999999999988877666655 6778889999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE---CCCCceeEecccccccCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~  685 (893)
                      ||+ +++|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||+   ++++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999 899999997543 35999999999999999999999   4899999999999999   788999999999998643


Q ss_pred             CCCCc-----cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          686 TLDHT-----HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       686 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      .....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........................
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            32111     1223467999999999999999999999999999999999999999765433322221111110000000


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .     .    ....++..+.+++.+||+.+|++||++.+|++.|+.+.+
T Consensus       240 ~-----~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          240 E-----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             H-----H----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             h-----h----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            0     0    011234678899999999999999999999999998775

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=355.79  Aligned_cols=254  Identities=17%  Similarity=0.191  Sum_probs=204.2

Q ss_pred             HhcCCccceeeeecCcEEEEEEE-----EcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc---ccceeeEEEEEeec
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGE-----IDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR---HRHLVSLIGYCEEN  601 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~-----~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~  601 (893)
                      ..++|...++||+|+||+||+|.     ....++.||+|++....   ..++..|++++.+++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35678899999999999999994     44556789999987544   446777888877776   99999999999999


Q ss_pred             CEEEEEEeeccCCCHHHHHhhC---CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC---------
Q 036624          602 CEMILVYDYMAYGTLREHLYKT---QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE---------  669 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---------  669 (893)
                      +..+||||||++|+|.+++...   ....+++..++.|+.|+++||+|||   ..+||||||||+||||+.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence            9999999999999999999752   3456999999999999999999999   589999999999999998         


Q ss_pred             --CCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccH
Q 036624          670 --KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL  747 (893)
Q Consensus       670 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l  747 (893)
                        ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||........   
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence              899999999999754322233344556799999999999999999999999999999999999999853221110   


Q ss_pred             HHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHHHh
Q 036624          748 AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIER-PSMGDVLWNLEFALQ  810 (893)
Q Consensus       748 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Ptm~evl~~L~~~~~  810 (893)
                                 .    +...+....   ..+.+.+++..|++.+|.+| |++.++.+.|+..++
T Consensus       294 -----------~----~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          294 -----------K----PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             -----------E----ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -----------e----echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                       0    111111111   23456778889999999998 678888888887664

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=9.9e-39  Score=346.16  Aligned_cols=264  Identities=19%  Similarity=0.252  Sum_probs=199.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh--hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE--QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..+.||+|+||+||+|+... +..||+|++.....  ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETT-SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCC-CCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            468889999999999999999854 47899998754332  234678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |++ ++|.+++.... ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        81 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  153 (288)
T 1ob3_A           81 HLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--  153 (288)
T ss_dssp             CCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--
Confidence            998 49999887543 45899999999999999999999   489999999999999999999999999998753321  


Q ss_pred             ccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc--cc---hhh-
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK--GI---LEQ-  762 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~---~~~-  762 (893)
                      ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.  +..........  ..   ..+ 
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhhcc
Confidence            1112334689999999999764 589999999999999999999999975432211  11111110000  00   000 


Q ss_pred             -hcccccc-------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          763 -IMDPYLK-------GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       763 -i~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                       ..++...       ..........+.+++.+||+.||++|||+.|++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  282 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence             0111110       011123456788999999999999999999998753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.2e-39  Score=355.37  Aligned_cols=270  Identities=27%  Similarity=0.390  Sum_probs=210.2

Q ss_pred             CccceeeeecCcEEEEEEEEc----CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEee--cCEEEE
Q 036624          534 FDEALLLGVGGFGKVYRGEID----GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE--NCEMIL  606 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~----~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l  606 (893)
                      |+..++||+|+||+||++.+.    ..++.||||++... .....+.+.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            478899999999999888653    34578999987754 34556789999999999999999999999987  467899


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++|+|.+++....   +++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       113 v~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            999999999999997643   899999999999999999999   48999999999999999999999999999986543


Q ss_pred             CCC-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDH-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ... ........+|..|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+.........+.+.++
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHHh
Confidence            221 122334558889999999999999999999999999999999999985421110 000000000000111222222


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .......+..++..+.+++.+||+.+|++||++.|+++.|+.+.+
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            222334455667789999999999999999999999999997764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=358.18  Aligned_cols=268  Identities=26%  Similarity=0.412  Sum_probs=212.2

Q ss_pred             cCCccceeeeecCcEEEEEEEE----cCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecC--EEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEI----DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC--EMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~  605 (893)
                      ++|+..+.||+|+||.||+|++    ...+..||+|++........+.+.+|++++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            5688889999999999999984    4456889999988777777788999999999999999999999987654  679


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +||||+++++|.+++.... ..+++..++.++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++...
T Consensus       121 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999997653 35999999999999999999999   4899999999999999999999999999998654


Q ss_pred             CCCCc-cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc-------
Q 036624          686 TLDHT-HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK-------  757 (893)
Q Consensus       686 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-------  757 (893)
                      ..... .......++..|+|||.+.+..++.++|||||||++|||++|+.|+....       .++.......       
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~-------~~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP-------AEFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-------HHHHHHHCTTCCTHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH-------HHHHHhhccccchhhhH
Confidence            32211 11223457788999999999999999999999999999999998875321       0111000000       


Q ss_pred             cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ..+.+.+........+..++..+.+++.+||+.+|++||++.||++.|+.+.+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            01111111111222344566789999999999999999999999999997764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.2e-38  Score=341.29  Aligned_cols=265  Identities=18%  Similarity=0.217  Sum_probs=207.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEE-eecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC-EENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E  609 (893)
                      .++|+..+.||+|+||.||+|+....++.||+|++.....  .+++.+|+.++++++|++++..+.++ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            4678999999999999999999987789999998654322  24688999999999988877666555 66778899999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE---CCCCceeEecccccccCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~~  686 (893)
                      |+ +++|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||+   ++++.+||+|||+++....
T Consensus        86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            99 899999997543 35999999999999999999999   5899999999999999   4889999999999876433


Q ss_pred             CCCc-----cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          687 LDHT-----HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       687 ~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      ....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........................
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence            2211     11244579999999999999999999999999999999999999997644322222211111100000000


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                           .    ....++..+.+++.+||+.+|++||++.+|++.|+.+.+-
T Consensus       241 -----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          241 -----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             -----H----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -----H----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence                 0    1122346788999999999999999999999999987653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.7e-38  Score=345.80  Aligned_cols=259  Identities=26%  Similarity=0.421  Sum_probs=203.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCc---ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEe-ecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE-ENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~l  606 (893)
                      .+|+..++||+|+||+||+|.+...   ...+|+|.+... .....+.+.+|+.++++++||||++++++|. ..+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4577889999999999999986433   245899987653 4455678999999999999999999999864 4567899


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++|+|.+++... ...+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus       105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999754 345899999999999999999999   58999999999999999999999999999986433


Q ss_pred             CCC--ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          687 LDH--THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       687 ~~~--~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      ...  ........||+.|+|||.+.+..++.++|||||||++|||++ |.+|+......+   +......          
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~~~----------  247 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQ----------  247 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHHHT----------
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHhc----------
Confidence            221  122334557889999999999999999999999999999999 555554332211   1111100          


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                        . .....+..++..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       248 --~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          248 --G-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             --T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --C-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              0 0111223345678999999999999999999999999998775

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-38  Score=343.83  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=206.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .++|+..+.||+|+||+||+|....++..||+|++....   ......+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467889999999999999999999888899999864321   12346789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus        88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            99999999999997654  4899999999999999999999   589999999999999999999999999998653321


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                          ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......      .......           
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-----------  221 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISR-----------  221 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHH-----------
T ss_pred             ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HHHHHHh-----------
Confidence                1234568999999999999999999999999999999999999996543211      1111100           


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .....+......+.+++.+||+.+|++||++.|++++-..
T Consensus       222 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~  261 (279)
T 3fdn_A          222 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI  261 (279)
T ss_dssp             TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred             CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccc
Confidence            0112233345678899999999999999999999998764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.9e-38  Score=340.27  Aligned_cols=256  Identities=23%  Similarity=0.290  Sum_probs=208.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      .++|+..+.||+|+||.||+|.....+..||+|++..  ......+.+.+|+.++++++||||+++++++.+....++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4688999999999999999999988888999998643  34455678899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc---eeEecccccccCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV---AKVSDFGLSKTGP  685 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~---~kl~DFGla~~~~  685 (893)
                      ||+++++|.+.+....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999999887653  4899999999999999999999   589999999999999986655   9999999997643


Q ss_pred             CCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ...   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......      ...... .+.    ..
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~-~~~----~~  225 (284)
T 3kk8_A          160 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQIK-AGA----YD  225 (284)
T ss_dssp             SSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HTC----CC
T ss_pred             cCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH------HHHHHH-hcc----cc
Confidence            221   2233569999999999999999999999999999999999999996543211      111110 000    00


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                        ........+...+.+++.+||+.+|++|||+.|++++-..
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (284)
T 3kk8_A          226 --YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI  265 (284)
T ss_dssp             --CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred             --CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence              0011112345678899999999999999999999987654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7e-39  Score=352.06  Aligned_cols=263  Identities=25%  Similarity=0.293  Sum_probs=207.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEe----ecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE----ENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~----~~~~~~l  606 (893)
                      .++|+..+.||+|+||.||+++....++.||+|++........+.+.+|++++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            367889999999999999999998777999999876666677788999999999999999999999986    3457899


Q ss_pred             EEeeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          607 VYDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ||||+++|+|.+++...  ....+++..++.++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999998753  3456999999999999999999999   479999999999999999999999999998753


Q ss_pred             CCCCCc-------cceeeeccCcCccChHhhhhcC---CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh
Q 036624          685 PTLDHT-------HVSTVVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC  754 (893)
Q Consensus       685 ~~~~~~-------~~~~~~~gt~~y~APE~~~~~~---~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  754 (893)
                      ......       .......||+.|+|||++.+..   ++.++|||||||++|||++|+.||....... ..+..     
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~-----  258 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVAL-----  258 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHH-----
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhH-----
Confidence            221100       0012345799999999987543   7899999999999999999999984311100 01110     


Q ss_pred             hcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          755 HKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       755 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                              .+...........+...+.+++.+||+.+|.+||++.+++++|+....
T Consensus       259 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          259 --------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             --------HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             --------HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                    000111111223445678999999999999999999999999986543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.9e-39  Score=374.71  Aligned_cols=257  Identities=24%  Similarity=0.338  Sum_probs=211.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .++|+..++||+|+||.||+|+...+++.||+|++...   .......+.+|+++|++++||||+++++++.+.+..+||
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            46789999999999999999999888899999987532   122356688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++|+|.+++.......+++..+..++.||+.||+|||   ..+||||||||+||||+.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999998776666999999999999999999999   489999999999999999999999999999865332


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                         .......||+.|+|||++.+..++.++|||||||+||||++|+.||........  ..+.....         ..  
T Consensus       340 ---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i---------~~--  403 (576)
T 2acx_A          340 ---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLV---------KE--  403 (576)
T ss_dssp             ---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHH---------HH--
T ss_pred             ---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHh---------hc--
Confidence               123345799999999999999999999999999999999999999976432211  11111110         00  


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                      ....++......+.+++.+||+.||.+||     ++.||+++-.
T Consensus       404 ~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf  447 (576)
T 2acx_A          404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL  447 (576)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred             ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence            01122334456788999999999999999     7889987644

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.3e-39  Score=356.38  Aligned_cols=251  Identities=20%  Similarity=0.246  Sum_probs=182.3

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEEeeccCCC
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVYDYMAYGT  615 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs  615 (893)
                      .++||+|+||+||+|.+...++.||||++..   .....+.+|+.+++++. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            3689999999999999988889999998753   34567889999999997 9999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC---ceeEecccccccCCCCCCccc
Q 036624          616 LREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHV  692 (893)
Q Consensus       616 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~kl~DFGla~~~~~~~~~~~  692 (893)
                      |.+++....  .+++..+..|+.|+++||+|||   +.+|+||||||+|||++.++   .+||+|||+++.....  ...
T Consensus        93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~  165 (325)
T 3kn6_A           93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQP  165 (325)
T ss_dssp             HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCc
Confidence            999997653  5999999999999999999999   58999999999999997665   8999999999864332  122


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccc-ccHHHHHHHhhcccchhhhcccccc--
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ-VSLAEWAAHCHKKGILEQIMDPYLK--  769 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~--  769 (893)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+....         +......  
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------i~~~~~~~~  236 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK---------IKKGDFSFE  236 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH---------HTTTCCCCC
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH---------HHcCCCCCC
Confidence            3345689999999999999999999999999999999999999975432211 111111111         1111110  


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..........+.+++.+||+.||++|||+.|++++-.
T Consensus       237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w  273 (325)
T 3kn6_A          237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW  273 (325)
T ss_dssp             SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred             cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence            0001124567889999999999999999999986533

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.6e-39  Score=344.59  Aligned_cols=252  Identities=29%  Similarity=0.434  Sum_probs=201.0

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeec-CEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN-CEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E  609 (893)
                      .++|+..+.||+|+||+||+|+..+  ..||+|.+....  ..+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT--EEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEcC--CEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            3578899999999999999998864  689999887543  457799999999999999999999997554 47899999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++|+|.+++.......+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            999999999997654445899999999999999999999   489999999999999999999999999998753321  


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                         .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......   +.   ..         +. ...
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~---~~---------~~-~~~  231 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV---PR---------VE-KGY  231 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH---HH---------HT-TTC
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HH---------Hh-cCC
Confidence               122357889999999999999999999999999999998 999986543221   11   11         10 111


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ....+..++..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            122334556778999999999999999999999999997654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.9e-39  Score=361.98  Aligned_cols=248  Identities=25%  Similarity=0.342  Sum_probs=194.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHH-HhhccccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEM-LSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++|+..++||+|+||+||+|+.+..+..||+|++...   .......+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            35789999999999999999999988899999986542   22334566777776 577899999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++|+|.+++.+..  .+++..+..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++....
T Consensus       117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999997654  4889999999999999999999   58999999999999999999999999999985322


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                        ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......      +...         .++..
T Consensus       192 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~---------~i~~~  254 (373)
T 2r5t_A          192 --HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYD---------NILNK  254 (373)
T ss_dssp             --CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHH---------HHHHS
T ss_pred             --CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHH---------HHHhc
Confidence              122234567999999999999999999999999999999999999999654321      1111         11111


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL  802 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl  802 (893)
                      .+  .+++.....+.+++.+||+.||.+||++.+.+
T Consensus       255 ~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          255 PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             CC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             cc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            11  12334456788999999999999999985433

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-38  Score=381.97  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=200.4

Q ss_pred             eeeeecCcEEEEEEEE--cCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEI--DGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~--~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||.||+|.+  ...+..||||+++..  .....++|.+|+++|++++|||||+++++|.. +..+||||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999965  345578999987753  23446789999999999999999999999965 458899999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC-ccc
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH-THV  692 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~-~~~  692 (893)
                      |+|.++|....  .+++..++.|+.||+.||+|||   +.+||||||||+||||++++.+||+|||+++....... ...
T Consensus       454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            99999997643  5999999999999999999999   48999999999999999999999999999986433221 222


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      .....+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+      ....          +.......
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~----------i~~~~~~~  592 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAM----------LEKGERMG  592 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHH----------HHTTCCCC
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH----------HHcCCCCC
Confidence            334457889999999999999999999999999999998 999997543321      1111          11111223


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      .+..++..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            34556778999999999999999999999999998765

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9e-39  Score=355.23  Aligned_cols=256  Identities=20%  Similarity=0.283  Sum_probs=204.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .++|+..+.||+|+||.||+|..+.+++.||+|++.....    .+.+|++++.++ +||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            4678999999999999999999998889999998764332    245788888888 79999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC----CceeEecccccccCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK----WVAKVSDFGLSKTGP  685 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~----~~~kl~DFGla~~~~  685 (893)
                      |+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||+.++    +.+||+|||+++...
T Consensus        97 ~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           97 LMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            999999999997653  5999999999999999999999   4899999999999998543    359999999998643


Q ss_pred             CCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..+....... +.      
T Consensus       172 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~~i~~-~~------  239 (342)
T 2qr7_A          172 AEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEEILARIGS-GK------  239 (342)
T ss_dssp             CTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HHHHHHHHHH-CC------
T ss_pred             CCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HHHHHHHHcc-CC------
Confidence            221  22334578999999999998889999999999999999999999997532211   1121111111 10      


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ..+...........+.+++.+||+.||++||++.+++++-..
T Consensus       240 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence            011111223445678899999999999999999999988765

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.9e-39  Score=364.08  Aligned_cols=268  Identities=24%  Similarity=0.342  Sum_probs=196.4

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeec--CEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEEN--CEM  604 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~  604 (893)
                      ..++|+..++||+|+||+||+|.+...++.||||++..  ......+.+.+|+.++.++. ||||+++++++...  ...
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            45789999999999999999999988889999998753  24556677889999999997 99999999999754  378


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++|||||+ |+|..++...   .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            99999998 6999998763   4899999999999999999999   489999999999999999999999999999753


Q ss_pred             CCC-------------------CCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccc
Q 036624          685 PTL-------------------DHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ  744 (893)
Q Consensus       685 ~~~-------------------~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  744 (893)
                      ...                   ......+...||+.|+|||++.+ ..++.++|||||||++|||++|++||........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            221                   01122334579999999999986 6799999999999999999999999976543221


Q ss_pred             ccHHHHHHHhh--cccchhhhccc------------------ccc------------CCCChHHHHHHHHHHHHccccCC
Q 036624          745 VSLAEWAAHCH--KKGILEQIMDP------------------YLK------------GKIAPECFKKFAETAMKCVSDQG  792 (893)
Q Consensus       745 ~~l~~~~~~~~--~~~~~~~i~d~------------------~l~------------~~~~~~~~~~l~~l~~~Cl~~~p  792 (893)
                      .  ........  ....+..+..+                  ...            ......+...+.+++.+||+.||
T Consensus       240 ~--~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          240 L--ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             H--HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             H--HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            1  11110000  00000000000                  000            00011234568899999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 036624          793 IERPSMGDVLWNLE  806 (893)
Q Consensus       793 ~~RPtm~evl~~L~  806 (893)
                      ++|||+.|++++-.
T Consensus       318 ~~R~t~~e~l~Hp~  331 (388)
T 3oz6_A          318 NKRISANDALKHPF  331 (388)
T ss_dssp             GGSCCHHHHTTSTT
T ss_pred             ccCCCHHHHhCCHH
Confidence            99999999997644

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=8.9e-39  Score=353.77  Aligned_cols=257  Identities=23%  Similarity=0.313  Sum_probs=192.0

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEe--------ec
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCE--------EN  601 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~--------~~  601 (893)
                      ..+|+..++||+|+||.||+|++...++.||+|++........+.+.+|+.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457889999999999999999998888899999876666677788999999999996 999999999993        44


Q ss_pred             CEEEEEEeeccCCCHHHHHhhC-CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCc--eEecCCCCCCEEECCCCceeEecc
Q 036624          602 CEMILVYDYMAYGTLREHLYKT-QKPPLPWKQRLEICIGAARGLHYLHTGAKHT--IIHRDVKTTNILLDEKWVAKVSDF  678 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlk~~NILld~~~~~kl~DF  678 (893)
                      ...++||||+. |+|.+++... ....+++..++.|+.|++.||+|||+   .+  |+||||||+|||++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence            56899999996 8999988652 34469999999999999999999994   66  999999999999999999999999


Q ss_pred             cccccCCCCCCc----------cceeeeccCcCccChHhh---hhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc
Q 036624          679 GLSKTGPTLDHT----------HVSTVVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV  745 (893)
Q Consensus       679 Gla~~~~~~~~~----------~~~~~~~gt~~y~APE~~---~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  745 (893)
                      |+++........          .......||+.|+|||++   .+..++.++|||||||++|||++|+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            999864332111          011234589999999998   56778999999999999999999999996432111  


Q ss_pred             cHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          746 SLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       746 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                                       ++...........+...+.+++.+||+.+|++||++.|++++|+.+..
T Consensus       261 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          261 -----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                             011111111112233457889999999999999999999999997765

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-38  Score=351.40  Aligned_cols=255  Identities=20%  Similarity=0.252  Sum_probs=206.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh------hhHHHHHHHHHHHhhccccceeeEEEEEeecCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE------QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  604 (893)
                      .++|+..+.||+|+||.||+|....++..||+|.+.....      ...+++.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            3568899999999999999999988888999997654321      1367899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC----ceeEecccc
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW----VAKVSDFGL  680 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~----~~kl~DFGl  680 (893)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999999754  35899999999999999999999   48999999999999999887    799999999


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .........  
T Consensus       166 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~--  234 (321)
T 2a2a_A          166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITSVS--  234 (321)
T ss_dssp             CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTC--
T ss_pred             ceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcc--
Confidence            97643221   1234569999999999999999999999999999999999999996543211      111110000  


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                       .-.++..    .......+.+++.+||+.||++|||+.|++++-.
T Consensus       235 -~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~  275 (321)
T 2a2a_A          235 -YDFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (321)
T ss_dssp             -CCCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred             -cccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence             0000000    1123456889999999999999999999997644

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=355.14  Aligned_cols=266  Identities=25%  Similarity=0.376  Sum_probs=205.1

Q ss_pred             cccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEE
Q 036624          520 RHFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYC  598 (893)
Q Consensus       520 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~  598 (893)
                      ..+++.++....++|+..+.||+|+||.||+|.+...++.||+|++.... ...+.+.+|+.+++++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            34455555667789999999999999999999998777899999875432 3356789999999999 799999999999


Q ss_pred             ee------cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc
Q 036624          599 EE------NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV  672 (893)
Q Consensus       599 ~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~  672 (893)
                      ..      ....++||||+++|+|.+++.......+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCC
Confidence            76      468899999999999999998765567999999999999999999999   489999999999999999999


Q ss_pred             eeEecccccccCCCCCCccceeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccH
Q 036624          673 AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL  747 (893)
Q Consensus       673 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l  747 (893)
                      +||+|||+++.....  ........||+.|+|||++.     +..++.++|||||||++|||++|+.||........   
T Consensus       168 ~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---  242 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---  242 (326)
T ss_dssp             EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---
T ss_pred             EEEeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---
Confidence            999999998764321  11223456899999999997     56789999999999999999999999965432111   


Q ss_pred             HHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          748 AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       748 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         ......      ...+.+   ....+...+.+++.+||+.+|.+||++.+++++-.
T Consensus       243 ---~~~~~~------~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~  289 (326)
T 2x7f_A          243 ---LFLIPR------NPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF  289 (326)
T ss_dssp             ---HHHHHH------SCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred             ---HHHhhc------CccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence               001000      001111   12234567889999999999999999999998654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=343.66  Aligned_cols=254  Identities=22%  Similarity=0.328  Sum_probs=202.6

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeecc
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMA  612 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  612 (893)
                      .|....+||+|+||.||+|.....+..||+|.+........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            34455689999999999999988888999998776655667789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCC-CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-CCceeEecccccccCCCCCCc
Q 036624          613 YGTLREHLYKTQ-KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       613 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++|.+++.... ...+++..+..++.|+++||+|||   +.+|+||||||+|||++. ++.+||+|||+++......  
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  177 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--  177 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence            999999997653 335778999999999999999999   489999999999999987 8999999999987643221  


Q ss_pred             cceeeeccCcCccChHhhhhcC--CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~--~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      .......||+.|+|||++.+..  ++.++|||||||++|||++|+.||........    .....          .....
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~----------~~~~~  243 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKV----------GMFKV  243 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HHHHH----------HHHCC
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HHHhh----------ccccc
Confidence            1223456899999999998754  89999999999999999999999964322110    00000          00011


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ....+..+...+.+++.+||+.+|++||++.+++++-
T Consensus       244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~  280 (295)
T 2clq_A          244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDE  280 (295)
T ss_dssp             CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred             cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            1223344566788999999999999999999998653

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=359.38  Aligned_cols=271  Identities=21%  Similarity=0.270  Sum_probs=214.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecC--EEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC--EMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~  608 (893)
                      ++|...++||+|+||+||+|.+...++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56888999999999999999999878999999876432 234577889999999999999999999998655  789999


Q ss_pred             eeccCCCHHHHHhhCC-CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE----CCCCceeEeccccccc
Q 036624          609 DYMAYGTLREHLYKTQ-KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL----DEKWVAKVSDFGLSKT  683 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----d~~~~~kl~DFGla~~  683 (893)
                      ||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999997653 234999999999999999999999   4899999999999999    7888899999999986


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhh--------cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRR--------QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      ....   .......||+.|+|||++.+        ..++.++|||||||++|||++|+.||.........  .+......
T Consensus       166 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~  240 (396)
T 4eut_A          166 LEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII  240 (396)
T ss_dssp             CCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHH
T ss_pred             ccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHh
Confidence            4332   12234569999999999875        56788999999999999999999999754322111  11111111


Q ss_pred             ccc---chhhh---c--------cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          756 KKG---ILEQI---M--------DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       756 ~~~---~~~~i---~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ...   .+..+   .        +..........+...+.+++.+||+.||++||++.|+++.++.++.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            110   00000   0        0011123456788889999999999999999999999999988775

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.6e-39  Score=343.42  Aligned_cols=257  Identities=23%  Similarity=0.295  Sum_probs=207.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .++|+..+.||+|+||.||+|.....++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            46788999999999999999999877789999986532 23445788999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++++|.+++...  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            99999999988643  35899999999999999999999   58999999999999999999999999999875432222


Q ss_pred             ccceeeeccCcCccChHhhhhcCC-CCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... ..+..|...   .          .
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~---~----------~  226 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK---K----------T  226 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTT---C----------T
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhc---c----------c
Confidence            222334568999999999987765 789999999999999999999997644321 112222110   0          0


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ...........+.+++.+||+.+|++|||+.|++++..
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (276)
T 2yex_A          227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (276)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence            00111234456889999999999999999999987543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-38  Score=367.75  Aligned_cols=252  Identities=26%  Similarity=0.364  Sum_probs=207.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|...+.||+|+||.||+|++..+++.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57888999999999999999998878999999875421   123467899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-  169 (476)
T 2y94_A           96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  169 (476)
T ss_dssp             ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence            999999999999654  35999999999999999999999   589999999999999999999999999999864322 


Q ss_pred             CccceeeeccCcCccChHhhhhcCC-CCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                        ......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......      ...         .+.+..
T Consensus       170 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~---------~i~~~~  232 (476)
T 2y94_A          170 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFK---------KICDGI  232 (476)
T ss_dssp             --CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHH---------HHHTTC
T ss_pred             --ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHH---------HHhcCC
Confidence              12334579999999999998765 689999999999999999999997543211      111         111111


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      .  ..+......+.+++.+||+.||++|||+.|++++-...
T Consensus       233 ~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~  271 (476)
T 2y94_A          233 F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK  271 (476)
T ss_dssp             C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence            1  12223445688999999999999999999999876543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6e-39  Score=357.41  Aligned_cols=264  Identities=17%  Similarity=0.169  Sum_probs=198.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC---cceEEEEEeCCCCChh-----------hHHHHHHHHHHHhhccccceeeEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG---ATTKVAIKRGNPLSEQ-----------GVHEFQTEIEMLSKLRHRHLVSLIGY  597 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~VavK~~~~~~~~-----------~~~~f~~E~~~l~~l~H~niv~l~g~  597 (893)
                      ++|...++||+|+||.||+|....   ....+|+|+.......           ....+.+|+.++..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            578899999999999999999976   6678999986544321           12246778889999999999999999


Q ss_pred             Eee----cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC--
Q 036624          598 CEE----NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW--  671 (893)
Q Consensus       598 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~--  671 (893)
                      +..    ....++||||+ +++|.+++....  .+++..++.|+.|++.||+|||   +.+|+||||||+|||++.++  
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            987    78899999999 899999997654  6999999999999999999999   48999999999999999887  


Q ss_pred             ceeEecccccccCCCCC-----CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccccc
Q 036624          672 VAKVSDFGLSKTGPTLD-----HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS  746 (893)
Q Consensus       672 ~~kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~  746 (893)
                      .+||+|||+++......     .........||+.|+|||++.+..++.++|||||||++|||++|+.||......... 
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA-  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH-
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH-
Confidence            99999999997542211     111123456999999999999999999999999999999999999999643221111 


Q ss_pred             HHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          747 LAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       747 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      +...... .... +...+.....   ...++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       270 ~~~~~~~-~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  325 (345)
T 2v62_A          270 VQTAKTN-LLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP  325 (345)
T ss_dssp             HHHHHHH-HHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred             HHHHHHh-hccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1111111 0000 0010000000   11345678999999999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9e-38  Score=346.91  Aligned_cols=273  Identities=23%  Similarity=0.361  Sum_probs=211.3

Q ss_pred             HHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhh--ccccceeeEEEEEeec
Q 036624          524 FAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK--LRHRHLVSLIGYCEEN  601 (893)
Q Consensus       524 ~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~  601 (893)
                      +..-....++|...+.||+|+||.||+|+..  ++.||||++..   .....+.+|++++..  ++||||+++++++...
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3334455678999999999999999999985  47899998764   335678889999887  7899999999999877


Q ss_pred             C----EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCC-----CCceEecCCCCCCEEECCCCc
Q 036624          602 C----EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA-----KHTIIHRDVKTTNILLDEKWV  672 (893)
Q Consensus       602 ~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlk~~NILld~~~~  672 (893)
                      .    ..++||||+++|+|.+++.+.   .+++..++.++.|+++||+|||+..     +.+|+||||||+|||++.++.
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~  185 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  185 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence            5    799999999999999999764   4899999999999999999999321     479999999999999999999


Q ss_pred             eeEecccccccCCCCCCc--cceeeeccCcCccChHhhhhc------CCCCcchhhhHHHHHHHHhhC----------CC
Q 036624          673 AKVSDFGLSKTGPTLDHT--HVSTVVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEILCA----------RP  734 (893)
Q Consensus       673 ~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~------~~s~ksDV~S~Gvvl~elltG----------~~  734 (893)
                      +||+|||+++........  .......||+.|+|||++.+.      .++.++|||||||++|||++|          ..
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            999999998754322111  122345699999999999875      334689999999999999999          66


Q ss_pred             CCCCCCccccccHHHHHHHhhcccchhhhccccccCC-CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          735 ALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK-IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       735 p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ||....... .....+.......     ...+.+... ...++...+.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus       266 p~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          266 PYYDLVPSD-PSVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             TTTTTSCSS-CCHHHHHHHHTTS-----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCcCc-ccHHHHHHHHHHH-----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            775433221 1222222221111     111111111 134678899999999999999999999999999998764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=342.82  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=186.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .++|...+.||+|+||.||+|+....++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            357889999999999999999997777899999875321   12246789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++++|.+++.... ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999997543 46999999999999999999999   489999999999999999999999999998764322


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                      ..  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........               +..+....
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~~  228 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------------LNKVVLAD  228 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred             CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---------------HHHHhhcc
Confidence            11  12235689999999999999999999999999999999999999975432211               01111111


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                        ...+......+.+++.+||+.||++||++.+++++-.
T Consensus       229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  265 (278)
T 3cok_A          229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF  265 (278)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred             --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence              1122334567889999999999999999999987543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.9e-38  Score=340.88  Aligned_cols=248  Identities=26%  Similarity=0.396  Sum_probs=199.7

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEee----cCEEEEE
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE----NCEMILV  607 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV  607 (893)
                      |...+.||+|+||+||+|.....+..||+|.+..  ......+.+.+|+.++++++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            6677789999999999999988888999997653  245567789999999999999999999999865    4568999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCc--eEecCCCCCCEEEC-CCCceeEecccccccC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT--IIHRDVKTTNILLD-EKWVAKVSDFGLSKTG  684 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlk~~NILld-~~~~~kl~DFGla~~~  684 (893)
                      |||+++|+|.+++....  .+++..+..++.|+++||.|||+   .+  |+||||||+|||++ +++.+||+|||+++..
T Consensus       108 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            99999999999997653  48999999999999999999994   66  99999999999998 7899999999999754


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ...    ......||+.|+|||++. +.++.++|||||||++|||++|+.||.......     .........       
T Consensus       183 ~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~~-------  245 (290)
T 1t4h_A          183 RAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSG-------  245 (290)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTTT-------
T ss_pred             ccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HHHHHHhcc-------
Confidence            321    223456999999999887 458999999999999999999999996543221     111111111       


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                        ......+......+.+++.+||+.+|.+||++.|++++-
T Consensus       246 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  284 (290)
T 1t4h_A          246 --VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA  284 (290)
T ss_dssp             --CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             --CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence              000111122335688999999999999999999999753

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.4e-39  Score=345.05  Aligned_cols=255  Identities=23%  Similarity=0.371  Sum_probs=205.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEe--ecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE--ENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~l  606 (893)
                      .++|+..+.||+|+||.||+|.....++.||+|.+..  ......+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            3578899999999999999999988888999998653  24556678999999999999999999999884  4678999


Q ss_pred             EEeeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCc-----eEecCCCCCCEEECCCCceeEeccc
Q 036624          607 VYDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHT-----IIHRDVKTTNILLDEKWVAKVSDFG  679 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDlk~~NILld~~~~~kl~DFG  679 (893)
                      ||||+++++|.+++...  ....+++..++.++.|++.||+|||+   .+     |+||||||+|||+++++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999754  34459999999999999999999995   55     9999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccc
Q 036624          680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI  759 (893)
Q Consensus       680 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  759 (893)
                      +++.....  ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......      +..... ..+.
T Consensus       162 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i-~~~~  232 (279)
T 2w5a_A          162 LARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKI-REGK  232 (279)
T ss_dssp             HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-HHTC
T ss_pred             hheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHHHHH-hhcc
Confidence            98764321  11122356899999999999999999999999999999999999999754321      111111 1111


Q ss_pred             hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       760 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                               ....+..+...+.+++.+||+.+|++||++.||+++++
T Consensus       233 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          233 ---------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ---------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                     01223345567899999999999999999999998765

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-38  Score=346.90  Aligned_cols=261  Identities=22%  Similarity=0.274  Sum_probs=202.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .++|+..++||+|+||.||+|.....++.||+|++...   .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            46899999999999999999999877899999987643   233457899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++++|.+++....  .+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999997653  5999999999999999999999   489999999999999999999999999998764332


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......       .........    ...  
T Consensus       188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~----~~~--  253 (309)
T 2h34_A          188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQA----IPR--  253 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSC----CCC--
T ss_pred             cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccC----CCC--
Confidence            11 1223456899999999999999999999999999999999999999653211       111111000    000  


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHhh
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERP-SMGDVLWNLEFALQL  811 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-tm~evl~~L~~~~~~  811 (893)
                       .....+.++..+.+++.+||+.+|++|| ++.++++.|+.++..
T Consensus       254 -~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          254 -PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             -GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             -ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence             1122334456788999999999999999 999999999977653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=9.1e-39  Score=357.97  Aligned_cols=270  Identities=23%  Similarity=0.319  Sum_probs=209.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..++||+|+||+||+|.+...+..||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            5788999999999999999999988889999987644 445567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++|+|.+++....  .+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++.+||+|||+++....    
T Consensus       113 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----  184 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----  184 (360)
T ss_dssp             CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc----
Confidence            99999999997654  48999999999999999999995  24899999999999999999999999999864211    


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHH---------------------
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAE---------------------  749 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------------------  749 (893)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............                     
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence            11233568999999999999999999999999999999999999997543322100000                     


Q ss_pred             --HHHHhhcccc----hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          750 --WAAHCHKKGI----LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       750 --~~~~~~~~~~----~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                        +.........    +..+................+.+++.+||+.||++|||+.|++++-....
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence              0000000000    01111111111111224567889999999999999999999998876543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=350.69  Aligned_cols=267  Identities=23%  Similarity=0.376  Sum_probs=197.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHH--HhhccccceeeEEEEEee-----cCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEM--LSKLRHRHLVSLIGYCEE-----NCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~  604 (893)
                      ++|+..++||+|+||.||+|+..+  +.||||++...   ....+..|.++  +..++|+||+++++.+..     ....
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETT--EEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             HHhheeeecccCCCeEEEEEEECC--eEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            578899999999999999998753  78999987643   23445555554  456899999999986532     3467


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCC------CCceEecCCCCCCEEECCCCceeEecc
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA------KHTIIHRDVKTTNILLDEKWVAKVSDF  678 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDlk~~NILld~~~~~kl~DF  678 (893)
                      ++||||+++|+|.+++....   .++..+..|+.|+++||+|||+.+      ..+|+||||||+||||+.++.+||+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            89999999999999997654   589999999999999999999521      129999999999999999999999999


Q ss_pred             cccccCCCCC------CccceeeeccCcCccChHhhhh-------cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc
Q 036624          679 GLSKTGPTLD------HTHVSTVVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV  745 (893)
Q Consensus       679 Gla~~~~~~~------~~~~~~~~~gt~~y~APE~~~~-------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  745 (893)
                      |+++......      .........||+.|+|||++.+       ..++.++|||||||++|||++|+.|+.........
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            9997543211      1112234569999999999986       56778999999999999999997776543221111


Q ss_pred             ------------cHHHHHHHhhcccchhhhccccccCC--CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          746 ------------SLAEWAAHCHKKGILEQIMDPYLKGK--IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       746 ------------~l~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                                  ...++.......     ...+.+...  ....+...+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSRE-----KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTS-----CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhhhcccCCCchHHHHHhhhccc-----ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence                        001111000000     001111111  1234677899999999999999999999999999988854

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.6e-38  Score=351.47  Aligned_cols=267  Identities=21%  Similarity=0.277  Sum_probs=196.7

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ..++|+..++||+|+||+||+|.....++.||||++....  ....+.+.+|++++++++||||+++++++.+....++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3568999999999999999999998888999999876443  22345688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE-----CCCCceeEecccccc
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL-----DEKWVAKVSDFGLSK  682 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl-----d~~~~~kl~DFGla~  682 (893)
                      |||++ |+|.+++....  .+++..+..|+.|+++||+|||   +.+|+||||||+|||+     ++++.+||+|||+++
T Consensus       112 ~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            99998 59999997654  4999999999999999999999   4899999999999999     555679999999997


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh--cccc
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH--KKGI  759 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--~~~~  759 (893)
                      .....  ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.  +........  ....
T Consensus       186 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          186 AFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTT
T ss_pred             ccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCchhh
Confidence            54321  1122345689999999999875 489999999999999999999999975433221  111111100  0000


Q ss_pred             hhhh------cc--ccccC-----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          760 LEQI------MD--PYLKG-----KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       760 ~~~i------~d--~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ....      ..  +....     .....+...+.+++.+||+.||++|||+.|++++-.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  321 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY  321 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence            0000      00  00000     001113466789999999999999999999987543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.5e-38  Score=341.77  Aligned_cols=248  Identities=21%  Similarity=0.313  Sum_probs=201.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .++|+..+.||+|+||+||+|.....+..||+|++...  ......++.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            46789999999999999999999877789999986542  344567789999999999 899999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCC--CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC----------------
Q 036624          608 YDYMAYGTLREHLYKTQ--KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE----------------  669 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~----------------  669 (893)
                      |||+++|+|.+++....  ...+++..+..|+.|+++||+|||   +.+|+||||||+|||++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999997642  246999999999999999999999   489999999999999984                


Q ss_pred             ---CCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc
Q 036624          670 ---KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV  745 (893)
Q Consensus       670 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  745 (893)
                         ...+||+|||+++.....      ....||+.|+|||++.+. .++.++|||||||++|||++|.+++....     
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----  235 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----  235 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence               448999999998864332      123489999999999876 66789999999999999999998763221     


Q ss_pred             cHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          746 SLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       746 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         .+.          .+.... ....+..+...+.+++.+||+.||++||++.|++++-.
T Consensus       236 ---~~~----------~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  282 (289)
T 1x8b_A          236 ---QWH----------EIRQGR-LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV  282 (289)
T ss_dssp             ---HHH----------HHHTTC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred             ---HHH----------HHHcCC-CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence               011          011111 11223344567889999999999999999999987643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.1e-38  Score=345.89  Aligned_cols=259  Identities=25%  Similarity=0.371  Sum_probs=199.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC---cceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG---ATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      ++|+..+.||+|+||+||+|++..   ....||+|++...   .....+.+.+|++++++++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            578889999999999999998643   2236899987643   2345678999999999999999999999998765 88


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +|+||+++|+|.+++.... ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            9999999999999997643 35899999999999999999999   4899999999999999999999999999988654


Q ss_pred             CCCCc-cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          686 TLDHT-HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       686 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......      +......        
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~--------  238 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKID--------  238 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH--------
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHH--------
Confidence            32221 12234457889999999999999999999999999999999 99999654321      1111111        


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                       ........+..++..+.+++.+||+.+|++||++.++++.|+++.+
T Consensus       239 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          239 -KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence             1111112233456778999999999999999999999999997654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.2e-38  Score=340.82  Aligned_cols=254  Identities=20%  Similarity=0.274  Sum_probs=203.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC------hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS------EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      ++|+..+.||+|+||.||+|.....++.||+|.+....      ....+.+.+|+.++++++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56888999999999999999998877899999764321      123678999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC----ceeEeccccc
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW----VAKVSDFGLS  681 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~----~~kl~DFGla  681 (893)
                      +||||+++++|.+++....  .+++..+..++.|+++||+|||   +.+|+||||||+||++++++    .+||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            9999999999999997643  5899999999999999999999   48999999999999998877    8999999998


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      +......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......      ........ .  
T Consensus       160 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-~--  227 (283)
T 3bhy_A          160 HKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTNISAV-N--  227 (283)
T ss_dssp             EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTT-C--
T ss_pred             eeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHHhHhc-c--
Confidence            7643211   1234568999999999999999999999999999999999999997543211      11110000 0  


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ....+.    ........+.+++.+||+.+|++||++.|++++-.
T Consensus       228 ~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  268 (283)
T 3bhy_A          228 YDFDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW  268 (283)
T ss_dssp             CCCCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred             cCCcch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence            000000    01123456889999999999999999999998654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.6e-38  Score=343.33  Aligned_cols=254  Identities=24%  Similarity=0.353  Sum_probs=209.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      +.|+..+.||+|+||.||+|.....+..||+|.+... .....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            5688899999999999999999887889999986543 234567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++..   ..+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++......  
T Consensus       102 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          102 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            999999999864   35999999999999999999999   4899999999999999999999999999987643221  


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ......      ....+    
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~------~~~~~----  237 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------VLFLIP------KNNPP----  237 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH------HSCCC----
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HHHHhh------cCCCC----
Confidence            12234568999999999999999999999999999999999999996543211      111100      00111    


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      .....+...+.+++.+||+.+|++||++.+++++.....
T Consensus       238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence            122334566889999999999999999999998776533

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4e-38  Score=361.01  Aligned_cols=264  Identities=21%  Similarity=0.226  Sum_probs=207.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc------cccceeeEEEEEeecCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL------RHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l------~H~niv~l~g~~~~~~~~  604 (893)
                      ..+|+..++||+|+||+||+|.....++.||||++.. .....+.+.+|+++++.+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            3578899999999999999999988889999999875 344456788899998887      467999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc--eeEecccccc
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV--AKVSDFGLSK  682 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~--~kl~DFGla~  682 (893)
                      ++||||+. ++|.+++.......+++..+..|+.|+++||+|||+   .+||||||||+||||+.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999997 799999988766679999999999999999999994   79999999999999999887  9999999997


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh-------
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH-------  755 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-------  755 (893)
                      .....     .....||+.|+|||++.+..++.++|||||||+||||++|++||......+.  +..+.....       
T Consensus       251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~--l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ--LACMIELLGMPSQKLL  323 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHH
T ss_pred             ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCCHHHH
Confidence            53321     2235689999999999999999999999999999999999999976543221  111111100       


Q ss_pred             -cccchhhhcccc---------------------------ccC---------CCChHHHHHHHHHHHHccccCCCCCCCH
Q 036624          756 -KKGILEQIMDPY---------------------------LKG---------KIAPECFKKFAETAMKCVSDQGIERPSM  798 (893)
Q Consensus       756 -~~~~~~~i~d~~---------------------------l~~---------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm  798 (893)
                       ........++..                           ...         .........+.+++.+||+.||++|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence             000000000000                           000         0011124568899999999999999999


Q ss_pred             HHHHHHHH
Q 036624          799 GDVLWNLE  806 (893)
Q Consensus       799 ~evl~~L~  806 (893)
                      .|++++-.
T Consensus       404 ~e~L~Hpw  411 (429)
T 3kvw_A          404 GQALRHPW  411 (429)
T ss_dssp             HHHHTSTT
T ss_pred             HHHhCChh
Confidence            99997655

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.1e-38  Score=342.19  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=208.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|...+.||+|+||.||++.....++.+|+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            5688899999999999999999988889999976432   3455678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++++|.+++....  .+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        95 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             ECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            9999999999887643  5899999999999999999999   4899999999999999999999999999987643211


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                        .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+      ......         ... 
T Consensus       170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~---------~~~-  231 (294)
T 2rku_A          170 --ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIK---------KNE-  231 (294)
T ss_dssp             --CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH---------TTC-
T ss_pred             --cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHh---------hcc-
Confidence              12234568999999999999999999999999999999999999996543211      111111         110 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                       ...+......+.+++.+||+.+|++||++.|++++...
T Consensus       232 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~  269 (294)
T 2rku_A          232 -YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF  269 (294)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             -CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence             11223344678899999999999999999999987654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2e-38  Score=370.85  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=208.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|...++||+|+||.||+|+...+++.||+|++....   ....+.+.+|++++++++||||+++++++.....++|||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888999999999999999998888999999875321   123567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCC--CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          609 DYMAYGTLREHLYKTQ--KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||+++|+|.+++....  ...+++..+..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999997653  456999999999999999999999   48999999999999999999999999999986432


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      ..  ......+||+.|+|||++.+..++.++|||||||+||||++|+.||.......  ...+....         +...
T Consensus       342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~---------i~~~  408 (543)
T 3c4z_A          342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQR---------VLEQ  408 (543)
T ss_dssp             TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHH---------HHHC
T ss_pred             CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHH---------Hhhc
Confidence            21  12234579999999999999999999999999999999999999997643211  11111111         1111


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSM-----GDVLWNL  805 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm-----~evl~~L  805 (893)
                      .  ..++......+.+++.+||+.+|++||++     .+|+++-
T Consensus       409 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp  450 (543)
T 3c4z_A          409 A--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP  450 (543)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred             c--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence            1  12334455678899999999999999975     5666543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=354.29  Aligned_cols=265  Identities=15%  Similarity=0.165  Sum_probs=206.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC--------cceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceee----------
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG--------ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVS----------  593 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~--------~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~----------  593 (893)
                      ++|...+.||+|+||.||+|+...        .+..||+|.....     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578899999999999999999876        3578999987643     35889999999999999987          


Q ss_pred             -----EEEEEee-cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE
Q 036624          594 -----LIGYCEE-NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL  667 (893)
Q Consensus       594 -----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  667 (893)
                           +++++.. ....++||||+ +++|.+++.......+++..++.|+.|+++||+|||   +.+|+||||||+|||+
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence                 6778776 78899999999 999999998764557999999999999999999999   4899999999999999


Q ss_pred             CCCC--ceeEecccccccCCCCCC-----ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCC
Q 036624          668 DEKW--VAKVSDFGLSKTGPTLDH-----THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTL  740 (893)
Q Consensus       668 d~~~--~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~  740 (893)
                      +.++  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  999999999976432111     111233469999999999999999999999999999999999999997543


Q ss_pred             ccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          741 PKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       741 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      .... .+.........  ....+.+...   ........+.+++.+||+.+|++||++.+|++.|+.+.+-
T Consensus       273 ~~~~-~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          273 PNTE-DIMKQKQKFVD--KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             TCHH-HHHHHHHHHHH--SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCHH-HHHHHHHhccC--Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            2211 11111111100  0011111100   0112346788999999999999999999999999987753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-38  Score=342.26  Aligned_cols=252  Identities=25%  Similarity=0.336  Sum_probs=198.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|...++||+|+||+||++.....+..||+|++... .....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            5688899999999999999999888889999976543 233467899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE---CCCCceeEecccccccCC
Q 036624          611 MAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       611 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~  685 (893)
                      +++|+|.+++...  ....+++..+..|+.|+++||+|||   +.+|+||||||+|||+   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988643  2356999999999999999999999   5899999999999999   456789999999997643


Q ss_pred             CCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ..   .......||+.|+|||++. +.++.++|||||||++|||++|+.||.......      ........       .
T Consensus       179 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~-------~  241 (285)
T 3is5_A          179 SD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYK-------E  241 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC-------C
T ss_pred             Cc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccC-------C
Confidence            21   1233456999999999986 568999999999999999999999997543211      11111000       0


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      +..... .......+.+++.+||+.||++||++.|++++
T Consensus       242 ~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          242 PNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            110000 01124567889999999999999999999865

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.6e-38  Score=351.21  Aligned_cols=263  Identities=19%  Similarity=0.233  Sum_probs=208.5

Q ss_pred             HHHHHHhcCCccc-eeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhcc-ccceeeEEEEEee
Q 036624          525 AEIKAATNNFDEA-LLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEE  600 (893)
Q Consensus       525 ~el~~at~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~  600 (893)
                      ...+...+.|... ++||+|+||+||+|.....++.||+|++...  .......+.+|+.++.+++ ||||+++++++.+
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3344455667776 7899999999999999888899999976542  2334678999999999995 6999999999999


Q ss_pred             cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC---CCceeEec
Q 036624          601 NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE---KWVAKVSD  677 (893)
Q Consensus       601 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~D  677 (893)
                      ....++||||+++|+|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEee
Confidence            999999999999999999997665667999999999999999999999   489999999999999998   78999999


Q ss_pred             ccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc
Q 036624          678 FGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK  757 (893)
Q Consensus       678 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  757 (893)
                      ||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||........      ....   
T Consensus       178 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i---  245 (327)
T 3lm5_A          178 FGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET------YLNI---  245 (327)
T ss_dssp             GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH---
T ss_pred             CccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH------HHHH---
Confidence            9999864321   122345699999999999999999999999999999999999999965432211      0000   


Q ss_pred             cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          758 GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         ... ...........+...+.+++.+||+.+|++|||+.+++++-.
T Consensus       246 ---~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~  290 (327)
T 3lm5_A          246 ---SQV-NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW  290 (327)
T ss_dssp             ---HHT-CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred             ---Hhc-ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence               000 011111222345567889999999999999999999987644

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.3e-39  Score=355.12  Aligned_cols=246  Identities=18%  Similarity=0.254  Sum_probs=204.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--------hhhHHHHHHHHHHHhhccccceeeEEEEEeecC
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--------EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  602 (893)
                      .++|+..++||+|+||+||+|.....+..||||++....        ....+.+.+|++++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            567999999999999999999998888999999765432        113346788999999999999999999999999


Q ss_pred             EEEEEEeeccCC-CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          603 EMILVYDYMAYG-TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       603 ~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      ..++||||+.+| +|.+++....  .+++..+..|+.|++.||+|||   ..+|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            999999999777 9999997553  4999999999999999999999   489999999999999999999999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCC-CCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      +.....   .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....                   
T Consensus       178 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------  235 (335)
T 3dls_A          178 AYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------------  235 (335)
T ss_dssp             EECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------------
T ss_pred             eECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------------
Confidence            864332   12234669999999999998876 7899999999999999999999954211                   


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                        ......  ..+..+...+.+++.+||+.+|++||++.+++++-..
T Consensus       236 --~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~  278 (335)
T 3dls_A          236 --TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV  278 (335)
T ss_dssp             --GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred             --HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence              011100  1112234568899999999999999999999987553

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.7e-38  Score=340.76  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=208.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||.||+|.....+..||+|.+....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57889999999999999999998888899999865321   123467899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++|+|.+++....  .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||++...... 
T Consensus        94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            9999999999997654  4899999999999999999999   589999999999999999999999999998754321 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                         ......|++.|+|||++.+..++.++||||||+++|||++|+.||.......      ....         +.... 
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~---------~~~~~-  228 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRR---------IVNVD-  228 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH---------HHTTC-
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHH---------Hhccc-
Confidence               1234568999999999999999999999999999999999999996543211      1111         11111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                       ..++......+.+++.+||+.+|.+||++.+++++-..
T Consensus       229 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~  266 (284)
T 2vgo_A          229 -LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV  266 (284)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred             -cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence             12233445678899999999999999999999987654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.9e-38  Score=362.87  Aligned_cols=264  Identities=19%  Similarity=0.206  Sum_probs=199.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec------C
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------C  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~  602 (893)
                      .++|+..++||+|+||+||+|.+...++.||||++...  .....+.+.+|+.+|++++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46799999999999999999999888899999987643  445567889999999999999999999999644      4


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ..+||||||++ +|.+.+..    .+++..+..++.|+++||+|||   ..+|+||||||+||||+.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            67999999985 56666642    3899999999999999999999   4899999999999999999999999999998


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh-------
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH-------  755 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-------  755 (893)
                      ....   ....+...||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+..  ......+.       
T Consensus       213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~--~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          213 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW--NKVIEQLGTPCPEFM  287 (464)
T ss_dssp             -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCHHHH
T ss_pred             ecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCCHHHH
Confidence            6432   12234467999999999999999999999999999999999999999765432211  11110000       


Q ss_pred             -----------cc------cchhhhccccccCCC---ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          756 -----------KK------GILEQIMDPYLKGKI---APECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       756 -----------~~------~~~~~i~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                                 ..      ..+.......+....   .......+.+|+.+||+.||++|||+.|++++-..
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~  359 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  359 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence                       00      000000000000000   01125678999999999999999999999987654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.1e-38  Score=350.19  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=209.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .++|...++||+|+||.||++.+...+..+|+|++...   .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            35788899999999999999999988889999976432   345567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++++|.+++....  .+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            99999999999887643  5899999999999999999999   489999999999999999999999999999764321


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ........         .
T Consensus       195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~---------~  257 (335)
T 2owb_A          195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKN---------E  257 (335)
T ss_dssp             T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHT---------C
T ss_pred             c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHhcC---------C
Confidence            1  12234569999999999999999999999999999999999999996543211      11111100         0


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                        ...+..+...+.+++.+||+.||++||++.|++++-..
T Consensus       258 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~  295 (335)
T 2owb_A          258 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF  295 (335)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence              11223344568889999999999999999999987654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.8e-38  Score=342.65  Aligned_cols=256  Identities=23%  Similarity=0.304  Sum_probs=205.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC----hhhHHHHHHHHHHHhhccccceeeEEEEE--eecCEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS----EQGVHEFQTEIEMLSKLRHRHLVSLIGYC--EENCEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~--~~~~~~  604 (893)
                      .++|...+.||+|+||.||++.....+..||+|.+....    ....+.+.+|+.++++++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999998888899999876432    23457799999999999999999999998  455678


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++||||++++ |.+++.......+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999976 888887766667999999999999999999999   489999999999999999999999999999865


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcC--CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                      .............||+.|+|||++.+..  ++.++|||||||++|||++|+.||......      +......       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~-------  226 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENIG-------  226 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHH-------
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHHh-------
Confidence            4322233334456999999999998654  377999999999999999999999754221      1111111       


Q ss_pred             hccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          763 IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       763 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                        ...  ...+..+...+.+++.+||+.||.+||++.|++++-..
T Consensus       227 --~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  267 (305)
T 2wtk_C          227 --KGS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF  267 (305)
T ss_dssp             --HCC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred             --cCC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence              000  12233455678899999999999999999999987664

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-37  Score=353.22  Aligned_cols=264  Identities=21%  Similarity=0.207  Sum_probs=207.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc--------ccceeeEEEEEe----
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR--------HRHLVSLIGYCE----  599 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~--------H~niv~l~g~~~----  599 (893)
                      ++|+..++||+|+||+||+|+...+++.||||++... ....+.+.+|++++++++        |+||+++++++.    
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            6799999999999999999999888899999998743 445677899999999996        788999999987    


Q ss_pred             ecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCC-ceEecCCCCCCEEECCCC-------
Q 036624          600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH-TIIHRDVKTTNILLDEKW-------  671 (893)
Q Consensus       600 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlk~~NILld~~~-------  671 (893)
                      .....+|||||+ +++|.+.+.......+++..+..|+.|++.||+|||+   . +|+||||||+||||+.++       
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhh
Confidence            556899999999 5777777766655679999999999999999999995   5 999999999999998765       


Q ss_pred             ------------------------------------------ceeEecccccccCCCCCCccceeeeccCcCccChHhhh
Q 036624          672 ------------------------------------------VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR  709 (893)
Q Consensus       672 ------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~  709 (893)
                                                                .+||+|||+++.....     .....||+.|+|||++.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc
Confidence                                                      8999999999864321     23346899999999999


Q ss_pred             hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH---hhccc---------chhhhcccc----------
Q 036624          710 RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH---CHKKG---------ILEQIMDPY----------  767 (893)
Q Consensus       710 ~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~---~~~~~---------~~~~i~d~~----------  767 (893)
                      +..++.++|||||||+||||++|+.||..........-.+....   ....-         ...+.....          
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            99999999999999999999999999976543221111111110   00000         000000000          


Q ss_pred             ---------ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          768 ---------LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       768 ---------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                               -....+.++...+.+|+.+||+.||++|||+.|++++-
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  393 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP  393 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence                     01124567788899999999999999999999999753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.8e-38  Score=345.37  Aligned_cols=255  Identities=21%  Similarity=0.314  Sum_probs=206.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|...+.||+|+||+||+++....++.||+|.+........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            45788999999999999999999877789999987755444556789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE---CCCCceeEecccccccCCCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~~~  687 (893)
                      +++++|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||+   ++++.+||+|||+++.....
T Consensus        88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            99999999987654  4899999999999999999999   4899999999999999   78899999999998754321


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ...... .+.    .  .
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~-~~~----~--~  225 (304)
T 2jam_A          163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LFEKIK-EGY----Y--E  225 (304)
T ss_dssp             ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HCC----C--C
T ss_pred             ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-cCC----C--C
Confidence                1233468999999999999999999999999999999999999996543211      111111 100    0  0


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ............+.+++.+||+.||++||++.|++++-..
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (304)
T 2jam_A          226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI  265 (304)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence            1112223445678899999999999999999999987653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-37  Score=343.49  Aligned_cols=264  Identities=18%  Similarity=0.254  Sum_probs=208.2

Q ss_pred             cCCccceeeeecCcEEEEEEEE-cCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccc------eeeEEEEEeecCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEI-DGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH------LVSLIGYCEENCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~~  604 (893)
                      ++|+..++||+|+||+||+|.. ...+..||||++... ....+.+.+|++++++++|++      ++++++++...+..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            5788999999999999999998 456688999998643 445678899999999998765      99999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC---------------
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE---------------  669 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---------------  669 (893)
                      ++||||+ +++|.+++......++++..+..++.|+++||+|||   +.+|+||||||+|||++.               
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            9999999 799999998776667999999999999999999999   489999999999999987               


Q ss_pred             ----CCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc
Q 036624          670 ----KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV  745 (893)
Q Consensus       670 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  745 (893)
                          ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             ccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                678999999999863321     22356899999999999999999999999999999999999999765433221


Q ss_pred             cHHHHHHHhhcccc--------------------------hhhhccccc-cCCCChHHHHHHHHHHHHccccCCCCCCCH
Q 036624          746 SLAEWAAHCHKKGI--------------------------LEQIMDPYL-KGKIAPECFKKFAETAMKCVSDQGIERPSM  798 (893)
Q Consensus       746 ~l~~~~~~~~~~~~--------------------------~~~i~d~~l-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm  798 (893)
                      ..............                          ......+.. .......+...+.+++.+||+.||.+|||+
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            11110000000000                          000000000 012234567889999999999999999999


Q ss_pred             HHHHHHH
Q 036624          799 GDVLWNL  805 (893)
Q Consensus       799 ~evl~~L  805 (893)
                      .|++++-
T Consensus       324 ~ell~hp  330 (339)
T 1z57_A          324 REALKHP  330 (339)
T ss_dssp             HHHTTSG
T ss_pred             HHHhcCH
Confidence            9998763

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.1e-39  Score=352.71  Aligned_cols=266  Identities=22%  Similarity=0.340  Sum_probs=199.2

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh-hHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|...++||+|+||+||+|....++..||+|++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            4688899999999999999999887889999987643322 122456899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      ++ |+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .
T Consensus        82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T  154 (324)
T ss_dssp             CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--c
Confidence            98 69999887653 35999999999999999999999   589999999999999999999999999999754321  1


Q ss_pred             cceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc---cchhhhcc-
Q 036624          691 HVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK---GILEQIMD-  765 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~i~d-  765 (893)
                      .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..  . ........   ........ 
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~-~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL--H-FIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--H-HHHHHHCCCCTTTSTTGGGC
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--H-HHHHHhCCCChHhchhhhcc
Confidence            22233468999999999976 57899999999999999999999999765432211  1 11111100   00000000 


Q ss_pred             --------ccccC----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          766 --------PYLKG----KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       766 --------~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                              +....    ...+.....+.+++.+||+.||++|||+.|++++-..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  285 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF  285 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence                    00000    0011234567899999999999999999999986553

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.8e-39  Score=363.52  Aligned_cols=245  Identities=14%  Similarity=0.150  Sum_probs=192.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC---CChhhHHHHHHHH---HHHhhccccceeeEE-------EE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEI---EMLSKLRHRHLVSLI-------GY  597 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~---~~~~~~~~f~~E~---~~l~~l~H~niv~l~-------g~  597 (893)
                      .++|...+.||+|+||+||+|++...++.||||++..   ......+.|.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            4678889999999999999999877778999998752   3344567899999   555566899999998       66


Q ss_pred             EeecC-----------------EEEEEEeeccCCCHHHHHhhCCC-----CCCCHHhHHHHHHHHHHhhhhhhcCCCCce
Q 036624          598 CEENC-----------------EMILVYDYMAYGTLREHLYKTQK-----PPLPWKQRLEICIGAARGLHYLHTGAKHTI  655 (893)
Q Consensus       598 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  655 (893)
                      +...+                 ..+|||||+ +|+|.+++.....     ..+++..++.|+.|+++||+|||+   .+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            65553                 278999999 5899999975421     234468899999999999999994   899


Q ss_pred             EecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhc-----------CCCCcchhhhHHH
Q 036624          656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGV  724 (893)
Q Consensus       656 vHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDV~S~Gv  724 (893)
                      +||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985322     2334567 999999999988           8999999999999


Q ss_pred             HHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          725 VLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       725 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      +||||++|+.||.......               ....+...      ...+...+.+++.+||+.||++||++.|++++
T Consensus       302 il~elltg~~Pf~~~~~~~---------------~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALG---------------GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHHSSCCC------C---------------CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHHCCCCCccccccc---------------chhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            9999999999996533211               11111111      12334678899999999999999999999976


Q ss_pred             HH
Q 036624          805 LE  806 (893)
Q Consensus       805 L~  806 (893)
                      -.
T Consensus       361 p~  362 (377)
T 3byv_A          361 PE  362 (377)
T ss_dssp             HH
T ss_pred             hH
Confidence            43

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-38  Score=366.06  Aligned_cols=270  Identities=20%  Similarity=0.231  Sum_probs=188.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEee-----cCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE-----NCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~~  604 (893)
                      ++|+..++||+|+||+||+|.+...++.||||++...  .....+.+.+|+++|++++||||+++++++..     ...+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            6799999999999999999999888899999987542  44556789999999999999999999999943     3578


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++||||+. |+|.+++...  ..+++..+..++.||++||+|||+   .+||||||||+||||+.++.+||+|||+++..
T Consensus       133 ~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            99999985 7999998654  359999999999999999999994   89999999999999999999999999999864


Q ss_pred             CCCCC-------------------------ccceeeeccCcCccChHhh-hhcCCCCcchhhhHHHHHHHHhh-------
Q 036624          685 PTLDH-------------------------THVSTVVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEILC-------  731 (893)
Q Consensus       685 ~~~~~-------------------------~~~~~~~~gt~~y~APE~~-~~~~~s~ksDV~S~Gvvl~ellt-------  731 (893)
                      .....                         ....+...||+.|+|||++ ....++.++|||||||+||||++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            32111                         0123445789999999986 56679999999999999999999       


Q ss_pred             ----CCCCCCCCCccc----c-------------ccHHHHHHHhhccc-----------chhhhcc---ccc---cCCCC
Q 036624          732 ----ARPALNPTLPKE----Q-------------VSLAEWAAHCHKKG-----------ILEQIMD---PYL---KGKIA  773 (893)
Q Consensus       732 ----G~~p~~~~~~~~----~-------------~~l~~~~~~~~~~~-----------~~~~i~d---~~l---~~~~~  773 (893)
                          |+++|.+.....    .             ..............           .....+.   ...   .....
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                556554322100    0             00000000000000           0000000   000   00011


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          774 PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       774 ~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      +.....+.+|+.+||+.||++|||+.|++++-..
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f  400 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFF  400 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence            2335678899999999999999999999987653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.3e-38  Score=352.36  Aligned_cols=267  Identities=24%  Similarity=0.352  Sum_probs=204.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..++||+|+||.||+|+....++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            5788899999999999999999888889999976433  33445678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++++|..++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       105 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  177 (331)
T 4aaa_A          105 FVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--  177 (331)
T ss_dssp             CCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             cCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence            999999988775443  4999999999999999999999   489999999999999999999999999999754321  


Q ss_pred             ccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH-----------hhcc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH-----------CHKK  757 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----------~~~~  757 (893)
                      ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.  +......           ....
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHHC
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhhhc
Confidence            1122345689999999999875 789999999999999999999999976543221  1111110           0001


Q ss_pred             cchhhhccccccCCC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          758 GILEQIMDPYLKGKI-----APECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       758 ~~~~~i~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ........+.+....     .+.+...+.+++.+||+.||++|||+.|++++-..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f  310 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF  310 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence            111111111111111     12345678999999999999999999999987654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.9e-38  Score=341.27  Aligned_cols=258  Identities=20%  Similarity=0.292  Sum_probs=193.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-Chh-hHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQ-GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      .++|+..+.||+|+||+||+|.....++.||+|++... ... ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788999999999999999999888899999987653 222 3334455566688889999999999999999999999


Q ss_pred             eeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCCCC-ceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          609 DYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGAKH-TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       609 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      ||++ |+|.+++...  ....+++..+..|+.|++.||+|||+   . +|+||||||+|||++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9998 5888877542  34569999999999999999999995   5 99999999999999999999999999997643


Q ss_pred             CCCCccceeeeccCcCccChHhh----hhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~----~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      ..   .......||+.|+|||++    .+..++.++|||||||++|||++|+.||.......    ....          
T Consensus       162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~----------  224 (290)
T 3fme_A          162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF----QQLK----------  224 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH----HHHH----------
T ss_pred             cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH----HHHH----------
Confidence            21   122334699999999996    56678999999999999999999999996532211    1111          


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ..+...............+.+++.+||+.+|++|||+.|++++-....
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          225 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            111111111112234567889999999999999999999998766543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.8e-38  Score=346.03  Aligned_cols=265  Identities=23%  Similarity=0.320  Sum_probs=188.0

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .++|+..+.||+|+||.||+|.....+..||||++.... ....+++.+|+.++++++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            568999999999999999999987777899999876432 3345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhC------CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          610 YMAYGTLREHLYKT------QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       610 ~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      |+++++|.+++...      ....+++..+..++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            99999999998641      2345999999999999999999999   48999999999999999999999999999875


Q ss_pred             CCCCC---CccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccc
Q 036624          684 GPTLD---HTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI  759 (893)
Q Consensus       684 ~~~~~---~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  759 (893)
                      .....   .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........   ..  . .... 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~--~-~~~~-  243 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---ML--T-LQND-  243 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HH--H-HTSS-
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HH--H-hccC-
Confidence            43211   1112234569999999999976 57899999999999999999999999765432211   00  0 0000 


Q ss_pred             hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       760 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ....................+.+++.+||+.||.+||++.+++++-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  289 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK  289 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence            0000000001111223345788999999999999999999999753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=9.8e-38  Score=350.28  Aligned_cols=259  Identities=24%  Similarity=0.313  Sum_probs=205.5

Q ss_pred             HHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--------hhhHHHHHHHHHHHhhc-cccceeeEEE
Q 036624          526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--------EQGVHEFQTEIEMLSKL-RHRHLVSLIG  596 (893)
Q Consensus       526 el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--------~~~~~~f~~E~~~l~~l-~H~niv~l~g  596 (893)
                      ......++|+..+.||+|+||.||+|.+..+++.||||++....        ....+.+.+|+.+++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34455678999999999999999999998777899999765432        11245688999999999 7999999999


Q ss_pred             EEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEe
Q 036624          597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVS  676 (893)
Q Consensus       597 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~  676 (893)
                      ++......++||||+++++|.+++....  .+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence            9999999999999999999999997543  4999999999999999999999   4899999999999999999999999


Q ss_pred             cccccccCCCCCCccceeeeccCcCccChHhhhhc------CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHH
Q 036624          677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEW  750 (893)
Q Consensus       677 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  750 (893)
                      |||++.......   ......||+.|+|||++.+.      .++.++|||||||++|||++|+.||.......      .
T Consensus       243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------~  313 (365)
T 2y7j_A          243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------M  313 (365)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------H
T ss_pred             ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH------H
Confidence            999987643321   22346799999999998743      58899999999999999999999996532211      1


Q ss_pred             HHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          751 AAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       751 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ..... .+... ...+.     ...+...+.+++.+||+.+|++||++.|++++-
T Consensus       314 ~~~i~-~~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  361 (365)
T 2y7j_A          314 LRMIM-EGQYQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQHP  361 (365)
T ss_dssp             HHHHH-HTCCC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHHHH-hCCCC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence            11100 00000 00000     012245688999999999999999999999753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-38  Score=352.59  Aligned_cols=262  Identities=22%  Similarity=0.284  Sum_probs=198.9

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec------C
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------C  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~  602 (893)
                      .++|+..+.||+|+||.||+|.+...++.||||++...  .....+.+.+|++++++++||||+++++++...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            36788999999999999999999888899999987542  344567889999999999999999999999765      3


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ..++||||+ +++|.+++...   .+++..+..++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            469999999 78999998763   4899999999999999999999   4899999999999999999999999999998


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh------
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH------  755 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~------  755 (893)
                      .....     .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........  ........      
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l--~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL--KEIMKVTGTPPAEF  249 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCCHHH
Confidence            64321     233568999999999987 78999999999999999999999999765432211  11110000      


Q ss_pred             ----cccchhhhcc--ccc----cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          756 ----KKGILEQIMD--PYL----KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       756 ----~~~~~~~i~d--~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                          ........+.  +..    .....+.....+.+++.+||+.||++|||+.|++++-.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~  310 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  310 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence                0000000000  000    01112334567889999999999999999999998654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-37  Score=357.40  Aligned_cols=200  Identities=26%  Similarity=0.349  Sum_probs=168.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec-----CE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN-----CE  603 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~  603 (893)
                      .++|+..++||+|+||+||+|.+..+++.||||++...  .....+.+.+|+++|++++|+||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            36899999999999999999999988899999987653  445567899999999999999999999999766     57


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      .++||||++ |+|.+++...  ..+++..+..++.||++||+|||+   .+|+||||||+||||+.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            999999987 6999999654  359999999999999999999994   8999999999999999999999999999986


Q ss_pred             CCCCCCc--------------------cceeeeccCcCccChHhh-hhcCCCCcchhhhHHHHHHHHhhCCCCC
Q 036624          684 GPTLDHT--------------------HVSTVVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEILCARPAL  736 (893)
Q Consensus       684 ~~~~~~~--------------------~~~~~~~gt~~y~APE~~-~~~~~s~ksDV~S~Gvvl~elltG~~p~  736 (893)
                      .......                    ...+...||+.|+|||++ ....++.++|||||||+||||++|..|+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            4322111                    123456799999999986 5667999999999999999999855444

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.3e-37  Score=358.34  Aligned_cols=264  Identities=19%  Similarity=0.207  Sum_probs=207.9

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccc-cceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .++|+..++||+|+||.||+|++...+..||||+......  ..++..|+++++.++| +++..+..++......+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            3678999999999999999999987778999997554322  2358899999999986 566667777788889999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE---CCCCceeEecccccccCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~~~  686 (893)
                      |+ +++|.+++.... ..+++..++.|+.||+.||+|||   ..+||||||||+||||   ++++.+||+|||+++....
T Consensus        84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99 899999997543 35999999999999999999999   5899999999999999   6889999999999986433


Q ss_pred             CCCc-----cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          687 LDHT-----HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       687 ~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      ....     .......||+.|+|||++.+..++.++|||||||+||||++|+.||.......................+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            2111     12235679999999999999999999999999999999999999997654332221111111111011111


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .+         ...++.++.+++.+||+.+|++||++.+|++.|+.+..
T Consensus       239 ~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          239 AL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             HH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            11         11234678999999999999999999999999998864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-38  Score=349.27  Aligned_cols=271  Identities=23%  Similarity=0.267  Sum_probs=200.9

Q ss_pred             HHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh-----hHHHHHHHHHHHhhccccceeeEEEEEeecC
Q 036624          528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-----GVHEFQTEIEMLSKLRHRHLVSLIGYCEENC  602 (893)
Q Consensus       528 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  602 (893)
                      ....++|+..+.||+|+||.||+|....+++.||+|++......     ..+.+.+|++++++++||||+++++++.+..
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            34457899999999999999999999887789999987643221     1246889999999999999999999999999


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ..++||||+++ +|..++.... ..+++..+..++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             ceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            99999999985 8988886543 46899999999999999999999   4889999999999999999999999999998


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc--cc
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK--GI  759 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~  759 (893)
                      .....  ........||+.|+|||++.+. .++.++|||||||++|||++|.+||......+  .+..........  ..
T Consensus       161 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          161 SFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             TTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTT
T ss_pred             eccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHcCCCChhh
Confidence            64322  1223345689999999999764 58999999999999999999999987543221  111111111000  00


Q ss_pred             hh---hhccccc---cCCCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          760 LE---QIMDPYL---KGKIA-----PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       760 ~~---~i~d~~l---~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ..   .+.+...   ....+     ..+...+.+++.+||+.||++|||+.|++++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f  295 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  295 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence            00   0000000   00001     2334678999999999999999999999987653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.3e-38  Score=355.08  Aligned_cols=258  Identities=11%  Similarity=0.029  Sum_probs=188.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhc--cccceeeEE-------EEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKL--RHRHLVSLI-------GYCE  599 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l--~H~niv~l~-------g~~~  599 (893)
                      .+|...++||+|+||+||+|++...++.||||++....   ....+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45788999999999999999998888999999876543   34456788886655555  599988855       4443


Q ss_pred             ec-----------------CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhH------HHHHHHHHHhhhhhhcCCCCceE
Q 036624          600 EN-----------------CEMILVYDYMAYGTLREHLYKTQKPPLPWKQR------LEICIGAARGLHYLHTGAKHTII  656 (893)
Q Consensus       600 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iv  656 (893)
                      ..                 ...+||||||+ |+|.+++..... .+.+..+      +.|+.|+++||+|||   +.+|+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            32                 34899999999 999999986532 3566777      888999999999999   58999


Q ss_pred             ecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhh--cCCCCcchhhhHHHHHHHHhhCCC
Q 036624          657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEILCARP  734 (893)
Q Consensus       657 HrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~S~Gvvl~elltG~~  734 (893)
                      ||||||+||||+.++.+||+|||+++....     ......+|+.|+|||++.+  ..++.++|||||||+||||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999986432     1113457799999999987  789999999999999999999999


Q ss_pred             CCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          735 ALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       735 p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ||....+.....        .....................+...+.+++.+||+.||++|||+.+++++-..
T Consensus       292 Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          292 PFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             STTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             CCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            997653321110        00000011111111111123456778999999999999999999999976543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.3e-38  Score=360.68  Aligned_cols=257  Identities=25%  Similarity=0.315  Sum_probs=194.7

Q ss_pred             HHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--------ChhhHHHHHHHHHHHhhccccceeeEEEEEee
Q 036624          529 AATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--------SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE  600 (893)
Q Consensus       529 ~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--------~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~  600 (893)
                      ...++|...++||+|+||+||+|....+++.||||++...        .......+.+|+++|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3467899999999999999999999988899999976532        11223358899999999999999999999854


Q ss_pred             cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC---CceeEec
Q 036624          601 NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK---WVAKVSD  677 (893)
Q Consensus       601 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~D  677 (893)
                       +..++||||+++|+|.+++...  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.+   +.+||+|
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             -CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEee
Confidence             5689999999999999988654  35999999999999999999999   4899999999999999654   4599999


Q ss_pred             ccccccCCCCCCccceeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh
Q 036624          678 FGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC  754 (893)
Q Consensus       678 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  754 (893)
                      ||+++....   ........||+.|+|||++.   ...++.++|||||||+||||++|+.||.......  .+.+.... 
T Consensus       286 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~~-  359 (419)
T 3i6u_A          286 FGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS-  359 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHHT-
T ss_pred             cccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHhc-
Confidence            999986432   22234567999999999985   3678889999999999999999999997543221  11111111 


Q ss_pred             hcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          755 HKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       755 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         +...  ..+..    .......+.+++.+||+.+|++||++.|++++-.
T Consensus       360 ---~~~~--~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  402 (419)
T 3i6u_A          360 ---GKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW  402 (419)
T ss_dssp             ---TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             ---CCCC--CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence               0000  00000    0123467889999999999999999999998654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-38  Score=351.79  Aligned_cols=258  Identities=24%  Similarity=0.290  Sum_probs=205.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEc---CcceEEEEEeCCCCC----hhhHHHHHHHHHHHhhc-cccceeeEEEEEeecC
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEID---GATTKVAIKRGNPLS----EQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENC  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~VavK~~~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~  602 (893)
                      .++|+..++||+|+||+||+|+..   ..++.||||+++...    ....+.+.+|+++++++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            357899999999999999999983   356889999876421    22345678899999999 5999999999999999


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ..+|||||+++|+|.+++....  .+++..+..++.|+++||+|||   +.+|+||||||+||||+.++.+||+|||+++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            9999999999999999997654  4899999999999999999999   4899999999999999999999999999997


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhh--cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      ..... .........||+.|+|||++.+  ..++.++|||||||+||||++|+.||.......  ....+......    
T Consensus       208 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~----  280 (355)
T 1vzo_A          208 EFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILK----  280 (355)
T ss_dssp             ECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHH----
T ss_pred             ecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhc----
Confidence            64321 2222334579999999999986  457899999999999999999999997543221  12222221111    


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLEF  807 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~~  807 (893)
                           .  ....+.+....+.+++.+||+.||++||     ++.|++++...
T Consensus       281 -----~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f  325 (355)
T 1vzo_A          281 -----S--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  325 (355)
T ss_dssp             -----C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             -----c--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence                 0  1123344556788999999999999999     99999987764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.2e-38  Score=378.98  Aligned_cols=252  Identities=23%  Similarity=0.298  Sum_probs=208.6

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  605 (893)
                      ..++|+..++||+|+||+||+|+....++.||||+++..   .....+.+..|.+++..+ +|+||+++++++.+.+.++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            346899999999999999999999988889999987632   223456688999999988 7999999999999999999


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      |||||+++|+|..+|....  .+++..+..++.||+.||+|||   +.+||||||||+||||+.++.+||+|||+++...
T Consensus       419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            9999999999999998654  4999999999999999999999   4899999999999999999999999999998533


Q ss_pred             CCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ..  ........||+.|+|||++.+..++.++|||||||+||||++|+.||......+      .         ...++.
T Consensus       494 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~------~---------~~~i~~  556 (674)
T 3pfq_A          494 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------L---------FQSIME  556 (674)
T ss_dssp             CT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H---------HHHHHS
T ss_pred             cC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH------H---------HHHHHh
Confidence            22  122345679999999999999999999999999999999999999997543211      1         112222


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSM-----GDVLWNL  805 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm-----~evl~~L  805 (893)
                      ..  ..++......+.+|+.+||+.||++||++     .||+++-
T Consensus       557 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~  599 (674)
T 3pfq_A          557 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA  599 (674)
T ss_dssp             SC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred             CC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence            11  12334456678999999999999999997     6666543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.1e-37  Score=336.99  Aligned_cols=254  Identities=23%  Similarity=0.265  Sum_probs=205.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---------hhhHHHHHHHHHHHhhcc-ccceeeEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---------EQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEE  600 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---------~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~  600 (893)
                      .++|+..+.||+|+||.||+|.....++.||||++....         ....+.+.+|++++++++ ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468899999999999999999998888999999875432         123467889999999996 9999999999999


Q ss_pred             cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccc
Q 036624          601 NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL  680 (893)
Q Consensus       601 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGl  680 (893)
                      ....++||||+++++|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            999999999999999999997643  5899999999999999999999   58999999999999999999999999999


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhh------hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC  754 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  754 (893)
                      ++......   ......||+.|+|||++.      ...++.++||||||+++|||++|+.||.......      .....
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~  241 (298)
T 1phk_A          171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMI  241 (298)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred             hhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------HHHHH
Confidence            87643221   223456899999999986      4568899999999999999999999996543211      11111


Q ss_pred             hcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          755 HKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       755 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ....       ..............+.+++.+||+.+|++||++.|++++-
T Consensus       242 ~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (298)
T 1phk_A          242 MSGN-------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP  285 (298)
T ss_dssp             HHTC-------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             hcCC-------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence            1100       0001111134556789999999999999999999998654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.6e-38  Score=343.79  Aligned_cols=255  Identities=22%  Similarity=0.330  Sum_probs=202.0

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..+.||+|+||.||+|.....+..||+|.+........+.+.+|++++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            46788999999999999999999887789999988766666778899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++++|.+++.... ..+++..+..++.|+++||.|||   ..+|+||||||+|||++.++.+||+|||++.....  ..
T Consensus        98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~  171 (302)
T 2j7t_A           98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TL  171 (302)
T ss_dssp             CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--HH
T ss_pred             CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--cc
Confidence            99999999887543 35999999999999999999999   48999999999999999999999999998753111  01


Q ss_pred             cceeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          691 HVSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      .......||+.|+|||++.     ...++.++|||||||++|||++|+.|+.......      .........      .
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~------~  239 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSD------P  239 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC------C
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccC------C
Confidence            1122346899999999984     5678999999999999999999999997543211      111111110      0


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      +  ....+..+...+.+++.+||+.+|++|||+.+++++-
T Consensus       240 ~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  277 (302)
T 2j7t_A          240 P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP  277 (302)
T ss_dssp             C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred             c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            0  0111234456788999999999999999999998653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-37  Score=347.30  Aligned_cols=270  Identities=21%  Similarity=0.302  Sum_probs=201.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEee--------c
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE--------N  601 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------~  601 (893)
                      ++|+..++||+|+||+||+|+....++.||+|++....  ......+.+|++++++++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            57889999999999999999998888899999765432  2334578899999999999999999999977        4


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      +..++||||++ |+|.+.+.... ..+++..+..|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           97 GSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            56899999998 57877776543 35999999999999999999999   489999999999999999999999999999


Q ss_pred             ccCCCCC--CccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc
Q 036624          682 KTGPTLD--HTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG  758 (893)
Q Consensus       682 ~~~~~~~--~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  758 (893)
                      +......  .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......................
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            7643211  1122334568999999999976 468999999999999999999999997654322211111000000000


Q ss_pred             chhhh-----cccc--ccC-CCC-hHH------HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          759 ILEQI-----MDPY--LKG-KIA-PEC------FKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       759 ~~~~i-----~d~~--l~~-~~~-~~~------~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ....+     .+..  ... ... .+.      ...+.+++.+||+.||++|||+.|++++-.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  314 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  314 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence            00000     0000  000 000 011      245789999999999999999999997654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-37  Score=363.97  Aligned_cols=255  Identities=25%  Similarity=0.326  Sum_probs=200.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      .++|+..++||+|+||+||+|+....+..||+|++...  .......+.+|+.++++++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            45688999999999999999999888889999986543  2334567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC---CceeEecccccccCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK---WVAKVSDFGLSKTGP  685 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla~~~~  685 (893)
                      ||+++|+|.+++....  .+++..+..|+.|+++||+|||   +.+|+||||||+|||++..   +.+||+|||+++...
T Consensus       116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            9999999999887653  4899999999999999999999   4899999999999999764   559999999997643


Q ss_pred             CCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ..   .......||+.|+|||++. +.++.++|||||||++|||++|+.||......+      ........ ...  .+
T Consensus       191 ~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~-~~~--~~  257 (494)
T 3lij_A          191 NQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKVEKG-KYT--FD  257 (494)
T ss_dssp             TT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHT-CCC--CC
T ss_pred             CC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC-CCC--CC
Confidence            22   1233456999999999986 568999999999999999999999997543321      11111110 000  00


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                          ..........+.+++.+||+.+|.+|||+.|++++-..
T Consensus       258 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  295 (494)
T 3lij_A          258 ----SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI  295 (494)
T ss_dssp             ----SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred             ----chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence                00011234568899999999999999999999977543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.8e-38  Score=365.29  Aligned_cols=255  Identities=23%  Similarity=0.302  Sum_probs=206.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .++|+..++||+|+||+||+|.....+..||||++...   .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            35788999999999999999999888899999986432   234567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE---CCCCceeEecccccccC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL---DEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl---d~~~~~kl~DFGla~~~  684 (893)
                      |||+.+|+|.+++....  .+++..+..|+.|++.||+|||   ..+|+||||||+|||+   +.++.+||+|||+++..
T Consensus       105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999999987653  5999999999999999999999   4899999999999999   56789999999998764


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ....   ......||+.|+|||++.+ .++.++|||||||++|||++|++||......+      ...... .+..    
T Consensus       180 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~-~~~~----  244 (484)
T 3nyv_A          180 EASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKKVE-KGKY----  244 (484)
T ss_dssp             CCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCCC----
T ss_pred             cccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-cCCC----
Confidence            3221   2234569999999999876 69999999999999999999999997643221      111111 1100    


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .  ............+.+++.+||+.+|.+|||+.|++++-..
T Consensus       245 ~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~  285 (484)
T 3nyv_A          245 T--FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI  285 (484)
T ss_dssp             C--CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred             C--CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence            0  0000112345678899999999999999999999977654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.8e-37  Score=363.43  Aligned_cols=256  Identities=25%  Similarity=0.317  Sum_probs=203.6

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh-------------hhHHHHHHHHHHHhhccccceeeEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-------------QGVHEFQTEIEMLSKLRHRHLVSLIG  596 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~-------------~~~~~f~~E~~~l~~l~H~niv~l~g  596 (893)
                      ..++|...++||+|+||+||+|....++..||+|++.....             ...+.+.+|+.+|++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            35789999999999999999999988888999998654221             33567899999999999999999999


Q ss_pred             EEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC---ce
Q 036624          597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW---VA  673 (893)
Q Consensus       597 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~---~~  673 (893)
                      ++.+....++||||+++|+|.+++....  .+++..+..|+.|++.||+|||   +.+|+||||||+|||++.++   .+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999999987654  4999999999999999999999   48999999999999998775   69


Q ss_pred             eEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH
Q 036624          674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH  753 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  753 (893)
                      ||+|||+++.....   .......||+.|+|||++. +.++.++|||||||++|||++|+.||......+      ....
T Consensus       189 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~  258 (504)
T 3q5i_A          189 KIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------IIKK  258 (504)
T ss_dssp             EECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH
T ss_pred             EEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH
Confidence            99999999864332   1223456999999999987 468999999999999999999999997543221      1111


Q ss_pred             hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       754 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ... +...  .+...    .......+.+++.+||+.+|.+|||+.|++++-..
T Consensus       259 i~~-~~~~--~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  305 (504)
T 3q5i_A          259 VEK-GKYY--FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI  305 (504)
T ss_dssp             HHH-CCCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HHc-CCCC--CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence            111 0000  00000    01234568899999999999999999999977654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.9e-37  Score=344.74  Aligned_cols=203  Identities=24%  Similarity=0.263  Sum_probs=176.5

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-cc-----ceeeEEEEEeecCE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HR-----HLVSLIGYCEENCE  603 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~g~~~~~~~  603 (893)
                      ..++|+..++||+|+||+||+|.....++.||||++.. ......++..|+++++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            35789999999999999999999988889999999874 3445677888999998885 44     49999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC--CCCceeEeccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD--EKWVAKVSDFGLS  681 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld--~~~~~kl~DFGla  681 (893)
                      .+|||||++ |+|.+++.......+++..+..++.|++.||.|||+ .+.+||||||||+||||+  .++.+||+|||++
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999996 699999987765679999999999999999999994 247899999999999994  5788999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCC
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTL  740 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~  740 (893)
                      +.....     .....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            864321     233568999999999999999999999999999999999999997654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.7e-38  Score=352.79  Aligned_cols=265  Identities=19%  Similarity=0.217  Sum_probs=200.0

Q ss_pred             HHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeec------
Q 036624          528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------  601 (893)
Q Consensus       528 ~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------  601 (893)
                      ....++|+..++||+|+||+||+|.+..+++.||+|++.....    ...+|+++|++++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            4556789999999999999999999988889999998754322    234799999999999999999998443      


Q ss_pred             --------------------------------CEEEEEEeeccCCCHHHHHhh--CCCCCCCHHhHHHHHHHHHHhhhhh
Q 036624          602 --------------------------------CEMILVYDYMAYGTLREHLYK--TQKPPLPWKQRLEICIGAARGLHYL  647 (893)
Q Consensus       602 --------------------------------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yL  647 (893)
                                                      ...++||||++ |+|.+.+..  .....+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            34889999998 688887764  2345699999999999999999999


Q ss_pred             hcCCCCceEecCCCCCCEEEC-CCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHH
Q 036624          648 HTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVV  725 (893)
Q Consensus       648 H~~~~~~ivHrDlk~~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvv  725 (893)
                      |   +.+|+||||||+|||++ +++.+||+|||+++......   ......||+.|+|||++.+. .++.++|||||||+
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9   58999999999999998 68899999999998643221   22345689999999998875 59999999999999


Q ss_pred             HHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh----------hcccc-----ccCCCChHHHHHHHHHHHHcccc
Q 036624          726 LFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ----------IMDPY-----LKGKIAPECFKKFAETAMKCVSD  790 (893)
Q Consensus       726 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~----------i~d~~-----l~~~~~~~~~~~l~~l~~~Cl~~  790 (893)
                      +|||++|+.||......+.  +....... .....+.          ..-+.     ....++..+...+.+++.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~~~--~~~i~~~~-g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQ--LVRIIQIM-GTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHH--HHHHHHHH-CCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChHHH--HHHHHHHh-CCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            9999999999976543221  11111110 0000000          00000     01112333456789999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 036624          791 QGIERPSMGDVLWNLE  806 (893)
Q Consensus       791 ~p~~RPtm~evl~~L~  806 (893)
                      +|++|||+.|++++-.
T Consensus       309 dP~~R~t~~e~l~hp~  324 (383)
T 3eb0_A          309 EPDLRINPYEAMAHPF  324 (383)
T ss_dssp             SGGGSCCHHHHHTSGG
T ss_pred             ChhhCCCHHHHhcCHH
Confidence            9999999999997644

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.7e-37  Score=339.48  Aligned_cols=260  Identities=17%  Similarity=0.225  Sum_probs=203.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEee--cCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEE--NCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~  608 (893)
                      ++|+..++||+|+||+||+|.....++.||+|++....   .+.+.+|++++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            57889999999999999999998888999999987533   467899999999997 9999999999987  67789999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC-ceeEecccccccCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW-VAKVSDFGLSKTGPTL  687 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~~~~  687 (893)
                      ||+++++|.+++..     +++..+..++.|+++||+|||   +.+|+||||||+|||++.++ .+||+|||+++.....
T Consensus       113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            99999999998842     889999999999999999999   58999999999999999776 8999999999864322


Q ss_pred             CCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc--------
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG--------  758 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------  758 (893)
                      .   ......||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+...........        
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHHHHHHHT
T ss_pred             C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhhhHHHHh
Confidence            1   1233468999999999987 679999999999999999999999996543221 11111111110000        


Q ss_pred             ------chhhhc--------cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          759 ------ILEQIM--------DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       759 ------~~~~i~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                            ...++.        ...............+.+++.+||+.||++|||+.|++++-.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~  322 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  322 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence                  000000        001111112224577899999999999999999999997644

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.4e-37  Score=344.54  Aligned_cols=262  Identities=19%  Similarity=0.247  Sum_probs=198.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEeecC------
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC------  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------  602 (893)
                      .++|+..+.||+|+||.||+|.....+..||||++..  ......+.+.+|+.++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            3678999999999999999999988889999998754  24455677899999999999999999999997654      


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ..++||||++ |+|.+.+..    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            7899999998 578888852    3899999999999999999999   4899999999999999999999999999998


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc----
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG----  758 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----  758 (893)
                      ....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......     .|.......+    
T Consensus       176 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          176 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-----QWNKVIEQLGTPCP  247 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHC-CCCCCH
T ss_pred             cccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCCH
Confidence            6432   112234568999999999999999999999999999999999999997643221     1111100000    


Q ss_pred             -----------------------chhhhccccccCC---CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          759 -----------------------ILEQIMDPYLKGK---IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       759 -----------------------~~~~i~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                                             .+.+.........   ........+.+++.+||+.||++|||+.|++++-...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence                                   0000110000000   0112356789999999999999999999999987753

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9.8e-37  Score=339.91  Aligned_cols=266  Identities=18%  Similarity=0.241  Sum_probs=206.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcc-eEEEEEeCCCCChhhHHHHHHHHHHHhhccccc------eeeEEEEEeecCE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGAT-TKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH------LVSLIGYCEENCE  603 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~-~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~  603 (893)
                      .++|+..+.||+|+||+||+|.....+ ..||+|++... ....+.+.+|++++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            367889999999999999999986654 68999998743 445677899999999998876      9999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE----------------
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL----------------  667 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----------------  667 (893)
                      .++||||+ +++|.+++.......+++..+..++.|+++||+|||   +.+|+||||||+|||+                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 678888887766567999999999999999999999   5899999999999999                


Q ss_pred             ---CCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccc
Q 036624          668 ---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ  744 (893)
Q Consensus       668 ---d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  744 (893)
                         +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence               56789999999999863321     2335699999999999999999999999999999999999999976543221


Q ss_pred             ccHHHHHHHhhcccch--------------------------hhhcccc-ccCCCChHHHHHHHHHHHHccccCCCCCCC
Q 036624          745 VSLAEWAAHCHKKGIL--------------------------EQIMDPY-LKGKIAPECFKKFAETAMKCVSDQGIERPS  797 (893)
Q Consensus       745 ~~l~~~~~~~~~~~~~--------------------------~~i~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt  797 (893)
                      ...............+                          .+...+. ........+...+.+++.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            1111000000000000                          0000000 001123345678999999999999999999


Q ss_pred             HHHHHHHHH
Q 036624          798 MGDVLWNLE  806 (893)
Q Consensus       798 m~evl~~L~  806 (893)
                      +.|++++-.
T Consensus       328 ~~e~l~hp~  336 (355)
T 2eu9_A          328 LAEALLHPF  336 (355)
T ss_dssp             HHHHTTSGG
T ss_pred             HHHHhcChh
Confidence            999987654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-37  Score=347.99  Aligned_cols=266  Identities=23%  Similarity=0.302  Sum_probs=205.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeec-----CEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN-----CEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  604 (893)
                      .++|+..++||+|+||.||+|.....+..||+|++... .....+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            45799999999999999999999888899999987653 344557899999999999999999999999655     468


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++||||+. |+|.+++...   .+++..+..|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            99999998 6999988654   4999999999999999999999   489999999999999999999999999999864


Q ss_pred             CCCC-CccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccc---
Q 036624          685 PTLD-HTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI---  759 (893)
Q Consensus       685 ~~~~-~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---  759 (893)
                      .... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+..  ...... .....   
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~i~~~-~~~~~~~~  255 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--NHILGI-LGSPSQED  255 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH--HHHHHH-HCSCCHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH--HHHHHH-hCCCCHHH
Confidence            3221 11122345799999999987654 5899999999999999999999999765433221  111110 00000   


Q ss_pred             hhh--------hccccc-cCC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          760 LEQ--------IMDPYL-KGK-----IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       760 ~~~--------i~d~~l-~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +..        ...... ...     ..+.....+.+++.+||+.||++|||+.|++++-.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  316 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  316 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            000        000000 000     11223456889999999999999999999997655

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.1e-37  Score=341.27  Aligned_cols=255  Identities=25%  Similarity=0.308  Sum_probs=199.1

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--------hhhHHHHHHHHHHHhhccccceeeEEEEEeec
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--------EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN  601 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~  601 (893)
                      ..++|...+.||+|+||.||+|.....++.||||.+....        ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999998888999999875421        12234588999999999999999999998766


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc---eeEecc
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV---AKVSDF  678 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~---~kl~DF  678 (893)
                      . .++||||+++++|.+++...  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.   +||+||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             c-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            5 89999999999999998654  35999999999999999999999   489999999999999987654   999999


Q ss_pred             cccccCCCCCCccceeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          679 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       679 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      |+++....   ........||+.|+|||++.   ...++.++|||||||++|||++|+.||.......  .+......  
T Consensus       162 g~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~--  234 (322)
T 2ycf_A          162 GHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS--  234 (322)
T ss_dssp             TTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHH--
T ss_pred             ccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHh--
Confidence            99986432   11223456899999999975   4678999999999999999999999997543221  12211111  


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                        +...  ..+..    .......+.+++.+||+.||++||++.+++++-
T Consensus       235 --~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~  276 (322)
T 2ycf_A          235 --GKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  276 (322)
T ss_dssp             --TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             --Cccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence              0000  00000    112346788999999999999999999999653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.7e-37  Score=333.87  Aligned_cols=251  Identities=26%  Similarity=0.362  Sum_probs=198.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|...+.||+|+||.||+|.+...++.||+|.+....   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57889999999999999999998777899999875321   223567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++++|.+++....  .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             eccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            9999999999997654  4899999999999999999999   4899999999999999999999999999988643321


Q ss_pred             CccceeeeccCcCccChHhhhhcCC-CCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                         ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......      +...... .+        .
T Consensus       166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~--------~  227 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKKIR-GG--------V  227 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HC--------C
T ss_pred             ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhh-cC--------c
Confidence               1233468999999999988765 68999999999999999999999653221      1111110 00        0


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                        ...+......+.+++.+||+.+|++||++.|++++-..
T Consensus       228 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~  265 (276)
T 2h6d_A          228 --FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF  265 (276)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred             --ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence              11223345678899999999999999999999987654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.5e-37  Score=355.38  Aligned_cols=263  Identities=24%  Similarity=0.272  Sum_probs=197.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeec------CEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------CEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~  605 (893)
                      .+|+..++||+|+||+||+|++...++.||||++....    ..+.+|+++|++++||||+++++++...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            45888999999999999999998877899999875432    2235799999999999999999998542      2367


Q ss_pred             EEEeeccCCCHHHHHhh--CCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC-CceeEecccccc
Q 036624          606 LVYDYMAYGTLREHLYK--TQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSK  682 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~  682 (893)
                      +||||+++ +|.+.+..  .....+++..+..++.||++||+|||   ..+|+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999985 66665543  23456999999999999999999999   5899999999999999955 678999999998


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc--cc
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK--GI  759 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~  759 (893)
                      ......   ......||+.|+|||++.+. .++.++|||||||+||||++|+.||......+  .+.+........  ..
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence            643221   12335689999999999765 79999999999999999999999997654322  122222211000  00


Q ss_pred             hhhh-------ccccccC-----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          760 LEQI-------MDPYLKG-----KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       760 ~~~i-------~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      +.++       ..+.+..     .+.+.....+.+|+.+||+.||.+||++.|++++-..
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence            1110       0011000     1223345678999999999999999999999987654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-37  Score=338.23  Aligned_cols=256  Identities=23%  Similarity=0.324  Sum_probs=203.5

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ..++|+..+.||+|+||.||+|.....+..||+|.+....  ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3567999999999999999999998877899999876432  34678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+++++|.+++... ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....  
T Consensus       105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (314)
T 3com_A          105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--  178 (314)
T ss_dssp             CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence            99999999998643 245999999999999999999999   589999999999999999999999999998754321  


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||........      .....      ....+.  
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~------~~~~~~--  244 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIP------TNPPPT--  244 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH------HSCCCC--
T ss_pred             ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHh------cCCCcc--
Confidence            1122345689999999999999999999999999999999999999965432111      11000      000111  


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      ...+......+.+++.+||+.+|.+||++.+++++-..
T Consensus       245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~  282 (314)
T 3com_A          245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV  282 (314)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred             cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence            11123345678899999999999999999999986553

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-37  Score=361.99  Aligned_cols=254  Identities=24%  Similarity=0.323  Sum_probs=203.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      .++|+..++||+|+||+||+|.....+..||||++...  .......+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            45789999999999999999999888889999986432  2234577899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC---CCCceeEecccccccCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld---~~~~~kl~DFGla~~~~  685 (893)
                      ||+.+|+|.+.+....  .+++..+..|+.|++.||.|||   ..+|+||||||+|||++   .++.+||+|||+++...
T Consensus       101 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            9999999999887654  4999999999999999999999   48999999999999995   45679999999997543


Q ss_pred             CCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ..   .......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+      ....... +..    .
T Consensus       176 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~-~~~----~  240 (486)
T 3mwu_A          176 QN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVET-GKY----A  240 (486)
T ss_dssp             CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-TCC----C
T ss_pred             CC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCC----C
Confidence            21   12234569999999999875 58999999999999999999999997543221      1111110 000    0


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                        ............+.+++.+||+.+|.+|||+.|++++-.
T Consensus       241 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~  279 (486)
T 3mwu_A          241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (486)
T ss_dssp             --SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred             --CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence              000011234567889999999999999999999998644

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.4e-37  Score=338.12  Aligned_cols=265  Identities=22%  Similarity=0.327  Sum_probs=204.6

Q ss_pred             cCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhcc--ccceeeEEEE
Q 036624          522 FSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLR--HRHLVSLIGY  597 (893)
Q Consensus       522 ~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~  597 (893)
                      +.+..+....++|+..+.||+|+||.||++.... +..||+|++..  ......+.+.+|++++.+++  |+||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            3334444455779999999999999999999876 47899997643  34556788999999999997  4999999999


Q ss_pred             EeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEec
Q 036624          598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSD  677 (893)
Q Consensus       598 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~D  677 (893)
                      +......++||| +.+++|.+++....  .+++..+..++.|+++||+|||   +.+|+||||||+|||+++ +.+||+|
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEee
Confidence            999999999999 66799999997654  5899999999999999999999   489999999999999965 7999999


Q ss_pred             ccccccCCCCCCccceeeeccCcCccChHhhhh-----------cCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccccc
Q 036624          678 FGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS  746 (893)
Q Consensus       678 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~  746 (893)
                      ||+++...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......   
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---  246 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---  246 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---
Confidence            999986433222222334568999999999975           478889999999999999999999996543211   


Q ss_pred             HHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          747 LAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       747 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                        .         .+..++++.....++..+...+.+++.+||+.+|++||++.|++++....
T Consensus       247 --~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~  297 (313)
T 3cek_A          247 --S---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  297 (313)
T ss_dssp             --H---------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             --H---------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence              1         11222233222233333456788999999999999999999999887653

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=342.52  Aligned_cols=267  Identities=21%  Similarity=0.301  Sum_probs=199.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEe------------
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE------------  599 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~------------  599 (893)
                      ++|...+.||+|+||.||+|.....++.||+|++........+.+.+|++++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            57889999999999999999999878999999887767777888999999999999999999999873            


Q ss_pred             --ecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC-CCCceeEe
Q 036624          600 --ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVS  676 (893)
Q Consensus       600 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-~~~~~kl~  676 (893)
                        +....++||||++ |+|.+++..   .++++..+..++.|+++||+|||   +.+|+||||||+|||++ +++.+||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence              4468899999998 699999854   35899999999999999999999   58999999999999997 56799999


Q ss_pred             cccccccCCCCC-CccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh
Q 036624          677 DFGLSKTGPTLD-HTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC  754 (893)
Q Consensus       677 DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  754 (893)
                      |||+++...... .........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||........  +.......
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~  241 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLILESI  241 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHS
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhc
Confidence            999998643211 1112233457899999999875 6789999999999999999999999976543211  11111000


Q ss_pred             h--cccchhhhcc-------cccc-C-----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          755 H--KKGILEQIMD-------PYLK-G-----KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       755 ~--~~~~~~~i~d-------~~l~-~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .  ......++..       .... .     ...+.+...+.+++.+||+.||++||++.|++++-..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM  309 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence            0  0000000000       0000 0     0112345678999999999999999999999987654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.5e-37  Score=348.37  Aligned_cols=274  Identities=20%  Similarity=0.212  Sum_probs=203.6

Q ss_pred             ccCHHHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-----------ChhhHHHHHHHHHHHhhcccc
Q 036624          521 HFSFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-----------SEQGVHEFQTEIEMLSKLRHR  589 (893)
Q Consensus       521 ~~~~~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-----------~~~~~~~f~~E~~~l~~l~H~  589 (893)
                      +....++....++|...+.||+|+||.||+|.... +..||||++...           .....+.+.+|++++++++||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   89 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP   89 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence            44567889999999999999999999999999876 588999976432           122347899999999999999


Q ss_pred             ceeeEEEEEee-----cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCC
Q 036624          590 HLVSLIGYCEE-----NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTN  664 (893)
Q Consensus       590 niv~l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N  664 (893)
                      ||+++++++..     ....++||||++ |+|.+.+... ...+++..+..++.|+++||+|||   ..+|+||||||+|
T Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~N  164 (362)
T 3pg1_A           90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGN  164 (362)
T ss_dssp             TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred             CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHH
Confidence            99999999843     346899999998 7888888744 346999999999999999999999   4899999999999


Q ss_pred             EEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccc
Q 036624          665 ILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKE  743 (893)
Q Consensus       665 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~  743 (893)
                      ||++.++.+||+|||+++.....   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+
T Consensus       165 Il~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  241 (362)
T 3pg1_A          165 ILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN  241 (362)
T ss_dssp             EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999753321   22334568999999999987 679999999999999999999999997643222


Q ss_pred             cccHHHHHHHhhcccc-----------hhhhccccccC-------CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          744 QVSLAEWAAHCHKKGI-----------LEQIMDPYLKG-------KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       744 ~~~l~~~~~~~~~~~~-----------~~~i~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      .  +...... .....           ..+.+...+..       ...+.....+.+++.+||+.||++|||+.|++++-
T Consensus       242 ~--~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  318 (362)
T 3pg1_A          242 Q--LNKIVEV-VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP  318 (362)
T ss_dssp             H--HHHHHHH-HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             H--HHHHHHH-cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence            1  1111110 00000           00111000000       01123345688999999999999999999999765


Q ss_pred             H
Q 036624          806 E  806 (893)
Q Consensus       806 ~  806 (893)
                      .
T Consensus       319 ~  319 (362)
T 3pg1_A          319 Y  319 (362)
T ss_dssp             G
T ss_pred             h
Confidence            4

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.3e-37  Score=343.37  Aligned_cols=263  Identities=19%  Similarity=0.259  Sum_probs=204.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-----------ccceeeEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-----------HRHLVSLIGYCEE  600 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~  600 (893)
                      ++|...+.||+|+||+||+|+....++.||||++.. .....+.+.+|+.++++++           |+||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            578899999999999999999988889999999874 3445677899999999886           8999999999876


Q ss_pred             cC----EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCC-ceEecCCCCCCEEEC------C
Q 036624          601 NC----EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH-TIIHRDVKTTNILLD------E  669 (893)
Q Consensus       601 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlk~~NILld------~  669 (893)
                      .+    ..++||||+ +++|.+++.......+++..+..|+.|++.||+|||+   . +|+||||||+|||++      .
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence            54    789999999 8999999987666679999999999999999999995   5 999999999999994      4


Q ss_pred             CCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccc----
Q 036624          670 KWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV----  745 (893)
Q Consensus       670 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~----  745 (893)
                      .+.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||+||||++|+.||.........    
T Consensus       174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            458999999999764321     22346899999999999999999999999999999999999999754322111    


Q ss_pred             cHHHHHHHhhc-------c-----------cc-----------hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCC
Q 036624          746 SLAEWAAHCHK-------K-----------GI-----------LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERP  796 (893)
Q Consensus       746 ~l~~~~~~~~~-------~-----------~~-----------~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  796 (893)
                      .+.........       .           +.           +.+++..  ...++..+...+.+++.+||+.||++||
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccC
Confidence            11111110000       0           00           0000000  1234567888999999999999999999


Q ss_pred             CHHHHHHHHH
Q 036624          797 SMGDVLWNLE  806 (893)
Q Consensus       797 tm~evl~~L~  806 (893)
                      |+.|++++-.
T Consensus       327 t~~ell~hp~  336 (373)
T 1q8y_A          327 DAGGLVNHPW  336 (373)
T ss_dssp             CHHHHHTCGG
T ss_pred             CHHHHhhChh
Confidence            9999987654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.5e-37  Score=340.89  Aligned_cols=268  Identities=23%  Similarity=0.332  Sum_probs=204.6

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEc-CcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhc---cccceeeEEEEEe----
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEID-GATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKL---RHRHLVSLIGYCE----  599 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~-~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~----  599 (893)
                      +.++|+..+.||+|+||.||+|... .+++.||+|++....  ......+.+|+.+++++   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999984 556889999764321  12223566788877776   7999999999987    


Q ss_pred             -ecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecc
Q 036624          600 -ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF  678 (893)
Q Consensus       600 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DF  678 (893)
                       .....++||||++ |+|.+++.......+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5677899999998 79999998776667999999999999999999999   489999999999999999999999999


Q ss_pred             cccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc--
Q 036624          679 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK--  756 (893)
Q Consensus       679 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--  756 (893)
                      |+++....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||........  +.........  
T Consensus       165 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~  239 (326)
T 1blx_A          165 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPG  239 (326)
T ss_dssp             CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCC
T ss_pred             cccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCC
Confidence            99976432   1223345689999999999999999999999999999999999999976543221  1111111000  


Q ss_pred             -ccchhhh------cc---ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          757 -KGILEQI------MD---PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       757 -~~~~~~i------~d---~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                       ..+....      ..   ......+.......+.+++.+||+.+|++||++.|++++-.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  299 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  299 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence             0000000      00   00011122345567889999999999999999999986543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.8e-38  Score=350.71  Aligned_cols=262  Identities=20%  Similarity=0.246  Sum_probs=187.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec------C
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------C  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~  602 (893)
                      .++|...+.||+|+||.||+|.....+..||||++...  .....+.+.+|++++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36889999999999999999999888899999987643  344567889999999999999999999998654      5


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ..++|+|++ +++|.+++..   ..+++..+..++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            679999999 6899998864   35999999999999999999999   4899999999999999999999999999998


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc--ccc
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK--KGI  759 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~  759 (893)
                      ....     ..+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........  .........  ...
T Consensus       181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l--~~i~~~~g~p~~~~  253 (367)
T 2fst_X          181 HTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL--KLILRLVGTPGAEL  253 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHH
T ss_pred             cccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHH
Confidence            6332     1234568999999999987 68999999999999999999999999765432211  111110000  000


Q ss_pred             h--------hhhccccc-cCCC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          760 L--------EQIMDPYL-KGKI-----APECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       760 ~--------~~i~d~~l-~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +        ...+.... ....     .+.....+.+|+.+||+.||++|||+.|++++-.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~  314 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  314 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence            0        00000000 0000     0122456889999999999999999999997754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.8e-37  Score=368.72  Aligned_cols=259  Identities=23%  Similarity=0.345  Sum_probs=207.4

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCc---ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      ..++|+..+.||+|+||.||+|.+...   ...||+|..... .....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            346788899999999999999998542   357999987653 44455789999999999999999999999854 5689


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +||||+++|+|.+++.... ..+++..++.++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++...
T Consensus       467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            9999999999999997543 45999999999999999999999   4899999999999999999999999999998653


Q ss_pred             CCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||......+      ........       
T Consensus       543 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~~~~i~~~-------  608 (656)
T 2j0j_A          543 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENG-------  608 (656)
T ss_dssp             C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHHT-------
T ss_pred             CCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHcC-------
Confidence            322 112233457889999999999999999999999999999997 999986543221      11111100       


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                         .....++.++..+.+++.+||+.+|++||++.++++.|+.+++
T Consensus       609 ---~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          609 ---ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence               0112344566788999999999999999999999999998764

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.2e-37  Score=344.12  Aligned_cols=274  Identities=20%  Similarity=0.213  Sum_probs=195.3

Q ss_pred             HHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCE-
Q 036624          525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE-  603 (893)
Q Consensus       525 ~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-  603 (893)
                      .+.....++|...++||+|+||+||+|++...+..||||++.... .....+.+|++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445667789999999999999999999998878899999765432 223456788888999999999999999966443 


Q ss_pred             ------EEEEEeeccCCCHHHHHhh--CCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-CCcee
Q 036624          604 ------MILVYDYMAYGTLREHLYK--TQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAK  674 (893)
Q Consensus       604 ------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~k  674 (893)
                            .++||||+++ +|...+..  .....+++..+..++.|++.||.|||. .+.+|+||||||+|||++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence                  8899999985 55554432  234568999999999999999999992 2489999999999999997 89999


Q ss_pred             EecccccccCCCCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH
Q 036624          675 VSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH  753 (893)
Q Consensus       675 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  753 (893)
                      |+|||+++......   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........  +......
T Consensus       173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~  247 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRV  247 (360)
T ss_dssp             ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHH
T ss_pred             EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHHH
Confidence            99999998643322   22345689999999999765 489999999999999999999999976543221  1222111


Q ss_pred             hhcc--cchhhh---------cc------ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          754 CHKK--GILEQI---------MD------PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       754 ~~~~--~~~~~i---------~d------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ....  ..+..+         .+      ..........+...+.+++.+||+.||.+|||+.|++++-.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  317 (360)
T 3e3p_A          248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY  317 (360)
T ss_dssp             HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred             cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence            1000  000000         00      00011122235678999999999999999999999997655

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5e-37  Score=334.20  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=198.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEee----------
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE----------  600 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----------  600 (893)
                      .++|+..+.||+|+||.||+|+....++.||+|++.. .....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            4678999999999999999999987778999998753 34556789999999999999999999998865          


Q ss_pred             ---cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEec
Q 036624          601 ---NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSD  677 (893)
Q Consensus       601 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~D  677 (893)
                         ....++||||+++|+|.+++.... ..+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence               467899999999999999997643 35788999999999999999999   48999999999999999999999999


Q ss_pred             ccccccCCCCC------------CccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCcccc
Q 036624          678 FGLSKTGPTLD------------HTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ  744 (893)
Q Consensus       678 FGla~~~~~~~------------~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  744 (893)
                      ||+++......            .........||+.|+|||++.+. .++.++|||||||++|||++   |+....  . 
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~-  233 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--E-  233 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--H-
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--h-
Confidence            99987643211            01122345689999999999864 78999999999999999998   442110  1 


Q ss_pred             ccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          745 VSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       745 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                        ..+.......       ....+.......++..+.+++.+||+.||.+|||+.+++++-..
T Consensus       234 --~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (303)
T 1zy4_A          234 --RVNILKKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL  287 (303)
T ss_dssp             --HHHHHHHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred             --HHHHHHhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence              1111111110       11112233445556778999999999999999999999976543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.6e-37  Score=342.18  Aligned_cols=267  Identities=20%  Similarity=0.249  Sum_probs=203.0

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeec-----CEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN-----CEM  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  604 (893)
                      .++|...+.||+|+||.||+|.....++.||||++... .......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            46788999999999999999999887889999987643 344566789999999999999999999998754     678


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      ++||||+. |+|.+++...   .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            99999998 6999988763   4999999999999999999999   489999999999999999999999999999764


Q ss_pred             CCCCCc--------cceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          685 PTLDHT--------HVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       685 ~~~~~~--------~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      ......        .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........  ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~  240 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL--LLIFGIIG  240 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHHHhC
Confidence            321111        01223468999999998865 77899999999999999999999999765422111  11100000


Q ss_pred             c-----------ccchhhhcccccc------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          756 K-----------KGILEQIMDPYLK------GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       756 ~-----------~~~~~~i~d~~l~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .           .....+.+.....      ....+.+...+.+++.+||+.||++|||+.|++++-.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY  308 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence            0           0000000000000      0011234567889999999999999999999997654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-37  Score=346.91  Aligned_cols=262  Identities=20%  Similarity=0.286  Sum_probs=204.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh-----------------hHHHHHHHHHHHhhccccceee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-----------------GVHEFQTEIEMLSKLRHRHLVS  593 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~-----------------~~~~f~~E~~~l~~l~H~niv~  593 (893)
                      .++|...+.||+|+||.||+|..  .+..||+|.+......                 ..+.+.+|+.++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            36889999999999999999999  4588999976532111                 1278999999999999999999


Q ss_pred             EEEEEeecCEEEEEEeeccCCCHHHH------HhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE
Q 036624          594 LIGYCEENCEMILVYDYMAYGTLREH------LYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL  667 (893)
Q Consensus       594 l~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl  667 (893)
                      +++++.+.+..++||||+++|+|.++      +.......+++..+..++.|++.||+|||+  +.+|+||||||+|||+
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILM  185 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEE
Confidence            99999999999999999999999998      655445679999999999999999999994  3899999999999999


Q ss_pred             CCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhc-CCCC-cchhhhHHHHHHHHhhCCCCCCCCCccccc
Q 036624          668 DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTE-KSDVYSFGVVLFEILCARPALNPTLPKEQV  745 (893)
Q Consensus       668 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  745 (893)
                      +.++.+||+|||+++.....    ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||.......  
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--  259 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--  259 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence            99999999999998764221    23345689999999999877 6666 9999999999999999999997543311  


Q ss_pred             cHHHHHHHhhcccchhhh------ccccc---cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          746 SLAEWAAHCHKKGILEQI------MDPYL---KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       746 ~l~~~~~~~~~~~~~~~i------~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                         +....... +.....      ..+..   .......+...+.+++.+||+.+|.+||++.|++++-.
T Consensus       260 ---~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~  325 (348)
T 2pml_X          260 ---ELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW  325 (348)
T ss_dssp             ---HHHHHHTS-CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             ---HHHHHHhc-cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence               11111111 100000      00000   00011334567889999999999999999999997543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.4e-37  Score=345.88  Aligned_cols=261  Identities=19%  Similarity=0.258  Sum_probs=200.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEE----
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEM----  604 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~----  604 (893)
                      .++|...+.||+|+||+||+|.+...++.||||++...  .....+.+.+|+.++++++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46788999999999999999999888899999987653  344567889999999999999999999999877654    


Q ss_pred             --EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          605 --ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       605 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                        ++||||+. ++|.+.+.    ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999998 68888773    23999999999999999999999   4899999999999999999999999999997


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc-----
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK-----  756 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-----  756 (893)
                      ....     ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.  +.........     
T Consensus       193 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          193 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEF  265 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred             cccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCcHHH
Confidence            5432     1234568999999999987 7899999999999999999999999976432211  1111110000     


Q ss_pred             -----ccchhhhccc---cccC---CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          757 -----KGILEQIMDP---YLKG---KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       757 -----~~~~~~i~d~---~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                           ..........   ....   ...+.+...+.+++.+||+.||++|||+.|++++-.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  326 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  326 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence                 0000000000   0000   011233567899999999999999999999997655

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9.1e-37  Score=336.92  Aligned_cols=256  Identities=22%  Similarity=0.309  Sum_probs=183.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHH-HHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIE-MLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|...+.||+|+||.||+|.....++.||||++... ......++..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            5788889999999999999999877899999987643 3344456666666 6777899999999999999999999999


Q ss_pred             eccCCCHHHHHhh---CCCCCCCHHhHHHHHHHHHHhhhhhhcCCCC-ceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          610 YMAYGTLREHLYK---TQKPPLPWKQRLEICIGAARGLHYLHTGAKH-TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       610 ~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      |++ |+|.+++..   .....+++..+..++.|+++||.|||+   . +|+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            998 488777653   234569999999999999999999995   5 99999999999999999999999999997643


Q ss_pred             CCCCccceeeeccCcCccChHhh----hhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~----~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      ..   .......||+.|+|||++    .+..++.++|||||||++|||++|+.||........              .+.
T Consensus       178 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------~~~  240 (327)
T 3aln_A          178 DS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------------QLT  240 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------C
T ss_pred             cc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--------------HHH
Confidence            21   112334689999999998    566789999999999999999999999965321100              011


Q ss_pred             hhcc---ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          762 QIMD---PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       762 ~i~d---~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      .+..   +.+.......+...+.+++.+||+.+|++||++.+++++-...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  290 (327)
T 3aln_A          241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL  290 (327)
T ss_dssp             CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence            1111   1111112234556789999999999999999999999876543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-36  Score=328.94  Aligned_cols=255  Identities=25%  Similarity=0.327  Sum_probs=203.9

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ..++|+..+.||+|+||.||+|+....++.||+|++...  .....+.+.+|++++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            346899999999999999999999877789999986432  234567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC---CceeEecccccccC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK---WVAKVSDFGLSKTG  684 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~---~~~kl~DFGla~~~  684 (893)
                      +||+++++|.+.+....  .+++..++.++.|+++||.|||   ..+|+||||||+|||++.+   +.+||+|||+++..
T Consensus       100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            99999999999887654  4899999999999999999999   4899999999999999754   47999999998764


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ....   ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......      +....... +...  .
T Consensus       175 ~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~--~  241 (287)
T 2wei_A          175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVET-GKYA--F  241 (287)
T ss_dssp             CCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCCC--C
T ss_pred             cCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHc-CCCC--C
Confidence            3221   1223458899999999876 4899999999999999999999999754321      11111111 1000  0


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      +    ..........+.+++.+||+.+|++|||+.|++++-.
T Consensus       242 ~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  279 (287)
T 2wei_A          242 D----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (287)
T ss_dssp             C----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             C----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence            0    0001123467889999999999999999999998654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=9.9e-38  Score=343.07  Aligned_cols=259  Identities=23%  Similarity=0.379  Sum_probs=199.7

Q ss_pred             HhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          530 ATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       530 at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ..++|+..++||+|+||.||+|...+   .+|+|.+...  .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            35678899999999999999999865   3888876543  223345688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++++|.+++.... ..+++..++.++.|+++||+|||   +.+|+||||||+|||++ ++.+||+|||+++.....
T Consensus       108 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             CBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            99999999999997543 46999999999999999999999   48999999999999998 679999999998753221


Q ss_pred             C---CccceeeeccCcCccChHhhhh---------cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          688 D---HTHVSTVVKGSFGYLDPEYFRR---------QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       688 ~---~~~~~~~~~gt~~y~APE~~~~---------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      .   .........||+.|+|||++..         ..++.++|||||||++|||++|+.||.......      ......
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~  256 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------IIWQMG  256 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------HHHHHH
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHhc
Confidence            1   1122234558999999999975         457889999999999999999999996543211      111111


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                       .+     ..+.+.   ...+...+.+++.+||+.+|++||++.++++.|+.+.+.
T Consensus       257 -~~-----~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          257 -TG-----MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             -TT-----CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             -cC-----CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence             11     111111   112345688999999999999999999999999976643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.4e-37  Score=346.71  Aligned_cols=262  Identities=22%  Similarity=0.260  Sum_probs=193.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCE------EE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE------MI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~  605 (893)
                      .+|...++||+|+||+||+|++..++. ||+|++.....    ...+|++++++++||||+++++++.....      .+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            468889999999999999999987744 88887543222    12479999999999999999999965433      78


Q ss_pred             EEEeeccCCCHHHHHh-hCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC-CCCceeEeccccccc
Q 036624          606 LVYDYMAYGTLREHLY-KTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKT  683 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-~~~~~kl~DFGla~~  683 (893)
                      +||||++++.+..... ......+++..+..++.|+++||+|||   ..+|+||||||+||||+ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998654443332 123456999999999999999999999   48999999999999999 799999999999986


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc--cch
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK--GIL  760 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~  760 (893)
                      .....   ......||+.|+|||++.+. .++.++|||||||+||||++|+.||......+.  +..........  ..+
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQI  266 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHH
Confidence            43221   12335689999999999765 599999999999999999999999976543221  22221111000  000


Q ss_pred             hh----hcc--------ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          761 EQ----IMD--------PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       761 ~~----i~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..    ...        ..+...+.+.....+.+++.+||+.||.+|||+.|++++-.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF  324 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence            00    000        00001122234567899999999999999999999997654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=339.89  Aligned_cols=260  Identities=19%  Similarity=0.263  Sum_probs=199.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCE------
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE------  603 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------  603 (893)
                      ++|...+.||+|+||.||+|.+...++.||||++...  .....+.+.+|+.++++++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            5788899999999999999999888899999987543  34456788999999999999999999999977643      


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      .++||||+. ++|.+++.    ..+++..+..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus       104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence            599999998 68887763    24899999999999999999999   48999999999999999999999999999975


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc--ccch
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK--KGIL  760 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~  760 (893)
                      ...     ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.  +.........  ....
T Consensus       176 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          176 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEFV  248 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHHHH
T ss_pred             CCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHH
Confidence            322     1233568999999999987 6789999999999999999999999976442211  1111110000  0000


Q ss_pred             h--------hhcc---cccc---CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          761 E--------QIMD---PYLK---GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       761 ~--------~i~d---~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .        ..+.   ....   ....+.....+.+++.+||+.||++|||+.|++++-.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  308 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  308 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence            0        0000   0000   1122345677899999999999999999999997654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-36  Score=337.95  Aligned_cols=257  Identities=20%  Similarity=0.257  Sum_probs=178.2

Q ss_pred             hcCCccce-eeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEee----cCEEE
Q 036624          531 TNNFDEAL-LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE----NCEMI  605 (893)
Q Consensus       531 t~~f~~~~-~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~  605 (893)
                      .++|...+ +||+|+||+||+|.+...++.||||++... ...   ..+....++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            46788854 699999999999999987899999987542 221   2222334566789999999999876    45689


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC---CCceeEecccccc
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE---KWVAKVSDFGLSK  682 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~  682 (893)
                      +||||+++|+|.+++.......+++..++.++.|+++||+|||   ..+|+||||||+|||++.   ++.+||+|||+++
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999998776667999999999999999999999   489999999999999976   4569999999997


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                      .....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........  ..... .   ....
T Consensus       180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~-~---~~~~  249 (336)
T 3fhr_A          180 ETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRR-I---RLGQ  249 (336)
T ss_dssp             EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             ecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHh-h---hccc
Confidence            54321    1234568999999999998899999999999999999999999996543221100  00000 0   0000


Q ss_pred             hccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          763 IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       763 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                         ..........+...+.+++.+||+.+|++|||+.|++++-..
T Consensus       250 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  291 (336)
T 3fhr_A          250 ---YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI  291 (336)
T ss_dssp             ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             ---cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence               001111112445678899999999999999999999987764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=346.20  Aligned_cols=269  Identities=21%  Similarity=0.254  Sum_probs=184.3

Q ss_pred             CCcc-ceeeeecCcEEEEEEEEc--CcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEe--ecCEEEEE
Q 036624          533 NFDE-ALLLGVGGFGKVYRGEID--GATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE--ENCEMILV  607 (893)
Q Consensus       533 ~f~~-~~~LG~G~fG~Vy~g~~~--~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV  607 (893)
                      .|+. .++||+|+||+||+|+..  ..+..||+|++.....  ...+.+|+.+|++++||||+++++++.  .....+||
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3554 458999999999999976  3457899998865322  346889999999999999999999995  46789999


Q ss_pred             EeeccCCCHHHHHhhC-------CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEE----CCCCceeEe
Q 036624          608 YDYMAYGTLREHLYKT-------QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILL----DEKWVAKVS  676 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILl----d~~~~~kl~  676 (893)
                      |||+. |+|.+++...       ....+++..+..|+.||+.||+|||   ..+|+||||||+||||    ++++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99997 5888877532       2235999999999999999999999   4889999999999999    778999999


Q ss_pred             cccccccCCCCC-CccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccc-------cccH
Q 036624          677 DFGLSKTGPTLD-HTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKE-------QVSL  747 (893)
Q Consensus       677 DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~-------~~~l  747 (893)
                      |||+++...... .........||+.|+|||++.+. .++.++|||||||+||||++|++||.......       ...+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            999998643211 11223346799999999999874 58999999999999999999999997543211       0011


Q ss_pred             HHHHHHhhc--ccchhh-------------hccccccC--------CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          748 AEWAAHCHK--KGILEQ-------------IMDPYLKG--------KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       748 ~~~~~~~~~--~~~~~~-------------i~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ......+..  ......             ........        .........+.+|+.+||+.||.+|||+.|++++
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            111110000  000000             00000000        0000113467899999999999999999999987


Q ss_pred             HHH
Q 036624          805 LEF  807 (893)
Q Consensus       805 L~~  807 (893)
                      -..
T Consensus       335 p~f  337 (405)
T 3rgf_A          335 PYF  337 (405)
T ss_dssp             GGG
T ss_pred             hhh
Confidence            664

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.2e-37  Score=334.47  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=194.2

Q ss_pred             HHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh------hhHHHHHHHHHHHhhc----cccceeeEEE
Q 036624          527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE------QGVHEFQTEIEMLSKL----RHRHLVSLIG  596 (893)
Q Consensus       527 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~------~~~~~f~~E~~~l~~l----~H~niv~l~g  596 (893)
                      .....++|+..++||+|+||.||+|.....++.||+|++.....      .....+.+|+.++.++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            34456789999999999999999999988788999998765432      1233467799999998    8999999999


Q ss_pred             EEeecCEEEEEEee-ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC-CCCcee
Q 036624          597 YCEENCEMILVYDY-MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAK  674 (893)
Q Consensus       597 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-~~~~~k  674 (893)
                      ++...+..++|+|+ +.+++|.+++....  .+++..++.++.|+++||+|||   +.+|+||||||+|||++ +++.+|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence            99999999999999 78999999997654  4999999999999999999999   47999999999999999 889999


Q ss_pred             EecccccccCCCCCCccceeeeccCcCccChHhhhhcCCC-CcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHH
Q 036624          675 VSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH  753 (893)
Q Consensus       675 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  753 (893)
                      |+|||+++.....    ......||..|+|||++.+..+. .++|||||||++|||++|+.||....        +.   
T Consensus       181 l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~---  245 (312)
T 2iwi_A          181 LIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EI---  245 (312)
T ss_dssp             ECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HH---
T ss_pred             EEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HH---
Confidence            9999998864332    12345689999999999877764 58999999999999999999985321        00   


Q ss_pred             hhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       754 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                                ....  ..++..+...+.+++.+||+.+|++||++.|++++-.
T Consensus       246 ----------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          246 ----------LEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             ----------HHTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             ----------hhhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                      0000  1123344567889999999999999999999997644

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.6e-36  Score=331.47  Aligned_cols=256  Identities=21%  Similarity=0.296  Sum_probs=182.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-h-hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-E-QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      .++|+..+.||+|+||.||+|.+...++.||||++.... . ...+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            457888999999999999999998777899999875432 2 22334555566788889999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+ ++.+..++. .....+++..+..++.|+++||.|||+  +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (318)
T 2dyl_A          104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-  178 (318)
T ss_dssp             CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence            999 445544443 333469999999999999999999994  248999999999999999999999999998754321 


Q ss_pred             CccceeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          689 HTHVSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                        .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.......     +.........     
T Consensus       179 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-----  246 (318)
T 2dyl_A          179 --KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQEE-----  246 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHHSC-----
T ss_pred             --ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhccC-----
Confidence              1223456899999999994     5678999999999999999999999997533211     1111111110     


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                       .+.+.  ....+...+.+++.+||+.+|.+||++.+++++-.
T Consensus       247 -~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (318)
T 2dyl_A          247 -PPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF  286 (318)
T ss_dssp             -CCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             -CCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence             01111  11124467889999999999999999999998654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.1e-37  Score=336.48  Aligned_cols=248  Identities=21%  Similarity=0.303  Sum_probs=201.2

Q ss_pred             HHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh------hhHHHHHHHHHHHhhcc--ccceeeEEEEE
Q 036624          527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE------QGVHEFQTEIEMLSKLR--HRHLVSLIGYC  598 (893)
Q Consensus       527 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~------~~~~~f~~E~~~l~~l~--H~niv~l~g~~  598 (893)
                      .....++|+..++||+|+||.||+|.....++.||||++.....      ...+.+.+|+.++++++  |+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            33445789999999999999999999988889999998653211      12245778999999996  59999999999


Q ss_pred             eecCEEEEEEeeccC-CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC-CCCceeEe
Q 036624          599 EENCEMILVYDYMAY-GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVS  676 (893)
Q Consensus       599 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-~~~~~kl~  676 (893)
                      ...+..++|+|++.+ ++|.+++....  .+++..+..++.|+++||+|||   +.+|+||||||+|||++ +++.+||+
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            999999999999976 89999997643  5899999999999999999999   58999999999999999 78999999


Q ss_pred             cccccccCCCCCCccceeeeccCcCccChHhhhhcCC-CCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          677 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       677 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      |||+++.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....        +..    
T Consensus       193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~----  256 (320)
T 3a99_A          193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EII----  256 (320)
T ss_dssp             CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH----
T ss_pred             eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hhh----
Confidence            99998864321    1233569999999999987766 688999999999999999999985321        000    


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                               ...  ......+...+.+++.+||+.+|++||++.|++++-.
T Consensus       257 ---------~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~  296 (320)
T 3a99_A          257 ---------RGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW  296 (320)
T ss_dssp             ---------HCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             ---------ccc--ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence                     000  0112234467889999999999999999999997654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-35  Score=341.21  Aligned_cols=251  Identities=21%  Similarity=0.257  Sum_probs=186.6

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEeec
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      .|...++||+|+||+||.+.... ++.||||++..   ...+.+.+|++++.++ +||||+++++++.+....+|||||+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~-g~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESS-SSEEEEEEEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeccCeEeeCCCeEEEEEEEEC-CeEEEEEEEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            34456789999999998765443 47899998753   2345678999999987 8999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCC-----CCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-------------CCce
Q 036624          612 AYGTLREHLYKTQKPP-----LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-------------KWVA  673 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-------------~~~~  673 (893)
                      . |+|.+++.......     ..+..++.|+.|++.||+|||   +.+|+||||||+||||+.             ++.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 69999997653221     244567889999999999999   489999999999999965             4589


Q ss_pred             eEecccccccCCCCCCc--cceeeeccCcCccChHhhhh-------cCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccc
Q 036624          674 KVSDFGLSKTGPTLDHT--HVSTVVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKE  743 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~-------~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~  743 (893)
                      ||+|||+++........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999865432211  11234579999999999976       678999999999999999999 999996543221


Q ss_pred             cccHHHHHHHhhcccchhhhcc-ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          744 QVSLAEWAAHCHKKGILEQIMD-PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       744 ~~~l~~~~~~~~~~~~~~~i~d-~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                          .....         .... +.........+...+.+++.+||+.||.+||++.||+++
T Consensus       248 ----~~i~~---------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 ----SNIIR---------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             ----HHHHH---------TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----HHHhc---------CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence                11111         1111 111112244667889999999999999999999999964

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-35  Score=335.47  Aligned_cols=251  Identities=23%  Similarity=0.259  Sum_probs=186.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ..+|+..++||+|+||+||...... ++.||||++.....   ..+.+|+++|+++ +||||+++++++.+....+||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~-~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESS-SSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeC-CeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            4568889999999999965433333 37899998765332   2357899999999 79999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC-----CCCceeEecccccccC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD-----EKWVAKVSDFGLSKTG  684 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld-----~~~~~kl~DFGla~~~  684 (893)
                      |+. |+|.+++..... .+.+..++.++.|+++||+|||+   .+|+||||||+||||+     ....+||+|||+++..
T Consensus        99 ~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            997 699999976543 35666778999999999999994   8999999999999994     3346889999999865


Q ss_pred             CCCCC-ccceeeeccCcCccChHhhh---hcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccc
Q 036624          685 PTLDH-THVSTVVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGI  759 (893)
Q Consensus       685 ~~~~~-~~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  759 (893)
                      ..... ........||+.|+|||++.   ...++.++|||||||++|||++ |+.||.......       .........
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACS  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCC
Confidence            43211 12234467999999999997   4678889999999999999999 888885432211       000010000


Q ss_pred             hhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       760 ~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      .     .  ...........+.+++.+||+.||.+|||+.||+++
T Consensus       247 ~-----~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          247 L-----D--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             C-----T--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             c-----c--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            0     0  001122445667899999999999999999999954

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-34  Score=313.91  Aligned_cols=233  Identities=12%  Similarity=0.086  Sum_probs=186.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||.||+|.+...++.||||++....   ....+.|.+|+.++.+++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57889999999999999999998877999999886542   345578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+++++|.+++...    ....++.+|+.|++.||+|||   +.+|+||||||+|||+++++.+||+++|         
T Consensus       111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            999999999999532    355678899999999999999   5899999999999999999999998543         


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                                   |++|       ++.++|||||||+||||++|+.||...........       ... .+....  ..
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------~~~-~~~~~~--~~  224 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------AER-DTAGQP--IE  224 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-------CCB-CTTSCB--CC
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-------HHH-HhccCC--CC
Confidence                         3333       68899999999999999999999976543221100       000 000000  00


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      .....+.++..+.+++.+||+.||++| |+.|+++.|+.+...
T Consensus       225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            001123345678999999999999999 999999999987653

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-35  Score=351.36  Aligned_cols=268  Identities=24%  Similarity=0.297  Sum_probs=205.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEee------cCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE------NCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~  604 (893)
                      ++|+..++||+|+||+||+|.+...+..||||++... .....+.+.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            5789999999999999999999887789999987653 45567789999999999999999999999765      6778


Q ss_pred             EEEEeeccCCCHHHHHhhCC-CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCc---eeEecccc
Q 036624          605 ILVYDYMAYGTLREHLYKTQ-KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWV---AKVSDFGL  680 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~---~kl~DFGl  680 (893)
                      ++||||+++|+|.+++.... ...+++..+..|+.|++.||+|||   ..+|+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999998643 336999999999999999999999   489999999999999996654   99999999


Q ss_pred             cccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          681 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       681 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...|..........
T Consensus       171 a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~  242 (676)
T 3qa8_A          171 AKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNE  242 (676)
T ss_dssp             CCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC-----
T ss_pred             ccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccch
Confidence            9864332   122345799999999999999999999999999999999999999965321     11222111111100


Q ss_pred             hhhccc------------cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHH-----HHHHHHHHh
Q 036624          761 EQIMDP------------YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDV-----LWNLEFALQ  810 (893)
Q Consensus       761 ~~i~d~------------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~ev-----l~~L~~~~~  810 (893)
                      ......            .............+.+++.+||+.||++|||+.++     .+.++..+.
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            000000            01123445678889999999999999999999884     455555543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6e-35  Score=354.24  Aligned_cols=240  Identities=18%  Similarity=0.278  Sum_probs=193.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC-cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCE-----E
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG-ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCE-----M  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----~  604 (893)
                      ++|+..++||+|+||+||+|.+.. .++.||||++... .......+.+|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999875 4588999987643 34556788999999999999999999999987655     7


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      +|||||+++++|.+++..    .++|.+++.|+.||++||+|||   +.+||||||||+|||++++ .+||+|||+++..
T Consensus       160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            999999999999987743    5999999999999999999999   4899999999999999986 9999999999864


Q ss_pred             CCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ...      ....||+.|+|||++.+.. +.++|||||||+||||++|.+|+.......                   +.
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~~  285 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------LP  285 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------CC
T ss_pred             ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------cc
Confidence            321      3456999999999998765 899999999999999999998875321100                   00


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPS-MGDVLWNLEFAL  809 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-m~evl~~L~~~~  809 (893)
                          ...........+.+++.+||+.+|++||+ +.++.+.|...+
T Consensus       286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                00001123457889999999999999995 566666666554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.6e-34  Score=312.07  Aligned_cols=231  Identities=20%  Similarity=0.323  Sum_probs=183.5

Q ss_pred             cCCccc-eeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHH-hhccccceeeEEEEEee----cCEEE
Q 036624          532 NNFDEA-LLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEML-SKLRHRHLVSLIGYCEE----NCEMI  605 (893)
Q Consensus       532 ~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~  605 (893)
                      ++|... ++||+|+||.||+|.....++.||+|++..     ...+.+|++++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456666 789999999999999988888999998753     24567888888 55589999999999977    67889


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC---CCceeEecccccc
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE---KWVAKVSDFGLSK  682 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla~  682 (893)
                      +||||+++|+|.+++.......+++..+..++.|++.||+|||   ..+|+||||||+|||++.   ++.+||+|||+++
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            9999999999999998876667999999999999999999999   489999999999999998   7899999999986


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                      ...                        +..++.++|||||||++|||++|+.||.........           ......
T Consensus       169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~  213 (299)
T 3m2w_A          169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTR  213 (299)
T ss_dssp             ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred             ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHH
Confidence            422                        134677999999999999999999999654321100           000000


Q ss_pred             hccccccCCCC----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          763 IMDPYLKGKIA----PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       763 i~d~~l~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      +....  ...+    ..+...+.+++.+||+.||++||++.|++++-..
T Consensus       214 ~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~  260 (299)
T 3m2w_A          214 IRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  260 (299)
T ss_dssp             SCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             Hhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence            10000  0111    1245678899999999999999999999987664

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.7e-35  Score=333.98  Aligned_cols=243  Identities=14%  Similarity=0.150  Sum_probs=183.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccc-cc---------ee-e---
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRH-RH---------LV-S---  593 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H-~n---------iv-~---  593 (893)
                      +.+|...++||+|+||+||+|++...++.||||++....   ....+.|.+|+.+++.++| +|         ++ .   
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777889999999999999998777899999876332   2335779999999999976 21         11 1   


Q ss_pred             --------EEEEEee-----cCEEEEEEeeccCCCHHHHHh-----hCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCce
Q 036624          594 --------LIGYCEE-----NCEMILVYDYMAYGTLREHLY-----KTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI  655 (893)
Q Consensus       594 --------l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  655 (893)
                              ++.++..     ....+++|+++ +++|.+++.     ......+++..++.|+.|+++||+|||   +.+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence                    1111111     12357777765 589999885     233445889999999999999999999   5899


Q ss_pred             EecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhh----------hhcCCCCcchhhhHHHH
Q 036624          656 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF----------RRQQLTEKSDVYSFGVV  725 (893)
Q Consensus       656 vHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~s~ksDV~S~Gvv  725 (893)
                      |||||||+||||+.++.+||+|||+++....     ......| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            9999999999999999999999999875322     1344567 999999999          55568889999999999


Q ss_pred             HHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          726 LFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       726 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ||||++|+.||.......               ....++...      ...+..+.+++.+||+.+|++||++.+++++
T Consensus       307 l~elltg~~Pf~~~~~~~---------------~~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALG---------------GSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGS---------------CSGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHCCCCCCCcchhh---------------hHHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            999999999996543211               111111111      1234678899999999999999999999865

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.1e-34  Score=317.07  Aligned_cols=243  Identities=19%  Similarity=0.181  Sum_probs=184.2

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--------ChhhHHHHHHHHHHHhhcc---------ccceee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--------SEQGVHEFQTEIEMLSKLR---------HRHLVS  593 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--------~~~~~~~f~~E~~~l~~l~---------H~niv~  593 (893)
                      .++|+..++||+|+||+||+|+..  ++.||||++...        .....+.+.+|+.++++++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEET--TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEeC--CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            356788899999999999999984  378999986543        2233477899999999886         888888


Q ss_pred             EEEEEe------------------------------ecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHh
Q 036624          594 LIGYCE------------------------------ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARG  643 (893)
Q Consensus       594 l~g~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g  643 (893)
                      +.+.+.                              .....+|||||+++|++.+.+.+   ..+++..+..|+.|++.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence            887642                              26789999999999987776643   358999999999999999


Q ss_pred             hhhhh-cCCCCceEecCCCCCCEEECCCC--------------------ceeEecccccccCCCCCCccceeeeccCcCc
Q 036624          644 LHYLH-TGAKHTIIHRDVKTTNILLDEKW--------------------VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGY  702 (893)
Q Consensus       644 L~yLH-~~~~~~ivHrDlk~~NILld~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  702 (893)
                      |+||| +   .+||||||||+||||+.++                    .+||+|||+++....       ....||+.|
T Consensus       174 L~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS  243 (336)
T ss_dssp             HHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred             HHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence            99999 5   7899999999999999887                    999999999986432       134699999


Q ss_pred             cChHhhhhcCCCCcchhhhHHHH-HHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh-ccccccCCCChHHHHHH
Q 036624          703 LDPEYFRRQQLTEKSDVYSFGVV-LFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI-MDPYLKGKIAPECFKKF  780 (893)
Q Consensus       703 ~APE~~~~~~~s~ksDV~S~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i-~d~~l~~~~~~~~~~~l  780 (893)
                      +|||++.+.. +.++|||||+++ .+++++|..||..         ..|....... .+... ..........+.....+
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDK-MLKQMTFKTKCNTPAMKQIKRKI  312 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHH-HHHTCCCSSCCCSHHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHh-hhhhhccCcccchhhhhhcCHHH
Confidence            9999998766 889999998777 7778889888731         1121111100 00000 01111111234577889


Q ss_pred             HHHHHHccccCCCCCCCHHHHH-HH
Q 036624          781 AETAMKCVSDQGIERPSMGDVL-WN  804 (893)
Q Consensus       781 ~~l~~~Cl~~~p~~RPtm~evl-~~  804 (893)
                      .+++.+||+.+     |+.|++ ++
T Consensus       313 ~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHhccC-----CHHHHHhcC
Confidence            99999999976     899888 54

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=3.2e-28  Score=287.45  Aligned_cols=186  Identities=20%  Similarity=0.089  Sum_probs=128.9

Q ss_pred             eeeecCcEEEEEEEEcCcceEEEEEeCCCC----------ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEE
Q 036624          539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPL----------SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       539 ~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~----------~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  607 (893)
                      .++.|++|.+..++..-.+..+++|.+...          .....++|.+|+++|+++ .|+||+++++++++....|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            356677776666554444467888875432          123456799999999999 699999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||++|++|.+.|...+  +++..   +|+.||+.||+|||   +.+||||||||+||||++++.+||+|||+|+.....
T Consensus       321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999997653  46543   58999999999999   599999999999999999999999999999865432


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCC
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPA  735 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p  735 (893)
                        .......+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       393 --~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 --CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             --CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence              122345679999999999975 467789999999999888766443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=2.5e-25  Score=261.21  Aligned_cols=184  Identities=18%  Similarity=0.192  Sum_probs=143.0

Q ss_pred             cceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---h-----hhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          536 EALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---E-----QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ..++||+|+||+||+|...+  ..+++|+.....   .     ...+.|.+|++++++++||||+++..++...+..+||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSYLD--FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEECSS--CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEEECC--CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            35689999999999996554  567887643221   1     1235589999999999999999666666677778999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      |||+++++|.+++..          ++.++.|+++||+|||   +.+|+||||||+|||+++  .+||+|||+++.....
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999999999865          5689999999999999   589999999999999999  9999999999875432


Q ss_pred             CCcc-----ceeeeccCcCccChHhhhh--cCCCCcchhhhHHHHHHHHhhCCCCC
Q 036624          688 DHTH-----VSTVVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEILCARPAL  736 (893)
Q Consensus       688 ~~~~-----~~~~~~gt~~y~APE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~  736 (893)
                      ....     ......||+.|||||++..  ..|+.++|+|+..+-.++-+.++.++
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1111     1235679999999999987  67888999999999998888777655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=7.7e-22  Score=212.45  Aligned_cols=153  Identities=14%  Similarity=0.046  Sum_probs=120.5

Q ss_pred             HHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh------------------hhHHHHHHHHHHHhhc
Q 036624          525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE------------------QGVHEFQTEIEMLSKL  586 (893)
Q Consensus       525 ~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~------------------~~~~~f~~E~~~l~~l  586 (893)
                      ..+......|+..+.||+|+||.||+|.. .++..||+|..+....                  .....+.+|+++|+++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            33444445577779999999999999999 5568999998754221                  2356789999999999


Q ss_pred             cccceeeEEEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEE
Q 036624          587 RHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNIL  666 (893)
Q Consensus       587 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIL  666 (893)
                      +|   +++.+++.. +..++||||+++|+|.+ +.        ......++.|+++||.|||   +.+|+||||||+|||
T Consensus       162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NIL  225 (282)
T 1zar_A          162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVL  225 (282)
T ss_dssp             TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred             cC---CCcCeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEE
Confidence            94   555554433 45699999999999988 42        1345579999999999999   589999999999999


Q ss_pred             ECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhh
Q 036624          667 LDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR  710 (893)
Q Consensus       667 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~  710 (893)
                      ++ ++.+||+|||+++.               +..++|||++.+
T Consensus       226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             EE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             EE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            99 99999999999863               336789999864

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=99.82  E-value=9.3e-21  Score=187.96  Aligned_cols=158  Identities=16%  Similarity=0.168  Sum_probs=117.5

Q ss_pred             heeeeeccCCcccCCCCCccccccccCCCCceecCCCCceeecCCCceeecCCCCCcccchhHHHHHhhhcCCCCCcccc
Q 036624          221 ENVYRLNVGGKDISPSGDTDLFRSWYDDQPYIFGAALGVPVTIGPNMTVRYPSNIPSYVAPVDVYATARQMGPNPQINLN  300 (893)
Q Consensus       221 ~~~~R~n~Gg~~~~~~~d~d~~r~w~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~v~~tA~~~~~~~~~~~~  300 (893)
                      |+++|+||||+.++   |+ .+|+|.+|..|....   .........     .....+.+|+.||||||.+.        
T Consensus         5 ~~~~~INcGg~~~~---d~-~gr~w~~D~~~~~~g---~~~~~~~~~-----~~~~~~~~~~~lY~TaR~~~--------   64 (174)
T 2jwp_A            5 KVIWAVNAGGESHV---DV-HGIHYRKDPLEGRVG---RASDYGMKL-----PILRSNPEDQVLYQTERYNE--------   64 (174)
T ss_dssp             HEEEEEEETSSSEE---ET-TTEEECSSCSSTTCC---CCCCCCTTS-----CCSSSCHHHHHTTTCCCCCC--------
T ss_pred             cEEEEEECCCCCcc---CC-CCCEEcCCcCcccCC---cccccccce-----EecccCCCCchhhhhhccCC--------
Confidence            67999999998765   32 569999998775211   111111111     11224678999999999855        


Q ss_pred             cceEEEEecCCCCeeEEEEeeeecccCccccccEEEEEEecCcccCCccCccccccCCCceEEEEEEEEecCCC------
Q 036624          301 YELSWVFSVDSGFSYLVRLHFCEVLPEITKINQRVFDILLNNQTAFPAFDVAGLTKGNGIPLYQDFAVFVPGNG------  374 (893)
Q Consensus       301 ~~~tw~~~~~~~~~y~v~lhF~e~~~~~~~~~~r~F~i~in~~~~~~~~dv~~~~~~~~~~l~~~~~~~i~~~~------  374 (893)
                      .+++|.+|++++.+|+|||||||+..  ++.++|+|||+|||+.+.+++|+..+++. ..++++++.+.|..+.      
T Consensus        65 ~~~tY~f~v~~~G~Y~VrLhF~ei~~--~~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~~~~~~v~~~~l~i~~~  141 (174)
T 2jwp_A           65 DSFGYDIPIKEEGEYVLVLKFAEVYF--AQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGE  141 (174)
T ss_dssp             SCEEEEEECCSCEEEEEEEEEECCSC--CCSSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEEEEEEEEETTEEEETTE
T ss_pred             CCeEEEEEeCCCeEEEEEEEEecccc--CCCCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEEEEEEEEecCceeeeee
Confidence            26899999998679999999999974  67999999999999999999999988875 6889999988764331      


Q ss_pred             ---CcceeEEeecccccCcccccccccccceeeec
Q 036624          375 ---PQKDLWLGLHPNVASKTQYYDAILNGVEIFKL  406 (893)
Q Consensus       375 ---~~~~~~l~l~~n~~~~~~~~~~~ln~l~~~~l  406 (893)
                         ....+++.+.+..     ...+++||+|+++-
T Consensus       142 ~~~~~g~L~I~f~p~~-----~~~a~inaIEI~~~  171 (174)
T 2jwp_A          142 VSTFTGKLSVEFVKGY-----YDNPKVCALFIMKG  171 (174)
T ss_dssp             EEECCSEEEEEEECSS-----SCSSSEEEEEEESS
T ss_pred             ecccCCeEEEEEeccC-----CCCcEEEEEEEEeC
Confidence               2345777777531     34788999999954

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=99.80  E-value=1.7e-19  Score=178.84  Aligned_cols=151  Identities=16%  Similarity=0.167  Sum_probs=110.5

Q ss_pred             CcEEEecCCCCCCCCCCCCccccCCCCc-ccccCCCcccccccCCCCCCCCCCcccceeecCCceEEeeecC-CceEEEE
Q 036624           34 EQILLNCGESSILSDDDKRSWTPDIGSK-FLLSTKDSTTSKAATQDPSTPTIPYMTARVFRSEFTYSFPVVA-GRKFVRL  111 (893)
Q Consensus        34 ~~~~I~CG~~~~~~~~~~~~w~~D~~~~-~g~~~~~~~~~~~~~~~~~~~~~~y~t~R~f~~~~cY~~p~~~-g~~yvR~  111 (893)
                      ..|+||||++... +..||+|.+|..|. .|................ .+...|+|+|.|+...||.||+.+ |.|.|||
T Consensus         6 ~~~~INcGg~~~~-d~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~-~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrL   83 (174)
T 2jwp_A            6 VIWAVNAGGESHV-DVHGIHYRKDPLEGRVGRASDYGMKLPILRSNP-EDQVLYQTERYNEDSFGYDIPIKEEGEYVLVL   83 (174)
T ss_dssp             EEEEEEETSSSEE-ETTTEEECSSCSSTTCCCCCCCCTTSCCSSSCH-HHHHTTTCCCCCCSCEEEEEECCSCEEEEEEE
T ss_pred             EEEEEECCCCCcc-CCCCCEEcCCcCcccCCcccccccceEecccCC-CCchhhhhhccCCCCeEEEEEeCCCeEEEEEE
Confidence            3699999987654 44699999998875 332211110100000000 112349999999999999999976 6666999


Q ss_pred             EEecCCCCCCCCCCcceEEEeCCeEEEeccChhhhhhhhccceeEEEEeeec-------------CCCcEEEEEeeCCCC
Q 036624          112 YFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPV-------------DGETLNITFSPMNVS  178 (893)
Q Consensus       112 ~F~~g~yd~~~~~~~~Fdv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v-------------~~~~~~i~f~p~~~~  178 (893)
                      ||++..|..  ...++|||+++|+.++.||+....++.  ..++.+++.+.|             ..+++.|+|.|..  
T Consensus        84 hF~ei~~~~--~~~rvFdV~ing~~~l~~fdi~~~ag~--~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~--  157 (174)
T 2jwp_A           84 KFAEVYFAQ--SQQKVFDVRVNGHTVVKDLDIFDRVGH--STAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGY--  157 (174)
T ss_dssp             EEECCSCCC--SSSSCEEEEETTEEEEEEECHHHHHSS--SSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSS--
T ss_pred             EEeccccCC--CCCeEeEEEECCEEeecCcCHHHhhCC--CeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccC--
Confidence            999999875  455899999999999999999876653  457788888764             4567999999864  


Q ss_pred             Ccceeecceeeeec
Q 036624          179 NAYAFVNGIEVMSM  192 (893)
Q Consensus       179 ~~~~fv~~~e~~~~  192 (893)
                      ..+||||||||++-
T Consensus       158 ~~~a~inaIEI~~~  171 (174)
T 2jwp_A          158 YDNPKVCALFIMKG  171 (174)
T ss_dssp             SCSSSEEEEEEESS
T ss_pred             CCCcEEEEEEEEeC
Confidence            33899999999986

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=1e-17  Score=177.83  Aligned_cols=137  Identities=15%  Similarity=0.112  Sum_probs=106.0

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceE--EEEEeCCCCCh------------------------hhHHHHHHHHHHHhhcc
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTK--VAIKRGNPLSE------------------------QGVHEFQTEIEMLSKLR  587 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~--VavK~~~~~~~------------------------~~~~~f~~E~~~l~~l~  587 (893)
                      |+..+.||+|+||.||+|.....+..  ||||+.+....                        .....+.+|+++|.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998444477  99997543211                        11236889999999999


Q ss_pred             ccce--eeEEEEEeecCEEEEEEeeccC-C----CHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCC
Q 036624          588 HRHL--VSLIGYCEENCEMILVYDYMAY-G----TLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDV  660 (893)
Q Consensus       588 H~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  660 (893)
                      |+++  ...+++    ...+|||||+.+ |    +|.+.+..     .++..+..++.|++.||.|||.  ..+||||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            8864  444443    345899999952 4    67766532     2356788999999999999993  379999999


Q ss_pred             CCCCEEECCCCceeEeccccccc
Q 036624          661 KTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       661 k~~NILld~~~~~kl~DFGla~~  683 (893)
                      ||+|||+++  .++|+|||++..
T Consensus       198 kp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEE
T ss_pred             CHHHEEEcC--cEEEEECccccc
Confidence            999999998  999999999875

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.53  E-value=4.6e-15  Score=163.99  Aligned_cols=133  Identities=15%  Similarity=0.128  Sum_probs=96.4

Q ss_pred             CccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--------------hhhHH--------HHHHHHHHHhhccccce
Q 036624          534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--------------EQGVH--------EFQTEIEMLSKLRHRHL  591 (893)
Q Consensus       534 f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--------------~~~~~--------~f~~E~~~l~~l~H~ni  591 (893)
                      |+....||+|+||.||+|....+ +.||||+.+...              .....        ....|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G-~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKG-KQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTC-CEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECCCC-CEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            88899999999999999998754 789999754210              00011        12346666777765544


Q ss_pred             e--eEEEEEeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC
Q 036624          592 V--SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE  669 (893)
Q Consensus       592 v--~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~  669 (893)
                      .  ..+++  .  ..+|||||+++++|..++.        ......++.|++.+|.|||   +.+||||||||.||||++
T Consensus       176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCCCEEEE--E--TTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEE
T ss_pred             CCCeeeec--c--CceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeC
Confidence            3  22222  1  2379999999988865431        2245678899999999999   589999999999999988


Q ss_pred             CC----------ceeEecccccc
Q 036624          670 KW----------VAKVSDFGLSK  682 (893)
Q Consensus       670 ~~----------~~kl~DFGla~  682 (893)
                      ++          .+.|+||+-+.
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCE
T ss_pred             CCCcccccccccceEEEEeCCcc
Confidence            76          38999998654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.18  E-value=6.7e-11  Score=125.30  Aligned_cols=147  Identities=14%  Similarity=0.076  Sum_probs=114.2

Q ss_pred             HHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEE
Q 036624          527 IKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       527 l~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  605 (893)
                      +......|.....++.|+.+.||+....+  ..+++|+...........+.+|+++++.+. |..+.++++++...+..+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~~--~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGEN--ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECSS--CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECCC--CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            34455678888888888899999987553  679999865421122345889999999985 677889999999888999


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcC-----------------------------------
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG-----------------------------------  650 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------  650 (893)
                      +||||++|.+|.+.+.       +......++.+++++|..||+-                                   
T Consensus        87 lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            9999999999987631       2234457889999999999961                                   


Q ss_pred             ---------------------CCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          651 ---------------------AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       651 ---------------------~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                                           ....++|+|+++.|||++++..+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 01458999999999999876667799998765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.98  E-value=4.4e-10  Score=118.40  Aligned_cols=137  Identities=20%  Similarity=0.123  Sum_probs=98.3

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccc--eeeEEEEEeecCEEEEEEee
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH--LVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++....+.+.|..+.||+....++ ..+++|.....   ....+..|+++++.+++.+  +.+++++....+..++||||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g-~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGR-PVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTS-CCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceEecccCCCCceEEEEecCCC-CeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            344433333455699999976543 56899986543   2245789999999997555  45688888887889999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCC---------------------------------------
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA---------------------------------------  651 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------  651 (893)
                      ++|.+|.  ...     .   ....++.++++.|..||+..                                       
T Consensus        97 i~G~~l~--~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           97 VPGQDLL--SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             CSSEETT--TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             cCCcccC--cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            9998884  211     1   12366777888888888521                                       


Q ss_pred             ----------------CCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          652 ----------------KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       652 ----------------~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                                      ...++|+|++|.|||++++..++|+|||.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                            12399999999999998876677999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.83  E-value=6.8e-09  Score=115.23  Aligned_cols=143  Identities=16%  Similarity=0.247  Sum_probs=107.2

Q ss_pred             cceeeeecCcEEEEEEEEcCcceEEEEEeCC--CCC-hhhHHHHHHHHHHHhhcc--ccceeeEEEEEeec---CEEEEE
Q 036624          536 EALLLGVGGFGKVYRGEIDGATTKVAIKRGN--PLS-EQGVHEFQTEIEMLSKLR--HRHLVSLIGYCEEN---CEMILV  607 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~--~~~-~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV  607 (893)
                      ..+.|+.|.++.||+....+  ..+++|+..  ... ......+.+|+++++.++  +..+.++++++.+.   +..++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            45679999999999988764  467888765  322 123456889999999997  45678899998776   447899


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCC------------------------------------
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA------------------------------------  651 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------  651 (893)
                      |||++|..+.+..    ...++..++..++.++++.|..||+..                                    
T Consensus       120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999988875421    123778888999999999999999620                                    


Q ss_pred             -------------------CCceEecCCCCCCEEECCCCc--eeEecccccccC
Q 036624          652 -------------------KHTIIHRDVKTTNILLDEKWV--AKVSDFGLSKTG  684 (893)
Q Consensus       652 -------------------~~~ivHrDlk~~NILld~~~~--~kl~DFGla~~~  684 (893)
                                         ...++|+|+++.|||+++++.  +.|.||+.+...
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                               257999999999999997753  689999988753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.77  E-value=9.4e-09  Score=111.29  Aligned_cols=187  Identities=16%  Similarity=0.183  Sum_probs=122.6

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccc--eeeEEEEEeecC---EEEEEEee
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRH--LVSLIGYCEENC---EMILVYDY  610 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~E~  610 (893)
                      .+.++.|....||+..     ..+++|+...  ......+.+|.++|+.+. +..  +.+.++.+....   ..++|||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999853     3578887542  344567899999999884 332  445565554333   34789999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcC----------------------------------------
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG----------------------------------------  650 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------  650 (893)
                      ++|.+|......    .++..++..++.++++.|..||+.                                        
T Consensus        98 i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           98 IKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            999888754332    266777788888888888888841                                        


Q ss_pred             ---------------CCCceEecCCCCCCEEECC--CCceeEecccccccCCCCC-Ccccee-----------eeccCcC
Q 036624          651 ---------------AKHTIIHRDVKTTNILLDE--KWVAKVSDFGLSKTGPTLD-HTHVST-----------VVKGSFG  701 (893)
Q Consensus       651 ---------------~~~~ivHrDlk~~NILld~--~~~~kl~DFGla~~~~~~~-~~~~~~-----------~~~gt~~  701 (893)
                                     ....++|+|+++.||++++  ...+.|+||+.+....... ......           ......+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                           1245899999999999998  5668999999887542210 000000           0000011


Q ss_pred             ccC-hHhhhhcCCCCcchhhhHHHHHHHHhhCCCCC
Q 036624          702 YLD-PEYFRRQQLTEKSDVYSFGVVLFEILCARPAL  736 (893)
Q Consensus       702 y~A-PE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~  736 (893)
                      ... |+.....  ....+.|+++.++|++.+|..++
T Consensus       254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence            222 3333221  12368999999999999998654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.31  E-value=3.8e-06  Score=88.83  Aligned_cols=136  Identities=19%  Similarity=0.159  Sum_probs=97.0

Q ss_pred             eeeecCcE-EEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCEEEEEEeeccCCCH
Q 036624          539 LLGVGGFG-KVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCEMILVYDYMAYGTL  616 (893)
Q Consensus       539 ~LG~G~fG-~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL  616 (893)
                      .+..|..| .||+-....++..+++|+...   ....++.+|.++|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556555 699887766667788997543   23567889999998885 33466889999999999999999998887


Q ss_pred             HHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhc-----------------------------------------------
Q 036624          617 REHLYKTQKPPLPWKQRLEICIGAARGLHYLHT-----------------------------------------------  649 (893)
Q Consensus       617 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----------------------------------------------  649 (893)
                      .+.....      ......++.++++.|.-||+                                               
T Consensus       108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            7654321      12333455555555555553                                               


Q ss_pred             --------CCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          650 --------GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       650 --------~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                              .....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    0122478999999999999887778999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.22  E-value=9.1e-06  Score=87.80  Aligned_cols=136  Identities=18%  Similarity=0.155  Sum_probs=93.2

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcccc---ceeeEEEEEe-ecCEEEEEEeecc
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHR---HLVSLIGYCE-ENCEMILVYDYMA  612 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~  612 (893)
                      .+.++.|....||+.   +  ..+++|+..  .......+..|.++|+.+.+.   .+.+.+.++. ..+..++|||+++
T Consensus        24 v~~l~~G~~n~v~~v---g--~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---N--GDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE---T--TTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE---C--CEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            457888888999987   2  457778743  234456789999999999752   3556777764 3455789999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcC------------------------------------------
Q 036624          613 YGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG------------------------------------------  650 (893)
Q Consensus       613 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------  650 (893)
                      |..|......    .++..++..++.++++.|..||+.                                          
T Consensus        97 G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           97 GQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             SEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             CeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            9888763211    133444445555555555555421                                          


Q ss_pred             ---------------CCCceEecCCCCCCEEECC---CCc-eeEeccccccc
Q 036624          651 ---------------AKHTIIHRDVKTTNILLDE---KWV-AKVSDFGLSKT  683 (893)
Q Consensus       651 ---------------~~~~ivHrDlk~~NILld~---~~~-~kl~DFGla~~  683 (893)
                                     ....++|+|+++.|||+++   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2346799999999999987   345 58999998765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.93  E-value=1.4e-05  Score=88.29  Aligned_cols=81  Identities=6%  Similarity=-0.044  Sum_probs=55.0

Q ss_pred             ceee-eecCcEEEEEEEEc---C---cceEEEEEeCCCCC---hhhHHHHHHHHHHHhhccc---cceeeEEEEEeec--
Q 036624          537 ALLL-GVGGFGKVYRGEID---G---ATTKVAIKRGNPLS---EQGVHEFQTEIEMLSKLRH---RHLVSLIGYCEEN--  601 (893)
Q Consensus       537 ~~~L-G~G~fG~Vy~g~~~---~---~~~~VavK~~~~~~---~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~--  601 (893)
                      .+.| +.|....+|+....   +   .+..+++|+.....   ......+.+|+++++.+..   -.+.++++++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999988764   1   13568888754322   0012457889999998853   3467788888665  


Q ss_pred             -CEEEEEEeeccCCCHH
Q 036624          602 -CEMILVYDYMAYGTLR  617 (893)
Q Consensus       602 -~~~~lV~E~~~~gsL~  617 (893)
                       +..++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3468999999986654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.80  E-value=4.8e-05  Score=85.27  Aligned_cols=76  Identities=13%  Similarity=0.107  Sum_probs=49.0

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCCh-------hhHHHHHHHHHHHhhccc--cc-eeeEEEEEeecCEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSE-------QGVHEFQTEIEMLSKLRH--RH-LVSLIGYCEENCEMIL  606 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~-------~~~~~f~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~l  606 (893)
                      .+.||.|.++.||++....++..++||.......       .....+..|.++++.+.+  +. +.+++.+.  ....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            5579999999999997654456799996543211       123456789999888742  33 44566543  334589


Q ss_pred             EEeeccCC
Q 036624          607 VYDYMAYG  614 (893)
Q Consensus       607 V~E~~~~g  614 (893)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.67  E-value=0.00012  Score=79.76  Aligned_cols=141  Identities=17%  Similarity=0.188  Sum_probs=81.5

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcccc--ceeeEEE------EEeecCEEEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHR--HLVSLIG------YCEENCEMILVY  608 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g------~~~~~~~~~lV~  608 (893)
                      .+.|+.|..+.||+....++  .+++|+....    ..++..|.+++..|...  .+.+++.      +....+..++||
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~--~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG--AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             EEECC----CEEEEEEETTE--EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCC--CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            34565567889999887653  4888887642    23344566666666421  2233332      123456789999


Q ss_pred             eeccCCCHH--------------HHHhhCCC----C--------CCCHHhHH----------------------------
Q 036624          609 DYMAYGTLR--------------EHLYKTQK----P--------PLPWKQRL----------------------------  634 (893)
Q Consensus       609 E~~~~gsL~--------------~~l~~~~~----~--------~l~~~~~~----------------------------  634 (893)
                      ||++|..+.              ..||....    +        .-.|....                            
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            999986542              12222100    0        11332211                            


Q ss_pred             ---HHHHHHHHhhhhhhc----------CCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          635 ---EICIGAARGLHYLHT----------GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       635 ---~i~~~ia~gL~yLH~----------~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                         .+...+.+++++|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence               111123345666652          1257899999999999998888999999997653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.29  E-value=0.00088  Score=72.15  Aligned_cols=139  Identities=14%  Similarity=0.146  Sum_probs=92.5

Q ss_pred             ccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccc---cceeeEEEEEeecCEEEEEEeec
Q 036624          535 DEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH---RHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ...+.|+.|....+|+....  +..+++|+...   .....|..|.+.|+.|..   ..+.+.++++...+..++||||+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDE--VQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESS--SCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeeEEeCCccceeeeEEEEC--CCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            34567899999999998754  35688887543   235678999999998852   56778999888888899999999


Q ss_pred             cCCCHH-----------HHHhhCCC-C-------------------CCCHHhHH---HHHH--H--------------HH
Q 036624          612 AYGTLR-----------EHLYKTQK-P-------------------PLPWKQRL---EICI--G--------------AA  641 (893)
Q Consensus       612 ~~gsL~-----------~~l~~~~~-~-------------------~l~~~~~~---~i~~--~--------------ia  641 (893)
                      ++..+.           ..||.... .                   .-+|....   ++..  +              +.
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            987642           12343221 0                   01454321   1111  1              11


Q ss_pred             Hh-hhhhh-cCCCCceEecCCCCCCEEECCCCceeEeccc
Q 036624          642 RG-LHYLH-TGAKHTIIHRDVKTTNILLDEKWVAKVSDFG  679 (893)
Q Consensus       642 ~g-L~yLH-~~~~~~ivHrDlk~~NILld~~~~~kl~DFG  679 (893)
                      +. ...|. ......+||+|+.+.|++++.++ +.|.|+.
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            11 12332 12357899999999999999887 8898974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.29  E-value=0.0012  Score=70.34  Aligned_cols=79  Identities=15%  Similarity=0.084  Sum_probs=56.5

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccc---cceeeEEEEEeecCEEEEEEe
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH---RHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .....+.+|.|..+.||+.+..++ +.+.+|+...........|..|.+.|+.|.-   --+.+.+++.    .-++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG-~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADG-TPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTS-CEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCC-CEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            455677899999999999998876 6799998654433334568899999988842   2344555543    2378999


Q ss_pred             eccCCCH
Q 036624          610 YMAYGTL  616 (893)
Q Consensus       610 ~~~~gsL  616 (893)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.18  E-value=0.0012  Score=74.30  Aligned_cols=78  Identities=14%  Similarity=0.172  Sum_probs=47.4

Q ss_pred             CCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccceeee-ccCcCccChHhhhhcC---CCCcchhhhHHHHHH
Q 036624          652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV-KGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLF  727 (893)
Q Consensus       652 ~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~---~s~ksDV~S~Gvvl~  727 (893)
                      ...++|+|+++.|||+++++ ++|+||+.+..+....  ...... .-...|++|+......   -....++......+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            57899999999999999876 9999999887543210  000000 0012455555443111   112355667788888


Q ss_pred             HHhhC
Q 036624          728 EILCA  732 (893)
Q Consensus       728 elltG  732 (893)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.85  E-value=0.0026  Score=68.61  Aligned_cols=158  Identities=11%  Similarity=0.078  Sum_probs=89.4

Q ss_pred             ccCHHHHHHHhcCCcc-----ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccce--ee
Q 036624          521 HFSFAEIKAATNNFDE-----ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL--VS  593 (893)
Q Consensus       521 ~~~~~el~~at~~f~~-----~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~ni--v~  593 (893)
                      .++.+++......|..     .+.|+.|....+|+....++  .+++|.....  ....++..|++++..+...++  .+
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g--~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc--cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence            4666777777666654     24566688889999887654  5778876542  112346678888887753232  23


Q ss_pred             EEEE------EeecCEEEEEEeeccCCCHHH--------------HHhhCC----CCC------CCHHhHHHH-------
Q 036624          594 LIGY------CEENCEMILVYDYMAYGTLRE--------------HLYKTQ----KPP------LPWKQRLEI-------  636 (893)
Q Consensus       594 l~g~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~----~~~------l~~~~~~~i-------  636 (893)
                      ++..      ....+..+++++|++|..+..              .+|...    ...      ..|...+.-       
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            3321      122356789999999765321              122211    000      123221110       


Q ss_pred             -----HHHHHHhhhhhhc----CCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          637 -----CIGAARGLHYLHT----GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       637 -----~~~ia~gL~yLH~----~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                           ...+.+.++.|+.    .....++|+|+.+.|||++++..+.|+||+.+.
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                 0113334444442    124578999999999999987666899998765

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.73  E-value=0.003  Score=71.24  Aligned_cols=74  Identities=16%  Similarity=0.144  Sum_probs=49.9

Q ss_pred             ceeeeecCcEEEEEEEEcC-------cceEEEEEeCCCCChhhHHHHHHHHHHHhhccccce-eeEEEEEeecCEEEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDG-------ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL-VSLIGYCEENCEMILVY  608 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~-------~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~  608 (893)
                      .+.|+.|....||+....+       .+..+++|+.....  ....+..|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4568888889999998753       13578888764311  11455689999998864445 467776643    2899


Q ss_pred             eeccCCCH
Q 036624          609 DYMAYGTL  616 (893)
Q Consensus       609 E~~~~gsL  616 (893)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.68  E-value=0.0034  Score=68.10  Aligned_cols=142  Identities=15%  Similarity=0.113  Sum_probs=73.8

Q ss_pred             eeeeecCcEE-EEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcccc--ceeeEEEEEeecCEEEEEEeeccCC
Q 036624          538 LLLGVGGFGK-VYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHR--HLVSLIGYCEENCEMILVYDYMAYG  614 (893)
Q Consensus       538 ~~LG~G~fG~-Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~~~~~~lV~E~~~~g  614 (893)
                      +.|+.|+... +|+....++ ..+++|.......   .++..|++++..+...  .+.+++.+..+.+  ++|||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~-~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTG-AKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTC-CEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCC-CeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            3565555444 667654323 4566776543221   2345677777777532  3456777654444  6899999876


Q ss_pred             CHHHHHhh---------------------CCCCC---CCHHhHH-------HH-------------HHHHHHhhhhhh--
Q 036624          615 TLREHLYK---------------------TQKPP---LPWKQRL-------EI-------------CIGAARGLHYLH--  648 (893)
Q Consensus       615 sL~~~l~~---------------------~~~~~---l~~~~~~-------~i-------------~~~ia~gL~yLH--  648 (893)
                      .+.+.+..                     .....   ++.....       ..             ...+.+.++.|.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            66543321                     11101   1111000       00             001111122221  


Q ss_pred             -cCCCCceEecCCCCCCEEECCC----CceeEecccccccCC
Q 036624          649 -TGAKHTIIHRDVKTTNILLDEK----WVAKVSDFGLSKTGP  685 (893)
Q Consensus       649 -~~~~~~ivHrDlk~~NILld~~----~~~kl~DFGla~~~~  685 (893)
                       ......++|||+.+.|||++.+    ..+.|.||+.+..++
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence             1124679999999999999874    689999999887643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.53  E-value=0.0017  Score=69.42  Aligned_cols=138  Identities=14%  Similarity=0.050  Sum_probs=75.7

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcccccee-eEEEEEeecCEEEEEEeec-cCC
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV-SLIGYCEENCEMILVYDYM-AYG  614 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~-~~g  614 (893)
                      .+.|+.|....+|+.      ..+++|+....... .....+|+.+++.+...++. ++++++.+  .-++|+||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCc
Confidence            668989999999998      34777765432211 11235688888887644443 56655433  236899999 654


Q ss_pred             CHHH------------------HHhhCCCC---CCC-HHhHHHHHHH--------------HHHhh----hhhh-cCCCC
Q 036624          615 TLRE------------------HLYKTQKP---PLP-WKQRLEICIG--------------AARGL----HYLH-TGAKH  653 (893)
Q Consensus       615 sL~~------------------~l~~~~~~---~l~-~~~~~~i~~~--------------ia~gL----~yLH-~~~~~  653 (893)
                      +|..                  .||.....   ..+ +.........              +.+.+    +.|. .....
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            4421                  11221110   011 1111111000              11111    1111 12245


Q ss_pred             ceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       654 ~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      .++|+|+.+.||+ .+++.+.|+||..+...
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            6899999999999 55667899999987653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.46  E-value=0.0076  Score=66.60  Aligned_cols=141  Identities=18%  Similarity=0.195  Sum_probs=83.4

Q ss_pred             eeeeecCcEEEEEEEEcC-------cceEEEEEeCCCCChhhHHHHHHHHHHHhhccccce-eeEEEEEeecCEEEEEEe
Q 036624          538 LLLGVGGFGKVYRGEIDG-------ATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL-VSLIGYCEENCEMILVYD  609 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~-------~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E  609 (893)
                      +.|..|-...+|+....+       .+..+++|+.... ......+.+|.++++.+.-.++ .++++++.++    +|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence            456667778899988642       2357888875332 2235567799999998864333 4677766542    8999


Q ss_pred             eccCCCHHH-----------------HHhhCC---CCCC--CHHhHHHHHHHHHH-------------------hhhhhh
Q 036624          610 YMAYGTLRE-----------------HLYKTQ---KPPL--PWKQRLEICIGAAR-------------------GLHYLH  648 (893)
Q Consensus       610 ~~~~gsL~~-----------------~l~~~~---~~~l--~~~~~~~i~~~ia~-------------------gL~yLH  648 (893)
                      |++|..|..                 .||...   ....  -|.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            999765531                 122221   1112  24455555444322                   122232


Q ss_pred             ----c-CCCCceEecCCCCCCEEECCC----CceeEeccccccc
Q 036624          649 ----T-GAKHTIIHRDVKTTNILLDEK----WVAKVSDFGLSKT  683 (893)
Q Consensus       649 ----~-~~~~~ivHrDlk~~NILld~~----~~~kl~DFGla~~  683 (893)
                          . .....++|+|+.+.|||++++    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                1 124568899999999999876    7899999987753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.38  E-value=0.0087  Score=67.93  Aligned_cols=75  Identities=11%  Similarity=0.097  Sum_probs=47.6

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccce-eeEEEEEeecCEEEEEEeeccCCC
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL-VSLIGYCEENCEMILVYDYMAYGT  615 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs  615 (893)
                      .+.|+.|-...+|+....+.+..+++|+....... .-+...|..++..|...++ .++++++..    .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            45688888899999987653366888875432211 1112588999998875555 467777632    25999998754


Q ss_pred             H
Q 036624          616 L  616 (893)
Q Consensus       616 L  616 (893)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.32  E-value=0.022  Score=61.34  Aligned_cols=159  Identities=13%  Similarity=0.118  Sum_probs=88.4

Q ss_pred             ccCHHHHHHHhcCCc-----cceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccc--eee
Q 036624          521 HFSFAEIKAATNNFD-----EALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRH--LVS  593 (893)
Q Consensus       521 ~~~~~el~~at~~f~-----~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~  593 (893)
                      .++.+++..+...|.     ....|+ |....||+....++ ..+++|...... .....+..|..++..+....  +.+
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g-~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~   86 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDR-RRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA   86 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTC-CCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCC-CEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence            445555555544442     234566 77889998766543 468899865321 12456777888888875322  333


Q ss_pred             EEEE-----EeecCEEEEEEeeccCCCHH-----H---------HHhhC----C---CCCCCHHhH--------------
Q 036624          594 LIGY-----CEENCEMILVYDYMAYGTLR-----E---------HLYKT----Q---KPPLPWKQR--------------  633 (893)
Q Consensus       594 l~g~-----~~~~~~~~lV~E~~~~gsL~-----~---------~l~~~----~---~~~l~~~~~--------------  633 (893)
                      ++..     ....+..++|||+++|..+.     .         .+|..    .   ...+++...              
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  166 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  166 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence            4332     12245668899999875432     1         12211    0   111222211              


Q ss_pred             --------HHHHHHHHHhhhhhhc-CCCCceEecCCCCCCEEECCCCceeEecccccccC
Q 036624          634 --------LEICIGAARGLHYLHT-GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       634 --------~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                              ...+..++..++-+.. .....++|+|+++.|||++ + .+.|+||+.+...
T Consensus       167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                    0111111222221111 1246688999999999999 4 8999999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.08  E-value=0.01  Score=65.40  Aligned_cols=75  Identities=11%  Similarity=0.115  Sum_probs=45.2

Q ss_pred             ceeeeecCcEEEEEEEEcCc--------ceEEEEEeCCCCChhhHHHHHHHHHHHhhcccccee-eEEEEEeecCEEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDGA--------TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV-SLIGYCEENCEMILV  607 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~--------~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV  607 (893)
                      ...|+.|..-.+|+....++        ...+++|+...... ...+...|.++++.+...+++ ++++..  .+  ++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence            34677787889999887542        24688887554322 122346788888888644543 666554  22  689


Q ss_pred             EeeccCCCH
Q 036624          608 YDYMAYGTL  616 (893)
Q Consensus       608 ~E~~~~gsL  616 (893)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.64  E-value=0.027  Score=56.31  Aligned_cols=101  Identities=16%  Similarity=0.155  Sum_probs=65.2

Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCccce
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS  693 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~  693 (893)
                      -+|.+.|...+ .+|++++++.+|.|.+++|.-+-.. +.+ ..+=+.+..|+|..+|.+.+.+ +.+.           
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            47899887554 5799999999999999998776210 011 1233456899999999888764 2111           


Q ss_pred             eeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCC
Q 036624          694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR  733 (893)
Q Consensus       694 ~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~  733 (893)
                         .....+.+||... ...+++.=|||+|++||.-+-=.
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence               0122456787663 34567889999999999988433

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.80  E-value=0.0066  Score=43.69  Aligned_cols=31  Identities=23%  Similarity=0.170  Sum_probs=13.5

Q ss_pred             eEEEecccchhhhhHHHHhhhhhhhhhcccC
Q 036624          444 KAIIGGGVGGGIALALVVGFCVFAASRCRRQ  474 (893)
Q Consensus       444 ~~ii~~~v~~~i~v~lvv~~~~~~~~~~r~~  474 (893)
                      ..|.+++|+++++++++++.++++++||+++
T Consensus        10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             ceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            3444455554444444443334444433333

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=94.65  E-value=0.0097  Score=42.97  Aligned_cols=30  Identities=27%  Similarity=0.228  Sum_probs=13.2

Q ss_pred             eEEEecccchhhhhHHHHhhhhhhhhhcccC
Q 036624          444 KAIIGGGVGGGIALALVVGFCVFAASRCRRQ  474 (893)
Q Consensus       444 ~~ii~~~v~~~i~v~lvv~~~~~~~~~~r~~  474 (893)
                      ..|.+++|++++++++++ ++++++.|||++
T Consensus        11 ~~IA~gVVgGv~~~~ii~-~~~~~~~RRr~~   40 (44)
T 2ks1_B           11 PSIATGMVGALLLLLVVA-LGIGLFMRRRHI   40 (44)
T ss_dssp             SSSTHHHHHHHHHHHHHH-HHHHHHHHTTTC
T ss_pred             ceEEeehhHHHHHHHHHH-HHHHHHhhhhHh
Confidence            344445555444444444 444444344433

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=93.66  E-value=0.1  Score=56.66  Aligned_cols=32  Identities=19%  Similarity=0.290  Sum_probs=28.4

Q ss_pred             CCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       652 ~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      ...++|+|+.+.||++++++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            46799999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=91.79  E-value=0.44  Score=53.15  Aligned_cols=75  Identities=8%  Similarity=0.074  Sum_probs=47.6

Q ss_pred             ceeeeecCcEEEEEEEEcCc-------ceEEEEEeCCCCChhhHHHHHHHHHHHhhccccce-eeEEEEEeecCEEEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDGA-------TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL-VSLIGYCEENCEMILVY  608 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~-------~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~  608 (893)
                      .+.|..|-...+|+......       +..+++++....... .-+..+|.++++.+.-.++ .++++.+.  +  ++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEE
Confidence            34676677889999887531       356888875443221 1224678888888864344 35565432  2  7899


Q ss_pred             eeccCCCH
Q 036624          609 DYMAYGTL  616 (893)
Q Consensus       609 E~~~~gsL  616 (893)
                      ||++|..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.35  E-value=1.1  Score=49.52  Aligned_cols=30  Identities=37%  Similarity=0.430  Sum_probs=25.2

Q ss_pred             ceEecCCCCCCEEE------CCCCceeEeccccccc
Q 036624          654 TIIHRDVKTTNILL------DEKWVAKVSDFGLSKT  683 (893)
Q Consensus       654 ~ivHrDlk~~NILl------d~~~~~kl~DFGla~~  683 (893)
                      .++|+|+.+.|||+      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35699999999999      4567899999998764

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=88.06  E-value=0.11  Score=37.24  Aligned_cols=27  Identities=37%  Similarity=0.454  Sum_probs=11.6

Q ss_pred             EEecccchhhhhHHHHhhhhhhhhhcccC
Q 036624          446 IIGGGVGGGIALALVVGFCVFAASRCRRQ  474 (893)
Q Consensus       446 ii~~~v~~~i~v~lvv~~~~~~~~~~r~~  474 (893)
                      +++++|+  ++++++++++++++.|||+.
T Consensus        14 Ia~~vVG--vll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           14 IISAVVG--ILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHH--HHHHHHHHHHHHHHHHHHCS
T ss_pred             hHHHHHH--HHHHHHHHHHHHhheehhhh
Confidence            4444444  33444444444444444443

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=86.51  E-value=0.11  Score=36.28  Aligned_cols=25  Identities=28%  Similarity=0.344  Sum_probs=12.5

Q ss_pred             eEEEecccchhhhhHHHHhhhhhhh
Q 036624          444 KAIIGGGVGGGIALALVVGFCVFAA  468 (893)
Q Consensus       444 ~~ii~~~v~~~i~v~lvv~~~~~~~  468 (893)
                      ..|.++++++++.++++++++++++
T Consensus        11 GaIAGiVvG~v~gv~li~~l~~~~~   35 (38)
T 2k1k_A           11 GEIVAVIFGLLLGAALLLGILVFRS   35 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CceeeeehHHHHHHHHHHHHHHHHe
Confidence            4455555554444555555554444

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	893
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-73
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-64
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-63
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-63
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-61
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-60
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-59
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-45
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-41
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-21

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (609), Expect = 7e-73
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 27/281 (9%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
            +G G FG VY+G+  G    VA+K       + Q +  F+ E+ +L K RH +++  +G
Sbjct: 15  RIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
           Y      + +V  +    +L  HL+   +      + ++I    A+G+ YLH     +II
Sbjct: 72  YSTAPQ-LAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLH---AKSII 126

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ---L 713
           HRD+K+ NI L E    K+ DFGL+        +H    + GS  ++ PE  R Q     
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186

Query: 714 TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIA 773
           + +SDVY+FG+VL+E++  +       P   ++  +       +G L   +      K+ 
Sbjct: 187 SFQSDVYAFGIVLYELMTGQL------PYSNINNRDQIIFMVGRGYLSPDLS-----KVR 235

Query: 774 PECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
             C K       +C+  +  ERP    +L ++E    L  S
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIE---LLARS 273

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 3e-65
 Identities = 67/297 (22%), Positives = 128/297 (43%), Gaps = 29/297 (9%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           +G G FG+V+RG+  G   +VA+K  +   E+     + EI     LRH +++  I    
Sbjct: 11  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67

Query: 600 EN----CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT- 654
           ++     ++ LV DY  +G+L ++L    +  +  +  +++ +  A GL +LH     T 
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 655 ----IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT--HVSTVVKGSFGYLDPEYF 708
               I HRD+K+ NIL+ +     ++D GL+    +   T         G+  Y+ PE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 709 RRQ------QLTEKSDVYSFGVVLFEILCARPALNPTL----PKEQVSLAEWAAHCHKKG 758
                    +  +++D+Y+ G+V +EI               P   +  ++ +    +K 
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244

Query: 759 ILEQIMDPYLKGKI-APECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
           + EQ + P +  +  + E  +  A+   +C    G  R +   +   L   L  QE 
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS-QLSQQEG 300

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 9e-64
 Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 28/269 (10%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
            +G G FG V  G+  G   KVA+K     ++     F  E  ++++LRH +LV L+G  
Sbjct: 14  TIGKGEFGDVMLGDYRG--NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 599 -EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            EE   + +V +YMA G+L ++L    +  L     L+  +     + YL     +  +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+   N+L+ E  VAKVSDFGL+K   +   T    V      +  PE  R ++ + KS
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKS 181

Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECF 777
           DV+SFG++L+EI        P +P +               ++ ++   Y K      C 
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKD--------------VVPRVEKGY-KMDAPDGCP 226

Query: 778 KKFAETAMKCVSDQGIERPSMGDVLWNLE 806
               E    C       RPS   +   LE
Sbjct: 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 1e-63
 Identities = 63/268 (23%), Positives = 115/268 (42%), Gaps = 22/268 (8%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
            LG G FG+V+ G  +G  TKVA+K            F  E  ++ +L+H+ LV L    
Sbjct: 20  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
            +   + ++ +YM  G+L + L       L   + L++    A G+ ++    +   IHR
Sbjct: 78  TQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133

Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           D++  NIL+ +    K++DFGL++     +        K    +  PE       T KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 719 VYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFK 778
           V+SFG++L EI+       P +   +              +++ +   Y +      C +
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPE--------------VIQNLERGY-RMVRPDNCPE 237

Query: 779 KFAETAMKCVSDQGIERPSMGDVLWNLE 806
           +  +    C  ++  +RP+   +   LE
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  213 bits (543), Expect = 2e-63
 Identities = 66/309 (21%), Positives = 127/309 (41%), Gaps = 35/309 (11%)

Query: 522 FSFAEIKAATNNFDEAL---------LLGVGGFGKVYRGEI---DGATTKVAIKRGNP-L 568
           F+F +   A   F + +         ++G G FG+V  G +         VAIK      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 569 SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPL 628
           +E+   +F +E  ++ +  H +++ L G   ++  ++++ ++M  G+L     +      
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQF 125

Query: 629 PWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD 688
              Q + +  G A G+ YL        +HRD+   NIL++   V KVSDFGLS+      
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 689 HTHVSTVV---KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQV 745
                T     K    +  PE  + ++ T  SDV+S+G+V++E++          P   +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----ERPYWDM 237

Query: 746 SLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL 805
           +  +         ++  I   Y +     +C     +  + C       RP  G ++  L
Sbjct: 238 TNQD---------VINAIEQDY-RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

Query: 806 EFALQLQES 814
           +  ++   S
Sbjct: 288 DKMIRNPNS 296

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  212 bits (540), Expect = 5e-63
 Identities = 70/292 (23%), Positives = 123/292 (42%), Gaps = 22/292 (7%)

Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSK 585
           E++    +      LG G +G+VY G     +  VA+K         V EF  E  ++ +
Sbjct: 13  EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69

Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
           ++H +LV L+G C       ++ ++M YG L ++L +  +  +     L +    +  + 
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YL    K   IHRD+   N L+ E  + KV+DFGLS+     D        K    +  P
Sbjct: 130 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 185

Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E     + + KSDV++FGV+L+EI     +  P +   Q               + ++++
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLE 230

Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQESAEE 817
              + +    C +K  E    C      +RPS  ++    E   Q    ++E
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (534), Expect = 7e-62
 Identities = 75/281 (26%), Positives = 131/281 (46%), Gaps = 28/281 (9%)

Query: 533 NFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRH 588
           +F+E  ++G G FG VY G +   DG     A+K  N +++ G V +F TE  ++    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 589 RHLVSLIGYC-EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
            +++SL+G C       ++V  YM +G LR +  + +      K  +   +  A+G+ +L
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIGFGLQVAKGMKFL 146

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDP 705
                   +HRD+   N +LDEK+  KV+DFGL++       D  H  T  K    ++  
Sbjct: 147 A---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E  + Q+ T KSDV+SFGV+L+E++          P   V+  +   +  +     +++ 
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQG---RRLLQ 255

Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
           P         C     E  +KC   +   RPS  +++  + 
Sbjct: 256 P-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  208 bits (531), Expect = 1e-61
 Identities = 76/319 (23%), Positives = 128/319 (40%), Gaps = 49/319 (15%)

Query: 523 SFAEIKAATNNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNP-LSEQGVHEF 576
               ++   NN +    +G G FG+V++    G       T VA+K      S     +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 577 QTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQK----------- 625
           Q E  ++++  + ++V L+G C     M L+++YMAYG L E L                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 626 -----------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAK 674
                      PPL   ++L I    A G+ YL    +   +HRD+ T N L+ E  V K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180

Query: 675 VSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP 734
           ++DFGLS+   + D+            ++ PE     + T +SDV+++GVVL+EI     
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 735 ALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIE 794
                +  E+              ++  + D  +       C  +       C S    +
Sbjct: 241 QPYYGMAHEE--------------VIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPAD 285

Query: 795 RPSMGDVLWNLEFALQLQE 813
           RPS   +   L+   ++ E
Sbjct: 286 RPSFCSIHRILQ---RMCE 301

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 2e-61
 Identities = 58/220 (26%), Positives = 109/220 (49%), Gaps = 11/220 (5%)

Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLS 584
           E+K   ++F++   LG G  G V++     +   +A K  +  +     ++   E+++L 
Sbjct: 2   ELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59

Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
           +    ++V   G    + E+ +  ++M  G+L + L K     +P +   ++ I   +GL
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGL 117

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
            YL    KH I+HRDVK +NIL++ +   K+ DFG+S     L  +  ++ V G+  Y+ 
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMS 171

Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ 744
           PE  +    + +SD++S G+ L E+   R  + P   KE 
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 4e-61
 Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 24/271 (8%)

Query: 540 LGVGGFGKVYRGE--IDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIG 596
           LG G FG V +G   +      VAIK     +E+    E   E +++ +L + ++V LIG
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 597 YCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
            C+    ++LV +    G L + L   ++  +P     E+    + G+ YL    +   +
Sbjct: 77  VCQA-EALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLE---EKNFV 131

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSK-TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE 715
           HRD+   N+LL  +  AK+SDFGLSK  G    +    +  K    +  PE    ++ + 
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 716 KSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPE 775
           +SDV+S+GV ++E L          P +++   E         ++  I     + +  PE
Sbjct: 192 RSDVWSYGVTMWEALSYG-----QKPYKKMKGPE---------VMAFIEQGK-RMECPPE 236

Query: 776 CFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
           C  +       C   +  +RP    V   + 
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 3e-60
 Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 25/283 (8%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL 591
           +       +G G FG V+ G       KVAIK           +F  E E++ KL H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLG-YWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKL 62

Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           V L G C E   + LV+++M +G L ++  +TQ+     +  L +C+    G+ YL    
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLE--- 118

Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
           +  +IHRD+   N L+ E  V KVSDFG+++     D    ST  K    +  PE F   
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFS 177

Query: 712 QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK 771
           + + KSDV+SFGV+++E+              +              ++E I   + +  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------------VVEDISTGF-RLY 222

Query: 772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
                     +    C  ++  +RP+   +L  L    ++ ES
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA---EIAES 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 3e-60
 Identities = 73/275 (26%), Positives = 116/275 (42%), Gaps = 22/275 (8%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHL 591
            +      LG G FG V  G+  G    VAIK           EF  E +++  L H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKL 61

Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
           V L G C +   + ++ +YMA G L  +L +  +     +Q LE+C      + YL    
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLE--- 117

Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQ 711
               +HRD+   N L++++ V KVSDFGLS+     D    S   K    +  PE     
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 712 QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK 771
           + + KSD+++FGV+++EI          +P E+ + +E           E I     +  
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSE---------TAEHIAQGL-RLY 221

Query: 772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
                 +K       C  ++  ERP+   +L N+ 
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 3e-60
 Identities = 69/295 (23%), Positives = 131/295 (44%), Gaps = 27/295 (9%)

Query: 526 EIKAATNNFDEALLLGVGGFGKVYRGEIDGATTK----VAIKRGNP-LSEQGVHEFQTEI 580
           EI    +      ++G G FG+VY+G +  ++ K    VAIK      +E+   +F  E 
Sbjct: 3   EIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 581 EMLSKLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGA 640
            ++ +  H +++ L G   +   M+++ +YM  G   +   + +       Q + +  G 
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGI 119

Query: 641 ARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGS 699
           A G+ YL        +HRD+   NIL++   V KVSDFGLS+      + T+ ++  K  
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 700 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI 759
             +  PE    ++ T  SDV+SFG+V++E++         L   +              +
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------------V 222

Query: 760 LEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
           ++ I D + +     +C     +  M+C   +   RP   D++  L+  ++  +S
Sbjct: 223 MKAINDGF-RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 5e-60
 Identities = 65/270 (24%), Positives = 109/270 (40%), Gaps = 29/270 (10%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G F  VY+G     T +VA        L++     F+ E EML  L+H ++V     
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 598 CEENCE----MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
            E   +    ++LV + M  GTL+ +L +     +  K     C    +GL +LHT    
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT-RTP 133

Query: 654 TIIHRDVKTTNILL-DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
            IIHRD+K  NI +       K+ D GL+     L     +  V G+  ++ PE +  ++
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMY-EEK 188

Query: 713 LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI 772
             E  DVY+FG+ + E+  +                 ++   +   I  ++         
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYP--------------YSECQNAAQIYRRVTSGVKPASF 234

Query: 773 APECFKKFAETAMKCVSDQGIERPSMGDVL 802
                 +  E    C+     ER S+ D+L
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 3e-59
 Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 39/301 (12%)

Query: 532 NNFDEALLLGVGGFGKVYRGEI--DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKL-R 587
           N+     ++G G FG+V +  I  DG     AIKR     S+    +F  E+E+L KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYK--------------TQKPPLPWKQR 633
           H ++++L+G CE    + L  +Y  +G L + L K              +    L  +Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 634 LEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVS 693
           L      ARG+ YL    +   IHRD+   NIL+ E +VAK++DFGLS+           
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183

Query: 694 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAH 753
           T+ +    ++  E       T  SDV+S+GV+L+EI+          P   ++ AE    
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAE---- 234

Query: 754 CHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE 813
                + E++   Y + +    C  +  +   +C  ++  ERPS   +L +L   L+ ++
Sbjct: 235 -----LYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288

Query: 814 S 814
           +
Sbjct: 289 T 289

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-59
 Identities = 76/267 (28%), Positives = 121/267 (45%), Gaps = 22/267 (8%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FG+V+ G  +G TT+VAIK   P        F  E +++ KLRH  LV L     
Sbjct: 25  LGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 82

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
           E   + +V +YM+ G+L + L       L   Q +++    A G+ Y+    +   +HRD
Sbjct: 83  EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 138

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDV 719
           ++  NIL+ E  V KV+DFGL++     +        K    +  PE     + T KSDV
Sbjct: 139 LRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197

Query: 720 YSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKK 779
           +SFG++L E+        P +   +              +L+Q+   Y +    PEC + 
Sbjct: 198 WSFGILLTELTTKGRVPYPGMVNRE--------------VLDQVERGY-RMPCPPECPES 242

Query: 780 FAETAMKCVSDQGIERPSMGDVLWNLE 806
             +   +C   +  ERP+   +   LE
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 3e-58
 Identities = 64/272 (23%), Positives = 108/272 (39%), Gaps = 26/272 (9%)

Query: 540 LGVGGFGKVYRGEIDGATT--KVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           LG G FG V +G          VA+K  +          E   E  ++ +L + ++V +I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 596 GYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTI 655
           G CE     +LV +    G L ++L +     +  K  +E+    + G+ YL    +   
Sbjct: 75  GICEAE-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLE---ESNF 128

Query: 656 IHRDVKTTNILLDEKWVAKVSDFGLSK-TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           +HRD+   N+LL  +  AK+SDFGLSK      ++    T  K    +  PE     + +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188

Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            KSDV+SFGV+++E            P   +  +E         +   +     +     
Sbjct: 189 SKSDVWSFGVLMWEAFSYG-----QKPYRGMKGSE---------VTAMLEKGE-RMGCPA 233

Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
            C ++  +    C +     RP    V   L 
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 4e-58
 Identities = 64/299 (21%), Positives = 115/299 (38%), Gaps = 42/299 (14%)

Query: 539 LLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPLSEQG-VHEFQTEIEMLSKL-RHRHL 591
            LG G FGKV      G         VA+K   P +         +E+++LS L  H ++
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHLYK----------------TQKPPLPWKQRLE 635
           V+L+G C      +++ +Y  YG L   L +                  +  L  +  L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                A+G+ +L        IHRD+   NILL    + K+ DFGL++      +  V   
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH 755
            +    ++ PE       T +SDV+S+G+ L+E+     +  P +P +            
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----------- 255

Query: 756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
                 +++    +         +  +    C     ++RP+   ++  +E   Q+ ES
Sbjct: 256 ---KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISES 309

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-57
 Identities = 62/296 (20%), Positives = 120/296 (40%), Gaps = 45/296 (15%)

Query: 539 LLGVGGFGKVYRGEI-----DGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKL-RHRHL 591
           +LG G FGKV           G + +VA+K     ++        +E++M+++L  H ++
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 592 VSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKP---------------------PLPW 630
           V+L+G C  +  + L+++Y  YG L  +L   ++                       L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 631 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 690
           +  L      A+G+ +L      + +HRD+   N+L+    V K+ DFGL++   +  + 
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEW 750
            V    +    ++ PE       T KSDV+S+G++L+EI        P +P +       
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA------ 274

Query: 751 AAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
                      +++    K        ++       C +    +RPS  ++   L 
Sbjct: 275 --------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 4e-57
 Identities = 60/278 (21%), Positives = 112/278 (40%), Gaps = 26/278 (9%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRH 590
           +++    +G G +G+  +         +  K      ++E       +E+ +L +L+H +
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 591 LVSLIGYC--EENCEMILVYDYMAYGTLREHLYKTQK--PPLPWKQRLEICIGAARGLHY 646
           +V          N  + +V +Y   G L   + K  K    L  +  L +       L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 647 LH--TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
            H  +   HT++HRD+K  N+ LD K   K+ DFGL++       T  +    G+  Y+ 
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMS 182

Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM 764
           PE   R    EKSD++S G +L+E+    P       KE               +  +I 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---------------LAGKIR 227

Query: 765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
           +   + +I      +  E   + ++ +   RPS+ ++L
Sbjct: 228 EGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 6e-57
 Identities = 60/282 (21%), Positives = 118/282 (41%), Gaps = 25/282 (8%)

Query: 534 FDEALLLGVGGFGKVYRGEI----DGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRH 588
           F +  +LG G FG VY+G      +     VAIK      S +   E   E  +++ + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
            H+  L+G C  +  + L+   M +G L +++ +  K  +  +  L  C+  A+G++YL 
Sbjct: 71  PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
                 ++HRD+   N+L+      K++DFGL+K     +  + +   K    ++  E  
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL 768
             +  T +SDV+S+GV ++E++         +P  +               +  I++   
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------ISSILEKGE 230

Query: 769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           +    P C        +KC       RP   +++       +
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-56
 Identities = 62/268 (23%), Positives = 110/268 (41%), Gaps = 25/268 (9%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCE 599
           LG G FGKVY+ +    +   A K  +  SE+ + ++  EI++L+   H ++V L+    
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 600 ENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRD 659
               + ++ ++ A G +   + + ++ PL   Q   +C      L+YLH    + IIHRD
Sbjct: 80  YENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH---DNKIIHRD 135

Query: 660 VKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF-----RRQQLT 714
           +K  NIL       K++DFG+S                G+  ++ PE       + +   
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193

Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
            K+DV+S G+ L E+    P  +   P   +             I +       +     
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRVL-----------LKIAKSEPPTLAQPSRWS 242

Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVL 802
             FK F +   KC+      R +   +L
Sbjct: 243 SNFKDFLK---KCLEKNVDARWTTSQLL 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 1e-56
 Identities = 71/280 (25%), Positives = 113/280 (40%), Gaps = 29/280 (10%)

Query: 540 LGVGGFGKVYRGEID---GATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG V RGE D   G T  VA+K   P      + + +F  E+  +  L HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L G       M +V +    G+L + L K  +            +  A G+ YL      
Sbjct: 76  LYGVVLTP-PMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLE---SK 130

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSK-TGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             IHRD+   N+LL  + + K+ DFGL +      DH  +    K  F +  PE  + + 
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190

Query: 713 LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI 772
            +  SD + FGV L+E+          L   Q              IL +I     +   
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------------ILHKIDKEGERLPR 236

Query: 773 APECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQ 812
             +C +      ++C + +  +RP+   +    +F L+ Q
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVAL---RDFLLEAQ 273

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-56
 Identities = 66/280 (23%), Positives = 113/280 (40%), Gaps = 25/280 (8%)

Query: 539 LLGVGGFGKVYRGEI---DGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSL 594
            +G G FG V++G     +     VAIK     +   V E F  E   + +  H H+V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 595 IGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT 654
           IG   EN  + ++ +    G LR  L   +K  L     +      +  L YL       
Sbjct: 74  IGVITENP-VWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLE---SKR 128

Query: 655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
            +HRD+   N+L+      K+ DFGLS+        + ++  K    ++ PE    ++ T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFT 187

Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAP 774
             SDV+ FGV ++EIL      +   P + V   +         ++ +I +   +  + P
Sbjct: 188 SASDVWMFGVCMWEILM-----HGVKPFQGVKNND---------VIGRIENGE-RLPMPP 232

Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQES 814
            C         KC +     RP   ++   L   L+ +++
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 8e-56
 Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 29/274 (10%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F+    LG G FG VY      +   +A+K   +         H+ + E+E+ S LRH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
            +++ L GY  +   + L+ +Y   GT+   L K        ++        A  L Y H
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCH 123

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
                 +IHRD+K  N+LL      K++DFG S   P    +   T + G+  YL PE  
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMI 176

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL 768
             +   EK D++S GV+ +E L  +P       +E                 ++I    +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---------------TYKRISR--V 219

Query: 769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
           +        +   +   + +     +RP + +VL
Sbjct: 220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (486), Expect = 3e-55
 Identities = 67/275 (24%), Positives = 98/275 (35%), Gaps = 32/275 (11%)

Query: 534 FDEALLLGVGGFGKVYRGEIDGATTKVAIKR---GNPLSEQGVHEFQTEIEMLSKLRHRH 590
           F +   +G G FG VY       +  VAIK+       S +   +   E+  L KLRH +
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
            +   G         LV +Y              K PL   +   +  GA +GL YLH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH-- 132

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR- 709
             H +IHRDVK  NILL E  + K+ DFG +           +    G+  ++ PE    
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWMAPEVILA 185

Query: 710 --RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY 767
               Q   K DV+S G+   E+   +P L                       L  I    
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---------------LYHIAQNE 230

Query: 768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
                +    + F      C+     +RP+   +L
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-53
 Identities = 52/264 (19%), Positives = 109/264 (41%), Gaps = 22/264 (8%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
            +G G  G VY         +VAI++ N   +        EI ++ + ++ ++V+ +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
               E+ +V +Y+A G+L + + +T    +   Q   +C    + L +LH    + +IHR
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHR 140

Query: 659 DVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSD 718
           D+K+ NILL      K++DFG              + + G+  ++ PE   R+    K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198

Query: 719 VYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFK 778
           ++S G++  E++   P               +      + +     +   + +   +   
Sbjct: 199 IWSLGIMAIEMIEGEPP--------------YLNENPLRALYLIATNGTPELQNPEKLSA 244

Query: 779 KFAETAMKCVSDQGIERPSMGDVL 802
            F +   +C+     +R S  ++L
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELL 268

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-53
 Identities = 72/296 (24%), Positives = 135/296 (45%), Gaps = 41/296 (13%)

Query: 539 LLGVGGFGKVYRGEIDG-------ATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKL-RHR 589
            LG G FG+V   E  G         TKVA+K      +E+ + +  +E+EM+  + +H+
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 590 HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPP--------------LPWKQRLE 635
           ++++L+G C ++  + ++ +Y + G LRE+L   + P               L  K  + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 636 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 695
                ARG+ YL        IHRD+   N+L+ E  V K++DFGL++    +D+   +T 
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 696 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH 755
            +    ++ PE    +  T +SDV+SFGV+L+EI     +  P +P E+           
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------- 245

Query: 756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL 811
              + + + + + +      C  +       C      +RP+   ++ +L+  + L
Sbjct: 246 ---LFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 3e-53
 Identities = 58/273 (21%), Positives = 100/273 (36%), Gaps = 21/273 (7%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRH 590
            ++D    LG G +G+V           VA+K  +   +       + EI +   L H +
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
           +V   G+  E     L  +Y + G L + +       +P             G+ YLH  
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH-- 120

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
               I HRD+K  N+LLDE+   K+SDFGL+      +   +   + G+  Y+ PE  +R
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 711 QQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK 769
           ++   E  DV+S G+VL  +L      +      Q                    +    
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--------------EYSDWKEKKTY 225

Query: 770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
                +          K + +    R ++ D+ 
Sbjct: 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIK 258

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 2e-52
 Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 32/285 (11%)

Query: 540 LGVGGFGKVYRGEIDGAT-----TKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVS 593
           LG G FG VY G   G       T+VAIK  N   S +   EF  E  ++ +    H+V 
Sbjct: 28  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQK--------PPLPWKQRLEICIGAARGLH 645
           L+G   +    +++ + M  G L+ +L   +          P    + +++    A G+ 
Sbjct: 88  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           YL+    +  +HRD+   N ++ E +  K+ DFG+++     D+            ++ P
Sbjct: 148 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204

Query: 706 EYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD 765
           E  +    T  SDV+SFGVVL+EI          L  EQ              +L  +M+
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------------VLRFVME 250

Query: 766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
             L       C     E    C       RPS  +++ +++  ++
Sbjct: 251 GGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  181 bits (459), Expect = 5e-51
 Identities = 59/268 (22%), Positives = 104/268 (38%), Gaps = 26/268 (9%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
            LG G FG V+R          A K      E      + EI+ +S LRH  LV+L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
           E++ EM+++Y++M+ G L E +   +   +   + +E      +GL ++H   ++  +H 
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHL 148

Query: 659 DVKTTNILLDEKW--VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           D+K  NI+   K     K+ DFGL+     LD      V  G+  +  PE    + +   
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205

Query: 717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM--DPYLKGKIAP 774
           +D++S GV+ + +L            E                L  +   D  +      
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDET---------------LRNVKSCDWNMDDSAFS 250

Query: 775 ECFKKFAETAMKCVSDQGIERPSMGDVL 802
              +   +   K +      R ++   L
Sbjct: 251 GISEDGKDFIRKLLLADPNTRMTIHQAL 278

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 6e-51
 Identities = 56/278 (20%), Positives = 105/278 (37%), Gaps = 25/278 (8%)

Query: 528 KAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLS 584
           K    +F    +LG G F  V        + + AIK   + + + E  V     E +++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 585 KLRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGL 644
           +L H   V L    +++ ++     Y   G L +++ K                     L
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSAL 121

Query: 645 HYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
            YLH      IIHRD+K  NILL+E    +++DFG +K          +    G+  Y+ 
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM 764
           PE    +   + SD+++ G ++++++   P                        I ++I+
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---------------IFQKII 223

Query: 765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
              L+     + F K  +   K +     +R    ++ 
Sbjct: 224 K--LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 4e-49
 Identities = 68/294 (23%), Positives = 120/294 (40%), Gaps = 39/294 (13%)

Query: 539 LLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPLSEQGVH-EFQTEIEMLSKLRHRH-L 591
            LG G FG+V   +  G         VA+K     +    H    +E+++L  + H   +
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 592 VSLIGYC-EENCEMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEI 636
           V+L+G C +    ++++ ++  +G L  +L   +              K  L  +  +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 637 CIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVV 696
               A+G+ +L        IHRD+   NILL EK V K+ DFGL++              
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 697 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK 756
           +    ++ PE    +  T +SDV+SFGV+L+EI           P   V + E      K
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCRRLK 251

Query: 757 KGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
           +G   +  D             +  +T + C   +  +RP+  +++ +L   LQ
Sbjct: 252 EGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  173 bits (439), Expect = 2e-48
 Identities = 53/266 (19%), Positives = 107/266 (40%), Gaps = 22/266 (8%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
            LG G FG V+R            K  N       +  + EI ++++L H  L++L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
           E+  EM+L+ ++++ G L + +   +   +   + +     A  GL ++H   +H+I+H 
Sbjct: 96  EDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHL 151

Query: 659 DVKTTNILLDEK--WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           D+K  NI+ + K     K+ DFGL+     L+   +  V   +  +  PE   R+ +   
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208

Query: 717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC 776
           +D+++ GV+ + +L            E +          K+       D           
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETL-------QNVKRC------DWEFDEDAFSSV 255

Query: 777 FKKFAETAMKCVSDQGIERPSMGDVL 802
             +  +     +  +  +R ++ D L
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDAL 281

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 6e-48
 Identities = 50/270 (18%), Positives = 107/270 (39%), Gaps = 31/270 (11%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
            LG G FG V+R     +      K    +        + EI +L+  RHR+++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
           E   E+++++++++   + E +  T    L  ++ +         L +LH    H I H 
Sbjct: 71  ESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126

Query: 659 DVKTTNILLDEK--WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEK 716
           D++  NI+   +     K+ +FG ++    L       ++  +  Y  PE  +   ++  
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183

Query: 717 SDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPEC 776
           +D++S G +++ +L           ++               I+E IM+   +     E 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQ---------------IIENIMNA--EYTFDEEA 226

Query: 777 FKKFAETA----MKCVSDQGIERPSMGDVL 802
           FK+ +  A     + +  +   R +  + L
Sbjct: 227 FKEISIEAMDFVDRLLVKERKSRMTASEAL 256

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  166 bits (421), Expect = 1e-46
 Identities = 64/279 (22%), Positives = 111/279 (39%), Gaps = 31/279 (11%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTEIEMLSKLRHRHLVSLI 595
           +LG GG  +V+          VA+K               F+ E +  + L H  +V++ 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 596 GYCEE----NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGA 651
              E          +V +Y+   TLR+ ++     P+  K+ +E+   A + L++ H   
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--- 128

Query: 652 KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEYFRR 710
           ++ IIHRDVK  NI++      KV DFG+++    + +    +  V G+  YL PE  R 
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188

Query: 711 QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM--DPYL 768
             +  +SDVYS G VL+E+L   P      P                 +  Q +  DP  
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---------------VAYQHVREDPIP 233

Query: 769 KGKIAPECFKKFAETAMKCVSDQGIERP-SMGDVLWNLE 806
                           +K ++     R  +  ++  +L 
Sbjct: 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  164 bits (415), Expect = 7e-46
 Identities = 64/282 (22%), Positives = 108/282 (38%), Gaps = 41/282 (14%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---------EQGVHEFQTEIEMLSKLR-H 588
           +LG G    V R        + A+K  +            ++       E+++L K+  H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
            +++ L    E N    LV+D M  G L ++L +  K  L  K+  +I       +  LH
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALH 127

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
              K  I+HRD+K  NILLD+    K++DFG S     LD       V G+  YL PE  
Sbjct: 128 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEII 181

Query: 709 R------RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ 762
                       ++ D++S GV+++ +L   P                  H  +  +L  
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF---------------WHRKQMLMLRM 226

Query: 763 IM--DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
           IM  +         +      +   + +  Q  +R +  + L
Sbjct: 227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (414), Expect = 2e-45
 Identities = 61/270 (22%), Positives = 106/270 (39%), Gaps = 29/270 (10%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHE-FQTEIEMLSKLRHRHLVSLIGY 597
           +LG G F +V   E       VAIK     + +G     + EI +L K++H ++V+L   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            E    + L+   ++ G L + + +  K     +    +       + YLH      I+H
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLH---DLGIVH 130

Query: 658 RDVKTTNILL---DEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLT 714
           RD+K  N+L    DE     +SDFGLSK     D   V +   G+ GY+ PE   ++  +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYS 187

Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM--DPYLKGKI 772
           +  D +S GV+ + +LC  P        +               + EQI+  +       
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAK---------------LFEQILKAEYEFDSPY 232

Query: 773 APECFKKFAETAMKCVSDQGIERPSMGDVL 802
             +      +     +     +R +    L
Sbjct: 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 3e-44
 Identities = 50/284 (17%), Positives = 107/284 (37%), Gaps = 19/284 (6%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRH 590
           NF +   +G G +G VY+         VA+K  R +  +E        EI +L +L H +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
           +V L+       ++ LV++++    L++ +  +    +P            +GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
             H ++HRD+K  N+L++ +   K++DFGL++          +  V   +          
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGC 177

Query: 711 QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG 770
           +  +   D++S G +  E++  R         +Q+           + +   +       
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 771 KIAPECFKKFAETAMKCVSDQGI------------ERPSMGDVL 802
              P+  ++     +  + + G             +R S    L
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 8e-44
 Identities = 62/305 (20%), Positives = 110/305 (36%), Gaps = 35/305 (11%)

Query: 518 LCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG-EIDGATTKVAIK--RGNPLSEQGVH 574
           LCR         A   ++    +G G +GKV++  ++      VA+K  R     E    
Sbjct: 2   LCR---------ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL 52

Query: 575 EFQTEIEMLSKL---RHRHLVSLIGYCEENCEMILVYDYM----AYGTLREHLYKTQKPP 627
               E+ +L  L    H ++V L   C  +         +        L  +L K  +P 
Sbjct: 53  STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG 112

Query: 628 LPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL 687
           +P +   ++     RGL +LH    H ++HRD+K  NIL+      K++DFGL++     
Sbjct: 113 VPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---Y 166

Query: 688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL 747
                 T V  +  Y  PE   +       D++S G +  E+   +P    +   +Q+  
Sbjct: 167 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 226

Query: 748 ----------AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS 797
                      +W                    K   +  +   +  +KC++    +R S
Sbjct: 227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286

Query: 798 MGDVL 802
               L
Sbjct: 287 AYSAL 291

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-43
 Identities = 63/282 (22%), Positives = 107/282 (37%), Gaps = 21/282 (7%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQG-VHEFQTEIEMLSKLRHRHLVSLIGY 597
            +G G +G V     +    +VAIK+ +P   Q        EI++L + RH +++ +   
Sbjct: 15  YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74

Query: 598 CEENCEMILVYDYMAYGTLREHLYK-TQKPPLPWKQRLEICIGAARGLHYLHTGAKHTII 656
                   +   Y+    +   LYK  +   L             RGL Y+H      ++
Sbjct: 75  IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 131

Query: 657 HRDVKTTNILLDEKWVAKVSDFGLSKT-GPTLDHTHVSTVVKGSFGYLDPEYFRRQQL-T 714
           HRD+K +N+LL+     K+ DFGL++   P  DHT   T    +  Y  PE     +  T
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191

Query: 715 EKSDVYSFGVVLFEILCARPALNPTLPKEQV----------SLAEWAAHCHKKGILEQIM 764
           +  D++S G +L E+L  RP        +Q+          S  +     + K     + 
Sbjct: 192 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251

Query: 765 DPYLKGKIAPECFKKFAETA----MKCVSDQGIERPSMGDVL 802
            P+         F      A     K ++    +R  +   L
Sbjct: 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 5e-43
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 11/207 (5%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSK-LR 587
            +F    +LG G FGKV+  E        AIK   +   L +  V     E  +LS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 588 HRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYL 647
           H  L  +    +    +  V +Y+  G L  H+           +          GL +L
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFL 119

Query: 648 HTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
           H      I++RD+K  NILLD+    K++DFG+ K     D         G+  Y+ PE 
Sbjct: 120 H---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEI 174

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARP 734
              Q+     D +SFGV+L+E+L  + 
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQS 201

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (396), Expect = 7e-43
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 13/206 (6%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
            +F     LG G FG+V+           A+K   +   +  + V     E  MLS + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
             ++ + G  ++  ++ ++ DY+  G L   L K+Q+ P P  +     +     L YLH
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV--CLALEYLH 121

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
                 II+RD+K  NILLD+    K++DFG +K  P + +T       G+  Y+ PE  
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVV 173

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARP 734
             +   +  D +SFG++++E+L    
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYT 199

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  155 bits (393), Expect = 8e-43
 Identities = 44/283 (15%), Positives = 84/283 (29%), Gaps = 27/283 (9%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHR-HLVSLIGY 597
            +G G FG ++ G       +VAIK           + + E      L     + ++  +
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
            +E    +LV D +  G   E L          K            +  +H   + ++++
Sbjct: 70  GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124

Query: 658 RDVKTTNILLDEKWV-----AKVSDFGLSK-----TGPTLDHTHVSTVVKGSFGYLDPEY 707
           RD+K  N L+            V DFG+ K                  + G+  Y+    
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 708 FRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY 767
              ++ + + D+ + G V    L                  E      +   L ++   +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF 244

Query: 768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ 810
                 PE F K+        +      P    +       L+
Sbjct: 245 ------PEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLE 278

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (393), Expect = 9e-43
 Identities = 49/276 (17%), Positives = 90/276 (32%), Gaps = 23/276 (8%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYC 598
            +G G FG +Y G    A  +VAIK     ++    +   E ++   ++    +  I +C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 599 EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHR 658
               +  ++   +   +L E L+         K  L +       + Y+H       IHR
Sbjct: 72  GAEGDYNVMVMELLGPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 127

Query: 659 DVKTTNIL---LDEKWVAKVSDFGLSK-----TGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
           DVK  N L     +  +  + DFGL+K               +  + G+  Y        
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187

Query: 711 QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG 770
            + + + D+ S G VL                 +    E  +       +E +   Y   
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY--- 244

Query: 771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE 806
              P  F  +      C S +  ++P    +     
Sbjct: 245 ---PSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-42
 Identities = 63/281 (22%), Positives = 107/281 (38%), Gaps = 24/281 (8%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR-----GNPLSEQGVHEFQTEIEMLSKLRHRHLVS 593
            LG G F  VY+         VAIK+      +   +        EI++L +L H +++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 594 LIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
           L+        + LV+D+M        + K     L         +   +GL YLH   +H
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 654 TIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL 713
            I+HRD+K  N+LLDE  V K++DFGL+K+  + +  +   V   +  Y  PE     ++
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFGARM 177

Query: 714 -TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL----------AEWAAHCHKKGILEQ 762
                D+++ G +L E+L   P L      +Q++            +W   C     +  
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 763 IMDPYLK-GKIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
              P +    I         +            R +    L
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  153 bits (387), Expect = 4e-42
 Identities = 46/277 (16%), Positives = 98/277 (35%), Gaps = 21/277 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G +G VY+ + +      A+K  R     E        EI +L +L+H ++V L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
                 ++LV++++        L    +  L         +    G+ Y H      ++H
Sbjct: 69  IHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+L++ +   K++DFGL++          +  +   +          ++ +   
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECF 777
           D++S G +  E++   P        +Q+                 + +            
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 778 KKFAETAMKCVSDQGI------------ERPSMGDVL 802
               E+ +K + + GI            +R +    L
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  155 bits (392), Expect = 7e-42
 Identities = 50/231 (21%), Positives = 87/231 (37%), Gaps = 16/231 (6%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP---LSEQGVHEFQTE---IEMLSK 585
           N+F    ++G GGFG+VY           A+K  +      +QG      E   + ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 586 LRHRHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLH 645
                +V +        ++  + D M  G L  HL +                    GL 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLE 121

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDP 705
           ++H      +++RD+K  NILLDE    ++SD GL+                G+ GY+ P
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAP 174

Query: 706 EYFRRQQ-LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH 755
           E  ++       +D +S G +LF++L           K++  +        
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-41
 Identities = 62/290 (21%), Positives = 106/290 (36%), Gaps = 29/290 (10%)

Query: 533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
           ++ +  ++G G FG VY+ ++  +   VAIK+      Q       E++++ KL H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIV 76

Query: 593 SLIGYCEENCE------MILVYDYMAYGTLREHL-YKTQKPPLPWKQRLEICIGAARGLH 645
            L  +   + E      + LV DY+     R    Y   K  LP            R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 646 YLHTGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLD 704
           Y+H      I HRD+K  N+LLD    V K+ DFG +K    +      + +   +    
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRYYRAP 191

Query: 705 PEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM 764
              F     T   DV+S G VL E+L  +P        +Q+           +  + ++ 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 765 DPYLKGKIAPECFKKFAETAMKCVSDQGI------------ERPSMGDVL 802
             Y + K        + +        + I             R +  +  
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 5e-41
 Identities = 53/272 (19%), Positives = 103/272 (37%), Gaps = 28/272 (10%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGY 597
           +LG+G  GKV +        K A+K           + + E+E+  +  +  H+V ++  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 73

Query: 598 CEENCE----MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKH 653
            E        +++V + +  G L   +          ++  EI       + YLH     
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 654 TIIHRDVKTTNILLDEKW---VAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
            I HRDVK  N+L   K    + K++DFG +K        +  T    +  Y+ PE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGP 187

Query: 711 QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG 770
           ++  +  D++S GV+++ +LC  P      P         +     +  + Q   P  + 
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP------PFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
               E  K         +  +  +R ++ + +
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTITEFM 270

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  150 bits (379), Expect = 2e-40
 Identities = 56/257 (21%), Positives = 105/257 (40%), Gaps = 15/257 (5%)

Query: 494 GNSHSA--GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATNNFDEALLLGVGGFGKVYRG 551
           GN+ +A  GS + +     A +    L +  + ++  A  + FD    LG G FG+V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60

Query: 552 EIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY 608
           +   +    A+K   +   +  + +     E  +L  +    LV L    ++N  + +V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120

Query: 609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD 668
           +Y+A G +  HL +                       YLH      +I+RD+K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLID 175

Query: 669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 728
           ++   +V+DFG +K       T     + G+   L PE    +   +  D ++ GV+++E
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 729 ILCARPALNPTLPKEQV 745
           +    P      P +  
Sbjct: 231 MAAGYPPFFADQPIQIY 247

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 4e-40
 Identities = 56/278 (20%), Positives = 111/278 (39%), Gaps = 39/278 (14%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR------GNPLSEQGVHEFQTEIEMLSKLRHRHLV 592
            LG G F  V +        + A K        +        + + E+ +L +++H +++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 593 SLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
           +L    E   ++IL+ + +A G L + L +  K  L  ++  E       G++YLH    
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---S 131

Query: 653 HTIIHRDVKTTNILLDEKWVA----KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
             I H D+K  NI+L ++ V     K+ DFGL+     +D  +    + G+  ++ PE  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIV 188

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL 768
             + L  ++D++S GV+ + +L           +E                L  +    +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---------------TLANVSA--V 231

Query: 769 KGKIAPECFKKFAETA----MKCVSDQGIERPSMGDVL 802
             +   E F   +  A     + +     +R ++ D L
Sbjct: 232 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 8e-39
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 10/206 (4%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIK---RGNPLSEQGVHEFQTEIEMLSKLRH 588
           N+FD   LLG G FGKV            A+K   +   +++  V    TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
             L +L    + +  +  V +Y   G L  HL +  +     ++           L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLH 122

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
                 +++RD+K  N++LD+    K++DFGL K G +   T  +    G+  YL PE  
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPEVL 177

Query: 709 RRQQLTEKSDVYSFGVVLFEILCARP 734
                    D +  GVV++E++C R 
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (357), Expect = 5e-38
 Identities = 49/278 (17%), Positives = 102/278 (36%), Gaps = 21/278 (7%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G +G V++ +       VA+K  R +   E        EI +L +L+H+++V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIH 657
              + ++ LV+++          + +    L  +          +GL + H      ++H
Sbjct: 70  LHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLH 124

Query: 658 RDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKS 717
           RD+K  N+L++     K+++FGL++          S  V   +       F  +  +   
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 718 DVYSFGVVLFEILCARPALNPTLPKEQV-----------SLAEWAAHCHKKGILEQIMDP 766
           D++S G +  E+  A   L P    +             +  +W +           M P
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 767 YLKG--KIAPECFKKFAETAMKCVSDQGIERPSMGDVL 802
                  + P+      +     +    ++R S  + L
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 9e-38
 Identities = 54/263 (20%), Positives = 95/263 (36%), Gaps = 34/263 (12%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKR------GNPLSEQGVHEFQTEIEMLSKLRHRH-- 590
           LLG GGFG VY G        VAIK        +            E+ +L K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 591 LVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
           ++ L+ + E     +L+ +              ++  L  +            + + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCH-- 127

Query: 651 AKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFR 709
               ++HRD+K  NIL+D  +   K+ DFG       L    V T   G+  Y  PE+ R
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDGTRVYSPPEWIR 182

Query: 710 RQQL-TEKSDVYSFGVVLFEILCARP-------------ALNPTLPKEQVSLAE--WAAH 753
             +     + V+S G++L++++C                     +  E   L     A  
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALR 242

Query: 754 CHKKGILEQIM-DPYLKGKIAPE 775
              +   E+I   P+++  + P+
Sbjct: 243 PSDRPTFEEIQNHPWMQDVLLPQ 265

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-37
 Identities = 58/286 (20%), Positives = 107/286 (37%), Gaps = 33/286 (11%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
            +G G +G V          KVAIK       SE        E+ +L  +RH +++ L+ 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 597 YCEEN------CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
               +       +  LV  +M  GT    L K     L   +   +     +GL Y+H  
Sbjct: 85  VFTPDETLDDFTDFYLVMPFM--GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIH-- 138

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
               IIHRD+K  N+ ++E    K+ DFGL++       + ++  V   +          
Sbjct: 139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVILNW 193

Query: 711 QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG 770
            + T+  D++S G ++ E++  +     +   +Q+              ++++     K 
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253

Query: 771 --KIAPECFKKFAETAMKCVSDQGI------------ERPSMGDVL 802
             K  PE  KK   + +   S   +            +R + G+ L
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 8e-37
 Identities = 59/291 (20%), Positives = 113/291 (38%), Gaps = 33/291 (11%)

Query: 540 LGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGY 597
           +G G FG+V++        KVA+K+       E        EI++L  L+H ++V+LI  
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 598 CEE--------NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHT 649
           C             + LV+D+  +           K  L   +R  +      GL+Y+H 
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYIH- 134

Query: 650 GAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK--TGPTLDHTHVSTVVKGSFGYLDPEY 707
             ++ I+HRD+K  N+L+    V K++DFGL++  +       +  T    +  Y  PE 
Sbjct: 135 --RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 708 FRRQQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSL---------AEWAAHCHKK 757
              ++      D++  G ++ E+    P +     + Q++L          E   +    
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252

Query: 758 GILEQIMDPYLKGKIAPECFKKFAETA------MKCVSDQGIERPSMGDVL 802
            + E++     + +   +  K +           K +     +R    D L
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 9e-32
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 16/223 (7%)

Query: 532 NNFDEALLLGVGGFGKVYRGE-IDGATT--KVAIKRGNPLS----EQGVHEFQTEIEMLS 584
            NF+   +LG G +GKV+    I G  T    A+K     +     +     +TE ++L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 585 KLRHR-HLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARG 643
            +R    LV+L    +   ++ L+ DY+  G L  HL + ++          + I     
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138

Query: 644 LHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
           +  L    K  II+RD+K  NILLD      ++DFGLSK     D T  +    G+  Y+
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYM 197

Query: 704 DPEYFRRQQ--LTEKSDVYSFGVVLFEILCARPALNPTLPKEQ 744
            P+  R       +  D +S GV+++E+L           K  
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (313), Expect = 1e-31
 Identities = 44/214 (20%), Positives = 84/214 (39%), Gaps = 19/214 (8%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
            +G G  G V           VAIK       ++        E+ ++  + H++++SL+ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 597 YC------EENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG 650
                   EE  ++ LV + M     +    +        ++   +      G+ +LH  
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLH-- 136

Query: 651 AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRR 710
               IIHRD+K +NI++      K+ DFGL++T      + + T    +  Y  PE    
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILG 192

Query: 711 QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQ 744
               E  D++S G ++ E++  +         +Q
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 4e-31
 Identities = 53/284 (18%), Positives = 98/284 (34%), Gaps = 29/284 (10%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK--RGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIG 596
            +G G +G V          +VA+K       S         E+ +L  ++H +++ L+ 
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 597 YCEENCEMILVYDYM----AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAK 652
                  +    D        G    ++ K QK  L       +     RGL Y+H    
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH---S 139

Query: 653 HTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQ 712
             IIHRD+K +N+ ++E    K+ DFGL++        +V+T     +            
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNWMH 195

Query: 713 LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKI 772
             +  D++S G ++ E+L  R     T   +Q+ L           +L++I     +  I
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 773 --APECFKKFAETAMKCVSDQGI------------ERPSMGDVL 802
               +  K          +   +            +R +    L
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  122 bits (307), Expect = 5e-31
 Identities = 40/212 (18%), Positives = 82/212 (38%), Gaps = 19/212 (8%)

Query: 532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRH 590
           +++     LG G + +V+         KV +K    L      + + EI++L  LR   +
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPN 91

Query: 591 LVSLIGYCEENCE--MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
           +++L    ++       LV++++     ++         L             + L Y H
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH 146

Query: 649 TGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEY 707
                 I+HRDVK  N+++D +    ++ D+GL++            V   S  +  PE 
Sbjct: 147 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQEYNVRVASRYFKGPEL 200

Query: 708 FRRQQL-TEKSDVYSFGVVLFEILCARPALNP 738
               Q+     D++S G +L  ++  +     
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (289), Expect = 1e-28
 Identities = 40/233 (17%), Positives = 78/233 (33%), Gaps = 18/233 (7%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH---------- 588
            LG G F  V+  +     T VA+K      +      + EI++L ++            
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 589 -RHLVSLIGYCEENCEMILVYDYMAYGTLREHLY---KTQKPPLPWKQRLEICIGAARGL 644
             H++ L+ +        +    +        L    K +   +P     +I      GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 645 HYLHTGAKHTIIHRDVKTTNILLD-EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYL 703
            Y+H   +  IIH D+K  N+L++       +    ++  G    +    T    +  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 704 DPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK 756
            PE          +D++S   ++FE++       P          +  A   +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.6 bits (224), Expect = 2e-21
 Identities = 29/193 (15%), Positives = 59/193 (30%), Gaps = 25/193 (12%)

Query: 539 LLGVGGFGKVYRGEIDGATTKVAIK----------RGNPLSEQGVHEFQTEIEMLSKLRH 588
           L+G G    V+         +  +K          +     + G   F       ++   
Sbjct: 7   LMGEGKESAVFNC-YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 589 RHLVSLIGYCEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLH 648
           R L  L G           Y +     L E +   +   +  +   E+       +   +
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 649 TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYF 708
                 I+H D+   N+L+ E+ +  + DF  S     +       +++     +   YF
Sbjct: 121 ---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSV---EVGEEGWREILERDVRNI-ITYF 172

Query: 709 RRQQLTEKSDVYS 721
            R     + D+ S
Sbjct: 173 SRTY-RTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	893
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.33
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.65
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.25
d2o14a1	146	Hypothetical protein YxiM {Bacillus subtilis [TaxI	96.29
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.45
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.21
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.35

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-50  Score=427.67  Aligned_cols=261  Identities=28%  Similarity=0.529  Sum_probs=206.6

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      .++|+..++||+|+||+||+|++++   .||||+++..  .....+.|.+|+++|++++|||||+++|++.+ +..+|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            3568888999999999999998754   4999987543  45667889999999999999999999999865 4689999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |||++|+|.++|+... .+++|..++.|+.|||+||+|||+   .+||||||||+||||++++.+||+|||+|+......
T Consensus        83 Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             ECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             ecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999997653 359999999999999999999994   899999999999999999999999999998754433


Q ss_pred             CccceeeeccCcCccChHhhhh---cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      .........||+.|||||++.+   ..++.++|||||||+||||+||+.||.........      ......+    ...
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~~~~----~~~  228 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRG----YLS  228 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHHT----SCC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHHhcC----CCC
Confidence            3344456779999999999974   35899999999999999999999999764432211      1111111    111


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      +.+ ...+..++..+.+++.+||+.+|++||||.||+++|+.+.+
T Consensus       229 p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         229 PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            111 12344566789999999999999999999999999997664

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.4e-50  Score=433.12  Aligned_cols=260  Identities=22%  Similarity=0.389  Sum_probs=202.7

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcc---eEEEEEeCCC-CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGAT---TKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~---~~VavK~~~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      +|+..++||+|+||+||+|+++..+   ..||||++.. ......++|.+|+++|++++|||||+++|+|.+.+..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            3455689999999999999986543   3689998764 35556778999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |||++|+|.+++.... ..++|.+++.|+.|||+||+|||   +.+||||||||+||||+.++.+||+|||+++......
T Consensus       107 Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         107 EFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             ECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999887543 45999999999999999999999   4899999999999999999999999999998643322


Q ss_pred             Cc---cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          689 HT---HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       689 ~~---~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ..   .......||+.|||||++.++.++.++|||||||+||||+| |+.||......+      .......        
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~------~~~~i~~--------  248 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD------VINAIEQ--------  248 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHT--------
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH------HHHHHHc--------
Confidence            11   11223458999999999999999999999999999999998 899986543221      1111111        


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhc
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQ  812 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~  812 (893)
                        ......+.+++..+.+++.+||+.+|++||||.||++.|+.+++..
T Consensus       249 --~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         249 --DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence              1112334566778999999999999999999999999999877643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-50  Score=431.71  Aligned_cols=260  Identities=25%  Similarity=0.404  Sum_probs=218.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..++||+|+||+||+|++..+++.||||+++... ...++|.+|+++|++++|||||+++|+|.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            357888899999999999999999888999999987543 3467899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      |++|+|.++|.+.....++|..++.|+.|+|+||+|||   +.+||||||||+||||++++.+||+|||+++..... ..
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~  170 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TY  170 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SS
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC-Cc
Confidence            99999999998877778999999999999999999999   489999999999999999999999999999875432 22


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      .......||+.|+|||++.++.++.|+|||||||+||||++|+.|+.......     +..          +++......
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-----~~~----------~~i~~~~~~  235 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVY----------ELLEKDYRM  235 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHH----------HHHHTTCCC
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-----HHH----------HHHhcCCCC
Confidence            23334568999999999999999999999999999999999877765433211     111          111111222


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ..+..++..+.+|+.+||+.||++||||.||++.|+...+
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            3445566789999999999999999999999999987654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=422.39  Aligned_cols=257  Identities=27%  Similarity=0.384  Sum_probs=201.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..+.||+|+||+||+|.+.++ ..||||+++.. ....++|.+|++++++++|||||+++|+|.+.+..++|||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTT-EEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCC-CEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            4688889999999999999998765 67999998754 334578999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|.+++.... ..++|..++.|+.|+|+||+|||   +.+|+||||||+||||++++.+||+|||+++....... .
T Consensus        83 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~  157 (263)
T d1sm2a_          83 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  157 (263)
T ss_dssp             TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence            9999999987543 45899999999999999999999   58999999999999999999999999999986543222 2


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ......||+.|+|||++.+..++.|+|||||||+||||+|++.|+......     .+.......          .....
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----~~~~~~i~~----------~~~~~  222 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDIST----------GFRLY  222 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----HHHHHHHHH----------TCCCC
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHh----------cCCCC
Confidence            233456899999999999999999999999999999999965444322211     111111111          01112


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .+..+..++.+++.+||+.||++||||+||+++|+++++
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            234456778999999999999999999999999997754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=422.16  Aligned_cols=257  Identities=25%  Similarity=0.383  Sum_probs=209.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..++||+|+||+||+|.++++ ..||||+++... ...++|.+|+++|++++|||||+++|+|.+ +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCC-CEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            35788889999999999999998764 789999987543 345789999999999999999999998865 457899999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++|+|.+++......+++|..+++|+.||++||+|||   ..+|+||||||+||||++++.+||+|||+|+..... ..
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~  164 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EY  164 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC-cc
Confidence            99999999887665556999999999999999999999   489999999999999999999999999999875432 22


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      .......||+.|||||++.++.++.++|||||||+||||+||+.|+.......     +....         +.. ....
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-----~~~~~---------i~~-~~~~  229 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQN---------LER-GYRM  229 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHH---------HHT-TCCC
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-----HHHHH---------HHh-cCCC
Confidence            22344568999999999999999999999999999999999766554332211     11111         111 1112


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ..+..++..+.+++.+||+.+|++||||.||++.|+...
T Consensus       230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            233455677899999999999999999999999998644

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=420.25  Aligned_cols=263  Identities=25%  Similarity=0.416  Sum_probs=207.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcc----eEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGAT----TKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~----~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      +.|+..++||+|+||+||+|.++..+    ..||||++... ......+|.+|+++|++++|||||+++|+|.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            46788899999999999999986543    46999987643 44556689999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      |||||.+|+|.+.+.... ..++|.++++++.|+++||+|||   +.+||||||||+||||+.++.+||+|||+++....
T Consensus        87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999876543 46999999999999999999999   48999999999999999999999999999986433


Q ss_pred             CC-CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LD-HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~-~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      .. .........||+.|||||++.++.++.++|||||||+||||++|+.|+.......     +....          +.
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-----~~~~~----------i~  227 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVMKA----------IN  227 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHH----------HH
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-----HHHHH----------Hh
Confidence            22 2223344568999999999999999999999999999999999766654332211     11111          11


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhhch
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQLQE  813 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~~~  813 (893)
                      ...+...+.+++..+.+|+.+||+.+|++||||.||++.|+.+++..+
T Consensus       228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~  275 (283)
T d1mqba_         228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  275 (283)
T ss_dssp             TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence            112233455667889999999999999999999999999998776543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=422.86  Aligned_cols=256  Identities=23%  Similarity=0.293  Sum_probs=206.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..++||+|+||+||+|+++.+++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57889999999999999999998888999999865432 23446789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++|+|.++|...  ..+++..+..++.|+++||+|||   +.+||||||||+||||++++.+||+|||+|+........
T Consensus        85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            9999999999654  35999999999999999999999   489999999999999999999999999999865433333


Q ss_pred             cceeeeccCcCccChHhhhhcCC-CCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      .......||+.|||||++.+..+ +.++|||||||+||||++|+.||........ .+..+             ......
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~-------------~~~~~~  225 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-------------KEKKTY  225 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHH-------------HTTCTT
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHHH-------------hcCCCC
Confidence            33455779999999999998876 6789999999999999999999975432211 11111             011101


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..........+.+++.+||+.||++|||+.|++++-.
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw  262 (271)
T d1nvra_         226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  262 (271)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            1111233466788999999999999999999986543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=428.60  Aligned_cols=258  Identities=24%  Similarity=0.387  Sum_probs=210.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcc-----eEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGAT-----TKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  604 (893)
                      ++|+..++||+|+||+||+|++.+..     ..||+|.+... .......|.+|+.+|.++ +|||||+++++|.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            57888999999999999999986543     36999987543 334456799999999998 899999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCCC---------------------CCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCC
Q 036624          605 ILVYDYMAYGTLREHLYKTQK---------------------PPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTT  663 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~  663 (893)
                      +||||||++|+|.++|+....                     ..++|..++.|+.|+++||+|||+   .+||||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence            999999999999999976432                     358999999999999999999994   89999999999


Q ss_pred             CEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCcc
Q 036624          664 NILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPK  742 (893)
Q Consensus       664 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~  742 (893)
                      |||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999986544333333445678999999999999999999999999999999997 89999754332


Q ss_pred             ccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          743 EQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       743 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                      .  .+..             ++........+..++..+.+|+.+||+.+|++|||+.||+++|..
T Consensus       274 ~--~~~~-------------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         274 A--NFYK-------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             H--HHHH-------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             H--HHHH-------------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            1  1111             111112223345566789999999999999999999999999963

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=412.47  Aligned_cols=249  Identities=26%  Similarity=0.395  Sum_probs=209.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..+.||+|+||+||+|+++.+++.||+|++...   .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4688999999999999999999988899999986532   1233567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |||++|+|.+++.+..  .+++..+..++.|+++||+|||   +.+||||||||+||||+.++.+||+|||+++..... 
T Consensus        86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred             eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence            9999999999997654  4999999999999999999999   489999999999999999999999999999864332 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                         ......||+.|||||++.+..++.++|||||||+||||++|+.||......+      ....         +.... 
T Consensus       160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~---------i~~~~-  220 (263)
T d2j4za1         160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKR---------ISRVE-  220 (263)
T ss_dssp             ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH---------HHTTC-
T ss_pred             ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HHHH---------HHcCC-
Confidence               2334679999999999999999999999999999999999999996543211      1111         11111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                       ..++..+...+.+++.+||+.||++|||+.|++++-.
T Consensus       221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~  257 (263)
T d2j4za1         221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  257 (263)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred             -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence             1233345567889999999999999999999998654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=417.46  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=210.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..+.||+|+||+||+|++..+++.||||++........+.+.+|+++|++++|||||++++++.+.+..+||||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            46899999999999999999998888999999876544455678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|.+++.+.   .+++.++..++.||+.||+|||   +.+||||||||+||||+.++++||+|||+++.....  ..
T Consensus       100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~  171 (293)
T d1yhwa1         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QS  171 (293)
T ss_dssp             TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TC
T ss_pred             CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc--cc
Confidence            999999988654   4999999999999999999999   489999999999999999999999999999864322  12


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ......||+.|+|||++.++.++.++|||||||++|||++|+.||........      .......+        .....
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~--------~~~~~  237 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG--------TPELQ  237 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHC--------SCCCS
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCC--------CCCCC
Confidence            23455799999999999999999999999999999999999999965432211      11111110        01112


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      .+..+...+.+++.+||+.||++|||+.|++++-
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp  271 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ  271 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            2344567788999999999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-48  Score=413.98  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=209.3

Q ss_pred             cCCccce-eeeecCcEEEEEEEEcC--cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEAL-LLGVGGFGKVYRGEIDG--ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~-~LG~G~fG~Vy~g~~~~--~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|...+ +||+|+||+||+|.++.  .+..||||+++.. .....++|.+|+++|++++|||||+++|+|.. +..+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 49999999999998753  3457999987654 44567889999999999999999999999965 468999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      ||||++|+|.+++.... ..+++..+++|+.|+|+||+|||+   .+||||||||+||||+.++.+||+|||+++.....
T Consensus        87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            99999999999886443 469999999999999999999994   89999999999999999999999999999875433


Q ss_pred             CC-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          688 DH-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       688 ~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      .. ........||+.|||||++.++.++.++|||||||+||||+| |+.||......+   +.   .. ...+       
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~---~~-i~~~-------  228 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM---AF-IEQG-------  228 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH---HH-HHTT-------
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HH---HH-HHcC-------
Confidence            22 222334568999999999999999999999999999999998 899997543221   11   11 1111       


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                        .....++.++..+.+|+.+||+.+|++||||.+|++.|+....
T Consensus       229 --~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         229 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence              1123445667789999999999999999999999999986553

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=416.08  Aligned_cols=255  Identities=24%  Similarity=0.383  Sum_probs=197.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEee--cCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE--NCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV  607 (893)
                      ++|+..+.||+|+||+||+|+.+.+++.||+|++...  .....+.|.+|+++|++++|||||++++++.+  .+.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5799999999999999999999888889999986543  45566789999999999999999999999864  4568999


Q ss_pred             EeeccCCCHHHHHhhC--CCCCCCHHhHHHHHHHHHHhhhhhhcCC--CCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          608 YDYMAYGTLREHLYKT--QKPPLPWKQRLEICIGAARGLHYLHTGA--KHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      ||||++|+|.+++.+.  .+..+++..++.++.|++.||+|||+..  ..+||||||||+||||++++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998653  3456999999999999999999999632  24599999999999999999999999999986


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      ...  .........||+.|||||++.+..++.++|||||||+||||++|+.||......+      ....         +
T Consensus       164 ~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~~~---------i  226 (269)
T d2java1         164 LNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGK---------I  226 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHH---------H
T ss_pred             ccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------HHHH---------H
Confidence            432  1222345679999999999999999999999999999999999999997543211      1111         1


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..... ...+..+...+.+++.+||+.||++|||+.|++++
T Consensus       227 ~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         227 REGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             HHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            11111 12233455678899999999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-48  Score=412.32  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=201.2

Q ss_pred             eeeeecCcEEEEEEEEcC--cceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeeccC
Q 036624          538 LLLGVGGFGKVYRGEIDG--ATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAY  613 (893)
Q Consensus       538 ~~LG~G~fG~Vy~g~~~~--~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  613 (893)
                      ++||+|+||+||+|.+..  ..+.||||+++..  .....++|.+|+++|++++|||||+++|+|..+ ..+||||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            579999999999998753  3467999987643  333467899999999999999999999999654 57899999999


Q ss_pred             CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC-ccc
Q 036624          614 GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH-THV  692 (893)
Q Consensus       614 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~-~~~  692 (893)
                      |+|.+++....  .++|..++.|+.|||+||+|||   +.+||||||||+||||+.++.+||+|||+++....... ...
T Consensus        92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            99999997654  4999999999999999999999   48899999999999999999999999999986543222 222


Q ss_pred             eeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          693 STVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       693 ~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      .....||+.|||||++.+..++.++|||||||++|||+| |+.||......+   +   .... ..+         ....
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~---~~~i-~~~---------~~~~  230 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V---TAML-EKG---------ERMG  230 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H---HHHH-HTT---------CCCC
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---H---HHHH-HcC---------CCCC
Confidence            334569999999999999999999999999999999998 899997543211   1   1111 111         1123


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      .+..++..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            34556778899999999999999999999999887543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-48  Score=416.11  Aligned_cols=253  Identities=24%  Similarity=0.353  Sum_probs=209.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      +.|+..+.||+|+||+||+|++..++..||||++........+.|.+|+++|++++|||||++++++.+.+..+||||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888999999999999999998888999999987666667788999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|.+++.+.. .++++.++..++.|+++||+|||   +.+||||||||+||||+.++.+||+|||+|+....  ...
T Consensus        92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~  165 (288)
T d2jfla1          92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQ  165 (288)
T ss_dssp             TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHH
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC--Ccc
Confidence            9999999886543 35999999999999999999999   48999999999999999999999999999875321  111


Q ss_pred             ceeeeccCcCccChHhhh-----hcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          692 VSTVVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                      ......||+.|||||++.     ...++.++|||||||+||||++|+.||......+.  +...    ...        .
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~i----~~~--------~  231 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKI----AKS--------E  231 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHH----HHS--------C
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHHH----HcC--------C
Confidence            233467999999999984     55689999999999999999999999976543221  1110    000        0


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ......+..+...+.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         232 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00112233456778899999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.1e-48  Score=418.08  Aligned_cols=266  Identities=28%  Similarity=0.424  Sum_probs=216.1

Q ss_pred             HHHHHHhcCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEE
Q 036624          525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYC  598 (893)
Q Consensus       525 ~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~  598 (893)
                      .+++-.+++|+..+.||+|+||+||+|+.++     .++.||||+++.. .....++|.+|+++|++++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            3444457889999999999999999999764     3468999998754 344567899999999999999999999999


Q ss_pred             eecCEEEEEEeeccCCCHHHHHhhCC----------------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceE
Q 036624          599 EENCEMILVYDYMAYGTLREHLYKTQ----------------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTII  656 (893)
Q Consensus       599 ~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  656 (893)
                      ......++||||+++|+|.++|+...                      ...++|..++.|+.|++.||+|||   +.+||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeE
Confidence            99999999999999999999996532                      234899999999999999999999   58999


Q ss_pred             ecCCCCCCEEECCCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCC-CC
Q 036624          657 HRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR-PA  735 (893)
Q Consensus       657 HrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~-~p  735 (893)
                      ||||||+|||||.++.+||+|||+++...........+...||+.|+|||++.+..++.|+|||||||+||||++|. +|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            99999999999999999999999998644333333445567899999999999999999999999999999999996 56


Q ss_pred             CCCCCccccccHHHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          736 LNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       736 ~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      |......+      ....         +.+.. ....+..++..+.+|+.+||+.+|++||||.||+++|+++.
T Consensus       243 ~~~~~~~e------~~~~---------v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         243 YYGMAHEE------VIYY---------VRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTSCHHH------HHHH---------HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCHHH------HHHH---------HHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            65433221      1111         11111 12234456678899999999999999999999999999764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=404.66  Aligned_cols=252  Identities=29%  Similarity=0.418  Sum_probs=210.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..++||+|+||+||+|+++++ ..||||+++... ...++|.+|+.++++++||||++++|+|.+.+..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTT-EEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCC-CEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            5788899999999999999998754 789999876543 34578999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|..++.... ..+++..+++|+.|+|+||+|||   +.+|+||||||+|||+++++.+||+|||+++....... .
T Consensus        82 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~  156 (258)
T d1k2pa_          82 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  156 (258)
T ss_dssp             TTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred             CCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence            9999999976543 35899999999999999999999   48999999999999999999999999999986543222 2


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhccccccC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKG  770 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~  770 (893)
                      ......||+.|+|||++.+..++.|+|||||||++|||+| |+.||......+      ...... .+         ...
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~~~i~-~~---------~~~  220 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIA-QG---------LRL  220 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHH-TT---------CCC
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH------HHHHHH-hC---------CCC
Confidence            3334568999999999999999999999999999999998 898986543221      111111 11         112


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          771 KIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       771 ~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      ..+..++..+.+++.+||+.+|++|||+.+|+++|.
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence            233445578899999999999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=406.32  Aligned_cols=246  Identities=26%  Similarity=0.416  Sum_probs=197.8

Q ss_pred             ccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEee----cCEEEEEE
Q 036624          535 DEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE----NCEMILVY  608 (893)
Q Consensus       535 ~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~  608 (893)
                      +..++||+|+||+||+|.+..++..||+|++..  ......+.|.+|+++|++++|||||++++++..    ...++|||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            445689999999999999998888999997653  245566789999999999999999999999865    35689999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCc--eEecCCCCCCEEEC-CCCceeEecccccccCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHT--IIHRDVKTTNILLD-EKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlk~~NILld-~~~~~kl~DFGla~~~~  685 (893)
                      ||+++|+|.+++.+..  .+++..+..++.||++||+|||+   .+  ||||||||+||||+ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999997654  49999999999999999999994   55  99999999999996 57899999999998633


Q ss_pred             CCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      .    .......||+.|||||++.+ .++.++|||||||+||||++|+.||.......     ....... .+    ...
T Consensus       167 ~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~~~~~i~-~~----~~~  231 (270)
T d1t4ha_         167 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVT-SG----VKP  231 (270)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHT-TT----CCC
T ss_pred             C----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----HHHHHHH-cC----CCC
Confidence            2    12345679999999999875 59999999999999999999999996543221     1111111 11    011


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      +    .++..+..++.+++.+||+.||++|||+.|++++
T Consensus       232 ~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         232 A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             c----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            1    1122234568899999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=411.46  Aligned_cols=256  Identities=29%  Similarity=0.419  Sum_probs=205.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..+.||+|+||+||+|+++++ ..||||+++.. ....+.|.+|+.+|++++|||||+++|+|.+ ++.++||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            5788999999999999999999876 57999998754 3445789999999999999999999999965 5678999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCcc
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTH  691 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~  691 (893)
                      ++|+|..++.......++|.+++.|+.||++||+|||   +.+|+||||||+|||||+++.+||+|||+++...... ..
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence            9999999988765556999999999999999999999   5889999999999999999999999999998653322 22


Q ss_pred             ceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccccCC
Q 036624          692 VSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLKGK  771 (893)
Q Consensus       692 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~  771 (893)
                      ......||+.|+|||++.++.++.++|||||||+||||++|+.|+.......     +......          ......
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-----~~~~~i~----------~~~~~~  234 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVE----------RGYRMP  234 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHH----------TTCCCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-----HHHHHHH----------hcCCCC
Confidence            2344569999999999999999999999999999999999766664432211     1111111          111223


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          772 IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       772 ~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      .++.+++++.+++.+||+.||++||+|.+|+++|+...
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            45566778999999999999999999999999888533

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-48  Score=421.41  Aligned_cols=268  Identities=23%  Similarity=0.332  Sum_probs=208.6

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .++|+..++||+|+||+||+|++..++..||+|+++.. .....+.+.+|+.+|++++|||||+++++|.+.+..+||||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            56899999999999999999999888899999987543 33445789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      ||++|+|.+++.+..  .+++..+..++.|+++||+|||+  +++|+||||||+||||++++.+||+|||+|+....   
T Consensus        85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---  157 (322)
T ss_dssp             CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred             cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence            999999999997654  49999999999999999999995  35899999999999999999999999999985321   


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHH---------------HHHH-
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAE---------------WAAH-  753 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------------~~~~-  753 (893)
                       .......||+.|||||++.+..|+.++||||+||++|||++|+.||.............               +... 
T Consensus       158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence             12234679999999999999999999999999999999999999997644321100000               0000 


Q ss_pred             -------hhcccchhhhcccccc---CCCC-hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          754 -------CHKKGILEQIMDPYLK---GKIA-PECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       754 -------~~~~~~~~~i~d~~l~---~~~~-~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                             ........+..+....   ...+ .....++.+++.+||+.||++|||+.|++++-.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf  300 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  300 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence                   0000000000000000   0011 112356888999999999999999999998744

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-48  Score=413.91  Aligned_cols=252  Identities=21%  Similarity=0.282  Sum_probs=206.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||+||+|++..+++.||||++...   .....+.+.+|+++|++++||||+++++++.+.+..+|||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5689999999999999999999888899999986532   2234567999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |||++|+|.+++...+  .+++..+..++.|++.||+|||   +.+||||||||+||||++++.+||+|||+|+......
T Consensus        88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            9999999999987654  4999999999999999999999   5899999999999999999999999999998754333


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                      .........||+.|||||++.+..++.++|||||||+||||++|+.||......+      ...         .+.... 
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~---------~i~~~~-  226 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQ---------KIIKLE-  226 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH---------HHHTTC-
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHH---------HHHcCC-
Confidence            3333445679999999999999999999999999999999999999997543211      111         111111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                       ..++......+.+++.+||+.||++|||+.|++.+.
T Consensus       227 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~  262 (288)
T d1uu3a_         227 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG  262 (288)
T ss_dssp             -CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred             -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence             122334456788999999999999999999986543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-47  Score=413.59  Aligned_cols=258  Identities=22%  Similarity=0.385  Sum_probs=206.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcce----EEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATT----KVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .+|+..++||+|+||+||+|.+...++    .||+|+++.. ..+..++|.+|+++|++++|||||+++|+|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            368999999999999999999865543    5899987643 445678899999999999999999999999875 5678


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ++||+.+|+|.+++.... ..+++..+++|+.|||+||+|||+   .+||||||||+||||+.++.+||+|||+++....
T Consensus        88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            889999999999887653 469999999999999999999994   8999999999999999999999999999987554


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      ...........||+.|||||++.++.++.++|||||||+||||+| |++||......+   +...             +.
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~-------------i~  227 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI-------------LE  227 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHH-------------HH
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHH-------------HH
Confidence            333333445669999999999999999999999999999999998 788886543222   1111             11


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ...+...++.++..+.+++.+||+.+|++|||+.||+++|+...+
T Consensus       228 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            111223345567789999999999999999999999999987653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-47  Score=412.33  Aligned_cols=247  Identities=27%  Similarity=0.345  Sum_probs=203.4

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .|+..+.||+|+||+||+|+...+++.||||++...   .....+.+.+|+++|++++|||||++++++.+.+..+||||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            488999999999999999999888899999986543   23445679999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      ||++|+|..++...  .++++.++..++.||+.||+|||   +.+||||||||+||||++++.+||+|||+++....   
T Consensus        96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            99999998766544  35999999999999999999999   48999999999999999999999999999986432   


Q ss_pred             ccceeeeccCcCccChHhhhh---cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                         .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.......      ........      ..+
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~~~------~~~  232 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN------ESP  232 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS------CCC
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhC------CCC
Confidence               223569999999999964   468999999999999999999999996543211      11111110      011


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      .   ..+..+...+.+++.+||+.||++|||+.|++++-
T Consensus       233 ~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp  268 (309)
T d1u5ra_         233 A---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (309)
T ss_dssp             C---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             C---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence            1   11223456788999999999999999999998753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-47  Score=400.88  Aligned_cols=250  Identities=29%  Similarity=0.428  Sum_probs=200.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEee-cCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE-NCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~  610 (893)
                      ++|+..++||+|+||.||+|++++  ..||||+++..  ...++|.+|++++++++||||++++|+|.+ .+.++|||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~--~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT--EEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEECC--eEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            457788899999999999999975  57999998653  345789999999999999999999999865 4568999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +++|+|.++|++.....++|..+++|+.||+.||+|||   +.+||||||||+|||++.++.+||+|||+++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99999999998765556999999999999999999999   489999999999999999999999999999864321   


Q ss_pred             cceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                        .....+|..|+|||++.++.++.++|||||||++|||+| |++|+......   .+..++.             ...+
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~-------------~~~~  218 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE-------------KGYK  218 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHT-------------TTCC
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH-------------cCCC
Confidence              233458899999999999999999999999999999998 67777544222   1222211             1112


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFAL  809 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~  809 (893)
                      ..++..++..+.+++.+||+.||++||||.+|+++|+.+.
T Consensus       219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            3345556678899999999999999999999999998754

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=407.64  Aligned_cols=262  Identities=24%  Similarity=0.392  Sum_probs=203.0

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCc-----ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeec-C
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGA-----TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEEN-C  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~  602 (893)
                      .++|+..++||+|+||.||+|++.+.     .+.||||+++.. .....+.+..|..++.++ +|+||+.+++++.+. .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            36788999999999999999997542     367999988653 445567788898888887 689999999998654 5


Q ss_pred             EEEEEEeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC
Q 036624          603 EMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD  668 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld  668 (893)
                      ..++|||||++|+|.++|+...              ...++|.+++.++.||++||+|||   +.+||||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence            6899999999999999997542              235899999999999999999999   48999999999999999


Q ss_pred             CCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCC-CCCCCCCccccccH
Q 036624          669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR-PALNPTLPKEQVSL  747 (893)
Q Consensus       669 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l  747 (893)
                      +++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||++|. +||.......  .+
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--~~  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF  246 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--HH
Confidence            99999999999998654433333344567999999999999999999999999999999999875 5665432211  11


Q ss_pred             HHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          748 AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       748 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                          ......+         .....+..++..+.+++.+||+.||++|||+.||+++|+.+++
T Consensus       247 ----~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         247 ----CRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             ----HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                1111111         1122334456678999999999999999999999999998775

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.4e-46  Score=413.15  Aligned_cols=254  Identities=22%  Similarity=0.279  Sum_probs=211.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..++||+|+||+||+|+...++..||||++........+.+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999999888899999998877777778899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC--CCCceeEecccccccCCCCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD--EKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld--~~~~~kl~DFGla~~~~~~~  688 (893)
                      |++|+|.+++.+.. ..+++..+..|+.||+.||+|||   +.+||||||||+||||+  .++.+||+|||+++..... 
T Consensus       105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-  179 (350)
T d1koaa2         105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  179 (350)
T ss_dssp             CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred             CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence            99999999986543 35999999999999999999999   58999999999999996  4678999999999864332 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                        .......||+.|||||++.+..++.++|||||||++|||++|+.||......+      .........       ...
T Consensus       180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~-------~~~  244 (350)
T d1koaa2         180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCD-------WNM  244 (350)
T ss_dssp             --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC-------CCS
T ss_pred             --cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------CCC
Confidence              23345679999999999999999999999999999999999999997543211      111111100       001


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ...........+.+++.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111112344678899999999999999999999876

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=399.74  Aligned_cols=258  Identities=23%  Similarity=0.346  Sum_probs=201.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCc---ceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  606 (893)
                      .++|+..++||+|+||+||+|++...   ...||||.++.. .....+.|.+|+++|++++|||||+++|++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            35788899999999999999988543   356899987654 44456789999999999999999999999964 57899


Q ss_pred             EEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCC
Q 036624          607 VYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~  686 (893)
                      ||||+++|+|.+++.... ..+++..++.++.||++||+|||   +.+||||||||+|||+++++.+||+|||+++....
T Consensus        85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            999999999999876543 46999999999999999999999   58999999999999999999999999999986433


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhhcc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD  765 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d  765 (893)
                      . .........||+.|+|||++.+..++.++|||||||+||||++ |++|+......+   +...+            ..
T Consensus       161 ~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i------------~~  224 (273)
T d1mp8a_         161 S-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI------------EN  224 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH------------HT
T ss_pred             C-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH------------Hc
Confidence            2 2223345668999999999999999999999999999999998 888887554322   11111            11


Q ss_pred             ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          766 PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       766 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      . .....++.++..+.+|+.+||+.||++|||+.||+++|+.+++
T Consensus       225 ~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         225 G-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C-CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1 1113345667789999999999999999999999999997764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-46  Score=408.90  Aligned_cols=254  Identities=23%  Similarity=0.324  Sum_probs=193.8

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC-hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS-EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      .+.|+..++||+|+||+||+|++..+++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..+||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            466899999999999999999998888999999865432 2334568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC---CCCceeEecccccccCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPT  686 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld---~~~~~kl~DFGla~~~~~  686 (893)
                      ||++|+|.++|...  ..+++..+..++.|++.||+|||   +.+||||||||+|||+.   +++.+||+|||+++....
T Consensus        88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            99999999999754  35999999999999999999999   58999999999999994   578999999999986432


Q ss_pred             CCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccc
Q 036624          687 LDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDP  766 (893)
Q Consensus       687 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~  766 (893)
                         ........||+.|||||++.+..++.++|||||||+||||++|+.||.......   +..   .....       +.
T Consensus       163 ---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~---~i~~~-------~~  226 (307)
T d1a06a_         163 ---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFE---QILKA-------EY  226 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHTT-------CC
T ss_pred             ---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHH---HHhcc-------CC
Confidence               222334679999999999999999999999999999999999999997543211   111   11000       01


Q ss_pred             cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          767 YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       767 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      .......+..+..+.+++.+||+.||++|||+.|++++-
T Consensus       227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  265 (307)
T d1a06a_         227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP  265 (307)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence            111222334556788999999999999999999998763

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-46  Score=405.33  Aligned_cols=257  Identities=30%  Similarity=0.472  Sum_probs=206.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcce--EEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATT--KVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~--~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|+..++||+|+||+||+|++++++.  .||||+++.. .....++|.+|+++|+++ +|||||+++|+|.+.+.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            577888999999999999999876544  5788876533 444567899999999999 799999999999999999999


Q ss_pred             EeeccCCCHHHHHhhC--------------CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCce
Q 036624          608 YDYMAYGTLREHLYKT--------------QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVA  673 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~  673 (893)
                      |||+++|+|.++|++.              ....++|..+++++.|||+||.|||   +.+||||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999754              2356999999999999999999999   4899999999999999999999


Q ss_pred             eEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCC-CCCCCCccccccHHHHHH
Q 036624          674 KVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARP-ALNPTLPKEQVSLAEWAA  752 (893)
Q Consensus       674 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~  752 (893)
                      ||+|||+++.....   .......||..|+|||.+.++.++.++|||||||++|||++|.. ||.....      .+...
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~~~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYE  237 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH------HHHHH
Confidence            99999999864321   12234568999999999999999999999999999999999765 5543321      11111


Q ss_pred             HhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          753 HCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       753 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .         +.. ......+..++..+.+++.+||+.||++||||.||+++|+.+++
T Consensus       238 ~---------i~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         238 K---------LPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             H---------GGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H---------HHh-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1         111 11123344566789999999999999999999999999998764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.8e-46  Score=410.33  Aligned_cols=253  Identities=20%  Similarity=0.285  Sum_probs=211.4

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYM  611 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  611 (893)
                      ++|+..++||+|+||+||+|+...+++.||||+++.......+.+.+|+++|++++|||||++++++.+.+.++||||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999998888999999887666666778999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC--CCCceeEecccccccCCCCCC
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD--EKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld--~~~~~kl~DFGla~~~~~~~~  689 (893)
                      ++|+|.+++... ..++++.++..|+.||+.||+|||   +.+||||||||+||||+  .++.+||+|||+|+....   
T Consensus       109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~---  181 (352)
T d1koba_         109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---  181 (352)
T ss_dssp             CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---
T ss_pred             CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCC---
Confidence            999999887544 345999999999999999999999   58999999999999998  678999999999986543   


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      ........||+.|||||++.+..++.++|||||||+||||+||+.||......+      ........       +....
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~-------~~~~~  248 (352)
T d1koba_         182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRC-------DWEFD  248 (352)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHC-------CCCCC
T ss_pred             CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC-------CCCCC
Confidence            223445679999999999999999999999999999999999999996543221      11111100       11111


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..........+.+++.+||+.||++|||+.|++++
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            22223445678899999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=402.76  Aligned_cols=261  Identities=23%  Similarity=0.383  Sum_probs=213.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEc-----CcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecCEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEID-----GATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENCEM  604 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  604 (893)
                      ++|+..++||+|+||.||+|++.     ...+.||||+++.. ......+|.+|+.+++++ +|||||+++|+|.+....
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            57788899999999999999874     34468999988754 344566899999999999 699999999999999999


Q ss_pred             EEEEeeccCCCHHHHHhhCC----------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC
Q 036624          605 ILVYDYMAYGTLREHLYKTQ----------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD  668 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld  668 (893)
                      +||||||++|+|.++|++..                ...+++..++.++.||++||+|||   .++||||||||+|||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence            99999999999999997643                235899999999999999999999   58999999999999999


Q ss_pred             CCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhC-CCCCCCCCccccccH
Q 036624          669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA-RPALNPTLPKEQVSL  747 (893)
Q Consensus       669 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l  747 (893)
                      .++.+||+|||+++...............||+.|+|||++.++.++.++|||||||+||||+|+ .+|+......+.   
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~---  256 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---  256 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            9999999999999876544444444567899999999999999999999999999999999995 554543322111   


Q ss_pred             HHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          748 AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       748 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                                  +.++++.......+..++..+.+|+.+||+.||++||||.||+++|++.+.
T Consensus       257 ------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         257 ------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             ------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence                        111122222223344456789999999999999999999999999997653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=399.36  Aligned_cols=257  Identities=26%  Similarity=0.383  Sum_probs=199.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCc---ceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      ++|+..+.||+|+||+||+|++...   ...||||+++..   .....++|.+|+++|++++||||++++|+|.+. ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            5688899999999999999987532   246899987643   334567899999999999999999999999764 678


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      +||||+++|+|.+++.... ..+++..++.++.|+|+||+|||+   .+|+||||||+||||+.++.+||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            9999999999999887543 359999999999999999999994   889999999999999999999999999998754


Q ss_pred             CCCC-ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccHHHHHHHhhcccchhhh
Q 036624          686 TLDH-THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSLAEWAAHCHKKGILEQI  763 (893)
Q Consensus       686 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i  763 (893)
                      .... ........||..|+|||++.+..++.++|||||||++|||+| |+.||......+      ....         +
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~---------i  227 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHK---------I  227 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHH---------H
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHH---------H
Confidence            3322 222334568899999999999999999999999999999998 899996543221      1111         1


Q ss_pred             ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 036624          764 MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFA  808 (893)
Q Consensus       764 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~  808 (893)
                      .........+..++..+.+++.+||+.||++||||.||++.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111112233445567789999999999999999999999999865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-46  Score=400.77  Aligned_cols=253  Identities=20%  Similarity=0.267  Sum_probs=206.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC------ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL------SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~------~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      +.|+..+.||+|+||+||+|++..+++.||||+++..      .....+.|.+|+++|++++|||||++++++.+.+.++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5789999999999999999999888899999976432      1224678999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC----ceeEeccccc
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW----VAKVSDFGLS  681 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~----~~kl~DFGla  681 (893)
                      ||||||++|+|.++|....  .+++..+..++.|++.||+|||   +.+||||||||+|||++.++    .+||+|||++
T Consensus        90 iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            9999999999999997654  5999999999999999999999   58999999999999998776    5999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      +.....   .......||+.|+|||++.+..++.++|||||||+||||++|+.||......+      .........   
T Consensus       165 ~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~---  232 (293)
T d1jksa_         165 HKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAVN---  232 (293)
T ss_dssp             EECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTC---
T ss_pred             hhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHHhcC---
Confidence            864322   22334569999999999999999999999999999999999999997543221      111111000   


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                          ........+.+...+.+++.+||+.||++|||+.|++++-
T Consensus       233 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  272 (293)
T d1jksa_         233 ----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP  272 (293)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             ----CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence                0000011122345688999999999999999999998753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=399.52  Aligned_cols=255  Identities=26%  Similarity=0.433  Sum_probs=205.0

Q ss_pred             ceeeeecCcEEEEEEEEcCc---ceEEEEEeCCC-CChhhHHHHHHHHHHHhhccccceeeEEEEEee-cCEEEEEEeec
Q 036624          537 ALLLGVGGFGKVYRGEIDGA---TTKVAIKRGNP-LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE-NCEMILVYDYM  611 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~---~~~VavK~~~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~  611 (893)
                      .++||+|+||+||+|.+...   ...||||+++. ......++|.+|+++|++++||||++++|+|.+ ....++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            35899999999999998543   24689998764 456667889999999999999999999999876 46899999999


Q ss_pred             cCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC--
Q 036624          612 AYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH--  689 (893)
Q Consensus       612 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~--  689 (893)
                      ++|+|.+++... ...+++..+++++.|+|+||.|||   ..+|+||||||+||||++++.+||+|||+++.......  
T Consensus       112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            999999988754 345889999999999999999999   58999999999999999999999999999986543221  


Q ss_pred             ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccccc
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYLK  769 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~  769 (893)
                      ........||+.|+|||.+.+..++.++||||||++||||+||+.|+.......  .+..+.   ....          .
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i---~~g~----------~  252 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL---LQGR----------R  252 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTTC----------C
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH---HcCC----------C
Confidence            122334568999999999999999999999999999999999888875432211  111111   1110          1


Q ss_pred             CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          770 GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       770 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ...+..++..+.+++.+||+.||++||+|.||+++|+.+++
T Consensus       253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            12234456778999999999999999999999999997764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-46  Score=401.28  Aligned_cols=261  Identities=27%  Similarity=0.444  Sum_probs=209.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcc-------eEEEEEeCCCC-ChhhHHHHHHHHHHHhhc-cccceeeEEEEEeecC
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGAT-------TKVAIKRGNPL-SEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEENC  602 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-------~~VavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~  602 (893)
                      ++|+..+.||+|+||.||+|+..+..       ..||||+++.. ......++.+|...+.++ +|||||+++++|.+.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            57788899999999999999875543       46999988654 345668899999999998 7999999999999999


Q ss_pred             EEEEEEeeccCCCHHHHHhhCC--------------CCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC
Q 036624          603 EMILVYDYMAYGTLREHLYKTQ--------------KPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD  668 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld  668 (893)
                      ..++|||||++|+|.++|....              ...+++.+++.++.|++.||+|||   +.+||||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence            9999999999999999997543              245899999999999999999999   58999999999999999


Q ss_pred             CCCceeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhh-CCCCCCCCCccccccH
Q 036624          669 EKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC-ARPALNPTLPKEQVSL  747 (893)
Q Consensus       669 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  747 (893)
                      .++.+||+|||+++...............||+.|+|||++.++.++.|+|||||||++|||++ |.+||.......   +
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---~  246 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L  246 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---H
Confidence            999999999999986544333333445678999999999999999999999999999999998 677775433211   1


Q ss_pred             HHHHHHhhcccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhh
Q 036624          748 AEWAAHCHKKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQL  811 (893)
Q Consensus       748 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~~  811 (893)
                      .+.    ...         ......+..++..+.+++.+||+.+|++|||+.||++.|+.++.+
T Consensus       247 ~~~----i~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         247 FKL----LKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HHH----HHT---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH----HHc---------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            111    111         111223344556789999999999999999999999999987654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=400.00  Aligned_cols=267  Identities=24%  Similarity=0.332  Sum_probs=199.8

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecC----EEEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC----EMILVY  608 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~  608 (893)
                      +|...++||+|+||+||+|++.+  ..||||+++.... ....+..|+..+.+++|||||+++|+|.+.+    .++|||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~g--~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETT--EEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECC--EEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            45667899999999999999864  6899998764322 1222334555566789999999999997653    689999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcC-----CCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG-----AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      |||++|+|.++|++.   .++|..+++++.|+|.||+|||+.     .+++||||||||+||||++++.+||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999999765   499999999999999999999953     247999999999999999999999999999986


Q ss_pred             CCCCCC--ccceeeeccCcCccChHhhhhcC------CCCcchhhhHHHHHHHHhhCCCCCCCCCccc---------ccc
Q 036624          684 GPTLDH--THVSTVVKGSFGYLDPEYFRRQQ------LTEKSDVYSFGVVLFEILCARPALNPTLPKE---------QVS  746 (893)
Q Consensus       684 ~~~~~~--~~~~~~~~gt~~y~APE~~~~~~------~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~---------~~~  746 (893)
                      ......  ........||+.|+|||++.+..      ++.|+|||||||+||||+||..|+.......         ...
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            433221  12234567999999999987643      6779999999999999999998875322111         011


Q ss_pred             HHHHHHHhhcccchhhhccccccCC-CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          747 LAEWAAHCHKKGILEQIMDPYLKGK-IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       747 l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      ........     ..+..+|.+... ...+++..+.+++.+||+.||++||||.||+++|+++.+
T Consensus       238 ~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         238 VEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            11111111     111122222111 133567789999999999999999999999999987664

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.9e-45  Score=399.15  Aligned_cols=248  Identities=24%  Similarity=0.329  Sum_probs=207.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||+||+|+++.+++.||||+++..   .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5789999999999999999999888899999987532   2234577999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |||++|+|..++....  .+++..+..++.|++.||+|||   +.+||||||||+||||+.++.+||+|||+|+..... 
T Consensus        84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            9999999999887654  4888999999999999999999   589999999999999999999999999999865322 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                          ....+||+.|||||++.+..++.++|||||||+||||++|+.||......+      ....         +.... 
T Consensus       158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~---------i~~~~-  217 (316)
T d1fota_         158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEK---------ILNAE-  217 (316)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH---------HHHCC-
T ss_pred             ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------HHHH---------HHcCC-
Confidence                234679999999999999999999999999999999999999997543211      1111         11111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                       ..+++.....+.+++.+||+.||.+||     |+.+++++-.
T Consensus       218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~  259 (316)
T d1fota_         218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW  259 (316)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence             122334456788999999999999996     8999987643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=402.31  Aligned_cols=251  Identities=24%  Similarity=0.292  Sum_probs=209.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||+||+|+.+.+++.||||+++..   .....+.+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999999888899999987532   2234577899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      |||++|+|.+++.+..  .+++..+..++.|++.||+|||   +.+||||||||+||||++++.+||+|||+|+......
T Consensus        85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            9999999999997754  4899999999999999999999   5899999999999999999999999999998653322


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                        ......+||+.|||||++.+..|+.++|||||||+||||++|++||......+      ....         +.... 
T Consensus       160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~---------i~~~~-  221 (337)
T d1o6la_         160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFEL---------ILMEE-  221 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH---------HHHCC-
T ss_pred             --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHH---------HhcCC-
Confidence              22345679999999999999999999999999999999999999997643221      1111         11111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L~  806 (893)
                       ..++......+.+++.+||+.||.+||+     +.|++++-.
T Consensus       222 -~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~  263 (337)
T d1o6la_         222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             -CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence             1223344566789999999999999995     788877543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=398.99  Aligned_cols=260  Identities=24%  Similarity=0.373  Sum_probs=212.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcC-----cceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDG-----ATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      ++|+..++||+|+||+||+|.+.+     ....||||+++.. ..+....|.+|+.++++++|||||+++|+|...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            577888999999999999998753     2367999988653 4455667999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHhhC--------CCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEec
Q 036624          606 LVYDYMAYGTLREHLYKT--------QKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSD  677 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~D  677 (893)
                      +|||||++|+|.++++..        ....+++..+.+++.|+|+||.|||   ..+|+||||||+||||++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence            999999999999988643        2245799999999999999999999   48999999999999999999999999


Q ss_pred             ccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCC-CCCCCCCccccccHHHHHHHhhc
Q 036624          678 FGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR-PALNPTLPKEQVSLAEWAAHCHK  756 (893)
Q Consensus       678 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~  756 (893)
                      ||+++...............||+.|+|||.+.++.++.++|||||||+||||+||+ +|+.....      .++...   
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~~---  247 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRF---  247 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHH---
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHHH---
Confidence            99998654433333344556899999999999999999999999999999999985 56643321      222222   


Q ss_pred             ccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          757 KGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       757 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                            +.+.. ....+..++..+.+++.+||+.+|++||||.+|+++|++.++
T Consensus       248 ------i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         248 ------VMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             ------HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ------HHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                  12211 122334566789999999999999999999999999986543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.3e-45  Score=390.08  Aligned_cols=260  Identities=24%  Similarity=0.342  Sum_probs=203.5

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecC----E
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC----E  603 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~  603 (893)
                      .++|+..+.||+|+||+||+|++...++.||||+++..   .....+.|.+|+++|++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36789999999999999999999888899999987643   3345567999999999999999999999987653    4


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      .+|||||+++|+|.+++...+  ++++.++..|+.|++.||+|||   +.+||||||||+||||+.++..+|+|||+++.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence            799999999999999887654  4999999999999999999999   58999999999999999999999999999875


Q ss_pred             CCCC-CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhh
Q 036624          684 GPTL-DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQ  762 (893)
Q Consensus       684 ~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  762 (893)
                      .... ..........||+.|||||++.+..++.++|||||||+||||+||+.||....+.+      ........+.   
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~---  231 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDP---  231 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCC---
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCC---
Confidence            4322 12223445679999999999999999999999999999999999999997543221      1111111111   


Q ss_pred             hccccccCCCChHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHH
Q 036624          763 IMDPYLKGKIAPECFKKFAETAMKCVSDQGIERP-SMGDVLWNLEFA  808 (893)
Q Consensus       763 i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-tm~evl~~L~~~  808 (893)
                          .......+..+..+.+++.+||+.||++|| |+.++++.|...
T Consensus       232 ----~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         232 ----IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             ----CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ----CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                111112233456788999999999999999 899998888754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.4e-44  Score=384.42  Aligned_cols=252  Identities=23%  Similarity=0.272  Sum_probs=205.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---------hhhHHHHHHHHHHHhhcc-ccceeeEEEEEeec
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---------EQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEEN  601 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---------~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~  601 (893)
                      ++|+..+.||+|+||+||+|+...+++.||||++....         ....+.+.+|+.+|++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57899999999999999999998888999999864321         122346889999999997 99999999999999


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      +..+||||||++|+|.++|....  ++++.++..++.||++||+|||   +.+|+||||||+||||+.++.+||+|||++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence            99999999999999999997654  5999999999999999999999   589999999999999999999999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhh------cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH  755 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  755 (893)
                      +.....   ...+...||+.|+|||++.+      ..++.++||||+||+||||++|+.||........      .....
T Consensus       158 ~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~------~~~i~  228 (277)
T d1phka_         158 CQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------LRMIM  228 (277)
T ss_dssp             EECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH
T ss_pred             eEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH------HHHHH
Confidence            864332   22344679999999999974      3468899999999999999999999975432110      11111


Q ss_pred             cccchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          756 KKGILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       756 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                       .+.      ........+.+..++.+++.+||+.+|++|||+.||+++
T Consensus       229 -~~~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         229 -SGN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             -HTC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -hCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             110      011112223455678899999999999999999999865

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-44  Score=398.13  Aligned_cols=248  Identities=20%  Similarity=0.279  Sum_probs=207.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  608 (893)
                      ++|+..++||+|+||+||+|+++.+++.||||++...   .....+.+.+|+++|++++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999999888899999986532   1234567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~  688 (893)
                      ||+.+|+|..++.+..  .+++..+..++.||+.||+|||   +.+||||||||+||||+.++.+||+|||+|+..... 
T Consensus       121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            9999999999997654  4999999999999999999999   589999999999999999999999999999864321 


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                          .....||+.|||||++.+..++.++|||||||+||||++|+.||.......      ....         +.... 
T Consensus       195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~---------i~~~~-  254 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEK---------IVSGK-  254 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH---------HHHCC-
T ss_pred             ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------HHHH---------HhcCC-
Confidence                234679999999999999999999999999999999999999997543211      1111         11111 


Q ss_pred             cCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 036624          769 KGKIAPECFKKFAETAMKCVSDQGIERP-----SMGDVLWNLE  806 (893)
Q Consensus       769 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----tm~evl~~L~  806 (893)
                       ...+..+...+.+++.+||+.||.+|+     |+.|++++-.
T Consensus       255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~  296 (350)
T d1rdqe_         255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence             112334456788999999999999994     8999987644

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.6e-44  Score=395.92  Aligned_cols=252  Identities=21%  Similarity=0.264  Sum_probs=201.7

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC---hhhHHHHHH---HHHHHhhccccceeeEEEEEeecCEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS---EQGVHEFQT---EIEMLSKLRHRHLVSLIGYCEENCEMI  605 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~---~~~~~~f~~---E~~~l~~l~H~niv~l~g~~~~~~~~~  605 (893)
                      ++|+..++||+|+||+||+|+...+++.||||++....   ......+.+   |+.+++.++|||||++++++.+.+.++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999998888999999865311   112233444   466777788999999999999999999


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      ||||||++|+|.++|.+..  .+++..+..++.||+.||+|||   +.+||||||||+||||++++.+||+|||+|+...
T Consensus        84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            9999999999999997654  4889999999999999999999   5899999999999999999999999999998643


Q ss_pred             CCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhc
Q 036624          686 TLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIM  764 (893)
Q Consensus       686 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~  764 (893)
                      ..    ......||+.|+|||++.. ..++.++|||||||+||||++|+.||.........   ....         ...
T Consensus       159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~~---------~~~  222 (364)
T d1omwa3         159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDR---------MTL  222 (364)
T ss_dssp             SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHHH---------HSS
T ss_pred             CC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH---------hcc
Confidence            22    2234579999999999975 56899999999999999999999999764432211   1111         011


Q ss_pred             cccccCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 036624          765 DPYLKGKIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNLE  806 (893)
Q Consensus       765 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L~  806 (893)
                      ..  ....+......+.+++.+||+.||++|||     +.|++++-.
T Consensus       223 ~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~  267 (364)
T d1omwa3         223 TM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  267 (364)
T ss_dssp             SC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred             cC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence            11  11223344567889999999999999999     688886643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-44  Score=390.07  Aligned_cols=252  Identities=17%  Similarity=0.245  Sum_probs=208.4

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .++|+..+.||+|+||+||+|.+..+++.||||.++... .....+.+|+++|++++|||||++++++.+.+.++|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467899999999999999999999888999999887543 3446688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC--CceeEecccccccCCCCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK--WVAKVSDFGLSKTGPTLD  688 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~--~~~kl~DFGla~~~~~~~  688 (893)
                      |++|+|.++|.... ..+++.++..|+.||+.||+|||   +.+|+||||||+|||++.+  ..+||+|||+++....  
T Consensus        83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--  156 (321)
T d1tkia_          83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--  156 (321)
T ss_dssp             CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence            99999999996543 35999999999999999999999   5899999999999999854  5899999999986432  


Q ss_pred             CccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhccccc
Q 036624          689 HTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPYL  768 (893)
Q Consensus       689 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l  768 (893)
                       ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+      ....         +.....
T Consensus       157 -~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~---------i~~~~~  220 (321)
T d1tkia_         157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIEN---------IMNAEY  220 (321)
T ss_dssp             -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH---------HHHTCC
T ss_pred             -CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHH---------HHhCCC
Confidence             222345679999999999999999999999999999999999999997543221      1111         111100


Q ss_pred             cCCCCh----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 036624          769 KGKIAP----ECFKKFAETAMKCVSDQGIERPSMGDVLWNLEF  807 (893)
Q Consensus       769 ~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~  807 (893)
                        .++.    .+...+.+++.+||+.||++|||+.|++++-..
T Consensus       221 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  261 (321)
T d1tkia_         221 --TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             --CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             --CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence              1111    234567899999999999999999999987543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=394.53  Aligned_cols=249  Identities=24%  Similarity=0.338  Sum_probs=204.8

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC---ChhhHHHHHHHHHHHh-hccccceeeEEEEEeecCEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL---SEQGVHEFQTEIEMLS-KLRHRHLVSLIGYCEENCEMILV  607 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~---~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV  607 (893)
                      ++|+..++||+|+||+||+|++..+++.||||+++..   .....+.+..|..++. .++|||||++++++.+++..+||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5788999999999999999999988899999987532   1233456777777765 68999999999999999999999


Q ss_pred             EeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCC
Q 036624          608 YDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       608 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~  687 (893)
                      ||||++|+|.+++....  .+++.++..++.||+.||+|||+   .+||||||||+|||+++++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            99999999999997654  48999999999999999999994   89999999999999999999999999999864332


Q ss_pred             CCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcccc
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMDPY  767 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~  767 (893)
                        ....+...||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +   .... ..+      .+ 
T Consensus       157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~---~~~i-~~~------~~-  220 (320)
T d1xjda_         157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---L---FHSI-RMD------NP-  220 (320)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHH-HHC------CC-
T ss_pred             --cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---H---HHHH-HcC------CC-
Confidence              222344679999999999999999999999999999999999999997543321   1   1111 010      11 


Q ss_pred             ccCCCChHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 036624          768 LKGKIAPECFKKFAETAMKCVSDQGIERPSMG-DVLWN  804 (893)
Q Consensus       768 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~-evl~~  804 (893)
                         .++..+...+.+++.+||+.||++||++. |++++
T Consensus       221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence               22333456688999999999999999995 77654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=393.78  Aligned_cols=254  Identities=19%  Similarity=0.276  Sum_probs=201.9

Q ss_pred             hcCCccce-eeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhc-cccceeeEEEEEee----cCEE
Q 036624          531 TNNFDEAL-LLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKL-RHRHLVSLIGYCEE----NCEM  604 (893)
Q Consensus       531 t~~f~~~~-~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~~  604 (893)
                      .++|.+.. +||+|+||+||+|++..+++.||||+++.     ...+.+|++++.++ +|||||++++++.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35788764 69999999999999988889999998753     24577899987665 89999999999865    4678


Q ss_pred             EEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC---CCceeEeccccc
Q 036624          605 ILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE---KWVAKVSDFGLS  681 (893)
Q Consensus       605 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~---~~~~kl~DFGla  681 (893)
                      +||||||+||+|.++|.+.....+++.++..|+.|++.||+|||   +.+|+||||||+|||+++   ++.+||+|||++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999998765567999999999999999999999   589999999999999985   467999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      +......   ......||+.|||||++.+..|+.++|||||||+||||+||+.||.........   ...        ..
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~--------~~  227 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGM--------KT  227 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHH--------HH
Confidence            8643322   234467999999999999999999999999999999999999999654322111   000        01


Q ss_pred             hhccccc--cCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          762 QIMDPYL--KGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       762 ~i~d~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .+.....  ...........+.+++.+||+.||++|||+.|++++-.
T Consensus       228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  274 (335)
T d2ozaa1         228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  274 (335)
T ss_dssp             CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred             HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence            1111111  00111234567899999999999999999999998643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-44  Score=385.67  Aligned_cols=259  Identities=24%  Similarity=0.244  Sum_probs=195.8

Q ss_pred             cceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChh-----hHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEee
Q 036624          536 EALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQ-----GVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      .+++||+|+||+||+|++..+++.||||+++.....     ..+.+.+|+.+|++++|||||++++++...+..+|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            467899999999999999888899999987643222     124688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCCc
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT  690 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~  690 (893)
                      +.++++...+..  ...+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++......  
T Consensus        82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--  154 (299)
T d1ua2a_          82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--  154 (299)
T ss_dssp             CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred             hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc--
Confidence            998877766543  345899999999999999999999   5899999999999999999999999999998643322  


Q ss_pred             cceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchhhhcc----
Q 036624          691 HVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILEQIMD----  765 (893)
Q Consensus       691 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d----  765 (893)
                      .......||+.|+|||++... .++.++|||||||++|||++|++||......+.  +....... .........+    
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l~~i~~~~-~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETL-GTPTEEQWPDMCSL  231 (299)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHH-CCCCTTTSSSTTSS
T ss_pred             ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--HHHHHHhc-CCCChhhccchhcc
Confidence            222345699999999998754 579999999999999999999999975543221  11111110 0000000000    


Q ss_pred             --c-cc--cCCC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          766 --P-YL--KGKI-----APECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       766 --~-~l--~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                        . ..  ....     .+.....+.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence              0 00  0000     11234568899999999999999999999865

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-43  Score=380.84  Aligned_cols=265  Identities=20%  Similarity=0.285  Sum_probs=202.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..++||+|+||+||+|++...++.||||+++...  ....+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999998877899999875432  2335679999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+.+ .+..++.......+++..+..++.|++.||+|||   +.+||||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  156 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence            9974 5555665555567999999999999999999999   5889999999999999999999999999998643322 


Q ss_pred             ccceeeeccCcCccChHhhhhcC-CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh--cccchhhhc-c
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH--KKGILEQIM-D  765 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--~~~~~~~i~-d  765 (893)
                       .......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+.  +........  .+.....+. .
T Consensus       157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred             -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhccccccc
Confidence             2233456999999999987765 58899999999999999999999975533221  111111000  000000000 0


Q ss_pred             ccccCC-----------CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          766 PYLKGK-----------IAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       766 ~~l~~~-----------~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      +.....           ..+.....+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000000           011223567889999999999999999999876

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-44  Score=379.84  Aligned_cols=242  Identities=21%  Similarity=0.318  Sum_probs=197.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC------hhhHHHHHHHHHHHhhcc--ccceeeEEEEEeecCE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS------EQGVHEFQTEIEMLSKLR--HRHLVSLIGYCEENCE  603 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~------~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~  603 (893)
                      ++|+..++||+|+||+||+|+...+++.||||++....      ......+.+|+.+|++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57899999999999999999998888999999764321      112234678999999996  8999999999999999


Q ss_pred             EEEEEeeccC-CCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-CCceeEeccccc
Q 036624          604 MILVYDYMAY-GTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-KWVAKVSDFGLS  681 (893)
Q Consensus       604 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-~~~~kl~DFGla  681 (893)
                      .++||||+.+ +++.+++....  .+++..+..++.|+++||+|||   +.+||||||||+|||++. ++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            9999999975 67888876543  4999999999999999999999   589999999999999985 479999999999


Q ss_pred             ccCCCCCCccceeeeccCcCccChHhhhhcCC-CCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          682 KTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       682 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      +.....    ..+...||+.|+|||++.+..+ +.++|||||||+||||++|+.||.....            ....   
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~~---  219 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRG---  219 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHC---
T ss_pred             eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hhhc---
Confidence            864321    2334679999999999988765 5779999999999999999999953210            0000   


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                          ..    .++...+..+.+++.+||+.||++|||+.|++++-
T Consensus       220 ----~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp  256 (273)
T d1xwsa_         220 ----QV----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP  256 (273)
T ss_dssp             ----CC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             ----cc----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence                00    11223345688899999999999999999998763

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.7e-42  Score=372.99  Aligned_cols=263  Identities=17%  Similarity=0.223  Sum_probs=199.5

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC--hhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS--EQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..++||+|+||+||+|+++.+ +.||||+++...  ....+.+.+|+.+|++++||||+++++++...+..++++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTS-CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCC-CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            5789999999999999999998754 789999876542  2335789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      |+.++.+..+....  ..+++..+..|+.|++.||+|||   +.+||||||||+||||+.++.+||+|||++....... 
T Consensus        81 ~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-  154 (286)
T d1ob3a_          81 HLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (286)
T ss_dssp             CCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             eehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence            99877766665433  45999999999999999999999   4899999999999999999999999999987643321 


Q ss_pred             ccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc--ccc---hhhh
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK--KGI---LEQI  763 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~---~~~i  763 (893)
                       .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+.  +.........  ...   ..+.
T Consensus       155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred             -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchhhh
Confidence             122334589999999999754 579999999999999999999999976543221  1111110000  000   0000


Q ss_pred             ---------ccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          764 ---------MDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       764 ---------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                               ..+.......+.....+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     00000011122344678899999999999999999999865

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=375.78  Aligned_cols=266  Identities=22%  Similarity=0.306  Sum_probs=198.7

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcC-cceEEEEEeCCCC--ChhhHHHHHHHHHHHhhc---cccceeeEEEEEee----
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDG-ATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKL---RHRHLVSLIGYCEE----  600 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~-~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~----  600 (893)
                      .++|+..++||+|+||+||+|++.. +++.||||+++..  .......+.+|+.+|+.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            4689999999999999999999854 4577999976432  222233466788877766   79999999999853    


Q ss_pred             -cCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccc
Q 036624          601 -NCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG  679 (893)
Q Consensus       601 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFG  679 (893)
                       ....+++|||+.++.+.... ......+++..+..++.|++.||+|||   +.+||||||||+|||+++++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence             35789999999977765444 344456999999999999999999999   5899999999999999999999999999


Q ss_pred             ccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhc--c
Q 036624          680 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHK--K  757 (893)
Q Consensus       680 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~  757 (893)
                      +++....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+.  +.........  .
T Consensus       162 ~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~  236 (305)
T d1blxa_         162 LARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGE  236 (305)
T ss_dssp             SCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCG
T ss_pred             hhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCch
Confidence            9886432   2233456799999999999999999999999999999999999999976543221  1111111000  0


Q ss_pred             cch-------hhhcc---ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          758 GIL-------EQIMD---PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       758 ~~~-------~~i~d---~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ...       .....   ......+.......+.+|+.+||+.||++|||+.|++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp  294 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  294 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence            000       00000   0000112223445678899999999999999999998763

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1e-40  Score=359.99  Aligned_cols=263  Identities=16%  Similarity=0.152  Sum_probs=207.6

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccc-cceeeEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRH-RHLVSLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..++||+|+||+||+|++...++.||||.+....  ....+.+|+++++.++| +|++.+++++......++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57899999999999999999998888999999864432  22457889999999975 8999999999999999999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECC-----CCceeEecccccccCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDE-----KWVAKVSDFGLSKTGP  685 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~-----~~~~kl~DFGla~~~~  685 (893)
                      + +++|.+++.... ..+++.++..++.|++.||+|||   +.+||||||||+|||++.     ++.+||+|||+|+...
T Consensus        83 ~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          83 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             c-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            9 589999886554 35999999999999999999999   589999999999999974     5689999999998643


Q ss_pred             CCCC-----ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccch
Q 036624          686 TLDH-----THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGIL  760 (893)
Q Consensus       686 ~~~~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  760 (893)
                      ....     ........||+.|||||++.+..++.++|||||||++|||++|+.||........................
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            2111     12233567999999999999999999999999999999999999999765433222111111111000011


Q ss_pred             hhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          761 EQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       761 ~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                      .+         ....++.++.+++..|++.+|++||++..+.+.|+++++
T Consensus       238 ~~---------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         238 RE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             HH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HH---------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            11         112344668889999999999999999999988887664

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.3e-41  Score=361.70  Aligned_cols=262  Identities=17%  Similarity=0.189  Sum_probs=199.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcccccee-eEEEEEeecCEEEEEEee
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV-SLIGYCEENCEMILVYDY  610 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~  610 (893)
                      ++|+..++||+|+||+||+|++..+++.||||.......  .+++..|++++++++|+|++ .+.++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            468999999999999999999988889999997654322  24578999999999877655 555566788889999999


Q ss_pred             ccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEEC---CCCceeEecccccccCCCC
Q 036624          611 MAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLD---EKWVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       611 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld---~~~~~kl~DFGla~~~~~~  687 (893)
                      +. ++|...+.... ..+++..++.++.|++.||+|||   +.+||||||||+|||++   .+..+||+|||+|+.....
T Consensus        85 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          85 LG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             cC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            95 66766665433 45999999999999999999999   48999999999999985   4567999999999864322


Q ss_pred             CC-----ccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHH-HHHHHhhcccchh
Q 036624          688 DH-----THVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA-EWAAHCHKKGILE  761 (893)
Q Consensus       688 ~~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~~~~~~~~~~~  761 (893)
                      ..     ........||+.|||||++.+..++.++|||||||++|||++|+.||............ .+..... .... 
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~-  237 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPI-  237 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-HSCH-
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-CCCh-
Confidence            11     12234567999999999999999999999999999999999999999765433222111 1110000 0000 


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLEFALQ  810 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~~~~~  810 (893)
                          +    .....++.++.+++.+||+.+|++||++.++.+.|+....
T Consensus       238 ----~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         238 ----E----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             ----H----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ----h----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence                0    1122345678899999999999999999999988886653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-41  Score=368.73  Aligned_cols=270  Identities=20%  Similarity=0.259  Sum_probs=198.0

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEee--------c
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE--------N  601 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------~  601 (893)
                      ++|+..++||+|+||+||+|++...++.||||++...  .....+++.+|+++|++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6788999999999999999999888899999986432  33445678999999999999999999999854        3


Q ss_pred             CEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccc
Q 036624          602 CEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLS  681 (893)
Q Consensus       602 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla  681 (893)
                      ...++||||+.++.+.....  ....++...+..++.|++.||+|||   +.+|+||||||+||||+.++.+||+|||++
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            45899999999777765543  3345889999999999999999999   589999999999999999999999999999


Q ss_pred             ccCCCCCC--ccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhccc
Q 036624          682 KTGPTLDH--THVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKG  758 (893)
Q Consensus       682 ~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  758 (893)
                      +.......  ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......................
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            75432221  1122335699999999999765 68999999999999999999999997644322211111110000000


Q ss_pred             chhhh--------ccccccCCCCh-H------HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          759 ILEQI--------MDPYLKGKIAP-E------CFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       759 ~~~~i--------~d~~l~~~~~~-~------~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                      .....        ........... +      ....+.+|+.+||+.||++|||+.|++++-.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf  307 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  307 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence            00000        00000000000 1      1234678999999999999999999997654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=374.55  Aligned_cols=261  Identities=25%  Similarity=0.252  Sum_probs=195.2

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhccccceeeEEEEEeec------CEEEE
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN------CEMIL  606 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l  606 (893)
                      +|...++||+|+||+||+|++...++.||||++.....    .+.+|+++|++++||||+++++++...      ..++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            57788899999999999999988889999998764332    235799999999999999999998543      34799


Q ss_pred             EEeeccCCCHHHHHhh-CCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC-ceeEecccccccC
Q 036624          607 VYDYMAYGTLREHLYK-TQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW-VAKVSDFGLSKTG  684 (893)
Q Consensus       607 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~-~~kl~DFGla~~~  684 (893)
                      |||||+++.+....+. .....+++.++..++.|++.||+|||   +.+|+||||||+||||+.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999986654444332 24456999999999999999999999   58999999999999999775 8999999999864


Q ss_pred             CCCCCccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh---------
Q 036624          685 PTLDHTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC---------  754 (893)
Q Consensus       685 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~---------  754 (893)
                      ....   ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.  +.......         
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhh
Confidence            3322   1233569999999998875 5789999999999999999999999975543221  11111110         


Q ss_pred             --hcc---cchhhhccccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          755 --HKK---GILEQIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       755 --~~~---~~~~~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                        ...   ................+.....+.+|+.+||+.||++|||+.|++++-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  304 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  304 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence              000   000000000001111223456688999999999999999999998763

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-41  Score=371.40  Aligned_cols=263  Identities=21%  Similarity=0.271  Sum_probs=195.3

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeecC------
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC------  602 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------  602 (893)
                      .++|+..++||+|+||+||+|.+...++.||||+++..  .....+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            35789999999999999999999888899999987642  4455678999999999999999999999997654      


Q ss_pred             EEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          603 EMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       603 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      .++|||||+ +.+|...+...   .+++..+..++.|++.||+|||   +.+||||||||+|||++.++.+||+|||+++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence            579999999 46777766543   4999999999999999999999   5899999999999999999999999999998


Q ss_pred             cCCCCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHh-------
Q 036624          683 TGPTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHC-------  754 (893)
Q Consensus       683 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-------  754 (893)
                      ....     ..+...||+.|+|||++.+. .++.++||||+||+||||++|+.||..................       
T Consensus       170 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         170 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            6432     12345699999999998764 5789999999999999999999999765432211110000000       


Q ss_pred             -hcccchhhhc--ccccc----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          755 -HKKGILEQIM--DPYLK----GKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       755 -~~~~~~~~i~--d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                       ..........  .+...    ..........+.+|+.+||+.||++|||+.|++++-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp  302 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP  302 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence             0000000000  00000    011122345678899999999999999999999863

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-40  Score=357.50  Aligned_cols=264  Identities=18%  Similarity=0.232  Sum_probs=205.1

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEeecCEEEEEEe
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYD  609 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  609 (893)
                      ++|+..++||+|+||+||+|++..+++.||||+++.  ......+.+.+|+.+|++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            578999999999999999999988889999998643  334456789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCCCCCC
Q 036624          610 YMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDH  689 (893)
Q Consensus       610 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~  689 (893)
                      ++.+++|..++...  ..+++..+..++.|++.||+|||   +.+||||||||+|||++.++.+||+|||.++.......
T Consensus        82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eccccccccccccc--cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            99999998877654  35899999999999999999999   58999999999999999999999999999986543221


Q ss_pred             ccceeeeccCcCccChHhhhhcC-CCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcc---cc---hhh
Q 036624          690 THVSTVVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKK---GI---LEQ  762 (893)
Q Consensus       690 ~~~~~~~~gt~~y~APE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~---~~~  762 (893)
                        ......+++.|+|||.+.... ++.++|||||||++|||++|+.||......... +.. .......   ..   ...
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKR-IFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHH-HHHHHCCCCTTTCTTGGG
T ss_pred             --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH-HHH-HHhhcCCCChhhhhhhhh
Confidence              223345788999999988665 699999999999999999999997543322111 111 1110000   00   000


Q ss_pred             hccc---------cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          763 IMDP---------YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       763 i~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                      ..+.         .......+.....+.+++.+||+.||.+|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000         00111222344568899999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-41  Score=371.93  Aligned_cols=268  Identities=21%  Similarity=0.275  Sum_probs=198.1

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-ChhhHHHHHHHHHHHhhccccceeeEEEEEeecC----EEE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENC----EMI  605 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~  605 (893)
                      +.+|+..++||+|+||+||+|.+..+++.||||++... .....+.+++|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35688999999999999999999888899999987654 3445678999999999999999999999996543    234


Q ss_pred             EEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEecccccccCC
Q 036624          606 LVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGP  685 (893)
Q Consensus       606 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~~~  685 (893)
                      ++++|+.+|+|.+++...   .+++..+..++.|++.||+|||   +.+||||||||+||||++++.+||+|||+++...
T Consensus        87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            445667789999999654   4999999999999999999999   5899999999999999999999999999997643


Q ss_pred             CCC-CccceeeeccCcCccChHhhhh-cCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccc----
Q 036624          686 TLD-HTHVSTVVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGI----  759 (893)
Q Consensus       686 ~~~-~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----  759 (893)
                      ... .........||+.|+|||++.. ..++.++||||+||++|||++|+.||......+................    
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            321 1222345679999999999854 5678999999999999999999999976543322211111100000000    


Q ss_pred             ----hhh-h-ccccccCC----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 036624          760 ----LEQ-I-MDPYLKGK----IAPECFKKFAETAMKCVSDQGIERPSMGDVLWN  804 (893)
Q Consensus       760 ----~~~-i-~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~  804 (893)
                          ... . ..+.....    ..+....++.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                000 0 00000000    011223467899999999999999999999976

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-40  Score=362.97  Aligned_cols=256  Identities=24%  Similarity=0.302  Sum_probs=203.2

Q ss_pred             cCCccceeeeecCcEEEEEEEE---cCcceEEEEEeCCCC----ChhhHHHHHHHHHHHhhccc-cceeeEEEEEeecCE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEI---DGATTKVAIKRGNPL----SEQGVHEFQTEIEMLSKLRH-RHLVSLIGYCEENCE  603 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~---~~~~~~VavK~~~~~----~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~  603 (893)
                      ++|+..++||+|+||+||+|+.   +..++.||||.++..    .....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999987   334678999987532    12234568899999999977 899999999999999


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      .++||||+.+|+|.+++.....  ++...+..++.|++.||+|||   +.+||||||||+||||+.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            9999999999999999976653  778899999999999999999   58999999999999999999999999999986


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhhc--CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhhcccchh
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCHKKGILE  761 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  761 (893)
                      ...... .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.........  ......        
T Consensus       179 ~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~--------  247 (322)
T d1vzoa_         179 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRR--------  247 (322)
T ss_dssp             CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHH--------
T ss_pred             hccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHh--------
Confidence            433222 223345799999999999764  4788999999999999999999999765433211  111111        


Q ss_pred             hhccccccCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 036624          762 QIMDPYLKGKIAPECFKKFAETAMKCVSDQGIERPS-----MGDVLWNLE  806 (893)
Q Consensus       762 ~i~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----m~evl~~L~  806 (893)
                       ....  ...++..+...+.+++.+||+.||++||+     +.|++++-.
T Consensus       248 -~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf  294 (322)
T d1vzoa_         248 -ILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  294 (322)
T ss_dssp             -HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             -cccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence             0111  11233456678899999999999999994     788876543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-39  Score=357.27  Aligned_cols=260  Identities=17%  Similarity=0.223  Sum_probs=198.9

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEee--cCEEEEEE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEE--NCEMILVY  608 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~  608 (893)
                      ++|+..++||+|+||+||+|++..+++.||||+++...   .+.+.+|+++|++++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999998888999999987543   457889999999995 9999999999874  35689999


Q ss_pred             eeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCC-CceeEecccccccCCCC
Q 036624          609 DYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEK-WVAKVSDFGLSKTGPTL  687 (893)
Q Consensus       609 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~-~~~kl~DFGla~~~~~~  687 (893)
                      |||.+++|....     ..+++..+..++.||+.||+|||   +.+||||||||+|||++.+ ..+||+|||+|+.....
T Consensus       112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            999999987653     24899999999999999999999   5899999999999999865 46999999999864332


Q ss_pred             CCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCcccccc-----------HHHHHHHhh
Q 036624          688 DHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS-----------LAEWAAHCH  755 (893)
Q Consensus       688 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-----------l~~~~~~~~  755 (893)
                      .   ......||+.|+|||.+.+. .++.++||||+||+++||++|+.||..........           ..+|.....
T Consensus       184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         184 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             C---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            1   23345689999999998875 47999999999999999999999997654322110           001111000


Q ss_pred             ccc--chhhhcc--------ccccCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 036624          756 KKG--ILEQIMD--------PYLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDVLWNL  805 (893)
Q Consensus       756 ~~~--~~~~i~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L  805 (893)
                      ...  .......        ..............+.+|+.+||+.||++|||+.|++++-
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp  320 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP  320 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            000  0000000        0011111123345688999999999999999999998754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-39  Score=360.63  Aligned_cols=264  Identities=20%  Similarity=0.216  Sum_probs=193.3

Q ss_pred             cCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCC--CChhhHHHHHHHHHHHhhccccceeeEEEEEee------cCE
Q 036624          532 NNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNP--LSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEE------NCE  603 (893)
Q Consensus       532 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~  603 (893)
                      ++|+..++||+|+||+||+|++..+++.||||++..  .+....+.+.+|+.+|++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            579999999999999999999998889999998753  344556779999999999999999999999853      468


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      +++|||||.++ |.+.+.    ..+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence            89999999755 444443    24899999999999999999999   48999999999999999999999999999876


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHH---------HHH---
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLA---------EWA---  751 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~---  751 (893)
                      ...   ....+...||+.|+|||++.+..++.++||||+||+++||++|+.||............         ++.   
T Consensus       169 ~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             ccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            432   22334567999999999999999999999999999999999999999754322111000         000   


Q ss_pred             ----HHhhcc-c-----chhhhccccccCC---CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          752 ----AHCHKK-G-----ILEQIMDPYLKGK---IAPECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       752 ----~~~~~~-~-----~~~~i~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                          ...... .     .............   ........+.+|+.+||+.||++|||+.|++++-.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw  313 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY  313 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence                000000 0     0011111111111   11234567899999999999999999999998754

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=360.72  Aligned_cols=265  Identities=18%  Similarity=0.225  Sum_probs=196.6

Q ss_pred             hcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCC--ChhhHHHHHHHHHHHhhccccceeeEEEEEeec-----CE
Q 036624          531 TNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL--SEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEEN-----CE  603 (893)
Q Consensus       531 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~  603 (893)
                      .++|+..++||+|+||+||+|++...++.||||++...  +....+.+.+|+++|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            45799999999999999999999888899999987643  344566789999999999999999999998533     34


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                      .+++++|+.+|+|.+++...   ++++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence            46677788899999998543   4999999999999999999999   58999999999999999999999999999875


Q ss_pred             CCCCCCccceeeeccCcCccChHhhhhc-CCCCcchhhhHHHHHHHHhhCCCCCCCCCccccccHHHHHHHhh-------
Q 036624          684 GPTLDHTHVSTVVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVSLAEWAAHCH-------  755 (893)
Q Consensus       684 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-------  755 (893)
                      ...     ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...................       
T Consensus       171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            322     22345689999999987765 46899999999999999999999997653322111100000000       


Q ss_pred             -cccchhhhcccccc-CCC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 036624          756 -KKGILEQIMDPYLK-GKI-----APECFKKFAETAMKCVSDQGIERPSMGDVLWNLE  806 (893)
Q Consensus       756 -~~~~~~~i~d~~l~-~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPtm~evl~~L~  806 (893)
                       .............. ...     .......+.+|+.+||+.||++|||+.|++++-.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~  303 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  303 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence             00000000000000 000     0122356788999999999999999999997643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.1e-35  Score=325.17  Aligned_cols=265  Identities=18%  Similarity=0.208  Sum_probs=194.5

Q ss_pred             CCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-----------ccceeeEEEEEeec
Q 036624          533 NFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-----------HRHLVSLIGYCEEN  601 (893)
Q Consensus       533 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~~  601 (893)
                      +|+..++||+|+||+||+|+...+++.||||+++.. ....+.+.+|+.++++++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            488999999999999999999888899999998753 334567889999998875           57899999887543


Q ss_pred             --CEEEEEEeeccCCC-HHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCC------c
Q 036624          602 --CEMILVYDYMAYGT-LREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKW------V  672 (893)
Q Consensus       602 --~~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~------~  672 (893)
                        ...+++++++..+. ............+++..+..++.|++.||+|||+  ..+|+||||||+||||+.++      .
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence              56667777665544 3334444555678999999999999999999995  58899999999999998664      4


Q ss_pred             eeEecccccccCCCCCCccceeeeccCcCccChHhhhhcCCCCcchhhhHHHHHHHHhhCCCCCCCCCcccccc----HH
Q 036624          673 AKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPTLPKEQVS----LA  748 (893)
Q Consensus       673 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~----l~  748 (893)
                      +|++|||.++....     ......||+.|+|||++....++.++||||+||+++||++|+.||..........    +.
T Consensus       171 ~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         171 IKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            99999999875332     1234569999999999999999999999999999999999999997543221111    11


Q ss_pred             HHHHHhhc--------ccchhhhccc-------------------cccCCCChHHHHHHHHHHHHccccCCCCCCCHHHH
Q 036624          749 EWAAHCHK--------KGILEQIMDP-------------------YLKGKIAPECFKKFAETAMKCVSDQGIERPSMGDV  801 (893)
Q Consensus       749 ~~~~~~~~--------~~~~~~i~d~-------------------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPtm~ev  801 (893)
                      .....+..        ........+.                   .............+.+|+.+||+.||++|||+.|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            11111000        0000000000                   01223445677889999999999999999999999


Q ss_pred             HHHH
Q 036624          802 LWNL  805 (893)
Q Consensus       802 l~~L  805 (893)
                      +++-
T Consensus       326 L~Hp  329 (362)
T d1q8ya_         326 VNHP  329 (362)
T ss_dssp             HTCG
T ss_pred             hcCc
Confidence            8654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=2.6e-21  Score=193.46  Aligned_cols=163  Identities=15%  Similarity=0.137  Sum_probs=119.5

Q ss_pred             cceeeeecCcEEEEEEEEcCcceEEEEEeCCCCC------------------hhhHHHHHHHHHHHhhccccceeeEEEE
Q 036624          536 EALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLS------------------EQGVHEFQTEIEMLSKLRHRHLVSLIGY  597 (893)
Q Consensus       536 ~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~------------------~~~~~~f~~E~~~l~~l~H~niv~l~g~  597 (893)
                      ..++||+|+||+||+|++..+ +.||||+.+...                  ......+..|...+.++.|.+++..+++
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g-~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKF-GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTT-EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCC-CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            467999999999999998754 789999654210                  0112345678889999999999998866


Q ss_pred             EeecCEEEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcCCCCceEecCCCCCCEEECCCCceeEec
Q 036624          598 CEENCEMILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSD  677 (893)
Q Consensus       598 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NILld~~~~~kl~D  677 (893)
                      ..    .+++|||+++..+..         ++......++.|++++|+|||   +.+|+||||||+|||++++ .++|+|
T Consensus        83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred             cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence            42    279999998765432         455667789999999999999   5899999999999999965 589999


Q ss_pred             ccccccCCCCCCccceeeeccCcCccC------hHhhhhcCCCCcchhhhHHHHHH
Q 036624          678 FGLSKTGPTLDHTHVSTVVKGSFGYLD------PEYFRRQQLTEKSDVYSFGVVLF  727 (893)
Q Consensus       678 FGla~~~~~~~~~~~~~~~~gt~~y~A------PE~~~~~~~s~ksDV~S~Gvvl~  727 (893)
                      ||+|+........          .|..      .|.+ .+.|+.++|+||..--++
T Consensus       146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         146 FPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred             CCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence            9998753221110          1111      1122 467788999999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.33  E-value=9.7e-07  Score=90.37  Aligned_cols=150  Identities=15%  Similarity=0.094  Sum_probs=99.9

Q ss_pred             HHHHHHhcCCccceeeeecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcc-ccceeeEEEEEeecCE
Q 036624          525 AEIKAATNNFDEALLLGVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLR-HRHLVSLIGYCEENCE  603 (893)
Q Consensus       525 ~el~~at~~f~~~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~  603 (893)
                      .|++..-..|+..+..+-++.+.||+....+  ..+.+|+...........+.+|...+..+. +--+.+++.++...+.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~--~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGEN--ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECSS--CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeCC--CeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            3566666777766554444457899876433  457788765443334445788888888774 4345678888888889


Q ss_pred             EEEEEeeccCCCHHHHHhhCCCCCCCHHhHHHHHHHHHHhhhhhhcC---------------------------------
Q 036624          604 MILVYDYMAYGTLREHLYKTQKPPLPWKQRLEICIGAARGLHYLHTG---------------------------------  650 (893)
Q Consensus       604 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------  650 (893)
                      .++||+++++.++.+.....       .....++.++++.|..||+.                                 
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             eEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            99999999988876543211       11223344444444444420                                 


Q ss_pred             -----------------------CCCceEecCCCCCCEEECCCCceeEeccccccc
Q 036624          651 -----------------------AKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKT  683 (893)
Q Consensus       651 -----------------------~~~~ivHrDlk~~NILld~~~~~kl~DFGla~~  683 (893)
                                             ....++|+|+.+.|||++++..+-|.||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                   123478999999999999876677999997653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.65  E-value=6.1e-05  Score=76.02  Aligned_cols=74  Identities=19%  Similarity=0.132  Sum_probs=52.3

Q ss_pred             eeeecC-cEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcccc--ceeeEEEEEeecCEEEEEEeeccCCC
Q 036624          539 LLGVGG-FGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHR--HLVSLIGYCEENCEMILVYDYMAYGT  615 (893)
Q Consensus       539 ~LG~G~-fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~~~~~~lV~E~~~~gs  615 (893)
                      .+..|. -+.||+....++ ..+++|.......   ..+..|.+.++.+...  .+.++++++.+.+..++|||+++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~-~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGR-PVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTS-CCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCC-CEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            344554 367999887665 5588887554332   3467888888877533  35578888888888999999998766


Q ss_pred             H
Q 036624          616 L  616 (893)
Q Consensus       616 L  616 (893)
                      +
T Consensus        93 ~   93 (255)
T d1nd4a_          93 L   93 (255)
T ss_dssp             T
T ss_pred             c
Confidence            5

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.25  E-value=0.00034  Score=75.42  Aligned_cols=77  Identities=13%  Similarity=0.074  Sum_probs=47.7

Q ss_pred             ceeeeecCcEEEEEEEEcCcceEEEEEeCCCC-------ChhhHHHHHHHHHHHhhcc-c--cceeeEEEEEeecCEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDGATTKVAIKRGNPL-------SEQGVHEFQTEIEMLSKLR-H--RHLVSLIGYCEENCEMIL  606 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~~~~VavK~~~~~-------~~~~~~~f~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~l  606 (893)
                      .+.||.|....||+.....+++.++||...+.       ..........|.+.|+.+. +  ..+.+++.+..  ...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence            34689999999999987766678999953321       0112233456888777663 2  34556666543  44578


Q ss_pred             EEeeccCCC
Q 036624          607 VYDYMAYGT  615 (893)
Q Consensus       607 V~E~~~~gs  615 (893)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]}

class: All beta proteins
fold: Galactose-binding domain-like
superfamily: Galactose-binding domain-like
family: YxiM N-terminal domain-like
domain: Hypothetical protein YxiM
species: Bacillus subtilis [TaxId: 1423]

Probab=96.29  E-value=0.009  Score=53.88  Aligned_cols=80  Identities=18%  Similarity=0.174  Sum_probs=60.9

Q ss_pred             ceEEeeecCCceEEEEEEecCCCCCCCCCCcceEEEeCCeEEEeccChhhhhhhhccceeEEEEeeecCCCcEEEEEeeC
Q 036624           96 FTYSFPVVAGRKFVRLYFYPNSYNRLNATDALFSVSTGPYTLLKNFSVAQTAEALNYAYVIKEYAIPVDGETLNITFSPM  175 (893)
Q Consensus        96 ~cY~~p~~~g~~yvR~~F~~g~yd~~~~~~~~Fdv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~i~f~p~  175 (893)
                      +.|.++++.|.|-|+++|..        . ...++.+.|.-.+.++..         .+.-+.|.|+|..++|+|.|...
T Consensus        65 ~~f~v~vPnG~Y~Vtv~~Gd--------~-~~~~~~~eg~~~~~~~~g---------~~~~~~~~V~VtDG~L~l~ft~~  126 (146)
T d2o14a1          65 NTFNVDLPNGLYEVKVTLGN--------T-ARASVAAEGVFQVINMTG---------DGAEDTFQIPVTDGQLNLLVTEG  126 (146)
T ss_dssp             CCEEEECCSEEEEEEEEESS--------C-SEEEEEETTEEEEEEEES---------TTCEEEEEEEECSSEEEEEEEES
T ss_pred             ceEEEECCCCeEEEEEEEec--------C-CCccEEEeeEEeccccCC---------ccEEEEEEEEEECCeEEEEEecC
Confidence            68999999999999999864        1 346788988555555532         34467788999999999999765


Q ss_pred             CCCCcceeecceeeeecCc
Q 036624          176 NVSNAYAFVNGIEVMSMPD  194 (893)
Q Consensus       176 ~~~~~~~fv~~~e~~~~~~  194 (893)
                      .+.. +|-||+|||-+.++
T Consensus       127 ~~G~-~~~in~l~I~~~~d  144 (146)
T d2o14a1         127 KAGT-AFTLSALKIKKLSD  144 (146)
T ss_dssp             STTS-CCEEEEEEEEEEES
T ss_pred             CCCC-ccEEEEEEEEeccc
Confidence            5333 89999999988743

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.45  E-value=0.018  Score=61.31  Aligned_cols=74  Identities=18%  Similarity=0.165  Sum_probs=49.3

Q ss_pred             ceeeeecCcEEEEEEEEcCc-------ceEEEEEeCCCCChhhHHHHHHHHHHHhhcccccee-eEEEEEeecCEEEEEE
Q 036624          537 ALLLGVGGFGKVYRGEIDGA-------TTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV-SLIGYCEENCEMILVY  608 (893)
Q Consensus       537 ~~~LG~G~fG~Vy~g~~~~~-------~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~  608 (893)
                      .+.|+.|-.=.+|+......       ...|.+++... .. ......+|..+++.+.-.++. ++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            34687788889999887542       24566665432 22 233556899999988644555 77777753    5889


Q ss_pred             eeccCCCH
Q 036624          609 DYMAYGTL  616 (893)
Q Consensus       609 E~~~~gsL  616 (893)
                      ||+++..|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.21  E-value=0.022  Score=58.98  Aligned_cols=135  Identities=12%  Similarity=0.161  Sum_probs=76.3

Q ss_pred             EEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcccccee--eEEE-----EEeecCEEEEEEeeccCCCHH-
Q 036624          546 GKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV--SLIG-----YCEENCEMILVYDYMAYGTLR-  617 (893)
Q Consensus       546 G~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv--~l~g-----~~~~~~~~~lV~E~~~~gsL~-  617 (893)
                      -.||+...+++ ..+++|..... ....+++..|.+.+..|...++.  ..+.     ........+.++++++|..+. 
T Consensus        36 N~vy~v~~~dg-~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          36 NRVYQFQDEDR-RRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SEEEEECCTTC-CCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             ceeEEEEcCCC-CEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            47999988766 67889986543 22346678888888887533221  1111     123456678899998764421 


Q ss_pred             ----H---------HHhh----C---CCCCCCH-------------------HhH---HHHHHHHHHhhhhh-hcCCCCc
Q 036624          618 ----E---------HLYK----T---QKPPLPW-------------------KQR---LEICIGAARGLHYL-HTGAKHT  654 (893)
Q Consensus       618 ----~---------~l~~----~---~~~~l~~-------------------~~~---~~i~~~ia~gL~yL-H~~~~~~  654 (893)
                          .         .+|.    .   .+..+++                   ..+   ..++.++...+.-+ .+....+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                0         1111    0   0111221                   111   12222222222211 1223467


Q ss_pred             eEecCCCCCCEEECCCCceeEecccccccC
Q 036624          655 IIHRDVKTTNILLDEKWVAKVSDFGLSKTG  684 (893)
Q Consensus       655 ivHrDlk~~NILld~~~~~kl~DFGla~~~  684 (893)
                      +||+|+.+.|||++++  ..+.||+-+...
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhcccC
Confidence            8999999999999754  458899987753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.35  E-value=0.058  Score=55.10  Aligned_cols=158  Identities=11%  Similarity=0.025  Sum_probs=84.7

Q ss_pred             ccCHHHHHHHhcCCccceee-----eecCcEEEEEEEEcCcceEEEEEeCCCCChhhHHHHHHHHHHHhhcccccee--e
Q 036624          521 HFSFAEIKAATNNFDEALLL-----GVGGFGKVYRGEIDGATTKVAIKRGNPLSEQGVHEFQTEIEMLSKLRHRHLV--S  593 (893)
Q Consensus       521 ~~~~~el~~at~~f~~~~~L-----G~G~fG~Vy~g~~~~~~~~VavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv--~  593 (893)
                      .++.+|++....+|...++.     ..|---+.|+.+..++  ..++|+.....  ..++...|+++|..|.+.++.  .
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g--~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~   77 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL   77 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC--cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccc
Confidence            35678888888888765433     3455567899887664  47788765421  223455677777777533221  1


Q ss_pred             EEE------EEeecCEEEEEEeeccCCCHHH--------------HHhhC----CCC----CC-----------------
Q 036624          594 LIG------YCEENCEMILVYDYMAYGTLRE--------------HLYKT----QKP----PL-----------------  628 (893)
Q Consensus       594 l~g------~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~~----~l-----------------  628 (893)
                      .+-      +.........++.++.+.....              .++..    ...    ..                 
T Consensus        78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (316)
T d2ppqa1          78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  157 (316)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence            110      1122344566666665543210              11100    000    00                 


Q ss_pred             CHHhHHHHHHHHHHhhhhhh-cCCCCceEecCCCCCCEEECCCCceeEecccccc
Q 036624          629 PWKQRLEICIGAARGLHYLH-TGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSK  682 (893)
Q Consensus       629 ~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDlk~~NILld~~~~~kl~DFGla~  682 (893)
                      ........+..+...+.-.+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            00111222222222233222 2345789999999999999998777899999775